ID   PVDA_PSEAE              Reviewed;         443 AA.
AC   Q51548;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   08-DEC-2000, sequence version 2.
DT   02-JUN-2021, entry version 116.
DE   RecName: Full=L-ornithine N(5)-monooxygenase {ECO:0000303|PubMed:17900176};
DE            EC=1.14.13.195 {ECO:0000269|PubMed:17015659, ECO:0000269|PubMed:17900176};
DE   AltName: Full=L-ornithine N(5)-hydroxylase {ECO:0000303|PubMed:17015659};
DE            Short=Ornithine hydroxylase {ECO:0000303|PubMed:17900176};
DE   AltName: Full=L-ornithine N(5)-oxygenase {ECO:0000303|PubMed:8106324};
DE   AltName: Full=Pyoverdin biosynthesis protein A {ECO:0000303|PubMed:8106324};
GN   Name=pvdA {ECO:0000303|PubMed:8106324}; Synonyms=pvd-1;
GN   OrderedLocusNames=PA2386;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=8106324; DOI=10.1128/jb.176.4.1128-1140.1994;
RA   Visca P., Ciervo A., Orsi N.;
RT   "Cloning and nucleotide sequence of the pvdA gene encoding the pyoverdin
RT   biosynthetic enzyme L-ornithine N5-oxygenase in Pseudomonas aeruginosa.";
RL   J. Bacteriol. 176:1128-1140(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=17015659; DOI=10.1128/jb.00949-06;
RA   Ge L., Seah S.Y.;
RT   "Heterologous expression, purification, and characterization of an l-
RT   ornithine N(5)-hydroxylase involved in pyoverdine siderophore biosynthesis
RT   in Pseudomonas aeruginosa.";
RL   J. Bacteriol. 188:7205-7210(2006).
RN   [4]
RP   CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17900176; DOI=10.1021/bi700932q;
RA   Meneely K.M., Lamb A.L.;
RT   "Biochemical characterization of a flavin adenine dinucleotide-dependent
RT   monooxygenase, ornithine hydroxylase from Pseudomonas aeruginosa, suggests
RT   a novel reaction mechanism.";
RL   Biochemistry 46:11930-11937(2007).
RN   [5]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF GLY-215.
RX   PubMed=18757814; DOI=10.1099/mic.0.2008/018804-0;
RA   Imperi F., Putignani L., Tiburzi F., Ambrosi C., Cipollone R., Ascenzi P.,
RA   Visca P.;
RT   "Membrane-association determinants of the omega-amino acid monooxygenase
RT   PvdA, a pyoverdine biosynthetic enzyme from Pseudomonas aeruginosa.";
RL   Microbiology 154:2804-2813(2008).
RN   [6]
RP   FUNCTION.
RX   PubMed=19368334; DOI=10.1021/bi900442z;
RA   Meneely K.M., Barr E.W., Bollinger J.M. Jr., Lamb A.L.;
RT   "Kinetic mechanism of ornithine hydroxylase (PvdA) from Pseudomonas
RT   aeruginosa: substrate triggering of O2 addition but not flavin reduction.";
RL   Biochemistry 48:4371-4376(2009).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH FAD; NADP;
RP   L-ORNITHINE AND N(5)-HYDROXY-L-ORNITHINE, AND COFACTOR.
RX   PubMed=21757711; DOI=10.1074/jbc.m111.265876;
RA   Olucha J., Meneely K.M., Chilton A.S., Lamb A.L.;
RT   "Two structures of an N-hydroxylating flavoprotein monooxygenase: ornithine
RT   hydroxylase from Pseudomonas aeruginosa.";
RL   J. Biol. Chem. 286:31789-31798(2011).
CC   -!- FUNCTION: Catalyzes the conversion of L-ornithine to N(5)-
CC       hydroxyornithine, the first step in the biosynthesis of all
CC       hydroxamate-containing siderophores, such as pyoverdin. Pyoverdin is a
CC       hydroxamate siderophore composed of a 6,7-dihydroxyquinoline-containing
CC       fluorescent chromophore joined to the N-terminus of a partly cyclic
CC       octapeptide (D-Ser-L-Arg-D-Ser-L-N(5)-OH-Orn-L-Lys-L-N(5)-OH-Orn-L-Thr-
CC       L-Thr in strain PAO1). Specific for NADPH, which plays a role in
CC       stabilization of the C4a-hydroperoxyflavin intermediate.
CC       {ECO:0000269|PubMed:17015659, ECO:0000269|PubMed:19368334,
CC       ECO:0000269|PubMed:8106324}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-ornithine + NADPH + O2 = H2O + N(5)-hydroxy-L-ornithine +
CC         NADP(+); Xref=Rhea:RHEA:41508, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:46911, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:78275; EC=1.14.13.195;
CC         Evidence={ECO:0000269|PubMed:17015659, ECO:0000269|PubMed:17900176};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:21757711};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:21757711};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.58 mM for L-ornithine {ECO:0000269|PubMed:17015659};
CC         KM=0.6 mM for L-ornithine {ECO:0000269|PubMed:17900176};
CC         KM=160 uM for NADPH {ECO:0000269|PubMed:17015659};
CC         KM=21.9 uM for FAD(+) {ECO:0000269|PubMed:17015659};
CC         Vmax=1.34 umol/min/mg enzyme {ECO:0000269|PubMed:17015659};
CC         Vmax=479 nmol/min/mg enzyme {ECO:0000269|PubMed:17015659};
CC       pH dependence:
CC         Optimum pH is 8.0-8.5. {ECO:0000269|PubMed:17015659,
CC         ECO:0000269|PubMed:17900176};
CC   -!- PATHWAY: Siderophore biosynthesis; pyoverdin biosynthesis.
CC       {ECO:0000269|PubMed:8106324}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:17015659}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane
CC       {ECO:0000269|PubMed:18757814}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:18757814}; Cytoplasmic side
CC       {ECO:0000269|PubMed:18757814}.
CC   -!- SIMILARITY: Belongs to the lysine N(6)-hydroxylase/L-ornithine N(5)-
CC       oxygenase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z25465; CAA80959.1; -; Genomic_DNA.
DR   EMBL; AE004091; AAG05774.1; -; Genomic_DNA.
DR   PIR; A49892; A49892.
DR   PIR; D83346; D83346.
DR   RefSeq; NP_251076.1; NC_002516.2.
DR   RefSeq; WP_003114509.1; NZ_QZGE01000021.1.
DR   PDB; 3S5W; X-ray; 1.90 A; A/B=1-443.
DR   PDB; 3S61; X-ray; 3.03 A; A/B=1-443.
DR   PDBsum; 3S5W; -.
DR   PDBsum; 3S61; -.
DR   SMR; Q51548; -.
DR   IntAct; Q51548; 3.
DR   MINT; Q51548; -.
DR   PaxDb; Q51548; -.
DR   PRIDE; Q51548; -.
DR   EnsemblBacteria; AAG05774; AAG05774; PA2386.
DR   GeneID; 882167; -.
DR   KEGG; pae:PA2386; -.
DR   PATRIC; fig|208964.12.peg.2496; -.
DR   PseudoCAP; PA2386; -.
DR   HOGENOM; CLU_020931_2_0_6; -.
DR   InParanoid; Q51548; -.
DR   OMA; YNDYLRW; -.
DR   PhylomeDB; Q51548; -.
DR   BioCyc; MetaCyc:MONOMER-15307; -.
DR   BioCyc; PAER208964:G1FZ6-2424-MONOMER; -.
DR   BRENDA; 1.14.13.195; 5087.
DR   UniPathway; UPA00019; -.
DR   PHI-base; PHI:6937; -.
DR   PHI-base; PHI:7942; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IDA:PseudoCAP.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016787; F:hydrolase activity; IBA:GO_Central.
DR   GO; GO:0031172; F:ornithine N5-monooxygenase activity; IEA:RHEA.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IBA:GO_Central.
DR   GO; GO:0002049; P:pyoverdine biosynthetic process; IDA:PseudoCAP.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR025700; Lys/Orn_oxygenase.
DR   Pfam; PF13434; K_oxygenase; 1.
DR   SUPFAM; SSF51905; SSF51905; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Cell inner membrane; Cell membrane; FAD; Flavoprotein;
KW   Membrane; Monooxygenase; NADP; Oxidoreductase; Reference proteome.
FT   CHAIN           1..443
FT                   /note="L-ornithine N(5)-monooxygenase"
FT                   /id="PRO_0000204029"
FT   NP_BIND         45..53
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21757711"
FT   NP_BIND         215..218
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:21757711"
FT   NP_BIND         284..286
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:21757711"
FT   NP_BIND         407..409
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21757711"
FT   REGION          254..257
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:21757711"
FT   BINDING         64
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:21757711"
FT   BINDING         69
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:21757711"
FT   BINDING         130
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:21757711"
FT   BINDING         240
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:21757711"
FT   BINDING         284
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:21757711"
FT   BINDING         410
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:21757711"
FT   MUTAGEN         215
FT                   /note="G->D: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:18757814"
FT   CONFLICT        384..443
FT                   /note="TDERCKVAIYAQGFSQASHGLSDTLLSVLPVRAEEISGSLYQHLKPGTAARA
FT                   LHEHALAS -> PTSAARWRSTRRASARPAMASATPCCRCCRCVPRKSPAPCTST (in
FT                   Ref. 1; CAA80959)"
FT                   /evidence="ECO:0000305"
FT   STRAND          10..16
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           20..36
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   STRAND          41..46
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           54..56
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   STRAND          69..72
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   TURN            73..75
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           83..89
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           93..99
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           106..117
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           118..120
FT                   /evidence="ECO:0007829|PDB:3S61"
FT   TURN            121..123
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   STRAND          124..138
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   STRAND          141..151
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   STRAND          156..166
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           176..181
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   STRAND          187..189
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           190..192
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           193..197
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   STRAND          208..213
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           217..229
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   STRAND          233..238
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   STRAND          240..243
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           251..254
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           255..257
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           259..267
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           270..279
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           281..283
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   STRAND          285..288
FT                   /evidence="ECO:0007829|PDB:3S61"
FT   HELIX           290..306
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   STRAND          311..314
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   STRAND          317..325
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   STRAND          328..335
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   TURN            336..338
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   STRAND          341..351
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   TURN            362..364
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           365..370
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   STRAND          390..396
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           399..402
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   TURN            404..407
FT                   /evidence="ECO:0007829|PDB:3S5W"
FT   HELIX           412..427
FT                   /evidence="ECO:0007829|PDB:3S5W"
SQ   SEQUENCE   443 AA;  49478 MW;  3971A2B223802ACA CRC64;
     MTQATATAVV HDLIGVGFGP SNIALAIALQ ERAQAQGALE VLFLDKQGDY RWHGNTLVSQ
     SELQISFLKD LVSLRNPTSP YSFVNYLHKH DRLVDFINLG TFYPCRMEFN DYLRWVASHF
     QEQSRYGEEV LRIEPMLSAG QVEALRVISR NADGEELVRT TRALVVSPGG TPRIPQVFRA
     LKGDGRVFHH SQYLEHMAKQ PCSSGKPMKI AIIGGGQSAA EAFIDLNDSY PSVQADMILR
     ASALKPADDS PFVNEVFAPK FTDLIYSREH AERERLLREY HNTNYSVVDT DLIERIYGVF
     YRQKVSGIPR HAFRCMTTVE RATATAQGIE LALRDAGSGE LSVETYDAVI LATGYERQLH
     RQLLEPLAEY LGDHEIGRDY RLQTDERCKV AIYAQGFSQA SHGLSDTLLS VLPVRAEEIS
     GSLYQHLKPG TAARALHEHA LAS
//
ID   PHR_SYNP6               Reviewed;         484 AA.
AC   P05327; Q5N288;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   02-JUN-2021, entry version 149.
DE   RecName: Full=Deoxyribodipyrimidine photo-lyase;
DE            EC=4.1.99.3;
DE   AltName: Full=DNA photolyase;
DE   AltName: Full=Photoreactivating enzyme;
GN   Name=phr; Synonyms=phrA; OrderedLocusNames=syc1392_c;
OS   Synechococcus sp. (strain ATCC 27144 / PCC 6301 / SAUG 1402/1) (Anacystis
OS   nidulans).
OC   Bacteria; Cyanobacteria; Synechococcales; Synechococcaceae; Synechococcus.
OX   NCBI_TaxID=269084;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2837735; DOI=10.1093/nar/16.10.4447;
RA   Yasui A., Takao M., Oikawa A., Kiener A., Walsh C.T., Eker A.P.M.;
RT   "Cloning and characterization of a photolyase gene from the cyanobacterium
RT   Anacystis nidulans.";
RL   Nucleic Acids Res. 16:4447-4463(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 27144 / PCC 6301 / SAUG 1402/1;
RX   PubMed=17211581; DOI=10.1007/s11120-006-9122-4;
RA   Sugita C., Ogata K., Shikata M., Jikuya H., Takano J., Furumichi M.,
RA   Kanehisa M., Omata T., Sugiura M., Sugita M.;
RT   "Complete nucleotide sequence of the freshwater unicellular cyanobacterium
RT   Synechococcus elongatus PCC 6301 chromosome: gene content and
RT   organization.";
RL   Photosyn. Res. 93:55-67(2007).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-26.
RX   PubMed=2110564;
RA   Eker A.P.M., Kooiman P., Hessels J.K.C., Yasui A.;
RT   "DNA photoreactivating enzyme from the cyanobacterium Anacystis nidulans.";
RL   J. Biol. Chem. 265:8009-8015(1990).
RN   [4]
RP   REVIEW.
RX   PubMed=15721603; DOI=10.1016/j.bbabio.2004.02.010;
RA   Weber S.;
RT   "Light-driven enzymatic catalysis of DNA repair: a review of recent
RT   biophysical studies on photolyase.";
RL   Biochim. Biophys. Acta 1707:1-23(2005).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH FAD AND 8-HDF.
RX   PubMed=9360600; DOI=10.1038/nsb1197-887;
RA   Tamada T., Kitadokoro K., Higuchi Y., Inaka K., Yasui A., de Ruiter P.E.,
RA   Eker A.P., Miki K.;
RT   "Crystal structure of DNA photolyase from Anacystis nidulans.";
RL   Nat. Struct. Biol. 4:887-891(1997).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH FAD, AND SUBUNIT.
RX   PubMed=15213381; DOI=10.1107/s0907444904009321;
RA   Kort R., Komori H., Adachi S., Miki K., Eker A.;
RT   "DNA apophotolyase from Anacystis nidulans: 1.8 A structure, 8-HDF
RT   reconstitution and X-ray-induced FAD reduction.";
RL   Acta Crystallogr. D 60:1205-1213(2004).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-475 IN COMPLEX WITH FAD; 8-HDF
RP   AND DAMAGED DNA.
RX   PubMed=15576622; DOI=10.1126/science.1101598;
RA   Mees A., Klar T., Gnau P., Hennecke U., Eker A.P.M., Carell T.,
RA   Essen L.-O.;
RT   "Crystal structure of a photolyase bound to a CPD-like DNA lesion after in
RT   situ repair.";
RL   Science 306:1789-1793(2004).
CC   -!- FUNCTION: Involved in repair of UV radiation-induced DNA damage.
CC       Catalyzes the light-dependent monomerization (300-600 nm) of cyclobutyl
CC       pyrimidine dimers (in cis-syn configuration), which are formed between
CC       adjacent bases on the same DNA strand upon exposure to ultraviolet
CC       radiation.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Cyclobutadipyrimidine (in DNA) = 2 pyrimidine residues (in
CC         DNA).; EC=4.1.99.3;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- COFACTOR:
CC       Name=coenzyme F420-(gamma-Glu)n; Xref=ChEBI:CHEBI:133980;
CC       Note=Binds 1 coenzyme F420 non-covalently per subunit.;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Absorption:
CC         Abs(max)=440 nm;
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:15213381,
CC       ECO:0000269|PubMed:15576622, ECO:0000269|PubMed:9360600}.
CC   -!- SIMILARITY: Belongs to the DNA photolyase class-1 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X07230; CAA30190.1; -; Genomic_DNA.
DR   EMBL; AP008231; BAD79582.1; -; Genomic_DNA.
DR   RefSeq; WP_011243704.1; NC_006576.1.
DR   PDB; 1OWL; X-ray; 1.80 A; A=1-484.
DR   PDB; 1OWM; X-ray; 2.30 A; A=1-484.
DR   PDB; 1OWN; X-ray; 2.30 A; A=1-484.
DR   PDB; 1OWO; X-ray; 2.30 A; A=1-484.
DR   PDB; 1OWP; X-ray; 2.30 A; A=1-484.
DR   PDB; 1QNF; X-ray; 1.80 A; A=1-484.
DR   PDB; 1TEZ; X-ray; 1.80 A; A/B/C/D=2-475.
DR   PDBsum; 1OWL; -.
DR   PDBsum; 1OWM; -.
DR   PDBsum; 1OWN; -.
DR   PDBsum; 1OWO; -.
DR   PDBsum; 1OWP; -.
DR   PDBsum; 1QNF; -.
DR   PDBsum; 1TEZ; -.
DR   SMR; P05327; -.
DR   STRING; 269084.syc1392_c; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   PRIDE; P05327; -.
DR   EnsemblBacteria; BAD79582; BAD79582; syc1392_c.
DR   KEGG; syc:syc1392_c; -.
DR   eggNOG; COG0415; Bacteria.
DR   OMA; WQWSASS; -.
DR   BioCyc; SELO269084:G1G2F-1501-MONOMER; -.
DR   BRENDA; 4.1.99.3; 325.
DR   EvolutionaryTrace; P05327; -.
DR   Proteomes; UP000001175; Chromosome.
DR   GO; GO:0003904; F:deoxyribodipyrimidine photo-lyase activity; IEA:UniProtKB-EC.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR036134; Crypto/Photolyase_FAD-like_sf.
DR   InterPro; IPR036155; Crypto/Photolyase_N_sf.
DR   InterPro; IPR005101; Cryptochr/Photolyase_FAD-bd.
DR   InterPro; IPR002081; Cryptochrome/DNA_photolyase_1.
DR   InterPro; IPR018394; DNA_photolyase_1_CS_C.
DR   InterPro; IPR006050; DNA_photolyase_N.
DR   InterPro; IPR019947; Photolyase_8HDF.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00875; DNA_photolyase; 1.
DR   Pfam; PF03441; FAD_binding_7; 1.
DR   PRINTS; PR00147; DNAPHOTLYASE.
DR   SUPFAM; SSF48173; SSF48173; 1.
DR   SUPFAM; SSF52425; SSF52425; 1.
DR   TIGRFAMs; TIGR03556; photolyase_8HDF; 1.
DR   PROSITE; PS00394; DNA_PHOTOLYASES_1_1; 1.
DR   PROSITE; PS51645; PHR_CRY_ALPHA_BETA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chromophore; Direct protein sequencing; DNA damage;
KW   DNA repair; DNA-binding; FAD; Flavoprotein; Lyase; Nucleotide-binding.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:2110564"
FT   CHAIN           2..484
FT                   /note="Deoxyribodipyrimidine photo-lyase"
FT                   /id="PRO_0000085112"
FT   DOMAIN          3..132
FT                   /note="Photolyase/cryptochrome alpha/beta"
FT   NP_BIND         240..247
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15213381,
FT                   ECO:0000269|PubMed:15576622, ECO:0000269|PubMed:9360600"
FT   NP_BIND         346..352
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15213381,
FT                   ECO:0000269|PubMed:15576622, ECO:0000269|PubMed:9360600"
FT   NP_BIND         380..382
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15213381,
FT                   ECO:0000269|PubMed:15576622, ECO:0000269|PubMed:9360600"
FT   REGION          36..38
FT                   /note="F420 binding"
FT   REGION          101..109
FT                   /note="F420 binding"
FT   REGION          141..148
FT                   /note="DNA binding"
FT   REGION          283..290
FT                   /note="Interaction with DNA"
FT   REGION          349..350
FT                   /note="Interaction with DNA"
FT   BINDING         51
FT                   /note="F420"
FT   BINDING         228
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15213381,
FT                   ECO:0000269|PubMed:15576622, ECO:0000269|PubMed:9360600"
FT   BINDING         232
FT                   /note="DNA"
FT   BINDING         248
FT                   /note="F420"
FT   BINDING         386
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15213381,
FT                   ECO:0000269|PubMed:15576622, ECO:0000269|PubMed:9360600"
FT   BINDING         411
FT                   /note="DNA"
FT   BINDING         472
FT                   /note="DNA"
FT   SITE            314
FT                   /note="Electron transfer via tryptophanyl radical"
FT                   /evidence="ECO:0000250"
FT   SITE            367
FT                   /note="Electron transfer via tryptophanyl radical"
FT                   /evidence="ECO:0000250"
FT   SITE            390
FT                   /note="Electron transfer via tryptophanyl radical"
FT                   /evidence="ECO:0000250"
FT   CONFLICT        259
FT                   /note="R -> Q (in Ref. 1; CAA30190)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        352
FT                   /note="W -> R (in Ref. 1; CAA30190)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        446
FT                   /note="G -> E (in Ref. 1; CAA30190)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..8
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   STRAND          15..17
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           19..27
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   STRAND          31..37
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           39..42
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           49..69
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   STRAND          73..78
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           80..90
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   STRAND          94..99
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           104..119
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   STRAND          123..127
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   STRAND          130..133
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   TURN            135..137
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           149..158
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           176..182
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           183..185
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           194..196
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           210..222
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           224..227
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           228..231
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           244..248
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           254..267
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           271..296
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           298..302
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           308..311
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           318..325
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           332..344
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           349..361
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           368..375
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           383..392
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   TURN            393..395
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   STRAND          397..399
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           408..415
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           420..425
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           427..429
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           434..439
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           444..447
FT                   /evidence="ECO:0007829|PDB:1OWL"
FT   HELIX           457..474
FT                   /evidence="ECO:0007829|PDB:1OWL"
SQ   SEQUENCE   484 AA;  54462 MW;  2DAC6D9CFD515E3D CRC64;
     MAAPILFWHR RDLRLSDNIG LAAARAQSAQ LIGLFCLDPQ ILQSADMAPA RVAYLQGCLQ
     ELQQRYQQAG SRLLLLQGDP QHLIPQLAQQ LQAEAVYWNQ DIEPYGRDRD GQVAAALKTA
     GIRAVQLWDQ LLHSPDQILS GSGNPYSVYG PFWKNWQAQP KPTPVATPTE LVDLSPEQLT
     AIAPLLLSEL PTLKQLGFDW DGGFPVEPGE TAAIARLQEF CDRAIADYDP QRNFPAEAGT
     SGLSPALKFG AIGIRQAWRA ASAAHALSRS DEARNSIRVW QQELAWREFY QHALYHFPSL
     ADGPYRSLWQ QFPWENREAL FTAWTQAQTG YPIVDAAMRQ LTETGWMHNR CWMIVASFLT
     KDLIIDWRRG EQFFMQHLVD GDLAANNGGW QWSASSGMDP KPLRIFNPAS QAKKFDATAT
     YIKRWLPELR HVHPKDLISG EITPIGRRGY PAPIVNHNLR QKQFKALYNQ LKAAIAEPEA
     EPDS
//
ID   POXB_ECOLI              Reviewed;         572 AA.
AC   P07003; Q47513; Q47514; Q47515; Q47516; Q47517; Q47518; Q47519; Q47520;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1988, sequence version 1.
DT   02-JUN-2021, entry version 175.
DE   RecName: Full=Pyruvate dehydrogenase [ubiquinone] {ECO:0000255|HAMAP-Rule:MF_00850};
DE            EC=1.2.5.1 {ECO:0000255|HAMAP-Rule:MF_00850, ECO:0000269|PubMed:18988747, ECO:0000269|PubMed:2663858};
DE   AltName: Full=Pyruvate oxidase {ECO:0000255|HAMAP-Rule:MF_00850};
DE            Short=POX {ECO:0000255|HAMAP-Rule:MF_00850};
DE   AltName: Full=Pyruvate:ubiquinone-8 oxidoreductase {ECO:0000255|HAMAP-Rule:MF_00850};
GN   Name=poxB {ECO:0000255|HAMAP-Rule:MF_00850};
GN   OrderedLocusNames=b0871, JW0855;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=3016647; DOI=10.1093/nar/14.13.5449;
RA   Grabau C., Cronan J.E. Jr.;
RT   "Nucleotide sequence and deduced amino acid sequence of Escherichia coli
RT   pyruvate oxidase, a lipid-activated flavoprotein.";
RL   Nucleic Acids Res. 14:5449-5460(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=8905232; DOI=10.1093/dnares/3.3.137;
RA   Oshima T., Aiba H., Baba T., Fujita K., Hayashi K., Honjo A., Ikemoto K.,
RA   Inada T., Itoh T., Kajihara M., Kanai K., Kashimoto K., Kimura S.,
RA   Kitagawa M., Makino K., Masuda S., Miki T., Mizobuchi K., Mori H.,
RA   Motomura K., Nakamura Y., Nashimoto H., Nishio Y., Saito N., Sampei G.,
RA   Seki Y., Tagami H., Takemoto K., Wada C., Yamamoto Y., Yano M.,
RA   Horiuchi T.;
RT   "A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to
RT   the 12.7-28.0 min region on the linkage map.";
RL   DNA Res. 3:137-155(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], CATALYTIC ACTIVITY, ACTIVITY REGULATION,
RP   MUTAGENESIS OF ALA-533; ALA-553; ASP-560; 564-GLU--ARG-572; GLU-564;
RP   570-TRP--ARG-572 AND ARG-572, AND LIPID-BINDING.
RC   STRAIN=K12;
RX   PubMed=2663858;
RA   Grabau C., Chang Y.Y., Cronan J.E. Jr.;
RT   "Lipid binding by Escherichia coli pyruvate oxidase is disrupted by small
RT   alterations of the carboxyl-terminal region.";
RL   J. Biol. Chem. 264:12510-12519(1989).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 550-572, PROTEIN SEQUENCE OF 1-20 AND
RP   550-570, AND ACTIVATION BY PROTEOLYTIC CLEAVAGE IN VITRO.
RC   STRAIN=K12;
RX   PubMed=3902830;
RA   Recny M.A., Grabau C., Cronan J.E. Jr., Hager L.P.;
RT   "Characterization of the alpha-peptide released upon protease activation of
RT   pyruvate oxidase.";
RL   J. Biol. Chem. 260:14287-14291(1985).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22, AND INDUCTION.
RX   PubMed=8022274; DOI=10.1111/j.1365-2958.1994.tb00380.x;
RA   Chang Y.Y., Wang A.Y., Cronan J.E. Jr.;
RT   "Expression of Escherichia coli pyruvate oxidase (PoxB) depends on the
RT   sigma factor encoded by the rpoS(katF) gene.";
RL   Mol. Microbiol. 11:1019-1028(1994).
RN   [8]
RP   CATALYTIC ACTIVITY, COFACTOR, SUBCELLULAR LOCATION, SUBUNIT, AND ACTIVATION
RP   BY PROTEOLYSIS IN VITRO.
RX   PubMed=5336022; DOI=10.1016/0003-9861(66)90025-7;
RA   Williams F.R., Hager L.P.;
RT   "Crystalline flavin pyruvate oxidase from Escherichia coli. I. Isolation
RT   and properties of the flavoprotein.";
RL   Arch. Biochem. Biophys. 116:168-176(1966).
RN   [9]
RP   ACTIVATION BY PROTEOLYSIS IN VITRO.
RC   STRAIN=W;
RX   PubMed=334770;
RA   Russell P., Hager L.P., Gennis R.B.;
RT   "Characterization of the proteolytic activation of pyruvate oxidase.
RT   Control by specific ligands and by the flavin oxidation-reduction state.";
RL   J. Biol. Chem. 252:7877-7882(1977).
RN   [10]
RP   ACTIVITY REGULATION, ACTIVATION BY PROTEOLYSIS IN VITRO, AND LIPID-BINDING.
RC   STRAIN=W;
RX   PubMed=334771;
RA   Russell P., Schrock H.L., Gennis R.B.;
RT   "Lipid activation and protease activation of pyruvate oxidase. Evidence
RT   suggesting a common site of interaction on the protein.";
RL   J. Biol. Chem. 252:7883-7887(1977).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RC   STRAIN=B;
RX   PubMed=365232; DOI=10.1021/bi00619a004;
RA   Shaw-Goldstein L.A., Gennis R.B., Walsh C.;
RT   "Identification, localization, and function of the thiamin pyrophosphate
RT   and flavin adenine dinucleotide dependent pyruvate oxidase in isolated
RT   membrane vesicles of Escherichia coli B.";
RL   Biochemistry 17:5605-5613(1978).
RN   [12]
RP   CATALYTIC ACTIVITY, ENZYME KINETICS, METAL COFACTOR, AND THIAMINE
RP   DIPHOSPHATE COFACTOR.
RX   PubMed=6286628;
RA   Blake R. II, O'Brien T.A., Gennis R.B., Hager L.P.;
RT   "Role of the divalent metal cation in the pyruvate oxidase reaction.";
RL   J. Biol. Chem. 257:9605-9611(1982).
RN   [13]
RP   CATALYTIC ACTIVITY, SUBUNIT, AND FAD COFACTOR.
RX   PubMed=6752142;
RA   Recny M.A., Hager L.P.;
RT   "Reconstitution of native Escherichia coli pyruvate oxidase from apoenzyme
RT   monomers and FAD.";
RL   J. Biol. Chem. 257:12878-12886(1982).
RN   [14]
RP   ACTIVITY REGULATION.
RX   PubMed=6385860; DOI=10.1016/0003-9861(84)90506-x;
RA   Kiuchi K., Hager L.P.;
RT   "Reconstitution of the lipid-depleted pyruvate oxidase system of
RT   Escherichia coli: the palmitic acid effect.";
RL   Arch. Biochem. Biophys. 233:776-784(1984).
RN   [15]
RP   CATALYTIC ACTIVITY, PROTEOLYTIC CLEAVAGE IS NOT RELEVANT IN VIVO, AND
RP   MUTAGENESIS OF 549-TYR--ARG-570.
RX   PubMed=3527254; DOI=10.1021/bi00361a003;
RA   Grabau C., Cronan J.E. Jr.;
RT   "In vivo function of Escherichia coli pyruvate oxidase specifically
RT   requires a functional lipid binding site.";
RL   Biochemistry 25:3748-3751(1986).
RN   [16]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R., Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [17]
RP   FUNCTION, INDUCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=16080684; DOI=10.1021/bp050073s;
RA   Dittrich C.R., Bennett G.N., San K.Y.;
RT   "Characterization of the acetate-producing pathways in Escherichia coli.";
RL   Biotechnol. Prog. 21:1062-1067(2005).
RN   [18] {ECO:0007744|PDB:3EY9, ECO:0007744|PDB:3EYA}
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) IN COMPLEX WITH FAD; MAGNESIUM AND
RP   THIAMINE PYROPHOSPHATE, X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 1-549 IN
RP   COMPLEX WITH FAD; MAGNESIUM AND THIAMINE PYROPHOSPHATE, FUNCTION, CATALYTIC
RP   ACTIVITY, COFACTOR, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   SUBUNIT, AND DOMAIN.
RX   PubMed=18988747; DOI=10.1073/pnas.0805027105;
RA   Neumann P., Weidner A., Pech A., Stubbs M.T., Tittmann K.;
RT   "Structural basis for membrane binding and catalytic activation of the
RT   peripheral membrane enzyme pyruvate oxidase from Escherichia coli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:17390-17395(2008).
CC   -!- FUNCTION: A peripheral cell membrane enzyme that catalyzes the
CC       oxidative decarboxylation of pyruvate to form acetate and CO(2). It
CC       channels electrons from the cytoplasm to the respiratory chain at the
CC       cell membrane via ubiquinone (By similarity) (PubMed:18988747,
CC       PubMed:2663858, PubMed:365232). The main pathway for acetate production
CC       during stationary phase (PubMed:16080684). {ECO:0000255|HAMAP-
CC       Rule:MF_00850, ECO:0000269|PubMed:16080684,
CC       ECO:0000269|PubMed:18988747, ECO:0000269|PubMed:2663858,
CC       ECO:0000269|PubMed:365232}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ubiquinone + H2O + pyruvate = a ubiquinol + acetate + CO2;
CC         Xref=Rhea:RHEA:27405, Rhea:RHEA-COMP:9565, Rhea:RHEA-COMP:9566,
CC         ChEBI:CHEBI:15361, ChEBI:CHEBI:15377, ChEBI:CHEBI:16389,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:17976, ChEBI:CHEBI:30089; EC=1.2.5.1;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00850,
CC         ECO:0000269|PubMed:18988747, ECO:0000269|PubMed:2663858,
CC         ECO:0000269|PubMed:3527254, ECO:0000269|PubMed:365232,
CC         ECO:0000269|PubMed:6286628, ECO:0000269|PubMed:6752142,
CC         ECO:0000305|PubMed:5336022};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00850,
CC         ECO:0000269|PubMed:5336022, ECO:0000269|PubMed:6752142};
CC       Note=Binds 1 FAD per subunit. {ECO:0000255|HAMAP-Rule:MF_00850,
CC       ECO:0000269|PubMed:6752142};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00850,
CC         ECO:0000269|PubMed:5336022, ECO:0000269|PubMed:6286628,
CC         ECO:0000269|PubMed:6752142};
CC       Note=Binds 1 Mg(2+) ion per subunit; Mn(2+) is also functional. The
CC       Me2+-thiamine diphosphate complex is the true cofactor.
CC       {ECO:0000255|HAMAP-Rule:MF_00850, ECO:0000269|PubMed:6286628,
CC       ECO:0000269|PubMed:6752142};
CC   -!- COFACTOR:
CC       Name=thiamine diphosphate; Xref=ChEBI:CHEBI:58937;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00850,
CC         ECO:0000269|PubMed:18988747, ECO:0000269|PubMed:5336022,
CC         ECO:0000269|PubMed:6286628};
CC       Note=Binds 1 thiamine pyrophosphate per subunit. {ECO:0000255|HAMAP-
CC       Rule:MF_00850, ECO:0000269|PubMed:18988747,
CC       ECO:0000269|PubMed:6286628};
CC   -!- ACTIVITY REGULATION: The C-terminus inhibits activity; it has to move
CC       for the enzyme to be active (PubMed:18988747). Activated by lipid-
CC       binding, which occurs via the C-terminus; detergents also activate the
CC       enzyme (PubMed:334770, PubMed:334771, PubMed:2663858, PubMed:18988747).
CC       Specifically activated by palmitic acid; 12 (lauric) and 14-carbon
CC       (myristic) fatty acids as well as unsaturated 16 and 18-carbon fatty
CC       acids also activate the enzyme (PubMed:6385860). Lipid affinity is
CC       increased in the presence of pyruvate plus the thiamine pyrophosphate
CC       cofactor (PubMed:334770, PubMed:334771, PubMed:2663858,
CC       PubMed:18988747). {ECO:0000255|HAMAP-Rule:MF_00850,
CC       ECO:0000269|PubMed:18988747, ECO:0000269|PubMed:2663858,
CC       ECO:0000269|PubMed:334770, ECO:0000269|PubMed:334771,
CC       ECO:0000269|PubMed:6385860}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=90 mM for pyruvate, non-activated form
CC         {ECO:0000269|PubMed:18988747};
CC         KM=12 mM for pyruvate, activated form {ECO:0000269|PubMed:18988747};
CC         Note=kcat is 7 sec(-1) for non-activated, 200 sec(-1) for activated
CC         form. {ECO:0000269|PubMed:18988747};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000255|HAMAP-Rule:MF_00850,
CC       ECO:0000269|PubMed:18988747, ECO:0000269|PubMed:6752142,
CC       ECO:0000305|PubMed:5336022}.
CC   -!- INTERACTION:
CC       P07003; P07003: poxB; NbExp=3; IntAct=EBI-909338, EBI-909338;
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_00850, ECO:0000269|PubMed:365232, ECO:0000305|PubMed:5336022};
CC       Peripheral membrane protein {ECO:0000255|HAMAP-Rule:MF_00850,
CC       ECO:0000269|PubMed:365232, ECO:0000305|PubMed:5336022}; Cytoplasmic
CC       side {ECO:0000255|HAMAP-Rule:MF_00850, ECO:0000269|PubMed:365232}.
CC   -!- INDUCTION: Activity is maximal in late exponential and early stationary
CC       phase (at protein level) (PubMed:8022274, PubMed:16080684). Expression
CC       increases at pH 6.0 (PubMed:16080684). Under control of rpoS (at
CC       protein level). Transcribed at lower levels during anaerobic growth
CC       (PubMed:8022274). {ECO:0000269|PubMed:16080684,
CC       ECO:0000269|PubMed:8022274}.
CC   -!- DOMAIN: Has 4 domains; the Pyr domain which binds the pyrimidine moiety
CC       of the thiamine pyrophosphate cofactor, the FAD-binding domain, the PP-
CC       binding domain which binds the pyrophosphate portion of thiamine
CC       pyrophosphate and the C-terminal membrane binding region, which
CC       includes the in vitro-derived alpha-peptide (residues 550-572). The C-
CC       terminus is held closely against the rest of the protein and covers the
CC       active site; during activation it detaches from the rest of the protein
CC       and folds into an amphipathic helix upon membrane binding. Comparison
CC       of full-length and proteolyzed structures shows activation is a result
CC       of conformational changes that expose the active site.
CC       {ECO:0000269|PubMed:18988747}.
CC   -!- PTM: Activated by limited proteolytic digestion in vitro. This cleavage
CC       produces a peptide (alpha-peptide) and mimics the activation of enzyme
CC       by phospholipids (PubMed:5336022, PubMed:3902830, PubMed:334770,
CC       PubMed:334771). Protease activation and lipid-activation are mutually
CC       exclusive. Proteolytic cleavage results in the loss of the high
CC       affinity lipid-binding site of the enzyme; the cleaved protein is no
CC       longer activated by lipids or detergents (PubMed:334771,
CC       PubMed:2663858). The proteolytically cleaved enzyme does not represent
CC       a functional cleavage in vivo (PubMed:3527254).
CC       {ECO:0000269|PubMed:2663858, ECO:0000269|PubMed:334770,
CC       ECO:0000269|PubMed:334771, ECO:0000269|PubMed:3527254,
CC       ECO:0000269|PubMed:3902830, ECO:0000269|PubMed:5336022}.
CC   -!- DISRUPTION PHENOTYPE: Not essential it can be deleted.
CC       {ECO:0000269|PubMed:16080684}.
CC   -!- SIMILARITY: Belongs to the TPP enzyme family. {ECO:0000255|HAMAP-
CC       Rule:MF_00850}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X04105; CAA27725.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC73958.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA35585.1; -; Genomic_DNA.
DR   EMBL; S73268; AAB31180.1; -; Genomic_DNA.
DR   EMBL; M28208; AAB59101.1; -; Genomic_DNA.
DR   EMBL; L47688; AAB59102.1; -; Genomic_DNA.
DR   EMBL; L47689; AAB59103.1; -; Genomic_DNA.
DR   EMBL; L47690; AAB59104.1; -; Genomic_DNA.
DR   EMBL; L47691; AAB59105.1; -; Genomic_DNA.
DR   EMBL; L47692; AAB59106.1; -; Genomic_DNA.
DR   EMBL; L47693; AAB59107.1; -; Genomic_DNA.
DR   EMBL; L47694; AAB59108.1; -; Genomic_DNA.
DR   EMBL; L47695; AAB59109.1; -; Genomic_DNA.
DR   PIR; A23648; DEECPC.
DR   RefSeq; NP_415392.1; NC_000913.3.
DR   RefSeq; WP_000815337.1; NZ_SSZK01000002.1.
DR   PDB; 3EY9; X-ray; 2.90 A; A/B=1-572.
DR   PDB; 3EYA; X-ray; 2.50 A; A/B/C/D/E/F/G/H/I/J/K/L=1-549.
DR   PDBsum; 3EY9; -.
DR   PDBsum; 3EYA; -.
DR   SMR; P07003; -.
DR   BioGRID; 4262101; 20.
DR   BioGRID; 850492; 1.
DR   DIP; DIP-36216N; -.
DR   IntAct; P07003; 4.
DR   STRING; 511145.b0871; -.
DR   ChEMBL; CHEMBL3380; -.
DR   SWISS-2DPAGE; P07003; -.
DR   jPOST; P07003; -.
DR   PaxDb; P07003; -.
DR   PRIDE; P07003; -.
DR   EnsemblBacteria; AAC73958; AAC73958; b0871.
DR   EnsemblBacteria; BAA35585; BAA35585; BAA35585.
DR   GeneID; 946132; -.
DR   KEGG; ecj:JW0855; -.
DR   KEGG; eco:b0871; -.
DR   PATRIC; fig|1411691.4.peg.1406; -.
DR   EchoBASE; EB0747; -.
DR   eggNOG; COG0028; Bacteria.
DR   HOGENOM; CLU_013748_3_0_6; -.
DR   InParanoid; P07003; -.
DR   PhylomeDB; P07003; -.
DR   BioCyc; EcoCyc:PYRUVOXID-MONOMER; -.
DR   BioCyc; MetaCyc:PYRUVOXID-MONOMER; -.
DR   BRENDA; 1.2.5.1; 2026.
DR   EvolutionaryTrace; P07003; -.
DR   PRO; PR:P07003; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032991; C:protein-containing complex; IDA:EcoCyc.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:EcoCyc.
DR   GO; GO:0042802; F:identical protein binding; IDA:EcoCyc.
DR   GO; GO:0008289; F:lipid binding; IDA:EcoCyc.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:EcoCyc.
DR   GO; GO:0052737; F:pyruvate dehydrogenase (quinone) activity; IDA:EcoCyc.
DR   GO; GO:0030976; F:thiamine pyrophosphate binding; IDA:EcoCyc.
DR   GO; GO:0048039; F:ubiquinone binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0042867; P:pyruvate catabolic process; IMP:EcoCyc.
DR   GO; GO:0006090; P:pyruvate metabolic process; IMP:EcoCyc.
DR   HAMAP; MF_00850; POX; 1.
DR   InterPro; IPR029035; DHS-like_NAD/FAD-binding_dom.
DR   InterPro; IPR044261; PoxB-like.
DR   InterPro; IPR029061; THDP-binding.
DR   InterPro; IPR012000; Thiamin_PyroP_enz_cen_dom.
DR   InterPro; IPR012001; Thiamin_PyroP_enz_TPP-bd_dom.
DR   InterPro; IPR000399; TPP-bd_CS.
DR   InterPro; IPR011766; TPP_enzyme-bd_C.
DR   Pfam; PF02775; TPP_enzyme_C; 1.
DR   Pfam; PF00205; TPP_enzyme_M; 1.
DR   Pfam; PF02776; TPP_enzyme_N; 1.
DR   SUPFAM; SSF52467; SSF52467; 1.
DR   SUPFAM; SSF52518; SSF52518; 2.
DR   PROSITE; PS00187; TPP_ENZYMES; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell inner membrane; Cell membrane;
KW   Direct protein sequencing; FAD; Flavoprotein; Lipid-binding; Magnesium;
KW   Membrane; Metal-binding; Nucleotide-binding; Oxidoreductase; Pyruvate;
KW   Reference proteome; Thiamine pyrophosphate; Ubiquinone.
FT   CHAIN           1..572
FT                   /note="Pyruvate dehydrogenase [ubiquinone]"
FT                   /id="PRO_0000044606"
FT   NP_BIND         234..235
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18988747,
FT                   ECO:0007744|PDB:3EY9, ECO:0007744|PDB:3EYA"
FT   NP_BIND         251..254
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00850,
FT                   ECO:0000269|PubMed:18988747, ECO:0007744|PDB:3EY9,
FT                   ECO:0007744|PDB:3EYA"
FT   NP_BIND         274..278
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00850,
FT                   ECO:0000269|PubMed:18988747, ECO:0007744|PDB:3EY9,
FT                   ECO:0007744|PDB:3EYA"
FT   NP_BIND         311..312
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18988747,
FT                   ECO:0007744|PDB:3EY9, ECO:0007744|PDB:3EYA"
FT   NP_BIND         403..404
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18988747,
FT                   ECO:0007744|PDB:3EY9, ECO:0007744|PDB:3EYA"
FT   REGION          1..182
FT                   /note="Pyr domain"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00850,
FT                   ECO:0000269|PubMed:18988747"
FT   REGION          183..334
FT                   /note="FAD-binding domain"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00850,
FT                   ECO:0000269|PubMed:18988747"
FT   REGION          335..530
FT                   /note="PP-binding domain"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00850,
FT                   ECO:0000269|PubMed:18988747"
FT   REGION          406..408
FT                   /note="Thiamine pyrophosphate binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00850,
FT                   ECO:0000269|PubMed:18988747, ECO:0007744|PDB:3EY9,
FT                   ECO:0007744|PDB:3EYA"
FT   REGION          433..435
FT                   /note="Thiamine pyrophosphate binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00850,
FT                   ECO:0000269|PubMed:18988747, ECO:0007744|PDB:3EY9,
FT                   ECO:0007744|PDB:3EYA"
FT   REGION          460..466
FT                   /note="Thiamine pyrophosphate binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00850,
FT                   ECO:0000269|PubMed:18988747, ECO:0007744|PDB:3EY9,
FT                   ECO:0007744|PDB:3EYA"
FT   REGION          531..572
FT                   /note="Membrane-binding domain"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00850,
FT                   ECO:0000269|PubMed:18988747"
FT   METAL           433
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00850,
FT                   ECO:0000269|PubMed:18988747, ECO:0007744|PDB:3EY9,
FT                   ECO:0007744|PDB:3EYA"
FT   METAL           460
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00850,
FT                   ECO:0000269|PubMed:18988747, ECO:0007744|PDB:3EY9,
FT                   ECO:0007744|PDB:3EYA"
FT   METAL           462
FT                   /note="Magnesium; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:18988747,
FT                   ECO:0007744|PDB:3EY9, ECO:0007744|PDB:3EYA"
FT   BINDING         50
FT                   /note="Thiamine pyrophosphate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00850,
FT                   ECO:0000269|PubMed:18988747, ECO:0007744|PDB:3EY9,
FT                   ECO:0007744|PDB:3EYA"
FT   BINDING         210
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18988747,
FT                   ECO:0007744|PDB:3EY9, ECO:0007744|PDB:3EYA"
FT   BINDING         292
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00850,
FT                   ECO:0000269|PubMed:18988747, ECO:0007744|PDB:3EY9,
FT                   ECO:0007744|PDB:3EYA"
FT   BINDING         297
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18988747,
FT                   ECO:0007744|PDB:3EY9, ECO:0007744|PDB:3EYA"
FT   BINDING         382
FT                   /note="Thiamine pyrophosphate"
FT                   /evidence="ECO:0000269|PubMed:18988747,
FT                   ECO:0007744|PDB:3EY9, ECO:0007744|PDB:3EYA"
FT   SITE            465
FT                   /note="Moves into active site upon enzyme activation, plays
FT                   a role in electron transfer"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00850,
FT                   ECO:0000269|PubMed:18988747"
FT   SITE            549..550
FT                   /note="In vitro cleavage to yield alpha-peptide"
FT                   /evidence="ECO:0000269|PubMed:3902830"
FT   MUTAGEN         533
FT                   /note="A->T: In poxB11; poor activity in vivo, no longer
FT                   activated by lipids."
FT                   /evidence="ECO:0000269|PubMed:2663858"
FT   MUTAGEN         549..572
FT                   /note="Missing: In poxB6. Inactive in vivo, does not
FT                   complement inactive mutants. Active in vitro, no longer
FT                   activated by nor binds to, detergents."
FT                   /evidence="ECO:0000269|PubMed:2663858,
FT                   ECO:0000269|PubMed:5336022"
FT   MUTAGEN         553
FT                   /note="A->V: In poxB14; poor activity in vivo, no longer
FT                   activated by lipids."
FT                   /evidence="ECO:0000269|PubMed:2663858"
FT   MUTAGEN         560
FT                   /note="D->P: In poxB15; normal activity."
FT                   /evidence="ECO:0000269|PubMed:2663858"
FT   MUTAGEN         564..572
FT                   /note="Missing: In poxB7 Inactive in vivo, reduced activity
FT                   in vitro."
FT                   /evidence="ECO:0000269|PubMed:2663858"
FT   MUTAGEN         564
FT                   /note="E->P: In poxB16; loss of activity, weakly activated
FT                   by cleavage."
FT                   /evidence="ECO:0000269|PubMed:2663858"
FT   MUTAGEN         570..572
FT                   /note="Missing: In poxB8; reduced activity in vitro, not
FT                   activated by lipids."
FT                   /evidence="ECO:0000269|PubMed:2663858"
FT   MUTAGEN         572
FT                   /note="R->G: In poxB10; reduced activity in vivo and in
FT                   vitro; may interact less with membranes."
FT                   /evidence="ECO:0000269|PubMed:2663858"
FT   CONFLICT        364..365
FT                   /note="QQ -> HE (in Ref. 5; AAB59101/AAB59102)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        414..416
FT                   /note="QAL -> HGV (in Ref. 5; AAB59101/AAB59102)"
FT                   /evidence="ECO:0000305"
FT   HELIX           5..15
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          20..23
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           27..29
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           30..39
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          41..46
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           50..64
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          68..72
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           76..79
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           82..90
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          95..102
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           104..106
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           117..120
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   TURN            121..124
FT                   /evidence="ECO:0007829|PDB:3EY9"
FT   STRAND          126..130
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           134..136
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           137..150
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          153..160
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           161..164
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          183..185
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           188..199
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          203..208
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           210..212
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           216..226
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          230..232
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           234..236
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           237..240
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          241..243
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          247..250
FT                   /evidence="ECO:0007829|PDB:3EY9"
FT   HELIX           257..265
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          267..273
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           279..281
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          284..293
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           295..297
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          300..302
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          305..309
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           312..319
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           320..322
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           330..348
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          349..351
FT                   /evidence="ECO:0007829|PDB:3EY9"
FT   STRAND          354..357
FT                   /evidence="ECO:0007829|PDB:3EY9"
FT   HELIX           359..369
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          375..378
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           382..390
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          398..400
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   TURN            403..405
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           411..421
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          427..432
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           433..438
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           440..442
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           443..448
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          454..459
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          461..466
FT                   /evidence="ECO:0007829|PDB:3EY9"
FT   STRAND          468..470
FT                   /evidence="ECO:0007829|PDB:3EY9"
FT   TURN            478..480
FT                   /evidence="ECO:0007829|PDB:3EY9"
FT   HELIX           487..493
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          496..501
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           504..506
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           507..516
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          517..519
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   STRAND          521..527
FT                   /evidence="ECO:0007829|PDB:3EYA"
FT   HELIX           536..542
FT                   /evidence="ECO:0007829|PDB:3EY9"
FT   TURN            543..545
FT                   /evidence="ECO:0007829|PDB:3EY9"
FT   HELIX           548..550
FT                   /evidence="ECO:0007829|PDB:3EY9"
FT   STRAND          551..555
FT                   /evidence="ECO:0007829|PDB:3EY9"
FT   STRAND          559..564
FT                   /evidence="ECO:0007829|PDB:3EY9"
SQ   SEQUENCE   572 AA;  62011 MW;  57B38B9E3A92BDEA CRC64;
     MKQTVAAYIA KTLESAGVKR IWGVTGDSLN GLSDSLNRMG TIEWMSTRHE EVAAFAAGAE
     AQLSGELAVC AGSCGPGNLH LINGLFDCHR NHVPVLAIAA HIPSSEIGSG YFQETHPQEL
     FRECSHYCEL VSSPEQIPQV LAIAMRKAVL NRGVSVVVLP GDVALKPAPE GATMHWYHAP
     QPVVTPEEEE LRKLAQLLRY SSNIALMCGS GCAGAHKELV EFAGKIKAPI VHALRGKEHV
     EYDNPYDVGM TGLIGFSSGF HTMMNADTLV LLGTQFPYRA FYPTDAKIIQ IDINPASIGA
     HSKVDMALVG DIKSTLRALL PLVEEKADRK FLDKALEDYR DARKGLDDLA KPSEKAIHPQ
     YLAQQISHFA ADDAIFTCDV GTPTVWAARY LKMNGKRRLL GSFNHGSMAN AMPQALGAQA
     TEPERQVVAM CGDGGFSMLM GDFLSVVQMK LPVKIVVFNN SVLGFVAMEM KAGGYLTDGT
     ELHDTNFARI AEACGITGIR VEKASEVDEA LQRAFSIDGP VLVDVVVAKE ELAIPPQIKL
     EQAKGFSLYM LRAIISGRGD EVIELAKTNW LR
//
ID   OXDA_PIG                Reviewed;         347 AA.
AC   P00371;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 2.
DT   02-JUN-2021, entry version 169.
DE   RecName: Full=D-amino-acid oxidase;
DE            Short=DAAO;
DE            Short=DAMOX;
DE            Short=DAO;
DE            EC=1.4.3.3;
GN   Name=DAO;
OS   Sus scrofa (Pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae; Sus.
OX   NCBI_TaxID=9823;
RN   [1]
RP   PROTEIN SEQUENCE.
RC   TISSUE=Kidney;
RX   PubMed=6124543;
RA   Ronchi S., Minchiotti L., Galliano M., Curti B., Swenson R.P.,
RA   Williams C.H. Jr., Massey V.;
RT   "The primary structure of D-amino acid oxidase from pig kidney. II.
RT   Isolation and sequence of overlap peptides and the complete sequence.";
RL   J. Biol. Chem. 257:8824-8834(1982).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=2888479; DOI=10.1021/bi00386a054;
RA   Fukui K., Watanabe F., Shibata T., Miyake Y.;
RT   "Molecular cloning and sequence analysis of cDNAs encoding porcine kidney
RT   D-amino acid oxidase.";
RL   Biochemistry 26:3612-3618(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=2893757; DOI=10.1016/0378-1119(87)90266-6;
RA   Jacobs P., Brockly F., Massaer M., Loriau R., Guillaume J.P.,
RA   Ciccarelli E., Heinderyckx M., Cravador A., Biemans R., van Elsen A.,
RA   Herzog A., Bollen A.;
RT   "Porcine D-amino acid oxidase: determination of the mRNA nucleotide
RT   sequence by the characterization of genomic and cDNA clones.";
RL   Gene 59:55-61(1987).
RN   [4]
RP   PROTEIN SEQUENCE.
RC   TISSUE=Kidney;
RX   PubMed=2905598; DOI=10.1042/bj2550907;
RA   Nicholson B.H., Batra S.P.;
RT   "Structural interpretation of the binding of 9-azidoacridine to D-amino
RT   acid oxidase.";
RL   Biochem. J. 255:907-912(1988).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 1-14.
RX   PubMed=2575382; DOI=10.1016/0006-291x(89)92762-9;
RA   Watanabe F., Fukui K., Momoi K., Miyake Y.;
RT   "Expression of normal and abnormal porcine kidney D-amino acid oxidase in
RT   Escherichia coli: purification and characterization of the enzymes.";
RL   Biochem. Biophys. Res. Commun. 165:1422-1427(1989).
RN   [6]
RP   CATALYTIC ACTIVITY, COFACTOR, AND INHIBITION BY CHEMICAL MODIFICATION.
RX   PubMed=6120171;
RA   Swenson R.P., Williams C.H. Jr., Massey V.;
RT   "Chemical modification of D-amino acid oxidase. Amino acid sequence of the
RT   tryptic peptides containing tyrosine and lysine residues modified by
RT   fluorodinitrobenzene.";
RL   J. Biol. Chem. 257:1937-1944(1982).
RN   [7]
RP   CATALYTIC ACTIVITY, AND INHIBITION BY CHEMICAL MODIFICATION.
RX   PubMed=6129252;
RA   Swenson R.P., Williams C.H. Jr., Massey V.;
RT   "Identification of the histidine residue in D-amino acid oxidase that is
RT   covalently modified during inactivation by 5-dimethylaminonaphthalene-1-
RT   sulfonyl chloride.";
RL   J. Biol. Chem. 258:497-502(1983).
RN   [8]
RP   MUTAGENESIS OF TYR-55; MET-110 AND HIS-217.
RX   PubMed=2901989; DOI=10.1016/0014-5793(88)80494-0;
RA   Watanabe F., Fukui K., Momoi K., Miyake Y.;
RT   "Effect of site-specific mutagenesis of tyrosine-55, methionine-110 and
RT   histidine-217 in porcine kidney D-amino acid oxidase on its catalytic
RT   function.";
RL   FEBS Lett. 238:269-272(1988).
RN   [9]
RP   CATALYTIC ACTIVITY, AND MUTAGENESIS OF TYR-228 AND HIS-307.
RX   PubMed=1673125; DOI=10.1093/oxfordjournals.jbchem.a123340;
RA   Miyano M., Fukui K., Watanabe F., Takahashi S., Tada M., Kanashiro M.,
RA   Miyake Y.;
RT   "Studies on Phe-228 and Leu-307 recombinant mutants of porcine kidney D-
RT   amino acid oxidase: expression, purification, and characterization.";
RL   J. Biochem. 109:171-177(1991).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RX   PubMed=8864836; DOI=10.1093/oxfordjournals.jbchem.a021376;
RA   Mizutani H., Miyahara I., Hirotsu K., Nishima Y., Shiga K., Setoyama C.,
RA   Miura R.;
RT   "Three-dimensional structure of porcine kidney D-amino acid oxidase at 3.0-
RT   A resolution.";
RL   J. Biochem. 120:14-17(1996).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH FAD AND BENZOATE.
RX   PubMed=8755502; DOI=10.1073/pnas.93.15.7496;
RA   Mattevi A., Vanoni M.A., Todone F., Rizzi M., Teplyakov A., Coda A.,
RA   Bolognesi M., Curti B.;
RT   "Crystal structure of D-amino acid oxidase: a case of active site mirror-
RT   image convergent evolution with flavocytochrome b2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:7496-7501(1996).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) IN COMPLEXES WITH FAD; D-ARGININE;
RP   IMINO-TRYPTOPHAN AND 3-METHYL-2-OXOBUTYRIC ACID, SUBUNIT, AND ENZYME
RP   MECHANISM.
RX   PubMed=9153426; DOI=10.1021/bi9630570;
RA   Todone F., Vanoni M.A., Mozzarelli A., Bolognesi M., Coda A., Curti B.,
RA   Mattevi A.;
RT   "Active site plasticity in D-amino acid oxidase: a crystallographic
RT   analysis.";
RL   Biochemistry 36:5853-5860(1997).
CC   -!- FUNCTION: Regulates the level of the neuromodulator D-serine in the
CC       brain. Has high activity towards D-DOPA and contributes to dopamine
CC       synthesis. Could act as a detoxifying agent which removes D-amino acids
CC       accumulated during aging. Acts on a variety of D-amino acids with a
CC       preference for those having small hydrophobic side chains followed by
CC       those bearing polar, aromatic, and basic groups. Does not act on acidic
CC       amino acids.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a D-alpha-amino acid + H2O + O2 = a 2-oxocarboxylate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:21816, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:35179,
CC         ChEBI:CHEBI:59871; EC=1.4.3.3; Evidence={ECO:0000269|PubMed:1673125,
CC         ECO:0000269|PubMed:6120171, ECO:0000269|PubMed:6129252};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:6120171};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:8755502,
CC       ECO:0000269|PubMed:9153426}.
CC   -!- SUBCELLULAR LOCATION: Peroxisome.
CC   -!- SIMILARITY: Belongs to the DAMOX/DASOX family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Worthington enzyme manual;
CC       URL="http://www.worthington-biochem.com/DAOFF/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M16972; AAA30985.1; -; mRNA.
DR   EMBL; M18447; AAA31025.1; -; Genomic_DNA.
DR   EMBL; M18444; AAA31025.1; JOINED; Genomic_DNA.
DR   EMBL; M18445; AAA31025.1; JOINED; Genomic_DNA.
DR   EMBL; M18446; AAA31025.1; JOINED; Genomic_DNA.
DR   EMBL; M18448; AAA31026.1; -; mRNA.
DR   PIR; A29598; OXPGDA.
DR   PIR; A33798; A33798.
DR   RefSeq; NP_999231.1; NM_214066.2.
DR   PDB; 1AN9; X-ray; 2.50 A; A/B=1-340.
DR   PDB; 1DAO; X-ray; 3.20 A; A/B/C/D/E/F/G/H=1-347.
DR   PDB; 1DDO; X-ray; 3.10 A; A/B/C/D/E/F/G/H=1-347.
DR   PDB; 1EVI; X-ray; 2.50 A; A/B=1-340.
DR   PDB; 1KIF; X-ray; 2.60 A; A/B/C/D/E/F/G/H=1-347.
DR   PDB; 1VE9; X-ray; 2.50 A; A/B=1-347.
DR   PDB; 3WGT; X-ray; 1.88 A; A/B=1-347.
DR   PDB; 4YJD; X-ray; 2.30 A; A/B=1-340.
DR   PDB; 4YJF; X-ray; 2.20 A; A=1-341, B=1-339.
DR   PDB; 4YJG; X-ray; 2.50 A; A=1-341, B=1-340.
DR   PDB; 4YJH; X-ray; 2.70 A; A/B=1-340.
DR   PDB; 5WWV; X-ray; 3.20 A; A/B/C/D/E/F/G/H=1-347.
DR   PDB; 5WX2; X-ray; 3.00 A; A/B/C/D/E/F/G/H=1-347.
DR   PDBsum; 1AN9; -.
DR   PDBsum; 1DAO; -.
DR   PDBsum; 1DDO; -.
DR   PDBsum; 1EVI; -.
DR   PDBsum; 1KIF; -.
DR   PDBsum; 1VE9; -.
DR   PDBsum; 3WGT; -.
DR   PDBsum; 4YJD; -.
DR   PDBsum; 4YJF; -.
DR   PDBsum; 4YJG; -.
DR   PDBsum; 4YJH; -.
DR   PDBsum; 5WWV; -.
DR   PDBsum; 5WX2; -.
DR   SMR; P00371; -.
DR   BioGRID; 1149269; 1.
DR   STRING; 9823.ENSSSCP00000010609; -.
DR   BindingDB; P00371; -.
DR   ChEMBL; CHEMBL6172; -.
DR   DrugCentral; P00371; -.
DR   PaxDb; P00371; -.
DR   PeptideAtlas; P00371; -.
DR   PRIDE; P00371; -.
DR   Ensembl; ENSSSCT00005072766; ENSSSCP00005045526; ENSSSCG00005045054.
DR   Ensembl; ENSSSCT00015010951; ENSSSCP00015004305; ENSSSCG00015008169.
DR   Ensembl; ENSSSCT00070005965; ENSSSCP00070004870; ENSSSCG00070003140.
DR   GeneID; 397134; -.
DR   KEGG; ssc:397134; -.
DR   CTD; 1610; -.
DR   eggNOG; KOG3923; Eukaryota.
DR   HOGENOM; CLU_034311_0_1_1; -.
DR   InParanoid; P00371; -.
DR   OMA; WPYRIEP; -.
DR   OrthoDB; 1363414at2759; -.
DR   TreeFam; TF313887; -.
DR   BRENDA; 1.4.3.3; 6170.
DR   Reactome; R-SSC-389661; Glyoxylate metabolism and glycine degradation.
DR   Reactome; R-SSC-9033241; Peroxisomal protein import.
DR   SABIO-RK; P00371; -.
DR   EvolutionaryTrace; P00371; -.
DR   PRO; PR:P00371; -.
DR   Proteomes; UP000008227; Unplaced.
DR   Proteomes; UP000314985; Chromosome 14.
DR   Bgee; ENSSSCG00000009942; Expressed in adult mammalian kidney and 28 other tissues.
DR   ExpressionAtlas; P00371; baseline and differential.
DR   Genevisible; P00371; SS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005777; C:peroxisome; IEA:UniProtKB-SubCell.
DR   GO; GO:0003884; F:D-amino-acid oxidase activity; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0055130; P:D-alanine catabolic process; IBA:GO_Central.
DR   GO; GO:0019478; P:D-amino acid catabolic process; IDA:UniProtKB.
DR   GO; GO:0036088; P:D-serine catabolic process; IBA:GO_Central.
DR   GO; GO:0006562; P:proline catabolic process; IBA:GO_Central.
DR   InterPro; IPR006181; D-amino_acid_oxidase_CS.
DR   InterPro; IPR023209; DAO.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   PANTHER; PTHR11530; PTHR11530; 1.
DR   Pfam; PF01266; DAO; 1.
DR   PIRSF; PIRSF000189; D-aa_oxidase; 1.
DR   PROSITE; PS00677; DAO; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; FAD; Flavoprotein; Oxidoreductase;
KW   Peroxisome; Reference proteome.
FT   CHAIN           1..347
FT                   /note="D-amino-acid oxidase"
FT                   /id="PRO_0000162763"
FT   NP_BIND         3..17
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8755502"
FT   NP_BIND         37..38
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8755502"
FT   NP_BIND         44..45
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8755502"
FT   NP_BIND         49..51
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8755502"
FT   NP_BIND         312..316
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8755502"
FT   MOTIF           345..347
FT                   /note="Microbody targeting signal"
FT   BINDING         53
FT                   /note="Substrate"
FT   BINDING         164
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:8755502"
FT   BINDING         182
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8755502"
FT   BINDING         217
FT                   /note="Substrate"
FT   BINDING         228
FT                   /note="Substrate"
FT   BINDING         283
FT                   /note="Substrate"
FT   BINDING         313
FT                   /note="Substrate; via carbonyl oxygen"
FT   BINDING         317
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8755502"
FT   MUTAGEN         55
FT                   /note="Y->F: No effect."
FT                   /evidence="ECO:0000269|PubMed:2901989"
FT   MUTAGEN         110
FT                   /note="M->L: No effect."
FT                   /evidence="ECO:0000269|PubMed:2901989"
FT   MUTAGEN         217
FT                   /note="H->L: No effect."
FT                   /evidence="ECO:0000269|PubMed:2901989"
FT   MUTAGEN         228
FT                   /note="Y->F: Reduces activity."
FT                   /evidence="ECO:0000269|PubMed:1673125"
FT   MUTAGEN         307
FT                   /note="H->L: Reduces activity."
FT                   /evidence="ECO:0000269|PubMed:1673125"
FT   STRAND          2..6
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   HELIX           10..23
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   TURN            24..26
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   STRAND          27..29
FT                   /evidence="ECO:0007829|PDB:1AN9"
FT   STRAND          31..37
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   HELIX           40..42
FT                   /evidence="ECO:0007829|PDB:1AN9"
FT   HELIX           44..47
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   HELIX           63..77
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   TURN            78..80
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   TURN            82..84
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   HELIX           85..87
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   STRAND          89..100
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   TURN            106..110
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   STRAND          111..116
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   HELIX           119..122
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   STRAND          125..127
FT                   /evidence="ECO:0007829|PDB:1DDO"
FT   STRAND          129..139
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   HELIX           141..154
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   STRAND          158..161
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   HELIX           167..172
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   STRAND          176..180
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   HELIX           183..188
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   STRAND          196..206
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   STRAND          212..216
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   TURN            219..221
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   TURN            222..224
FT                   /evidence="ECO:0007829|PDB:1DDO"
FT   STRAND          228..231
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   STRAND          233..239
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   HELIX           253..266
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   HELIX           268..272
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   STRAND          274..285
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   STRAND          290..298
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   STRAND          301..309
FT                   /evidence="ECO:0007829|PDB:3WGT"
FT   HELIX           312..314
FT                   /evidence="ECO:0007829|PDB:4YJF"
FT   HELIX           315..336
FT                   /evidence="ECO:0007829|PDB:3WGT"
SQ   SEQUENCE   347 AA;  39336 MW;  0EC6577BDB2BF46C CRC64;
     MRVVVIGAGV IGLSTALCIH ERYHSVLQPL DVKVYADRFT PFTTTDVAAG LWQPYTSEPS
     NPQEANWNQQ TFNYLLSHIG SPNAANMGLT PVSGYNLFRE AVPDPYWKDM VLGFRKLTPR
     ELDMFPDYRY GWFNTSLILE GRKYLQWLTE RLTERGVKFF LRKVESFEEV ARGGADVIIN
     CTGVWAGVLQ PDPLLQPGRG QIIKVDAPWL KNFIITHDLE RGIYNSPYII PGLQAVTLGG
     TFQVGNWNEI NNIQDHNTIW EGCCRLEPTL KDAKIVGEYT GFRPVRPQVR LEREQLRFGS
     SNTEVIHNYG HGGYGLTIHW GCALEVAKLF GKVLEERNLL TMPPSHL
//
ID   PHHY_CUTCT              Reviewed;         665 AA.
AC   P15245;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-JUN-2021, entry version 125.
DE   RecName: Full=Phenol hydroxylase {ECO:0000303|PubMed:4146224};
DE            Short=PHHY {ECO:0000303|PubMed:9634698};
DE            EC=1.14.13.7 {ECO:0000269|PubMed:11591156, ECO:0000269|PubMed:1429434, ECO:0000269|PubMed:17425111, ECO:0000269|PubMed:2022646, ECO:0000269|PubMed:3203745, ECO:0000269|PubMed:4146224, ECO:0000269|PubMed:7851397, ECO:0000269|PubMed:7858421};
OS   Cutaneotrichosporon cutaneum (Yeast) (Trichosporon cutaneum).
OC   Eukaryota; Fungi; Dikarya; Basidiomycota; Agaricomycotina; Tremellomycetes;
OC   Trichosporonales; Trichosporonaceae; Cutaneotrichosporon.
OX   NCBI_TaxID=5554;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, FUNCTION, AND
RP   CATALYTIC ACTIVITY.
RC   STRAIN=ATCC 46490;
RX   PubMed=1429434; DOI=10.1128/jb.174.22.7112-7120.1992;
RA   Kalin M., Neujahr H.Y., Weissmahr R.N., Sejlitz T., Johl R., Fiechter A.,
RA   Reiser J.;
RT   "Phenol hydroxylase from Trichosporon cutaneum: gene cloning, sequence
RT   analysis, and functional expression in Escherichia coli.";
RL   J. Bacteriol. 174:7112-7120(1992).
RN   [2]
RP   PROTEIN SEQUENCE OF 30-64; 299-311 AND 352-377.
RC   STRAIN=ATCC 46490;
RX   PubMed=2298204; DOI=10.1111/j.1432-1033.1990.tb15298.x;
RA   Sejlitz T., Wernstedt C., Engstroem A., Neujahr H.N.;
RT   "Amino acid sequences around the pyridoxal-5'-phosphate-binding sites of
RT   phenol hydroxylase.";
RL   Eur. J. Biochem. 187:225-228(1990).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-80 AND 662-665.
RX   PubMed=1924266;
RA   Sejlitz T., Wernstedt C., Hellman U., Neujahr H.Y.;
RT   "The N-terminal amino acid sequence of phenol hydroxylase contains a
RT   dinucleotide-binding sequence motif.";
RL   Protein Seq. Data Anal. 4:21-23(1991).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, AND
RP   ACTIVITY REGULATION.
RX   PubMed=4146224; DOI=10.1111/j.1432-1033.1973.tb02851.x;
RA   Neujahr H.Y., Gaal A.;
RT   "Phenol hydroxylase from yeast. Purification and properties of the enzyme
RT   from Trichosporon cutaneum.";
RL   Eur. J. Biochem. 35:386-400(1973).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=3203745; DOI=10.1016/0014-5793(88)80988-8;
RA   Moertberg M., Neujahr H.Y.;
RT   "Activation enthalpies and pH dependence of phenol hydroxylase from
RT   Trichosporon cutaneum, in vitro and in situ.";
RL   FEBS Lett. 242:75-78(1988).
RN   [6]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=2022646;
RA   Taylor M.G., Massey V.;
RT   "Kinetic and isotopic studies of the oxidative half-reaction of phenol
RT   hydroxylase.";
RL   J. Biol. Chem. 266:8291-8301(1991).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=7858421; DOI=10.1006/prep.1994.1073;
RA   Waters S., Neujahr H.Y.;
RT   "A fermentor culture for production of recombinant phenol hydroxylase.";
RL   Protein Expr. Purif. 5:534-540(1994).
RN   [8]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=7851397; DOI=10.1111/j.1432-1033.1995.tb20386.x;
RA   Peelen S., Rietjens I.M., Boersma M.G., Vervoort J.;
RT   "Conversion of phenol derivatives to hydroxylated products by phenol
RT   hydroxylase from Trichosporon cutaneum. A comparison of regioselectivity
RT   and rate of conversion with calculated molecular orbital substrate
RT   characteristics.";
RL   Eur. J. Biochem. 227:284-291(1995).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF ASP-55; ARG-282 AND
RP   TYR-290.
RX   PubMed=11591156; DOI=10.1021/bi010962y;
RA   Xu D., Ballou D.P., Massey V.;
RT   "Studies of the mechanism of phenol hydroxylase: mutants Tyr289Phe,
RT   Asp54Asn, and Arg281Met.";
RL   Biochemistry 40:12369-12378(2001).
RN   [10]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RC   STRAIN=R57;
RX   PubMed=17425111; DOI=10.1515/znc-2007-1-215;
RA   Gerginova M., Manasiev J., Shivarova N., Alexieva Z.;
RT   "Influence of various phenolic compounds on phenol hydroxylase activity of
RT   a Trichosporon cutaneum strain.";
RL   Z. Naturforsch. C 62:83-86(2007).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 2-665 IN COMPLEX WITH FAD AND
RP   PHENOL, SUBUNIT, AND COFACTOR.
RC   STRAIN=ATCC 46490;
RX   PubMed=9634698; DOI=10.1016/s0969-2126(98)00062-8;
RA   Enroth C., Neujahr H.Y., Schneider G., Lindqvist Y.;
RT   "The crystal structure of phenol hydroxylase in complex with FAD and phenol
RT   provides evidence for a concerted conformational change in the enzyme and
RT   its cofactor during catalysis.";
RL   Structure 6:605-617(1998).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) IN COMPLEX WITH FAD AND PHENOL, AND
RP   COFACTOR.
RX   PubMed=12925790; DOI=10.1107/s0907444903014902;
RA   Enroth C.;
RT   "High-resolution structure of phenol hydroxylase and correction of sequence
RT   errors.";
RL   Acta Crystallogr. D 59:1597-1602(2003).
CC   -!- FUNCTION: Hydroxylates phenol to catechol (PubMed:1429434,
CC       PubMed:4146224, PubMed:3203745, PubMed:2022646, PubMed:7858421,
CC       PubMed:7851397, PubMed:11591156). Phenol is the best substrate, but the
CC       enzyme also accepts isomeric diphenols, hydroxyl-, amino-, halogen- or
CC       methyl-substituted phenols and, to a lesser degree, cresols
CC       (PubMed:4146224, PubMed:17425111, PubMed:7851397).
CC       {ECO:0000269|PubMed:11591156, ECO:0000269|PubMed:1429434,
CC       ECO:0000269|PubMed:17425111, ECO:0000269|PubMed:2022646,
CC       ECO:0000269|PubMed:3203745, ECO:0000269|PubMed:4146224,
CC       ECO:0000269|PubMed:7851397, ECO:0000269|PubMed:7858421}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADPH + O2 + phenol = catechol + H2O + NADP(+);
CC         Xref=Rhea:RHEA:17061, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:15882, ChEBI:CHEBI:18135,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.14.13.7;
CC         Evidence={ECO:0000269|PubMed:11591156, ECO:0000269|PubMed:1429434,
CC         ECO:0000269|PubMed:17425111, ECO:0000269|PubMed:2022646,
CC         ECO:0000269|PubMed:3203745, ECO:0000269|PubMed:4146224,
CC         ECO:0000269|PubMed:7851397, ECO:0000269|PubMed:7858421};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:12925790, ECO:0000269|PubMed:4146224,
CC         ECO:0000269|PubMed:9634698};
CC   -!- ACTIVITY REGULATION: Inhibited by excess phenol (PubMed:4146224). Heavy
CC       metals such AsCuSO(4), AgNO(3), or HgCl(2) severely inhibit activity
CC       (PubMed:4146224). {ECO:0000269|PubMed:4146224}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=18 uM for phenol {ECO:0000269|PubMed:4146224};
CC         KM=71 uM for NADPH {ECO:0000269|PubMed:4146224};
CC         KM=53 uM for O(2) {ECO:0000269|PubMed:4146224};
CC       pH dependence:
CC         Optimum pH is 7.2-7.6. {ECO:0000269|PubMed:3203745,
CC         ECO:0000269|PubMed:4146224};
CC       Temperature dependence:
CC         Optimum temperature is 30 degrees Celsius.
CC         {ECO:0000269|PubMed:3203745};
CC   -!- PATHWAY: Aromatic compound metabolism; phenol degradation.
CC       {ECO:0000269|PubMed:1429434}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:9634698}.
CC   -!- SIMILARITY: Belongs to the PheA/TfdB FAD monooxygenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L04488; AAA34202.1; -; mRNA.
DR   PIR; S07772; S07772.
DR   PDB; 1FOH; X-ray; 2.40 A; A/B/C/D=2-665.
DR   PDB; 1PN0; X-ray; 1.70 A; A/B/C/D=1-665.
DR   PDBsum; 1FOH; -.
DR   PDBsum; 1PN0; -.
DR   SMR; P15245; -.
DR   KEGG; ag:AAA34202; -.
DR   BioCyc; MetaCyc:MONOMER-14669; -.
DR   UniPathway; UPA00728; -.
DR   EvolutionaryTrace; P15245; -.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0018662; F:phenol 2-monooxygenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0019336; P:phenol-containing compound catabolic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.40.30.20; -; 1.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR012941; Phe_hydrox_C_dim_dom.
DR   InterPro; IPR038220; PHOX_C_sf.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   Pfam; PF07976; Phe_hydrox_dim; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aromatic hydrocarbons catabolism; Direct protein sequencing;
KW   FAD; Flavoprotein; Monooxygenase; NADP; Oxidoreductase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:1924266"
FT   CHAIN           2..665
FT                   /note="Phenol hydroxylase"
FT                   /id="PRO_0000214045"
FT   NP_BIND         18..19
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12925790,
FT                   ECO:0000269|PubMed:9634698, ECO:0007744|PDB:1FOH,
FT                   ECO:0007744|PDB:1PN0"
FT   NP_BIND         43..45
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12925790,
FT                   ECO:0000269|PubMed:9634698, ECO:0007744|PDB:1FOH,
FT                   ECO:0007744|PDB:1PN0"
FT   NP_BIND         51..56
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12925790,
FT                   ECO:0000269|PubMed:9634698, ECO:0007744|PDB:1FOH,
FT                   ECO:0007744|PDB:1PN0"
FT   NP_BIND         368..372
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12925790,
FT                   ECO:0000269|PubMed:9634698, ECO:0007744|PDB:1FOH,
FT                   ECO:0007744|PDB:1PN0"
FT   BINDING         55
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:12925790,
FT                   ECO:0000269|PubMed:9634698, ECO:0007744|PDB:1FOH,
FT                   ECO:0007744|PDB:1PN0"
FT   BINDING         118
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12925790,
FT                   ECO:0000269|PubMed:9634698, ECO:0007744|PDB:1FOH,
FT                   ECO:0007744|PDB:1PN0"
FT   BINDING         290
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12925790,
FT                   ECO:0000269|PubMed:9634698, ECO:0007744|PDB:1FOH,
FT                   ECO:0007744|PDB:1PN0"
FT   BINDING         290
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:12925790,
FT                   ECO:0000269|PubMed:9634698, ECO:0007744|PDB:1FOH,
FT                   ECO:0007744|PDB:1PN0"
FT   BINDING         358
FT                   /note="FAD"
FT                   /evidence="ECO:0007744|PDB:1FOH, ECO:0007744|PDB:1PN0"
FT   MUTAGEN         55
FT                   /note="D->N: Leads to a significant slower initial step of
FT                   the oxidative half-reaction."
FT                   /evidence="ECO:0000269|PubMed:11591156"
FT   MUTAGEN         282
FT                   /note="R->M: Leads to a significant slower initial step of
FT                   the oxidative half-reaction."
FT                   /evidence="ECO:0000269|PubMed:11591156"
FT   MUTAGEN         290
FT                   /note="Y->F: Leads to a slightly higher redox potential but
FT                   is reduced by NADPH much slower."
FT                   /evidence="ECO:0000269|PubMed:11591156"
FT   STRAND          4..14
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           18..33
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          39..42
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          44..47
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           59..66
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   TURN            67..69
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           71..75
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          83..89
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          95..104
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           118..133
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          142..150
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           152..154
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          163..169
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           172..174
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          186..188
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           192..200
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          214..224
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           231..236
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          241..257
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   TURN            261..264
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          265..270
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          272..274
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          276..281
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          287..293
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   TURN            305..307
FT                   /evidence="ECO:0007829|PDB:1FOH"
FT   HELIX           310..321
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          327..343
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          347..349
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   TURN            350..352
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          353..355
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           357..359
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           370..389
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           395..399
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           400..424
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          429..432
FT                   /evidence="ECO:0007829|PDB:1FOH"
FT   STRAND          435..437
FT                   /evidence="ECO:0007829|PDB:1FOH"
FT   HELIX           439..453
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           473..475
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          489..492
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   TURN            493..496
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          497..500
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           501..504
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          511..518
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           523..537
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           542..546
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          555..565
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           572..574
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   TURN            577..580
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          587..591
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          596..598
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           603..607
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   TURN            611..613
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          615..619
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          623..629
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   HELIX           634..642
FT                   /evidence="ECO:0007829|PDB:1PN0"
FT   STRAND          649..651
FT                   /evidence="ECO:0007829|PDB:1PN0"
SQ   SEQUENCE   665 AA;  75162 MW;  1401BE35D38BFB71 CRC64;
     MTKYSESYCD VLIVGAGPAG LMAARVLSEY VRQKPDLKVR IIDKRSTKVY NGQADGLQCR
     TLESLKNLGL ADKILSEAND MSTIALYNPD ENGHIRRTDR IPDTLPGISR YHQVVLHQGR
     IERHILDSIA EISDTRIKVE RPLIPEKMEI DSSKAEDPEA YPVTMTLRYM SDHESTPLQF
     GHKTENSLFH SNLQTQEEED ANYRLPEGKE AGEIETVHCK YVIGCDGGHS WVRRTLGFEM
     IGEQTDYIWG VLDAVPASNF PDIRSPCAIH SAESGSIMII PRENNLVRFY VQLQARAEKG
     GRVDRTKFTP EVVIANAKKI FHPYTFDVQQ LDWFTAYHIG QRVTEKFSKD ERVFIAGDAC
     HTHSPKAGQG MNTSMMDTYN LGWKLGLVLT GRAKRDILKT YEEERHAFAQ ALIDFDHQFS
     RLFSGRPAKD VADEMGVSMD VFKEAFVKGN EFASGTAINY DENLVTDKKS SKQELAKNCV
     VGTRFKSQPV VRHSEGLWMH FGDRLVTDGR FRIIVFAGKA TDATQMSRIK KFSAYLDSEN
     SVISLYTPKV SDRNSRIDVI TIHSCHRDDI EMHDFPAPAL HPKWQYDFIY ADCDSWHHPH
     PKSYQAWGVD ETKGAVVVVR PDGYTSLVTD LEGTAEIDRY FSGILVEPKE KSGAQTEADW
     TKSTA
//
ID   ETFA_HUMAN              Reviewed;         333 AA.
AC   P13804; B4DT43; Q53XN3;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   02-JUN-2021, entry version 221.
DE   RecName: Full=Electron transfer flavoprotein subunit alpha, mitochondrial;
DE            Short=Alpha-ETF;
DE   Flags: Precursor;
GN   Name=ETFA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3170610;
RA   Finocchiaro G., Ito M., Ikeda Y., Tanaka K.;
RT   "Molecular cloning and nucleotide sequence of cDNAs encoding the alpha-
RT   subunit of human electron transfer flavoprotein.";
RL   J. Biol. Chem. 263:15773-15780(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, FUNCTION, AND
RP   VARIANT GA2A MET-266.
RX   PubMed=12815589; DOI=10.1002/humu.10226;
RA   Olsen R.K.J., Andresen B.S., Christensen E., Bross P., Skovby F.,
RA   Gregersen N.;
RT   "Clear relationship between ETF/ETFDH genotype and phenotype in patients
RT   with multiple acyl-CoA dehydrogenation deficiency.";
RL   Hum. Mutat. 22:12-23(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Chondrosarcoma, and Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 86-101 AND 170-203, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   REVIEW.
RX   PubMed=17941859; DOI=10.1111/j.1742-4658.2007.06107.x;
RA   Toogood H.S., Leys D., Scrutton N.S.;
RT   "Dynamics driving function: new insights from electron transferring
RT   flavoproteins and partner complexes.";
RL   FEBS J. 274:5481-5504(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER PHE-19, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   FUNCTION, INTERACTION WITH ETFRF1, AND IDENTIFICATION IN A COMPLEX WITH
RP   ETFB AND ETFRF1.
RX   PubMed=27499296; DOI=10.1016/j.molcel.2016.06.033;
RA   Floyd B.J., Wilkerson E.M., Veling M.T., Minogue C.E., Xia C., Beebe E.T.,
RA   Wrobel R.L., Cho H., Kremer L.S., Alston C.L., Gromek K.A., Dolan B.K.,
RA   Ulbrich A., Stefely J.A., Bohl S.L., Werner K.M., Jochem A.,
RA   Westphall M.S., Rensvold J.W., Taylor R.W., Prokisch H., Kim J.J.,
RA   Coon J.J., Pagliarini D.J.;
RT   "Mitochondrial protein interaction mapping identifies regulators of
RT   respiratory chain function.";
RL   Mol. Cell 63:621-632(2016).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 20-333 IN COMPLEX WITH FAD AND
RP   ETFB, SUBUNIT, COFACTOR, AND DOMAIN.
RX   PubMed=8962055; DOI=10.1073/pnas.93.25.14355;
RA   Roberts D.L., Frerman F.E., Kim J.-J.P.;
RT   "Three-dimensional structure of human electron transfer flavoprotein to
RT   2.1-A resolution.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:14355-14360(1996).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) IN COMPLEX WITH ETFB AND ACADM,
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=15159392; DOI=10.1074/jbc.m404884200;
RA   Toogood H.S., van Thiel A., Basran J., Sutcliffe M.J., Scrutton N.S.,
RA   Leys D.;
RT   "Extensive domain motion and electron transfer in the human electron
RT   transferring flavoprotein.medium chain acyl-CoA dehydrogenase complex.";
RL   J. Biol. Chem. 279:32904-32912(2004).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.11 ANGSTROMS) IN COMPLEX WITH FAD; ETFB AND ACADM,
RP   FUNCTION, COFACTOR, AND MUTAGENESIS OF ARG-249.
RX   PubMed=15975918; DOI=10.1074/jbc.m505562200;
RA   Toogood H.S., van Thiel A., Scrutton N.S., Leys D.;
RT   "Stabilization of non-productive conformations underpins rapid electron
RT   transfer to electron-transferring flavoprotein.";
RL   J. Biol. Chem. 280:30361-30366(2005).
RN   [18]
RP   VARIANT GA2A GLY-157, AND FUNCTION.
RX   PubMed=1882842;
RA   Indo Y., Glassberg R., Yokota I., Tanaka K.;
RT   "Molecular characterization of variant alpha-subunit of electron transfer
RT   flavoprotein in three patients with glutaric acidemia type II -- and
RT   identification of glycine substitution for valine-157 in the sequence of
RT   the precursor, producing an unstable mature protein in a patient.";
RL   Am. J. Hum. Genet. 49:575-580(1991).
RN   [19]
RP   VARIANTS GA2A ARG-116 AND MET-266, FUNCTION, AND CHARACTERIZATION OF
RP   VARIANT GA2A MET-266.
RX   PubMed=1430199; DOI=10.1172/jci116040;
RA   Freneaux E., Sheffield V.C., Molin L., Shires A., Rhead W.;
RT   "Glutaric acidemia type II. Heterogeneity in beta-oxidation flux,
RT   polypeptide synthesis, and complementary DNA mutations in the alpha subunit
RT   of electron transfer flavoprotein in eight patients.";
RL   J. Clin. Invest. 90:1679-1686(1992).
RN   [20]
RP   CHARACTERIZATION OF VARIANTS GA2A ARG-116 AND MET-266, FUNCTION, COFACTOR,
RP   AND SUBUNIT.
RX   PubMed=9334218; DOI=10.1074/jbc.272.42.26425;
RA   Salazar D., Zhang L., deGala G.D., Frerman F.E.;
RT   "Expression and characterization of two pathogenic mutations in human
RT   electron transfer flavoprotein.";
RL   J. Biol. Chem. 272:26425-26433(1997).
RN   [21]
RP   VARIANT ILE-171, CHARACTERIZATION OF VARIANT ILE-171, AND FUNCTION.
RX   PubMed=10356313; DOI=10.1006/mgme.1999.2856;
RA   Bross P., Pedersen P., Winter V., Nyholm M., Johansen B.N., Olsen R.K.,
RA   Corydon M.J., Andresen B.S., Eiberg H., Kolvraa S., Gregersen N.;
RT   "A polymorphic variant in the human electron transfer flavoprotein alpha-
RT   chain (alpha-T171) displays decreased thermal stability and is
RT   overrepresented in very-long-chain acyl-CoA dehydrogenase-deficient
RT   patients with mild childhood presentation.";
RL   Mol. Genet. Metab. 67:138-147(1999).
CC   -!- FUNCTION: Heterodimeric electron transfer flavoprotein that accepts
CC       electrons from several mitochondrial dehydrogenases, including acyl-CoA
CC       dehydrogenases, glutaryl-CoA and sarcosine dehydrogenase
CC       (PubMed:27499296, PubMed:15159392, PubMed:15975918, PubMed:9334218,
CC       PubMed:10356313). It transfers the electrons to the main mitochondrial
CC       respiratory chain via ETF-ubiquinone oxidoreductase (ETF dehydrogenase)
CC       (PubMed:9334218). Required for normal mitochondrial fatty acid
CC       oxidation and normal amino acid metabolism (PubMed:12815589,
CC       PubMed:1882842, PubMed:1430199). {ECO:0000269|PubMed:10356313,
CC       ECO:0000269|PubMed:12815589, ECO:0000269|PubMed:1430199,
CC       ECO:0000269|PubMed:15159392, ECO:0000269|PubMed:15975918,
CC       ECO:0000269|PubMed:27499296, ECO:0000269|PubMed:9334218,
CC       ECO:0000303|PubMed:17941859, ECO:0000305|PubMed:1882842}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:15975918, ECO:0000269|PubMed:8962055,
CC         ECO:0000269|PubMed:9334218};
CC       Note=Binds 1 FAD per dimer. {ECO:0000269|PubMed:15975918,
CC       ECO:0000269|PubMed:8962055};
CC   -!- SUBUNIT: Heterodimer composed of ETFA and ETFB (PubMed:8962055,
CC       PubMed:15159392, PubMed:15975918, PubMed:9334218). Identified in a
CC       complex that contains ETFA, ETFB and ETFRF1 (PubMed:27499296).
CC       Interaction with ETFRF1 promotes dissociation of the bound FAD and loss
CC       of electron transfer activity (PubMed:27499296). Interacts with TASOR
CC       (By similarity). {ECO:0000250|UniProtKB:Q99LC5,
CC       ECO:0000269|PubMed:15159392, ECO:0000269|PubMed:15975918,
CC       ECO:0000269|PubMed:27499296, ECO:0000269|PubMed:8962055}.
CC   -!- INTERACTION:
CC       P13804; P38117: ETFB; NbExp=2; IntAct=EBI-1052886, EBI-1056543;
CC       P13804; Q8IWL3: HSCB; NbExp=3; IntAct=EBI-1052886, EBI-1805738;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P13804-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P13804-2; Sequence=VSP_043246;
CC   -!- DOMAIN: Domain I shares an identical polypeptide fold with the beta
CC       subunit ETFB though there is no sequence similarity.
CC       {ECO:0000269|PubMed:8962055}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- DISEASE: Glutaric aciduria 2A (GA2A) [MIM:231680]: An autosomal
CC       recessively inherited disorder of fatty acid, amino acid, and choline
CC       metabolism. It is characterized by multiple acyl-CoA dehydrogenase
CC       deficiencies resulting in large excretion not only of glutaric acid,
CC       but also of lactic, ethylmalonic, butyric, isobutyric, 2-methyl-
CC       butyric, and isovaleric acids. {ECO:0000269|PubMed:12815589,
CC       ECO:0000269|PubMed:1430199, ECO:0000269|PubMed:1882842,
CC       ECO:0000269|PubMed:9334218}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ETF alpha-subunit/FixB family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J04058; AAA52406.1; -; mRNA.
DR   EMBL; S55815; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; S55816; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AJ224002; CAA11802.1; -; Genomic_DNA.
DR   EMBL; AF436657; AAN03712.1; -; Genomic_DNA.
DR   EMBL; AF436646; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436647; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436648; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436649; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436650; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436651; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436652; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436653; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436654; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436655; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; AF436656; AAN03712.1; JOINED; Genomic_DNA.
DR   EMBL; BT009796; AAP88798.1; -; mRNA.
DR   EMBL; AK292979; BAF85668.1; -; mRNA.
DR   EMBL; AK300044; BAG61855.1; -; mRNA.
DR   EMBL; AC027243; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091100; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471136; EAW99221.1; -; Genomic_DNA.
DR   EMBL; BC015526; AAH15526.1; -; mRNA.
DR   EMBL; BC095457; AAH95457.1; -; mRNA.
DR   CCDS; CCDS32299.1; -. [P13804-1]
DR   CCDS; CCDS45311.1; -. [P13804-2]
DR   PIR; A31998; A31998.
DR   RefSeq; NP_000117.1; NM_000126.3. [P13804-1]
DR   RefSeq; NP_001121188.1; NM_001127716.1. [P13804-2]
DR   PDB; 1EFV; X-ray; 2.10 A; A=20-333.
DR   PDB; 1T9G; X-ray; 2.90 A; R=1-333.
DR   PDB; 2A1T; X-ray; 2.80 A; R=1-333.
DR   PDB; 2A1U; X-ray; 2.11 A; A=1-333.
DR   PDBsum; 1EFV; -.
DR   PDBsum; 1T9G; -.
DR   PDBsum; 2A1T; -.
DR   PDBsum; 2A1U; -.
DR   SMR; P13804; -.
DR   BioGRID; 108409; 208.
DR   ComplexPortal; CPX-2731; Mitochondrial electron transfer flavoprotein complex.
DR   DIP; DIP-6161N; -.
DR   IntAct; P13804; 64.
DR   MINT; P13804; -.
DR   STRING; 9606.ENSP00000452762; -.
DR   CarbonylDB; P13804; -.
DR   iPTMnet; P13804; -.
DR   MetOSite; P13804; -.
DR   PhosphoSitePlus; P13804; -.
DR   SwissPalm; P13804; -.
DR   BioMuta; ETFA; -.
DR   DMDM; 119636; -.
DR   UCD-2DPAGE; P13804; -.
DR   CPTAC; CPTAC-365; -.
DR   CPTAC; CPTAC-366; -.
DR   EPD; P13804; -.
DR   jPOST; P13804; -.
DR   MassIVE; P13804; -.
DR   PaxDb; P13804; -.
DR   PeptideAtlas; P13804; -.
DR   PRIDE; P13804; -.
DR   ProteomicsDB; 52989; -. [P13804-1]
DR   ProteomicsDB; 52990; -. [P13804-2]
DR   TopDownProteomics; P13804-1; -. [P13804-1]
DR   TopDownProteomics; P13804-2; -. [P13804-2]
DR   Antibodypedia; 14895; 364 antibodies.
DR   DNASU; 2108; -.
DR   Ensembl; ENST00000433983; ENSP00000399273; ENSG00000140374. [P13804-2]
DR   Ensembl; ENST00000557943; ENSP00000452762; ENSG00000140374. [P13804-1]
DR   GeneID; 2108; -.
DR   KEGG; hsa:2108; -.
DR   UCSC; uc002bbt.3; human. [P13804-1]
DR   CTD; 2108; -.
DR   DisGeNET; 2108; -.
DR   GeneCards; ETFA; -.
DR   GeneReviews; ETFA; -.
DR   HGNC; HGNC:3481; ETFA.
DR   HPA; ENSG00000140374; Low tissue specificity.
DR   MalaCards; ETFA; -.
DR   MIM; 231680; phenotype.
DR   MIM; 608053; gene.
DR   neXtProt; NX_P13804; -.
DR   OpenTargets; ENSG00000140374; -.
DR   Orphanet; 394532; Multiple acyl-CoA dehydrogenase deficiency, mild type.
DR   Orphanet; 394529; Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type.
DR   PharmGKB; PA27897; -.
DR   VEuPathDB; HostDB:ENSG00000140374.15; -.
DR   eggNOG; KOG3954; Eukaryota.
DR   GeneTree; ENSGT00390000013422; -.
DR   HOGENOM; CLU_034178_0_0_1; -.
DR   InParanoid; P13804; -.
DR   OMA; WRPHSEH; -.
DR   PhylomeDB; P13804; -.
DR   TreeFam; TF105763; -.
DR   PathwayCommons; P13804; -.
DR   Reactome; R-HSA-611105; Respiratory electron transport.
DR   BioGRID-ORCS; 2108; 4 hits in 1002 CRISPR screens.
DR   ChiTaRS; ETFA; human.
DR   EvolutionaryTrace; P13804; -.
DR   GeneWiki; ETFA; -.
DR   GenomeRNAi; 2108; -.
DR   Pharos; P13804; Tbio.
DR   PRO; PR:P13804; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; P13804; protein.
DR   Bgee; ENSG00000140374; Expressed in oocyte and 246 other tissues.
DR   ExpressionAtlas; P13804; baseline and differential.
DR   Genevisible; P13804; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0009055; F:electron transfer activity; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:UniProtKB.
DR   GO; GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; IDA:UniProtKB.
DR   GO; GO:0022904; P:respiratory electron transport chain; TAS:Reactome.
DR   CDD; cd01715; ETF_alpha; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR029035; DHS-like_NAD/FAD-binding_dom.
DR   InterPro; IPR014730; ETF_a/b_N.
DR   InterPro; IPR001308; ETF_a/FixB.
DR   InterPro; IPR033947; ETF_alpha_N.
DR   InterPro; IPR014731; ETF_asu_C.
DR   InterPro; IPR018206; ETF_asu_C_CS.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF01012; ETF; 1.
DR   Pfam; PF00766; ETF_alpha; 1.
DR   PIRSF; PIRSF000089; Electra_flavoP_a; 1.
DR   SMART; SM00893; ETF; 1.
DR   SUPFAM; SSF52467; SSF52467; 1.
DR   PROSITE; PS00696; ETF_ALPHA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Direct protein sequencing;
KW   Disease variant; Electron transport; FAD; Flavoprotein; Glutaricaciduria;
KW   Mitochondrion; Phosphoprotein; Reference proteome; Transit peptide;
KW   Transport.
FT   TRANSIT         1..19
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255, ECO:0007744|PubMed:25944712"
FT   CHAIN           20..333
FT                   /note="Electron transfer flavoprotein subunit alpha,
FT                   mitochondrial"
FT                   /id="PRO_0000008650"
FT   NP_BIND         263..266
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15975918,
FT                   ECO:0000269|PubMed:8962055, ECO:0007744|PDB:1EFV,
FT                   ECO:0007744|PDB:2A1T"
FT   NP_BIND         281..286
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15975918,
FT                   ECO:0000269|PubMed:8962055, ECO:0007744|PDB:1EFV,
FT                   ECO:0007744|PDB:2A1T"
FT   NP_BIND         318..319
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15975918,
FT                   ECO:0000269|PubMed:8962055, ECO:0007744|PDB:1EFV,
FT                   ECO:0007744|PDB:2A1T"
FT   REGION          20..204
FT                   /note="Domain I"
FT                   /evidence="ECO:0000269|PubMed:8962055"
FT   REGION          205..333
FT                   /note="Domain II"
FT                   /evidence="ECO:0000269|PubMed:8962055"
FT   BINDING         223
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15975918,
FT                   ECO:0000269|PubMed:8962055, ECO:0007744|PDB:1EFV,
FT                   ECO:0007744|PDB:2A1T"
FT   BINDING         248
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15975918,
FT                   ECO:0000269|PubMed:8962055, ECO:0007744|PDB:1EFV,
FT                   ECO:0007744|PDB:2A1T"
FT   BINDING         300
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15975918,
FT                   ECO:0000269|PubMed:8962055, ECO:0007744|PDB:1EFV,
FT                   ECO:0007744|PDB:2A1T"
FT   MOD_RES         59
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         59
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         62
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         69
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         69
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         75
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         85
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         85
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         93
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         101
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         139
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         140
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         158
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         158
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         164
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         187
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         203
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         203
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         216
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         226
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         226
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         232
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         232
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   MOD_RES         301
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LC5"
FT   VAR_SEQ         14..62
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043246"
FT   VARIANT         116
FT                   /note="G -> R (in GA2A; impaired protein stability and loss
FT                   of electron transfer activity; dbSNP:rs119458971)"
FT                   /evidence="ECO:0000269|PubMed:1430199,
FT                   ECO:0000269|PubMed:9334218"
FT                   /id="VAR_002366"
FT   VARIANT         157
FT                   /note="V -> G (in GA2A; dbSNP:rs119458969)"
FT                   /evidence="ECO:0000269|PubMed:1882842"
FT                   /id="VAR_002367"
FT   VARIANT         171
FT                   /note="T -> I (decreased protein stability;
FT                   dbSNP:rs1801591)"
FT                   /evidence="ECO:0000269|PubMed:10356313"
FT                   /id="VAR_008547"
FT   VARIANT         266
FT                   /note="T -> M (in GA2A; decreased electron transfer
FT                   activity; dbSNP:rs119458970)"
FT                   /evidence="ECO:0000269|PubMed:12815589,
FT                   ECO:0000269|PubMed:1430199"
FT                   /id="VAR_002368"
FT   MUTAGEN         249
FT                   /note="R->A: Loss of electron transfer activity."
FT                   /evidence="ECO:0000269|PubMed:15975918"
FT   STRAND          21..25
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          28..31
FT                   /evidence="ECO:0007829|PDB:2A1U"
FT   HELIX           36..45
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          49..58
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           61..69
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          75..80
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           82..84
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           89..103
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          106..113
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           114..127
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          132..135
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          137..140
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          143..148
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   TURN            149..152
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          153..159
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          162..168
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           170..172
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          178..180
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          184..187
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          196..204
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           212..214
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          216..221
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           223..225
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           229..231
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           232..241
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          244..247
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           249..253
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           259..261
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          262..264
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          273..279
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           284..287
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   TURN            288..292
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          294..301
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           306..309
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   STRAND          312..317
FT                   /evidence="ECO:0007829|PDB:1EFV"
FT   HELIX           319..329
FT                   /evidence="ECO:0007829|PDB:1EFV"
SQ   SEQUENCE   333 AA;  35080 MW;  2EC6D1ADE68CBDB5 CRC64;
     MFRAAAPGQL RRAASLLRFQ STLVIAEHAN DSLAPITLNT ITAATRLGGE VSCLVAGTKC
     DKVAQDLCKV AGIAKVLVAQ HDVYKGLLPE ELTPLILATQ KQFNYTHICA GASAFGKNLL
     PRVAAKLEVA PISDIIAIKS PDTFVRTIYA GNALCTVKCD EKVKVFSVRG TSFDAAATSG
     GSASSEKASS TSPVEISEWL DQKLTKSDRP ELTGAKVVVS GGRGLKSGEN FKLLYDLADQ
     LHAAVGASRA AVDAGFVPND MQVGQTGKIV APELYIAVGI SGAIQHLAGM KDSKTIVAIN
     KDPEAPIFQV ADYGIVADLF KVVPEMTEIL KKK
//
ID   QSOX1_HUMAN             Reviewed;         747 AA.
AC   O00391; Q59G29; Q5T2X0; Q8TDL6; Q8WVP4;
DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 3.
DT   02-JUN-2021, entry version 182.
DE   RecName: Full=Sulfhydryl oxidase 1;
DE            Short=hQSOX;
DE            EC=1.8.3.2 {ECO:0000269|PubMed:18393449, ECO:0000269|PubMed:22801504, ECO:0000269|PubMed:23704371, ECO:0000269|PubMed:23867277, ECO:0000269|PubMed:26819240, ECO:0000269|PubMed:29757379, ECO:0000269|PubMed:30367560};
DE   AltName: Full=Quiescin Q6 {ECO:0000303|PubMed:10708601, ECO:0000303|PubMed:9878249};
DE   Flags: Precursor;
GN   Name=QSOX1; Synonyms=QSCN6 {ECO:0000303|PubMed:9878249};
GN   ORFNames=UNQ2520/PRO6013;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INDUCTION.
RC   TISSUE=Lung;
RX   PubMed=9878249; DOI=10.1006/geno.1998.5605;
RA   Coppock D.L., Cina-Poppe D., Gilleran S.;
RT   "The quiescin Q6 gene (QSCN6) is a fusion of two ancient gene families:
RT   thioredoxin and ERV1.";
RL   Genomics 54:460-468(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANTS ALA-200 AND ARG-444.
RC   TISSUE=Placenta;
RX   PubMed=16806532; DOI=10.1016/j.bbaexp.2006.04.008;
RA   Radom J., Colin D., Thiebault F., Dognin-Bergeret M.J., Mairet-Coello G.,
RA   Esnard-Feve A., Fellmann D., Jouvenot M.;
RT   "Identification and expression of a new splicing variant of FAD-sulfhydryl
RT   oxidase in adult rat brain.";
RL   Biochim. Biophys. Acta 1759:225-233(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ALA-200.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   ALA-200.
RC   TISSUE=Chondrosarcoma, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INDUCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10708601; DOI=10.1006/bbrc.2000.2324;
RA   Coppock D.L., Kopman C., Gudas J., Cina-Poppe D.A.;
RT   "Regulation of the quiescence-induced genes: quiescin Q6, decorin, and
RT   ribosomal protein S29.";
RL   Biochem. Biophys. Res. Commun. 269:604-610(2000).
RN   [8]
RP   TISSUE SPECIFICITY.
RA   Turi G.K.;
RT   "The distribution and specificity of expression of quiescin Q6 (Q6) in
RT   Human tissues is associated with both endocrine and non-endocrine protein
RT   secretion.";
RL   Proc. Annu. Meet. Am. Assoc. Cancer Res. 42:397-397(2001).
RN   [9]
RP   REVIEW, AND NOMENCLATURE.
RX   PubMed=12176051; DOI=10.1016/s0003-9861(02)00337-5;
RA   Thorpe C., Hoober K.L., Raje S., Glynn N.M., Burnside J., Turi G.K.,
RA   Coppock D.L.;
RT   "Sulfhydryl oxidases: emerging catalysts of protein disulfide bond
RT   formation in eukaryotes.";
RL   Arch. Biochem. Biophys. 405:1-12(2002).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-130.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, AND GLYCOSYLATION.
RX   PubMed=17331072; DOI=10.1042/bj20061510;
RA   Chakravarthi S., Jessop C.E., Willer M., Stirling C.J., Bulleid N.J.;
RT   "Intracellular catalysis of disulfide bond formation by the human
RT   sulfhydryl oxidase, QSOX1.";
RL   Biochem. J. 404:403-411(2007).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, COFACTOR, MUTAGENESIS OF CYS-70;
RP   CYS-73; CYS-449; CYS-452; CYS-509 AND CYS-512, AND ACTIVE SITE.
RX   PubMed=18393449; DOI=10.1021/bi702522q;
RA   Heckler E.J., Alon A., Fass D., Thorpe C.;
RT   "Human quiescin-sulfhydryl oxidase, QSOX1: probing internal redox steps by
RT   mutagenesis.";
RL   Biochemistry 47:4955-4963(2008).
RN   [13]
RP   GLYCOSYLATION AT ASN-130.
RX   PubMed=19139490; DOI=10.1074/mcp.m800504-mcp200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F., Zheng Z.B.,
RA   Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y., Zhang Y.K., Deng Y.L.,
RA   Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core fucosylated
RT   glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [14]
RP   PHOSPHORYLATION AT SER-426.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS
RP   SPECTROMETRY, ALTERNATIVE SPLICING, MUTAGENESIS OF 70-CYS--CYS-73, AND
RP   ACTIVE SITE.
RX   PubMed=23704371; DOI=10.1126/science.1238279;
RA   Ilani T., Alon A., Grossman I., Horowitz B., Kartvelishvily E., Cohen S.R.,
RA   Fass D.;
RT   "A secreted disulfide catalyst controls extracellular matrix composition
RT   and function.";
RL   Science 341:74-76(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   CATALYTIC ACTIVITY.
RX   PubMed=26819240; DOI=10.1093/protein/gzv067;
RA   Grossman I., Ilani T., Fleishman S.J., Fass D.;
RT   "Overcoming a species-specificity barrier in development of an inhibitory
RT   antibody targeting a modulator of tumor stroma.";
RL   Protein Eng. Des. Sel. 29:135-147(2016).
RN   [18]
RP   SUBCELLULAR LOCATION, CATALYTIC ACTIVITY, GLYCOSYLATION AT ASN-130 AND
RP   ASN-243, IDENTIFICATION BY MASS SPECTROMETRY, AND MUTAGENESIS OF ASN-130;
RP   ASN-243 AND 276-THR--THR-282.
RX   PubMed=29757379; DOI=10.1093/glycob/cwy044;
RA   Horowitz B., Javitt G., Ilani T., Gat Y., Morgenstern D., Bard F.A.,
RA   Fass D.;
RT   "Quiescin sulfhydryl oxidase 1 (QSOX1) glycosite mutation perturbs
RT   secretion but not Golgi localization.";
RL   Glycobiology 28:580-591(2018).
RN   [19]
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF 70-CYS--CYS-73; HIS-72 AND
RP   PRO-119, AND ACTIVE SITE.
RX   PubMed=30367560; DOI=10.1002/pro.3537;
RA   Javitt G., Grossman-Haham I., Alon A., Resnick E., Mutsafi Y., Ilani T.,
RA   Fass D.;
RT   "cis-Proline mutants of quiescin sulfhydryl oxidase 1 with altered redox
RT   properties undermine extracellular matrix integrity and cell adhesion in
RT   fibroblast cultures.";
RL   Protein Sci. 28:228-238(2019).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 286-546 IN COMPLEX WITH FAD,
RP   SUBUNIT, COFACTOR, AND DISULFIDE BONDS.
RX   PubMed=20211621; DOI=10.1016/j.febslet.2010.03.001;
RA   Alon A., Heckler E.J., Thorpe C., Fass D.;
RT   "QSOX contains a pseudo-dimer of functional and degenerate sulfhydryl
RT   oxidase domains.";
RL   FEBS Lett. 584:1521-1525(2010).
RN   [21] {ECO:0007744|PDB:3Q6O}
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 33-272, CATALYTIC ACTIVITY, AND
RP   DISULFIDE BONDS.
RX   PubMed=22801504; DOI=10.1038/nature11267;
RA   Alon A., Grossman I., Gat Y., Kodali V.K., DiMaio F., Mehlman T., Haran G.,
RA   Baker D., Thorpe C., Fass D.;
RT   "The dynamic disulphide relay of quiescin sulphydryl oxidase.";
RL   Nature 488:414-418(2012).
RN   [22] {ECO:0007744|PDB:4IJ3}
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 33-272 IN COMPLEX WITH INHIBITORY
RP   ANTIBODY, FUNCTION, CATALYTIC ACTIVITY, AND DISULFIDE BONDS.
RX   PubMed=23867277; DOI=10.1016/j.jmb.2013.07.011;
RA   Grossman I., Alon A., Ilani T., Fass D.;
RT   "An inhibitory antibody blocks the first step in the dithiol/disulfide
RT   relay mechanism of the enzyme QSOX1.";
RL   J. Mol. Biol. 425:4366-4378(2013).
CC   -!- FUNCTION: Catalyzes the oxidation of sulfhydryl groups in peptide and
CC       protein thiols to disulfides with the reduction of oxygen to hydrogen
CC       peroxide (PubMed:17331072, PubMed:18393449, PubMed:23704371,
CC       PubMed:30367560, PubMed:23867277). Plays a role in disulfide bond
CC       formation in a variety of extracellular proteins (PubMed:17331072,
CC       PubMed:30367560, PubMed:22801504, PubMed:23867277). In fibroblasts,
CC       required for normal incorporation of laminin into the extracellular
CC       matrix, and thereby for normal cell-cell adhesion and cell migration
CC       (PubMed:23704371, PubMed:30367560, PubMed:23867277).
CC       {ECO:0000269|PubMed:17331072, ECO:0000269|PubMed:18393449,
CC       ECO:0000269|PubMed:22801504, ECO:0000269|PubMed:23704371,
CC       ECO:0000269|PubMed:23867277, ECO:0000269|PubMed:30367560}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + 2 R'C(R)SH = H2O2 + R'C(R)S-S(R)CR';
CC         Xref=Rhea:RHEA:17357, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:16520, ChEBI:CHEBI:17412; EC=1.8.3.2;
CC         Evidence={ECO:0000269|PubMed:18393449, ECO:0000269|PubMed:22801504,
CC         ECO:0000269|PubMed:23704371, ECO:0000269|PubMed:23867277,
CC         ECO:0000269|PubMed:26819240, ECO:0000269|PubMed:29757379,
CC         ECO:0000269|PubMed:30367560};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:18393449, ECO:0000269|PubMed:20211621};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:18393449,
CC       ECO:0000269|PubMed:20211621};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:18393449,
CC       ECO:0000269|PubMed:20211621}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:17331072, ECO:0000269|PubMed:23704371}; Single-pass
CC       membrane protein {ECO:0000305|PubMed:17331072}. Secreted
CC       {ECO:0000269|PubMed:29757379}. Note=A small proportion is secreted,
CC       probably via a proteolytic cleavage that removes the membrane anchor.
CC       {ECO:0000305|PubMed:29757379}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted
CC       {ECO:0000269|PubMed:10708601}. Note=Found in the extracellular medium
CC       of quiescent cells but is not found in proliferating cells.
CC       {ECO:0000269|PubMed:10708601}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=a {ECO:0000303|PubMed:17331072}, QSOX-L
CC       {ECO:0000303|PubMed:23704371};
CC         IsoId=O00391-1; Sequence=Displayed;
CC       Name=2; Synonyms=b, QSOX-S {ECO:0000303|PubMed:23704371};
CC         IsoId=O00391-2; Sequence=VSP_020489, VSP_020490;
CC   -!- TISSUE SPECIFICITY: Expressed in heart, placenta, lung, liver, skeletal
CC       muscle, pancreas and very weakly in brain and kidney.
CC       {ECO:0000269|PubMed:10708601, ECO:0000269|Ref.8}.
CC   -!- INDUCTION: Induced in quiescent cells just as fibroblasts begin to
CC       leave the proliferative cycle and enter quiescence.
CC       {ECO:0000269|PubMed:10708601, ECO:0000269|PubMed:9878249}.
CC   -!- PTM: N-glycosylated (PubMed:17331072, PubMed:29757379). O-glycosylated
CC       on Thr and Ser residues (PubMed:29757379).
CC       {ECO:0000269|PubMed:17331072, ECO:0000269|PubMed:29757379}.
CC   -!- MISCELLANEOUS: 'Quiescin Q6' means that it was the sixth clone to be
CC       found at a higher level of expression in quiescent fibroblasts.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the quiescin-sulfhydryl oxidase (QSOX) family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92517.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U97276; AAC09010.2; -; mRNA.
DR   EMBL; AF361868; AAM00263.1; -; mRNA.
DR   EMBL; AY358941; AAQ89300.1; -; mRNA.
DR   EMBL; AB209280; BAD92517.1; ALT_INIT; mRNA.
DR   EMBL; AL390718; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017692; AAH17692.1; -; mRNA.
DR   EMBL; BC100023; AAI00024.1; -; mRNA.
DR   CCDS; CCDS1337.1; -. [O00391-1]
DR   CCDS; CCDS30950.1; -. [O00391-2]
DR   RefSeq; NP_001004128.1; NM_001004128.2. [O00391-2]
DR   RefSeq; NP_002817.2; NM_002826.4. [O00391-1]
DR   PDB; 3LLI; X-ray; 2.05 A; A=286-546.
DR   PDB; 3LLK; X-ray; 2.00 A; A/B/C=286-546.
DR   PDB; 3Q6O; X-ray; 2.05 A; A=33-272.
DR   PDB; 4IJ3; X-ray; 2.70 A; A=33-272.
DR   PDBsum; 3LLI; -.
DR   PDBsum; 3LLK; -.
DR   PDBsum; 3Q6O; -.
DR   PDBsum; 4IJ3; -.
DR   SMR; O00391; -.
DR   BioGRID; 111734; 31.
DR   IntAct; O00391; 24.
DR   MINT; O00391; -.
DR   STRING; 9606.ENSP00000356574; -.
DR   BindingDB; O00391; -.
DR   ChEMBL; CHEMBL4523117; -.
DR   GlyConnect; 1774; 24 N-Linked glycans (4 sites).
DR   GlyGen; O00391; 6 sites, 5 N-linked glycans (3 sites), 2 O-linked glycans (2 sites).
DR   iPTMnet; O00391; -.
DR   PhosphoSitePlus; O00391; -.
DR   BioMuta; QSOX1; -.
DR   EPD; O00391; -.
DR   jPOST; O00391; -.
DR   MassIVE; O00391; -.
DR   MaxQB; O00391; -.
DR   PaxDb; O00391; -.
DR   PeptideAtlas; O00391; -.
DR   PRIDE; O00391; -.
DR   ProteomicsDB; 47862; -. [O00391-1]
DR   ProteomicsDB; 47863; -. [O00391-2]
DR   ABCD; O00391; 2 sequenced antibodies.
DR   Antibodypedia; 47086; 193 antibodies.
DR   DNASU; 5768; -.
DR   Ensembl; ENST00000367600; ENSP00000356572; ENSG00000116260. [O00391-2]
DR   Ensembl; ENST00000367602; ENSP00000356574; ENSG00000116260. [O00391-1]
DR   GeneID; 5768; -.
DR   KEGG; hsa:5768; -.
DR   UCSC; uc001gny.4; human. [O00391-1]
DR   CTD; 5768; -.
DR   DisGeNET; 5768; -.
DR   GeneCards; QSOX1; -.
DR   HGNC; HGNC:9756; QSOX1.
DR   HPA; ENSG00000116260; Tissue enhanced (placenta).
DR   MIM; 603120; gene.
DR   neXtProt; NX_O00391; -.
DR   OpenTargets; ENSG00000116260; -.
DR   PharmGKB; PA162400559; -.
DR   VEuPathDB; HostDB:ENSG00000116260.16; -.
DR   eggNOG; KOG1731; Eukaryota.
DR   GeneTree; ENSGT00940000159504; -.
DR   HOGENOM; CLU_020182_1_0_1; -.
DR   InParanoid; O00391; -.
DR   OMA; VTEFPSC; -.
DR   PhylomeDB; O00391; -.
DR   TreeFam; TF316749; -.
DR   BRENDA; 1.8.3.2; 2681.
DR   PathwayCommons; O00391; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-8957275; Post-translational protein phosphorylation.
DR   BioGRID-ORCS; 5768; 8 hits in 994 CRISPR screens.
DR   ChiTaRS; QSOX1; human.
DR   EvolutionaryTrace; O00391; -.
DR   GeneWiki; QSOX1; -.
DR   GenomeRNAi; 5768; -.
DR   Pharos; O00391; Tbio.
DR   PRO; PR:O00391; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O00391; protein.
DR   Bgee; ENSG00000116260; Expressed in right testis and 240 other tissues.
DR   ExpressionAtlas; O00391; baseline and differential.
DR   Genevisible; O00391; HS.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0000139; C:Golgi membrane; IDA:UniProtKB.
DR   GO; GO:0030173; C:integral component of Golgi membrane; IDA:UniProtKB.
DR   GO; GO:0045171; C:intercellular bridge; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0016971; F:flavin-linked sulfhydryl oxidase activity; IDA:UniProtKB.
DR   GO; GO:0003756; F:protein disulfide isomerase activity; IDA:UniProtKB.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0085029; P:extracellular matrix assembly; IMP:UniProtKB.
DR   GO; GO:0016242; P:negative regulation of macroautophagy; IMP:CACAO.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0006457; P:protein folding; IBA:GO_Central.
DR   Gene3D; 1.20.120.1960; -; 1.
DR   Gene3D; 1.20.120.310; -; 1.
DR   Gene3D; 3.40.30.10; -; 2.
DR   InterPro; IPR036774; ERV/ALR_sulphydryl_oxid_sf.
DR   InterPro; IPR017905; ERV/ALR_sulphydryl_oxidase.
DR   InterPro; IPR040986; QSOX_FAD-bd_dom.
DR   InterPro; IPR042568; QSOX_FAD-bd_sf.
DR   InterPro; IPR041269; QSOX_Trx1.
DR   InterPro; IPR039798; Sulfhydryl_oxidase.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   PANTHER; PTHR22897; PTHR22897; 1.
DR   Pfam; PF04777; Evr1_Alr; 1.
DR   Pfam; PF18371; FAD_SOX; 1.
DR   Pfam; PF18108; QSOX_Trx1; 1.
DR   Pfam; PF00085; Thioredoxin; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   SUPFAM; SSF69000; SSF69000; 1.
DR   PROSITE; PS51324; ERV_ALR; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disulfide bond; FAD; Flavoprotein;
KW   Glycoprotein; Golgi apparatus; Membrane; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; Secreted; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..29
FT                   /evidence="ECO:0000255"
FT   CHAIN           30..747
FT                   /note="Sulfhydryl oxidase 1"
FT                   /id="PRO_0000249533"
FT   TRANSMEM        710..730
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          36..156
FT                   /note="Thioredoxin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00691"
FT   DOMAIN          396..503
FT                   /note="ERV/ALR sulfhydryl oxidase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654"
FT   NP_BIND         478..485
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20211621,
FT                   ECO:0007744|PDB:3LLI, ECO:0007744|PDB:3LLK"
FT   REGION          573..633
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        70
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000305|PubMed:18393449,
FT                   ECO:0000305|PubMed:30367560"
FT   ACT_SITE        73
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000305|PubMed:18393449,
FT                   ECO:0000305|PubMed:30367560"
FT   BINDING         401
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20211621,
FT                   ECO:0007744|PDB:3LLI, ECO:0007744|PDB:3LLK"
FT   BINDING         408
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20211621,
FT                   ECO:0007744|PDB:3LLI, ECO:0007744|PDB:3LLK"
FT   BINDING         412
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20211621,
FT                   ECO:0007744|PDB:3LLI, ECO:0007744|PDB:3LLK"
FT   BINDING         451
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20211621,
FT                   ECO:0007744|PDB:3LLI, ECO:0007744|PDB:3LLK"
FT   BINDING         455
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20211621,
FT                   ECO:0007744|PDB:3LLI, ECO:0007744|PDB:3LLK"
FT   BINDING         500
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20211621,
FT                   ECO:0007744|PDB:3LLI, ECO:0007744|PDB:3LLK"
FT   BINDING         503
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20211621,
FT                   ECO:0007744|PDB:3LLI, ECO:0007744|PDB:3LLK"
FT   MOD_RES         426
FT                   /note="Phosphoserine; by FAM20C"
FT                   /evidence="ECO:0000269|PubMed:26091039"
FT   CARBOHYD        130
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19139490, ECO:0000269|PubMed:29757379"
FT   CARBOHYD        243
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:29757379"
FT   CARBOHYD        575
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        70..73
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000305|PubMed:18393449,
FT                   ECO:0000305|PubMed:20211621, ECO:0000305|PubMed:23704371,
FT                   ECO:0000305|PubMed:30367560, ECO:0007744|PDB:3LLI,
FT                   ECO:0007744|PDB:3LLK"
FT   DISULFID        101..110
FT                   /evidence="ECO:0000269|PubMed:22801504,
FT                   ECO:0000269|PubMed:23867277, ECO:0007744|PDB:3Q6O,
FT                   ECO:0007744|PDB:4IJ3"
FT   DISULFID        393..405
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000269|PubMed:20211621, ECO:0007744|PDB:3LLI,
FT                   ECO:0007744|PDB:3LLK"
FT   DISULFID        449..452
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000269|PubMed:20211621, ECO:0007744|PDB:3LLI,
FT                   ECO:0007744|PDB:3LLK"
FT   DISULFID        509..512
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000269|PubMed:20211621, ECO:0007744|PDB:3LLI,
FT                   ECO:0007744|PDB:3LLK"
FT   VAR_SEQ         603..604
FT                   /note="AS -> LI (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16806532"
FT                   /id="VSP_020489"
FT   VAR_SEQ         605..747
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16806532"
FT                   /id="VSP_020490"
FT   VARIANT         114
FT                   /note="N -> S (in dbSNP:rs3894211)"
FT                   /id="VAR_027429"
FT   VARIANT         200
FT                   /note="G -> A (in dbSNP:rs17855475)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:16806532, ECO:0000269|Ref.4"
FT                   /id="VAR_027430"
FT   VARIANT         256
FT                   /note="R -> M (in dbSNP:rs4360492)"
FT                   /id="VAR_027431"
FT   VARIANT         294
FT                   /note="A -> S (in dbSNP:rs2278943)"
FT                   /id="VAR_027432"
FT   VARIANT         444
FT                   /note="H -> R (in dbSNP:rs12371)"
FT                   /evidence="ECO:0000269|PubMed:16806532"
FT                   /id="VAR_027433"
FT   VARIANT         591
FT                   /note="N -> H (in dbSNP:rs3738115)"
FT                   /id="VAR_027434"
FT   VARIANT         605
FT                   /note="R -> P (in dbSNP:rs16855466)"
FT                   /id="VAR_053652"
FT   MUTAGEN         70..73
FT                   /note="CGHC->AGHA: Loss of catalytic activity. Cannot
FT                   prevent cell detachment after depletion of the endogenous
FT                   protein."
FT                   /evidence="ECO:0000269|PubMed:23704371,
FT                   ECO:0000269|PubMed:30367560"
FT   MUTAGEN         70
FT                   /note="C->S: Reduces activity by 93%."
FT                   /evidence="ECO:0000269|PubMed:18393449"
FT   MUTAGEN         72
FT                   /note="H->A: Decreased protein stability and catalytic
FT                   activity; when associated with S-119 or T-119."
FT                   /evidence="ECO:0000269|PubMed:30367560"
FT   MUTAGEN         73
FT                   /note="C->S: Reduces activity by 93%."
FT                   /evidence="ECO:0000269|PubMed:18393449"
FT   MUTAGEN         119
FT                   /note="P->S,T: Loss of catalytic activity. Decreased
FT                   protein stability and catalytic activity; when associated
FT                   with A-72."
FT                   /evidence="ECO:0000269|PubMed:30367560"
FT   MUTAGEN         130
FT                   /note="N->Q: Loss of glycosylation site."
FT                   /evidence="ECO:0000269|PubMed:29757379"
FT   MUTAGEN         243
FT                   /note="N->Q: Loss of glycosylation site. Abolishes
FT                   secretion. No effect on catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:29757379"
FT   MUTAGEN         276..282
FT                   /note="TTVAPTT->ANVAPVA: Decreased O-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:29757379"
FT   MUTAGEN         449
FT                   /note="C->S: Reduces activity by 96%."
FT                   /evidence="ECO:0000269|PubMed:18393449"
FT   MUTAGEN         452
FT                   /note="C->S: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:18393449"
FT   MUTAGEN         509
FT                   /note="C->S: No effect. Reduces activity by 70%; when
FT                   associated with S-512."
FT                   /evidence="ECO:0000269|PubMed:18393449"
FT   MUTAGEN         512
FT                   /note="C->S: Reduces activity by 40%. Reduces activity by
FT                   70%; when associated with S-509."
FT                   /evidence="ECO:0000269|PubMed:18393449"
FT   STRAND          40..45
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   TURN            47..49
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   HELIX           50..54
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   STRAND          58..66
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   HELIX           71..80
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   HELIX           83..86
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   HELIX           88..90
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   TURN            91..93
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   STRAND          94..100
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   TURN            104..106
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   HELIX           107..112
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   STRAND          117..124
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   STRAND          130..132
FT                   /evidence="ECO:0007829|PDB:4IJ3"
FT   STRAND          134..136
FT                   /evidence="ECO:0007829|PDB:4IJ3"
FT   HELIX           143..155
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   HELIX           174..177
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   HELIX           179..182
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   STRAND          186..193
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   HELIX           199..206
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   TURN            207..209
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   STRAND          213..219
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   HELIX           223..229
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   STRAND          234..241
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   STRAND          246..248
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   STRAND          252..255
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   HELIX           256..264
FT                   /evidence="ECO:0007829|PDB:3Q6O"
FT   STRAND          298..300
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   HELIX           301..313
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   HELIX           316..318
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   STRAND          320..323
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   HELIX           324..340
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   HELIX           345..360
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   STRAND          363..367
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   HELIX           368..377
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   HELIX           380..383
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   STRAND          400..402
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   HELIX           403..419
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   HELIX           426..431
FT                   /evidence="ECO:0007829|PDB:3LLI"
FT   HELIX           432..434
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   HELIX           435..446
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   HELIX           450..463
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   HELIX           464..466
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   HELIX           470..488
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   STRAND          502..504
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   TURN            506..508
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   HELIX           510..512
FT                   /evidence="ECO:0007829|PDB:3LLI"
FT   STRAND          517..519
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   HELIX           524..534
FT                   /evidence="ECO:0007829|PDB:3LLK"
FT   HELIX           537..539
FT                   /evidence="ECO:0007829|PDB:3LLK"
SQ   SEQUENCE   747 AA;  82578 MW;  52639D09A50E00C5 CRC64;
     MRRCNSGSGP PPSLLLLLLW LLAVPGANAA PRSALYSPSD PLTLLQADTV RGAVLGSRSA
     WAVEFFASWC GHCIAFAPTW KALAEDVKAW RPALYLAALD CAEETNSAVC RDFNIPGFPT
     VRFFKAFTKN GSGAVFPVAG ADVQTLRERL IDALESHHDT WPPACPPLEP AKLEEIDGFF
     ARNNEEYLAL IFEKGGSYLG REVALDLSQH KGVAVRRVLN TEANVVRKFG VTDFPSCYLL
     FRNGSVSRVP VLMESRSFYT AYLQRLSGLT REAAQTTVAP TTANKIAPTV WKLADRSKIY
     MADLESALHY ILRIEVGRFP VLEGQRLVAL KKFVAVLAKY FPGRPLVQNF LHSVNEWLKR
     QKRNKIPYSF FKTALDDRKE GAVLAKKVNW IGCQGSEPHF RGFPCSLWVL FHFLTVQAAR
     QNVDHSQEAA KAKEVLPAIR GYVHYFFGCR DCASHFEQMA AASMHRVGSP NAAVLWLWSS
     HNRVNARLAG APSEDPQFPK VQWPPRELCS ACHNERLDVP VWDVEATLNF LKAHFSPSNI
     ILDFPAAGSA ARRDVQNVAA APELAMGALE LESRNSTLDP GKPEMMKSPT NTTPHVPAEG
     PEASRPPKLH PGLRAAPGQE PPEHMAELQR NEQEQPLGQW HLSKRDTGAA LLAESRAEKN
     RLWGPLEVRR VGRSSKQLVD IPEGQLEARA GRGRGQWLQV LGGGFSYLDI SLCVGLYSLS
     FMGLLAMYTY FQAKIRALKG HAGHPAA
//
ID   SDHA_ECOLI              Reviewed;         588 AA.
AC   P0AC41; P10444; P78282;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   08-NOV-2005, sequence version 1.
DT   02-JUN-2021, entry version 139.
DE   RecName: Full=Succinate dehydrogenase flavoprotein subunit;
DE            EC=1.3.5.1 {ECO:0000305|PubMed:19710024};
GN   Name=sdhA; OrderedLocusNames=b0723, JW0713;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=6383359; DOI=10.1042/bj2220519;
RA   Wood D., Darlison M.G., Wilde R.J., Guest J.R.;
RT   "Nucleotide sequence encoding the flavoprotein and hydrophobic subunits of
RT   the succinate dehydrogenase of Escherichia coli.";
RL   Biochem. J. 222:519-534(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=8905232; DOI=10.1093/dnares/3.3.137;
RA   Oshima T., Aiba H., Baba T., Fujita K., Hayashi K., Honjo A., Ikemoto K.,
RA   Inada T., Itoh T., Kajihara M., Kanai K., Kashimoto K., Kimura S.,
RA   Kitagawa M., Makino K., Masuda S., Miki T., Mizobuchi K., Mori H.,
RA   Motomura K., Nakamura Y., Nashimoto H., Nishio Y., Saito N., Sampei G.,
RA   Seki Y., Tagami H., Takemoto K., Wada C., Yamamoto Y., Yano M.,
RA   Horiuchi T.;
RT   "A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to
RT   the 12.7-28.0 min region on the linkage map.";
RL   DNA Res. 3:137-155(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 578-588.
RC   STRAIN=K12;
RX   PubMed=6388571; DOI=10.1042/bj2230507;
RA   Darlison M.G., Guest J.R.;
RT   "Nucleotide sequence encoding the iron-sulphur protein subunit of the
RT   succinate dehydrogenase of Escherichia coli.";
RL   Biochem. J. 223:507-517(1984).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-12.
RC   STRAIN=K12 / EMG2;
RX   PubMed=9298646; DOI=10.1002/elps.1150180807;
RA   Link A.J., Robison K., Church G.M.;
RT   "Comparing the predicted and observed properties of proteins encoded in the
RT   genome of Escherichia coli K-12.";
RL   Electrophoresis 18:1259-1313(1997).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-4.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9600841; DOI=10.1006/jmbi.1998.1726;
RA   Wilkins M.R., Gasteiger E., Tonella L., Ou K., Tyler M., Sanchez J.-C.,
RA   Gooley A.A., Walsh B.J., Bairoch A., Appel R.D., Williams K.L.,
RA   Hochstrasser D.F.;
RT   "Protein identification with N and C-terminal sequence tags in proteome
RT   projects.";
RL   J. Mol. Biol. 278:599-608(1998).
RN   [8]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R., Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [9]
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RC   STRAIN=BL21-DE3;
RX   PubMed=16079137; DOI=10.1074/jbc.m506479200;
RA   Stenberg F., Chovanec P., Maslen S.L., Robinson C.V., Ilag L.,
RA   von Heijne G., Daley D.O.;
RT   "Protein complexes of the Escherichia coli cell envelope.";
RL   J. Biol. Chem. 280:34409-34419(2005).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-267, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=K12 / JW1106, and K12 / MG1655 / ATCC 47076;
RX   PubMed=18723842; DOI=10.1074/mcp.m800187-mcp200;
RA   Zhang J., Sprung R., Pei J., Tan X., Kim S., Zhu H., Liu C.F.,
RA   Grishin N.V., Zhao Y.;
RT   "Lysine acetylation is a highly abundant and evolutionarily conserved
RT   modification in Escherichia coli.";
RL   Mol. Cell. Proteomics 8:215-225(2009).
RN   [11]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=K12 / BW25113;
RX   PubMed=24374335; DOI=10.1016/j.febslet.2013.12.019;
RA   McNeil M.B., Hampton H.G., Hards K.J., Watson B.N., Cook G.M.,
RA   Fineran P.C.;
RT   "The succinate dehydrogenase assembly factor, SdhE, is required for the
RT   flavinylation and activation of fumarate reductase in bacteria.";
RL   FEBS Lett. 588:414-421(2014).
RN   [12]
RP   COFACTOR, SUBUNIT, AND MUTAGENESIS OF GLU-186 AND THR-187.
RC   STRAIN=K12 / RP437;
RX   PubMed=26644464; DOI=10.1074/jbc.m115.690396;
RA   Maklashina E., Rajagukguk S., Starbird C.A., McDonald W.H., Koganitsky A.,
RA   Eisenbach M., Iverson T.M., Cecchini G.;
RT   "Binding of the covalent flavin assembly factor to the flavoprotein subunit
RT   of complex II.";
RL   J. Biol. Chem. 291:2904-2916(2016).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH FAD AND OXALOACETATE,
RP   FUNCTION, COFACTOR, ACTIVITY REGULATION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=12560550; DOI=10.1126/science.1079605;
RA   Yankovskaya V., Horsefield R., Toernroth S., Luna-Chavez C., Miyoshi H.,
RA   Leger C., Byrne B., Cecchini G., Iwata S.;
RT   "Architecture of succinate dehydrogenase and reactive oxygen species
RT   generation.";
RL   Science 299:700-704(2003).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) IN COMPLEX WITH FAD AND OXALOACETATE,
RP   FUNCTION, COFACTOR, AND SUBUNIT.
RX   PubMed=16407191; DOI=10.1074/jbc.m508173200;
RA   Horsefield R., Yankovskaya V., Sexton G., Whittingham W., Shiomi K.,
RA   Omura S., Byrne B., Cecchini G., Iwata S.;
RT   "Structural and computational analysis of the quinone-binding site of
RT   complex II (succinate-ubiquinone oxidoreductase): a mechanism of electron
RT   transfer and proton conduction during ubiquinone reduction.";
RL   J. Biol. Chem. 281:7309-7316(2006).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH FAD AND MALATE-LIKE
RP   INTERMEDIATE, FUNCTION, COFACTOR, CATALYTIC ACTIVITY, PATHWAY, SUBUNIT, AND
RP   ACTIVE SITE.
RX   PubMed=19710024; DOI=10.1074/jbc.m109.010058;
RA   Ruprecht J., Yankovskaya V., Maklashina E., Iwata S., Cecchini G.;
RT   "Structure of Escherichia coli succinate:quinone oxidoreductase with an
RT   occupied and empty quinone-binding site.";
RL   J. Biol. Chem. 284:29836-29846(2009).
CC   -!- FUNCTION: Two distinct, membrane-bound, FAD-containing enzymes are
CC       responsible for the catalysis of fumarate and succinate
CC       interconversion; the fumarate reductase is used in anaerobic growth,
CC       and the succinate dehydrogenase is used in aerobic growth.
CC       {ECO:0000269|PubMed:24374335, ECO:0000305|PubMed:12560550,
CC       ECO:0000305|PubMed:16407191, ECO:0000305|PubMed:19710024}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + succinate = a quinol + fumarate;
CC         Xref=Rhea:RHEA:40523, ChEBI:CHEBI:24646, ChEBI:CHEBI:29806,
CC         ChEBI:CHEBI:30031, ChEBI:CHEBI:132124; EC=1.3.5.1;
CC         Evidence={ECO:0000305|PubMed:19710024};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:12560550, ECO:0000269|PubMed:16407191,
CC         ECO:0000269|PubMed:19710024};
CC       Note=Flavinylated by SdhE, about 5% flavinylation occurs in the absence
CC       of SdhE. {ECO:0000269|PubMed:26644464};
CC   -!- ACTIVITY REGULATION: Inhibited by oxaloacetate.
CC       {ECO:0000269|PubMed:12560550}.
CC   -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle; fumarate
CC       from succinate (bacterial route): step 1/1.
CC       {ECO:0000305|PubMed:19710024}.
CC   -!- SUBUNIT: Part of an enzyme complex containing four subunits: a
CC       flavoprotein, an iron-sulfur, cytochrome b-556, and a hydrophobic
CC       anchor protein. The complex forms trimers. Can be cross-linked to SdhE
CC       (PubMed:26644464). {ECO:0000269|PubMed:12560550,
CC       ECO:0000269|PubMed:16079137, ECO:0000269|PubMed:16407191,
CC       ECO:0000269|PubMed:19710024, ECO:0000269|PubMed:26644464}.
CC   -!- INTERACTION:
CC       P0AC41; P07014: sdhB; NbExp=2; IntAct=EBI-371263, EBI-1035514;
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000269|PubMed:12560550,
CC       ECO:0000269|PubMed:16079137}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:12560550, ECO:0000269|PubMed:16079137}; Cytoplasmic
CC       side {ECO:0000269|PubMed:12560550, ECO:0000269|PubMed:16079137}.
CC   -!- DISRUPTION PHENOTYPE: No effect on anaerobic growth on glycerol
CC       fumarate medium. {ECO:0000269|PubMed:18723842}.
CC   -!- SIMILARITY: Belongs to the FAD-dependent oxidoreductase 2 family.
CC       FRD/SDH subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J01619; AAA23895.1; -; Genomic_DNA.
DR   EMBL; X00980; CAA25487.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC73817.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA35390.1; -; Genomic_DNA.
DR   EMBL; X01070; CAA25533.1; -; Genomic_DNA.
DR   PIR; B64808; DEECSF.
DR   RefSeq; NP_415251.1; NC_000913.3.
DR   RefSeq; WP_000775540.1; NZ_STEB01000035.1.
DR   PDB; 1NEK; X-ray; 2.60 A; A=1-588.
DR   PDB; 1NEN; X-ray; 2.90 A; A=1-588.
DR   PDB; 2ACZ; X-ray; 3.10 A; A=1-588.
DR   PDB; 2AD0; Model; -; A=1-588.
DR   PDB; 2WDQ; X-ray; 2.40 A; A/E/I=1-588.
DR   PDB; 2WDR; X-ray; 3.20 A; A/E/I=1-588.
DR   PDB; 2WDV; X-ray; 3.20 A; A/E/I=1-588.
DR   PDB; 2WP9; X-ray; 2.70 A; A/E/I=1-588.
DR   PDB; 2WS3; X-ray; 3.20 A; A/E/I=1-588.
DR   PDB; 2WU2; X-ray; 2.50 A; A/E/I=1-588.
DR   PDB; 2WU5; X-ray; 2.80 A; A/E/I=1-588.
DR   PDB; 7JZ2; EM; 2.50 A; A/E/I=1-588.
DR   PDBsum; 1NEK; -.
DR   PDBsum; 1NEN; -.
DR   PDBsum; 2ACZ; -.
DR   PDBsum; 2AD0; -.
DR   PDBsum; 2WDQ; -.
DR   PDBsum; 2WDR; -.
DR   PDBsum; 2WDV; -.
DR   PDBsum; 2WP9; -.
DR   PDBsum; 2WS3; -.
DR   PDBsum; 2WU2; -.
DR   PDBsum; 2WU5; -.
DR   PDBsum; 7JZ2; -.
DR   SMR; P0AC41; -.
DR   BioGRID; 4262907; 31.
DR   BioGRID; 849776; 2.
DR   ComplexPortal; CPX-1931; Respiratory chain complex II.
DR   DIP; DIP-31877N; -.
DR   IntAct; P0AC41; 91.
DR   MINT; P0AC41; -.
DR   STRING; 511145.b0723; -.
DR   DrugBank; DB07671; 2-[1-METHYLHEXYL]-4,6-DINITROPHENOL.
DR   DrugBank; DB04631; Atpenin A5.
DR   DrugBank; DB08690; Ubiquinone Q2.
DR   iPTMnet; P0AC41; -.
DR   SWISS-2DPAGE; P0AC41; -.
DR   jPOST; P0AC41; -.
DR   PaxDb; P0AC41; -.
DR   PRIDE; P0AC41; -.
DR   EnsemblBacteria; AAC73817; AAC73817; b0723.
DR   EnsemblBacteria; BAA35390; BAA35390; BAA35390.
DR   GeneID; 61753019; -.
DR   GeneID; 945402; -.
DR   KEGG; ecj:JW0713; -.
DR   KEGG; eco:b0723; -.
DR   PATRIC; fig|1411691.4.peg.1549; -.
DR   EchoBASE; EB0924; -.
DR   eggNOG; COG1053; Bacteria.
DR   HOGENOM; CLU_014312_6_1_6; -.
DR   InParanoid; P0AC41; -.
DR   PhylomeDB; P0AC41; -.
DR   BioCyc; EcoCyc:SDH-FLAVO; -.
DR   BioCyc; MetaCyc:SDH-FLAVO; -.
DR   BRENDA; 1.3.5.1; 2026.
DR   UniPathway; UPA00223; UER01005.
DR   EvolutionaryTrace; P0AC41; -.
DR   PHI-base; PHI:7964; -.
DR   PRO; PR:P0AC41; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IDA:EcoliWiki.
DR   GO; GO:0045282; C:plasma membrane succinate dehydrogenase complex; IDA:EcoliWiki.
DR   GO; GO:0009055; F:electron transfer activity; IDA:EcoCyc.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:EcoliWiki.
DR   GO; GO:0008177; F:succinate dehydrogenase (ubiquinone) activity; IEA:UniProtKB-EC.
DR   GO; GO:0000104; F:succinate dehydrogenase activity; IMP:EcoliWiki.
DR   GO; GO:0009060; P:aerobic respiration; IGI:EcoliWiki.
DR   GO; GO:0009061; P:anaerobic respiration; IBA:GO_Central.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IGI:EcoliWiki.
DR   Gene3D; 3.50.50.60; -; 1.
DR   Gene3D; 3.90.700.10; -; 1.
DR   InterPro; IPR003953; FAD-binding_2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR003952; FRD_SDH_FAD_BS.
DR   InterPro; IPR037099; Fum_R/Succ_DH_flav-like_C_sf.
DR   InterPro; IPR015939; Fum_Rdtase/Succ_DH_flav-like_C.
DR   InterPro; IPR027477; Succ_DH/fumarate_Rdtase_cat_sf.
DR   InterPro; IPR011281; Succ_DH_flav_su_fwd.
DR   InterPro; IPR014006; Succ_Dhase_FrdA_Gneg.
DR   Pfam; PF00890; FAD_binding_2; 1.
DR   Pfam; PF02910; Succ_DH_flav_C; 1.
DR   SUPFAM; SSF46977; SSF46977; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF56425; SSF56425; 1.
DR   TIGRFAMs; TIGR01816; sdhA_forward; 1.
DR   TIGRFAMs; TIGR01812; sdhA_frdA_Gneg; 1.
DR   PROSITE; PS00504; FRD_SDH_FAD_BINDING; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell inner membrane; Cell membrane;
KW   Direct protein sequencing; Electron transport; FAD; Flavoprotein; Membrane;
KW   Oxidoreductase; Reference proteome; Transport; Tricarboxylic acid cycle.
FT   CHAIN           1..588
FT                   /note="Succinate dehydrogenase flavoprotein subunit"
FT                   /id="PRO_0000158652"
FT   NP_BIND         14..19
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12560550,
FT                   ECO:0000269|PubMed:16407191, ECO:0000269|PubMed:19710024"
FT   NP_BIND         37..52
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12560550,
FT                   ECO:0000269|PubMed:16407191, ECO:0000269|PubMed:19710024"
FT   NP_BIND         404..405
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12560550,
FT                   ECO:0000269|PubMed:16407191, ECO:0000269|PubMed:19710024"
FT   ACT_SITE        286
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000269|PubMed:19710024"
FT   BINDING         221
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12560550,
FT                   ECO:0000269|PubMed:16407191, ECO:0000269|PubMed:19710024"
FT   BINDING         242
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:19710024"
FT   BINDING         254
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:19710024"
FT   BINDING         354
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:19710024"
FT   BINDING         388
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12560550,
FT                   ECO:0000269|PubMed:16407191, ECO:0000269|PubMed:19710024"
FT   BINDING         399
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:19710024"
FT   MOD_RES         45
FT                   /note="Tele-8alpha-FAD histidine"
FT                   /evidence="ECO:0000269|PubMed:12560550,
FT                   ECO:0000269|PubMed:16407191, ECO:0000269|PubMed:19710024"
FT   MOD_RES         267
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:18723842"
FT   MUTAGEN         186
FT                   /note="E->M: Allows recovery of protein cross-linked to
FT                   SdhE, SdhA is flavinylated."
FT                   /evidence="ECO:0000269|PubMed:26644464"
FT   MUTAGEN         187
FT                   /note="T->M: No recovery of protein cross-linked to SdhE,
FT                   SdhA is flavinylated."
FT                   /evidence="ECO:0000269|PubMed:26644464"
FT   CONFLICT        20..22
FT                   /note="MRA -> IAR (in Ref. 1; AAA23895/CAA25487)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..13
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           17..28
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          33..39
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           41..43
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           45..48
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          59..61
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           65..75
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   TURN            76..78
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           82..101
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          112..114
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          119..121
FT                   /evidence="ECO:0007829|PDB:1NEK"
FT   TURN            125..127
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          129..135
FT                   /evidence="ECO:0007829|PDB:1NEK"
FT   HELIX           141..155
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          159..162
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          164..171
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          177..184
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   TURN            185..187
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          190..200
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           206..208
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          209..214
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           221..228
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          233..235
FT                   /evidence="ECO:0007829|PDB:1NEK"
FT   STRAND          239..246
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   TURN            247..249
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           256..259
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          263..265
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           273..276
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   TURN            278..280
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           281..283
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           286..298
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          305..307
FT                   /evidence="ECO:0007829|PDB:1NEK"
FT   STRAND          309..314
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           316..318
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           319..326
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           328..337
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   TURN            342..344
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          347..356
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          359..362
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          367..371
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          373..375
FT                   /evidence="ECO:0007829|PDB:1NEK"
FT   STRAND          377..385
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           387..389
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          393..395
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           403..417
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           419..426
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           434..439
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           442..449
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          452..454
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           456..470
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          471..475
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           477..494
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          504..506
FT                   /evidence="ECO:0007829|PDB:2WU2"
FT   HELIX           508..532
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          542..545
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   HELIX           550..553
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          554..560
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   TURN            561..564
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          565..569
FT                   /evidence="ECO:0007829|PDB:2WDQ"
FT   STRAND          576..578
FT                   /evidence="ECO:0007829|PDB:2WDQ"
SQ   SEQUENCE   588 AA;  64422 MW;  837F9A63991B6CE8 CRC64;
     MKLPVREFDA VVIGAGGAGM RAALQISQSG QTCALLSKVF PTRSHTVSAQ GGITVALGNT
     HEDNWEWHMY DTVKGSDYIG DQDAIEYMCK TGPEAILELE HMGLPFSRLD DGRIYQRPFG
     GQSKNFGGEQ AARTAAAADR TGHALLHTLY QQNLKNHTTI FSEWYALDLV KNQDGAVVGC
     TALCIETGEV VYFKARATVL ATGGAGRIYQ STTNAHINTG DGVGMAIRAG VPVQDMEMWQ
     FHPTGIAGAG VLVTEGCRGE GGYLLNKHGE RFMERYAPNA KDLAGRDVVA RSIMIEIREG
     RGCDGPWGPH AKLKLDHLGK EVLESRLPGI LELSRTFAHV DPVKEPIPVI PTCHYMMGGI
     PTKVTGQALT VNEKGEDVVV PGLFAVGEIA CVSVHGANRL GGNSLLDLVV FGRAAGLHLQ
     ESIAEQGALR DASESDVEAS LDRLNRWNNN RNGEDPVAIR KALQECMQHN FSVFREGDAM
     AKGLEQLKVI RERLKNARLD DTSSEFNTQR VECLELDNLM ETAYATAVSA NFRTESRGAH
     SRFDFPDRDD ENWLCHSLYL PESESMTRRS VNMEPKLRPA FPPKIRTY
//
ID   SIDA_ASPFU              Reviewed;         501 AA.
AC   E9QYP0; Q4X250; Q5SE95;
DT   26-NOV-2014, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 1.
DT   02-JUN-2021, entry version 61.
DE   RecName: Full=L-ornithine N(5)-monooxygenase {ECO:0000303|PubMed:15504822};
DE            Short=OMO {ECO:0000250|UniProtKB:G5EB76};
DE            EC=1.14.13.196 {ECO:0000269|PubMed:20614882, ECO:0000269|PubMed:20650894};
DE   AltName: Full=L-ornithine N(5)-oxygenase {ECO:0000303|PubMed:16113265};
DE   AltName: Full=Siderophore biosynthesis protein A {ECO:0000303|PubMed:15504822};
GN   Name=sidA {ECO:0000303|PubMed:15504822}; ORFNames=Afu2g07680;
OS   Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC
OS   A1100) (Aspergillus fumigatus).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC   Aspergillus subgen. Fumigati.
OX   NCBI_TaxID=330879;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, PATHWAY, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=15504822; DOI=10.1084/jem.20041242;
RA   Schrettl M., Bignell E., Kragl C., Joechl C., Rogers T., Arst H.N. Jr.,
RA   Haynes K., Haas H.;
RT   "Siderophore biosynthesis but not reductive iron assimilation is essential
RT   for Aspergillus fumigatus virulence.";
RL   J. Exp. Med. 200:1213-1219(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=NIH 5233 / ATCC 13073;
RX   PubMed=16113265; DOI=10.1128/iai.73.9.5493-5503.2005;
RA   Hissen A.H., Wan A.N., Warwas M.L., Pinto L.J., Moore M.M.;
RT   "The Aspergillus fumigatus siderophore biosynthetic gene sidA, encoding L-
RT   ornithine N(5)-oxygenase, is required for virulence.";
RL   Infect. Immun. 73:5493-5503(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100;
RX   PubMed=16372009; DOI=10.1038/nature04332;
RA   Nierman W.C., Pain A., Anderson M.J., Wortman J.R., Kim H.S., Arroyo J.,
RA   Berriman M., Abe K., Archer D.B., Bermejo C., Bennett J.W., Bowyer P.,
RA   Chen D., Collins M., Coulsen R., Davies R., Dyer P.S., Farman M.L.,
RA   Fedorova N., Fedorova N.D., Feldblyum T.V., Fischer R., Fosker N.,
RA   Fraser A., Garcia J.L., Garcia M.J., Goble A., Goldman G.H., Gomi K.,
RA   Griffith-Jones S., Gwilliam R., Haas B.J., Haas H., Harris D.E.,
RA   Horiuchi H., Huang J., Humphray S., Jimenez J., Keller N., Khouri H.,
RA   Kitamoto K., Kobayashi T., Konzack S., Kulkarni R., Kumagai T., Lafton A.,
RA   Latge J.-P., Li W., Lord A., Lu C., Majoros W.H., May G.S., Miller B.L.,
RA   Mohamoud Y., Molina M., Monod M., Mouyna I., Mulligan S., Murphy L.D.,
RA   O'Neil S., Paulsen I., Penalva M.A., Pertea M., Price C., Pritchard B.L.,
RA   Quail M.A., Rabbinowitsch E., Rawlins N., Rajandream M.A., Reichard U.,
RA   Renauld H., Robson G.D., Rodriguez de Cordoba S., Rodriguez-Pena J.M.,
RA   Ronning C.M., Rutter S., Salzberg S.L., Sanchez M., Sanchez-Ferrero J.C.,
RA   Saunders D., Seeger K., Squares R., Squares S., Takeuchi M., Tekaia F.,
RA   Turner G., Vazquez de Aldana C.R., Weidman J., White O., Woodward J.R.,
RA   Yu J.-H., Fraser C.M., Galagan J.E., Asai K., Machida M., Hall N.,
RA   Barrell B.G., Denning D.W.;
RT   "Genomic sequence of the pathogenic and allergenic filamentous fungus
RT   Aspergillus fumigatus.";
RL   Nature 438:1151-1156(2005).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17845073; DOI=10.1371/journal.ppat.0030128;
RA   Schrettl M., Bignell E., Kragl C., Sabiha Y., Loss O., Eisendle M.,
RA   Wallner A., Arst H.N. Jr., Haynes K., Haas H.;
RT   "Distinct roles for intra- and extracellular siderophores during
RT   Aspergillus fumigatus infection.";
RL   PLoS Pathog. 3:1195-1207(2007).
RN   [5]
RP   INDUCTION.
RX   PubMed=18721228; DOI=10.1111/j.1365-2958.2008.06376.x;
RA   Schrettl M., Kim H.S., Eisendle M., Kragl C., Nierman W.C., Heinekamp T.,
RA   Werner E.R., Jacobsen I., Illmer P., Yi H., Brakhage A.A., Haas H.;
RT   "SreA-mediated iron regulation in Aspergillus fumigatus.";
RL   Mol. Microbiol. 70:27-43(2008).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR,
RP   PATHWAY, SUBUNIT, AND MASS SPECTROMETRY.
RC   STRAIN=ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100;
RX   PubMed=20614882; DOI=10.1021/bi100291n;
RA   Chocklett S.W., Sobrado P.;
RT   "Aspergillus fumigatus SidA is a highly specific ornithine hydroxylase with
RT   bound flavin cofactor.";
RL   Biochemistry 49:6777-6783(2010).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND COFACTOR.
RX   PubMed=20650894; DOI=10.1074/jbc.m110.157578;
RA   Mayfield J.A., Frederick R.E., Streit B.R., Wencewicz T.A., Ballou D.P.,
RA   DuBois J.L.;
RT   "Comprehensive spectroscopic, steady state, and transient kinetic studies
RT   of a representative siderophore-associated flavin monooxygenase.";
RL   J. Biol. Chem. 285:30375-30388(2010).
RN   [8]
RP   FUNCTION.
RX   PubMed=21622789; DOI=10.1128/aem.00182-11;
RA   Blatzer M., Schrettl M., Sarg B., Lindner H.H., Pfaller K., Haas H.;
RT   "SidL, an Aspergillus fumigatus transacetylase involved in biosynthesis of
RT   the siderophores ferricrocin and hydroxyferricrocin.";
RL   Appl. Environ. Microbiol. 77:4959-4966(2011).
RN   [9]
RP   FUNCTION.
RX   PubMed=22465572; DOI=10.1016/j.bbapap.2012.03.004;
RA   Romero E., Fedkenheuer M., Chocklett S.W., Qi J., Oppenheimer M.,
RA   Sobrado P.;
RT   "Dual role of NADP(H) in the reaction of a flavin dependent N-hydroxylating
RT   monooxygenase.";
RL   Biochim. Biophys. Acta 1824:850-857(2012).
RN   [10]
RP   FUNCTION.
RX   PubMed=22106303; DOI=10.1073/pnas.1106399108;
RA   Yasmin S., Alcazar-Fuoli L., Gruendlinger M., Puempel T., Cairns T.,
RA   Blatzer M., Lopez J.F., Grimalt J.O., Bignell E., Haas H.;
RT   "Mevalonate governs interdependency of ergosterol and siderophore
RT   biosyntheses in the fungal pathogen Aspergillus fumigatus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:E497-E504(2012).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH FAD; NADP;
RP   L-ORNITHINE; LYSINE AND L-ARGININE.
RX   PubMed=22928747; DOI=10.1021/bi301072w;
RA   Franceschini S., Fedkenheuer M., Vogelaar N.J., Robinson H.H., Sobrado P.,
RA   Mattevi A.;
RT   "Structural insight into the mechanism of oxygen activation and substrate
RT   selectivity of flavin-dependent N-hydroxylating monooxygenases.";
RL   Biochemistry 51:7043-7045(2012).
CC   -!- FUNCTION: L-ornithine N(5)-monooxygenase; part of the siderophore
CC       biosynthetic pathway (PubMed:15504822, PubMed:16113265,
CC       PubMed:17845073, PubMed:20614882, PubMed:20650894, PubMed:22465572).
CC       Aspergillus fumigatus produces four types of siderophores, low-
CC       molecular-mass iron chelators, including excreted fusarinine C (FsC)
CC       and triacetylfusarinine C (TAFC) for iron uptake; and intacellular
CC       ferricrocin (FC) for hyphal and hydroxyferricrocin (HFC) for conidial
CC       iron distribution and storage. TAFC consists of three N(2)-acetyl-N(5)-
CC       anhydromevalonyl-N(5)-hydroxyornithine residues cyclically linked by
CC       ester bonds; FC is a cyclic hexapeptide with the structure Gly-Ser-Gly-
CC       (N(5)-acetyl-N(5)-hydroxyornithine)x3. The biosynthesis of all four
CC       siderophores depends on the hydroxylation of ornithine, catalyzed by
CC       the monooxygenase sidA (PubMed:15504822, PubMed:16113265,
CC       PubMed:20614882, PubMed:20650894, PubMed:22465572). SidA is highly
CC       specific for its substrate, only hydrolyzing l-ornithine, and has
CC       preference for NADPH over NADH, NADPH playing a role in stabilization
CC       of the C4a-hydroperoxyflavin intermediate (PubMed:20614882,
CC       PubMed:22465572). Subsequently, the pathways for biosynthesis of
CC       extra- and intracellular siderophores split (PubMed:17845073). For
CC       biosynthesis of extracellular siderophores, the transacylase sidF
CC       transfers anhydromevalonyl to N(5)-hydroxyornithine (PubMed:17845073).
CC       The required anhydromevalonyl-CoA moiety is derived from mevalonate by
CC       CoA ligation and dehydration catalyzed by sidI and sidH respectively
CC       (PubMed:22106303). The acetylation of N(5)-hydroxyornithine for FC
CC       biosynthesis involves the constitutively expressed sidL
CC       (PubMed:21622789). FC is hydroxylated to HFC by an as yet
CC       uncharacterized enzyme during conidiation (PubMed:17845073). Assembly
CC       of fusarinine C (FsC) and FC is catalyzed by two different nonribosomal
CC       peptide synthetases (NRPS), sidD and sidC respectively
CC       (PubMed:17845073). Subsequently, sidG catalyzes N2-acetylation of FsC
CC       for forming TAFC (PubMed:17845073). Both extra- and intracellular
CC       siderophores are crucial for growth during iron limitation and
CC       virulence (PubMed:16113265). {ECO:0000269|PubMed:15504822,
CC       ECO:0000269|PubMed:16113265, ECO:0000269|PubMed:17845073,
CC       ECO:0000269|PubMed:20614882, ECO:0000269|PubMed:20650894,
CC       ECO:0000269|PubMed:21622789, ECO:0000269|PubMed:22106303,
CC       ECO:0000269|PubMed:22465572}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-ornithine + NADPH + O2 = H2O + N(5)-hydroxy-L-ornithine +
CC         NADP(+); Xref=Rhea:RHEA:41508, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:46911, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:78275; EC=1.14.13.196;
CC         Evidence={ECO:0000269|PubMed:20614882, ECO:0000269|PubMed:20650894};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-ornithine + NADH + O2 = H2O + N(5)-hydroxy-L-ornithine +
CC         NAD(+); Xref=Rhea:RHEA:41512, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:46911, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:78275; EC=1.14.13.196;
CC         Evidence={ECO:0000269|PubMed:20614882, ECO:0000269|PubMed:20650894};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:20614882, ECO:0000269|PubMed:20650894,
CC         ECO:0000269|PubMed:22928747};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:20614882,
CC       ECO:0000269|PubMed:20650894, ECO:0000269|PubMed:22928747};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.7 mM for L-ornithine (in the presence of 1 mM NADH)
CC         {ECO:0000269|PubMed:20614882};
CC         KM=1.7 mM for L-ornithine (in the presence of 1 mM NADPH)
CC         {ECO:0000269|PubMed:20614882};
CC         KM=0.49 mM for L-ornithine (at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:20650894};
CC         KM=0.58 mM for L-ornithine (at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:20650894};
CC         KM=0.94 mM for NADPH (in the presence of 15 mM L-ornithine)
CC         {ECO:0000269|PubMed:20614882};
CC         KM=0.90 mM for NADH (in the presence of 15 mM L-ornithine)
CC         {ECO:0000269|PubMed:20614882};
CC         KM=4.6 uM for NADPH (at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:20650894};
CC         KM=2.6 uM for NADPH (at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:20650894};
CC         KM=18 uM for O(2) (at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:20650894};
CC         KM=16 uM for O(2) (at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:20650894};
CC         Note=kcat is 29 min(-1) with L-ornithine as substrate and 75 min(-1)
CC         with NADPH as substrate. {ECO:0000269|PubMed:20614882};
CC   -!- PATHWAY: Siderophore biosynthesis; ferrichrome biosynthesis.
CC       {ECO:0000269|PubMed:15504822, ECO:0000269|PubMed:16113265,
CC       ECO:0000269|PubMed:17845073, ECO:0000269|PubMed:20614882,
CC       ECO:0000269|PubMed:20650894, ECO:0000269|PubMed:22465572}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:20614882}.
CC   -!- MASS SPECTROMETRY: Mass=57210; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:20614882};
CC   -!- DISRUPTION PHENOTYPE: Moderatley reduced growth rate during iron
CC       starvation and in iron replete conditions. Only displays 1% of wild-
CC       type conidiospore production in iron-depleted and replete conditions.
CC       Completely attenuates virulence in a mouse model of invasive pulmonary
CC       aspergillosis. {ECO:0000269|PubMed:15504822,
CC       ECO:0000269|PubMed:16113265}.
CC   -!- SIMILARITY: Belongs to the lysine N(6)-hydroxylase/L-ornithine N(5)-
CC       oxygenase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY586511; AAT84594.1; -; Genomic_DNA.
DR   EMBL; AY819708; AAX40989.1; -; Genomic_DNA.
DR   EMBL; AAHF01000001; EAL93065.1; -; Genomic_DNA.
DR   RefSeq; XP_755103.1; XM_750010.1.
DR   PDB; 4B63; X-ray; 1.90 A; A=1-501.
DR   PDB; 4B64; X-ray; 2.28 A; A=1-501.
DR   PDB; 4B65; X-ray; 2.32 A; A=1-501.
DR   PDB; 4B66; X-ray; 2.90 A; A=1-501.
DR   PDB; 4B67; X-ray; 2.75 A; A=1-501.
DR   PDB; 4B68; X-ray; 2.29 A; A=1-501.
DR   PDB; 4B69; X-ray; 2.30 A; A=1-501.
DR   PDB; 4NZH; X-ray; 2.00 A; A=1-501.
DR   PDB; 5CKU; X-ray; 2.10 A; A=1-501.
DR   PDB; 6X0H; X-ray; 2.09 A; A/B/C/D=29-501.
DR   PDB; 6X0I; X-ray; 1.95 A; A/B/C/D=1-501.
DR   PDB; 6X0J; X-ray; 2.33 A; A/B/C/D=29-501.
DR   PDB; 6X0K; X-ray; 2.23 A; A/B/C/D/E/F/G/H=29-501.
DR   PDB; 7JVK; X-ray; 2.20 A; A/B/C/D=1-501.
DR   PDB; 7JVL; X-ray; 2.10 A; A/B/C/D=1-501.
DR   PDBsum; 4B63; -.
DR   PDBsum; 4B64; -.
DR   PDBsum; 4B65; -.
DR   PDBsum; 4B66; -.
DR   PDBsum; 4B67; -.
DR   PDBsum; 4B68; -.
DR   PDBsum; 4B69; -.
DR   PDBsum; 4NZH; -.
DR   PDBsum; 5CKU; -.
DR   PDBsum; 6X0H; -.
DR   PDBsum; 6X0I; -.
DR   PDBsum; 6X0J; -.
DR   PDBsum; 6X0K; -.
DR   PDBsum; 7JVK; -.
DR   PDBsum; 7JVL; -.
DR   SMR; E9QYP0; -.
DR   STRING; 746128.CADAFUBP00002315; -.
DR   ChEMBL; CHEMBL4295542; -.
DR   EnsemblFungi; EAL93065; EAL93065; AFUA_2G07680.
DR   GeneID; 3513640; -.
DR   KEGG; afm:AFUA_2G07680; -.
DR   VEuPathDB; FungiDB:Afu2g07680; -.
DR   eggNOG; KOG1399; Eukaryota.
DR   HOGENOM; CLU_020931_2_0_1; -.
DR   InParanoid; E9QYP0; -.
DR   OMA; YNDYLRW; -.
DR   OrthoDB; 1235295at2759; -.
DR   BRENDA; 1.14.13.195; 508.
DR   BRENDA; 1.14.13.196; 508.
DR   UniPathway; UPA00783; -.
DR   PHI-base; PHI:377; -.
DR   PHI-base; PHI:486; -.
DR   Proteomes; UP000002530; Chromosome 2.
DR   Proteomes; UP000002530; Unassembled WGS sequence.
DR   GO; GO:0005506; F:iron ion binding; IDA:AspGD.
DR   GO; GO:0004497; F:monooxygenase activity; IDA:AspGD.
DR   GO; GO:0004499; F:N,N-dimethylaniline monooxygenase activity; IDA:AspGD.
DR   GO; GO:0070401; F:NADP+ binding; IDA:AspGD.
DR   GO; GO:0031172; F:ornithine N5-monooxygenase activity; IEA:RHEA.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IMP:AspGD.
DR   GO; GO:0010106; P:cellular response to iron ion starvation; IMP:AspGD.
DR   GO; GO:0006696; P:ergosterol biosynthetic process; IMP:AspGD.
DR   GO; GO:0031169; P:ferrichrome biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0009405; P:pathogenesis; IMP:AspGD.
DR   GO; GO:0044550; P:secondary metabolite biosynthetic process; IMP:AspGD.
DR   GO; GO:0019290; P:siderophore biosynthetic process; IMP:AspGD.
DR   GO; GO:0033214; P:siderophore-dependent iron import into cell; IMP:AspGD.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR025700; Lys/Orn_oxygenase.
DR   Pfam; PF13434; K_oxygenase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Monooxygenase; NADP; Nucleotide-binding;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN           1..501
FT                   /note="L-ornithine N(5)-monooxygenase"
FT                   /id="PRO_0000431070"
FT   NP_BIND         83..91
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22928747"
FT   NP_BIND         254..257
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:22928747"
FT   NP_BIND         323..325
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:22928747"
FT   NP_BIND         466..468
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22928747"
FT   REGION          1..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          293..296
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:22928747"
FT   REGION          366..390
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         102
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:22928747"
FT   BINDING         107
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:22928747"
FT   BINDING         168
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:22928747"
FT   BINDING         279
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:22928747"
FT   BINDING         323
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:22928747"
FT   BINDING         469
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:22928747"
FT   STRAND          40..45
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           49..62
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   TURN            64..66
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           68..70
FT                   /evidence="ECO:0007829|PDB:6X0H"
FT   STRAND          79..87
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           92..94
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           105..107
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   STRAND          108..110
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   TURN            111..113
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           121..128
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           131..135
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           144..156
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           157..161
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   STRAND          162..174
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   STRAND          185..192
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   TURN            193..195
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   STRAND          198..208
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   STRAND          218..220
FT                   /evidence="ECO:0007829|PDB:4B67"
FT   STRAND          226..228
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           229..231
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           232..239
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   STRAND          248..252
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           256..268
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   STRAND          273..277
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   STRAND          279..282
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           292..296
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           300..305
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           309..318
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           320..322
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   TURN            323..325
FT                   /evidence="ECO:0007829|PDB:4NZH"
FT   HELIX           329..345
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           349..351
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   STRAND          353..357
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   STRAND          359..366
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   STRAND          369..372
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   STRAND          374..381
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   STRAND          395..403
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           412..415
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           417..422
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   STRAND          436..438
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   TURN            442..444
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   STRAND          450..453
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           458..461
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   TURN            463..466
FT                   /evidence="ECO:0007829|PDB:4B63"
FT   HELIX           471..490
FT                   /evidence="ECO:0007829|PDB:4B63"
SQ   SEQUENCE   501 AA;  56877 MW;  DD1D4DEDD2509506 CRC64;
     MESVERKSES SYLGMRNMQP EQRLSLDPPR LRSTPQDELH DLLCVGFGPA SLAIAIALHD
     ALDPRLNKSA SNIHAQPKIC FLERQKQFAW HSGMLVPGSK MQISFIKDLA TLRDPRSSFT
     FLNYLHQKGR LIHFTNLSTF LPARLEFEDY MRWCAQQFSD VVAYGEEVVE VIPGKSDPSS
     SVVDFFTVRS RNVETGEISA RRTRKVVIAI GGTAKMPSGL PQDPRIIHSS KYCTTLPALL
     KDKSKPYNIA VLGSGQSAAE IFHDLQKRYP NSRTTLIMRD SAMRPSDDSP FVNEIFNPER
     VDKFYSQSAA ERQRSLLADK ATNYSVVRLE LIEEIYNDMY LQRVKNPDET QWQHRILPER
     KITRVEHHGP QSRMRIHLKS SKPESEGAAN DVKETLEVDA LMVATGYNRN AHERLLSKVQ
     HLRPTGQDQW KPHRDYRVEM DPSKVSSEAG IWLQGCNERT HGLSDSLLSV LAVRGGEMVQ
     SIFGEQLERA AVQGHQLRAM L
//
ID   OXLA_CALRH              Reviewed;         516 AA.
AC   P81382; Q9I849;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 2.
DT   02-JUN-2021, entry version 118.
DE   RecName: Full=L-amino-acid oxidase {ECO:0000303|PubMed:8080286};
DE            Short=LAO;
DE            Short=MPV-LAAO {ECO:0000303|PubMed:8080286};
DE            EC=1.4.3.2 {ECO:0000269|PubMed:11248687, ECO:0000269|PubMed:8080286};
DE   Flags: Precursor;
OS   Calloselasma rhodostoma (Malayan pit viper) (Agkistrodon rhodostoma).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC   Serpentes; Colubroidea; Viperidae; Crotalinae; Calloselasma.
OX   NCBI_TaxID=8717;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 19-33, FUNCTION, CATALYTIC
RP   ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=11248687; DOI=10.1046/j.1432-1033.2001.02042.x;
RA   Macheroux P., Seth O., Bollschweiler C., Schwarz M., Kurfuerst M.,
RA   Au L.-C., Ghisla S.;
RT   "L-amino-acid oxidase from Malayan pit viper Calloselasma rhodostoma:
RT   comparative sequence analysis and characterization of active and inactive
RT   forms of the enzyme.";
RL   Eur. J. Biochem. 268:1679-1686(2001).
RN   [2]
RP   PROTEIN SEQUENCE OF 19-38, SUBUNIT, SUBCELLULAR LOCATION, FUNCTION,
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBSTRATE
RP   SPECIFICITY.
RC   TISSUE=Venom;
RX   PubMed=8080286; DOI=10.1006/abbi.1994.1401;
RA   Ponnudurai G., Chung M.C.M., Tan N.-H.;
RT   "Purification and properties of the L-amino acid oxidase from Malayan pit
RT   viper (Calloselasma rhodostoma) venom.";
RL   Arch. Biochem. Biophys. 313:373-378(1994).
RN   [3]
RP   GLYCOSYLATION AT ASN-190 AND ASN-379, AND MASS SPECTROMETRY.
RX   PubMed=11453999; DOI=10.1046/j.1432-1327.2001.02321.x;
RA   Geyer A., Fitzpatrick T.B., Pawelek P.D., Kitzing K., Vrielink A.,
RA   Ghisla S., Macheroux P.;
RT   "Structure and characterization of the glycan moiety of L-amino-acid
RT   oxidase from the Malayan pit viper Calloselasma rhodostoma.";
RL   Eur. J. Biochem. 268:4044-4053(2001).
RN   [4]
RP   EXPRESSION OF ACTIVE RECOMBINANT LAAO.
RX   PubMed=17127077; DOI=10.1016/j.pep.2006.09.016;
RA   Kommoju P.R., Macheroux P., Ghisla S.;
RT   "Molecular cloning, expression and purification of L-amino acid oxidase
RT   from the Malayan pit viper Calloselasma rhodostoma.";
RL   Protein Expr. Purif. 52:89-95(2007).
RN   [5] {ECO:0000312|PDB:1F8R, ECO:0000312|PDB:1F8S}
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 19-516 IN COMPLEX WITH FAD,
RP   DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-190 AND ASN-379.
RC   TISSUE=Venom;
RX   PubMed=10944103; DOI=10.1093/emboj/19.16.4204;
RA   Pawelek P.D., Cheah J., Coulombe R., Macheroux P., Ghisla S., Vrielink A.;
RT   "The structure of L-amino acid oxidase reveals the substrate trajectory
RT   into an enantiomerically conserved active site.";
RL   EMBO J. 19:4204-4215(2000).
RN   [6] {ECO:0000312|PDB:2IID}
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 19-516 IN COMPLEX WITH FAD AND
RP   SUBSTRATE L-PHE, AND GLYCOSYLATION AT ASN-190 AND ASN-379.
RC   TISSUE=Venom;
RX   PubMed=17046020; DOI=10.1016/j.jmb.2006.09.032;
RA   Moustafa I.M., Foster S., Lyubimov A.Y., Vrielink A.;
RT   "Crystal structure of LAAO from Calloselasma rhodostoma with an L-
RT   phenylalanine substrate: insights into structure and mechanism.";
RL   J. Mol. Biol. 364:991-1002(2006).
CC   -!- FUNCTION: Catalyzes an oxidative deamination of predominantly
CC       hydrophobic and aromatic L-amino acids, thus producing hydrogen
CC       peroxide that may contribute to the diverse toxic effects of this
CC       enzyme (PubMed:11248687, PubMed:8080286). Shows high affinity for L-
CC       Phe, L-Trp, L-Met, L-Leu, and L-Ile, moderate affinity for L-Arg, L-
CC       Asp, and L-His, and very low affinity for L-Gln, L-Lys, and L-Ala
CC       (PubMed:8080286). Also shows high activity on L-norleucine (L-2-
CC       aminohexanoate), and L-norvaline (L-2-aminopentanoate) and a weak
CC       activity on L-ornithine and L-aminobutyric acid (PubMed:8080286). Also
CC       exhibits diverse biological activities, such as hemorrhage, hemolysis,
CC       edema, apoptosis of vascular endothelial cells or tumor cell lines, and
CC       antiparasitic activities, as well as regulation of platelet aggregation
CC       (By similarity). Its effect on platelets is controversial, since it
CC       either induces aggregation or inhibits agonist-induced aggregation.
CC       These different effects are probably due to different experimental
CC       conditions (By similarity). A possible explanation of high efficacy it
CC       that LAAO may bind to target cells through its sialylated glycan moiety
CC       that would bind to sialic acid-binding lectins (siglec) on target cells
CC       (PubMed:11453999). This interaction may result in production of locally
CC       high concentrations of hydrogen peroxide in or near the binding
CC       interface, leading, in turn to oxidative damage of the siglec or
CC       another adjacent cell structural elements (PubMed:11453999).
CC       {ECO:0000250, ECO:0000269|PubMed:11248687, ECO:0000269|PubMed:8080286,
CC       ECO:0000305|PubMed:11453999}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an L-alpha-amino acid + H2O + O2 = a 2-oxocarboxylate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:13781, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:35179,
CC         ChEBI:CHEBI:59869; EC=1.4.3.2; Evidence={ECO:0000269|PubMed:11248687,
CC         ECO:0000269|PubMed:8080286};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-leucine + O2 = 4-methyl-2-oxopentanoate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:60996, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:17865, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:57427; Evidence={ECO:0000269|PubMed:11248687,
CC         ECO:0000269|PubMed:8080286};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-phenylalanine + O2 = 3-phenylpyruvate + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:61240, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:18005, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:58095; Evidence={ECO:0000269|PubMed:8080286};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-tryptophan + O2 = H2O2 + indole-3-pyruvate + NH4(+);
CC         Xref=Rhea:RHEA:61244, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:17640, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:57912; Evidence={ECO:0000269|PubMed:8080286};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-methionine + O2 = 4-methylsulfanyl-2-oxobutanoate +
CC         H2O2 + NH4(+); Xref=Rhea:RHEA:61236, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:16723,
CC         ChEBI:CHEBI:28938, ChEBI:CHEBI:57844;
CC         Evidence={ECO:0000269|PubMed:8080286};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-isoleucine + O2 = (S)-3-methyl-2-oxopentanoate + H2O2
CC         + NH4(+); Xref=Rhea:RHEA:61232, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:35146,
CC         ChEBI:CHEBI:58045; Evidence={ECO:0000269|PubMed:8080286};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-arginine + O2 = 5-guanidino-2-oxopentanoate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:51404, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:32682,
CC         ChEBI:CHEBI:58489; Evidence={ECO:0000269|PubMed:8080286};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-aspartate + O2 = H2O2 + NH4(+) + oxaloacetate;
CC         Xref=Rhea:RHEA:19025, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:16452, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:29991; Evidence={ECO:0000269|PubMed:8080286};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-histidine + O2 = 3-(imidazol-5-yl)pyruvate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:61228, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:57595,
CC         ChEBI:CHEBI:58133; Evidence={ECO:0000269|PubMed:8080286};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-2-aminohexanoate + O2 = 2-oxohexanoate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:61268, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:35177,
CC         ChEBI:CHEBI:58455; Evidence={ECO:0000269|PubMed:8080286};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-2-aminopentanoate + O2 = 2-oxopentanoate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:61272, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28644, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:58441; Evidence={ECO:0000269|PubMed:8080286};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:10944103, ECO:0000269|PubMed:17046020};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.05 mM for L-Phe {ECO:0000269|PubMed:8080286};
CC         KM=0.08 mM for L-Trp {ECO:0000269|PubMed:8080286};
CC         KM=0.13 mM for L-norleucine (L-2-aminohexanoate)
CC         {ECO:0000269|PubMed:8080286};
CC         KM=0.24 mM for L-Met {ECO:0000269|PubMed:8080286};
CC         KM=0.56 mM for L-Leu {ECO:0000269|PubMed:11248687};
CC         KM=0.63 mM for L-Leu {ECO:0000269|PubMed:8080286};
CC         KM=0.8 mM for L-Ile {ECO:0000269|PubMed:8080286};
CC         KM=0.91 mM for L-norvaline (L-2-aminopentanoate)
CC         {ECO:0000269|PubMed:8080286};
CC         KM=2.0 mM for L-Arg {ECO:0000269|PubMed:8080286};
CC         KM=2.5 mM for L-Asn {ECO:0000269|PubMed:8080286};
CC         KM=2.5 mM for L-His {ECO:0000269|PubMed:8080286};
CC         KM=5.0 mM for L-aminobutyric acid {ECO:0000269|PubMed:8080286};
CC         KM=8.0 mM for L-Gln {ECO:0000269|PubMed:8080286};
CC         KM=10.0 mM for L-Lys {ECO:0000269|PubMed:8080286};
CC         KM=12.5 mM for L-Ala {ECO:0000269|PubMed:8080286};
CC         KM=13.3 mM for L-ornithine {ECO:0000269|PubMed:8080286};
CC       pH dependence:
CC         Optimum pH is 9.0.;
CC       Temperature dependence:
CC         Thermostable.;
CC   -!- SUBUNIT: Homodimer; non-covalently linked.
CC       {ECO:0000269|PubMed:10944103, ECO:0000269|PubMed:17046020,
CC       ECO:0000269|PubMed:8080286}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:8080286}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC       {ECO:0000305|PubMed:8080286}.
CC   -!- PTM: N-glycosylated at Asn-190 and Asn-379 with bis-sialylated,
CC       biantennary, core-fucosylated dodecasaccharide (composed of N-
CC       acetylglucosamine, fucose, mannose, galactose, and sialic acid
CC       residues). {ECO:0000269|PubMed:11453999}.
CC   -!- MASS SPECTROMETRY: Mass=59968; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:11453999};
CC   -!- SIMILARITY: Belongs to the flavin monoamine oxidase family. FIG1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ271725; CAB71136.1; -; mRNA.
DR   PDB; 1F8R; X-ray; 2.00 A; A/B/C/D=19-516.
DR   PDB; 1F8S; X-ray; 2.00 A; A/B/C/D/E/F/G/H=19-516.
DR   PDB; 2IID; X-ray; 1.80 A; A/B/C/D=19-516.
DR   PDBsum; 1F8R; -.
DR   PDBsum; 1F8S; -.
DR   PDBsum; 2IID; -.
DR   SMR; P81382; -.
DR   GlyConnect; 322; 4 N-Linked glycans.
DR   iPTMnet; P81382; -.
DR   PRIDE; P81382; -.
DR   BRENDA; 1.4.3.2; 198.
DR   SABIO-RK; P81382; -.
DR   EvolutionaryTrace; P81382; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0106329; F:L-phenylalaine oxidase activity; IEA:RHEA.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0019835; P:cytolysis; IEA:UniProtKB-KW.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic; Antimicrobial; Apoptosis; Cytolysis;
KW   Direct protein sequencing; Disulfide bond; FAD; Flavoprotein; Glycoprotein;
KW   Hemostasis impairing toxin; Oxidoreductase;
KW   Platelet aggregation inhibiting toxin; Secreted; Signal; Toxin.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000269|PubMed:11248687,
FT                   ECO:0000269|PubMed:8080286"
FT   CHAIN           19..516
FT                   /note="L-amino-acid oxidase"
FT                   /evidence="ECO:0000305|PubMed:11248687,
FT                   ECO:0000305|PubMed:8080286"
FT                   /id="PRO_0000001707"
FT   NP_BIND         61..62
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10944103,
FT                   ECO:0000269|PubMed:17046020"
FT   NP_BIND         81..82
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10944103,
FT                   ECO:0000269|PubMed:17046020"
FT   NP_BIND         105..108
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10944103,
FT                   ECO:0000269|PubMed:17046020"
FT   NP_BIND         482..487
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10944103,
FT                   ECO:0000269|PubMed:17046020"
FT   REGION          482..483
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:17046020,
FT                   ECO:0007744|PDB:1F8S, ECO:0007744|PDB:2IID"
FT   BINDING         89
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10944103,
FT                   ECO:0000269|PubMed:17046020"
FT   BINDING         108
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:17046020,
FT                   ECO:0007744|PDB:1F8R, ECO:0007744|PDB:1F8S,
FT                   ECO:0007744|PDB:2IID"
FT   BINDING         241
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:17046020,
FT                   ECO:0007744|PDB:1F8R, ECO:0007744|PDB:1F8S,
FT                   ECO:0007744|PDB:2IID"
FT   BINDING         279
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:10944103,
FT                   ECO:0000269|PubMed:17046020"
FT   BINDING         390
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:17046020,
FT                   ECO:0007744|PDB:1F8R, ECO:0007744|PDB:1F8S,
FT                   ECO:0007744|PDB:2IID"
FT   BINDING         475
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10944103,
FT                   ECO:0000269|PubMed:17046020"
FT   CARBOHYD        190
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:10944103,
FT                   ECO:0000269|PubMed:11453999"
FT   CARBOHYD        379
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:10944103,
FT                   ECO:0000269|PubMed:11453999"
FT   DISULFID        28..191
FT                   /evidence="ECO:0000269|PubMed:10944103"
FT   DISULFID        349..430
FT                   /evidence="ECO:0000269|PubMed:10944103"
FT   CONFLICT        28
FT                   /note="C -> E (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        33
FT                   /note="D -> N (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   HELIX           26..29
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           34..43
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          53..57
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           61..73
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          76..80
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          82..87
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          92..95
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   TURN            96..99
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          100..105
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           114..122
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          127..130
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          137..141
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          144..147
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           148..153
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           155..158
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           164..166
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           171..178
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           180..188
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           191..198
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          200..202
FT                   /evidence="ECO:0007829|PDB:1F8R"
FT   HELIX           203..209
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           215..224
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           228..230
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           235..245
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          251..254
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           260..268
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           269..272
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          273..276
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          278..284
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          289..294
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          296..298
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          302..310
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           314..317
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          320..324
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           328..336
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          342..351
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           353..357
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          361..368
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          372..374
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          385..392
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           393..397
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   TURN            398..401
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           404..419
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           423..429
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          430..437
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           438..440
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   TURN            442..444
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          446..449
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           455..464
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          470..472
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           475..477
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   STRAND          478..482
FT                   /evidence="ECO:0007829|PDB:2IID"
FT   HELIX           484..503
FT                   /evidence="ECO:0007829|PDB:2IID"
SQ   SEQUENCE   516 AA;  58221 MW;  5F9435718B3A3BDE CRC64;
     MNVFFMFSLL FLAALGSCAD DRNPLAECFQ ENDYEEFLEI ARNGLKATSN PKHVVIVGAG
     MAGLSAAYVL AGAGHQVTVL EASERPGGRV RTYRNEEAGW YANLGPMRLP EKHRIVREYI
     RKFDLRLNEF SQENDNAWYF IKNIRKKVGE VKKDPGLLKY PVKPSEAGKS AGQLYEESLG
     KVVEELKRTN CSYILNKYDT YSTKEYLIKE GDLSPGAVDM IGDLLNEDSG YYVSFIESLK
     HDDIFAYEKR FDEIVDGMDK LPTAMYRDIQ DKVHFNAQVI KIQQNDQKVT VVYETLSKET
     PSVTADYVIV CTTSRAVRLI KFNPPLLPKK AHALRSVHYR SGTKIFLTCT TKFWEDDGIH
     GGKSTTDLPS RFIYYPNHNF TNGVGVIIAY GIGDDANFFQ ALDFKDCADI VFNDLSLIHQ
     LPKKDIQSFC YPSVIQKWSL DKYAMGGITT FTPYQFQHFS DPLTASQGRI YFAGEYTAQA
     HGWIDSTIKS GLRAARDVNL ASENPSGIHL SNDNEL
//
ID   THCAS_CANSA             Reviewed;         545 AA.
AC   Q8GTB6; Q33DQ4; Q5NTX8;
DT   06-FEB-2013, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   02-JUN-2021, entry version 75.
DE   RecName: Full=Tetrahydrocannabinolic acid synthase {ECO:0000303|Ref.4};
DE            Short=THCA synthase {ECO:0000303|Ref.4};
DE            EC=1.21.3.7 {ECO:0000269|PubMed:15190053, ECO:0000269|PubMed:17669365, ECO:0000269|Ref.4};
DE   AltName: Full=Delta(1)-tetrahydrocannabinolic acid synthase {ECO:0000303|PubMed:15190053};
DE   Flags: Precursor;
GN   Name=THCAS {ECO:0000303|Ref.4};
OS   Cannabis sativa (Hemp) (Marijuana).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; fabids; Rosales; Cannabaceae; Cannabis.
OX   NCBI_TaxID=3483;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 29-52; 330-339; 426-437 AND
RP   441-455, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   GLYCOSYLATION, AND MUTAGENESIS OF HIS-92; ARG-108; ARG-110; HIS-114 AND
RP   HIS-208.
RX   PubMed=15190053; DOI=10.1074/jbc.m403693200;
RA   Sirikantaramas S., Morimoto S., Shoyama Y., Ishikawa Y., Wada Y.,
RA   Shoyama Y., Taura F.;
RT   "The gene controlling marijuana psychoactivity: molecular cloning and
RT   heterologous expression of Delta1-tetrahydrocannabinolic acid synthase from
RT   Cannabis sativa L.";
RL   J. Biol. Chem. 279:39767-39774(2004).
RN   [2]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=16024552; DOI=10.1093/pcp/pci166;
RA   Sirikantaramas S., Taura F., Tanaka Y., Ishikawa Y., Morimoto S.,
RA   Shoyama Y.;
RT   "Tetrahydrocannabinolic acid synthase, the enzyme controlling marijuana
RT   psychoactivity, is secreted into the storage cavity of the glandular
RT   trichomes.";
RL   Plant Cell Physiol. 46:1578-1582(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], POLYMORPHISM, AND VARIANT LEU-63.
RC   STRAIN=001, 010, 013, 020, 053, 054, and 069;
RX   PubMed=16143478; DOI=10.1016/j.forsciint.2005.07.005;
RA   Kojoma M., Seki H., Yoshida S., Muranaka T.;
RT   "DNA polymorphisms in the tetrahydrocannabinolic acid (THCA) synthase gene
RT   in 'drug-type' and 'fiber-type' Cannabis sativa L.";
RL   Forensic Sci. Int. 159:132-140(2006).
RN   [4]
RP   PROTEIN SEQUENCE OF 29-44, FUNCTION, CATALYTIC ACTIVITY, SUBUNIT,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE SPECIFICITY, AND ACTIVITY
RP   REGULATION.
RA   Taura F., Morimoto S., Shoyama Y.;
RT   "First direct evidence for the mechanism of delta(1)-tetra
RT   hydrocannabinolic acid biosynthesis.";
RL   J. Am. Chem. Soc. 117:9766-9767(1995).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND GLYCOSYLATION.
RX   PubMed=17669365; DOI=10.1016/j.bbrc.2007.07.079;
RA   Taura F., Dono E., Sirikantaramas S., Yoshimura K., Shoyama Y.,
RA   Morimoto S.;
RT   "Production of Delta(1)-tetrahydrocannabinolic acid by the biosynthetic
RT   enzyme secreted from transgenic Pichia pastoris.";
RL   Biochem. Biophys. Res. Commun. 361:675-680(2007).
RN   [6]
RP   REVIEW.
RX   PubMed=17712812; DOI=10.1002/cbdv.200790145;
RA   Taura F., Sirikantaramas S., Shoyama Y., Shoyama Y., Morimoto S.;
RT   "Phytocannabinoids in Cannabis sativa: recent studies on biosynthetic
RT   enzymes.";
RL   Chem. Biodivers. 4:1649-1663(2007).
RN   [7]
RP   PATHWAY, AND REVIEW.
RX   PubMed=30468448; DOI=10.1039/c8np00077h;
RA   Liu Y., Jing S.-X., Luo S.-H., Li S.-H.;
RT   "Non-volatile natural products in plant glandular trichomes: chemistry,
RT   biological activities and biosynthesis.";
RL   Nat. Prod. Rep. 36:626-665(2019).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 28-545 IN COMPLEX WITH FAD,
RP   MUTAGENESIS OF HIS-114; HIS-292; TYR-417; GLU-442 AND TYR-484,
RP   GLYCOSYLATION AT ASN-65; ASN-89; ASN-168; ASN-329; ASN-467 AND ASN-499, AND
RP   DISULFIDE BOND.
RX   PubMed=22766313; DOI=10.1016/j.jmb.2012.06.030;
RA   Shoyama Y., Tamada T., Kurihara K., Takeuchi A., Taura F., Arai S.,
RA   Blaber M., Shoyama Y., Morimoto S., Kuroki R.;
RT   "Structure and function of delta(1)-tetrahydrocannabinolic acid (THCA)
RT   synthase, the enzyme controlling the psychoactivity of Cannabis sativa.";
RL   J. Mol. Biol. 423:96-105(2012).
CC   -!- FUNCTION: Oxidoreductase involved in the biosynthesis of cannabinoids-
CC       related terpenophenolic natural products, which have pharmacological
CC       activity (PubMed:15190053, PubMed:17669365, Ref.4). Catalyzes the
CC       oxidative cyclization of the monoterpene moiety in cannabigerolic acid
CC       (CBGA), producing delta(9)-tetrahydrocannabinolate (THCA), the major
CC       cannabioid in drug-type Cannabis plants (PubMed:15190053,
CC       PubMed:17669365, Ref.4). Can also use cannabinerolic acid as substrate,
CC       but not cannabigerol or cannabinerol (PubMed:15190053, PubMed:17669365,
CC       Ref.4). {ECO:0000269|PubMed:15190053, ECO:0000269|PubMed:17669365,
CC       ECO:0000269|Ref.4}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cannabigerolate + O2 = Delta(9)-tetrahydrocannabinolate +
CC         H2O2; Xref=Rhea:RHEA:34135, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:66962, ChEBI:CHEBI:66963; EC=1.21.3.7;
CC         Evidence={ECO:0000269|PubMed:15190053, ECO:0000269|PubMed:17669365,
CC         ECO:0000269|Ref.4};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:34136;
CC         Evidence={ECO:0000269|PubMed:15190053, ECO:0000269|PubMed:17669365,
CC         ECO:0000269|Ref.4};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:22766313};
CC       Note=Binds 1 FAD per subunit in a bicovalent manner.
CC       {ECO:0000269|PubMed:22766313};
CC   -!- ACTIVITY REGULATION: Inhibited by Hg(2+). {ECO:0000269|Ref.4}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=134 uM for cannabigerolic acid {ECO:0000269|PubMed:15190053,
CC         ECO:0000269|Ref.4};
CC         KM=254 uM for cannabinerolic acid {ECO:0000269|PubMed:15190053,
CC         ECO:0000269|Ref.4};
CC         Vmax=2.68 nmol/sec/mg enzyme with cannabigerolic acid as substrate
CC         {ECO:0000269|PubMed:15190053, ECO:0000269|Ref.4};
CC         Vmax=0.37 nmol/sec/mg enzyme with cannabinerolic acid as substrate
CC         {ECO:0000269|PubMed:15190053, ECO:0000269|Ref.4};
CC         Note=kcat is 0.30 sec(-1) for cannabigerolate.;
CC       pH dependence:
CC         Optimum pH is 5.5-6.0. {ECO:0000269|PubMed:15190053,
CC         ECO:0000269|Ref.4};
CC   -!- PATHWAY: Secondary metabolite biosynthesis; terpenoid biosynthesis.
CC       {ECO:0000303|PubMed:30468448}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:22766313, ECO:0000269|Ref.4}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:16024552}. Secreted,
CC       extracellular space, apoplast {ECO:0000269|PubMed:16024552}.
CC       Note=Sorted from the secretory cells into the storage cavity of
CC       glandular trichomes. {ECO:0000269|PubMed:16024552}.
CC   -!- TISSUE SPECIFICITY: Expressed in the secretory cells of glandular
CC       trichomes. {ECO:0000269|PubMed:16024552}.
CC   -!- PTM: Glycosylated when produced in a heterologous system. The
CC       deglycosylated THCA synthase has more catalytic activity than the
CC       glycosylated form. {ECO:0000269|PubMed:15190053,
CC       ECO:0000269|PubMed:17669365}.
CC   -!- PTM: The FAD cofactor is bound via a bicovalent 6-S-cysteinyl, 8alpha-
CC       N1-histidyl FAD linkage. {ECO:0000269|PubMed:22766313}.
CC   -!- POLYMORPHISM: Several isoforms of the active tetrahydrocannabinolic
CC       acid synthase found in the 'drug-type' cannabis plants exist due to
CC       polymorphism. {ECO:0000269|PubMed:16143478}.
CC   -!- MISCELLANEOUS: THCA synthase might contribute to the self-defense of
CC       Cannabis plants by producing both THCA and hydrogen peroxide, but since
CC       these reaction products are toxic to the plant itself, THCA synthase
CC       must be secreted from secretory cells into the storage cavity to avoid
CC       cellular damage.
CC   -!- SIMILARITY: Belongs to the oxygen-dependent FAD-linked oxidoreductase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB057805; BAC41356.1; -; mRNA.
DR   EMBL; AB212829; BAE48241.1; -; Genomic_DNA.
DR   EMBL; AB212832; BAE48244.1; -; Genomic_DNA.
DR   EMBL; AB212834; BAE48246.1; -; Genomic_DNA.
DR   EMBL; AB212835; BAE48247.1; -; Genomic_DNA.
DR   EMBL; AB212837; BAE48249.1; -; Genomic_DNA.
DR   EMBL; AB212838; BAE48250.1; -; Genomic_DNA.
DR   EMBL; AB183698; BAD82947.1; -; Genomic_DNA.
DR   EMBL; AB183699; BAD82948.1; -; Genomic_DNA.
DR   EMBL; AB183700; BAD82949.1; -; Genomic_DNA.
DR   EMBL; AB183701; BAD82950.1; -; Genomic_DNA.
DR   EMBL; AB183702; BAD82951.1; -; Genomic_DNA.
DR   EMBL; AB183703; BAD82952.1; -; Genomic_DNA.
DR   EMBL; AB183704; BAD82953.1; -; Genomic_DNA.
DR   EMBL; AB183705; BAD82954.1; -; Genomic_DNA.
DR   PDB; 3VTE; X-ray; 2.75 A; A=28-545.
DR   PDBsum; 3VTE; -.
DR   SMR; Q8GTB6; -.
DR   KEGG; ag:BAC41356; -.
DR   BioCyc; MetaCyc:MONOMER-12033; -.
DR   BRENDA; 1.21.3.7; 1159.
DR   UniPathway; UPA00213; -.
DR   GO; GO:0048046; C:apoplast; IEA:UniProtKB-SubCell.
DR   GO; GO:0102778; F:Delta9-tetrahydrocannabinolate synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:1901696; P:cannabinoid biosynthetic process; TAS:UniProtKB.
DR   Gene3D; 3.30.43.10; -; 1.
DR   InterPro; IPR012951; BBE.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR016167; FAD-bd_PCMH_sub1.
DR   InterPro; IPR006094; Oxid_FAD_bind_N.
DR   Pfam; PF08031; BBE; 1.
DR   Pfam; PF01565; FAD_binding_4; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoplast; Direct protein sequencing; Disulfide bond; FAD;
KW   Flavoprotein; Glycoprotein; Oxidoreductase; Secreted; Signal.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000269|PubMed:15190053, ECO:0000269|Ref.4"
FT   CHAIN           29..545
FT                   /note="Tetrahydrocannabinolic acid synthase"
FT                   /id="PRO_0000421142"
FT   DOMAIN          77..251
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   NP_BIND         109..115
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22766313,
FT                   ECO:0007744|PDB:3VTE"
FT   NP_BIND         180..184
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22766313,
FT                   ECO:0007744|PDB:3VTE"
FT   NP_BIND         481..483
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22766313,
FT                   ECO:0007744|PDB:3VTE"
FT   ACT_SITE        484
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:22766313"
FT   BINDING         120
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22766313,
FT                   ECO:0007744|PDB:3VTE"
FT   BINDING         176
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22766313,
FT                   ECO:0007744|PDB:3VTE"
FT   BINDING         190
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:22766313,
FT                   ECO:0007744|PDB:3VTE"
FT   BINDING         236
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22766313,
FT                   ECO:0007744|PDB:3VTE"
FT   BINDING         241
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:22766313,
FT                   ECO:0007744|PDB:3VTE"
FT   BINDING         292
FT                   /note="Cannabigerolate"
FT                   /evidence="ECO:0000305|PubMed:22766313"
FT   BINDING         417
FT                   /note="Cannabigerolate"
FT                   /evidence="ECO:0000305|PubMed:22766313"
FT   BINDING         442
FT                   /note="Cannabigerolate"
FT                   /evidence="ECO:0000250|UniProtKB:G2QG48"
FT   CARBOHYD        65
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498,
FT                   ECO:0000269|PubMed:22766313, ECO:0007744|PDB:3VTE"
FT   CARBOHYD        89
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498,
FT                   ECO:0000269|PubMed:22766313, ECO:0007744|PDB:3VTE"
FT   CARBOHYD        168
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498,
FT                   ECO:0000269|PubMed:22766313, ECO:0007744|PDB:3VTE"
FT   CARBOHYD        297
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        305
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        329
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498,
FT                   ECO:0000269|PubMed:22766313, ECO:0007744|PDB:3VTE"
FT   CARBOHYD        467
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498,
FT                   ECO:0000269|PubMed:22766313, ECO:0007744|PDB:3VTE"
FT   CARBOHYD        499
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498,
FT                   ECO:0000269|PubMed:22766313, ECO:0007744|PDB:3VTE"
FT   DISULFID        37..99
FT                   /evidence="ECO:0000269|PubMed:22766313,
FT                   ECO:0007744|PDB:3VTE"
FT   CROSSLNK        114..176
FT                   /note="6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-
FT                   Cys)"
FT                   /evidence="ECO:0000269|PubMed:22766313"
FT   VARIANT         63
FT                   /note="I -> L (in strain: 001)"
FT                   /evidence="ECO:0000269|PubMed:16143478"
FT   MUTAGEN         92
FT                   /note="H->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:15190053"
FT   MUTAGEN         108
FT                   /note="R->A: Strongly reduced catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:15190053"
FT   MUTAGEN         110
FT                   /note="R->A: Strongly reduced catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:15190053"
FT   MUTAGEN         114
FT                   /note="H->A: Loss of FAD binding and loss of catalytic
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:15190053,
FT                   ECO:0000269|PubMed:22766313"
FT   MUTAGEN         208
FT                   /note="H->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:15190053"
FT   MUTAGEN         292
FT                   /note="H->A: Strongly reduced catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:22766313"
FT   MUTAGEN         417
FT                   /note="Y->F: Reduced catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:22766313"
FT   MUTAGEN         442
FT                   /note="E->Q: Slightly reduced catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:22766313"
FT   MUTAGEN         484
FT                   /note="Y->F: Loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:22766313"
FT   HELIX           30..41
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           60..66
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           71..73
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          75..78
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          82..85
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           90..103
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          106..112
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   TURN            119..121
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          124..131
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          138..141
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   TURN            142..145
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          146..150
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           155..165
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           181..186
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           194..197
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           200..203
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          204..210
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           219..222
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           224..230
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           235..237
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          240..247
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          255..262
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           266..279
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           280..282
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          287..297
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          308..319
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           321..331
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           333..335
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           339..341
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          342..345
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           347..353
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          355..357
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           367..371
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          379..390
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           394..402
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           403..406
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   TURN            409..411
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          412..418
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           421..424
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          430..432
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   STRAND          441..449
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   TURN            452..454
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           455..468
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           470..472
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           487..489
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           500..510
FT                   /evidence="ECO:0007829|PDB:3VTE"
FT   HELIX           515..525
FT                   /evidence="ECO:0007829|PDB:3VTE"
SQ   SEQUENCE   545 AA;  61927 MW;  6C24D805208E7421 CRC64;
     MNCSAFSFWF VCKIIFFFLS FHIQISIANP RENFLKCFSK HIPNNVANPK LVYTQHDQLY
     MSILNSTIQN LRFISDTTPK PLVIVTPSNN SHIQATILCS KKVGLQIRTR SGGHDAEGMS
     YISQVPFVVV DLRNMHSIKI DVHSQTAWVE AGATLGEVYY WINEKNENLS FPGGYCPTVG
     VGGHFSGGGY GALMRNYGLA ADNIIDAHLV NVDGKVLDRK SMGEDLFWAI RGGGGENFGI
     IAAWKIKLVA VPSKSTIFSV KKNMEIHGLV KLFNKWQNIA YKYDKDLVLM THFITKNITD
     NHGKNKTTVH GYFSSIFHGG VDSLVDLMNK SFPELGIKKT DCKEFSWIDT TIFYSGVVNF
     NTANFKKEIL LDRSAGKKTA FSIKLDYVKK PIPETAMVKI LEKLYEEDVG AGMYVLYPYG
     GIMEEISESA IPFPHRAGIM YELWYTASWE KQEDNEKHIN WVRSVYNFTT PYVSQNPRLA
     YLNYRDLDLG KTNHASPNNY TQARIWGEKY FGKNFNRLVK VKTKVDPNNF FRNEQSIPPL
     PPHHH
//
ID   TRXR1_DROME             Reviewed;         596 AA.
AC   P91938; Q1RKZ0; Q53YG2; Q961E3; Q9W3H2; Q9W3H3;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   27-JAN-2003, sequence version 2.
DT   02-JUN-2021, entry version 201.
DE   RecName: Full=Thioredoxin reductase 1, mitochondrial;
DE            Short=TrxR-1;
DE            EC=1.8.1.9;
DE   Flags: Precursor;
GN   Name=Trxr-1; Synonyms=GR; ORFNames=CG2151;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RX   PubMed=9056265; DOI=10.1006/abbi.1996.9872;
RA   Candas M., Sohal R.S., Radyuk S.N., Klichko V.I., Orr W.C.;
RT   "Molecular organization of the glutathione reductase gene in Drosophila
RT   melanogaster.";
RL   Arch. Biochem. Biophys. 339:323-334(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND D), FUNCTION, CATALYTIC
RP   ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF CYS-594 AND
RP   CYS-595.
RX   PubMed=11158675; DOI=10.1126/science.291.5504.643;
RA   Kanzok S.M., Fechner A., Bauer H., Ulschmid J.K., Muller H.M.,
RA   Botella-Munoz J., Schneuwly S., Schirmer R., Becker K.;
RT   "Substitution of the thioredoxin system for glutathione reductase in
RT   Drosophila melanogaster.";
RL   Science 291:643-646(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND C).
RC   STRAIN=Berkeley;
RA   Stapleton M., Brokstein P., Hong L., Agbayani A., Carlson J.W., Champe M.,
RA   Chavez C., Dorsett V., Dresnek D., Farfan D., Frise E., George R.A.,
RA   Gonzalez M., Guarin H., Kronmiller B., Li P.W., Liao G., Miranda A.,
RA   Mungall C.J., Nunoo J., Pacleb J.M., Paragas V., Park S., Patel S.,
RA   Phouanenavong S., Wan K.H., Yu C., Lewis S.E., Rubin G.M., Celniker S.E.;
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-447 (ISOFORM B).
RC   STRAIN=Berkeley; TISSUE=Ovary;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M., George R.A.,
RA   Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H., Rubin G.M.,
RA   Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [7]
RP   FUNCTION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=11525742; DOI=10.1016/s0960-9822(01)00393-1;
RA   Missirlis F., Phillips J.P., Jackle H.;
RT   "Cooperative action of antioxidant defense systems in Drosophila.";
RL   Curr. Biol. 11:1272-1277(2001).
RN   [8]
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11782468; DOI=10.1074/jbc.m109234200;
RA   Gromer S., Gross J.H.;
RT   "Methylseleninate is a substrate rather than an inhibitor of mammalian
RT   thioredoxin reductase. Implications for the antitumor effects of
RT   selenium.";
RL   J. Biol. Chem. 277:9701-9706(2002).
RN   [9]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=11796729; DOI=10.1074/jbc.m111692200;
RA   Missirlis F., Ulschmid J.K., Hirosawa-Takamori M., Groenke S., Schaefer U.,
RA   Becker K., Phillips J.P., Jaeckle H.;
RT   "Mitochondrial and cytoplasmic thioredoxin reductase variants encoded by a
RT   single Drosophila gene are both essential for viability.";
RL   J. Biol. Chem. 277:11521-11526(2002).
RN   [10]
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11877442; DOI=10.1074/jbc.m200636200;
RA   Bauer H., Kanzok S.M., Schirmer R.H.;
RT   "Thioredoxin-2 but not thioredoxin-1 is a substrate of thioredoxin
RT   peroxidase-1 from Drosophila melanogaster: isolation and characterization
RT   of a second thioredoxin in D.melanogaster and evidence for distinct
RT   biological functions of Trx-1 and Trx-2.";
RL   J. Biol. Chem. 277:17457-17463(2002).
RN   [11]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF HIS-569.
RX   PubMed=18211101; DOI=10.1021/bi702040u;
RA   Huang H.H., Arscott L.D., Ballou D.P., Williams C.H. Jr.;
RT   "Acid-base catalysis in the mechanism of thioredoxin reductase from
RT   Drosophila melanogaster.";
RL   Biochemistry 47:1721-1731(2008).
RN   [12]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF GLU-574.
RX   PubMed=18991392; DOI=10.1021/bi801449h;
RA   Huang H.H., Arscott L.D., Ballou D.P., Williams C.H.;
RT   "Function of Glu-469' in the acid-base catalysis of thioredoxin reductase
RT   from Drosophila melanogaster.";
RL   Biochemistry 47:12769-12776(2008).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 111-593 IN COMPLEX WITH FAD AND
RP   NADP, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, ACTIVE SITE, AND DISULFIDE
RP   BOND.
RX   PubMed=17385893; DOI=10.1021/bi602394p;
RA   Eckenroth B.E., Rould M.A., Hondal R.J., Everse S.J.;
RT   "Structural and biochemical studies reveal differences in the catalytic
RT   mechanisms of mammalian and Drosophila melanogaster thioredoxin
RT   reductases.";
RL   Biochemistry 46:4694-4705(2007).
CC   -!- FUNCTION: Thioredoxin system is a major player in glutathione
CC       metabolism, due to the demonstrated absence of a glutathione reductase.
CC       Functionally interacts with the Sod/Cat reactive oxidation species
CC       (ROS) defense system and thereby has a role in preadult development and
CC       life span. Lack of a glutathione reductase suggests antioxidant defense
CC       in Drosophila, and probably in related insects, differs fundamentally
CC       from that in other organisms. {ECO:0000269|PubMed:11158675,
CC       ECO:0000269|PubMed:11525742, ECO:0000269|PubMed:11796729}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[thioredoxin]-dithiol + NADP(+) = [thioredoxin]-disulfide +
CC         H(+) + NADPH; Xref=Rhea:RHEA:20345, Rhea:RHEA-COMP:10698, Rhea:RHEA-
CC         COMP:10700, ChEBI:CHEBI:15378, ChEBI:CHEBI:29950, ChEBI:CHEBI:50058,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.8.1.9;
CC         Evidence={ECO:0000269|PubMed:11158675};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=6.5 uM for NADPH (at pH 7.4) {ECO:0000269|PubMed:11158675,
CC         ECO:0000269|PubMed:11782468, ECO:0000269|PubMed:11796729,
CC         ECO:0000269|PubMed:11877442, ECO:0000269|PubMed:17385893,
CC         ECO:0000269|PubMed:18211101, ECO:0000269|PubMed:18991392};
CC         KM=1 uM for NADPH (at pH 7.4, 2 mM EDTA, 100 mM KPO(4))
CC         {ECO:0000269|PubMed:11158675, ECO:0000269|PubMed:11782468,
CC         ECO:0000269|PubMed:11796729, ECO:0000269|PubMed:11877442,
CC         ECO:0000269|PubMed:17385893, ECO:0000269|PubMed:18211101,
CC         ECO:0000269|PubMed:18991392};
CC         KM=1 uM for NADPH (isoform B at pH 7.4, 2 mM EDTA, 100 mM KPO(4))
CC         {ECO:0000269|PubMed:11158675, ECO:0000269|PubMed:11782468,
CC         ECO:0000269|PubMed:11796729, ECO:0000269|PubMed:11877442,
CC         ECO:0000269|PubMed:17385893, ECO:0000269|PubMed:18211101,
CC         ECO:0000269|PubMed:18991392};
CC         KM=7.0 uM for dhd (at pH 7.4, 200 uM NADPH, 100 mM KPO(4))
CC         {ECO:0000269|PubMed:11158675, ECO:0000269|PubMed:11782468,
CC         ECO:0000269|PubMed:11796729, ECO:0000269|PubMed:11877442,
CC         ECO:0000269|PubMed:17385893, ECO:0000269|PubMed:18211101,
CC         ECO:0000269|PubMed:18991392};
CC         KM=141 uM for dhd (at pH 7.0, 0.15 mM NADPH, 1 mM EDTA, 1 mg/ml
CC         insulin, 50 mM KPO(4), 25 degrees Celsius)
CC         {ECO:0000269|PubMed:11158675, ECO:0000269|PubMed:11782468,
CC         ECO:0000269|PubMed:11796729, ECO:0000269|PubMed:11877442,
CC         ECO:0000269|PubMed:17385893, ECO:0000269|PubMed:18211101,
CC         ECO:0000269|PubMed:18991392};
CC         KM=7 uM for dhd (at pH 7.4, 2 mM EDTA, 100 mM KPO(4))
CC         {ECO:0000269|PubMed:11158675, ECO:0000269|PubMed:11782468,
CC         ECO:0000269|PubMed:11796729, ECO:0000269|PubMed:11877442,
CC         ECO:0000269|PubMed:17385893, ECO:0000269|PubMed:18211101,
CC         ECO:0000269|PubMed:18991392};
CC         KM=19 uM for dhd (isoform B at pH 7.4, 2 mM EDTA, 100 mM KPO(4))
CC         {ECO:0000269|PubMed:11158675, ECO:0000269|PubMed:11782468,
CC         ECO:0000269|PubMed:11796729, ECO:0000269|PubMed:11877442,
CC         ECO:0000269|PubMed:17385893, ECO:0000269|PubMed:18211101,
CC         ECO:0000269|PubMed:18991392};
CC         KM=5.9 uM for Trx-2 (at pH 7.4, 100 uM NADPH, 2 mM EDTA, 100 mM
CC         KPO(4)) {ECO:0000269|PubMed:11158675, ECO:0000269|PubMed:11782468,
CC         ECO:0000269|PubMed:11796729, ECO:0000269|PubMed:11877442,
CC         ECO:0000269|PubMed:17385893, ECO:0000269|PubMed:18211101,
CC         ECO:0000269|PubMed:18991392};
CC         KM=310 uM for 5,5'-dithiobis-2-nitrobenzoic acid (DTNB) (at pH 7.4,
CC         100 uM NADPH, 100 mM KPO(4)) {ECO:0000269|PubMed:11158675,
CC         ECO:0000269|PubMed:11782468, ECO:0000269|PubMed:11796729,
CC         ECO:0000269|PubMed:11877442, ECO:0000269|PubMed:17385893,
CC         ECO:0000269|PubMed:18211101, ECO:0000269|PubMed:18991392};
CC         KM=0.17 mM for DTNB (at pH 7.0, 0.2 mM NADPH, 10 mM EDTA, 100 mM
CC         KPO(4), 25 degrees Celsius) {ECO:0000269|PubMed:11158675,
CC         ECO:0000269|PubMed:11782468, ECO:0000269|PubMed:11796729,
CC         ECO:0000269|PubMed:11877442, ECO:0000269|PubMed:17385893,
CC         ECO:0000269|PubMed:18211101, ECO:0000269|PubMed:18991392};
CC         KM=380 uM for DTNB (at pH 7.4, 2 mM EDTA, 100 mM KPO(4))
CC         {ECO:0000269|PubMed:11158675, ECO:0000269|PubMed:11782468,
CC         ECO:0000269|PubMed:11796729, ECO:0000269|PubMed:11877442,
CC         ECO:0000269|PubMed:17385893, ECO:0000269|PubMed:18211101,
CC         ECO:0000269|PubMed:18991392};
CC         KM=410 uM for DTNB (isoform B at pH 7.4, 2 mM EDTA, 100 mM KPO(4))
CC         {ECO:0000269|PubMed:11158675, ECO:0000269|PubMed:11782468,
CC         ECO:0000269|PubMed:11796729, ECO:0000269|PubMed:11877442,
CC         ECO:0000269|PubMed:17385893, ECO:0000269|PubMed:18211101,
CC         ECO:0000269|PubMed:18991392};
CC         KM=675 uM for methylseleninate (100 uM NADPH)
CC         {ECO:0000269|PubMed:11158675, ECO:0000269|PubMed:11782468,
CC         ECO:0000269|PubMed:11796729, ECO:0000269|PubMed:11877442,
CC         ECO:0000269|PubMed:17385893, ECO:0000269|PubMed:18211101,
CC         ECO:0000269|PubMed:18991392};
CC         Vmax=24.3 umol/min/mg enzyme toward NADPH (at pH 7.4)
CC         {ECO:0000269|PubMed:11158675, ECO:0000269|PubMed:11782468,
CC         ECO:0000269|PubMed:11796729, ECO:0000269|PubMed:11877442,
CC         ECO:0000269|PubMed:17385893, ECO:0000269|PubMed:18211101,
CC         ECO:0000269|PubMed:18991392};
CC         Vmax=16 umol/min/mg enzyme toward Trx-2 (at pH 7.4, 100 uM NADPH, 2
CC         mM EDTA, 100 mM KPO(4), 25 degrees Celsius)
CC         {ECO:0000269|PubMed:11158675, ECO:0000269|PubMed:11782468,
CC         ECO:0000269|PubMed:11796729, ECO:0000269|PubMed:11877442,
CC         ECO:0000269|PubMed:17385893, ECO:0000269|PubMed:18211101,
CC         ECO:0000269|PubMed:18991392};
CC         Note=Measurements were conducted with isoform A unless noted
CC         otherwise.;
CC       pH dependence:
CC         Optimum pH is 7.6 for isoform A with Trx-2 and NADPH as substrates.
CC         {ECO:0000269|PubMed:11158675, ECO:0000269|PubMed:11782468,
CC         ECO:0000269|PubMed:11796729, ECO:0000269|PubMed:11877442,
CC         ECO:0000269|PubMed:17385893, ECO:0000269|PubMed:18211101,
CC         ECO:0000269|PubMed:18991392};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:17385893}.
CC   -!- SUBCELLULAR LOCATION: [Isoform B]: Mitochondrion.
CC   -!- SUBCELLULAR LOCATION: [Isoform A]: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=4;
CC       Name=B; Synonyms=Mito;
CC         IsoId=P91938-1; Sequence=Displayed;
CC       Name=A; Synonyms=Cyto;
CC         IsoId=P91938-2; Sequence=VSP_005572, VSP_005574;
CC       Name=C;
CC         IsoId=P91938-3; Sequence=VSP_005571, VSP_005573;
CC       Name=D;
CC         IsoId=P91938-4; Sequence=VSP_005572;
CC   -!- TISSUE SPECIFICITY: During embryogenesis, expression is seen in germ
CC       cell progenitors, developing midgut, hindgut and proventriculus.
CC       {ECO:0000269|PubMed:11525742}.
CC   -!- DEVELOPMENTAL STAGE: Expressed both maternally and zygotically during
CC       all stages of development, highest expression during adult stages.
CC       {ECO:0000269|PubMed:11525742, ECO:0000269|PubMed:11796729}.
CC   -!- MISCELLANEOUS: The active site is a redox-active disulfide bond.
CC   -!- MISCELLANEOUS: [Isoform B]: Can partially substitute for the
CC       cytoplasmic enzyme activity.
CC   -!- MISCELLANEOUS: [Isoform A]: Unable to compensate for the loss of the
CC       mitochondrial enzyme activity. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform D]: Produced by alternative initiation at Met-
CC       106 of isoform B. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to be a glutathione reductase.
CC       {ECO:0000305|PubMed:9056265}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK93067.1; Type=Miscellaneous discrepancy; Note=Chimeric cDNA. Chimeric cDNA originating from chromosomes X and 3.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U81995; AAB48441.1; -; mRNA.
DR   EMBL; AF301145; AAG25640.1; -; mRNA.
DR   EMBL; AF301144; AAG25639.1; -; mRNA.
DR   EMBL; AE014298; AAF46354.1; -; Genomic_DNA.
DR   EMBL; AE014298; AAF46355.2; -; Genomic_DNA.
DR   EMBL; AE014298; AAN09228.1; -; Genomic_DNA.
DR   EMBL; BT003266; AAO25023.1; -; mRNA.
DR   EMBL; BT025070; ABE73241.1; -; mRNA.
DR   EMBL; AY051643; AAK93067.1; ALT_SEQ; mRNA.
DR   RefSeq; NP_511082.2; NM_078527.3. [P91938-2]
DR   RefSeq; NP_727251.1; NM_167149.2. [P91938-1]
DR   RefSeq; NP_727252.1; NM_167150.2. [P91938-3]
DR   PDB; 2NVK; X-ray; 2.40 A; X=111-593.
DR   PDB; 3DGH; X-ray; 1.75 A; A/B=111-588.
DR   PDB; 3DH9; X-ray; 2.25 A; A/B=111-591.
DR   PDBsum; 2NVK; -.
DR   PDBsum; 3DGH; -.
DR   PDBsum; 3DH9; -.
DR   SMR; P91938; -.
DR   BioGRID; 58221; 35.
DR   DIP; DIP-19145N; -.
DR   IntAct; P91938; 20.
DR   STRING; 7227.FBpp0071116; -.
DR   PaxDb; P91938; -.
DR   PRIDE; P91938; -.
DR   DNASU; 31760; -.
DR   EnsemblMetazoa; FBtr0071167; FBpp0071115; FBgn0020653. [P91938-2]
DR   EnsemblMetazoa; FBtr0071168; FBpp0071116; FBgn0020653. [P91938-1]
DR   EnsemblMetazoa; FBtr0071169; FBpp0071117; FBgn0020653. [P91938-3]
DR   GeneID; 31760; -.
DR   KEGG; dme:Dmel_CG2151; -.
DR   CTD; 31760; -.
DR   FlyBase; FBgn0020653; Trxr-1.
DR   eggNOG; KOG4716; Eukaryota.
DR   GeneTree; ENSGT00940000167606; -.
DR   InParanoid; P91938; -.
DR   OMA; VYGLHYL; -.
DR   PhylomeDB; P91938; -.
DR   BRENDA; 1.8.1.9; 1994.
DR   BioGRID-ORCS; 31760; 1 hit in 3 CRISPR screens.
DR   ChiTaRS; Trxr-1; fly.
DR   EvolutionaryTrace; P91938; -.
DR   GenomeRNAi; 31760; -.
DR   PRO; PR:P91938; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0020653; Expressed in adult Malpighian tubule (Drosophila) and 38 other tissues.
DR   Genevisible; P91938; DM.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; HDA:FlyBase.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0016209; F:antioxidant activity; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0045174; F:glutathione dehydrogenase (ascorbate) activity; IMP:FlyBase.
DR   GO; GO:0004362; F:glutathione-disulfide reductase activity; IMP:FlyBase.
DR   GO; GO:0016651; F:oxidoreductase activity, acting on NAD(P)H; IMP:FlyBase.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:FlyBase.
DR   GO; GO:0004791; F:thioredoxin-disulfide reductase activity; IDA:UniProtKB.
DR   GO; GO:0045454; P:cell redox homeostasis; IMP:UniProtKB.
DR   GO; GO:0008340; P:determination of adult lifespan; IMP:FlyBase.
DR   GO; GO:0001666; P:response to hypoxia; IMP:FlyBase.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR001100; Pyr_nuc-diS_OxRdtase.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   InterPro; IPR012999; Pyr_OxRdtase_I_AS.
DR   InterPro; IPR006338; Thioredoxin/glutathione_Rdtase.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   PIRSF; PIRSF000350; Mercury_reductase_MerA; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
DR   TIGRFAMs; TIGR01438; TGR; 1.
DR   PROSITE; PS00076; PYRIDINE_REDOX_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Alternative splicing; Cytoplasm;
KW   Disulfide bond; FAD; Flavoprotein; Mitochondrion; NADP; Nucleotide-binding;
KW   Oxidoreductase; Redox-active center; Reference proteome; Transit peptide.
FT   TRANSIT         1..?
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           ?..596
FT                   /note="Thioredoxin reductase 1, mitochondrial"
FT                   /id="PRO_0000030291"
FT   NP_BIND         120..126
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   NP_BIND         143..147
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   NP_BIND         159..170
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   NP_BIND         233..235
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   NP_BIND         262..266
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   NP_BIND         322..328
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   NP_BIND         392..399
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   NP_BIND         429..432
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   NP_BIND         438..443
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   REGION          59..87
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        59..75
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        569
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   BINDING         282
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   BINDING         286
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   BINDING         302
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   BINDING         355
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   BINDING         472
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   BINDING         570
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   DISULFID        162..167
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   DISULFID        594..595
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:17385893"
FT   VAR_SEQ         1..105
FT                   /note="Missing (in isoform A and isoform D)"
FT                   /evidence="ECO:0000303|PubMed:11158675,
FT                   ECO:0000303|PubMed:9056265, ECO:0000303|Ref.5"
FT                   /id="VSP_005572"
FT   VAR_SEQ         1..88
FT                   /note="Missing (in isoform C)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_005571"
FT   VAR_SEQ         89..110
FT                   /note="QHPHCDRAAMYAQPVRKMSTKG -> MLKYMICAIVVGAKKSTSSKYN (in
FT                   isoform C)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_005573"
FT   VAR_SEQ         106..110
FT                   /note="MSTKG -> MAPVQ (in isoform A)"
FT                   /evidence="ECO:0000303|PubMed:11158675,
FT                   ECO:0000303|PubMed:9056265, ECO:0000303|Ref.5"
FT                   /id="VSP_005574"
FT   MUTAGEN         569
FT                   /note="H->Q: Almost complete loss of TrX reduction."
FT                   /evidence="ECO:0000269|PubMed:18211101"
FT   MUTAGEN         574
FT                   /note="E->A: Reduced Trx reduction."
FT                   /evidence="ECO:0000269|PubMed:18991392"
FT   MUTAGEN         574
FT                   /note="E->Q: Reduced Trx reduction."
FT                   /evidence="ECO:0000269|PubMed:18991392"
FT   MUTAGEN         594
FT                   /note="C->S: Loss of Trx reduction."
FT                   /evidence="ECO:0000269|PubMed:11158675"
FT   MUTAGEN         595
FT                   /note="C->S: Loss of Trx reduction."
FT                   /evidence="ECO:0000269|PubMed:11158675"
FT   CONFLICT        88
FT                   /note="F -> L (in Ref. 6; AAK93067)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        134
FT                   /note="V -> S (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        151
FT                   /note="Missing (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        189..190
FT                   /note="Missing (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        195
FT                   /note="E -> D (in Ref. 1; AAB48441 and 6; AAK93067)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        203..207
FT                   /note="KLVQS -> RLCAV (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        213..216
FT                   /note="KSVN -> SRH (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        220
FT                   /note="R -> V (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        239..247
FT                   /note="DSHTLLAKL -> TRTHCCPSM (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        264
FT                   /note="Missing (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        276..280
FT                   /note="VEYGI -> AEIGT (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        292
FT                   /note="Missing (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        317..318
FT                   /note="EP -> G (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        351..386
FT                   /note="RKTVPLSVEKQDDGKLLVKYKNVETGEEAEDVYDTV -> ADVDRCREADDA
FT                   AAREYRLTQIRFTTSHHR (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        379
FT                   /note="A -> S (in Ref. 6; AAK93067)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        396..398
FT                   /note="VDD -> CDS (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        403..406
FT                   /note="NAGV -> MPAL (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        424..425
FT                   /note="AN -> PH (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        455
FT                   /note="Y -> F (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        461
FT                   /note="R -> S (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        473..483
FT                   /note="TPLEYACVGLS -> SWSTSASGLA (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        488..495
FT                   /note="VKQFGADE -> SSSSEPR (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        559..560
FT                   /note="IN -> L (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        583
FT                   /note="K -> KP (in Ref. 1; AAB48441)"
FT                   /evidence="ECO:0000305"
FT   STRAND          114..120
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           124..135
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          140..143
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   TURN            150..152
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           161..165
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           167..188
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           201..225
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          229..231
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          233..239
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          242..246
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          252..261
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          265..267
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           275..278
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           282..285
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          294..298
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           302..313
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          317..324
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           332..344
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          349..351
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          353..360
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          366..372
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   TURN            373..375
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          378..388
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          392..394
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           397..399
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           401..403
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          409..413
FT                   /evidence="ECO:0007829|PDB:2NVK"
FT   STRAND          426..428
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           430..432
FT                   /evidence="ECO:0007829|PDB:3DH9"
FT   HELIX           440..455
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          469..471
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          473..481
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           484..491
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           493..495
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          496..502
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           506..508
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   TURN            509..512
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          519..527
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   STRAND          531..539
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           542..554
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           559..563
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   HELIX           573..578
FT                   /evidence="ECO:0007829|PDB:3DGH"
FT   TURN            583..585
FT                   /evidence="ECO:0007829|PDB:3DGH"
SQ   SEQUENCE   596 AA;  64322 MW;  8DA6FC08CF6A7292 CRC64;
     MNLCNSRFSV TFVRQCSTIL TSPSAGIIQN RGSLTTKVPH WISSSLSCAH HTFQRTMNLT
     GQRGSRDSTG ATGGNAPAGS GAGAPPPFQH PHCDRAAMYA QPVRKMSTKG GSYDYDLIVI
     GGGSAGLACA KEAVLNGARV ACLDFVKPTP TLGTKWGVGG TCVNVGCIPK KLMHQASLLG
     EAVHEAAAYG WNVDEKIKPD WHKLVQSVQN HIKSVNWVTR VDLRDKKVEY INGLGSFVDS
     HTLLAKLKSG ERTITAQTFV IAVGGRPRYP DIPGAVEYGI TSDDLFSLDR EPGKTLVVGA
     GYIGLECAGF LKGLGYEPTV MVRSIVLRGF DQQMAELVAA SMEERGIPFL RKTVPLSVEK
     QDDGKLLVKY KNVETGEEAE DVYDTVLWAI GRKGLVDDLN LPNAGVTVQK DKIPVDSQEA
     TNVANIYAVG DIIYGKPELT PVAVLAGRLL ARRLYGGSTQ RMDYKDVATT VFTPLEYACV
     GLSEEDAVKQ FGADEIEVFH GYYKPTEFFI PQKSVRYCYL KAVAERHGDQ RVYGLHYIGP
     VAGEVIQGFA AALKSGLTIN TLINTVGIHP TTAEEFTRLA ITKRSGLDPT PASCCS
//
ID   UVR3_ARATH              Reviewed;         556 AA.
AC   O48652; Q2V3V6;
DT   05-OCT-2010, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 2.
DT   02-JUN-2021, entry version 120.
DE   RecName: Full=(6-4)DNA photolyase;
DE            EC=4.1.99.13;
DE   AltName: Full=Protein UV repair defective 3;
GN   Name=UVR3; OrderedLocusNames=At3g15620; ORFNames=SJ11.2;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND COFACTOR.
RC   STRAIN=cv. Landsberg erecta;
RX   PubMed=9421527; DOI=10.1093/nar/26.2.638;
RA   Nakajima S., Sugiyama M., Iwai S., Hitomi K., Otoshi E., Kim S.T.,
RA   Jiang C.Z., Todo T., Britt A.B., Yamamoto K.;
RT   "Cloning and characterization of a gene (UVR3) required for photorepair of
RT   6-4 photoproducts in Arabidopsis thaliana.";
RL   Nucleic Acids Res. 26:638-644(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RA   Sakamoto A., Tanaka A., Tano S., Nakajima S., Yamamoto K., Watanabe H.;
RT   "The genomic organization of the Arabidopsis 6-4 photolyase gene.";
RL   (er) Plant Gene Register PGR98-180(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10819329; DOI=10.1093/dnares/7.2.131;
RA   Sato S., Nakamura Y., Kaneko T., Katoh T., Asamizu E., Tabata S.;
RT   "Structural analysis of Arabidopsis thaliana chromosome 3. I. Sequence
RT   features of the regions of 4,504,864 bp covered by sixty P1 and TAC
RT   clones.";
RL   DNA Res. 7:131-135(2000).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [5]
RP   TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND INDUCTION BY LIGHT.
RX   PubMed=11971912; DOI=10.1093/jexbot/53.371.1005;
RA   Waterworth W.M., Jiang Q., West C.E., Nikaido M., Bray C.M.;
RT   "Characterization of Arabidopsis photolyase enzymes and analysis of their
RT   role in protection from ultraviolet-B radiation.";
RL   J. Exp. Bot. 53:1005-1015(2002).
RN   [6]
RP   FUNCTION.
RX   PubMed=17164245; DOI=10.1074/jbc.m604734200;
RA   Schleicher E., Hitomi K., Kay C.W., Getzoff E.D., Todo T., Weber S.;
RT   "Electron nuclear double resonance differentiates complementary roles for
RT   active site histidines in (6-4) photolyase.";
RL   J. Biol. Chem. 282:4738-4747(2007).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) IN COMPLEX WITH FAD, AND MUTAGENESIS
RP   OF LYS-263; THR-276; HIS-383; HIS-387 AND ARG-439.
RX   PubMed=19359474; DOI=10.1073/pnas.0809180106;
RA   Hitomi K., DiTacchio L., Arvai A.S., Yamamoto J., Kim S.T., Todo T.,
RA   Tainer J.A., Iwai S., Panda S., Getzoff E.D.;
RT   "Functional motifs in the (6-4) photolyase crystal structure make a
RT   comparative framework for DNA repair photolyases and clock cryptochromes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:6962-6967(2009).
CC   -!- FUNCTION: Involved in repair of UV radiation-induced DNA damage.
CC       Catalyzes the photoreactivation of pyrimidine [6-4] pyrimidone
CC       photoproduct (6-4 products). Binds specifically to DNA containing 6-4
CC       products and repairs these lesions in a visible light-dependent manner.
CC       Not required for repair of cyclobutane pyrimidine dimer (CPD).
CC       {ECO:0000269|PubMed:17164245, ECO:0000269|PubMed:9421527}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6-4) photoproduct (in DNA) = 2 pyrimidine residues (in DNA).;
CC         EC=4.1.99.13;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:9421527};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:9421527};
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O48652-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O48652-2; Sequence=VSP_039720, VSP_039721;
CC   -!- TISSUE SPECIFICITY: Expressed in siliques, flowers and leaves. Not
CC       detected in roots. {ECO:0000269|PubMed:11971912}.
CC   -!- DEVELOPMENTAL STAGE: Expressed at all developmental stages.
CC       {ECO:0000269|PubMed:11971912}.
CC   -!- INDUCTION: Not induced by white or UV-B light.
CC       {ECO:0000269|PubMed:11971912}.
CC   -!- SIMILARITY: Belongs to the DNA photolyase class-1 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA24449.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA34711.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB003687; BAA24449.1; ALT_INIT; mRNA.
DR   EMBL; AB017331; BAA34711.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AB017071; BAB02293.1; -; Genomic_DNA.
DR   EMBL; CP002686; AEE75703.1; -; Genomic_DNA.
DR   EMBL; CP002686; AEE75704.1; -; Genomic_DNA.
DR   RefSeq; NP_001030703.1; NM_001035626.2. [O48652-2]
DR   RefSeq; NP_566520.1; NM_112432.2. [O48652-1]
DR   PDB; 3FY4; X-ray; 2.70 A; A/B/C=20-556.
DR   PDBsum; 3FY4; -.
DR   SMR; O48652; -.
DR   STRING; 3702.AT3G15620.1; -.
DR   PaxDb; O48652; -.
DR   PRIDE; O48652; -.
DR   ProteomicsDB; 228566; -. [O48652-1]
DR   EnsemblPlants; AT3G15620.1; AT3G15620.1; AT3G15620. [O48652-1]
DR   EnsemblPlants; AT3G15620.2; AT3G15620.2; AT3G15620. [O48652-2]
DR   GeneID; 820804; -.
DR   Gramene; AT3G15620.1; AT3G15620.1; AT3G15620. [O48652-1]
DR   Gramene; AT3G15620.2; AT3G15620.2; AT3G15620. [O48652-2]
DR   KEGG; ath:AT3G15620; -.
DR   Araport; AT3G15620; -.
DR   TAIR; locus:2093217; AT3G15620.
DR   eggNOG; KOG0133; Eukaryota.
DR   HOGENOM; CLU_010348_3_4_1; -.
DR   InParanoid; O48652; -.
DR   OMA; WQWSASS; -.
DR   OrthoDB; 378952at2759; -.
DR   PhylomeDB; O48652; -.
DR   BioCyc; MetaCyc:MONOMER-15021; -.
DR   BRENDA; 4.1.99.13; 399.
DR   EvolutionaryTrace; O48652; -.
DR   PRO; PR:O48652; -.
DR   Proteomes; UP000006548; Chromosome 3.
DR   ExpressionAtlas; O48652; baseline and differential.
DR   Genevisible; O48652; AT.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003914; F:DNA (6-4) photolyase activity; IDA:TAIR.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0071949; F:FAD binding; IBA:GO_Central.
DR   GO; GO:0032922; P:circadian regulation of gene expression; IBA:GO_Central.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; IBA:GO_Central.
DR   GO; GO:0009411; P:response to UV; IMP:TAIR.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR036134; Crypto/Photolyase_FAD-like_sf.
DR   InterPro; IPR036155; Crypto/Photolyase_N_sf.
DR   InterPro; IPR005101; Cryptochr/Photolyase_FAD-bd.
DR   InterPro; IPR006050; DNA_photolyase_N.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00875; DNA_photolyase; 1.
DR   Pfam; PF03441; FAD_binding_7; 1.
DR   SUPFAM; SSF48173; SSF48173; 1.
DR   SUPFAM; SSF52425; SSF52425; 1.
DR   PROSITE; PS51645; PHR_CRY_ALPHA_BETA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; DNA damage; DNA repair; DNA-binding;
KW   FAD; Flavoprotein; Lyase; Nucleotide-binding; Reference proteome.
FT   CHAIN           1..556
FT                   /note="(6-4)DNA photolyase"
FT                   /id="PRO_0000397886"
FT   DOMAIN          24..162
FT                   /note="Photolyase/cryptochrome alpha/beta"
FT   NP_BIND         276..280
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19359474"
FT   NP_BIND         317..321
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19359474"
FT   NP_BIND         380..383
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19359474"
FT   NP_BIND         415..417
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19359474"
FT   REGION          382..387
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   REGION          534..556
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         262
FT                   /note="Phosphate; via amide nitrogen and carbonyl oxygen"
FT   BINDING         263
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19359474"
FT   BINDING         320
FT                   /note="DNA"
FT                   /evidence="ECO:0000250"
FT   BINDING         386
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19359474"
FT   BINDING         421
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19359474"
FT   BINDING         427
FT                   /note="DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            348
FT                   /note="Electron transfer via tryptophanyl radical"
FT                   /evidence="ECO:0000250"
FT   SITE            402
FT                   /note="Electron transfer via tryptophanyl radical"
FT                   /evidence="ECO:0000250"
FT   SITE            425
FT                   /note="Electron transfer via tryptophanyl radical"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         437..445
FT                   /note="FNRIYSPIS -> ALSPFCFSF (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_039720"
FT   VAR_SEQ         446..556
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_039721"
FT   MUTAGEN         263
FT                   /note="K->R: No effect on DNA repair activity."
FT                   /evidence="ECO:0000269|PubMed:19359474"
FT   MUTAGEN         276
FT                   /note="T->P: No effect on DNA repair activity."
FT                   /evidence="ECO:0000269|PubMed:19359474"
FT   MUTAGEN         383
FT                   /note="H->A: Loss of DNA repair activity."
FT                   /evidence="ECO:0000269|PubMed:19359474"
FT   MUTAGEN         387
FT                   /note="H->A: Loss of DNA repair activity."
FT                   /evidence="ECO:0000269|PubMed:19359474"
FT   MUTAGEN         439
FT                   /note="R->H,A: No effect on DNA repair activity."
FT                   /evidence="ECO:0000269|PubMed:19359474"
FT   STRAND          25..32
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           40..46
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   STRAND          52..58
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           60..63
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   STRAND          69..73
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           79..98
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   STRAND          104..108
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           110..118
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   STRAND          123..128
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           134..149
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   STRAND          153..155
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   STRAND          160..163
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           165..171
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   STRAND          173..175
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           180..187
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   TURN            191..194
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   TURN            221..225
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           228..230
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           241..251
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           255..259
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           263..265
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           280..284
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           290..302
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   TURN            310..312
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           314..329
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   TURN            332..335
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           352..359
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           366..378
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           383..393
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   TURN            394..398
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           402..412
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           418..428
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   STRAND          431..433
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   TURN            443..446
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           447..449
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           455..460
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           462..464
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   TURN            469..473
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           475..477
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           480..486
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   TURN            490..492
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           501..521
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   TURN            522..524
FT                   /evidence="ECO:0007829|PDB:3FY4"
FT   HELIX           528..541
FT                   /evidence="ECO:0007829|PDB:3FY4"
SQ   SEQUENCE   556 AA;  63790 MW;  3110841DBA33CAC8 CRC64;
     MQRFCVCSPS SYRLNPITSM ATGSGSLIWF RKGLRVHDNP ALEYASKGSE FMYPVFVIDP
     HYMESDPSAF SPGSSRAGVN RIRFLLESLK DLDSSLKKLG SRLLVFKGEP GEVLVRCLQE
     WKVKRLCFEY DTDPYYQALD VKVKDYASST GVEVFSPVSH TLFNPAHIIE KNGGKPPLSY
     QSFLKVAGEP SCAKSELVMS YSSLPPIGDI GNLGISEVPS LEELGYKDDE QADWTPFRGG
     ESEALKRLTK SISDKAWVAN FEKPKGDPSA FLKPATTVMS PYLKFGCLSS RYFYQCLQNI
     YKDVKKHTSP PVSLLGQLLW REFFYTTAFG TPNFDKMKGN RICKQIPWNE DHAMLAAWRD
     GKTGYPWIDA IMVQLLKWGW MHHLARHCVA CFLTRGDLFI HWEQGRDVFE RLLIDSDWAI
     NNGNWMWLSC SSFFYQFNRI YSPISFGKKY DPDGKYIRHF LPVLKDMPKQ YIYEPWTAPL
     SVQTKANCIV GKDYPKPMVL HDSASKECKR KMGEAYALNK KMDGKVDEEN LRDLRRKLQK
     DEHEESKIRN QRPKLK
//
ID   XDH_RAT                 Reviewed;        1331 AA.
AC   P22985; Q63157;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-JUN-2021, entry version 178.
DE   RecName: Full=Xanthine dehydrogenase/oxidase;
DE   Includes:
DE     RecName: Full=Xanthine dehydrogenase;
DE              Short=XD;
DE              EC=1.17.1.4 {ECO:0000269|PubMed:15878860, ECO:0000269|PubMed:17301076};
DE   Includes:
DE     RecName: Full=Xanthine oxidase;
DE              Short=XO;
DE              EC=1.17.3.2 {ECO:0000269|PubMed:15878860, ECO:0000269|PubMed:17301076};
DE     AltName: Full=Xanthine oxidoreductase;
DE              Short=XOR;
GN   Name=Xdh;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, ACTIVITY REGULATION,
RP   PROTEOLYTIC CONVERSION, AND SUBUNIT.
RC   TISSUE=Liver;
RX   PubMed=2387845;
RA   Amaya Y., Yamazaki K., Sato M., Noda K., Nishino T., Nishino T.;
RT   "Proteolytic conversion of xanthine dehydrogenase from the NAD-dependent
RT   type to the O2-dependent type. Amino acid sequence of rat liver xanthine
RT   dehydrogenase and identification of the cleavage sites of the enzyme
RT   protein during irreversible conversion by trypsin.";
RL   J. Biol. Chem. 265:14170-14175(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE OF 1-55.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=8208609; DOI=10.1093/nar/22.10.1846;
RA   Chow C.W., Clark M., Rinaldo J., Chalkley R.;
RT   "Identification of the rat xanthine dehydrogenase/oxidase promoter.";
RL   Nucleic Acids Res. 22:1846-1854(1994).
RN   [3]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11993848; DOI=10.1078/0065-1281-00629;
RA   Frederiks W.M., Vreeling-Sindelarova H.;
RT   "Ultrastructural localization of xanthine oxidoreductase activity in
RT   isolated rat liver cells.";
RL   Acta Histochem. 104:29-37(2002).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF MUTANT ALA-535/ARG-992/SER-1324 IN
RP   COMPLEX WITH FAD; URIC ACID AND IRON-SULFUR CENTERS, CATALYTIC ACTIVITY,
RP   DISULFIDE BOND, ACTIVITY REGULATION, MUTAGENESIS OF CYS-535; CYS-992 AND
RP   CYS-1316, AND COFACTOR.
RX   PubMed=15878860; DOI=10.1074/jbc.m501830200;
RA   Nishino T., Okamoto K., Kawaguchi Y., Hori H., Matsumura T., Eger B.T.,
RA   Pai E.F., Nishino T.;
RT   "Mechanism of the conversion of xanthine dehydrogenase to xanthine oxidase:
RT   identification of the two cysteine disulfide bonds and crystal structure of
RT   a non-convertible rat liver xanthine dehydrogenase mutant.";
RL   J. Biol. Chem. 280:24888-24894(2005).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.28 ANGSTROMS) OF MUTANT ALA-335/LEU-336 IN COMPLEX
RP   WITH FAD AND IRON-SULFUR CENTER, MUTAGENESIS OF 335-TRP-PHE-336, CATALYTIC
RP   ACTIVITY, FUNCTION, AND COFACTOR.
RX   PubMed=17301076; DOI=10.1093/jb/mvm054;
RA   Asai R., Nishino T., Matsumura T., Okamoto K., Igarashi K., Pai E.F.,
RA   Nishino T.;
RT   "Two mutations convert mammalian xanthine oxidoreductase to highly
RT   superoxide-productive xanthine oxidase.";
RL   J. Biochem. 141:525-534(2007).
CC   -!- FUNCTION: Key enzyme in purine degradation. Catalyzes the oxidation of
CC       hypoxanthine to xanthine. Catalyzes the oxidation of xanthine to uric
CC       acid. Contributes to the generation of reactive oxygen species.
CC       {ECO:0000269|PubMed:17301076}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NAD(+) + xanthine = H(+) + NADH + urate;
CC         Xref=Rhea:RHEA:16669, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17712, ChEBI:CHEBI:17775, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.17.1.4;
CC         Evidence={ECO:0000269|PubMed:15878860, ECO:0000269|PubMed:17301076};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + hypoxanthine + NAD(+) = H(+) + NADH + xanthine;
CC         Xref=Rhea:RHEA:24670, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17368, ChEBI:CHEBI:17712, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.17.1.4;
CC         Evidence={ECO:0000269|PubMed:15878860, ECO:0000269|PubMed:17301076};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O2 + xanthine = H2O2 + urate; Xref=Rhea:RHEA:21132,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:17712, ChEBI:CHEBI:17775; EC=1.17.3.2;
CC         Evidence={ECO:0000269|PubMed:15878860, ECO:0000269|PubMed:17301076};
CC   -!- COFACTOR:
CC       Name=[2Fe-2S] cluster; Xref=ChEBI:CHEBI:49601;
CC       Note=Binds 2 [2Fe-2S] clusters.;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- COFACTOR:
CC       Name=Mo-molybdopterin; Xref=ChEBI:CHEBI:71302; Evidence={ECO:0000250};
CC       Note=Binds 1 Mo-molybdopterin (Mo-MPT) cofactor per subunit.
CC       {ECO:0000250};
CC   -!- ACTIVITY REGULATION: Can be converted from the dehydrogenase form (D)
CC       to the oxidase form (O) irreversibly by proteolysis or reversibly
CC       through the oxidation of sulfhydryl groups.
CC       {ECO:0000269|PubMed:15878860, ECO:0000269|PubMed:2387845}.
CC   -!- SUBUNIT: Homodimer. Interacts with BTN1A1 (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Peroxisome {ECO:0000269|PubMed:11993848}.
CC       Cytoplasm {ECO:0000269|PubMed:11993848}. Secreted {ECO:0000250}.
CC   -!- INDUCTION: By interferon.
CC   -!- PTM: Subject to partial proteolysis; this alters the enzyme from the
CC       dehydrogenase form (D) to the oxidase form (O).
CC   -!- PTM: Contains sulfhydryl groups that are easily oxidized (in vitro);
CC       this alters the enzyme from the dehydrogenase form (D) to the oxidase
CC       form (O).
CC   -!- SIMILARITY: Belongs to the xanthine dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J05579; AAA42349.1; -; mRNA.
DR   EMBL; AH000836; AAA18869.1; -; Unassigned_DNA.
DR   RefSeq; NP_058850.1; NM_017154.1.
DR   PDB; 1WYG; X-ray; 2.60 A; A=1-1331.
DR   PDB; 2E3T; X-ray; 2.28 A; A/B=1-1331.
DR   PDB; 3AN1; X-ray; 1.73 A; A/B=1-1331.
DR   PDB; 4YRW; X-ray; 1.99 A; A/B=1-1315.
DR   PDB; 4YSW; X-ray; 1.99 A; A/B=1-1315.
DR   PDB; 4YTY; X-ray; 2.20 A; A/B=1-1331.
DR   PDB; 4YTZ; X-ray; 2.30 A; A/B=1-1315.
DR   PDB; 6A7X; X-ray; 2.15 A; A/B=1-1331.
DR   PDB; 6ABU; X-ray; 1.77 A; A/B=1-1331.
DR   PDB; 6AC1; X-ray; 1.77 A; A/B=1-1331.
DR   PDB; 6AC4; X-ray; 2.19 A; A/B=1-1331.
DR   PDB; 6AD4; X-ray; 1.80 A; A/B=1-1331.
DR   PDB; 6ADJ; X-ray; 2.18 A; A/B=1-1331.
DR   PDB; 6AJU; X-ray; 1.94 A; A/F=1-1331.
DR   PDBsum; 1WYG; -.
DR   PDBsum; 2E3T; -.
DR   PDBsum; 3AN1; -.
DR   PDBsum; 4YRW; -.
DR   PDBsum; 4YSW; -.
DR   PDBsum; 4YTY; -.
DR   PDBsum; 4YTZ; -.
DR   PDBsum; 6A7X; -.
DR   PDBsum; 6ABU; -.
DR   PDBsum; 6AC1; -.
DR   PDBsum; 6AC4; -.
DR   PDBsum; 6AD4; -.
DR   PDBsum; 6ADJ; -.
DR   PDBsum; 6AJU; -.
DR   SMR; P22985; -.
DR   STRING; 10116.ENSRNOP00000009634; -.
DR   BindingDB; P22985; -.
DR   ChEMBL; CHEMBL1075246; -.
DR   DrugCentral; P22985; -.
DR   iPTMnet; P22985; -.
DR   PhosphoSitePlus; P22985; -.
DR   PaxDb; P22985; -.
DR   PRIDE; P22985; -.
DR   GeneID; 497811; -.
DR   KEGG; rno:497811; -.
DR   UCSC; RGD:62043; rat.
DR   CTD; 7498; -.
DR   RGD; 62043; Xdh.
DR   eggNOG; KOG0430; Eukaryota.
DR   InParanoid; P22985; -.
DR   OrthoDB; 48717at2759; -.
DR   PhylomeDB; P22985; -.
DR   BioCyc; MetaCyc:MONOMER-15163; -.
DR   BRENDA; 1.17.1.4; 5301.
DR   BRENDA; 1.17.3.2; 5301.
DR   Reactome; R-RNO-74259; Purine catabolism.
DR   Reactome; R-RNO-8851680; Butyrophilin (BTN) family interactions.
DR   SABIO-RK; P22985; -.
DR   EvolutionaryTrace; P22985; -.
DR   PRO; PR:P22985; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005777; C:peroxisome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; ISO:RGD.
DR   GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; IDA:UniProtKB.
DR   GO; GO:0009055; F:electron transfer activity; IEA:InterPro.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0070674; F:hypoxanthine dehydrogenase activity; ISO:RGD.
DR   GO; GO:0070675; F:hypoxanthine oxidase activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0043546; F:molybdopterin cofactor binding; IDA:UniProtKB.
DR   GO; GO:0050421; F:nitrite reductase (NO-forming) activity; IDA:RGD.
DR   GO; GO:0016491; F:oxidoreductase activity; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0004854; F:xanthine dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0004855; F:xanthine oxidase activity; IDA:UniProtKB.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; ISO:RGD.
DR   GO; GO:0006154; P:adenosine catabolic process; ISO:RGD.
DR   GO; GO:0007568; P:aging; IEP:RGD.
DR   GO; GO:0006196; P:AMP catabolic process; ISO:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0046055; P:dGMP catabolic process; ISO:RGD.
DR   GO; GO:0046038; P:GMP catabolic process; ISO:RGD.
DR   GO; GO:0009114; P:hypoxanthine catabolic process; IDA:RGD.
DR   GO; GO:0006204; P:IMP catabolic process; ISO:RGD.
DR   GO; GO:0006148; P:inosine catabolic process; ISO:RGD.
DR   GO; GO:0016226; P:iron-sulfur cluster assembly; ISO:RGD.
DR   GO; GO:0007595; P:lactation; ISO:RGD.
DR   GO; GO:0045602; P:negative regulation of endothelial cell differentiation; ISO:RGD.
DR   GO; GO:0001937; P:negative regulation of endothelial cell proliferation; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0051898; P:negative regulation of protein kinase B signaling; ISO:RGD.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:1900747; P:negative regulation of vascular endothelial growth factor signaling pathway; ISO:RGD.
DR   GO; GO:2001213; P:negative regulation of vasculogenesis; ISO:RGD.
DR   GO; GO:1900745; P:positive regulation of p38MAPK cascade; ISO:RGD.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:0030856; P:regulation of epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0010044; P:response to aluminum ion; IDA:RGD.
DR   GO; GO:0097184; P:response to azide; IEP:RGD.
DR   GO; GO:0034465; P:response to carbon monoxide; IEP:RGD.
DR   GO; GO:0009408; P:response to heat; IEP:RGD.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0009115; P:xanthine catabolic process; IDA:UniProtKB.
DR   InterPro; IPR002888; 2Fe-2S-bd.
DR   InterPro; IPR036884; 2Fe-2S-bd_dom_sf.
DR   InterPro; IPR036010; 2Fe-2S_ferredoxin-like_sf.
DR   InterPro; IPR001041; 2Fe-2S_ferredoxin-type.
DR   InterPro; IPR006058; 2Fe2S_fd_BS.
DR   InterPro; IPR000674; Ald_Oxase/Xan_DH_a/b.
DR   InterPro; IPR036856; Ald_Oxase/Xan_DH_a/b_sf.
DR   InterPro; IPR016208; Ald_Oxase/xanthine_DH.
DR   InterPro; IPR008274; AldOxase/xan_DH_Mopterin-bd.
DR   InterPro; IPR037165; AldOxase/xan_DH_Mopterin-bd_sf.
DR   InterPro; IPR005107; CO_DH_flav_C.
DR   InterPro; IPR036683; CO_DH_flav_C_dom_sf.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR002346; Mopterin_DH_FAD-bd.
DR   InterPro; IPR022407; OxRdtase_Mopterin_BS.
DR   InterPro; IPR014307; Xanthine_DH_ssu.
DR   Pfam; PF01315; Ald_Xan_dh_C; 1.
DR   Pfam; PF02738; Ald_Xan_dh_C2; 1.
DR   Pfam; PF03450; CO_deh_flav_C; 1.
DR   Pfam; PF00941; FAD_binding_5; 1.
DR   Pfam; PF00111; Fer2; 1.
DR   Pfam; PF01799; Fer2_2; 1.
DR   PIRSF; PIRSF000127; Xanthine_DH; 1.
DR   SMART; SM01008; Ald_Xan_dh_C; 1.
DR   SMART; SM01092; CO_deh_flav_C; 1.
DR   SUPFAM; SSF47741; SSF47741; 1.
DR   SUPFAM; SSF54292; SSF54292; 1.
DR   SUPFAM; SSF54665; SSF54665; 1.
DR   SUPFAM; SSF55447; SSF55447; 1.
DR   SUPFAM; SSF56003; SSF56003; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   TIGRFAMs; TIGR02963; xanthine_xdhA; 1.
DR   PROSITE; PS00197; 2FE2S_FER_1; 1.
DR   PROSITE; PS51085; 2FE2S_FER_2; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
DR   PROSITE; PS00559; MOLYBDOPTERIN_EUK; 1.
PE   1: Evidence at protein level;
KW   2Fe-2S; 3D-structure; Cytoplasm; Direct protein sequencing; Disulfide bond;
KW   FAD; Flavoprotein; Iron; Iron-sulfur; Metal-binding; Molybdenum; NAD;
KW   Oxidoreductase; Peroxisome; Reference proteome; Secreted.
FT   CHAIN           1..1331
FT                   /note="Xanthine dehydrogenase/oxidase"
FT                   /id="PRO_0000166086"
FT   DOMAIN          4..91
FT                   /note="2Fe-2S ferredoxin-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00465"
FT   DOMAIN          228..413
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   NP_BIND         256..263
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15878860,
FT                   ECO:0000269|PubMed:17301076"
FT   NP_BIND         346..350
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15878860,
FT                   ECO:0000269|PubMed:17301076"
FT   ACT_SITE        1261
FT                   /note="Proton acceptor"
FT   METAL           43
FT                   /note="Iron-sulfur 1"
FT   METAL           48
FT                   /note="Iron-sulfur 1"
FT   METAL           51
FT                   /note="Iron-sulfur 1"
FT   METAL           73
FT                   /note="Iron-sulfur 1"
FT   METAL           112
FT                   /note="Iron-sulfur 2"
FT   METAL           115
FT                   /note="Iron-sulfur 2"
FT   METAL           147
FT                   /note="Iron-sulfur 2"
FT   METAL           149
FT                   /note="Iron-sulfur 2"
FT   METAL           767
FT                   /note="Molybdenum"
FT                   /evidence="ECO:0000250"
FT   METAL           798
FT                   /note="Molybdenum; via carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   METAL           912
FT                   /note="Molybdenum; via amide nitrogen"
FT                   /evidence="ECO:0000250"
FT   METAL           1079
FT                   /note="Molybdenum; via amide nitrogen"
FT                   /evidence="ECO:0000250"
FT   BINDING         336
FT                   /note="FAD"
FT                   /evidence="ECO:0000250"
FT   BINDING         359
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15878860,
FT                   ECO:0000269|PubMed:17301076"
FT   BINDING         403
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:15878860,
FT                   ECO:0000269|PubMed:17301076"
FT   BINDING         421
FT                   /note="FAD"
FT                   /evidence="ECO:0000250"
FT   BINDING         802
FT                   /note="Substrate"
FT   BINDING         880
FT                   /note="Substrate"
FT   BINDING         914
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         1010
FT                   /note="Substrate; via amide nitrogen"
FT   DISULFID        535..992
FT                   /note="In oxidase form"
FT                   /evidence="ECO:0000305|PubMed:15878860"
FT   MUTAGEN         335..336
FT                   /note="WF->AL: Converts the enzyme to the oxidase form that
FT                   utilizes molecular oxygen as electron acceptor. Interferes
FT                   with normal conversion to the dehydrogenase form by
FT                   reducing agents."
FT                   /evidence="ECO:0000269|PubMed:17301076"
FT   MUTAGEN         535
FT                   /note="C->A: Slows the conversion from the dehydrogenase
FT                   form to the oxidase form; when associated with R-992.
FT                   Abolishes conversion from the dehydrogenase form to the
FT                   oxidase form; when associated with R-992 and S-1316."
FT                   /evidence="ECO:0000269|PubMed:15878860"
FT   MUTAGEN         992
FT                   /note="C->R: Slows the conversion from the dehydrogenase
FT                   form to the oxidase form; when associated with A-535.
FT                   Abolishes conversion from the dehydrogenase form to the
FT                   oxidase form; when associated with A-535 and S-1316."
FT                   /evidence="ECO:0000269|PubMed:15878860"
FT   MUTAGEN         1316
FT                   /note="C->S: Abolishes conversion from the dehydrogenase
FT                   form to the oxidase form; when associated with A-535 and R-
FT                   992."
FT                   /evidence="ECO:0000269|PubMed:15878860"
FT   STRAND          6..10
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          13..17
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           26..32
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          44..48
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          52..59
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   TURN            60..63
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          64..71
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           72..74
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           77..79
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          84..86
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           88..91
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          94..96
FT                   /evidence="ECO:0007829|PDB:1WYG"
FT   HELIX           99..106
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           116..129
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           135..140
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   TURN            141..144
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          148..150
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           153..159
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           160..162
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           197..199
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           205..207
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           213..218
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          226..229
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          234..237
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           241..250
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           263..269
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          275..279
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           284..287
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          289..291
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          293..299
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           304..317
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           320..322
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           324..334
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           339..342
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           347..353
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           361..366
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          370..375
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          378..383
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           386..388
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          402..409
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          415..422
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          424..428
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          432..441
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          445..461
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   TURN            466..468
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           470..472
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          476..478
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           479..492
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           504..528
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   TURN            529..531
FT                   /evidence="ECO:0007829|PDB:4YTY"
FT   HELIX           532..535
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           540..546
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          555..559
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          565..567
FT                   /evidence="ECO:0007829|PDB:1WYG"
FT   HELIX           582..586
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           593..595
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          603..609
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          611..621
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           625..627
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          631..635
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           637..639
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          645..647
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          652..655
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          658..660
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          666..674
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           675..683
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          686..691
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           698..703
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          707..710
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          712..717
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           719..725
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          727..736
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          748..753
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          760..764
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           769..780
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           784..786
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          787..792
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   TURN            798..801
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          802..804
FT                   /evidence="ECO:0007829|PDB:1WYG"
FT   HELIX           806..819
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          823..826
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           829..835
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          842..850
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          856..866
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           874..883
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   TURN            884..888
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          892..901
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   TURN            912..915
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           916..934
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           938..945
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           964..974
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           977..990
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          992..1008
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           1012..1014
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          1016..1023
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          1029..1034
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          1038..1040
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           1042..1054
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           1058..1060
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          1061..1063
FT                   /evidence="ECO:0007829|PDB:4YSW"
FT   TURN            1068..1070
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   TURN            1079..1081
FT                   /evidence="ECO:0007829|PDB:1WYG"
FT   HELIX           1082..1107
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          1108..1111
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           1113..1122
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          1128..1134
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   TURN            1142..1145
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          1151..1165
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   TURN            1166..1168
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          1171..1181
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           1188..1207
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   TURN            1224..1226
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           1232..1234
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          1237..1243
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   TURN            1250..1252
FT                   /evidence="ECO:0007829|PDB:1WYG"
FT   HELIX           1253..1255
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           1264..1267
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           1268..1285
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   STRAND          1286..1289
FT                   /evidence="ECO:0007829|PDB:2E3T"
FT   HELIX           1301..1307
FT                   /evidence="ECO:0007829|PDB:3AN1"
FT   HELIX           1311..1316
FT                   /evidence="ECO:0007829|PDB:3AN1"
SQ   SEQUENCE   1331 AA;  146243 MW;  BF2586A9C63A0B2C CRC64;
     MTADELVFFV NGKKVVEKNA DPETTLLVYL RRKLGLCGTK LGCGEGGCGA CTVMISKYDR
     LQNKIVHFSV NACLAPICSL HHVAVTTVEG IGNTQKLHPV QERIARSHGS QCGFCTPGIV
     MSMYTLLRNQ PEPTVEEIEN AFQGNLCRCT GYRPILQGFR TFAKDGGCCG GSGNNPNCCM
     NQTKDQTVSL SPSLFNPEDF KPLDPTQEPI FPPELLRLKD TPQKKLRFEG ERVTWIQAST
     MEELLDLKAQ HPDAKLVVGN TEIGIEMKFK NMLFPLIVCP AWIPELNSVV HGPEGISFGA
     SCPLSLVESV LAEEIAKLPE QKTEVFRGVM EQLRWFAGKQ VKSVASIGGN IITASPISDL
     NPVFMASGAK LTLVSRGTRR TVRMDHTFFP GYRKTLLRPE EILLSIEIPY SKEGEFFSAF
     KQASRREDDI AKVTSGMRVL FKPGTIEVQE LSLCFGGMAD RTISALKTTP KQLSKSWNEE
     LLQSVCAGLA EELQLAPDAP GGMVEFRRTL TLSFFFKFYL TVLQKLGRAD LEDMCGKLDP
     TFASATLLFQ KDPPANVQLF QEVPKDQSEE DMVGRPLPHL AANMQASGEA VYCDDIPRYE
     NELSLRLVTS TRAHAKITSI DTSEAKKVPG FVCFLTAEDV PNSNATGLFN DETVFAKDEV
     TCVGHIIGAV VADTPEHAQR AARGVKITYE DLPAIITIQD AINNNSFYGS EIKIEKGDLK
     KGFSEADNVV SGELYIGGQE HFYLETNCTI AVPKGEAGEM ELFVSTQNTM KTQSFVAKML
     GVPDNRIVVR VKRMGGGFGG KETRSTVVST ALALAAHKTG RPVRCMLDRD EDMLITGGRH
     PFLAKYKVGF MKTGTVVALE VAHFSNGGNT EDLSRSIMER ALFHMDNAYK IPNIRGTGRI
     CKTNLPSNTA FRGFGGPQGM LIAEYWMSEV AITCGLPAEE VRRKNMYKEG DLTHFNQKLE
     GFTLPRCWDE CIASSQYLAR KREVEKFNRE NCWKKRGLCI IPTKFGISFT LPFLNQGGAL
     VHVYTDGSVL LTHGGTEMGQ GLHTKMVQVA SRALKIPTSK IHISETSTNT VPNTSPTAAS
     ASADLNGQGV YEACQTILKR LEPFKKKKPT GPWEAWVMDA YTSAVSLSAT GFYKTPNLGY
     SFETNSGNPF HYFSYGVACS EVEIDCLTGD HKNLRTDIVM DVGSSLNPAI DIGQVEGAFV
     QGLGLFTMEE LHYSPEGSLH TRGPSTYKIP AFGSIPIEFR VSLLRDCPNK RAIYASKAVG
     EPPLFLASSI FFAIKDAIRA ARAQHGDNAK QLFQLDSPAT PEKIRNACVD QFTTLCVTGV
     PENCKSWSVR I
//
ID   PHR_ORYSJ               Reviewed;         506 AA.
AC   Q6F6A2; A0A0P0XT34; C7J833; Q3LGA3; Q84LN6; Q8LM09;
DT   03-MAY-2011, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 1.
DT   02-JUN-2021, entry version 96.
DE   RecName: Full=Deoxyribodipyrimidine photo-lyase;
DE            EC=4.1.99.3;
DE   AltName: Full=DNA photolyase;
DE   AltName: Full=OsCPDII;
DE   AltName: Full=Photoreactivating enzyme;
GN   Name=PHR; OrderedLocusNames=Os10g0167600, LOC_Os10g08580;
GN   ORFNames=OSJNAb0015J03.12;
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   STRAIN=cv. Sasanishiki;
RX   PubMed=12764611; DOI=10.1007/s00438-003-0856-9;
RA   Hirouchi T., Nakajima S., Najrana T., Tanaka M., Matsunaga T., Hidema J.,
RA   Teranishi M., Fujino T., Kumagai T., Yamamoto K.;
RT   "A gene for a Class II DNA photolyase from Oryza sativa: cloning of the
RT   cDNA by dilution-amplification.";
RL   Mol. Genet. Genomics 269:508-516(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=cv. Nohrin;
RX   PubMed=15653803; DOI=10.1093/pcp/pch215;
RA   Teranishi M., Iwamatsu Y., Hidema J., Kumagai T.;
RT   "Ultraviolet-B sensitivities in Japanese lowland rice cultivars:
RT   cyclobutane pyrimidine dimer photolyase activity and gene mutation.";
RL   Plant Cell Physiol. 45:1848-1856(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RX   PubMed=15965242; DOI=10.1534/genetics.105.044735;
RA   Ueda T., Sato T., Hidema J., Hirouchi T., Yamamoto K., Kumagai T., Yano M.;
RT   "qUVR-10, a major quantitative trait locus for ultraviolet-B resistance in
RT   rice, encodes cyclobutane pyrimidine dimer photolyase.";
RL   Genetics 171:1941-1950(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   STRAIN=cv. Gulfmont;
RX   PubMed=17895582; DOI=10.1266/ggs.82.311;
RA   Ymamoto A., Hirouchi T., Mori T., Teranishi M., Hidema J., Morioka H.,
RA   Kumagai T., Yamamoto K.;
RT   "Biochemical and biological properties of DNA photolyases derived from
RT   utraviolet-sensitive rice cultivars.";
RL   Genes Genet. Syst. 82:311-319(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=12791992; DOI=10.1126/science.1083523;
RA   Yu Y., Rambo T., Currie J., Saski C., Kim H.-R., Collura K., Thompson S.,
RA   Simmons J., Yang T.-J., Nah G., Patel A.J., Thurmond S., Henry D.,
RA   Oates R., Palmer M., Pries G., Gibson J., Anderson H., Paradkar M.,
RA   Crane L., Dale J., Carver M.B., Wood T., Frisch D., Engler F.,
RA   Soderlund C., Palmer L.E., Teytelman L., Nascimento L., De la Bastide M.,
RA   Spiegel L., Ware D., O'Shaughnessy A., Dike S., Dedhia N., Preston R.,
RA   Huang E., Ferraro K., Kuit K., Miller B., Zutavern T., Katzenberger F.,
RA   Muller S., Balija V., Martienssen R.A., Stein L., Minx P., Johnson D.,
RA   Cordum H., Mardis E., Cheng Z., Jiang J., Wilson R., McCombie W.R.,
RA   Wing R.A., Yuan Q., Ouyang S., Liu J., Jones K.M., Gansberger K.,
RA   Moffat K., Hill J., Tsitrin T., Overton L., Bera J., Kim M., Jin S.,
RA   Tallon L., Ciecko A., Pai G., Van Aken S., Utterback T., Reidmuller S.,
RA   Bormann J., Feldblyum T., Hsiao J., Zismann V., Blunt S., de Vazeille A.R.,
RA   Shaffer T., Koo H., Suh B., Yang Q., Haas B., Peterson J., Pertea M.,
RA   Volfovsky N., Wortman J., White O., Salzberg S.L., Fraser C.M., Buell C.R.,
RA   Messing J., Song R., Fuks G., Llaca V., Kovchak S., Young S., Bowers J.E.,
RA   Paterson A.H., Johns M.A., Mao L., Pan H., Dean R.A.;
RT   "In-depth view of structure, activity, and evolution of rice chromosome
RT   10.";
RL   Science 300:1566-1569(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [7]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=18089549; DOI=10.1093/nar/gkm978;
RG   The rice annotation project (RAP);
RT   "The rice annotation project database (RAP-DB): 2008 update.";
RL   Nucleic Acids Res. 36:D1028-D1033(2008).
RN   [8]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H., McCombie W.R.,
RA   Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S., Childs K.L.,
RA   Davidson R.M., Lin H., Quesada-Ocampo L., Vaillancourt B., Sakai H.,
RA   Lee S.S., Kim J., Numa H., Itoh T., Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using next
RT   generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=15150342; DOI=10.1093/nar/gkh591;
RA   Kimura S., Tahira Y., Ishibashi T., Mori Y., Mori T., Hashimoto J.,
RA   Sakaguchi K.;
RT   "DNA repair in higher plants; photoreactivation is the major DNA repair
RT   pathway in non-proliferating cells while excision repair (nucleotide
RT   excision repair and base excision repair) is active in proliferating
RT   cells.";
RL   Nucleic Acids Res. 32:2760-2767(2004).
RN   [10]
RP   FUNCTION.
RX   PubMed=17397507; DOI=10.1111/j.1365-313x.2007.03041.x;
RA   Hidema J., Taguchi T., Ono T., Teranishi M., Yamamoto K., Kumagai T.;
RT   "Increase in CPD photolyase activity functions effectively to prevent
RT   growth inhibition caused by UVB radiation.";
RL   Plant J. 50:70-79(2007).
RN   [11]
RP   FUNCTION, PHOSPHORYLATION AT SER-312, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=18235036; DOI=10.1104/pp.107.110189;
RA   Teranishi M., Nakamura K., Morioka H., Yamamoto K., Hidema J.;
RT   "The native cyclobutane pyrimidine dimer photolyase of rice is
RT   phosphorylated.";
RL   Plant Physiol. 146:1941-1951(2008).
RN   [12]
RP   FUNCTION, AND COFACTOR.
RX   PubMed=20227927; DOI=10.1016/j.dnarep.2010.01.014;
RA   Okafuji A., Biskup T., Hitomi K., Getzoff E.D., Kaiser G., Batschauer A.,
RA   Bacher A., Hidema J., Teranishi M., Yamamoto K., Schleicher E., Weber S.;
RT   "Light-induced activation of class II cyclobutane pyrimidine dimer
RT   photolyases.";
RL   DNA Repair 9:495-505(2010).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.71 ANGSTROMS) IN COMPLEX WITH FAD.
RX   PubMed=22170053; DOI=10.1074/jbc.m111.244020;
RA   Hitomi K., Arvai A.S., Yamamoto J., Hitomi C., Teranishi M., Hirouchi T.,
RA   Yamamoto K., Iwai S., Tainer J.A., Hidema J., Getzoff E.D.;
RT   "Eukaryotic class II cyclobutane pyrimidine dimer photolyase structure
RT   reveals basis for improved ultraviolet tolerance in plants.";
RL   J. Biol. Chem. 287:12060-12069(2012).
RN   [14]
RP   INDUCTION BY GAMMA IRRADIATION.
RX   PubMed=25124817; DOI=10.1093/jhered/esu025;
RA   Hayashi G., Shibato J., Imanaka T., Cho K., Kubo A., Kikuchi S., Satoh K.,
RA   Kimura S., Ozawa S., Fukutani S., Endo S., Ichikawa K., Agrawal G.K.,
RA   Shioda S., Fukumoto M., Rakwal R.;
RT   "Unraveling low-level gamma radiation--responsive changes in expression of
RT   early and late genes in leaves of rice seedlings at Iitate Village,
RT   Fukushima.";
RL   J. Hered. 105:723-738(2014).
CC   -!- FUNCTION: Involved in repair of UV radiation-induced DNA damage.
CC       Catalyzes the light-dependent monomerization (300-600 nm) of
CC       cyclobutylpyrimidine dimers (CPDs), which are formed between adjacent
CC       bases on the same DNA strand upon exposure to ultraviolet radiation.
CC       Required for plant survival in the presence of UV-B light. Not involved
CC       in the repair of (6-4) photoproducts. {ECO:0000269|PubMed:12764611,
CC       ECO:0000269|PubMed:15965242, ECO:0000269|PubMed:17397507,
CC       ECO:0000269|PubMed:17895582, ECO:0000269|PubMed:18235036,
CC       ECO:0000269|PubMed:20227927}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Cyclobutadipyrimidine (in DNA) = 2 pyrimidine residues (in
CC         DNA).; EC=4.1.99.3;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:20227927, ECO:0000269|PubMed:22170053};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:20227927,
CC       ECO:0000269|PubMed:22170053};
CC   -!- INTERACTION:
CC       Q6F6A2; Q10B79-1: SPX4; NbExp=2; IntAct=EBI-16205114, EBI-16205145;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in proliferating tissues. Highly
CC       expressed in roots and shoot apical meristem (SAM). Expressed in
CC       leaves, flag leaves, and panicle. {ECO:0000269|PubMed:15150342}.
CC   -!- INDUCTION: Induced by gamma irradiation. {ECO:0000269|PubMed:25124817}.
CC   -!- MISCELLANEOUS: Over-expression of PHR decreases growth inhibition, leaf
CC       necrosis and CPDs accumulation under UV-B treatment.
CC   -!- SIMILARITY: Belongs to the DNA photolyase class-2 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAN04184.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAH94769.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB096003; BAC76449.2; -; mRNA.
DR   EMBL; AB099694; BAD26607.1; -; Genomic_DNA.
DR   EMBL; AB198744; BAE06248.1; -; Genomic_DNA.
DR   EMBL; AB210109; BAE45635.1; -; mRNA.
DR   EMBL; AC131375; AAN04184.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; DP000086; ABB46863.1; -; Genomic_DNA.
DR   EMBL; AP008216; BAH94769.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AP014966; BAT10044.1; -; Genomic_DNA.
DR   RefSeq; XP_015614933.1; XM_015759447.1.
DR   PDB; 3UMV; X-ray; 1.70 A; A/B=1-506.
DR   PDBsum; 3UMV; -.
DR   SMR; Q6F6A2; -.
DR   DIP; DIP-62040N; -.
DR   IntAct; Q6F6A2; 1.
DR   STRING; 4530.OS10T0167600-01; -.
DR   iPTMnet; Q6F6A2; -.
DR   PaxDb; Q6F6A2; -.
DR   PRIDE; Q6F6A2; -.
DR   EnsemblPlants; Os10t0167600-02; Os10t0167600-02; Os10g0167600.
DR   GeneID; 9272017; -.
DR   Gramene; Os10t0167600-02; Os10t0167600-02; Os10g0167600.
DR   KEGG; osa:9272017; -.
DR   eggNOG; KOG0133; Eukaryota.
DR   HOGENOM; CLU_026342_2_0_1; -.
DR   InParanoid; Q6F6A2; -.
DR   OrthoDB; 985150at2759; -.
DR   BRENDA; 4.1.99.3; 8948.
DR   Proteomes; UP000000763; Chromosome 10.
DR   Proteomes; UP000059680; Chromosome 10.
DR   ExpressionAtlas; Q6F6A2; baseline and differential.
DR   Genevisible; Q6F6A2; OS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003904; F:deoxyribodipyrimidine photo-lyase activity; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IDA:UniProtKB.
DR   GO; GO:0000719; P:photoreactive repair; IBA:GO_Central.
DR   GO; GO:0009650; P:UV protection; IDA:UniProtKB.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR036134; Crypto/Photolyase_FAD-like_sf.
DR   InterPro; IPR036155; Crypto/Photolyase_N_sf.
DR   InterPro; IPR008148; DNA_photolyase_2.
DR   InterPro; IPR032673; DNA_photolyase_2_CS.
DR   InterPro; IPR006050; DNA_photolyase_N.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00875; DNA_photolyase; 1.
DR   SUPFAM; SSF48173; SSF48173; 1.
DR   SUPFAM; SSF52425; SSF52425; 1.
DR   TIGRFAMs; TIGR00591; phr2; 1.
DR   PROSITE; PS01083; DNA_PHOTOLYASES_2_1; 1.
DR   PROSITE; PS01084; DNA_PHOTOLYASES_2_2; 1.
DR   PROSITE; PS51645; PHR_CRY_ALPHA_BETA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; DNA damage; DNA repair; DNA-binding; FAD; Flavoprotein;
KW   Lyase; Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome.
FT   CHAIN           1..506
FT                   /note="Deoxyribodipyrimidine photo-lyase"
FT                   /id="PRO_0000407852"
FT   DOMAIN          38..171
FT                   /note="Photolyase/cryptochrome alpha/beta"
FT   NP_BIND         282..285
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22170053,
FT                   ECO:0007744|PDB:3UMV"
FT   NP_BIND         319..327
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:P00914"
FT   NP_BIND         427..429
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:P00914"
FT   REGION          1..33
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          487..506
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..20
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        489..506
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         268
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22170053,
FT                   ECO:0007744|PDB:3UMV"
FT   BINDING         390
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22170053,
FT                   ECO:0007744|PDB:3UMV"
FT   BINDING         421
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22170053,
FT                   ECO:0007744|PDB:3UMV"
FT   BINDING         427
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:22170053,
FT                   ECO:0007744|PDB:3UMV"
FT   SITE            378
FT                   /note="Electron transfer via tryptophanyl radical"
FT                   /evidence="ECO:0000255"
FT   SITE            399
FT                   /note="Electron transfer via tryptophanyl radical"
FT                   /evidence="ECO:0000255"
FT   SITE            406
FT                   /note="Electron transfer via tryptophanyl radical"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         312
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:18235036"
FT   CONFLICT        126
FT                   /note="R -> Q (in Ref. 1; BAC76449)"
FT                   /evidence="ECO:0000305"
FT   HELIX           23..25
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   STRAND          26..30
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   STRAND          40..46
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           54..65
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   STRAND          70..75
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           82..84
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           87..106
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   STRAND          111..116
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           120..127
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   STRAND          131..135
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           141..157
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   STRAND          161..166
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           174..177
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           185..193
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           196..199
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           222..231
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           246..254
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   TURN            256..258
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           260..263
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           265..267
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           268..271
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           278..280
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           285..289
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           295..305
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           306..308
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           310..320
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           322..333
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   TURN            335..338
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           340..342
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           345..353
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   TURN            354..356
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           365..369
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           376..388
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           393..405
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   STRAND          407..409
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           410..424
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           431..442
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   TURN            453..455
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           463..469
FT                   /evidence="ECO:0007829|PDB:3UMV"
FT   HELIX           472..489
FT                   /evidence="ECO:0007829|PDB:3UMV"
SQ   SEQUENCE   506 AA;  56637 MW;  954450951EE78EA4 CRC64;
     MPPTSVSPPR TAPGPANPSP AHPSRVRVIH PGGGKPGGPV VYWMLRDQRL ADNWALLHAA
     GLAAASASPL AVAFALFPRP FLLSARRRQL GFLLRGLRRL AADAAARHLP FFLFTGGPAE
     IPALVRRLGA STLVADFSPL RPVREALDAV VGDLRREAPG VAVHQVDAHN VVPVWTASAK
     MEYSAKTFRG KVSKVMDEYL VEFPELPAVV PWDREQPEGV DWDALIARVC SEAENVPEID
     WCEPGEEAAI EALLGSKDGF LTKRIKSYET DRNDPTKPRA LSGLSPYLHF GHISAQRCAL
     EAKKCRHLSP KSVDAFLEEL VVRRELADNF CYYQPQYDSL SGAWEWARKT LMDHAADKRE
     HIYTREQLEN AKTHDPLWNA SQLEMVHHGK MHGFMRMYWA KKILEWTSGP EEALSTAIYL
     NDKYEIDGRD PSGYVGCMWS ICGLHDQGWK ERPVFGKIRY MNYAGCKRKF DVDAYISYVK
     RLAGQSKKRN AEESPNPVVK LSKSQH
//
ID   PAO1_MAIZE              Reviewed;         500 AA.
AC   O64411; Q546R6;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   02-JUN-2021, entry version 135.
DE   RecName: Full=Polyamine oxidase 1 {ECO:0000303|Ref.2};
DE            EC=1.5.3.14 {ECO:0000269|Ref.4};
DE            EC=1.5.3.15 {ECO:0000269|Ref.4};
DE   Flags: Precursor;
GN   Name=MPAO1 {ECO:0000303|Ref.2};
GN   Synonyms=MPAO {ECO:0000303|PubMed:16331971},
GN   PAO {ECO:0000303|PubMed:9598979};
OS   Zea mays (Maize).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; Liliopsida; Poales; Poaceae; PACMAD clade;
OC   Panicoideae; Andropogonodae; Andropogoneae; Tripsacinae; Zea.
OX   NCBI_TaxID=4577;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 29-93; 97-111; 115-147;
RP   150-152; 154-162; 164-225; 227-241; 254-266; 270-278; 292-314; 317-323;
RP   329-332; 343-352; 355-383; 385-394; 404-459; 461-471; 477-487 AND 493-496.
RC   STRAIN=cv. Paolo; TISSUE=Etiolated seedling;
RX   PubMed=9598979; DOI=10.1016/s0014-5793(98)00311-1;
RA   Tavladoraki P., Schinina M.E., Cecconi F., Di Agostino S., Manera F.,
RA   Rea G., Mariottini P., Federico R., Angelini R.;
RT   "Maize polyamine oxidase: primary structure from protein and cDNA
RT   sequencing.";
RL   FEBS Lett. 426:62-66(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=cv. Paolo;
RX   DOI=10.1016/S0981-9428(00)01170-0;
RA   Cervelli M., Tavladoraki P., Di Agostino S., Angelini R., Federico R.,
RA   Mariottini P.;
RT   "Isolation and characterization of three polyamine oxidase genes from Zea
RT   mays.";
RL   Plant Physiol. Biochem. 38:667-677(2000).
RN   [3]
RP   SUBUNIT, AND COFACTOR.
RX   DOI=10.1016/0031-9422(89)85004-6;
RA   Federico R., Alisi C., Forlani F.;
RT   "Properties of the polyamine oxidase from the cell wall of maize
RT   seedlings.";
RL   Phytochemistry 28:45-46(1989).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   DOI=10.1016/0031-9422(96)00316-0;
RA   Federico R., Ercolini L., Laurenzi M., Angelini R.;
RT   "Oxidation of acetylpolyamines by maize polyamine oxidase.";
RL   Phytochemistry 43:339-341(1996).
RN   [5]
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=12586904; DOI=10.1104/pp.011379;
RA   Cona A., Cenci F., Cervelli M., Federico R., Mariottini P., Moreno S.,
RA   Angelini R.;
RT   "Polyamine oxidase, a hydrogen peroxide-producing enzyme, is up-regulated
RT   by light and down-regulated by auxin in the outer tissues of the maize
RT   mesocotyl.";
RL   Plant Physiol. 131:803-813(2003).
RN   [6]
RP   FUNCTION, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF
RP   LYS-328.
RX   PubMed=16331971; DOI=10.1021/bi050983i;
RA   Polticelli F., Basran J., Faso C., Cona A., Minervini G., Angelini R.,
RA   Federico R., Scrutton N.S., Tavladoraki P.;
RT   "Lys300 plays a major role in the catalytic mechanism of maize polyamine
RT   oxidase.";
RL   Biochemistry 44:16108-16120(2005).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS), AND CRYSTALLIZATION.
RX   PubMed=10089528; DOI=10.1107/s0907444998005836;
RA   Binda C., Coda A., Angelini R., Federico R., Ascenzi P., Mattevi A.;
RT   "Crystallization and preliminary X-ray analysis of polyamine oxidase from
RT   Zea mays L.";
RL   Acta Crystallogr. D 54:1429-1431(1998).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 29-500 IN COMPLEXES WITH FAD AND
RP   SYNTHETIC INHIBITORS, GLYCOSYLATION AT ASN-105, AND DISULFIDE BOND.
RX   PubMed=10368296; DOI=10.1016/s0969-2126(99)80037-9;
RA   Binda C., Coda A., Angelini R., Federico R., Ascenzi P., Mattevi A.;
RT   "A 30-A-long U-shaped catalytic tunnel in the crystal structure of
RT   polyamine oxidase.";
RL   Structure 7:265-276(1999).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 29-500 IN COMPLEXES WITH FAD AND
RP   SYNTHETIC INHIBITORS, GLYCOSYLATION AT ASN-105, AND DISULFIDE BOND.
RX   PubMed=11258887; DOI=10.1021/bi002751j;
RA   Binda C., Angelini R., Federico R., Ascenzi P., Mattevi A.;
RT   "Structural bases for inhibitor binding and catalysis in polyamine
RT   oxidase.";
RL   Biochemistry 40:2766-2776(2001).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (3.20 ANGSTROMS) OF 29-500 IN COMPLEX WITH SPERMINE
RP   AND SPERMIDINE.
RA   Fiorillo A., Ilari A., Tavladoraki P.;
RT   "The crystal structure of the mutant Lys300Met of polyamine oxidase from
RT   Zea Mays unveils the role of Lys300 in catalysis.";
RL   Submitted (NOV-2009) to the PDB data bank.
CC   -!- FUNCTION: Flavoenzyme involved in polyamine back-conversion (Ref.4,
CC       PubMed:16331971). Catalyzes the oxidation of the secondary amino group
CC       of polyamines, such as spermine, spermidine and their acetyl
CC       derivatives (Ref.4, PubMed:16331971). Plays an important role in the
CC       regulation of polyamine intracellular concentration (Probable).
CC       {ECO:0000269|PubMed:16331971, ECO:0000269|Ref.4, ECO:0000305|Ref.4}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O2 + spermidine = 4-aminobutanal + H2O2 + propane-1,3-
CC         diamine; Xref=Rhea:RHEA:25820, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:57484, ChEBI:CHEBI:57834,
CC         ChEBI:CHEBI:58264; EC=1.5.3.14; Evidence={ECO:0000269|Ref.4};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N(8)-acetylspermidine + O2 = 4-acetamidobutanal + H2O2 +
CC         propane-1,3-diamine; Xref=Rhea:RHEA:25972, ChEBI:CHEBI:7386,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:57484, ChEBI:CHEBI:58535; EC=1.5.3.15;
CC         Evidence={ECO:0000269|Ref.4};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O2 + spermine = H2O2 + N-(3-aminopropyl)-4-aminobutanal
CC         + propane-1,3-diamine; Xref=Rhea:RHEA:25824, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:45725,
CC         ChEBI:CHEBI:57484, ChEBI:CHEBI:58869; EC=1.5.3.14;
CC         Evidence={ECO:0000269|Ref.4};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N(1)-acetylspermine + O2 = H2O2 + N-(3-acetamidopropyl)-
CC         4-aminobutanal + propane-1,3-diamine; Xref=Rhea:RHEA:25996,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:57484, ChEBI:CHEBI:58101, ChEBI:CHEBI:58858; EC=1.5.3.14;
CC         Evidence={ECO:0000269|Ref.4};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:16331971, ECO:0000269|Ref.3};
CC       Note=Binds 1 FAD per subunit. {ECO:0000305|Ref.3};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=38 uM for spermine {ECO:0000269|Ref.4};
CC         KM=40 uM for spermidine {ECO:0000269|Ref.4};
CC         KM=62 uM for N(1)-acetylspermine {ECO:0000269|Ref.4};
CC         KM=274 uM for N(1)-acetylspermidine {ECO:0000269|Ref.4};
CC         KM=100 uM for dioxygen {ECO:0000269|Ref.4};
CC         Vmax=6 umol/min/ug enzyme with spermine as substrate
CC         {ECO:0000269|Ref.4};
CC         Vmax=70 umol/min/ug enzyme with spermidine as substrate
CC         {ECO:0000269|Ref.4};
CC         Vmax=21 umol/min/ug enzyme with N(1)-acetylspermine as substrate
CC         {ECO:0000269|Ref.4};
CC         Vmax=2.5 umol/min/ug enzyme with N(1)-acetylspermidine as substrate
CC         {ECO:0000269|Ref.4};
CC       pH dependence:
CC         Optimum pH is 6.5. {ECO:0000269|PubMed:16331971, ECO:0000269|Ref.4};
CC   -!- PATHWAY: Amine and polyamine degradation; spermine degradation.
CC       {ECO:0000305}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|Ref.3}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, apoplast
CC       {ECO:0000269|PubMed:12586904}. Secreted, cell wall
CC       {ECO:0000269|PubMed:12586904}.
CC   -!- INDUCTION: Induced by light (at protein level) (PubMed:12586904). Down-
CC       regulated by auxin (at protein level) (PubMed:12586904).
CC       {ECO:0000269|PubMed:12586904}.
CC   -!- SIMILARITY: Belongs to the flavin monoamine oxidase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ002204; CAA05249.1; -; mRNA.
DR   EMBL; AJ251568; CAC03739.1; -; Genomic_DNA.
DR   EMBL; AJ251018; CAC04001.1; -; Genomic_DNA.
DR   PIR; T03387; T03387.
DR   RefSeq; NP_001105106.1; NM_001111636.1.
DR   PDB; 1B37; X-ray; 1.90 A; A/B/C=29-500.
DR   PDB; 1B5Q; X-ray; 1.90 A; A/B/C=29-500.
DR   PDB; 1H81; X-ray; 2.10 A; A/B/C=29-500.
DR   PDB; 1H82; X-ray; 1.90 A; A/B/C=29-500.
DR   PDB; 1H83; X-ray; 1.90 A; A/B/C=29-500.
DR   PDB; 1H84; X-ray; 2.00 A; A/B/C=29-500.
DR   PDB; 1H86; X-ray; 2.00 A; A/B/C=29-500.
DR   PDB; 3KPF; X-ray; 2.90 A; A/B=29-500.
DR   PDB; 3KU9; X-ray; 3.20 A; A/B=29-500.
DR   PDB; 3L1R; X-ray; 3.20 A; A/B=29-500.
DR   PDBsum; 1B37; -.
DR   PDBsum; 1B5Q; -.
DR   PDBsum; 1H81; -.
DR   PDBsum; 1H82; -.
DR   PDBsum; 1H83; -.
DR   PDBsum; 1H84; -.
DR   PDBsum; 1H86; -.
DR   PDBsum; 3KPF; -.
DR   PDBsum; 3KU9; -.
DR   PDBsum; 3L1R; -.
DR   SMR; O64411; -.
DR   STRING; 4577.GRMZM2G034152_P01; -.
DR   BindingDB; O64411; -.
DR   ChEMBL; CHEMBL6108; -.
DR   Allergome; 955; Zea m PAO.
DR   iPTMnet; O64411; -.
DR   PaxDb; O64411; -.
DR   PRIDE; O64411; -.
DR   GeneID; 541983; -.
DR   KEGG; zma:541983; -.
DR   eggNOG; KOG0029; Eukaryota.
DR   OrthoDB; 508351at2759; -.
DR   BioCyc; MetaCyc:MONOMER-9461; -.
DR   BRENDA; 1.5.3.14; 6752.
DR   SABIO-RK; O64411; -.
DR   UniPathway; UPA00211; -.
DR   EvolutionaryTrace; O64411; -.
DR   PRO; PR:O64411; -.
DR   Proteomes; UP000007305; Unplaced.
DR   ExpressionAtlas; O64411; baseline and differential.
DR   GO; GO:0048046; C:apoplast; IDA:UniProtKB.
DR   GO; GO:0009505; C:plant-type cell wall; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0052898; F:N1-acetylspermidine:oxygen oxidoreductase (propane-1,3-diamine-forming) activity; IEA:UniProtKB-EC.
DR   GO; GO:0052893; F:N1-acetylspermine:oxygen oxidoreductase (propane-1,3-diamine-forming) activity; IEA:UniProtKB-EC.
DR   GO; GO:0052897; F:N8-acetylspermidine:oxygen oxidoreductase (propane-1,3-diamine-forming) activity; IEA:UniProtKB-EC.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0046592; F:polyamine oxidase activity; IDA:UniProtKB.
DR   GO; GO:0052896; F:spermidine oxidase (propane-1,3-diamine-forming) activity; IEA:UniProtKB-EC.
DR   GO; GO:0052900; F:spermine oxidase (propane-1,3-diamine-forming) activity; IEA:UniProtKB-EC.
DR   GO; GO:0006598; P:polyamine catabolic process; IDA:UniProtKB.
DR   GO; GO:0046208; P:spermine catabolic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR001613; Flavin_amine_oxidase.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   PRINTS; PR00757; AMINEOXDASEF.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoplast; Cell wall; Direct protein sequencing;
KW   Disulfide bond; FAD; Flavoprotein; Glycoprotein; Oxidoreductase;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000269|PubMed:9598979"
FT   CHAIN           29..500
FT                   /note="Polyamine oxidase 1"
FT                   /id="PRO_0000001712"
FT   NP_BIND         42..43
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10368296,
FT                   ECO:0000269|PubMed:11258887, ECO:0007744|PDB:1B5Q,
FT                   ECO:0007744|PDB:1H82"
FT   NP_BIND         87..88
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10368296,
FT                   ECO:0000269|PubMed:11258887, ECO:0007744|PDB:1B5Q,
FT                   ECO:0007744|PDB:1H82"
FT   NP_BIND         467..468
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10368296,
FT                   ECO:0000269|PubMed:11258887, ECO:0007744|PDB:1B5Q,
FT                   ECO:0007744|PDB:1H82"
FT   BINDING         63
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10368296,
FT                   ECO:0000269|PubMed:11258887, ECO:0007744|PDB:1B5Q,
FT                   ECO:0007744|PDB:1H82"
FT   BINDING         71
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:10368296,
FT                   ECO:0000269|PubMed:11258887, ECO:0007744|PDB:1B5Q,
FT                   ECO:0007744|PDB:1H82"
FT   BINDING         90
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|Ref.10, ECO:0007744|PDB:3KU9,
FT                   ECO:0007744|PDB:3L1R"
FT   BINDING         198
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|Ref.10, ECO:0007744|PDB:3KU9,
FT                   ECO:0007744|PDB:3L1R"
FT   BINDING         265
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:10368296,
FT                   ECO:0000269|PubMed:11258887, ECO:0007744|PDB:1B5Q,
FT                   ECO:0007744|PDB:1H82"
FT   BINDING         427
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10368296,
FT                   ECO:0000269|PubMed:11258887, ECO:0007744|PDB:1B5Q,
FT                   ECO:0007744|PDB:1H82"
FT   BINDING         458
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:10368296,
FT                   ECO:0000269|PubMed:11258887, ECO:0007744|PDB:1B5Q,
FT                   ECO:0007744|PDB:1H82"
FT   BINDING         466
FT                   /note="Substrate; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|Ref.10, ECO:0007744|PDB:3KU9,
FT                   ECO:0007744|PDB:3L1R"
FT   CARBOHYD        105
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:10368296,
FT                   ECO:0000269|PubMed:11258887, ECO:0007744|PDB:1B5Q,
FT                   ECO:0007744|PDB:1H82"
FT   DISULFID        485..491
FT                   /evidence="ECO:0000269|PubMed:10368296,
FT                   ECO:0000269|PubMed:11258887, ECO:0007744|PDB:1B5Q,
FT                   ECO:0007744|PDB:1H82"
FT   MUTAGEN         328
FT                   /note="K->M: Abolishes enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:16331971"
FT   STRAND          35..38
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           42..53
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          59..62
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          64..69
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          74..77
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          80..85
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          88..96
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           100..105
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          112..114
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           120..122
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          124..126
FT                   /evidence="ECO:0007829|PDB:1B5Q"
FT   STRAND          127..131
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           134..156
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           168..176
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          178..181
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           185..194
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           196..199
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   TURN            203..205
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          206..208
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   TURN            209..211
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           215..220
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          222..227
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           235..242
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   TURN            249..251
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          259..262
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          265..270
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          275..279
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          284..292
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           296..300
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          303..308
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           312..320
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          321..324
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          326..332
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          345..349
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          352..357
FT                   /evidence="ECO:0007829|PDB:3KU9"
FT   STRAND          359..362
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   TURN            364..366
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          367..369
FT                   /evidence="ECO:0007829|PDB:3KPF"
FT   STRAND          372..378
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           379..386
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           390..404
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          406..408
FT                   /evidence="ECO:0007829|PDB:3KU9"
FT   STRAND          414..417
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   TURN            421..423
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   TURN            425..427
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          428..433
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           440..447
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   STRAND          453..455
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           458..460
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   TURN            462..466
FT                   /evidence="ECO:0007829|PDB:1B37"
FT   HELIX           468..488
FT                   /evidence="ECO:0007829|PDB:1B37"
SQ   SEQUENCE   500 AA;  56344 MW;  00BB4BAF7A2E41CB CRC64;
     MSSSPSFGLL AVAALLLALS LAQHGSLAAT VGPRVIVVGA GMSGISAAKR LSEAGITDLL
     ILEATDHIGG RMHKTNFAGI NVELGANWVE GVNGGKMNPI WPIVNSTLKL RNFRSDFDYL
     AQNVYKEDGG VYDEDYVQKR IELADSVEEM GEKLSATLHA SGRDDMSILA MQRLNEHQPN
     GPATPVDMVV DYYKFDYEFA EPPRVTSLQN TVPLATFSDF GDDVYFVADQ RGYEAVVYYL
     AGQYLKTDDK SGKIVDPRLQ LNKVVREIKY SPGGVTVKTE DNSVYSADYV MVSASLGVLQ
     SDLIQFKPKL PTWKVRAIYQ FDMAVYTKIF LKFPRKFWPE GKGREFFLYA SSRRGYYGVW
     QEFEKQYPDA NVLLVTVTDE ESRRIEQQSD EQTKAEIMQV LRKMFPGKDV PDATDILVPR
     WWSDRFYKGT FSNWPVGVNR YEYDQLRAPV GRVYFTGEHT SEHYNGYVHG AYLSGIDSAE
     ILINCAQKKM CKYHVQGKYD
//
ID   PPOX_HUMAN              Reviewed;         477 AA.
AC   P50336; D3DVG0; Q5VTW8;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   02-JUN-2021, entry version 188.
DE   RecName: Full=Protoporphyrinogen oxidase;
DE            Short=PPO;
DE            EC=1.3.3.4;
GN   Name=PPOX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   TISSUE=Placenta;
RX   PubMed=7713909; DOI=10.1074/jbc.270.14.8076;
RA   Nishimura K., Taketani S., Inokuchi H.;
RT   "Cloning of a human cDNA for protoporphyrinogen oxidase by complementation
RT   in vivo of a hemG mutant of Escherichia coli.";
RL   J. Biol. Chem. 270:8076-8080(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=8771201; DOI=10.1002/pro.5560050112;
RA   Dailey T.A., Dailey H.A.;
RT   "Human protoporphyrinogen oxidase: expression, purification, and
RT   characterization of the cloned enzyme.";
RL   Protein Sci. 5:98-105(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HIS-304.
RX   PubMed=8806618; DOI=10.1006/bbrc.1996.1337;
RA   Puy H., Robreau A.-M., Rosipal R., Nordmann Y., Deybach J.-C.;
RT   "Protoporphyrinogen oxidase: complete genomic sequence and polymorphisms in
RT   the human gene.";
RL   Biochem. Biophys. Res. Commun. 226:226-230(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH FAD AND ACIFLUORFEN,
RP   CATALYTIC ACTIVITY, FUNCTION, SUBUNIT, CHARACTERIZATION OF VARIANTS VP
RP   ASP-11; THR-12; PHE-15; PRO-20; PRO-38; ALA-40; GLU-40; TRP-59; PRO-73;
RP   GLY-84; PRO-85; PRO-106; PRO-138; ASP-139; VAL-143; CYS-152; PRO-154;
RP   MET-158; HIS-168; VAL-178; VAL-205; CYS-217; GLY-224; ARG-232; ASP-282;
RP   ASN-283; PRO-295; ARG-330; ALA-332; GLY-335; CYS-348; ALA-349; PRO-350;
RP   ARG-358; ASP-397; PHE-401; PRO-433; PRO-444; ARG-448; PRO-450 AND ARG-453,
RP   AND MUTAGENESIS OF LEU-74; ARG-97; LEU-166; GLY-169; SER-284; VAL-290;
RP   PHE-331; LEU-334; VAL-347 AND MET-368.
RX   PubMed=21048046; DOI=10.1096/fj.10-170811;
RA   Qin X., Tan Y., Wang L., Wang Z., Wang B., Wen X., Yang G., Xi Z., Shen Y.;
RT   "Structural insight into human variegate porphyria disease.";
RL   FASEB J. 25:653-664(2011).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF MUTANTS GLY-59 AND GLN-59 IN
RP   COMPLEXES WITH FAD AND ACIFLUORFEN, FUNCTION, CATALYTIC ACTIVITY,
RP   MUTAGENESIS OF ARG-59; ARG-97; LEU-166; GLY-169; PHE-331; LEU-334; VAL-347
RP   AND MET-368, AND CHARACTERIZATION OF VARIANTS VP TRP-59; HIS-168; ARG-330;
RP   GLY-335; ALA-349; PHE-401 AND ARG-453.
RX   PubMed=23467411; DOI=10.1074/jbc.m113.459768;
RA   Wang B., Wen X., Qin X., Wang Z., Tan Y., Shen Y., Xi Z.;
RT   "Quantitative structural insight into human variegate porphyria disease.";
RL   J. Biol. Chem. 288:11731-11740(2013).
RN   [11]
RP   VARIANT VP ARG-232, AND VARIANT HIS-304.
RX   PubMed=8852667; DOI=10.1093/hmg/5.3.407;
RA   Deybach J.-C., Puy H., Robreau A.-M., Lamoril J., da Silva V.,
RA   Grandchamp B., Nordmann Y.;
RT   "Mutations in the protoporphyrinogen oxidase gene in patients with
RT   variegate porphyria.";
RL   Hum. Mol. Genet. 5:407-410(1996).
RN   [12]
RP   VARIANTS VP PRO-20; TRP-59 AND CYS-168.
RX   PubMed=8817334; DOI=10.1093/hmg/5.7.981;
RA   Warnich L., Kotze M.J., Groenewald I.M., Groenewald J.Z., van Brakel M.G.,
RA   van Heerden C.J., de Villiers J.N., van de Ven W.J., Schoenmakers E.F.,
RA   Taketani S., Retief A.E.;
RT   "Identification of three mutations and associated haplotypes in the
RT   protoporphyrinogen oxidase gene in South African families with variegate
RT   porphyria.";
RL   Hum. Mol. Genet. 5:981-984(1996).
RN   [13]
RP   VARIANTS VP TRP-59 AND CYS-168.
RX   PubMed=8673113; DOI=10.1038/ng0596-95;
RA   Meissner P.N., Dailey T.A., Hift R.J., Ziman M., Corrigall A.V.,
RA   Roberts A.G., Meissner D.M., Kirsch R.E., Dailey H.A.;
RT   "A R59W mutation in human protoporphyrinogen oxidase results in decreased
RT   enzyme activity and is prevalent in South Africans with variegate
RT   porphyria.";
RL   Nat. Genet. 13:95-97(1996).
RN   [14]
RP   VARIANT VP CYS-152.
RX   PubMed=9763307; DOI=10.1007/s004030050333;
RA   Frank J., Poh-Fitzpatrick M.B., King L.E. Jr., Christiano A.M.;
RT   "The genetic basis of 'Scarsdale Gourmet Diet' variegate porphyria: a
RT   missense mutation in the protoporphyrinogen oxidase gene.";
RL   Arch. Dermatol. Res. 290:441-445(1998).
RN   [15]
RP   VARIANT VP PRO-450.
RX   PubMed=9541112; DOI=10.1136/jmg.35.3.244;
RA   Frank J., Lam H., Zaider E., Poh-Fitzpatrick M., Christiano A.M.;
RT   "Molecular basis of variegate porphyria: a missense mutation in the
RT   protoporphyrinogen oxidase gene.";
RL   J. Med. Genet. 35:244-247(1998).
RN   [16]
RP   VARIANTS VP GLU-169; ALA-349; ARG-358 AND PRO-433, AND CHARACTERIZATION OF
RP   VARIANTS VP GLU-169; ALA-349; ARG-358 AND PRO-433.
RX   PubMed=9811936; DOI=10.1093/hmg/7.12.1921;
RA   Roberts A.G., Puy H., Dailey T.A., Morgan R.R., Whatley S.D., Dailey H.A.,
RA   Martasek P., Nordmann Y., Deybach J.C., Elder G.H.;
RT   "Molecular characterization of homozygous variegate porphyria.";
RL   Hum. Mol. Genet. 7:1921-1925(1998).
RN   [17]
RP   VARIANTS ARG-256 AND HIS-304, AND VARIANTS VP PRO-38; GLU-40; PRO-73;
RP   GLY-84; PRO-85; VAL-143; CYS-152; PRO-154; MET-158; HIS-168; VAL-172;
RP   ARG-232; HIS-281 DEL; ASP-282; PRO-295; GLY-335; PRO-350; PRO-444; ARG-453
RP   AND VAL-453.
RX   PubMed=10486317; DOI=10.1086/302586;
RA   Whatley S.D., Puy H., Morgan R.R., Robreau A.M., Roberts A.G., Nordmann Y.,
RA   Elder G.H., Deybach J.C.;
RT   "Variegate porphyria in Western Europe: identification of PPOX gene
RT   mutations in 104 families, extent of allelic heterogeneity, and absence of
RT   correlation between phenotype and type of mutation.";
RL   Am. J. Hum. Genet. 65:984-994(1999).
RN   [18]
RP   VARIANT VP ARG-448.
RX   PubMed=11074242; DOI=10.1016/s0009-9120(00)00142-9;
RA   Maeda N., Horie Y., Sasaki Y., Adachi K., Nanba E., Nishida K., Saigo R.,
RA   Nakagawa M., Kawasaki H., Kudo Y., Kondo M.;
RT   "Three novel mutations in the protoporphyrinogen oxidase gene in Japanese
RT   patients with variegate porphyria.";
RL   Clin. Biochem. 33:495-500(2000).
RN   [19]
RP   VARIANTS VP PRO-106 AND VAL-178.
RX   PubMed=11102990;
RX   DOI=10.1002/1098-1004(200012)16:6<532::aid-humu18>3.0.co;2-s;
RA   De Siervi A., Parera V.E., del C Batlle A.M., Rossetti M.V.;
RT   "Two new mutations (H106P and L178V) in the protoporphyrinogen oxidase gene
RT   in Argentinean patients with variegate porphyria.";
RL   Hum. Mutat. 16:532-532(2000).
RN   [20]
RP   VARIANTS VP TRP-59; PRO-138 AND CYS-348.
RX   PubMed=10870850; DOI=10.1006/mgme.2000.2975;
RA   Corrigall A.V., Hift R.J., Davids L.M., Hancock V., Meissner D.,
RA   Kirsch R.E., Meissner P.N.;
RT   "Homozygous variegate porphyria in South Africa: genotypic analysis in two
RT   cases.";
RL   Mol. Genet. Metab. 69:323-330(2000).
RN   [21]
RP   VARIANT VP THR-12, VARIANT ARG-256, CHARACTERIZATION OF VARIANT VP THR-12,
RP   AND CHARACTERIZATION OF VARIANT ARG-256.
RX   PubMed=11286631; DOI=10.1046/j.1523-1747.2001.01293.x;
RA   Kauppinen R., Timonen K., von und zu Fraunberg M., Laitinen E., Ahola H.,
RA   Tenhunen R., Taketani S., Mustajoki P.;
RT   "Homozygous variegate porphyria: 20 y follow-up and characterization of
RT   molecular defect.";
RL   J. Invest. Dermatol. 116:610-613(2001).
RN   [22]
RP   VARIANT VP SER-11.
RX   PubMed=11348478; DOI=10.1046/j.1523-1747.2001.01308.x;
RA   Frank J., Jugert F.K., Merk H.F., Kalka K., Goerz G., Anderson K.,
RA   Bickers D.R., Poh-Fitzpatrick M.B., Christiano A.M.;
RT   "A spectrum of novel mutations in the protoporphyrinogen oxidase gene in 13
RT   families with variegate porphyria.";
RL   J. Invest. Dermatol. 116:821-823(2001).
RN   [23]
RP   VARIANTS VP PHE-15 AND MET-290.
RX   PubMed=11350188; DOI=10.1006/mgme.2001.3163;
RA   Corrigall A.V., Hift R.J., Davids L.M., Hancock V., Meissner D.,
RA   Kirsch R.E., Meissner P.N.;
RT   "Identification of the first variegate porphyria mutation in an indigenous
RT   black South African and further evidence for heterogeneity in variegate
RT   porphyria.";
RL   Mol. Genet. Metab. 73:91-96(2001).
RN   [24]
RP   VARIANTS VP CYS-152 AND PHE-401, AND CHARACTERIZATION OF VARIANT VP
RP   CYS-152.
RX   PubMed=11474578;
RA   von und zu Fraunberg M., Tenhunen R., Kauppinen R.;
RT   "Expression and characterization of six mutations in the protoporphyrinogen
RT   oxidase gene among Finnish variegate porphyria patients.";
RL   Mol. Med. 7:320-328(2001).
RN   [25]
RP   VARIANTS VP TRP-59; CYS-217 AND SER-236.
RX   PubMed=12380696; DOI=10.1046/j.1445-5994.2002.00274.x;
RA   Rossi E., Chin C.Y., Beilby J.P., Waso H.F., Warnich L.;
RT   "Variegate porphyria in Western Australian Aboriginal patients.";
RL   Intern. Med. J. 32:445-450(2002).
RN   [26]
RP   CHARACTERIZATION OF VARIANTS VP PRO-20; TRP-59; CYS-168 AND CYS-348.
RX   PubMed=12922165; DOI=10.1016/s1570-9639(03)00186-9;
RA   Maneli M.H., Corrigall A.V., Klump H.H., Davids L.M., Kirsch R.E.,
RA   Meissner P.N.;
RT   "Kinetic and physical characterisation of recombinant wild-type and mutant
RT   human protoporphyrinogen oxidases.";
RL   Biochim. Biophys. Acta 1650:10-21(2003).
RN   [27]
RP   VARIANTS VP CYS-152; LEU-158; VAL-205 AND ARG-330.
RX   PubMed=12859407; DOI=10.1034/j.1399-0004.2003.00116.x;
RA   Wiman A., Harper P., Floderus Y.;
RT   "Nine novel mutations in the protoporphyrinogen oxidase gene in Swedish
RT   families with variegate porphyria.";
RL   Clin. Genet. 64:122-130(2003).
RN   [28]
RP   VARIANT VP ASN-283.
RX   PubMed=12655566; DOI=10.1002/humu.9125;
RA   D'Amato M., Bonuglia M., Barile S., Griso D., Macri A., Biolcati G.;
RT   "Genetic analysis of variegate porphyria (VP) in Italy: identification of
RT   six novel mutations in the protoporphyrinogen oxidase (PPOX) gene.";
RL   Hum. Mutat. 21:448-448(2003).
RN   [29]
RP   VARIANT VP ALA-40.
RX   PubMed=14669009; DOI=10.1007/s00439-003-1059-5;
RA   Gouya L., Puy H., Robreau A.-M., Lyoumi S., Lamoril J., Da Silva V.,
RA   Grandchamp B., Deybach J.-C.;
RT   "Modulation of penetrance by the wild-type allele in dominantly inherited
RT   erythropoietic protoporphyria and acute hepatic porphyrias.";
RL   Hum. Genet. 114:256-262(2004).
RN   [30]
RP   VARIANT VP SER-232.
RX   PubMed=16433813; DOI=10.1111/j.1365-2133.2005.06978.x;
RA   Poblete-Gutierrez P., Wolff C., Farias R., Frank J.;
RT   "A Chilean boy with severe photosensitivity and finger shortening: the
RT   first case of homozygous variegate porphyria in South America.";
RL   Br. J. Dermatol. 154:368-371(2006).
RN   [31]
RP   CHARACTERIZATION OF VARIANTS VP PRO-20; TRP-59 AND CYS-168.
RX   PubMed=16621625; DOI=10.1016/j.cellbi.2006.02.001;
RA   Davids L.M., Corrigall A.V., Meissner P.N.;
RT   "Mitochondrial targeting of human protoporphyrinogen oxidase.";
RL   Cell Biol. Int. 30:416-426(2006).
RN   [32]
RP   VARIANT VP ARG-224.
RX   PubMed=16922948; DOI=10.1111/j.1468-3083.2006.01705.x;
RA   Lecha M., Badenas C., Puig S., Orfila J., Mila M., To-Figueras J.,
RA   Munoz C., Mercader P., Herrero C.;
RT   "Genetic studies in variegate porphyria in Spain. Identification of gene
RT   mutations and family study for carrier detection.";
RL   J. Eur. Acad. Dermatol. Venereol. 20:974-979(2006).
RN   [33]
RP   VARIANT VP ASP-11.
RX   PubMed=16947091;
RA   Schneider-Yin X., Minder E.I.;
RT   "Swiss patients with variegate porphyria have unique mutations.";
RL   Swiss. Med. Wkly. 136:515-519(2006).
RN   [34]
RP   VARIANT VP ASP-139.
RX   PubMed=18350656;
RA   Ausenda S., Di Pierro E., Brancaleoni V., Besana V., Cappellini M.D.;
RT   "Novel human pathological mutations. Gene symbol: PPOX. Disease: porphyria,
RT   variegate.";
RL   Hum. Genet. 122:417-417(2007).
RN   [35]
RP   VARIANTS VP VAL-34; GLY-224 AND ALA-332.
RX   PubMed=18570668; DOI=10.1186/1471-2350-9-54;
RA   Rossetti M.V., Granata B.X., Giudice J., Parera V.E., Batlle A.;
RT   "Genetic and biochemical studies in Argentinean patients with variegate
RT   porphyria.";
RL   BMC Med. Genet. 9:54-54(2008).
RN   [36]
RP   VARIANT VP ASP-397.
RX   PubMed=19320019;
RA   Ausenda S., Moriondo V., Marchini S., Besana V., Di Pierro E.,
RA   Brancaleoni V., Ventura P., Rocchi E., Cappellini M.D.;
RT   "Novel human pathological mutations. Gene symbol: PPOX. Disease: porphyria,
RT   variegate.";
RL   Hum. Genet. 125:344-344(2009).
RN   [37]
RP   VARIANTS VP VAL-34; PHE-76; GLY-224; ALA-332 AND CYS-422, AND
RP   CHARACTERIZATION OF VARIANTS VP VAL-34; PHE-76; GLY-224; ALA-332 AND
RP   CYS-422.
RX   PubMed=23430901; DOI=10.1007/8904_2011_77;
RA   Mendez M., Granata B.X., Jimenez M.J., Parera V.E., Batlle A.,
RA   de Salamanca R.E., Rossetti M.V.;
RT   "Functional characterization of five protoporphyrinogen oxidase missense
RT   mutations found in Argentinean variegate porphyria patients.";
RL   JIMD Rep. 4:91-97(2012).
RN   [38]
RP   VARIANTS VP ARG-57 AND ARG-420.
RX   PubMed=24073655; DOI=10.1111/ced.12071;
RA   Pinder V.A., Holden S.T., Deshpande C., Siddiqui A., Mellerio J.E.,
RA   Wraige E., Powell A.M.;
RT   "Homozygous variegate porphyria presenting with developmental and language
RT   delay in childhood.";
RL   Clin. Exp. Dermatol. 38:737-740(2013).
CC   -!- FUNCTION: Catalyzes the 6-electron oxidation of protoporphyrinogen-IX
CC       to form protoporphyrin-IX. {ECO:0000269|PubMed:21048046,
CC       ECO:0000269|PubMed:23467411, ECO:0000269|PubMed:7713909}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3 O2 + protoporphyrinogen IX = 3 H2O2 + protoporphyrin IX;
CC         Xref=Rhea:RHEA:25576, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:57306, ChEBI:CHEBI:57307; EC=1.3.3.4;
CC         Evidence={ECO:0000269|PubMed:21048046, ECO:0000269|PubMed:23467411};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- PATHWAY: Porphyrin-containing compound metabolism; protoporphyrin-IX
CC       biosynthesis; protoporphyrin-IX from protoporphyrinogen-IX: step 1/1.
CC   -!- SUBUNIT: Monomer. Homodimer. {ECO:0000269|PubMed:21048046}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}; Intermembrane side
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in heart, brain, placenta, lung, liver,
CC       skeletal muscle, kidney and pancreas.
CC   -!- DISEASE: Variegate porphyria (VP) [MIM:176200]: A form of porphyria.
CC       Porphyrias are inherited defects in the biosynthesis of heme, resulting
CC       in the accumulation and increased excretion of porphyrins or porphyrin
CC       precursors. They are classified as erythropoietic or hepatic, depending
CC       on whether the enzyme deficiency occurs in red blood cells or in the
CC       liver. Variegate porphyria is the most common form of porphyria in
CC       South Africa. It is characterized by skin hyperpigmentation and
CC       hypertrichosis, abdominal pain, tachycardia, hypertension and
CC       neuromuscular disturbances. High fecal levels of protoporphyrin and
CC       coproporphyrin, increased urine uroporphyrins and iron overload are
CC       typical markers of the disease. {ECO:0000269|PubMed:10486317,
CC       ECO:0000269|PubMed:10870850, ECO:0000269|PubMed:11074242,
CC       ECO:0000269|PubMed:11102990, ECO:0000269|PubMed:11286631,
CC       ECO:0000269|PubMed:11348478, ECO:0000269|PubMed:11350188,
CC       ECO:0000269|PubMed:11474578, ECO:0000269|PubMed:12380696,
CC       ECO:0000269|PubMed:12655566, ECO:0000269|PubMed:12859407,
CC       ECO:0000269|PubMed:12922165, ECO:0000269|PubMed:14669009,
CC       ECO:0000269|PubMed:16433813, ECO:0000269|PubMed:16621625,
CC       ECO:0000269|PubMed:16922948, ECO:0000269|PubMed:16947091,
CC       ECO:0000269|PubMed:18350656, ECO:0000269|PubMed:18570668,
CC       ECO:0000269|PubMed:19320019, ECO:0000269|PubMed:21048046,
CC       ECO:0000269|PubMed:23430901, ECO:0000269|PubMed:23467411,
CC       ECO:0000269|PubMed:24073655, ECO:0000269|PubMed:8673113,
CC       ECO:0000269|PubMed:8817334, ECO:0000269|PubMed:8852667,
CC       ECO:0000269|PubMed:9541112, ECO:0000269|PubMed:9763307,
CC       ECO:0000269|PubMed:9811936}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry. Mutations leading to
CC       severe PPOX deficiency cause the rare homozygous variant form of VP.
CC       Missense mutations that preserve 10%-25% of wild-type activity may not
CC       cause clinically overt VP in heterozygotes (PubMed:9811936). Mutations
CC       with intermediate effect on catalytic activity may cause VP, but with a
CC       low clinical penetrance (PubMed:10486317).
CC       {ECO:0000269|PubMed:10486317, ECO:0000269|PubMed:9811936}.
CC   -!- SIMILARITY: Belongs to the protoporphyrinogen/coproporphyrinogen
CC       oxidase family. Protoporphyrinogen oxidase subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Protoporphyrinogen oxidase entry;
CC       URL="https://en.wikipedia.org/wiki/Protoporphyrinogen_oxidase";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D38537; BAA07538.1; -; mRNA.
DR   EMBL; U26446; AAA67690.1; -; mRNA.
DR   EMBL; X99450; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590714; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW52636.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52639.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52641.1; -; Genomic_DNA.
DR   EMBL; BC002357; AAH02357.1; -; mRNA.
DR   CCDS; CCDS1221.1; -.
DR   PIR; JC4971; A56449.
DR   RefSeq; NP_000300.1; NM_000309.3.
DR   RefSeq; NP_001116236.1; NM_001122764.1.
DR   PDB; 3NKS; X-ray; 1.90 A; A=1-477.
DR   PDB; 4IVM; X-ray; 2.77 A; B=1-477.
DR   PDB; 4IVO; X-ray; 2.60 A; B=1-477.
DR   PDBsum; 3NKS; -.
DR   PDBsum; 4IVM; -.
DR   PDBsum; 4IVO; -.
DR   SMR; P50336; -.
DR   BioGRID; 111492; 45.
DR   IntAct; P50336; 30.
DR   STRING; 9606.ENSP00000356978; -.
DR   BindingDB; P50336; -.
DR   ChEMBL; CHEMBL1926488; -.
DR   iPTMnet; P50336; -.
DR   PhosphoSitePlus; P50336; -.
DR   SwissPalm; P50336; -.
DR   BioMuta; PPOX; -.
DR   DMDM; 1709742; -.
DR   EPD; P50336; -.
DR   jPOST; P50336; -.
DR   MassIVE; P50336; -.
DR   MaxQB; P50336; -.
DR   PaxDb; P50336; -.
DR   PeptideAtlas; P50336; -.
DR   PRIDE; P50336; -.
DR   ProteomicsDB; 56214; -.
DR   Antibodypedia; 34299; 260 antibodies.
DR   DNASU; 5498; -.
DR   Ensembl; ENST00000352210; ENSP00000343943; ENSG00000143224.
DR   Ensembl; ENST00000367999; ENSP00000356978; ENSG00000143224.
DR   GeneID; 5498; -.
DR   KEGG; hsa:5498; -.
DR   UCSC; uc001fyg.3; human.
DR   CTD; 5498; -.
DR   DisGeNET; 5498; -.
DR   GeneCards; PPOX; -.
DR   GeneReviews; PPOX; -.
DR   HGNC; HGNC:9280; PPOX.
DR   HPA; ENSG00000143224; Low tissue specificity.
DR   MalaCards; PPOX; -.
DR   MIM; 176200; phenotype.
DR   MIM; 600923; gene.
DR   neXtProt; NX_P50336; -.
DR   OpenTargets; ENSG00000143224; -.
DR   Orphanet; 79473; Porphyria variegata.
DR   PharmGKB; PA33608; -.
DR   VEuPathDB; HostDB:ENSG00000143224.17; -.
DR   eggNOG; KOG1276; Eukaryota.
DR   GeneTree; ENSGT00390000008744; -.
DR   HOGENOM; CLU_009629_2_1_1; -.
DR   InParanoid; P50336; -.
DR   OMA; IFDSCCF; -.
DR   OrthoDB; 1578484at2759; -.
DR   PhylomeDB; P50336; -.
DR   TreeFam; TF323479; -.
DR   BioCyc; MetaCyc:HS07011-MONOMER; -.
DR   BRENDA; 1.3.3.4; 2681.
DR   PathwayCommons; P50336; -.
DR   Reactome; R-HSA-189451; Heme biosynthesis.
DR   SABIO-RK; P50336; -.
DR   UniPathway; UPA00251; UER00324.
DR   BioGRID-ORCS; 5498; 19 hits in 997 CRISPR screens.
DR   GeneWiki; PPOX; -.
DR   GenomeRNAi; 5498; -.
DR   Pharos; P50336; Tchem.
DR   PRO; PR:P50336; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P50336; protein.
DR   Bgee; ENSG00000143224; Expressed in right uterine tube and 220 other tissues.
DR   ExpressionAtlas; P50336; baseline and differential.
DR   Genevisible; P50336; HS.
DR   GO; GO:0031305; C:integral component of mitochondrial inner membrane; IEA:Ensembl.
DR   GO; GO:0031304; C:intrinsic component of mitochondrial inner membrane; ISS:UniProtKB.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; TAS:Reactome.
DR   GO; GO:0031966; C:mitochondrial membrane; IMP:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; TAS:UniProtKB.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0004729; F:oxygen-dependent protoporphyrinogen oxidase activity; IDA:UniProtKB.
DR   GO; GO:0006783; P:heme biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006779; P:porphyrin-containing compound biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006782; P:protoporphyrinogen IX biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR004572; Protoporphyrinogen_oxidase.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR00562; proto_IX_ox; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disease variant; FAD; Flavoprotein; Heme biosynthesis;
KW   Membrane; Mitochondrion; Mitochondrion inner membrane; Oxidoreductase;
KW   Porphyrin biosynthesis; Reference proteome.
FT   CHAIN           1..477
FT                   /note="Protoporphyrinogen oxidase"
FT                   /id="PRO_0000135270"
FT   NP_BIND         9..14
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21048046"
FT   NP_BIND         34..35
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21048046"
FT   NP_BIND         57..60
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21048046"
FT   NP_BIND         454..456
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21048046"
FT   BINDING         42
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:21048046"
FT   BINDING         257
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:21048046"
FT   BINDING         449
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:21048046"
FT   VARIANT         11
FT                   /note="G -> D (in VP; abolishes enzyme activity; impairs
FT                   protein folding and/or stability)"
FT                   /evidence="ECO:0000269|PubMed:16947091,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070378"
FT   VARIANT         11
FT                   /note="G -> S (in VP)"
FT                   /evidence="ECO:0000269|PubMed:11348478"
FT                   /id="VAR_070377"
FT   VARIANT         12
FT                   /note="I -> T (in VP; strongly decreases enzyme activity;
FT                   impairs protein folding and/or stability;
FT                   dbSNP:rs28936677)"
FT                   /evidence="ECO:0000269|PubMed:11286631,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070379"
FT   VARIANT         15
FT                   /note="L -> F (in VP; strongly decreases enzyme activity;
FT                   impairs protein folding and/or stability;
FT                   dbSNP:rs769452432)"
FT                   /evidence="ECO:0000269|PubMed:11350188,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070380"
FT   VARIANT         20
FT                   /note="H -> P (in VP; strongly decreases enzyme activity;
FT                   more resistant to thermal denaturation than wild-type
FT                   enzyme; abolishes mitochondrial protein targeting and
FT                   localization; dbSNP:rs121918326)"
FT                   /evidence="ECO:0000269|PubMed:12922165,
FT                   ECO:0000269|PubMed:16621625, ECO:0000269|PubMed:21048046,
FT                   ECO:0000269|PubMed:8817334"
FT                   /id="VAR_070381"
FT   VARIANT         34
FT                   /note="E -> V (in VP; decreases enzyme activity)"
FT                   /evidence="ECO:0000269|PubMed:18570668,
FT                   ECO:0000269|PubMed:23430901"
FT                   /id="VAR_070382"
FT   VARIANT         38
FT                   /note="R -> P (in VP; strongly decreases enzyme activity;
FT                   impairs protein folding and/or stability)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070383"
FT   VARIANT         40
FT                   /note="G -> A (in VP; strongly decreases enzyme activity;
FT                   impairs protein folding and/or stability)"
FT                   /evidence="ECO:0000269|PubMed:14669009,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070384"
FT   VARIANT         40
FT                   /note="G -> E (in VP; abolishes enzyme activity; impairs
FT                   protein folding and/or stability; dbSNP:rs1317835140)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070385"
FT   VARIANT         57
FT                   /note="G -> R (in VP; dbSNP:rs764352037)"
FT                   /evidence="ECO:0000269|PubMed:24073655"
FT                   /id="VAR_070386"
FT   VARIANT         59
FT                   /note="R -> W (in VP; strongly decreases enzyme activity;
FT                   does not affect mitochondrial protein targeting and
FT                   localization; more resistant to thermal denaturation than
FT                   wild-type enzyme; dbSNP:rs121918324)"
FT                   /evidence="ECO:0000269|PubMed:10870850,
FT                   ECO:0000269|PubMed:12380696, ECO:0000269|PubMed:12922165,
FT                   ECO:0000269|PubMed:16621625, ECO:0000269|PubMed:21048046,
FT                   ECO:0000269|PubMed:23467411, ECO:0000269|PubMed:8673113,
FT                   ECO:0000269|PubMed:8817334"
FT                   /id="VAR_003686"
FT   VARIANT         73
FT                   /note="L -> P (in VP; strongly decreases enzyme activity;
FT                   impairs protein folding and/or stability)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070387"
FT   VARIANT         76
FT                   /note="S -> F (in VP; decreases enzyme activity)"
FT                   /evidence="ECO:0000269|PubMed:23430901"
FT                   /id="VAR_070388"
FT   VARIANT         84
FT                   /note="V -> G (in VP; strongly decreases enzyme activity;
FT                   impairs protein folding and/or stability)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070389"
FT   VARIANT         85
FT                   /note="L -> P (in VP; abolishes enzyme activity; impairs
FT                   protein folding and/or stability)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070390"
FT   VARIANT         106
FT                   /note="H -> P (in VP; strongly decreases enzyme activity)"
FT                   /evidence="ECO:0000269|PubMed:11102990,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070391"
FT   VARIANT         138
FT                   /note="R -> P (in VP; slightly decreases enzyme activity;
FT                   dbSNP:rs767419411)"
FT                   /evidence="ECO:0000269|PubMed:10870850,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070392"
FT   VARIANT         139
FT                   /note="G -> D (in VP; strongly decreases enzyme activity;
FT                   dbSNP:rs369381477)"
FT                   /evidence="ECO:0000269|PubMed:18350656,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070393"
FT   VARIANT         143
FT                   /note="D -> V (in VP; strongly decreases enzyme activity)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070394"
FT   VARIANT         152
FT                   /note="R -> C (in VP; strongly decreases enzyme activity)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:11474578, ECO:0000269|PubMed:12859407,
FT                   ECO:0000269|PubMed:21048046, ECO:0000269|PubMed:9763307"
FT                   /id="VAR_003687"
FT   VARIANT         154
FT                   /note="L -> P (in VP; strongly decreases enzyme activity)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070395"
FT   VARIANT         158
FT                   /note="V -> L (in VP)"
FT                   /evidence="ECO:0000269|PubMed:12859407"
FT                   /id="VAR_070396"
FT   VARIANT         158
FT                   /note="V -> M (in VP; strongly decreases enzyme activity)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070397"
FT   VARIANT         168
FT                   /note="R -> C (in VP; strongly decreases enzyme activity;
FT                   does not affect mitochondrial protein targeting and
FT                   localization; dbSNP:rs121918325)"
FT                   /evidence="ECO:0000269|PubMed:12922165,
FT                   ECO:0000269|PubMed:16621625, ECO:0000269|PubMed:8673113,
FT                   ECO:0000269|PubMed:8817334"
FT                   /id="VAR_003688"
FT   VARIANT         168
FT                   /note="R -> H (in VP; strongly decreases enzyme activity;
FT                   dbSNP:rs41270025)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046, ECO:0000269|PubMed:23467411"
FT                   /id="VAR_070398"
FT   VARIANT         169
FT                   /note="G -> E (in VP; strongly decreases enzyme activity)"
FT                   /evidence="ECO:0000269|PubMed:9811936"
FT                   /id="VAR_070399"
FT   VARIANT         172
FT                   /note="A -> V (in VP)"
FT                   /evidence="ECO:0000269|PubMed:10486317"
FT                   /id="VAR_070400"
FT   VARIANT         178
FT                   /note="L -> V (in VP; strongly decreases enzyme activity;
FT                   dbSNP:rs757473753)"
FT                   /evidence="ECO:0000269|PubMed:11102990,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070401"
FT   VARIANT         205
FT                   /note="A -> V (in VP; no effect on enzyme activity)"
FT                   /evidence="ECO:0000269|PubMed:12859407,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070402"
FT   VARIANT         217
FT                   /note="R -> C (in VP; decreases enzyme activity; impairs
FT                   protein folding and/or stability; dbSNP:rs751599052)"
FT                   /evidence="ECO:0000269|PubMed:12380696,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070403"
FT   VARIANT         224
FT                   /note="W -> G (in VP; abolishes enzyme activity; impairs
FT                   protein folding and/or stability)"
FT                   /evidence="ECO:0000269|PubMed:18570668,
FT                   ECO:0000269|PubMed:21048046, ECO:0000269|PubMed:23430901"
FT                   /id="VAR_070404"
FT   VARIANT         224
FT                   /note="W -> R (in VP)"
FT                   /evidence="ECO:0000269|PubMed:16922948"
FT                   /id="VAR_070405"
FT   VARIANT         232
FT                   /note="G -> R (in VP; strongly decreases enzyme activity;
FT                   impairs protein folding and/or stability;
FT                   dbSNP:rs121918323)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046, ECO:0000269|PubMed:8852667"
FT                   /id="VAR_003689"
FT   VARIANT         232
FT                   /note="G -> S (in VP)"
FT                   /evidence="ECO:0000269|PubMed:16433813"
FT                   /id="VAR_070406"
FT   VARIANT         236
FT                   /note="L -> S (in VP)"
FT                   /evidence="ECO:0000269|PubMed:12380696"
FT                   /id="VAR_070407"
FT   VARIANT         256
FT                   /note="P -> R (found in patients with the homozygous
FT                   variant of variegate porphyria; unknown pathological
FT                   significance; results in reduction of activity in a
FT                   prokariotyc expression system but has normal activity when
FT                   expressed in an eukaryotic system; dbSNP:rs12735723)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:11286631"
FT                   /id="VAR_034395"
FT   VARIANT         281
FT                   /note="Missing (in VP)"
FT                   /evidence="ECO:0000269|PubMed:10486317"
FT                   /id="VAR_070408"
FT   VARIANT         282
FT                   /note="V -> D (in VP; strongly decreases enzyme activity;
FT                   impairs protein folding and/or stability)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070409"
FT   VARIANT         283
FT                   /note="I -> N (in VP; strongly decreases enzyme activity;
FT                   impairs protein folding and/or stability)"
FT                   /evidence="ECO:0000269|PubMed:12655566,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070410"
FT   VARIANT         290
FT                   /note="V -> M (in VP)"
FT                   /evidence="ECO:0000269|PubMed:11350188"
FT                   /id="VAR_070411"
FT   VARIANT         295
FT                   /note="L -> P (in VP; strongly decreases enzyme activity;
FT                   impairs protein folding and/or stability)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070412"
FT   VARIANT         304
FT                   /note="R -> H (in dbSNP:rs36013429)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:8806618, ECO:0000269|PubMed:8852667"
FT                   /id="VAR_003690"
FT   VARIANT         330
FT                   /note="G -> R (in VP; strongly decreases enzyme activity)"
FT                   /evidence="ECO:0000269|PubMed:12859407,
FT                   ECO:0000269|PubMed:21048046, ECO:0000269|PubMed:23467411"
FT                   /id="VAR_070413"
FT   VARIANT         332
FT                   /note="G -> A (in VP; abolishes activity; impairs protein
FT                   folding and/or stability)"
FT                   /evidence="ECO:0000269|PubMed:18570668,
FT                   ECO:0000269|PubMed:21048046, ECO:0000269|PubMed:23430901"
FT                   /id="VAR_070414"
FT   VARIANT         335
FT                   /note="V -> G (in VP; strongly decreases enzyme activity;
FT                   impairs protein folding and/or stability)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046, ECO:0000269|PubMed:23467411"
FT                   /id="VAR_070415"
FT   VARIANT         348
FT                   /note="Y -> C (in VP; results in enzyme activity decrease;
FT                   impairs protein folding and/or stability; more resistant to
FT                   thermal denaturation than wild-type enzyme;
FT                   dbSNP:rs900431442)"
FT                   /evidence="ECO:0000269|PubMed:10870850,
FT                   ECO:0000269|PubMed:12922165, ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070416"
FT   VARIANT         349
FT                   /note="D -> A (in VP; decreases enzyme activity;
FT                   dbSNP:rs28936676)"
FT                   /evidence="ECO:0000269|PubMed:21048046,
FT                   ECO:0000269|PubMed:23467411, ECO:0000269|PubMed:9811936"
FT                   /id="VAR_070417"
FT   VARIANT         350
FT                   /note="S -> P (in VP; abolishes activity; impairs protein
FT                   folding and/or stability)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070418"
FT   VARIANT         358
FT                   /note="G -> R (in VP; strongly decreases enzyme activity;
FT                   impairs protein folding and/or stability;
FT                   dbSNP:rs374936130)"
FT                   /evidence="ECO:0000269|PubMed:21048046,
FT                   ECO:0000269|PubMed:9811936"
FT                   /id="VAR_070419"
FT   VARIANT         397
FT                   /note="A -> D (in VP; strongly decreases enzyme activity;
FT                   impairs protein folding and/or stability;
FT                   dbSNP:rs141274934)"
FT                   /evidence="ECO:0000269|PubMed:19320019,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070420"
FT   VARIANT         401
FT                   /note="L -> F (in VP; strongly decreases enzyme activity;
FT                   dbSNP:rs776530007)"
FT                   /evidence="ECO:0000269|PubMed:11474578,
FT                   ECO:0000269|PubMed:21048046, ECO:0000269|PubMed:23467411"
FT                   /id="VAR_070421"
FT   VARIANT         420
FT                   /note="P -> R (in VP)"
FT                   /evidence="ECO:0000269|PubMed:24073655"
FT                   /id="VAR_070422"
FT   VARIANT         422
FT                   /note="Y -> C (in VP; decreases enzyme activity)"
FT                   /evidence="ECO:0000269|PubMed:23430901"
FT                   /id="VAR_070423"
FT   VARIANT         433
FT                   /note="A -> P (in VP; decreases enzyme activity; impairs
FT                   protein folding and/or stability; dbSNP:rs1361576529)"
FT                   /evidence="ECO:0000269|PubMed:21048046,
FT                   ECO:0000269|PubMed:9811936"
FT                   /id="VAR_070424"
FT   VARIANT         444
FT                   /note="L -> P (in VP; strongly decreases enzyme activity)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070425"
FT   VARIANT         448
FT                   /note="G -> R (in VP; abolishes enzyme activity; impairs
FT                   protein folding and/or stability)"
FT                   /evidence="ECO:0000269|PubMed:11074242,
FT                   ECO:0000269|PubMed:21048046"
FT                   /id="VAR_070426"
FT   VARIANT         450
FT                   /note="S -> P (in VP; strongly decreases enzyme activity)"
FT                   /evidence="ECO:0000269|PubMed:21048046,
FT                   ECO:0000269|PubMed:9541112"
FT                   /id="VAR_070427"
FT   VARIANT         453
FT                   /note="G -> R (in VP; strongly decreases enzyme activity;
FT                   dbSNP:rs928944841)"
FT                   /evidence="ECO:0000269|PubMed:10486317,
FT                   ECO:0000269|PubMed:21048046, ECO:0000269|PubMed:23467411"
FT                   /id="VAR_070428"
FT   VARIANT         453
FT                   /note="G -> V (in VP)"
FT                   /evidence="ECO:0000269|PubMed:10486317"
FT                   /id="VAR_070429"
FT   MUTAGEN         59
FT                   /note="R->G: Decreases enzyme activity by 75%."
FT                   /evidence="ECO:0000269|PubMed:23467411"
FT   MUTAGEN         59
FT                   /note="R->Q: Decreases enzyme activity by 90%. Strongly
FT                   decreases affinity for protoporphyrinogen-IX."
FT                   /evidence="ECO:0000269|PubMed:23467411"
FT   MUTAGEN         74
FT                   /note="L->P: Abolishes enzyme activity. Impairs protein
FT                   folding and/or stability."
FT                   /evidence="ECO:0000269|PubMed:21048046"
FT   MUTAGEN         97
FT                   /note="R->D: Decreases enzyme activity by 89%. Impairs
FT                   protein folding and/or stability."
FT                   /evidence="ECO:0000269|PubMed:21048046,
FT                   ECO:0000269|PubMed:23467411"
FT   MUTAGEN         166
FT                   /note="L->N: Decreases enzyme activity by 95%."
FT                   /evidence="ECO:0000269|PubMed:21048046,
FT                   ECO:0000269|PubMed:23467411"
FT   MUTAGEN         169
FT                   /note="G->A: Decreases enzyme activity by 64%."
FT                   /evidence="ECO:0000269|PubMed:21048046,
FT                   ECO:0000269|PubMed:23467411"
FT   MUTAGEN         284
FT                   /note="S->I: Decreases enzyme activity by 87%. Impairs
FT                   protein folding and/or stability."
FT                   /evidence="ECO:0000269|PubMed:21048046"
FT   MUTAGEN         290
FT                   /note="V->L: No effect on enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:21048046"
FT   MUTAGEN         331
FT                   /note="F->A: Decreases enzyme activity by 50%."
FT                   /evidence="ECO:0000269|PubMed:21048046,
FT                   ECO:0000269|PubMed:23467411"
FT   MUTAGEN         334
FT                   /note="L->A: Decreases enzyme activity by 86%."
FT                   /evidence="ECO:0000269|PubMed:21048046,
FT                   ECO:0000269|PubMed:23467411"
FT   MUTAGEN         347
FT                   /note="V->A: Decreases enzyme activity by 45%."
FT                   /evidence="ECO:0000269|PubMed:21048046,
FT                   ECO:0000269|PubMed:23467411"
FT   MUTAGEN         368
FT                   /note="M->A: Decreases enzyme activity by 52%."
FT                   /evidence="ECO:0000269|PubMed:21048046,
FT                   ECO:0000269|PubMed:23467411"
FT   STRAND          4..8
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           12..22
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          24..26
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          29..33
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          35..40
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          45..47
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          53..57
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          59..61
FT                   /evidence="ECO:0007829|PDB:4IVO"
FT   HELIX           65..77
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           81..83
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          84..87
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           92..95
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          97..101
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          104..107
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           128..131
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   TURN            132..135
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           146..154
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           156..161
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           163..171
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   TURN            175..177
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           180..183
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           185..194
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           197..203
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           214..221
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          225..229
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           235..246
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          250..252
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          259..262
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           264..266
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          268..271
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          276..284
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           288..294
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           297..299
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           300..307
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          311..321
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          330..334
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   TURN            337..339
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          341..347
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           349..352
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           354..356
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   TURN            358..361
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          363..369
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           371..379
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           386..401
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          408..420
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           426..439
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   STRAND          443..446
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   TURN            449..451
FT                   /evidence="ECO:0007829|PDB:3NKS"
FT   HELIX           456..472
FT                   /evidence="ECO:0007829|PDB:3NKS"
SQ   SEQUENCE   477 AA;  50765 MW;  2444DEAC2E6C33EE CRC64;
     MGRTVVVLGG GISGLAASYH LSRAPCPPKV VLVESSERLG GWIRSVRGPN GAIFELGPRG
     IRPAGALGAR TLLLVSELGL DSEVLPVRGD HPAAQNRFLY VGGALHALPT GLRGLLRPSP
     PFSKPLFWAG LRELTKPRGK EPDETVHSFA QRRLGPEVAS LAMDSLCRGV FAGNSRELSI
     RSCFPSLFQA EQTHRSILLG LLLGAGRTPQ PDSALIRQAL AERWSQWSLR GGLEMLPQAL
     ETHLTSRGVS VLRGQPVCGL SLQAEGRWKV SLRDSSLEAD HVISAIPASV LSELLPAEAA
     PLARALSAIT AVSVAVVNLQ YQGAHLPVQG FGHLVPSSED PGVLGIVYDS VAFPEQDGSP
     PGLRVTVMLG GSWLQTLEAS GCVLSQELFQ QRAQEAAATQ LGLKEMPSHC LVHLHKNCIP
     QYTLGHWQKL ESARQFLTAH RLPLTLAGAS YEGVAVNDCI ESGRQAAVSV LGTEPNS
//
ID   PHRB_AGRFC              Reviewed;         507 AA.
AC   A9CH39;
DT   04-FEB-2015, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 1.
DT   02-JUN-2021, entry version 65.
DE   RecName: Full=(6-4) photolyase {ECO:0000303|PubMed:23589886};
DE            EC=4.1.99.13 {ECO:0000269|PubMed:23589886};
DE   AltName: Full=(6-4)DNA photolyase {ECO:0000305};
DE   AltName: Full=DNA photolyase PhrB {ECO:0000303|PubMed:22066008};
DE   AltName: Full=Photoreactivating enzyme PhrB;
GN   Name=phrB {ECO:0000303|PubMed:22066008};
GN   OrderedLocusNames=Atu4765 {ECO:0000312|EMBL:AAK88685.1};
OS   Agrobacterium fabrum (strain C58 / ATCC 33970) (Agrobacterium tumefaciens
OS   (strain C58)).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Rhizobiales; Rhizobiaceae;
OC   Rhizobium/Agrobacterium group; Agrobacterium;
OC   Agrobacterium tumefaciens complex.
OX   NCBI_TaxID=176299;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C58 / ATCC 33970;
RX   PubMed=11743193; DOI=10.1126/science.1066804;
RA   Wood D.W., Setubal J.C., Kaul R., Monks D.E., Kitajima J.P., Okura V.K.,
RA   Zhou Y., Chen L., Wood G.E., Almeida N.F. Jr., Woo L., Chen Y.,
RA   Paulsen I.T., Eisen J.A., Karp P.D., Bovee D. Sr., Chapman P.,
RA   Clendenning J., Deatherage G., Gillet W., Grant C., Kutyavin T., Levy R.,
RA   Li M.-J., McClelland E., Palmieri A., Raymond C., Rouse G.,
RA   Saenphimmachak C., Wu Z., Romero P., Gordon D., Zhang S., Yoo H., Tao Y.,
RA   Biddle P., Jung M., Krespan W., Perry M., Gordon-Kamm B., Liao L., Kim S.,
RA   Hendrick C., Zhao Z.-Y., Dolan M., Chumley F., Tingey S.V., Tomb J.-F.,
RA   Gordon M.P., Olson M.V., Nester E.W.;
RT   "The genome of the natural genetic engineer Agrobacterium tumefaciens
RT   C58.";
RL   Science 294:2317-2323(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C58 / ATCC 33970;
RX   PubMed=11743194; DOI=10.1126/science.1066803;
RA   Goodner B., Hinkle G., Gattung S., Miller N., Blanchard M., Qurollo B.,
RA   Goldman B.S., Cao Y., Askenazi M., Halling C., Mullin L., Houmiel K.,
RA   Gordon J., Vaudin M., Iartchouk O., Epp A., Liu F., Wollam C., Allinger M.,
RA   Doughty D., Scott C., Lappas C., Markelz B., Flanagan C., Crowell C.,
RA   Gurson J., Lomo C., Sear C., Strub G., Cielo C., Slater S.;
RT   "Genome sequence of the plant pathogen and biotechnology agent
RT   Agrobacterium tumefaciens C58.";
RL   Science 294:2323-2328(2001).
RN   [3]
RP   COFACTOR, AND DISRUPTION PHENOTYPE.
RC   STRAIN=C58 / ATCC 33970;
RX   PubMed=22066008; DOI=10.1371/journal.pone.0026775;
RA   Oberpichler I., Pierik A.J., Wesslowski J., Pokorny R., Rosen R.,
RA   Vugman M., Zhang F., Neubauer O., Ron E.Z., Batschauer A., Lamparter T.;
RT   "A photolyase-like protein from Agrobacterium tumefaciens with an iron-
RT   sulfur cluster.";
RL   PLoS ONE 6:E26775-E26775(2011).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) IN COMPLEX WITH FAD;
RP   6,7-DIMETHYL-8-RIBITYLLUMAZINE AND IRON-SULFUR (4FE-4S), FUNCTION,
RP   CATALYTIC ACTIVITY, AND COFACTOR.
RC   STRAIN=C58 / ATCC 33970;
RX   PubMed=23589886; DOI=10.1073/pnas.1302377110;
RA   Zhang F., Scheerer P., Oberpichler I., Lamparter T., Krauss N.;
RT   "Crystal structure of a prokaryotic (6-4) photolyase with an Fe-S cluster
RT   and a 6,7-dimethyl-8-ribityllumazine antenna chromophore.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:7217-7222(2013).
CC   -!- FUNCTION: Photolyase involved in the repair of UV-induced (6-4) lesions
CC       in DNA. Catalyzes the photoreactivation of (6-4) pyrimidine-pyrimidone
CC       photoproducts by using blue-light energy. Can repair (6-4)
CC       photoproducts in ssDNA as well as in dsDNA.
CC       {ECO:0000269|PubMed:23589886}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6-4) photoproduct (in DNA) = 2 pyrimidine residues (in DNA).;
CC         EC=4.1.99.13; Evidence={ECO:0000269|PubMed:23589886};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:22066008, ECO:0000269|PubMed:23589886};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:23589886};
CC   -!- COFACTOR:
CC       Name=6,7-dimethyl-8-(1-D-ribityl)lumazine; Xref=ChEBI:CHEBI:58201;
CC         Evidence={ECO:0000269|PubMed:23589886};
CC       Note=Binds 6,7-dimethyl-8-ribityllumazine (DMRL) as antenna
CC       chromophore. {ECO:0000269|PubMed:23589886};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000269|PubMed:23589886, ECO:0000305|PubMed:22066008};
CC       Note=Binds 1 [4Fe-4S] cluster per subunit.
CC       {ECO:0000269|PubMed:23589886};
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene show a strongly
CC       attenuated photoreactivation after treatment with UV-B irradiation.
CC       {ECO:0000269|PubMed:22066008}.
CC   -!- SIMILARITY: Belongs to the iron-sulfur bacterial
CC       cryptochrome/photolyase (FeS-BCP) family.
CC       {ECO:0000305|PubMed:22066008}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE007870; AAK88685.1; -; Genomic_DNA.
DR   PIR; AI3142; AI3142.
DR   PIR; C98145; C98145.
DR   RefSeq; NP_355900.1; NC_003063.2.
DR   PDB; 4DJA; X-ray; 1.45 A; A=1-507.
DR   PDB; 5KCM; X-ray; 2.15 A; A/B=1-507.
DR   PDB; 5LFA; X-ray; 2.50 A; A=1-507.
DR   PDB; 6DD6; X-ray; 2.30 A; A=1-507.
DR   PDBsum; 4DJA; -.
DR   PDBsum; 5KCM; -.
DR   PDBsum; 5LFA; -.
DR   PDBsum; 6DD6; -.
DR   SMR; A9CH39; -.
DR   STRING; 176299.Atu4765; -.
DR   PRIDE; A9CH39; -.
DR   DNASU; 1136639; -.
DR   EnsemblBacteria; AAK88685; AAK88685; Atu4765.
DR   KEGG; atu:Atu4765; -.
DR   PATRIC; fig|176299.10.peg.4572; -.
DR   eggNOG; COG3046; Bacteria.
DR   HOGENOM; CLU_031632_1_0_5; -.
DR   OMA; IQRLMIT; -.
DR   BioCyc; AGRO:ATU4765-MONOMER; -.
DR   BRENDA; 4.1.99.13; 14964.
DR   Proteomes; UP000000813; Chromosome linear.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IDA:UniProtKB.
DR   GO; GO:0003914; F:DNA (6-4) photolyase activity; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000719; P:photoreactive repair; IDA:UniProtKB.
DR   GO; GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR036134; Crypto/Photolyase_FAD-like_sf.
DR   InterPro; IPR007357; PhrB-like.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF04244; DPRP; 1.
DR   SUPFAM; SSF48173; SSF48173; 1.
PE   1: Evidence at protein level;
KW   3D-structure; 4Fe-4S; Chromophore; DNA damage; DNA repair; DNA-binding;
KW   FAD; Flavoprotein; Iron; Iron-sulfur; Lyase; Metal-binding;
KW   Nucleotide-binding; Reference proteome.
FT   CHAIN           1..507
FT                   /note="(6-4) photolyase"
FT                   /id="PRO_0000431763"
FT   NP_BIND         265..269
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23589886,
FT                   ECO:0007744|PDB:4DJA"
FT   NP_BIND         363..366
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23589886,
FT                   ECO:0007744|PDB:4DJA"
FT   REGION          9..10
FT                   /note="6,7-dimethyl-8-(1-D-ribityl)lumazine binding"
FT                   /evidence="ECO:0000269|PubMed:23589886,
FT                   ECO:0007744|PDB:4DJA"
FT   REGION          32..40
FT                   /note="6,7-dimethyl-8-(1-D-ribityl)lumazine binding"
FT                   /evidence="ECO:0000269|PubMed:23589886,
FT                   ECO:0007744|PDB:4DJA"
FT   METAL           350
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:23589886,
FT                   ECO:0007744|PDB:4DJA"
FT   METAL           438
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:23589886,
FT                   ECO:0007744|PDB:4DJA"
FT   METAL           441
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:23589886,
FT                   ECO:0007744|PDB:4DJA"
FT   METAL           454
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:23589886,
FT                   ECO:0007744|PDB:4DJA"
FT   BINDING         105
FT                   /note="6,7-dimethyl-8-(1-D-ribityl)lumazine; via amide
FT                   nitrogen"
FT                   /evidence="ECO:0000269|PubMed:23589886,
FT                   ECO:0007744|PDB:4DJA"
FT   BINDING         273
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23589886,
FT                   ECO:0007744|PDB:4DJA"
FT   BINDING         397
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23589886,
FT                   ECO:0007744|PDB:4DJA"
FT   BINDING         406
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23589886,
FT                   ECO:0007744|PDB:4DJA"
FT   STRAND          3..6
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           17..19
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   TURN            24..26
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   STRAND          28..32
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           35..39
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           45..64
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   STRAND          68..72
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           83..94
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   STRAND          97..102
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           107..114
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           116..120
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   STRAND          122..127
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   STRAND          132..134
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           136..143
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           151..162
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           172..174
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           179..181
FT                   /evidence="ECO:0007829|PDB:5KCM"
FT   HELIX           202..214
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   STRAND          218..220
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           231..244
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           246..248
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   TURN            249..254
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   STRAND          260..262
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           269..272
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   TURN            273..275
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           279..291
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           297..308
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           310..321
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           323..327
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           340..343
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           349..361
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           366..371
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           373..379
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           384..394
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           400..408
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   TURN            409..412
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   TURN            414..419
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           428..434
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           437..440
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   STRAND          442..444
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   STRAND          448..450
FT                   /evidence="ECO:0007829|PDB:6DD6"
FT   HELIX           455..466
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           468..471
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           475..477
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           478..485
FT                   /evidence="ECO:0007829|PDB:4DJA"
FT   HELIX           489..507
FT                   /evidence="ECO:0007829|PDB:4DJA"
SQ   SEQUENCE   507 AA;  57864 MW;  9DB788BDA687ECF5 CRC64;
     MSQLVLILGD QLSPSIAALD GVDKKQDTIV LCEVMAEASY VGHHKKKIAF IFSAMRHFAE
     ELRGEGYRVR YTRIDDADNA GSFTGEVKRA IDDLTPSRIC VTEPGEWRVR SEMDGFAGAF
     GIQVDIRSDR RFLSSHGEFR NWAAGRKSLT MEYFYREMRR KTGLLMNGEQ PVGGRWNFDA
     ENRQPARPDL LRPKHPVFAP DKITKEVIDT VERLFPDNFG KLENFGFAVT RTDAERALSA
     FIDDFLCNFG ATQDAMLQDD PNLNHSLLSF YINCGLLDAL DVCKAAERAY HEGGAPLNAV
     EGFIRQIIGW REYMRGIYWL AGPDYVDSNF FENDRSLPVF YWTGKTHMNC MAKVITETIE
     NAYAHHIQRL MITGNFALLA GIDPKAVHRW YLEVYADAYE WVELPNVIGM SQFADGGFLG
     TKPYAASGNY INRMSDYCDT CRYDPKERLG DNACPFNALY WDFLARNREK LKSNHRLAQP
     YATWARMSED VRHDLRAKAA AFLRKLD
//
ID   OXLA_RHOOP              Reviewed;         534 AA.
AC   Q8VPD4;
DT   16-OCT-2019, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   02-JUN-2021, entry version 74.
DE   RecName: Full=L-amino acid oxidase {ECO:0000303|PubMed:17234209, ECO:0000303|Ref.1};
DE            Short=L-AAO {ECO:0000303|Ref.1};
DE            Short=LAO;
DE            Short=roLAAO {ECO:0000303|PubMed:17234209};
DE            EC=1.4.3.2 {ECO:0000269|Ref.1};
DE   Flags: Precursor;
OS   Rhodococcus opacus (Nocardia opaca).
OC   Bacteria; Actinobacteria; Corynebacteriales; Nocardiaceae; Rhodococcus.
OX   NCBI_TaxID=37919;
RN   [1] {ECO:0000312|EMBL:AAL14831.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PARTIAL PROTEIN SEQUENCE, FUNCTION,
RP   CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, COFACTOR, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBUNIT, AND BIOTECHNOLOGY.
RC   STRAIN=DSM 43250;
RX   DOI=10.1016/S0141-0229(02)00072-8;
RA   Geueke B., Hummel W.;
RT   "A new bacterial L-amino acid oxidase with a broad substrate specificity:
RT   purification and characterization.";
RL   Enzyme Microb. Technol. 31:77-87(2002).
RN   [2] {ECO:0007744|PDB:2JAE, ECO:0007744|PDB:2JB1, ECO:0007744|PDB:2JB2}
RP   X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS) OF 46-534 IN COMPLEX WITH FAD AND
RP   SUBSTRATE, AND COFACTOR.
RX   PubMed=17234209; DOI=10.1016/j.jmb.2006.11.071;
RA   Faust A., Niefind K., Hummel W., Schomburg D.;
RT   "The structure of a bacterial L-amino acid oxidase from Rhodococcus opacus
RT   gives new evidence for the hydride mechanism for dehydrogenation.";
RL   J. Mol. Biol. 367:234-248(2007).
CC   -!- FUNCTION: Catalyzes an oxidative deamination of basic, hydrophobic and
CC       aromatic L-amino acids, thus producing hydrogen peroxide that may
CC       contribute to the diverse toxic effects of this enzyme (Ref.1). Is
CC       active on most L-amino acid (39 on 43 tested) with the exception of L-
CC       Thr, L-Pro, and L-Gly (Ref.1). {ECO:0000269|Ref.1}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an L-alpha-amino acid + H2O + O2 = a 2-oxocarboxylate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:13781, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:35179,
CC         ChEBI:CHEBI:59869; EC=1.4.3.2; Evidence={ECO:0000269|Ref.1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-asparagine + O2 = 2-oxosuccinamate + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:61224, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:57735,
CC         ChEBI:CHEBI:58048; Evidence={ECO:0000269|Ref.1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-methionine + O2 = 4-methylsulfanyl-2-oxobutanoate +
CC         H2O2 + NH4(+); Xref=Rhea:RHEA:61236, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:16723,
CC         ChEBI:CHEBI:28938, ChEBI:CHEBI:57844; Evidence={ECO:0000269|Ref.1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-phenylalanine + O2 = 3-phenylpyruvate + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:61240, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:18005, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:58095; Evidence={ECO:0000269|Ref.1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-tyrosine + O2 = 3-(4-hydroxyphenyl)pyruvate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:61248, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:36242,
CC         ChEBI:CHEBI:58315; Evidence={ECO:0000269|Ref.1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-glutamine + O2 = 2-oxoglutaramate + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:61260, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:16769, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:58359; Evidence={ECO:0000269|Ref.1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-alanine + O2 = H2O2 + NH4(+) + pyruvate;
CC         Xref=Rhea:RHEA:61264, ChEBI:CHEBI:15361, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:57972; Evidence={ECO:0000269|Ref.1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-leucine + O2 = 4-methyl-2-oxopentanoate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:60996, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:17865, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:57427; Evidence={ECO:0000269|Ref.1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-lysine + O2 = 6-amino-2-oxohexanoate + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:14437, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:32551,
CC         ChEBI:CHEBI:58183; Evidence={ECO:0000269|Ref.1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-arginine + O2 = 5-guanidino-2-oxopentanoate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:51404, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:32682,
CC         ChEBI:CHEBI:58489; Evidence={ECO:0000269|Ref.1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-glutamate + O2 = 2-oxoglutarate + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:20728, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:16810, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:29985; Evidence={ECO:0000269|Ref.1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-cystine + O2 = (2R)-2-amino-2-carboxylatoethyl-
CC         disulfanyl-oxopropanoate + H2O2 + NH4(+); Xref=Rhea:RHEA:61284,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:28938, ChEBI:CHEBI:35491, ChEBI:CHEBI:144484;
CC         Evidence={ECO:0000269|Ref.1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-serine + O2 = 3-hydroxypyruvate + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:61344, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:17180, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:33384; Evidence={ECO:0000269|Ref.1};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:17234209, ECO:0000269|Ref.1};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:17234209,
CC       ECO:0000269|Ref.1};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.019 mM for L-Tyr {ECO:0000269|Ref.1};
CC         KM=0.070 mM for L-Arg {ECO:0000269|Ref.1};
CC         KM=0.026 mM for L-norleucine {ECO:0000269|Ref.1};
CC         KM=0.034 mM for L-ornithine {ECO:0000269|Ref.1};
CC         KM=0.022 mM for L-Phe {ECO:0000269|Ref.1};
CC         KM=0.028 mM for L-Leu {ECO:0000269|Ref.1};
CC         KM=0.039 mM for L-Met {ECO:0000269|Ref.1};
CC         KM=0.026 mM for L-citrulline {ECO:0000269|Ref.1};
CC         KM=0.028 mM for L-Asn {ECO:0000269|Ref.1};
CC         KM=0.085 mM for L-Gln {ECO:0000269|Ref.1};
CC         KM=0.274 mM for L-Ala {ECO:0000269|Ref.1};
CC         KM=0.015 mM for L-Lys {ECO:0000269|Ref.1};
CC         KM=5.11 mM for L-Ile {ECO:0000269|Ref.1};
CC         KM=0.411 mM for L-Glu {ECO:0000269|Ref.1};
CC         KM=3.73 mM for L-Val {ECO:0000269|Ref.1};
CC         KM=1.36 mM for L-Ser {ECO:0000269|Ref.1};
CC         Vmax=9.69 umol/min/mg enzyme toward L-Tyr {ECO:0000269|Ref.1};
CC         Vmax=8.12 umol/min/mg enzyme toward L-Arg {ECO:0000269|Ref.1};
CC         Vmax=7.55 umol/min/mg enzyme toward L-norleucine {ECO:0000269|Ref.1};
CC         Vmax=7.48 umol/min/mg enzyme toward L-ornithine {ECO:0000269|Ref.1};
CC         Vmax=6.97 umol/min/mg enzyme toward L-Phe {ECO:0000269|Ref.1};
CC         Vmax=6.45 umol/min/mg enzyme toward L-Leu {ECO:0000269|Ref.1};
CC         Vmax=6.43 umol/min/mg enzyme toward L-Met {ECO:0000269|Ref.1};
CC         Vmax=5.47 umol/min/mg enzyme toward L-citrulline {ECO:0000269|Ref.1};
CC         Vmax=5.37 umol/min/mg enzyme toward L-Asn {ECO:0000269|Ref.1};
CC         Vmax=5.06 umol/min/mg enzyme toward L-Gln {ECO:0000269|Ref.1};
CC         Vmax=4.27 umol/min/mg enzyme toward L-Ala {ECO:0000269|Ref.1};
CC         Vmax=3.56 umol/min/mg enzyme toward L-Lys {ECO:0000269|Ref.1};
CC         Vmax=2.84 umol/min/mg enzyme toward L-Ile {ECO:0000269|Ref.1};
CC         Vmax=2.32 umol/min/mg enzyme toward L-Glu {ECO:0000269|Ref.1};
CC         Vmax=1.93 umol/min/mg enzyme toward L-Val {ECO:0000269|Ref.1};
CC         Vmax=4.36 umol/min/mg enzyme toward L-Ser {ECO:0000269|Ref.1};
CC       pH dependence:
CC         Optimum pH is 8-9. {ECO:0000269|Ref.1};
CC   -!- SUBUNIT: Homodimer; non-covalently linked. {ECO:0000269|Ref.1}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305|Ref.1}. Note=Unexpectedly,
CC       is not secreted into the medium. {ECO:0000269|Ref.1}.
CC   -!- PTM: Predicted to be exported by the Tat system. {ECO:0000255|PROSITE-
CC       ProRule:PRU00648}.
CC   -!- PTM: Not glycosylated. {ECO:0000269|PubMed:17234209}.
CC   -!- BIOTECHNOLOGY: Can be used for the preparation of D-amino acids by
CC       resolving racemic amino acid mixtures and for the production of alpha-
CC       keto acids. {ECO:0000305|Ref.1}.
CC   -!- SIMILARITY: Belongs to the flavin monoamine oxidase family. FIG1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY053450; AAL14831.1; -; Genomic_DNA.
DR   PDB; 2JAE; X-ray; 1.25 A; A/B=46-534.
DR   PDB; 2JB1; X-ray; 1.55 A; A/B=46-534.
DR   PDB; 2JB2; X-ray; 1.45 A; A/B=46-534.
DR   PDB; 2JB3; X-ray; 1.85 A; A/B=46-534.
DR   PDBsum; 2JAE; -.
DR   PDBsum; 2JB1; -.
DR   PDBsum; 2JB2; -.
DR   PDBsum; 2JB3; -.
DR   SMR; Q8VPD4; -.
DR   BRENDA; 1.4.3.2; 4353.
DR   EvolutionaryTrace; Q8VPD4; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0050025; F:L-glutamate oxidase activity; IEA:RHEA.
DR   GO; GO:0050029; F:L-lysine oxidase activity; IEA:RHEA.
DR   GO; GO:0106329; F:L-phenylalaine oxidase activity; IEA:RHEA.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR006311; TAT_signal.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   PROSITE; PS51318; TAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Direct protein sequencing; FAD; Flavoprotein;
KW   Glycoprotein; Nucleotide-binding; Oxidoreductase; Signal.
FT   SIGNAL          1..45
FT                   /note="Tat-type signal"
FT                   /evidence="ECO:0000269|Ref.1"
FT   CHAIN           46..534
FT                   /note="L-amino acid oxidase"
FT                   /evidence="ECO:0000305|Ref.1"
FT                   /id="PRO_0000448256"
FT   NP_BIND         66..67
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17234209,
FT                   ECO:0007744|PDB:2JAE, ECO:0007744|PDB:2JB1,
FT                   ECO:0007744|PDB:2JB2, ECO:0007744|PDB:2JB3"
FT   NP_BIND         86..88
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17234209,
FT                   ECO:0007744|PDB:2JAE, ECO:0007744|PDB:2JB1,
FT                   ECO:0007744|PDB:2JB2, ECO:0007744|PDB:2JB3"
FT   NP_BIND         125..128
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17234209,
FT                   ECO:0007744|PDB:2JAE, ECO:0007744|PDB:2JB1,
FT                   ECO:0007744|PDB:2JB2, ECO:0007744|PDB:2JB3"
FT   NP_BIND         510..512
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17234209,
FT                   ECO:0007744|PDB:2JAE, ECO:0007744|PDB:2JB1,
FT                   ECO:0007744|PDB:2JB2, ECO:0007744|PDB:2JB3"
FT   BINDING         94
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:17234209,
FT                   ECO:0007744|PDB:2JAE, ECO:0007744|PDB:2JB1,
FT                   ECO:0007744|PDB:2JB2, ECO:0007744|PDB:2JB3"
FT   BINDING         128
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:17234209,
FT                   ECO:0007744|PDB:2JB1, ECO:0007744|PDB:2JB2"
FT   BINDING         272
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:17234209,
FT                   ECO:0007744|PDB:2JB1, ECO:0007744|PDB:2JB2"
FT   BINDING         305
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:17234209,
FT                   ECO:0007744|PDB:2JAE, ECO:0007744|PDB:2JB1,
FT                   ECO:0007744|PDB:2JB2, ECO:0007744|PDB:2JB3"
FT   BINDING         415
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:17234209,
FT                   ECO:0007744|PDB:2JB1, ECO:0007744|PDB:2JB2"
FT   BINDING         503
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17234209,
FT                   ECO:0007744|PDB:2JAE, ECO:0007744|PDB:2JB1,
FT                   ECO:0007744|PDB:2JB2, ECO:0007744|PDB:2JB3"
FT   BINDING         510
FT                   /note="Substrate; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:17234209,
FT                   ECO:0007744|PDB:2JB1, ECO:0007744|PDB:2JB2"
FT   STRAND          58..62
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           66..77
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          81..85
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          87..91
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          97..99
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          103..105
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          121..125
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           135..142
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          146..149
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          156..159
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   TURN            165..168
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           173..194
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   TURN            195..200
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           203..216
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           229..231
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          233..235
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           252..258
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   TURN            259..263
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           264..268
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   TURN            270..272
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          273..279
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           285..294
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           296..298
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          299..302
FT                   /evidence="ECO:0007829|PDB:2JB2"
FT   STRAND          304..311
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          314..321
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          324..335
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           339..342
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          345..347
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           351..358
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          365..374
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           376..379
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          387..392
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          396..398
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          401..403
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          409..417
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           419..425
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           429..444
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           446..449
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          450..459
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           460..462
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   TURN            464..466
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          467..470
FT                   /evidence="ECO:0007829|PDB:2JB2"
FT   HELIX           486..491
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          498..500
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           503..505
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   STRAND          506..508
FT                   /evidence="ECO:0007829|PDB:2JAE"
FT   HELIX           512..531
FT                   /evidence="ECO:0007829|PDB:2JAE"
SQ   SEQUENCE   534 AA;  57805 MW;  D8D367949BB2D444 CRC64;
     MAFTRRSFMK GLGATGGAGL AYGAMSTLGL APSTAAPART FQPLAAGDLI GKVKGSHSVV
     VLGGGPAGLC SAFELQKAGY KVTVLEARTR PGGRVWTARG GSEETDLSGE TQKCTFSEGH
     FYNVGATRIP QSHITLDYCR ELGVEIQGFG NQNANTFVNY QSDTSLSGQS VTYRAAKADT
     FGYMSELLKK ATDQGALDQV LSREDKDALS EFLSDFGDLS DDGRYLGSSR RGYDSEPGAG
     LNFGTEKKPF AMQEVIRSGI GRNFSFDFGY DQAMMMFTPV GGMDRIYYAF QDRIGTDNIV
     FGAEVTSMKN VSEGVTVEYT AGGSKKSITA DYAICTIPPH LVGRLQNNLP GDVLTALKAA
     KPSSSGKLGI EYSRRWWETE DRIYGGASNT DKDISQIMFP YDHYNSDRGV VVAYYSSGKR
     QEAFESLTHR QRLAKAIAEG SEIHGEKYTR DISSSFSGSW RRTKYSESAW ANWAGSGGSH
     GGAATPEYEK LLEPVDKIYF AGDHLSNAIA WQHGALTSAR DVVTHIHERV AQEA
//
ID   PHHY_PSEFL              Reviewed;         394 AA.
AC   P00438;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 2.
DT   02-JUN-2021, entry version 124.
DE   RecName: Full=p-hydroxybenzoate hydroxylase {ECO:0000303|PubMed:1459126};
DE            Short=PHBH {ECO:0000303|PubMed:1459126};
DE            Short=PHBHase {ECO:0000303|PubMed:3351945};
DE            EC=1.14.13.2 {ECO:0000269|PubMed:10025942, ECO:0000269|PubMed:10493859, ECO:0000269|PubMed:1459126, ECO:0000269|PubMed:7628466, ECO:0000269|PubMed:7756982, ECO:0000269|PubMed:9578477, ECO:0000269|PubMed:9694855};
DE   AltName: Full=4-hydroxybenzoate 3-monooxygenase {ECO:0000305};
GN   Name=pobA;
OS   Pseudomonas fluorescens.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=294;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY,
RP   MUTAGENESIS OF CYS-116 AND ARG-214, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   COFACTOR.
RX   PubMed=1459126; DOI=10.1111/j.1432-1033.1992.tb17436.x;
RA   van Berkel W., Westphal A., Eschrich K., Eppink M., de Kok A.;
RT   "Substitution of Arg214 at the substrate-binding site of p-hydroxybenzoate
RT   hydroxylase from Pseudomonas fluorescens.";
RL   Eur. J. Biochem. 210:411-419(1992).
RN   [2]
RP   PROTEIN SEQUENCE.
RX   PubMed=6809053; DOI=10.1016/0167-4838(82)90170-4;
RA   Weijer W.J., Hofsteenge J., Vereijken J.M., Jekel P.A., Beintema J.J.;
RT   "Primary structure of p-hydroxybenzoate hydroxylase from Pseudomonas
RT   fluorescens.";
RL   Biochim. Biophys. Acta 704:385-388(1982).
RN   [3]
RP   PROTEIN SEQUENCE OF 111-138 AND 270-280.
RX   PubMed=6780352;
RA   Hofsteenge J., Vereijken J.M., Weijer W.J., Beintema J.J., Wierenga R.K.,
RA   Drenth J.;
RT   "Primary and tertiary structure studies of p-hydroxybenzoate hydroxylase
RT   from Pseudomonas fluorescens. Isolation and alignment of the CNBr peptides;
RT   interactions of the protein with flavin adenine dinucleotide.";
RL   Eur. J. Biochem. 113:141-150(1980).
RN   [4]
RP   PROTEIN SEQUENCE OF 1-52; 53-65 AND 66-110.
RX   PubMed=6780353; DOI=10.1111/j.1432-1033.1980.tb06149.x;
RA   Vereijken J.M., Hofsteenge J., Bak H.J., Beintema J.J.;
RT   "The amino-acid sequence of the three smallest CNBr peptides from p-
RT   hydroxybenzoate hydroxylase from Pseudomonas fluorescens.";
RL   Eur. J. Biochem. 113:151-157(1980).
RN   [5]
RP   PROTEIN SEQUENCE OF CNBR PEPTIDES AND TERTIARY STRUCTURE.
RX   PubMed=6406229; DOI=10.1111/j.1432-1033.1983.tb07433.x;
RA   Hofsteenge J., Weijer W.J., Jekel P.A., Beintema J.J.;
RT   "p-hydroxybenzoate hydroxylase from Pseudomonas fluorescens. 1. Completion
RT   of the elucidation of the primary structure.";
RL   Eur. J. Biochem. 133:91-108(1983).
RN   [6]
RP   PROTEIN SEQUENCE OF CNBR PEPTIDES, AND FAD BINDING SITE.
RX   PubMed=6406227; DOI=10.1111/j.1432-1033.1983.tb07435.x;
RA   Weijer W.J., Hofsteenge J., Beintema J.J., Wierenga R.K., Drenth J.;
RT   "p-hydroxybenzoate hydroxylase from Pseudomonas fluorescens. 2. Fitting of
RT   the amino-acid sequence to the tertiary structure.";
RL   Eur. J. Biochem. 133:109-118(1983).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH SUBSTRATE AND FAD,
RP   AND SUBUNIT.
RX   PubMed=40036; DOI=10.1016/0022-2836(79)90301-2;
RA   Wierenga R.K., de Jong R.J., Kalk K.H., Hol W.G.J., Drenth J.;
RT   "Crystal structure of p-hydroxybenzoate hydroxylase.";
RL   J. Mol. Biol. 131:55-73(1979).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF REDUCED FORM IN COMPLEX WITH
RP   SUBSTRATE AND FAD, AND COFACTOR.
RX   PubMed=1409567; DOI=10.1002/prot.340140205;
RA   Schreuder H.A., van der Laan J.M., Swarte M.B.A., Kalk K.H., Hol W.G.J.,
RA   Drenth J.;
RT   "Crystal structure of the reduced form of p-hydroxybenzoate hydroxylase
RT   refined at 2.3-A resolution.";
RL   Proteins 14:178-190(1992).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) IN COMPLEX WITH SUBSTRATE ANALOG AND
RP   FAD, FUNCTION, COFACTOR, AND SUBUNIT.
RX   PubMed=3351945; DOI=10.1016/0022-2836(88)90307-5;
RA   Schreuder H.A., van der Laan J.M., Hol W.G., Drenth J.;
RT   "Crystal structure of p-hydroxybenzoate hydroxylase complexed with its
RT   reaction product 3,4-dihydroxybenzoate.";
RL   J. Mol. Biol. 199:637-648(1988).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) IN COMPLEX WITH SUBSTRATE AND FAD
RP   ANALOG, FUNCTION, COFACTOR, AND SUBUNIT.
RX   PubMed=2819062; DOI=10.1021/bi00444a011;
RA   van der Laan J.M., Schreuder H.A., Swarte M.B., Wierenga R.K., Kalk K.H.,
RA   Hol W.G., Drenth J.;
RT   "The coenzyme analogue adenosine 5-diphosphoribose displaces FAD in the
RT   active site of p-hydroxybenzoate hydroxylase. An x-ray crystallographic
RT   investigation.";
RL   Biochemistry 28:7199-7205(1989).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH SUBSTRATE AND FAD
RP   ANALOG, AND SUBUNIT.
RX   PubMed=2553983; DOI=10.1016/0022-2836(89)90158-7;
RA   Schreuder H.A., Prick P.A., Wierenga R.K., Vriend G., Wilson K.S.,
RA   Hol W.G., Drenth J.;
RT   "Crystal structure of the p-hydroxybenzoate hydroxylase-substrate complex
RT   refined at 1.9 A resolution. Analysis of the enzyme-substrate and enzyme-
RT   product complexes.";
RL   J. Mol. Biol. 208:679-696(1989).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF WILD-TYPE AND MUTANT ALA-222 IN
RP   COMPLEX WITH SUBSTRATE ANALOGS AND FAD, FUNCTION, MUTAGENESIS OF TYR-222,
RP   AND SUBUNIT.
RX   PubMed=7520279; DOI=10.1021/bi00199a044;
RA   Schreuder H.A., Mattevi A., Obmolova G., Kalk K.H., Hol W.G.,
RA   van der Bolt F.J., van Berkel W.J.;
RT   "Crystal structures of wild-type p-hydroxybenzoate hydroxylase complexed
RT   with 4-aminobenzoate,2,4-dihydroxybenzoate, and 2-hydroxy-4-aminobenzoate
RT   and of the Tyr222Ala mutant complexed with 2-hydroxy-4-aminobenzoate.
RT   Evidence for a proton channel and a new binding mode of the flavin ring.";
RL   Biochemistry 33:10161-10170(1994).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH SUBSTRATE AND FAD
RP   ANALOG, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   SUBUNIT.
RX   PubMed=7756982; DOI=10.1002/pro.5560031210;
RA   van Berkel W.J., Eppink M.H., Schreuder H.A.;
RT   "Crystal structure of p-hydroxybenzoate hydroxylase reconstituted with the
RT   modified FAD present in alcohol oxidase from methylotrophic yeasts:
RT   evidence for an arabinoflavin.";
RL   Protein Sci. 3:2245-2253(1994).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF MUTANT LYS-44 IN COMPLEX WITH
RP   SUBSTRATE AND FAD, FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF ARG-44,
RP   COFACTOR, AND SUBUNIT.
RX   PubMed=7628466; DOI=10.1111/j.1432-1033.1995.0157f.x;
RA   Eppink M.H., Schreuder H.A., Van Berkel W.J.;
RT   "Structure and function of mutant Arg44Lys of 4-hydroxybenzoate hydroxylase
RT   implications for NADPH binding.";
RL   Eur. J. Biochem. 231:157-165(1995).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF MUTANT LYS-42 AND SER-42 IN
RP   COMPLEX WITH SUBSTRATE AND FAD, FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF ARG-42, COFACTOR, AND
RP   SUBUNIT.
RX   PubMed=9578477; DOI=10.1046/j.1432-1327.1998.2530194.x;
RA   Eppink M.H., Schreuder H.A., van Berkel W.J.;
RT   "Lys42 and Ser42 variants of p-hydroxybenzoate hydroxylase from Pseudomonas
RT   fluorescens reveal that Arg42 is essential for NADPH binding.";
RL   Eur. J. Biochem. 253:194-201(1998).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF MUTANTS ARG-162 AND THR-269 IN
RP   COMPLEX WITH SUBSTRATE AND FAD, FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF HIS-162 AND ARG-269,
RP   COFACTOR, AND SUBUNIT.
RX   PubMed=9694855; DOI=10.1074/jbc.273.33.21031;
RA   Eppink M.H., Schreuder H.A., van Berkel W.J.;
RT   "Interdomain binding of NADPH in p-hydroxybenzoate hydroxylase as suggested
RT   by kinetic, crystallographic and modeling studies of histidine 162 and
RT   arginine 269 variants.";
RL   J. Biol. Chem. 273:21031-21039(1998).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF ALA-161 AND SER-166 IN COMPLEX
RP   WITH SUBSTRATE AND FAD, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, MUTAGENESIS OF PHE-161 AND ARG-166, COFACTOR, AND SUBUNIT.
RX   PubMed=10025942; DOI=10.1016/s0014-5793(98)01726-8;
RA   Eppink M.H., Bunthol C., Schreuder H.A., van Berkel W.J.;
RT   "Phe161 and Arg166 variants of p-hydroxybenzoate hydroxylase. Implications
RT   for NADPH recognition and structural stability.";
RL   FEBS Lett. 443:251-255(1999).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 1-392 OF MUTANTS ARG-34; THR-34
RP   AND GLU-38 IN COMPLEX WITH SUBSTRATE AND FAD, FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF ARG-33; GLN-34 AND TYR-38,
RP   COFACTOR, AND SUBUNIT.
RX   PubMed=10493859; DOI=10.1006/jmbi.1999.3015;
RA   Eppink M.H., Overkamp K.M., Schreuder H.A., Van Berkel W.J.;
RT   "Switch of coenzyme specificity of p-hydroxybenzoate hydroxylase.";
RL   J. Mol. Biol. 292:87-96(1999).
CC   -!- FUNCTION: Catalyzes the incorporation of an atom of dioxygen into p-
CC       hydroxybenzoate (p-OHB) to form 3,4-dihydroxybenzoate (3,4DOHB). The
CC       reaction occurs in two parts: reduction of the flavin adenine
CC       dinucleotide (FAD) in the enzyme by reduced nicotinamide adenine
CC       dinucleotide phosphate (NADPH) in response to binding p-hydroxybenzoate
CC       to the enzyme and oxidation of reduced FAD with oxygen to form a
CC       hydroperoxide, which then oxygenates p-hydroxybenzoate.
CC       {ECO:0000269|PubMed:10025942, ECO:0000269|PubMed:10493859,
CC       ECO:0000269|PubMed:1459126, ECO:0000269|PubMed:2819062,
CC       ECO:0000269|PubMed:3351945, ECO:0000269|PubMed:7520279,
CC       ECO:0000269|PubMed:7628466, ECO:0000269|PubMed:7756982,
CC       ECO:0000269|PubMed:9578477, ECO:0000269|PubMed:9694855}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-hydroxybenzoate + H(+) + NADPH + O2 = 3,4-dihydroxybenzoate
CC         + H2O + NADP(+); Xref=Rhea:RHEA:19477, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:17879,
CC         ChEBI:CHEBI:36241, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         EC=1.14.13.2; Evidence={ECO:0000269|PubMed:10025942,
CC         ECO:0000269|PubMed:10493859, ECO:0000269|PubMed:1459126,
CC         ECO:0000269|PubMed:7628466, ECO:0000269|PubMed:7756982,
CC         ECO:0000269|PubMed:9578477, ECO:0000269|PubMed:9694855};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:10025942, ECO:0000269|PubMed:10493859,
CC         ECO:0000269|PubMed:1409567, ECO:0000269|PubMed:1459126,
CC         ECO:0000269|PubMed:2819062, ECO:0000269|PubMed:3351945,
CC         ECO:0000269|PubMed:7628466, ECO:0000269|PubMed:9578477,
CC         ECO:0000269|PubMed:9694855};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:10025942,
CC       ECO:0000269|PubMed:10493859, ECO:0000269|PubMed:2819062,
CC       ECO:0000269|PubMed:3351945, ECO:0000269|PubMed:7628466,
CC       ECO:0000269|PubMed:9578477, ECO:0000269|PubMed:9694855};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=15 uM for p-OHB {ECO:0000269|PubMed:9578477};
CC         KM=15 uM for p-OHB (at pH 6) {ECO:0000269|PubMed:10025942,
CC         ECO:0000269|PubMed:10493859};
CC         KM=20 uM for p-OHB {ECO:0000269|PubMed:7756982,
CC         ECO:0000269|PubMed:9694855};
CC         KM=25 uM for p-OHB (at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:1459126};
CC         KM=30 uM for NADPH {ECO:0000269|PubMed:9694855};
CC         KM=30 uM for p-OHB (at 6 degrees Celsius)
CC         {ECO:0000269|PubMed:1459126};
CC         KM=34 uM for NADPH (at pH 6) {ECO:0000269|PubMed:10025942,
CC         ECO:0000269|PubMed:10493859};
CC         KM=40 uM for NADPH (at 6 degrees Celsius)
CC         {ECO:0000269|PubMed:1459126};
CC         KM=50 uM for NADPH (at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:1459126};
CC         KM=50 uM for NADPH {ECO:0000269|PubMed:9578477};
CC         KM=70 uM for NADPH {ECO:0000269|PubMed:7756982};
CC         Note=Kcat is 55 sec(-1) for hydroxylase activity (PubMed:9578477,
CC         PubMed:9694855). Kcat is 55 sec(-1) for hydroxylase activity (at 25
CC         degrees Celsius) (PubMed:1459126). Kcat is 55 sec(-1) for hydroxylase
CC         activity (at pH 8) (PubMed:10025942, PubMed:10493859). Kcat is 9
CC         sec(-1) for hydroxylase activity (at 6 degrees Celsius)
CC         (PubMed:1459126). {ECO:0000269|PubMed:10025942,
CC         ECO:0000269|PubMed:10493859, ECO:0000269|PubMed:1459126,
CC         ECO:0000269|PubMed:7756982, ECO:0000269|PubMed:9578477,
CC         ECO:0000269|PubMed:9694855};
CC   -!- PATHWAY: Aromatic compound metabolism; benzoate degradation via
CC       hydroxylation; 3,4-dihydroxybenzoate from benzoate: step 2/2.
CC       {ECO:0000305}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:10025942,
CC       ECO:0000269|PubMed:10493859, ECO:0000269|PubMed:2553983,
CC       ECO:0000269|PubMed:2819062, ECO:0000269|PubMed:3351945,
CC       ECO:0000269|PubMed:40036, ECO:0000269|PubMed:7520279,
CC       ECO:0000269|PubMed:7628466, ECO:0000269|PubMed:7756982,
CC       ECO:0000269|PubMed:9578477, ECO:0000269|PubMed:9694855}.
CC   -!- SIMILARITY: Belongs to the aromatic-ring hydroxylase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X68438; CAA48483.1; -; Genomic_DNA.
DR   PIR; A90643; WHPSBF.
DR   PDB; 1BF3; X-ray; 2.20 A; A=1-394.
DR   PDB; 1BGJ; X-ray; 3.00 A; A=1-394.
DR   PDB; 1BGN; X-ray; 2.00 A; A=1-394.
DR   PDB; 1BKW; X-ray; 2.20 A; A=1-394.
DR   PDB; 1CC4; X-ray; 2.00 A; A=1-394.
DR   PDB; 1CC6; X-ray; 2.20 A; A=1-394.
DR   PDB; 1CJ2; X-ray; 2.80 A; A=1-391.
DR   PDB; 1CJ3; X-ray; 2.50 A; A=1-392.
DR   PDB; 1CJ4; X-ray; 2.40 A; A=1-392.
DR   PDB; 1PBB; X-ray; 2.50 A; A=1-394.
DR   PDB; 1PBC; X-ray; 2.80 A; A=1-394.
DR   PDB; 1PBD; X-ray; 2.30 A; A=1-394.
DR   PDB; 1PBE; X-ray; 1.90 A; A=1-394.
DR   PDB; 1PBF; X-ray; 2.70 A; A=1-394.
DR   PDB; 1PDH; X-ray; 2.10 A; A=1-394.
DR   PDB; 1PHH; X-ray; 2.30 A; A=1-394.
DR   PDB; 2PHH; X-ray; 2.70 A; A=1-394.
DR   PDBsum; 1BF3; -.
DR   PDBsum; 1BGJ; -.
DR   PDBsum; 1BGN; -.
DR   PDBsum; 1BKW; -.
DR   PDBsum; 1CC4; -.
DR   PDBsum; 1CC6; -.
DR   PDBsum; 1CJ2; -.
DR   PDBsum; 1CJ3; -.
DR   PDBsum; 1CJ4; -.
DR   PDBsum; 1PBB; -.
DR   PDBsum; 1PBC; -.
DR   PDBsum; 1PBD; -.
DR   PDBsum; 1PBE; -.
DR   PDBsum; 1PBF; -.
DR   PDBsum; 1PDH; -.
DR   PDBsum; 1PHH; -.
DR   PDBsum; 2PHH; -.
DR   SMR; P00438; -.
DR   BindingDB; P00438; -.
DR   ChEMBL; CHEMBL3675; -.
DR   DrugBank; DB02839; 2,4-Dihydroxybenzoic Acid.
DR   DrugBank; DB04242; 4-hydroxybenzoic acid.
DR   DrugBank; DB02059; Adenosine-5-Diphosphoribose.
DR   DrugBank; DB02362; Aminobenzoic acid.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   BioCyc; MetaCyc:MONOMER-11534; -.
DR   BRENDA; 1.14.13.2; 5121.
DR   UniPathway; UPA00156; UER00257.
DR   EvolutionaryTrace; P00438; -.
DR   GO; GO:0018659; F:4-hydroxybenzoate 3-monooxygenase activity; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0043640; P:benzoate catabolic process via hydroxylation; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR012733; HB_mOase.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR02360; pbenz_hydroxyl; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aromatic hydrocarbons catabolism; Direct protein sequencing;
KW   FAD; Flavoprotein; Monooxygenase; NADP; Oxidoreductase.
FT   CHAIN           1..394
FT                   /note="p-hydroxybenzoate hydroxylase"
FT                   /id="PRO_0000058382"
FT   NP_BIND         42..47
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10025942,
FT                   ECO:0000269|PubMed:10493859, ECO:0000269|PubMed:2553983,
FT                   ECO:0000269|PubMed:2819062, ECO:0000269|PubMed:3351945,
FT                   ECO:0000269|PubMed:7520279, ECO:0000269|PubMed:7628466,
FT                   ECO:0000269|PubMed:7756982, ECO:0000269|PubMed:9578477,
FT                   ECO:0000269|PubMed:9694855"
FT   NP_BIND         299..300
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10025942,
FT                   ECO:0000269|PubMed:10493859, ECO:0000269|PubMed:2553983,
FT                   ECO:0000269|PubMed:2819062, ECO:0000269|PubMed:3351945,
FT                   ECO:0000269|PubMed:7520279, ECO:0000269|PubMed:7628466,
FT                   ECO:0000269|PubMed:7756982, ECO:0000269|PubMed:9578477,
FT                   ECO:0000269|PubMed:9694855"
FT   REGION          212..214
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:10025942,
FT                   ECO:0000269|PubMed:10493859, ECO:0000269|PubMed:2553983,
FT                   ECO:0000269|PubMed:2819062, ECO:0000269|PubMed:3351945,
FT                   ECO:0000269|PubMed:7520279, ECO:0000269|PubMed:7628466,
FT                   ECO:0000269|PubMed:7756982, ECO:0000269|PubMed:9578477,
FT                   ECO:0000269|PubMed:9694855"
FT   BINDING         13
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10025942,
FT                   ECO:0000269|PubMed:10493859, ECO:0000269|PubMed:2553983,
FT                   ECO:0000269|PubMed:2819062, ECO:0000269|PubMed:3351945,
FT                   ECO:0000269|PubMed:7520279, ECO:0000269|PubMed:7628466,
FT                   ECO:0000269|PubMed:7756982, ECO:0000269|PubMed:9578477,
FT                   ECO:0000269|PubMed:9694855"
FT   BINDING         32
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10025942,
FT                   ECO:0000269|PubMed:10493859, ECO:0000269|PubMed:2553983,
FT                   ECO:0000269|PubMed:2819062, ECO:0000269|PubMed:3351945,
FT                   ECO:0000269|PubMed:7520279, ECO:0000269|PubMed:7628466,
FT                   ECO:0000269|PubMed:7756982, ECO:0000269|PubMed:9578477,
FT                   ECO:0000269|PubMed:9694855"
FT   BINDING         102
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10025942,
FT                   ECO:0000269|PubMed:10493859, ECO:0000269|PubMed:2553983,
FT                   ECO:0000269|PubMed:2819062, ECO:0000269|PubMed:3351945,
FT                   ECO:0000269|PubMed:7520279, ECO:0000269|PubMed:7628466,
FT                   ECO:0000269|PubMed:7756982, ECO:0000269|PubMed:9578477,
FT                   ECO:0000269|PubMed:9694855"
FT   BINDING         201
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:10025942,
FT                   ECO:0000269|PubMed:10493859, ECO:0000269|PubMed:2553983,
FT                   ECO:0000269|PubMed:2819062, ECO:0000269|PubMed:3351945,
FT                   ECO:0000269|PubMed:7520279, ECO:0000269|PubMed:7628466,
FT                   ECO:0000269|PubMed:7756982, ECO:0000269|PubMed:9578477,
FT                   ECO:0000269|PubMed:9694855"
FT   BINDING         222
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:10025942,
FT                   ECO:0000269|PubMed:10493859, ECO:0000269|PubMed:2553983,
FT                   ECO:0000269|PubMed:2819062, ECO:0000269|PubMed:3351945,
FT                   ECO:0000269|PubMed:7520279, ECO:0000269|PubMed:7628466,
FT                   ECO:0000269|PubMed:7756982, ECO:0000269|PubMed:9578477,
FT                   ECO:0000269|PubMed:9694855"
FT   BINDING         286
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10025942,
FT                   ECO:0000269|PubMed:10493859, ECO:0000269|PubMed:2553983,
FT                   ECO:0000269|PubMed:2819062, ECO:0000269|PubMed:3351945,
FT                   ECO:0000269|PubMed:7520279, ECO:0000269|PubMed:7628466,
FT                   ECO:0000269|PubMed:7756982, ECO:0000269|PubMed:9578477,
FT                   ECO:0000269|PubMed:9694855"
FT   BINDING         293
FT                   /note="Substrate; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:10025942,
FT                   ECO:0000269|PubMed:10493859, ECO:0000269|PubMed:2553983,
FT                   ECO:0000269|PubMed:2819062, ECO:0000269|PubMed:3351945,
FT                   ECO:0000269|PubMed:7520279, ECO:0000269|PubMed:7628466,
FT                   ECO:0000269|PubMed:7756982, ECO:0000269|PubMed:9578477,
FT                   ECO:0000269|PubMed:9694855"
FT   SITE            201
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000250|UniProtKB:P20586"
FT   SITE            385
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000250|UniProtKB:P20586"
FT   MUTAGEN         33
FT                   /note="R->E: Slight decrease of affinity for p-OHB and
FT                   strong decrease of affinity for NADPH."
FT                   /evidence="ECO:0000269|PubMed:10493859"
FT   MUTAGEN         33
FT                   /note="R->K: Slight decrease of affinity for p-OHB and
FT                   NADPH."
FT                   /evidence="ECO:0000269|PubMed:10493859"
FT   MUTAGEN         33
FT                   /note="R->S: Slight decrease of affinity for p-OHB and
FT                   strong decrease of affinity for NADPH."
FT                   /evidence="ECO:0000269|PubMed:10493859"
FT   MUTAGEN         34
FT                   /note="Q->K: Slight decrease of affinity for p-OHB and
FT                   NADPH."
FT                   /evidence="ECO:0000269|PubMed:10493859"
FT   MUTAGEN         34
FT                   /note="Q->R: Slight decrease of affinity for p-OHB and
FT                   NADPH."
FT                   /evidence="ECO:0000269|PubMed:10493859"
FT   MUTAGEN         34
FT                   /note="Q->T: Slight decrease of affinity for p-OHB and
FT                   NADPH."
FT                   /evidence="ECO:0000269|PubMed:10493859"
FT   MUTAGEN         38
FT                   /note="Y->E: Slight decrease of affinity for p-OHB and
FT                   strong decrease of affinity for NADPH."
FT                   /evidence="ECO:0000269|PubMed:10493859"
FT   MUTAGEN         38
FT                   /note="Y->F: Slight decrease of affinity for p-OHB and
FT                   strong decrease of affinity for NADPH."
FT                   /evidence="ECO:0000269|PubMed:10493859"
FT   MUTAGEN         38
FT                   /note="Y->K: Slight decrease of affinity for p-OHB and
FT                   strong decrease of affinity for NADPH."
FT                   /evidence="ECO:0000269|PubMed:10493859"
FT   MUTAGEN         42
FT                   /note="R->K: 4-fold and 10-fold decrease of affinity for p-
FT                   OHB and NADPH, respectively. The turnover rate of p-
FT                   hydroxybenzoate hydroxylase results from impaired binding
FT                   of NADPH."
FT                   /evidence="ECO:0000269|PubMed:9578477"
FT   MUTAGEN         42
FT                   /note="R->S: 3-fold and 10-fold decrease of affinity for p-
FT                   OHB and NADPH, respectively. The turnover rate of p-
FT                   hydroxybenzoate hydroxylase results from impaired binding
FT                   of NADPH. Hardly disturbs the binding of FAD."
FT                   /evidence="ECO:0000269|PubMed:9578477"
FT   MUTAGEN         44
FT                   /note="R->K: Decrease of affinity for the flavin prosthetic
FT                   group. It affects NADPH binding, resulting in a low yield
FT                   of the charge-transfer species between reduced flavin and
FT                   NADP."
FT                   /evidence="ECO:0000269|PubMed:7628466"
FT   MUTAGEN         116
FT                   /note="C->S: Slight decrease of affinity for NADPH and p-
FT                   OHB are observed."
FT                   /evidence="ECO:0000269|PubMed:1459126"
FT   MUTAGEN         161
FT                   /note="F->A: Decrease of affinity for NADPH."
FT                   /evidence="ECO:0000269|PubMed:10025942"
FT   MUTAGEN         161
FT                   /note="F->G: Decrease of affinity for NADPH."
FT                   /evidence="ECO:0000269|PubMed:10025942"
FT   MUTAGEN         162
FT                   /note="H->D: No significant changes in affinity for p-OHB
FT                   are observed. However, the affinity for NADPH decreases
FT                   strongly."
FT                   /evidence="ECO:0000269|PubMed:9694855"
FT   MUTAGEN         162
FT                   /note="H->K: No significant changes in affinity for p-OHB
FT                   are observed. However, the affinity for NADPH decreases
FT                   slightly."
FT                   /evidence="ECO:0000269|PubMed:9694855"
FT   MUTAGEN         162
FT                   /note="H->N: No significant changes in affinity for p-OHB
FT                   are observed. However, the affinity for NADPH decreases
FT                   strongly."
FT                   /evidence="ECO:0000269|PubMed:9694855"
FT   MUTAGEN         162
FT                   /note="H->R: No significant changes in affinity for p-OHB
FT                   are observed. However, the affinity for NADPH decreases
FT                   slightly."
FT                   /evidence="ECO:0000269|PubMed:9694855"
FT   MUTAGEN         162
FT                   /note="H->S: No significant changes in affinity for p-OHB
FT                   are observed. However, the affinity for NADPH decreases
FT                   strongly."
FT                   /evidence="ECO:0000269|PubMed:9694855"
FT   MUTAGEN         162
FT                   /note="H->T: No significant changes in affinity for p-OHB
FT                   are observed. However, the affinity for NADPH decreases
FT                   strongly."
FT                   /evidence="ECO:0000269|PubMed:9694855"
FT   MUTAGEN         162
FT                   /note="H->Y: No significant changes in affinity for p-OHB
FT                   are observed. However, the affinity for NADPH decreases
FT                   slightly."
FT                   /evidence="ECO:0000269|PubMed:9694855"
FT   MUTAGEN         166
FT                   /note="R->E: Loses the ability to bind NADPH and FAD."
FT                   /evidence="ECO:0000269|PubMed:10025942"
FT   MUTAGEN         166
FT                   /note="R->K: Loses the ability to bind NADPH."
FT                   /evidence="ECO:0000269|PubMed:10025942"
FT   MUTAGEN         166
FT                   /note="R->S: Loses the ability to bind NADPH."
FT                   /evidence="ECO:0000269|PubMed:10025942"
FT   MUTAGEN         214
FT                   /note="R->K: Strong decrease of affinity for NADPH and 4-
FT                   fold decrease of affinity for p-OHB are observed."
FT                   /evidence="ECO:0000269|PubMed:1459126"
FT   MUTAGEN         222
FT                   /note="Y->A: Results in the removal of a large side chain
FT                   involving in the binding of the carboxyl group of the
FT                   substrate."
FT                   /evidence="ECO:0000269|PubMed:7520279"
FT   MUTAGEN         269
FT                   /note="R->D: No significant changes in affinity for p-OHB
FT                   are observed. However, the affinity for NADPH decreases
FT                   strongly."
FT                   /evidence="ECO:0000269|PubMed:9694855"
FT   MUTAGEN         269
FT                   /note="R->K: No significant changes in affinity for p-OHB
FT                   are observed. However, the affinity for NADPH decreases
FT                   slightly."
FT                   /evidence="ECO:0000269|PubMed:9694855"
FT   MUTAGEN         269
FT                   /note="R->N: No significant changes in affinity for p-OHB
FT                   are observed. However, the affinity for NADPH decreases
FT                   strongly."
FT                   /evidence="ECO:0000269|PubMed:9694855"
FT   MUTAGEN         269
FT                   /note="R->S: No significant changes in affinity for p-OHB
FT                   are observed. However, the affinity for NADPH decreases
FT                   slightly."
FT                   /evidence="ECO:0000269|PubMed:9694855"
FT   MUTAGEN         269
FT                   /note="R->T: No significant changes in affinity for p-OHB
FT                   are observed. However, the affinity for NADPH decreases
FT                   strongly."
FT                   /evidence="ECO:0000269|PubMed:9694855"
FT   MUTAGEN         269
FT                   /note="R->Y: No significant changes in affinity for p-OHB
FT                   are observed. However, the affinity for NADPH decreases
FT                   strongly."
FT                   /evidence="ECO:0000269|PubMed:9694855"
FT   CONFLICT        344
FT                   /note="W -> Y (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          4..8
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           12..23
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          28..31
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           36..40
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          47..49
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           50..58
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           63..68
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          70..79
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          82..87
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           88..91
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          97..99
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           102..116
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          119..121
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          125..130
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          134..136
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          138..143
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          146..151
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          153..157
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           164..167
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           171..173
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          175..192
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          195..198
FT                   /evidence="ECO:0007829|PDB:1BGN"
FT   STRAND          200..203
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          209..215
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          218..225
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           231..233
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           236..246
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           249..254
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          260..278
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   STRAND          281..283
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           285..287
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           293..295
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           298..318
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           322..327
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           328..350
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           358..371
FT                   /evidence="ECO:0007829|PDB:1PBE"
FT   HELIX           375..386
FT                   /evidence="ECO:0007829|PDB:1PBE"
SQ   SEQUENCE   394 AA;  44322 MW;  D29599224AC81E00 CRC64;
     MKTQVAIIGA GPSGLLLGQL LHKAGIDNVI LERQTPDYVL GRIRAGVLEQ GMVDLLREAG
     VDRRMARDGL VHEGVEIAFA GQRRRIDLKR LSGGKTVTVY GQTEVTRDLM EAREACGATT
     VYQAAEVRLH DLQGERPYVT FERDGERLRL DCDYIAGCDG FHGISRQSIP AERLKVFERV
     YPFGWLGLLA DTPPVSHELI YANHPRGFAL CSQRSATRSR YYVQVPLTEK VEDWSDERFW
     TELKARLPAE VAEKLVTGPS LEKSIAPLRS FVVEPMQHGR LFLAGDAAHI VPPTGAKGLN
     LAASDVSTLY RLLLKAYREG RGELLERYSA ICLRRIWKAE RFSWWMTSVL HRFPDTDAFS
     QRIQQTELEY YLGSEAGLAT IAENYVGLPY EEIE
//
ID   OXLA_GLOHA              Reviewed;         504 AA.
AC   Q6STF1;
DT   23-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   02-JUN-2021, entry version 79.
DE   RecName: Full=L-amino-acid oxidase {ECO:0000303|PubMed:15103157};
DE            Short=AHP-LAAO {ECO:0000303|PubMed:15103157};
DE            Short=LAO;
DE            EC=1.4.3.2 {ECO:0000269|PubMed:15103157};
DE   Flags: Precursor;
OS   Gloydius halys (Chinese water mocassin) (Agkistrodon halys).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC   Serpentes; Colubroidea; Viperidae; Crotalinae; Gloydius.
OX   NCBI_TaxID=8714;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Venom gland;
RA   Zhang H., Zhang T., Teng M., Niu L.;
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000312|PDB:1REO}
RP   X-RAY CRYSTALLOGRAPHY (2.31 ANGSTROMS) OF 19-504 IN COMPLEX WITH FAD,
RP   PARTIAL PROTEIN SEQUENCE, DISULFIDE BONDS, GLYCOSYLATION AT ASN-190 AND
RP   ASN-379, FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR
RP   LOCATION, CATALYTIC ACTIVITY, COFACTOR, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Venom;
RX   PubMed=15103157; DOI=10.1107/s0907444904000046;
RA   Zhang H., Teng M., Niu L., Wang Y., Wang Y., Liu Q., Huang Q., Hao Q.,
RA   Dong Y., Liu P.;
RT   "Purification, partial characterization, crystallization and structural
RT   determination of AHP-LAAO, a novel L-amino-acid oxidase with cell
RT   apoptosis-inducing activity from Agkistrodon halys pallas venom.";
RL   Acta Crystallogr. D 60:974-977(2004).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 19-504 IN COMPLEX WITH FAD AND
RP   SUBSTRATE ANALOGS, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-190 AND
RP   ASN-379.
RA   Zhang H., Teng M., Niu L.;
RT   "Structures of L-amino acid oxidase in complex with substrates and
RT   substrate analogue.";
RL   Submitted (MAY-2004) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes an oxidative deamination of predominantly
CC       hydrophobic and aromatic L-amino acids, thus producing hydrogen
CC       peroxide that may contribute to the diverse toxic effects of this
CC       enzyme (PubMed:15103157). Shows activity on L-Leu (PubMed:15103157).
CC       Exhibits diverse biological activities, such as hemorrhage, hemolysis,
CC       edema, antibacterial and antiparasitic activities, as well as
CC       regulation of platelet aggregation (By similarity). Its effect on
CC       platelets is controversial, since it either induces aggregation or
CC       inhibits agonist-induced aggregation (By similarity). These different
CC       effects are probably due to different experimental conditions (By
CC       similarity). This protein induces apoptosis of cultured HeLa cells
CC       (PubMed:15103157). {ECO:0000250|UniProtKB:P0CC17,
CC       ECO:0000269|PubMed:15103157}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an L-alpha-amino acid + H2O + O2 = a 2-oxocarboxylate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:13781, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:35179,
CC         ChEBI:CHEBI:59869; EC=1.4.3.2;
CC         Evidence={ECO:0000269|PubMed:15103157};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-leucine + O2 = 4-methyl-2-oxopentanoate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:60996, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:17865, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:57427; Evidence={ECO:0000269|PubMed:15103157};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:15103157};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.25 mM for L-Leu {ECO:0000269|PubMed:15103157};
CC       pH dependence:
CC         Optimum pH is 8.8. {ECO:0000269|PubMed:15103157};
CC   -!- SUBUNIT: Homodimer; non-covalently linked.
CC       {ECO:0000250|UniProtKB:P81382}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:15103157}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC       {ECO:0000305|PubMed:15103157}.
CC   -!- SIMILARITY: Belongs to the flavin monoamine oxidase family. FIG1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY450403; AAR20248.1; -; mRNA.
DR   PDB; 1REO; X-ray; 2.31 A; A=19-504.
DR   PDB; 1TDK; X-ray; 2.70 A; A=19-504.
DR   PDB; 1TDN; X-ray; 2.70 A; A=19-504.
DR   PDB; 1TDO; X-ray; 3.00 A; A=19-504.
DR   PDBsum; 1REO; -.
DR   PDBsum; 1TDK; -.
DR   PDBsum; 1TDN; -.
DR   PDBsum; 1TDO; -.
DR   SMR; Q6STF1; -.
DR   iPTMnet; Q6STF1; -.
DR   PRIDE; Q6STF1; -.
DR   EvolutionaryTrace; Q6STF1; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0001716; F:L-amino-acid oxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR   GO; GO:0044179; P:hemolysis in other organism; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic; Antimicrobial; Apoptosis; Cytolysis;
KW   Direct protein sequencing; Disulfide bond; FAD; Flavoprotein; Glycoprotein;
KW   Hemolysis; Hemorrhagic toxin; Hemostasis impairing toxin; Oxidoreductase;
KW   Secreted; Signal; Toxin.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000269|PubMed:15103157"
FT   CHAIN           19..504
FT                   /note="L-amino-acid oxidase"
FT                   /id="PRO_0000273563"
FT   NP_BIND         61..62
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15103157, ECO:0000269|Ref.3"
FT   NP_BIND         81..82
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15103157, ECO:0000269|Ref.3"
FT   NP_BIND         105..108
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15103157, ECO:0000269|Ref.3"
FT   NP_BIND         482..487
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15103157, ECO:0000269|Ref.3"
FT   REGION          482..483
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:P81382"
FT   BINDING         89
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15103157, ECO:0000269|Ref.3"
FT   BINDING         108
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|Ref.3, ECO:0007744|PDB:1TDK,
FT                   ECO:0007744|PDB:1TDN, ECO:0007744|PDB:1TDO"
FT   BINDING         241
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|Ref.3, ECO:0007744|PDB:1TDK"
FT   BINDING         279
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:15103157, ECO:0000269|Ref.3"
FT   BINDING         390
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|Ref.3, ECO:0007744|PDB:1TDN"
FT   BINDING         475
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15103157, ECO:0000269|Ref.3"
FT   CARBOHYD        190
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:15103157, ECO:0000269|Ref.3"
FT   CARBOHYD        379
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:15103157, ECO:0000269|Ref.3"
FT   DISULFID        28..191
FT                   /evidence="ECO:0000269|PubMed:15103157, ECO:0000269|Ref.3"
FT   DISULFID        349..430
FT                   /evidence="ECO:0000269|PubMed:15103157, ECO:0000269|Ref.3"
FT   HELIX           26..29
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           34..43
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          53..57
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           61..72
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          76..80
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          82..86
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          92..95
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   TURN            96..99
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          100..105
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          109..112
FT                   /evidence="ECO:0007829|PDB:1TDN"
FT   HELIX           114..122
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          127..129
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          137..141
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          144..147
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           148..153
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           155..158
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           164..166
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           171..178
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           180..188
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           191..197
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           198..200
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           203..209
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           215..224
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           228..230
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          231..234
FT                   /evidence="ECO:0007829|PDB:1TDO"
FT   HELIX           235..245
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          251..254
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           260..268
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           269..272
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          273..276
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          278..285
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          288..294
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          296..298
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          300..310
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           314..318
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          320..324
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           328..336
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          342..351
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           353..357
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          363..368
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          372..374
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          385..392
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           393..397
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   TURN            398..401
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           404..419
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           423..429
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          430..437
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           438..440
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   TURN            442..444
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          446..449
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           455..464
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          470..472
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           475..477
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   STRAND          478..480
FT                   /evidence="ECO:0007829|PDB:1REO"
FT   HELIX           484..503
FT                   /evidence="ECO:0007829|PDB:1REO"
SQ   SEQUENCE   504 AA;  57125 MW;  AEB034155184F0A7 CRC64;
     MNVFFMFSLL FLAALGSCAN DRNPLEECFR ETDYEEFLEI ARNGLKATSN PKHVVVVGAG
     MSGLSAAYVL SGAGHQVTVL EASERAGGRV RTYRNDKEDW YANLGPMRLP EKHRIVREYI
     RKFGLQLNEF SQENDNAWYF IKNIRKRVGE VKKDPGVLKY PVKPSEEGKS AGQLYEESLG
     KVVEELKRTN CSYILNKYDT YSTKEYLLKE GNLSPGAVDM IGDLMNEDSG YYVSFPESLR
     HDDIFAYEKR FDEIVGGMDK LPTSMYRAIE EKVHLNAQVI KIQKNAEKVT VVYQTPAKEM
     ASVTADYVIV CTTSRATRRI KFEPPLPPKK AHALRSVHYR SGTKIFLTCT KKFWEDEGIH
     GGKSTTDLPS RFIYYPNHNF TSGVGVIIAY GIGDDANFFQ ALDFKDCADI VINDLSLIHQ
     LPREEIQTFC YPSMIQKWSL DKYAMGGITT FTPYQFQHFS ESLTASVDRI YFAGEHTAEA
     HGWIDSTIKS GLRAARDVNR ASEQ
//
ID   NIA1_MAIZE              Reviewed;         621 AA.
AC   P17571;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 2.
DT   02-JUN-2021, entry version 152.
DE   RecName: Full=Nitrate reductase [NADH];
DE            Short=NR;
DE            EC=1.7.1.1;
DE   Flags: Fragment;
OS   Zea mays (Maize).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; Liliopsida; Poales; Poaceae; PACMAD clade;
OC   Panicoideae; Andropogonodae; Andropogoneae; Tripsacinae; Zea.
OX   NCBI_TaxID=4577;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. W64 X W128E; TISSUE=Leaf;
RX   PubMed=16666879; DOI=10.1104/pp.90.3.792;
RA   Gowri G., Campbell W.H.;
RT   "cDNA clones for corn leaf NADH: nitrate reductase and chloroplast
RT   NAD(P)(+): glyceraldehyde-3-phosphate dehydrogenase.";
RL   Plant Physiol. 90:792-798(1989).
RN   [2]
RP   SEQUENCE REVISION TO 389-390; 405-406 AND 414-417, AND CHARACTERIZATION.
RC   STRAIN=cv. W64 X W128E; TISSUE=Leaf;
RX   PubMed=2189408; DOI=10.1016/0006-291x(90)91168-r;
RA   Hyde G.E., Campbell W.H.;
RT   "High-level expression in Escherichia coli of the catalytically active
RT   flavin domain of corn leaf NADH:nitrate reductase and its comparison to
RT   human NADH:cytochrome B5 reductase.";
RL   Biochem. Biophys. Res. Commun. 168:1285-1291(1990).
RN   [3]
RP   SECONDARY STRUCTURE OF FAD DOMAIN.
RX   PubMed=1748631;
RA   Hyde G.E., Crawford N.M., Campbell W.H.;
RT   "The sequence of squash NADH:nitrate reductase and its relationship to the
RT   sequences of other flavoprotein oxidoreductases. A family of flavoprotein
RT   pyridine nucleotide cytochrome reductases.";
RL   J. Biol. Chem. 266:23542-23547(1991).
RN   [4]
RP   MUTAGENESIS OF CYS-593.
RX   PubMed=8188655;
RA   Dwivedi U.N., Shiraishi N., Campbell W.H.;
RT   "Identification of an 'essential' cysteine of nitrate reductase via
RT   mutagenesis of its recombinant cytochrome b reductase domain.";
RL   J. Biol. Chem. 269:13785-13791(1994).
RN   [5] {ECO:0007744|PDB:2CND}
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 352-621 IN COMPLEX WITH FAD, AND
RP   COFACTOR.
RX   PubMed=7812715; DOI=10.1016/s0969-2126(94)00082-4;
RA   Lu G., Campbell W.H., Schneider G., Lindqvist Y.;
RT   "Crystal structure of the FAD-containing fragment of corn nitrate reductase
RT   at 2.5-A resolution: relationship to other flavoprotein reductases.";
RL   Structure 2:809-821(1994).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 232-501.
RX   PubMed=7760334; DOI=10.1006/jmbi.1995.0273;
RA   Lu G., Lindqvist Y., Schneider G., Dwivedi U., Campbell W.H.;
RT   "Structural studies on corn nitrate reductase: refined structure of the
RT   cytochrome b reductase fragment at 2.5 A, its ADP complex and an active-
RT   site mutant and modeling of the cytochrome b domain.";
RL   J. Mol. Biol. 248:931-948(1995).
CC   -!- FUNCTION: Nitrate reductase is a key enzyme involved in the first step
CC       of nitrate assimilation in plants, fungi and bacteria.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NAD(+) + nitrite = H(+) + NADH + nitrate;
CC         Xref=Rhea:RHEA:17913, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16301, ChEBI:CHEBI:17632, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.7.1.1;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:7812715};
CC       Note=Binds 1 FAD. {ECO:0000269|PubMed:7812715};
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC       Note=Binds 1 heme group. The heme group is called cytochrome b-557.;
CC   -!- COFACTOR:
CC       Name=Mo-molybdopterin; Xref=ChEBI:CHEBI:71302; Evidence={ECO:0000250};
CC       Note=Binds 1 Mo-molybdopterin (Mo-MPT) cofactor per subunit.
CC       {ECO:0000250};
CC   -!- SUBUNIT: Homodimer.
CC   -!- SIMILARITY: Belongs to the nitrate reductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M27821; AAA03202.1; ALT_SEQ; mRNA.
DR   PIR; S19254; S19254.
DR   PDB; 1CNE; X-ray; 3.00 A; A=352-621.
DR   PDB; 1CNF; X-ray; 2.70 A; A=352-621.
DR   PDB; 2CND; X-ray; 2.50 A; A=352-621.
DR   PDBsum; 1CNE; -.
DR   PDBsum; 1CNF; -.
DR   PDBsum; 2CND; -.
DR   SMR; P17571; -.
DR   STRING; 4577.GRMZM2G568636_P01; -.
DR   iPTMnet; P17571; -.
DR   PaxDb; P17571; -.
DR   PRIDE; P17571; -.
DR   MaizeGDB; 25899; -.
DR   eggNOG; KOG0534; Eukaryota.
DR   eggNOG; KOG0535; Eukaryota.
DR   eggNOG; KOG0537; Eukaryota.
DR   BRENDA; 1.7.1.1; 6752.
DR   EvolutionaryTrace; P17571; -.
DR   Proteomes; UP000007305; Unplaced.
DR   ExpressionAtlas; P17571; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0030151; F:molybdenum ion binding; IEA:InterPro.
DR   GO; GO:0009703; F:nitrate reductase (NADH) activity; IDA:UniProtKB.
DR   GO; GO:0042128; P:nitrate assimilation; IDA:UniProtKB.
DR   GO; GO:0006809; P:nitric oxide biosynthetic process; IBA:GO_Central.
DR   Gene3D; 3.10.120.10; -; 1.
DR   Gene3D; 3.40.50.80; -; 1.
DR   Gene3D; 3.90.420.10; -; 1.
DR   InterPro; IPR001834; CBR-like.
DR   InterPro; IPR008333; Cbr1-like_FAD-bd_dom.
DR   InterPro; IPR001199; Cyt_B5-like_heme/steroid-bd.
DR   InterPro; IPR036400; Cyt_B5-like_heme/steroid_sf.
DR   InterPro; IPR018506; Cyt_B5_heme-BS.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR005066; MoCF_OxRdtse_dimer.
DR   InterPro; IPR008335; Mopterin_OxRdtase_euk.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR000572; OxRdtase_Mopterin-bd_dom.
DR   InterPro; IPR036374; OxRdtase_Mopterin-bd_sf.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF00173; Cyt-b5; 1.
DR   Pfam; PF00970; FAD_binding_6; 1.
DR   Pfam; PF03404; Mo-co_dimer; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   Pfam; PF00174; Oxidored_molyb; 1.
DR   PRINTS; PR00406; CYTB5RDTASE.
DR   PRINTS; PR00363; CYTOCHROMEB5.
DR   PRINTS; PR00407; EUMOPTERIN.
DR   PRINTS; PR00371; FPNCR.
DR   SMART; SM01117; Cyt-b5; 1.
DR   SUPFAM; SSF52343; SSF52343; 1.
DR   SUPFAM; SSF55856; SSF55856; 1.
DR   SUPFAM; SSF56524; SSF56524; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS00191; CYTOCHROME_B5_1; 1.
DR   PROSITE; PS50255; CYTOCHROME_B5_2; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; FAD; Flavoprotein; Heme; Iron; Metal-binding;
KW   Molybdenum; NAD; Nitrate assimilation; Oxidoreductase; Reference proteome.
FT   CHAIN           <1..621
FT                   /note="Nitrate reductase [NADH]"
FT                   /id="PRO_0000166062"
FT   DOMAIN          249..324
FT                   /note="Cytochrome b5 heme-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00279"
FT   DOMAIN          361..473
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   NP_BIND         413..416
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7812715,
FT                   ECO:0007744|PDB:2CND"
FT   NP_BIND         430..432
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7812715,
FT                   ECO:0007744|PDB:2CND"
FT   NP_BIND         447..449
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7812715,
FT                   ECO:0007744|PDB:2CND"
FT   METAL           284
FT                   /note="Iron (heme axial ligand)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00279"
FT   METAL           307
FT                   /note="Iron (heme axial ligand)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00279"
FT   BINDING         435
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:7812715,
FT                   ECO:0007744|PDB:2CND"
FT   BINDING         497
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7812715,
FT                   ECO:0007744|PDB:2CND"
FT   BINDING         500
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7812715,
FT                   ECO:0007744|PDB:2CND"
FT   SITE            593
FT                   /note="Necessary for efficient electron Transfer"
FT   DISULFID        138
FT                   /note="Interchain"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         593
FT                   /note="C->S: Reduction of activity."
FT                   /evidence="ECO:0000269|PubMed:8188655"
FT   NON_TER         1
FT   STRAND          364..375
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          378..384
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          399..406
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          409..415
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          425..432
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          436..438
FT                   /evidence="ECO:0007829|PDB:1CNF"
FT   HELIX           447..454
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          460..467
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          469..471
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          474..476
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          478..480
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          483..485
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          488..495
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   HELIX           496..498
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   HELIX           499..511
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   TURN            512..515
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          519..527
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   HELIX           529..531
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   HELIX           535..544
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   TURN            546..548
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          549..556
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   HELIX           561..563
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          567..571
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   HELIX           574..580
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          585..593
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   HELIX           596..600
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   TURN            601..603
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   HELIX           604..608
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   TURN            609..611
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   HELIX           614..617
FT                   /evidence="ECO:0007829|PDB:2CND"
FT   STRAND          618..620
FT                   /evidence="ECO:0007829|PDB:2CND"
SQ   SEQUENCE   621 AA;  69773 MW;  ACC276E4ED0FF5D3 CRC64;
     GFPVRVIIPG CIGGRMVKWL KRIIVTPAES DNYYHFKDNR VLPSHVDAEL ANAEAWWYKP
     EYIINELNIN SVITTPCHDE ILPINAFTTQ RPYTLKGYAY SGGGKKVTRV EVTLDGGETW
     LVCTDHPEKP TKYGKYWCWC FWSLEVEVLD LLSAKEIAVR AWDESLNTQP EKLIWNVMGM
     MNNCWFRVKT NVCKPHKGEI GIVFDHPTLP GNESGGWMAK EKHLETAEAA APGLKRSTST
     PFMNTTDVGK EFTMSEVRKH ASQESAWIVV HGHVYDCTKF LKDHPGGADS ILINAGTDCT
     EEFDAIHSDK AKALLDTYRI GELITTGTGY SSDNSVHGGS VLSHLAPIRR AVRAPALSNP
     REKIHCRLVG KKELSRDVRL FRFSLPSPDQ VLGLPIGKHI FVCASIEGKL CMRAYTPTSM
     VDEIGHFDLL VKVYFKNEHP KFPNGGLMTQ YLDSLPVGSY IDVKGPLGHV EYTGRGSFVI
     NGKQRHASRL AMICGGSGIT PMYQIIQAVL RDQPEDHTEM HLVYANRTED DILLRDELDR
     WAAEYPDRLK VWYVIDQVKR PEEGWKYSVG FVTEAVLREH VPEGGDDTLA LACGPPPMIQ
     FAISPNLEKM KYDMANSFVV F
//
ID   OTEMO_PSEPU             Reviewed;         545 AA.
AC   H3JQW0; M5AXJ6;
DT   01-MAY-2013, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2012, sequence version 1.
DT   02-JUN-2021, entry version 30.
DE   RecName: Full=2-oxo-Delta(3)-4,5,5-trimethylcyclopentenylacetyl-CoA monooxygenase;
DE            Short=OTEMO;
DE            EC=1.14.13.160;
DE   AltName: Full=(2,2,3-trimethyl-5-oxocyclopent-3-enyl)acetyl-CoA 1,5-monooxygenase;
DE   AltName: Full=MO2;
GN   Name=otemo; Synonyms=camG {ECO:0000303|PubMed:23524667};
OS   Pseudomonas putida (Arthrobacter siderocapsulatus).
OG   Plasmid CAM.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=303;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND SUBSTRATE SPECIFICITY.
RC   STRAIN=ATCC 17453 / DSM 50198 / JCM 6157 / NCIMB 10007 / NRRL B-4067 /
RC   Stanier 77 / Biotype A;
RX   PubMed=22286514; DOI=10.1007/s00253-011-3859-1;
RA   Kadow M., Loschinski K., Sass S., Schmidt M., Bornscheuer U.T.;
RT   "Completing the series of BVMOs involved in camphor metabolism of
RT   Pseudomonas putida NCIMB 10007 by identification of the two missing genes,
RT   their functional expression in E. coli, and biochemical characterization.";
RL   Appl. Microbiol. Biotechnol. 96:419-429(2012).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 17453 / DSM 50198 / JCM 6157 / NCIMB 10007 / NRRL B-4067 /
RC   Stanier 77 / Biotype A;
RX   PubMed=23524667; DOI=10.1128/aem.03958-12;
RA   Iwaki H., Grosse S., Bergeron H., Leisch H., Morley K., Hasegawa Y.,
RA   Lau P.C.K.;
RT   "Camphor pathway redux: functional recombinant expression of 2,5- and 3,6-
RT   diketocamphane monooxygenases of Pseudomonas putida ATCC 17453 with their
RT   cognate flavin reductase catalyzing Baeyer-Villiger reactions.";
RL   Appl. Environ. Microbiol. 79:3282-3293(2013).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, INDUCTION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   COFACTOR, AND SUBUNIT.
RX   PubMed=6848481; DOI=10.1128/jb.153.1.140-152.1983;
RA   Ougham H.J., Taylor D.G., Trudgill P.W.;
RT   "Camphor revisited: involvement of a unique monooxygenase in metabolism of
RT   2-oxo-delta 3-4,5,5-trimethylcyclopentenylacetic acid by Pseudomonas
RT   putida.";
RL   J. Bacteriol. 153:140-152(1983).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.04 ANGSTROMS) IN COMPLEX WITH FAD AND NADP,
RP   FUNCTION, MUTAGENESIS OF TYR-53; ASP-59 AND ARG-337, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBSTRATE SPECIFICITY, COFACTOR, AND SUBUNIT.
RC   STRAIN=ATCC 17453 / DSM 50198 / JCM 6157 / NCIMB 10007 / NRRL B-4067 /
RC   Stanier 77 / Biotype A;
RX   PubMed=22267661; DOI=10.1128/aem.07694-11;
RA   Leisch H., Shi R., Grosse S., Morley K., Bergeron H., Cygler M., Iwaki H.,
RA   Hasegawa Y., Lau P.C.K.;
RT   "Cloning, Baeyer-Villiger biooxidations, and structures of the camphor
RT   pathway 2-oxo-Delta(3)-4,5,5-trimethylcyclopentenylacetyl-coenzyme A
RT   monooxygenase of Pseudomonas putida ATCC 17453.";
RL   Appl. Environ. Microbiol. 78:2200-2212(2012).
CC   -!- FUNCTION: Involved in the degradation of (+)-camphor. Catalyzes the
CC       lactonization of 2-oxo-delta(3)-4,5, 5-trimethylcyclopentenylacetyl-CoA
CC       (OT-CoA), a key intermediate in the metabolism of camphor. 2-
CC       Oxocyclopentyl ethyl acetate is also a good substrate, as is 2-
CC       oxocyclohexyl ethyl acetate and methyl-substituted cyclohexanones, but
CC       free acid is a poor substrate. {ECO:0000269|PubMed:22267661,
CC       ECO:0000269|PubMed:22286514, ECO:0000269|PubMed:6848481}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[(1R)-2,2,3-trimethyl-5-oxocyclopent-3-enyl]acetyl-CoA + H(+)
CC         + NADPH + O2 = [(2R)-3,3,4-trimethyl-6-oxo-3,6-dihydro-1H-pyran-2-
CC         yl]acetyl-CoA + H2O + NADP(+); Xref=Rhea:RHEA:33015,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:64784,
CC         ChEBI:CHEBI:64785; EC=1.14.13.160;
CC         Evidence={ECO:0000269|PubMed:22286514, ECO:0000269|PubMed:6848481};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:22267661, ECO:0000269|PubMed:6848481};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:22267661,
CC       ECO:0000269|PubMed:6848481};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.018 mM for OT-CoA (at pH 9 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:22267661, ECO:0000269|PubMed:22286514,
CC         ECO:0000269|PubMed:6848481};
CC         KM=0.032 mM for 2-n-hexyl cyclopentanone (at pH 9 and at 25 degrees
CC         Celsius) {ECO:0000269|PubMed:22267661, ECO:0000269|PubMed:22286514,
CC         ECO:0000269|PubMed:6848481};
CC         KM=0.16 mM for 2-oxocyclohexyl ethyl acetate (at pH 9 and at 25
CC         degrees Celsius) {ECO:0000269|PubMed:22267661,
CC         ECO:0000269|PubMed:22286514, ECO:0000269|PubMed:6848481};
CC         KM=0.31 mM for 2-oxocyclopentyl ethyl acetate (at pH 9 and at 25
CC         degrees Celsius) {ECO:0000269|PubMed:22267661,
CC         ECO:0000269|PubMed:22286514, ECO:0000269|PubMed:6848481};
CC         KM=0.6 mM for 4-methyl cyclohexanone (at pH 9 and at 25 degrees
CC         Celsius) {ECO:0000269|PubMed:22267661, ECO:0000269|PubMed:22286514,
CC         ECO:0000269|PubMed:6848481};
CC         KM=1.4 mM for 2-methyl cyclohexanone (at pH 9 and at 25 degrees
CC         Celsius) {ECO:0000269|PubMed:22267661, ECO:0000269|PubMed:22286514,
CC         ECO:0000269|PubMed:6848481};
CC       pH dependence:
CC         Optimum pH is 9. {ECO:0000269|PubMed:22267661,
CC         ECO:0000269|PubMed:22286514, ECO:0000269|PubMed:6848481};
CC       Temperature dependence:
CC         Optimum temperature is 20 degrees Celsius.
CC         {ECO:0000269|PubMed:22267661, ECO:0000269|PubMed:22286514,
CC         ECO:0000269|PubMed:6848481};
CC   -!- PATHWAY: Terpene metabolism; (R)-camphor degradation.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:22267661,
CC       ECO:0000269|PubMed:6848481}.
CC   -!- INDUCTION: Induced by (+)-camphor and 2-oxo-delta(3)-4,5,5-
CC       trimethylcyclopentenylacetic acid. {ECO:0000269|PubMed:6848481}.
CC   -!- SIMILARITY: Belongs to the FAD-binding monooxygenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JQ034405; AEZ35248.1; -; Genomic_DNA.
DR   EMBL; AB771747; BAN13280.1; -; Genomic_DNA.
DR   PDB; 3UOV; X-ray; 2.04 A; A/B=1-545.
DR   PDB; 3UOX; X-ray; 1.96 A; A/B=1-545.
DR   PDB; 3UOY; X-ray; 2.00 A; A/B=1-545.
DR   PDB; 3UOZ; X-ray; 2.41 A; A/B=1-545.
DR   PDB; 3UP4; X-ray; 2.80 A; A/B=1-545.
DR   PDB; 3UP5; X-ray; 2.45 A; A/B=1-545.
DR   PDBsum; 3UOV; -.
DR   PDBsum; 3UOX; -.
DR   PDBsum; 3UOY; -.
DR   PDBsum; 3UOZ; -.
DR   PDBsum; 3UP4; -.
DR   PDBsum; 3UP5; -.
DR   SMR; H3JQW0; -.
DR   KEGG; ag:AEZ35248; -.
DR   KEGG; ag:BAN13280; -.
DR   BRENDA; 1.14.13.160; 5092.
DR   UniPathway; UPA00719; -.
DR   GO; GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW.
DR   GO; GO:0019383; P:(+)-camphor catabolic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF51905; SSF51905; 2.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Monooxygenase; NADP; Oxidoreductase;
KW   Plasmid.
FT   CHAIN           1..545
FT                   /note="2-oxo-Delta(3)-4,5,5-trimethylcyclopentenylacetyl-
FT                   CoA monooxygenase"
FT                   /id="PRO_0000422223"
FT   NP_BIND         47..50
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   NP_BIND         57..59
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   NP_BIND         59..60
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   NP_BIND         193..199
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   NP_BIND         216..217
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   BINDING         20
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   BINDING         39
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   BINDING         65
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   BINDING         112
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   BINDING         446
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   BINDING         501
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   SITE            337
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   MUTAGEN         53
FT                   /note="Y->A: Loss of monooxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   MUTAGEN         53
FT                   /note="Y->F: Retains 32% of monooxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   MUTAGEN         59
FT                   /note="D->A: Loss of monooxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   MUTAGEN         59
FT                   /note="D->N: Loss of monooxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   MUTAGEN         337
FT                   /note="R->A: Loss of monooxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   MUTAGEN         337
FT                   /note="R->K: Loss of monooxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:22267661"
FT   STRAND          9..15
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           19..30
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          35..38
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          40..44
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           47..50
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           62..65
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           67..70
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          80..83
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           86..100
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           103..105
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          106..109
FT                   /evidence="ECO:0007829|PDB:3UOZ"
FT   STRAND          112..118
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           119..121
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          123..128
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   TURN            129..131
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          132..141
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           157..159
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          162..166
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           167..169
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          174..176
FT                   /evidence="ECO:0007829|PDB:3UOV"
FT   STRAND          178..180
FT                   /evidence="ECO:0007829|PDB:3UOZ"
FT   STRAND          187..191
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           195..204
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   TURN            205..207
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          208..217
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           231..239
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           241..248
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          251..256
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          260..262
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           264..266
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           269..281
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          282..284
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           286..289
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          290..292
FT                   /evidence="ECO:0007829|PDB:3UOZ"
FT   TURN            293..297
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           299..316
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           320..325
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          329..331
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          340..343
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           344..347
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          353..357
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   TURN            358..360
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          363..367
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          370..375
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          377..379
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          381..385
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          390..393
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           395..398
FT                   /evidence="ECO:0007829|PDB:3UOY"
FT   STRAND          399..402
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           404..406
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           409..412
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   TURN            413..415
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   TURN            421..423
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          431..433
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           437..439
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           441..443
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           446..467
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          472..474
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           476..491
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           495..498
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           500..502
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          503..507
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          509..511
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          513..519
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   HELIX           524..536
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   TURN            537..541
FT                   /evidence="ECO:0007829|PDB:3UOX"
FT   STRAND          542..544
FT                   /evidence="ECO:0007829|PDB:3UOX"
SQ   SEQUENCE   545 AA;  61374 MW;  4ABB95E87E817D8D CRC64;
     MSNRAKSPAL DAVVIGAGVT GIYQAFLINQ AGMKVLGIEA GEDVGGTWYW NRYPGCRLDT
     ESYAYGYFAL KGIIPEWEWS ENFASQPEML RYVNRAADAM DVRKHYRFNT RVTAARYVEN
     DRLWEVTLDN EEVVTCRFLI SATGPLSASR MPDIKGIDSF KGESFHSSRW PTDAEGAPKG
     VDFTGKRVGV IGTGATGVQI IPIAAETAKE LYVFQRTPNW CTPLGNSPMS KEKMDSLRNR
     YPTILEYVKS TDTAFPYHRD PRKGTDVSES ERDAFFEELY RQPGYGIWLS GFRDLLLNKE
     SNKFLADFVA KKIRQRVKDP VVAEKLIPKD HPFGAKRVPM ETNYYETYNR DNVHLVDIRE
     APIQEVTPEG IKTADAAYDL DVIIYATGFD AVTGSLDRID IRGKDNVRLI DAWAEGPSTY
     LGLQARGFPN FFTLVGPHNG STFCNVGVCG GLQAEWVLRM ISYMKDNGFT YSEPTQAAEN
     RWTEEVYADF SRTLLAEANA WWVKTTTKPD GSVVRRTLVH VSGGPEYRKR CEQVAYNNYN
     GFELA
//
ID   NCPPR_PYRHO             Reviewed;         445 AA.
AC   O58308;
DT   27-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   02-JUN-2021, entry version 131.
DE   RecName: Full=NAD(P)H coenzyme A polysulfide/persulfide reductase {ECO:0000305};
DE            EC=1.8.1.- {ECO:0000269|PubMed:23530771};
DE   AltName: Full=Coenzyme A disulfide reductase {ECO:0000303|PubMed:15720393, ECO:0000303|PubMed:23530771};
DE            Short=CoA-disulfide reductase {ECO:0000305};
DE            Short=CoADR {ECO:0000303|PubMed:15720393};
DE            EC=1.8.1.14 {ECO:0000269|PubMed:15720393};
DE   AltName: Full=Polysulfide reductase {ECO:0000303|PubMed:23530771};
GN   OrderedLocusNames=PH0572;
OS   Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC
OS   100139 / OT-3).
OC   Archaea; Euryarchaeota; Thermococci; Thermococcales; Thermococcaceae;
OC   Pyrococcus.
OX   NCBI_TaxID=70601;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3;
RX   PubMed=9679194; DOI=10.1093/dnares/5.2.55;
RA   Kawarabayasi Y., Sawada M., Horikawa H., Haikawa Y., Hino Y., Yamamoto S.,
RA   Sekine M., Baba S., Kosugi H., Hosoyama A., Nagai Y., Sakai M., Ogura K.,
RA   Otsuka R., Nakazawa H., Takamiya M., Ohfuku Y., Funahashi T., Tanaka T.,
RA   Kudoh Y., Yamazaki J., Kushida N., Oguchi A., Aoki K., Yoshizawa T.,
RA   Nakamura Y., Robb F.T., Horikoshi K., Masuchi Y., Shizuya H., Kikuchi H.;
RT   "Complete sequence and gene organization of the genome of a hyper-
RT   thermophilic archaebacterium, Pyrococcus horikoshii OT3.";
RL   DNA Res. 5:55-76(1998).
RN   [2]
RP   FUNCTION AS A COA-DISULFIDE REDUCTASE, CATALYTIC ACTIVITY, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=15720393; DOI=10.1111/j.1742-4658.2005.04555.x;
RA   Harris D.R., Ward D.E., Feasel J.M., Lancaster K.M., Murphy R.D.,
RA   Mallet T.C., Crane E.J. III;
RT   "Discovery and characterization of a coenzyme A disulfide reductase from
RT   Pyrococcus horikoshii. Implications for this disulfide metabolism of
RT   anaerobic hyperthermophiles.";
RL   FEBS J. 272:1189-1200(2005).
RN   [3] {ECO:0007744|PDB:3KD9}
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 7-444.
RA   Agarwal R., Burley S.K., Swaminathan S.;
RT   "Crystal structure of pyridine nucleotide disulfide oxidoreductase from
RT   Pyrococcus horikoshii.";
RL   Submitted (OCT-2009) to the PDB data bank.
RN   [4] {ECO:0007744|PDB:4FX9}
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) IN COMPLEX WITH COENZYME A AND FAD,
RP   FUNCTION, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND DOMAIN.
RX   PubMed=23530771; DOI=10.1021/bi3014399;
RA   Herwald S., Liu A.Y., Zhu B.E., Sea K.W., Lopez K.M., Sazinsky M.H.,
RA   Crane E.J.;
RT   "Structure and substrate specificity of the pyrococcal coenzyme A disulfide
RT   reductases/polysulfide reductases (CoADR/Psr): implications for S(0)-based
RT   respiration and a sulfur-dependent antioxidant system in Pyrococcus.";
RL   Biochemistry 52:2764-2773(2013).
RN   [5] {ECO:0007744|PDB:5L1N}
RP   X-RAY CRYSTALLOGRAPHY (3.60 ANGSTROMS) OF QUADRUPLE MUTANT IN COMPLEX WITH
RP   COENZYME A AND FAD, AND DOMAIN.
RX   PubMed=29988575; DOI=10.1002/2211-5463.12439;
RA   Sea K., Lee J., To D., Chen B., Sazinsky M.H., Crane E.J.;
RT   "A broader active site in Pyrococcus horikoshii CoA disulfide reductase
RT   accommodates larger substrates and reveals evidence of subunit asymmetry.";
RL   FEBS Open Bio 8:1083-1092(2018).
CC   -!- FUNCTION: Catalyzes the NAD(P)H-dependent reduction of polysulfide,
CC       CoA-polysulfides, and CoA persulfide, as well as the reduction of a
CC       range of other small persulfides, including TNB and glutathione
CC       persulfides. The likely in vivo substrates are di-, poly-, and
CC       persulfide derivatives of coenzyme A, although polysulfide itself is
CC       also efficiently reduced (PubMed:23530771). Shows coenzyme A disulfide
CC       reductase (CoADR) activity with both NADH and NADPH, with a preference
CC       for NADPH (PubMed:15720393). May also play a role in the reduction of
CC       elemental sulfur (PubMed:23530771). {ECO:0000269|PubMed:15720393,
CC       ECO:0000269|PubMed:23530771}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 CoA + NADP(+) = CoA-disulfide + H(+) + NADPH;
CC         Xref=Rhea:RHEA:14705, ChEBI:CHEBI:15378, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:62209; EC=1.8.1.14;
CC         Evidence={ECO:0000269|PubMed:15720393};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 CoA + NAD(+) = CoA-disulfide + H(+) + NADH;
CC         Xref=Rhea:RHEA:14701, ChEBI:CHEBI:15378, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:62209;
CC         Evidence={ECO:0000269|PubMed:15720393};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:15720393, ECO:0000269|PubMed:23530771};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:23530771};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=73 uM for NADH {ECO:0000269|PubMed:15720393};
CC         KM=20.5 uM for CoA persulfide (in the presence of NADH)
CC         {ECO:0000269|PubMed:23530771};
CC         KM=56.2 uM for CoA persulfide (in the presence of NADPH)
CC         {ECO:0000269|PubMed:23530771};
CC         KM=13.9 uM for NADH (in the presence of CoA persulfide)
CC         {ECO:0000269|PubMed:23530771};
CC         KM=12.7 uM for NADPH (in the presence of CoA persulfide)
CC         {ECO:0000269|PubMed:23530771};
CC         KM=94.9 uM for CoA polysulfide (in the presence of NADH)
CC         {ECO:0000269|PubMed:23530771};
CC         KM=125 uM for NADH (in the presence of CoA polysulfide)
CC         {ECO:0000269|PubMed:23530771};
CC         KM=14.1 uM for NADPH (in the presence of CoA polysulfide)
CC         {ECO:0000269|PubMed:23530771};
CC         KM=12.3 uM for polysulfide (in the presence of NADH)
CC         {ECO:0000269|PubMed:23530771};
CC         KM=25.1 uM for TNB persulfide (in the presence of NADH)
CC         {ECO:0000269|PubMed:23530771};
CC         KM=129 uM for DTNB (in the presence of NADH)
CC         {ECO:0000269|PubMed:23530771};
CC         Note=kcat is 1.11 sec(-1) with CoA persulfide as substrate (in the
CC         presence of NADH). kcat is 1.50 sec(-1) with CoA persulfide as
CC         substrate (in the presence of NADPH). kcat is 1.07 sec(-1) with NADH
CC         as substrate (in the presence of CoA persulfide). kcat is 2.08 sec(-
CC         1) with NADPH as substrate (in the presence of CoA persulfide). kcat
CC         is 6.56 sec(-1) with CoA polysulfide as substrate (in the presence of
CC         NADH). kcat is 8.86 sec(-1) with NADH as substrate (in the presence
CC         of CoA polysulfide). kcat is 16.1 sec(-1) with NADPH as substrate (in
CC         the presence of CoA polysulfide). kcat is 1.04 sec(-1) with
CC         polysulfide as substrate (in the presence of NADH). kcat is 3.37
CC         sec(-1) with TNB persulfide as substrate (in the presence of NADH).
CC         kcat is 0.69 sec(-1) with DTNB as substrate (in the presence of
CC         NADH). {ECO:0000269|PubMed:23530771};
CC       Temperature dependence:
CC         Optimum temperature is 85 degrees Celsius. Thermostable.
CC         {ECO:0000269|PubMed:15720393};
CC   -!- SUBUNIT: Homodimer (PubMed:23530771). Homotetramer (PubMed:15720393).
CC       {ECO:0000269|PubMed:15720393, ECO:0000269|PubMed:23530771}.
CC   -!- DOMAIN: When compared to homologous enzymes known to reduce CoA
CC       disulfide, this enzyme shows a narrower access channel for CoA
CC       substrates, which suggests that this restriction might be responsible
CC       for the enzyme's poor activity toward the bulky CoA disulfide substrate
CC       (PubMed:23530771). The substrate channel was widened by making four
CC       mutations along the channel wall (Y65A, Y66A, P67G, and H367G), leading
CC       to a fourfold increase in kcat for the NAD(P)H-dependent reduction of
CC       CoA disulfide and enhanced activity toward the substrate at lower
CC       temperatures (PubMed:29988575). It suggests that substrate channel
CC       morphology is an important determinant of substrate specificity for
CC       this family of pyridine nucleotide disulfide oxidoreductase (PNDOR)
CC       enzymes (PubMed:29988575). {ECO:0000269|PubMed:23530771,
CC       ECO:0000269|PubMed:29988575}.
CC   -!- SIMILARITY: Belongs to the class-III pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BA000001; BAA29661.1; -; Genomic_DNA.
DR   PIR; H71171; H71171.
DR   PDB; 3KD9; X-ray; 2.75 A; A/B/C=7-444.
DR   PDB; 4FX9; X-ray; 2.70 A; A/B=1-445.
DR   PDB; 5L1N; X-ray; 3.60 A; A/B=1-445.
DR   PDBsum; 3KD9; -.
DR   PDBsum; 4FX9; -.
DR   PDBsum; 5L1N; -.
DR   SMR; O58308; -.
DR   STRING; 70601.3256978; -.
DR   EnsemblBacteria; BAA29661; BAA29661; BAA29661.
DR   KEGG; pho:PH0572; -.
DR   eggNOG; arCOG01069; Archaea.
DR   OMA; WVSHAPC; -.
DR   BRENDA; 1.8.1.14; 5244.
DR   SABIO-RK; O58308; -.
DR   EvolutionaryTrace; O58308; -.
DR   Proteomes; UP000000752; Chromosome.
DR   GO; GO:0050451; F:CoA-disulfide reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0050661; F:NADP binding; IEA:InterPro.
DR   GO; GO:0003756; F:protein disulfide isomerase activity; IEA:InterPro.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   Gene3D; 3.50.50.60; -; 3.
DR   InterPro; IPR017758; CoA_disulphide_reductase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
DR   TIGRFAMs; TIGR03385; CoA_CoA_reduc; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; NAD; NADP; Oxidoreductase;
KW   Redox-active center.
FT   CHAIN           1..445
FT                   /note="NAD(P)H coenzyme A polysulfide/persulfide reductase"
FT                   /id="PRO_0000184699"
FT   NP_BIND         16..17
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23530771,
FT                   ECO:0000269|PubMed:29988575, ECO:0007744|PDB:4FX9"
FT   NP_BIND         38..39
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23530771,
FT                   ECO:0000269|PubMed:29988575, ECO:0007744|PDB:4FX9"
FT   NP_BIND         45..47
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23530771,
FT                   ECO:0000269|PubMed:29988575, ECO:0007744|PDB:4FX9"
FT   REGION          44..48
FT                   /note="Coenzyme A binding"
FT                   /evidence="ECO:0000269|PubMed:23530771,
FT                   ECO:0000269|PubMed:29988575, ECO:0007744|PDB:4FX9"
FT   REGION          65..66
FT                   /note="Coenzyme A binding"
FT                   /evidence="ECO:0000269|PubMed:23530771,
FT                   ECO:0007744|PDB:4FX9"
FT   ACT_SITE        48
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000305|PubMed:23530771"
FT   BINDING         27
FT                   /note="Coenzyme A"
FT                   /evidence="ECO:0000269|PubMed:23530771,
FT                   ECO:0000269|PubMed:29988575, ECO:0007744|PDB:4FX9"
FT   BINDING         75
FT                   /note="Coenzyme A"
FT                   /evidence="ECO:0000269|PubMed:23530771,
FT                   ECO:0000269|PubMed:29988575, ECO:0007744|PDB:4FX9"
FT   BINDING         85
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:23530771,
FT                   ECO:0000269|PubMed:29988575, ECO:0007744|PDB:4FX9"
FT   BINDING         283
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23530771,
FT                   ECO:0000269|PubMed:29988575, ECO:0007744|PDB:4FX9"
FT   BINDING         301
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:23530771,
FT                   ECO:0007744|PDB:4FX9"
FT   BINDING         305
FT                   /note="Coenzyme A"
FT                   /evidence="ECO:0000269|PubMed:23530771,
FT                   ECO:0000269|PubMed:29988575, ECO:0007744|PDB:4FX9"
FT   BINDING         361
FT                   /note="Coenzyme A; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:23530771,
FT                   ECO:0000269|PubMed:29988575, ECO:0007744|PDB:4FX9"
FT   BINDING         425
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:23530771,
FT                   ECO:0000269|PubMed:29988575, ECO:0007744|PDB:4FX9"
FT   BINDING         433
FT                   /note="Coenzyme A"
FT                   /evidence="ECO:0000269|PubMed:23530771,
FT                   ECO:0000269|PubMed:29988575, ECO:0007744|PDB:4FX9"
FT   BINDING         441
FT                   /note="Coenzyme A"
FT                   /evidence="ECO:0000269|PubMed:23530771,
FT                   ECO:0000269|PubMed:29988575, ECO:0007744|PDB:4FX9"
FT   STRAND          8..12
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   HELIX           16..28
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          32..37
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          39..41
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          43..45
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   HELIX           47..49
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   HELIX           50..54
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   HELIX           60..63
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          64..66
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   HELIX           68..72
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   TURN            73..75
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          78..80
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          84..89
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          92..96
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          103..105
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          107..111
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          115..117
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   TURN            124..126
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   HELIX           136..148
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          153..157
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   HELIX           161..171
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   TURN            172..174
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          176..180
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          182..185
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   TURN            186..190
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   HELIX           193..206
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          207..210
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          215..231
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          233..235
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          237..241
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          245..247
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   HELIX           250..253
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   TURN            254..256
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          263..266
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          278..280
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   HELIX           282..284
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          285..289
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   TURN            290..292
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   HELIX           301..315
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          329..333
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          336..342
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   HELIX           345..350
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          355..365
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          367..370
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          374..382
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   TURN            383..385
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   STRAND          387..397
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   HELIX           399..411
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   HELIX           415..419
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   TURN            427..429
FT                   /evidence="ECO:0007829|PDB:4FX9"
FT   HELIX           435..443
FT                   /evidence="ECO:0007829|PDB:4FX9"
SQ   SEQUENCE   445 AA;  48977 MW;  896A034000A0B233 CRC64;
     MGENMKKKVV IIGGGAAGMS AASRVKRLKP EWDVKVFEAT EWVSHAPCGI PYVVEGLSTP
     DKLMYYPPEV FIKKRGIDLH LNAEVIEVDT GYVRVRENGG EKSYEWDYLV FANGASPQVP
     AIEGVNLKGV FTADLPPDAL AIREYMEKYK VENVVIIGGG YIGIEMAEAF AAQGKNVTMI
     VRGERVLRRS FDKEVTDILE EKLKKHVNLR LQEITMKIEG EERVEKVVTD AGEYKAELVI
     LATGIKPNIE LAKQLGVRIG ETGAIWTNEK MQTSVENVYA AGDVAETRHV ITGRRVWVPL
     APAGNKMGYV AGSNIAGKEL HFPGVLGTAV TKFMDVEIGK TGLTEMEALK EGYDVRTAFI
     KASTRPHYYP GGREIWLKGV VDNETNRLLG VQVVGSDILP RIDTAAAMLM AGFTTKDAFF
     TDLAYAPPFA PVWDPLIVLA RVLKF
//
ID   NDH_STAA8               Reviewed;         402 AA.
AC   Q2FZV7;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2006, sequence version 1.
DT   02-JUN-2021, entry version 89.
DE   RecName: Full=Type II NADH:quinone oxidoreductase {ECO:0000303|PubMed:25849513};
DE            EC=1.6.5.9 {ECO:0000269|PubMed:26172206, ECO:0000269|PubMed:28801048, ECO:0000269|PubMed:29524843};
DE   AltName: Full=NDH-2 {ECO:0000303|PubMed:26172206};
GN   OrderedLocusNames=SAOUHSC_00878;
OS   Staphylococcus aureus (strain NCTC 8325 / PS 47).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC   Staphylococcus.
OX   NCBI_TaxID=93061;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NCTC 8325 / PS 47;
RA   Gillaspy A.F., Worrell V., Orvis J., Roe B.A., Dyer D.W., Iandolo J.J.;
RT   "The Staphylococcus aureus NCTC 8325 genome.";
RL   (In) Fischetti V., Novick R., Ferretti J., Portnoy D., Rood J. (eds.);
RL   Gram positive pathogens, 2nd edition, pp.381-412, ASM Press, Washington
RL   D.C. (2006).
RN   [2]
RP   COFACTOR, SUBUNIT, SUBCELLULAR LOCATION, AND CRYSTALLIZATION.
RC   STRAIN=NCTC 8325 / PS 47;
RX   PubMed=25849513; DOI=10.1107/s2053230x15005178;
RA   Rosario A.L., Sena F.V., Batista A.P., Oliveira T.F., Athayde D.,
RA   Pereira M.M., Brito J.A., Archer M.;
RT   "Expression, purification, crystallization and preliminary X-ray
RT   diffraction analysis of a type II NADH:quinone oxidoreductase from the
RT   human pathogen Staphylococcus aureus.";
RL   Acta Crystallogr. F Struct. Biol. Commun. 71:477-482(2015).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ACTIVITY REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, SUBCELLULAR LOCATION, AND DOMAIN.
RC   STRAIN=NCTC 8325 / PS 47;
RX   PubMed=26172206; DOI=10.1111/mmi.13120;
RA   Sena F.V., Batista A.P., Catarino T., Brito J.A., Archer M., Viertler M.,
RA   Madl T., Cabrita E.J., Pereira M.M.;
RT   "Type-II NADH:quinone oxidoreductase from Staphylococcus aureus has two
RT   distinct binding sites and is rate limited by quinone reduction.";
RL   Mol. Microbiol. 98:272-288(2015).
RN   [4]
RP   REACTION MECHANISM, ACTIVE SITE, AND DOMAIN.
RX   PubMed=28181562; DOI=10.1038/srep42303;
RA   Marreiros B.C., Sena F.V., Sousa F.M., Oliveira A.S., Soares C.M.,
RA   Batista A.P., Pereira M.M.;
RT   "Structural and functional insights into the catalytic mechanism of the
RT   type II NADH:quinone oxidoreductase family.";
RL   Sci. Rep. 7:42303-42303(2017).
RN   [5]
RP   CATALYTIC ACTIVITY, AND ACTIVITY REGULATION.
RC   STRAIN=NCTC 8325 / PS 47;
RX   PubMed=29524843; DOI=10.1016/j.redox.2018.02.004;
RA   Sena F.V., Sousa F.M., Oliveira A.S.F., Soares C.M., Catarino T.,
RA   Pereira M.M.;
RT   "Regulation of the mechanism of Type-II NADH: Quinone oxidoreductase from
RT   S. aureus.";
RL   Redox Biol. 16:209-214(2018).
RN   [6] {ECO:0007744|PDB:5NA1, ECO:0007744|PDB:5NA4}
RP   X-RAY CRYSTALLOGRAPHY (2.32 ANGSTROMS) OF WILD-TYPE AND MUTANT SER-172 IN
RP   COMPLEXES WITH FAD, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ACTIVE SITE,
RP   AND MUTAGENESIS OF GLU-172.
RC   STRAIN=NCTC 8325 / PS 47;
RX   PubMed=28801048; DOI=10.1016/j.bbabio.2017.08.002;
RA   Sousa F.M., Sena F.V., Batista A.P., Athayde D., Brito J.A., Archer M.,
RA   Oliveira A.S.F., Soares C.M., Catarino T., Pereira M.M.;
RT   "The key role of glutamate 172 in the mechanism of type II NADH:quinone
RT   oxidoreductase of Staphylococcus aureus.";
RL   Biochim. Biophys. Acta 1858:823-832(2017).
CC   -!- FUNCTION: Alternative, nonproton pumping NADH:quinone oxidoreductase
CC       that delivers electrons to the respiratory chain by oxidation of NADH
CC       and reduction of quinones, and contributes to the regeneration of
CC       NAD(+) (PubMed:26172206, PubMed:28801048). Can use DMN, a menaquinone
CC       analog, 2,3-dimethoxy-5,6-dimethyl-benzoquinone (DDB), an ubiquinone
CC       analog, or 2,3,5,6-tetramethyl-1,4-benzoquinone (Duroquinone, DQ) a
CC       plastoquinone analog as electron acceptors (PubMed:26172206).
CC       {ECO:0000269|PubMed:26172206, ECO:0000269|PubMed:28801048}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADH = a quinol + NAD(+);
CC         Xref=Rhea:RHEA:46160, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:132124; EC=1.6.5.9;
CC         Evidence={ECO:0000269|PubMed:26172206, ECO:0000269|PubMed:28801048,
CC         ECO:0000269|PubMed:29524843};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a menaquinone + H(+) + NADH = a menaquinol + NAD(+);
CC         Xref=Rhea:RHEA:29235, Rhea:RHEA-COMP:9537, Rhea:RHEA-COMP:9539,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16374, ChEBI:CHEBI:18151,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         Evidence={ECO:0000269|PubMed:26172206};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ubiquinone + H(+) + NADH = a ubiquinol + NAD(+);
CC         Xref=Rhea:RHEA:23152, Rhea:RHEA-COMP:9565, Rhea:RHEA-COMP:9566,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16389, ChEBI:CHEBI:17976,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         Evidence={ECO:0000269|PubMed:26172206};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:25849513, ECO:0000269|PubMed:26172206,
CC         ECO:0000269|PubMed:28801048};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:26172206,
CC       ECO:0000269|PubMed:28801048};
CC   -!- ACTIVITY REGULATION: Inhibited by HQNO, a quinone derivative.
CC       {ECO:0000269|PubMed:26172206, ECO:0000269|PubMed:29524843}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=69.9 uM for DMN {ECO:0000269|PubMed:26172206};
CC         KM=63.7 uM for DDB {ECO:0000269|PubMed:26172206};
CC         KM=55.4 uM for DQ {ECO:0000269|PubMed:26172206};
CC         KM=20.5 uM for NADH {ECO:0000269|PubMed:26172206};
CC         Vmax=132.7 umol/min/mg enzyme with DMN as substrate
CC         {ECO:0000269|PubMed:26172206};
CC         Vmax=129.3 umol/min/mg enzyme with DDB as substrate
CC         {ECO:0000269|PubMed:26172206};
CC         Vmax=119.1 umol/min/mg enzyme with DQ as substrate
CC         {ECO:0000269|PubMed:26172206};
CC         Vmax=175.9 umol/min/mg enzyme with NADH as substrate
CC         {ECO:0000269|PubMed:26172206};
CC         Note=kcat is 67.9 sec(-1) with DMN as substrate. kcat is 69.4 sec(-1)
CC         with DDB as substrate. kcat is 68.2 sec(-1) with DQ as substrate.
CC         {ECO:0000269|PubMed:26172206};
CC   -!- SUBUNIT: Homodimer in solution (PubMed:25849513, PubMed:26172206).
CC       Forms homotetramers; dimer of dimers (PubMed:25849513,
CC       PubMed:26172206). {ECO:0000269|PubMed:25849513,
CC       ECO:0000269|PubMed:26172206}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:25849513,
CC       ECO:0000269|PubMed:26172206}. Note=Interacts with the membrane via an
CC       anti-parallel three-stranded beta-sheet followed by two helices
CC       arranged in a helix-turn-helix motif at the C-terminal region.
CC       {ECO:0000269|PubMed:26172206}.
CC   -!- DOMAIN: Contains a first dinucleotide binding domain, which harbors
CC       FAD, a second dinucleotide binding domain, which interacts with NADH
CC       and C-terminal domain that provides anchoring to the membrane
CC       (PubMed:28801048). A long discussion has taken place about whether NADH
CC       and the quinone bind to the same or to different sites. Structural
CC       studies clearly indicate the presence of distinct binding sites for the
CC       two substrates (PubMed:26172206, PubMed:28181562).
CC       {ECO:0000269|PubMed:26172206, ECO:0000269|PubMed:28181562,
CC       ECO:0000269|PubMed:28801048}.
CC   -!- SIMILARITY: Belongs to the NADH dehydrogenase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000253; ABD30003.1; -; Genomic_DNA.
DR   RefSeq; WP_000046076.1; NZ_LS483365.1.
DR   RefSeq; YP_499431.1; NC_007795.1.
DR   PDB; 5NA1; X-ray; 2.32 A; A=1-402.
DR   PDB; 5NA4; X-ray; 2.55 A; A=1-402.
DR   PDBsum; 5NA1; -.
DR   PDBsum; 5NA4; -.
DR   SMR; Q2FZV7; -.
DR   STRING; 1280.SAXN108_0936; -.
DR   EnsemblBacteria; ABD30003; ABD30003; SAOUHSC_00878.
DR   GeneID; 3919225; -.
DR   KEGG; sao:SAOUHSC_00878; -.
DR   PATRIC; fig|93061.5.peg.798; -.
DR   eggNOG; COG1252; Bacteria.
DR   HOGENOM; CLU_021377_7_2_9; -.
DR   OMA; DHCIFLD; -.
DR   PRO; PR:Q2FZV7; -.
DR   Proteomes; UP000008816; Chromosome.
DR   GO; GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; IBA:GO_Central.
DR   GO; GO:0019646; P:aerobic electron transport chain; IBA:GO_Central.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF51905; SSF51905; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; FAD; Flavoprotein; Membrane; NAD;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN           1..402
FT                   /note="Type II NADH:quinone oxidoreductase"
FT                   /id="PRO_0000287371"
FT   NP_BIND         12..16
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   NP_BIND         39..40
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   NP_BIND         319..320
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   ACT_SITE        172
FT                   /evidence="ECO:0000305|PubMed:28181562,
FT                   ECO:0000305|PubMed:28801048"
FT   BINDING         83
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   BINDING         302
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   BINDING         379
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   MUTAGEN         172
FT                   /note="E->A: 3.4-fold decrease in kcat for DMN. Decreases
FT                   the overall affinity for NAD(+) and the quinone."
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   MUTAGEN         172
FT                   /note="E->D: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   MUTAGEN         172
FT                   /note="E->Q: 12-fold decrease in kcat for DMN. Decreases
FT                   the overall affinity for NAD(+) and the quinone."
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   MUTAGEN         172
FT                   /note="E->S: 6-fold decrease in kcat for DMN. Decreases the
FT                   overall affinity for NAD(+) and the quinone."
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   STRAND          6..11
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           15..27
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   TURN            30..32
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          33..45
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           47..49
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           50..55
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           60..63
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          64..67
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           68..70
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   TURN            73..75
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          76..80
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          83..87
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   TURN            88..91
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          92..95
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          98..101
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          103..107
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           121..124
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           131..150
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           156..159
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          160..164
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           168..188
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           192..194
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          196..200
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          202..207
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           212..224
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          227..230
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          235..239
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          242..247
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          250..255
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          257..261
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          265..267
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           270..274
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          275..279
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          282..284
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          289..291
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          294..299
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           301..303
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           319..337
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          351..355
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          357..359
FT                   /evidence="ECO:0007829|PDB:5NA4"
FT   STRAND          361..365
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          368..371
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           373..399
FT                   /evidence="ECO:0007829|PDB:5NA1"
SQ   SEQUENCE   402 AA;  44104 MW;  2C3DE4D5098C2D53 CRC64;
     MAQDRKKVLV LGAGYAGLQT VTKLQKAIST EEAEITLINK NEYHYEATWL HEASAGTLNY
     EDVLYPVESV LKKDKVNFVQ AEVTKIDRDA KKVETNQGIY DFDILVVALG FVSETFGIEG
     MKDHAFQIEN VITARELSRH IEDKFANYAA SKEKDDNDLS ILVGGAGFTG VEFLGELTDR
     IPELCSKYGV DQNKVKITCV EAAPKMLPMF SEELVNHAVS YLEDRGVEFK IATPIVACNE
     KGFVVEVDGE KQQLNAGTSV WAAGVRGSKL MEESFEGVKR GRIVTKQDLT INGYDNIFVI
     GDCSAFIPAG EERPLPTTAQ IAMQQGESVA KNIKRILNGE STEEFEYVDR GTVCSLGSHD
     GVGMVFGKPI AGKKAAFMKK VIDTRAVFKI GGIGLAFKKG KF
//
ID   NQO1_HUMAN              Reviewed;         274 AA.
AC   P15559; B2R5Y9; B4DNM7; B7ZAD1; Q86UK1;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   02-JUN-2021, entry version 220.
DE   RecName: Full=NAD(P)H dehydrogenase [quinone] 1;
DE            EC=1.6.5.2;
DE   AltName: Full=Azoreductase;
DE   AltName: Full=DT-diaphorase;
DE            Short=DTD;
DE   AltName: Full=Menadione reductase;
DE   AltName: Full=NAD(P)H:quinone oxidoreductase 1;
DE   AltName: Full=Phylloquinone reductase;
DE   AltName: Full=Quinone reductase 1;
DE            Short=QR1;
GN   Name=NQO1; Synonyms=DIA4, NMOR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=2843525;
RA   Jaiswal A.K., McBride O.W., Adesnik M., Nebert D.W.;
RT   "Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA
RT   sequence and localization of gene to chromosome 16.";
RL   J. Biol. Chem. 263:13572-13578(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND INDUCTION.
RX   PubMed=1657151; DOI=10.1021/bi00108a007;
RA   Jaiswal A.K.;
RT   "Human NAD(P)H:quinone oxidoreductase (NQO1) gene structure and induction
RT   by dioxin.";
RL   Biochemistry 30:10647-10653(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-187.
RG   NIEHS SNPs program;
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND VARIANT
RP   SER-187.
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   INTERACTION WITH PDLIM4, AND INDUCTION.
RX   PubMed=21636573; DOI=10.1074/jbc.m111.241554;
RA   Guryanova O.A., Drazba J.A., Frolova E.I., Chumakov P.M.;
RT   "Actin cytoskeleton remodeling by the alternatively spliced isoform of
RT   PDLIM4/RIL protein.";
RL   J. Biol. Chem. 286:26849-26859(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-250 AND LYS-251, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 4-274 IN COMPLEX WITH FAD, AND
RP   SUBUNIT.
RX   PubMed=10543876; DOI=10.1021/jm991060m;
RA   Skelly J.V., Sanderson M.R., Suter D.A., Baumann U., Read M.A.,
RA   Gregory D.S.J., Bennett M., Hobbs S.M., Neidle S.;
RT   "Crystal structure of human DT-diaphorase: a model for interaction with the
RT   cytotoxic prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954).";
RL   J. Med. Chem. 42:4325-4330(1999).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH FAD AND DUROQUINONE.
RX   PubMed=10706635; DOI=10.1073/pnas.97.7.3177;
RA   Faig M., Bianchet M.A., Talalay P., Chen S., Winski S., Ross D.,
RA   Amzel L.M.;
RT   "Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases:
RT   species comparison and structural changes with substrate binding and
RT   release.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:3177-3182(2000).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH FAD AND THE INHIBITOR
RP   ES936, AND MASS SPECTROMETRY.
RX   PubMed=11735396; DOI=10.1021/bi011324i;
RA   Winski S.L., Faig M., Bianchet M.A., Siegel D., Swann E., Fung K.,
RA   Duncan M.W., Moody C.J., Amzel L.M., Ross D.;
RT   "Characterization of a mechanism-based inhibitor of NAD(P)H:quinone
RT   oxidoreductase 1 by biochemical, X-ray crystallographic, and mass
RT   spectrometric approaches.";
RL   Biochemistry 40:15135-15142(2001).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEXES WITH FAD AND INHIBITORS,
RP   AND SUBUNIT.
RX   PubMed=11587640; DOI=10.1016/s0969-2126(01)00636-0;
RA   Faig M., Bianchet M.A., Winski S., Hargreaves R., Moody C.J., Hudnott A.R.,
RA   Ross D., Amzel L.M.;
RT   "Structure-based development of anticancer drugs: complexes of
RT   NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones.";
RL   Structure 9:659-667(2001).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) IN COMPLEX WITH THE INHIBITOR
RP   DICOUMAROL.
RX   PubMed=16700548; DOI=10.1021/bi0600087;
RA   Asher G., Dym O., Tsvetkov P., Adler J., Shaul Y.;
RT   "The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with
RT   its potent inhibitor dicoumarol.";
RL   Biochemistry 45:6372-6378(2006).
RN   [17]
RP   VARIANT SER-187.
RX   PubMed=1737339;
RA   Traver R.D., Horikoshi T., Danenberg K.D., Stadlbauer T.H., Danenberg P.V.,
RA   Ross D., Gibson N.W.;
RT   "NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma
RT   cells: characterization of a mutation which modulates DT-diaphorase
RT   activity and mitomycin sensitivity.";
RL   Cancer Res. 52:797-802(1992).
RN   [18]
RP   VARIANT SER-187.
RX   PubMed=10447260;
RX   DOI=10.1002/(sici)1098-1004(1999)14:1<67::aid-humu8>3.0.co;2-5;
RA   Kristiansen O.P., Larsen Z.M., Johannesen J., Nerup J., Mandrup-Poulsen T.,
RA   Pociot F.;
RT   "No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase
RT   (NQO1/DIA4) and type 1 diabetes in the Danish population.";
RL   Hum. Mutat. 14:67-70(1999).
CC   -!- FUNCTION: The enzyme apparently serves as a quinone reductase in
CC       connection with conjugation reactions of hydroquinons involved in
CC       detoxification pathways as well as in biosynthetic processes such as
CC       the vitamin K-dependent gamma-carboxylation of glutamate residues in
CC       prothrombin synthesis.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADH = a quinol + NAD(+);
CC         Xref=Rhea:RHEA:46160, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:132124; EC=1.6.5.2;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADPH = a quinol + NADP(+);
CC         Xref=Rhea:RHEA:46164, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:132124; EC=1.6.5.2;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- ACTIVITY REGULATION: Inhibited by dicoumarol.
CC   -!- SUBUNIT: Homodimer (PubMed:10543876, PubMed:10706635, PubMed:11735396,
CC       PubMed:11587640, PubMed:16700548). Interacts with PDLIM4 isoform 2;
CC       this interaction stabilizes PDLIM4 isoform 2 in response to oxidative
CC       stress and protects it from ubiquitin-independent degradation by the
CC       core 20S proteasome (PubMed:21636573). {ECO:0000269|PubMed:10543876,
CC       ECO:0000269|PubMed:10706635, ECO:0000269|PubMed:11587640,
CC       ECO:0000269|PubMed:11735396, ECO:0000269|PubMed:16700548,
CC       ECO:0000269|PubMed:21636573}.
CC   -!- INTERACTION:
CC       P15559; P07902: GALT; NbExp=3; IntAct=EBI-3989435, EBI-750827;
CC       P15559; Q9UK53: ING1; NbExp=3; IntAct=EBI-3989435, EBI-399198;
CC       P15559; P15559: NQO1; NbExp=5; IntAct=EBI-3989435, EBI-3989435;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P15559-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P15559-2; Sequence=VSP_042716;
CC       Name=3;
CC         IsoId=P15559-3; Sequence=VSP_044446;
CC   -!- INDUCTION: By dioxin (PubMed:1657151). By oxidative stress
CC       (PubMed:21636573). {ECO:0000269|PubMed:1657151,
CC       ECO:0000269|PubMed:21636573}.
CC   -!- MASS SPECTROMETRY: Mass=30864; Mass_error=6; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:11735396};
CC   -!- POLYMORPHISM: The Ser-187 polymorphism may be linked to susceptibility
CC       to forms of cancers.
CC   -!- MISCELLANEOUS: Quinone reductase accepts electrons from both NADH and
CC       NADPH with equal efficiency.
CC   -!- SIMILARITY: Belongs to the NAD(P)H dehydrogenase (quinone) family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NQO1ID375.html";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/nqo1/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J03934; AAA59940.1; -; mRNA.
DR   EMBL; M81600; AAB60701.1; -; Genomic_DNA.
DR   EMBL; M81596; AAB60701.1; JOINED; Genomic_DNA.
DR   EMBL; M81597; AAB60701.1; JOINED; Genomic_DNA.
DR   EMBL; M81598; AAB60701.1; JOINED; Genomic_DNA.
DR   EMBL; M81599; AAB60701.1; JOINED; Genomic_DNA.
DR   EMBL; AY281093; AAP20940.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AK297979; BAG60289.1; -; mRNA.
DR   EMBL; AK312368; BAG35286.1; -; mRNA.
DR   EMBL; AK316246; BAH14617.1; -; mRNA.
DR   EMBL; AC092115; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471092; EAW83283.1; -; Genomic_DNA.
DR   EMBL; CH471092; EAW83284.1; -; Genomic_DNA.
DR   EMBL; BC007659; AAH07659.1; -; mRNA.
DR   CCDS; CCDS10883.1; -. [P15559-1]
DR   CCDS; CCDS32471.1; -. [P15559-3]
DR   CCDS; CCDS32472.1; -. [P15559-2]
DR   PIR; A41135; A30879.
DR   RefSeq; NP_000894.1; NM_000903.2. [P15559-1]
DR   RefSeq; NP_001020604.1; NM_001025433.1. [P15559-2]
DR   RefSeq; NP_001020605.1; NM_001025434.1. [P15559-3]
DR   PDB; 1D4A; X-ray; 1.70 A; A/B/C/D=2-274.
DR   PDB; 1DXO; X-ray; 2.50 A; A/B/C/D=2-274.
DR   PDB; 1GG5; X-ray; 2.50 A; A/B/C/D=2-274.
DR   PDB; 1H66; X-ray; 2.00 A; A/B/C/D=3-274.
DR   PDB; 1H69; X-ray; 1.86 A; A/B/C/D=3-274.
DR   PDB; 1KBO; X-ray; 2.30 A; A/B/C/D=2-274.
DR   PDB; 1KBQ; X-ray; 1.80 A; A/B/C/D=2-274.
DR   PDB; 1QBG; X-ray; 2.30 A; A/B/C/D=4-274.
DR   PDB; 2F1O; X-ray; 2.75 A; A/B/C/D/E/F/G/H=2-274.
DR   PDB; 3JSX; X-ray; 2.45 A; A/B/C/D/E/F/G/H=2-274.
DR   PDB; 4CET; X-ray; 2.20 A; A=1-274.
DR   PDB; 4CF6; X-ray; 2.69 A; A/B=1-274.
DR   PDB; 5A4K; X-ray; 2.09 A; A/B/C/D=1-274.
DR   PDB; 5EA2; X-ray; 2.01 A; A/C/E/G=1-273.
DR   PDB; 5EAI; X-ray; 2.90 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-274.
DR   PDB; 5FUQ; X-ray; 2.04 A; A/B=1-274.
DR   PDB; 6FY4; X-ray; 2.76 A; A/B/C/D=1-274.
DR   PDB; 6LLC; X-ray; 2.50 A; A/B/C/D/E/F/G/H/I/J/K/L=2-274.
DR   PDBsum; 1D4A; -.
DR   PDBsum; 1DXO; -.
DR   PDBsum; 1GG5; -.
DR   PDBsum; 1H66; -.
DR   PDBsum; 1H69; -.
DR   PDBsum; 1KBO; -.
DR   PDBsum; 1KBQ; -.
DR   PDBsum; 1QBG; -.
DR   PDBsum; 2F1O; -.
DR   PDBsum; 3JSX; -.
DR   PDBsum; 4CET; -.
DR   PDBsum; 4CF6; -.
DR   PDBsum; 5A4K; -.
DR   PDBsum; 5EA2; -.
DR   PDBsum; 5EAI; -.
DR   PDBsum; 5FUQ; -.
DR   PDBsum; 6FY4; -.
DR   PDBsum; 6LLC; -.
DR   SMR; P15559; -.
DR   BioGRID; 108072; 56.
DR   DIP; DIP-24210N; -.
DR   IntAct; P15559; 8.
DR   MINT; P15559; -.
DR   STRING; 9606.ENSP00000319788; -.
DR   BindingDB; P15559; -.
DR   ChEMBL; CHEMBL3623; -.
DR   DrugBank; DB07385; 3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE.
DR   DrugBank; DB02395; 3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol.
DR   DrugBank; DB03626; 5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione.
DR   DrugBank; DB14001; alpha-Tocopherol succinate.
DR   DrugBank; DB04392; Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone].
DR   DrugBank; DB09061; Cannabidiol.
DR   DrugBank; DB00958; Carboplatin.
DR   DrugBank; DB02633; Cibacron Blue.
DR   DrugBank; DB00515; Cisplatin.
DR   DrugBank; DB14002; D-alpha-Tocopherol acetate.
DR   DrugBank; DB00266; Dicoumarol.
DR   DrugBank; DB00997; Doxorubicin.
DR   DrugBank; DB01927; Duroquinone.
DR   DrugBank; DB02400; ES-936.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB00170; Menadione.
DR   DrugBank; DB00526; Oxaliplatin.
DR   DrugBank; DB00252; Phenytoin.
DR   DrugBank; DB04090; RH-1.
DR   DrugBank; DB00163; Vitamin E.
DR   DrugCentral; P15559; -.
DR   iPTMnet; P15559; -.
DR   MetOSite; P15559; -.
DR   PhosphoSitePlus; P15559; -.
DR   SwissPalm; P15559; -.
DR   BioMuta; NQO1; -.
DR   DMDM; 118607; -.
DR   EPD; P15559; -.
DR   jPOST; P15559; -.
DR   MassIVE; P15559; -.
DR   MaxQB; P15559; -.
DR   PaxDb; P15559; -.
DR   PeptideAtlas; P15559; -.
DR   PRIDE; P15559; -.
DR   ProteomicsDB; 12688; -. [P15559-2]
DR   ProteomicsDB; 53187; -. [P15559-1]
DR   ProteomicsDB; 53188; -. [P15559-2]
DR   TopDownProteomics; P15559-1; -. [P15559-1]
DR   Antibodypedia; 1549; 803 antibodies.
DR   DNASU; 1728; -.
DR   Ensembl; ENST00000320623; ENSP00000319788; ENSG00000181019. [P15559-1]
DR   Ensembl; ENST00000379046; ENSP00000368334; ENSG00000181019. [P15559-3]
DR   Ensembl; ENST00000379047; ENSP00000368335; ENSG00000181019. [P15559-2]
DR   GeneID; 1728; -.
DR   KEGG; hsa:1728; -.
DR   UCSC; uc002exp.5; human. [P15559-1]
DR   CTD; 1728; -.
DR   DisGeNET; 1728; -.
DR   GeneCards; NQO1; -.
DR   HGNC; HGNC:2874; NQO1.
DR   HPA; ENSG00000181019; Tissue enhanced (stomach).
DR   MIM; 125860; gene.
DR   neXtProt; NX_P15559; -.
DR   OpenTargets; ENSG00000181019; -.
DR   PharmGKB; PA31744; -.
DR   VEuPathDB; HostDB:ENSG00000181019.12; -.
DR   eggNOG; ENOG502QQMI; Eukaryota.
DR   GeneTree; ENSGT00940000159150; -.
DR   InParanoid; P15559; -.
DR   OMA; WFERVLV; -.
DR   OrthoDB; 1394543at2759; -.
DR   PhylomeDB; P15559; -.
DR   TreeFam; TF300296; -.
DR   BioCyc; MetaCyc:HS11566-MONOMER; -.
DR   BRENDA; 1.6.5.2; 2681.
DR   PathwayCommons; P15559; -.
DR   Reactome; R-HSA-350562; Regulation of ornithine decarboxylase (ODC).
DR   SABIO-RK; P15559; -.
DR   SIGNOR; P15559; -.
DR   BioGRID-ORCS; 1728; 9 hits in 995 CRISPR screens.
DR   ChiTaRS; NQO1; human.
DR   EvolutionaryTrace; P15559; -.
DR   GeneWiki; NAD(P)H_dehydrogenase_(quinone_1); -.
DR   GenomeRNAi; 1728; -.
DR   Pharos; P15559; Tchem.
DR   PRO; PR:P15559; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; P15559; protein.
DR   Bgee; ENSG00000181019; Expressed in stomach and 231 other tissues.
DR   ExpressionAtlas; P15559; baseline and differential.
DR   Genevisible; P15559; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:CAFA.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0045202; C:synapse; IEA:GOC.
DR   GO; GO:0004128; F:cytochrome-b5 reductase activity, acting on NAD(P)H; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; IBA:GO_Central.
DR   GO; GO:0050136; F:NADH dehydrogenase (quinone) activity; IEA:RHEA.
DR   GO; GO:0008753; F:NADPH dehydrogenase (quinone) activity; IEA:RHEA.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0004784; F:superoxide dismutase activity; IEA:Ensembl.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0045454; P:cell redox homeostasis; IEP:UniProtKB.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0071248; P:cellular response to metal ion; IEA:Ensembl.
DR   GO; GO:0006116; P:NADH oxidation; IEA:Ensembl.
DR   GO; GO:0070995; P:NADPH oxidation; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0043086; P:negative regulation of catalytic activity; IEA:Ensembl.
DR   GO; GO:0006809; P:nitric oxide biosynthetic process; TAS:ProtInc.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome.
DR   GO; GO:0043279; P:response to alkaloid; IEA:Ensembl.
DR   GO; GO:0014075; P:response to amine; IEA:Ensembl.
DR   GO; GO:0009743; P:response to carbohydrate; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0051602; P:response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:1905395; P:response to flavonoid; IEA:Ensembl.
DR   GO; GO:0009725; P:response to hormone; IEA:Ensembl.
DR   GO; GO:1904880; P:response to hydrogen sulfide; IEA:Ensembl.
DR   GO; GO:0002931; P:response to ischemia; IEA:Ensembl.
DR   GO; GO:1904844; P:response to L-glutamine; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; IEP:UniProtKB.
DR   GO; GO:0033574; P:response to testosterone; IEA:Ensembl.
DR   GO; GO:1904772; P:response to tetrachloromethane; IEA:Ensembl.
DR   GO; GO:0009636; P:response to toxic substance; TAS:ProtInc.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; TAS:ProtInc.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:ProtInc.
DR   Gene3D; 3.40.50.360; -; 1.
DR   InterPro; IPR003680; Flavodoxin_fold.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   Pfam; PF02525; Flavodoxin_2; 1.
DR   SUPFAM; SSF52218; SSF52218; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; FAD; Flavoprotein;
KW   Isopeptide bond; NAD; NADP; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN           1..274
FT                   /note="NAD(P)H dehydrogenase [quinone] 1"
FT                   /id="PRO_0000071622"
FT   NP_BIND         18..19
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10543876,
FT                   ECO:0000269|PubMed:10706635, ECO:0000269|PubMed:11735396"
FT   NP_BIND         104..107
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10543876,
FT                   ECO:0000269|PubMed:10706635, ECO:0000269|PubMed:11735396"
FT   NP_BIND         148..151
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10543876,
FT                   ECO:0000269|PubMed:10706635, ECO:0000269|PubMed:11735396"
FT   REGION          126..128
FT                   /note="Substrate binding"
FT   BINDING         12
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10543876,
FT                   ECO:0000269|PubMed:10706635, ECO:0000269|PubMed:11735396"
FT   BINDING         67
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10543876,
FT                   ECO:0000269|PubMed:10706635, ECO:0000269|PubMed:11735396"
FT   BINDING         156
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10543876,
FT                   ECO:0000269|PubMed:10706635, ECO:0000269|PubMed:11735396"
FT   BINDING         201
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10543876,
FT                   ECO:0000269|PubMed:10706635, ECO:0000269|PubMed:11735396"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   CROSSLNK        250
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        251
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         102..139
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044446"
FT   VAR_SEQ         140..173
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042716"
FT   VARIANT         139
FT                   /note="R -> W (in dbSNP:rs1131341)"
FT                   /id="VAR_016170"
FT   VARIANT         187
FT                   /note="P -> S (lack of activity; dbSNP:rs1800566)"
FT                   /evidence="ECO:0000269|PubMed:10447260,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:1737339,
FT                   ECO:0000269|Ref.3"
FT                   /id="VAR_008384"
FT   VARIANT         269
FT                   /note="Q -> H (in dbSNP:rs34447156)"
FT                   /id="VAR_050220"
FT   CONFLICT        252
FT                   /note="F -> S (in Ref. 4; BAG60289)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..10
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   STRAND          15..17
FT                   /evidence="ECO:0007829|PDB:1QBG"
FT   HELIX           18..32
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   STRAND          36..41
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   TURN            42..46
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   HELIX           53..55
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   STRAND          56..58
FT                   /evidence="ECO:0007829|PDB:5EA2"
FT   HELIX           63..65
FT                   /evidence="ECO:0007829|PDB:5EA2"
FT   HELIX           68..78
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   HELIX           83..94
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   STRAND          96..103
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   STRAND          106..108
FT                   /evidence="ECO:0007829|PDB:4CET"
FT   HELIX           111..120
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   TURN            124..126
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   HELIX           129..131
FT                   /evidence="ECO:0007829|PDB:1H69"
FT   HELIX           133..135
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   TURN            137..140
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   STRAND          142..148
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   HELIX           154..156
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   STRAND          160..162
FT                   /evidence="ECO:0007829|PDB:1H69"
FT   HELIX           165..173
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   TURN            174..177
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   HELIX           178..180
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   STRAND          188..190
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   HELIX           193..195
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   HELIX           198..212
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   HELIX           213..217
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   HELIX           226..228
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   HELIX           233..235
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   STRAND          237..239
FT                   /evidence="ECO:0007829|PDB:1H69"
FT   HELIX           241..248
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   STRAND          254..256
FT                   /evidence="ECO:0007829|PDB:1D4A"
FT   TURN            266..270
FT                   /evidence="ECO:0007829|PDB:1D4A"
SQ   SEQUENCE   274 AA;  30868 MW;  A4010462AD00F3FE CRC64;
     MVGRRALIVL AHSERTSFNY AMKEAAAAAL KKKGWEVVES DLYAMNFNPI ISRKDITGKL
     KDPANFQYPA ESVLAYKEGH LSPDIVAEQK KLEAADLVIF QFPLQWFGVP AILKGWFERV
     FIGEFAYTYA AMYDKGPFRS KKAVLSITTG GSGSMYSLQG IHGDMNVILW PIQSGILHFC
     GFQVLEPQLT YSIGHTPADA RIQILEGWKK RLENIWDETP LYFAPSSLFD LNFQAGFLMK
     KEVQDEEKNK KFGLSVGHHL GKSIPTDNQI KARK
//
ID   PYRE3_STRRG             Reviewed;         463 AA.
AC   K7QRJ5;
DT   07-OCT-2020, integrated into UniProtKB/Swiss-Prot.
DT   07-OCT-2020, sequence version 2.
DT   02-JUN-2021, entry version 27.
DE   RecName: Full=Dialkyldecalin synthase {ECO:0000303|PubMed:25730548};
DE            EC=5.5.1.- {ECO:0000269|PubMed:25730548};
DE   AltName: Full=FAD-dependent [4+2] cyclase {ECO:0000303|PubMed:29657086};
GN   Name=pyrE3 {ECO:0000312|EMBL:AFV71312.1};
OS   Streptomyces rugosporus.
OC   Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC   Streptomyces.
OX   NCBI_TaxID=295838;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=NRRL 21084;
RX   PubMed=23062149; DOI=10.1021/ja304829g;
RA   Wu Q., Wu Z., Qu X., Liu W.;
RT   "Insights into pyrroindomycin biosynthesis reveal a uniform paradigm for
RT   tetramate/tetronate formation.";
RL   J. Am. Chem. Soc. 134:17342-17345(2012).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES,
RP   DISRUPTION PHENOTYPE, PATHWAY, REEXAMINATION OF THE N-TERMINAL SEQUENCE,
RP   MUTAGENESIS OF GLU-32 AND ASP-275, AND REACTION MECHANISM.
RX   PubMed=25730548; DOI=10.1038/nchembio.1769;
RA   Tian Z., Sun P., Yan Y., Wu Z., Zheng Q., Zhou S., Zhang H., Yu F., Jia X.,
RA   Chen D., Mandi A., Kurtan T., Liu W.;
RT   "An enzymatic [4+2] cyclization cascade creates the pentacyclic core of
RT   pyrroindomycins.";
RL   Nat. Chem. Biol. 11:259-265(2015).
RN   [3] {ECO:0007744|PDB:5XGV}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH FAD, FUNCTION,
RP   COFACTOR, SUBUNIT, AND MUTAGENESIS OF HIS-74.
RX   PubMed=29657086; DOI=10.1016/j.chembiol.2018.03.007;
RA   Zheng Q., Gong Y., Guo Y., Zhao Z., Wu Z., Zhou Z., Chen D., Pan L.,
RA   Liu W.;
RT   "Structural Insights into a Flavin-Dependent [4+2] Cyclase that Catalyzes
RT   trans-Decalin Formation in Pyrroindomycin Biosynthesis.";
RL   Cell Chem. Biol. 25:718-727.e3(2018).
CC   -!- FUNCTION: Involved in the biosynthesis of the spirotetramate
CC       antibiotics pyrroindomycins. Catalyzes the intramolecular cyclization
CC       forming the dialkyldecalin moiety in pyrroindomycins, via an endo-
CC       selective [4+2] cycloaddition reaction. {ECO:0000269|PubMed:25730548,
CC       ECO:0000269|PubMed:29657086}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-[(2E,7S,8E,10E,13R,14R,16E,18E)-14-ethyl-7,13-dihydroxy-
CC         2,16,18-trimethylicosa-2,8,10,16,18-pentaenoyl]-2-methylidene-5-oxo-
CC         2,5-dihydro-1H-pyrrol-3-olate = 4-[(1R,2R,4aS,5S,8aR)-2-
CC         [(2R,3R,5E,7E)-3-ethyl-2-hydroxy-5,7-dimethylnona-5,7-dien-1-yl]-5-
CC         hydroxy-1-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-
CC         2-methylidene-5-oxo-2,5-dihydro-1H-pyrrol-3-olate;
CC         Xref=Rhea:RHEA:64476, ChEBI:CHEBI:155854, ChEBI:CHEBI:155855;
CC         Evidence={ECO:0000269|PubMed:25730548};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64477;
CC         Evidence={ECO:0000269|PubMed:25730548};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:25730548, ECO:0000269|PubMed:29657086};
CC       Note=Binds 1 FAD per subunit. The FAD cofactor does not cycle between
CC       oxidized and reduced forms and therefore does not have a typical redox
CC       role in the reaction; it plays a structural role essential for PyrE3
CC       catalysis, to maintain the requisite geometry of the protein and
CC       position the 1,3-diene and dienophile groups through specific
CC       interactions with the substrate. {ECO:0000269|PubMed:29657086};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=51.5 uM for 4-[(2E,7S,8E,10E,13R,14R,16E,18E)-14-ethyl-7,13-
CC         dihydroxy-2,16,18-trimethylicosa-2,8,10,16,18-pentaenoyl]-2-
CC         methylidene-5-oxo-2,5-dihydro-1H-pyrrol-3-olate
CC         {ECO:0000269|PubMed:25730548};
CC         Note=kcat is 223.2 min(-1). {ECO:0000269|PubMed:25730548};
CC   -!- PATHWAY: Antibiotic biosynthesis. {ECO:0000269|PubMed:25730548}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:29657086}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene lose the ability to
CC       produce pyrroindomycins. {ECO:0000269|PubMed:25730548}.
CC   -!- SIMILARITY: Belongs to the PheA/TfdB FAD monooxygenase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AFV71312.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305|PubMed:25730548};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JX042309; AFV71312.1; ALT_INIT; Genomic_DNA.
DR   PDB; 5XGV; X-ray; 2.10 A; A/B=1-463.
DR   PDBsum; 5XGV; -.
DR   SMR; K7QRJ5; -.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0016853; F:isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic biosynthesis; FAD; Flavoprotein; Isomerase.
FT   CHAIN           1..463
FT                   /note="Dialkyldecalin synthase"
FT                   /id="PRO_0000450858"
FT   NP_BIND         32..33
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29657086,
FT                   ECO:0007744|PDB:5XGV"
FT   BINDING         13
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:29657086,
FT                   ECO:0007744|PDB:5XGV"
FT   BINDING         121
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:29657086,
FT                   ECO:0007744|PDB:5XGV"
FT   BINDING         275
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29657086,
FT                   ECO:0007744|PDB:5XGV"
FT   MUTAGEN         32
FT                   /note="E->A: Loss of catalytic activity. Loss of FAD
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:25730548"
FT   MUTAGEN         74
FT                   /note="H->A: 81% loss of catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:29657086"
FT   MUTAGEN         275
FT                   /note="D->A: Loss of catalytic activity. Loss of FAD
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:25730548"
FT   HELIX           16..23
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          28..31
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          33..36
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   HELIX           48..55
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   TURN            56..58
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   HELIX           59..63
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   TURN            64..66
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          68..70
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   HELIX           82..84
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          92..94
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   HELIX           97..110
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          114..116
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          121..127
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          130..135
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          140..148
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   HELIX           155..159
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          171..179
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   HELIX           185..189
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          191..194
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          196..206
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          209..219
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   HELIX           230..241
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          247..255
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          259..261
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          265..267
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          270..272
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   HELIX           274..276
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   HELIX           286..306
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   HELIX           314..338
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   HELIX           343..356
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   HELIX           360..370
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          382..385
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          388..391
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   HELIX           392..396
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          400..407
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          418..423
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          432..436
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   STRAND          440..445
FT                   /evidence="ECO:0007829|PDB:5XGV"
FT   HELIX           451..459
FT                   /evidence="ECO:0007829|PDB:5XGV"
SQ   SEQUENCE   463 AA;  49361 MW;  98C84D9B2CC45113 CRC64;
     MSDTVIIAGG GPVGLMLACE LGLAGVDTVV LERHDAPREP SRGGAINATV VELFTQRGIM
     ESLRDDGFEF RMAHFAHIPL APERVPGDRA FSFAVPHAQV ERRLEERARS LGVRVRRSTE
     ITSVRQTPDG VQVTTGDGEV VEGAYLVGCD GSASLVREQA GIPFPGVDPD FHGLWGDIKV
     EPGAPVLERI GARQYELGLC MVAPIGPDTV RVITGEFDVP SPPADQEVGF DELRAAVARI
     AGVELDGVPG WLSRWTATSR QAERYREGRI LLAGDAAHTL FPLGGQALGT GIEDAVNLGW
     KLAATVQGWA PPSLLDSYHE ERHAAGARAC ASTRAQTTIM RSLARVGELR ALLTELAGLE
     EVNAYLVRMV GGIDGSRLPD VPLVTAEGET SVYRLLEAGR GVLLDLGAGL PAVRHPQVTY
     VRAEPTNRLD ATAVLLRPDG VVAWRAPQDG LEAALETWFG PAA
//
ID   PHR_THET8               Reviewed;         420 AA.
AC   P61497; P37250; Q53W60;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2004, sequence version 1.
DT   02-JUN-2021, entry version 108.
DE   RecName: Full=Deoxyribodipyrimidine photo-lyase;
DE            EC=4.1.99.3;
DE   AltName: Full=DNA photolyase;
DE   AltName: Full=Photoreactivating enzyme;
GN   Name=phr; OrderedLocusNames=TTHB102;
OS   Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8).
OG   Plasmid pTT27.
OC   Bacteria; Deinococcus-Thermus; Deinococci; Thermales; Thermaceae; Thermus.
OX   NCBI_TaxID=300852;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Tsujiuchi H., Masui R., Inoue Y., Shibata T., Yokoyama S., Kuramitsu S.;
RT   "Characterization of photolyase from Thermus thermophilus HB8.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 27634 / DSM 579 / HB8; PLASMID=pTT27;
RA   Masui R., Kurokawa K., Nakagawa N., Tokunaga F., Koyama Y., Shibata T.,
RA   Oshima T., Yokoyama S., Yasunaga T., Kuramitsu S.;
RT   "Complete genome sequence of Thermus thermophilus HB8.";
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   STRUCTURE BY NMR OF INTERACTION WITH DNA, AND MUTAGENESIS OF ARG-311;
RP   TRP-353 AND ARG-366.
RX   PubMed=15169780; DOI=10.1074/jbc.m404536200;
RA   Torizawa T., Ueda T., Kuramitsu S., Hitomi K., Todo T., Iwai S.,
RA   Morikawa K., Shimada I.;
RT   "Investigation of the cyclobutane pyrimidine dimer (CPD) photolyase DNA
RT   recognition mechanism by NMR analyses.";
RL   J. Biol. Chem. 279:32950-32956(2004).
RN   [4]
RP   REVIEW.
RX   PubMed=15721603; DOI=10.1016/j.bbabio.2004.02.010;
RA   Weber S.;
RT   "Light-driven enzymatic catalysis of DNA repair: a review of recent
RT   biophysical studies on photolyase.";
RL   Biochim. Biophys. Acta 1707:1-23(2005).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEX WITH FAD AND THYMINE.
RX   PubMed=11707580; DOI=10.1073/pnas.241371398;
RA   Komori H., Masui R., Kuramitsu S., Yokoyama S., Shibata T., Inoue Y.,
RA   Miki K.;
RT   "Crystal structure of thermostable DNA photolyase: pyrimidine-dimer
RT   recognition mechanism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:13560-13565(2001).
RN   [6]
RP   ERRATUM OF PUBMED:11707580.
RA   Komori H., Masui R., Kuramitsu S., Yokoyama S., Shibata T., Inoue Y.,
RA   Miki K.;
RL   Proc. Natl. Acad. Sci. U.S.A. 99:1098-1098(2002).
CC   -!- FUNCTION: Involved in repair of UV radiation-induced DNA damage.
CC       Catalyzes the light-dependent monomerization (300-600 nm) of cyclobutyl
CC       pyrimidine dimers (in cis-syn configuration), which are formed between
CC       adjacent bases on the same DNA strand upon exposure to ultraviolet
CC       radiation (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Cyclobutadipyrimidine (in DNA) = 2 pyrimidine residues (in
CC         DNA).; EC=4.1.99.3;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the DNA photolyase class-1 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB064548; BAB61864.2; -; Genomic_DNA.
DR   EMBL; AP008227; BAD71898.1; -; Genomic_DNA.
DR   RefSeq; WP_011229192.1; NC_006462.1.
DR   RefSeq; YP_145341.1; NC_006462.1.
DR   PDB; 1IQR; X-ray; 2.10 A; A=1-420.
DR   PDB; 1IQU; X-ray; 2.20 A; A=1-420.
DR   PDB; 2J07; X-ray; 1.95 A; A=1-420.
DR   PDB; 2J08; X-ray; 2.61 A; A=1-420.
DR   PDB; 2J09; X-ray; 2.00 A; A=1-420.
DR   PDBsum; 1IQR; -.
DR   PDBsum; 1IQU; -.
DR   PDBsum; 2J07; -.
DR   PDBsum; 2J08; -.
DR   PDBsum; 2J09; -.
DR   SMR; P61497; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB03462; Thymine.
DR   PRIDE; P61497; -.
DR   EnsemblBacteria; BAD71898; BAD71898; BAD71898.
DR   GeneID; 3169528; -.
DR   KEGG; ttj:TTHB102; -.
DR   PATRIC; fig|300852.9.peg.2045; -.
DR   HOGENOM; CLU_010348_2_2_0; -.
DR   OMA; WQWSASS; -.
DR   PhylomeDB; P61497; -.
DR   BRENDA; 4.1.99.3; 2305.
DR   EvolutionaryTrace; P61497; -.
DR   Proteomes; UP000000532; Plasmid pTT27.
DR   GO; GO:0003904; F:deoxyribodipyrimidine photo-lyase activity; IEA:UniProtKB-EC.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR036134; Crypto/Photolyase_FAD-like_sf.
DR   InterPro; IPR036155; Crypto/Photolyase_N_sf.
DR   InterPro; IPR005101; Cryptochr/Photolyase_FAD-bd.
DR   InterPro; IPR002081; Cryptochrome/DNA_photolyase_1.
DR   InterPro; IPR018394; DNA_photolyase_1_CS_C.
DR   InterPro; IPR006050; DNA_photolyase_N.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00875; DNA_photolyase; 1.
DR   Pfam; PF03441; FAD_binding_7; 1.
DR   PRINTS; PR00147; DNAPHOTLYASE.
DR   SUPFAM; SSF48173; SSF48173; 1.
DR   SUPFAM; SSF52425; SSF52425; 1.
DR   PROSITE; PS00394; DNA_PHOTOLYASES_1_1; 1.
DR   PROSITE; PS00691; DNA_PHOTOLYASES_1_2; 1.
DR   PROSITE; PS51645; PHR_CRY_ALPHA_BETA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chromophore; DNA damage; DNA repair; DNA-binding; FAD;
KW   Flavoprotein; Lyase; Nucleotide-binding; Plasmid; Reference proteome.
FT   CHAIN           1..420
FT                   /note="Deoxyribodipyrimidine photo-lyase"
FT                   /id="PRO_0000085115"
FT   DOMAIN          2..124
FT                   /note="Photolyase/cryptochrome alpha/beta"
FT   NP_BIND         209..213
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11707580"
FT   NP_BIND         341..343
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11707580"
FT   REGION          147..176
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          244..251
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   REGION          310..311
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   BINDING         197
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11707580"
FT   BINDING         201
FT                   /note="DNA"
FT                   /evidence="ECO:0000250"
FT   BINDING         241
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11707580"
FT   BINDING         248
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11707580"
FT   BINDING         310
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11707580"
FT   BINDING         373
FT                   /note="DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            275
FT                   /note="Electron transfer via tryptophanyl radical"
FT                   /evidence="ECO:0000250"
FT   SITE            328
FT                   /note="Electron transfer via tryptophanyl radical"
FT                   /evidence="ECO:0000250"
FT   SITE            351
FT                   /note="Electron transfer via tryptophanyl radical"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         201
FT                   /note="R->A: Reduces CPD repair activity by 20%."
FT   MUTAGEN         240
FT                   /note="K->A: Reduces CPD repair activity by 20%."
FT   MUTAGEN         247
FT                   /note="W->A: Reduces CPD repair activity by 20%."
FT   MUTAGEN         311
FT                   /note="R->A: Strongly reduces interaction with DNA."
FT                   /evidence="ECO:0000269|PubMed:15169780"
FT   MUTAGEN         353
FT                   /note="W->A: Strongly reduces interaction with DNA. Reduces
FT                   CPD repair activity by 80%."
FT                   /evidence="ECO:0000269|PubMed:15169780"
FT   MUTAGEN         366
FT                   /note="R->A: Strongly reduces interaction with DNA."
FT                   /evidence="ECO:0000269|PubMed:15169780"
FT   STRAND          4..7
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   STRAND          14..16
FT                   /evidence="ECO:0007829|PDB:2J09"
FT   HELIX           18..24
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   STRAND          29..35
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           37..40
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           44..63
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   STRAND          68..73
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           75..85
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   STRAND          89..94
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           99..111
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   STRAND          116..119
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           136..140
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           179..192
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           194..196
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           197..200
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           213..217
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           223..233
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           236..257
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           259..262
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           268..270
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           279..286
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           293..305
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           310..322
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           328..338
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           344..354
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           359..361
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           370..377
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   STRAND          379..381
FT                   /evidence="ECO:0007829|PDB:1IQU"
FT   HELIX           382..387
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   STRAND          392..395
FT                   /evidence="ECO:0007829|PDB:2J07"
FT   HELIX           403..418
FT                   /evidence="ECO:0007829|PDB:2J07"
SQ   SEQUENCE   420 AA;  47901 MW;  773968AC2D300893 CRC64;
     MGPLLVWHRG DLRLHDHPAL LEALARGPVV GLVVLDPNNL KTTPRRRAWF LENVRALREA
     YRARGGALWV LEGLPWEKVP EAARRLKAKA VYALTSHTPY GRYRDGRVRE ALPVPLHLLP
     APHLLPPDLP RAYRVYTPFS RLYRGAAPPL PPPEALPKGP EEGEIPREDP GLPLPEPGEE
     AALAGLRAFL EAKLPRYAEE RDRLDGEGGS RLSPYFALGV LSPRLAAWEA ERRGGEGARK
     WVAELLWRDF SYHLLYHFPW MAERPLDPRF QAFPWQEDEA LFQAWYEGKT GVPLVDAAMR
     ELHATGFLSN RARMNAAQFA VKHLLLPWKR CEEAFRHLLL DGDRAVNLQG WQWAGGLGVD
     AAPYFRVFNP VLQGERHDPE GRWLKRWAPE YPSYAPKDPV VDLEEARRRY LRLARDLARG
//
ID   GGR_THEAC               Reviewed;         396 AA.
AC   Q9HKS9;
DT   23-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 2.
DT   02-JUN-2021, entry version 115.
DE   RecName: Full=Digeranylgeranylglycerophospholipid reductase;
DE            Short=DGGGPL reductase;
DE            EC=1.3.1.101 {ECO:0000269|PubMed:16788058};
DE   AltName: Full=2,3-bis-O-geranylgeranylglyceryl phosphate reductase;
DE   AltName: Full=Geranylgeranyl reductase;
DE            Short=GGR;
GN   OrderedLocusNames=Ta0516;
OS   Thermoplasma acidophilum (strain ATCC 25905 / DSM 1728 / JCM 9062 / NBRC
OS   15155 / AMRC-C165).
OC   Archaea; Candidatus Thermoplasmatota; Thermoplasmata; Thermoplasmatales;
OC   Thermoplasmataceae; Thermoplasma.
OX   NCBI_TaxID=273075;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25905 / DSM 1728 / JCM 9062 / NBRC 15155 / AMRC-C165;
RX   PubMed=11029001; DOI=10.1038/35035069;
RA   Ruepp A., Graml W., Santos-Martinez M.-L., Koretke K.K., Volker C.,
RA   Mewes H.-W., Frishman D., Stocker S., Lupas A.N., Baumeister W.;
RT   "The genome sequence of the thermoacidophilic scavenger Thermoplasma
RT   acidophilum.";
RL   Nature 407:508-513(2000).
RN   [2]
RP   PROTEIN SEQUENCE OF 1-20, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, SUBSTRATE
RP   SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   STRAIN=ATCC 25905 / DSM 1728 / JCM 9062 / NBRC 15155 / AMRC-C165;
RX   PubMed=16788058; DOI=10.1093/jb/mvj118;
RA   Nishimura Y., Eguchi T.;
RT   "Biosynthesis of archaeal membrane lipids:
RT   digeranylgeranylglycerophospholipid reductase of the thermoacidophilic
RT   archaeon Thermoplasma acidophilum.";
RL   J. Biochem. 139:1073-1081(2006).
RN   [3]
RP   FUNCTION, COFACTOR, AND REACTION STEREOCHEMISTRY.
RC   STRAIN=ATCC 25905 / DSM 1728 / JCM 9062 / NBRC 15155 / AMRC-C165;
RX   PubMed=17275067; DOI=10.1016/j.bioorg.2006.12.001;
RA   Nishimura Y., Eguchi T.;
RT   "Stereochemistry of reduction in digeranylgeranylglycerophospholipid
RT   reductase involved in the biosynthesis of archaeal membrane lipids from
RT   Thermoplasma acidophilum.";
RL   Bioorg. Chem. 35:276-283(2007).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) IN COMPLEX WITH FAD AND LIPID,
RP   COFACTOR, AND SUBUNIT.
RX   PubMed=20869368; DOI=10.1016/j.jmb.2010.09.032;
RA   Xu Q., Eguchi T., Mathews I.I., Rife C.L., Chiu H.J., Farr C.L.,
RA   Feuerhelm J., Jaroszewski L., Klock H.E., Knuth M.W., Miller M.D.,
RA   Weekes D., Elsliger M.A., Deacon A.M., Godzik A., Lesley S.A., Wilson I.A.;
RT   "Insights into substrate specificity of geranylgeranyl reductases revealed
RT   by the structure of digeranylgeranylglycerophospholipid reductase, an
RT   essential enzyme in the biosynthesis of archaeal membrane lipids.";
RL   J. Mol. Biol. 404:403-417(2010).
CC   -!- FUNCTION: Is involved in the reduction of 2,3-
CC       digeranylgeranylglycerophospholipids (unsaturated archaeols) into 2,3-
CC       diphytanylglycerophospholipids (saturated archaeols) in the
CC       biosynthesis of archaeal membrane lipids. Catalyzes the formation of
CC       archaetidic acid (2,3-di-O-phytanyl-sn-glyceryl phosphate) from 2,3-di-
CC       O-geranylgeranylglyceryl phosphate (DGGGP) via the hydrogenation of
CC       each double bond of the isoprenoid chains. Can use both NADH and NADPH
CC       as electron donors. Also catalyzes the reduction of the naturally
CC       occurring 2,3-di-O-geranylgeranylglyceryl phosphate derivatives such as
CC       2,3-di-O-phytyl-sn-glyceryl phosphate (DPHGP), 3-O-(2,3-di-O-phytyl-sn-
CC       glycero-phospho)-sn-glycerol (DPHGPG) and 2,3-di-O-phytyl-sn-glycero-
CC       phosphoethanolamine (DPHGPE). Is not active toward 2,3-di-O-
CC       geranylgeranylglycerol. {ECO:0000269|PubMed:16788058,
CC       ECO:0000269|PubMed:17275067}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2,3-bis-O-(phytanyl)-sn-glycerol 1-phosphate + 8 NADP(+) =
CC         2,3-bis-O-(geranylgeranyl)-sn-glycerol 1-phosphate + 8 H(+) + 8
CC         NADPH; Xref=Rhea:RHEA:36035, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:58837, ChEBI:CHEBI:73125;
CC         EC=1.3.1.101; Evidence={ECO:0000269|PubMed:16788058};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:36037;
CC         Evidence={ECO:0000305|PubMed:16788058};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2,3-bis-O-(phytanyl)-sn-glycerol 1-phosphate + 8 NAD(+) = 2,3-
CC         bis-O-(geranylgeranyl)-sn-glycerol 1-phosphate + 8 H(+) + 8 NADH;
CC         Xref=Rhea:RHEA:36039, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:58837, ChEBI:CHEBI:73125;
CC         EC=1.3.1.101; Evidence={ECO:0000269|PubMed:16788058};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:36041;
CC         Evidence={ECO:0000305|PubMed:16788058};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:16788058, ECO:0000269|PubMed:17275067,
CC         ECO:0000269|PubMed:20869368};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:16788058,
CC       ECO:0000269|PubMed:17275067, ECO:0000269|PubMed:20869368};
CC   -!- PATHWAY: Membrane lipid metabolism; glycerophospholipid metabolism.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:20869368}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16788058}.
CC   -!- MISCELLANEOUS: Reduction reaction proceeds via syn addition of hydrogen
CC       for double bonds.
CC   -!- SIMILARITY: Belongs to the geranylgeranyl reductase family. DGGGPL
CC       reductase subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAC11656.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL445064; CAC11656.1; ALT_INIT; Genomic_DNA.
DR   RefSeq; WP_010900941.1; NC_002578.1.
DR   PDB; 3OZ2; X-ray; 1.60 A; A=1-396.
DR   PDBsum; 3OZ2; -.
DR   SMR; Q9HKS9; -.
DR   STRING; 273075.Ta0516m; -.
DR   EnsemblBacteria; CAC11656; CAC11656; CAC11656.
DR   GeneID; 1457015; -.
DR   KEGG; tac:Ta0516; -.
DR   eggNOG; arCOG00570; Archaea.
DR   HOGENOM; CLU_024648_0_0_2; -.
DR   OMA; KPNRYTI; -.
DR   OrthoDB; 31233at2157; -.
DR   BioCyc; MetaCyc:MONOMER-17979; -.
DR   BioCyc; TACI273075:G1GT7-545-MONOMER; -.
DR   BRENDA; 1.3.1.101; 6324.
DR   BRENDA; 1.3.7.11; 6324.
DR   UniPathway; UPA00940; -.
DR   EvolutionaryTrace; Q9HKS9; -.
DR   Proteomes; UP000001024; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0045550; F:geranylgeranyl reductase activity; IEA:InterPro.
DR   GO; GO:0051287; F:NAD binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0050661; F:NADP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0016628; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; IEA:UniProtKB-UniRule.
DR   GO; GO:0006650; P:glycerophospholipid metabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0046467; P:membrane lipid biosynthetic process; IEA:InterPro.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.50.50.60; -; 1.
DR   HAMAP; MF_01287; DGGGPL_reductase; 1.
DR   InterPro; IPR023590; DGGGPL_reductase.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR011777; Geranylgeranyl_Rdtase_fam.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR02032; GG-red-SF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Direct protein sequencing; FAD; Flavoprotein;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; NAD; NADP; Oxidoreductase;
KW   Phospholipid biosynthesis; Phospholipid metabolism; Reference proteome.
FT   CHAIN           1..396
FT                   /note="Digeranylgeranylglycerophospholipid reductase"
FT                   /id="PRO_0000350723"
FT   NP_BIND         10..14
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20869368"
FT   NP_BIND         33..35
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20869368"
FT   NP_BIND         44..47
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20869368"
FT   NP_BIND         295..296
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20869368"
FT   REGION          208..214
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:20869368"
FT   REGION          291..294
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:20869368"
FT   REGION          372..374
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:20869368"
FT   BINDING         49
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:20869368"
FT   BINDING         100
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20869368"
FT   BINDING         124
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:20869368"
FT   BINDING         162
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20869368"
FT   BINDING         283
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20869368"
FT   BINDING         338
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:20869368"
FT   STRAND          1..9
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   HELIX           13..24
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          29..32
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          34..37
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          47..49
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   HELIX           51..55
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   TURN            62..64
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          65..75
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          83..86
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          88..91
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          95..98
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   HELIX           100..114
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          117..121
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          124..130
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          133..141
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          144..155
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   HELIX           162..167
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   HELIX           170..172
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   HELIX           176..178
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          179..189
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          196..200
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          208..216
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          219..227
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   TURN            228..230
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   HELIX           234..246
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   HELIX           249..252
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          254..265
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   STRAND          278..280
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   HELIX           282..285
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   TURN            290..292
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   HELIX           296..316
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   HELIX           321..350
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   HELIX           354..364
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   HELIX           374..384
FT                   /evidence="ECO:0007829|PDB:3OZ2"
FT   HELIX           386..395
FT                   /evidence="ECO:0007829|PDB:3OZ2"
SQ   SEQUENCE   396 AA;  43353 MW;  C607688CD4144EF8 CRC64;
     METYDVLVVG GGPGGSTAAR YAAKYGLKTL MIEKRPEIGS PVRCGEGLSK GILNEADIKA
     DRSFIANEVK GARIYGPSEK RPIILQSEKA GNEVGYVLER DKFDKHLAAL AAKAGADVWV
     KSPALGVIKE NGKVAGAKIR HNNEIVDVRA KMVIAADGFE SEFGRWAGLK SVILARNDII
     SALQYRMINV DVDPDYTDFY LGSIAPAGYI WVFPKGEGMA NVGIGSSINW IHNRFELKNY
     LDRFIENHPG LKKGQDIQLV TGGVSVSKVK MPITMPGLML VGDAARLIDP ITGGGIANAI
     VSGMYAAQVT KEAIESNDYS PQMMQKYEKL IKERFERKHL RNWVAKEKLA MLSDDTLDKL
     VDIVSEQVLT TISVEAILKA IAEKYPEVVK ELEDLI
//
ID   RNLS_PSE14              Reviewed;         328 AA.
AC   Q48MT7;
DT   02-NOV-2016, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 1.
DT   02-JUN-2021, entry version 95.
DE   RecName: Full=Renalase {ECO:0000303|PubMed:26016690};
DE            EC=1.6.3.5 {ECO:0000269|PubMed:26016690};
GN   OrderedLocusNames=PSPPH_1014 {ECO:0000312|EMBL:AAZ37485.1};
OS   Pseudomonas savastanoi pv. phaseolicola (strain 1448A / Race 6)
OS   (Pseudomonas syringae pv. phaseolicola (strain 1448A / Race 6)).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=264730;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=1448A / Race 6;
RX   PubMed=16159782; DOI=10.1128/jb.187.18.6488-6498.2005;
RA   Joardar V., Lindeberg M., Jackson R.W., Selengut J., Dodson R.,
RA   Brinkac L.M., Daugherty S.C., DeBoy R.T., Durkin A.S., Gwinn Giglio M.,
RA   Madupu R., Nelson W.C., Rosovitz M.J., Sullivan S.A., Crabtree J.,
RA   Creasy T., Davidsen T.M., Haft D.H., Zafar N., Zhou L., Halpin R.,
RA   Holley T., Khouri H.M., Feldblyum T.V., White O., Fraser C.M.,
RA   Chatterjee A.K., Cartinhour S., Schneider D., Mansfield J.W., Collmer A.,
RA   Buell R.;
RT   "Whole-genome sequence analysis of Pseudomonas syringae pv. phaseolicola
RT   1448A reveals divergence among pathovars in genes involved in virulence and
RT   transposition.";
RL   J. Bacteriol. 187:6488-6498(2005).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (1.66 ANGSTROMS) IN COMPLEXES WITH BETA-NADH;
RP   BETA-NAD(+) AND FAD, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND SUBSTRATE
RP   SPECIFICITY.
RC   STRAIN=1448A / Race 6;
RX   PubMed=26016690; DOI=10.1021/acs.biochem.5b00451;
RA   Hoag M.R., Roman J., Beaupre B.A., Silvaggi N.R., Moran G.R.;
RT   "Bacterial renalase: structure and kinetics of an enzyme with 2- and 6-
RT   dihydro-beta-NAD(P) oxidase activity from Pseudomonas phaseolicola.";
RL   Biochemistry 54:3791-3802(2015).
CC   -!- FUNCTION: Catalyzes the oxidation of the 1,2-dihydro- and 1,6-
CC       dihydro- isomeric forms of beta-NAD(P) back to beta-NAD(P)+. Has a
CC       preference for 1,2-dihydro-beta-NAD as substrate. May serve to protect
CC       primary metabolism dehydrogenases from inhibition by the 1,2-
CC       dihydro- and 1,6-dihydro-beta-NAD(P) isomers.
CC       {ECO:0000269|PubMed:26016690}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihydro-beta-NAD + H(+) + O2 = H2O2 + NAD(+);
CC         Xref=Rhea:RHEA:40395, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:57540, ChEBI:CHEBI:88138; EC=1.6.3.5;
CC         Evidence={ECO:0000269|PubMed:26016690};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihydro-beta-NADP + H(+) + O2 = H2O2 + NADP(+);
CC         Xref=Rhea:RHEA:40399, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:58349, ChEBI:CHEBI:88137; EC=1.6.3.5;
CC         Evidence={ECO:0000269|PubMed:26016690};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,6-dihydro-beta-NADP + H(+) + O2 = H2O2 + NADP(+);
CC         Xref=Rhea:RHEA:48000, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:58349, ChEBI:CHEBI:88139; EC=1.6.3.5;
CC         Evidence={ECO:0000269|PubMed:26016690};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,6-dihydro-beta-NAD + H(+) + O2 = H2O2 + NAD(+);
CC         Xref=Rhea:RHEA:47996, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:57540, ChEBI:CHEBI:88140; EC=1.6.3.5;
CC         Evidence={ECO:0000269|PubMed:26016690};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:26016690};
CC   -!- SIMILARITY: Belongs to the bacterial renalase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000058; AAZ37485.1; -; Genomic_DNA.
DR   RefSeq; WP_011167855.1; NC_005773.3.
DR   PDB; 4ZCC; X-ray; 2.00 A; A/B/C/D=1-328.
DR   PDB; 4ZCD; X-ray; 1.66 A; A/B=1-328.
DR   PDB; 5KRQ; X-ray; 2.09 A; A/B=1-328.
DR   PDBsum; 4ZCC; -.
DR   PDBsum; 4ZCD; -.
DR   PDBsum; 5KRQ; -.
DR   SMR; Q48MT7; -.
DR   STRING; 264730.PSPPH_1014; -.
DR   EnsemblBacteria; AAZ37485; AAZ37485; PSPPH_1014.
DR   KEGG; psp:PSPPH_1014; -.
DR   eggNOG; COG3380; Bacteria.
DR   HOGENOM; CLU_036034_0_0_6; -.
DR   OMA; VHRWRYA; -.
DR   OrthoDB; 1442136at2; -.
DR   BRENDA; 1.6.3.5; 5174.
DR   Proteomes; UP000000551; Chromosome.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; IDA:UniProtKB.
DR   GO; GO:0050661; F:NADP binding; IDA:UniProtKB.
DR   GO; GO:0050664; F:oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor; IDA:UniProtKB.
DR   Gene3D; 3.50.50.60; -; 1.
DR   HAMAP; MF_02074; Bact_renalase; 1.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR034721; Bac_renal.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; NAD; NADP; Nucleotide-binding;
KW   Oxidoreductase.
FT   CHAIN           1..328
FT                   /note="Renalase"
FT                   /id="PRO_0000437674"
FT   NP_BIND         32..33
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26016690"
FT   NP_BIND         56..57
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26016690"
FT   REGION          57..61
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000305|PubMed:26016690"
FT   REGION          96..98
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000305|PubMed:26016690"
FT   BINDING         13
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:26016690"
FT   BINDING         40
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26016690"
FT   BINDING         128
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:26016690"
FT   BINDING         185
FT                   /note="Substrate"
FT                   /evidence="ECO:0000305|PubMed:26016690"
FT   BINDING         302
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26016690"
FT   BINDING         308
FT                   /note="Substrate"
FT                   /evidence="ECO:0000305|PubMed:26016690"
FT   BINDING         309
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:26016690"
FT   STRAND          5..8
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   HELIX           12..23
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          28..31
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          33..37
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   HELIX           39..41
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   HELIX           63..74
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          77..81
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          85..89
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          92..95
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          102..107
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   HELIX           111..117
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          128..133
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          138..142
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          147..152
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          154..156
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   HELIX           160..163
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   HELIX           164..166
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   HELIX           171..178
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          182..194
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          202..205
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          207..215
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   HELIX           216..218
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          227..233
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   HELIX           235..240
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   TURN            241..243
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   HELIX           246..260
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          269..283
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          290..292
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   TURN            293..296
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   STRAND          297..299
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   HELIX           302..304
FT                   /evidence="ECO:0007829|PDB:4ZCD"
FT   HELIX           309..326
FT                   /evidence="ECO:0007829|PDB:4ZCD"
SQ   SEQUENCE   328 AA;  35712 MW;  B3225EA8F53B5EE6 CRC64;
     MTVPIAIIGT GIAGLSAAQA LTSAGHQVHL FDKSRGSGGR MSSKRSDAGS LDMGAQYFTA
     RDRRFATAVK QWQAQGHVSE WTPLLYNFHG GRLSPSPDEQ VRWVGEPGMS AITRAMRGDL
     PVSFSCRITD VFRGEQHWNL LDAEGENHGP FSHVIIATPA PQATALLAAA PKLASVVAGV
     KMDPTWAVAL AFETPLQTPM QGCFVQDSPL DWLARNRSKP GRDDTLDSWV LHATSQWSRQ
     NLDASREQVI EHLHGAFAEL IDCAMPAPVF SLAHRWLYAR PAGSHEWGAL SDADLGIYVC
     GDWCLSGRVE GAWLSGQEAA RRLLEHLQ
//
ID   NDFS_EUBBA              Reviewed;         296 AA.
AC   Q0QLF4;
DT   08-FEB-2011, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2006, sequence version 1.
DT   02-JUN-2021, entry version 64.
DE   RecName: Full=Nicotinate dehydrogenase FAD-subunit {ECO:0000312|EMBL:ABC88396.1};
DE            Short=NDH {ECO:0000303|PubMed:19549881};
DE            EC=1.17.1.5;
DE   AltName: Full=Nicotinic acid hydroxylase FAD-subunit {ECO:0000303|PubMed:8555176};
DE            Short=NAH {ECO:0000303|PubMed:8555176};
GN   Name=ndhF;
OS   Eubacterium barkeri (Clostridium barkeri).
OC   Bacteria; Firmicutes; Clostridia; Eubacteriales; Eubacteriaceae;
OC   Eubacterium.
OX   NCBI_TaxID=1528;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:ABC88396.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PATHWAY.
RC   STRAIN=ATCC 25849 / DSM 1223 / JCM 1389 / NCIMB 10623 / VKM B-1775 / VPI
RC   5359 {ECO:0000312|EMBL:ABC88396.1};
RX   PubMed=16894175; DOI=10.1073/pnas.0601635103;
RA   Alhapel A., Darley D.J., Wagener N., Eckel E., Elsner N., Pierik A.J.;
RT   "Molecular and functional analysis of nicotinate catabolism in Eubacterium
RT   barkeri.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:12341-12346(2006).
RN   [2] {ECO:0000305}
RP   PROTEIN SEQUENCE OF 1-25, FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY REGULATION, AND SUBUNIT.
RC   STRAIN=ATCC 25849 / DSM 1223 / JCM 1389 / NCIMB 10623 / VKM B-1775 / VPI
RC   5359 {ECO:0000269|PubMed:8555176};
RX   PubMed=8555176; DOI=10.1021/bi951793i;
RA   Gladyshev V.N., Khangulov S.V., Stadtman T.C.;
RT   "Properties of the selenium- and molybdenum-containing nicotinic acid
RT   hydroxylase from Clostridium barkeri.";
RL   Biochemistry 35:212-223(1996).
RN   [3] {ECO:0000305}
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH FAD; NDHM; NDHS AND
RP   NDHL, COFACTOR, AND SUBUNIT.
RC   STRAIN=ATCC 25849 / DSM 1223 / JCM 1389 / NCIMB 10623 / VKM B-1775 / VPI
RC   5359 {ECO:0000269|PubMed:19549881};
RX   PubMed=19549881; DOI=10.1073/pnas.0902210106;
RA   Wagener N., Pierik A.J., Ibdah A., Hille R., Dobbek H.;
RT   "The Mo-Se active site of nicotinate dehydrogenase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:11055-11060(2009).
CC   -!- FUNCTION: Catalyzes the hydroxylation of nicotinate to 6-
CC       hydroxynicotinate. Also active against 2-pyrazinecarboxylic acid, but
CC       inactive against other nicotinate analogs.
CC       {ECO:0000269|PubMed:8555176}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NADP(+) + nicotinate = 6-hydroxynicotinate + H(+) +
CC         NADPH; Xref=Rhea:RHEA:12236, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:32544, ChEBI:CHEBI:57664, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.17.1.5;
CC         Evidence={ECO:0000269|PubMed:8555176};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:19549881, ECO:0000269|PubMed:8555176};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:19549881,
CC       ECO:0000269|PubMed:8555176};
CC   -!- ACTIVITY REGULATION: Reversibly inactivated by selenide and sulfide.
CC       Not inhibited by cyanide. {ECO:0000269|PubMed:8555176}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Most stable at pH 8.0. Unstable at acidic pH values.
CC         {ECO:0000269|PubMed:8555176};
CC   -!- PATHWAY: Cofactor degradation; nicotinate degradation; 6-
CC       hydroxynicotinate from nicotinate: step 1/1.
CC       {ECO:0000269|PubMed:16894175}.
CC   -!- SUBUNIT: Heterooctamer of NDHM, NDHL, NDHS and NDHF. Dimer of
CC       heterotetramers. {ECO:0000269|PubMed:19549881,
CC       ECO:0000269|PubMed:8555176}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ310789; ABC88396.1; -; Genomic_DNA.
DR   PDB; 3HRD; X-ray; 2.20 A; C/G=1-296.
DR   PDBsum; 3HRD; -.
DR   SMR; Q0QLF4; -.
DR   DIP; DIP-48911N; -.
DR   IntAct; Q0QLF4; 3.
DR   KEGG; ag:ABC88396; -.
DR   BioCyc; MetaCyc:MONOMER-11707; -.
DR   UniPathway; UPA01010; UER01011.
DR   EvolutionaryTrace; Q0QLF4; -.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0050138; F:nicotinate dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:1901848; P:nicotinate catabolic process; IDA:UniProtKB.
DR   Gene3D; 3.30.465.10; -; 1.
DR   InterPro; IPR005107; CO_DH_flav_C.
DR   InterPro; IPR036683; CO_DH_flav_C_dom_sf.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR016169; FAD-bd_PCMH_sub2.
DR   InterPro; IPR002346; Mopterin_DH_FAD-bd.
DR   Pfam; PF03450; CO_deh_flav_C; 1.
DR   Pfam; PF00941; FAD_binding_5; 1.
DR   SMART; SM01092; CO_deh_flav_C; 1.
DR   SUPFAM; SSF55447; SSF55447; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; FAD; Flavoprotein; NADP;
KW   Oxidoreductase.
FT   CHAIN           1..296
FT                   /note="Nicotinate dehydrogenase FAD-subunit"
FT                   /id="PRO_0000404245"
FT   DOMAIN          1..179
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   NP_BIND         29..36
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19549881"
FT   NP_BIND         110..114
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19549881"
FT   BINDING         101
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:19549881"
FT   BINDING         123
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19549881"
FT   BINDING         160
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19549881"
FT   BINDING         169
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:19549881"
FT   BINDING         187
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19549881"
FT   STRAND          5..7
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   HELIX           12..21
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   TURN            22..24
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   STRAND          28..32
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   HELIX           36..41
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   STRAND          48..52
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   HELIX           57..59
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   STRAND          62..64
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   STRAND          66..72
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   HELIX           77..82
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   HELIX           84..89
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   HELIX           91..98
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   HELIX           103..108
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   HELIX           111..117
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   HELIX           123..130
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   STRAND          134..139
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   STRAND          142..147
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   HELIX           148..153
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   STRAND          156..162
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   STRAND          168..175
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   STRAND          181..188
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   STRAND          190..194
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   STRAND          198..208
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   TURN            209..211
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   STRAND          212..221
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   STRAND          223..226
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   HELIX           231..237
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   HELIX           244..248
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   HELIX           251..261
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   TURN            262..264
FT                   /evidence="ECO:0007829|PDB:3HRD"
FT   HELIX           268..290
FT                   /evidence="ECO:0007829|PDB:3HRD"
SQ   SEQUENCE   296 AA;  32622 MW;  B14B447981D8E7FD CRC64;
     MKDFEFFAPK TLEEAKGLLH QYKDVPPAII AGGTDLVIEI NDRWEKPDVV IDIKKLKELE
     YIRVEENTIH IGALSTFTQI ENHPFIRSHV RALYKAASQV GSPQIRNLGT IGGNLSTSSV
     AGDGVSAMTT LDATVVLESV RGTRQMKLTD FFDGEGFKRR NALEADEIMT EVIIDRPDAH
     SASAFYKLAK RKSLAISVIG GGMAVKVDDA GVCTWASMRG GCIGRYPLHF KQAEEMLVGA
     PLTMETMEAT LPILHDTVYD MARARPSVLY KKESVQGVFK KLFVDILDQL EGGCNE
//
ID   PRODH_DEIRA             Reviewed;         310 AA.
AC   Q9RW55;
DT   07-SEP-2016, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   02-JUN-2021, entry version 115.
DE   RecName: Full=Proline dehydrogenase {ECO:0000303|PubMed:23151026, ECO:0000312|EMBL:AAF10393.1};
DE            Short=PRODH {ECO:0000303|PubMed:23151026};
DE            EC=1.5.5.2 {ECO:0000269|PubMed:23151026};
DE   AltName: Full=DrPRODH {ECO:0000303|PubMed:23151026};
DE   AltName: Full=Proline oxidase {ECO:0000305};
GN   OrderedLocusNames=DR_0814 {ECO:0000312|EMBL:AAF10393.1};
GN   ORFNames=A2G07_09440 {ECO:0000312|EMBL:ANC71972.1};
OS   Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG
OS   4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422).
OC   Bacteria; Deinococcus-Thermus; Deinococci; Deinococcales; Deinococcaceae;
OC   Deinococcus.
OX   NCBI_TaxID=243230 {ECO:0000312|EMBL:AAF10393.1};
RN   [1] {ECO:0000312|EMBL:AAF10393.1, ECO:0000312|Proteomes:UP000002524}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB
RC   9279 / R1 / VKM B-1422 {ECO:0000312|Proteomes:UP000002524};
RX   PubMed=10567266; DOI=10.1126/science.286.5444.1571;
RA   White O., Eisen J.A., Heidelberg J.F., Hickey E.K., Peterson J.D.,
RA   Dodson R.J., Haft D.H., Gwinn M.L., Nelson W.C., Richardson D.L.,
RA   Moffat K.S., Qin H., Jiang L., Pamphile W., Crosby M., Shen M.,
RA   Vamathevan J.J., Lam P., McDonald L.A., Utterback T.R., Zalewski C.,
RA   Makarova K.S., Aravind L., Daly M.J., Minton K.W., Fleischmann R.D.,
RA   Ketchum K.A., Nelson K.E., Salzberg S.L., Smith H.O., Venter J.C.,
RA   Fraser C.M.;
RT   "Genome sequence of the radioresistant bacterium Deinococcus radiodurans
RT   R1.";
RL   Science 286:1571-1577(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB
RC   9279 / R1 / VKM B-1422 {ECO:0000312|EMBL:ANC71972.1};
RA   Hua X., Hua Y.;
RT   "Compelete genome sequence of the extremely radiation-resistant bacteria
RT   Deinococcus radiodurans R1.";
RL   Submitted (MAR-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0007744|PDB:4H6Q, ECO:0007744|PDB:4H6R}
RP   X-RAY CRYSTALLOGRAPHY (1.36 ANGSTROMS) IN COMPLEXES WITH FAD AND SUBSTRATE
RP   ANALOG, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF GLY-63 AND GLU-64.
RX   PubMed=23151026; DOI=10.1021/bi301312f;
RA   Luo M., Arentson B.W., Srivastava D., Becker D.F., Tanner J.J.;
RT   "Crystal structures and kinetics of monofunctional proline dehydrogenase
RT   provide insight into substrate recognition and conformational changes
RT   associated with flavin reduction and product release.";
RL   Biochemistry 51:10099-10108(2012).
CC   -!- FUNCTION: Converts proline to delta-1-pyrroline-5-carboxylate.
CC       {ECO:0000269|PubMed:23151026}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + L-proline = (S)-1-pyrroline-5-carboxylate + a
CC         quinol + H(+); Xref=Rhea:RHEA:23784, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17388, ChEBI:CHEBI:24646, ChEBI:CHEBI:60039,
CC         ChEBI:CHEBI:132124; EC=1.5.5.2;
CC         Evidence={ECO:0000269|PubMed:23151026};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:23151026};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=290 mM for proline (at 23 degrees Celsius and pH 7.5)
CC         {ECO:0000269|PubMed:23151026};
CC         KM=0.155 mM for coenzyme Q1 (at 23 degrees Celsius and pH 7.5)
CC         {ECO:0000269|PubMed:23151026};
CC         Note=kcat 8.7 s(-1) is for proline. kcat is 14 s(-1) for coenzyme Q1.
CC         {ECO:0000269|PubMed:23151026};
CC   -!- PATHWAY: Amino-acid degradation; L-proline degradation into L-
CC       glutamate; L-glutamate from L-proline: step 1/2. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the proline dehydrogenase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE000513; AAF10393.1; -; Genomic_DNA.
DR   EMBL; CP015081; ANC71972.1; -; Genomic_DNA.
DR   PIR; D75471; D75471.
DR   RefSeq; NP_294538.1; NC_001263.1.
DR   RefSeq; WP_010887460.1; NZ_CP015081.1.
DR   PDB; 4H6Q; X-ray; 1.36 A; A/C=1-310.
DR   PDB; 4H6R; X-ray; 1.75 A; A/C=1-310.
DR   PDBsum; 4H6Q; -.
DR   PDBsum; 4H6R; -.
DR   SMR; Q9RW55; -.
DR   STRING; 243230.DR_0814; -.
DR   EnsemblBacteria; AAF10393; AAF10393; DR_0814.
DR   KEGG; dra:DR_0814; -.
DR   PATRIC; fig|243230.17.peg.995; -.
DR   eggNOG; COG0506; Bacteria.
DR   HOGENOM; CLU_061158_0_0_0; -.
DR   InParanoid; Q9RW55; -.
DR   OMA; YPMIGSH; -.
DR   OrthoDB; 1746057at2; -.
DR   BRENDA; 1.5.99.B2; 1856.
DR   UniPathway; UPA00261; UER00373.
DR   Proteomes; UP000002524; Chromosome I.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0004657; F:proline dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0006562; P:proline catabolic process; IDA:UniProtKB.
DR   GO; GO:0010133; P:proline catabolic process to glutamate; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR029041; FAD-linked_oxidoreductase-like.
DR   InterPro; IPR008219; PRODH_bac_arc.
DR   InterPro; IPR002872; Proline_DH_dom.
DR   InterPro; IPR015659; Proline_oxidase.
DR   PANTHER; PTHR13914; PTHR13914; 2.
DR   Pfam; PF01619; Pro_dh; 1.
DR   PIRSF; PIRSF000196; Pro_dehydrog; 1.
DR   SUPFAM; SSF51730; SSF51730; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Nucleotide-binding; Oxidoreductase;
KW   Proline metabolism; Reference proteome.
FT   CHAIN           1..310
FT                   /note="Proline dehydrogenase"
FT                   /id="PRO_0000436838"
FT   NP_BIND         187..192
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23151026,
FT                   ECO:0007744|PDB:4H6Q"
FT   NP_BIND         229..230
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23151026,
FT                   ECO:0007744|PDB:4H6Q"
FT   NP_BIND         292..295
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23151026,
FT                   ECO:0007744|PDB:4H6Q"
FT   REGION          291..292
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:23151026,
FT                   ECO:0007744|PDB:4H6Q"
FT   ACT_SITE        135
FT                   /evidence="ECO:0000250|UniProtKB:Q72IB8"
FT   ACT_SITE        187
FT                   /evidence="ECO:0000250|UniProtKB:Q72IB8"
FT   BINDING         98
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:23151026,
FT                   ECO:0007744|PDB:4H6Q"
FT   BINDING         136
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:23151026,
FT                   ECO:0007744|PDB:4H6Q"
FT   BINDING         166
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23151026,
FT                   ECO:0007744|PDB:4H6Q"
FT   SITE            278
FT                   /note="Critical for catalytic activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q72IB8"
FT   MUTAGEN         63
FT                   /note="G->A: 140-fold decrease in catalytic efficiency for
FT                   proline."
FT                   /evidence="ECO:0000269|PubMed:23151026"
FT   MUTAGEN         64
FT                   /note="E->A: 27-fold decrease in catalytic efficiency for
FT                   proline."
FT                   /evidence="ECO:0000269|PubMed:23151026"
FT   HELIX           18..20
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   HELIX           21..31
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   TURN            32..34
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   HELIX           40..52
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   STRAND          56..61
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   HELIX           69..88
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   STRAND          94..97
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   HELIX           99..101
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   TURN            102..105
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   HELIX           113..127
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   STRAND          131..134
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   HELIX           139..141
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   HELIX           142..156
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   TURN            158..160
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   STRAND          161..166
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   HELIX           172..178
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   HELIX           179..182
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   STRAND          186..189
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   TURN            197..199
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   HELIX           204..220
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   STRAND          225..228
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   HELIX           232..244
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   STRAND          251..257
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   HELIX           262..270
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   STRAND          275..283
FT                   /evidence="ECO:0007829|PDB:4H6Q"
FT   HELIX           286..294
FT                   /evidence="ECO:0007829|PDB:4H6Q"
SQ   SEQUENCE   310 AA;  34927 MW;  BFD5B7607E17B063 CRC64;
     MIDQLYRKAV LTVAERPQVE QLARQKMWNL AERFVAGESI ESAIQAVQAL ERDGIAGNLD
     LLGEFIDSPA KCTEFADDVI KLIEAAHAAG IKPYVSIKLS SVGQGKDENG EDLGLTNARR
     IIAKAKEYGG FICLDMEDHT RVDVTLEQFR TLVGEFGAEH VGTVLQSYLY RSLGDRASLD
     DLRPNIRMVK GAYLEPATVA YPDKADVDQN YRRLVFQHLK AGNYTNVATH DERIIDDVKR
     FVLAHGIGKD AFEFQMLYGI RRDLQKQLAA EGYRVRVYLP YGRDWYAYFS RRIAETPRNA
     AFVVQGMLKG
//
ID   OXLA_VIPAA              Reviewed;         484 AA.
AC   P0DI84;
DT   21-SEP-2011, integrated into UniProtKB/Swiss-Prot.
DT   21-SEP-2011, sequence version 1.
DT   02-JUN-2021, entry version 37.
DE   RecName: Full=L-amino-acid oxidase;
DE            Short=LAO;
DE            Short=VAA-LAAO I {ECO:0000303|PubMed:18931435};
DE            EC=1.4.3.2 {ECO:0000250|UniProtKB:P81382};
OS   Vipera ammodytes ammodytes (Western sand viper).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC   Serpentes; Colubroidea; Viperidae; Viperinae; Vipera.
OX   NCBI_TaxID=8705;
RN   [1]
RP   IDENTIFICATION BY MASS SPECTROMETRY, CRYSTALLIZATION, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Venom;
RX   PubMed=18931435; DOI=10.1107/s1744309108027036;
RA   Georgieva D., Kardas A., Buck F., Perbandt M., Betzel C.;
RT   "Isolation, crystallization and preliminary X-ray diffraction analysis of
RT   L-amino-acid oxidase from Vipera ammodytes ammodytes venom.";
RL   Acta Crystallogr. F 64:918-921(2008).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Venom;
RX   PubMed=18257516; DOI=10.1021/pr070376c;
RA   Georgieva D., Risch M., Kardas A., Buck F., von Bergen M., Betzel C.;
RT   "Comparative analysis of the venom proteomes of Vipera ammodytes ammodytes
RT   and Vipera ammodytes meridionalis.";
RL   J. Proteome Res. 7:866-886(2008).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.57 ANGSTROMS) IN COMPLEX WITH FAD AND ZINC IONS,
RP   COFACTOR, SUBUNIT, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-170.
RC   TISSUE=Venom;
RX   PubMed=20938508; DOI=10.1039/c0mb00101e;
RA   Georgieva D., Murakami M., Perband M., Arni R., Betzel C.;
RT   "The structure of a native L-amino acid oxidase, the major component of the
RT   Vipera ammodytes ammodytes venomic, reveals dynamic active site and
RT   quaternary structure stabilization by divalent ions.";
RL   Mol. Biosyst. 7:379-384(2011).
CC   -!- FUNCTION: Catalyzes an oxidative deamination of predominantly
CC       hydrophobic and aromatic L-amino acids, thus producing hydrogen
CC       peroxide that may contribute to the diverse toxic effects of this
CC       enzyme. Exhibits diverse biological activities, such as hemorrhage,
CC       hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell
CC       lines, antibacterial and antiparasitic activities, as well as
CC       regulation of platelet aggregation. Effects of snake L-amino oxidases
CC       on platelets are controversial, since they either induce aggregation or
CC       inhibit agonist-induced aggregation. These different effects are
CC       probably due to different experimental conditions.
CC       {ECO:0000250|UniProtKB:P0CC17}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an L-alpha-amino acid + H2O + O2 = a 2-oxocarboxylate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:13781, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:35179,
CC         ChEBI:CHEBI:59869; EC=1.4.3.2;
CC         Evidence={ECO:0000250|UniProtKB:P81382};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:20938508};
CC   -!- SUBUNIT: Homodimer; non-covalently linked.
CC       {ECO:0000269|PubMed:20938508}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:18931435}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC       {ECO:0000305|PubMed:18931435}.
CC   -!- SIMILARITY: Belongs to the flavin monoamine oxidase family. FIG1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   PDB; 3KVE; X-ray; 2.57 A; A/B/C/D=1-484.
DR   PDBsum; 3KVE; -.
DR   SMR; P0DI84; -.
DR   iPTMnet; P0DI84; -.
DR   EvolutionaryTrace; P0DI84; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0001716; F:L-amino-acid oxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR   GO; GO:0044179; P:hemolysis in other organism; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR001613; Flavin_amine_oxidase.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   PRINTS; PR00757; AMINEOXDASEF.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic; Antimicrobial; Apoptosis; Cytolysis;
KW   Disulfide bond; FAD; Flavoprotein; Glycoprotein; Hemolysis;
KW   Hemostasis impairing toxin; Metal-binding; Oxidoreductase; Secreted; Toxin;
KW   Zinc.
FT   CHAIN           1..484
FT                   /note="L-amino-acid oxidase"
FT                   /id="PRO_0000412591"
FT   NP_BIND         41..42
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20938508,
FT                   ECO:0007744|PDB:3KVE"
FT   NP_BIND         61..62
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20938508,
FT                   ECO:0007744|PDB:3KVE"
FT   NP_BIND         85..88
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20938508,
FT                   ECO:0007744|PDB:3KVE"
FT   NP_BIND         462..467
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20938508,
FT                   ECO:0007744|PDB:3KVE"
FT   REGION          462..463
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:P81382"
FT   METAL           73
FT                   /note="Zinc"
FT                   /evidence="ECO:0000269|PubMed:20938508,
FT                   ECO:0007744|PDB:3KVE"
FT   METAL           277
FT                   /note="Zinc"
FT                   /evidence="ECO:0000269|PubMed:20938508,
FT                   ECO:0007744|PDB:3KVE"
FT   BINDING         69
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20938508,
FT                   ECO:0007744|PDB:3KVE"
FT   BINDING         88
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P81382"
FT   BINDING         221
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P81382"
FT   BINDING         259
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:20938508,
FT                   ECO:0007744|PDB:3KVE"
FT   BINDING         370
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P81382"
FT   BINDING         455
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20938508,
FT                   ECO:0007744|PDB:3KVE"
FT   CARBOHYD        170
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:20938508,
FT                   ECO:0007744|PDB:3KVE"
FT   DISULFID        8..171
FT                   /evidence="ECO:0000269|PubMed:20938508"
FT   DISULFID        329..410
FT                   /evidence="ECO:0000269|PubMed:20938508"
FT   HELIX           6..9
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           14..23
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          33..37
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           41..52
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          56..60
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          62..67
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          72..75
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   TURN            76..79
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          80..85
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           94..102
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          107..110
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          117..121
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          124..127
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           128..133
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           135..138
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           144..146
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           151..158
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           160..166
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           171..177
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           178..180
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           183..189
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           195..204
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           208..210
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           215..225
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          231..234
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           240..248
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           249..252
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          253..256
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          258..264
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          269..274
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          276..278
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          281..290
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           294..297
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          300..304
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           308..316
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          322..331
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           333..337
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          341..348
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          352..354
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          365..372
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           373..380
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           384..399
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           403..409
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          410..417
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           418..420
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   TURN            422..424
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          425..429
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           435..444
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          450..452
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           455..457
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   STRAND          458..462
FT                   /evidence="ECO:0007829|PDB:3KVE"
FT   HELIX           464..481
FT                   /evidence="ECO:0007829|PDB:3KVE"
SQ   SEQUENCE   484 AA;  54748 MW;  FF2BBFB0EB5D1C47 CRC64;
     DRNPLEECFR ETDYEEFLEI ARNGLKKTSN PKHVVVVGAG MSGLSAAYVL AGAGHKVTVL
     EASERAGGRV RTHRNSKEGW YANLGPMRIP EKHRIVREYI RKFGLNLNEF SQENDNAWYF
     IKNIRKRVGE VNKDPGLLKY PVKPSEEGKS AGQLYEESLG SAVKDLKRTN CSYILNKYDT
     YSTKEYLIKE GNLSPGAVDM IGDLLNEDSG YYVSFIESLK HDDIFAYEKR FDEIVGGMDQ
     LPTSMYRAIE EKVKFNARVI KIQQNANQVT VTYQTPEKDT SSNTADYVIV CTTSRAARRI
     QFEPPLPPKK QHALRSVHYR SGTKIFLTCS SKFWEDDGIH GGKSTTDLPS RFIYYPNHNF
     STGVGVIIAY GIGDDANFFQ ALKFKDCADI VFNDLSLIHQ LPKEEIQSFC YPSMIQKWSL
     DKYAMGAITT FTPYQFQRFS EALTAPQGRI FFAGEYTAEA HGWIDSTIKS GLTAARDVNR
     ASEQ
//
ID   RNLS_PSESM              Reviewed;         328 AA.
AC   Q888A4;
DT   02-NOV-2016, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   02-JUN-2021, entry version 120.
DE   RecName: Full=Renalase {ECO:0000250|UniProtKB:Q48MT7};
DE            EC=1.6.3.5 {ECO:0000250|UniProtKB:Q48MT7};
GN   OrderedLocusNames=PSPTO_1126 {ECO:0000312|EMBL:AAO54655.1};
OS   Pseudomonas syringae pv. tomato (strain ATCC BAA-871 / DC3000).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=223283;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC BAA-871 / DC3000;
RX   PubMed=12928499; DOI=10.1073/pnas.1731982100;
RA   Buell C.R., Joardar V., Lindeberg M., Selengut J., Paulsen I.T.,
RA   Gwinn M.L., Dodson R.J., DeBoy R.T., Durkin A.S., Kolonay J.F., Madupu R.,
RA   Daugherty S.C., Brinkac L.M., Beanan M.J., Haft D.H., Nelson W.C.,
RA   Davidsen T.M., Zafar N., Zhou L., Liu J., Yuan Q., Khouri H.M.,
RA   Fedorova N.B., Tran B., Russell D., Berry K.J., Utterback T.R.,
RA   Van Aken S.E., Feldblyum T.V., D'Ascenzo M., Deng W.-L., Ramos A.R.,
RA   Alfano J.R., Cartinhour S., Chatterjee A.K., Delaney T.P., Lazarowitz S.G.,
RA   Martin G.B., Schneider D.J., Tang X., Bender C.L., White O., Fraser C.M.,
RA   Collmer A.;
RT   "The complete genome sequence of the Arabidopsis and tomato pathogen
RT   Pseudomonas syringae pv. tomato DC3000.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:10181-10186(2003).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) IN COMPLEX WITH FAD.
RG   Northeast structural genomics consortium (NESG);
RT   "X-ray structure of P. syringae Q888A4 oxidoreductase at resolution 2.5A,
RT   Northeast Structural Genomics Consortium target PsR10.";
RL   Submitted (NOV-2009) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes the oxidation of the 1,2-dihydro- and 1,6-
CC       dihydro- isomeric forms of beta-NAD(P) back to beta-NAD(P)+. Has a
CC       preference for 1,2-dihydro-beta-NAD as substrate. May serve to protect
CC       primary metabolism dehydrogenases from inhibition by the 1,2-
CC       dihydro- and 1,6-dihydro-beta-NAD(P) isomers.
CC       {ECO:0000250|UniProtKB:Q48MT7}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihydro-beta-NAD + H(+) + O2 = H2O2 + NAD(+);
CC         Xref=Rhea:RHEA:40395, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:57540, ChEBI:CHEBI:88138; EC=1.6.3.5;
CC         Evidence={ECO:0000250|UniProtKB:Q48MT7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihydro-beta-NADP + H(+) + O2 = H2O2 + NADP(+);
CC         Xref=Rhea:RHEA:40399, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:58349, ChEBI:CHEBI:88137; EC=1.6.3.5;
CC         Evidence={ECO:0000250|UniProtKB:Q48MT7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,6-dihydro-beta-NADP + H(+) + O2 = H2O2 + NADP(+);
CC         Xref=Rhea:RHEA:48000, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:58349, ChEBI:CHEBI:88139; EC=1.6.3.5;
CC         Evidence={ECO:0000250|UniProtKB:Q48MT7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,6-dihydro-beta-NAD + H(+) + O2 = H2O2 + NAD(+);
CC         Xref=Rhea:RHEA:47996, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:57540, ChEBI:CHEBI:88140; EC=1.6.3.5;
CC         Evidence={ECO:0000250|UniProtKB:Q48MT7};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000250|UniProtKB:Q48MT7};
CC   -!- SIMILARITY: Belongs to the bacterial renalase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE016853; AAO54655.1; -; Genomic_DNA.
DR   RefSeq; NP_790960.1; NC_004578.1.
DR   RefSeq; WP_005768828.1; NC_004578.1.
DR   PDB; 3KKJ; X-ray; 2.50 A; A/B=1-328.
DR   PDBsum; 3KKJ; -.
DR   SMR; Q888A4; -.
DR   STRING; 223283.PSPTO_1126; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   EnsemblBacteria; AAO54655; AAO54655; PSPTO_1126.
DR   GeneID; 1182762; -.
DR   KEGG; pst:PSPTO_1126; -.
DR   PATRIC; fig|223283.9.peg.1136; -.
DR   eggNOG; COG3380; Bacteria.
DR   HOGENOM; CLU_036034_0_0_6; -.
DR   OMA; VHRWRYA; -.
DR   OrthoDB; 1442136at2; -.
DR   BioCyc; PSYR223283:G1G0D-1149-MONOMER; -.
DR   EvolutionaryTrace; Q888A4; -.
DR   Proteomes; UP000002515; Chromosome.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0051287; F:NAD binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0050661; F:NADP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0050664; F:oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.50.50.60; -; 1.
DR   HAMAP; MF_02074; Bact_renalase; 1.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR034721; Bac_renal.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; NAD; NADP; Nucleotide-binding;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN           1..328
FT                   /note="Renalase"
FT                   /id="PRO_0000437675"
FT   NP_BIND         32..33
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.2, ECO:0007744|PDB:3KKJ"
FT   NP_BIND         56..57
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.2, ECO:0007744|PDB:3KKJ"
FT   REGION          57..61
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q48MT7"
FT   REGION          96..98
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q48MT7"
FT   BINDING         13
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|Ref.2, ECO:0007744|PDB:3KKJ"
FT   BINDING         40
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.2, ECO:0007744|PDB:3KKJ"
FT   BINDING         128
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|Ref.2, ECO:0007744|PDB:3KKJ"
FT   BINDING         185
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q48MT7"
FT   BINDING         302
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.2, ECO:0007744|PDB:3KKJ"
FT   BINDING         308
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q48MT7"
FT   BINDING         309
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|Ref.2, ECO:0007744|PDB:3KKJ"
FT   STRAND          5..8
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   HELIX           12..23
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          28..31
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          33..37
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   HELIX           39..41
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          43..46
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          49..52
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   HELIX           63..75
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          77..81
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          85..92
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          102..108
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   HELIX           111..117
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          128..133
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          138..142
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          147..152
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          154..156
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   HELIX           160..163
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   HELIX           164..167
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   HELIX           171..177
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          182..194
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          202..205
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          207..215
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   HELIX           216..218
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          225..233
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   HELIX           235..240
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   TURN            241..243
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   HELIX           246..258
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          269..283
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          288..292
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   TURN            293..296
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   STRAND          297..299
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   HELIX           302..304
FT                   /evidence="ECO:0007829|PDB:3KKJ"
FT   HELIX           309..326
FT                   /evidence="ECO:0007829|PDB:3KKJ"
SQ   SEQUENCE   328 AA;  35840 MW;  672D6BC25518DE76 CRC64;
     MTVPIAIIGT GIAGLSAAQA LTAAGHQVHL FDKSRGSGGR MSSKRSDAGA LDMGAQYFTA
     RDRRFATAVK QWQAQGHVAE WTPLLYNFHA GRLSPSPDEQ VRWVGKPGMS AITRAMRGDM
     PVSFSCRITE VFRGEEHWNL LDAEGQNHGP FSHVIIATPA PQASTLLAAA PKLASVVAGV
     KMDPTWAVAL AFETPLQTPM QGCFVQDSPL DWLARNRSKP ERDDTLDTWI LHATSQWSRQ
     NLDASREQVI EHLHGAFAEL IDCTMPAPVF SLAHRWLYAR PAGAHEWGAL SDADLGIYVC
     GDWCLSGRVE GAWLSGQEAA RRLLEHLQ
//
ID   PPOM_TOBAC              Reviewed;         504 AA.
AC   O24164;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   02-JUN-2021, entry version 118.
DE   RecName: Full=Protoporphyrinogen oxidase, mitochondrial;
DE            EC=1.3.3.4;
DE   AltName: Full=PX-2;
DE   AltName: Full=Protoporphyrinogen IX oxidase isozyme II;
DE            Short=PPO II;
DE            Short=PPX II;
GN   Name=PPXII; Synonyms=PPOX2;
OS   Nicotiana tabacum (Common tobacco).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   asterids; lamiids; Solanales; Solanaceae; Nicotianoideae; Nicotianeae;
OC   Nicotiana.
OX   NCBI_TaxID=4097;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, DEVELOPMENTAL STAGE, INDUCTION, AND
RP   SUBCELLULAR LOCATION.
RC   STRAIN=cv. SR1;
RX   PubMed=9238074; DOI=10.1073/pnas.94.16.8895;
RA   Lermontova I., Kruse E., Mock H.-P., Grimm B.;
RT   "Cloning and characterization of a plastidal and a mitochondrial isoform of
RT   tobacco protoporphyrinogen IX oxidase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:8895-8900(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Samsun NN;
RX   PubMed=9808719; DOI=10.1104/pp.118.3.751;
RA   Watanabe N., Che F., Iwano M., Takayama S., Nakano T., Yoshida S.,
RA   Isogai A.;
RT   "Molecular characterization of photomixotrophic cultured tobacco cells
RT   resistant to protoporphyrinogen oxidase-inhibiting herbicides.";
RL   Plant Physiol. 118:751-758(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. SR1;
RA   Horikoshi M., Mametsuka K., Hirooka T.;
RT   "The molecular basis of photobleaching herbicide resistance in Tobacco.";
RL   Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) IN COMPLEX WITH SYNTHETIC INHIBITOR
RP   AND FAD, IDENTIFICATION BY MASS SPECTROMETRY, AND COFACTOR.
RX   PubMed=15057273; DOI=10.1038/sj.emboj.7600189;
RA   Koch M., Breithaupt C., Kiefersauer R., Freigang J., Huber R.,
RA   Messerschmidt A.;
RT   "Crystal structure of protoporphyrinogen IX oxidase: a key enzyme in haem
RT   and chlorophyll biosynthesis.";
RL   EMBO J. 23:1720-1728(2004).
CC   -!- FUNCTION: Catalyzes the 6-electron oxidation of protoporphyrinogen-IX
CC       to form protoporphyrin-IX. {ECO:0000269|PubMed:9238074}.
CC   -!- FUNCTION: Provides precursor for the mitochondrial and plastidic heme
CC       synthesis and the predominant chlorophyll synthesis in plastids.
CC       {ECO:0000269|PubMed:9238074}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3 O2 + protoporphyrinogen IX = 3 H2O2 + protoporphyrin IX;
CC         Xref=Rhea:RHEA:25576, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:57306, ChEBI:CHEBI:57307; EC=1.3.3.4;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:15057273};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:15057273};
CC   -!- ACTIVITY REGULATION: Inhibited by the herbicide acifluorfen.
CC   -!- PATHWAY: Porphyrin-containing compound metabolism; protoporphyrin-IX
CC       biosynthesis; protoporphyrin-IX from protoporphyrinogen-IX: step 1/1.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:9238074}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in expanding premature leaves. Decreased
CC       expression in oldest leaves. Also detected in roots.
CC       {ECO:0000269|PubMed:9238074}.
CC   -!- INDUCTION: Oscillating expression during diurnal growth. Maximal
CC       expression in the dark period. {ECO:0000269|PubMed:9238074}.
CC   -!- SIMILARITY: Belongs to the protoporphyrinogen/coproporphyrinogen
CC       oxidase family. Protoporphyrinogen oxidase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y13466; CAA73866.1; -; mRNA.
DR   EMBL; AB020500; BAA34712.1; -; mRNA.
DR   EMBL; AF044129; AAD02291.1; -; mRNA.
DR   PIR; T04076; T04076.
DR   RefSeq; NP_001312887.1; NM_001325958.1.
DR   PDB; 1SEZ; X-ray; 2.90 A; A/B=1-504.
DR   PDBsum; 1SEZ; -.
DR   SMR; O24164; -.
DR   BindingDB; O24164; -.
DR   ChEMBL; CHEMBL1926489; -.
DR   PRIDE; O24164; -.
DR   GeneID; 107815753; -.
DR   KEGG; nta:107815753; -.
DR   BioCyc; MetaCyc:MONOMER-11759; -.
DR   BRENDA; 1.3.3.4; 3645.
DR   UniPathway; UPA00251; UER00324.
DR   EvolutionaryTrace; O24164; -.
DR   Proteomes; UP000084051; Genome assembly.
DR   GO; GO:0009507; C:chloroplast; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0004729; F:oxygen-dependent protoporphyrinogen oxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006782; P:protoporphyrinogen IX biosynthetic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR004572; Protoporphyrinogen_oxidase.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR00562; proto_IX_ox; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Heme biosynthesis; Mitochondrion;
KW   Oxidoreductase; Porphyrin biosynthesis; Reference proteome.
FT   CHAIN           1..504
FT                   /note="Protoporphyrinogen oxidase, mitochondrial"
FT                   /id="PRO_0000135273"
FT   NP_BIND         20..25
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15057273"
FT   NP_BIND         43..44
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15057273"
FT   NP_BIND         65..68
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15057273"
FT   NP_BIND         473..475
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15057273"
FT   REGION          213..232
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         51
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15057273"
FT   BINDING         264
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:15057273"
FT   STRAND          15..19
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           23..33
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          38..42
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          44..48
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          54..57
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          60..65
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           74..82
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           86..88
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          98..108
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           113..118
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          119..122
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           124..131
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           133..136
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           152..160
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           162..166
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           169..177
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           181..183
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           186..189
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           191..199
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           203..210
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          236..238
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           243..250
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   TURN            255..257
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          264..270
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          272..277
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          279..285
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          287..290
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          296..302
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           306..310
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          312..320
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          331..342
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           343..345
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          346..348
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          352..356
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           359..364
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          368..373
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           374..377
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           379..381
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          386..395
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           399..401
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           406..421
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          428..440
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           446..459
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          463..465
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   STRAND          468..471
FT                   /evidence="ECO:0007829|PDB:1SEZ"
FT   HELIX           475..493
FT                   /evidence="ECO:0007829|PDB:1SEZ"
SQ   SEQUENCE   504 AA;  55407 MW;  B85B55EC881DC00A CRC64;
     MAPSAGEDKH SSAKRVAVIG AGVSGLAAAY KLKIHGLNVT VFEAEGKAGG KLRSVSQDGL
     IWDEGANTMT ESEGDVTFLI DSLGLREKQQ FPLSQNKRYI ARNGTPVLLP SNPIDLIKSN
     FLSTGSKLQM LLEPILWKNK KLSQVSDSHE SVSGFFQRHF GKEVVDYLID PFVAGTCGGD
     PDSLSMHHSF PELWNLEKRF GSVILGAIRS KLSPKNEKKQ GPPKTSANKK RQRGSFSFLG
     GMQTLTDAIC KDLREDELRL NSRVLELSCS CTEDSAIDSW SIISASPHKR QSEEESFDAV
     IMTAPLCDVK SMKIAKRGNP FLLNFIPEVD YVPLSVVITT FKRENVKYPL EGFGVLVPSK
     EQQHGLKTLG TLFSSMMFPD RAPNNVYLYT TFVGGSRNRE LAKASRTELK EIVTSDLKQL
     LGAEGEPTYV NHLYWSKAFP LYGHNYDSVL DAIDKMEKNL PGLFYAGNHR GGLSVGKALS
     SGCNAADLVI SYLESVSTDS KRHC
//
ID   OXYS_STRR1              Reviewed;         503 AA.
AC   L8EUQ6;
DT   28-MAR-2018, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2013, sequence version 1.
DT   02-JUN-2021, entry version 45.
DE   RecName: Full=12-dehydrotetracycline 5-monooxygenase/anhydrotetracycline 6-monooxygenase {ECO:0000303|PubMed:23621493};
DE            EC=1.14.13.234 {ECO:0000269|PubMed:23621493};
DE            EC=1.14.13.38 {ECO:0000269|PubMed:23621493};
GN   Name=oxyS {ECO:0000312|EMBL:ELQ83303.1};
GN   ORFNames=SRIM_10936 {ECO:0000312|EMBL:ELQ83303.1};
OS   Streptomyces rimosus subsp. rimosus (strain ATCC 10970 / DSM 40260 / JCM
OS   4667 / NRRL 2234).
OC   Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC   Streptomyces.
OX   NCBI_TaxID=1265868;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 10970 / DSM 40260 / JCM 4667 / NRRL 2234;
RX   PubMed=23516198; DOI=10.1128/genomea.00063-13;
RA   Pethick F.E., MacFadyen A.C., Tang Z., Sangal V., Liu T.-T., Chu J.,
RA   Kosec G., Petkovic H., Guo M., Kirby R., Hoskisson P.A., Herron P.R.,
RA   Hunter I.S.;
RT   "Draft genome sequence of the oxytetracycline-producing bacterium
RT   Streptomyces rimosus ATCC 10970.";
RL   Genome Announc. 1:E00063-E00063(2013).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) IN COMPLEX WITH FAD, FUNCTION,
RP   CATALYTIC ACTIVITY, MUTAGENESIS OF HIS-47 AND PHE-215, COFACTOR, SUBUNIT,
RP   AND PATHWAY.
RC   STRAIN=ATCC 10970 / DSM 40260 / JCM 4667 / NRRL 2234;
RX   PubMed=23621493; DOI=10.1021/ja403516u;
RA   Wang P., Bashiri G., Gao X., Sawaya M.R., Tang Y.;
RT   "Uncovering the enzymes that catalyze the final steps in oxytetracycline
RT   biosynthesis.";
RL   J. Am. Chem. Soc. 135:7138-7141(2013).
CC   -!- FUNCTION: Involved in the biosynthesis of the antibiotics
CC       oxytetracycline and tetracycline. OxyS starts by catalyzing the
CC       stereospecific hydroxylation of anhydrotetracycline at C(6) position to
CC       yield 5a,11a-dehydrotetracycline (12-dehydrotetracycline). If the
CC       released product is captured by OxyR, it is reduced to tetracycline.
CC       However, if the released product is recaptured by OxyS, it performs an
CC       additional hydroxylation at C(5), producing 5a,11a-
CC       dehydrooxytetracycline, which, following the action of OxyR becomes
CC       oxytetracycline. {ECO:0000269|PubMed:23621493}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5a,11a-dehydrotetracycline + H(+) + NADPH + O2 = 5a,11a-
CC         dehydrooxytetracycline + H2O + NADP(+); Xref=Rhea:RHEA:50388,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57522, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:133012; EC=1.14.13.234;
CC         Evidence={ECO:0000269|PubMed:23621493};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=anhydrotetracycline + H(+) + NADPH + O2 = 5a,11a-
CC         dehydrotetracycline + H2O + NADP(+); Xref=Rhea:RHEA:11976,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57522, ChEBI:CHEBI:57783, ChEBI:CHEBI:58032,
CC         ChEBI:CHEBI:58349; EC=1.14.13.38;
CC         Evidence={ECO:0000269|PubMed:23621493};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:23621493};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:23621493};
CC   -!- PATHWAY: Antibiotic biosynthesis; oxytetracycline biosynthesis.
CC       {ECO:0000305|PubMed:23621493}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:23621493}.
CC   -!- SIMILARITY: Belongs to the PheA/TfdB FAD monooxygenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; ANSJ01000024; ELQ83303.1; -; Genomic_DNA.
DR   RefSeq; WP_003981036.1; NZ_ANSJ01000024.1.
DR   PDB; 4K2X; X-ray; 2.55 A; A/B=1-503.
DR   PDBsum; 4K2X; -.
DR   SMR; L8EUQ6; -.
DR   EnsemblBacteria; ELQ83303; ELQ83303; SRIM_10936.
DR   GeneID; 57895592; -.
DR   PATRIC; fig|1265868.3.peg.2256; -.
DR   OMA; HPEDWAI; -.
DR   BioCyc; MetaCyc:MONOMER-19943; -.
DR   BRENDA; 1.14.13.234; 14570.
DR   UniPathway; UPA00926; -.
DR   Proteomes; UP000011074; Unassembled WGS sequence.
DR   GO; GO:0047670; F:anhydrotetracycline monooxygenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic biosynthesis; FAD; Flavoprotein; Monooxygenase;
KW   NADP; Nucleotide-binding; Oxidoreductase.
FT   CHAIN           1..503
FT                   /note="12-dehydrotetracycline 5-
FT                   monooxygenase/anhydrotetracycline 6-monooxygenase"
FT                   /id="PRO_0000443522"
FT   NP_BIND         32..33
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23621493,
FT                   ECO:0007744|PDB:4K2X"
FT   NP_BIND         301..302
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23621493,
FT                   ECO:0007744|PDB:4K2X"
FT   BINDING         13
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23621493,
FT                   ECO:0007744|PDB:4K2X"
FT   BINDING         44
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:23621493,
FT                   ECO:0007744|PDB:4K2X"
FT   BINDING         99
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23621493,
FT                   ECO:0007744|PDB:4K2X"
FT   BINDING         123
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:23621493,
FT                   ECO:0007744|PDB:4K2X"
FT   BINDING         160
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23621493,
FT                   ECO:0007744|PDB:4K2X"
FT   BINDING         288
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23621493,
FT                   ECO:0007744|PDB:4K2X"
FT   MUTAGEN         47
FT                   /note="H->A: Decrease of the ratio between oxytetracycline
FT                   and tetracycline."
FT                   /evidence="ECO:0000269|PubMed:23621493"
FT   MUTAGEN         215
FT                   /note="F->I: Dramatic change in the product ratio, in which
FT                   the amount of tetracycline exceeds that of
FT                   oxytetracycline."
FT                   /evidence="ECO:0000269|PubMed:23621493"
FT   STRAND          4..8
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           12..23
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          28..33
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           48..56
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           60..64
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          87..90
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          93..95
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           99..112
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          116..119
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          122..128
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          133..139
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          142..153
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           160..165
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          175..187
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          201..205
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   TURN            206..209
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          210..218
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          221..229
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           242..253
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          259..269
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          272..274
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          278..280
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          283..285
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           287..289
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           300..319
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   TURN            325..329
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           330..352
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           357..359
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           360..370
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           373..384
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          393..395
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   TURN            397..400
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          407..410
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          413..416
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           417..420
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          426..433
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           436..441
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           442..444
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   TURN            445..447
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          448..457
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   TURN            462..465
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          467..471
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   STRAND          475..481
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   TURN            483..485
FT                   /evidence="ECO:0007829|PDB:4K2X"
FT   HELIX           490..498
FT                   /evidence="ECO:0007829|PDB:4K2X"
SQ   SEQUENCE   503 AA;  54481 MW;  D04DB9128E0A7566 CRC64;
     MRYDVVIAGA GPTGLMLACE LRLAGARTLV LERLAEPVDF SKALGVHART VELLDMRGLG
     EGFQAEAPKL RGGNFASLGV PLDFSSFDTR HPYALFVPQV RTEELLTGRA LELGAELRRG
     HAVTALEQDA DGVTVSVTGP EGPYEVECAY LVGCDGGGST VRKLLGIDFP GQDPHMFAVI
     ADARFREELP HGEGMGPMRP YGVMRHDLRA WFAAFPLEPD VYRATVAFFD RPYADRRAPV
     TEEDVRAALT EVAGSDFGMH DVRWLSRLTD TSRQAERYRD GRVLLAGDAC HIHLPAGGQG
     LNLGFQDAVN LGWKLGATIA GTAPPELLDT YEAERRPIAA GVLRNTRAQA VLIDPDPRYE
     GLRELMIELL HVPETNRYLA GLISALDVRY PMAGEHPLLG RRVPDLPLVT EDGTRQLSTY
     FHAARGVLLT LGCDQPLADE AAAWKDRVDL VAAEGVADPG SAVDGLTALL VRPDGYICWT
     AAPETGTDGL TDALRTWFGP PAM
//
ID   PLTA_PSEF5              Reviewed;         449 AA.
AC   Q4KCZ0; Q9X3R1;
DT   07-APR-2021, integrated into UniProtKB/Swiss-Prot.
DT   02-AUG-2005, sequence version 1.
DT   02-JUN-2021, entry version 101.
DE   RecName: Full=1H-pyrrole-2-carbonyl-[peptidyl-carrier protein] chlorinase {ECO:0000305};
DE            EC=1.14.19.56 {ECO:0000269|PubMed:16162666};
DE   AltName: Full=FADH2-dependent halogenase PltA {ECO:0000303|PubMed:16162666};
GN   Name=pltA {ECO:0000303|PubMed:10094695};
GN   OrderedLocusNames=PFL_2787 {ECO:0000312|EMBL:AAY92059.1};
OS   Pseudomonas fluorescens (strain ATCC BAA-477 / NRRL B-23932 / Pf-5).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=220664;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC BAA-477 / NRRL B-23932 / Pf-5;
RX   PubMed=10094695; DOI=10.1128/jb.181.7.2166-2174.1999;
RA   Nowak-Thompson B., Chaney N., Wing J.S., Gould S.J., Loper J.E.;
RT   "Characterization of the pyoluteorin biosynthetic gene cluster of
RT   Pseudomonas fluorescens Pf-5.";
RL   J. Bacteriol. 181:2166-2174(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC BAA-477 / NRRL B-23932 / Pf-5;
RX   PubMed=15980861; DOI=10.1038/nbt1110;
RA   Paulsen I.T., Press C.M., Ravel J., Kobayashi D.Y., Myers G.S.A.,
RA   Mavrodi D.V., DeBoy R.T., Seshadri R., Ren Q., Madupu R., Dodson R.J.,
RA   Durkin A.S., Brinkac L.M., Daugherty S.C., Sullivan S.A., Rosovitz M.J.,
RA   Gwinn M.L., Zhou L., Schneider D.J., Cartinhour S.W., Nelson W.C.,
RA   Weidman J., Watkins K., Tran K., Khouri H., Pierson E.A., Pierson L.S. III,
RA   Thomashow L.S., Loper J.E.;
RT   "Complete genome sequence of the plant commensal Pseudomonas fluorescens
RT   Pf-5.";
RL   Nat. Biotechnol. 23:873-878(2005).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RC   STRAIN=ATCC BAA-477 / NRRL B-23932 / Pf-5;
RX   PubMed=16162666; DOI=10.1073/pnas.0506964102;
RA   Dorrestein P.C., Yeh E., Garneau-Tsodikova S., Kelleher N.L., Walsh C.T.;
RT   "Dichlorination of a pyrrolyl-S-carrier protein by FADH2-dependent
RT   halogenase PltA during pyoluteorin biosynthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:13843-13848(2005).
RN   [4] {ECO:0007744|PDB:5DBJ}
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) IN COMPLEX WITH FAD AND CHLORIDE,
RP   SUBUNIT, AND DOMAIN.
RC   STRAIN=ATCC BAA-477 / NRRL B-23932 / Pf-5;
RX   PubMed=26416533; DOI=10.1016/j.jsb.2015.09.013;
RA   Pang A.H., Garneau-Tsodikova S., Tsodikov O.V.;
RT   "Crystal structure of halogenase PltA from the pyoluteorin biosynthetic
RT   pathway.";
RL   J. Struct. Biol. 192:349-357(2015).
CC   -!- FUNCTION: Involved in the biosynthesis of the antibiotic pyoluteorin
CC       (PubMed:16162666). Catalyzes the dichlorination of the pyrrole ring of
CC       pyrrolyl-S-PltL, generating the 5-chloropyrrolyl-S-PltL intermediate
CC       and then the 4,5-dichloropyrrolyl-S-PltL product (PubMed:16162666).
CC       {ECO:0000269|PubMed:16162666}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(1H-pyrrole-2-carbonyl)-[peptidyl-carrier protein] + 2
CC         chloride + 2 FADH2 + 2 O2 = (4,5-dichloro-1H-pyrrole-2-carbonyl)-
CC         [peptidyl-carrier protein] + 2 FAD + 4 H2O; Xref=Rhea:RHEA:56380,
CC         Rhea:RHEA-COMP:14110, Rhea:RHEA-COMP:14498, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:17996, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:138623, ChEBI:CHEBI:140219;
CC         EC=1.14.19.56; Evidence={ECO:0000269|PubMed:16162666};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:56381;
CC         Evidence={ECO:0000269|PubMed:16162666};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(1H-pyrrole-2-carbonyl)-[peptidyl-carrier protein] + chloride
CC         + FADH2 + O2 = (5-chloro-1H-pyrrole-2-carbonyl)-[peptidyl-carrier
CC         protein] + FAD + 2 H2O; Xref=Rhea:RHEA:56384, Rhea:RHEA-COMP:14110,
CC         Rhea:RHEA-COMP:14497, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:17996, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:138623, ChEBI:CHEBI:140221;
CC         Evidence={ECO:0000269|PubMed:16162666};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:56385;
CC         Evidence={ECO:0000269|PubMed:16162666};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5-chloro-1H-pyrrole-2-carbonyl)-[peptidyl-carrier protein] +
CC         chloride + FADH2 + O2 = (4,5-dichloro-1H-pyrrole-2-carbonyl)-
CC         [peptidyl-carrier protein] + FAD + 2 H2O; Xref=Rhea:RHEA:56388,
CC         Rhea:RHEA-COMP:14497, Rhea:RHEA-COMP:14498, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:17996, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:140219, ChEBI:CHEBI:140221;
CC         Evidence={ECO:0000269|PubMed:16162666};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:56389;
CC         Evidence={ECO:0000269|PubMed:16162666};
CC   -!- PATHWAY: Antibiotic biosynthesis. {ECO:0000269|PubMed:16162666}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:26416533}.
CC   -!- DOMAIN: Contains an additional unique helical region at the C-terminus.
CC       This C-terminal region blocks a putative substrate-binding cleft,
CC       suggesting that a conformational change involving repositioning of this
CC       region is necessary to allow binding of the pyrrolyl-S-PltL substrate
CC       for its dichlorination by PltA. {ECO:0000269|PubMed:26416533}.
CC   -!- SIMILARITY: Belongs to the flavin-dependent halogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF081920; AAD24884.1; -; Genomic_DNA.
DR   EMBL; CP000076; AAY92059.1; -; Genomic_DNA.
DR   PIR; T17419; T17419.
DR   RefSeq; WP_011061079.1; NC_004129.6.
DR   PDB; 5DBJ; X-ray; 2.75 A; A/B/C/D/E=1-449.
DR   PDBsum; 5DBJ; -.
DR   SMR; Q4KCZ0; -.
DR   STRING; 220664.PFL_2787; -.
DR   PRIDE; Q4KCZ0; -.
DR   EnsemblBacteria; AAY92059; AAY92059; PFL_2787.
DR   GeneID; 57475838; -.
DR   KEGG; pfl:PFL_2787; -.
DR   PATRIC; fig|220664.5.peg.2843; -.
DR   eggNOG; COG0644; Bacteria.
DR   HOGENOM; CLU_024648_4_0_6; -.
DR   OMA; FPRYQIG; -.
DR   OrthoDB; 1770293at2; -.
DR   BioCyc; MetaCyc:MONOMER-20315; -.
DR   BioCyc; PPRO220664:G1G4K-2858-MONOMER; -.
DR   BRENDA; 1.14.19.56; 5121.
DR   Proteomes; UP000008540; Chromosome.
DR   GO; GO:0047651; F:alkylhalidase activity; IDA:JCVI.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   GO; GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR006905; Flavin_halogenase.
DR   Pfam; PF04820; Trp_halogenase; 2.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic biosynthesis; Chloride; FAD; Flavoprotein;
KW   Nucleotide-binding; Oxidoreductase; Reference proteome.
FT   CHAIN           1..449
FT                   /note="1H-pyrrole-2-carbonyl-[peptidyl-carrier protein]
FT                   chlorinase"
FT                   /id="PRO_0000452248"
FT   NP_BIND         15..16
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26416533,
FT                   ECO:0007744|PDB:5DBJ"
FT   NP_BIND         41..47
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26416533,
FT                   ECO:0007744|PDB:5DBJ"
FT   REGION          327..328
FT                   /note="Chloride binding"
FT                   /evidence="ECO:0000269|PubMed:26416533,
FT                   ECO:0007744|PDB:5DBJ"
FT   BINDING         36
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26416533,
FT                   ECO:0007744|PDB:5DBJ"
FT   BINDING         123
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26416533,
FT                   ECO:0007744|PDB:5DBJ"
FT   BINDING         147
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:26416533,
FT                   ECO:0007744|PDB:5DBJ"
FT   BINDING         316
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26416533,
FT                   ECO:0007744|PDB:5DBJ"
FT   BINDING         329
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:26416533,
FT                   ECO:0007744|PDB:5DBJ"
SQ   SEQUENCE   449 AA;  50677 MW;  0D761E587B9B16DE CRC64;
     MSDHDYDVVI IGGGPAGSTM ASYLAKAGVK CAVFEKELFE REHVGESLVP ATTPVLLEIG
     VMEKIEKANF PKKFGAAWTS ADSGPEDKMG FQGLDHDFRS AEILFNERKQ EGVDRDFTFH
     VDRGKFDRIL LEHAGSLGAK VFQGVEIADV EFLSPGNVIV NAKLGKRSVE IKAKMVVDAS
     GRNVLLGRRL GLREKDPVFN QFAIHSWFDN FDRKSATQSP DKVDYIFIHF LPMTNTWVWQ
     IPITETITSV GVVTQKQNYT NSDLTYEEFF WEAVKTRENL HDALKASEQV RPFKKEADYS
     YGMKEVCGDS FVLIGDAARF VDPIFSSGVS VALNSARIAS GDIIEAVKNN DFSKSSFTHY
     EGMIRNGIKN WYEFITLYYR LNILFTAFVQ DPRYRLDILQ LLQGDVYSGK RLEVLDKMRE
     IIAAVESDPE HLWHKYLGDM QVPTAKPAF
//
ID   PHZS_PSEAE              Reviewed;         402 AA.
AC   Q9HWG9;
DT   27-SEP-2017, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   02-JUN-2021, entry version 120.
DE   RecName: Full=5-methylphenazine-1-carboxylate 1-monooxygenase {ECO:0000305};
DE            EC=1.14.13.218 {ECO:0000269|PubMed:17253782};
GN   Name=phzS {ECO:0000303|PubMed:17012792};
GN   OrderedLocusNames=PA4217 {ECO:0000312|EMBL:AAG07605.1};
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND SUBUNIT.
RX   PubMed=17253782; DOI=10.1021/bi6024403;
RA   Parsons J.F., Greenhagen B.T., Shi K., Calabrese K., Robinson H.,
RA   Ladner J.E.;
RT   "Structural and functional analysis of the pyocyanin biosynthetic protein
RT   PhzM from Pseudomonas aeruginosa.";
RL   Biochemistry 46:1821-1828(2007).
RN   [3]
RP   CRYSTALLIZATION.
RX   PubMed=17012792; DOI=10.1107/s1744309106034464;
RA   Gohain N., Thomashow L.S., Mavrodi D.V., Blankenfeldt W.;
RT   "The purification, crystallization and preliminary structural
RT   characterization of FAD-dependent monooxygenase PhzS, a phenazine-modifying
RT   enzyme from Pseudomonas aeruginosa.";
RL   Acta Crystallogr. F 62:989-992(2006).
RN   [4] {ECO:0007744|PDB:2RGJ}
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) IN COMPLEX WITH FAD, AND COFACTOR.
RX   PubMed=18416536; DOI=10.1021/bi702480t;
RA   Greenhagen B.T., Shi K., Robinson H., Gamage S., Bera A.K., Ladner J.E.,
RA   Parsons J.F.;
RT   "Crystal structure of the pyocyanin biosynthetic protein PhzS.";
RL   Biochemistry 47:5281-5289(2008).
RN   [5] {ECO:0007744|PDB:3C96}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH FAD, AND COFACTOR.
RG   Northeast structural genomics consortium (NESG);
RA   Vorobiev S.M., Chen Y., Seetharaman J., Wang D., Mao L., Xiao R.,
RA   Acton T.B., Montelione G.T., Tong L., Hunt J.F.;
RT   "Crystal structure of the flavin-containing monooxygenase phzS from
RT   Pseudomonas aeruginosa.";
RL   Submitted (FEB-2008) to the PDB data bank.
CC   -!- FUNCTION: Involved in the biosynthesis of pyocyanine, a blue-pigmented
CC       phenazine derivative, which plays a role in virulence. Catalyzes the
CC       oxidative decarboxylation of 5-methylphenazine-1-carboxylate (5-methyl-
CC       PCA) to pyocyanine. Can also act on phenazine-1-carboxylate (PCA),
CC       converting it into 1-hydroxyphenazine (1-HP). However, PCA is a poor
CC       substrate. {ECO:0000269|PubMed:17253782}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5-methyl-phenazine-1-carboxylate + 2 H(+) + NADH + O2 = CO2 +
CC         H2O + NAD(+) + pyocyanin; Xref=Rhea:RHEA:48976, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:62220,
CC         ChEBI:CHEBI:62221; EC=1.14.13.218;
CC         Evidence={ECO:0000269|PubMed:17253782};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:18416536, ECO:0000269|Ref.5};
CC   -!- PATHWAY: Secondary metabolite biosynthesis; pyocyanine biosynthesis.
CC       {ECO:0000269|PubMed:17253782}.
CC   -!- SUBUNIT: Monomer in solution. Probably interacts transiently with PhzM.
CC       {ECO:0000269|PubMed:17253782}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE004091; AAG07605.1; -; Genomic_DNA.
DR   PIR; E83119; E83119.
DR   RefSeq; NP_252907.1; NC_002516.2.
DR   RefSeq; WP_003115086.1; NZ_QZGE01000042.1.
DR   PDB; 2RGJ; X-ray; 2.40 A; A=1-402.
DR   PDB; 3C96; X-ray; 1.90 A; A=1-402.
DR   PDBsum; 2RGJ; -.
DR   PDBsum; 3C96; -.
DR   SMR; Q9HWG9; -.
DR   PaxDb; Q9HWG9; -.
DR   PRIDE; Q9HWG9; -.
DR   DNASU; 881836; -.
DR   EnsemblBacteria; AAG07605; AAG07605; PA4217.
DR   GeneID; 881836; -.
DR   KEGG; pae:PA4217; -.
DR   PATRIC; fig|208964.12.peg.4418; -.
DR   PseudoCAP; PA4217; -.
DR   HOGENOM; CLU_009665_19_5_6; -.
DR   InParanoid; Q9HWG9; -.
DR   OMA; AYENPMI; -.
DR   PhylomeDB; Q9HWG9; -.
DR   BioCyc; MetaCyc:MONOMER-16022; -.
DR   BioCyc; PAER208964:G1FZ6-4290-MONOMER; -.
DR   BRENDA; 1.14.13.218; 5087.
DR   UniPathway; UPA00235; -.
DR   EvolutionaryTrace; Q9HWG9; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; IDA:PseudoCAP.
DR   GO; GO:0102169; F:pyocyanin hydroxylase activity; IEA:RHEA.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01494; FAD_binding_3; 2.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Monooxygenase; NAD; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN           1..402
FT                   /note="5-methylphenazine-1-carboxylate 1-monooxygenase"
FT                   /id="PRO_0000441708"
FT   NP_BIND         14..15
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18416536, ECO:0000269|Ref.5,
FT                   ECO:0007744|PDB:2RGJ, ECO:0007744|PDB:3C96"
FT   NP_BIND         35..36
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18416536, ECO:0000269|Ref.5,
FT                   ECO:0007744|PDB:2RGJ, ECO:0007744|PDB:3C96"
FT   NP_BIND         43..45
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18416536, ECO:0000269|Ref.5,
FT                   ECO:0007744|PDB:2RGJ, ECO:0007744|PDB:3C96"
FT   REGION          368..402
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         106
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18416536, ECO:0000269|Ref.5,
FT                   ECO:0007744|PDB:2RGJ, ECO:0007744|PDB:3C96"
FT   BINDING         132
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:18416536, ECO:0000269|Ref.5,
FT                   ECO:0007744|PDB:2RGJ, ECO:0007744|PDB:3C96"
FT   BINDING         191
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18416536, ECO:0000269|Ref.5,
FT                   ECO:0007744|PDB:2RGJ, ECO:0007744|PDB:3C96"
FT   BINDING         310
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18416536, ECO:0000269|Ref.5,
FT                   ECO:0007744|PDB:2RGJ, ECO:0007744|PDB:3C96"
FT   STRAND          6..10
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   HELIX           14..25
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          29..39
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          46..49
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   HELIX           51..59
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   HELIX           63..69
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          70..73
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          75..79
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          85..90
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   HELIX           92..95
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          101..105
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   HELIX           106..121
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          125..138
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          141..148
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          153..163
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   HELIX           170..175
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          183..197
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          202..209
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          215..220
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   HELIX           223..226
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   TURN            227..229
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          231..240
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   HELIX           241..244
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   HELIX           259..266
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          272..274
FT                   /evidence="ECO:0007829|PDB:2RGJ"
FT   HELIX           276..281
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          284..293
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   STRAND          305..307
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   HELIX           310..313
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   HELIX           323..339
FT                   /evidence="ECO:0007829|PDB:3C96"
FT   HELIX           343..377
FT                   /evidence="ECO:0007829|PDB:3C96"
SQ   SEQUENCE   402 AA;  43645 MW;  F2BB36662ABAC790 CRC64;
     MSEPIDILIA GAGIGGLSCA LALHQAGIGK VTLLESSSEI RPLGVGINIQ PAAVEALAEL
     GLGPALAATA IPTHELRYID QSGATVWSEP RGVEAGNAYP QYSIHRGELQ MILLAAVRER
     LGQQAVRTGL GVERIEERDG RVLIGARDGH GKPQALGADV LVGADGIHSA VRAHLHPDQR
     PLSHGGITMW RGVTEFDRFL DGKTMIVAND EHWSRLVAYP ISARHAAEGK SLVNWVCMVP
     SAAVGQLDNE ADWNRDGRLE DVLPFFADWD LGWFDIRDLL TRNQLILQYP MVDRDPLPHW
     GRGRITLLGD AAHLMYPMGA NGASQAILDG IELAAALARN ADVAAALREY EEARRPTANK
     IILANREREK EEWAAASRPK TEKSAALEAI TGSYRNQVER PR
//
ID   SQRD_ACIAM              Reviewed;         409 AA.
AC   Q7ZAG8;
DT   29-OCT-2014, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   02-JUN-2021, entry version 60.
DE   RecName: Full=Sulfide-quinone reductase {ECO:0000305};
DE            Short=SQR;
DE            EC=1.8.5.4 {ECO:0000269|PubMed:19438211};
DE   AltName: Full=Sulfide:quinone oxidoreductase {ECO:0000303|PubMed:19438211};
GN   Name=sqr {ECO:0000305}; Synonyms=noxA {ECO:0000303|PubMed:12417325};
OS   Acidianus ambivalens (Desulfurolobus ambivalens).
OC   Archaea; Crenarchaeota; Thermoprotei; Sulfolobales; Sulfolobaceae;
OC   Acidianus.
OX   NCBI_TaxID=2283 {ECO:0000312|EMBL:CAD33806.1};
RN   [1] {ECO:0000312|EMBL:CAD33806.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Lei 10 / DSM 3772 / JCM 9191 {ECO:0000312|EMBL:CAD33806.1};
RX   PubMed=12417325; DOI=10.1016/s0014-5793(02)03514-7;
RA   Bandeiras T.M., Salgueiro C., Kletzin A., Gomes C.M., Teixeira M.;
RT   "Acidianus ambivalens type-II NADH dehydrogenase: genetic characterisation
RT   and identification of the flavin moiety as FMN.";
RL   FEBS Lett. 531:273-277(2002).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.57 ANGSTROMS) IN COMPLEX WITH FAD, FUNCTION,
RP   CATALYTIC ACTIVITY, ACTIVE SITE, ACTIVITY REGULATION, COFACTOR, DISULFIDE
RP   BOND, SUBCELLULAR LOCATION, SUBUNIT, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19438211; DOI=10.1021/bi9003827;
RA   Brito J.A., Sousa F.L., Stelter M., Bandeiras T.M., Vonrhein C.,
RA   Teixeira M., Pereira M.M., Archer M.;
RT   "Structural and functional insights into sulfide:quinone oxidoreductase.";
RL   Biochemistry 48:5613-5622(2009).
CC   -!- FUNCTION: Catalyzes the oxidation of sulfides, such as hydrogen
CC       sulfide, with the help of a quinone. Has the highest activity with
CC       caldariella quinone and decylubiquinone, and lower activity with
CC       naphtoquinones. Consecutive reaction cycles lead to the accumulation of
CC       a polysulfide product on the active site Cys residues; these products
CC       are released when they exceed a critical length, typically as
CC       cyclooctasulfur. {ECO:0000269|PubMed:19438211}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=n a quinone + n H(+) + n hydrogen sulfide = n a quinol + n
CC         sulfur; Xref=Rhea:RHEA:30239, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:26833, ChEBI:CHEBI:29919, ChEBI:CHEBI:132124; EC=1.8.5.4;
CC         Evidence={ECO:0000269|PubMed:19438211};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:19438211};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:19438211};
CC   -!- ACTIVITY REGULATION: Inhibited by the quinone analog 2-heptyl-4-
CC       hydroxyquinolone N-oxide (HQNO). Inactivated by iodoacetamide
CC       treatment. Inhibited by KCN. {ECO:0000269|PubMed:19438211}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is about 6. {ECO:0000269|PubMed:19438211};
CC       Temperature dependence:
CC         Optimum temperature is above 70 degrees Celsius.
CC         {ECO:0000269|PubMed:19438211};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:19438211}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000303|PubMed:19438211};
CC       Peripheral membrane protein {ECO:0000303|PubMed:19438211}.
CC   -!- SIMILARITY: Belongs to the SQRD family. {ECO:0000305}.
CC   -!- CAUTION: Was originally identified as FMN-containing NADH dehydrogenase
CC       (PubMed:12417325), based on the NADH oxidase activity of the C-
CC       terminally truncated protein. Was then shown to function as
CC       sulfide:quinone reductase. The full-length protein does not have NADH
CC       oxidase activity (PubMed:19438211). {ECO:0000269|PubMed:19438211,
CC       ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ489504; CAD33806.1; -; Genomic_DNA.
DR   PDB; 3H8I; X-ray; 2.65 A; A/B=1-409.
DR   PDB; 3H8L; X-ray; 2.57 A; A/B=1-409.
DR   PDBsum; 3H8I; -.
DR   PDBsum; 3H8L; -.
DR   SMR; Q7ZAG8; -.
DR   EvolutionaryTrace; Q7ZAG8; -.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0048038; F:quinone binding; IEA:UniProtKB-KW.
DR   GO; GO:0070224; F:sulfide:quinone oxidoreductase activity; IEA:RHEA.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   Pfam; PF07992; Pyr_redox_2; 2.
DR   SUPFAM; SSF51905; SSF51905; 2.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Membrane; Nucleotide-binding;
KW   Oxidoreductase; Quinone.
FT   CHAIN           1..409
FT                   /note="Sulfide-quinone reductase"
FT                   /id="PRO_0000430826"
FT   NP_BIND         8..12
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19438211"
FT   NP_BIND         34..35
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19438211"
FT   ACT_SITE        178
FT                   /note="Cysteine persulfide intermediate"
FT                   /evidence="ECO:0000269|PubMed:19438211"
FT   ACT_SITE        350
FT                   /note="Cysteine persulfide intermediate"
FT                   /evidence="ECO:0000269|PubMed:19438211"
FT   BINDING         129
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19438211"
FT   BINDING         271
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19438211"
FT   BINDING         307
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19438211"
FT   BINDING         317
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:19438211"
FT   STRAND          3..7
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   HELIX           11..24
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   HELIX           25..27
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          28..41
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          58..61
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   HELIX           62..65
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   HELIX           67..69
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          72..75
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          77..82
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   TURN            83..86
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          87..91
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          97..101
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          103..107
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   HELIX           115..117
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   HELIX           121..124
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          126..130
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   HELIX           133..143
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          146..153
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   HELIX           180..194
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   TURN            195..197
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   TURN            199..201
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          202..207
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          209..213
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   HELIX           218..231
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          234..236
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          241..244
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          246..251
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          256..258
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          260..265
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   HELIX           272..275
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   HELIX           279..281
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          294..298
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   STRAND          302..304
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   HELIX           306..308
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   HELIX           317..334
FT                   /evidence="ECO:0007829|PDB:3H8L"
FT   HELIX           351..353
FT                   /evidence="ECO:0007829|PDB:3H8L"
SQ   SEQUENCE   409 AA;  45152 MW;  2E5BC25064F47F21 CRC64;
     MTKVLVLGGR FGALTAAYTL KRLVGSKADV KVINKSRFSY FRPALPHVAI GVRDVDELKV
     DLSEALPEKG IQFQEGTVEK IDAKSSMVYY TKPDGSMAEE EYDYVIVGIG AHLATELVKG
     WDKYGYSVCE PEFATKLREK LESFQGGNIA IGSGPFYQGH NPKPKVPENF VPNADSACEG
     PVFEMSLMLH GYFKKKGMLD KVHVTVFSPG EYLSDLSPNS RKAVASIYNQ LGIKLVHNFK
     IKEIREHEIV DEKGNTIPAD ITILLPPYTG NPALKNSTPD LVDDGGFIPT DLNMVSIKYD
     NVYAVGDANS MTVPKLGYLA VMTGRIAAQH LANRLGVPTK VDKYYPTIMC VADNPYEGYA
     VSVKDDTWYG GTVSIADPAA VNHLKKELFT KYYMWTKGDM ALEKFLASW
//
ID   THYX_HELPY              Reviewed;         208 AA.
AC   O26061;
DT   11-JUL-2001, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2001, sequence version 2.
DT   02-JUN-2021, entry version 123.
DE   RecName: Full=Flavin-dependent thymidylate synthase {ECO:0000303|PubMed:12029065};
DE            Short=FDTS {ECO:0000255|HAMAP-Rule:MF_01408};
DE            EC=2.1.1.148 {ECO:0000269|PubMed:12029065};
DE   AltName: Full=FAD-dependent thymidylate synthase {ECO:0000255|HAMAP-Rule:MF_01408};
DE   AltName: Full=Thymidylate synthase ThyX {ECO:0000303|PubMed:12029065};
DE            Short=TS {ECO:0000255|HAMAP-Rule:MF_01408};
DE            Short=TSase {ECO:0000255|HAMAP-Rule:MF_01408};
GN   Name=thyX {ECO:0000303|PubMed:12029065}; OrderedLocusNames=HP_1533;
OS   Helicobacter pylori (strain ATCC 700392 / 26695) (Campylobacter pylori).
OC   Bacteria; Proteobacteria; Epsilonproteobacteria; Campylobacterales;
OC   Helicobacteraceae; Helicobacter.
OX   NCBI_TaxID=85962;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700392 / 26695;
RX   PubMed=9252185; DOI=10.1038/41483;
RA   Tomb J.-F., White O., Kerlavage A.R., Clayton R.A., Sutton G.G.,
RA   Fleischmann R.D., Ketchum K.A., Klenk H.-P., Gill S.R., Dougherty B.A.,
RA   Nelson K.E., Quackenbush J., Zhou L., Kirkness E.F., Peterson S.N.,
RA   Loftus B.J., Richardson D.L., Dodson R.J., Khalak H.G., Glodek A.,
RA   McKenney K., FitzGerald L.M., Lee N., Adams M.D., Hickey E.K., Berg D.E.,
RA   Gocayne J.D., Utterback T.R., Peterson J.D., Kelley J.M., Cotton M.D.,
RA   Weidman J.F., Fujii C., Bowman C., Watthey L., Wallin E., Hayes W.S.,
RA   Borodovsky M., Karp P.D., Smith H.O., Fraser C.M., Venter J.C.;
RT   "The complete genome sequence of the gastric pathogen Helicobacter
RT   pylori.";
RL   Nature 388:539-547(1997).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, SUBUNIT, AND MUTAGENESIS OF SER-84.
RX   PubMed=12029065; DOI=10.1126/science.1072113;
RA   Myllykallio H., Lipowski G., Leduc D., Filee J., Forterre P., Liebl U.;
RT   "An alternative flavin-dependent mechanism for thymidylate synthesis.";
RL   Science 297:105-107(2002).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) IN COMPLEX WITH FAD AND DUMP, AND
RP   COFACTOR.
RC   STRAIN=ATCC 700392 / 26695;
RX   PubMed=22512654; DOI=10.2174/092986612803217105;
RA   Zhang X., Zhang J., Guo G., Mao X., Hu Y., Zou Q.;
RT   "Crystal structure of a flavin-dependent thymidylate synthase from
RT   Helicobacter pylori strain 26695.";
RL   Protein Pept. Lett. 19:1225-1230(2012).
CC   -!- FUNCTION: Catalyzes the reductive methylation of 2'-deoxyuridine-5'-
CC       monophosphate (dUMP) to 2'-deoxythymidine-5'-monophosphate (dTMP) while
CC       utilizing 5,10-methylenetetrahydrofolate (mTHF) as the methyl donor,
CC       and NAD(P)H and FADH(2) as the reductant.
CC       {ECO:0000269|PubMed:12029065}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6R)-5,10-methylene-5,6,7,8-tetrahydrofolate + dUMP + H(+) +
CC         NADPH = (6S)-5,6,7,8-tetrahydrofolate + dTMP + NADP(+);
CC         Xref=Rhea:RHEA:29043, ChEBI:CHEBI:15378, ChEBI:CHEBI:15636,
CC         ChEBI:CHEBI:57453, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:63528, ChEBI:CHEBI:246422; EC=2.1.1.148;
CC         Evidence={ECO:0000269|PubMed:12029065};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:22512654, ECO:0000305|PubMed:12029065};
CC       Note=Binds 4 FAD per tetramer. Each FAD binding site is formed by three
CC       monomers. {ECO:0000269|PubMed:22512654};
CC   -!- PATHWAY: Pyrimidine metabolism; dTTP biosynthesis. {ECO:0000255|HAMAP-
CC       Rule:MF_01408}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:12029065}.
CC   -!- MISCELLANEOUS: ThyX activity is mechanistically distinct from ThyA
CC       activity.
CC   -!- SIMILARITY: Belongs to the thymidylate synthase ThyX family.
CC       {ECO:0000255|HAMAP-Rule:MF_01408}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD08571.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE000511; AAD08571.1; ALT_INIT; Genomic_DNA.
DR   PIR; E64711; E64711.
DR   RefSeq; NP_208323.1; NC_000915.1.
DR   RefSeq; WP_000451918.1; NC_000915.1.
DR   PDB; 3AH5; X-ray; 2.50 A; A/B/C/D/E/F=1-208.
DR   PDBsum; 3AH5; -.
DR   SMR; O26061; -.
DR   IntAct; O26061; 12.
DR   MINT; O26061; -.
DR   STRING; 85962.C694_07940; -.
DR   PaxDb; O26061; -.
DR   EnsemblBacteria; AAD08571; AAD08571; HP_1533.
DR   KEGG; hpy:HP1533; -.
DR   PATRIC; fig|85962.47.peg.1648; -.
DR   eggNOG; COG1351; Bacteria.
DR   OMA; CWQSFDK; -.
DR   BioCyc; MetaCyc:MONOMER-15768; -.
DR   BRENDA; 2.1.1.148; 2604.
DR   BRENDA; 2.1.1.45; 2604.
DR   UniPathway; UPA00575; -.
DR   EvolutionaryTrace; O26061; -.
DR   Proteomes; UP000000429; Chromosome.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:0070402; F:NADPH binding; IBA:GO_Central.
DR   GO; GO:0050797; F:thymidylate synthase (FAD) activity; IBA:GO_Central.
DR   GO; GO:0004799; F:thymidylate synthase activity; IBA:GO_Central.
DR   GO; GO:0006231; P:dTMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006235; P:dTTP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.1360.170; -; 1.
DR   HAMAP; MF_01408; ThyX; 1.
DR   InterPro; IPR003669; Thymidylate_synthase_ThyX.
DR   InterPro; IPR036098; Thymidylate_synthase_ThyX_sf.
DR   PANTHER; PTHR34934; PTHR34934; 1.
DR   Pfam; PF02511; Thy1; 1.
DR   SUPFAM; SSF69796; SSF69796; 1.
DR   TIGRFAMs; TIGR02170; thyX; 1.
DR   PROSITE; PS51331; THYX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Methyltransferase; NADP;
KW   Nucleotide biosynthesis; Reference proteome; Transferase.
FT   CHAIN           1..208
FT                   /note="Flavin-dependent thymidylate synthase"
FT                   /id="PRO_0000175566"
FT   DOMAIN          1..208
FT                   /note="ThyX"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00661"
FT   NP_BIND         71..74
FT                   /note="dUMP; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:22512654,
FT                   ECO:0007744|PDB:3AH5"
FT   NP_BIND         74..76
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22512654,
FT                   ECO:0007744|PDB:3AH5"
FT   NP_BIND         84..86
FT                   /note="dUMP"
FT                   /evidence="ECO:0000269|PubMed:22512654,
FT                   ECO:0007744|PDB:3AH5"
FT   NP_BIND         163..165
FT                   /note="FAD; shared with neighboring subunits"
FT                   /evidence="ECO:0000269|PubMed:22512654,
FT                   ECO:0007744|PDB:3AH5"
FT   MOTIF           74..84
FT                   /note="ThyX motif"
FT                   /evidence="ECO:0000305|PubMed:12029065"
FT   ACT_SITE        174
FT                   /note="Involved in ionization of N3 of dUMP, leading to its
FT                   activation"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01408"
FT   BINDING         50
FT                   /note="FAD; shared with neighboring subunits"
FT                   /evidence="ECO:0000269|PubMed:22512654,
FT                   ECO:0007744|PDB:3AH5"
FT   BINDING         147
FT                   /note="dUMP"
FT                   /evidence="ECO:0000269|PubMed:22512654"
FT   BINDING         169
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22512654,
FT                   ECO:0007744|PDB:3AH5"
FT   BINDING         174
FT                   /note="dUMP; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:22512654,
FT                   ECO:0007744|PDB:3AH5"
FT   MUTAGEN         84
FT                   /note="S->A: Abolishes complementation when expressed in an
FT                   E.coli thyA deletion mutant."
FT                   /evidence="ECO:0000269|PubMed:12029065"
FT   STRAND          2..8
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   HELIX           12..22
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   HELIX           25..27
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   STRAND          30..32
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   HELIX           33..43
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   HELIX           46..54
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   STRAND          56..65
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   HELIX           66..72
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   STRAND          77..82
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   HELIX           85..88
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   HELIX           89..92
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   HELIX           103..109
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   TURN            110..112
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   HELIX           119..137
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   HELIX           143..146
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   HELIX           147..149
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   STRAND          154..163
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   HELIX           164..174
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   HELIX           181..193
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   TURN            196..198
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   HELIX           199..201
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   HELIX           203..205
FT                   /evidence="ECO:0007829|PDB:3AH5"
FT   TURN            206..208
FT                   /evidence="ECO:0007829|PDB:3AH5"
SQ   SEQUENCE   208 AA;  24071 MW;  88FF23ED4B26283C CRC64;
     MEVICKHYTP LDIASQAIRT CWQSFEYSDD GGCKDKELIH RVGNIFRHSS TLEHLYYNFE
     IKGLSRGALQ ELSRHRIASL SVKSSRYTLR ELKEVESFLP LNETNLERAK EFLVFVDNEK
     VNAMSVLALE NLRILLSEHN IKNDLAKYAM PESYKTHLAY SINARSLQNF LTLRSSNKAL
     KEMQDLAKAL FDALPGEHQY LFEDCLKH
//
ID   SPCAD_ADVMD             Reviewed;         401 AA.
AC   K4L7X3;
DT   10-FEB-2021, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2013, sequence version 1.
DT   02-JUN-2021, entry version 44.
DE   RecName: Full=3-sulfinopropanoyl-CoA desulfinase {ECO:0000305};
DE            EC=3.13.1.4 {ECO:0000269|PubMed:23354747, ECO:0000269|PubMed:26057676};
DE   AltName: Full=3-sulfinopropionyl coenzyme A desulfinase {ECO:0000303|PubMed:23354747};
DE            Short=3-sulfinopropionyl-CoA desulfinase {ECO:0000305};
DE            Short=3SP-CoA desulfinase {ECO:0000305};
GN   Name=acd {ECO:0000303|PubMed:23354747};
GN   ORFNames=MIM_c31390 {ECO:0000312|EMBL:AHG65203.1};
OS   Advenella mimigardefordensis (strain DSM 17166 / LMG 22922 / DPN7).
OC   Bacteria; Proteobacteria; Betaproteobacteria; Burkholderiales;
OC   Alcaligenaceae.
OX   NCBI_TaxID=1247726;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND DISRUPTION PHENOTYPE.
RC   STRAIN=DSM 17166 / LMG 22922 / DPN7;
RX   PubMed=23354747; DOI=10.1128/jb.02105-12;
RA   Schurmann M., Deters A., Wubbeler J.H., Steinbuchel A.;
RT   "A novel 3-sulfinopropionyl coenzyme A (3SP-CoA) desulfinase from Advenella
RT   mimigardefordensis strain DPN7T acting as a key enzyme during catabolism of
RT   3,3'-dithiodipropionic acid is a member of the acyl-CoA dehydrogenase
RT   superfamily.";
RL   J. Bacteriol. 195:1538-1551(2013).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=DSM 17166 / LMG 22922 / DPN7;
RX   PubMed=24739217; DOI=10.1099/mic.0.078279-0;
RA   Wubbeler J.H., Hiessl S., Schuldes J., Thurmer A., Daniel R.,
RA   Steinbuchel A.;
RT   "Unravelling the complete genome sequence of Advenella mimigardefordensis
RT   strain DPN7T and novel insights in the catabolism of the xenobiotic
RT   polythioester precursor 3,3'-dithiodipropionate.";
RL   Microbiology 160:1401-1416(2014).
RN   [3] {ECO:0007744|PDB:5AF7, ECO:0007744|PDB:5AHS}
RP   X-RAY CRYSTALLOGRAPHY (1.89 ANGSTROMS) IN COMPLEXES WITH FAD AND
RP   SUCCINYL-COA, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, SUBUNIT, AND
RP   MUTAGENESIS OF ARG-84 AND GLN-246.
RC   STRAIN=DSM 17166 / LMG 22922 / DPN7;
RX   PubMed=26057676; DOI=10.1107/s1399004715006616;
RA   Schurmann M., Meijers R., Schneider T.R., Steinbuchel A., Cianci M.;
RT   "3-Sulfinopropionyl-coenzyme A (3SP-CoA) desulfinase from Advenella
RT   mimigardefordensis DPN7(T): crystal structure and function of a desulfinase
RT   with an acyl-CoA dehydrogenase fold.";
RL   Acta Crystallogr. D 71:1360-1372(2015).
CC   -!- FUNCTION: Catalyzes the conversion 3-sulfinopropanoyl-CoA (3SP-CoA) to
CC       propanoyl-CoA by abstraction of sulfite (PubMed:23354747,
CC       PubMed:26057676). Does not show dehydrogenase activity
CC       (PubMed:23354747). Involved in the degradation of 3,3'-
CC       dithiodipropionate (DTDP), a sulfur-containing precursor substrate for
CC       biosynthesis of polythioesters (PTEs) (PubMed:23354747).
CC       {ECO:0000269|PubMed:23354747, ECO:0000269|PubMed:26057676}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-sulfinopropanoyl-CoA + H2O = H(+) + propanoyl-CoA + sulfite;
CC         Xref=Rhea:RHEA:41624, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17359, ChEBI:CHEBI:57392, ChEBI:CHEBI:78349; EC=3.13.1.4;
CC         Evidence={ECO:0000269|PubMed:23354747, ECO:0000269|PubMed:26057676};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41625;
CC         Evidence={ECO:0000269|PubMed:23354747, ECO:0000269|PubMed:26057676};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:23354747, ECO:0000269|PubMed:26057676};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:26057676};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.013 mM for 3SP-CoA {ECO:0000269|PubMed:23354747};
CC         Vmax=4.19 umol/min/mg enzyme {ECO:0000269|PubMed:23354747};
CC         Note=kcat is 3.13 sec(-1). {ECO:0000269|PubMed:23354747};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:23354747,
CC       ECO:0000269|PubMed:26057676}.
CC   -!- DISRUPTION PHENOTYPE: Deletion of the gene completely impairs growth on
CC       DTDP or 3-sulfinopropanoyl (3SP) as the sole carbon source.
CC       {ECO:0000269|PubMed:23354747}.
CC   -!- MISCELLANEOUS: Does not catalyze the dehydrogenation of acyl-CoA
CC       thioesters (PubMed:23354747). The absence of dehydrogenase activity is
CC       most probably caused by the absence of a catalytic glutamate residue in
CC       either of the two positions conserved throughout the acyl-CoA
CC       dehydrogenase family (PubMed:23354747). {ECO:0000269|PubMed:23354747}.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JX535522; AFV08642.1; -; Genomic_DNA.
DR   EMBL; CP003915; AHG65203.1; -; Genomic_DNA.
DR   RefSeq; WP_025373864.1; NZ_CP003915.1.
DR   PDB; 5AF7; X-ray; 1.89 A; A/B=1-401.
DR   PDB; 5AHS; X-ray; 2.30 A; A/B/C/D/E/F=1-401.
DR   PDBsum; 5AF7; -.
DR   PDBsum; 5AHS; -.
DR   SMR; K4L7X3; -.
DR   STRING; 1247726.MIM_c31390; -.
DR   EnsemblBacteria; AHG65203; AHG65203; MIM_c31390.
DR   KEGG; amim:MIM_c31390; -.
DR   PATRIC; fig|1247726.3.peg.3460; -.
DR   eggNOG; COG1960; Bacteria.
DR   HOGENOM; CLU_018204_0_2_4; -.
DR   OrthoDB; 760677at2; -.
DR   BioCyc; MetaCyc:MONOMER-18550; -.
DR   BRENDA; 3.13.1.4; 10048.
DR   Proteomes; UP000019095; Chromosome.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016627; F:oxidoreductase activity, acting on the CH-CH group of donors; IEA:InterPro.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Hydrolase; Reference proteome.
FT   CHAIN           1..401
FT                   /note="3-sulfinopropanoyl-CoA desulfinase"
FT                   /id="PRO_0000452007"
FT   NP_BIND         121..124
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26057676,
FT                   ECO:0007744|PDB:5AF7, ECO:0007744|PDB:5AHS"
FT   NP_BIND         153..156
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26057676,
FT                   ECO:0007744|PDB:5AF7, ECO:0007744|PDB:5AHS"
FT   NP_BIND         366..370
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26057676,
FT                   ECO:0007744|PDB:5AF7, ECO:0007744|PDB:5AHS"
FT   REGION          243..244
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000305|PubMed:26057676"
FT   BINDING         130
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26057676,
FT                   ECO:0007744|PDB:5AF7, ECO:0007744|PDB:5AHS"
FT   BINDING         272
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26057676,
FT                   ECO:0007744|PDB:5AF7, ECO:0007744|PDB:5AHS"
FT   BINDING         339
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:26057676,
FT                   ECO:0007744|PDB:5AF7, ECO:0007744|PDB:5AHS"
FT   BINDING         343
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26057676,
FT                   ECO:0007744|PDB:5AF7, ECO:0007744|PDB:5AHS"
FT   BINDING         387
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26057676,
FT                   ECO:0007744|PDB:5AF7, ECO:0007744|PDB:5AHS"
FT   SITE            84
FT                   /note="Important for activity"
FT                   /evidence="ECO:0000269|PubMed:26057676"
FT   MUTAGEN         84
FT                   /note="R->K: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:26057676"
FT   MUTAGEN         246
FT                   /note="Q->E: Slight decrease in catalytic efficiency, but
FT                   still acts as a desulfinase. Does not gain acyl-CoA
FT                   dehydrogenase activity."
FT                   /evidence="ECO:0000269|PubMed:26057676"
FT   HELIX           6..21
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           24..26
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           27..33
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           38..46
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           56..58
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           65..78
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           80..88
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           93..100
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           103..114
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   STRAND          120..122
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   STRAND          128..131
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           132..134
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   STRAND          138..142
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   STRAND          145..156
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   TURN            157..160
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   STRAND          163..172
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   STRAND          175..185
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   STRAND          194..199
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   STRAND          202..204
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   STRAND          210..221
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           222..224
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           232..240
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           242..271
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           279..281
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           283..308
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   STRAND          309..313
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           316..340
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           343..346
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           352..359
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           360..363
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   TURN            364..366
FT                   /evidence="ECO:0007829|PDB:5AF7"
FT   HELIX           369..380
FT                   /evidence="ECO:0007829|PDB:5AF7"
SQ   SEQUENCE   401 AA;  43531 MW;  3FC28DD46398636B CRC64;
     MYELTPEQRT LQTQARELAQ SVFASTAVQT DLTEQYPWDN VAQLRDAGFM GMMLPTSVGG
     RGLSTLDTVI VIEEMAKACA TMGRITVDSN LGAIGAITKY GSEEQIKLAA DLVLAGDKPA
     ICISEPNAGS AASEMTTRAD KNGDHYILNG EKYWITGGGV SKLHLIFARV FDDGVEQGIG
     AFITVLDDHG PEGLKVGRRL YAMGVRGIPE THLEFHDLKI HKSMMITFPD GLKRGFAALM
     SAYNAQRVGA GAVALGIAQC AFEEGVAYLK RREQFGRPLA EFQGLQWMVA DMSVQLEAAR
     LMLRSAAVSG ETFPDINKAA QAKIFAAETA NKVTNDALQF FGSSGYGRHN PMERHVRDAR
     MFTIAGGTAQ ILRTQVASKI LDMKLPQTRD GYLKAAQNSK R
//
ID   NIA_ULVPR               Reviewed;         863 AA.
AC   A0A286R227;
DT   17-JUN-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-NOV-2017, sequence version 1.
DT   02-JUN-2021, entry version 18.
DE   RecName: Full=Nitrate reductase [NADH] {ECO:0000305};
DE            Short=NR {ECO:0000303|PubMed:28650572};
DE            EC=1.7.1.1 {ECO:0000269|PubMed:29371148};
OS   Ulva prolifera (Green seaweed) (Enteromorpha prolifera).
OC   Eukaryota; Viridiplantae; Chlorophyta; Ulvophyceae; OUU clade; Ulvales;
OC   Ulvaceae; Ulva.
OX   NCBI_TaxID=3117;
RN   [1] {ECO:0000312|EMBL:ASV49154.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND INDUCTION.
RX   PubMed=28650572; DOI=10.1111/jpy.12556;
RA   Guo Y., Wang H.Z., Wu C.H., Fu H.H., Jiang P.;
RT   "Cloning and characterization of nitrate reductase gene in Ulva prolifera
RT   (Ulvophyceae, Chlorophyta).";
RL   J. Phycol. 53:1035-1043(2017).
RN   [2] {ECO:0007744|PDB:5YLY}
RP   X-RAY CRYSTALLOGRAPHY (1.76 ANGSTROMS) OF 572-863 IN COMPLEX WITH FAD,
RP   CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF
RP   HIS-640; ARG-659; THR-662 AND CYS-835, AND 3D-STRUCTURE MODELING OF THE
RP   FAD-BINDING DOMAIN IN COMPLEX WITH CYTOCHROME B5 FRAGMENT.
RX   PubMed=29371148; DOI=10.1016/j.ijbiomac.2018.01.140;
RA   You C., Liu C., Li Y., Jiang P., Ma Q.;
RT   "Structural and enzymatic analysis of the cytochrome b5 reductase domain of
RT   Ulva prolifera nitrate reductase.";
RL   Int. J. Biol. Macromol. 111:1175-1182(2018).
CC   -!- FUNCTION: Nitrate reductase is a key enzyme involved in the first step
CC       of nitrate assimilation in plants, fungi and bacteria. {ECO:0000305}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NAD(+) + nitrite = H(+) + NADH + nitrate;
CC         Xref=Rhea:RHEA:17913, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16301, ChEBI:CHEBI:17632, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.7.1.1;
CC         Evidence={ECO:0000269|PubMed:29371148};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:29371148};
CC       Note=Binds 1 FAD (per monomer/chain). {ECO:0000269|PubMed:29371148};
CC   -!- COFACTOR:
CC       Name=Mo-molybdopterin; Xref=ChEBI:CHEBI:71302;
CC         Evidence={ECO:0000250|UniProtKB:P49050};
CC       Note=Binds 1 Mo-molybdopterin (Mo-MPT) cofactor per subunit.
CC       {ECO:0000250|UniProtKB:P49050};
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000305|PubMed:29371148};
CC       Note=Binds 1 heme group. The heme group is called cytochrome b-557.
CC       {ECO:0000305};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=13 uM for NADH in the ferricyanide reduction by the FAD-binding
CC         domain (at ph 7.0 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:29371148};
CC         Vmax=9055 umol/min/mg enzyme in the ferricyanide reduction by the
CC         FAD-binding domain (at ph 7.0 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:29371148};
CC         Note=kcat is 4900 s(-1) for NADH in the ferricyanide reduction by the
CC         FAD-binding domain (at ph 7.0 and 25 degrees Celsius).
CC         {ECO:0000269|PubMed:29371148};
CC   -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC   -!- INDUCTION: By nitrate. Repressed by ammonium, the repression is not
CC       removed by the addition of extra nitrate. Urea weakens the effect of
CC       nitrate, but does not repress expression itself, implying it possibly
CC       reduces nitrate uptake rather than nitrate reduction. Up-regulated by
CC       nitrite. {ECO:0000269|PubMed:28650572}.
CC   -!- SIMILARITY: Belongs to the nitrate reductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KY438973; ASV49153.1; -; Genomic_DNA.
DR   EMBL; KY438974; ASV49154.1; -; mRNA.
DR   PDB; 5YLY; X-ray; 1.76 A; A/B=572-863.
DR   PDBsum; 5YLY; -.
DR   SMR; A0A286R227; -.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0030151; F:molybdenum ion binding; ISS:UniProtKB.
DR   GO; GO:0043546; F:molybdopterin cofactor binding; ISS:UniProtKB.
DR   GO; GO:0009703; F:nitrate reductase (NADH) activity; IEA:UniProtKB-EC.
DR   GO; GO:0008940; F:nitrate reductase activity; IDA:UniProtKB.
DR   GO; GO:0071250; P:cellular response to nitrite; IEP:UniProtKB.
DR   GO; GO:0042128; P:nitrate assimilation; IEA:UniProtKB-KW.
DR   GO; GO:0042126; P:nitrate metabolic process; IEP:UniProtKB.
DR   Gene3D; 3.10.120.10; -; 1.
DR   Gene3D; 3.40.50.80; -; 1.
DR   Gene3D; 3.90.420.10; -; 1.
DR   InterPro; IPR001834; CBR-like.
DR   InterPro; IPR008333; Cbr1-like_FAD-bd_dom.
DR   InterPro; IPR001199; Cyt_B5-like_heme/steroid-bd.
DR   InterPro; IPR036400; Cyt_B5-like_heme/steroid_sf.
DR   InterPro; IPR018506; Cyt_B5_heme-BS.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR005066; MoCF_OxRdtse_dimer.
DR   InterPro; IPR008335; Mopterin_OxRdtase_euk.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR000572; OxRdtase_Mopterin-bd_dom.
DR   InterPro; IPR036374; OxRdtase_Mopterin-bd_sf.
DR   InterPro; IPR022407; OxRdtase_Mopterin_BS.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF00173; Cyt-b5; 1.
DR   Pfam; PF00970; FAD_binding_6; 1.
DR   Pfam; PF03404; Mo-co_dimer; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   Pfam; PF00174; Oxidored_molyb; 1.
DR   PRINTS; PR00406; CYTB5RDTASE.
DR   PRINTS; PR00363; CYTOCHROMEB5.
DR   PRINTS; PR00407; EUMOPTERIN.
DR   PRINTS; PR00371; FPNCR.
DR   SMART; SM01117; Cyt-b5; 1.
DR   SUPFAM; SSF52343; SSF52343; 1.
DR   SUPFAM; SSF55856; SSF55856; 1.
DR   SUPFAM; SSF56524; SSF56524; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS00191; CYTOCHROME_B5_1; 1.
DR   PROSITE; PS50255; CYTOCHROME_B5_2; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
DR   PROSITE; PS00559; MOLYBDOPTERIN_EUK; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Heme; Iron; Metal-binding; Molybdenum;
KW   Nitrate assimilation; Oxidoreductase.
FT   CHAIN           1..863
FT                   /note="Nitrate reductase [NADH]"
FT                   /id="PRO_0000450331"
FT   DOMAIN          484..559
FT                   /note="Cytochrome b5 heme-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00279"
FT   DOMAIN          602..719
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   NP_BIND         659..662
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29371148,
FT                   ECO:0007744|PDB:5YLY"
FT   NP_BIND         676..680
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29371148,
FT                   ECO:0007744|PDB:5YLY"
FT   NP_BIND         693..695
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29371148,
FT                   ECO:0007744|PDB:5YLY"
FT   METAL           137
FT                   /note="Molybdenum"
FT                   /evidence="ECO:0000250|UniProtKB:P49050"
FT   METAL           519
FT                   /note="Iron (heme axial ligand)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00279"
FT   METAL           542
FT                   /note="Iron (heme axial ligand)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00279"
FT   BINDING         688
FT                   /note="FAD; via pi-pi stacking"
FT                   /evidence="ECO:0000269|PubMed:29371148,
FT                   ECO:0007744|PDB:5YLY"
FT   BINDING         746
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29371148,
FT                   ECO:0007744|PDB:5YLY"
FT   MUTAGEN         640
FT                   /note="H->A: Minimal effect in enzyme activity and a minor
FT                   change in affinity for NADH."
FT                   /evidence="ECO:0000269|PubMed:29371148"
FT   MUTAGEN         659
FT                   /note="R->A: Loss of enzyme activity to 13% of that of the
FT                   wild-type and decreased affinity for NADH."
FT                   /evidence="ECO:0000269|PubMed:29371148"
FT   MUTAGEN         662
FT                   /note="T->A: Loss of enzyme activity to 18% of that of the
FT                   wild-type and decreased affinity for NADH."
FT                   /evidence="ECO:0000269|PubMed:29371148"
FT   MUTAGEN         835
FT                   /note="C->A: Loss of enzyme activity to 21% of that of the
FT                   wild-type, but increased affinity for NADH."
FT                   /evidence="ECO:0000269|PubMed:29371148"
FT   STRAND          605..616
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   STRAND          619..625
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   STRAND          640..646
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   STRAND          656..661
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   STRAND          671..678
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   STRAND          684..687
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   HELIX           693..700
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   STRAND          706..713
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   STRAND          715..720
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   STRAND          723..726
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   STRAND          729..732
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   STRAND          734..741
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   HELIX           742..744
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   HELIX           745..756
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   STRAND          764..773
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   HELIX           774..776
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   HELIX           780..789
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   TURN            791..793
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   STRAND          794..802
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   STRAND          809..813
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   HELIX           816..822
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   STRAND          830..836
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   HELIX           838..843
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   HELIX           846..851
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   TURN            856..858
FT                   /evidence="ECO:0007829|PDB:5YLY"
FT   STRAND          859..862
FT                   /evidence="ECO:0007829|PDB:5YLY"
SQ   SEQUENCE   863 AA;  95563 MW;  644219E1578CDF84 CRC64;
     MGVRHSASKD YIAGRPLVPG EAPLDKKNSN FSSWKPVTEI DDRDAKCADN WVPRHPDLIR
     LTGKHPFNSE PPHADVMKEG WLTPVSMHFV RNHGAVPRLE WGSHRITITG LVERPMEITM
     DDIAKLPAVT VPCLLTCCGN RRKEVNMVKN SQGFSWGPGA VSVNNWTGAR LSDVLKLVGV
     KSQAQGAKYV HFCGPKGELP KGVDGSYGTA LTLGHALDPS MDVLIAYKQN GQFLHPDHGF
     PCRMLIPGWI GGRSVKWLSH LHVSDKDSQN WYHFHDNKVL PPHVDAESAA KQGWWKDPSF
     ILKELNINST ISSPGHDERI LMDQNRRYTM KGYAYSGGGR KIVRVEVSFN GGETWSHPAK
     IIVTETPNQA GKHWTWVHWE LPVDTSQFFT ATEVVCRAWD ESQNTQPAVL TWTLLGQGNN
     SMFRLRLHKE VDPQGRLCIR FQQPAPILPG PLGNVGWREQ EAGSAVPSAP AAVAAAAPGL
     DSTKKYVTKA MLEQHVEEAS VWFAYKGKVY DGTKFLDDHP GGADSILMAG GEDATEDFDA
     VHSDSAKKQL EQFYIAELAP EGVPVPANLL YGGVDAAVVV MPGTAAAPLP AIDVDAPFLN
     PKKQKAAELK EKIKISHDVT LFRFGLEHDE QLLGLPTGKH MLIRKKVTNA EGDEEVVMRA
     YTPTTANETR GHFDLVVKIY KANVHPKFPE GGKFSQILEA LEVGDTVEVK GPIGHFHYDR
     PGHYKNHKLE SEVKRINMIA GGTGLTPMYQ VMKAILSNPS DLTEIRLLYA NQTEADILLR
     PELEALAKSH PDRVKIHYTV DRPTPGWKYS SGFIDLDMCE RALFRYEPGT ISVLCGPPPM
     LKFACHPNLE KMGFEKGVTS IEF
//
ID   NQO2_HUMAN              Reviewed;         231 AA.
AC   P16083; B2R492; Q5TD04;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 5.
DT   02-JUN-2021, entry version 218.
DE   RecName: Full=Ribosyldihydronicotinamide dehydrogenase [quinone];
DE            EC=1.10.5.1 {ECO:0000269|PubMed:18579530};
DE   AltName: Full=NRH dehydrogenase [quinone] 2;
DE   AltName: Full=NRH:quinone oxidoreductase 2;
DE   AltName: Full=Quinone reductase 2;
DE            Short=QR2;
GN   Name=NQO2; Synonyms=NMOR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT PHE-47.
RC   TISSUE=Liver;
RX   PubMed=1691923; DOI=10.1021/bi00459a034;
RA   Jaiswal A.K., Burnett P., Adesnik M., McBride O.W.;
RT   "Nucleotide and deduced amino acid sequence of a human cDNA (NQO2)
RT   corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene
RT   family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.";
RL   Biochemistry 29:1899-1906(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT PHE-47.
RC   TISSUE=Liver;
RX   PubMed=8182056;
RA   Jaiswal A.K.;
RT   "Human NAD(P)H:quinone oxidoreductase 2. Gene structure, activity, and
RT   tissue-specific expression.";
RL   J. Biol. Chem. 269:14502-14508(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT PHE-47.
RA   Iida A., Osawa S., Kitamura Y., Kitamoto T., Koyama K., Nakamura Y.;
RT   "Human NRH:quinone oxidoreductase 2, complete genomic sequence.";
RL   Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARG-16; GLY-29; PHE-47;
RP   ASP-58 AND ALA-184.
RG   NIEHS SNPs program;
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PHE-47.
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PHE-47.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PHE-47.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   CHARACTERIZATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9367528; DOI=10.1006/abbi.1997.0344;
RA   Wu K., Knox R., Sun X.Z., Joseph P., Jaiswal A.K., Zhang D., Deng P.S.-K.,
RA   Chen S.;
RT   "Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a
RT   dihydronicotinamide riboside dependent oxidoreductase.";
RL   Arch. Biochem. Biophys. 347:221-228(1997).
RN   [10]
RP   CHARACTERIZATION.
RX   PubMed=9050836; DOI=10.1073/pnas.94.5.1669;
RA   Zhao Q., Yang X.L., Holtzclaw W.D., Talalay P.;
RT   "Unexpected genetic and structural relationships of a long-forgotten
RT   flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase).";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:1669-1674(1997).
RN   [11]
RP   ERRATUM OF PUBMED:9050836.
RA   Zhao Q., Yang X.L., Holtzclaw W.D., Talalay P.;
RL   Proc. Natl. Acad. Sci. U.S.A. 94:5979-5979(1997).
RN   [12]
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15078100; DOI=10.1021/bi035923w;
RA   Kwiek J.J., Haystead T.A.J., Rudolph J.;
RT   "Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the
RT   antimalarial quinolines.";
RL   Biochemistry 43:4538-4547(2004).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-197, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS).
RX   PubMed=10433694; DOI=10.1021/bi990799v;
RA   Foster C.E., Bianchet M.A., Talalay P., Zhao Q., Amzel L.M.;
RT   "Crystal structure of human quinone reductase type 2, a
RT   metalloflavoprotein.";
RL   Biochemistry 38:9881-9886(1999).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) IN COMPLEX WITH RESVERATROL.
RX   PubMed=15350128; DOI=10.1021/bi049162o;
RA   Buryanovskyy L., Fu Y., Boyd M., Ma Y., Hsieh T.-C., Wu J.M., Zhang Z.;
RT   "Crystal structure of quinone reductase 2 in complex with resveratrol.";
RL   Biochemistry 43:11417-11426(2004).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) IN COMPLEX WITH CB1954, AND
RP   MUTAGENESIS OF ASN-162.
RX   PubMed=16129418; DOI=10.1016/j.bbrc.2005.08.081;
RA   Fu Y., Buryanovskyy L., Zhang Z.;
RT   "Crystal structure of quinone reductase 2 in complex with cancer prodrug
RT   CB1954.";
RL   Biochem. Biophys. Res. Commun. 336:332-338(2005).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) IN COMPLEX WITH MELATONIN AND FAD,
RP   FUNCTION, SUBUNIT, AND ACTIVITY REGULATION.
RX   PubMed=18254726; DOI=10.1042/bj20071373;
RA   Calamini B., Santarsiero B.D., Boutin J.A., Mesecar A.D.;
RT   "Kinetic, thermodynamic and X-ray structural insights into the interaction
RT   of melatonin and analogues with quinone reductase 2.";
RL   Biochem. J. 413:81-91(2008).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEXES WITH DOPAMINE AND
RP   ADRENOCHROME, AND ENZYME ACTIVITY.
RX   PubMed=18579530; DOI=10.1074/jbc.m801371200;
RA   Fu Y., Buryanovskyy L., Zhang Z.;
RT   "Quinone reductase 2 is a catechol quinone reductase.";
RL   J. Biol. Chem. 283:23829-23835(2008).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) IN COMPLEX WITH ZINC IONS; FAD AND
RP   IMATINIB.
RX   PubMed=19236722; DOI=10.1186/1472-6807-9-7;
RA   Winger J.A., Hantschel O., Superti-Furga G., Kuriyan J.;
RT   "The structure of the leukemia drug imatinib bound to human quinone
RT   reductase 2 (NQO2).";
RL   BMC Struct. Biol. 9:7-7(2009).
CC   -!- FUNCTION: The enzyme apparently serves as a quinone reductase in
CC       connection with conjugation reactions of hydroquinones involved in
CC       detoxification pathways as well as in biosynthetic processes such as
CC       the vitamin K-dependent gamma-carboxylation of glutamate residues in
CC       prothrombin synthesis. {ECO:0000269|PubMed:18254726}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide + a quinone +
CC         H(+) = a quinol + beta-nicotinamide D-riboside; Xref=Rhea:RHEA:12364,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15927, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:55458, ChEBI:CHEBI:132124; EC=1.10.5.1;
CC         Evidence={ECO:0000269|PubMed:18579530};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds 1 zinc ion per subunit.;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- ACTIVITY REGULATION: Inhibited by melatonin, resveratrol and 5-
CC       hydroxytryptamine. {ECO:0000269|PubMed:18254726}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=28 uM for NRH {ECO:0000269|PubMed:15078100,
CC         ECO:0000269|PubMed:9367528};
CC         KM=11.6 uM for menadione {ECO:0000269|PubMed:15078100,
CC         ECO:0000269|PubMed:9367528};
CC         KM=252 uM for NADH {ECO:0000269|PubMed:15078100,
CC         ECO:0000269|PubMed:9367528};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:15350128,
CC       ECO:0000269|PubMed:16129418, ECO:0000269|PubMed:18254726,
CC       ECO:0000269|PubMed:19236722}.
CC   -!- INTERACTION:
CC       P16083; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-358466, EBI-742054;
CC       P16083; Q5JVL4: EFHC1; NbExp=3; IntAct=EBI-358466, EBI-743105;
CC       P16083; Q9H8Y8: GORASP2; NbExp=5; IntAct=EBI-358466, EBI-739467;
CC       P16083; Q8IWL3: HSCB; NbExp=4; IntAct=EBI-358466, EBI-1805738;
CC       P16083; A1L1C6: LRRC7; NbExp=6; IntAct=EBI-358466, EBI-10171988;
CC       P16083; Q9NZD8: SPG21; NbExp=3; IntAct=EBI-358466, EBI-742688;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- MISCELLANEOUS: Uses dihydronicotinamide riboside (NRH) rather than
CC       NAD(P)H as an electron donor.
CC   -!- SIMILARITY: Belongs to the NAD(P)H dehydrogenase (quinone) family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/nqo2/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J02888; AAA60239.1; -; mRNA.
DR   EMBL; AY299456; AAB60642.3; -; Genomic_DNA.
DR   EMBL; AB050248; BAB16974.1; -; Genomic_DNA.
DR   EMBL; AY855291; AAW29945.1; -; Genomic_DNA.
DR   EMBL; AK311746; BAG34689.1; -; mRNA.
DR   EMBL; AL133351; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471087; EAW55107.1; -; Genomic_DNA.
DR   EMBL; BC006096; AAH06096.1; -; mRNA.
DR   CCDS; CCDS4481.1; -.
DR   PIR; A32667; A32667.
DR   RefSeq; NP_000895.2; NM_000904.4.
DR   RefSeq; NP_001277150.1; NM_001290221.1.
DR   RefSeq; NP_001305869.1; NM_001318940.1.
DR   PDB; 1QR2; X-ray; 2.10 A; A/B=2-231.
DR   PDB; 1SG0; X-ray; 1.50 A; A/B=2-231.
DR   PDB; 1XI2; X-ray; 1.50 A; A/B=2-231.
DR   PDB; 1ZX1; X-ray; 2.16 A; A/B=1-231.
DR   PDB; 2BZS; X-ray; 2.00 A; A/B=2-231.
DR   PDB; 2QMY; X-ray; 2.50 A; A/B=2-231.
DR   PDB; 2QMZ; X-ray; 2.10 A; A/B=2-231.
DR   PDB; 2QR2; X-ray; 2.45 A; A/B=2-231.
DR   PDB; 2QWX; X-ray; 1.50 A; A/B=1-231.
DR   PDB; 2QX4; X-ray; 1.65 A; A/B=2-231.
DR   PDB; 2QX6; X-ray; 1.75 A; A/B=2-231.
DR   PDB; 2QX8; X-ray; 1.60 A; A/B=2-231.
DR   PDB; 2QX9; X-ray; 2.31 A; A/B=2-231.
DR   PDB; 3FW1; X-ray; 1.75 A; A=1-231.
DR   PDB; 3G5M; X-ray; 1.84 A; A/B=1-231.
DR   PDB; 3GAM; X-ray; 1.98 A; A/B=1-231.
DR   PDB; 3NFR; X-ray; 1.57 A; A/B=2-231.
DR   PDB; 3NHF; X-ray; 2.00 A; A/B=2-231.
DR   PDB; 3NHJ; X-ray; 2.33 A; A/B=2-231.
DR   PDB; 3NHK; X-ray; 1.96 A; A/B=2-231.
DR   PDB; 3NHL; X-ray; 1.57 A; A/B=2-231.
DR   PDB; 3NHP; X-ray; 1.70 A; A/B=2-231.
DR   PDB; 3NHR; X-ray; 1.80 A; A/B=2-231.
DR   PDB; 3NHS; X-ray; 1.78 A; A/B=2-231.
DR   PDB; 3NHU; X-ray; 1.90 A; A/B=2-231.
DR   PDB; 3NHW; X-ray; 1.65 A; A/B=2-231.
DR   PDB; 3NHY; X-ray; 1.90 A; A/B=2-231.
DR   PDB; 3O2N; X-ray; 1.60 A; A/B=2-231.
DR   PDB; 3O73; X-ray; 2.00 A; A/B=1-231.
DR   PDB; 3OVM; X-ray; 2.09 A; A/B=1-231.
DR   PDB; 3OWH; X-ray; 2.28 A; A/B=1-231.
DR   PDB; 3OWX; X-ray; 1.85 A; A/B=1-231.
DR   PDB; 3OX1; X-ray; 2.00 A; A/B=1-231.
DR   PDB; 3OX2; X-ray; 2.41 A; A/B=1-231.
DR   PDB; 3OX3; X-ray; 1.80 A; A/B=1-231.
DR   PDB; 3TE7; X-ray; 1.70 A; A/B=3-230.
DR   PDB; 3TEM; X-ray; 1.45 A; A/B=3-230.
DR   PDB; 3TZB; X-ray; 2.19 A; A/B/C/D=3-230.
DR   PDB; 3UXE; X-ray; 1.50 A; A/B=2-231.
DR   PDB; 3UXH; X-ray; 1.53 A; A/B=2-231.
DR   PDB; 4FGJ; X-ray; 1.35 A; A/B=1-231.
DR   PDB; 4FGK; X-ray; 1.40 A; A/B=1-231.
DR   PDB; 4FGL; X-ray; 1.20 A; A/B/C/D=1-231.
DR   PDB; 4GQI; X-ray; 1.95 A; A/B=2-231.
DR   PDB; 4GR9; X-ray; 2.29 A; A/B=2-231.
DR   PDB; 4QOD; X-ray; 1.35 A; A/B=1-231.
DR   PDB; 4QOE; X-ray; 1.45 A; A/B=1-231.
DR   PDB; 4QOF; X-ray; 1.55 A; A/B=1-231.
DR   PDB; 4QOG; X-ray; 1.40 A; A/B=1-231.
DR   PDB; 4QOH; X-ray; 1.60 A; A/B=1-231.
DR   PDB; 4QOI; X-ray; 1.55 A; A/B=1-231.
DR   PDB; 4QOJ; X-ray; 1.85 A; A/B=1-231.
DR   PDB; 4U7F; X-ray; 1.80 A; A/B=2-231.
DR   PDB; 4U7G; X-ray; 1.96 A; A/B=2-231.
DR   PDB; 4U7H; X-ray; 1.48 A; A/B=2-231.
DR   PDB; 4XDG; X-ray; 1.50 A; A/B=1-231.
DR   PDB; 4XDH; X-ray; 1.90 A; A/B=1-231.
DR   PDB; 4ZVK; X-ray; 1.87 A; A/B=2-231.
DR   PDB; 4ZVL; X-ray; 1.90 A; A/B=2-231.
DR   PDB; 4ZVM; X-ray; 1.97 A; A/B=2-231.
DR   PDB; 4ZVN; X-ray; 1.87 A; A/B=2-231.
DR   PDB; 5BUC; X-ray; 1.87 A; A/B=2-231.
DR   PDB; 5LBT; X-ray; 1.75 A; A/B=1-231.
DR   PDB; 5LBU; X-ray; 1.65 A; A/B=1-231.
DR   PDB; 5LBW; X-ray; 1.90 A; A/B=1-231.
DR   PDB; 5LBY; X-ray; 1.40 A; A/B=1-231.
DR   PDB; 5LBZ; X-ray; 1.40 A; A/B=1-231.
DR   PDBsum; 1QR2; -.
DR   PDBsum; 1SG0; -.
DR   PDBsum; 1XI2; -.
DR   PDBsum; 1ZX1; -.
DR   PDBsum; 2BZS; -.
DR   PDBsum; 2QMY; -.
DR   PDBsum; 2QMZ; -.
DR   PDBsum; 2QR2; -.
DR   PDBsum; 2QWX; -.
DR   PDBsum; 2QX4; -.
DR   PDBsum; 2QX6; -.
DR   PDBsum; 2QX8; -.
DR   PDBsum; 2QX9; -.
DR   PDBsum; 3FW1; -.
DR   PDBsum; 3G5M; -.
DR   PDBsum; 3GAM; -.
DR   PDBsum; 3NFR; -.
DR   PDBsum; 3NHF; -.
DR   PDBsum; 3NHJ; -.
DR   PDBsum; 3NHK; -.
DR   PDBsum; 3NHL; -.
DR   PDBsum; 3NHP; -.
DR   PDBsum; 3NHR; -.
DR   PDBsum; 3NHS; -.
DR   PDBsum; 3NHU; -.
DR   PDBsum; 3NHW; -.
DR   PDBsum; 3NHY; -.
DR   PDBsum; 3O2N; -.
DR   PDBsum; 3O73; -.
DR   PDBsum; 3OVM; -.
DR   PDBsum; 3OWH; -.
DR   PDBsum; 3OWX; -.
DR   PDBsum; 3OX1; -.
DR   PDBsum; 3OX2; -.
DR   PDBsum; 3OX3; -.
DR   PDBsum; 3TE7; -.
DR   PDBsum; 3TEM; -.
DR   PDBsum; 3TZB; -.
DR   PDBsum; 3UXE; -.
DR   PDBsum; 3UXH; -.
DR   PDBsum; 4FGJ; -.
DR   PDBsum; 4FGK; -.
DR   PDBsum; 4FGL; -.
DR   PDBsum; 4GQI; -.
DR   PDBsum; 4GR9; -.
DR   PDBsum; 4QOD; -.
DR   PDBsum; 4QOE; -.
DR   PDBsum; 4QOF; -.
DR   PDBsum; 4QOG; -.
DR   PDBsum; 4QOH; -.
DR   PDBsum; 4QOI; -.
DR   PDBsum; 4QOJ; -.
DR   PDBsum; 4U7F; -.
DR   PDBsum; 4U7G; -.
DR   PDBsum; 4U7H; -.
DR   PDBsum; 4XDG; -.
DR   PDBsum; 4XDH; -.
DR   PDBsum; 4ZVK; -.
DR   PDBsum; 4ZVL; -.
DR   PDBsum; 4ZVM; -.
DR   PDBsum; 4ZVN; -.
DR   PDBsum; 5BUC; -.
DR   PDBsum; 5LBT; -.
DR   PDBsum; 5LBU; -.
DR   PDBsum; 5LBW; -.
DR   PDBsum; 5LBY; -.
DR   PDBsum; 5LBZ; -.
DR   SMR; P16083; -.
DR   BioGRID; 110898; 18.
DR   CORUM; P16083; -.
DR   DIP; DIP-39704N; -.
DR   IntAct; P16083; 16.
DR   MINT; P16083; -.
DR   STRING; 9606.ENSP00000369822; -.
DR   BindingDB; P16083; -.
DR   ChEMBL; CHEMBL3959; -.
DR   DrugBank; DB07339; (3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione.
DR   DrugBank; DB03541; 10-Propargyl-5,8-Dideazafolic Acid.
DR   DrugBank; DB08228; 5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one.
DR   DrugBank; DB08744; Casimiroin.
DR   DrugBank; DB06695; Dabigatran etexilate.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB01065; Melatonin.
DR   DrugBank; DB00170; Menadione.
DR   DrugBank; DB08190; N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB01087; Primaquine.
DR   DrugBank; DB04216; Quercetin.
DR   DrugBank; DB02709; Resveratrol.
DR   DrugBank; DB04253; Tretazicar.
DR   DrugCentral; P16083; -.
DR   iPTMnet; P16083; -.
DR   PhosphoSitePlus; P16083; -.
DR   BioMuta; NQO2; -.
DR   DMDM; 317373581; -.
DR   EPD; P16083; -.
DR   jPOST; P16083; -.
DR   MassIVE; P16083; -.
DR   MaxQB; P16083; -.
DR   PaxDb; P16083; -.
DR   PeptideAtlas; P16083; -.
DR   PRIDE; P16083; -.
DR   ProteomicsDB; 12689; -.
DR   ProteomicsDB; 53285; -.
DR   Antibodypedia; 9328; 528 antibodies.
DR   DNASU; 4835; -.
DR   Ensembl; ENST00000338130; ENSP00000337773; ENSG00000124588.
DR   Ensembl; ENST00000380430; ENSP00000369795; ENSG00000124588.
DR   Ensembl; ENST00000380455; ENSP00000369822; ENSG00000124588.
DR   GeneID; 4835; -.
DR   KEGG; hsa:4835; -.
DR   UCSC; uc003mus.3; human.
DR   CTD; 4835; -.
DR   DisGeNET; 4835; -.
DR   GeneCards; NQO2; -.
DR   HGNC; HGNC:7856; NQO2.
DR   HPA; ENSG00000124588; Low tissue specificity.
DR   MalaCards; NQO2; -.
DR   MIM; 160998; gene.
DR   neXtProt; NX_P16083; -.
DR   OpenTargets; ENSG00000124588; -.
DR   PharmGKB; PA31745; -.
DR   VEuPathDB; HostDB:ENSG00000124588.19; -.
DR   eggNOG; ENOG502QWY5; Eukaryota.
DR   GeneTree; ENSGT00940000156563; -.
DR   HOGENOM; CLU_058643_2_0_1; -.
DR   InParanoid; P16083; -.
DR   OMA; LFPIHHG; -.
DR   OrthoDB; 1394543at2759; -.
DR   PhylomeDB; P16083; -.
DR   TreeFam; TF300296; -.
DR   BRENDA; 1.10.5.1; 2681.
DR   PathwayCommons; P16083; -.
DR   Reactome; R-HSA-211945; Phase I - Functionalization of compounds.
DR   SABIO-RK; P16083; -.
DR   BioGRID-ORCS; 4835; 2 hits in 995 CRISPR screens.
DR   ChiTaRS; NQO2; human.
DR   EvolutionaryTrace; P16083; -.
DR   GeneWiki; NAD(P)H_dehydrogenase,_quinone_2; -.
DR   GenomeRNAi; 4835; -.
DR   Pharos; P16083; Tchem.
DR   PRO; PR:P16083; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P16083; protein.
DR   Bgee; ENSG00000124588; Expressed in nephron tubule and 235 other tissues.
DR   ExpressionAtlas; P16083; baseline and differential.
DR   Genevisible; P16083; HS.
DR   GO; GO:0005829; C:cytosol; IDA:CAFA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0031404; F:chloride ion binding; IDA:CAFA.
DR   GO; GO:0001512; F:dihydronicotinamide riboside quinone reductase activity; IDA:CAFA.
DR   GO; GO:0009055; F:electron transfer activity; IDA:CAFA.
DR   GO; GO:0071949; F:FAD binding; IDA:CAFA.
DR   GO; GO:1904408; F:melatonin binding; IDA:CAFA.
DR   GO; GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; IBA:GO_Central.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:CAFA.
DR   GO; GO:0016661; F:oxidoreductase activity, acting on other nitrogenous compounds as donors; IDA:CAFA.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:CAFA.
DR   GO; GO:1905594; F:resveratrol binding; IDA:CAFA.
DR   GO; GO:0008270; F:zinc ion binding; IDA:CAFA.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IEA:Ensembl.
DR   GO; GO:1904707; P:positive regulation of vascular associated smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:1901662; P:quinone catabolic process; IDA:CAFA.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   Gene3D; 3.40.50.360; -; 1.
DR   InterPro; IPR003680; Flavodoxin_fold.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   Pfam; PF02525; Flavodoxin_2; 1.
DR   SUPFAM; SSF52218; SSF52218; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; FAD; Flavoprotein; Metal-binding; Oxidoreductase;
KW   Phosphoprotein; Reference proteome; Zinc.
FT   CHAIN           1..231
FT                   /note="Ribosyldihydronicotinamide dehydrogenase [quinone]"
FT                   /id="PRO_0000071626"
FT   NP_BIND         18..21
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18254726,
FT                   ECO:0000269|PubMed:19236722"
FT   NP_BIND         104..107
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18254726,
FT                   ECO:0000269|PubMed:19236722"
FT   NP_BIND         148..151
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18254726,
FT                   ECO:0000269|PubMed:19236722"
FT   REGION          127..129
FT                   /note="Substrate binding"
FT   METAL           174
FT                   /note="Zinc"
FT   METAL           178
FT                   /note="Zinc"
FT   METAL           223
FT                   /note="Zinc"
FT   BINDING         12
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18254726,
FT                   ECO:0000269|PubMed:19236722"
FT   BINDING         156
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18254726,
FT                   ECO:0000269|PubMed:19236722"
FT   BINDING         194
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18254726,
FT                   ECO:0000269|PubMed:19236722"
FT   BINDING         201
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18254726,
FT                   ECO:0000269|PubMed:19236722"
FT   MOD_RES         80
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   MOD_RES         197
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   VARIANT         16
FT                   /note="K -> R (in dbSNP:rs28383623)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_021399"
FT   VARIANT         29
FT                   /note="E -> G (in dbSNP:rs17136117)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_021400"
FT   VARIANT         47
FT                   /note="L -> F (in dbSNP:rs1143684)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:1691923,
FT                   ECO:0000269|PubMed:8182056, ECO:0000269|Ref.3,
FT                   ECO:0000269|Ref.4, ECO:0000269|Ref.7"
FT                   /id="VAR_021401"
FT   VARIANT         58
FT                   /note="G -> D (in dbSNP:rs17300141)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_021402"
FT   VARIANT         184
FT                   /note="V -> A (in dbSNP:rs28383651)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_021403"
FT   MUTAGEN         162
FT                   /note="N->H: Loss of activity toward CB1954, no effect
FT                   toward menadione."
FT                   /evidence="ECO:0000269|PubMed:16129418"
FT   CONFLICT        140
FT                   /note="G -> C (in Ref. 2; AAB60642)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..10
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   HELIX           18..33
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   STRAND          36..41
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   TURN            42..46
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   HELIX           53..55
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   STRAND          63..65
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   HELIX           68..77
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   HELIX           83..94
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   STRAND          96..103
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   STRAND          105..108
FT                   /evidence="ECO:0007829|PDB:3O2N"
FT   HELIX           111..120
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   TURN            123..125
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   STRAND          129..132
FT                   /evidence="ECO:0007829|PDB:3NHF"
FT   HELIX           133..135
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   TURN            137..140
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   STRAND          142..148
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   TURN            153..156
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   STRAND          160..162
FT                   /evidence="ECO:0007829|PDB:1SG0"
FT   HELIX           165..173
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   HELIX           174..178
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   TURN            179..181
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   STRAND          188..190
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   TURN            193..195
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   HELIX           198..212
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   HELIX           213..217
FT                   /evidence="ECO:0007829|PDB:4FGL"
FT   HELIX           225..229
FT                   /evidence="ECO:0007829|PDB:4FGL"
SQ   SEQUENCE   231 AA;  25919 MW;  FE1F4D577517B972 CRC64;
     MAGKKVLIVY AHQEPKSFNG SLKNVAVDEL SRQGCTVTVS DLYAMNLEPR ATDKDITGTL
     SNPEVFNYGV ETHEAYKQRS LASDITDEQK KVREADLVIF QFPLYWFSVP AILKGWMDRV
     LCQGFAFDIP GFYDSGLLQG KLALLSVTTG GTAEMYTKTG VNGDSRYFLW PLQHGTLHFC
     GFKVLAPQIS FAPEIASEEE RKGMVAAWSQ RLQTIWKEEP IPCTAHWHFG Q
//
ID   NAO_PODAN               Reviewed;         430 AA.
AC   B2AM55;
DT   02-NOV-2016, integrated into UniProtKB/Swiss-Prot.
DT   20-MAY-2008, sequence version 1.
DT   02-JUN-2021, entry version 78.
DE   RecName: Full=Nitroalkane oxidase {ECO:0000303|PubMed:20481475};
DE            Short=NAO {ECO:0000303|PubMed:20481475};
DE            EC=1.7.3.1 {ECO:0000269|PubMed:20481475};
GN   OrderedLocusNames=Pa_5_6340; ORFNames=PODANS_5_6340;
OS   Podospora anserina (strain S / ATCC MYA-4624 / DSM 980 / FGSC 10383)
OS   (Pleurage anserina).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;
OC   Sordariomycetidae; Sordariales; Chaetomiaceae; Podospora;
OC   Podospora anserina.
OX   NCBI_TaxID=515849;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=S / ATCC MYA-4624 / DSM 980 / FGSC 10383;
RX   PubMed=18460219; DOI=10.1186/gb-2008-9-5-r77;
RA   Espagne E., Lespinet O., Malagnac F., Da Silva C., Jaillon O., Porcel B.M.,
RA   Couloux A., Aury J.-M., Segurens B., Poulain J., Anthouard V.,
RA   Grossetete S., Khalili H., Coppin E., Dequard-Chablat M., Picard M.,
RA   Contamine V., Arnaise S., Bourdais A., Berteaux-Lecellier V., Gautheret D.,
RA   de Vries R.P., Battaglia E., Coutinho P.M., Danchin E.G.J., Henrissat B.,
RA   El Khoury R., Sainsard-Chanet A., Boivin A., Pinan-Lucarre B., Sellem C.H.,
RA   Debuchy R., Wincker P., Weissenbach J., Silar P.;
RT   "The genome sequence of the model ascomycete fungus Podospora anserina.";
RL   Genome Biol. 9:R77.1-R77.22(2008).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=S / ATCC MYA-4624 / DSM 980 / FGSC 10383;
RX   PubMed=24558260; DOI=10.1534/genetics.113.159988;
RA   Grognet P., Bidard F., Kuchly C., Tong L.C.H., Coppin E., Benkhali J.A.,
RA   Couloux A., Wincker P., Debuchy R., Silar P.;
RT   "Maintaining two mating types: Structure of the mating type locus and its
RT   role in heterokaryosis in Podospora anserina.";
RL   Genetics 197:421-432(2014).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH FAD, COFACTOR,
RP   SUBUNIT, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   ACTIVE SITE, AND MUTAGENESIS OF SER-273; ASP-399 AND ARG-406.
RX   PubMed=20481475; DOI=10.1021/bi100610e;
RA   Tormos J.R., Taylor A.B., Daubner S.C., Hart P.J., Fitzpatrick P.F.;
RT   "Identification of a hypothetical protein from Podospora anserina as a
RT   nitroalkane oxidase.";
RL   Biochemistry 49:5035-5041(2010).
CC   -!- FUNCTION: Nitroalkane oxidase (NAO) catalyzes the oxidation of
CC       nitroalkanes to the corresponding aldehydes or ketones with the release
CC       of nitrite and the consumption of molecular oxygen to yield hydrogen
CC       peroxide (PubMed:20481475). NAO is unusual, since it catalyzes
CC       substrate oxidation by removing a substrate proton to form a carbanion
CC       intermediate (PubMed:20481475). Prefers longer nitroalkanes, with 1-
CC       nitrohexane having the highest activity (PubMed:20481475).
CC       {ECO:0000269|PubMed:20481475}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a primary nitroalkane + H2O + O2 = an aldehyde + H(+) + H2O2 +
CC         nitrite; Xref=Rhea:RHEA:20976, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:16301,
CC         ChEBI:CHEBI:17478, ChEBI:CHEBI:133972; EC=1.7.3.1;
CC         Evidence={ECO:0000269|PubMed:20481475};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a secondary nitroalkane + H2O + O2 = a ketone + H(+) + H2O2 +
CC         nitrite; Xref=Rhea:RHEA:26490, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:16301,
CC         ChEBI:CHEBI:17087, ChEBI:CHEBI:139218; EC=1.7.3.1;
CC         Evidence={ECO:0000269|PubMed:20481475};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:20481475};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=13.0 mM for nitroethane {ECO:0000269|PubMed:20481475};
CC         KM=0.39 mM for O(2) {ECO:0000269|PubMed:20481475};
CC       pH dependence:
CC         Optimally active at alkaline pHs. {ECO:0000269|PubMed:20481475};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:20481475}.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CU633870; CAP65043.1; -; Genomic_DNA.
DR   EMBL; FO904940; CDP29865.1; -; Genomic_DNA.
DR   RefSeq; XP_001905136.1; XM_001905101.1.
DR   PDB; 3MKH; X-ray; 2.00 A; A/B/C/D=1-430.
DR   PDBsum; 3MKH; -.
DR   SMR; B2AM55; -.
DR   STRING; 5145.XP_001905136.1; -.
DR   EnsemblFungi; CAP65043; CAP65043; PODANS_5_6340.
DR   GeneID; 6189407; -.
DR   KEGG; pan:PODANSg2158; -.
DR   eggNOG; KOG0140; Eukaryota.
DR   HOGENOM; CLU_018204_3_0_1; -.
DR   OrthoDB; 589058at2759; -.
DR   BRENDA; 1.7.3.1; 4930.
DR   EvolutionaryTrace; B2AM55; -.
DR   Proteomes; UP000001197; Chromosome 5.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0050141; F:nitroethane oxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016627; F:oxidoreductase activity, acting on the CH-CH group of donors; IEA:InterPro.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Nucleotide-binding; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN           1..430
FT                   /note="Nitroalkane oxidase"
FT                   /id="PRO_0000437677"
FT   NP_BIND         132..135
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20481475"
FT   NP_BIND         140..142
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20481475"
FT   NP_BIND         170..172
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20481475"
FT   NP_BIND         372..376
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20481475"
FT   NP_BIND         397..401
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20481475"
FT   ACT_SITE        399
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:20481475"
FT   BINDING         301
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20481475"
FT   BINDING         311
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20481475"
FT   MUTAGEN         273
FT                   /note="S->A: Slightly decreases the catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:20481475"
FT   MUTAGEN         399
FT                   /note="D->N: Strongly decreases the catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:20481475"
FT   MUTAGEN         406
FT                   /note="R->K: Slightly decreases the catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:20481475"
FT   HELIX           9..24
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           26..33
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           42..45
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           48..56
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   TURN            57..60
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           61..63
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           66..68
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           75..88
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           90..109
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           112..114
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           115..118
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           119..121
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   STRAND          122..124
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   STRAND          130..133
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   TURN            141..144
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   STRAND          154..158
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   STRAND          161..168
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   TURN            172..175
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   STRAND          183..191
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           202..205
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   STRAND          206..212
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           213..219
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   STRAND          223..228
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   STRAND          242..251
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           252..254
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   STRAND          255..257
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   TURN            259..261
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           262..298
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           307..309
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           311..340
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           345..374
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           375..379
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           385..392
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           394..397
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   STRAND          398..400
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   TURN            402..405
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           406..415
FT                   /evidence="ECO:0007829|PDB:3MKH"
FT   HELIX           423..426
FT                   /evidence="ECO:0007829|PDB:3MKH"
SQ   SEQUENCE   430 AA;  45482 MW;  F6CB9DF2890B82D5 CRC64;
     MPIDFHLSAS QKGTYQAARS LARNLLMPAR QTYLQHPPNS PLRFQSTQPT YAAAVSAGIL
     KGQISPAHGG TGGTLIESAI LVEECYSVEP SAALTIFATG LGLTPINLAA GPQHAEFLAP
     FLSGEGSPLA SLVFSEPGGV ANALEKGAPG FQTTARLEGD EWVINGEKMW ATNCAGWDFK
     GCDLACVVCR DATTPLEEGQ DPENKVMIIL VTRADLDRNG EGSFEVLRHV ATPGHTSVSG
     PHVRYTNVRV PTKNVLCPAG QGAKVAFGAF DGSAVLVGAM GVGLMRAAFD AALKFAKEDN
     RGGAVPLLER QAFADLLSGV KIQTEAARAL TWKAAHAMEN GPGDYDARRE LALAAKVFCS
     EAAVKACTDV INAVGISAYD LQRPFSDLLN TAVVLPIFDG GNVGIRRRHL QQLMLKPTYD
     AWSSTYGSFP
//
ID   PRODH_THET2             Reviewed;         307 AA.
AC   Q72IB8;
DT   06-JUL-2016, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   02-JUN-2021, entry version 107.
DE   RecName: Full=Proline dehydrogenase {ECO:0000303|PubMed:17344208};
DE            Short=PRODH {ECO:0000303|PubMed:17344208};
DE            EC=1.5.5.2 {ECO:0000269|PubMed:17344208, ECO:0000269|PubMed:18426222};
DE   AltName: Full=Proline oxidase {ECO:0000305};
DE   AltName: Full=TtPRODH {ECO:0000303|PubMed:17344208};
GN   OrderedLocusNames=TT_C1214 {ECO:0000312|EMBL:AAS81556.1};
OS   Thermus thermophilus (strain ATCC BAA-163 / DSM 7039 / HB27).
OC   Bacteria; Deinococcus-Thermus; Deinococci; Thermales; Thermaceae; Thermus.
OX   NCBI_TaxID=262724 {ECO:0000312|EMBL:AAS81556.1};
RN   [1] {ECO:0000312|EMBL:AAS81556.1, ECO:0000312|Proteomes:UP000000592}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC BAA-163 / DSM 7039 / HB27 {ECO:0000312|Proteomes:UP000000592};
RX   PubMed=15064768; DOI=10.1038/nbt956;
RA   Henne A., Brueggemann H., Raasch C., Wiezer A., Hartsch T., Liesegang H.,
RA   Johann A., Lienard T., Gohl O., Martinez-Arias R., Jacobi C.,
RA   Starkuviene V., Schlenczeck S., Dencker S., Huber R., Klenk H.-P.,
RA   Kramer W., Merkl R., Gottschalk G., Fritz H.-J.;
RT   "The genome sequence of the extreme thermophile Thermus thermophilus.";
RL   Nat. Biotechnol. 22:547-553(2004).
RN   [2] {ECO:0007744|PDB:2G37}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH FAD, FUNCTION,
RP   CATALYTIC ACTIVITY, COFACTOR, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBUNIT, AND PHYLOGENETIC STUDY.
RX   PubMed=17344208; DOI=10.1074/jbc.m700912200;
RA   White T.A., Krishnan N., Becker D.F., Tanner J.J.;
RT   "Structure and kinetics of monofunctional proline dehydrogenase from
RT   Thermus thermophilus.";
RL   J. Biol. Chem. 282:14316-14327(2007).
RN   [3] {ECO:0007744|PDB:2EKG}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF INACTIVE ENZYME IN COMPLEX WITH
RP   FAD, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ACTIVITY REGULATION, AND MASS
RP   SPECTROMETRY.
RX   PubMed=18426222; DOI=10.1021/bi800055w;
RA   White T.A., Johnson W.H., Whitman C.P., Tanner J.J.;
RT   "Structural basis for the inactivation of Thermus thermophilus proline
RT   dehydrogenase by N-propargylglycine.";
RL   Biochemistry 47:5573-5580(2008).
CC   -!- FUNCTION: Converts proline to delta-1-pyrroline-5-carboxylate
CC       (PubMed:17344208, PubMed:18426222). Has significant activity against
CC       O(2) producing superoxide during proline oxidation catalytic cycle
CC       (PubMed:17344208). {ECO:0000269|PubMed:17344208,
CC       ECO:0000269|PubMed:18426222}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + L-proline = (S)-1-pyrroline-5-carboxylate + a
CC         quinol + H(+); Xref=Rhea:RHEA:23784, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17388, ChEBI:CHEBI:24646, ChEBI:CHEBI:60039,
CC         ChEBI:CHEBI:132124; EC=1.5.5.2;
CC         Evidence={ECO:0000269|PubMed:17344208, ECO:0000269|PubMed:18426222};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:17344208, ECO:0000269|PubMed:18426222};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:17344208};
CC   -!- ACTIVITY REGULATION: Inhibited by L-tetrahydro-2-furoic acid (THFA), L-
CC       mandelate and L-lactate (PubMed:17344208). Inhibited by N-
CC       propargylglycine (PubMed:18426222). {ECO:0000269|PubMed:18426222}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=27 mM for L-proline (at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:17344208};
CC         KM=4 mM for 3,4-dehydro-L-proline (at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:17344208};
CC         Vmax=20.5 umol/min/mg enzyme for L-proline (at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:17344208};
CC         Vmax=119 umol/min/mg enzyme for 3,4-dehydro-L-proline (at 25 degrees
CC         Celsius) {ECO:0000269|PubMed:17344208};
CC         Note=kcat is 13 s(-1) for L-proline. kcat is 75 s(-1) for 3,4-
CC         dehydro-L-proline. {ECO:0000269|PubMed:17344208};
CC       Redox potential:
CC         E(0) is -75 mV. {ECO:0000269|PubMed:17344208};
CC       Temperature dependence:
CC         Highly thermostable. Exhibits over 85% or 60% of activity after a 1
CC         hour or 3 hours incubation at 90 degrees Celsius, respectively. The
CC         half-life is estimated to be 257 minutes.
CC         {ECO:0000269|PubMed:17344208};
CC   -!- PATHWAY: Amino-acid degradation; L-proline degradation into L-
CC       glutamate; L-glutamate from L-proline: step 1/2.
CC       {ECO:0000305|PubMed:17344208}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:17344208}.
CC   -!- MASS SPECTROMETRY: Mass=37981; Method=Electrospray; Note=The measured
CC       mass is that of native enzyme without the flavin.;
CC       Evidence={ECO:0000269|PubMed:18426222};
CC   -!- SIMILARITY: Belongs to the proline dehydrogenase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE017221; AAS81556.1; -; Genomic_DNA.
DR   RefSeq; WP_011173620.1; NC_005835.1.
DR   PDB; 2EKG; X-ray; 1.90 A; A/B=1-307.
DR   PDB; 2G37; X-ray; 2.00 A; A/B=1-307.
DR   PDBsum; 2EKG; -.
DR   PDBsum; 2G37; -.
DR   SMR; Q72IB8; -.
DR   STRING; 262724.TT_C1214; -.
DR   EnsemblBacteria; AAS81556; AAS81556; TT_C1214.
DR   KEGG; tth:TT_C1214; -.
DR   eggNOG; COG0506; Bacteria.
DR   HOGENOM; CLU_061158_0_0_0; -.
DR   OMA; YPMIGSH; -.
DR   OrthoDB; 1746057at2; -.
DR   BRENDA; 1.5.5.2; 2305.
DR   BRENDA; 1.5.99.B2; 2305.
DR   UniPathway; UPA00261; UER00373.
DR   EvolutionaryTrace; Q72IB8; -.
DR   Proteomes; UP000000592; Chromosome.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0004657; F:proline dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0006562; P:proline catabolic process; IDA:UniProtKB.
DR   GO; GO:0010133; P:proline catabolic process to glutamate; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR029041; FAD-linked_oxidoreductase-like.
DR   InterPro; IPR008219; PRODH_bac_arc.
DR   InterPro; IPR002872; Proline_DH_dom.
DR   InterPro; IPR015659; Proline_oxidase.
DR   PANTHER; PTHR13914; PTHR13914; 2.
DR   Pfam; PF01619; Pro_dh; 1.
DR   PIRSF; PIRSF000196; Pro_dehydrog; 1.
DR   SUPFAM; SSF51730; SSF51730; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Nucleotide-binding; Oxidoreductase;
KW   Proline metabolism.
FT   CHAIN           1..307
FT                   /note="Proline dehydrogenase"
FT                   /id="PRO_0000436837"
FT   NP_BIND         187..189
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17344208,
FT                   ECO:0000269|PubMed:18426222, ECO:0007744|PDB:2EKG,
FT                   ECO:0007744|PDB:2G37"
FT   NP_BIND         226..227
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17344208,
FT                   ECO:0000269|PubMed:18426222, ECO:0007744|PDB:2EKG,
FT                   ECO:0007744|PDB:2G37"
FT   REGION          288..289
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9RW55"
FT   ACT_SITE        133
FT                   /evidence="ECO:0000305|PubMed:18426222"
FT   ACT_SITE        184
FT                   /evidence="ECO:0000305|PubMed:18426222"
FT   BINDING         99
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9RW55"
FT   BINDING         134
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:17344208,
FT                   ECO:0000269|PubMed:18426222, ECO:0007744|PDB:2EKG,
FT                   ECO:0007744|PDB:2G37"
FT   BINDING         163
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17344208,
FT                   ECO:0000269|PubMed:18426222, ECO:0007744|PDB:2EKG,
FT                   ECO:0007744|PDB:2G37"
FT   BINDING         201
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17344208,
FT                   ECO:0007744|PDB:2G37"
FT   SITE            275
FT                   /note="Critical for catalytic activity"
FT                   /evidence="ECO:0000305|PubMed:18426222"
FT   HELIX           6..15
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           18..27
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           29..35
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           41..53
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   STRAND          57..63
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           70..87
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   STRAND          94..100
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           101..103
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   TURN            104..107
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           109..123
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           124..126
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   STRAND          128..132
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           137..139
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           140..152
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   STRAND          157..163
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           169..176
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           177..179
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   STRAND          183..186
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   TURN            194..196
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           201..217
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   STRAND          222..225
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           229..241
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           246..248
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   STRAND          249..254
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           259..267
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   STRAND          271..279
FT                   /evidence="ECO:0007829|PDB:2EKG"
FT   HELIX           282..292
FT                   /evidence="ECO:0007829|PDB:2EKG"
SQ   SEQUENCE   307 AA;  35492 MW;  FAF48017D95B3EDD CRC64;
     MNLDLAYRSF VLGVAGHPQV ERLIKHRAKG LVRRYVAGET LEEALKAAEA LEREGVHAIL
     DLLGEMVRTE EEARAFQRGL LELVWALAGK PWPKYISLKL TQLGLDLSED LALALLREVL
     REAEPRGVFV RLDMEDSPRV EATLRLYRAL REEGFSQVGI VLQSYLYRTE KDLLDLLPYR
     PNLRLVKGAY REPKEVAFPD KRLIDAEYLH LGKLALKEGL YVAFATHDPR IIAELKRYTE
     AMGIPRSRFE FQFLYGVRPE EQRRLAREGY TVRAYVPYGR DWYPYLTRRI AERPENLLLV
     LRSLVSG
//
ID   MTRR_HUMAN              Reviewed;         698 AA.
AC   Q9UBK8; O60471; Q32MA9; Q7Z4M8;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   16-JAN-2019, sequence version 4.
DT   02-JUN-2021, entry version 198.
DE   RecName: Full=Methionine synthase reductase;
DE            Short=MSR;
DE            EC=1.16.1.8 {ECO:0000269|PubMed:17892308};
DE   AltName: Full=Aquacobalamin reductase {ECO:0000303|PubMed:16769880};
DE            Short=AqCbl reductase {ECO:0000303|PubMed:16769880};
GN   Name=MTRR {ECO:0000312|HGNC:HGNC:7473};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS A AND B), AND VARIANT
RP   LEU-175.
RX   PubMed=10564814; DOI=10.1016/s0378-1119(99)00431-x;
RA   Leclerc D., Odievre M.-H., Wu Q., Wilson A., Huizenga J., Rozen R.,
RA   Scherer S.W., Gravel R.A.;
RT   "Molecular cloning, expression and physical mapping of the human methionine
RT   synthase reductase gene.";
RL   Gene 240:75-88(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), VARIANT LEU-175, AND VARIANT HMAE
RP   LEU-576 DEL.
RX   PubMed=9501215; DOI=10.1073/pnas.95.6.3059;
RA   Leclerc D., Wilson A., Dumas R., Gafuik C., Song D., Watkins D.,
RA   Heng H.H.Q., Rommens J.M., Scherer S.W., Rosenblatt D.S., Gravel R.A.;
RT   "Cloning and mapping of a cDNA for methionine synthase reductase, a
RT   flavoprotein defective in patients with homocystinuria.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:3059-3064(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND B).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16769880; DOI=10.1073/pnas.0603694103;
RA   Yamada K., Gravel R.A., Toraya T., Matthews R.G.;
RT   "Human methionine synthase reductase is a molecular chaperone for human
RT   methionine synthase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:9476-9481(2006).
RN   [6]
RP   SUBCELLULAR LOCATION (ISOFORM A).
RX   PubMed=18221906; DOI=10.1016/j.ymgme.2007.11.019;
RA   Froese D.S., Wu X., Zhang J., Dumas R., Schoel W.M., Amrein M.,
RA   Gravel R.A.;
RT   "Restricted role for methionine synthase reductase defined by subcellular
RT   localization.";
RL   Mol. Genet. Metab. 94:68-77(2008).
RN   [7]
RP   FUNCTION.
RX   PubMed=19243433; DOI=10.1111/j.1742-4658.2009.06919.x;
RA   Wolthers K.R., Scrutton N.S.;
RT   "Cobalamin uptake and reactivation occurs through specific protein
RT   interactions in the methionine synthase-methionine synthase reductase
RT   complex.";
RL   FEBS J. 276:1942-1951(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-171, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-171 AND SER-189, VARIANT
RP   [LARGE SCALE ANALYSIS] LEU-175, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH MMACHC; MMADHC AND MTR.
RX   PubMed=27771510; DOI=10.1016/j.bbadis.2016.10.016;
RA   Bassila C., Ghemrawi R., Flayac J., Froese D.S., Baumgartner M.R.,
RA   Gueant J.L., Coelho D.;
RT   "Methionine synthase and methionine synthase reductase interact with MMACHC
RT   and with MMADHC.";
RL   Biochim. Biophys. Acta 1863:103-112(2017).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 165-698 IN COMPLEX WITH FAD AND
RP   NADP, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, CATALYTIC ACTIVITY, AND
RP   FUNCTION.
RX   PubMed=17892308; DOI=10.1021/bi701209p;
RA   Wolthers K.R., Lou X., Toogood H.S., Leys D., Scrutton N.S.;
RT   "Mechanism of coenzyme binding to human methionine synthase reductase
RT   revealed through the crystal structure of the FNR-like module and
RT   isothermal titration calorimetry.";
RL   Biochemistry 46:11833-11844(2007).
RN   [14]
RP   VARIANTS HMAE VAL-54 DEL; MET-56; THR-129; ARG-405; ARG-487 AND ARG-554,
RP   AND VARIANT VAL-333.
RX   PubMed=10484769; DOI=10.1093/hmg/8.11.2009;
RA   Wilson A., Leclerc D., Rosenblatt D.S., Gravel R.A.;
RT   "Molecular basis for methionine synthase reductase deficiency in patients
RT   belonging to the cblE complementation group of disorders in
RT   folate/cobalamin metabolism.";
RL   Hum. Mol. Genet. 8:2009-2016(1999).
RN   [15]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO NTDFS, AND VARIANT MET-22.
RX   PubMed=10444342; DOI=10.1006/mgme.1999.2879;
RA   Wilson A., Platt R., Wu Q., Leclerc D., Christensen B., Yang H.,
RA   Gravel R.A., Rozen R.;
RT   "A common variant in methionine synthase reductase combined with low
RT   cobalamin (vitamin B12) increases risk for spina bifida.";
RL   Mol. Genet. Metab. 67:317-323(1999).
RN   [16]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO NTDFS, AND VARIANT MET-22.
RX   PubMed=12375236; DOI=10.1086/344209;
RA   Doolin M.-T., Barbaux S., McDonnell M., Hoess K., Whitehead A.S.,
RA   Mitchell L.E.;
RT   "Maternal genetic effects, exerted by genes involved in homocysteine
RT   remethylation, influence the risk of spina bifida.";
RL   Am. J. Hum. Genet. 71:1222-1226(2002).
RN   [17]
RP   VARIANTS MET-22; LEU-175 AND ARG-350.
RX   PubMed=15979034; DOI=10.1016/j.ymgme.2005.02.003;
RA   O'Leary V.B., Mills J.L., Pangilinan F., Kirke P.N., Cox C., Conley M.,
RA   Weiler A., Peng K., Shane B., Scott J.M., Parle-McDermott A., Molloy A.M.,
RA   Brody L.C.;
RT   "Analysis of methionine synthase reductase polymorphisms for neural tube
RT   defects risk association.";
RL   Mol. Genet. Metab. 85:220-227(2005).
CC   -!- FUNCTION: Key enzyme in methionine and folate homeostasis responsible
CC       for the reactivation of methionine synthase (MTR/MS) activity by
CC       catalyzing the reductive methylation of MTR-bound cob(II)alamin
CC       (PubMed:17892308). Cobalamin (vitamin B12) forms a complex with MTR to
CC       serve as an intermediary in methyl transfer reactions that cycles
CC       between MTR-bound methylcob(III)alamin and MTR bound-cob(I)alamin
CC       forms, and occasional oxidative escape of the cob(I)alamin intermediate
CC       during the catalytic cycle leads to the inactive cob(II)alamin species
CC       (Probable). The processing of cobalamin in the cytosol occurs in a
CC       multiprotein complex composed of at least MMACHC, MMADHC, MTRR and MTR
CC       which may contribute to shuttle safely and efficiently cobalamin
CC       towards MTR in order to produce methionine (PubMed:27771510). Also
CC       necessary for the utilization of methyl groups from the folate cycle,
CC       thereby affecting transgenerational epigenetic inheritance (By
CC       similarity). Also acts as a molecular chaperone for methionine synthase
CC       by stabilizing apoMTR and incorporating methylcob(III)alamin into
CC       apoMTR to form the holoenzyme (PubMed:16769880). Also serves as an
CC       aquacob(III)alamin reductase by reducing aquacob(III)alamin to
CC       cob(II)alamin; this reduction leads to stimulation of the conversion of
CC       apoMTR and aquacob(III)alamin to MTR holoenzyme (PubMed:16769880).
CC       {ECO:0000250|UniProtKB:Q8C1A3, ECO:0000269|PubMed:16769880,
CC       ECO:0000269|PubMed:17892308, ECO:0000269|PubMed:27771510,
CC       ECO:0000305|PubMed:19243433}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 [methionine synthase]-methylcob(III)alamin + H(+) + NADP(+)
CC         + 2 S-adenosyl-L-homocysteine = 2 [methionine synthase]-cob(II)alamin
CC         + NADPH + 2 S-adenosyl-L-methionine; Xref=Rhea:RHEA:23908, Rhea:RHEA-
CC         COMP:14714, Rhea:RHEA-COMP:14715, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16304, ChEBI:CHEBI:28115, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:58349, ChEBI:CHEBI:59789; EC=1.16.1.8;
CC         Evidence={ECO:0000269|PubMed:17892308};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:23910;
CC         Evidence={ECO:0000305|PubMed:17892308};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=A + 2 cob(II)alamin + 2 H(+) + 2 H2O = AH2 + 2
CC         aquacob(III)alamin; Xref=Rhea:RHEA:20752, ChEBI:CHEBI:13193,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15852,
CC         ChEBI:CHEBI:16304, ChEBI:CHEBI:17499;
CC         Evidence={ECO:0000269|PubMed:16769880};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:20754;
CC         Evidence={ECO:0000305|PubMed:16769880};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:17892308};
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000269|PubMed:17892308};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.89 uM for NADPH {ECO:0000269|PubMed:17892308};
CC         KM=3540 uM for NADH {ECO:0000269|PubMed:17892308};
CC         KM=3.7 uM for aquacob(III)alamin (at 37 degrees Celsius, pH 7.2)
CC         {ECO:0000269|PubMed:16769880};
CC         Note=kcat is 3.92 s(-1) for the reduction of cytochrome c3 with NADPH
CC         (PubMed:17892308). kcat is 0.24 s(-1) for the reduction of cytochrome
CC         c3 with NADH (PubMed:17892308). kcat is 220 min(-1) for
CC         aquacob(III)alamin reduction (PubMed:16769880).
CC         {ECO:0000269|PubMed:16769880, ECO:0000269|PubMed:17892308};
CC   -!- SUBUNIT: Forms a multiprotein complex with MMACHC, MMADHC AND MTR.
CC       {ECO:0000269|PubMed:27771510}.
CC   -!- INTERACTION:
CC       Q9UBK8; Q53SE7: FLJ13057; NbExp=3; IntAct=EBI-10319161, EBI-10172181;
CC   -!- SUBCELLULAR LOCATION: [Isoform B]: Cytoplasm.
CC   -!- SUBCELLULAR LOCATION: [Isoform A]: Cytoplasm
CC       {ECO:0000269|PubMed:18221906}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=B;
CC         IsoId=Q9UBK8-2; Sequence=Displayed;
CC       Name=A;
CC         IsoId=Q9UBK8-1; Sequence=VSP_060027;
CC   -!- TISSUE SPECIFICITY: Found in all tissues tested, particularly abundant
CC       in skeletal muscle.
CC   -!- DISEASE: Homocystinuria-megaloblastic anemia, cblE complementation type
CC       (HMAE) [MIM:236270]: An autosomal recessive inborn error of metabolism
CC       resulting from defects in the cobalamin-dependent pathway that converts
CC       homocysteine to methionine. It causes delayed psychomotor development,
CC       megaloblastic anemia, homocystinuria, and hypomethioninemia. Cells from
CC       patients with HMAE fail to incorporate methyltetrahydrofolate into
CC       methionine in whole cells, but cell extracts show normal methionine
CC       synthase activity in the presence of a reducing agent.
CC       {ECO:0000269|PubMed:10484769, ECO:0000269|PubMed:9501215}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Neural tube defects, folate-sensitive (NTDFS) [MIM:601634]:
CC       The most common NTDs are open spina bifida (myelomeningocele) and
CC       anencephaly. {ECO:0000269|PubMed:10444342,
CC       ECO:0000269|PubMed:12375236}. Note=Disease susceptibility is associated
CC       with variants affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: It is debated whether the reduction of free
CC       aquacob(II)alamin occurs spontaneously or is enzyme catalyzed.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=The hidden things - Issue
CC       166 of December 2014;
CC       URL="https://web.expasy.org/spotlight/back_issues/166/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF121213; AAF17303.1; -; Genomic_DNA.
DR   EMBL; AF121202; AAF17303.1; JOINED; Genomic_DNA.
DR   EMBL; AF121203; AAF17303.1; JOINED; Genomic_DNA.
DR   EMBL; AF121204; AAF17303.1; JOINED; Genomic_DNA.
DR   EMBL; AF121205; AAF17303.1; JOINED; Genomic_DNA.
DR   EMBL; AF121206; AAF17303.1; JOINED; Genomic_DNA.
DR   EMBL; AF121207; AAF17303.1; JOINED; Genomic_DNA.
DR   EMBL; AF121208; AAF17303.1; JOINED; Genomic_DNA.
DR   EMBL; AF121209; AAF17303.1; JOINED; Genomic_DNA.
DR   EMBL; AF121210; AAF17303.1; JOINED; Genomic_DNA.
DR   EMBL; AF121211; AAF17303.1; JOINED; Genomic_DNA.
DR   EMBL; AF121212; AAF17303.1; JOINED; Genomic_DNA.
DR   EMBL; AF121214; AAF16876.1; -; mRNA.
DR   EMBL; AF121213; AAF17304.1; -; Genomic_DNA.
DR   EMBL; AF121202; AAF17304.1; JOINED; Genomic_DNA.
DR   EMBL; AF121203; AAF17304.1; JOINED; Genomic_DNA.
DR   EMBL; AF121204; AAF17304.1; JOINED; Genomic_DNA.
DR   EMBL; AF121205; AAF17304.1; JOINED; Genomic_DNA.
DR   EMBL; AF121206; AAF17304.1; JOINED; Genomic_DNA.
DR   EMBL; AF121207; AAF17304.1; JOINED; Genomic_DNA.
DR   EMBL; AF121208; AAF17304.1; JOINED; Genomic_DNA.
DR   EMBL; AF121209; AAF17304.1; JOINED; Genomic_DNA.
DR   EMBL; AF121210; AAF17304.1; JOINED; Genomic_DNA.
DR   EMBL; AF121211; AAF17304.1; JOINED; Genomic_DNA.
DR   EMBL; AF121212; AAF17304.1; JOINED; Genomic_DNA.
DR   EMBL; AF025794; AAC39667.1; -; mRNA.
DR   EMBL; AC010346; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025174; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC054816; AAH54816.2; -; mRNA.
DR   EMBL; BC109216; AAI09217.1; -; mRNA.
DR   CCDS; CCDS3874.1; -. [Q9UBK8-2]
DR   CCDS; CCDS47190.1; -. [Q9UBK8-2]
DR   RefSeq; NP_002445.2; NM_002454.2. [Q9UBK8-2]
DR   RefSeq; NP_076915.2; NM_024010.2. [Q9UBK8-2]
DR   PDB; 2QTL; X-ray; 1.90 A; A=165-698.
DR   PDB; 2QTZ; X-ray; 1.90 A; A=165-698.
DR   PDBsum; 2QTL; -.
DR   PDBsum; 2QTZ; -.
DR   SMR; Q9UBK8; -.
DR   BioGRID; 110645; 15.
DR   DIP; DIP-61183N; -.
DR   IntAct; Q9UBK8; 9.
DR   STRING; 9606.ENSP00000264668; -.
DR   DrugBank; DB00115; Cyanocobalamin.
DR   DrugBank; DB00134; Methionine.
DR   DrugCentral; Q9UBK8; -.
DR   iPTMnet; Q9UBK8; -.
DR   PhosphoSitePlus; Q9UBK8; -.
DR   SwissPalm; Q9UBK8; -.
DR   BioMuta; MTRR; -.
DR   DMDM; 296439300; -.
DR   EPD; Q9UBK8; -.
DR   jPOST; Q9UBK8; -.
DR   MassIVE; Q9UBK8; -.
DR   MaxQB; Q9UBK8; -.
DR   PaxDb; Q9UBK8; -.
DR   PeptideAtlas; Q9UBK8; -.
DR   PRIDE; Q9UBK8; -.
DR   ProteomicsDB; 83984; -. [Q9UBK8-1]
DR   ProteomicsDB; 83985; -. [Q9UBK8-2]
DR   Antibodypedia; 22429; 87 antibodies.
DR   DNASU; 4552; -.
DR   Ensembl; ENST00000264668; ENSP00000264668; ENSG00000124275. [Q9UBK8-1]
DR   Ensembl; ENST00000440940; ENSP00000402510; ENSG00000124275. [Q9UBK8-2]
DR   GeneID; 4552; -.
DR   KEGG; hsa:4552; -.
DR   UCSC; uc003jed.4; human. [Q9UBK8-2]
DR   CTD; 4552; -.
DR   DisGeNET; 4552; -.
DR   GeneCards; MTRR; -.
DR   GeneReviews; MTRR; -.
DR   HGNC; HGNC:7473; MTRR.
DR   HPA; ENSG00000124275; Low tissue specificity.
DR   MalaCards; MTRR; -.
DR   MIM; 236270; phenotype.
DR   MIM; 601634; phenotype.
DR   MIM; 602568; gene.
DR   neXtProt; NX_Q9UBK8; -.
DR   OpenTargets; ENSG00000124275; -.
DR   Orphanet; 2169; Methylcobalamin deficiency type cblE.
DR   PharmGKB; PA31277; -.
DR   VEuPathDB; HostDB:ENSG00000124275.14; -.
DR   eggNOG; KOG1158; Eukaryota.
DR   GeneTree; ENSGT00940000155822; -.
DR   HOGENOM; CLU_001570_17_7_1; -.
DR   InParanoid; Q9UBK8; -.
DR   OMA; EYTFFCN; -.
DR   OrthoDB; 318396at2759; -.
DR   PhylomeDB; Q9UBK8; -.
DR   TreeFam; TF105716; -.
DR   BioCyc; MetaCyc:HS04756-MONOMER; -.
DR   BRENDA; 1.16.1.8; 2681.
DR   PathwayCommons; Q9UBK8; -.
DR   Reactome; R-HSA-156581; Methylation.
DR   Reactome; R-HSA-1614635; Sulfur amino acid metabolism.
DR   Reactome; R-HSA-196741; Cobalamin (Cbl, vitamin B12) transport and metabolism.
DR   Reactome; R-HSA-3359467; Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE.
DR   Reactome; R-HSA-3359469; Defective MTR causes methylmalonic aciduria and homocystinuria type cblG.
DR   SABIO-RK; Q9UBK8; -.
DR   BioGRID-ORCS; 4552; 34 hits in 1007 CRISPR screens.
DR   ChiTaRS; MTRR; human.
DR   EvolutionaryTrace; Q9UBK8; -.
DR   GeneWiki; MTRR_(gene); -.
DR   GenomeRNAi; 4552; -.
DR   Pharos; Q9UBK8; Tbio.
DR   PRO; PR:Q9UBK8; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q9UBK8; protein.
DR   Bgee; ENSG00000124275; Expressed in corpus callosum and 235 other tissues.
DR   ExpressionAtlas; Q9UBK8; baseline and differential.
DR   Genevisible; Q9UBK8; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0045111; C:intermediate filament cytoskeleton; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0030586; F:[methionine synthase] reductase activity; IDA:BHF-UCL.
DR   GO; GO:0071949; F:FAD binding; IDA:BHF-UCL.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0010181; F:FMN binding; IDA:BHF-UCL.
DR   GO; GO:0070402; F:NADPH binding; IDA:BHF-UCL.
DR   GO; GO:0003958; F:NADPH-hemoprotein reductase activity; IDA:BHF-UCL.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0016723; F:oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor; IDA:UniProtKB.
DR   GO; GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; IBA:GO_Central.
DR   GO; GO:0009235; P:cobalamin metabolic process; TAS:Reactome.
DR   GO; GO:0006306; P:DNA methylation; ISS:UniProtKB.
DR   GO; GO:0046655; P:folic acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0043418; P:homocysteine catabolic process; IDA:BHF-UCL.
DR   GO; GO:0050667; P:homocysteine metabolic process; IBA:GO_Central.
DR   GO; GO:0009086; P:methionine biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0032259; P:methylation; TAS:Reactome.
DR   GO; GO:1904042; P:negative regulation of cystathionine beta-synthase activity; IDA:BHF-UCL.
DR   GO; GO:0033353; P:S-adenosylmethionine cycle; ISS:BHF-UCL.
DR   GO; GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome.
DR   Gene3D; 1.20.990.10; -; 1.
DR   Gene3D; 3.40.50.360; -; 1.
DR   Gene3D; 3.40.50.80; -; 1.
DR   InterPro; IPR003097; CysJ-like_FAD-binding.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001094; Flavdoxin-like.
DR   InterPro; IPR008254; Flavodoxin/NO_synth.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR023173; NADPH_Cyt_P450_Rdtase_alpha.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF00667; FAD_binding_1; 1.
DR   Pfam; PF00258; Flavodoxin_1; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   PRINTS; PR00369; FLAVODOXIN.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52218; SSF52218; 1.
DR   SUPFAM; SSF52343; SSF52343; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
DR   PROSITE; PS50902; FLAVODOXIN_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Amino-acid biosynthesis; Cytoplasm;
KW   Disease variant; FAD; Flavoprotein; FMN; Methionine biosynthesis; NADP;
KW   Oxidoreductase; Phosphoprotein; Reference proteome;
KW   S-adenosyl-L-methionine.
FT   CHAIN           1..698
FT                   /note="Methionine synthase reductase"
FT                   /id="PRO_0000021785"
FT   DOMAIN          5..147
FT                   /note="Flavodoxin-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00088"
FT   DOMAIN          271..533
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   NP_BIND         93..124
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00088"
FT   NP_BIND         451..454
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17892308"
FT   NP_BIND         487..490
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17892308"
FT   NP_BIND         610..611
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:17892308"
FT   NP_BIND         624..626
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:17892308"
FT   REGION          166..247
FT                   /note="Hinge"
FT   BINDING         291
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:17892308"
FT   BINDING         659
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:17892308"
FT   BINDING         697
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17892308"
FT   MOD_RES         171
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         189
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         1
FT                   /note="M -> MGAASVRAGARLVEVALCSFTVTCLEVM (in isoform A)"
FT                   /evidence="ECO:0000303|PubMed:10564814,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:9501215"
FT                   /id="VSP_060027"
FT   VARIANT         22
FT                   /note="I -> M (may increase risk for spina bifida;
FT                   dbSNP:rs1801394)"
FT                   /evidence="ECO:0000269|PubMed:10444342,
FT                   ECO:0000269|PubMed:12375236, ECO:0000269|PubMed:15979034"
FT                   /id="VAR_012836"
FT   VARIANT         54
FT                   /note="Missing (in HMAE)"
FT                   /evidence="ECO:0000269|PubMed:10484769"
FT                   /id="VAR_012837"
FT   VARIANT         56
FT                   /note="V -> M (in HMAE; dbSNP:rs761061866)"
FT                   /evidence="ECO:0000269|PubMed:10484769"
FT                   /id="VAR_012838"
FT   VARIANT         129
FT                   /note="A -> T (in HMAE)"
FT                   /evidence="ECO:0000269|PubMed:10484769"
FT                   /id="VAR_012839"
FT   VARIANT         175
FT                   /note="S -> L (in dbSNP:rs1532268)"
FT                   /evidence="ECO:0000269|PubMed:10564814,
FT                   ECO:0000269|PubMed:15979034, ECO:0000269|PubMed:9501215,
FT                   ECO:0007744|PubMed:23186163"
FT                   /id="VAR_034595"
FT   VARIANT         257
FT                   /note="S -> T (in dbSNP:rs2303080)"
FT                   /id="VAR_034596"
FT   VARIANT         333
FT                   /note="L -> V (in dbSNP:rs10064631)"
FT                   /evidence="ECO:0000269|PubMed:10484769"
FT                   /id="VAR_012840"
FT   VARIANT         350
FT                   /note="K -> R (in dbSNP:rs162036)"
FT                   /evidence="ECO:0000269|PubMed:15979034"
FT                   /id="VAR_034597"
FT   VARIANT         405
FT                   /note="C -> R (in HMAE)"
FT                   /evidence="ECO:0000269|PubMed:10484769"
FT                   /id="VAR_012841"
FT   VARIANT         415
FT                   /note="R -> C (in dbSNP:rs2287780)"
FT                   /id="VAR_034598"
FT   VARIANT         450
FT                   /note="P -> R (in dbSNP:rs16879334)"
FT                   /id="VAR_034599"
FT   VARIANT         487
FT                   /note="G -> R (in HMAE; dbSNP:rs137853061)"
FT                   /evidence="ECO:0000269|PubMed:10484769"
FT                   /id="VAR_012842"
FT   VARIANT         515
FT                   /note="A -> V (in dbSNP:rs16879355)"
FT                   /id="VAR_056947"
FT   VARIANT         554
FT                   /note="G -> R (in HMAE)"
FT                   /evidence="ECO:0000269|PubMed:10484769"
FT                   /id="VAR_015731"
FT   VARIANT         576
FT                   /note="Missing (in HMAE)"
FT                   /evidence="ECO:0000269|PubMed:9501215"
FT                   /id="VAR_012843"
FT   VARIANT         595
FT                   /note="H -> Y (in dbSNP:rs10380)"
FT                   /id="VAR_014944"
FT   HELIX           235..237
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   STRAND          250..255
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   STRAND          274..283
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   STRAND          293..299
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   STRAND          312..316
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           321..330
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           334..336
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   STRAND          339..345
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           366..372
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           382..389
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           395..405
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           410..416
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   TURN            417..421
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           424..430
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           438..444
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   STRAND          451..454
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   TURN            459..461
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   STRAND          465..471
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   STRAND          474..476
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   STRAND          483..486
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           488..496
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   TURN            497..500
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   STRAND          519..524
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   STRAND          540..543
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           546..549
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           550..565
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   STRAND          574..581
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   TURN            583..585
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           590..598
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   STRAND          604..612
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           625..631
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           633..642
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   STRAND          646..652
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           654..672
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   HELIX           676..688
FT                   /evidence="ECO:0007829|PDB:2QTL"
FT   STRAND          691..696
FT                   /evidence="ECO:0007829|PDB:2QTL"
SQ   SEQUENCE   698 AA;  77674 MW;  D4B394F0B24A07E5 CRC64;
     MRRFLLLYAT QQGQAKAIAE EICEQAVVHG FSADLHCISE SDKYDLKTET APLVVVVSTT
     GTGDPPDTAR KFVKEIQNQT LPVDFFAHLR YGLLGLGDSE YTYFCNGGKI IDKRLQELGA
     RHFYDTGHAD DCVGLELVVE PWIAGLWPAL RKHFRSSRGQ EEISGALPVA SPASSRTDLV
     KSELLHIESQ VELLRFDDSG RKDSEVLKQN AVNSNQSNVV IEDFESSLTR SVPPLSQASL
     NIPGLPPEYL QVHLQESLGQ EESQVSVTSA DPVFQVPISK AVQLTTNDAI KTTLLVELDI
     SNTDFSYQPG DAFSVICPNS DSEVQSLLQR LQLEDKREHC VLLKIKADTK KKGATLPQHI
     PAGCSLQFIF TWCLEIRAIP KKAFLRALVD YTSDSAEKRR LQELCSKQGA ADYSRFVRDA
     CACLLDLLLA FPSCQPPLSL LLEHLPKLQP RPYSCASSSL FHPGKLHFVF NIVEFLSTAT
     TEVLRKGVCT GWLALLVASV LQPNIHASHE DSGKALAPKI SISPRTTNSF HLPDDPSIPI
     IMVGPGTGIA PFIGFLQHRE KLQEQHPDGN FGAMWLFFGC RHKDRDYLFR KELRHFLKHG
     ILTHLKVSFS RDAPVGEEEA PAKYVQDNIQ LHGQQVARIL LQENGHIYVC GDAKNMAKDV
     HDALVQIISK EVGVEKLEAM KTLATLKEEK RYLQDIWS
//
ID   QSOX1_RAT               Reviewed;         750 AA.
AC   Q6IUU3; Q8K4M2; Q99J80;
DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   02-JUN-2021, entry version 121.
DE   RecName: Full=Sulfhydryl oxidase 1;
DE            Short=rQSOX;
DE            Short=rSOx;
DE            EC=1.8.3.2 {ECO:0000269|PubMed:11278790, ECO:0000269|PubMed:26819240};
DE   AltName: Full=FAD-dependent sulfhydryl oxidase-2;
DE            Short=SOx-2;
DE   AltName: Full=Quiescin Q6;
DE   Flags: Precursor;
GN   Name=Qsox1; Synonyms=Qscn6, Sox2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), PARTIAL PROTEIN SEQUENCE,
RP   FUNCTION, CATALYTIC ACTIVITY, GLYCOSYLATION, TISSUE SPECIFICITY, COFACTOR,
RP   SUBUNIT, AND SUBCELLULAR LOCATION (ISOFORM 3).
RC   STRAIN=Wistar; TISSUE=Seminal vesicle;
RX   PubMed=11278790; DOI=10.1074/jbc.m010933200;
RA   Benayoun B., Esnard-Feve A., Castella S., Courty Y., Esnard F.;
RT   "Rat seminal vesicle FAD-dependent sulfhydryl oxidase: biochemical
RT   characterization and molecular cloning of a member of the new sulfhydryl
RT   oxidase/quiescin Q6 gene family.";
RL   J. Biol. Chem. 276:13830-13837(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), PROTEIN SEQUENCE OF 33-65,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=12354420; DOI=10.1016/s0923-1811(02)00061-0;
RA   Matsuba S., Suga Y., Ishidoh K., Hashimoto Y., Takamori K., Kominami E.,
RA   Wilhelm B., Seitz J., Ogawa H.;
RT   "Sulfhydryl oxidase (SOx) from mouse epidermis: molecular cloning,
RT   nucleotide sequence, and expression of recombinant protein in the cultured
RT   cells.";
RL   J. Dermatol. Sci. 30:50-62(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=16806532; DOI=10.1016/j.bbaexp.2006.04.008;
RA   Radom J., Colin D., Thiebault F., Dognin-Bergeret M.J., Mairet-Coello G.,
RA   Esnard-Feve A., Fellmann D., Jouvenot M.;
RT   "Identification and expression of a new splicing variant of FAD-sulfhydryl
RT   oxidase in adult rat brain.";
RL   Biochim. Biophys. Acta 1759:225-233(2006).
RN   [4]
RP   CATALYTIC ACTIVITY.
RX   PubMed=26819240; DOI=10.1093/protein/gzv067;
RA   Grossman I., Ilani T., Fleishman S.J., Fass D.;
RT   "Overcoming a species-specificity barrier in development of an inhibitory
RT   antibody targeting a modulator of tumor stroma.";
RL   Protein Eng. Des. Sel. 29:135-147(2016).
RN   [5] {ECO:0007744|PDB:4P2L}
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 33-550 IN COMPLEX WITH FAD,
RP   DISULFIDE BONDS, AND COFACTOR.
RX   PubMed=24888638; DOI=10.1002/pro.2496;
RA   Gat Y., Vardi-Kilshtain A., Grossman I., Major D.T., Fass D.;
RT   "Enzyme structure captures four cysteines aligned for disulfide relay.";
RL   Protein Sci. 23:1102-1112(2014).
CC   -!- FUNCTION: Catalyzes the oxidation of sulfhydryl groups in peptide and
CC       protein thiols to disulfides with the reduction of oxygen to hydrogen
CC       peroxide (PubMed:11278790). Plays a role in disulfide bond formation in
CC       a variety of extracellular proteins. In fibroblasts, required for
CC       normal incorporation of laminin into the extracellular matrix, and
CC       thereby for normal cell-cell adhesion and cell migration (By
CC       similarity). {ECO:0000250|UniProtKB:O00391,
CC       ECO:0000269|PubMed:11278790}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + 2 R'C(R)SH = H2O2 + R'C(R)S-S(R)CR';
CC         Xref=Rhea:RHEA:17357, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:16520, ChEBI:CHEBI:17412; EC=1.8.3.2;
CC         Evidence={ECO:0000269|PubMed:11278790, ECO:0000269|PubMed:26819240};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:11278790};
CC       Note=Binds 1 FAD per subunit. {ECO:0000250|UniProtKB:O00391};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:11278790}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:O00391}; Single-pass membrane protein
CC       {ECO:0000250|UniProtKB:O00391}. Secreted
CC       {ECO:0000250|UniProtKB:O00391}. Note=A small proportion is secreted,
CC       probably via a proteolytic cleavage that removes the membrane anchor.
CC       {ECO:0000250|UniProtKB:O00391}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Secreted
CC       {ECO:0000269|PubMed:11278790, ECO:0000269|PubMed:12354420}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=QSOX-L;
CC         IsoId=Q6IUU3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6IUU3-2; Sequence=VSP_020499, VSP_020497, VSP_020498;
CC       Name=3;
CC         IsoId=Q6IUU3-3; Sequence=VSP_020497, VSP_020498;
CC   -!- TISSUE SPECIFICITY: Isoform 3: Detected in seminal vesicle fluid (at
CC       protein level) (PubMed:11278790, PubMed:12354420). Isoform 1: Detected
CC       in brain, hypophysis, heart, testis and the seminal vesicle. Isoform 3:
CC       Highly expressed in the seminal vesicles followed by testis, heart,
CC       brain, thymus, hypophysis and lung. Also expressed in prostate, kidney,
CC       spleen, liver. {ECO:0000269|PubMed:11278790,
CC       ECO:0000269|PubMed:12354420, ECO:0000269|PubMed:16806532}.
CC   -!- PTM: N-glycosylated. O-glycosylated on Thr and Ser residues.
CC       {ECO:0000250|UniProtKB:O00391}.
CC   -!- SIMILARITY: Belongs to the quiescin-sulfhydryl oxidase (QSOX) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF217799; AAM67412.1; -; mRNA.
DR   EMBL; AF285078; AAG53892.1; -; mRNA.
DR   EMBL; AB044285; BAB21937.1; -; mRNA.
DR   EMBL; AY623665; AAT40988.1; -; mRNA.
DR   RefSeq; NP_001103368.1; NM_001109898.1. [Q6IUU3-1]
DR   RefSeq; NP_445883.1; NM_053431.3. [Q6IUU3-3]
DR   PDB; 4P2L; X-ray; 2.90 A; A/B=36-550.
DR   PDBsum; 4P2L; -.
DR   SMR; Q6IUU3; -.
DR   STRING; 10116.ENSRNOP00000005052; -.
DR   GlyGen; Q6IUU3; 2 sites.
DR   PaxDb; Q6IUU3; -.
DR   PRIDE; Q6IUU3; -.
DR   Ensembl; ENSRNOT00000005052; ENSRNOP00000005052; ENSRNOG00000003649. [Q6IUU3-3]
DR   Ensembl; ENSRNOT00000068044; ENSRNOP00000061072; ENSRNOG00000003649. [Q6IUU3-1]
DR   GeneID; 84491; -.
DR   KEGG; rno:84491; -.
DR   UCSC; RGD:68957; rat. [Q6IUU3-1]
DR   CTD; 5768; -.
DR   RGD; 68957; Qsox1.
DR   eggNOG; KOG1731; Eukaryota.
DR   GeneTree; ENSGT00940000159504; -.
DR   HOGENOM; CLU_020182_1_0_1; -.
DR   InParanoid; Q6IUU3; -.
DR   OMA; VTEFPSC; -.
DR   OrthoDB; 498515at2759; -.
DR   PhylomeDB; Q6IUU3; -.
DR   BRENDA; 1.8.3.2; 5301.
DR   Reactome; R-RNO-114608; Platelet degranulation.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-8957275; Post-translational protein phosphorylation.
DR   PRO; PR:Q6IUU3; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000003649; Expressed in pancreas and 21 other tissues.
DR   Genevisible; Q6IUU3; RN.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; ISS:UniProtKB.
DR   GO; GO:0030173; C:integral component of Golgi membrane; ISS:UniProtKB.
DR   GO; GO:0045171; C:intercellular bridge; IEA:Ensembl.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0016971; F:flavin-linked sulfhydryl oxidase activity; IDA:UniProtKB.
DR   GO; GO:0003756; F:protein disulfide isomerase activity; ISS:UniProtKB.
DR   GO; GO:0085029; P:extracellular matrix assembly; ISO:RGD.
DR   GO; GO:0016242; P:negative regulation of macroautophagy; ISO:RGD.
DR   GO; GO:0006457; P:protein folding; IBA:GO_Central.
DR   Gene3D; 1.20.120.1960; -; 1.
DR   Gene3D; 1.20.120.310; -; 1.
DR   Gene3D; 3.40.30.10; -; 2.
DR   InterPro; IPR036774; ERV/ALR_sulphydryl_oxid_sf.
DR   InterPro; IPR017905; ERV/ALR_sulphydryl_oxidase.
DR   InterPro; IPR040986; QSOX_FAD-bd_dom.
DR   InterPro; IPR042568; QSOX_FAD-bd_sf.
DR   InterPro; IPR041269; QSOX_Trx1.
DR   InterPro; IPR039798; Sulfhydryl_oxidase.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   PANTHER; PTHR22897; PTHR22897; 1.
DR   Pfam; PF04777; Evr1_Alr; 1.
DR   Pfam; PF18371; FAD_SOX; 1.
DR   Pfam; PF18108; QSOX_Trx1; 1.
DR   Pfam; PF00085; Thioredoxin; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   SUPFAM; SSF69000; SSF69000; 1.
DR   PROSITE; PS51324; ERV_ALR; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Direct protein sequencing;
KW   Disulfide bond; FAD; Flavoprotein; Glycoprotein; Golgi apparatus; Membrane;
KW   Oxidoreductase; Reference proteome; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..32
FT                   /evidence="ECO:0000269|PubMed:11278790,
FT                   ECO:0000269|PubMed:12354420"
FT   CHAIN           33..750
FT                   /note="Sulfhydryl oxidase 1"
FT                   /id="PRO_0000249535"
FT   TRANSMEM        710..730
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          33..159
FT                   /note="Thioredoxin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00691"
FT   DOMAIN          399..506
FT                   /note="ERV/ALR sulfhydryl oxidase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654"
FT   NP_BIND         481..488
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:24888638,
FT                   ECO:0007744|PDB:4P2L"
FT   REGION          545..567
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          585..632
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        73
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        76
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250"
FT   BINDING         404
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:24888638,
FT                   ECO:0007744|PDB:4P2L"
FT   BINDING         411
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:24888638,
FT                   ECO:0007744|PDB:4P2L"
FT   BINDING         415
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:24888638,
FT                   ECO:0007744|PDB:4P2L"
FT   BINDING         454
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:O00391"
FT   BINDING         458
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:O00391"
FT   BINDING         503
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:24888638,
FT                   ECO:0007744|PDB:4P2L"
FT   BINDING         506
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:24888638,
FT                   ECO:0007744|PDB:4P2L"
FT   CARBOHYD        133
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        246
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        73..76
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000255|PROSITE-ProRule:PRU00691,
FT                   ECO:0000269|PubMed:24888638, ECO:0007744|PDB:4P2L"
FT   DISULFID        104..113
FT                   /evidence="ECO:0000269|PubMed:24888638,
FT                   ECO:0007744|PDB:4P2L"
FT   DISULFID        396..408
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000269|PubMed:24888638, ECO:0007744|PDB:4P2L"
FT   DISULFID        452..455
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000269|PubMed:24888638, ECO:0007744|PDB:4P2L"
FT   DISULFID        512..515
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000269|PubMed:24888638, ECO:0007744|PDB:4P2L"
FT   VAR_SEQ         27..32
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11278790"
FT                   /id="VSP_020499"
FT   VAR_SEQ         569..570
FT                   /note="VM -> LL (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11278790,
FT                   ECO:0000303|PubMed:12354420"
FT                   /id="VSP_020497"
FT   VAR_SEQ         571..750
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11278790,
FT                   ECO:0000303|PubMed:12354420"
FT                   /id="VSP_020498"
FT   CONFLICT        352
FT                   /note="N -> S (in Ref. 1; AAM67412)"
FT                   /evidence="ECO:0000305"
FT   STRAND          41..48
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   TURN            50..52
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           53..57
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   STRAND          61..69
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           74..89
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           91..93
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   TURN            94..96
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   STRAND          97..103
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           107..109
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           110..115
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   STRAND          120..127
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           146..157
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           176..180
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   TURN            181..185
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   STRAND          189..196
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           202..209
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   TURN            210..212
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   STRAND          216..222
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           226..231
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   STRAND          237..244
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   STRAND          249..251
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   STRAND          255..258
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           259..266
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           293..296
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   STRAND          301..303
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           304..316
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           319..321
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   STRAND          323..325
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           327..343
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           348..363
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           371..380
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           383..386
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   STRAND          403..405
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           406..427
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           437..448
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           453..466
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           467..469
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           473..490
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   STRAND          505..507
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   TURN            509..511
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   STRAND          516..519
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           528..538
FT                   /evidence="ECO:0007829|PDB:4P2L"
FT   HELIX           541..543
FT                   /evidence="ECO:0007829|PDB:4P2L"
SQ   SEQUENCE   750 AA;  82412 MW;  1781E657ED085114 CRC64;
     MRRCGRHSGP PSLLLLLLLL PPLLLSVPGA YAARLSVLYS SSDPLTLLDA DTVRPAVLGS
     SSAWAVEFFA SWCGHCIAFA PTWKELANDV KDWRPALNLA VLDCADETNS AVCREFNIAG
     FPTVRFFKAF SKNGTGTALP AAGANVQTLR MRLIDALESH RDTWPPACPP LEPAKLKDIN
     EFFTRSKAEY LALIFEREDS YLGREVTLDL SQFHAVAVRR VLNSESDVVS KFAVTDFPSC
     YLLLRNGSVS RVPVLVESRP FYTSYLRGLP GLTREAPPTT AAPVTPDKIA PTVWKFADRS
     KIYMADLESA LHYILRVEVG KFSVLEGQRL VALKKFVAVL AKYFPGQPLV QNFLHSINDW
     LQKQQKKKIP YSYFKAALDS RKENAVLAEK VNWIGCQGSE PHFRGFPCSL WVLFHFLTVQ
     AHRYSEAHPQ EPADGQEVLQ AMRSYVQSFF GCRDCANHFE QMAAASMHQV KSPSNAVLWL
     WTSHNRVNAR LSGALSEDPQ FPKVQWPPRE LCSACHNEVN GQVPLWDLGA TLNFLKAHFS
     PANIVRDPPA PGPASRRGTQ DPEASPNLVM DTLKLETGNS VLGHEQAASA ASPGATALDV
     PAGKPEASGP QELNAGLSMG GASPGQGPPE HTEELLRDVQ ENAQGQQHLS KRDTEALLLP
     EVNHLQGPLA PRRGGHSPKQ LASILEGEPE ALAIQGRRQW LQVLGGGVSF LDISLCVGLY
     SVSFMGLLAM YTYFRARMRT PKGHVSYPTA
//
ID   TRXB1_ARATH             Reviewed;         375 AA.
AC   Q39243; Q84W20; Q9SVW9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   15-JUN-2010, sequence version 3.
DT   02-JUN-2021, entry version 164.
DE   RecName: Full=Thioredoxin reductase 1, mitochondrial;
DE            EC=1.8.1.9;
DE   AltName: Full=NADPH-dependent thioredoxin reductase 1;
DE            Short=NTR1;
DE   AltName: Full=NADPH-dependent thioredoxin reductase B;
DE            Short=AtNTRB;
DE   Flags: Precursor;
GN   Name=NTR1; Synonyms=NTRB; OrderedLocusNames=At4g35460; ORFNames=F15J1.30;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617198; DOI=10.1038/47134;
RA   Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G., Pohl T.,
RA   Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N., Harris B.,
RA   Ansorge W., Brandt P., Grivell L.A., Rieger M., Weichselgartner M.,
RA   de Simone V., Obermaier B., Mache R., Mueller M., Kreis M., Delseny M.,
RA   Puigdomenech P., Watson M., Schmidtheini T., Reichert B., Portetelle D.,
RA   Perez-Alonso M., Boutry M., Bancroft I., Vos P., Hoheisel J.,
RA   Zimmermann W., Wedler H., Ridley P., Langham S.-A., McCullagh B.,
RA   Bilham L., Robben J., van der Schueren J., Grymonprez B., Chuang Y.-J.,
RA   Vandenbussche F., Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R.,
RA   Defoor E., Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M.,
RA   Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W., Mooijman P.,
RA   Klein Lankhorst R., Rose M., Hauf J., Koetter P., Berneiser S., Hempel S.,
RA   Feldpausch M., Lamberth S., Van den Daele H., De Keyser A., Buysshaert C.,
RA   Gielen J., Villarroel R., De Clercq R., van Montagu M., Rogers J.,
RA   Cronin A., Quail M.A., Bray-Allen S., Clark L., Doggett J., Hall S.,
RA   Kay M., Lennard N., McLay K., Mayes R., Pettett A., Rajandream M.A.,
RA   Lyne M., Benes V., Rechmann S., Borkova D., Bloecker H., Scharfe M.,
RA   Grimm M., Loehnert T.-H., Dose S., de Haan M., Maarse A.C., Schaefer M.,
RA   Mueller-Auer S., Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D.,
RA   Herzl A., Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E.,
RA   Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R., Schnabl S.,
RA   Hiller R., Schmidt W., Lecharny A., Aubourg S., Chefdor F., Cooke R.,
RA   Berger C., Monfort A., Casacuberta E., Gibbons T., Weber N., Vandenbol M.,
RA   Bargues M., Terol J., Torres A., Perez-Perez A., Purnelle B., Bent E.,
RA   Johnson S., Tacon D., Jesse T., Heijnen L., Schwarz S., Scholler P.,
RA   Heber S., Francs P., Bielke C., Frishman D., Haase D., Lemcke K.,
RA   Mewes H.-W., Stocker S., Zaccaria P., Bevan M., Wilson R.K.,
RA   de la Bastide M., Habermann K., Parnell L., Dedhia N., Gnoj L., Schutz K.,
RA   Huang E., Spiegel L., Sekhon M., Murray J., Sheet P., Cordes M.,
RA   Abu-Threideh J., Stoneking T., Kalicki J., Graves T., Harmon G.,
RA   Edwards J., Latreille P., Courtney L., Cloud J., Abbott A., Scott K.,
RA   Johnson D., Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K.,
RA   Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W.,
RA   Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D., Du H.,
RA   Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C., Antonoiu B.,
RA   Zidanic M., Strong C., Sun H., Lamar B., Yordan C., Ma P., Zhong J.,
RA   Preston R., Vil D., Shekher M., Matero A., Shah R., Swaby I.K.,
RA   O'Shaughnessy A., Rodriguez M., Hoffman J., Till S., Granat S., Shohdy N.,
RA   Hasegawa A., Hameed A., Lodhi M., Johnson A., Chen E., Marra M.A.,
RA   Martienssen R., McCombie W.R.;
RT   "Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana.";
RL   Nature 402:769-777(1999).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 12-375.
RC   TISSUE=Silique;
RX   PubMed=8308900; DOI=10.1006/jmbi.1994.1091;
RA   Jacquot J.-P., Rivera-Madrid R., Marinho P., Kollarova M., le Marechal P.,
RA   Miginiac-Maslow M., Meyer Y.;
RT   "Arabidopsis thaliana NAPHP thioredoxin reductase. cDNA characterization
RT   and expression of the recombinant protein in Escherichia coli.";
RL   J. Mol. Biol. 235:1357-1363(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 19-375.
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J., Southwick A.M.,
RA   Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F., Karlin-Newmann G.,
RA   Liu S.X., Lam B., Sakano H., Wu T., Yu G., Miranda M., Quach H.L.,
RA   Tripp M., Chang C.H., Lee J.M., Toriumi M.J., Chan M.M., Tang C.C.,
RA   Onodera C.S., Deng J.M., Akiyama K., Ansari Y., Arakawa T., Banh J.,
RA   Banno F., Bowser L., Brooks S.Y., Carninci P., Chao Q., Choy N., Enju A.,
RA   Goldsmith A.D., Gurjal M., Hansen N.F., Hayashizaki Y., Johnson-Hopson C.,
RA   Hsuan V.W., Iida K., Karnes M., Khan S., Koesema E., Ishida J., Jiang P.X.,
RA   Jones T., Kawai J., Kamiya A., Meyers C., Nakajima M., Narusaka M.,
RA   Seki M., Sakurai T., Satou M., Tamse R., Vaysberg M., Wallender E.K.,
RA   Wong C., Yamamura Y., Yuan S., Shinozaki K., Davis R.W., Theologis A.,
RA   Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [5]
RP   FUNCTION.
RX   PubMed=11717467; DOI=10.1073/pnas.241340898;
RA   Laloi C., Rayapuram N., Chartier Y., Grienenberger J.M., Bonnard G.,
RA   Meyer Y.;
RT   "Identification and characterization of a mitochondrial thioredoxin system
RT   in plants.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:14144-14149(2001).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15642341; DOI=10.1016/j.febslet.2004.11.094;
RA   Reichheld J.P., Meyer E., Khafif M., Bonnard G., Meyer Y.;
RT   "AtNTRB is the major mitochondrial thioredoxin reductase in Arabidopsis
RT   thaliana.";
RL   FEBS Lett. 579:337-342(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND CLEAVAGE OF TRANSIT PEPTIDE AFTER
RP   PHE-37.
RX   PubMed=25732537; DOI=10.1093/jxb/erv064;
RA   Carrie C., Venne A.S., Zahedi R.P., Soll J.;
RT   "Identification of cleavage sites and substrate proteins for two
RT   mitochondrial intermediate peptidases in Arabidopsis thaliana.";
RL   J. Exp. Bot. 66:2691-2708(2015).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 43-375 IN COMPLEX WITH FAD, AND
RP   DISULFIDE BOND.
RX   PubMed=9000629; DOI=10.1006/jmbi.1996.0695;
RA   Dai S., Saarinrn M., Ramaswamy S., Meyer Y., Jacquot J.-P., Eklund H.;
RT   "Crystal structure of Arabidopsis thaliana NADPH dependent thioredoxin
RT   reductase at 2.5-A resolution.";
RL   J. Mol. Biol. 264:1044-1057(1996).
CC   -!- FUNCTION: Possesses thioredoxin-disulfide reductase activity towards
CC       thioredoxins O1, O2 and F3. {ECO:0000269|PubMed:11717467}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[thioredoxin]-dithiol + NADP(+) = [thioredoxin]-disulfide +
CC         H(+) + NADPH; Xref=Rhea:RHEA:20345, Rhea:RHEA-COMP:10698, Rhea:RHEA-
CC         COMP:10700, ChEBI:CHEBI:15378, ChEBI:CHEBI:29950, ChEBI:CHEBI:50058,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.8.1.9;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:9000629}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15642341}.
CC       Mitochondrion {ECO:0000269|PubMed:15642341,
CC       ECO:0000305|PubMed:25732537}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- MISCELLANEOUS: The active site is a redox-active disulfide bond.
CC   -!- SIMILARITY: Belongs to the class-II pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAO42318.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAA80656.1; Type=Miscellaneous discrepancy; Note=Sequencing errors.; Evidence={ECO:0000305};
CC       Sequence=CAB54874.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAB80262.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z23109; CAA80656.1; ALT_SEQ; mRNA.
DR   EMBL; AL117188; CAB54874.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL161587; CAB80262.1; ALT_INIT; Genomic_DNA.
DR   EMBL; CP002687; AEE86518.1; -; Genomic_DNA.
DR   EMBL; BT004322; AAO42318.1; ALT_INIT; mRNA.
DR   PIR; S44027; S44027.
DR   PIR; T41743; T41743.
DR   RefSeq; NP_195271.2; NM_119711.4.
DR   PDB; 1VDC; X-ray; 2.50 A; A=43-375.
DR   PDBsum; 1VDC; -.
DR   SMR; Q39243; -.
DR   STRING; 3702.AT4G35460.1; -.
DR   iPTMnet; Q39243; -.
DR   PaxDb; Q39243; -.
DR   PRIDE; Q39243; -.
DR   ProteomicsDB; 232449; -.
DR   EnsemblPlants; AT4G35460.1; AT4G35460.1; AT4G35460.
DR   GeneID; 829698; -.
DR   Gramene; AT4G35460.1; AT4G35460.1; AT4G35460.
DR   KEGG; ath:AT4G35460; -.
DR   Araport; AT4G35460; -.
DR   TAIR; locus:2117612; AT4G35460.
DR   eggNOG; KOG0404; Eukaryota.
DR   HOGENOM; CLU_031864_5_1_1; -.
DR   InParanoid; Q39243; -.
DR   OMA; FRAEDYW; -.
DR   OrthoDB; 1108990at2759; -.
DR   PhylomeDB; Q39243; -.
DR   BioCyc; ARA:AT4G35460-MONOMER; -.
DR   BRENDA; 1.8.1.9; 399.
DR   EvolutionaryTrace; Q39243; -.
DR   PRO; PR:Q39243; -.
DR   Proteomes; UP000006548; Chromosome 4.
DR   ExpressionAtlas; Q39243; baseline and differential.
DR   Genevisible; Q39243; AT.
DR   GO; GO:0009941; C:chloroplast envelope; IDA:TAIR.
DR   GO; GO:0005829; C:cytosol; IDA:TAIR.
DR   GO; GO:0005739; C:mitochondrion; IDA:TAIR.
DR   GO; GO:0005886; C:plasma membrane; HDA:TAIR.
DR   GO; GO:0004791; F:thioredoxin-disulfide reductase activity; IDA:TAIR.
DR   GO; GO:0051781; P:positive regulation of cell division; IGI:TAIR.
DR   GO; GO:0019430; P:removal of superoxide radicals; IEA:InterPro.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR008255; Pyr_nucl-diS_OxRdtase_2_AS.
DR   InterPro; IPR005982; Thioredox_Rdtase.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR01292; TRX_reduct; 1.
DR   PROSITE; PS00573; PYRIDINE_REDOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Disulfide bond; Electron transport; FAD;
KW   Flavoprotein; Mitochondrion; NADP; Oxidoreductase; Redox-active center;
KW   Reference proteome; Transit peptide; Transport.
FT   TRANSIT         1..37
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:25732537"
FT   CHAIN           38..375
FT                   /note="Thioredoxin reductase 1, mitochondrial"
FT                   /id="PRO_0000166771"
FT   NP_BIND         58..61
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9000629"
FT   NP_BIND         79..80
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9000629"
FT   NP_BIND         87..92
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9000629"
FT   NP_BIND         344..346
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9000629"
FT   BINDING         101
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9000629"
FT   BINDING         134
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:9000629"
FT   BINDING         192
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9000629"
FT   BINDING         337
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9000629"
FT   DISULFID        189..192
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:9000629"
FT   CONFLICT        255
FT                   /note="I -> F (in Ref. 4; AAO42318)"
FT                   /evidence="ECO:0000305"
FT   STRAND          47..56
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   HELIX           60..71
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          77..79
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          82..84
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   HELIX           92..95
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          97..99
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   HELIX           111..124
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          128..130
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          136..138
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          140..147
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          149..160
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          164..166
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          175..179
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   TURN            183..185
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          186..188
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   HELIX           190..193
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   HELIX           197..199
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          202..207
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   HELIX           211..220
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   TURN            221..223
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          224..230
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          232..235
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   HELIX           240..247
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          252..255
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          257..279
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   TURN            280..282
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          285..289
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          291..295
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          299..302
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   HELIX           304..306
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   STRAND          332..334
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   HELIX           336..339
FT                   /evidence="ECO:0007829|PDB:1VDC"
FT   HELIX           346..366
FT                   /evidence="ECO:0007829|PDB:1VDC"
SQ   SEQUENCE   375 AA;  39626 MW;  F86B7FF70340C952 CRC64;
     MNCVSRLKCL ISKARSFARL GGESTLSQPP SLASAAFSSS AVMNGLETHN TRLCIVGSGP
     AAHTAAIYAA RAELKPLLFE GWMANDIAPG GQLTTTTDVE NFPGFPEGIL GVELTDKFRK
     QSERFGTTIF TETVTKVDFS SKPFKLFTDS KAILADAVIL ATGAVAKRLS FVGSGEASGG
     FWNRGISACA VCDGAAPIFR NKPLAVIGGG DSAMEEANFL TKYGSKVYII HRRDAFRASK
     IMQQRALSNP KIDVIWNSSV VEAYGDGERD VLGGLKVKNV VTGDVSDLKV SGLFFAIGHE
     PATKFLDGGV ELDSDGYVVT KPGTTQTSVP GVFAAGDVQD KKYRQAITAA GTGCMAALDA
     EHYLQEIGSQ QGKSD
//
ID   XDH_HUMAN               Reviewed;        1333 AA.
AC   P47989; Q16681; Q16712; Q4PJ16;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   02-JUN-2021, entry version 210.
DE   RecName: Full=Xanthine dehydrogenase/oxidase;
DE   Includes:
DE     RecName: Full=Xanthine dehydrogenase;
DE              Short=XD;
DE              EC=1.17.1.4 {ECO:0000269|PubMed:8670112};
DE   Includes:
DE     RecName: Full=Xanthine oxidase;
DE              Short=XO;
DE              EC=1.17.3.2 {ECO:0000269|PubMed:17301077, ECO:0000269|PubMed:8670112};
DE     AltName: Full=Xanthine oxidoreductase;
DE              Short=XOR;
GN   Name=XDH; Synonyms=XDHA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=8224915; DOI=10.1016/0378-1119(93)90652-j;
RA   Ichida K., Amaya Y., Noda K., Minoshima S., Hosoya T., Sakai O.,
RA   Shimizu N., Nishino T.;
RT   "Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase):
RT   structural analysis of the protein and chromosomal location of the gene.";
RL   Gene 133:279-284(1993).
RN   [2]
RP   SEQUENCE REVISION TO 191; 231 AND 1150.
RA   Ichida K.;
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ARG-172.
RC   TISSUE=Liver;
RX   PubMed=8135849; DOI=10.1006/bbrc.1994.1328;
RA   Xu P., Huecksteadt T.P., Harrison R., Hoidal J.R.;
RT   "Molecular cloning, tissue expression of human xanthine dehydrogenase.";
RL   Biochem. Biophys. Res. Commun. 199:998-1004(1994).
RN   [4]
RP   ERRATUM OF PUBMED:8135849.
RX   PubMed=7575623; DOI=10.1006/bbrc.1995.2482;
RA   Xu P., Huecksteadt T.P., Harrison R., Hoidal J.R.;
RL   Biochem. Biophys. Res. Commun. 215:429-429(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CATALYTIC ACTIVITY.
RC   TISSUE=Small intestine;
RX   PubMed=8670112; DOI=10.1042/bj3150235;
RA   Saksela M., Raivio K.O.;
RT   "Cloning and expression in vitro of human xanthine dehydrogenase/oxidase.";
RL   Biochem. J. 315:235-239(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LYS-133; ARG-172; MET-235;
RP   MET-395; SER-555; ALA-584; GLN-607; ASN-617; ILE-623; VAL-646; VAL-703;
RP   MET-910; LEU-1091; THR-1109; CYS-1176 AND TRP-1296.
RG   NIEHS SNPs program;
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   INVOLVEMENT IN XAN1, AND VARIANT ARG-1150.
RX   PubMed=9153281; DOI=10.1172/jci119421;
RA   Ichida K., Amaya Y., Kamatani N., Nishino T., Hosoya T., Sakai O.;
RT   "Identification of two mutations in human xanthine dehydrogenase gene
RT   responsible for classical type I xanthinuria.";
RL   J. Clin. Invest. 99:2391-2397(1997).
RN   [8]
RP   INVOLVEMENT IN XAN1.
RX   PubMed=10844591; DOI=10.1046/j.1523-1755.2000.00082.x;
RA   Levartovsky D., Lagziel A., Sperling O., Liberman U., Yaron M., Hosoya T.,
RA   Ichida K., Peretz H.;
RT   "XDH gene mutation is the underlying cause of classical xanthinuria: a
RT   second report.";
RL   Kidney Int. 57:2215-2220(2000).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Milk;
RX   PubMed=18780401; DOI=10.1002/pmic.200701057;
RA   Picariello G., Ferranti P., Mamone G., Roepstorff P., Addeo F.;
RT   "Identification of N-linked glycoproteins in human milk by hydrophilic
RT   interaction liquid chromatography and mass spectrometry.";
RL   Proteomics 8:3833-3847(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF MUTANT VAL-803 IN COMPLEX WITH
RP   FAD; 2FE-2S IRON-SULFUR CENTERS; SALICYLATE; MOLYBDOPTERIN AND CALCIUM
RP   IONS, COFACTOR, CATALYTIC ACTIVITY, FUNCTION, AND SUBUNIT.
RX   PubMed=17301077; DOI=10.1093/jb/mvm053;
RA   Yamaguchi Y., Matsumura T., Ichida K., Okamoto K., Nishino T.;
RT   "Human xanthine oxidase changes its substrate specificity to aldehyde
RT   oxidase type upon mutation of amino acid residues in the active site: roles
RT   of active site residues in binding and activation of purine substrate.";
RL   J. Biochem. 141:513-524(2007).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (3.59 ANGSTROMS) IN COMPLEX WITH FAD AND IRON-SULFUR
RP   CENTERS, TISSUE SPECIFICITY, ACTIVITY REGULATION, AND DISULFIDE BONDS.
RA   Pearson A.R., Godber B.L.J., Eisenthal R., Taylor G.L., Harrison R.;
RT   "Human milk xanthine dehydrogenase is incompletely converted to the oxidase
RT   form in the absence of proteolysis. A structural explanation.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [13]
RP   VARIANT XAN1 CYS-149.
RX   PubMed=11379872; DOI=10.1007/s004390100477;
RA   Sakamoto N., Yamamoto T., Moriwaki Y., Teranishi T., Toyoda M., Onishi Y.,
RA   Kuroda S., Sakaguchi K., Fujisawa T., Maeda M., Hada T.;
RT   "Identification of a new point mutation in the human xanthine dehydrogenase
RT   gene responsible for a case of classical type I xanthinuria.";
RL   Hum. Genet. 108:279-283(2001).
RN   [14]
RP   INVOLVEMENT IN XAN1.
RX   PubMed=14551354; DOI=10.1093/ndt/gfg385;
RA   Gok F., Ichida K., Topaloglu R.;
RT   "Mutational analysis of the xanthine dehydrogenase gene in a Turkish family
RT   with autosomal recessive classical xanthinuria.";
RL   Nephrol. Dial. Transplant. 18:2278-2283(2003).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] PHE-763 AND GLY-791.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Key enzyme in purine degradation. Catalyzes the oxidation of
CC       hypoxanthine to xanthine. Catalyzes the oxidation of xanthine to uric
CC       acid. Contributes to the generation of reactive oxygen species. Has
CC       also low oxidase activity towards aldehydes (in vitro).
CC       {ECO:0000269|PubMed:17301077}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NAD(+) + xanthine = H(+) + NADH + urate;
CC         Xref=Rhea:RHEA:16669, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17712, ChEBI:CHEBI:17775, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.17.1.4;
CC         Evidence={ECO:0000269|PubMed:8670112};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + hypoxanthine + NAD(+) = H(+) + NADH + xanthine;
CC         Xref=Rhea:RHEA:24670, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17368, ChEBI:CHEBI:17712, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.17.1.4;
CC         Evidence={ECO:0000269|PubMed:8670112};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O2 + xanthine = H2O2 + urate; Xref=Rhea:RHEA:21132,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:17712, ChEBI:CHEBI:17775; EC=1.17.3.2;
CC         Evidence={ECO:0000269|PubMed:17301077, ECO:0000269|PubMed:8670112};
CC   -!- COFACTOR:
CC       Name=[2Fe-2S] cluster; Xref=ChEBI:CHEBI:49601;
CC         Evidence={ECO:0000269|PubMed:17301077};
CC       Note=Binds 2 [2Fe-2S] clusters. {ECO:0000269|PubMed:17301077};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:17301077};
CC   -!- COFACTOR:
CC       Name=Mo-molybdopterin; Xref=ChEBI:CHEBI:71302;
CC         Evidence={ECO:0000269|PubMed:17301077};
CC       Note=Binds 1 Mo-molybdopterin (Mo-MPT) cofactor per subunit.
CC       {ECO:0000269|PubMed:17301077};
CC   -!- ACTIVITY REGULATION: Can be converted from the dehydrogenase form (D)
CC       to the oxidase form (O) irreversibly by proteolysis or reversibly
CC       through the oxidation of sulfhydryl groups. {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Interacts with BTN1A1 (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       P47989; Q9Y3R0-3: GRIP1; NbExp=3; IntAct=EBI-2557331, EBI-12193965;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Peroxisome
CC       {ECO:0000250}. Secreted.
CC   -!- TISSUE SPECIFICITY: Detected in milk (at protein level).
CC       {ECO:0000269|Ref.12}.
CC   -!- PTM: Subject to partial proteolysis; this alters the enzyme from the
CC       dehydrogenase form (D) to the oxidase form (O). {ECO:0000250}.
CC   -!- PTM: Contains sulfhydryl groups that are easily oxidized (in vitro);
CC       this alters the enzyme from the dehydrogenase form (D) to the oxidase
CC       form (O). {ECO:0000250}.
CC   -!- DISEASE: Xanthinuria 1 (XAN1) [MIM:278300]: A disorder characterized by
CC       excretion of very large amounts of xanthine in the urine and a tendency
CC       to form xanthine stones. Uric acid is strikingly diminished in serum
CC       and urine. XAN1 is due to isolated xanthine dehydrogenase deficiency.
CC       Patients can metabolize allopurinol. {ECO:0000269|PubMed:10844591,
CC       ECO:0000269|PubMed:11379872, ECO:0000269|PubMed:14551354,
CC       ECO:0000269|PubMed:9153281}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the xanthine dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/xdh/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D11456; BAA02013.2; -; mRNA.
DR   EMBL; U06117; AAA75287.1; -; mRNA.
DR   EMBL; U39487; AAB08399.1; -; mRNA.
DR   EMBL; DQ089481; AAY68219.1; -; Genomic_DNA.
DR   CCDS; CCDS1775.1; -.
DR   PIR; S66573; XOHUDH.
DR   RefSeq; NP_000370.2; NM_000379.3.
DR   PDB; 2CKJ; X-ray; 3.59 A; A/B/C/D=2-1333.
DR   PDB; 2E1Q; X-ray; 2.60 A; A/B/C/D=1-1333.
DR   PDBsum; 2CKJ; -.
DR   PDBsum; 2E1Q; -.
DR   SMR; P47989; -.
DR   BioGRID; 113335; 7.
DR   CORUM; P47989; -.
DR   IntAct; P47989; 4.
DR   STRING; 9606.ENSP00000368727; -.
DR   BindingDB; P47989; -.
DR   ChEMBL; CHEMBL1929; -.
DR   DrugBank; DB00041; Aldesleukin.
DR   DrugBank; DB00437; Allopurinol.
DR   DrugBank; DB00993; Azathioprine.
DR   DrugBank; DB00958; Carboplatin.
DR   DrugBank; DB01136; Carvedilol.
DR   DrugBank; DB00856; Chlorphenesin.
DR   DrugBank; DB00515; Cisplatin.
DR   DrugBank; DB00694; Daunorubicin.
DR   DrugBank; DB00746; Deferoxamine.
DR   DrugBank; DB03328; Dioxo(sulfanyl)molybdenum.
DR   DrugBank; DB00997; Doxorubicin.
DR   DrugBank; DB03516; Eniluracil.
DR   DrugBank; DB12466; Favipiravir.
DR   DrugBank; DB04854; Febuxostat.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB04335; Inosine.
DR   DrugBank; DB01020; Isosorbide mononitrate.
DR   DrugBank; DB00583; Levocarnitine.
DR   DrugBank; DB00170; Menadione.
DR   DrugBank; DB01033; Mercaptopurine.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB03841; Niraxostat.
DR   DrugBank; DB00336; Nitrofural.
DR   DrugBank; DB05262; Oxypurinol.
DR   DrugBank; DB06478; Porfiromycin.
DR   DrugBank; DB01168; Procarbazine.
DR   DrugBank; DB00339; Pyrazinamide.
DR   DrugBank; DB00127; Spermine.
DR   DrugBank; DB01685; Topiroxostat.
DR   DrugBank; DB00831; Trifluoperazine.
DR   DrugCentral; P47989; -.
DR   GuidetoPHARMACOLOGY; 2646; -.
DR   iPTMnet; P47989; -.
DR   PhosphoSitePlus; P47989; -.
DR   BioMuta; XDH; -.
DR   DMDM; 2506326; -.
DR   EPD; P47989; -.
DR   jPOST; P47989; -.
DR   MassIVE; P47989; -.
DR   MaxQB; P47989; -.
DR   PaxDb; P47989; -.
DR   PeptideAtlas; P47989; -.
DR   PRIDE; P47989; -.
DR   ProteomicsDB; 55829; -.
DR   Antibodypedia; 4018; 262 antibodies.
DR   DNASU; 7498; -.
DR   Ensembl; ENST00000379416; ENSP00000368727; ENSG00000158125.
DR   GeneID; 7498; -.
DR   KEGG; hsa:7498; -.
DR   UCSC; uc002rnv.2; human.
DR   CTD; 7498; -.
DR   DisGeNET; 7498; -.
DR   GeneCards; XDH; -.
DR   HGNC; HGNC:12805; XDH.
DR   HPA; ENSG00000158125; Tissue enhanced (intestine, liver).
DR   MalaCards; XDH; -.
DR   MIM; 278300; phenotype.
DR   MIM; 607633; gene.
DR   neXtProt; NX_P47989; -.
DR   OpenTargets; ENSG00000158125; -.
DR   Orphanet; 93601; Xanthinuria type I.
DR   PharmGKB; PA37404; -.
DR   VEuPathDB; HostDB:ENSG00000158125.9; -.
DR   eggNOG; KOG0430; Eukaryota.
DR   GeneTree; ENSGT00950000183114; -.
DR   HOGENOM; CLU_001681_1_2_1; -.
DR   InParanoid; P47989; -.
DR   OMA; VPLMYKQ; -.
DR   OrthoDB; 48717at2759; -.
DR   PhylomeDB; P47989; -.
DR   TreeFam; TF353036; -.
DR   BioCyc; MetaCyc:HS08270-MONOMER; -.
DR   BRENDA; 1.17.1.4; 2681.
DR   BRENDA; 1.17.3.2; 2681.
DR   PathwayCommons; P47989; -.
DR   Reactome; R-HSA-74259; Purine catabolism.
DR   Reactome; R-HSA-8851680; Butyrophilin (BTN) family interactions.
DR   SABIO-RK; P47989; -.
DR   BioGRID-ORCS; 7498; 5 hits in 983 CRISPR screens.
DR   ChiTaRS; XDH; human.
DR   EvolutionaryTrace; P47989; -.
DR   GeneWiki; Xanthine_dehydrogenase; -.
DR   GenomeRNAi; 7498; -.
DR   Pharos; P47989; Tclin.
DR   PRO; PR:P47989; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P47989; protein.
DR   Bgee; ENSG00000158125; Expressed in jejunal mucosa and 132 other tissues.
DR   Genevisible; P47989; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; IDA:UniProtKB.
DR   GO; GO:0009055; F:electron transfer activity; IEA:InterPro.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0070674; F:hypoxanthine dehydrogenase activity; IEA:Ensembl.
DR   GO; GO:0070675; F:hypoxanthine oxidase activity; IEA:Ensembl.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0043546; F:molybdopterin cofactor binding; IDA:UniProtKB.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0004854; F:xanthine dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0004855; F:xanthine oxidase activity; IDA:UniProtKB.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; TAS:Reactome.
DR   GO; GO:0006154; P:adenosine catabolic process; IDA:MGI.
DR   GO; GO:0006196; P:AMP catabolic process; IDA:MGI.
DR   GO; GO:0046055; P:dGMP catabolic process; IEA:Ensembl.
DR   GO; GO:0046038; P:GMP catabolic process; IEA:Ensembl.
DR   GO; GO:0006204; P:IMP catabolic process; IEA:Ensembl.
DR   GO; GO:0006148; P:inosine catabolic process; IDA:MGI.
DR   GO; GO:0016226; P:iron-sulfur cluster assembly; IEA:Ensembl.
DR   GO; GO:0007595; P:lactation; IEA:Ensembl.
DR   GO; GO:0045602; P:negative regulation of endothelial cell differentiation; IDA:UniProtKB.
DR   GO; GO:0001937; P:negative regulation of endothelial cell proliferation; IDA:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0051898; P:negative regulation of protein kinase B signaling; IDA:UniProtKB.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:1900747; P:negative regulation of vascular endothelial growth factor signaling pathway; IDA:UniProtKB.
DR   GO; GO:2001213; P:negative regulation of vasculogenesis; IDA:UniProtKB.
DR   GO; GO:1900745; P:positive regulation of p38MAPK cascade; IDA:UniProtKB.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IDA:UniProtKB.
DR   GO; GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome.
DR   GO; GO:0009115; P:xanthine catabolic process; IDA:UniProtKB.
DR   InterPro; IPR002888; 2Fe-2S-bd.
DR   InterPro; IPR036884; 2Fe-2S-bd_dom_sf.
DR   InterPro; IPR036010; 2Fe-2S_ferredoxin-like_sf.
DR   InterPro; IPR001041; 2Fe-2S_ferredoxin-type.
DR   InterPro; IPR006058; 2Fe2S_fd_BS.
DR   InterPro; IPR000674; Ald_Oxase/Xan_DH_a/b.
DR   InterPro; IPR036856; Ald_Oxase/Xan_DH_a/b_sf.
DR   InterPro; IPR016208; Ald_Oxase/xanthine_DH.
DR   InterPro; IPR008274; AldOxase/xan_DH_Mopterin-bd.
DR   InterPro; IPR037165; AldOxase/xan_DH_Mopterin-bd_sf.
DR   InterPro; IPR005107; CO_DH_flav_C.
DR   InterPro; IPR036683; CO_DH_flav_C_dom_sf.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR002346; Mopterin_DH_FAD-bd.
DR   InterPro; IPR022407; OxRdtase_Mopterin_BS.
DR   InterPro; IPR014307; Xanthine_DH_ssu.
DR   Pfam; PF01315; Ald_Xan_dh_C; 1.
DR   Pfam; PF02738; Ald_Xan_dh_C2; 1.
DR   Pfam; PF03450; CO_deh_flav_C; 1.
DR   Pfam; PF00941; FAD_binding_5; 1.
DR   Pfam; PF00111; Fer2; 1.
DR   Pfam; PF01799; Fer2_2; 1.
DR   PIRSF; PIRSF000127; Xanthine_DH; 1.
DR   SMART; SM01008; Ald_Xan_dh_C; 1.
DR   SMART; SM01092; CO_deh_flav_C; 1.
DR   SUPFAM; SSF47741; SSF47741; 1.
DR   SUPFAM; SSF54292; SSF54292; 1.
DR   SUPFAM; SSF54665; SSF54665; 1.
DR   SUPFAM; SSF55447; SSF55447; 1.
DR   SUPFAM; SSF56003; SSF56003; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   TIGRFAMs; TIGR02963; xanthine_xdhA; 1.
DR   PROSITE; PS00197; 2FE2S_FER_1; 1.
DR   PROSITE; PS51085; 2FE2S_FER_2; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
DR   PROSITE; PS00559; MOLYBDOPTERIN_EUK; 1.
PE   1: Evidence at protein level;
KW   2Fe-2S; 3D-structure; Cytoplasm; Disease variant; Disulfide bond; FAD;
KW   Flavoprotein; Iron; Iron-sulfur; Metal-binding; Molybdenum; NAD;
KW   Oxidoreductase; Peroxisome; Reference proteome; Secreted.
FT   CHAIN           1..1333
FT                   /note="Xanthine dehydrogenase/oxidase"
FT                   /id="PRO_0000166084"
FT   DOMAIN          4..91
FT                   /note="2Fe-2S ferredoxin-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00465"
FT   DOMAIN          229..414
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   NP_BIND         257..264
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17301077, ECO:0000269|Ref.12"
FT   NP_BIND         347..351
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17301077, ECO:0000269|Ref.12"
FT   ACT_SITE        1262
FT                   /note="Proton acceptor"
FT   METAL           43
FT                   /note="Iron-sulfur (2Fe-2S) 1"
FT   METAL           48
FT                   /note="Iron-sulfur (2Fe-2S) 1"
FT   METAL           51
FT                   /note="Iron-sulfur (2Fe-2S) 1"
FT   METAL           73
FT                   /note="Iron-sulfur (2Fe-2S) 1"
FT   METAL           113
FT                   /note="Iron-sulfur (2Fe-2S) 2"
FT   METAL           116
FT                   /note="Iron-sulfur (2Fe-2S) 2"
FT   METAL           148
FT                   /note="Iron-sulfur (2Fe-2S) 2"
FT   METAL           150
FT                   /note="Iron-sulfur (2Fe-2S) 2"
FT   METAL           768
FT                   /note="Molybdenum"
FT   METAL           799
FT                   /note="Molybdenum; via carbonyl oxygen"
FT   METAL           913
FT                   /note="Molybdenum; via amide nitrogen"
FT   METAL           1080
FT                   /note="Molybdenum; via amide nitrogen"
FT   BINDING         337
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17301077, ECO:0000269|Ref.12"
FT   BINDING         360
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17301077, ECO:0000269|Ref.12"
FT   BINDING         404
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   BINDING         422
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17301077, ECO:0000269|Ref.12"
FT   BINDING         803
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         881
FT                   /note="Substrate"
FT   BINDING         915
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         1011
FT                   /note="Substrate"
FT   DISULFID        509..1318
FT                   /note="In oxidase form"
FT                   /evidence="ECO:0000269|Ref.12"
FT   DISULFID        536..993
FT                   /note="In oxidase form"
FT                   /evidence="ECO:0000269|Ref.12"
FT   VARIANT         133
FT                   /note="E -> K (in dbSNP:rs45447191)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023976"
FT   VARIANT         149
FT                   /note="R -> C (in XAN1; dbSNP:rs72549369)"
FT                   /evidence="ECO:0000269|PubMed:11379872"
FT                   /id="VAR_045900"
FT   VARIANT         172
FT                   /note="G -> R (in dbSNP:rs45523133)"
FT                   /evidence="ECO:0000269|PubMed:8135849, ECO:0000269|Ref.6"
FT                   /id="VAR_023977"
FT   VARIANT         235
FT                   /note="T -> M (in dbSNP:rs45469499)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023978"
FT   VARIANT         395
FT                   /note="K -> M (in dbSNP:rs34929837)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023979"
FT   VARIANT         555
FT                   /note="P -> S (in dbSNP:rs45577338)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023980"
FT   VARIANT         584
FT                   /note="D -> A (in dbSNP:rs45491693)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023981"
FT   VARIANT         607
FT                   /note="R -> Q (in dbSNP:rs45442092)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023982"
FT   VARIANT         617
FT                   /note="K -> N (in dbSNP:rs45442398)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023983"
FT   VARIANT         623
FT                   /note="T -> I (in dbSNP:rs45448694)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023984"
FT   VARIANT         646
FT                   /note="I -> V (in dbSNP:rs17323225)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023985"
FT   VARIANT         703
FT                   /note="I -> V (in dbSNP:rs17011368)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023986"
FT   VARIANT         763
FT                   /note="L -> F (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035899"
FT   VARIANT         791
FT                   /note="R -> G (in a breast cancer sample; somatic mutation;
FT                   dbSNP:rs775646772)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035900"
FT   VARIANT         910
FT                   /note="T -> M (in dbSNP:rs669884)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023987"
FT   VARIANT         1091
FT                   /note="V -> L (in dbSNP:rs45619033)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023988"
FT   VARIANT         1109
FT                   /note="N -> T (in dbSNP:rs45547640)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023989"
FT   VARIANT         1150
FT                   /note="P -> R (in dbSNP:rs1042036)"
FT                   /evidence="ECO:0000269|PubMed:9153281"
FT                   /id="VAR_045901"
FT   VARIANT         1176
FT                   /note="R -> C (in dbSNP:rs45624433)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023990"
FT   VARIANT         1296
FT                   /note="R -> W (in dbSNP:rs45564939)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023991"
FT   MUTAGEN         803
FT                   /note="E->V: Strongly decreased activity towards xanthine
FT                   and hypoxanthine. Increased affinity and activity towards
FT                   aromatic aldehydes."
FT   MUTAGEN         881
FT                   /note="R->M: Abolishes xanthine oxidase activity."
FT   CONFLICT        259
FT                   /note="V -> E (in Ref. 3; AAA75287)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        333..334
FT                   /note="QL -> HV (in Ref. 3; AAA75287)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        495
FT                   /note="H -> Q (in Ref. 3; AAA75287)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        515..517
FT                   /note="FFF -> LLL (in Ref. 3; AAA75287)"
FT                   /evidence="ECO:0000305"
FT   STRAND          6..10
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          13..17
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           26..32
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          44..48
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          52..59
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   TURN            60..63
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          64..71
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   TURN            72..74
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           77..79
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          84..86
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           88..90
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           100..107
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           117..130
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           136..141
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   TURN            142..145
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          149..151
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           154..160
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           161..163
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           198..200
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           206..208
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           214..218
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          227..230
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          235..238
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           242..251
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           264..270
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          276..280
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           285..288
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          290..292
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          294..300
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           305..318
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           321..323
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           325..335
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           340..345
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           348..354
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           362..367
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          371..375
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          380..384
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           387..389
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          403..410
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          416..423
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          425..429
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          433..442
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          448..465
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           467..471
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   TURN            472..475
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          477..479
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           480..493
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           505..529
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   TURN            541..543
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           544..547
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          556..560
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           583..587
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           594..596
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          604..610
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          612..622
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           626..628
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          632..637
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           638..640
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          645..648
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          653..656
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          659..661
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          667..675
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           676..684
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          687..692
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           699..705
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          708..718
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           720..726
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          728..737
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          749..754
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          761..765
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           770..781
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           785..787
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          788..793
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   TURN            799..802
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           807..820
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          824..827
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           830..837
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          843..851
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          857..871
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           875..884
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          893..903
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   TURN            913..916
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           917..935
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           939..945
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           965..976
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           978..991
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          993..1009
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           1013..1015
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          1017..1024
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          1030..1035
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          1039..1041
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           1043..1055
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           1059..1061
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   TURN            1069..1071
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           1083..1108
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           1114..1123
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          1129..1135
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   TURN            1143..1146
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          1152..1166
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   TURN            1167..1169
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          1172..1182
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           1189..1208
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   TURN            1225..1227
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           1233..1235
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   STRAND          1238..1244
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           1254..1256
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           1263..1268
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           1269..1286
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           1303..1309
FT                   /evidence="ECO:0007829|PDB:2E1Q"
FT   HELIX           1315..1317
FT                   /evidence="ECO:0007829|PDB:2E1Q"
SQ   SEQUENCE   1333 AA;  146424 MW;  806FF2C7413F84C5 CRC64;
     MTADKLVFFV NGRKVVEKNA DPETTLLAYL RRKLGLSGTK LGCGEGGCGA CTVMLSKYDR
     LQNKIVHFSA NACLAPICSL HHVAVTTVEG IGSTKTRLHP VQERIAKSHG SQCGFCTPGI
     VMSMYTLLRN QPEPTMEEIE NAFQGNLCRC TGYRPILQGF RTFARDGGCC GGDGNNPNCC
     MNQKKDHSVS LSPSLFKPEE FTPLDPTQEP IFPPELLRLK DTPRKQLRFE GERVTWIQAS
     TLKELLDLKA QHPDAKLVVG NTEIGIEMKF KNMLFPMIVC PAWIPELNSV EHGPDGISFG
     AACPLSIVEK TLVDAVAKLP AQKTEVFRGV LEQLRWFAGK QVKSVASVGG NIITASPISD
     LNPVFMASGA KLTLVSRGTR RTVQMDHTFF PGYRKTLLSP EEILLSIEIP YSREGEYFSA
     FKQASRREDD IAKVTSGMRV LFKPGTTEVQ ELALCYGGMA NRTISALKTT QRQLSKLWKE
     ELLQDVCAGL AEELHLPPDA PGGMVDFRCT LTLSFFFKFY LTVLQKLGQE NLEDKCGKLD
     PTFASATLLF QKDPPADVQL FQEVPKGQSE EDMVGRPLPH LAADMQASGE AVYCDDIPRY
     ENELSLRLVT STRAHAKIKS IDTSEAKKVP GFVCFISADD VPGSNITGIC NDETVFAKDK
     VTCVGHIIGA VVADTPEHTQ RAAQGVKITY EELPAIITIE DAIKNNSFYG PELKIEKGDL
     KKGFSEADNV VSGEIYIGGQ EHFYLETHCT IAVPKGEAGE MELFVSTQNT MKTQSFVAKM
     LGVPANRIVV RVKRMGGGFG GKETRSTVVS TAVALAAYKT GRPVRCMLDR DEDMLITGGR
     HPFLARYKVG FMKTGTVVAL EVDHFSNVGN TQDLSQSIME RALFHMDNCY KIPNIRGTGR
     LCKTNLPSNT AFRGFGGPQG MLIAECWMSE VAVTCGMPAE EVRRKNLYKE GDLTHFNQKL
     EGFTLPRCWE ECLASSQYHA RKSEVDKFNK ENCWKKRGLC IIPTKFGISF TVPFLNQAGA
     LLHVYTDGSV LLTHGGTEMG QGLHTKMVQV ASRALKIPTS KIYISETSTN TVPNTSPTAA
     SVSADLNGQA VYAACQTILK RLEPYKKKNP SGSWEDWVTA AYMDTVSLSA TGFYRTPNLG
     YSFETNSGNP FHYFSYGVAC SEVEIDCLTG DHKNLRTDIV MDVGSSLNPA IDIGQVEGAF
     VQGLGLFTLE ELHYSPEGSL HTRGPSTYKI PAFGSIPIEF RVSLLRDCPN KKAIYASKAV
     GEPPLFLAAS IFFAIKDAIR AARAQHTGNN VKELFRLDSP ATPEKIRNAC VDKFTTLCVT
     GVPENCKPWS VRV
//
ID   NROR_CLOAB              Reviewed;         379 AA.
AC   Q9AL95;
DT   08-MAR-2011, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   02-JUN-2021, entry version 119.
DE   RecName: Full=NADH-rubredoxin oxidoreductase;
DE            Short=NROR;
DE            EC=1.18.1.1;
DE   AltName: Full=NADH:rubredoxin oxidoreductase;
GN   Name=nroR; OrderedLocusNames=CA_C2448;
OS   Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710
OS   / VKM B-1787).
OC   Bacteria; Firmicutes; Clostridia; Eubacteriales; Clostridiaceae;
OC   Clostridium.
OX   NCBI_TaxID=272562;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 1-20, FUNCTION AS
RP   NROR, SUBSTRATE SPECIFICITY, CATALYTIC ACTIVITY, COFACTOR, AND KINETIC
RP   PARAMETERS.
RC   STRAIN=ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787;
RX   PubMed=11444870; DOI=10.1006/bbrc.2001.5196;
RA   Guedon E., Petitdemange H.;
RT   "Identification of the gene encoding NADH-rubredoxin oxidoreductase in
RT   Clostridium acetobutylicum.";
RL   Biochem. Biophys. Res. Commun. 285:496-502(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787;
RX   PubMed=11466286; DOI=10.1128/jb.183.16.4823-4838.2001;
RA   Noelling J., Breton G., Omelchenko M.V., Makarova K.S., Zeng Q., Gibson R.,
RA   Lee H.M., Dubois J., Qiu D., Hitti J., Wolf Y.I., Tatusov R.L., Sabathe F.,
RA   Doucette-Stamm L.A., Soucaille P., Daly M.J., Bennett G.N., Koonin E.V.,
RA   Smith D.R.;
RT   "Genome sequence and comparative analysis of the solvent-producing
RT   bacterium Clostridium acetobutylicum.";
RL   J. Bacteriol. 183:4823-4838(2001).
RN   [3]
RP   PROTEIN SEQUENCE OF 1-20, AND FUNCTION.
RC   STRAIN=ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787;
RX   PubMed=19124587; DOI=10.1128/aem.01425-08;
RA   Kawasaki S., Sakai Y., Takahashi T., Suzuki I., Niimura Y.;
RT   "O2 and reactive oxygen species detoxification complex, composed of O2-
RT   responsive NADH:rubredoxin oxidoreductase-flavoprotein A2-desulfoferrodoxin
RT   operon enzymes, rubperoxin, and rubredoxin, in Clostridium
RT   acetobutylicum.";
RL   Appl. Environ. Microbiol. 75:1021-1029(2009).
RN   [4]
RP   INDUCTION BY O(2).
RC   STRAIN=ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787;
RX   PubMed=16332833; DOI=10.1128/aem.71.12.8442-8450.2005;
RA   Kawasaki S., Watamura Y., Ono M., Watanabe T., Takeda K., Niimura Y.;
RT   "Adaptive responses to oxygen stress in obligatory anaerobes Clostridium
RT   acetobutylicum and Clostridium aminovalericum.";
RL   Appl. Environ. Microbiol. 71:8442-8450(2005).
RN   [5]
RP   FUNCTION.
RC   STRAIN=ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787;
RX   PubMed=19084524; DOI=10.1016/j.febslet.2008.12.004;
RA   Hillmann F., Riebe O., Fischer R.J., Mot A., Caranto J.D., Kurtz D.M. Jr.,
RA   Bahl H.;
RT   "Reductive dioxygen scavenging by flavo-diiron proteins of Clostridium
RT   acetobutylicum.";
RL   FEBS Lett. 583:241-245(2009).
RN   [6]
RP   INDUCTION BY O(2), AND REPRESSION BY PERR.
RC   STRAIN=ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787;
RX   PubMed=19648241; DOI=10.1128/jb.00351-09;
RA   Hillmann F., Doring C., Riebe O., Ehrenreich A., Fischer R.J., Bahl H.;
RT   "The role of PerR in O2-affected gene expression of Clostridium
RT   acetobutylicum.";
RL   J. Bacteriol. 191:6082-6093(2009).
RN   [7]
RP   FUNCTION, AND COFACTOR.
RC   STRAIN=ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787;
RX   PubMed=19118342; DOI=10.1099/mic.0.022756-0;
RA   Riebe O., Fischer R.J., Wampler D.A., Kurtz D.M. Jr., Bahl H.;
RT   "Pathway for H2O2 and O2 detoxification in Clostridium acetobutylicum.";
RL   Microbiology 155:16-24(2009).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 2-379 IN COMPLEX WITH FAD,
RP   COFACTOR, DISULFIDE BONDS, SUBUNIT, AND DOMAIN.
RC   STRAIN=ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787;
RX   PubMed=20017214; DOI=10.1002/prot.22650;
RA   Nishikawa K., Shomura Y., Kawasaki S., Niimura Y., Higuchi Y.;
RT   "Crystal structure of NADH:rubredoxin oxidoreductase from Clostridium
RT   acetobutylicum: a key component of the dioxygen scavenging system in
RT   obligatory anaerobes.";
RL   Proteins 78:1066-1070(2010).
CC   -!- FUNCTION: Catalyzes the NADH-dependent reduction of rubredoxin (Rd).
CC       NADPH is a very poor electron donor compared to NADH. Functions as an
CC       intermediate component in the electron transfer chain:
CC       NADH->NROR->Rd->FprA1/2. Also functions as an intermediate component in
CC       the electron transfer chains from NADH to revRbr and Dfx. Therefore, is
CC       a key electron carrier in an efficient multienzyme complex that can
CC       scavenge O(2) and reactive oxygen species (ROS), and thus plays an
CC       important role in the oxidative stress defense system in
CC       C.acetobutylicum, an obligate anaerobic bacterium.
CC       {ECO:0000269|PubMed:11444870, ECO:0000269|PubMed:19084524,
CC       ECO:0000269|PubMed:19118342, ECO:0000269|PubMed:19124587}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NAD(+) + 2 reduced [rubredoxin] = NADH + 2 oxidized
CC         [rubredoxin]; Xref=Rhea:RHEA:18597, Rhea:RHEA-COMP:10302, Rhea:RHEA-
CC         COMP:10303, ChEBI:CHEBI:15378, ChEBI:CHEBI:29033, ChEBI:CHEBI:29034,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.18.1.1;
CC         Evidence={ECO:0000269|PubMed:11444870};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:11444870, ECO:0000269|PubMed:19118342,
CC         ECO:0000269|PubMed:20017214};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:11444870,
CC       ECO:0000269|PubMed:19118342, ECO:0000269|PubMed:20017214};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.0 uM for rubredoxin {ECO:0000269|PubMed:11444870};
CC         KM=17.4 uM for NADH {ECO:0000269|PubMed:11444870};
CC         KM=2070 uM for NADPH {ECO:0000269|PubMed:11444870};
CC         Vmax=570 umol/min/mg enzyme with rubredoxin and NADH as substrates
CC         {ECO:0000269|PubMed:11444870};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:20017214}.
CC   -!- INDUCTION: Up-regulated upon exposure to O(2). Repressed by PerR.
CC       {ECO:0000269|PubMed:16332833, ECO:0000269|PubMed:19648241}.
CC   -!- DOMAIN: Is composed of three domains: an FAD-binding domain (residues
CC       2-107 and 223-297), an NADH-binding domain (residues 108-222), and a C-
CC       terminal domain (residues 298-379). {ECO:0000269|PubMed:20017214}.
CC   -!- MISCELLANEOUS: The disulfide bonds are not involved in the electron
CC       transfer from NADH to rubredoxin catalyzed by NROR.
CC   -!- SIMILARITY: Belongs to the FAD-dependent oxidoreductase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY026492; AAK08126.1; -; Genomic_DNA.
DR   EMBL; AE001437; AAK80402.1; -; Genomic_DNA.
DR   PIR; G97201; G97201.
DR   PIR; JC7710; JC7710.
DR   RefSeq; NP_349062.1; NC_003030.1.
DR   RefSeq; WP_010965743.1; NC_003030.1.
DR   PDB; 3KLJ; X-ray; 2.10 A; A=2-379.
DR   PDBsum; 3KLJ; -.
DR   SMR; Q9AL95; -.
DR   STRING; 272562.CA_C2448; -.
DR   EnsemblBacteria; AAK80402; AAK80402; CA_C2448.
DR   GeneID; 44998926; -.
DR   KEGG; cac:CA_C2448; -.
DR   PATRIC; fig|272562.8.peg.2644; -.
DR   eggNOG; COG1251; Bacteria.
DR   HOGENOM; CLU_003291_4_4_9; -.
DR   OMA; IHHFWTF; -.
DR   OrthoDB; 1149616at2; -.
DR   BRENDA; 1.18.1.1; 1452.
DR   SABIO-RK; Q9AL95; -.
DR   EvolutionaryTrace; Q9AL95; -.
DR   Proteomes; UP000000814; Chromosome.
DR   GO; GO:0009055; F:electron transfer activity; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0015044; F:rubredoxin-NAD+ reductase activity; IDA:UniProtKB.
DR   GO; GO:0072592; P:oxygen metabolic process; IDA:UniProtKB.
DR   GO; GO:0009636; P:response to toxic substance; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR041575; Rubredoxin_C.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF18267; Rubredoxin_C; 1.
DR   SUPFAM; SSF51905; SSF51905; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Detoxification; Direct protein sequencing; Disulfide bond;
KW   Electron transport; FAD; Flavoprotein; NAD; Oxidoreductase;
KW   Reference proteome; Stress response; Transport.
FT   CHAIN           1..379
FT                   /note="NADH-rubredoxin oxidoreductase"
FT                   /id="PRO_0000405536"
FT   NP_BIND         33..35
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20017214"
FT   BINDING         42
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20017214"
FT   BINDING         79
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:20017214"
FT   BINDING         125
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20017214"
FT   BINDING         259
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20017214"
FT   DISULFID        26..286
FT                   /evidence="ECO:0000269|PubMed:20017214"
FT   DISULFID        137..216
FT                   /evidence="ECO:0000269|PubMed:20017214"
FT   STRAND          5..9
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   HELIX           13..22
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   TURN            23..25
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          29..32
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          34..37
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   HELIX           42..44
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   HELIX           45..50
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   HELIX           55..57
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          59..61
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   HELIX           63..68
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          72..74
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          79..83
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   TURN            84..87
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          88..91
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          96..98
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          100..104
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          108..110
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   HELIX           127..140
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          143..146
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   HELIX           150..162
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          166..169
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          171..175
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   TURN            177..179
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   HELIX           182..193
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   TURN            194..196
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          198..200
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   HELIX           205..207
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   HELIX           209..214
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          215..219
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          223..225
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   HELIX           228..230
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          237..243
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          254..256
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   HELIX           258..260
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          261..263
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   HELIX           271..285
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          300..303
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          306..312
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          320..326
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          331..337
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   STRAND          340..348
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   HELIX           350..361
FT                   /evidence="ECO:0007829|PDB:3KLJ"
FT   HELIX           372..376
FT                   /evidence="ECO:0007829|PDB:3KLJ"
SQ   SEQUENCE   379 AA;  41286 MW;  08C83695DB7FE3E9 CRC64;
     MKSTKILILG AGPAGFSAAK AALGKCDDIT MINSEKYLPY YRPRLNEIIA KNKSIDDILI
     KKNDWYEKNN IKVITSEFAT SIDPNNKLVT LKSGEKIKYE KLIIASGSIA NKIKVPHADE
     IFSLYSYDDA LKIKDECKNK GKAFIIGGGI LGIELAQAII DSGTPASIGI ILEYPLERQL
     DRDGGLFLKD KLDRLGIKIY TNSNFEEMGD LIRSSCVITA VGVKPNLDFI KDTEIASKRG
     ILVNDHMETS IKDIYACGDV AEFYGKNPGL INIANKQGEV AGLNACGEDA SYSEIIPSPI
     LKVSGISIIS CGDIENNKPS KVFRSTQEDK YIVCMLKENK IDAAAVIGDV SLGTKLKKAI
     DSSKSFDNIS SLDAILNNL
//
ID   Y4991_PSEAE             Reviewed;         391 AA.
AC   Q9HUH4;
DT   10-MAY-2017, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   02-JUN-2021, entry version 102.
DE   RecName: Full=Probable FAD-dependent oxidoreductase PA4991 {ECO:0000305};
DE            EC=1.-.-.- {ECO:0000305};
GN   OrderedLocusNames=PA4991 {ECO:0000312|EMBL:AAG08376.1};
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [2]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=25775563; DOI=10.1073/pnas.1419677112;
RA   Turner K.H., Wessel A.K., Palmer G.C., Murray J.L., Whiteley M.;
RT   "Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:4110-4115(2015).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) IN COMPLEX WITH FAD, FUNCTION,
RP   COFACTOR, AND SUBUNIT.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=26841760; DOI=10.1107/s2053230x15024437;
RA   Jacewicz A., Schnell R., Lindqvist Y., Schneider G.;
RT   "Crystal structure of the flavoenzyme PA4991 from Pseudomonas aeruginosa.";
RL   Acta Crystallogr. F Struct. Biol. Commun. 72:105-111(2016).
CC   -!- FUNCTION: Probably functions as a FAD-dependent oxidoreductase, whose
CC       physiological substrate is unknown. Does not display amino-acid oxidase
CC       or glycerol-3-phosphate dehydrogenase activities (PubMed:26841760). Is
CC       essential for growth of P.aeruginosa in the sputum of cystic fibrosis
CC       patients (PubMed:25775563). {ECO:0000269|PubMed:25775563,
CC       ECO:0000269|PubMed:26841760}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000305|PubMed:26841760};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:26841760};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:26841760}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene show growth defect in
CC       natural and synthetic cystic fibrosis sputum.
CC       {ECO:0000269|PubMed:25775563}.
CC   -!- SIMILARITY: Belongs to the DAO family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE004091; AAG08376.1; -; Genomic_DNA.
DR   PIR; D83021; D83021.
DR   RefSeq; NP_253678.1; NC_002516.2.
DR   RefSeq; WP_003114540.1; NZ_QZGE01000002.1.
DR   PDB; 5EZ7; X-ray; 2.40 A; A=1-391.
DR   PDBsum; 5EZ7; -.
DR   SMR; Q9HUH4; -.
DR   PaxDb; Q9HUH4; -.
DR   PRIDE; Q9HUH4; -.
DR   DNASU; 880166; -.
DR   EnsemblBacteria; AAG08376; AAG08376; PA4991.
DR   GeneID; 880166; -.
DR   KEGG; pae:PA4991; -.
DR   PATRIC; fig|208964.12.peg.5231; -.
DR   PseudoCAP; PA4991; -.
DR   HOGENOM; CLU_705707_0_0_6; -.
DR   OMA; WPTKLAL; -.
DR   PhylomeDB; Q9HUH4; -.
DR   BioCyc; PAER208964:G1FZ6-5107-MONOMER; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01266; DAO; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Oxidoreductase; Reference proteome.
FT   CHAIN           1..391
FT                   /note="Probable FAD-dependent oxidoreductase PA4991"
FT                   /id="PRO_0000439959"
FT   NP_BIND         44..45
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26841760"
FT   NP_BIND         49..51
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26841760"
FT   NP_BIND         346..347
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26841760"
FT   BINDING         17
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:26841760"
FT   BINDING         36
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26841760"
FT   STRAND          8..12
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           16..27
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          32..38
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   TURN            41..44
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           45..47
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           69..72
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           74..81
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          83..88
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          95..98
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          101..104
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          126..128
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           130..132
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           135..137
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          144..148
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          152..154
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           156..167
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           168..170
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          171..173
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          177..182
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          185..191
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          194..197
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          199..203
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           206..208
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           209..215
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          223..237
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          243..245
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          248..251
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          253..260
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          266..272
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           273..275
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           277..281
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           284..298
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          308..319
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          331..335
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   STRAND          338..342
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           346..348
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           349..363
FT                   /evidence="ECO:0007829|PDB:5EZ7"
FT   HELIX           385..388
FT                   /evidence="ECO:0007829|PDB:5EZ7"
SQ   SEQUENCE   391 AA;  42109 MW;  D2614EA26F47A949 CRC64;
     MPQALSTDIL IVGGGIAGLW LNARLRRAGY ATVLVESASL GGGQSVKSQG IIHGGAKYAL
     HGALTGASEA IADMPRRWRA CLGSDGELDL RGVRLLSEAH YLWSPGGLAG SLTSFFASKA
     VRSRVEQAKG EDLPPALRDK GFKGKAYRLT EIVFDVPDLI RRLAELAGDS LLAGERIEPL
     REGRELAGLC VDGREIRAQR VVLSAGAGNE ALLRELGLEQ PAMQRRPLHM VMVKAATLKP
     LYAHCLGAGP KPRITVTTHP TRDGQSVWYL GGDIAETDGV ARDEAAQIAE ARRELAKLLP
     WIDLGQAQWA TLRVDRAEPA QSNLLRPDNA FLAEQGRLLV GWPTKLALAP DFADRVCARL
     EEDGIRPSEH AALPQLPRPP LAEPAWEVAF A
//
ID   OXDA_HUMAN              Reviewed;         347 AA.
AC   P14920; B2R7I5; Q16758; Q8N6R2;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2002, sequence version 3.
DT   02-JUN-2021, entry version 198.
DE   RecName: Full=D-amino-acid oxidase;
DE            Short=DAAO;
DE            Short=DAMOX;
DE            Short=DAO;
DE            EC=1.4.3.3;
GN   Name=DAO; Synonyms=DAMOX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=2901986; DOI=10.1016/0014-5793(88)80252-7;
RA   Momoi K., Fukui K., Watanabe F., Miyake Y.;
RT   "Molecular cloning and sequence analysis of cDNA encoding human kidney D-
RT   amino acid oxidase.";
RL   FEBS Lett. 238:180-184(1988).
RN   [2]
RP   SEQUENCE REVISION.
RA   Momoi K.;
RL   Submitted (SEP-1990) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Colon, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-65.
RX   PubMed=1356107;
RA   Fukui K., Miyake Y.;
RT   "Molecular cloning and chromosomal localization of a human gene encoding D-
RT   amino-acid oxidase.";
RL   J. Biol. Chem. 267:18631-18638(1992).
RN   [7]
RP   INVOLVEMENT IN SCZD, AND INTERACTION WITH DAOA.
RX   PubMed=12364586; DOI=10.1073/pnas.182412499;
RA   Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M.,
RA   Abderrahim H., Bougueleret L., Barry C., Tanaka H., La Rosa P., Puech A.,
RA   Tahri N., Cohen-Akenine A., Delabrosse S., Lissarrague S., Picard F.-P.,
RA   Maurice K., Essioux L., Millasseau P., Grel P., Debailleul V., Simon A.-M.,
RA   Caterina D., Dufaure I., Malekzadeh K., Belova M., Luan J.-J., Bouillot M.,
RA   Sambucy J.-L., Primas G., Saumier M., Boubkiri N., Martin-Saumier S.,
RA   Nasroune M., Peixoto H., Delaye A., Pinchot V., Bastucci M., Guillou S.,
RA   Chevillon M., Sainz-Fuertes R., Meguenni S., Aurich-Costa J., Cherif D.,
RA   Gimalac A., Van Duijn C., Gauvreau D., Ouellette G., Fortier I.,
RA   Raelson J., Sherbatich T., Riazanskay N., Rogaev E., Raeymaekers P.,
RA   Aerssens J., Konings F., Luyten W., Macciardi F., Sham P.C., Straub R.E.,
RA   Weinberger D.R., Cohen N., Cohen D.;
RT   "Genetic and physiological data implicating the new human gene G72 and the
RT   gene for D-amino acid oxidase in schizophrenia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:13675-13680(2002).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH FAD AND THE INHIBITOR
RP   BENZOATE, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=17088322; DOI=10.1110/ps.062421606;
RA   Kawazoe T., Tsuge H., Pilone M.S., Fukui K.;
RT   "Crystal structure of human D-amino acid oxidase: context-dependent
RT   variability of the backbone conformation of the VAAGL hydrophobic stretch
RT   located at the si-face of the flavin ring.";
RL   Protein Sci. 15:2708-2717(2006).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEXES WITH FAD AND
RP   IMINO-SERINE; IMINO-DOPA AND O-AMINOBENZOATE, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND FUNCTION.
RX   PubMed=17303072; DOI=10.1016/j.bbrc.2007.01.181;
RA   Kawazoe T., Tsuge H., Imagawa T., Aki K., Kuramitsu S., Fukui K.;
RT   "Structural basis of D-DOPA oxidation by D-amino acid oxidase: alternative
RT   pathway for dopamine biosynthesis.";
RL   Biochem. Biophys. Res. Commun. 355:385-391(2007).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.49 ANGSTROMS) IN COMPLEX WITH FAD AND SYNTHETIC
RP   INHIBITOR.
RX   PubMed=18455394; DOI=10.1016/j.bmcl.2008.04.020;
RA   Sparey T., Abeywickrema P., Almond S., Brandon N., Byrne N., Campbell A.,
RA   Hutson P.H., Jacobson M., Jones B., Munshi S., Pascarella D., Pike A.,
RA   Prasad G.S., Sachs N., Sakatis M., Sardana V., Venkatraman S., Young M.B.;
RT   "The discovery of fused pyrrole carboxylic acids as novel, potent D-amino
RT   acid oxidase (DAO) inhibitors.";
RL   Bioorg. Med. Chem. Lett. 18:3386-3391(2008).
CC   -!- FUNCTION: Regulates the level of the neuromodulator D-serine in the
CC       brain. Has high activity towards D-DOPA and contributes to dopamine
CC       synthesis. Could act as a detoxifying agent which removes D-amino acids
CC       accumulated during aging. Acts on a variety of D-amino acids with a
CC       preference for those having small hydrophobic side chains followed by
CC       those bearing polar, aromatic, and basic groups. Does not act on acidic
CC       amino acids. {ECO:0000269|PubMed:17303072}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a D-alpha-amino acid + H2O + O2 = a 2-oxocarboxylate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:21816, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:35179,
CC         ChEBI:CHEBI:59871; EC=1.4.3.3;
CC         Evidence={ECO:0000269|PubMed:17088322};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.6 mM for D-serine {ECO:0000269|PubMed:17088322,
CC         ECO:0000269|PubMed:17303072};
CC         KM=1.7 mM for D-proline {ECO:0000269|PubMed:17088322,
CC         ECO:0000269|PubMed:17303072};
CC         KM=1.1 mM for D-tyrosine {ECO:0000269|PubMed:17088322,
CC         ECO:0000269|PubMed:17303072};
CC         KM=1.5 mM for D-DOPA {ECO:0000269|PubMed:17088322,
CC         ECO:0000269|PubMed:17303072};
CC         KM=1.2 mM for D-phenylalanine {ECO:0000269|PubMed:17088322,
CC         ECO:0000269|PubMed:17303072};
CC         KM=0.9 mM for D-alanine {ECO:0000269|PubMed:17088322,
CC         ECO:0000269|PubMed:17303072};
CC   -!- SUBUNIT: Homodimer (PubMed:17088322, PubMed:18455394). Interacts with
CC       DAOA (PubMed:12364586). {ECO:0000269|PubMed:12364586,
CC       ECO:0000269|PubMed:17088322, ECO:0000269|PubMed:18455394}.
CC   -!- INTERACTION:
CC       P14920; O43741: PRKAB2; NbExp=6; IntAct=EBI-3908043, EBI-1053424;
CC   -!- SUBCELLULAR LOCATION: Peroxisome.
CC   -!- DISEASE: Schizophrenia (SCZD) [MIM:181500]: A complex, multifactorial
CC       psychotic disorder or group of disorders characterized by disturbances
CC       in the form and content of thought (e.g. delusions, hallucinations), in
CC       mood (e.g. inappropriate affect), in sense of self and relationship to
CC       the external world (e.g. loss of ego boundaries, withdrawal), and in
CC       behavior (e.g bizarre or apparently purposeless behavior). Although it
CC       affects emotions, it is distinguished from mood disorders in which such
CC       disturbances are primary. Similarly, there may be mild impairment of
CC       cognitive function, and it is distinguished from the dementias in which
CC       disturbed cognitive function is considered primary. Some patients
CC       manifest schizophrenic as well as bipolar disorder symptoms and are
CC       often given the diagnosis of schizoaffective disorder.
CC       {ECO:0000269|PubMed:12364586}. Note=Disease susceptibility may be
CC       associated with variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the DAMOX/DASOX family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X13227; CAA31614.1; -; mRNA.
DR   EMBL; AK312995; BAG35832.1; -; mRNA.
DR   EMBL; CH471054; EAW97837.1; -; Genomic_DNA.
DR   EMBL; BC029057; AAH29057.1; -; mRNA.
DR   EMBL; BC074770; AAH74770.1; -; mRNA.
DR   EMBL; D11370; BAA20974.1; -; Genomic_DNA.
DR   CCDS; CCDS9122.1; -.
DR   PIR; S01340; S01340.
DR   RefSeq; NP_001908.3; NM_001917.4.
DR   RefSeq; XP_011536306.1; XM_011538004.2.
DR   RefSeq; XP_011536307.1; XM_011538005.2.
DR   PDB; 2DU8; X-ray; 2.50 A; A/B/G/J=1-347.
DR   PDB; 2E48; X-ray; 2.90 A; A/B/C/D=1-347.
DR   PDB; 2E49; X-ray; 3.20 A; A/B/C/D=1-347.
DR   PDB; 2E4A; X-ray; 2.60 A; A/B/C/D=1-347.
DR   PDB; 2E82; X-ray; 2.70 A; A/B/C/D=1-347.
DR   PDB; 2GNZ; Model; -; A=1-339.
DR   PDB; 3CUK; X-ray; 2.49 A; A/B/C/D=1-347.
DR   PDB; 3G3E; X-ray; 2.20 A; A/B/C/D=1-347.
DR   PDB; 3W4I; X-ray; 2.50 A; A/B/C/D=1-347.
DR   PDB; 3W4J; X-ray; 2.74 A; A/B/C/D=1-347.
DR   PDB; 3W4K; X-ray; 2.86 A; A/B/C/D=1-347.
DR   PDB; 3ZNN; X-ray; 1.90 A; A/B=1-347.
DR   PDB; 3ZNO; X-ray; 2.30 A; A/B=1-347.
DR   PDB; 3ZNP; X-ray; 2.40 A; A/B=1-347.
DR   PDB; 3ZNQ; X-ray; 2.75 A; A/B=1-347.
DR   PDB; 4QFC; X-ray; 2.40 A; A/B=1-347.
DR   PDB; 4QFD; X-ray; 2.85 A; A/B=1-347.
DR   PDB; 5ZJ9; X-ray; 2.60 A; A/B/C/D=1-340.
DR   PDB; 5ZJA; X-ray; 2.60 A; A/B/C/D=1-340.
DR   PDB; 6KBP; X-ray; 2.25 A; A/B/C/D=1-338.
DR   PDBsum; 2DU8; -.
DR   PDBsum; 2E48; -.
DR   PDBsum; 2E49; -.
DR   PDBsum; 2E4A; -.
DR   PDBsum; 2E82; -.
DR   PDBsum; 2GNZ; -.
DR   PDBsum; 3CUK; -.
DR   PDBsum; 3G3E; -.
DR   PDBsum; 3W4I; -.
DR   PDBsum; 3W4J; -.
DR   PDBsum; 3W4K; -.
DR   PDBsum; 3ZNN; -.
DR   PDBsum; 3ZNO; -.
DR   PDBsum; 3ZNP; -.
DR   PDBsum; 3ZNQ; -.
DR   PDBsum; 4QFC; -.
DR   PDBsum; 4QFD; -.
DR   PDBsum; 5ZJ9; -.
DR   PDBsum; 5ZJA; -.
DR   PDBsum; 6KBP; -.
DR   SMR; P14920; -.
DR   BioGRID; 107980; 10.
DR   IntAct; P14920; 5.
DR   STRING; 9606.ENSP00000228476; -.
DR   BindingDB; P14920; -.
DR   ChEMBL; CHEMBL5485; -.
DR   DrugBank; DB07979; (2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID.
DR   DrugBank; DB02838; 3,4-Dihydro-2h-Pyrrolium-5-Carboxylate.
DR   DrugBank; DB04166; Anthranilic acid.
DR   DrugBank; DB03793; Benzoic acid.
DR   DrugBank; DB03225; D-Tryptophan.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB03531; Flavin-adenine dinucleotide-N5-isobutyl ketone.
DR   DrugBank; DB02988; Imino-Tryptophan.
DR   DrugCentral; P14920; -.
DR   iPTMnet; P14920; -.
DR   PhosphoSitePlus; P14920; -.
DR   BioMuta; DAO; -.
DR   DMDM; 25453448; -.
DR   MassIVE; P14920; -.
DR   PaxDb; P14920; -.
DR   PeptideAtlas; P14920; -.
DR   PRIDE; P14920; -.
DR   ProteomicsDB; 53094; -.
DR   TopDownProteomics; P14920; -.
DR   Antibodypedia; 30788; 291 antibodies.
DR   DNASU; 1610; -.
DR   Ensembl; ENST00000228476; ENSP00000228476; ENSG00000110887.
DR   GeneID; 1610; -.
DR   KEGG; hsa:1610; -.
DR   UCSC; uc001tnr.5; human.
DR   CTD; 1610; -.
DR   DisGeNET; 1610; -.
DR   GeneCards; DAO; -.
DR   HGNC; HGNC:2671; DAO.
DR   HPA; ENSG00000110887; Group enriched (brain, kidney, liver).
DR   MalaCards; DAO; -.
DR   MIM; 124050; gene.
DR   MIM; 181500; phenotype.
DR   neXtProt; NX_P14920; -.
DR   OpenTargets; ENSG00000110887; -.
DR   Orphanet; 803; Amyotrophic lateral sclerosis.
DR   PharmGKB; PA27139; -.
DR   VEuPathDB; HostDB:ENSG00000110887.7; -.
DR   eggNOG; KOG3923; Eukaryota.
DR   GeneTree; ENSGT00390000018635; -.
DR   InParanoid; P14920; -.
DR   OMA; WPYRIEP; -.
DR   OrthoDB; 1363414at2759; -.
DR   PhylomeDB; P14920; -.
DR   TreeFam; TF313887; -.
DR   BioCyc; MetaCyc:HS03351-MONOMER; -.
DR   BRENDA; 1.4.3.3; 2681.
DR   PathwayCommons; P14920; -.
DR   Reactome; R-HSA-389661; Glyoxylate metabolism and glycine degradation.
DR   Reactome; R-HSA-9033241; Peroxisomal protein import.
DR   SABIO-RK; P14920; -.
DR   BioGRID-ORCS; 1610; 7 hits in 986 CRISPR screens.
DR   ChiTaRS; DAO; human.
DR   EvolutionaryTrace; P14920; -.
DR   GenomeRNAi; 1610; -.
DR   Pharos; P14920; Tchem.
DR   PRO; PR:P14920; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P14920; protein.
DR   Bgee; ENSG00000110887; Expressed in liver and 110 other tissues.
DR   ExpressionAtlas; P14920; baseline and differential.
DR   Genevisible; P14920; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome.
DR   GO; GO:0005778; C:peroxisomal membrane; IDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0003884; F:D-amino-acid oxidase activity; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0019752; P:carboxylic acid metabolic process; TAS:Reactome.
DR   GO; GO:0055130; P:D-alanine catabolic process; IDA:UniProtKB.
DR   GO; GO:0019478; P:D-amino acid catabolic process; IBA:GO_Central.
DR   GO; GO:0036088; P:D-serine catabolic process; IDA:UniProtKB.
DR   GO; GO:0070178; P:D-serine metabolic process; IDA:UniProtKB.
DR   GO; GO:0042416; P:dopamine biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006562; P:proline catabolic process; IDA:UniProtKB.
DR   GO; GO:0008104; P:protein localization; TAS:Reactome.
DR   InterPro; IPR006181; D-amino_acid_oxidase_CS.
DR   InterPro; IPR023209; DAO.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   PANTHER; PTHR11530; PTHR11530; 1.
DR   Pfam; PF01266; DAO; 1.
DR   PIRSF; PIRSF000189; D-aa_oxidase; 1.
DR   PROSITE; PS00677; DAO; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Oxidoreductase; Peroxisome;
KW   Reference proteome; Schizophrenia.
FT   CHAIN           1..347
FT                   /note="D-amino-acid oxidase"
FT                   /id="PRO_0000162761"
FT   NP_BIND         3..17
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17088322,
FT                   ECO:0000269|PubMed:18455394"
FT   NP_BIND         37..38
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17088322,
FT                   ECO:0000269|PubMed:18455394"
FT   NP_BIND         44..45
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17088322,
FT                   ECO:0000269|PubMed:18455394"
FT   NP_BIND         49..51
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17088322,
FT                   ECO:0000269|PubMed:18455394"
FT   NP_BIND         312..317
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17088322,
FT                   ECO:0000269|PubMed:18455394"
FT   MOTIF           345..347
FT                   /note="Microbody targeting signal"
FT   BINDING         53
FT                   /note="Substrate"
FT   BINDING         164
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:17088322,
FT                   ECO:0000269|PubMed:18455394"
FT   BINDING         182
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17088322,
FT                   ECO:0000269|PubMed:18455394"
FT   BINDING         217
FT                   /note="Substrate"
FT   BINDING         228
FT                   /note="Substrate"
FT   BINDING         283
FT                   /note="Substrate"
FT   BINDING         313
FT                   /note="Substrate; via carbonyl oxygen"
FT   CONFLICT        31
FT                   /note="D -> H (in Ref. 1; CAA31614)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        279
FT                   /note="R -> A (in Ref. 1; CAA31614)"
FT                   /evidence="ECO:0000305"
FT   STRAND          2..6
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   HELIX           10..23
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   STRAND          25..28
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   STRAND          31..37
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   HELIX           40..42
FT                   /evidence="ECO:0007829|PDB:3G3E"
FT   HELIX           44..47
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   HELIX           63..77
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   TURN            78..80
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   HELIX           84..87
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   STRAND          89..100
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   TURN            106..110
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   STRAND          111..116
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   HELIX           119..122
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   STRAND          129..139
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   HELIX           141..154
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   STRAND          158..161
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   HELIX           167..172
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   STRAND          176..180
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   HELIX           183..188
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   STRAND          196..206
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   STRAND          212..216
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   TURN            219..221
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   STRAND          228..231
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   STRAND          233..239
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   HELIX           253..266
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   HELIX           268..272
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   STRAND          274..285
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   STRAND          290..296
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   STRAND          298..301
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   STRAND          303..309
FT                   /evidence="ECO:0007829|PDB:3ZNN"
FT   HELIX           312..314
FT                   /evidence="ECO:0007829|PDB:6KBP"
FT   HELIX           315..336
FT                   /evidence="ECO:0007829|PDB:3ZNN"
SQ   SEQUENCE   347 AA;  39474 MW;  A508E603872F3072 CRC64;
     MRVVVIGAGV IGLSTALCIH ERYHSVLQPL DIKVYADRFT PLTTTDVAAG LWQPYLSDPN
     NPQEADWSQQ TFDYLLSHVH SPNAENLGLF LISGYNLFHE AIPDPSWKDT VLGFRKLTPR
     ELDMFPDYGY GWFHTSLILE GKNYLQWLTE RLTERGVKFF QRKVESFEEV AREGADVIVN
     CTGVWAGALQ RDPLLQPGRG QIMKVDAPWM KHFILTHDPE RGIYNSPYII PGTQTVTLGG
     IFQLGNWSEL NNIQDHNTIW EGCCRLEPTL KNARIIGERT GFRPVRPQIR LEREQLRTGP
     SNTEVIHNYG HGGYGLTIHW GCALEAAKLF GRILEEKKLS RMPPSHL
//
ID   PRNA_PSEFL              Reviewed;         538 AA.
AC   P95480;
DT   29-MAY-2013, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   02-JUN-2021, entry version 73.
DE   RecName: Full=Flavin-dependent tryptophan halogenase PrnA;
DE            EC=1.14.19.9;
GN   Name=prnA;
OS   Pseudomonas fluorescens.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=294;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, DISRUPTION PHENOTYPE, AND
RP   NOMENCLATURE.
RC   STRAIN=Bl915;
RX   PubMed=9172332; DOI=10.1128/aem.63.6.2147-2154.1997;
RA   Hammer P.E., Hill D.S., Lam S.T., Van Pee K.H., Ligon J.M.;
RT   "Four genes from Pseudomonas fluorescens that encode the biosynthesis of
RT   pyrrolnitrin.";
RL   Appl. Environ. Microbiol. 63:2147-2154(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP   DISRUPTION PHENOTYPE.
RC   STRAIN=Bl915;
RX   PubMed=9537395; DOI=10.1128/jb.180.7.1939-1943.1998;
RA   Kirner S., Hammer P.E., Hill D.S., Altmann A., Fischer I., Weislo L.J.,
RA   Lanahan M., van Pee K.H., Ligon J.M.;
RT   "Functions encoded by pyrrolnitrin biosynthetic genes from Pseudomonas
RT   fluorescens.";
RL   J. Bacteriol. 180:1939-1943(1998).
RN   [3]
RP   FUNCTION.
RX   PubMed=10941070;
RX   DOI=10.1002/1521-3773(20000703)39:13<2300::aid-anie2300>3.0.co;2-i;
RA   Keller S., Wage T., Hohaus K., Holzer M., Eichhorn E., van Pee K.H.;
RT   "Purification and partial characterization of tryptophan 7-halogenase
RT   (PrnA) from Pseudomonas fluorescens.";
RL   Angew. Chem. Int. Ed. 39:2300-2302(2000).
RN   [4]
RP   CRYSTALLIZATION.
RX   PubMed=15272170; DOI=10.1107/s0907444904012521;
RA   Dong C., Kotzsch A., Dorward M., van Pee K.H., Naismith J.H.;
RT   "Crystallization and X-ray diffraction of a halogenating enzyme, tryptophan
RT   7-halogenase, from Pseudomonas fluorescens.";
RL   Acta Crystallogr. D 60:1438-1440(2004).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH FAD, CHLORIDE AND
RP   TRYPTOPHAN, ACTIVE SITE, MUTAGENESIS OF LYS-79 AND GLU-346, AND SUBUNIT.
RX   PubMed=16195462; DOI=10.1126/science.1116510;
RA   Dong C., Flecks S., Unversucht S., Haupt C., van Pee K.H., Naismith J.H.;
RT   "Tryptophan 7-halogenase (PrnA) structure suggests a mechanism for
RT   regioselective chlorination.";
RL   Science 309:2216-2219(2005).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF MUTANT ASP-346 IN COMPLEX WITH
RP   FAD AND TRYPTOPHAN, MUTAGENESIS OF TRP-272; TRP-274; GLU-346 AND SER-347,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND REACTION MECHANISM.
RX   PubMed=18979475; DOI=10.1002/anie.200802466;
RA   Flecks S., Patallo E.P., Zhu X., Ernyei A.J., Seifert G., Schneider A.,
RA   Dong C., Naismith J.H., van Pee K.H.;
RT   "New insights into the mechanism of enzymatic chlorination of tryptophan.";
RL   Angew. Chem. Int. Ed. 47:9533-9536(2008).
CC   -!- FUNCTION: Involved in the biosynthesis of the antifungal antibiotic
CC       pyrrolnitrin. Catalyzes the chlorination of tryptophan (Trp) at C7
CC       position to yield 7-chloro-L-tryptophan (7-CLT). The reaction between
CC       FADH2, Cl-, and O2 generates the powerful oxidant HOCl, which is
CC       presumed to carry out the chlorination reaction. The reaction of HOCl
CC       with the active site Lys-79 generates a lysine chloramine, which plays
CC       a key role in directing regiospecific chlorination of substrate in this
CC       important class of biosynthetic enzymes. It is also able to use bromide
CC       ions to generate monobrominated Trp. {ECO:0000269|PubMed:10941070,
CC       ECO:0000269|PubMed:9172332, ECO:0000269|PubMed:9537395}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chloride + FADH2 + L-tryptophan + O2 = 7-chloro-L-tryptophan +
CC         FAD + 2 H2O; Xref=Rhea:RHEA:26494, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:17996, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:57912, ChEBI:CHEBI:58307, ChEBI:CHEBI:58713;
CC         EC=1.14.19.9; Evidence={ECO:0000269|PubMed:9537395};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=17.1 uM for tryptophan (with FAD at pH 7.2 and 30 degrees Celsius)
CC         {ECO:0000269|PubMed:18979475};
CC         Vmax=43 pmol/min/mg enzyme {ECO:0000269|PubMed:18979475};
CC   -!- PATHWAY: Antibiotic biosynthesis.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:16195462,
CC       ECO:0000269|PubMed:18979475}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene lose the ability to
CC       produce pyrrolnitrin. {ECO:0000269|PubMed:9172332,
CC       ECO:0000269|PubMed:9537395}.
CC   -!- SIMILARITY: Belongs to the flavin-dependent halogenase family.
CC       Bacterial tryptophan halogenase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U74493; AAB97504.1; -; Genomic_DNA.
DR   PDB; 2APG; X-ray; 1.90 A; A=1-538.
DR   PDB; 2AQJ; X-ray; 1.80 A; A=1-538.
DR   PDB; 2AR8; X-ray; 2.20 A; A=1-538.
DR   PDB; 2ARD; X-ray; 2.60 A; A=1-538.
DR   PDB; 2JKC; X-ray; 2.30 A; A=1-538.
DR   PDB; 4Z43; X-ray; 2.29 A; A=1-538.
DR   PDB; 4Z44; X-ray; 2.20 A; A=1-538.
DR   PDBsum; 2APG; -.
DR   PDBsum; 2AQJ; -.
DR   PDBsum; 2AR8; -.
DR   PDBsum; 2ARD; -.
DR   PDBsum; 2JKC; -.
DR   PDBsum; 4Z43; -.
DR   PDBsum; 4Z44; -.
DR   SMR; P95480; -.
DR   PRIDE; P95480; -.
DR   KEGG; ag:AAB97504; -.
DR   BioCyc; MetaCyc:MONOMER-16710; -.
DR   BRENDA; 1.14.19.9; 5121.
DR   SABIO-RK; P95480; -.
DR   EvolutionaryTrace; P95480; -.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   GO; GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR006905; Flavin_halogenase.
DR   InterPro; IPR033856; Trp_halogen.
DR   Pfam; PF04820; Trp_halogenase; 1.
DR   PIRSF; PIRSF011396; Trp_halogenase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic biosynthesis; FAD; Flavoprotein;
KW   Nucleotide-binding; Oxidoreductase.
FT   CHAIN           1..538
FT                   /note="Flavin-dependent tryptophan halogenase PrnA"
FT                   /id="PRO_0000422330"
FT   NP_BIND         13..16
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16195462,
FT                   ECO:0000269|PubMed:18979475"
FT   NP_BIND         39..50
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16195462,
FT                   ECO:0000269|PubMed:18979475"
FT   REGION          348..349
FT                   /note="Chloride binding"
FT   REGION          443..444
FT                   /note="L-tryptophan binding"
FT   ACT_SITE        79
FT                   /evidence="ECO:0000269|PubMed:16195462"
FT   BINDING         79
FT                   /note="L-tryptophan"
FT   BINDING         187
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:16195462,
FT                   ECO:0000269|PubMed:18979475"
FT   BINDING         337
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:16195462,
FT                   ECO:0000269|PubMed:18979475"
FT   BINDING         346
FT                   /note="L-tryptophan; via carbonyl oxygen"
FT   BINDING         350
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:16195462,
FT                   ECO:0000269|PubMed:18979475"
FT   BINDING         450
FT                   /note="L-tryptophan"
FT   BINDING         454
FT                   /note="L-tryptophan; via carbonyl oxygen"
FT   SITE            79
FT                   /note="Role in guiding and activating HOCl"
FT   SITE            346
FT                   /note="Role in stabilization and deprotonation of the
FT                   intermediate"
FT   MUTAGEN         79
FT                   /note="K->A: Loss of halogenase activity."
FT                   /evidence="ECO:0000269|PubMed:16195462"
FT   MUTAGEN         272
FT                   /note="W->A: No change in halogenase activity."
FT                   /evidence="ECO:0000269|PubMed:18979475"
FT   MUTAGEN         272
FT                   /note="W->F: No change in halogenase activity."
FT                   /evidence="ECO:0000269|PubMed:18979475"
FT   MUTAGEN         274
FT                   /note="W->A: No change in halogenase activity."
FT                   /evidence="ECO:0000269|PubMed:18979475"
FT   MUTAGEN         274
FT                   /note="W->F: No change in halogenase activity."
FT                   /evidence="ECO:0000269|PubMed:18979475"
FT   MUTAGEN         346
FT                   /note="E->D: Loss of halogenase activity."
FT                   /evidence="ECO:0000269|PubMed:16195462,
FT                   ECO:0000269|PubMed:18979475"
FT   MUTAGEN         346
FT                   /note="E->Q: The catalytic efficiency decreases by about
FT                   two orders of magnitude, however the binding affinity is
FT                   unchanged."
FT                   /evidence="ECO:0000269|PubMed:16195462,
FT                   ECO:0000269|PubMed:18979475"
FT   MUTAGEN         347
FT                   /note="S->A: Does not completely abolish halogenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:18979475"
FT   STRAND          7..11
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           15..27
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   TURN            28..30
FT                   /evidence="ECO:0007829|PDB:2JKC"
FT   STRAND          33..38
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          40..42
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           54..58
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           60..63
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           67..70
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           71..74
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          77..79
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          81..86
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          88..90
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          98..104
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          108..113
FT                   /evidence="ECO:0007829|PDB:4Z44"
FT   HELIX           114..123
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           130..134
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           138..142
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          159..162
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           164..177
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          181..184
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          187..192
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          194..196
FT                   /evidence="ECO:0007829|PDB:2ARD"
FT   STRAND          198..203
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          208..210
FT                   /evidence="ECO:0007829|PDB:4Z44"
FT   STRAND          212..216
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           219..221
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           223..228
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          233..235
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   TURN            237..239
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          244..251
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           254..257
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          261..267
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          269..278
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          281..288
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   TURN            290..292
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           295..306
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          315..318
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          322..325
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          327..329
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   STRAND          332..334
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           336..338
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           344..346
FT                   /evidence="ECO:0007829|PDB:2APG"
FT   HELIX           349..362
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           371..397
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           405..412
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           418..429
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           440..445
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           447..452
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           457..467
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           476..480
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           482..505
FT                   /evidence="ECO:0007829|PDB:2AQJ"
FT   HELIX           509..516
FT                   /evidence="ECO:0007829|PDB:2AQJ"
SQ   SEQUENCE   538 AA;  61075 MW;  03AAAC041A00CE7B CRC64;
     MNKPIKNIVI VGGGTAGWMA ASYLVRALQQ QANITLIESA AIPRIGVGEA TIPSLQKVFF
     DFLGIPEREW MPQVNGAFKA AIKFVNWRKS PDPSRDDHFY HLFGNVPNCD GVPLTHYWLR
     KREQGFQQPM EYACYPQPGA LDGKLAPCLS DGTRQMSHAW HFDAHLVADF LKRWAVERGV
     NRVVDEVVDV RLNNRGYISN LLTKEGRTLE ADLFIDCSGM RGLLINQALK EPFIDMSDYL
     LCDSAVASAV PNDDARDGVE PYTSSIAMNS GWTWKIPMLG RFGSGYVFSS HFTSRDQATA
     DFLKLWGLSD NQPLNQIKFR VGRNKRAWVN NCVSIGLSSC FLEPLESTGI YFIYAALYQL
     VKHFPDTSFD PRLSDAFNAE IVHMFDDCRD FVQAHYFTTS RDDTPFWLAN RHDLRLSDAI
     KEKVQRYKAG LPLTTTSFDD STYYETFDYE FKNFWLNGNY YCIFAGLGML PDRSLPLLQH
     RPESIEKAEA MFASIRREAE RLRTSLPTNY DYLRSLRDGD AGLSRGQRGP KLAAQESL
//
ID   PHR_ECOLI               Reviewed;         472 AA.
AC   P00914;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   02-JUN-2021, entry version 178.
DE   RecName: Full=Deoxyribodipyrimidine photo-lyase;
DE            EC=4.1.99.3;
DE   AltName: Full=DNA photolyase;
DE   AltName: Full=Photoreactivating enzyme;
GN   Name=phrB; Synonyms=phr; OrderedLocusNames=b0708, JW0698;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6325460;
RA   Sancar G.B., Smith F.W., Lorence M.C., Rupert C.S., Sancar A.;
RT   "Sequences of the Escherichia coli photolyase gene and protein.";
RL   J. Biol. Chem. 259:6033-6038(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RA   Begley T.P.;
RL   Submitted (JAN-1991) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=8905232; DOI=10.1093/dnares/3.3.137;
RA   Oshima T., Aiba H., Baba T., Fujita K., Hayashi K., Honjo A., Ikemoto K.,
RA   Inada T., Itoh T., Kajihara M., Kanai K., Kashimoto K., Kimura S.,
RA   Kitagawa M., Makino K., Masuda S., Miki T., Mizobuchi K., Mori H.,
RA   Motomura K., Nakamura Y., Nashimoto H., Nishio Y., Saito N., Sampei G.,
RA   Seki Y., Tagami H., Takemoto K., Wada C., Yamamoto Y., Yano M.,
RA   Horiuchi T.;
RT   "A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to
RT   the 12.7-28.0 min region on the linkage map.";
RL   DNA Res. 3:137-155(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [6]
RP   REVIEW.
RA   Sancar G.B., Sancar A.;
RT   "Structure and function of DNA photolyases.";
RL   Trends Biochem. Sci. 12:259-261(1987).
RN   [7]
RP   MUTAGENESIS OF TRP-278.
RX   PubMed=2200511; DOI=10.1021/bi00476a009;
RA   Li Y.F., Sancar A.;
RT   "Active site of Escherichia coli DNA photolyase: mutations at Trp277 alter
RT   the selectivity of the enzyme without affecting the quantum yield of
RT   photorepair.";
RL   Biochemistry 29:5698-5706(1990).
RN   [8]
RP   MUTAGENESIS OF TRP-383, AND ELECTRON TRANSFER CHAIN.
RX   PubMed=12835419; DOI=10.1073/pnas.1531645100;
RA   Byrdin M., Eker A.P., Vos M.H., Brettel K.;
RT   "Dissection of the triple tryptophan electron transfer chain in Escherichia
RT   coli DNA photolyase: Trp382 is the primary donor in photoactivation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:8676-8681(2003).
RN   [9]
RP   REVIEW.
RX   PubMed=15721603; DOI=10.1016/j.bbabio.2004.02.010;
RA   Weber S.;
RT   "Light-driven enzymatic catalysis of DNA repair: a review of recent
RT   biophysical studies on photolyase.";
RL   Biochim. Biophys. Acta 1707:1-23(2005).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH FAD AND MTF, AND
RP   SUBUNIT.
RX   PubMed=7604260; DOI=10.1126/science.7604260;
RA   Park H.-W., Kim S.-T., Sancar A., Deisenhofer J.;
RT   "Crystal structure of DNA photolyase from Escherichia coli.";
RL   Science 268:1866-1872(1995).
CC   -!- FUNCTION: Involved in repair of UV radiation-induced DNA damage.
CC       Catalyzes the light-dependent monomerization (300-600 nm) of cyclobutyl
CC       pyrimidine dimers (in cis-syn configuration), which are formed between
CC       adjacent bases on the same DNA strand upon exposure to ultraviolet
CC       radiation.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Cyclobutadipyrimidine (in DNA) = 2 pyrimidine residues (in
CC         DNA).; EC=4.1.99.3;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- COFACTOR:
CC       Name=(6R)-5,10-methylene-5,6,7,8-tetrahydrofolate;
CC         Xref=ChEBI:CHEBI:15636;
CC       Note=Binds 1 5,10-methenyltetrahydrofolate (MTHF) non-covalently per
CC       subunit.;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Absorption:
CC         Abs(max)=384 nm;
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:7604260}.
CC   -!- INTERACTION:
CC       P00914; P68739: nfi; NbExp=2; IntAct=EBI-555781, EBI-551698;
CC   -!- MISCELLANEOUS: There are only 10-20 molecules of photolyase per E.coli
CC       cell.
CC   -!- MISCELLANEOUS: Upon absorption of visible light electrons are
CC       transferred from Trp-307 through Trp-360 to Trp 383, and from there to
CC       FADH, giving rise to the fully reduced catalytic FADH(-).
CC   -!- SIMILARITY: Belongs to the DNA photolyase class-1 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; K01299; AAA24388.1; -; Genomic_DNA.
DR   EMBL; X57399; CAB56782.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC73802.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA35367.1; -; Genomic_DNA.
DR   PIR; A01137; WZECD.
DR   RefSeq; NP_415236.1; NC_000913.3.
DR   RefSeq; WP_000207142.1; NZ_SSZK01000033.1.
DR   PDB; 1DNP; X-ray; 2.30 A; A/B=2-472.
DR   PDBsum; 1DNP; -.
DR   SMR; P00914; -.
DR   BioGRID; 4259920; 166.
DR   BioGRID; 851344; 1.
DR   DIP; DIP-10505N; -.
DR   IntAct; P00914; 12.
DR   STRING; 511145.b0708; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   jPOST; P00914; -.
DR   PaxDb; P00914; -.
DR   PRIDE; P00914; -.
DR   EnsemblBacteria; AAC73802; AAC73802; b0708.
DR   EnsemblBacteria; BAA35367; BAA35367; BAA35367.
DR   GeneID; 947005; -.
DR   KEGG; ecj:JW0698; -.
DR   KEGG; eco:b0708; -.
DR   PATRIC; fig|1411691.4.peg.1565; -.
DR   EchoBASE; EB0729; -.
DR   eggNOG; COG0415; Bacteria.
DR   HOGENOM; CLU_010348_2_2_6; -.
DR   InParanoid; P00914; -.
DR   PhylomeDB; P00914; -.
DR   BioCyc; EcoCyc:EG10736-MONOMER; -.
DR   BioCyc; MetaCyc:EG10736-MONOMER; -.
DR   BRENDA; 4.1.99.3; 2026.
DR   SABIO-RK; P00914; -.
DR   EvolutionaryTrace; P00914; -.
DR   PRO; PR:P00914; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0003684; F:damaged DNA binding; IDA:EcoCyc.
DR   GO; GO:0003904; F:deoxyribodipyrimidine photo-lyase activity; IDA:EcoCyc.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0071949; F:FAD binding; IBA:GO_Central.
DR   GO; GO:0000719; P:photoreactive repair; IDA:EcoCyc.
DR   GO; GO:0007603; P:phototransduction, visible light; IDA:EcoCyc.
DR   GO; GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW.
DR   GO; GO:0009416; P:response to light stimulus; IBA:GO_Central.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR036134; Crypto/Photolyase_FAD-like_sf.
DR   InterPro; IPR036155; Crypto/Photolyase_N_sf.
DR   InterPro; IPR005101; Cryptochr/Photolyase_FAD-bd.
DR   InterPro; IPR002081; Cryptochrome/DNA_photolyase_1.
DR   InterPro; IPR018394; DNA_photolyase_1_CS_C.
DR   InterPro; IPR006050; DNA_photolyase_N.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00875; DNA_photolyase; 1.
DR   Pfam; PF03441; FAD_binding_7; 1.
DR   PRINTS; PR00147; DNAPHOTLYASE.
DR   SUPFAM; SSF48173; SSF48173; 1.
DR   SUPFAM; SSF52425; SSF52425; 1.
DR   PROSITE; PS00394; DNA_PHOTOLYASES_1_1; 1.
DR   PROSITE; PS00691; DNA_PHOTOLYASES_1_2; 1.
DR   PROSITE; PS51645; PHR_CRY_ALPHA_BETA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chromophore; DNA damage; DNA repair; DNA-binding; FAD;
KW   Flavoprotein; Lyase; Nucleotide-binding; Reference proteome.
FT   CHAIN           1..472
FT                   /note="Deoxyribodipyrimidine photo-lyase"
FT                   /id="PRO_0000085108"
FT   DOMAIN          2..134
FT                   /note="Photolyase/cryptochrome alpha/beta"
FT   NP_BIND         235..239
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7604260"
FT   NP_BIND         275..282
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7604260"
FT   NP_BIND         373..375
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7604260"
FT   REGION          109..110
FT                   /note="MTF binding"
FT   REGION          275..282
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   REGION          342..343
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   BINDING         223
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7604260"
FT   BINDING         227
FT                   /note="DNA"
FT                   /evidence="ECO:0000250"
FT   BINDING         272
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7604260"
FT   BINDING         405
FT                   /note="DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            307
FT                   /note="Electron transfer via tryptophanyl radical"
FT   SITE            360
FT                   /note="Electron transfer via tryptophanyl radical"
FT   SITE            383
FT                   /note="Electron transfer via tryptophanyl radical"
FT   MUTAGEN         278
FT                   /note="W->X: Reduces DNA-binding affinity."
FT                   /evidence="ECO:0000269|PubMed:2200511"
FT   MUTAGEN         383
FT                   /note="W->F: Abolishes photolyase activity."
FT                   /evidence="ECO:0000269|PubMed:12835419"
FT   STRAND          3..7
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           18..23
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   STRAND          24..26
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   STRAND          29..37
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           39..44
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           49..68
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   STRAND          73..77
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           81..95
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   STRAND          99..103
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           108..120
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   STRAND          124..129
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   STRAND          132..135
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           151..163
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   TURN            198..200
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           205..217
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           219..226
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           239..244
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           249..259
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           261..265
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           270..288
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           290..294
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           300..304
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           311..319
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           325..337
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           342..354
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           360..370
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           376..386
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           402..409
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   TURN            410..412
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           414..419
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           421..423
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           430..432
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           434..439
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   TURN            440..442
FT                   /evidence="ECO:0007829|PDB:1DNP"
FT   HELIX           454..468
FT                   /evidence="ECO:0007829|PDB:1DNP"
SQ   SEQUENCE   472 AA;  53667 MW;  B06048703F18F7AE CRC64;
     MTTHLVWFRQ DLRLHDNLAL AAACRNSSAR VLALYIATPR QWATHNMSPR QAELINAQLN
     GLQIALAEKG IPLLFREVDD FVASVEIVKQ VCAENSVTHL FYNYQYEVNE RARDVEVERA
     LRNVVCEGFD DSVILPPGAV MTGNHEMYKV FTPFKNAWLK RLREGMPECV AAPKVRSSGS
     IEPSPSITLN YPRQSFDTAH FPVEEKAAIA QLRQFCQNGA GEYEQQRDFP AVEGTSRLSA
     SLATGGLSPR QCLHRLLAEQ PQALDGGAGS VWLNELIWRE FYRHLITYHP SLCKHRPFIA
     WTDRVQWQSN PAHLQAWQEG KTGYPIVDAA MRQLNSTGWM HNRLRMITAS FLVKDLLIDW
     REGERYFMSQ LIDGDLAANN GGWQWAASTG TDAAPYFRIF NPTTQGEKFD HEGEFIRQWL
     PELRDVPGKV VHEPWKWAQK AGVTLDYPQP IVEHKEARVQ TLAAYEAARK GK
//
ID   NAPE_ENTFA              Reviewed;         447 AA.
AC   P37062;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-APR-2003, sequence version 2.
DT   02-JUN-2021, entry version 152.
DE   RecName: Full=NADH peroxidase;
DE            Short=NPXase;
DE            Short=Npx;
DE            EC=1.11.1.1;
GN   Name=npr; OrderedLocusNames=EF_1211;
OS   Enterococcus faecalis (strain ATCC 700802 / V583).
OC   Bacteria; Firmicutes; Bacilli; Lactobacillales; Enterococcaceae;
OC   Enterococcus.
OX   NCBI_TaxID=226185;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=ATCC 11700 / DSM 20409 / NCIMB 8661 / 10C1;
RX   PubMed=1719212; DOI=10.1016/0022-2836(91)80180-3;
RA   Ross R.P., Claiborne A.;
RT   "Cloning, sequence and overexpression of NADH peroxidase from Streptococcus
RT   faecalis 10C1. Structural relationship with the flavoprotein disulfide
RT   reductases.";
RL   J. Mol. Biol. 221:857-871(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700802 / V583;
RX   PubMed=12663927; DOI=10.1126/science.1080613;
RA   Paulsen I.T., Banerjei L., Myers G.S.A., Nelson K.E., Seshadri R.,
RA   Read T.D., Fouts D.E., Eisen J.A., Gill S.R., Heidelberg J.F., Tettelin H.,
RA   Dodson R.J., Umayam L.A., Brinkac L.M., Beanan M.J., Daugherty S.C.,
RA   DeBoy R.T., Durkin S.A., Kolonay J.F., Madupu R., Nelson W.C.,
RA   Vamathevan J.J., Tran B., Upton J., Hansen T., Shetty J., Khouri H.M.,
RA   Utterback T.R., Radune D., Ketchum K.A., Dougherty B.A., Fraser C.M.;
RT   "Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus
RT   faecalis.";
RL   Science 299:2071-2074(2003).
RN   [3]
RP   PROTEIN SEQUENCE OF 1-51.
RC   STRAIN=ATCC 11700 / DSM 20409 / NCIMB 8661 / 10C1;
RX   PubMed=2501302;
RA   Poole L.B., Claiborne A.;
RT   "The non-flavin redox center of the streptococcal NADH peroxidase. I. Thiol
RT   reactivity and redox behavior in the presence of urea.";
RL   J. Biol. Chem. 264:12322-12329(1989).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS).
RC   STRAIN=ATCC 11700 / DSM 20409 / NCIMB 8661 / 10C1;
RX   PubMed=1942054; DOI=10.1016/0022-2836(91)90936-z;
RA   Stehle T., Ahmed S.A., Claiborne A., Schulz G.E.;
RT   "Structure of NADH peroxidase from Streptococcus faecalis 10C1 refined at
RT   2.16-A resolution.";
RL   J. Mol. Biol. 221:1325-1344(1991).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH NAD AND FAD.
RC   STRAIN=ATCC 11700 / DSM 20409 / NCIMB 8661 / 10C1;
RX   PubMed=8425532; DOI=10.1111/j.1432-1033.1993.tb19889.x;
RA   Stehle T., Claiborne A., Schulz G.E.;
RT   "NADH binding site and catalysis of NADH peroxidase.";
RL   Eur. J. Biochem. 211:221-226(1993).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH FAD, ACTIVE SITE, AND
RP   OXIDATION AT CYS-42.
RC   STRAIN=ATCC 11700 / DSM 20409 / NCIMB 8661 / 10C1;
RX   PubMed=8756456; DOI=10.1021/bi961037s;
RA   Yeh J.I., Claiborne A., Hol W.G.J.;
RT   "Structure of the native cysteine-sulfenic acid redox center of
RT   enterococcal NADH peroxidase refined at 2.8-A resolution.";
RL   Biochemistry 35:9951-9957(1996).
RN   [7]
RP   STRUCTURE BY NMR.
RC   STRAIN=ATCC 11700 / DSM 20409 / NCIMB 8661 / 10C1;
RX   PubMed=9214307; DOI=10.1021/bi9707990;
RA   Crane E.J. III, Vervoort J., Clairborne A.;
RT   "13C NMR analysis of the cysteine-sulfenic acid redox center of
RT   enterococcal NADH peroxidase.";
RL   Biochemistry 36:8611-8618(1997).
CC   -!- FUNCTION: Peroxidase whose active site is a redox-active cysteine-
CC       sulfenic acid.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + H2O2 + NADH = 2 H2O + NAD(+); Xref=Rhea:RHEA:18509,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.11.1.1;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:8425532,
CC       ECO:0000269|PubMed:8756456}.
CC   -!- MISCELLANEOUS: The active site is the redox-active Cys-42 oxidized to
CC       Cys-SOH. The oxidized form is stabilized by a hydrogen bond formation
CC       with His-10.
CC   -!- SIMILARITY: Belongs to the class-III pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X62755; CAA44611.1; -; Genomic_DNA.
DR   EMBL; AE016830; AAO81008.1; -; Genomic_DNA.
DR   PIR; S18332; S18332.
DR   RefSeq; NP_814938.1; NC_004668.1.
DR   RefSeq; WP_002379347.1; NZ_KE136528.1.
DR   PDB; 1F8W; X-ray; 2.45 A; A=1-447.
DR   PDB; 1JOA; X-ray; 2.80 A; A=1-447.
DR   PDB; 1NHP; X-ray; 2.00 A; A=1-447.
DR   PDB; 1NHQ; X-ray; 2.00 A; A=1-447.
DR   PDB; 1NHR; X-ray; 2.10 A; A=1-447.
DR   PDB; 1NHS; X-ray; 2.00 A; A=1-447.
DR   PDB; 1NPX; X-ray; 2.16 A; A=1-447.
DR   PDB; 2NPX; X-ray; 2.40 A; A=1-447.
DR   PDBsum; 1F8W; -.
DR   PDBsum; 1JOA; -.
DR   PDBsum; 1NHP; -.
DR   PDBsum; 1NHQ; -.
DR   PDBsum; 1NHR; -.
DR   PDBsum; 1NHS; -.
DR   PDBsum; 1NPX; -.
DR   PDBsum; 2NPX; -.
DR   SMR; P37062; -.
DR   STRING; 226185.EF_1211; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB03382; S-oxy-L-cysteine.
DR   PeroxiBase; 4010; EfNadPrx01.
DR   EnsemblBacteria; AAO81008; AAO81008; EF_1211.
DR   KEGG; efa:EF1211; -.
DR   PATRIC; fig|226185.45.peg.2288; -.
DR   eggNOG; COG0446; Bacteria.
DR   HOGENOM; CLU_003291_1_0_9; -.
DR   OMA; WVSHAPC; -.
DR   BioCyc; EFAE226185:G1G0C-1199-MONOMER; -.
DR   BRENDA; 1.11.1.1; 2095.
DR   SABIO-RK; P37062; -.
DR   EvolutionaryTrace; P37062; -.
DR   Proteomes; UP000001415; Chromosome.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0016692; F:NADH peroxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; FAD; Flavoprotein; NAD; Oxidation;
KW   Oxidoreductase; Peroxidase; Redox-active center; Reference proteome.
FT   CHAIN           1..447
FT                   /note="NADH peroxidase"
FT                   /id="PRO_0000184705"
FT   NP_BIND         7..11
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8425532,
FT                   ECO:0000269|PubMed:8756456"
FT   NP_BIND         110..113
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8425532,
FT                   ECO:0000269|PubMed:8756456"
FT   ACT_SITE        10
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000269|PubMed:8756456"
FT   ACT_SITE        42
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:8756456"
FT   BINDING         32
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8425532,
FT                   ECO:0000269|PubMed:8756456"
FT   BINDING         42
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8425532,
FT                   ECO:0000269|PubMed:8756456"
FT   BINDING         132
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8425532,
FT                   ECO:0000269|PubMed:8756456"
FT   BINDING         160
FT                   /note="NAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:8425532"
FT   BINDING         179
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:8425532"
FT   BINDING         188
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:8425532"
FT   BINDING         243
FT                   /note="NAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:8425532"
FT   BINDING         281
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8425532,
FT                   ECO:0000269|PubMed:8756456"
FT   BINDING         297
FT                   /note="NAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:8425532"
FT   BINDING         299
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:8425532,
FT                   ECO:0000269|PubMed:8756456"
FT   BINDING         328
FT                   /note="NAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:8425532"
FT   MOD_RES         42
FT                   /note="Cysteine sulfenic acid (-SOH)"
FT                   /evidence="ECO:0000269|PubMed:8756456"
FT   CONFLICT        226
FT                   /note="I -> V (in Ref. 1; CAA44611)"
FT                   /evidence="ECO:0000305"
FT   STRAND          2..6
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   HELIX           10..22
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          26..39
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   HELIX           41..43
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   HELIX           44..48
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   HELIX           55..57
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          58..60
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   HELIX           63..68
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          72..75
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          77..83
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   TURN            84..87
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          88..93
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   TURN            94..96
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          99..103
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          105..109
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          113..115
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   TURN            121..124
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          125..129
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   HELIX           133..144
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          151..155
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   HELIX           159..170
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          174..183
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   TURN            184..188
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   HELIX           191..202
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   TURN            203..205
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          206..211
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          214..218
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          220..222
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          225..230
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          232..234
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          236..240
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          244..247
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   HELIX           249..251
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   TURN            252..254
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          276..278
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   HELIX           280..282
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          285..287
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   TURN            288..291
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          292..294
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   HELIX           299..311
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          313..315
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          327..331
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          334..340
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   HELIX           343..349
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          354..363
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          372..379
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   TURN            381..383
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   STRAND          385..395
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   HELIX           400..409
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   HELIX           414..418
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   TURN            426..428
FT                   /evidence="ECO:0007829|PDB:1NHP"
FT   HELIX           434..445
FT                   /evidence="ECO:0007829|PDB:1NHP"
SQ   SEQUENCE   447 AA;  49566 MW;  3FAF85AF5BB2A70B CRC64;
     MKVIVLGSSH GGYEAVEELL NLHPDAEIQW YEKGDFISFL SCGMQLYLEG KVKDVNSVRY
     MTGEKMESRG VNVFSNTEIT AIQPKEHQVT VKDLVSGEER VENYDKLIIS PGAVPFELDI
     PGKDLDNIYL MRGRQWAIKL KQKTVDPEVN NVVVIGSGYI GIEAAEAFAK AGKKVTVIDI
     LDRPLGVYLD KEFTDVLTEE MEANNITIAT GETVERYEGD GRVQKIVTDK NAYDADLVVV
     AVGVRPNTAW LKGTLELHPN GLIKTDEYMR TSEPDVFAVG DATLIKYNPA DTEVNIALAT
     NARKQGRFAV KNLEEPVKPF PGVQGSSGLA VFDYKFASTG INEVMAQKLG KETKAVTVVE
     DYLMDFNPDK QKAWFKLVYD PETTQILGAQ LMSKADLTAN INAISLAIQA KMTIEDLAYA
     DFFFQPAFDK PWNIINTAAL EAVKQER
//
ID   MDAB_ECO57              Reviewed;         193 AA.
AC   P0AEY7; P40717;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   02-JUN-2021, entry version 86.
DE   RecName: Full=NADPH:quinone oxidoreductase MdaB {ECO:0000305};
DE            EC=1.6.5.10 {ECO:0000250|UniProtKB:P0AEY5};
DE   AltName: Full=Modulator of drug activity B {ECO:0000303|PubMed:16511004};
GN   Name=mdaB {ECO:0000303|PubMed:16511004}; OrderedLocusNames=Z4379, ECs3910;
OS   Escherichia coli O157:H7.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83334;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=O157:H7 / EDL933 / ATCC 700927 / EHEC;
RX   PubMed=11206551; DOI=10.1038/35054089;
RA   Perna N.T., Plunkett G. III, Burland V., Mau B., Glasner J.D., Rose D.J.,
RA   Mayhew G.F., Evans P.S., Gregor J., Kirkpatrick H.A., Posfai G.,
RA   Hackett J., Klink S., Boutin A., Shao Y., Miller L., Grotbeck E.J.,
RA   Davis N.W., Lim A., Dimalanta E.T., Potamousis K., Apodaca J.,
RA   Anantharaman T.S., Lin J., Yen G., Schwartz D.C., Welch R.A.,
RA   Blattner F.R.;
RT   "Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.";
RL   Nature 409:529-533(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=O157:H7 / Sakai / RIMD 0509952 / EHEC;
RX   PubMed=11258796; DOI=10.1093/dnares/8.1.11;
RA   Hayashi T., Makino K., Ohnishi M., Kurokawa K., Ishii K., Yokoyama K.,
RA   Han C.-G., Ohtsubo E., Nakayama K., Murata T., Tanaka M., Tobe T., Iida T.,
RA   Takami H., Honda T., Sasakawa C., Ogasawara N., Yasunaga T., Kuhara S.,
RA   Shiba T., Hattori M., Shinagawa H.;
RT   "Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and
RT   genomic comparison with a laboratory strain K-12.";
RL   DNA Res. 8:11-22(2001).
RN   [3]
RP   SUBUNIT, AND CRYSTALLIZATION.
RC   STRAIN=O157:H7 / EDL933 / ATCC 700927 / EHEC;
RX   PubMed=16511004; DOI=10.1107/s1744309105001545;
RA   Adams M.A., Iannuzzi P., Jia Z.;
RT   "MdaB from Escherichia coli: cloning, purification, crystallization and
RT   preliminary X-ray analysis.";
RL   Acta Crystallogr. F 61:235-238(2005).
RN   [4] {ECO:0007744|PDB:2B3D}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 2-193 OF APOENZYME AND IN COMPLEX
RP   WITH FAD, COFACTOR, AND SUBUNIT.
RX   PubMed=16630630; DOI=10.1016/j.jmb.2006.03.053;
RA   Adams M.A., Jia Z.;
RT   "Modulator of drug activity B from Escherichia coli: crystal structure of a
RT   prokaryotic homologue of DT-diaphorase.";
RL   J. Mol. Biol. 359:455-465(2006).
CC   -!- FUNCTION: NADPH-specific quinone reductase.
CC       {ECO:0000250|UniProtKB:P0AEY5}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADPH = a quinol + NADP(+);
CC         Xref=Rhea:RHEA:46164, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:132124;
CC         EC=1.6.5.10; Evidence={ECO:0000250|UniProtKB:P0AEY5};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:16630630};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:16511004,
CC       ECO:0000269|PubMed:16630630}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P0AEY5}.
CC   -!- SIMILARITY: Belongs to the oxidoreductase MdaB family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE005174; AAG58161.1; -; Genomic_DNA.
DR   EMBL; BA000007; BAB37333.1; -; Genomic_DNA.
DR   PIR; E85962; E85962.
DR   PIR; F91117; F91117.
DR   RefSeq; NP_311937.1; NC_002695.1.
DR   RefSeq; WP_000065430.1; NZ_SWKA01000005.1.
DR   PDB; 2AMJ; X-ray; 1.80 A; A/B/C/D=2-193.
DR   PDB; 2B3D; X-ray; 2.10 A; A/B=2-193.
DR   PDBsum; 2AMJ; -.
DR   PDBsum; 2B3D; -.
DR   SMR; P0AEY7; -.
DR   STRING; 155864.EDL933_4248; -.
DR   EnsemblBacteria; AAG58161; AAG58161; Z4379.
DR   EnsemblBacteria; BAB37333; BAB37333; ECs_3910.
DR   GeneID; 61752135; -.
DR   GeneID; 916264; -.
DR   KEGG; ece:Z4379; -.
DR   KEGG; ecs:ECs3910; -.
DR   PATRIC; fig|386585.9.peg.4078; -.
DR   eggNOG; COG2249; Bacteria.
DR   HOGENOM; CLU_083846_0_0_6; -.
DR   EvolutionaryTrace; P0AEY7; -.
DR   Proteomes; UP000000558; Chromosome.
DR   Proteomes; UP000002519; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0008753; F:NADPH dehydrogenase (quinone) activity; IEA:UniProtKB-EC.
DR   Gene3D; 3.40.50.360; -; 1.
DR   InterPro; IPR003680; Flavodoxin_fold.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   Pfam; PF02525; Flavodoxin_2; 1.
DR   SUPFAM; SSF52218; SSF52218; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; FAD; Flavoprotein; Oxidoreductase;
KW   Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P0AEY5"
FT   CHAIN           2..193
FT                   /note="NADPH:quinone oxidoreductase MdaB"
FT                   /id="PRO_0000096314"
FT   NP_BIND         16..23
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16630630,
FT                   ECO:0007744|PDB:2B3D"
FT   NP_BIND         69..72
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16630630,
FT                   ECO:0007744|PDB:2B3D"
FT   NP_BIND         124..127
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16630630,
FT                   ECO:0007744|PDB:2B3D"
FT   BINDING         108
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16630630,
FT                   ECO:0007744|PDB:2B3D"
FT   STRAND          3..8
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   HELIX           19..34
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   STRAND          38..46
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   HELIX           50..59
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   STRAND          61..68
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   HELIX           76..88
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   TURN            89..92
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   STRAND          93..97
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   STRAND          118..124
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   HELIX           130..133
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   STRAND          137..139
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   HELIX           144..147
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   HELIX           149..157
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   STRAND          166..168
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   TURN            171..173
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   TURN            177..179
FT                   /evidence="ECO:0007829|PDB:2AMJ"
FT   HELIX           180..192
FT                   /evidence="ECO:0007829|PDB:2AMJ"
SQ   SEQUENCE   193 AA;  21891 MW;  FEE3B4D13C2733CA CRC64;
     MSNILIINGA KKFAHSNGQL NDTLTEVADG TLRDLGHDVR IVRADSDYDV KAEVQNFLWA
     DVVIWQMPGW WMGAPWTVKK YIDDVFTEGH GTLYASDGRT RKDPSKKYGS GGLVQGKKYM
     LSLTWNAPME AFTEKDQFFH GVGVDGVYLP FHKANQFLGM EPLPTFIAND VIKMPDVPRY
     TEEYRKHLVE IFG
//
ID   NCPR_YEAST              Reviewed;         691 AA.
AC   P16603; D3DKZ0;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-JUN-2021, entry version 218.
DE   RecName: Full=NADPH--cytochrome P450 reductase {ECO:0000255|HAMAP-Rule:MF_03212};
DE            Short=CPR {ECO:0000255|HAMAP-Rule:MF_03212};
DE            Short=P450R {ECO:0000255|HAMAP-Rule:MF_03212};
DE            EC=1.6.2.4 {ECO:0000255|HAMAP-Rule:MF_03212};
GN   Name=NCP1 {ECO:0000255|HAMAP-Rule:MF_03212}; Synonyms=CPR1, NCPR1, PRD1;
GN   OrderedLocusNames=YHR042W {ECO:0000312|SGD:S000001084};
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 2-13 AND 45-62.
RX   PubMed=3139648; DOI=10.1093/oxfordjournals.jbchem.a122370;
RA   Yabusaki Y., Murakami H., Ohkawa H.;
RT   "Primary structure of Saccharomyces cerevisiae NADPH-cytochrome P450
RT   reductase deduced from nucleotide sequence of its cloned gene.";
RL   J. Biochem. 103:1004-1010(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=8091229; DOI=10.1126/science.8091229;
RA   Johnston M., Andrews S., Brinkman R., Cooper J., Ding H., Dover J., Du Z.,
RA   Favello A., Fulton L., Gattung S., Geisel C., Kirsten J., Kucaba T.,
RA   Hillier L.W., Jier M., Johnston L., Langston Y., Latreille P., Louis E.J.,
RA   Macri C., Mardis E., Menezes S., Mouser L., Nhan M., Rifkin L., Riles L.,
RA   St Peter H., Trevaskis E., Vaughan K., Vignati D., Wilcox L., Wohldman P.,
RA   Waterston R., Wilson R., Vaudin M.;
RT   "Complete nucleotide sequence of Saccharomyces cerevisiae chromosome
RT   VIII.";
RL   Science 265:2077-2082(1994).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A., Raphael J.,
RA   Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F., Williamson J.,
RA   Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G., Kolodner R.D.,
RA   LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-encoding
RT   clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [5]
RP   FUNCTION.
RX   PubMed=1730736;
RA   Turi T.G., Loper J.C.;
RT   "Multiple regulatory elements control expression of the gene encoding the
RT   Saccharomyces cerevisiae cytochrome P450, lanosterol 14 alpha-demethylase
RT   (ERG11).";
RL   J. Biol. Chem. 267:2046-2056(1992).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=9368374; DOI=10.1111/j.1574-6968.1997.tb12720.x;
RA   Lesuisse E., Casteras-Simon M., Labbe P.;
RT   "Cytochrome P-450 reductase is responsible for the ferrireductase activity
RT   associated with isolated plasma membranes of Saccharomyces cerevisiae.";
RL   FEMS Microbiol. Lett. 156:147-152(1997).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, SUBCELLULAR LOCATION, TOPOLOGY, AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=9468503; DOI=10.1074/jbc.273.8.4492;
RA   Venkateswarlu K., Lamb D.C., Kelly D.E., Manning N.J., Kelly S.L.;
RT   "The N-terminal membrane domain of yeast NADPH-cytochrome P450 (CYP)
RT   oxidoreductase is not required for catalytic activity in sterol
RT   biosynthesis or in reconstitution of CYP activity.";
RL   J. Biol. Chem. 273:4492-4496(1998).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND TOPOLOGY.
RX   PubMed=11485306; DOI=10.1006/bbrc.2001.5338;
RA   Lamb D.C., Warrilow A.G., Venkateswarlu K., Kelly D.E., Kelly S.L.;
RT   "Activities and kinetic mechanisms of native and soluble NADPH-cytochrome
RT   P450 reductase.";
RL   Biochem. Biophys. Res. Commun. 286:48-54(2001).
RN   [9]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=14562095; DOI=10.1038/nature02026;
RA   Huh W.-K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W.,
RA   Weissman J.S., O'Shea E.K.;
RT   "Global analysis of protein localization in budding yeast.";
RL   Nature 425:686-691(2003).
RN   [10]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [11]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-666, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=14557538; DOI=10.1073/pnas.2135500100;
RA   Hitchcock A.L., Auld K., Gygi S.P., Silver P.A.;
RT   "A subset of membrane-associated proteins is ubiquitinated in response to
RT   mutations in the endoplasmic reticulum degradation machinery.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:12735-12740(2003).
RN   [12]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=14576278; DOI=10.1073/pnas.2135385100;
RA   Sickmann A., Reinders J., Wagner Y., Joppich C., Zahedi R.P., Meyer H.E.,
RA   Schoenfisch B., Perschil I., Chacinska A., Guiard B., Rehling P.,
RA   Pfanner N., Meisinger C.;
RT   "The proteome of Saccharomyces cerevisiae mitochondria.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:13207-13212(2003).
RN   [13]
RP   PHOSPHORYLATION, AND INTERACTION WITH PCL1.
RX   PubMed=15082539; DOI=10.1534/genetics.166.3.1177;
RA   Keniry M.E., Kemp H.A., Rivers D.M., Sprague G.F. Jr.;
RT   "The identification of Pcl1-interacting proteins that genetically interact
RT   with Cla4 may indicate a link between G1 progression and mitotic exit.";
RL   Genetics 166:1177-1186(2004).
RN   [14]
RP   SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16407407; DOI=10.1091/mbc.e05-08-0740;
RA   Zahedi R.P., Sickmann A., Boehm A.M., Winkler C., Zufall N.,
RA   Schoenfisch B., Guiard B., Pfanner N., Meisinger C.;
RT   "Proteomic analysis of the yeast mitochondrial outer membrane reveals
RT   accumulation of a subclass of preproteins.";
RL   Mol. Biol. Cell 17:1436-1450(2006).
RN   [15]
RP   FMN-BINDING AND FAD-BINDING.
RX   PubMed=20557022; DOI=10.1021/cb100055v;
RA   Ivanov A.S., Gnedenko O.V., Molnar A.A., Archakov A.I., Podust L.M.;
RT   "FMN binding site of yeast NADPH-cytochrome P450 reductase exposed at the
RT   surface is highly specific.";
RL   ACS Chem. Biol. 5:767-776(2010).
RN   [16]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-666, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22106047; DOI=10.1002/pmic.201100166;
RA   Starita L.M., Lo R.S., Eng J.K., von Haller P.D., Fields S.;
RT   "Sites of ubiquitin attachment in Saccharomyces cerevisiae.";
RL   Proteomics 12:236-240(2012).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.91 ANGSTROMS) OF 34-691 IN COMPLEX WITH FAD; FMN
RP   AND NADP.
RX   PubMed=16407065; DOI=10.1016/j.str.2005.09.015;
RA   Lamb D.C., Kim Y., Yermalitskaya L.V., Yermalitsky V.N., Lepesheva G.I.,
RA   Kelly S.L., Waterman M.R., Podust L.M.;
RT   "A second FMN binding site in yeast NADPH-cytochrome P450 reductase
RT   suggests a mechanism of electron transfer by diflavin reductases.";
RL   Structure 14:51-61(2006).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 44-211 IN COMPLEX WITH FMN.
RX   PubMed=19483672; DOI=10.1038/embor.2009.82;
RA   Aigrain L., Pompon D., Morera S., Truan G.;
RT   "Structure of the open conformation of a functional chimeric NADPH
RT   cytochrome P450 reductase.";
RL   EMBO Rep. 10:742-747(2009).
CC   -!- FUNCTION: This enzyme is required for electron transfer from NADP to
CC       cytochrome P450 in microsomes. It can also provide electron transfer to
CC       heme oxygenase and cytochrome B5. Involved in ergosterol biosynthesis.
CC       Has NADPH-dependent ferrireductase activity on the plasma membrane.
CC       {ECO:0000255|HAMAP-Rule:MF_03212, ECO:0000269|PubMed:11485306,
CC       ECO:0000269|PubMed:1730736, ECO:0000269|PubMed:9368374,
CC       ECO:0000269|PubMed:9468503}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADPH + 2 oxidized [cytochrome P450] = H(+) + NADP(+) + 2
CC         reduced [cytochrome P450]; Xref=Rhea:RHEA:24040, Rhea:RHEA-
CC         COMP:14627, Rhea:RHEA-COMP:14628, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:55376, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:60344; EC=1.6.2.4; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_03212, ECO:0000269|PubMed:11485306,
CC         ECO:0000269|PubMed:9368374, ECO:0000269|PubMed:9468503};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03212,
CC         ECO:0000269|PubMed:9468503};
CC       Note=Binds 1 FAD per monomer. {ECO:0000255|HAMAP-Rule:MF_03212,
CC       ECO:0000269|PubMed:9468503};
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03212,
CC         ECO:0000269|PubMed:9468503};
CC       Note=Binds 1 FMN per monomer. {ECO:0000255|HAMAP-Rule:MF_03212,
CC       ECO:0000269|PubMed:9468503};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.59 uM for cytochrome c {ECO:0000269|PubMed:11485306};
CC         KM=1.46 uM for NADPH {ECO:0000269|PubMed:11485306};
CC         Note=The Vmax of the reaction is 721 pmol/min/pmol enzyme towards
CC         cytochrome c, and 662 pmol/min/pmol enzyme toward NADPH.
CC         {ECO:0000269|PubMed:11485306};
CC   -!- SUBUNIT: Interacts with PCL1. {ECO:0000269|PubMed:15082539,
CC       ECO:0000269|PubMed:16407065}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000255|HAMAP-Rule:MF_03212, ECO:0000269|PubMed:14562095,
CC       ECO:0000269|PubMed:9468503}; Single-pass membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_03212, ECO:0000305|PubMed:11485306,
CC       ECO:0000305|PubMed:9468503}; Cytoplasmic side {ECO:0000255|HAMAP-
CC       Rule:MF_03212, ECO:0000305|PubMed:11485306,
CC       ECO:0000305|PubMed:9468503}. Mitochondrion outer membrane
CC       {ECO:0000255|HAMAP-Rule:MF_03212, ECO:0000269|PubMed:14576278,
CC       ECO:0000269|PubMed:16407407}; Single-pass membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_03212, ECO:0000305|PubMed:11485306,
CC       ECO:0000305|PubMed:9468503}; Cytoplasmic side {ECO:0000255|HAMAP-
CC       Rule:MF_03212, ECO:0000305|PubMed:11485306,
CC       ECO:0000305|PubMed:9468503}. Cell membrane {ECO:0000255|HAMAP-
CC       Rule:MF_03212, ECO:0000269|PubMed:9368374}; Single-pass membrane
CC       protein {ECO:0000255|HAMAP-Rule:MF_03212, ECO:0000305|PubMed:11485306,
CC       ECO:0000305|PubMed:9468503}; Cytoplasmic side {ECO:0000255|HAMAP-
CC       Rule:MF_03212, ECO:0000305|PubMed:11485306,
CC       ECO:0000305|PubMed:9468503}.
CC   -!- INDUCTION: By galactose and on the plasma membrane by iron or copper
CC       deficiency. Repressed by glucose. {ECO:0000269|PubMed:9368374}.
CC   -!- PTM: Phosphorylated by the cyclin-CDK PCL1-PHO85.
CC       {ECO:0000269|PubMed:15082539}.
CC   -!- DISRUPTION PHENOTYPE: Accumulates 20% of ergosterol of wild type.
CC       {ECO:0000269|PubMed:9468503}.
CC   -!- MISCELLANEOUS: Present with 46600 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the NADPH--cytochrome P450 reductase family.
CC       {ECO:0000255|HAMAP-Rule:MF_03212}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the flavodoxin
CC       family. {ECO:0000255|HAMAP-Rule:MF_03212}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the flavoprotein
CC       pyridine nucleotide cytochrome reductase family. {ECO:0000255|HAMAP-
CC       Rule:MF_03212}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D13788; BAA02936.1; -; Genomic_DNA.
DR   EMBL; U00062; AAB68904.1; -; Genomic_DNA.
DR   EMBL; AY693091; AAT93110.1; -; Genomic_DNA.
DR   EMBL; BK006934; DAA06734.1; -; Genomic_DNA.
DR   PIR; S46735; S46735.
DR   RefSeq; NP_011908.1; NM_001179172.1.
DR   PDB; 2BF4; X-ray; 3.00 A; A/B=47-691.
DR   PDB; 2BN4; X-ray; 2.91 A; A/B=47-691.
DR   PDB; 2BPO; X-ray; 2.90 A; A/B=47-691.
DR   PDB; 3FJO; X-ray; 2.50 A; A=44-211.
DR   PDBsum; 2BF4; -.
DR   PDBsum; 2BN4; -.
DR   PDBsum; 2BPO; -.
DR   PDBsum; 3FJO; -.
DR   SMR; P16603; -.
DR   BioGRID; 36474; 70.
DR   DIP; DIP-8294N; -.
DR   IntAct; P16603; 9.
DR   MINT; P16603; -.
DR   STRING; 4932.YHR042W; -.
DR   iPTMnet; P16603; -.
DR   MaxQB; P16603; -.
DR   PaxDb; P16603; -.
DR   PRIDE; P16603; -.
DR   EnsemblFungi; YHR042W_mRNA; YHR042W; YHR042W.
DR   GeneID; 856438; -.
DR   KEGG; sce:YHR042W; -.
DR   SGD; S000001084; NCP1.
DR   VEuPathDB; FungiDB:YHR042W; -.
DR   eggNOG; KOG1158; Eukaryota.
DR   GeneTree; ENSGT00940000156847; -.
DR   HOGENOM; CLU_001570_17_3_1; -.
DR   InParanoid; P16603; -.
DR   OMA; QKRYQRD; -.
DR   BRENDA; 1.6.2.4; 984.
DR   Reactome; R-SCE-1222556; ROS and RNS production in phagocytes.
DR   Reactome; R-SCE-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   Reactome; R-SCE-203615; eNOS activation.
DR   Reactome; R-SCE-392154; Nitric oxide stimulates guanylate cyclase.
DR   Reactome; R-SCE-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-SCE-5578775; Ion homeostasis.
DR   Reactome; R-SCE-9009391; Extra-nuclear estrogen signaling.
DR   Reactome; R-SCE-9033241; Peroxisomal protein import.
DR   ChiTaRS; CPR1; yeast.
DR   EvolutionaryTrace; P16603; -.
DR   PRO; PR:P16603; -.
DR   Proteomes; UP000002311; Chromosome VIII.
DR   RNAct; P16603; protein.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005741; C:mitochondrial outer membrane; HDA:SGD.
DR   GO; GO:0005739; C:mitochondrion; HDA:SGD.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0009055; F:electron transfer activity; IDA:SGD.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:0010181; F:FMN binding; IBA:GO_Central.
DR   GO; GO:0050661; F:NADP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003959; F:NADPH dehydrogenase activity; IDA:CACAO.
DR   GO; GO:0003958; F:NADPH-hemoprotein reductase activity; IDA:SGD.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; IBA:GO_Central.
DR   GO; GO:0006696; P:ergosterol biosynthetic process; IMP:SGD.
DR   Gene3D; 1.20.990.10; -; 1.
DR   Gene3D; 3.40.50.360; -; 1.
DR   Gene3D; 3.40.50.80; -; 1.
DR   HAMAP; MF_03212; NCPR; 1.
DR   InterPro; IPR003097; CysJ-like_FAD-binding.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001094; Flavdoxin-like.
DR   InterPro; IPR008254; Flavodoxin/NO_synth.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR023173; NADPH_Cyt_P450_Rdtase_alpha.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR023208; P450R.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF00667; FAD_binding_1; 1.
DR   Pfam; PF00258; Flavodoxin_1; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   PIRSF; PIRSF000208; P450R; 1.
DR   PRINTS; PR00369; FLAVODOXIN.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52218; SSF52218; 1.
DR   SUPFAM; SSF52343; SSF52343; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
DR   PROSITE; PS50902; FLAVODOXIN_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Direct protein sequencing;
KW   Endoplasmic reticulum; FAD; Flavoprotein; FMN; Isopeptide bond;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Mitochondrion;
KW   Mitochondrion outer membrane; NADP; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; Steroid biosynthesis; Steroid metabolism;
KW   Sterol biosynthesis; Sterol metabolism; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:3139648"
FT   CHAIN           2..691
FT                   /note="NADPH--cytochrome P450 reductase"
FT                   /id="PRO_0000167608"
FT   TOPO_DOM        2..7
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        8..24
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        25..691
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          61..204
FT                   /note="Flavodoxin-like"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212"
FT   DOMAIN          266..529
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212"
FT   NP_BIND         67..72
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:16407065, ECO:0000269|PubMed:19483672"
FT   NP_BIND         116..119
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:16407065, ECO:0000269|PubMed:19483672"
FT   NP_BIND         152..161
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:16407065, ECO:0000269|PubMed:19483672"
FT   NP_BIND         439..442
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:16407065"
FT   NP_BIND         457..459
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:16407065"
FT   NP_BIND         476..479
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:16407065"
FT   NP_BIND         610..611
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:16407065"
FT   NP_BIND         617..621
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:16407065"
FT   BINDING         78
FT                   /note="FMN; alternate"
FT                   /evidence="ECO:0000269|PubMed:16407065"
FT   BINDING         187
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212"
FT   BINDING         187
FT                   /note="FMN; alternate"
FT                   /evidence="ECO:0000269|PubMed:16407065"
FT   BINDING         285
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:16407065"
FT   BINDING         543
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:16407065"
FT   BINDING         646
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:16407065"
FT   BINDING         691
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:16407065"
FT   CROSSLNK        666
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0007744|PubMed:22106047"
FT   VARIANT         474
FT                   /note="V -> G"
FT   CONFLICT        423
FT                   /note="T -> N (in Ref. 1; BAA02936)"
FT                   /evidence="ECO:0000305"
FT   HELIX           50..56
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   STRAND          60..66
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   STRAND          68..70
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   HELIX           71..87
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   STRAND          91..95
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   HELIX           96..98
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   HELIX           104..106
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   STRAND          109..116
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   STRAND          119..121
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   HELIX           125..127
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   HELIX           128..136
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   TURN            139..144
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   STRAND          146..153
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   STRAND          157..159
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   HELIX           162..173
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   STRAND          183..186
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   TURN            187..190
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   HELIX           192..210
FT                   /evidence="ECO:0007829|PDB:3FJO"
FT   STRAND          223..226
FT                   /evidence="ECO:0007829|PDB:2BN4"
FT   STRAND          234..239
FT                   /evidence="ECO:0007829|PDB:2BN4"
FT   HELIX           243..245
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   STRAND          271..278
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   STRAND          287..293
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   STRAND          306..309
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           315..325
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   STRAND          332..334
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   STRAND          337..339
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   STRAND          348..351
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           352..358
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           368..374
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           375..377
FT                   /evidence="ECO:0007829|PDB:2BN4"
FT   HELIX           381..390
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           394..400
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           402..404
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           408..416
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           426..432
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   STRAND          439..443
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   TURN            447..449
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   STRAND          453..459
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   STRAND          469..471
FT                   /evidence="ECO:0007829|PDB:2BF4"
FT   HELIX           477..489
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   TURN            494..496
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           508..510
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   TURN            511..515
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   STRAND          519..522
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   STRAND          536..541
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           542..545
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           546..560
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   TURN            564..566
FT                   /evidence="ECO:0007829|PDB:2BN4"
FT   STRAND          574..585
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   TURN            587..591
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           592..599
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           600..602
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   STRAND          603..610
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           620..626
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           628..635
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   TURN            636..638
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   STRAND          640..645
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           650..665
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   HELIX           670..682
FT                   /evidence="ECO:0007829|PDB:2BPO"
FT   STRAND          685..690
FT                   /evidence="ECO:0007829|PDB:2BPO"
SQ   SEQUENCE   691 AA;  76772 MW;  82BB847701E5438B CRC64;
     MPFGIDNTDF TVLAGLVLAV LLYVKRNSIK ELLMSDDGDI TAVSSGNRDI AQVVTENNKN
     YLVLYASQTG TAEDYAKKFS KELVAKFNLN VMCADVENYD FESLNDVPVI VSIFISTYGE
     GDFPDGAVNF EDFICNAEAG ALSNLRYNMF GLGNSTYEFF NGAAKKAEKH LSAAGAIRLG
     KLGEADDGAG TTDEDYMAWK DSILEVLKDE LHLDEQEAKF TSQFQYTVLN EITDSMSLGE
     PSAHYLPSHQ LNRNADGIQL GPFDLSQPYI APIVKSRELF SSNDRNCIHS EFDLSGSNIK
     YSTGDHLAVW PSNPLEKVEQ FLSIFNLDPE TIFDLKPLDP TVKVPFPTPT TIGAAIKHYL
     EITGPVSRQL FSSLIQFAPN ADVKEKLTLL SKDKDQFAVE ITSKYFNIAD ALKYLSDGAK
     WDTVPMQFLV ESVPQMTPRY YSISSSSLSE KQTVHVTSIV ENFPNPELPD APPVVGVTTN
     LLRNIQLAQN NVNIAETNLP VHYDLNGPRK LFANYKLPVH VRRSNFRLPS NPSTPVIMIG
     PGTGVAPFRG FIRERVAFLE SQKKGGNNVS LGKHILFYGS RNTDDFLYQD EWPEYAKKLD
     GSFEMVVAHS RLPNTKKVYV QDKLKDYEDQ VFEMINNGAF IYVCGDAKGM AKGVSTALVG
     ILSRGKSITT DEATELIKML KTSGRYQEDV W
//
ID   THYX_THEMA              Reviewed;         220 AA.
AC   Q9WYT0;
DT   11-JUL-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   02-JUN-2021, entry version 140.
DE   RecName: Full=Flavin-dependent thymidylate synthase {ECO:0000303|PubMed:19370033, ECO:0000303|PubMed:23019356, ECO:0000303|PubMed:24563811, ECO:0000303|PubMed:27214228};
DE            Short=FDTS {ECO:0000303|PubMed:19370033, ECO:0000303|PubMed:23019356, ECO:0000303|PubMed:24563811, ECO:0000303|PubMed:27214228};
DE            EC=2.1.1.148 {ECO:0000269|PubMed:12791256, ECO:0000269|PubMed:19370033};
DE   AltName: Full=FAD-dependent thymidylate synthase {ECO:0000255|HAMAP-Rule:MF_01408};
DE   AltName: Full=Thymidylate synthase ThyX {ECO:0000255|HAMAP-Rule:MF_01408};
DE            Short=TS {ECO:0000255|HAMAP-Rule:MF_01408};
DE            Short=TSase {ECO:0000255|HAMAP-Rule:MF_01408};
GN   Name=thyX {ECO:0000303|PubMed:19370033};
GN   Synonyms=thy1 {ECO:0000303|PubMed:12211025}; OrderedLocusNames=TM_0449;
OS   Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826
OS   / MSB8).
OC   Bacteria; Thermotogae; Thermotogales; Thermotogaceae; Thermotoga.
OX   NCBI_TaxID=243274;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8;
RX   PubMed=10360571; DOI=10.1038/20601;
RA   Nelson K.E., Clayton R.A., Gill S.R., Gwinn M.L., Dodson R.J., Haft D.H.,
RA   Hickey E.K., Peterson J.D., Nelson W.C., Ketchum K.A., McDonald L.A.,
RA   Utterback T.R., Malek J.A., Linher K.D., Garrett M.M., Stewart A.M.,
RA   Cotton M.D., Pratt M.S., Phillips C.A., Richardson D.L., Heidelberg J.F.,
RA   Sutton G.G., Fleischmann R.D., Eisen J.A., White O., Salzberg S.L.,
RA   Smith H.O., Venter J.C., Fraser C.M.;
RT   "Evidence for lateral gene transfer between Archaea and Bacteria from
RT   genome sequence of Thermotoga maritima.";
RL   Nature 399:323-329(1999).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) IN COMPLEX WITH FAD, COFACTOR, AND
RP   SUBUNIT.
RC   STRAIN=ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8;
RX   PubMed=12211025; DOI=10.1002/prot.10202;
RA   Kuhn P., Lesley S.A., Mathews I.I., Canaves J.M., Brinen L.S., Dai X.,
RA   Deacon A.M., Elsliger M.-A., Eshaghi S., Floyd R., Godzik A., Grittini C.,
RA   Grzechnik S.K., Guda C., Hodgson K.O., Jaroszewski L., Karlak C.,
RA   Klock H.E., Koesema E., Kovarik J.M., Kreusch A.T., McMullan D.,
RA   McPhillips T.M., Miller M.A., Miller M., Morse A., Moy K., Ouyang J.,
RA   Robb A., Rodrigues K., Selby T.L., Spraggon G., Stevens R.C., Taylor S.S.,
RA   van den Bedem H., Velasquez J., Vincent J., Wang X., West B., Wolf G.,
RA   Wooley J., Wilson I.A.;
RT   "Crystal structure of thy1, a thymidylate synthase complementing protein
RT   from Thermotoga maritima at 2.25 A resolution.";
RL   Proteins 49:142-145(2002).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF APOENZYME AND COMPLEXES WITH FAD;
RP   DUMP AND SUBSTRATE ANALOGS, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND
RP   SUBUNIT.
RC   STRAIN=ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8;
RX   PubMed=12791256; DOI=10.1016/s0969-2126(03)00097-2;
RA   Mathews I.I., Deacon A.M., Canaves J.M., McMullan D., Lesley S.A.,
RA   Agarwalla S., Kuhn P.;
RT   "Functional analysis of substrate and cofactor complex structures of a
RT   thymidylate synthase-complementing protein.";
RL   Structure 11:677-690(2003).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF MUTANTS ALA-88 AND CYS-88 IN
RP   COMPLEX WITH FAD AND DUMP, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, REACTION MECHANISM, AND MUTAGENESIS OF SER-88.
RX   PubMed=19370033; DOI=10.1038/nature07973;
RA   Koehn E.M., Fleischmann T., Conrad J.A., Palfey B.A., Lesley S.A.,
RA   Mathews I.I., Kohen A.;
RT   "An unusual mechanism of thymidylate biosynthesis in organisms containing
RT   the thyX gene.";
RL   Nature 458:919-923(2009).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) IN COMPLEX WITH FAD AND DUMP.
RX   PubMed=22477781; DOI=10.1107/s0021889810040409;
RA   Berger M.A., Decker J.H., Mathews I.I.;
RT   "Diffraction study of protein crystals grown in cryoloops and
RT   micromounts.";
RL   J. Appl. Crystallogr. 43:1513-1518(2010).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.39 ANGSTROMS) OF WILD-TYPE AND MUTANTS ALA-53;
RP   ARG-144 AND LYS-174 IN COMPLEXES WITH FAD; DUMP AND SEVERAL FOLATE
RP   DERIVATIVES, REACTION MECHANISM, AND MUTAGENESIS OF HIS-53; GLU-144 AND
RP   ARG-174.
RX   PubMed=23019356; DOI=10.1073/pnas.1206077109;
RA   Koehn E.M., Perissinotti L.L., Moghram S., Prabhakar A., Lesley S.A.,
RA   Mathews I.I., Kohen A.;
RT   "Folate binding site of flavin-dependent thymidylate synthase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:15722-15727(2012).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF MUTANT ASP-53 IN COMPLEXES WITH
RP   FAD; FADH2 AND DUMP, AND SUBUNIT.
RX   PubMed=24563811; DOI=10.4172/2157-2526.s12-004;
RA   Mathews I.I.;
RT   "Flavin-dependent thymidylate synthase as a drug target for deadly
RT   microbes: mutational study and a strategy for inhibitor design.";
RL   J. Bioterror. Biodef. 12:004-004(2013).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF WILD-TYPE AND MUTANTS ALA-90 AND
RP   ALA-174 IN COMPLEXES WITH FAD; DUMP AND DEOXYURIDINE, REACTION MECHANISM,
RP   ACTIVE SITE, AND MUTAGENESIS OF ARG-90 AND ARG-174.
RX   PubMed=27214228; DOI=10.1021/acs.biochem.6b00510;
RA   Stull F.W., Bernard S.M., Sapra A., Smith J.L., Zuiderweg E.R.,
RA   Palfey B.A.;
RT   "Deprotonations in the reaction of flavin-dependent thymidylate synthase.";
RL   Biochemistry 55:3261-3269(2016).
CC   -!- FUNCTION: Catalyzes the reductive methylation of 2'-deoxyuridine-5'-
CC       monophosphate (dUMP) to 2'-deoxythymidine-5'-monophosphate (dTMP) while
CC       utilizing 5,10-methylenetetrahydrofolate (mTHF) as the methyl donor,
CC       and NAD(P)H and FADH(2) as the reductant. {ECO:0000269|PubMed:12791256,
CC       ECO:0000269|PubMed:19370033}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6R)-5,10-methylene-5,6,7,8-tetrahydrofolate + dUMP + H(+) +
CC         NADPH = (6S)-5,6,7,8-tetrahydrofolate + dTMP + NADP(+);
CC         Xref=Rhea:RHEA:29043, ChEBI:CHEBI:15378, ChEBI:CHEBI:15636,
CC         ChEBI:CHEBI:57453, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:63528, ChEBI:CHEBI:246422; EC=2.1.1.148;
CC         Evidence={ECO:0000269|PubMed:12791256, ECO:0000269|PubMed:19370033};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:12791256, ECO:0000305|PubMed:12211025};
CC       Note=Binds 4 FAD per tetramer. Each FAD binding site is formed by three
CC       monomers. {ECO:0000269|PubMed:12211025, ECO:0000269|PubMed:12791256};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=30 uM for dUMP (at 65 degrees Celsius)
CC         {ECO:0000269|PubMed:19370033};
CC         Note=kcat is 1.2 sec(-1) (at 65 degrees Celsius).
CC         {ECO:0000269|PubMed:19370033};
CC   -!- PATHWAY: Pyrimidine metabolism; dTTP biosynthesis. {ECO:0000255|HAMAP-
CC       Rule:MF_01408}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:12211025,
CC       ECO:0000269|PubMed:12791256, ECO:0000269|PubMed:24563811}.
CC   -!- MISCELLANEOUS: Reaction mechanism involved a direct methylene transfer
CC       from mTHF to dUMP (PubMed:23019356). FDTS ionizes N3 of dUMP using the
CC       active-site Arg-174, providing a new mechanism for dUMP activation. The
CC       phosphate of dUMP is crucial for flavin oxidation, suggesting that it
CC       acts as the base that deprotonates C5 of the dUMP-methylene adduct
CC       (PubMed:27214228). {ECO:0000269|PubMed:23019356,
CC       ECO:0000269|PubMed:27214228}.
CC   -!- SIMILARITY: Belongs to the thymidylate synthase ThyX family.
CC       {ECO:0000255|HAMAP-Rule:MF_01408}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE000512; AAD35532.1; -; Genomic_DNA.
DR   PIR; B72375; B72375.
DR   RefSeq; NP_228259.1; NC_000853.1.
DR   RefSeq; WP_004081517.1; NZ_CP011107.1.
DR   PDB; 1KQ4; X-ray; 2.25 A; A/B/C/D=1-220.
DR   PDB; 1O24; X-ray; 2.00 A; A/B/C/D=1-220.
DR   PDB; 1O25; X-ray; 2.40 A; A/B/C/D=1-220.
DR   PDB; 1O26; X-ray; 1.60 A; A/B/C/D=1-220.
DR   PDB; 1O27; X-ray; 2.30 A; A/B/C/D=1-220.
DR   PDB; 1O28; X-ray; 2.10 A; A/B/C/D=1-220.
DR   PDB; 1O29; X-ray; 2.00 A; A/B/C/D=1-220.
DR   PDB; 1O2A; X-ray; 1.80 A; A/B/C/D=1-220.
DR   PDB; 1O2B; X-ray; 2.45 A; A/B/C/D=1-220.
DR   PDB; 3G4A; X-ray; 1.95 A; A/B/C/D=1-220.
DR   PDB; 3G4C; X-ray; 2.05 A; A/B/C/D=1-220.
DR   PDB; 3N0B; X-ray; 2.30 A; A/B/C/D=1-220.
DR   PDB; 3N0C; X-ray; 2.30 A; A/B/C/D=1-220.
DR   PDB; 4GT9; X-ray; 1.39 A; A=1-220.
DR   PDB; 4GTA; X-ray; 1.50 A; A=1-220.
DR   PDB; 4GTB; X-ray; 1.70 A; A=1-220.
DR   PDB; 4GTC; X-ray; 1.97 A; A/B/C/D=1-220.
DR   PDB; 4GTD; X-ray; 1.76 A; A/B/C/D=1-220.
DR   PDB; 4GTE; X-ray; 1.89 A; A/B/C/D=1-220.
DR   PDB; 4GTF; X-ray; 1.77 A; A=1-220.
DR   PDB; 4GTL; X-ray; 2.17 A; A/B/C/D=1-220.
DR   PDB; 4KAR; X-ray; 2.03 A; A/B/C/D=1-220.
DR   PDB; 4KAS; X-ray; 1.85 A; A/B/C/D=1-220.
DR   PDB; 4KAT; X-ray; 2.14 A; A/B/C/D=1-220.
DR   PDB; 5CHP; X-ray; 1.70 A; A=1-220.
DR   PDB; 5IOQ; X-ray; 1.93 A; A/B/C/D=1-220.
DR   PDB; 5IOR; X-ray; 1.95 A; A=1-220.
DR   PDB; 5IOS; X-ray; 1.90 A; A/B/C/D=1-220.
DR   PDB; 5IOT; X-ray; 2.00 A; A/B/C/D=1-220.
DR   PDB; 5JFE; X-ray; 2.03 A; A=1-220.
DR   PDBsum; 1KQ4; -.
DR   PDBsum; 1O24; -.
DR   PDBsum; 1O25; -.
DR   PDBsum; 1O26; -.
DR   PDBsum; 1O27; -.
DR   PDBsum; 1O28; -.
DR   PDBsum; 1O29; -.
DR   PDBsum; 1O2A; -.
DR   PDBsum; 1O2B; -.
DR   PDBsum; 3G4A; -.
DR   PDBsum; 3G4C; -.
DR   PDBsum; 3N0B; -.
DR   PDBsum; 3N0C; -.
DR   PDBsum; 4GT9; -.
DR   PDBsum; 4GTA; -.
DR   PDBsum; 4GTB; -.
DR   PDBsum; 4GTC; -.
DR   PDBsum; 4GTD; -.
DR   PDBsum; 4GTE; -.
DR   PDBsum; 4GTF; -.
DR   PDBsum; 4GTL; -.
DR   PDBsum; 4KAR; -.
DR   PDBsum; 4KAS; -.
DR   PDBsum; 4KAT; -.
DR   PDBsum; 5CHP; -.
DR   PDBsum; 5IOQ; -.
DR   PDBsum; 5IOR; -.
DR   PDBsum; 5IOS; -.
DR   PDBsum; 5IOT; -.
DR   PDBsum; 5JFE; -.
DR   SMR; Q9WYT0; -.
DR   DIP; DIP-60076N; -.
DR   STRING; 243274.THEMA_02480; -.
DR   DrugBank; DB01903; 5-Bromo-2'-deoxyuridine 5'-(dihydrogen phosphate).
DR   DrugBank; DB03761; 5-fluoro-2'-deoxyuridine-5'-monophosphate.
DR   DrugBank; DB03800; Deoxyuridine monophosphate.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   EnsemblBacteria; AAD35532; AAD35532; TM_0449.
DR   KEGG; tma:TM0449; -.
DR   eggNOG; COG1351; Bacteria.
DR   InParanoid; Q9WYT0; -.
DR   OMA; QQGRPGK; -.
DR   OrthoDB; 896350at2; -.
DR   BioCyc; MetaCyc:MONOMER-15758; -.
DR   BRENDA; 2.1.1.148; 6331.
DR   SABIO-RK; Q9WYT0; -.
DR   UniPathway; UPA00575; -.
DR   EvolutionaryTrace; Q9WYT0; -.
DR   Proteomes; UP000008183; Chromosome.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:0070402; F:NADPH binding; IBA:GO_Central.
DR   GO; GO:0050797; F:thymidylate synthase (FAD) activity; IBA:GO_Central.
DR   GO; GO:0004799; F:thymidylate synthase activity; IBA:GO_Central.
DR   GO; GO:0006231; P:dTMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006235; P:dTTP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.1360.170; -; 1.
DR   HAMAP; MF_01408; ThyX; 1.
DR   InterPro; IPR003669; Thymidylate_synthase_ThyX.
DR   InterPro; IPR036098; Thymidylate_synthase_ThyX_sf.
DR   PANTHER; PTHR34934; PTHR34934; 1.
DR   Pfam; PF02511; Thy1; 1.
DR   SUPFAM; SSF69796; SSF69796; 1.
DR   TIGRFAMs; TIGR02170; thyX; 1.
DR   PROSITE; PS51331; THYX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Methyltransferase; NAD; NADP;
KW   Nucleotide biosynthesis; Reference proteome; Transferase.
FT   CHAIN           1..220
FT                   /note="Flavin-dependent thymidylate synthase"
FT                   /id="PRO_0000175579"
FT   DOMAIN          1..208
FT                   /note="ThyX"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00661"
FT   NP_BIND         75..78
FT                   /note="dUMP; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:12791256,
FT                   ECO:0000269|PubMed:19370033, ECO:0000269|PubMed:22477781,
FT                   ECO:0000269|PubMed:23019356, ECO:0000269|PubMed:24563811,
FT                   ECO:0000269|PubMed:27214228, ECO:0007744|PDB:1O26,
FT                   ECO:0007744|PDB:3G4A, ECO:0007744|PDB:3N0B,
FT                   ECO:0007744|PDB:4GT9, ECO:0007744|PDB:4KAS"
FT   NP_BIND         78..81
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12211025,
FT                   ECO:0000269|PubMed:12791256, ECO:0000269|PubMed:19370033,
FT                   ECO:0000269|PubMed:22477781, ECO:0000269|PubMed:23019356,
FT                   ECO:0000269|PubMed:24563811, ECO:0000269|PubMed:27214228,
FT                   ECO:0007744|PDB:1KQ4, ECO:0007744|PDB:1O26,
FT                   ECO:0007744|PDB:3G4A, ECO:0007744|PDB:3N0B,
FT                   ECO:0007744|PDB:4GTD, ECO:0007744|PDB:4KAS"
FT   NP_BIND         86..90
FT                   /note="dUMP"
FT                   /evidence="ECO:0000269|PubMed:12791256,
FT                   ECO:0000269|PubMed:19370033, ECO:0000269|PubMed:22477781,
FT                   ECO:0000269|PubMed:23019356, ECO:0000269|PubMed:24563811,
FT                   ECO:0000269|PubMed:27214228, ECO:0007744|PDB:1O26,
FT                   ECO:0007744|PDB:3G4A, ECO:0007744|PDB:3N0B,
FT                   ECO:0007744|PDB:4GT9, ECO:0007744|PDB:4KAS"
FT   NP_BIND         163..165
FT                   /note="FAD; shared with neighboring subunits"
FT                   /evidence="ECO:0000269|PubMed:12211025,
FT                   ECO:0000269|PubMed:12791256, ECO:0000269|PubMed:19370033,
FT                   ECO:0000269|PubMed:22477781, ECO:0000269|PubMed:23019356,
FT                   ECO:0000269|PubMed:24563811, ECO:0000269|PubMed:27214228,
FT                   ECO:0007744|PDB:1KQ4, ECO:0007744|PDB:1O26,
FT                   ECO:0007744|PDB:3G4A, ECO:0007744|PDB:3N0B,
FT                   ECO:0007744|PDB:4GTD, ECO:0007744|PDB:4KAS"
FT   MOTIF           78..88
FT                   /note="ThyX motif"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01408"
FT   ACT_SITE        174
FT                   /note="Involved in ionization of N3 of dUMP, leading to its
FT                   activation"
FT                   /evidence="ECO:0000269|PubMed:27214228"
FT   BINDING         55
FT                   /note="FAD; shared with neighboring subunits"
FT                   /evidence="ECO:0000269|PubMed:12791256,
FT                   ECO:0000269|PubMed:19370033, ECO:0000269|PubMed:22477781,
FT                   ECO:0000269|PubMed:23019356, ECO:0000269|PubMed:24563811,
FT                   ECO:0000269|PubMed:27214228, ECO:0007744|PDB:1O26,
FT                   ECO:0007744|PDB:3G4A, ECO:0007744|PDB:3N0B,
FT                   ECO:0007744|PDB:4GTD, ECO:0007744|PDB:4KAS"
FT   BINDING         86
FT                   /note="FAD; shared with neighboring subunits"
FT                   /evidence="ECO:0000269|PubMed:12211025,
FT                   ECO:0000269|PubMed:12791256, ECO:0000269|PubMed:19370033,
FT                   ECO:0000269|PubMed:22477781, ECO:0000269|PubMed:23019356,
FT                   ECO:0000269|PubMed:24563811, ECO:0000269|PubMed:27214228,
FT                   ECO:0007744|PDB:1KQ4, ECO:0007744|PDB:1O26,
FT                   ECO:0007744|PDB:3G4A, ECO:0007744|PDB:3N0B,
FT                   ECO:0007744|PDB:4GTD, ECO:0007744|PDB:4KAS"
FT   BINDING         147
FT                   /note="dUMP"
FT                   /evidence="ECO:0000269|PubMed:12791256,
FT                   ECO:0000269|PubMed:19370033, ECO:0000269|PubMed:22477781,
FT                   ECO:0000269|PubMed:23019356, ECO:0000269|PubMed:24563811,
FT                   ECO:0000269|PubMed:27214228, ECO:0007744|PDB:1O26,
FT                   ECO:0007744|PDB:3G4A, ECO:0007744|PDB:3N0B,
FT                   ECO:0007744|PDB:4GT9, ECO:0007744|PDB:4KAS"
FT   BINDING         169
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12211025,
FT                   ECO:0000269|PubMed:12791256, ECO:0000269|PubMed:19370033,
FT                   ECO:0000269|PubMed:22477781, ECO:0000269|PubMed:23019356,
FT                   ECO:0000269|PubMed:24563811, ECO:0000269|PubMed:27214228,
FT                   ECO:0007744|PDB:1KQ4, ECO:0007744|PDB:1O26,
FT                   ECO:0007744|PDB:3G4A, ECO:0007744|PDB:3N0B,
FT                   ECO:0007744|PDB:4GTD, ECO:0007744|PDB:4KAS"
FT   BINDING         174
FT                   /note="dUMP; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:12791256,
FT                   ECO:0000269|PubMed:19370033, ECO:0000269|PubMed:22477781,
FT                   ECO:0000269|PubMed:23019356, ECO:0000269|PubMed:24563811,
FT                   ECO:0000269|PubMed:27214228, ECO:0007744|PDB:1O26,
FT                   ECO:0007744|PDB:3G4A, ECO:0007744|PDB:3N0B,
FT                   ECO:0007744|PDB:4GT9, ECO:0007744|PDB:4KAS"
FT   MUTAGEN         53
FT                   /note="H->A: Shows 1.39% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:23019356"
FT   MUTAGEN         88
FT                   /note="S->A,C: Still catalytically active although shows a
FT                   large decrease in activity."
FT                   /evidence="ECO:0000269|PubMed:19370033"
FT   MUTAGEN         90
FT                   /note="R->A: Binds dUMP 670-fold weaker than wild-type."
FT                   /evidence="ECO:0000269|PubMed:27214228"
FT   MUTAGEN         144
FT                   /note="E->A: Shows 0.113% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:23019356"
FT   MUTAGEN         144
FT                   /note="E->R: Shows 0.016% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:23019356"
FT   MUTAGEN         174
FT                   /note="R->A: Still catalytically active although only shows
FT                   0.0008% of wild-type activity. Binds dUMP 7300-fold weaker
FT                   than wild-type."
FT                   /evidence="ECO:0000269|PubMed:23019356,
FT                   ECO:0000269|PubMed:27214228"
FT   MUTAGEN         174
FT                   /note="R->K: Loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:23019356"
FT   STRAND          2..5
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   TURN            6..8
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   STRAND          9..17
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   HELIX           20..28
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   HELIX           29..31
FT                   /evidence="ECO:0007829|PDB:1O26"
FT   HELIX           39..51
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   HELIX           55..59
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   STRAND          61..69
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   HELIX           70..76
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   STRAND          81..86
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   TURN            89..91
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   HELIX           103..106
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   HELIX           115..138
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   HELIX           143..146
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   HELIX           147..149
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   STRAND          154..163
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   HELIX           164..174
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   HELIX           181..197
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   HELIX           199..208
FT                   /evidence="ECO:0007829|PDB:4GT9"
FT   HELIX           214..216
FT                   /evidence="ECO:0007829|PDB:1O26"
SQ   SEQUENCE   220 AA;  26004 MW;  E3B9712014185907 CRC64;
     MKIDILDKGF VELVDVMGND LSAVRAARVS FDMGLKDEER DRHLIEYLMK HGHETPFEHI
     VFTFHVKAPI FVARQWFRHR IASYNELSGR YSKLSYEFYI PSPERLEGYK TTIPPERVTE
     KISEIVDKAY RTYLELIESG VPREVARIVL PLNLYTRFFW TVNARSLMNF LNLRADSHAQ
     WEIQQYALAI ARIFKEKCPW TFEAFLKYAY KGDILKEVQV
//
ID   PDS_ORYSI               Reviewed;         578 AA.
AC   A2XDA1; Q93Y74; Q9ZTN9;
DT   10-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   10-JUL-2007, sequence version 2.
DT   02-JUN-2021, entry version 70.
DE   RecName: Full=15-cis-phytoene desaturase, chloroplastic/chromoplastic {ECO:0000305};
DE            EC=1.3.5.5 {ECO:0000269|PubMed:26147209, ECO:0000269|PubMed:29176862};
DE   AltName: Full=Phytoene dehydrogenase {ECO:0000303|PubMed:28669634};
DE   AltName: Full=Phytoene desaturase {ECO:0000303|Ref.2};
DE   Flags: Precursor;
GN   Name=PDS1; Synonyms=PDS; ORFNames=OsI_010044;
OS   Oryza sativa subsp. indica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39946;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. 93-11;
RX   PubMed=15685292; DOI=10.1371/journal.pbio.0030038;
RA   Yu J., Wang J., Lin W., Li S., Li H., Zhou J., Ni P., Dong W., Hu S.,
RA   Zeng C., Zhang J., Zhang Y., Li R., Xu Z., Li S., Li X., Zheng H., Cong L.,
RA   Lin L., Yin J., Geng J., Li G., Shi J., Liu J., Lv H., Li J., Wang J.,
RA   Deng Y., Ran L., Shi X., Wang X., Wu Q., Li C., Ren X., Wang J., Wang X.,
RA   Li D., Liu D., Zhang X., Ji Z., Zhao W., Sun Y., Zhang Z., Bao J., Han Y.,
RA   Dong L., Ji J., Chen P., Wu S., Liu J., Xiao Y., Bu D., Tan J., Yang L.,
RA   Ye C., Zhang J., Xu J., Zhou Y., Yu Y., Zhang B., Zhuang S., Wei H.,
RA   Liu B., Lei M., Yu H., Li Y., Xu H., Wei S., He X., Fang L., Zhang Z.,
RA   Zhang Y., Huang X., Su Z., Tong W., Li J., Tong Z., Li S., Ye J., Wang L.,
RA   Fang L., Lei T., Chen C.-S., Chen H.-C., Xu Z., Li H., Huang H., Zhang F.,
RA   Xu H., Li N., Zhao C., Li S., Dong L., Huang Y., Li L., Xi Y., Qi Q.,
RA   Li W., Zhang B., Hu W., Zhang Y., Tian X., Jiao Y., Liang X., Jin J.,
RA   Gao L., Zheng W., Hao B., Liu S.-M., Wang W., Yuan L., Cao M.,
RA   McDermott J., Samudrala R., Wang J., Wong G.K.-S., Yang H.;
RT   "The genomes of Oryza sativa: a history of duplications.";
RL   PLoS Biol. 3:266-281(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-578.
RC   STRAIN=cv. IR36;
RA   Vigneswaran A., Wurtzel E.T.;
RT   "A rice cDNA encoding phytoene desaturase.";
RL   (er) Plant Gene Register PGR99-131(1999).
RN   [3]
RP   PROTEIN SEQUENCE OF 122-136; 394-397; 413-425; 479-500; 521-536 AND
RP   550-564, IDENTIFICATION BY MASS SPECTROMETRY, CRYSTALLIZATION, FUNCTION,
RP   CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, COFACTOR, ACTIVITY REGULATION,
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=26147209; DOI=10.1371/journal.pone.0131717;
RA   Gemmecker S., Schaub P., Koschmieder J., Brausemann A., Drepper F.,
RA   Rodriguez-Franco M., Ghisla S., Warscheid B., Einsle O., Beyer P.;
RT   "Phytoene Desaturase from Oryza sativa: Oligomeric Assembly, Membrane
RT   Association and Preliminary 3D-Analysis.";
RL   PLoS ONE 10:E0131717-E0131717(2015).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ACTIVITY REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF PHE-162; ARG-300; TYR-506;
RP   THR-508 AND LEU-538, AND REACTION MECHANISM.
RX   PubMed=29176862; DOI=10.1371/journal.pone.0187628;
RA   Koschmieder J., Fehling-Kaschek M., Schaub P., Ghisla S., Brausemann A.,
RA   Timmer J., Beyer P.;
RT   "Plant-type phytoene desaturase: Functional evaluation of structural
RT   implications.";
RL   PLoS ONE 12:E0187628-E0187628(2017).
RN   [5] {ECO:0007744|PDB:5MOG}
RP   X-RAY CRYSTALLOGRAPHY (2.77 ANGSTROMS) OF 88-578 IN COMPLEX WITH FAD AND
RP   HERBICIDAL INHIBITOR, SUBUNIT, AND REACTION MECHANISM.
RX   PubMed=28669634; DOI=10.1016/j.str.2017.06.002;
RA   Brausemann A., Gemmecker S., Koschmieder J., Ghisla S., Beyer P.,
RA   Einsle O.;
RT   "Structure of Phytoene Desaturase Provides Insights into Herbicide Binding
RT   and Reaction Mechanisms Involved in Carotene Desaturation.";
RL   Structure 25:1222-1232(2017).
CC   -!- FUNCTION: Converts phytoene into zeta-carotene via the intermediary of
CC       phytofluene by the symmetrical introduction of two double bonds at the
CC       C-11 and C-11' positions of phytoene with a concomitant isomerization
CC       of two neighboring double bonds at the C9 and C9' positions from trans
CC       to cis. Active with decylplastoquinone (DPQ) as substrate
CC       (PubMed:26147209, PubMed:29176862). Also active with other
CC       benzoquinones, which are strongly preferred over naphthoquinones as
CC       substrates (PubMed:26147209). {ECO:0000269|PubMed:26147209,
CC       ECO:0000269|PubMed:29176862}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=15-cis-phytoene + 2 a plastoquinone = 9,9',15-tri-cis-zeta-
CC         carotene + 2 a plastoquinol; Xref=Rhea:RHEA:30287, Rhea:RHEA-
CC         COMP:9561, Rhea:RHEA-COMP:9562, ChEBI:CHEBI:17757, ChEBI:CHEBI:27787,
CC         ChEBI:CHEBI:48717, ChEBI:CHEBI:62192; EC=1.3.5.5;
CC         Evidence={ECO:0000269|PubMed:26147209, ECO:0000269|PubMed:29176862};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:26147209, ECO:0000269|PubMed:28669634,
CC         ECO:0000269|PubMed:29176862};
CC   -!- ACTIVITY REGULATION: Inhibited by the herbicide norflurazon (NFZ).
CC       {ECO:0000269|PubMed:26147209, ECO:0000269|PubMed:29176862}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.3 mM for decylplastoquinone (DPQ) {ECO:0000269|PubMed:29176862};
CC         KM=53.9 mM for phytoene {ECO:0000269|PubMed:29176862};
CC         KM=66.8 mM for phytofluene {ECO:0000269|PubMed:29176862};
CC         Vmax=28 nmol/min/mg enzyme with decylplastoquinone (DPQ) as substrate
CC         {ECO:0000269|PubMed:29176862};
CC         Vmax=46.3 nmol/min/mg enzyme with phytoene as substrate
CC         {ECO:0000269|PubMed:29176862};
CC         Vmax=48.4 nmol/min/mg enzyme with phytofluene as substrate
CC         {ECO:0000269|PubMed:29176862};
CC       pH dependence:
CC         Optimum pH is 6.0. {ECO:0000269|PubMed:29176862};
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius.
CC         {ECO:0000269|PubMed:29176862};
CC   -!- PATHWAY: Carotenoid biosynthesis; lycopene biosynthesis.
CC   -!- SUBUNIT: Homotetramer (PubMed:26147209, PubMed:28669634). Homotetramer
CC       is the active form of the enzyme (PubMed:26147209).
CC       {ECO:0000269|PubMed:26147209, ECO:0000269|PubMed:28669634}.
CC   -!- SUBCELLULAR LOCATION: Plastid, chloroplast
CC       {ECO:0000250|UniProtKB:Q40406}. Plastid, chromoplast
CC       {ECO:0000250|UniProtKB:Q40406}. Membrane {ECO:0000269|PubMed:26147209};
CC       Peripheral membrane protein {ECO:0000269|PubMed:26147209}.
CC   -!- SIMILARITY: Belongs to the carotenoid/retinoid oxidoreductase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CM000128; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF049356; AAD02489.1; -; mRNA.
DR   PDB; 5MOG; X-ray; 2.77 A; A/B/C/D/E=88-578.
DR   PDBsum; 5MOG; -.
DR   SMR; A2XDA1; -.
DR   BRENDA; 1.3.5.5; 11590.
DR   UniPathway; UPA00803; -.
DR   Proteomes; UP000007015; Chromosome 3.
DR   GO; GO:0009507; C:chloroplast; ISS:UniProtKB.
DR   GO; GO:0009509; C:chromoplast; ISS:UniProtKB.
DR   GO; GO:0035452; C:extrinsic component of plastid membrane; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0016166; F:phytoene dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0016120; P:carotene biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0016117; P:carotenoid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR014102; Phytoene_desaturase.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR02731; phytoene_desat; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Carotenoid biosynthesis; Chloroplast; Chromoplast;
KW   Direct protein sequencing; FAD; Flavoprotein; Membrane; Oxidoreductase;
KW   Plastid; Reference proteome; Transit peptide.
FT   TRANSIT         1..87
FT                   /note="Chloroplast and chromoplast"
FT                   /evidence="ECO:0000255"
FT   CHAIN           88..578
FT                   /note="15-cis-phytoene desaturase,
FT                   chloroplastic/chromoplastic"
FT                   /id="PRO_0000295009"
FT   NP_BIND         134..135
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28669634,
FT                   ECO:0007744|PDB:5MOG"
FT   NP_BIND         159..160
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28669634,
FT                   ECO:0007744|PDB:5MOG"
FT   BINDING         115
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:28669634,
FT                   ECO:0007744|PDB:5MOG"
FT   BINDING         142
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28669634,
FT                   ECO:0007744|PDB:5MOG"
FT   BINDING         165
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28669634,
FT                   ECO:0007744|PDB:5MOG"
FT   BINDING         300
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:28669634,
FT                   ECO:0007744|PDB:5MOG"
FT   BINDING         342
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28669634,
FT                   ECO:0007744|PDB:5MOG"
FT   BINDING         531
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28669634,
FT                   ECO:0007744|PDB:5MOG"
FT   BINDING         539
FT                   /note="Substrate; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28669634,
FT                   ECO:0007744|PDB:5MOG"
FT   BINDING         541
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:28669634,
FT                   ECO:0007744|PDB:5MOG"
FT   MUTAGEN         162
FT                   /note="F->V: Shows less than 5% activity of that of the
FT                   wild-type. Confers norflurazon (NFZ) resistance. Remains
FT                   flavinylated."
FT                   /evidence="ECO:0000269|PubMed:29176862"
FT   MUTAGEN         300
FT                   /note="R->S: 15% of the zeta-carotene forming activity of
FT                   that of the wild-type. 3.5-fold increase in affinity, but
FT                   23-fold decrease in reaction rate with decylplastoquinone
FT                   (DPQ) as substrate. 12-fold increase in affinity, but 46-
FT                   fold decrease in reaction rate with phytoene as substrate.
FT                   Incorporation of FAD into the enzyme is not affected. No
FT                   difference in membrane association compared to wild-type.
FT                   No effect on the oligomeric assembly or solubility of the
FT                   protein. 5-fold increased resistance to norflurazon (NFZ)
FT                   compared to wild-type."
FT                   /evidence="ECO:0000269|PubMed:29176862"
FT   MUTAGEN         300
FT                   /note="R->T: 6% of the zeta-carotene forming activity of
FT                   that of the wild-type."
FT                   /evidence="ECO:0000269|PubMed:29176862"
FT   MUTAGEN         506
FT                   /note="Y->F: 5% of the zeta-carotene forming activity of
FT                   that of the wild-type. Forms 9,15-di-cis-phytofluene and
FT                   9,15,9'-tri-cis-zeta-carotene as the sole products normally
FT                   as does the wild-type."
FT                   /evidence="ECO:0000269|PubMed:29176862"
FT   MUTAGEN         508
FT                   /note="T->V: 5% of the zeta-carotene forming activity of
FT                   that of the wild-type. Forms 9,15-di-cis-phytofluene and
FT                   9,15,9'-tri-cis-zeta-carotene as the sole products normally
FT                   as does the wild-type."
FT                   /evidence="ECO:0000269|PubMed:29176862"
FT   MUTAGEN         538
FT                   /note="L->F,R: Shows less than 5% activity of that of the
FT                   wild-type. Confers norflurazon (NFZ) resistance. Remains
FT                   flavinylated."
FT                   /evidence="ECO:0000269|PubMed:29176862"
FT   CONFLICT        15..16
FT                   /note="SQ -> AS (in Ref. 2; AAD02489)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        19
FT                   /note="S -> Y (in Ref. 2; AAD02489)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        40
FT                   /note="S -> G (in Ref. 2; AAD02489)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        199
FT                   /note="F -> S (in Ref. 2; AAD02489)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        446
FT                   /note="N -> S (in Ref. 2; AAD02489)"
FT                   /evidence="ECO:0000305"
FT   STRAND          106..110
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           114..125
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          129..133
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          135..140
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           141..143
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          145..147
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          153..157
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           166..174
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           178..180
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          181..183
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          186..191
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          193..195
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          199..203
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           212..220
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           227..242
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           245..250
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           251..253
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           256..262
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           267..272
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           274..282
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   TURN            286..288
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           291..302
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   TURN            305..308
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          310..315
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           317..320
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           322..331
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          335..339
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          342..347
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          351..358
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          367..371
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           375..381
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   TURN            384..388
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           390..393
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           394..396
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          403..412
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          427..434
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           435..438
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          449..454
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   TURN            458..462
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           465..479
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   TURN            481..483
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          488..491
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          493..501
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           513..515
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   STRAND          526..528
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           541..557
FT                   /evidence="ECO:0007829|PDB:5MOG"
FT   HELIX           559..566
FT                   /evidence="ECO:0007829|PDB:5MOG"
SQ   SEQUENCE   578 AA;  64770 MW;  6561B0DE071282EF CRC64;
     MDTGCLSSMN ITGTSQARSF AGQLPTHRCF ASSSIQALKS SQHVSFGVKS LVLRNKGKRF
     RRRLGALQVV CQDFPRPPLE NTINFLEAGQ LSSFFRNSEQ PTKPLQVVIA GAGLAGLSTA
     KYLADAGHKP ILLEARDVLG GKIAAWKDED GDWYETGLHI FFGAYPNIQN LFGELGINDR
     LQWKEHSMIF AMPNKPGEFS RFDFPETLPA PLNGIWAILR NNEMLTWPEK VKFALGLLPA
     MVGGQAYVEA QDGFTVSEWM KKQGVPDRVN DEVFIAMSKA LNFINPDELS MQCILIALNR
     FLQEKHGSKM AFLDGNPPER LCMPIVDHVR SLGGEVRLNS RIQKIELNPD GTVKHFALTD
     GTQITGDAYV FATPVDILKL LVPQEWKEIS YFKKLEKLVG VPVINVHIWF DRKLKNTYDH
     LLFSRSSLLS VYADMSVTCK EYYDPNRSML ELVFAPAEEW VGRSDTEIIE ATMQELAKLF
     PDEIAADQSK AKILKYHVVK TPRSVYKTIP DCEPCRPLQR SPIEGFYLAG DYTKQKYLAS
     MEGAVLSGKL CAQSVVEDYK MLSRRSLKSL QSEVPVAS
//
ID   PAOX_MOUSE              Reviewed;         504 AA.
AC   Q8C0L6; Q8K254;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-JUN-2021, entry version 140.
DE   RecName: Full=Peroxisomal N(1)-acetyl-spermine/spermidine oxidase;
DE            EC=1.5.3.13 {ECO:0000269|PubMed:12660232, ECO:0000269|PubMed:28029774};
DE   AltName: Full=Polyamine oxidase;
GN   Name=Paox; Synonyms=Pao;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   PATHWAY, TISSUE SPECIFICITY, COFACTOR, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=12660232; DOI=10.1074/jbc.m302149200;
RA   Wu T., Yankovskaya V., McIntire W.S.;
RT   "Cloning, sequencing, and heterologous expression of the murine peroxisomal
RT   flavoprotein, N(1)-acetylated polyamine oxidase.";
RL   J. Biol. Chem. 278:20514-20525(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Head;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=FVB/N; TISSUE=Colon, and Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Kidney, Lung, Pancreas, Spleen, and
RC   Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [5] {ECO:0007744|PDB:5LAE, ECO:0007744|PDB:5LFO, ECO:0007744|PDB:5LGB, ECO:0007744|PDB:5MBX}
RP   X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) OF 4-504 IN COMPLEXES WITH FAD;
RP   N(1)-ACETYLSPERMINE AND SYNTHETIC INHIBITOR, FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, MUTAGENESIS OF ASN-313, AND PATHWAY.
RX   PubMed=28029774; DOI=10.1021/acs.biochem.6b01140;
RA   Sjogren T., Wassvik C.M., Snijder A., Aagaard A., Kumanomidou T.,
RA   Barlind L., Kaminski T.P., Kashima A., Yokota T., Fjellstrom O.;
RT   "The Structure of Murine N1-Acetylspermine Oxidase Reveals Molecular
RT   Details of Vertebrate Polyamine Catabolism.";
RL   Biochemistry 56:458-467(2017).
CC   -!- FUNCTION: Flavoenzyme which catalyzes the oxidation of N(1)-
CC       acetylspermine to spermidine and is thus involved in the polyamine
CC       back-conversion (PubMed:12660232, PubMed:28029774). Can also oxidize
CC       N(1)-acetylspermidine to putrescine. Substrate specificity: N(1)-
CC       acetylspermine = N(1)-acetylspermidine > N(1),N(12)-diacylspermine >>
CC       spermine. Does not oxidize spermidine. Plays an important role in the
CC       regulation of polyamine intracellular concentration and has the
CC       potential to act as a determinant of cellular sensitivity to the
CC       antitumor polyamine analogs (PubMed:12660232).
CC       {ECO:0000269|PubMed:12660232, ECO:0000269|PubMed:28029774}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N(1)-acetylspermine + O2 = 3-acetamidopropanal + H2O2 +
CC         spermidine; Xref=Rhea:RHEA:25800, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:30322,
CC         ChEBI:CHEBI:57834, ChEBI:CHEBI:58101; EC=1.5.3.13;
CC         Evidence={ECO:0000269|PubMed:12660232, ECO:0000269|PubMed:28029774};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N(1)-acetylspermidine + O2 = 3-acetamidopropanal + H2O2
CC         + putrescine; Xref=Rhea:RHEA:25812, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:30322,
CC         ChEBI:CHEBI:58324, ChEBI:CHEBI:326268; EC=1.5.3.13;
CC         Evidence={ECO:0000269|PubMed:12660232};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N(1),N(12)-diacetylspermine + O2 = 3-acetamidopropanal +
CC         H2O2 + N(1)-acetylspermidine; Xref=Rhea:RHEA:25868,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:30322, ChEBI:CHEBI:58324, ChEBI:CHEBI:58550; EC=1.5.3.13;
CC         Evidence={ECO:0000269|PubMed:12660232};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:12660232, ECO:0000269|PubMed:28029774};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:12660232,
CC       ECO:0000269|PubMed:28029774};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.78 uM for N(1)-acetylspermine {ECO:0000269|PubMed:12660232};
CC         KM=36.8 uM for N(1)-acetylspermidine {ECO:0000269|PubMed:12660232};
CC         KM=716 uM for spermine {ECO:0000269|PubMed:12660232};
CC         KM=150 uM for N(1),N(12)-diacetylspermine
CC         {ECO:0000269|PubMed:12660232};
CC   -!- PATHWAY: Amine and polyamine metabolism; spermine metabolism.
CC       {ECO:0000269|PubMed:12660232, ECO:0000269|PubMed:28029774}.
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Peroxisome {ECO:0000250}. Cytoplasm
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8C0L6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8C0L6-2; Sequence=VSP_011263, VSP_011264;
CC   -!- TISSUE SPECIFICITY: Widely expressed at different developmental stages.
CC       Expressed at high level in the liver and the stomach, expressed at
CC       lower level in heart, spleen, thymus, small intestine, muscle,
CC       pancreas, uterus, and breast and expressed at very low level in brain,
CC       kidney, lung, testis, skin, adrenal gland and prostate gland.
CC       {ECO:0000269|PubMed:12660232}.
CC   -!- DEVELOPMENTAL STAGE: Expression increased during embryonic development:
CC       there is a gradual increase in the tissues on going from 8.5 to 19 day
CC       embryos. In the breast, expression is very low in virgin mouse and
CC       quite high in pregnant mouse, but decreases in lactating and involuting
CC       breasts.
CC   -!- INDUCTION: By polyamine analogs.
CC   -!- MISCELLANEOUS: Oxidizes N(1)-acetylated polyamines on the exo-side of
CC       their N(4)-amino groups. Plant PAO oxidizes spermine on the endo-side
CC       of the N(4)-nitrogen (By similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: N-ethylated polyamines are also good substrates for this
CC       enzyme: they have been used for cancer clinical trials. They down-
CC       regulate polyamine biosynthetic enzymes, but dramatically up-regulate
CC       SSAT synthesis, which results in mammalian cells becoming apoptotic.
CC   -!- SIMILARITY: Belongs to the flavin monoamine oxidase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF226656; AAN40705.2; -; mRNA.
DR   EMBL; AK030664; BAC27070.1; -; mRNA.
DR   EMBL; BC033913; AAH33913.1; -; mRNA.
DR   EMBL; BC082783; AAH82783.1; -; mRNA.
DR   CCDS; CCDS21965.1; -. [Q8C0L6-1]
DR   RefSeq; NP_722478.2; NM_153783.4. [Q8C0L6-1]
DR   PDB; 5LAE; X-ray; 1.85 A; A=4-450, A=458-504.
DR   PDB; 5LFO; X-ray; 1.66 A; A=4-450, A=458-504.
DR   PDB; 5LGB; X-ray; 1.80 A; A=4-450, A=458-504.
DR   PDB; 5MBX; X-ray; 1.40 A; A=4-504.
DR   PDBsum; 5LAE; -.
DR   PDBsum; 5LFO; -.
DR   PDBsum; 5LGB; -.
DR   PDBsum; 5MBX; -.
DR   SMR; Q8C0L6; -.
DR   STRING; 10090.ENSMUSP00000026537; -.
DR   BindingDB; Q8C0L6; -.
DR   ChEMBL; CHEMBL3408; -.
DR   iPTMnet; Q8C0L6; -.
DR   PhosphoSitePlus; Q8C0L6; -.
DR   EPD; Q8C0L6; -.
DR   PaxDb; Q8C0L6; -.
DR   PeptideAtlas; Q8C0L6; -.
DR   PRIDE; Q8C0L6; -.
DR   ProteomicsDB; 288053; -. [Q8C0L6-1]
DR   ProteomicsDB; 288054; -. [Q8C0L6-2]
DR   DNASU; 212503; -.
DR   Ensembl; ENSMUST00000026537; ENSMUSP00000026537; ENSMUSG00000025464. [Q8C0L6-1]
DR   GeneID; 212503; -.
DR   KEGG; mmu:212503; -.
DR   UCSC; uc009kha.1; mouse. [Q8C0L6-2]
DR   UCSC; uc009khb.1; mouse. [Q8C0L6-1]
DR   CTD; 196743; -.
DR   MGI; MGI:1916983; Paox.
DR   eggNOG; KOG0685; Eukaryota.
DR   GeneTree; ENSGT00940000158274; -.
DR   HOGENOM; CLU_004498_2_3_1; -.
DR   InParanoid; Q8C0L6; -.
DR   OMA; ELGAHWI; -.
DR   OrthoDB; 508351at2759; -.
DR   PhylomeDB; Q8C0L6; -.
DR   TreeFam; TF318348; -.
DR   BioCyc; MetaCyc:MONOMER-14466; -.
DR   BRENDA; 1.5.3.13; 3474.
DR   Reactome; R-MMU-141334; PAOs oxidise polyamines to amines.
DR   Reactome; R-MMU-351200; Interconversion of polyamines.
DR   Reactome; R-MMU-9033241; Peroxisomal protein import.
DR   UniPathway; UPA00826; -.
DR   BioGRID-ORCS; 212503; 1 hit in 53 CRISPR screens.
DR   ChiTaRS; Paox; mouse.
DR   PRO; PR:Q8C0L6; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   RNAct; Q8C0L6; protein.
DR   Bgee; ENSMUSG00000025464; Expressed in liver and 82 other tissues.
DR   Genevisible; Q8C0L6; MM.
DR   GO; GO:0005782; C:peroxisomal matrix; ISO:MGI.
DR   GO; GO:0052899; F:N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; IEA:UniProtKB-EC.
DR   GO; GO:0052904; F:N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; IEA:UniProtKB-EC.
DR   GO; GO:0052903; F:N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; IEA:UniProtKB-EC.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0046592; F:polyamine oxidase activity; IDA:MGI.
DR   GO; GO:0052902; F:spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity; IEA:UniProtKB-EC.
DR   GO; GO:0052901; F:spermine:oxygen oxidoreductase (spermidine-forming) activity; IEA:UniProtKB-EC.
DR   GO; GO:0006598; P:polyamine catabolic process; IDA:MGI.
DR   GO; GO:1901307; P:positive regulation of spermidine biosynthetic process; ISO:MGI.
DR   GO; GO:0009446; P:putrescine biosynthetic process; ISO:MGI.
DR   GO; GO:0009447; P:putrescine catabolic process; ISO:MGI.
DR   GO; GO:0046203; P:spermidine catabolic process; ISO:MGI.
DR   GO; GO:0046208; P:spermine catabolic process; ISO:MGI.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; FAD; Flavoprotein;
KW   Oxidoreductase; Peroxisome; Reference proteome.
FT   CHAIN           1..504
FT                   /note="Peroxisomal N(1)-acetyl-spermine/spermidine oxidase"
FT                   /id="PRO_0000099876"
FT   NP_BIND         61..62
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28029774,
FT                   ECO:0007744|PDB:5LAE, ECO:0007744|PDB:5LFO,
FT                   ECO:0007744|PDB:5MBX"
FT   NP_BIND         474..475
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28029774,
FT                   ECO:0007744|PDB:5LAE, ECO:0007744|PDB:5LFO,
FT                   ECO:0007744|PDB:5MBX"
FT   MOTIF           502..504
FT                   /note="Microbody targeting signal"
FT                   /evidence="ECO:0000255"
FT   BINDING         16
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:28029774,
FT                   ECO:0007744|PDB:5LAE, ECO:0007744|PDB:5LFO,
FT                   ECO:0007744|PDB:5MBX"
FT   BINDING         37
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28029774,
FT                   ECO:0007744|PDB:5LAE, ECO:0007744|PDB:5LFO,
FT                   ECO:0007744|PDB:5MBX"
FT   BINDING         45
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28029774,
FT                   ECO:0007744|PDB:5LAE, ECO:0007744|PDB:5LFO,
FT                   ECO:0007744|PDB:5MBX"
FT   BINDING         64
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:28029774,
FT                   ECO:0007744|PDB:5MBX"
FT   BINDING         187
FT                   /note="Substrate; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28029774,
FT                   ECO:0007744|PDB:5LFO, ECO:0007744|PDB:5MBX"
FT   BINDING         240
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28029774,
FT                   ECO:0007744|PDB:5LAE, ECO:0007744|PDB:5LFO,
FT                   ECO:0007744|PDB:5MBX"
FT   BINDING         313
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:28029774,
FT                   ECO:0007744|PDB:5LFO, ECO:0007744|PDB:5MBX"
FT   BINDING         465
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:28029774,
FT                   ECO:0007744|PDB:5LAE, ECO:0007744|PDB:5LFO,
FT                   ECO:0007744|PDB:5MBX"
FT   VAR_SEQ         1..280
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011263"
FT   VAR_SEQ         281..282
FT                   /note="PL -> ME (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011264"
FT   MUTAGEN         313
FT                   /note="N->A,D,L,T: Decreased enzyme activity with N(1)-
FT                   acetylspermine."
FT                   /evidence="ECO:0000269|PubMed:28029774"
FT   STRAND          7..11
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           15..25
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          27..29
FT                   /evidence="ECO:0007829|PDB:5LAE"
FT   STRAND          32..36
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          38..43
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          48..51
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          54..59
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          63..65
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           71..78
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           84..87
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           89..93
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          105..108
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:5LFO"
FT   HELIX           116..132
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           133..136
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          143..146
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           147..159
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           170..188
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           193..195
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   TURN            198..200
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           201..203
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           219..228
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          234..237
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          240..244
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          252..255
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          258..265
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          270..278
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           282..292
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          293..295
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           299..307
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          308..311
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          313..322
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          331..335
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   TURN            341..343
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           353..356
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          359..362
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          370..378
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           379..386
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           389..403
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          413..417
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   TURN            420..422
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   TURN            424..426
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          427..432
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           439..446
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   STRAND          459..462
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           465..467
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   TURN            469..473
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           475..495
FT                   /evidence="ECO:0007829|PDB:5MBX"
FT   HELIX           496..500
FT                   /evidence="ECO:0007829|PDB:5MBX"
SQ   SEQUENCE   504 AA;  55447 MW;  B40BD34C7A0B98F1 CRC64;
     MAFPGPRVLV VGSGIAGLGA AQKLCSHRAA PHLRVLEATA SAGGRIRSER CFGGVVELGA
     HWIHGPSQDN PVFQLAAEFG LLGEKELSEE NQLVDTGGHV ALPSMIWSSS GTSVSLELMT
     EMARLFYGLI ERTREFLNES ETPMASVGEF LKKEISQQVA SWTEDDEDTR KRKLAILNTF
     FNIECCVSGT HSMDLVALAP FGEYTVLPGL DCILAGGYQG LTDRILASLP KDTVAFDKPV
     KTIHWNGSFQ EAAFPGETFP VLVECEDGAR LPAHHVIVTV PLGFLKEHQD TFFEPPLPAK
     KAEAIKKLGF GTNNKIFLEF EEPFWEPDCQ FIQVVWEDTS PLQDTALSLQ DTWFKKLIGF
     LVQPSFESSH VLCGFIAGLE SEFMETLSDE EVLLSLTQVL RRVTGNPQLP AAKSVRRSQW
     HSAPYTRGSY SYVAVGSTGD DLDLMAQPLP EDGTGTQLQV LFAGEATHRT FYSTTHGALL
     SGWREADRLV SLWDSQVEQS RPRL
//
ID   SQRD_AQUAE              Reviewed;         430 AA.
AC   O67931;
DT   29-OCT-2014, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   02-JUN-2021, entry version 126.
DE   RecName: Full=Sulfide-quinone reductase;
DE            Short=SQR;
DE            EC=1.8.5.4 {ECO:0000303|PubMed:10816041, ECO:0000303|PubMed:19487671};
DE   AltName: Full=Sulfide:quinone oxidoreductase {ECO:0000303|PubMed:10816041, ECO:0000303|PubMed:19487671};
GN   Name=sqr {ECO:0000312|EMBL:AAC07903.1};
GN   OrderedLocusNames=aq_2186 {ECO:0000312|EMBL:AAC07903.1};
OS   Aquifex aeolicus (strain VF5).
OC   Bacteria; Aquificae; Aquificales; Aquificaceae; Aquifex.
OX   NCBI_TaxID=224324;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=VF5;
RX   PubMed=9537320; DOI=10.1038/32831;
RA   Deckert G., Warren P.V., Gaasterland T., Young W.G., Lenox A.L.,
RA   Graham D.E., Overbeek R., Snead M.A., Keller M., Aujay M., Huber R.,
RA   Feldman R.A., Short J.M., Olsen G.J., Swanson R.V.;
RT   "The complete genome of the hyperthermophilic bacterium Aquifex aeolicus.";
RL   Nature 392:353-358(1998).
RN   [2]
RP   SUBCELLULAR LOCATION, IDENTIFICATION, FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=10816041; DOI=10.1007/s002030000135;
RA   Nuebel T., Klughammer C., Huber R., Hauska G., Schuetz M.;
RT   "Sulfide:quinone oxidoreductase in membranes of the hyperthermophilic
RT   bacterium Aquifex aeolicus (VF5).";
RL   Arch. Microbiol. 173:233-244(2000).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH FAD AND UBIQUINONE
RP   ANALOG, FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE, COFACTOR, SUBUNIT,
RP   SUBCELLULAR LOCATION, AND DISULFIDE BOND.
RX   PubMed=19487671; DOI=10.1073/pnas.0904165106;
RA   Marcia M., Ermler U., Peng G., Michel H.;
RT   "The structure of Aquifex aeolicus sulfide:quinone oxidoreductase, a basis
RT   to understand sulfide detoxification and respiration.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:9625-9630(2009).
CC   -!- FUNCTION: Catalyzes the oxidation of hydrogen sulfide, with the help of
CC       a quinone. Consecutive reaction cycles lead to the accumulation of a
CC       polysulfide product on the active site Cys residues; these products are
CC       released when they exceed a critical length, typically as
CC       cyclooctasulfur. {ECO:0000303|PubMed:10816041,
CC       ECO:0000303|PubMed:19487671}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=n a quinone + n H(+) + n hydrogen sulfide = n a quinol + n
CC         sulfur; Xref=Rhea:RHEA:30239, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:26833, ChEBI:CHEBI:29919, ChEBI:CHEBI:132124; EC=1.8.5.4;
CC         Evidence={ECO:0000303|PubMed:10816041, ECO:0000303|PubMed:19487671};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:19487671};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:19487671};
CC   -!- SUBUNIT: Homotrimer. {ECO:0000269|PubMed:19487671}.
CC   -!- INTERACTION:
CC       O67931; O67931: sqr; NbExp=2; IntAct=EBI-15785206, EBI-15785206;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:10816041,
CC       ECO:0000269|PubMed:19487671}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:10816041, ECO:0000269|PubMed:19487671}.
CC   -!- SIMILARITY: Belongs to the SQRD family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE000657; AAC07903.1; -; Genomic_DNA.
DR   PIR; G70487; G70487.
DR   RefSeq; NP_214500.1; NC_000918.1.
DR   RefSeq; WP_010881436.1; NC_000918.1.
DR   PDB; 3HYV; X-ray; 2.30 A; A/B/C/D/E/F=1-430.
DR   PDB; 3HYW; X-ray; 2.00 A; A/B/C/D/E/F=1-430.
DR   PDB; 3HYX; X-ray; 2.90 A; A/B/C/D/E/F=1-430.
DR   PDBsum; 3HYV; -.
DR   PDBsum; 3HYW; -.
DR   PDBsum; 3HYX; -.
DR   SMR; O67931; -.
DR   DIP; DIP-48896N; -.
DR   STRING; 224324.aq_2186; -.
DR   DrugBank; DB07640; 2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione.
DR   EnsemblBacteria; AAC07903; AAC07903; aq_2186.
DR   KEGG; aae:aq_2186; -.
DR   eggNOG; COG0446; Bacteria.
DR   HOGENOM; CLU_030742_5_2_0; -.
DR   InParanoid; O67931; -.
DR   OMA; TGFMIES; -.
DR   OrthoDB; 403436at2; -.
DR   BioCyc; AAEO224324:G1G15-1562-MONOMER; -.
DR   BRENDA; 1.8.5.4; 396.
DR   EvolutionaryTrace; O67931; -.
DR   Proteomes; UP000000798; Chromosome.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; IBA:GO_Central.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0048038; F:quinone binding; IEA:UniProtKB-KW.
DR   GO; GO:0070224; F:sulfide:quinone oxidoreductase activity; IEA:RHEA.
DR   GO; GO:0019646; P:aerobic electron transport chain; IBA:GO_Central.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF51905; SSF51905; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; FAD; Flavoprotein; Membrane;
KW   Nucleotide-binding; Oxidoreductase; Quinone; Reference proteome.
FT   CHAIN           1..430
FT                   /note="Sulfide-quinone reductase"
FT                   /id="PRO_0000430824"
FT   NP_BIND         9..13
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19487671"
FT   NP_BIND         34..36
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19487671"
FT   NP_BIND         42..43
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19487671"
FT   ACT_SITE        156
FT                   /note="Cysteine persulfide intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:Q7ZAG8,
FT                   ECO:0000303|PubMed:19487671"
FT   ACT_SITE        347
FT                   /note="Cysteine persulfide intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:Q7ZAG8,
FT                   ECO:0000303|PubMed:19487671"
FT   BINDING         105
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:19487671"
FT   BINDING         294
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:19487671"
FT   BINDING         314
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:19487671"
FT   BINDING         346
FT                   /note="Quinone; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:19487671"
FT   BINDING         382
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19487671"
FT   DISULFID        280..422
FT                   /evidence="ECO:0000269|PubMed:19487671"
FT   DISULFID        419..430
FT                   /evidence="ECO:0000269|PubMed:19487671"
FT   STRAND          4..8
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   HELIX           12..24
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          29..33
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          35..40
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   HELIX           42..44
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   HELIX           45..49
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   HELIX           55..57
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          58..62
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   TURN            63..65
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   HELIX           66..69
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          71..74
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          78..82
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   TURN            83..86
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          87..90
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          95..97
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          99..103
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          108..110
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   HELIX           116..119
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   HELIX           126..141
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          146..150
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   HELIX           158..173
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   HELIX           177..179
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          182..185
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          187..190
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   TURN            194..197
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   HELIX           202..212
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          216..218
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          222..226
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          228..234
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          240..244
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          246..251
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          253..255
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   HELIX           258..261
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   TURN            265..267
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   TURN            270..272
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          284..286
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          289..291
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   HELIX           314..332
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          339..341
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          345..350
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          352..366
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          368..375
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   HELIX           377..395
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   HELIX           401..411
FT                   /evidence="ECO:0007829|PDB:3HYW"
FT   STRAND          415..418
FT                   /evidence="ECO:0007829|PDB:3HYW"
SQ   SEQUENCE   430 AA;  47449 MW;  7489B07FADEAA9A8 CRC64;
     MAKHVVVIGG GVGGIATAYN LRNLMPDLKI TLISDRPYFG FTPAFPHLAM GWRKFEDISV
     PLAPLLPKFN IEFINEKAES IDPDANTVTT QSGKKIEYDY LVIATGPKLV FGAEGQEENS
     TSICTAEHAL ETQKKLQELY ANPGPVVIGA IPGVSCFGPA YEFALMLHYE LKKRGIRYKV
     PMTFITSEPY LGHFGVGGIG ASKRLVEDLF AERNIDWIAN VAVKAIEPDK VIYEDLNGNT
     HEVPAKFTMF MPSFQGPEVV ASAGDKVANP ANKMVIVNRC FQNPTYKNIF GVGVVTAIPP
     IEKTPIPTGV PKTGMMIEQM AMAVAHNIVN DIRNNPDKYA PRLSAICIAD FGEDAGFFFA
     DPVIPPRERV ITKMGKWAHY FKTAFEKYFL WKVRNGNIAP SFEEKVLEIF LKVHPIELCK
     DCEGAPGSRC
//
ID   REBH_LENAE              Reviewed;         530 AA.
AC   Q8KHZ8;
DT   29-MAY-2013, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   02-JUN-2021, entry version 76.
DE   RecName: Full=Flavin-dependent tryptophan halogenase RebH;
DE            EC=1.14.19.9;
GN   Name=rebH; Synonyms=rbmJ;
OS   Lentzea aerocolonigenes (Lechevalieria aerocolonigenes) (Saccharothrix
OS   aerocolonigenes).
OC   Bacteria; Actinobacteria; Pseudonocardiales; Pseudonocardiaceae; Lentzea.
OX   NCBI_TaxID=68170;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RC   STRAIN=ATCC 39243 / DSM 44217 / BCRC 13729 / KCTC 9384;
RX   PubMed=11983340; DOI=10.1016/s1074-5521(02)00126-6;
RA   Sanchez C., Butovich I.A., Brana A.F., Rohr J., Mendez C., Salas J.A.;
RT   "The biosynthetic gene cluster for the antitumor rebeccamycin:
RT   characterization and generation of indolocarbazole derivatives.";
RL   Chem. Biol. 9:519-531(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12617516; DOI=10.7164/antibiotics.55.1063;
RA   Onaka H., Taniguchi S., Igarashi Y., Furumai T.;
RT   "Cloning of the staurosporine biosynthetic gene cluster from Streptomyces
RT   sp. TP-A0274 and its heterologous expression in Streptomyces lividans.";
RL   J. Antibiot. 55:1063-1071(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Hyun C.-G., Bililign T., Liao J., Thorson J.S.;
RT   "The Biosynthesis of Indolocarbazoles in a Heterologous E. coli Host.";
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12619684; DOI=10.1271/bbb.67.127;
RA   Onaka H., Taniguchi S., Igarashi Y., Furumai T.;
RT   "Characterization of the biosynthetic gene cluster of rebeccamycin from
RT   Lechevalieria aerocolonigenes ATCC 39243.";
RL   Biosci. Biotechnol. Biochem. 67:127-138(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=14763561; DOI=10.7164/antibiotics.56.950;
RA   Onaka H., Taniguchi S., Ikeda H., Igarashi Y., Furumai T.;
RT   "pTOYAMAcos, pTYM18, and pTYM19, actinomycete-Escherichia coli integrating
RT   vectors for heterologous gene expression.";
RL   J. Antibiot. 56:950-956(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=15743957; DOI=10.1128/jb.187.6.2084-2092.2005;
RA   Nishizawa T., Aldrich C.C., Sherman D.H.;
RT   "Molecular analysis of the rebeccamycin L-amino acid oxidase from
RT   Lechevalieria aerocolonigenes ATCC 39243.";
RL   J. Bacteriol. 187:2084-2092(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Onaka H.;
RT   "Biosynthesis of heterocyclic antibiotics in actinomycetes and an approach
RT   to synthesize the natural compounds.";
RL   Nihon Hosenkin Gakkaishi 20:62-71(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Asamizu S., Kato Y., Igarashi Y., Furumai T., Onaka H.;
RT   "Direct formation of chromopyrrolic acid from indole-3-pyruvic acid by
RT   StaD, a novel hemoprotein in indolocarbazole biosynthesis.";
RL   Tetrahedron Lett. 47:473-475(2006).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=15743914; DOI=10.1073/pnas.0500755102;
RA   Yeh E., Garneau S., Walsh C.T.;
RT   "Robust in vitro activity of RebF and RebH, a two-component
RT   reductase/halogenase, generating 7-chlorotryptophan during rebeccamycin
RT   biosynthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:3960-3965(2005).
RN   [10]
RP   REACTION MECHANISM.
RX   PubMed=16784243; DOI=10.1021/bi060607d;
RA   Yeh E., Cole L.J., Barr E.W., Bollinger J.M. Jr., Ballou D.P., Walsh C.T.;
RT   "Flavin redox chemistry precedes substrate chlorination during the reaction
RT   of the flavin-dependent halogenase RebH.";
RL   Biochemistry 45:7904-7912(2006).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.08 ANGSTROMS) IN COMPLEX WITH FAD, CHLORIDE AND
RP   TRYPTOPHAN, FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE, MUTAGENESIS OF
RP   LYS-79, REACTION MECHANISM, AND SUBUNIT.
RX   PubMed=17260957; DOI=10.1021/bi0621213;
RA   Yeh E., Blasiak L.C., Koglin A., Drennan C.L., Walsh C.T.;
RT   "Chlorination by a long-lived intermediate in the mechanism of flavin-
RT   dependent halogenases.";
RL   Biochemistry 46:1284-1292(2007).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) IN COMPLEX WITH FAD, CHLORIDE AND
RP   TRYPTOPHAN, AND SUBUNIT.
RX   PubMed=17876823; DOI=10.1002/prot.21627;
RA   Bitto E., Huang Y., Bingman C.A., Singh S., Thorson J.S., Phillips G.N.;
RT   "The structure of flavin-dependent tryptophan 7-halogenase RebH.";
RL   Proteins 70:289-293(2008).
CC   -!- FUNCTION: Involved in the biosynthesis of the indolocarbazole antitumor
CC       agent rebeccamycin. Catalyzes the chlorination of tryptophan (Trp) at
CC       C7 position to yield 7-chlorotryptophan. The reaction between FADH2,
CC       Cl-, and O2 generates the powerful oxidant HOCl, which is presumed to
CC       carry out the chlorination reaction. The reaction of HOCl with the
CC       active site Lys-79 generates a lysine chloramine, which plays a key
CC       role in directing regiospecific chlorination of substrate in this
CC       important class of biosynthetic enzymes. It is also able to use bromide
CC       ions to generate monobrominated Trp. {ECO:0000269|PubMed:11983340,
CC       ECO:0000269|PubMed:15743914, ECO:0000269|PubMed:17260957}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chloride + FADH2 + L-tryptophan + O2 = 7-chloro-L-tryptophan +
CC         FAD + 2 H2O; Xref=Rhea:RHEA:26494, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:17996, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:57912, ChEBI:CHEBI:58307, ChEBI:CHEBI:58713;
CC         EC=1.14.19.9; Evidence={ECO:0000269|PubMed:15743914,
CC         ECO:0000269|PubMed:17260957};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2 uM for tryptophan (with FAD) {ECO:0000269|PubMed:15743914};
CC         Note=Kcat for tryptophan is 1.4 (min-1).;
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:17260957,
CC       ECO:0000269|PubMed:17876823}.
CC   -!- SIMILARITY: Belongs to the flavin-dependent halogenase family.
CC       Bacterial tryptophan halogenase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF534707; AAN01216.1; -; Genomic_DNA.
DR   EMBL; AB090952; BAC10682.1; -; Genomic_DNA.
DR   EMBL; AB071405; BAC15758.1; -; Genomic_DNA.
DR   EMBL; AJ414559; CAC93722.1; -; Genomic_DNA.
DR   PDB; 2E4G; X-ray; 2.08 A; A/B=1-530.
DR   PDB; 2O9Z; X-ray; 2.49 A; A/B=1-530.
DR   PDB; 2OA1; X-ray; 2.15 A; A/B=1-530.
DR   PDB; 2OAL; X-ray; 2.10 A; A/B=1-530.
DR   PDB; 2OAM; X-ray; 2.30 A; A/B=1-530.
DR   PDB; 4LU6; X-ray; 3.05 A; A/B=1-530.
DR   PDB; 6P00; X-ray; 2.25 A; A/B=1-530.
DR   PDB; 6P2V; X-ray; 2.55 A; A/B=1-530.
DR   PDB; 7JU0; X-ray; 2.60 A; A/B=1-530.
DR   PDBsum; 2E4G; -.
DR   PDBsum; 2O9Z; -.
DR   PDBsum; 2OA1; -.
DR   PDBsum; 2OAL; -.
DR   PDBsum; 2OAM; -.
DR   PDBsum; 4LU6; -.
DR   PDBsum; 6P00; -.
DR   PDBsum; 6P2V; -.
DR   PDBsum; 7JU0; -.
DR   SMR; Q8KHZ8; -.
DR   KEGG; ag:BAC10682; -.
DR   BioCyc; MetaCyc:MONOMER-15085; -.
DR   BRENDA; 1.14.19.9; 4340.
DR   EvolutionaryTrace; Q8KHZ8; -.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR006905; Flavin_halogenase.
DR   InterPro; IPR033856; Trp_halogen.
DR   Pfam; PF04820; Trp_halogenase; 1.
DR   PIRSF; PIRSF011396; Trp_halogenase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Nucleotide-binding; Oxidoreductase.
FT   CHAIN           1..530
FT                   /note="Flavin-dependent tryptophan halogenase RebH"
FT                   /id="PRO_0000422334"
FT   NP_BIND         13..16
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17260957,
FT                   ECO:0000269|PubMed:17876823"
FT   NP_BIND         39..50
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:P95480"
FT   NP_BIND         39..41
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17260957,
FT                   ECO:0000269|PubMed:17876823"
FT   NP_BIND         49..50
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17260957,
FT                   ECO:0000269|PubMed:17876823"
FT   REGION          359..360
FT                   /note="Chloride binding"
FT                   /evidence="ECO:0000250|UniProtKB:P95480"
FT   REGION          454..455
FT                   /note="L-tryptophan binding"
FT   ACT_SITE        79
FT                   /evidence="ECO:0000269|PubMed:17260957"
FT   BINDING         197
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:17260957,
FT                   ECO:0000269|PubMed:17876823"
FT   BINDING         348
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17260957,
FT                   ECO:0000269|PubMed:17876823"
FT   BINDING         357
FT                   /note="L-tryptophan; via carbonyl oxygen"
FT   BINDING         360
FT                   /note="Chloride; via amide nitrogen"
FT   BINDING         361
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:17260957,
FT                   ECO:0000269|PubMed:17876823"
FT   BINDING         461
FT                   /note="L-tryptophan"
FT   BINDING         465
FT                   /note="L-tryptophan; via carbonyl oxygen"
FT   MUTAGEN         79
FT                   /note="K->A: Complete loss of halogenase activity."
FT                   /evidence="ECO:0000269|PubMed:17260957"
FT   MUTAGEN         79
FT                   /note="K->M: Complete loss of halogenase activity."
FT                   /evidence="ECO:0000269|PubMed:17260957"
FT   STRAND          7..11
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           15..27
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   TURN            28..30
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          31..38
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           54..58
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           60..63
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           67..73
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          77..79
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          81..89
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          103..112
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          116..121
FT                   /evidence="ECO:0007829|PDB:4LU6"
FT   HELIX           122..131
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           139..143
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           146..151
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          168..171
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           173..187
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          191..194
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          197..202
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          208..213
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          218..220
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          222..226
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           229..231
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           233..238
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          243..245
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   TURN            247..249
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          254..261
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           264..267
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          271..277
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          279..287
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          289..298
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   TURN            300..302
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           305..315
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   TURN            320..322
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          326..329
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          333..336
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          338..340
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          343..345
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   TURN            348..350
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           360..373
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           382..408
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           416..421
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           428..438
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   STRAND          447..449
FT                   /evidence="ECO:0007829|PDB:2OAL"
FT   HELIX           451..456
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           458..462
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           468..478
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           487..491
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           493..498
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           500..516
FT                   /evidence="ECO:0007829|PDB:2E4G"
FT   HELIX           520..527
FT                   /evidence="ECO:0007829|PDB:2E4G"
SQ   SEQUENCE   530 AA;  60297 MW;  41825423F03151AB CRC64;
     MSGKIDKILI VGGGTAGWMA ASYLGKALQG TADITLLQAP DIPTLGVGEA TIPNLQTAFF
     DFLGIPEDEW MRECNASYKV AIKFINWRTA GEGTSEAREL DGGPDHFYHS FGLLKYHEQI
     PLSHYWFDRS YRGKTVEPFD YACYKEPVIL DANRSPRRLD GSKVTNYAWH FDAHLVADFL
     RRFATEKLGV RHVEDRVEHV QRDANGNIES VRTATGRVFD ADLFVDCSGF RGLLINKAME
     EPFLDMSDHL LNDSAVATQV PHDDDANGVE PFTSAIAMKS GWTWKIPMLG RFGTGYVYSS
     RFATEDEAVR EFCEMWHLDP ETQPLNRIRF RVGRNRRAWV GNCVSIGTSS CFVEPLESTG
     IYFVYAALYQ LVKHFPDKSL NPVLTARFNR EIETMFDDTR DFIQAHFYFS PRTDTPFWRA
     NKELRLADGM QEKIDMYRAG MAINAPASDD AQLYYGNFEE EFRNFWNNSN YYCVLAGLGL
     VPDAPSPRLA HMPQATESVD EVFGAVKDRQ RNLLETLPSL HEFLRQQHGR
//
ID   SDHA_CHICK              Reviewed;         665 AA.
AC   Q9YHT1;
DT   22-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 2.
DT   02-JUN-2021, entry version 121.
DE   RecName: Full=Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial;
DE            EC=1.3.5.1 {ECO:0000305|PubMed:16371358};
DE   AltName: Full=Flavoprotein subunit of complex II;
DE            Short=Fp;
DE   Flags: Precursor;
GN   Name=SDHA;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae;
OC   Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-324.
RX   PubMed=15373743; DOI=10.1111/j.1365-2052.2004.01184.x;
RA   Fitzsimmons C.J., Savolainen P., Amini B., Hjaelm G., Lundeberg J.,
RA   Andersson L.;
RT   "Detection of sequence polymorphisms in red junglefowl and white leghorn
RT   ESTs.";
RL   Anim. Genet. 35:391-396(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 167-665.
RC   TISSUE=Heart;
RA   Weinreich D.M.;
RT   "OXPHOS genes in mammals and the molecular clock.";
RL   Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 45-665 IN COMPLEX WITH FAD,
RP   SUBUNIT, SUBCELLULAR LOCATION, AND COFACTOR.
RX   PubMed=15805592; DOI=10.1107/s0907444905000181;
RA   Huang L.-S., Borders T.M., Shen J.T., Wang C.-J., Berry E.A.;
RT   "Crystallization of mitochondrial respiratory complex II from chicken
RT   heart: a membrane-protein complex diffracting to 2.0 A.";
RL   Acta Crystallogr. D 61:380-387(2005).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.74 ANGSTROMS) OF 45-665 IN COMPLEXES WITH FAD AND
RP   MALONATE, SUBUNIT, SUBCELLULAR LOCATION, AND COFACTOR.
RX   PubMed=16935256; DOI=10.1016/j.bbabio.2006.06.015;
RA   Huang L.-S., Shen J.T., Wang A.C., Berry E.A.;
RT   "Crystallographic studies of the binding of ligands to the dicarboxylate
RT   site of complex II, and the identity of the ligand in the 'oxaloacetate-
RT   inhibited' state.";
RL   Biochim. Biophys. Acta 1757:1073-1083(2006).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 45-665 IN COMPLEXES WITH FAD;
RP   OXALOACETATE AND 3-NITROPROPIONIC ACID, COFACTOR, FUNCTION, CATALYTIC
RP   ACTIVITY, PATHWAY, ACTIVE SITE, SUBUNIT, SUBCELLULAR LOCATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16371358; DOI=10.1074/jbc.m511270200;
RA   Huang L.-S., Sun G., Cobessi D., Wang A.C., Shen J.T., Tung E.Y.,
RA   Anderson V.E., Berry E.A.;
RT   "3-nitropropionic acid is a suicide inhibitor of mitochondrial respiration
RT   that, upon oxidation by complex II, forms a covalent adduct with a
RT   catalytic base arginine in the active site of the enzyme.";
RL   J. Biol. Chem. 281:5965-5972(2006).
CC   -!- FUNCTION: Flavoprotein (FP) subunit of succinate dehydrogenase (SDH)
CC       that is involved in complex II of the mitochondrial electron transport
CC       chain and is responsible for transferring electrons from succinate to
CC       ubiquinone (coenzyme Q). {ECO:0000305|PubMed:16371358}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + succinate = a quinol + fumarate;
CC         Xref=Rhea:RHEA:40523, ChEBI:CHEBI:24646, ChEBI:CHEBI:29806,
CC         ChEBI:CHEBI:30031, ChEBI:CHEBI:132124; EC=1.3.5.1;
CC         Evidence={ECO:0000305|PubMed:16371358};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:15805592, ECO:0000269|PubMed:16371358,
CC         ECO:0000269|PubMed:16935256};
CC   -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle; fumarate
CC       from succinate (eukaryal route): step 1/1.
CC       {ECO:0000305|PubMed:16371358}.
CC   -!- SUBUNIT: Component of complex II composed of four subunits: the
CC       flavoprotein (FP) SDHA, iron-sulfur protein (IP) SDHB, and a cytochrome
CC       b560 composed of SDHC and SDHD. {ECO:0000269|PubMed:15805592,
CC       ECO:0000269|PubMed:16371358, ECO:0000269|PubMed:16935256}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:15805592, ECO:0000269|PubMed:16371358,
CC       ECO:0000269|PubMed:16935256}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:15805592, ECO:0000269|PubMed:16371358,
CC       ECO:0000269|PubMed:16935256}; Matrix side {ECO:0000269|PubMed:15805592,
CC       ECO:0000269|PubMed:16371358, ECO:0000269|PubMed:16935256}.
CC   -!- SIMILARITY: Belongs to the FAD-dependent oxidoreductase 2 family.
CC       FRD/SDH subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CO635738; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AF095939; AAC72374.1; -; mRNA.
DR   RefSeq; NP_001264327.1; NM_001277398.1.
DR   PDB; 1YQ3; X-ray; 2.20 A; A=45-665.
DR   PDB; 1YQ4; X-ray; 2.33 A; A=45-665.
DR   PDB; 2FBW; X-ray; 2.10 A; A/N=45-665.
DR   PDB; 2H88; X-ray; 1.74 A; A/N=45-665.
DR   PDB; 2H89; X-ray; 2.40 A; A=45-665.
DR   PDB; 2WQY; X-ray; 2.10 A; A/N=45-665.
DR   PDB; 6MYO; X-ray; 2.20 A; A=45-665.
DR   PDB; 6MYP; X-ray; 2.10 A; A=45-665.
DR   PDB; 6MYQ; X-ray; 1.97 A; A=45-665.
DR   PDB; 6MYR; X-ray; 2.15 A; A=45-665.
DR   PDB; 6MYS; X-ray; 2.37 A; A=45-665.
DR   PDB; 6MYT; X-ray; 2.27 A; A=45-665.
DR   PDB; 6MYU; X-ray; 1.97 A; A=45-665.
DR   PDBsum; 1YQ3; -.
DR   PDBsum; 1YQ4; -.
DR   PDBsum; 2FBW; -.
DR   PDBsum; 2H88; -.
DR   PDBsum; 2H89; -.
DR   PDBsum; 2WQY; -.
DR   PDBsum; 6MYO; -.
DR   PDBsum; 6MYP; -.
DR   PDBsum; 6MYQ; -.
DR   PDBsum; 6MYR; -.
DR   PDBsum; 6MYS; -.
DR   PDBsum; 6MYT; -.
DR   PDBsum; 6MYU; -.
DR   SMR; Q9YHT1; -.
DR   STRING; 9031.ENSGALP00000021475; -.
DR   PaxDb; Q9YHT1; -.
DR   PRIDE; Q9YHT1; -.
DR   GeneID; 395758; -.
DR   KEGG; gga:395758; -.
DR   CTD; 6389; -.
DR   eggNOG; KOG2403; Eukaryota.
DR   InParanoid; Q9YHT1; -.
DR   OrthoDB; 606981at2759; -.
DR   PhylomeDB; Q9YHT1; -.
DR   Reactome; R-GGA-372987; The tricarboxylic acid cycle.
DR   UniPathway; UPA00223; UER01006.
DR   EvolutionaryTrace; Q9YHT1; -.
DR   PRO; PR:Q9YHT1; -.
DR   Proteomes; UP000000539; Unplaced.
DR   GO; GO:0005743; C:mitochondrial inner membrane; ISS:UniProtKB.
DR   GO; GO:0005749; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); IDA:UniProtKB.
DR   GO; GO:0009055; F:electron transfer activity; IBA:GO_Central.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:0008177; F:succinate dehydrogenase (ubiquinone) activity; ISS:UniProtKB.
DR   GO; GO:0000104; F:succinate dehydrogenase activity; IBA:GO_Central.
DR   GO; GO:0006121; P:mitochondrial electron transport, succinate to ubiquinone; IBA:GO_Central.
DR   GO; GO:0022904; P:respiratory electron transport chain; ISS:UniProtKB.
DR   GO; GO:0006105; P:succinate metabolic process; ISS:UniProtKB.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IC:UniProtKB.
DR   Gene3D; 3.50.50.60; -; 1.
DR   Gene3D; 3.90.700.10; -; 1.
DR   InterPro; IPR003953; FAD-binding_2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR003952; FRD_SDH_FAD_BS.
DR   InterPro; IPR037099; Fum_R/Succ_DH_flav-like_C_sf.
DR   InterPro; IPR015939; Fum_Rdtase/Succ_DH_flav-like_C.
DR   InterPro; IPR027477; Succ_DH/fumarate_Rdtase_cat_sf.
DR   InterPro; IPR011281; Succ_DH_flav_su_fwd.
DR   InterPro; IPR014006; Succ_Dhase_FrdA_Gneg.
DR   Pfam; PF00890; FAD_binding_2; 1.
DR   Pfam; PF02910; Succ_DH_flav_C; 1.
DR   SUPFAM; SSF46977; SSF46977; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF56425; SSF56425; 1.
DR   TIGRFAMs; TIGR01816; sdhA_forward; 1.
DR   TIGRFAMs; TIGR01812; sdhA_frdA_Gneg; 1.
DR   PROSITE; PS00504; FRD_SDH_FAD_BINDING; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Electron transport; FAD; Flavoprotein; Membrane;
KW   Mitochondrion; Mitochondrion inner membrane; Oxidoreductase;
KW   Reference proteome; Transit peptide; Transport; Tricarboxylic acid cycle.
FT   TRANSIT         1..44
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:15805592,
FT                   ECO:0000269|PubMed:16371358, ECO:0000269|PubMed:16935256"
FT   CHAIN           45..665
FT                   /note="Succinate dehydrogenase [ubiquinone] flavoprotein
FT                   subunit, mitochondrial"
FT                   /id="PRO_0000344984"
FT   NP_BIND         69..74
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15805592,
FT                   ECO:0000269|PubMed:16371358, ECO:0000269|PubMed:16935256"
FT   NP_BIND         92..107
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15805592,
FT                   ECO:0000269|PubMed:16371358, ECO:0000269|PubMed:16935256"
FT   NP_BIND         457..458
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15805592,
FT                   ECO:0000269|PubMed:16371358, ECO:0000269|PubMed:16935256"
FT   ACT_SITE        341
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000269|PubMed:16371358"
FT   BINDING         276
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15805592,
FT                   ECO:0000269|PubMed:16371358, ECO:0000269|PubMed:16935256"
FT   BINDING         297
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:16371358,
FT                   ECO:0000269|PubMed:16935256"
FT   BINDING         309
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:16371358,
FT                   ECO:0000269|PubMed:16935256"
FT   BINDING         408
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:16371358,
FT                   ECO:0000269|PubMed:16935256"
FT   BINDING         441
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15805592,
FT                   ECO:0000269|PubMed:16371358, ECO:0000269|PubMed:16935256"
FT   BINDING         452
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:16371358,
FT                   ECO:0000269|PubMed:16935256"
FT   MOD_RES         100
FT                   /note="Tele-8alpha-FAD histidine"
FT                   /evidence="ECO:0000269|PubMed:16371358,
FT                   ECO:0000269|PubMed:16935256"
FT   STRAND          58..68
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           72..83
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          88..94
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           96..98
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           100..103
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          114..116
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           120..130
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   TURN            131..133
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           137..156
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          167..169
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          171..179
FT                   /evidence="ECO:0007829|PDB:2WQY"
FT   TURN            180..183
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          186..191
FT                   /evidence="ECO:0007829|PDB:2WQY"
FT   HELIX           197..209
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          215..218
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          220..228
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          231..239
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   TURN            240..242
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          245..255
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           261..263
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          264..269
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           276..283
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          294..301
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   TURN            302..304
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           311..314
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          318..320
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           328..331
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   TURN            333..335
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           336..338
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           341..353
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   TURN            354..356
FT                   /evidence="ECO:0007829|PDB:6MYQ"
FT   TURN            359..362
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          364..368
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           374..380
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           382..392
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   TURN            396..398
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          401..411
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          413..416
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          420..426
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          429..438
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           440..442
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          446..448
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           457..475
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   TURN            487..490
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           491..501
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          504..508
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           509..523
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          524..528
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           530..545
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           546..549
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   HELIX           561..585
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          593..595
FT                   /evidence="ECO:0007829|PDB:6MYQ"
FT   HELIX           619..621
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          625..632
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   TURN            633..636
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   STRAND          637..644
FT                   /evidence="ECO:0007829|PDB:2H88"
FT   TURN            652..654
FT                   /evidence="ECO:0007829|PDB:2H88"
SQ   SEQUENCE   665 AA;  72931 MW;  9476AA19A7A3AE84 CRC64;
     MAAVVAASRS LAKCWLRPAV RAWPAACQTH ARNFHFTVDG KKNASTKVSD SISTQYPVVD
     HEFDAVVVGA GGAGLRAAFG LSEAGFNTAC VTKLFPTRSH TVAAQGGINA ALGNMEDDNW
     RWHFYDTVKG SDWLGDQDAI HYMTEQAPAA VIELENYGMP FSRTEEGKIY QRAFGGQSLQ
     FGKGGQAHRC CCVADRTGHS LLHTLYGRSL RYDTSYFVEY FALDLLMENG ECRGVIALCI
     EDGTIHRFRA KNTVIATGGY GRTYFSCTSA HTSTGDGTAM VTRAGLPCQD LEFVQFHPTG
     IYGAGCLITE GCRGEGGILI NSQGERFMER YAPVAKDLAS RDVVSRSMTI EIREGRGCGP
     EKDHVYLQLH HLPPQQLATR LPGISETAMI FAGVDVTKEP IPVLPTVHYN MGGIPTNYKG
     QVITHVNGED KVVPGLYACG EAASASVHGA NRLGANSLLD LVVFGRACAL TIAETCKPGE
     PVPSIKPNAG EESVANLDKL RFADGTIRTS EARLNMQKTM QSHAAVFRTG SILQEGCEKL
     SQIYCDLAHL KTFDRGIVWN TDLVETLELQ NLMLCALQTI YGAEARKESR GAHAREDYKF
     RIDDFDYSKP LQGQQKRPFE EHWRKHTLSY VDVKSGKVTL KYRPVIDRTL NEEDCSSVPP
     AIRSY
//
ID   SQOR_HUMAN              Reviewed;         450 AA.
AC   Q9Y6N5; Q9UQM8;
DT   13-DEC-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   02-JUN-2021, entry version 170.
DE   RecName: Full=Sulfide:quinone oxidoreductase, mitochondrial {ECO:0000305};
DE            Short=SQOR {ECO:0000312|HGNC:HGNC:20390};
DE            EC=1.8.5.8 {ECO:0000269|PubMed:22852582};
DE   AltName: Full=Sulfide dehydrogenase-like;
DE   AltName: Full=Sulfide quinone oxidoreductase {ECO:0000312|HGNC:HGNC:20390};
DE   Flags: Precursor;
GN   Name=SQOR {ECO:0000312|HGNC:HGNC:20390};
GN   Synonyms=SQRDL {ECO:0000312|HGNC:HGNC:20390}; ORFNames=CGI-44;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=10224084; DOI=10.1074/jbc.274.19.13250;
RA   Vande Weghe J.G., Ow D.W.;
RT   "A fission yeast gene for mitochondrial sulfide oxidation.";
RL   J. Biol. Chem. 274:13250-13257(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-264.
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ACTIVE SITE, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=22852582; DOI=10.1021/bi300778t;
RA   Jackson M.R., Melideo S.L., Jorns M.S.;
RT   "Human sulfide:quinone oxidoreductase catalyzes the first step in hydrogen
RT   sulfide metabolism and produces a sulfane sulfur metabolite.";
RL   Biochemistry 51:6804-6815(2012).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND ENZYME
RP   KINETICS.
RX   PubMed=25225291; DOI=10.1074/jbc.m114.602664;
RA   Libiad M., Yadav P.K., Vitvitsky V., Martinov M., Banerjee R.;
RT   "Organization of the human mitochondrial hydrogen sulfide oxidation
RT   pathway.";
RL   J. Biol. Chem. 289:30901-30910(2014).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, AND ENZYME KINETICS.
RX   PubMed=29715001; DOI=10.1021/acschembio.8b00258;
RA   Landry A.P., Ballou D.P., Banerjee R.;
RT   "Modulation of catalytic promiscuity during hydrogen sulfide oxidation.";
RL   ACS Chem. Biol. 13:1651-1658(2018).
RN   [10] {ECO:0007744|PDB:6MO6, ECO:0007744|PDB:6MP5}
RP   X-RAY CRYSTALLOGRAPHY (2.59 ANGSTROMS) OF 42-450 IN COMPLEX WITH FAD,
RP   COFACTOR, ACTIVE SITE, AND DISULFIDE BOND.
RX   PubMed=30905673; DOI=10.1016/j.str.2019.03.002;
RA   Jackson M.R., Loll P.J., Jorns M.S.;
RT   "X-ray structure of human sulfide:quinone oxidoreductase: insights into the
RT   mechanism of mitochondrial hydrogen sulfide oxidation.";
RL   Structure 27:794-805.e4(2019).
CC   -!- FUNCTION: Catalyzes the oxidation of hydrogen sulfide with the help of
CC       a quinone, such as ubiquinone-10, giving rise to thiosulfate and
CC       ultimately to sulfane (molecular sulfur) atoms. Requires an additional
CC       electron acceptor; can use sulfite, sulfide or cyanide (in vitro)
CC       (PubMed:22852582). It is believed the in vivo electron acceptor is
CC       glutathione (PubMed:25225291,PubMed:29715001).
CC       {ECO:0000269|PubMed:22852582, ECO:0000269|PubMed:25225291,
CC       ECO:0000269|PubMed:29715001}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 H(+) + hydrogen sulfide + sulfite + ubiquinone-10 =
CC         thiosulfate + ubiquinol-10; Xref=Rhea:RHEA:38359, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17359, ChEBI:CHEBI:29919, ChEBI:CHEBI:33542,
CC         ChEBI:CHEBI:46245, ChEBI:CHEBI:64183;
CC         Evidence={ECO:0000269|PubMed:22852582};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38360;
CC         Evidence={ECO:0000269|PubMed:22852582};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + glutathione + H(+) + hydrogen sulfide = a quinol +
CC         S-sulfanylglutathione; Xref=Rhea:RHEA:55156, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:24646, ChEBI:CHEBI:29919, ChEBI:CHEBI:57925,
CC         ChEBI:CHEBI:58905, ChEBI:CHEBI:132124; EC=1.8.5.8;
CC         Evidence={ECO:0000269|PubMed:25225291, ECO:0000269|PubMed:29715001};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:55157;
CC         Evidence={ECO:0000269|PubMed:25225291, ECO:0000269|PubMed:29715001};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glutathione + H(+) + hydrogen sulfide + ubiquinone-10 = S-
CC         sulfanylglutathione + ubiquinol-10; Xref=Rhea:RHEA:62608,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29919, ChEBI:CHEBI:46245,
CC         ChEBI:CHEBI:57925, ChEBI:CHEBI:58905, ChEBI:CHEBI:64183;
CC         Evidence={ECO:0000269|PubMed:29715001};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62609;
CC         Evidence={ECO:0000269|PubMed:29715001};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:22852582, ECO:0000269|PubMed:30905673};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:22852582,
CC       ECO:0000269|PubMed:30905673};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=13 uM for sulfide (with sulfite as electron acceptor)
CC         {ECO:0000269|PubMed:22852582};
CC         KM=10 uM for sulfide (with glutathione as electron acceptor)
CC         {ECO:0000269|PubMed:25225291};
CC         KM=5 uM for sulfide (with cysteine as electron acceptor)
CC         {ECO:0000269|PubMed:25225291};
CC         KM=0.22 mM for sulfite {ECO:0000269|PubMed:25225291};
CC         KM=22 mM for glutathione {ECO:0000269|PubMed:25225291};
CC         KM=23 uM for cysteine {ECO:0000269|PubMed:25225291};
CC         Vmax=476 umol/min/mg enzyme with sulfite as electron acceptor
CC         {ECO:0000269|PubMed:25225291};
CC         Vmax=144 umol/min/mg enzyme with glutathione as electron acceptor
CC         {ECO:0000269|PubMed:25225291};
CC         Vmax=120 umol/min/mg enzyme with cysteine as electron acceptor
CC         {ECO:0000269|PubMed:25225291};
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the SQRD family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF042284; AAD41160.1; -; mRNA.
DR   EMBL; AF151802; AAD34039.1; -; mRNA.
DR   EMBL; BC016836; AAH16836.1; -; mRNA.
DR   CCDS; CCDS10127.1; -.
DR   RefSeq; NP_001258142.1; NM_001271213.1.
DR   RefSeq; NP_067022.1; NM_021199.3.
DR   PDB; 6MO6; X-ray; 2.59 A; A/B/C/D=42-450.
DR   PDB; 6MP5; X-ray; 2.99 A; A/B/C/D=42-450.
DR   PDB; 6OI5; X-ray; 2.81 A; A/B=42-450.
DR   PDB; 6OI6; X-ray; 2.56 A; A/B=42-450.
DR   PDB; 6OIB; X-ray; 2.03 A; A/B=42-450.
DR   PDB; 6OIC; X-ray; 2.21 A; A/B=42-450.
DR   PDBsum; 6MO6; -.
DR   PDBsum; 6MP5; -.
DR   PDBsum; 6OI5; -.
DR   PDBsum; 6OI6; -.
DR   PDBsum; 6OIB; -.
DR   PDBsum; 6OIC; -.
DR   SMR; Q9Y6N5; -.
DR   BioGRID; 121806; 65.
DR   IntAct; Q9Y6N5; 66.
DR   MINT; Q9Y6N5; -.
DR   STRING; 9606.ENSP00000260324; -.
DR   ChEMBL; CHEMBL4523512; -.
DR   iPTMnet; Q9Y6N5; -.
DR   PhosphoSitePlus; Q9Y6N5; -.
DR   SwissPalm; Q9Y6N5; -.
DR   BioMuta; SQOR; -.
DR   DMDM; 27151704; -.
DR   EPD; Q9Y6N5; -.
DR   jPOST; Q9Y6N5; -.
DR   MassIVE; Q9Y6N5; -.
DR   MaxQB; Q9Y6N5; -.
DR   PaxDb; Q9Y6N5; -.
DR   PeptideAtlas; Q9Y6N5; -.
DR   PRIDE; Q9Y6N5; -.
DR   ProteomicsDB; 86742; -.
DR   Antibodypedia; 2131; 129 antibodies.
DR   DNASU; 58472; -.
DR   Ensembl; ENST00000260324; ENSP00000260324; ENSG00000137767.
DR   Ensembl; ENST00000568606; ENSP00000456019; ENSG00000137767.
DR   GeneID; 58472; -.
DR   KEGG; hsa:58472; -.
DR   UCSC; uc001zvv.4; human.
DR   CTD; 58472; -.
DR   DisGeNET; 58472; -.
DR   GeneCards; SQOR; -.
DR   HGNC; HGNC:20390; SQOR.
DR   HPA; ENSG00000137767; Low tissue specificity.
DR   MIM; 617658; gene.
DR   neXtProt; NX_Q9Y6N5; -.
DR   OpenTargets; ENSG00000137767; -.
DR   PharmGKB; PA134894920; -.
DR   VEuPathDB; HostDB:ENSG00000137767.13; -.
DR   eggNOG; KOG3851; Eukaryota.
DR   GeneTree; ENSGT00390000019406; -.
DR   HOGENOM; CLU_030742_2_1_1; -.
DR   InParanoid; Q9Y6N5; -.
DR   OMA; KHYYQPM; -.
DR   OrthoDB; 1267127at2759; -.
DR   PhylomeDB; Q9Y6N5; -.
DR   TreeFam; TF314384; -.
DR   BioCyc; MetaCyc:HS06393-MONOMER; -.
DR   BRENDA; 1.8.5.4; 2681.
DR   BRENDA; 1.8.5.8; 2681.
DR   PathwayCommons; Q9Y6N5; -.
DR   Reactome; R-HSA-1614517; Sulfide oxidation to sulfate.
DR   BioGRID-ORCS; 58472; 5 hits in 989 CRISPR screens.
DR   ChiTaRS; SQRDL; human.
DR   GenomeRNAi; 58472; -.
DR   Pharos; Q9Y6N5; Tbio.
DR   PRO; PR:Q9Y6N5; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q9Y6N5; protein.
DR   Bgee; ENSG00000137767; Expressed in colon and 227 other tissues.
DR   ExpressionAtlas; Q9Y6N5; baseline and differential.
DR   Genevisible; Q9Y6N5; HS.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0071949; F:FAD binding; IBA:GO_Central.
DR   GO; GO:0048038; F:quinone binding; IEA:UniProtKB-KW.
DR   GO; GO:0070224; F:sulfide:quinone oxidoreductase activity; IDA:UniProtKB.
DR   GO; GO:0070813; P:hydrogen sulfide metabolic process; IDA:UniProtKB.
DR   GO; GO:0070221; P:sulfide oxidation, using sulfide:quinone oxidoreductase; IDA:UniProtKB.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR015904; Sulphide_quinone_reductase.
DR   PANTHER; PTHR10632; PTHR10632; 1.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Disulfide bond; FAD; Flavoprotein;
KW   Mitochondrion; Oxidoreductase; Phosphoprotein; Quinone; Reference proteome;
KW   Transit peptide.
FT   TRANSIT         1..?
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           ?..450
FT                   /note="Sulfide:quinone oxidoreductase, mitochondrial"
FT                   /id="PRO_0000022408"
FT   NP_BIND         53..54
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30905673"
FT   NP_BIND         344..347
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30905673"
FT   ACT_SITE        201
FT                   /note="Cysteine persulfide intermediate"
FT                   /evidence="ECO:0000269|PubMed:30905673,
FT                   ECO:0000303|PubMed:22852582"
FT   ACT_SITE        379
FT                   /note="Cysteine persulfide intermediate"
FT                   /evidence="ECO:0000269|PubMed:30905673,
FT                   ECO:0000303|PubMed:22852582"
FT   BINDING         75
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30905673"
FT   BINDING         83
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30905673"
FT   BINDING         118
FT                   /note="FAD; via amide nitrongen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:30905673"
FT   BINDING         336
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30905673"
FT   MOD_RES         173
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R112"
FT   MOD_RES         343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R112"
FT   DISULFID        201..379
FT                   /evidence="ECO:0000269|PubMed:30905673"
FT   VARIANT         264
FT                   /note="I -> T (in dbSNP:rs1044032)"
FT                   /evidence="ECO:0000269|PubMed:10810093"
FT                   /id="VAR_014959"
FT   STRAND          42..49
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           53..66
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           68..70
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          71..74
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          78..81
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           83..85
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           86..89
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   TURN            90..92
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           97..99
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          100..102
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           103..106
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          112..114
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          118..122
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           123..125
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          127..130
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   TURN            131..133
FT                   /evidence="ECO:0007829|PDB:6OI6"
FT   STRAND          135..143
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           151..153
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   TURN            156..158
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           159..162
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          163..167
FT                   /evidence="ECO:0007829|PDB:6OI6"
FT   TURN            172..174
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           175..184
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          187..194
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           204..218
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           222..224
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          225..236
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           240..252
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          256..267
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   TURN            268..271
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          272..277
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          284..288
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          290..293
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          298..300
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           302..305
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          314..316
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   TURN            320..322
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          324..327
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          331..333
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           335..337
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           346..364
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          377..384
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          387..393
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   STRAND          397..399
FT                   /evidence="ECO:0007829|PDB:6OI6"
FT   STRAND          402..405
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           412..419
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           421..428
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   TURN            429..433
FT                   /evidence="ECO:0007829|PDB:6OIB"
FT   HELIX           439..445
FT                   /evidence="ECO:0007829|PDB:6OIB"
SQ   SEQUENCE   450 AA;  49961 MW;  943ABD4049E3634D CRC64;
     MVPLVAVVSG PRAQLFACLL RLGTQQVGPL QLHTGASHAA RNHYEVLVLG GGSGGITMAA
     RMKRKVGAEN VAIVEPSERH FYQPIWTLVG AGAKQLSSSG RPTASVIPSG VEWIKARVTE
     LNPDKNCIHT DDDEKISYRY LIIALGIQLD YEKIKGLPEG FAHPKIGSNY SVKTVEKTWK
     ALQDFKEGNA IFTFPNTPVK CAGAPQKIMY LSEAYFRKTG KRSKANIIFN TSLGAIFGVK
     KYADALQEII QERNLTVNYK KNLIEVRADK QEAVFENLDK PGETQVISYE MLHVTPPMSP
     PDVLKTSPVA DAAGWVDVDK ETLQHRRYPN VFGIGDCTNL PTSKTAAAVA AQSGILDRTI
     SVIMKNQTPT KKYDGYTSCP LVTGYNRVIL AEFDYKAEPL ETFPFDQSKE RLSMYLMKAD
     LMPFLYWNMM LRGYWGGPAF LRKLFHLGMS
//
ID   QSOX1_MOUSE             Reviewed;         748 AA.
AC   Q8BND5; Q3TDY9; Q3TE19; Q3TR29; Q3UEL4; Q8K041; Q9DBL6;
DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   02-JUN-2021, entry version 150.
DE   RecName: Full=Sulfhydryl oxidase 1;
DE            Short=mSOx;
DE            EC=1.8.3.2 {ECO:0000269|PubMed:26819240};
DE   AltName: Full=Quiescin Q6;
DE   AltName: Full=Skin sulfhydryl oxidase;
DE   Flags: Precursor;
GN   Name=Qsox1; Synonyms=Qscn6, Sox;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), SUBCELLULAR LOCATION (ISOFORM 3),
RP   AND TISSUE SPECIFICITY.
RX   PubMed=12354420; DOI=10.1016/s0923-1811(02)00061-0;
RA   Matsuba S., Suga Y., Ishidoh K., Hashimoto Y., Takamori K., Kominami E.,
RA   Wilhelm B., Seitz J., Ogawa H.;
RT   "Sulfhydryl oxidase (SOx) from mouse epidermis: molecular cloning,
RT   nucleotide sequence, and expression of recombinant protein in the cultured
RT   cells.";
RL   J. Dermatol. Sci. 30:50-62(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 3 AND 4).
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Cerebellum, Liver, and Spinal ganglion;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 137-538 (ISOFORM 3).
RC   STRAIN=C57BL/6J, and FVB/N; TISSUE=Eye, and Salivary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas, and
RC   Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [5] {ECO:0007744|PDB:3T58, ECO:0007744|PDB:3T59}
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 36-550 IN COMPLEX WITH FAD,
RP   COFACTOR, AND DISULFIDE BONDS.
RX   PubMed=22801504; DOI=10.1038/nature11267;
RA   Alon A., Grossman I., Gat Y., Kodali V.K., DiMaio F., Mehlman T., Haran G.,
RA   Baker D., Thorpe C., Fass D.;
RT   "The dynamic disulphide relay of quiescin sulphydryl oxidase.";
RL   Nature 488:414-418(2012).
RN   [6] {ECO:0007744|PDB:5D8I, ECO:0007744|PDB:5D93, ECO:0007744|PDB:5D96}
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 36-275, FUNCTION, CATALYTIC
RP   ACTIVITY, SUBCELLULAR LOCATION, AND DISULFIDE BONDS.
RX   PubMed=26819240; DOI=10.1093/protein/gzv067;
RA   Grossman I., Ilani T., Fleishman S.J., Fass D.;
RT   "Overcoming a species-specificity barrier in development of an inhibitory
RT   antibody targeting a modulator of tumor stroma.";
RL   Protein Eng. Des. Sel. 29:135-147(2016).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) OF 36-550 OF MUTANT ALA-75/THR-122,
RP   AND MUTAGENESIS OF HIS-75 AND PRO-122.
RX   PubMed=30367560; DOI=10.1002/pro.3537;
RA   Javitt G., Grossman-Haham I., Alon A., Resnick E., Mutsafi Y., Ilani T.,
RA   Fass D.;
RT   "cis-Proline mutants of quiescin sulfhydryl oxidase 1 with altered redox
RT   properties undermine extracellular matrix integrity and cell adhesion in
RT   fibroblast cultures.";
RL   Protein Sci. 28:228-238(2019).
CC   -!- FUNCTION: Catalyzes the oxidation of sulfhydryl groups in peptide and
CC       protein thiols to disulfides with the reduction of oxygen to hydrogen
CC       peroxide (PubMed:26819240). Plays a role in disulfide bond formation in
CC       a variety of extracellular proteins (PubMed:26819240). In fibroblasts,
CC       required for normal incorporation of laminin into the extracellular
CC       matrix, and thereby for normal cell-cell adhesion and cell migration
CC       (PubMed:26819240). {ECO:0000269|PubMed:26819240}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + 2 R'C(R)SH = H2O2 + R'C(R)S-S(R)CR';
CC         Xref=Rhea:RHEA:17357, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:16520, ChEBI:CHEBI:17412; EC=1.8.3.2;
CC         Evidence={ECO:0000269|PubMed:26819240};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:22801504};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:22801504};
CC   -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:Q6IUU3}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:O00391}; Single-pass membrane protein
CC       {ECO:0000250|UniProtKB:O00391}. Secreted {ECO:0000269|PubMed:26819240}.
CC       Note=A small proportion is secreted, probably via a proteolytic
CC       cleavage that removes the membrane anchor.
CC       {ECO:0000250|UniProtKB:O00391}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Secreted
CC       {ECO:0000269|PubMed:12354420}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8BND5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8BND5-2; Sequence=VSP_020495, VSP_020496;
CC       Name=3;
CC         IsoId=Q8BND5-3; Sequence=VSP_020493, VSP_020494;
CC       Name=4;
CC         IsoId=Q8BND5-4; Sequence=VSP_020491, VSP_020492;
CC   -!- TISSUE SPECIFICITY: Detected in skin (at protein level)
CC       (PubMed:12354420). Expressed in the seminal vesicles and skin.
CC       {ECO:0000269|PubMed:12354420}.
CC   -!- PTM: N-glycosylated. O-glycosylated on Thr and Ser residues.
CC       {ECO:0000250|UniProtKB:O00391}.
CC   -!- SIMILARITY: Belongs to the quiescin-sulfhydryl oxidase (QSOX) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB044284; BAB21936.1; -; mRNA.
DR   EMBL; AK004880; BAB23638.1; -; mRNA.
DR   EMBL; AK083938; BAC39073.1; -; mRNA.
DR   EMBL; AK149465; BAE28897.1; -; mRNA.
DR   EMBL; AK163119; BAE37202.1; -; mRNA.
DR   EMBL; AK166839; BAE39061.1; -; mRNA.
DR   EMBL; AK169877; BAE41429.1; -; mRNA.
DR   EMBL; AK169920; BAE41459.1; -; mRNA.
DR   EMBL; AK170449; BAE41807.1; -; mRNA.
DR   EMBL; BC034131; AAH34131.1; -; mRNA.
DR   EMBL; BC076590; AAH76590.1; -; mRNA.
DR   CCDS; CCDS15386.1; -. [Q8BND5-1]
DR   CCDS; CCDS78713.1; -. [Q8BND5-3]
DR   RefSeq; NP_001020116.1; NM_001024945.1. [Q8BND5-1]
DR   RefSeq; NP_075757.1; NM_023268.2. [Q8BND5-3]
DR   PDB; 3T58; X-ray; 2.40 A; A/B/C/D=36-550.
DR   PDB; 3T59; X-ray; 2.80 A; A/B/C/D=36-550.
DR   PDB; 5D8I; X-ray; 2.05 A; A/B=36-275.
DR   PDB; 5D93; X-ray; 2.20 A; A/D=36-275.
DR   PDB; 5D96; X-ray; 2.30 A; A/D=36-275.
DR   PDB; 6HF1; X-ray; 1.94 A; A/D=37-274.
DR   PDBsum; 3T58; -.
DR   PDBsum; 3T59; -.
DR   PDBsum; 5D8I; -.
DR   PDBsum; 5D93; -.
DR   PDBsum; 5D96; -.
DR   PDBsum; 6HF1; -.
DR   SMR; Q8BND5; -.
DR   BioGRID; 222277; 1.
DR   STRING; 10090.ENSMUSP00000035658; -.
DR   GlyGen; Q8BND5; 2 sites.
DR   iPTMnet; Q8BND5; -.
DR   PhosphoSitePlus; Q8BND5; -.
DR   CPTAC; non-CPTAC-3297; -.
DR   PaxDb; Q8BND5; -.
DR   PeptideAtlas; Q8BND5; -.
DR   PRIDE; Q8BND5; -.
DR   ProteomicsDB; 300336; -. [Q8BND5-1]
DR   ProteomicsDB; 300337; -. [Q8BND5-2]
DR   ProteomicsDB; 300338; -. [Q8BND5-3]
DR   ProteomicsDB; 300339; -. [Q8BND5-4]
DR   ABCD; Q8BND5; 2 sequenced antibodies.
DR   Antibodypedia; 47086; 193 antibodies.
DR   DNASU; 104009; -.
DR   Ensembl; ENSMUST00000035325; ENSMUSP00000035658; ENSMUSG00000033684. [Q8BND5-1]
DR   Ensembl; ENSMUST00000111764; ENSMUSP00000107394; ENSMUSG00000033684. [Q8BND5-2]
DR   Ensembl; ENSMUST00000194632; ENSMUSP00000142301; ENSMUSG00000033684. [Q8BND5-3]
DR   GeneID; 104009; -.
DR   KEGG; mmu:104009; -.
DR   UCSC; uc007dbo.1; mouse. [Q8BND5-3]
DR   UCSC; uc007dbp.1; mouse. [Q8BND5-1]
DR   UCSC; uc007dbq.1; mouse. [Q8BND5-4]
DR   UCSC; uc011wtx.1; mouse. [Q8BND5-2]
DR   CTD; 5768; -.
DR   MGI; MGI:1330818; Qsox1.
DR   eggNOG; KOG1731; Eukaryota.
DR   GeneTree; ENSGT00940000159504; -.
DR   HOGENOM; CLU_020182_1_0_1; -.
DR   InParanoid; Q8BND5; -.
DR   OMA; VTEFPSC; -.
DR   OrthoDB; 498515at2759; -.
DR   PhylomeDB; Q8BND5; -.
DR   TreeFam; TF316749; -.
DR   BRENDA; 1.8.3.2; 3474.
DR   Reactome; R-MMU-114608; Platelet degranulation.
DR   Reactome; R-MMU-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-MMU-6798695; Neutrophil degranulation.
DR   Reactome; R-MMU-8957275; Post-translational protein phosphorylation.
DR   BioGRID-ORCS; 104009; 0 hits in 52 CRISPR screens.
DR   ChiTaRS; Qsox1; mouse.
DR   PRO; PR:Q8BND5; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; Q8BND5; protein.
DR   Bgee; ENSMUSG00000033684; Expressed in seminal vesicle and 269 other tissues.
DR   Genevisible; Q8BND5; MM.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0070062; C:extracellular exosome; ISO:MGI.
DR   GO; GO:0005615; C:extracellular space; HDA:BHF-UCL.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:MGI.
DR   GO; GO:0000139; C:Golgi membrane; ISS:UniProtKB.
DR   GO; GO:0030173; C:integral component of Golgi membrane; ISS:UniProtKB.
DR   GO; GO:0045171; C:intercellular bridge; ISO:MGI.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI.
DR   GO; GO:0071949; F:FAD binding; ISO:MGI.
DR   GO; GO:0016971; F:flavin-linked sulfhydryl oxidase activity; ISS:UniProtKB.
DR   GO; GO:0003756; F:protein disulfide isomerase activity; ISS:UniProtKB.
DR   GO; GO:0085029; P:extracellular matrix assembly; ISO:MGI.
DR   GO; GO:0016242; P:negative regulation of macroautophagy; ISO:MGI.
DR   GO; GO:0006457; P:protein folding; IBA:GO_Central.
DR   Gene3D; 1.20.120.1960; -; 1.
DR   Gene3D; 1.20.120.310; -; 1.
DR   Gene3D; 3.40.30.10; -; 2.
DR   InterPro; IPR036774; ERV/ALR_sulphydryl_oxid_sf.
DR   InterPro; IPR017905; ERV/ALR_sulphydryl_oxidase.
DR   InterPro; IPR040986; QSOX_FAD-bd_dom.
DR   InterPro; IPR042568; QSOX_FAD-bd_sf.
DR   InterPro; IPR041269; QSOX_Trx1.
DR   InterPro; IPR039798; Sulfhydryl_oxidase.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   PANTHER; PTHR22897; PTHR22897; 1.
DR   Pfam; PF04777; Evr1_Alr; 1.
DR   Pfam; PF18371; FAD_SOX; 1.
DR   Pfam; PF18108; QSOX_Trx1; 1.
DR   Pfam; PF00085; Thioredoxin; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   SUPFAM; SSF69000; SSF69000; 1.
DR   PROSITE; PS51324; ERV_ALR; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disulfide bond; FAD; Flavoprotein;
KW   Glycoprotein; Golgi apparatus; Membrane; Oxidoreductase;
KW   Reference proteome; Secreted; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..32
FT                   /evidence="ECO:0000255"
FT   CHAIN           33..748
FT                   /note="Sulfhydryl oxidase 1"
FT                   /id="PRO_0000249534"
FT   TRANSMEM        711..731
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          33..159
FT                   /note="Thioredoxin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00691"
FT   DOMAIN          399..506
FT                   /note="ERV/ALR sulfhydryl oxidase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654"
FT   NP_BIND         481..488
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22801504,
FT                   ECO:0007744|PDB:3T58, ECO:0007744|PDB:3T59"
FT   REGION          581..647
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        73
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        76
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250"
FT   BINDING         404
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22801504,
FT                   ECO:0007744|PDB:3T58, ECO:0007744|PDB:3T59"
FT   BINDING         411
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22801504,
FT                   ECO:0007744|PDB:3T58, ECO:0007744|PDB:3T59"
FT   BINDING         415
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22801504,
FT                   ECO:0007744|PDB:3T58, ECO:0007744|PDB:3T59"
FT   BINDING         454
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:O00391"
FT   BINDING         458
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:O00391"
FT   BINDING         503
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22801504,
FT                   ECO:0007744|PDB:3T58, ECO:0007744|PDB:3T59"
FT   BINDING         506
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22801504,
FT                   ECO:0007744|PDB:3T58, ECO:0007744|PDB:3T59"
FT   CARBOHYD        133
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        246
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        73..76
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000255|PROSITE-ProRule:PRU00691,
FT                   ECO:0000269|PubMed:22801504, ECO:0007744|PDB:5D8I,
FT                   ECO:0007744|PDB:5D93, ECO:0007744|PDB:5D96"
FT   DISULFID        104..113
FT                   /evidence="ECO:0000269|PubMed:22801504,
FT                   ECO:0000269|PubMed:26819240, ECO:0007744|PDB:3T58,
FT                   ECO:0007744|PDB:3T59, ECO:0007744|PDB:5D8I,
FT                   ECO:0007744|PDB:5D93, ECO:0007744|PDB:5D96"
FT   DISULFID        396..408
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000269|PubMed:22801504, ECO:0007744|PDB:3T58,
FT                   ECO:0007744|PDB:3T59"
FT   DISULFID        452..455
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654"
FT   DISULFID        512..515
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000269|PubMed:22801504, ECO:0007744|PDB:3T58,
FT                   ECO:0007744|PDB:3T59"
FT   VAR_SEQ         126..154
FT                   /note="FFQAFTKNGSGATLPGAGANVQTLRMRLI -> VCEGGATVEWFWPSTQSSV
FT                   PHFPGTFLGC (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_020491"
FT   VAR_SEQ         155..748
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_020492"
FT   VAR_SEQ         567..568
FT                   /note="VM -> LL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12354420,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:16141072"
FT                   /id="VSP_020493"
FT   VAR_SEQ         569..748
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12354420,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:16141072"
FT                   /id="VSP_020494"
FT   VAR_SEQ         660..661
FT                   /note="VN -> LL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_020495"
FT   VAR_SEQ         662..748
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_020496"
FT   MUTAGEN         75
FT                   /note="H->A: Causes local perturbations of protein folding;
FT                   when associated with T-122."
FT                   /evidence="ECO:0000269|PubMed:30367560"
FT   MUTAGEN         122
FT                   /note="P->T: Causes local perturbations of protein folding;
FT                   when associated with T-122."
FT                   /evidence="ECO:0000269|PubMed:30367560"
FT   CONFLICT        637
FT                   /note="M -> I (in Ref. 2; BAE41429)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        656
FT                   /note="F -> L (in Ref. 2; BAE41429)"
FT                   /evidence="ECO:0000305"
FT   STRAND          43..48
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   TURN            50..52
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   HELIX           53..57
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   STRAND          61..69
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   HELIX           74..89
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   HELIX           91..93
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   TURN            94..96
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   STRAND          97..103
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   HELIX           107..109
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   HELIX           110..115
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   STRAND          123..127
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   STRAND          133..135
FT                   /evidence="ECO:0007829|PDB:5D8I"
FT   STRAND          137..139
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   HELIX           146..158
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   TURN            160..162
FT                   /evidence="ECO:0007829|PDB:5D8I"
FT   HELIX           176..179
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   HELIX           182..185
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   STRAND          189..196
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   HELIX           202..209
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   TURN            210..212
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   STRAND          216..222
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   HELIX           226..232
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   STRAND          236..244
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   STRAND          249..251
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   HELIX           259..267
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   STRAND          269..271
FT                   /evidence="ECO:0007829|PDB:6HF1"
FT   HELIX           293..296
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   STRAND          301..303
FT                   /evidence="ECO:0007829|PDB:3T59"
FT   HELIX           304..316
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   HELIX           319..321
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   STRAND          323..326
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   HELIX           327..343
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   HELIX           348..363
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   STRAND          367..370
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   HELIX           371..380
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   HELIX           383..386
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   STRAND          403..405
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   HELIX           406..426
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   HELIX           437..449
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   HELIX           453..466
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   HELIX           467..469
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   HELIX           473..491
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   STRAND          505..507
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   TURN            509..511
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   HELIX           513..515
FT                   /evidence="ECO:0007829|PDB:3T59"
FT   HELIX           528..538
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   HELIX           541..543
FT                   /evidence="ECO:0007829|PDB:3T58"
FT   CONFLICT        Q8BND5-4:127
FT                   /note="C -> Y (in Ref. 2; BAE37202)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   748 AA;  82785 MW;  0499F6B8DAB5A8D1 CRC64;
     MRRCGRLSGP PSLLLLLLLL SPLLFSGPGA YAARLSVLYS SSDPLTLLDA DSVRPTVLGS
     SSAWAVEFFA SWCGHCIAFA PTWKELANDV KDWRPALNLA VLDCAEETNS AVCREFNIAG
     FPTVRFFQAF TKNGSGATLP GAGANVQTLR MRLIDALESH RDTWPPACPP LEPAKLNDID
     GFFTRNKADY LALVFEREDS YLGREVTLDL SQYHAVAVRR VLNTESDLVN KFGVTDFPSC
     YLLLRNGSVS RVPVLVESRS FYTSYLRGLP GLTRDAPPTT ATPVTADKIA PTVWKFADRS
     KIYMADLESA LHYILRVEVG KFSVLEGQRL VALKKFVAVL AKYFPGQPLV QNFLHSINDW
     LQKQQKKRIP YSFFKAALDS RKEDAVLTEK VNWVGCQGSE PHFRGFPCSL WVLFHFLTVQ
     ANRYSEAHPQ EPADGQEVLQ AMRSYVQFFF GCRDCADHFE QMAAASMHQV RSPSNAILWL
     WTSHNRVNAR LSGALSEDPH FPKVQWPPRE LCSACHNELN GQVPLWDLGA TLNFLKAHFS
     PANIVIDSSA SRHTGRRGSP EATPELVMDT LKLESRNSVL GHEQAASAES PGATALDVPA
     EKPEASGPQE LYTGLRMGGA SPGQGPPERM EDHQRDMQEN APGQQHLSKR DTEALFLPEV
     NHLQGPLELR RGGRSPKQLA PILEEEPEAL AIQGQGQWLQ VLGGGISHLD ISLCVGLYSV
     SFMGLLAMYT YFRARLRTPK GHASYPTA
//
ID   RURE_PSEAE              Reviewed;         384 AA.
AC   Q9HTK9;
DT   23-MAR-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   02-JUN-2021, entry version 123.
DE   RecName: Full=Rubredoxin-NAD(+) reductase;
DE            Short=RdxR;
DE            EC=1.18.1.1;
GN   Name=alkT; OrderedLocusNames=PA5349;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [2]
RP   FUNCTION IN ALKANE DEGRADATION.
RX   PubMed=14574114; DOI=10.1023/a:1026000622765;
RA   Smits T.H., Witholt B., van Beilen J.B.;
RT   "Functional characterization of genes involved in alkane oxidation by
RT   Pseudomonas aeruginosa.";
RL   Antonie Van Leeuwenhoek 84:193-200(2003).
RN   [3]
RP   FUNCTION, SUBUNIT, AND INDUCTION.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=12730186; DOI=10.1128/jb.185.10.3232-3237.2003;
RA   Marin M.M., Yuste L., Rojo F.;
RT   "Differential expression of the components of the two alkane hydroxylases
RT   from Pseudomonas aeruginosa.";
RL   J. Bacteriol. 185:3232-3237(2003).
RN   [4] {ECO:0007744|PDB:2V3A, ECO:0007744|PDB:2V3B}
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH RUBREDOXIN AND FAD,
RP   AND SUBUNIT.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=17636129; DOI=10.1073/pnas.0702919104;
RA   Hagelueken G., Wiehlmann L., Adams T.M., Kolmar H., Heinz D.W., Tummler B.,
RA   Schubert W.D.;
RT   "Crystal structure of the electron transfer complex rubredoxin rubredoxin
RT   reductase of Pseudomonas aeruginosa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:12276-12281(2007).
CC   -!- FUNCTION: Involved in the hydrocarbon hydroxylating system, which
CC       transfers electrons from NADH to rubredoxin reductase and then through
CC       rubredoxin to alkane 1 monooxygenase. {ECO:0000269|PubMed:12730186,
CC       ECO:0000269|PubMed:14574114}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NAD(+) + 2 reduced [rubredoxin] = NADH + 2 oxidized
CC         [rubredoxin]; Xref=Rhea:RHEA:18597, Rhea:RHEA-COMP:10302, Rhea:RHEA-
CC         COMP:10303, ChEBI:CHEBI:15378, ChEBI:CHEBI:29033, ChEBI:CHEBI:29034,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.18.1.1;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- PATHWAY: Hydrocarbon metabolism; alkane degradation.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:12730186,
CC       ECO:0000269|PubMed:17636129}.
CC   -!- INTERACTION:
CC       Q9HTK9; Q9HTK8: rubA2; NbExp=2; IntAct=EBI-15647858, EBI-15647891;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- INDUCTION: Constitutively expressed. {ECO:0000269|PubMed:12730186}.
CC   -!- SIMILARITY: Belongs to the FAD-dependent oxidoreductase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE004091; AAG08734.1; -; Genomic_DNA.
DR   PIR; G82976; G82976.
DR   RefSeq; NP_254036.1; NC_002516.2.
DR   RefSeq; WP_003114369.1; NZ_QZGE01000020.1.
DR   PDB; 2V3A; X-ray; 2.40 A; A=1-384.
DR   PDB; 2V3B; X-ray; 2.45 A; A=1-384.
DR   PDBsum; 2V3A; -.
DR   PDBsum; 2V3B; -.
DR   SMR; Q9HTK9; -.
DR   IntAct; Q9HTK9; 1.
DR   PaxDb; Q9HTK9; -.
DR   PRIDE; Q9HTK9; -.
DR   DNASU; 879643; -.
DR   EnsemblBacteria; AAG08734; AAG08734; PA5349.
DR   GeneID; 879643; -.
DR   KEGG; pae:PA5349; -.
DR   PATRIC; fig|208964.12.peg.5606; -.
DR   PseudoCAP; PA5349; -.
DR   HOGENOM; CLU_003291_4_4_6; -.
DR   InParanoid; Q9HTK9; -.
DR   OMA; IHHFWTF; -.
DR   PhylomeDB; Q9HTK9; -.
DR   BioCyc; PAER208964:G1FZ6-5471-MONOMER; -.
DR   BRENDA; 1.18.1.1; 5087.
DR   UniPathway; UPA00191; -.
DR   EvolutionaryTrace; Q9HTK9; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0015044; F:rubredoxin-NAD+ reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0015046; F:rubredoxin-NADP+ reductase activity; IDA:UniProtKB.
DR   GO; GO:0043448; P:alkane catabolic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR041364; Rbx-bd.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF18113; Rbx_binding; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; FAD; Flavoprotein; NAD; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN           1..384
FT                   /note="Rubredoxin-NAD(+) reductase"
FT                   /id="PRO_0000392226"
FT   NP_BIND         12..15
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17636129,
FT                   ECO:0007744|PDB:2V3A, ECO:0007744|PDB:2V3B"
FT   NP_BIND         36..37
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17636129,
FT                   ECO:0007744|PDB:2V3A, ECO:0007744|PDB:2V3B"
FT   BINDING         45
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17636129,
FT                   ECO:0007744|PDB:2V3A, ECO:0007744|PDB:2V3B"
FT   BINDING         83
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:17636129,
FT                   ECO:0007744|PDB:2V3A, ECO:0007744|PDB:2V3B"
FT   BINDING         159
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17636129,
FT                   ECO:0007744|PDB:2V3A, ECO:0007744|PDB:2V3B"
FT   BINDING         277
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17636129,
FT                   ECO:0007744|PDB:2V3A, ECO:0007744|PDB:2V3B"
FT   BINDING         289
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:17636129,
FT                   ECO:0007744|PDB:2V3A, ECO:0007744|PDB:2V3B"
FT   BINDING         320
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17636129,
FT                   ECO:0007744|PDB:2V3A, ECO:0007744|PDB:2V3B"
FT   STRAND          7..10
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   HELIX           14..24
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          28..30
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          32..35
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   HELIX           45..50
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   TURN            51..55
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   HELIX           58..61
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          62..64
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   HELIX           66..72
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          76..78
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          85..87
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   HELIX           88..90
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          92..95
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          98..101
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          103..107
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   TURN            121..124
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          126..128
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   HELIX           132..142
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          147..151
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   HELIX           155..166
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          170..181
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   TURN            182..184
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   HELIX           187..198
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   TURN            199..201
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          203..207
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          210..216
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          219..224
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          229..237
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          241..243
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   HELIX           246..250
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          255..261
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          272..274
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   HELIX           276..278
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          279..281
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   HELIX           289..303
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          317..319
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          326..329
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          338..344
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          347..353
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   STRAND          359..365
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   HELIX           366..371
FT                   /evidence="ECO:0007829|PDB:2V3A"
FT   HELIX           372..376
FT                   /evidence="ECO:0007829|PDB:2V3A"
SQ   SEQUENCE   384 AA;  40618 MW;  C98EA1FC3E15FA8F CRC64;
     MSERAPLVII GTGLAGYNLA REWRKLDGET PLLMITADDG RSYSKPMLST GFSKNKDADG
     LAMAEPGAMA EQLNARILTH TRVTGIDPGH QRIWIGEEEV RYRDLVLAWG AEPIRVPVEG
     DAQDALYPIN DLEDYARFRQ AAAGKRRVLL LGAGLIGCEF ANDLSSGGYQ LDVVAPCEQV
     MPGLLHPAAA KAVQAGLEGL GVRFHLGPVL ASLKKAGEGL EAHLSDGEVI PCDLVVSAVG
     LRPRTELAFA AGLAVNRGIV VDRSLRTSHA NIYALGDCAE VDGLNLLYVM PLMACARALA
     QTLAGNPSQV AYGPMPVTVK TPACPLVVSP PPRGMDGQWL VEGSGTDLKV LCRDTAGRVI
     GYALTGAAVN EKLALNKELP GLMA
//
ID   SQRD_ACIF2              Reviewed;         434 AA.
AC   B7JBP8;
DT   29-OCT-2014, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 1.
DT   02-JUN-2021, entry version 72.
DE   RecName: Full=Sulfide-quinone reductase;
DE            Short=SQR;
DE            EC=1.8.5.4 {ECO:0000269|PubMed:20303979, ECO:0000269|PubMed:22542586};
DE   AltName: Full=Sulfide:quinone oxidoreductase;
GN   OrderedLocusNames=AFE_1792 {ECO:0000312|EMBL:ACK80359.1};
OS   Acidithiobacillus ferrooxidans (strain ATCC 23270 / DSM 14882 / CIP 104768
OS   / NCIMB 8455) (Ferrobacillus ferrooxidans (strain ATCC 23270)).
OC   Bacteria; Proteobacteria; Acidithiobacillia; Acidithiobacillales;
OC   Acidithiobacillaceae; Acidithiobacillus.
OX   NCBI_TaxID=243159;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 23270 / DSM 14882 / CIP 104768 / NCIMB 8455;
RX   PubMed=19077236; DOI=10.1186/1471-2164-9-597;
RA   Valdes J., Pedroso I., Quatrini R., Dodson R.J., Tettelin H., Blake R. II,
RA   Eisen J.A., Holmes D.S.;
RT   "Acidithiobacillus ferrooxidans metabolism: from genome sequence to
RT   industrial applications.";
RL   BMC Genomics 9:597-597(2008).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) IN COMPLEX WITH FAD; UBIQUINONE AND
RP   HYDROGEN SULFIDE, FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE, COFACTOR,
RP   SUBCELLULAR LOCATION, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF CYS-128; CYS-160 AND CYS-356.
RX   PubMed=20303979; DOI=10.1016/j.jmb.2010.03.018;
RA   Cherney M.M., Zhang Y., Solomonson M., Weiner J.H., James M.N.;
RT   "Crystal structure of sulfide:quinone oxidoreductase from Acidithiobacillus
RT   ferrooxidans: insights into sulfidotrophic respiration and
RT   detoxification.";
RL   J. Mol. Biol. 398:292-305(2010).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 2-434 IN COMPLEX WITH FAD;
RP   UBIQUINONE AND HYDROGEN SULFIDE, ACTIVE SITE, AND MUTAGENESIS OF SER-126;
RP   CYS-128; HIS-132; CYS-160; HIS-198 AND CYS-356.
RX   PubMed=22542586; DOI=10.1016/j.jsb.2012.04.007;
RA   Cherney M.M., Zhang Y., James M.N., Weiner J.H.;
RT   "Structure-activity characterization of sulfide:quinone oxidoreductase
RT   variants.";
RL   J. Struct. Biol. 178:319-328(2012).
CC   -!- FUNCTION: Catalyzes the oxidation of hydrogen sulfide, with the help of
CC       a quinone. Consecutive reaction cycles lead to the accumulation of a
CC       polysulfide product on the active site Cys residues; these products are
CC       released when they exceed a critical length, typically as
CC       cyclooctasulfur. {ECO:0000269|PubMed:20303979,
CC       ECO:0000269|PubMed:22542586}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=n a quinone + n H(+) + n hydrogen sulfide = n a quinol + n
CC         sulfur; Xref=Rhea:RHEA:30239, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:26833, ChEBI:CHEBI:29919, ChEBI:CHEBI:132124; EC=1.8.5.4;
CC         Evidence={ECO:0000269|PubMed:20303979, ECO:0000269|PubMed:22542586};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:20303979, ECO:0000269|PubMed:22542586};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:20303979,
CC       ECO:0000269|PubMed:22542586};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.8 uM for sodium sulfide {ECO:0000269|PubMed:20303979};
CC         KM=22 uM for decylubiquinone {ECO:0000269|PubMed:20303979};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:20303979}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000303|PubMed:20303979};
CC       Peripheral membrane protein {ECO:0000303|PubMed:20303979}.
CC   -!- SIMILARITY: Belongs to the SQRD family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001219; ACK80359.1; -; Genomic_DNA.
DR   RefSeq; WP_012536761.1; NC_011761.1.
DR   PDB; 3KPK; X-ray; 2.05 A; A=1-434.
DR   PDB; 3SX6; X-ray; 1.80 A; A=2-434.
DR   PDB; 3SXI; X-ray; 2.18 A; A=2-434.
DR   PDB; 3SY4; X-ray; 1.91 A; A=2-434.
DR   PDB; 3SYI; X-ray; 2.20 A; A=2-434.
DR   PDB; 3SZ0; X-ray; 2.15 A; A=2-434.
DR   PDB; 3SZC; X-ray; 2.20 A; A=2-434.
DR   PDB; 3SZF; X-ray; 2.10 A; A=2-434.
DR   PDB; 3SZW; X-ray; 2.20 A; A=2-434.
DR   PDB; 3T0K; X-ray; 2.00 A; A=2-434.
DR   PDB; 3T14; X-ray; 2.21 A; A=2-434.
DR   PDB; 3T2K; X-ray; 2.35 A; A=2-434.
DR   PDB; 3T2Y; X-ray; 2.50 A; A=1-434.
DR   PDB; 3T2Z; X-ray; 2.30 A; A/B=2-434.
DR   PDB; 3T31; X-ray; 2.30 A; A=2-434.
DR   PDBsum; 3KPK; -.
DR   PDBsum; 3SX6; -.
DR   PDBsum; 3SXI; -.
DR   PDBsum; 3SY4; -.
DR   PDBsum; 3SYI; -.
DR   PDBsum; 3SZ0; -.
DR   PDBsum; 3SZC; -.
DR   PDBsum; 3SZF; -.
DR   PDBsum; 3SZW; -.
DR   PDBsum; 3T0K; -.
DR   PDBsum; 3T14; -.
DR   PDBsum; 3T2K; -.
DR   PDBsum; 3T2Y; -.
DR   PDBsum; 3T2Z; -.
DR   PDBsum; 3T31; -.
DR   SMR; B7JBP8; -.
DR   STRING; 243159.AFE_1792; -.
DR   DrugBank; DB07640; 2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione.
DR   PaxDb; B7JBP8; -.
DR   EnsemblBacteria; ACK80359; ACK80359; AFE_1792.
DR   KEGG; afr:AFE_1792; -.
DR   eggNOG; COG0446; Bacteria.
DR   HOGENOM; CLU_030742_5_2_6; -.
DR   OMA; TGFMIES; -.
DR   OrthoDB; 403436at2; -.
DR   BioCyc; AFER243159:G1GU1-1687-MONOMER; -.
DR   BRENDA; 1.8.5.4; 91.
DR   EvolutionaryTrace; B7JBP8; -.
DR   Proteomes; UP000001362; Chromosome.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0048038; F:quinone binding; IEA:UniProtKB-KW.
DR   GO; GO:0070224; F:sulfide:quinone oxidoreductase activity; IEA:RHEA.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF51905; SSF51905; 2.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Membrane; Nucleotide-binding;
KW   Oxidoreductase; Quinone; Reference proteome.
FT   CHAIN           1..434
FT                   /note="Sulfide-quinone reductase"
FT                   /id="PRO_0000430825"
FT   NP_BIND         8..12
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20303979,
FT                   ECO:0000269|PubMed:22542586"
FT   NP_BIND         34..35
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20303979,
FT                   ECO:0000269|PubMed:22542586"
FT   NP_BIND         77..78
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20303979,
FT                   ECO:0000269|PubMed:22542586"
FT   ACT_SITE        160
FT                   /note="Cysteine persulfide intermediate"
FT                   /evidence="ECO:0000269|PubMed:20303979,
FT                   ECO:0000269|PubMed:22542586"
FT   ACT_SITE        356
FT                   /note="Cysteine persulfide intermediate"
FT                   /evidence="ECO:0000269|PubMed:20303979,
FT                   ECO:0000269|PubMed:22542586"
FT   BINDING         302
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:20303979,
FT                   ECO:0000269|PubMed:22542586"
FT   BINDING         322
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:20303979,
FT                   ECO:0000269|PubMed:22542586"
FT   BINDING         391
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20303979,
FT                   ECO:0000269|PubMed:22542586"
FT   MUTAGEN         126
FT                   /note="S->A: No effect on FAD reduction. Strongly reduced
FT                   activity with decylubiquinone."
FT                   /evidence="ECO:0000269|PubMed:22542586"
FT   MUTAGEN         128
FT                   /note="C->A: No effect on FAD reduction. Strongly reduced
FT                   activity with decylubiquinone."
FT                   /evidence="ECO:0000269|PubMed:20303979,
FT                   ECO:0000269|PubMed:22542586"
FT   MUTAGEN         128
FT                   /note="C->S: No effect on FAD reduction. Abolishes activity
FT                   with decylubiquinone."
FT                   /evidence="ECO:0000269|PubMed:22542586"
FT   MUTAGEN         132
FT                   /note="H->A: No effect on FAD reduction. Reduced activity
FT                   with decylubiquinone."
FT                   /evidence="ECO:0000269|PubMed:22542586"
FT   MUTAGEN         160
FT                   /note="C->A: Strongly reduces FAD reduction. Abolishes
FT                   activity with decylubiquinone."
FT                   /evidence="ECO:0000269|PubMed:20303979,
FT                   ECO:0000269|PubMed:22542586"
FT   MUTAGEN         198
FT                   /note="H->A: No effect on FAD reduction. Reduced activity
FT                   with decylubiquinone."
FT                   /evidence="ECO:0000269|PubMed:22542586"
FT   MUTAGEN         356
FT                   /note="C->A: Complete loss of enzyme activity. Abolishes
FT                   enzyme FAD reduction. Abolishes activity with
FT                   decylubiquinone."
FT                   /evidence="ECO:0000269|PubMed:20303979,
FT                   ECO:0000269|PubMed:22542586"
FT   STRAND          3..7
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   HELIX           13..24
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   HELIX           25..27
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          28..33
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          35..40
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   HELIX           42..44
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   HELIX           45..49
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   HELIX           55..58
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          59..61
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   HELIX           63..67
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   TURN            68..70
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          72..74
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          78..82
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   TURN            83..86
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          87..90
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          95..97
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          99..103
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          107..109
FT                   /evidence="ECO:0007829|PDB:3T0K"
FT   HELIX           111..113
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   TURN            119..121
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          122..125
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   HELIX           130..145
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          150..154
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   HELIX           162..177
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   HELIX           181..183
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          187..195
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   TURN            199..202
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   HELIX           207..217
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          221..223
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          225..232
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          235..241
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          247..254
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          256..261
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          264..266
FT                   /evidence="ECO:0007829|PDB:3T0K"
FT   HELIX           268..271
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   TURN            274..276
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          289..293
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          297..299
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   HELIX           301..303
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   HELIX           322..339
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   TURN            340..342
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          354..359
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          364..375
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          377..384
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   HELIX           385..404
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   STRAND          408..410
FT                   /evidence="ECO:0007829|PDB:3SY4"
FT   HELIX           413..416
FT                   /evidence="ECO:0007829|PDB:3SX6"
FT   TURN            423..426
FT                   /evidence="ECO:0007829|PDB:3T2Z"
SQ   SEQUENCE   434 AA;  47406 MW;  FEADC108550141FB CRC64;
     MAHVVILGAG TGGMPAAYEM KEALGSGHEV TLISANDYFQ FVPSNPWVGV GWKERDDIAF
     PIRHYVERKG IHFIAQSAEQ IDAEAQNITL ADGNTVHYDY LMIATGPKLA FENVPGSDPH
     EGPVQSICTV DHAERAFAEY QALLREPGPI VIGAMAGASC FGPAYEYAMI VASDLKKRGM
     RDKIPSFTFI TSEPYIGHLG IQGVGDSKGI LTKGLKEEGI EAYTNCKVTK VEDNKMYVTQ
     VDEKGETIKE MVLPVKFGMM IPAFKGVPAV AGVEGLCNPG GFVLVDEHQR SKKYANIFAA
     GIAIAIPPVE TTPVPTGAPK TGYMIESMVS AAVHNIKADL EGRKGEQTMG TWNAVCFADM
     GDRGAAFIAL PQLKPRKVDV FAYGRWVHLA KVAFEKYFIR KMKMGVSEPF YEKVLFKMMG
     ITRLKEEDTH RKAS
//
ID   SDHA_PIG                Reviewed;         664 AA.
AC   Q0QF01; A0SNV1;
DT   02-MAR-2010, integrated into UniProtKB/Swiss-Prot.
DT   02-MAR-2010, sequence version 2.
DT   02-JUN-2021, entry version 86.
DE   RecName: Full=Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial;
DE            EC=1.3.5.1 {ECO:0000305|PubMed:15989954};
DE   AltName: Full=Flavoprotein subunit of complex II;
DE            Short=Fp;
DE   Flags: Precursor;
GN   Name=SDHA;
OS   Sus scrofa (Pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae; Sus.
OX   NCBI_TaxID=9823;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 43-47, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Heart;
RX   PubMed=17480203; DOI=10.1111/j.1742-4658.2007.05698.x;
RA   Huo X., Su D., Wang A., Zhai Y., Xu J., Li X., Bartlam M., Sun F., Rao Z.;
RT   "Preliminary molecular characterization and crystallization of
RT   mitochondrial respiratory complex II from porcine heart.";
RL   FEBS J. 274:1524-1529(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 59-599.
RC   TISSUE=Liver;
RX   PubMed=16751257; DOI=10.1093/molbev/msl027;
RA   Kullberg M., Nilsson M.A., Arnason U., Harley E.H., Janke A.;
RT   "Housekeeping genes for phylogenetic analysis of eutherian relationships.";
RL   Mol. Biol. Evol. 23:1493-1503(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 165-663.
RX   PubMed=17697375; DOI=10.1186/1471-2199-8-67;
RA   Nygard A.B., Jorgensen C.B., Cirera S., Fredholm M.;
RT   "Selection of reference genes for gene expression studies in pig tissues
RT   using SYBR green qPCR.";
RL   BMC Mol. Biol. 8:67-67(2007).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH FAD AND SUBSTRATE
RP   ANALOG 3-NITROPROPIONATE, FUNCTION, CATALYTIC ACTIVITY, PATHWAY, COFACTOR,
RP   AND SUBUNIT.
RX   PubMed=15989954; DOI=10.1016/j.cell.2005.05.025;
RA   Sun F., Huo X., Zhai Y., Wang A., Xu J., Su D., Bartlam M., Rao Z.;
RT   "Crystal structure of mitochondrial respiratory membrane protein complex
RT   II.";
RL   Cell 121:1043-1057(2005).
CC   -!- FUNCTION: Flavoprotein (FP) subunit of succinate dehydrogenase (SDH)
CC       that is involved in complex II of the mitochondrial electron transport
CC       chain and is responsible for transferring electrons from succinate to
CC       ubiquinone (coenzyme Q) (Probable). Can act as a tumor suppressor (By
CC       similarity). {ECO:0000250|UniProtKB:P31040,
CC       ECO:0000305|PubMed:15989954}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + succinate = a quinol + fumarate;
CC         Xref=Rhea:RHEA:40523, ChEBI:CHEBI:24646, ChEBI:CHEBI:29806,
CC         ChEBI:CHEBI:30031, ChEBI:CHEBI:132124; EC=1.3.5.1;
CC         Evidence={ECO:0000305|PubMed:15989954};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:15989954};
CC   -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle; fumarate
CC       from succinate (eukaryal route): step 1/1.
CC       {ECO:0000305|PubMed:15989954}.
CC   -!- SUBUNIT: Component of complex II composed of four subunits: the
CC       flavoprotein (FP) SDHA, iron-sulfur protein (IP) SDHB, and a cytochrome
CC       b560 composed of SDHC and SDHD (PubMed:15989954, PubMed:17480203).
CC       Interacts with SDHAF2/SDH5; interaction is required for FAD attachment
CC       (By similarity). Interacts with TRAP1 (By similarity). Interacts with
CC       LACC1 (By similarity). {ECO:0000250|UniProtKB:P31040,
CC       ECO:0000269|PubMed:15989954, ECO:0000269|PubMed:17480203}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:17480203}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:17480203}; Matrix side
CC       {ECO:0000269|PubMed:17480203}.
CC   -!- PTM: Phosphorylation at Tyr-215 is important for efficient electron
CC       transfer in complex II and the prevention of ROS generation.
CC       {ECO:0000250|UniProtKB:P31040}.
CC   -!- PTM: Acetylated. Deacetylated by SIRT3. {ECO:0000250|UniProtKB:Q8K2B3}.
CC   -!- SIMILARITY: Belongs to the FAD-dependent oxidoreductase 2 family.
CC       FRD/SDH subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=ABI29191.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ402993; ABD77326.1; -; mRNA.
DR   EMBL; DQ845177; ABI29191.1; ALT_INIT; mRNA.
DR   PDB; 1ZOY; X-ray; 2.40 A; A=43-664.
DR   PDB; 1ZP0; X-ray; 3.50 A; A=43-664.
DR   PDB; 3ABV; X-ray; 3.24 A; A=43-664.
DR   PDB; 3AE1; X-ray; 3.14 A; A=43-664.
DR   PDB; 3AE2; X-ray; 3.10 A; A=43-664.
DR   PDB; 3AE3; X-ray; 3.35 A; A=43-664.
DR   PDB; 3AE4; X-ray; 2.91 A; A=43-664.
DR   PDB; 3AE5; X-ray; 3.41 A; A=43-664.
DR   PDB; 3AE6; X-ray; 3.40 A; A=43-664.
DR   PDB; 3AE7; X-ray; 3.62 A; A=43-664.
DR   PDB; 3AE8; X-ray; 3.40 A; A=43-664.
DR   PDB; 3AE9; X-ray; 3.31 A; A=43-664.
DR   PDB; 3AEA; X-ray; 3.39 A; A=43-664.
DR   PDB; 3AEB; X-ray; 3.00 A; A=43-664.
DR   PDB; 3AEC; X-ray; 3.61 A; A=43-664.
DR   PDB; 3AED; X-ray; 3.52 A; A=43-664.
DR   PDB; 3AEE; X-ray; 3.22 A; A=43-664.
DR   PDB; 3AEF; X-ray; 2.80 A; A=43-664.
DR   PDB; 3AEG; X-ray; 3.27 A; A=43-664.
DR   PDB; 3SFD; X-ray; 2.61 A; A=43-664.
DR   PDB; 3SFE; X-ray; 2.81 A; A=43-664.
DR   PDB; 4YTP; X-ray; 3.10 A; A=1-664.
DR   PDB; 4YXD; X-ray; 3.00 A; A=1-664.
DR   PDBsum; 1ZOY; -.
DR   PDBsum; 1ZP0; -.
DR   PDBsum; 3ABV; -.
DR   PDBsum; 3AE1; -.
DR   PDBsum; 3AE2; -.
DR   PDBsum; 3AE3; -.
DR   PDBsum; 3AE4; -.
DR   PDBsum; 3AE5; -.
DR   PDBsum; 3AE6; -.
DR   PDBsum; 3AE7; -.
DR   PDBsum; 3AE8; -.
DR   PDBsum; 3AE9; -.
DR   PDBsum; 3AEA; -.
DR   PDBsum; 3AEB; -.
DR   PDBsum; 3AEC; -.
DR   PDBsum; 3AED; -.
DR   PDBsum; 3AEE; -.
DR   PDBsum; 3AEF; -.
DR   PDBsum; 3AEG; -.
DR   PDBsum; 3SFD; -.
DR   PDBsum; 3SFE; -.
DR   PDBsum; 4YTP; -.
DR   PDBsum; 4YXD; -.
DR   SMR; Q0QF01; -.
DR   PeptideAtlas; Q0QF01; -.
DR   PRIDE; Q0QF01; -.
DR   Ensembl; ENSSSCT00000031591; ENSSSCP00000026945; ENSSSCG00000020686.
DR   Ensembl; ENSSSCT00015035859; ENSSSCP00015014270; ENSSSCG00015026639.
DR   Ensembl; ENSSSCT00025042442; ENSSSCP00025018064; ENSSSCG00025031010.
DR   Ensembl; ENSSSCT00030061501; ENSSSCP00030028123; ENSSSCG00030043981.
DR   Ensembl; ENSSSCT00035020617; ENSSSCP00035007412; ENSSSCG00035016133.
DR   Ensembl; ENSSSCT00040063165; ENSSSCP00040026647; ENSSSCG00040044535.
DR   Ensembl; ENSSSCT00045051093; ENSSSCP00045035533; ENSSSCG00045028783.
DR   Ensembl; ENSSSCT00050066913; ENSSSCP00050028731; ENSSSCG00050049167.
DR   Ensembl; ENSSSCT00055029043; ENSSSCP00055023128; ENSSSCG00055014552.
DR   Ensembl; ENSSSCT00060007021; ENSSSCP00060002482; ENSSSCG00060005542.
DR   GeneTree; ENSGT00910000144277; -.
DR   InParanoid; Q0QF01; -.
DR   OMA; DPIPIQP; -.
DR   UniPathway; UPA00223; UER01006.
DR   EvolutionaryTrace; Q0QF01; -.
DR   Proteomes; UP000008227; Chromosome 16.
DR   Proteomes; UP000314985; Unplaced.
DR   ExpressionAtlas; Q0QF01; baseline and differential.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0005749; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); IDA:UniProtKB.
DR   GO; GO:0009055; F:electron transfer activity; IBA:GO_Central.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:0008177; F:succinate dehydrogenase (ubiquinone) activity; ISS:UniProtKB.
DR   GO; GO:0000104; F:succinate dehydrogenase activity; IBA:GO_Central.
DR   GO; GO:0006121; P:mitochondrial electron transport, succinate to ubiquinone; IBA:GO_Central.
DR   GO; GO:0022904; P:respiratory electron transport chain; IC:UniProtKB.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IC:UniProtKB.
DR   Gene3D; 3.50.50.60; -; 1.
DR   Gene3D; 3.90.700.10; -; 1.
DR   InterPro; IPR003953; FAD-binding_2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR003952; FRD_SDH_FAD_BS.
DR   InterPro; IPR037099; Fum_R/Succ_DH_flav-like_C_sf.
DR   InterPro; IPR015939; Fum_Rdtase/Succ_DH_flav-like_C.
DR   InterPro; IPR027477; Succ_DH/fumarate_Rdtase_cat_sf.
DR   InterPro; IPR011281; Succ_DH_flav_su_fwd.
DR   InterPro; IPR014006; Succ_Dhase_FrdA_Gneg.
DR   Pfam; PF00890; FAD_binding_2; 1.
DR   Pfam; PF02910; Succ_DH_flav_C; 1.
DR   SUPFAM; SSF46977; SSF46977; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF56425; SSF56425; 1.
DR   TIGRFAMs; TIGR01816; sdhA_forward; 1.
DR   TIGRFAMs; TIGR01812; sdhA_frdA_Gneg; 1.
DR   PROSITE; PS00504; FRD_SDH_FAD_BINDING; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Direct protein sequencing; Electron transport;
KW   FAD; Flavoprotein; Membrane; Mitochondrion; Mitochondrion inner membrane;
KW   Oxidoreductase; Phosphoprotein; Reference proteome; Transit peptide;
KW   Transport; Tricarboxylic acid cycle; Tumor suppressor.
FT   TRANSIT         1..42
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:17480203"
FT   CHAIN           43..664
FT                   /note="Succinate dehydrogenase [ubiquinone] flavoprotein
FT                   subunit, mitochondrial"
FT                   /id="PRO_0000391718"
FT   NP_BIND         68..73
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15989954"
FT   NP_BIND         91..106
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15989954"
FT   NP_BIND         456..457
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15989954"
FT   ACT_SITE        340
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9YHT1"
FT   BINDING         275
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15989954"
FT   BINDING         296
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:15989954"
FT   BINDING         308
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:15989954"
FT   BINDING         407
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:15989954"
FT   BINDING         440
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15989954"
FT   BINDING         451
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:15989954"
FT   MOD_RES         99
FT                   /note="Tele-8alpha-FAD histidine"
FT                   /evidence="ECO:0000269|PubMed:15989954"
FT   MOD_RES         167
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         179
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P31040"
FT   MOD_RES         179
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         182
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         215
FT                   /note="Phosphotyrosine; by SRC"
FT                   /evidence="ECO:0000250|UniProtKB:P31040"
FT   MOD_RES         335
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P31040"
FT   MOD_RES         335
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         480
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         485
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         485
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         498
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         498
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         517
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         538
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         538
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         550
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         598
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         608
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P31040"
FT   MOD_RES         615
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         624
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         633
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         636
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   MOD_RES         647
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2B3"
FT   CONFLICT        165..171
FT                   /note="DGKIYQR -> LQESARG (in Ref. 3; ABI29191)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        222
FT                   /note="L -> S (in Ref. 1; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        235
FT                   /note="I -> T (in Ref. 1; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        358
FT                   /note="G -> N (in Ref. 1; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        453
FT                   /note="G -> E (in Ref. 1; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        509
FT                   /note="S -> W (in Ref. 2; ABD77326)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        566
FT                   /note="L -> P (in Ref. 2; ABD77326)"
FT                   /evidence="ECO:0000305"
FT   STRAND          57..61
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          63..67
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           71..82
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          87..93
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           95..97
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           99..102
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          113..115
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           119..129
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   TURN            130..132
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           136..156
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          166..168
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          170..178
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   TURN            179..182
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          185..190
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           196..208
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   TURN            209..212
FT                   /evidence="ECO:0007829|PDB:4YXD"
FT   STRAND          214..217
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          219..227
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          230..238
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   TURN            239..241
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          244..248
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          250..254
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           260..262
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          263..268
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           275..282
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   TURN            289..291
FT                   /evidence="ECO:0007829|PDB:4YXD"
FT   STRAND          293..297
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   TURN            301..303
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           310..314
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          317..319
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          323..325
FT                   /evidence="ECO:0007829|PDB:3AE2"
FT   TURN            327..329
FT                   /evidence="ECO:0007829|PDB:3SFD"
FT   TURN            332..336
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           340..353
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          357..361
FT                   /evidence="ECO:0007829|PDB:3SFD"
FT   STRAND          365..367
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          369..371
FT                   /evidence="ECO:0007829|PDB:3AE1"
FT   HELIX           375..378
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           381..391
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   TURN            395..397
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          400..402
FT                   /evidence="ECO:0007829|PDB:4YXD"
FT   STRAND          405..409
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          412..415
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          419..425
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          428..437
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           439..441
FT                   /evidence="ECO:0007829|PDB:3AEF"
FT   STRAND          442..444
FT                   /evidence="ECO:0007829|PDB:3SFD"
FT   HELIX           456..474
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   TURN            486..489
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           490..500
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          505..507
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           508..522
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          523..527
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           529..545
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          548..550
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           560..584
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          587..589
FT                   /evidence="ECO:0007829|PDB:3AE6"
FT   STRAND          594..596
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          606..608
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          610..613
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   HELIX           618..620
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          624..630
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   TURN            632..634
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   STRAND          637..642
FT                   /evidence="ECO:0007829|PDB:1ZOY"
FT   TURN            651..653
FT                   /evidence="ECO:0007829|PDB:1ZOY"
SQ   SEQUENCE   664 AA;  72832 MW;  0120E14F7F6F60EE CRC64;
     MSGVRAVSRL LRARRLALTW AQPAASPIGA RSFHFTVDGN KRSSAKVSDA ISTQYPVVDH
     EFDAVVVGAG GAGLRAAFGL SEAGFNTACV TKLFPTRSHT VAAQGGINAA LGNMEEDNWR
     WHFYDTVKGS DWLGDQDAIH YMTEQAPASV VELENYGMPF SRTEDGKIYQ RAFGGQSLKF
     GKGGQAHRCC CVADRTGHSL LHTLYGRSLR YDTSYFVEYF ALDLLMENGE CRGVIALCIE
     DGSIHRIRAR NTVVATGGYG RTYFSCTSAH TSTGDGTAMV TRAGLPCQDL EFVQFHPTGI
     YGAGCLITEG CRGEGGILIN SQGERFMERY APVAKDLASR DVVSRSMTLE IREGRGCGPE
     KDHVYLQLHH LPPEQLAVRL PGISETAMIF AGVDVTKEPI PVLPTVHYNM GGIPTNYKGQ
     VLRHVNGQDQ VVPGLYACGE AACASVHGAN RLGANSLLDL VVFGRACALS IAESCRPGDK
     VPSIKPNAGE ESVMNLDKLR FANGTIRTSE LRLSMQKSMQ SHAAVFRVGS VLQEGCEKIL
     RLYGDLQHLK TFDRGMVWNT DLVETLELQN LMLCALQTIY GAEARKESRG AHAREDFKER
     VDEYDYSKPI QGQQKKPFQE HWRKHTLSYV DVKTGKVSLE YRPVIDKTLN EADCATVPPA
     IRSY
//
ID   ALR_HUMAN               Reviewed;         205 AA.
AC   P55789; Q53YM6; Q8TAH6; Q9H290; Q9UK40;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   02-JUN-2021, entry version 179.
DE   RecName: Full=FAD-linked sulfhydryl oxidase ALR;
DE            EC=1.8.3.2;
DE   AltName: Full=Augmenter of liver regeneration;
DE            Short=hERV1;
DE   AltName: Full=Hepatopoietin;
GN   Name=GFER; Synonyms=ALR, HERV1, HPO;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Liu M.-M., He F.-C., Wei H.-D., Zhou W.-Q.;
RT   "Genomic structure, chromosomal localization, and characterization of a
RT   functional promoter for human hepatopoietin (HPO) gene.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RA   Li Y., Xing G.-C., He F.-C., Wei H.-D., Zhang C.-G., Zhu L., Yu Y.-T.;
RT   "HERV different transcription sequence.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal liver;
RA   Jun L., Wangxiang X., Xiaoming Y.;
RT   "Isolation of human HPO cDNA from human liver tissue.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Dai W.-J., Jiang H.-C.;
RT   "Human augmenter of liver regeneration/hepatopoietin gene open reading
RT   frame sequence.";
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2-205.
RC   TISSUE=Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-205.
RX   PubMed=10712775;
RA   Cheng J., Zhong Y.;
RT   "Cloning and sequence analysis of human genomic DNA of augmenter of liver
RT   regeneration hepatitis.";
RL   Zhonghua Gan Zang Bing Za Zhi 8:12-14(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-205.
RC   TISSUE=Renal cyst lining cell;
RX   PubMed=8575761; DOI=10.1006/geno.1995.9950;
RA   Lisowsky T., Weinstat-Saslow D.L., Barton N., Reeders S.T., Schneider M.C.;
RT   "A new human gene located in the PKD1 region of chromosome 16 is a
RT   functional homologue to ERV1 of yeast.";
RL   Genomics 29:690-697(1995).
RN   [9]
RP   ALTERNATIVE SPLICING, AND SUBUNIT.
RX   PubMed=12180965; DOI=10.1046/j.1432-1033.2002.03054.x;
RA   Li Y., Wei K., Lu C., Li Y., Li M., Xing G., Wei H., Wang Q., Chen J.,
RA   Wu C., Chen H., Yang S., He F.;
RT   "Identification of hepatopoietin dimerization, its interacting regions and
RT   alternative splicing of its transcription.";
RL   Eur. J. Biochem. 269:3888-3893(2002).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19397338; DOI=10.1021/bi900347v;
RA   Daithankar V.N., Farrell S.R., Thorpe C.;
RT   "Augmenter of liver regeneration: substrate specificity of a flavin-
RT   dependent oxidoreductase from the mitochondrial intermembrane space.";
RL   Biochemistry 48:4828-4837(2009).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CHCHD4.
RX   PubMed=23676665; DOI=10.1091/mbc.e12-12-0862;
RA   Fischer M., Horn S., Belkacemi A., Kojer K., Petrungaro C., Habich M.,
RA   Ali M., Kuettner V., Bien M., Kauff F., Dengjel J., Herrmann J.M.,
RA   Riemer J.;
RT   "Protein import and oxidative folding in the mitochondrial intermembrane
RT   space of intact mammalian cells.";
RL   Mol. Biol. Cell 24:2160-2170(2013).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23186364; DOI=10.1111/tra.12030;
RA   Sztolsztener M.E., Brewinska A., Guiard B., Chacinska A.;
RT   "Disulfide bond formation: sulfhydryl oxidase ALR controls mitochondrial
RT   biogenesis of human MIA40.";
RL   Traffic 14:309-320(2013).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 81-205, CATALYTIC ACTIVITY,
RP   FUNCTION, SUBUNIT, DISULFIDE BONDS, FAD-BINDING SITES, AND CHARACTERIZATION
RP   OF VARIANT MPMCHD HIS-194.
RX   PubMed=20593814; DOI=10.1021/bi100912m;
RA   Daithankar V.N., Schaefer S.A., Dong M., Bahnson B.J., Thorpe C.;
RT   "Structure of the human sulfhydryl oxidase augmenter of liver regeneration
RT   and characterization of a human mutation causing an autosomal recessive
RT   myopathy.";
RL   Biochemistry 49:6737-6745(2010).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 81-205 IN COMPLEX WITH FAD,
RP   FUNCTION, COFACTOR, SUBUNIT, DISULFIDE BONDS, AND INTERACTION WITH CHCHD4.
RX   PubMed=21383138; DOI=10.1073/pnas.1014542108;
RA   Banci L., Bertini I., Calderone V., Cefaro C., Ciofi-Baffoni S., Gallo A.,
RA   Kallergi E., Lionaki E., Pozidis C., Tokatlidis K.;
RT   "Molecular recognition and substrate mimicry drive the electron-transfer
RT   process between MIA40 and ALR.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:4811-4816(2011).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 91-205, FUNCTION, CATALYTIC
RP   ACTIVITY, DISULFIDE BONDS, AND SUBUNIT.
RX   PubMed=22224850; DOI=10.1021/ja209881f;
RA   Banci L., Bertini I., Calderone V., Cefaro C., Ciofi-Baffoni S., Gallo A.,
RA   Tokatlidis K.;
RT   "An electron-transfer path through an extended disulfide relay system: the
RT   case of the redox protein ALR.";
RL   J. Am. Chem. Soc. 134:1442-1445(2012).
RN   [19]
RP   VARIANT MPMCHD HIS-194, CHARACTERIZATION OF VARIANT MPMCHD HIS-194, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=19409522; DOI=10.1016/j.ajhg.2009.04.004;
RA   Di Fonzo A., Ronchi D., Lodi T., Fassone E., Tigano M., Lamperti C.,
RA   Corti S., Bordoni A., Fortunato F., Nizzardo M., Napoli L., Donadoni C.,
RA   Salani S., Saladino F., Moggio M., Bresolin N., Ferrero I., Comi G.P.;
RT   "The mitochondrial disulfide relay system protein GFER is mutated in
RT   autosomal-recessive myopathy with cataract and combined respiratory-chain
RT   deficiency.";
RL   Am. J. Hum. Genet. 84:594-604(2009).
CC   -!- FUNCTION: [Isoform 1]: FAD-dependent sulfhydryl oxidase that
CC       regenerates the redox-active disulfide bonds in CHCHD4/MIA40, a
CC       chaperone essential for disulfide bond formation and protein folding in
CC       the mitochondrial intermembrane space. The reduced form of CHCHD4/MIA40
CC       forms a transient intermolecular disulfide bridge with GFER/ERV1,
CC       resulting in regeneration of the essential disulfide bonds in
CC       CHCHD4/MIA40, while GFER/ERV1 becomes re-oxidized by donating electrons
CC       to cytochrome c or molecular oxygen. {ECO:0000269|PubMed:19397338,
CC       ECO:0000269|PubMed:20593814, ECO:0000269|PubMed:21383138,
CC       ECO:0000269|PubMed:22224850, ECO:0000269|PubMed:23186364,
CC       ECO:0000269|PubMed:23676665}.
CC   -!- FUNCTION: [Isoform 2]: May act as an autocrine hepatotrophic growth
CC       factor promoting liver regeneration.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + 2 R'C(R)SH = H2O2 + R'C(R)S-S(R)CR';
CC         Xref=Rhea:RHEA:17357, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:16520, ChEBI:CHEBI:17412; EC=1.8.3.2;
CC         Evidence={ECO:0000269|PubMed:20593814, ECO:0000269|PubMed:22224850};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00654,
CC         ECO:0000269|PubMed:20593814, ECO:0000269|PubMed:21383138};
CC   -!- SUBUNIT: Homodimer; disulfide-linked. May form heterodimers of isoform
CC       1 and isoform 2 (PubMed:12180965, PubMed:20593814, PubMed:21383138,
CC       PubMed:22224850). Interacts with CHCHD4/MIA40 (PubMed:23676665,
CC       PubMed:21383138). {ECO:0000269|PubMed:12180965,
CC       ECO:0000269|PubMed:20593814, ECO:0000269|PubMed:21383138,
CC       ECO:0000269|PubMed:22224850, ECO:0000269|PubMed:23676665}.
CC   -!- INTERACTION:
CC       P55789; Q9H8W4: PLEKHF2; NbExp=3; IntAct=EBI-718281, EBI-742388;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Mitochondrion intermembrane space.
CC       Mitochondrion {ECO:0000269|PubMed:23676665}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm. Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=HPO-205, lfALR;
CC         IsoId=P55789-1; Sequence=Displayed;
CC       Name=2; Synonyms=HPO-125, sfALR;
CC         IsoId=P55789-2; Sequence=VSP_040393;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Highest expression in the
CC       testis and liver and low expression in the muscle.
CC       {ECO:0000269|PubMed:19409522}.
CC   -!- DISEASE: Myopathy, mitochondrial progressive, with congenital cataract,
CC       hearing loss and developmental delay (MPMCHD) [MIM:613076]: A disease
CC       characterized by progressive myopathy and partial combined respiratory-
CC       chain deficiency, congenital cataract, sensorineural hearing loss, and
CC       developmental delay. {ECO:0000269|PubMed:19409522,
CC       ECO:0000269|PubMed:20593814}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA96390.2; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAD36986.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAD56538.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH02429.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH28348.2; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF183892; AAD56538.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AF124604; AAD17328.1; -; mRNA.
DR   EMBL; AF306863; AAG38105.1; -; mRNA.
DR   EMBL; AY550027; AAS55642.1; -; mRNA.
DR   EMBL; AC005606; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002429; AAH02429.1; ALT_INIT; mRNA.
DR   EMBL; BC028348; AAH28348.2; ALT_INIT; mRNA.
DR   EMBL; AF146394; AAD36986.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U31176; AAA96390.2; ALT_FRAME; mRNA.
DR   CCDS; CCDS32368.1; -. [P55789-1]
DR   RefSeq; NP_005253.3; NM_005262.2. [P55789-1]
DR   PDB; 3MBG; X-ray; 1.85 A; A/B/C=81-205.
DR   PDB; 3O55; X-ray; 1.90 A; A=81-205.
DR   PDB; 3TK0; X-ray; 1.61 A; A=81-205.
DR   PDB; 3U2L; X-ray; 1.95 A; A=91-205.
DR   PDB; 3U2M; X-ray; 2.00 A; A=91-205.
DR   PDB; 3U5S; X-ray; 1.50 A; A=82-203.
DR   PDB; 4LDK; X-ray; 2.04 A; A=81-205.
DR   PDBsum; 3MBG; -.
DR   PDBsum; 3O55; -.
DR   PDBsum; 3TK0; -.
DR   PDBsum; 3U2L; -.
DR   PDBsum; 3U2M; -.
DR   PDBsum; 3U5S; -.
DR   PDBsum; 4LDK; -.
DR   BMRB; P55789; -.
DR   SMR; P55789; -.
DR   BioGRID; 108939; 64.
DR   IntAct; P55789; 29.
DR   MINT; P55789; -.
DR   STRING; 9606.ENSP00000248114; -.
DR   ChEMBL; CHEMBL1741189; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugCentral; P55789; -.
DR   iPTMnet; P55789; -.
DR   MetOSite; P55789; -.
DR   PhosphoSitePlus; P55789; -.
DR   BioMuta; GFER; -.
DR   DMDM; 218511915; -.
DR   EPD; P55789; -.
DR   jPOST; P55789; -.
DR   MassIVE; P55789; -.
DR   MaxQB; P55789; -.
DR   PaxDb; P55789; -.
DR   PeptideAtlas; P55789; -.
DR   PRIDE; P55789; -.
DR   ProteomicsDB; 56865; -. [P55789-1]
DR   ProteomicsDB; 56866; -. [P55789-2]
DR   Antibodypedia; 42516; 266 antibodies.
DR   DNASU; 2671; -.
DR   Ensembl; ENST00000248114; ENSP00000248114; ENSG00000127554. [P55789-1]
DR   GeneID; 2671; -.
DR   KEGG; hsa:2671; -.
DR   UCSC; uc002cob.4; human. [P55789-1]
DR   CTD; 2671; -.
DR   DisGeNET; 2671; -.
DR   GeneCards; GFER; -.
DR   HGNC; HGNC:4236; GFER.
DR   HPA; ENSG00000127554; Low tissue specificity.
DR   MalaCards; GFER; -.
DR   MIM; 600924; gene.
DR   MIM; 613076; phenotype.
DR   neXtProt; NX_P55789; -.
DR   OpenTargets; ENSG00000127554; -.
DR   Orphanet; 330054; Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome.
DR   PharmGKB; PA28648; -.
DR   VEuPathDB; HostDB:ENSG00000127554.12; -.
DR   eggNOG; KOG3355; Eukaryota.
DR   GeneTree; ENSGT00390000001979; -.
DR   HOGENOM; CLU_070631_1_1_1; -.
DR   InParanoid; P55789; -.
DR   OMA; KPCRSCT; -.
DR   OrthoDB; 1537996at2759; -.
DR   PhylomeDB; P55789; -.
DR   TreeFam; TF105271; -.
DR   BRENDA; 1.8.3.2; 2681.
DR   PathwayCommons; P55789; -.
DR   Reactome; R-HSA-1268020; Mitochondrial protein import.
DR   SIGNOR; P55789; -.
DR   BioGRID-ORCS; 2671; 544 hits in 1013 CRISPR screens.
DR   EvolutionaryTrace; P55789; -.
DR   GeneWiki; GFER; -.
DR   GenomeRNAi; 2671; -.
DR   Pharos; P55789; Tchem.
DR   PRO; PR:P55789; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; P55789; protein.
DR   Bgee; ENSG00000127554; Expressed in dorsal plus ventral thalamus and 190 other tissues.
DR   ExpressionAtlas; P55789; baseline and differential.
DR   Genevisible; P55789; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0016971; F:flavin-linked sulfhydryl oxidase activity; IBA:GO_Central.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0015035; F:protein disulfide oxidoreductase activity; IDA:UniProtKB.
DR   GO; GO:0001889; P:liver development; IBA:GO_Central.
DR   Gene3D; 1.20.120.310; -; 1.
DR   InterPro; IPR039799; ALR/ERV.
DR   InterPro; IPR036774; ERV/ALR_sulphydryl_oxid_sf.
DR   InterPro; IPR017905; ERV/ALR_sulphydryl_oxidase.
DR   PANTHER; PTHR12645; PTHR12645; 1.
DR   Pfam; PF04777; Evr1_Alr; 1.
DR   SUPFAM; SSF69000; SSF69000; 1.
DR   PROSITE; PS51324; ERV_ALR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cataract; Cytoplasm; Deafness;
KW   Disease variant; Disulfide bond; FAD; Flavoprotein; Growth factor;
KW   Mitochondrion; Oxidoreductase; Phosphoprotein;
KW   Primary mitochondrial disease; Reference proteome; Secreted.
FT   CHAIN           1..205
FT                   /note="FAD-linked sulfhydryl oxidase ALR"
FT                   /id="PRO_0000208548"
FT   DOMAIN          95..195
FT                   /note="ERV/ALR sulfhydryl oxidase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654"
FT   NP_BIND         99..107
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21383138"
FT   NP_BIND         171..183
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21383138"
FT   NP_BIND         194..195
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21383138"
FT   REGION          1..65
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         111
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21383138"
FT   BINDING         140
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21383138"
FT   MOD_RES         59
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   DISULFID        95
FT                   /note="Interchain (with C-204)"
FT   DISULFID        142..145
FT                   /note="Redox-active"
FT   DISULFID        171..188
FT   DISULFID        204
FT                   /note="Interchain (with C-95)"
FT   VAR_SEQ         1..80
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2, ECO:0000303|Ref.4"
FT                   /id="VSP_040393"
FT   VARIANT         166
FT                   /note="F -> L (in dbSNP:rs36041021)"
FT                   /id="VAR_061994"
FT   VARIANT         194
FT                   /note="R -> H (in MPMCHD; less stable than the wild-type
FT                   protein within the mitochondria, increased rate of
FT                   dissociation of FAD by about 45-fold; dbSNP:rs121908192)"
FT                   /evidence="ECO:0000269|PubMed:19409522,
FT                   ECO:0000269|PubMed:20593814"
FT                   /id="VAR_063435"
FT   CONFLICT        30
FT                   /note="L -> S (in Ref. 7; AAA96390)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        127
FT                   /note="Q -> R (in Ref. 3; AAG38105)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        180
FT                   /note="K -> E (in Ref. 3; AAG38105)"
FT                   /evidence="ECO:0000305"
FT   HELIX           86..88
FT                   /evidence="ECO:0007829|PDB:3U5S"
FT   STRAND          93..95
FT                   /evidence="ECO:0007829|PDB:3U5S"
FT   HELIX           99..115
FT                   /evidence="ECO:0007829|PDB:3U5S"
FT   HELIX           123..139
FT                   /evidence="ECO:0007829|PDB:3U5S"
FT   HELIX           143..155
FT                   /evidence="ECO:0007829|PDB:3U5S"
FT   HELIX           163..180
FT                   /evidence="ECO:0007829|PDB:3U5S"
FT   HELIX           188..190
FT                   /evidence="ECO:0007829|PDB:3U5S"
FT   HELIX           191..195
FT                   /evidence="ECO:0007829|PDB:3U5S"
SQ   SEQUENCE   205 AA;  23449 MW;  43CBF8CCB5BA91C8 CRC64;
     MAAPGERGRF HGGNLFFLPG GARSEMMDDL ATDARGRGAG RRDAAASAST PAQAPTSDSP
     VAEDASRRRP CRACVDFKTW MRTQQKRDTK FREDCPPDRE ELGRHSWAVL HTLAAYYPDL
     PTPEQQQDMA QFIHLFSKFY PCEECAEDLR KRLCRNHPDT RTRACFTQWL CHLHNEVNRK
     LGKPDFDCSK VDERWRDGWK DGSCD
//
ID   DLDH_HUMAN              Reviewed;         509 AA.
AC   P09622; B2R5X0; B4DHG0; B4DT69; Q14131; Q14167; Q59EV8; Q8WTS4;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 2.
DT   02-JUN-2021, entry version 247.
DE   RecName: Full=Dihydrolipoyl dehydrogenase, mitochondrial;
DE            EC=1.8.1.4 {ECO:0000269|PubMed:15712224, ECO:0000269|PubMed:16442803, ECO:0000269|PubMed:16770810, ECO:0000269|PubMed:17404228, ECO:0000269|PubMed:20160912, ECO:0000269|PubMed:20385101};
DE   AltName: Full=Dihydrolipoamide dehydrogenase;
DE   AltName: Full=Glycine cleavage system L protein;
DE   Flags: Precursor;
GN   Name=DLD; Synonyms=GCSL, LAD, PHE3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-104.
RX   PubMed=3693355;
RA   Otulakowski G., Robinson B.H.;
RT   "Isolation and sequence determination of cDNA clones for porcine and human
RT   lipoamide dehydrogenase. Homology to other disulfide oxidoreductases.";
RL   J. Biol. Chem. 262:17313-17318(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3278312; DOI=10.1073/pnas.85.5.1422;
RA   Pons G., Raefsky-Estrin C., Carothers D.J., Pepin R.A., Javed A.A.,
RA   Jesse B.W., Ganapathi M.K., Samols D., Patel M.S.;
RT   "Cloning and cDNA sequence of the dihydrolipoamide dehydrogenase component
RT   human alpha-ketoacid dehydrogenase complexes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:1422-1426(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-104.
RC   TISSUE=Liver;
RX   PubMed=8406489; DOI=10.1006/geno.1993.1335;
RA   Feigenbaum A.S., Robinson B.H.;
RT   "The structure of the human dihydrolipoamide dehydrogenase gene (DLD) and
RT   its upstream elements.";
RL   Genomics 17:376-381(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain, Brain cortex, and Pericardium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-13.
RX   PubMed=1332063; DOI=10.1073/pnas.89.22.10964;
RA   Johanning G.L., Morris J.I., Madhusudhan K.T., Samols D., Patel M.S.;
RT   "Characterization of the transcriptional regulatory region of the human
RT   dihydrolipoamide dehydrogenase gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:10964-10968(1992).
RN   [11]
RP   SUBUNIT.
RX   PubMed=14638692; DOI=10.1074/jbc.m308172200;
RA   Hiromasa Y., Fujisawa T., Aso Y., Roche T.E.;
RT   "Organization of the cores of the mammalian pyruvate dehydrogenase complex
RT   formed by E2 and E2 plus the E3-binding protein and their capacities to
RT   bind the E1 and E3 components.";
RL   J. Biol. Chem. 279:6921-6933(2004).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15888450; DOI=10.1074/jbc.m500310200;
RA   Mitra K., Rangaraj N., Shivaji S.;
RT   "Novelty of the pyruvate metabolic enzyme dihydrolipoamide dehydrogenase in
RT   spermatozoa: correlation of its localization, tyrosine phosphorylation, and
RT   activity during sperm capacitation.";
RL   J. Biol. Chem. 280:25743-25753(2005).
RN   [13]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, CHARACTERIZATION OF
RP   VARIANT DLDD ASP-479, AND MUTAGENESIS OF GLU-466; HIS-485 AND SER-491.
RX   PubMed=17404228; DOI=10.1073/pnas.0610618104;
RA   Babady N.E., Pang Y.P., Elpeleg O., Isaya G.;
RT   "Cryptic proteolytic activity of dihydrolipoamide dehydrogenase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:6158-6163(2007).
RN   [14]
RP   CATALYTIC ACTIVITY, INTERACTION WITH PDHX, MUTAGENESIS OF LYS-89; ARG-482;
RP   GLU-492 AND LYS-505, AND CHARACTERIZATION OF VARIANTS DLDD GLU-72; LYS-375;
RP   LEU-488 AND GLY-495.
RX   PubMed=20160912; DOI=10.1016/j.molcatb.2009.05.001;
RA   Patel M.S., Korotchkina L.G., Sidhu S.;
RT   "Interaction of E1 and E3 components with the core proteins of the human
RT   pyruvate dehydrogenase complex.";
RL   J. Mol. Catal., B Enzym. 61:2-6(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-143; LYS-410 AND LYS-417, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [16]
RP   CATALYTIC ACTIVITY, INTERACTION WITH PDHX, AND MUTAGENESIS OF HIS-383;
RP   ASP-448; TYR-473 AND ARG-482.
RX   PubMed=20385101; DOI=10.1016/j.bbrc.2010.04.038;
RA   Park Y.H., Patel M.S.;
RT   "Characterization of interactions of dihydrolipoamide dehydrogenase with
RT   its binding protein in the human pyruvate dehydrogenase complex.";
RL   Biochem. Biophys. Res. Commun. 395:416-419(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S., Fischer-Posovszky P.,
RA   Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-502, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER TYR-35, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=29211711; DOI=10.1038/nature25003;
RA   Wang Y., Guo Y.R., Liu K., Yin Z., Liu R., Xia Y., Tan L., Yang P.,
RA   Lee J.H., Li X.J., Hawke D., Zheng Y., Qian X., Lyu J., He J., Xing D.,
RA   Tao Y.J., Lu Z.;
RT   "KAT2A coupled with the alpha-KGDH complex acts as a histone H3
RT   succinyltransferase.";
RL   Nature 552:273-277(2017).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.08 ANGSTROMS) OF 36-509 IN COMPLEXES WITH NAD AND
RP   FAD, AND SUBUNIT.
RX   PubMed=15946682; DOI=10.1016/j.jmb.2005.05.014;
RA   Brautigam C.A., Chuang J.L., Tomchick D.R., Machius M., Chuang D.T.;
RT   "Crystal structure of human dihydrolipoamide dehydrogenase: NAD+/NADH
RT   binding and the structural basis of disease-causing mutations.";
RL   J. Mol. Biol. 350:543-552(2005).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.59 ANGSTROMS) OF 36-509.
RX   PubMed=16263718; DOI=10.1074/jbc.m507850200;
RA   Ciszak E.M., Makal A., Hong Y.S., Vettaikkorumakankauv A.K.,
RA   Korotchkina L.G., Patel M.S.;
RT   "How dihydrolipoamide dehydrogenase-binding protein binds dihydrolipoamide
RT   dehydrogenase in the human pyruvate dehydrogenase complex.";
RL   J. Biol. Chem. 281:648-655(2006).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.18 ANGSTROMS) OF 36-509 IN COMPLEX WITH PDHX,
RP   CATALYTIC ACTIVITY, AND CHARACTERIZATION OF VARIANT DLDD GLY-495.
RX   PubMed=16442803; DOI=10.1016/j.str.2006.01.001;
RA   Brautigam C.A., Wynn R.M., Chuang J.L., Machius M., Tomchick D.R.,
RA   Chuang D.T.;
RT   "Structural insight into interactions between dihydrolipoamide
RT   dehydrogenase (E3) and E3 binding protein of human pyruvate dehydrogenase
RT   complex.";
RL   Structure 14:611-621(2006).
RN   [26]
RP   STRUCTURE BY ELECTRON MICROSCOPY (33.3 ANGSTROMS) OF INNER CORE OF THE
RP   COMPLEX, AND SUBUNIT.
RX   PubMed=20361979; DOI=10.1016/j.jmb.2010.03.043;
RA   Vijayakrishnan S., Kelly S.M., Gilbert R.J., Callow P., Bhella D.,
RA   Forsyth T., Lindsay J.G., Byron O.;
RT   "Solution structure and characterisation of the human pyruvate
RT   dehydrogenase complex core assembly.";
RL   J. Mol. Biol. 399:71-93(2010).
RN   [27]
RP   VARIANTS DLDD GLU-72 AND LEU-488.
RX   PubMed=8506365; DOI=10.1073/pnas.90.11.5186;
RA   Liu T.-C., Kim H., Arizmendi C., Kitano A., Patel M.S.;
RT   "Identification of two missense mutations in a dihydrolipoamide
RT   dehydrogenase-deficient patient.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:5186-5190(1993).
RN   [28]
RP   VARIANTS DLDD GLY-136 DEL AND LYS-375.
RX   PubMed=9540846; DOI=10.1016/s0925-4439(97)00073-2;
RA   Hong Y.S., Kerr D.S., Liu T.C., Lusk M., Powell B.R., Patel M.S.;
RT   "Deficiency of dihydrolipoamide dehydrogenase due to two mutant alleles
RT   (E340K and G101del). Analysis of a family and prenatal testing.";
RL   Biochim. Biophys. Acta 1362:160-168(1997).
RN   [29]
RP   VARIANT DLDD GLY-495.
RX   PubMed=8968745; DOI=10.1093/hmg/5.12.1925;
RA   Hong Y.S., Kerr D.S., Craigen W.J., Tan J., Pan Y., Lusk M., Patel M.S.;
RT   "Identification of two mutations in a compound heterozygous child with
RT   dihydrolipoamide dehydrogenase deficiency.";
RL   Hum. Mol. Genet. 5:1925-1930(1996).
RN   [30]
RP   VARIANT DLDD VAL-479.
RX   PubMed=10448086; DOI=10.1006/bbrc.1999.1133;
RA   Shany E., Saada A., Landau D., Shaag A., Hershkovitz E., Elpeleg O.N.;
RT   "Lipoamide dehydrogenase deficiency due to a novel mutation in the
RT   interface domain.";
RL   Biochem. Biophys. Res. Commun. 262:163-166(1999).
RN   [31]
RP   VARIANTS DLDD VAL-361 AND LYS-375.
RX   PubMed=11687750;
RA   Cerna L., Wenchich L., Hansikova H., Kmoch S., Peskova K., Chrastina P.,
RA   Brynda J., Zeman J.;
RT   "Novel mutations in a boy with dihydrolipoamide dehydrogenase deficiency.";
RL   Med. Sci. Monit. 7:1319-1325(2001).
RN   [32]
RP   VARIANT DLDD THR-393.
RX   PubMed=12925875; DOI=10.1007/s00431-003-1282-z;
RA   Grafakou O., Oexle K., van den Heuvel L., Smeets R., Trijbels F.,
RA   Goebel H.H., Bosshard N., Superti-Furga A., Steinmann B., Smeitink J.;
RT   "Leigh syndrome due to compound heterozygosity of dihydrolipoamide
RT   dehydrogenase gene mutations. Description of the first E3 splice site
RT   mutation.";
RL   Eur. J. Pediatr. 162:714-718(2003).
RN   [33]
RP   VARIANT DLDD GLY-482, CHARACTERIZATION OF VARIANT DLDD GLY-482, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=15712224; DOI=10.1002/humu.9319;
RA   Odievre M.H., Chretien D., Munnich A., Robinson B.H., Dumoulin R.,
RA   Masmoudi S., Kadhom N., Roetig A., Rustin P., Bonnefont J.P.;
RT   "A novel mutation in the dihydrolipoamide dehydrogenase E3 subunit gene
RT   (DLD) resulting in an atypical form of alpha-ketoglutarate dehydrogenase
RT   deficiency.";
RL   Hum. Mutat. 25:323-324(2005).
RN   [34]
RP   VARIANTS DLDD THR-47; CYS-229 AND LYS-375, AND CATALYTIC ACTIVITY.
RX   PubMed=16770810; DOI=10.1002/ajmg.a.31313;
RA   Cameron J.M., Levandovskiy V., Mackay N., Raiman J., Renaud D.L.,
RA   Clarke J.T., Feigenbaum A., Elpeleg O., Robinson B.H.;
RT   "Novel mutations in dihydrolipoamide dehydrogenase deficiency in two
RT   cousins with borderline-normal PDH complex activity.";
RL   Am. J. Med. Genet. A 140:1542-1552(2006).
RN   [35]
RP   VARIANT DLDD CYS-229.
RX   PubMed=9934985;
RX   DOI=10.1002/(sici)1096-8628(19990115)82:2<177::aid-ajmg15>3.0.co;2-9;
RA   Shaag A., Saada A., Berger I., Mandel H., Joseph A., Feigenbaum A.,
RA   Elpeleg O.N.;
RT   "Molecular basis of lipoamide dehydrogenase deficiency in Ashkenazi Jews.";
RL   Am. J. Med. Genet. 82:177-182(1999).
CC   -!- FUNCTION: Lipoamide dehydrogenase is a component of the glycine
CC       cleavage system as well as an E3 component of three alpha-ketoacid
CC       dehydrogenase complexes (pyruvate-, alpha-ketoglutarate-, and branched-
CC       chain amino acid-dehydrogenase complex) (PubMed:15712224,
CC       PubMed:16442803, PubMed:16770810, PubMed:17404228, PubMed:20160912,
CC       PubMed:20385101). The 2-oxoglutarate dehydrogenase complex is mainly
CC       active in the mitochondrion (PubMed:29211711). A fraction of the 2-
CC       oxoglutarate dehydrogenase complex also localizes in the nucleus and is
CC       required for lysine succinylation of histones: associates with KAT2A on
CC       chromatin and provides succinyl-CoA to histone succinyltransferase
CC       KAT2A (PubMed:29211711). In monomeric form may have additional
CC       moonlighting function as serine protease (PubMed:17404228). Involved in
CC       the hyperactivation of spermatazoa during capacitation and in the
CC       spermatazoal acrosome reaction (By similarity).
CC       {ECO:0000250|UniProtKB:Q811C4, ECO:0000269|PubMed:15712224,
CC       ECO:0000269|PubMed:16442803, ECO:0000269|PubMed:16770810,
CC       ECO:0000269|PubMed:17404228, ECO:0000269|PubMed:20160912,
CC       ECO:0000269|PubMed:20385101, ECO:0000269|PubMed:29211711}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-N(6)-dihydrolipoyl-L-lysyl-[protein] + NAD(+) = (R)-N(6)-
CC         lipoyl-L-lysyl-[protein] + H(+) + NADH; Xref=Rhea:RHEA:15045,
CC         Rhea:RHEA-COMP:10474, Rhea:RHEA-COMP:10475, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:83099,
CC         ChEBI:CHEBI:83100; EC=1.8.1.4; Evidence={ECO:0000269|PubMed:15712224,
CC         ECO:0000269|PubMed:16442803, ECO:0000269|PubMed:16770810,
CC         ECO:0000269|PubMed:17404228, ECO:0000269|PubMed:20160912,
CC         ECO:0000269|PubMed:20385101};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:15946682, ECO:0000269|PubMed:16442803};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:15946682,
CC       ECO:0000269|PubMed:16442803};
CC   -!- ACTIVITY REGULATION: Disruption of native heterodimer state inhibits
CC       primary dihydrolipoamide dehydrogenase activity and induces serine
CC       protease activity. {ECO:0000269|PubMed:17404228}.
CC   -!- SUBUNIT: Homodimer (PubMed:15946682). Part of the multimeric pyruvate
CC       dehydrogenase complex that contains multiple copies of pyruvate
CC       dehydrogenase (subunits PDHA (PDHA1 or PDHA2) and PDHB, E1),
CC       dihydrolipoamide acetyltransferase (DLAT, E2) and lipoamide
CC       dehydrogenase (DLD, E3) (PubMed:14638692). These subunits are bound to
CC       an inner core composed of about 48 DLAT and 12 PDHX molecules (by non
CC       covalent bonds) (PubMed:14638692, PubMed:20361979). The 2-oxoglutarate
CC       dehydrogenase complex is composed of OGDH (2-oxoglutarate
CC       dehydrogenase; E1), DLST (dihydrolipoamide succinyltransferase; E2) and
CC       DLD (dihydrolipoamide dehydrogenase; E3). It contains multiple copies
CC       of the three enzymatic components (E1, E2 and E3). In the nucleus, the
CC       2-oxoglutarate dehydrogenase complex associates with KAT2A
CC       (PubMed:29211711). Interacts with PDHX (PubMed:20385101,
CC       PubMed:16442803, PubMed:20160912, PubMed:20361979).
CC       {ECO:0000269|PubMed:14638692, ECO:0000269|PubMed:15946682,
CC       ECO:0000269|PubMed:16442803, ECO:0000269|PubMed:20160912,
CC       ECO:0000269|PubMed:20361979, ECO:0000269|PubMed:20385101,
CC       ECO:0000269|PubMed:29211711}.
CC   -!- INTERACTION:
CC       P09622; P42858: HTT; NbExp=3; IntAct=EBI-353366, EBI-466029;
CC       P09622; O14713: ITGB1BP1; NbExp=3; IntAct=EBI-353366, EBI-2127319;
CC       P09622; O00330: PDHX; NbExp=7; IntAct=EBI-353366, EBI-751566;
CC       P09622; P30041: PRDX6; NbExp=3; IntAct=EBI-353366, EBI-2255129;
CC       P09622; P62258: YWHAE; NbExp=5; IntAct=EBI-353366, EBI-356498;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000305|PubMed:29211711, ECO:0000305|PubMed:3693355}. Nucleus
CC       {ECO:0000269|PubMed:29211711}. Cell projection, cilium, flagellum
CC       {ECO:0000250|UniProtKB:Q811C4}. Cytoplasmic vesicle, secretory vesicle,
CC       acrosome {ECO:0000269|PubMed:15888450}. Note=Mainly localizes in the
CC       mitochondrion. A small fraction localizes to the nucleus, where the 2-
CC       oxoglutarate dehydrogenase complex is required for histone
CC       succinylation. {ECO:0000269|PubMed:29211711}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P09622-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P09622-2; Sequence=VSP_055855;
CC       Name=3;
CC         IsoId=P09622-3; Sequence=VSP_055856;
CC   -!- PTM: Tyrosine phosphorylated. {ECO:0000250|UniProtKB:Q811C4}.
CC   -!- DISEASE: Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900]:
CC       An autosomal recessive metabolic disorder characterized biochemically
CC       by a combined deficiency of the branched-chain alpha-keto acid
CC       dehydrogenase complex (BCKDC), pyruvate dehydrogenase complex (PDC),
CC       and alpha-ketoglutarate dehydrogenase complex (KGDC). Clinically,
CC       affected individuals have lactic acidosis and neurologic deterioration
CC       due to sensitivity of the central nervous system to defects in
CC       oxidative metabolism. {ECO:0000269|PubMed:10448086,
CC       ECO:0000269|PubMed:11687750, ECO:0000269|PubMed:12925875,
CC       ECO:0000269|PubMed:15712224, ECO:0000269|PubMed:16442803,
CC       ECO:0000269|PubMed:16770810, ECO:0000269|PubMed:17404228,
CC       ECO:0000269|PubMed:20160912, ECO:0000269|PubMed:8506365,
CC       ECO:0000269|PubMed:8968745, ECO:0000269|PubMed:9540846,
CC       ECO:0000269|PubMed:9934985}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The active site is a redox-active disulfide bond.
CC       {ECO:0000250|UniProtKB:P09624}.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92940.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J03490; AAA59527.1; -; mRNA.
DR   EMBL; J03620; AAA35764.1; -; mRNA.
DR   EMBL; L13761; AAB01381.1; -; Genomic_DNA.
DR   EMBL; L13749; AAB01381.1; JOINED; Genomic_DNA.
DR   EMBL; L13750; AAB01381.1; JOINED; Genomic_DNA.
DR   EMBL; L13751; AAB01381.1; JOINED; Genomic_DNA.
DR   EMBL; L13752; AAB01381.1; JOINED; Genomic_DNA.
DR   EMBL; L13753; AAB01381.1; JOINED; Genomic_DNA.
DR   EMBL; L13754; AAB01381.1; JOINED; Genomic_DNA.
DR   EMBL; L13748; AAB01381.1; JOINED; Genomic_DNA.
DR   EMBL; L13755; AAB01381.1; JOINED; Genomic_DNA.
DR   EMBL; L13759; AAB01381.1; JOINED; Genomic_DNA.
DR   EMBL; L13760; AAB01381.1; JOINED; Genomic_DNA.
DR   EMBL; L13756; AAB01381.1; JOINED; Genomic_DNA.
DR   EMBL; L13757; AAB01381.1; JOINED; Genomic_DNA.
DR   EMBL; L13758; AAB01381.1; JOINED; Genomic_DNA.
DR   EMBL; AK295080; BAG58122.1; -; mRNA.
DR   EMBL; AK300077; BAG61881.1; -; mRNA.
DR   EMBL; AK312346; BAG35267.1; -; mRNA.
DR   EMBL; AB209703; BAD92940.1; ALT_INIT; mRNA.
DR   EMBL; AC005046; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236947; EAL24389.1; -; Genomic_DNA.
DR   EMBL; CH471070; EAW83421.1; -; Genomic_DNA.
DR   EMBL; BC018648; AAH18648.1; -; mRNA.
DR   EMBL; BC018696; AAH18696.1; -; mRNA.
DR   EMBL; M99384; AAA35759.1; -; Genomic_DNA.
DR   CCDS; CCDS5749.1; -. [P09622-1]
DR   CCDS; CCDS78268.1; -. [P09622-3]
DR   PIR; A92622; DEHULP.
DR   RefSeq; NP_000099.2; NM_000108.4. [P09622-1]
DR   RefSeq; NP_001276679.1; NM_001289750.1. [P09622-2]
DR   RefSeq; NP_001276680.1; NM_001289751.1.
DR   RefSeq; NP_001276681.1; NM_001289752.1. [P09622-3]
DR   PDB; 1ZMC; X-ray; 2.53 A; A/B/C/D/E/F/G/H=36-509.
DR   PDB; 1ZMD; X-ray; 2.08 A; A/B/C/D/E/F/G/H=36-509.
DR   PDB; 1ZY8; X-ray; 2.59 A; A/B/C/D/E/F/G/H/I/J=36-509.
DR   PDB; 2F5Z; X-ray; 2.18 A; A/B/C/D/E/F/G/H/I/J=36-509.
DR   PDB; 3RNM; X-ray; 2.40 A; A/B/C/D=36-509.
DR   PDB; 5J5Z; X-ray; 1.84 A; A/B=36-509.
DR   PDB; 5NHG; X-ray; 2.27 A; A/B/C/D/E/F/G/H=36-509.
DR   PDB; 6HG8; X-ray; 1.76 A; A/B=36-509.
DR   PDB; 6I4P; X-ray; 1.60 A; A/B=36-509.
DR   PDB; 6I4Q; X-ray; 1.75 A; A/B=36-509.
DR   PDB; 6I4R; X-ray; 1.44 A; A/B=36-509.
DR   PDB; 6I4S; X-ray; 1.75 A; A/B=36-509.
DR   PDB; 6I4T; X-ray; 1.82 A; A/B=36-509.
DR   PDB; 6I4U; X-ray; 1.84 A; A/B=36-509.
DR   PDB; 6I4Z; X-ray; 2.34 A; A/B/C/D/E/F/G/H=36-509.
DR   PDBsum; 1ZMC; -.
DR   PDBsum; 1ZMD; -.
DR   PDBsum; 1ZY8; -.
DR   PDBsum; 2F5Z; -.
DR   PDBsum; 3RNM; -.
DR   PDBsum; 5J5Z; -.
DR   PDBsum; 5NHG; -.
DR   PDBsum; 6HG8; -.
DR   PDBsum; 6I4P; -.
DR   PDBsum; 6I4Q; -.
DR   PDBsum; 6I4R; -.
DR   PDBsum; 6I4S; -.
DR   PDBsum; 6I4T; -.
DR   PDBsum; 6I4U; -.
DR   PDBsum; 6I4Z; -.
DR   SMR; P09622; -.
DR   BioGRID; 108082; 431.
DR   ComplexPortal; CPX-2216; Mitochondrial 2-oxoisovalerate dehydrogenase complex.
DR   CORUM; P09622; -.
DR   DIP; DIP-29027N; -.
DR   IntAct; P09622; 353.
DR   MINT; P09622; -.
DR   STRING; 9606.ENSP00000205402; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB00145; Glycine.
DR   DrugBank; DB00157; NADH.
DR   iPTMnet; P09622; -.
DR   PhosphoSitePlus; P09622; -.
DR   SwissPalm; P09622; -.
DR   BioMuta; DLD; -.
DR   DMDM; 269849557; -.
DR   REPRODUCTION-2DPAGE; IPI00015911; -.
DR   UCD-2DPAGE; P09622; -.
DR   EPD; P09622; -.
DR   jPOST; P09622; -.
DR   MassIVE; P09622; -.
DR   MaxQB; P09622; -.
DR   PaxDb; P09622; -.
DR   PeptideAtlas; P09622; -.
DR   PRIDE; P09622; -.
DR   ProteomicsDB; 4221; -.
DR   ProteomicsDB; 5080; -.
DR   ProteomicsDB; 52254; -. [P09622-1]
DR   Antibodypedia; 17237; 499 antibodies.
DR   DNASU; 1738; -.
DR   Ensembl; ENST00000205402; ENSP00000205402; ENSG00000091140. [P09622-1]
DR   Ensembl; ENST00000417551; ENSP00000390667; ENSG00000091140. [P09622-1]
DR   Ensembl; ENST00000437604; ENSP00000387542; ENSG00000091140. [P09622-3]
DR   GeneID; 1738; -.
DR   KEGG; hsa:1738; -.
DR   UCSC; uc003vet.5; human. [P09622-1]
DR   CTD; 1738; -.
DR   DisGeNET; 1738; -.
DR   GeneCards; DLD; -.
DR   GeneReviews; DLD; -.
DR   HGNC; HGNC:2898; DLD.
DR   HPA; ENSG00000091140; Low tissue specificity.
DR   MalaCards; DLD; -.
DR   MIM; 238331; gene.
DR   MIM; 246900; phenotype.
DR   neXtProt; NX_P09622; -.
DR   OpenTargets; ENSG00000091140; -.
DR   Orphanet; 2394; Pyruvate dehydrogenase E3 deficiency.
DR   PharmGKB; PA27352; -.
DR   VEuPathDB; HostDB:ENSG00000091140.12; -.
DR   eggNOG; KOG1335; Eukaryota.
DR   GeneTree; ENSGT00550000074844; -.
DR   HOGENOM; CLU_016755_0_1_1; -.
DR   InParanoid; P09622; -.
DR   OMA; TMSEAVM; -.
DR   PhylomeDB; P09622; -.
DR   TreeFam; TF300414; -.
DR   BioCyc; MetaCyc:HS01727-MONOMER; -.
DR   BRENDA; 1.8.1.4; 2681.
DR   PathwayCommons; P09622; -.
DR   Reactome; R-HSA-204174; Regulation of pyruvate dehydrogenase (PDH) complex.
DR   Reactome; R-HSA-389661; Glyoxylate metabolism and glycine degradation.
DR   Reactome; R-HSA-5362517; Signaling by Retinoic Acid.
DR   Reactome; R-HSA-6783984; Glycine degradation.
DR   Reactome; R-HSA-70268; Pyruvate metabolism.
DR   Reactome; R-HSA-70895; Branched-chain amino acid catabolism.
DR   Reactome; R-HSA-71064; Lysine catabolism.
DR   Reactome; R-HSA-71403; Citric acid cycle (TCA cycle).
DR   SABIO-RK; P09622; -.
DR   BioGRID-ORCS; 1738; 197 hits in 998 CRISPR screens.
DR   ChiTaRS; DLD; human.
DR   EvolutionaryTrace; P09622; -.
DR   GeneWiki; Dihydrolipoamide_dehydrogenase; -.
DR   GenomeRNAi; 1738; -.
DR   Pharos; P09622; Tbio.
DR   PRO; PR:P09622; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; P09622; protein.
DR   Bgee; ENSG00000091140; Expressed in heart right ventricle and 247 other tissues.
DR   ExpressionAtlas; P09622; baseline and differential.
DR   Genevisible; P09622; HS.
DR   GO; GO:0043159; C:acrosomal matrix; IEA:Ensembl.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0031514; C:motile cilium; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0045252; C:oxoglutarate dehydrogenase complex; IDA:UniProtKB.
DR   GO; GO:0045254; C:pyruvate dehydrogenase complex; IDA:MGI.
DR   GO; GO:0004148; F:dihydrolipoyl dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:0043544; F:lipoamide binding; IEA:Ensembl.
DR   GO; GO:0051287; F:NAD binding; IEA:Ensembl.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; IEA:Ensembl.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:0051068; P:dihydrolipoamide metabolic process; IEA:Ensembl.
DR   GO; GO:0007369; P:gastrulation; IEA:Ensembl.
DR   GO; GO:0006546; P:glycine catabolic process; TAS:Reactome.
DR   GO; GO:0106077; P:histone succinylation; IDA:UniProtKB.
DR   GO; GO:0009106; P:lipoate metabolic process; IEA:Ensembl.
DR   GO; GO:0006554; P:lysine catabolic process; TAS:Reactome.
DR   GO; GO:0061732; P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; IC:MGI.
DR   GO; GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; IEA:Ensembl.
DR   GO; GO:0006508; P:proteolysis; IEA:Ensembl.
DR   GO; GO:0006090; P:pyruvate metabolic process; TAS:Reactome.
DR   GO; GO:0042391; P:regulation of membrane potential; IEA:Ensembl.
DR   GO; GO:0048240; P:sperm capacitation; IEA:Ensembl.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR006258; Lipoamide_DH.
DR   InterPro; IPR001100; Pyr_nuc-diS_OxRdtase.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   InterPro; IPR012999; Pyr_OxRdtase_I_AS.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   PIRSF; PIRSF000350; Mercury_reductase_MerA; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
DR   TIGRFAMs; TIGR01350; lipoamide_DH; 1.
DR   PROSITE; PS00076; PYRIDINE_REDOX_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell projection; Cilium;
KW   Cytoplasmic vesicle; Disease variant; Disulfide bond; FAD; Flagellum;
KW   Flavoprotein; Mitochondrion; NAD; Nucleus; Oxidoreductase; Phosphoprotein;
KW   Redox-active center; Reference proteome; Transit peptide.
FT   TRANSIT         1..35
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0007744|PubMed:25944712"
FT   CHAIN           36..509
FT                   /note="Dihydrolipoyl dehydrogenase, mitochondrial"
FT                   /id="PRO_0000030295"
FT   NP_BIND         71..80
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15946682"
FT   NP_BIND         183..185
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15946682"
FT   NP_BIND         220..227
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:15946682"
FT   NP_BIND         361..364
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15946682"
FT   ACT_SITE        487
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P09624"
FT   BINDING         89
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15946682"
FT   BINDING         154
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:15946682"
FT   BINDING         243
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:15946682"
FT   BINDING         278
FT                   /note="NAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:15946682"
FT   BINDING         314
FT                   /note="NAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:15946682"
FT   BINDING         355
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15946682"
FT   SITE            448
FT                   /note="Important for interaction with PDHX and activity of
FT                   multienzyme pyruvate dehydrogenase complex"
FT                   /evidence="ECO:0000269|PubMed:20385101"
FT   SITE            473
FT                   /note="Important for interaction with PDHX and activity of
FT                   multienzyme pyruvate dehydrogenase complex"
FT                   /evidence="ECO:0000269|PubMed:20385101"
FT   MOD_RES         66
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         66
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         104
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         104
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         122
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         122
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         132
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         132
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         143
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         143
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         159
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         166
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         273
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         277
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         285
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         297
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6P6R2"
FT   MOD_RES         346
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         410
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         410
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         417
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         420
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         430
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         502
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         505
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   MOD_RES         505
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O08749"
FT   DISULFID        80..85
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000250|UniProtKB:P09624"
FT   VAR_SEQ         1..99
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055855"
FT   VAR_SEQ         147..194
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055856"
FT   VARIANT         47
FT                   /note="I -> T (in DLDD; dbSNP:rs397514651)"
FT                   /evidence="ECO:0000269|PubMed:16770810"
FT                   /id="VAR_076985"
FT   VARIANT         72
FT                   /note="K -> E (in DLDD; reduced dihydrolipoyl dehydrogenase
FT                   activity; no effect on interaction with PDHX;
FT                   dbSNP:rs121964987)"
FT                   /evidence="ECO:0000269|PubMed:20160912,
FT                   ECO:0000269|PubMed:8506365"
FT                   /id="VAR_006907"
FT   VARIANT         104
FT                   /note="K -> T (in dbSNP:rs1130477)"
FT                   /evidence="ECO:0000269|PubMed:3693355,
FT                   ECO:0000269|PubMed:8406489"
FT                   /id="VAR_031922"
FT   VARIANT         136
FT                   /note="Missing (in DLDD)"
FT                   /evidence="ECO:0000269|PubMed:9540846"
FT                   /id="VAR_076986"
FT   VARIANT         229
FT                   /note="G -> C (in DLDD; dbSNP:rs121964990)"
FT                   /evidence="ECO:0000269|PubMed:16770810,
FT                   ECO:0000269|PubMed:9934985"
FT                   /id="VAR_015820"
FT   VARIANT         331
FT                   /note="L -> V (in dbSNP:rs17624)"
FT                   /id="VAR_014555"
FT   VARIANT         361
FT                   /note="M -> V (in DLDD; dbSNP:rs121964993)"
FT                   /evidence="ECO:0000269|PubMed:11687750"
FT                   /id="VAR_076987"
FT   VARIANT         375
FT                   /note="E -> K (in DLDD; loss of enzyme activity; abolished
FT                   interaction with PDHX; dbSNP:rs121964992)"
FT                   /evidence="ECO:0000269|PubMed:11687750,
FT                   ECO:0000269|PubMed:16770810, ECO:0000269|PubMed:20160912,
FT                   ECO:0000269|PubMed:9540846"
FT                   /id="VAR_076988"
FT   VARIANT         393
FT                   /note="I -> T (in DLDD; dbSNP:rs121964991)"
FT                   /evidence="ECO:0000269|PubMed:12925875"
FT                   /id="VAR_076989"
FT   VARIANT         479
FT                   /note="D -> V (in DLDD; reduced dehydrogenase activity;
FT                   increased proteolytic activity; dbSNP:rs397514649)"
FT                   /evidence="ECO:0000269|PubMed:10448086,
FT                   ECO:0000269|PubMed:17404228"
FT                   /id="VAR_076990"
FT   VARIANT         482
FT                   /note="R -> G (in DLDD; reduced enzyme activity;
FT                   dbSNP:rs397514650)"
FT                   /id="VAR_076991"
FT   VARIANT         488
FT                   /note="P -> L (in DLDD; no effect on interaction with PDHX;
FT                   dbSNP:rs121964988)"
FT                   /evidence="ECO:0000269|PubMed:20160912,
FT                   ECO:0000269|PubMed:8506365"
FT                   /id="VAR_006908"
FT   VARIANT         495
FT                   /note="R -> G (in DLDD; loss of enzyme activity; reduced
FT                   interaction with PDHX; dbSNP:rs121964989)"
FT                   /evidence="ECO:0000269|PubMed:16442803,
FT                   ECO:0000269|PubMed:20160912, ECO:0000269|PubMed:8968745"
FT                   /id="VAR_015821"
FT   MUTAGEN         89
FT                   /note="K->E: Abolishes dihydrolipoyl dehydrogenase
FT                   activity. Does not affect interaction with PDHX."
FT                   /evidence="ECO:0000269|PubMed:20160912"
FT   MUTAGEN         383
FT                   /note="H->A: Reduces dihydrolipoyl dehydrogenase activity."
FT                   /evidence="ECO:0000269|PubMed:20385101"
FT   MUTAGEN         383
FT                   /note="H->L: Reduces dihydrolipoyl dehydrogenase activity."
FT                   /evidence="ECO:0000269|PubMed:20385101"
FT   MUTAGEN         448
FT                   /note="D->A: Reduces interaction with PDHX. Inhibits
FT                   multienzyme pyruvate dehydrogenase complex activity. Does
FT                   not affect dihydrolipoyl dehydrogenase activity."
FT                   /evidence="ECO:0000269|PubMed:20385101"
FT   MUTAGEN         448
FT                   /note="D->N: Does not affect dihydrolipoyl dehydrogenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:20385101"
FT   MUTAGEN         466
FT                   /note="E->A: Decreases dehydrogenase activity. Loss of
FT                   proteolytic activity."
FT                   /evidence="ECO:0000269|PubMed:17404228"
FT   MUTAGEN         473
FT                   /note="Y->A: Reduces interaction with PDHX. Inhibits
FT                   multienzyme pyruvate dehydrogenase complex activity. Does
FT                   not affect dihydrolipoyl dehydrogenase activity."
FT                   /evidence="ECO:0000269|PubMed:20385101"
FT   MUTAGEN         473
FT                   /note="Y->F: Does not affect dihydrolipoyl dehydrogenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:20385101"
FT   MUTAGEN         473
FT                   /note="Y->H: Reduces interaction with PDHX. Inhibits
FT                   multienzyme pyruvate dehydrogenase complex activity. Does
FT                   not affect dihydrolipoyl dehydrogenase activity."
FT                   /evidence="ECO:0000269|PubMed:20385101"
FT   MUTAGEN         482
FT                   /note="R->A: Does not affect dihydrolipoyl dehydrogenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:20385101"
FT   MUTAGEN         482
FT                   /note="R->M: Does not affect interaction with PDHX."
FT                   /evidence="ECO:0000269|PubMed:20160912"
FT   MUTAGEN         485
FT                   /note="H->A: Loss of dehydrogenase activity. Increases
FT                   proteolytic activity."
FT                   /evidence="ECO:0000269|PubMed:17404228"
FT   MUTAGEN         491
FT                   /note="S->A: Loss of proteolytic activity. Does not affect
FT                   dehydrogenase activity."
FT                   /evidence="ECO:0000269|PubMed:17404228"
FT   MUTAGEN         492
FT                   /note="E->Q: Reduces dihydrolipoyl dehydrogenase activity.
FT                   Does not affect interaction with PDHX."
FT                   /evidence="ECO:0000269|PubMed:20160912"
FT   MUTAGEN         505
FT                   /note="K->M: Reduces dihydrolipoyl dehydrogenase activity.
FT                   Does not affect interaction with PDHX."
FT                   /evidence="ECO:0000269|PubMed:20160912"
FT   CONFLICT        154
FT                   /note="G -> R (in Ref. 2; AAA35764)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        209
FT                   /note="L -> F (in Ref. 5; BAD92940)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        493
FT                   /note="A -> AEA (in Ref. 3; AAB01381)"
FT                   /evidence="ECO:0000305"
FT   STRAND          40..47
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           51..62
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          67..71
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          73..77
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           78..83
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           85..102
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           105..108
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          111..114
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          116..118
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           120..144
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          148..158
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          161..165
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          171..181
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          185..187
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          197..201
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           203..206
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          214..219
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           223..235
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          238..242
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          244..249
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           255..268
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          271..273
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          275..283
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          289..295
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          302..311
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          315..317
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           324..327
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          350..352
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           354..356
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          357..359
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           363..377
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           386..388
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          391..393
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          395..403
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           406..412
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          416..422
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           423..425
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           427..432
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          438..444
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   TURN            445..447
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   STRAND          449..457
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           460..473
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           477..482
FT                   /evidence="ECO:0007829|PDB:6I4R"
FT   HELIX           491..503
FT                   /evidence="ECO:0007829|PDB:6I4R"
SQ   SEQUENCE   509 AA;  54177 MW;  7613492C516F3835 CRC64;
     MQSWSRVYCS LAKRGHFNRI SHGLQGLSAV PLRTYADQPI DADVTVIGSG PGGYVAAIKA
     AQLGFKTVCI EKNETLGGTC LNVGCIPSKA LLNNSHYYHM AHGKDFASRG IEMSEVRLNL
     DKMMEQKSTA VKALTGGIAH LFKQNKVVHV NGYGKITGKN QVTATKADGG TQVIDTKNIL
     IATGSEVTPF PGITIDEDTI VSSTGALSLK KVPEKMVVIG AGVIGVELGS VWQRLGADVT
     AVEFLGHVGG VGIDMEISKN FQRILQKQGF KFKLNTKVTG ATKKSDGKID VSIEAASGGK
     AEVITCDVLL VCIGRRPFTK NLGLEELGIE LDPRGRIPVN TRFQTKIPNI YAIGDVVAGP
     MLAHKAEDEG IICVEGMAGG AVHIDYNCVP SVIYTHPEVA WVGKSEEQLK EEGIEYKVGK
     FPFAANSRAK TNADTDGMVK ILGQKSTDRV LGAHILGPGA GEMVNEAALA LEYGASCEDI
     ARVCHAHPTL SEAFREANLA ASFGKSINF
//
ID   FADE5_MYCS2             Reviewed;         611 AA.
AC   Q3L887; A0QPI1; I7FWC0;
DT   07-APR-2021, integrated into UniProtKB/Swiss-Prot.
DT   08-NOV-2005, sequence version 1.
DT   02-JUN-2021, entry version 111.
DE   RecName: Full=Broad-specificity linear acyl-CoA dehydrogenase FadE5 {ECO:0000305};
DE   AltName: Full=Long-chain-acyl-CoA dehydrogenase {ECO:0000305};
DE            EC=1.3.8.8 {ECO:0000269|PubMed:32601219};
DE   AltName: Full=Medium-chain-acyl-CoA dehydrogenase {ECO:0000305};
DE            EC=1.3.8.7 {ECO:0000269|PubMed:32601219};
DE   AltName: Full=Short-chain-acyl-CoA dehydrogenase {ECO:0000305};
DE            EC=1.3.8.1 {ECO:0000269|PubMed:32601219};
GN   Name=fadE5 {ECO:0000303|PubMed:32601219};
GN   OrderedLocusNames=MSMEG_0406 {ECO:0000312|EMBL:ABK75628.1},
GN   MSMEI_0396 {ECO:0000312|EMBL:AFP36877.1};
OS   Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) (Mycobacterium
OS   smegmatis).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycolicibacterium.
OX   NCBI_TaxID=246196;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=16194230; DOI=10.1111/j.1365-2958.2005.04847.x;
RA   Sonden B., Kocincova D., Deshayes C., Euphrasie D., Rhayat L., Laval F.,
RA   Frehel C., Daffe M., Etienne G., Reyrat J.M.;
RT   "Gap, a mycobacterial specific integral membrane protein, is required for
RT   glycolipid transport to the cell surface.";
RL   Mol. Microbiol. 58:426-440(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700084 / mc(2)155;
RA   Fleischmann R.D., Dodson R.J., Haft D.H., Merkel J.S., Nelson W.C.,
RA   Fraser C.M.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=17295914; DOI=10.1186/gb-2007-8-2-r20;
RA   Deshayes C., Perrodou E., Gallien S., Euphrasie D., Schaeffer C.,
RA   Van-Dorsselaer A., Poch O., Lecompte O., Reyrat J.-M.;
RT   "Interrupted coding sequences in Mycobacterium smegmatis: authentic
RT   mutations or sequencing errors?";
RL   Genome Biol. 8:R20.1-R20.9(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=18955433; DOI=10.1101/gr.081901.108;
RA   Gallien S., Perrodou E., Carapito C., Deshayes C., Reyrat J.-M.,
RA   Van Dorsselaer A., Poch O., Schaeffer C., Lecompte O.;
RT   "Ortho-proteogenomics: multiple proteomes investigation through orthology
RT   and a new MS-based protocol.";
RL   Genome Res. 19:128-135(2009).
RN   [5] {ECO:0007744|PDB:6KPT, ECO:0007744|PDB:6KRI, ECO:0007744|PDB:6KS9, ECO:0007744|PDB:6KSA, ECO:0007744|PDB:6KSB, ECO:0007744|PDB:6LPY, ECO:0007744|PDB:6LQ0, ECO:0007744|PDB:6LQ1, ECO:0007744|PDB:6LQ2, ECO:0007744|PDB:6LQ3, ECO:0007744|PDB:6LQ4}
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF WILD-TYPE IN COMPLEX WITH FAD AND
RP   MUTANT ALA-447 IN COMPLEXES WITH FAD AND LINEAR ACYL-COA SUBSTRATES,
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES,
RP   PATHWAY, SUBUNIT, DISRUPTION PHENOTYPE, ACTIVE SITE, AND MUTAGENESIS OF
RP   GLU-447.
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=32601219; DOI=10.1073/pnas.2002835117;
RA   Chen X., Chen J., Yan B., Zhang W., Guddat L.W., Liu X., Rao Z.;
RT   "Structural basis for the broad substrate specificity of two acyl-CoA
RT   dehydrogenases FadE5 from mycobacteria.";
RL   Proc. Natl. Acad. Sci. U.S.A. 117:16324-16332(2020).
CC   -!- FUNCTION: Acyl-CoA dehydrogenase that exhibits broad specificity for
CC       linear acyl-CoA substrates, with a preference for long-chain
CC       substrates. {ECO:0000269|PubMed:32601219}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a long-chain 2,3-saturated fatty acyl-CoA + H(+) + oxidized
CC         [electron-transfer flavoprotein] = a long-chain (2E)-enoyl-CoA +
CC         reduced [electron-transfer flavoprotein]; Xref=Rhea:RHEA:17721,
CC         Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:83721,
CC         ChEBI:CHEBI:83727; EC=1.3.8.8;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a medium-chain 2,3-saturated fatty acyl-CoA + H(+) + oxidized
CC         [electron-transfer flavoprotein] = a medium-chain trans-(2E)-enoyl-
CC         CoA + reduced [electron-transfer flavoprotein]; Xref=Rhea:RHEA:14477,
CC         Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:83723,
CC         ChEBI:CHEBI:83726; EC=1.3.8.7;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a short-chain 2,3-saturated fatty acyl-CoA + H(+) + oxidized
CC         [electron-transfer flavoprotein] = a short-chain (2E)-enoyl-CoA +
CC         reduced [electron-transfer flavoprotein]; Xref=Rhea:RHEA:47196,
CC         Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:87487,
CC         ChEBI:CHEBI:87488; EC=1.3.8.1;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + octadecanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] = (2E)-octadecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47240, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57394, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:71412;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hexadecanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] = (2E)-hexadecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:43448, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57379, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:61526;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-dodecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47296, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57330, ChEBI:CHEBI:57375,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=decanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-decenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:48176, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:61406, ChEBI:CHEBI:61430;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hexanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] = (2E)-hexenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:43464, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:62077, ChEBI:CHEBI:62620;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=butanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-butenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:24004, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57332, ChEBI:CHEBI:57371,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000305|PubMed:32601219};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=285.9 uM for butanoyl-CoA {ECO:0000269|PubMed:32601219};
CC         Note=kcat is 0.53 sec(-1) with butanoyl-CoA as substrate.
CC         {ECO:0000269|PubMed:32601219};
CC   -!- PATHWAY: Lipid metabolism; fatty acid metabolism.
CC       {ECO:0000305|PubMed:32601219}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:32601219}.
CC   -!- DISRUPTION PHENOTYPE: Disruption of the gene does not affect the growth
CC       rate, but mutant shows decreased resistance to ethambutol and
CC       streptomycin. {ECO:0000269|PubMed:32601219}.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY439015; AAU04876.1; -; Genomic_DNA.
DR   EMBL; CP000480; ABK75628.1; -; Genomic_DNA.
DR   EMBL; CP001663; AFP36877.1; -; Genomic_DNA.
DR   RefSeq; WP_011726920.1; NZ_SIJM01000040.1.
DR   RefSeq; YP_884819.1; NC_008596.1.
DR   PDB; 6KPT; X-ray; 1.96 A; A/B=1-611.
DR   PDB; 6KRI; X-ray; 1.60 A; A/B=1-611.
DR   PDB; 6KS9; X-ray; 2.00 A; A/B=1-611.
DR   PDB; 6KSA; X-ray; 1.77 A; A/B=1-611.
DR   PDB; 6KSB; X-ray; 1.97 A; A/B=1-611.
DR   PDB; 6LPY; X-ray; 1.90 A; A/B=1-611.
DR   PDB; 6LQ0; X-ray; 2.20 A; A/B=1-611.
DR   PDB; 6LQ1; X-ray; 2.80 A; A/B=1-611.
DR   PDB; 6LQ2; X-ray; 1.90 A; A/B=1-611.
DR   PDB; 6LQ3; X-ray; 2.50 A; A/B=1-611.
DR   PDB; 6LQ4; X-ray; 2.40 A; A/B=1-611.
DR   PDB; 6LQ5; X-ray; 1.90 A; A/B=1-611.
DR   PDB; 6LQ6; X-ray; 2.00 A; A/B=1-611.
DR   PDB; 6LQ7; X-ray; 1.90 A; A/B=1-611.
DR   PDBsum; 6KPT; -.
DR   PDBsum; 6KRI; -.
DR   PDBsum; 6KS9; -.
DR   PDBsum; 6KSA; -.
DR   PDBsum; 6KSB; -.
DR   PDBsum; 6LPY; -.
DR   PDBsum; 6LQ0; -.
DR   PDBsum; 6LQ1; -.
DR   PDBsum; 6LQ2; -.
DR   PDBsum; 6LQ3; -.
DR   PDBsum; 6LQ4; -.
DR   PDBsum; 6LQ5; -.
DR   PDBsum; 6LQ6; -.
DR   PDBsum; 6LQ7; -.
DR   SMR; Q3L887; -.
DR   STRING; 246196.MSMEI_0396; -.
DR   PRIDE; Q3L887; -.
DR   EnsemblBacteria; ABK75628; ABK75628; MSMEG_0406.
DR   EnsemblBacteria; AFP36877; AFP36877; MSMEI_0396.
DR   GeneID; 45741997; -.
DR   KEGG; msg:MSMEI_0396; -.
DR   KEGG; msm:MSMEG_0406; -.
DR   PATRIC; fig|246196.19.peg.402; -.
DR   eggNOG; COG1960; Bacteria.
DR   OMA; IEHARMM; -.
DR   OrthoDB; 357522at2; -.
DR   BioCyc; MSME246196:G1H7P-414-MONOMER; -.
DR   UniPathway; UPA00199; -.
DR   Proteomes; UP000000757; Chromosome.
DR   Proteomes; UP000006158; Chromosome.
DR   GO; GO:0004085; F:butyryl-CoA dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0004466; F:long-chain-acyl-CoA dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR025878; Acyl-CoA_dh-like_C_dom.
DR   InterPro; IPR020953; Acyl-CoA_DH_N_bac.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF12806; Acyl-CoA_dh_C; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF12418; AcylCoA_DH_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Fatty acid metabolism; Flavoprotein; Lipid metabolism;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN           1..611
FT                   /note="Broad-specificity linear acyl-CoA dehydrogenase
FT                   FadE5"
FT                   /id="PRO_0000452497"
FT   NP_BIND         162..165
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   NP_BIND         420..424
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   REGION          224..225
FT                   /note="A 2,3-saturated acyl-CoA binding"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   REGION          460..461
FT                   /note="A 2,3-saturated acyl-CoA binding"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   ACT_SITE        447
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:32601219"
FT   BINDING         171
FT                   /note="A 2,3-saturated acyl-CoA"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         171
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         198
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         301
FT                   /note="A 2,3-saturated acyl-CoA"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         326
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         338
FT                   /note="A 2,3-saturated acyl-CoA"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         447
FT                   /note="A 2,3-saturated acyl-CoA"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         449
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         456
FT                   /note="A 2,3-saturated acyl-CoA"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   MUTAGEN         447
FT                   /note="E->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:32601219"
SQ   SEQUENCE   611 AA;  66532 MW;  41D1ABFE887E0206 CRC64;
     MSHYKSNVRD QVFNLFEVFG VDKVLGADKF SDLDADTARE MLTEIARLAE GPIAESFVEG
     DRNPPVFDPE THTVTLPEGF KKSMRALFDG GWDKVGLAEH LGGIPMPRAL QWALIEHILG
     ANPAAYMYAM GPGMSEIFYN NGTDEQKKWA TIAAERGWGA TMVLTEPDAG SDVGAGRTKA
     VQQPDGTWHI EGVKRFITSA DSDDLFENIM HLVLARPEGA GPGTKGLSLF FVPKFHFDHE
     TGEIGERNGV FVTNVEHKMG LKVSATCELS LGQHGIPAVG WLVGEVHNGI AQMFDVIEQA
     RMMVGTKAIA TLSTGYLNAL EYAKERVQGA DMTQMTDKTA PRVTITHHPD VRRSLMTQKA
     YAEGLRAIYL YTATFQDAEV AQAVHGVDGD LAARVNDLLL PIVKGFGSET AYAKLTESLQ
     TLGGSGFLQD YPIEQYIRDS KIDSLYEGTT AIQAQDFFFR KIIRDKGQAL AYVAGEIEQF
     IKNENGNGRL KTERELLATA LADVQGMAAS LTGYLMAAQE DAASIYKVGL GSVRFLMAVG
     DLLSGWLLAR QAAVAIEKLD AGATGADKSF YEGKIAAASF FAKNMLPLLT STRQIIENLD
     NDVMELDEAA F
//
ID   FENR_AZOVI              Reviewed;         258 AA.
AC   Q44532;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-JUN-2021, entry version 100.
DE   RecName: Full=Ferredoxin--NADP reductase {ECO:0000305};
DE            Short=FNR {ECO:0000305};
DE            EC=1.18.1.2 {ECO:0000269|PubMed:8034707};
DE   AltName: Full=NADPH:ferredoxin reductase {ECO:0000303|PubMed:7673160};
DE   AltName: Full=Protein X {ECO:0000303|PubMed:8034707};
GN   Name=fpr {ECO:0000303|PubMed:7673160};
OS   Azotobacter vinelandii.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Azotobacter.
OX   NCBI_TaxID=354;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND INDUCTION.
RC   STRAIN=ATCC 13705 / OP1 / DSM 366 / NCIB 11614 / LMG 3878 / UW;
RX   PubMed=7673160; DOI=10.1074/jbc.270.36.21258;
RA   Isas J.M., Yannone S.M., Burgess B.K.;
RT   "Azotobacter vinelandii NADPH:ferredoxin reductase cloning, sequencing, and
RT   overexpression.";
RL   J. Biol. Chem. 270:21258-21263(1995).
RN   [2]
RP   PROTEIN SEQUENCE OF 1-36, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND
RP   SUBUNIT.
RC   STRAIN=ATCC 13705 / OP1 / DSM 366 / NCIB 11614 / LMG 3878 / UW;
RX   PubMed=8034707;
RA   Isas J.M., Burgess B.K.;
RT   "Purification and characterization of a NADP+/NADPH-specific flavoprotein
RT   that is overexpressed in FdI-strains of Azotobacter vinelandii.";
RL   J. Biol. Chem. 269:19404-19409(1994).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH FAD, AND COFACTOR.
RC   STRAIN=LM100;
RX   PubMed=9865948; DOI=10.1002/pro.5560071207;
RA   Prasad G.S., Kresge N., Muhlberg A.B., Shaw A., Jung Y.S., Burgess B.K.,
RA   Stout C.D.;
RT   "The crystal structure of NADPH:ferredoxin reductase from Azotobacter
RT   vinelandii.";
RL   Protein Sci. 7:2541-2549(1998).
CC   -!- FUNCTION: Transports electrons between ferredoxin and NADPH.
CC       {ECO:0000269|PubMed:8034707}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADP(+) + 2 reduced [2Fe-2S]-[ferredoxin] = NADPH + 2
CC         oxidized [2Fe-2S]-[ferredoxin]; Xref=Rhea:RHEA:20125, Rhea:RHEA-
CC         COMP:10000, Rhea:RHEA-COMP:10001, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:33737, ChEBI:CHEBI:33738, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.18.1.2;
CC         Evidence={ECO:0000269|PubMed:8034707};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:8034707, ECO:0000269|PubMed:9865948};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:8034707}.
CC   -!- INDUCTION: Overexpressed under N(2)-fixing conditions.
CC       {ECO:0000269|PubMed:7673160}.
CC   -!- SIMILARITY: Belongs to the ferredoxin--NADP reductase type 1 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L36319; AAA83029.1; -; Genomic_DNA.
DR   PIR; A57432; A57432.
DR   RefSeq; WP_012702363.1; NZ_FPKM01000003.1.
DR   PDB; 1A8P; X-ray; 2.00 A; A=1-258.
DR   PDBsum; 1A8P; -.
DR   SMR; Q44532; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   PRIDE; Q44532; -.
DR   EvolutionaryTrace; Q44532; -.
DR   GO; GO:0004324; F:ferredoxin-NADP+ reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   CDD; cd06195; FNR1; 1.
DR   Gene3D; 3.40.50.80; -; 1.
DR   InterPro; IPR008333; Cbr1-like_FAD-bd_dom.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR033892; FNR_bac.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF00970; FAD_binding_6; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52343; SSF52343; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; FAD; Flavoprotein; NADP;
KW   Nucleotide-binding; Oxidoreductase.
FT   CHAIN           1..258
FT                   /note="Ferredoxin--NADP reductase"
FT                   /id="PRO_0000167639"
FT   DOMAIN          2..102
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   NP_BIND         51..54
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9865948"
FT   NP_BIND         67..69
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9865948"
FT   NP_BIND         74..77
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9865948"
FT   NP_BIND         144..145
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:P28861"
FT   NP_BIND         181..182
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:P28861"
FT   NP_BIND         254..258
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9865948"
FT   BINDING         17
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:P28861"
FT   BINDING         117
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9865948"
FT   BINDING         190
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:P28861"
FT   STRAND          4..16
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   STRAND          19..25
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   STRAND          37..44
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   STRAND          47..54
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   STRAND          61..69
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   HELIX           77..80
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   STRAND          88..93
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   HELIX           101..103
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   STRAND          108..115
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   HELIX           116..119
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   HELIX           120..125
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   HELIX           129..134
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   STRAND          136..146
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   HELIX           147..149
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   HELIX           153..157
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   HELIX           160..162
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   TURN            164..166
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   HELIX           167..173
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   STRAND          174..183
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   STRAND          186..189
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   HELIX           191..196
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   HELIX           199..204
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   TURN            211..213
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   STRAND          214..220
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   HELIX           222..234
FT                   /evidence="ECO:0007829|PDB:1A8P"
FT   STRAND          247..255
FT                   /evidence="ECO:0007829|PDB:1A8P"
SQ   SEQUENCE   258 AA;  29417 MW;  2865C2FC786A6C04 CRC64;
     MSNLNVERVL SVHHWNDTLF SFKTTRNPSL RFENGQFVMI GLEVDGRPLM RAYSIASPNY
     EEHLEFFSIK VQNGPLTSRL QHLKEGDELM VSRKPTGTLV TSDLLPGKHL YMLSTGTGLA
     PFMSLIQDPE VYERFEKVVL IHGVRQVNEL AYQQFITEHL PQSEYFGEAV KEKLIYYPTV
     TRESFHNQGR LTDLMRSGKL FEDIGLPPIN PQDDRAMICG SPSMLDESCE VLDGFGLKIS
     PRMGEPGDYL IERAFVEK
//
ID   GCOB_AMYS7              Reviewed;         334 AA.
AC   P0DPQ8;
DT   10-OCT-2018, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2018, sequence version 1.
DT   26-FEB-2020, entry version 7.
DE   RecName: Full=Aromatic O-demethylase, reductase subunit {ECO:0000305|PubMed:29950589};
DE            EC=1.6.2.- {ECO:0000269|PubMed:29950589};
DE   AltName: Full=NADH--hemoprotein reductase {ECO:0000305|PubMed:29950589};
GN   Name=gcoB {ECO:0000303|PubMed:29950589};
OS   Amycolatopsis sp. (strain ATCC 39116 / 75iv2).
OC   Bacteria; Actinobacteria; Pseudonocardiales; Pseudonocardiaceae;
OC   Amycolatopsis; unclassified Amycolatopsis.
OX   NCBI_TaxID=385957;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 39116 / 75iv2;
RX   PubMed=22493203; DOI=10.1128/jb.00186-12;
RA   Davis J.R., Goodwin L.A., Woyke T., Teshima H., Bruce D., Detter C.,
RA   Tapia R., Han S., Han J., Pitluck S., Nolan M., Mikhailova N., Land M.L.,
RA   Sello J.K.;
RT   "Genome sequence of Amycolatopsis sp. strain ATCC 39116, a plant biomass-
RT   degrading actinomycete.";
RL   J. Bacteriol. 194:2396-2397(2012).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (1.72 ANGSTROMS) IN COMPLEX WITH FAD AND 2FE-2S
RP   CLUSTER, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBUNIT, AND DOMAIN.
RC   STRAIN=ATCC 39116 / 75iv2;
RX   PubMed=29950589; DOI=10.1038/s41467-018-04878-2;
RA   Mallinson S.J.B., Machovina M.M., Silveira R.L., Garcia-Borras M.,
RA   Gallup N., Johnson C.W., Allen M.D., Skaf M.S., Crowley M.F., Neidle E.L.,
RA   Houk K.N., Beckham G.T., DuBois J.L., McGeehan J.E.;
RT   "A promiscuous cytochrome P450 aromatic O-demethylase for lignin
RT   bioconversion.";
RL   Nat. Commun. 9:2487-2487(2018).
CC   -!- FUNCTION: Part of a two-component P450 system that efficiently O-
CC       demethylates diverse aromatic substrates such as guaiacol and a wide
CC       variety of lignin-derived monomers. Is likely involved in lignin
CC       degradation, allowing Amycolatopsis sp. ATCC 39116 to catabolize plant
CC       biomass. GcoB transfers electrons from NADH to the cytochrome P450
CC       subunit GcoA. Highly prefers NADH over NADPH as the electron donor.
CC       {ECO:0000269|PubMed:29950589}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADH + 2 oxidized [cytochrome P450] = H(+) + NAD(+) + 2
CC         reduced [cytochrome P450]; Xref=Rhea:RHEA:57420, Rhea:RHEA-
CC         COMP:14627, Rhea:RHEA-COMP:14628, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:55376, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:60344; Evidence={ECO:0000269|PubMed:29950589};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:29950589};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:29950589};
CC   -!- COFACTOR:
CC       Name=[2Fe-2S] cluster; Xref=ChEBI:CHEBI:49601;
CC         Evidence={ECO:0000269|PubMed:29950589};
CC       Note=Binds 1 [2Fe-2S] cluster per subunit.
CC       {ECO:0000269|PubMed:29950589};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=16 uM for NADH {ECO:0000269|PubMed:29950589};
CC         Note=kcat is 44 sec(-1) for NADH-mediated reduction of cytochrome c.
CC         {ECO:0000269|PubMed:29950589};
CC   -!- PATHWAY: Aromatic compound metabolism. {ECO:0000305|PubMed:29950589}.
CC   -!- SUBUNIT: Monomer. Forms a heterodimer with GcoA.
CC       {ECO:0000269|PubMed:29950589}.
CC   -!- DOMAIN: GcoB has an unusual three-domain structure, with an N-terminal
CC       2Fe-2S domain and a C-terminal region that consists of an FAD-binding
CC       domain followed by an NADH-binding domain.
CC       {ECO:0000269|PubMed:29950589}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AFWY03000000; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; WP_020419854.1; NZ_AFWY03000022.1.
DR   PDB; 5OGX; X-ray; 1.72 A; A=1-334.
DR   PDBsum; 5OGX; -.
DR   SMR; P0DPQ8; -.
DR   GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0009055; F:electron transfer activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-KW.
DR   CDD; cd00207; fer2; 1.
DR   Gene3D; 3.10.20.30; -; 1.
DR   Gene3D; 3.40.50.80; -; 1.
DR   InterPro; IPR036010; 2Fe-2S_ferredoxin-like_sf.
DR   InterPro; IPR001041; 2Fe-2S_ferredoxin-type.
DR   InterPro; IPR006058; 2Fe2S_fd_BS.
DR   InterPro; IPR012675; Beta-grasp_dom_sf.
DR   InterPro; IPR008333; Cbr1-like_FAD-bd_dom.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF00970; FAD_binding_6; 1.
DR   Pfam; PF00111; Fer2; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52343; SSF52343; 1.
DR   SUPFAM; SSF54292; SSF54292; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   PROSITE; PS00197; 2FE2S_FER_1; 1.
DR   PROSITE; PS51085; 2FE2S_FER_2; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
PE   1: Evidence at protein level;
KW   2Fe-2S; 3D-structure; Aromatic hydrocarbons catabolism; Electron transport;
KW   FAD; Flavoprotein; Iron; Iron-sulfur; Metal-binding; NAD; Oxidoreductase;
KW   Transport.
FT   CHAIN           1..334
FT                   /note="Aromatic O-demethylase, reductase subunit"
FT                   /id="PRO_0000445480"
FT   DOMAIN          1..91
FT                   /note="2Fe-2S ferredoxin-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00465"
FT   DOMAIN          98..198
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   NP_BIND         145..148
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29950589"
FT   NP_BIND         162..164
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29950589"
FT   NP_BIND         170..172
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29950589"
FT   METAL           35
FT                   /note="Iron-sulfur (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:29950589"
FT   METAL           40
FT                   /note="Iron-sulfur (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:29950589"
FT   METAL           43
FT                   /note="Iron-sulfur (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:29950589"
FT   METAL           75
FT                   /note="Iron-sulfur (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:29950589"
FT   BINDING         215
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29950589"
FT   BINDING         330
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29950589"
FT   BINDING         334
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29950589"
SQ   SEQUENCE   334 AA;  35566 MW;  176005B2CFFF7C7E CRC64;
     MTFAVSVGGR RVDCEPGQTL LEAFLRGGVW MPNSCNQGTC GTCKLQVLSG EVDHGGAPED
     TLSAEERASG LALACQARPL ADTEVRSTAD AGRVTHPLRD LTATVLEVAD IARDTRRVLL
     GLAEPLAFEA GQYVELVVPG SGARRQYSLA NTADEDKVLE LHVRRVPGGV ATDGWLFDGL
     AAGDRVEATG PLGDFHLPPP DEDDGGPMVL IGGGTGLAPL VGIARTALAR HPSREVLLYH
     GVRGAADLYD LGRFAEIAEE HPGFRFVPVL SDEPDPAYRG GFPTDAFVED VPSGRGWSGW
     LCGPPAMVEA GVKAFKRRRM SPRRIHREKF TPAS
//
ID   6HN3M_PSEPK             Reviewed;         382 AA.
AC   Q88FY2;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   02-JUN-2021, entry version 97.
DE   RecName: Full=6-hydroxynicotinate 3-monooxygenase {ECO:0000303|PubMed:27218267};
DE            Short=6-HNA monooxygenase {ECO:0000303|PubMed:27218267};
DE            EC=1.14.13.114 {ECO:0000269|PubMed:18678916, ECO:0000269|PubMed:27218267};
DE   AltName: Full=Nicotinate degradation protein C;
DE   Flags: Precursor;
GN   Name=nicC {ECO:0000303|PubMed:27218267}; OrderedLocusNames=PP_3944;
OS   Pseudomonas putida (strain ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=160488;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440;
RX   PubMed=12534463; DOI=10.1046/j.1462-2920.2002.00366.x;
RA   Nelson K.E., Weinel C., Paulsen I.T., Dodson R.J., Hilbert H.,
RA   Martins dos Santos V.A.P., Fouts D.E., Gill S.R., Pop M., Holmes M.,
RA   Brinkac L.M., Beanan M.J., DeBoy R.T., Daugherty S.C., Kolonay J.F.,
RA   Madupu R., Nelson W.C., White O., Peterson J.D., Khouri H.M., Hance I.,
RA   Chris Lee P., Holtzapple E.K., Scanlan D., Tran K., Moazzez A.,
RA   Utterback T.R., Rizzo M., Lee K., Kosack D., Moestl D., Wedler H.,
RA   Lauber J., Stjepandic D., Hoheisel J., Straetz M., Heim S., Kiewitz C.,
RA   Eisen J.A., Timmis K.N., Duesterhoeft A., Tuemmler B., Fraser C.M.;
RT   "Complete genome sequence and comparative analysis of the metabolically
RT   versatile Pseudomonas putida KT2440.";
RL   Environ. Microbiol. 4:799-808(2002).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440;
RX   PubMed=18678916; DOI=10.1073/pnas.0802273105;
RA   Jimenez J.I., Canales A., Jimenez-Barbero J., Ginalski K., Rychlewski L.,
RA   Garcia J.L., Diaz E.;
RT   "Deciphering the genetic determinants for aerobic nicotinic acid
RT   degradation: the nic cluster from Pseudomonas putida KT2440.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:11329-11334(2008).
RN   [3]
RP   INDUCTION.
RC   STRAIN=ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440;
RX   PubMed=21450002; DOI=10.1111/j.1462-2920.2011.02471.x;
RA   Jimenez J.I., Juarez J.F., Garcia J.L., Diaz E.;
RT   "A finely tuned regulatory circuit of the nicotinic acid degradation
RT   pathway in Pseudomonas putida.";
RL   Environ. Microbiol. 13:1718-1732(2011).
RN   [4] {ECO:0007744|PDB:5EOW}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH FAD, FUNCTION,
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, SUBUNIT, AND
RP   PATHWAY.
RC   STRAIN=ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440;
RX   PubMed=27218267; DOI=10.1021/acs.biochem.6b00105;
RA   Hicks K.A., Yuen M.E., Zhen W.F., Gerwig T.J., Story R.W., Kopp M.C.,
RA   Snider M.J.;
RT   "Structural and Biochemical Characterization of 6-Hydroxynicotinic Acid 3-
RT   Monooxygenase, A Novel Decarboxylative Hydroxylase Involved in Aerobic
RT   Nicotinate Degradation.";
RL   Biochemistry 55:3432-3446(2016).
CC   -!- FUNCTION: Flavin-dependent monooxygenase (FMO) that catalyzes the
CC       decarboxylative hydroxylation of 6-hydroxynicotinic acid (6-HNA) to
CC       2,5-dihydroxypyridine (2,5-DHP) with concomitant oxidation of NADH, a
CC       step in the aerobic nicotinate degradation pathway.
CC       {ECO:0000269|PubMed:18678916, ECO:0000269|PubMed:27218267}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=6-hydroxynicotinate + 2 H(+) + NADH + O2 = 2,5-
CC         dihydroxypyridine + CO2 + H2O + NAD(+); Xref=Rhea:RHEA:27333,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16364, ChEBI:CHEBI:16526, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57664, ChEBI:CHEBI:57945; EC=1.14.13.114;
CC         Evidence={ECO:0000269|PubMed:18678916, ECO:0000269|PubMed:27218267};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:27218267};
CC       Note=Binds 1 FAD molecule per subunit. {ECO:0000269|PubMed:27218267};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=97 uM for 6-hydroxynicotinate (at pH 7.5 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:27218267};
CC         KM=3 uM for NADH (at pH 7.5 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:27218267};
CC         Note=kcat is 2.2 sec(-1) with 6-hydroxynicotinate as substrate (at pH
CC         7.5 and 25 degrees Celsius). {ECO:0000269|PubMed:27218267};
CC   -!- PATHWAY: Cofactor degradation; nicotinate degradation.
CC       {ECO:0000269|PubMed:18678916, ECO:0000305|PubMed:27218267}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:27218267}.
CC   -!- INDUCTION: Repressed by NicR in the absence of 6-hydroxynicotinate
CC       (6HNA) inducer. In presence of 6HNA, repression is alleviated.
CC       {ECO:0000269|PubMed:21450002}.
CC   -!- DISRUPTION PHENOTYPE: Cells show a complete conversion of nicotinate to
CC       6-hydroxynicotinate. {ECO:0000269|PubMed:18678916}.
CC   -!- SIMILARITY: Belongs to the 6-hydroxynicotinate 3-monooxygenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE015451; AAN69538.1; -; Genomic_DNA.
DR   RefSeq; NP_746074.1; NC_002947.4.
DR   RefSeq; WP_010954763.1; NC_002947.4.
DR   PDB; 5EOW; X-ray; 2.10 A; A=1-382.
DR   PDBsum; 5EOW; -.
DR   SMR; Q88FY2; -.
DR   STRING; 160488.PP_3944; -.
DR   EnsemblBacteria; AAN69538; AAN69538; PP_3944.
DR   KEGG; ppu:PP_3944; -.
DR   PATRIC; fig|160488.4.peg.4199; -.
DR   eggNOG; COG0654; Bacteria.
DR   HOGENOM; CLU_009665_19_5_6; -.
DR   OMA; FTGQVAW; -.
DR   BioCyc; MetaCyc:G1G01-4209-MONOMER; -.
DR   BioCyc; PPUT160488:G1G01-4209-MONOMER; -.
DR   BRENDA; 1.14.13.114; 5092.
DR   UniPathway; UPA01010; -.
DR   Proteomes; UP000000556; Chromosome.
DR   GO; GO:0043731; F:6-hydroxynicotinate 3-monooxygenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; IDA:UniProtKB.
DR   GO; GO:0019439; P:aromatic compound catabolic process; IDA:UniProtKB.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aromatic hydrocarbons catabolism; FAD; Flavoprotein;
KW   Monooxygenase; NAD; Oxidoreductase; Reference proteome; Signal.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..382
FT                   /note="6-hydroxynicotinate 3-monooxygenase"
FT                   /id="PRO_0000418466"
FT   NP_BIND         34..35
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27218267,
FT                   ECO:0007744|PDB:5EOW"
FT   NP_BIND         307..308
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27218267,
FT                   ECO:0007744|PDB:5EOW"
FT   ACT_SITE        47
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0H3LKL4"
FT   ACT_SITE        215
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0H3LKL4"
FT   BINDING         15
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:27218267,
FT                   ECO:0007744|PDB:5EOW"
FT   BINDING         47
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:27218267,
FT                   ECO:0007744|PDB:5EOW"
FT   BINDING         108
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27218267,
FT                   ECO:0007744|PDB:5EOW"
FT   BINDING         130
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:27218267,
FT                   ECO:0007744|PDB:5EOW"
FT   BINDING         294
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27218267,
FT                   ECO:0007744|PDB:5EOW"
FT   STRAND          6..10
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   HELIX           14..25
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          29..33
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          36..38
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          45..48
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   HELIX           50..58
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   HELIX           62..68
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          73..79
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   TURN            80..82
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          85..90
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   HELIX           92..99
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          104..107
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   HELIX           108..117
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          123..127
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          130..132
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          140..144
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          149..157
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   HELIX           164..170
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          180..187
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   HELIX           196..198
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          201..206
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          211..218
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          224..231
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   HELIX           246..252
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   TURN            253..255
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   HELIX           258..265
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          270..275
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   STRAND          289..291
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   HELIX           293..296
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   HELIX           306..324
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   HELIX           326..328
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   HELIX           329..353
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   TURN            356..358
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   HELIX           364..367
FT                   /evidence="ECO:0007829|PDB:5EOW"
FT   TURN            371..373
FT                   /evidence="ECO:0007829|PDB:5EOW"
SQ   SEQUENCE   382 AA;  42694 MW;  0EB72444137FED72 CRC64;
     MRGRQKIAIV GAGLGGAAAA TLLQQAGFDV EVFEQAPAFT RLGAGIHIGP NVMKIFRRMG
     LEQKLELMGS HPDFWFSRDG NTGDYLSRIP LGEFARREYG AAYITIHRGD LHALQIEAIQ
     PGTVHFGKRL EKIVDEGDQV RLDFADGTHT VADIVIGADG IHSKIREELL GAEAPIYSGW
     VAHRALIRGV NLAQHADVFE PCVKWWSEDR HMMVYYTTGK RDEYYFVTGV PHEAWDFQGA
     FVDSSQEEMR AAFEGYHPTV QKLIDATESI TKWPLRNRNP LPLWSRGRLV LLGDACHPMK
     PHMAQGACMA IEDAAMLTRC LQETGLSDHR TAFALYEANR KERASQVQSV SNANTWLYSQ
     EDPAWVYGYD LYGQQLESGE AA
//
ID   AOXA_HUMAN              Reviewed;        1338 AA.
AC   Q06278; O14765; Q53RR8; Q53TV3; Q9BYF0; Q9UPG6;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   02-JUN-2021, entry version 202.
DE   RecName: Full=Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553};
DE            EC=1.2.3.1 {ECO:0000269|PubMed:22996261, ECO:0000269|PubMed:26322824};
DE   AltName: Full=Aldehyde oxidase 1;
DE   AltName: Full=Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};
DE            EC=1.17.3.- {ECO:0000269|PubMed:7786031, ECO:0000269|PubMed:9224775};
GN   Name=AOX1 {ECO:0000312|HGNC:HGNC:553}; Synonyms=AO;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=8248161; DOI=10.1073/pnas.90.22.10690;
RA   Wright R.M., Vaitaitis G.M., Wilson C.M., Repine T.B., Terada L.S.,
RA   Repine J.E.;
RT   "cDNA cloning, characterization, and tissue-specific expression of human
RT   xanthine dehydrogenase/xanthine oxidase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:10690-10694(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Wright R.M., Weigel L.K., Varella-Garcia M., Vaitaitis G., Repine J.E.;
RT   "Molecular cloning, refined chromosomal mapping, and structural analysis of
RT   the human gene encoding aldehyde oxidase (AOX1), a candidate for the ALS2
RT   gene.";
RL   Redox Rep. 3:135-144(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=11302742; DOI=10.1006/bbrc.2001.4719;
RA   Ichida K., Matsumura T., Sakuma R., Hosoya T., Nishino T.;
RT   "Mutation of human molybdenum cofactor sulfurase gene is responsible to
RT   classical xanthinuria type II.";
RL   Biochem. Biophys. Res. Commun. 282:1194-1200(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION AS AZAHETEROCYCLE OXIDASE, AND SUBSTRATE SPECIFICITY.
RX   PubMed=7786031; DOI=10.1006/abbi.1995.1320;
RA   Beedham C., Critchley D.J., Rance D.J.;
RT   "Substrate specificity of human liver aldehyde oxidase toward substituted
RT   quinazolines and phthalazines: a comparison with hepatic enzyme from guinea
RT   pig, rabbit, and baboon.";
RL   Arch. Biochem. Biophys. 319:481-490(1995).
RN   [8]
RP   FUNCTION AS AZAHETEROCYCLE OXIDASE, CATALYTIC ACTIVITY, ACTIVITY
RP   REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9224775;
RA   Rashidi M.R., Smith J.A., Clarke S.E., Beedham C.;
RT   "In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde
RT   oxidase from human, guinea pig, rabbit, and rat liver.";
RL   Drug Metab. Dispos. 25:805-813(1997).
RN   [9]
RP   INDUCTION.
RX   PubMed=17022944; DOI=10.1016/j.bbrc.2006.09.101;
RA   Neumeier M., Weigert J., Schaeffler A., Weiss T.S., Schmidl C.,
RA   Buettner R., Bollheimer C., Aslanidis C., Schoelmerich J., Buechler C.;
RT   "Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is down-
RT   regulated by adiponectin and fenofibric acid in hepatocytes in vitro.";
RL   Biochem. Biophys. Res. Commun. 350:731-735(2006).
RN   [10]
RP   REVIEW, NOMENCLATURE, AND TISSUE SPECIFICITY.
RX   PubMed=18066686; DOI=10.1007/s00018-007-7398-y;
RA   Garattini E., Fratelli M., Terao M.;
RT   "Mammalian aldehyde oxidases: genetics, evolution and biochemistry.";
RL   Cell. Mol. Life Sci. 65:1019-1048(2008).
RN   [11]
RP   TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND SUBCELLULAR LOCATION.
RX   PubMed=18671973; DOI=10.1016/j.febslet.2008.07.034;
RA   Weigert J., Neumeier M., Bauer S., Mages W., Schnitzbauer A.A., Obed A.,
RA   Groeschl B., Hartmann A., Schaeffler A., Aslanidis C., Schoelmerich J.,
RA   Buechler C.;
RT   "Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1
RT   cells impairs adipogenesis and adiponectin release.";
RL   FEBS Lett. 582:2965-2972(2008).
RN   [12]
RP   FUNCTION AS DRUG-METABOLIZING ENZYME, SUBSTRATE SPECIFICITY, TISSUE
RP   SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=20444863; DOI=10.1124/dmd.110.033555;
RA   Zientek M., Jiang Y., Youdim K., Obach R.S.;
RT   "In vitro-in vivo correlation for intrinsic clearance for drugs metabolized
RT   by human aldehyde oxidase.";
RL   Drug Metab. Dispos. 38:1322-1327(2010).
RN   [13]
RP   FUNCTION AS DRUG-METABOLIZING ENZYME, ACTIVITY REGULATION, SUBSTRATE
RP   SPECIFICITY, AND TISSUE SPECIFICITY.
RX   PubMed=22031625; DOI=10.1124/dmd.111.042861;
RA   Hutzler J.M., Yang Y.S., Albaugh D., Fullenwider C.L., Schmenk J.,
RA   Fisher M.B.;
RT   "Characterization of aldehyde oxidase enzyme activity in cryopreserved
RT   human hepatocytes.";
RL   Drug Metab. Dispos. 40:267-275(2012).
RN   [14]
RP   FUNCTION AS DRUG-METABOLIZING ENZYME, ACTIVITY REGULATION, SUBSTRATE
RP   SPECIFICITY, AND TISSUE SPECIFICITY.
RX   PubMed=22522748; DOI=10.1124/dmd.112.045195;
RA   Strelevitz T.J., Orozco C.C., Obach R.S.;
RT   "Hydralazine as a selective probe inactivator of aldehyde oxidase in human
RT   hepatocytes: estimation of the contribution of aldehyde oxidase to
RT   metabolic clearance.";
RL   Drug Metab. Dispos. 40:1441-1448(2012).
RN   [15]
RP   REVIEW.
RX   PubMed=22335465; DOI=10.1517/17425255.2012.663352;
RA   Garattini E., Terao M.;
RT   "The role of aldehyde oxidase in drug metabolism.";
RL   Expert Opin. Drug Metab. Toxicol. 8:487-503(2012).
RN   [16]
RP   FUNCTION AS AZAHETEROCYCLE OXIDASE, CATALYTIC ACTIVITY, ACTIVITY
RP   REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22996261; DOI=10.1124/dmd.112.048546;
RA   Barr J.T., Jones J.P.;
RT   "Evidence for substrate-dependent inhibition profiles for human liver
RT   aldehyde oxidase.";
RL   Drug Metab. Dispos. 41:24-29(2013).
RN   [17]
RP   FUNCTION AS DRUG-METABOLIZING ENZYME, SUBSTRATE SPECIFICITY, TISSUE
RP   SPECIFICITY, SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23857892; DOI=10.1124/dmd.113.053082;
RA   Fu C., Di L., Han X., Soderstrom C., Snyder M., Troutman M.D., Obach R.S.,
RA   Zhang H.;
RT   "Aldehyde oxidase 1 (AOX1) in human liver cytosols: quantitative
RT   characterization of AOX1 expression level and activity relationship.";
RL   Drug Metab. Dispos. 41:1797-1804(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1068, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) IN COMPLEX WITH FAD; IRON-SULFUR
RP   (2FE-2S); MOLYBDOPTERIN; AN INHIBITOR AND SUBSTRATE, SUBUNIT, CATALYTIC
RP   ACTIVITY, ACTIVITY REGULATION, FUNCTION, AND COFACTOR.
RX   PubMed=26322824; DOI=10.1038/nchembio.1895;
RA   Coelho C., Foti A., Hartmann T., Santos-Silva T., Leimkuhler S.,
RA   Romao M.J.;
RT   "Structural insights into xenobiotic and inhibitor binding to human
RT   aldehyde oxidase.";
RL   Nat. Chem. Biol. 11:779-783(2015).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (3.39 ANGSTROMS) OF VARIANT LEU-1271 IN COMPLEX WITH
RP   FAD; IRON-SULFUR (2FE-2S) AND MOLYBDOPTERIN, CHARACTERIZATION OF VARIANT
RP   LEU-1271, FUNCTION, SUBUNIT, COFACTOR, MUTAGENESIS OF CYS-44 AND GLY-1269,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=26842593; DOI=10.1124/dmd.115.068395;
RA   Foti A., Hartmann T., Coelho C., Santos-Silva T., Romao M.J.,
RA   Leimkuhler S.;
RT   "Optimization of the Expression of Human Aldehyde Oxidase for
RT   Investigations of Single-Nucleotide Polymorphisms.";
RL   Drug Metab. Dispos. 44:1277-1285(2016).
RN   [21]
RP   VARIANTS CYS-802; HIS-921; SER-1135; LEU-1271 AND ARG-1297,
RP   CHARACTERIZATION OF VARIANTS CYS-802; HIS-921; SER-1135 AND ARG-1297,
RP   FUNCTION AS OXIDASE, HOMODIMER, COFACTOR, SUBSTRATE SPECIFICITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22279051; DOI=10.1124/dmd.111.043828;
RA   Hartmann T., Terao M., Garattini E., Teutloff C., Alfaro J.F., Jones J.P.,
RA   Leimkuehler S.;
RT   "The impact of single nucleotide polymorphisms on human aldehyde oxidase.";
RL   Drug Metab. Dispos. 40:856-864(2012).
CC   -!- FUNCTION: Oxidase with broad substrate specificity, oxidizing aromatic
CC       azaheterocycles, such as N1-methylnicotinamide, N-methylphthalazinium
CC       and phthalazine, as well as aldehydes, such as benzaldehyde, retinal,
CC       pyridoxal, and vanillin. Plays a key role in the metabolism of
CC       xenobiotics and drugs containing aromatic azaheterocyclic substituents.
CC       Participates in the bioactivation of prodrugs such as famciclovir,
CC       catalyzing the oxidation step from 6-deoxypenciclovir to penciclovir,
CC       which is a potent antiviral agent. Is probably involved in the
CC       regulation of reactive oxygen species homeostasis. May be a prominent
CC       source of superoxide generation via the one-electron reduction of
CC       molecular oxygen. Also may catalyze nitric oxide (NO) production via
CC       the reduction of nitrite to NO with NADH or aldehyde as electron donor.
CC       May play a role in adipogenesis. {ECO:0000269|PubMed:20444863,
CC       ECO:0000269|PubMed:22031625, ECO:0000269|PubMed:22279051,
CC       ECO:0000269|PubMed:22522748, ECO:0000269|PubMed:22996261,
CC       ECO:0000269|PubMed:23857892, ECO:0000269|PubMed:26322824,
CC       ECO:0000269|PubMed:7786031, ECO:0000269|PubMed:9224775}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an aldehyde + H2O + O2 = a carboxylate + H(+) + H2O2;
CC         Xref=Rhea:RHEA:16829, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:17478,
CC         ChEBI:CHEBI:29067; EC=1.2.3.1; Evidence={ECO:0000269|PubMed:22996261,
CC         ECO:0000269|PubMed:26322824};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O2 + retinal = H(+) + H2O2 + retinoate;
CC         Xref=Rhea:RHEA:56736, ChEBI:CHEBI:15035, ChEBI:CHEBI:15036,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240; Evidence={ECO:0000250|UniProtKB:O54754};
CC   -!- COFACTOR:
CC       Name=[2Fe-2S] cluster; Xref=ChEBI:CHEBI:49601;
CC         Evidence={ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:26322824,
CC         ECO:0000269|PubMed:26842593};
CC       Note=Binds 2 [2Fe-2S] clusters per subunit.
CC       {ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:26322824};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:26322824};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:22279051,
CC       ECO:0000269|PubMed:26322824};
CC   -!- COFACTOR:
CC       Name=Mo-molybdopterin; Xref=ChEBI:CHEBI:71302;
CC         Evidence={ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:26322824,
CC         ECO:0000269|PubMed:26842593};
CC       Note=Binds 1 Mo-molybdopterin (Mo-MPT) cofactor per subunit.
CC       {ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:26322824};
CC   -!- ACTIVITY REGULATION: Is very potently inhibited by raloxifene
CC       (PubMed:26842593). Also inhibited by estradiol, ethinyl estradiol,
CC       hydralazine, menadione, isovanillin and thioridazine. Not inhibited by
CC       allopurinol, a xanthine dehydrogenase potent inhibitor
CC       (PubMed:22031625, PubMed:22522748, PubMed:22996261, PubMed:9224775,
CC       PubMed:26322824). {ECO:0000269|PubMed:22031625,
CC       ECO:0000269|PubMed:22522748, ECO:0000269|PubMed:22996261,
CC       ECO:0000269|PubMed:26322824, ECO:0000269|PubMed:26842593,
CC       ECO:0000269|PubMed:9224775}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.6 uM for benzaldehyde (in the presence of 2,6-dichlorophenol
CC         indophenol as electron acceptor) {ECO:0000269|PubMed:26842593};
CC         KM=45.18 uM for benzaldehyde (in the presence of ferricyanide as
CC         electron acceptor) {ECO:0000269|PubMed:26842593};
CC         KM=1.3 uM for phthalazine (at 25 degrees Celsius and pH 7.5)
CC         {ECO:0000269|PubMed:22279051};
CC         KM=8.96 uM for phthalazine (in the presence of 2,6-dichlorophenol
CC         indophenol as electron acceptor) {ECO:0000269|PubMed:26842593};
CC         KM=125.7 uM for phthalazine (in the presence of ferricyanide as
CC         electron acceptor) {ECO:0000269|PubMed:26842593};
CC         KM=0.78 uM for phenanthridine (in the pres 2,6-dichlorophenol
CC         indophenol as electron acceptor) {ECO:0000269|PubMed:26842593};
CC         KM=25.5 uM for phenanthridine (in the presence of ferricyanide as
CC         electron acceptor) {ECO:0000269|PubMed:26842593};
CC         KM=26.53 uM for phenanthridine (in the presence of molecular oxygen
CC         as electron acceptor) {ECO:0000269|PubMed:26842593};
CC         KM=3.9 uM for phenanthridine (at 25 degrees Celsius and pH 7.5)
CC         {ECO:0000269|PubMed:22279051};
CC         KM=5.2 uM for chloroquinazolinone (at 25 degrees Celsius and pH 7.5)
CC         {ECO:0000269|PubMed:22279051};
CC         KM=0.42 mM for 6-deoxypenciclovir (at 37 degrees Celsius and pH 7)
CC         {ECO:0000269|PubMed:9224775};
CC         KM=0.15 mM for famciclovir (at 37 degrees Celsius and pH 7)
CC         {ECO:0000269|PubMed:9224775};
CC         KM=6.3 uM for N-[(2-dimethylamino)ethyl]acridine-4-carboxamide (at 37
CC         degrees Celsius and pH 7.4) {ECO:0000269|PubMed:22996261};
CC         Vmax=16 nmol/min/mg enzyme with 6-deoxypenciclovir as substrate
CC         {ECO:0000269|PubMed:9224775};
CC         Vmax=61 nmol/min/mg enzyme with famciclovir as substrate
CC         {ECO:0000269|PubMed:9224775};
CC         Vmax=2.3 nmol/min/mg enzyme with N-[(2-dimethylamino)ethyl]acridine-
CC         4-carboxamide as substrate {ECO:0000269|PubMed:22996261};
CC         Note=kcat is 6.4 min(-1) for benzaldehyde oxidation, 5.6 min(-1) for
CC         phthalazine oxidation, 12.2 min(-1) for phenanthridine oxidation and
CC         5.6 min(-1) for chloroquinazolinone oxidation.
CC         {ECO:0000269|PubMed:22279051};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:26322824,
CC       ECO:0000269|PubMed:26842593}.
CC   -!- INTERACTION:
CC       Q06278; Q06278: AOX1; NbExp=2; IntAct=EBI-3926368, EBI-3926368;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18671973,
CC       ECO:0000269|PubMed:20444863, ECO:0000269|PubMed:23857892}.
CC   -!- TISSUE SPECIFICITY: Abundant in liver, expressed in adipose tissue and
CC       at lower levels in lung, skeletal muscle, pancreas. In contrast to
CC       mice, no significant gender difference in AOX1 expression level (at
CC       protein level). {ECO:0000269|PubMed:18066686,
CC       ECO:0000269|PubMed:18671973, ECO:0000269|PubMed:20444863,
CC       ECO:0000269|PubMed:22031625, ECO:0000269|PubMed:22522748,
CC       ECO:0000269|PubMed:23857892, ECO:0000269|PubMed:8248161}.
CC   -!- DEVELOPMENTAL STAGE: Not detected in preadipocytes but strongly induced
CC       in mature adipocytes. {ECO:0000269|PubMed:18671973}.
CC   -!- INDUCTION: In liver, is down-regulated by adiponectin and by the PPARA
CC       agonist, fenofibric acid. {ECO:0000269|PubMed:17022944}.
CC   -!- MISCELLANEOUS: AOX genes evolved from a xanthine oxidoreductase
CC       ancestral precursor via a series of gene duplication and
CC       suppression/deletion events. Different animal species contain a
CC       different complement of AOX genes encoding an equivalent number of AOX
CC       isoenzymes. In mammals, the two extremes are represented by certain
CC       rodents such as mice and rats, which are endowed with 4 AOX genes, and
CC       by humans, whose genome is characterized by a single active gene
CC       (PubMed:22335465). {ECO:0000305|PubMed:22335465}.
CC   -!- SIMILARITY: Belongs to the xanthine dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to be a xanthine dehydrogenase.
CC       {ECO:0000305|PubMed:8248161}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA96650.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAB83966.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L11005; AAA96650.1; ALT_FRAME; mRNA.
DR   EMBL; AF017060; AAB83966.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; AF009441; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009442; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009443; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009444; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009445; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009446; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009447; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009448; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009449; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009450; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009451; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009452; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009453; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009454; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009455; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009456; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009457; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009458; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009459; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009460; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009461; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009462; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009463; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009464; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009465; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009466; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009467; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009468; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009469; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009470; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009471; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009472; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009473; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009474; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF010260; AAB83968.1; -; Genomic_DNA.
DR   EMBL; AB046692; BAB40305.1; -; mRNA.
DR   EMBL; AC007163; AAX93285.1; -; Genomic_DNA.
DR   EMBL; AC080164; AAY24265.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70209.1; -; Genomic_DNA.
DR   EMBL; BC117179; AAI17180.1; -; mRNA.
DR   EMBL; BC117181; AAI17182.1; -; mRNA.
DR   CCDS; CCDS33360.1; -.
DR   PIR; A49634; A49634.
DR   RefSeq; NP_001150.3; NM_001159.3.
DR   PDB; 4UHW; X-ray; 2.60 A; A=1-1338.
DR   PDB; 4UHX; X-ray; 2.70 A; A=1-1338.
DR   PDB; 5EPG; X-ray; 3.39 A; A=1-1338.
DR   PDB; 6Q6Q; X-ray; 3.10 A; A=1-1338.
DR   PDBsum; 4UHW; -.
DR   PDBsum; 4UHX; -.
DR   PDBsum; 5EPG; -.
DR   PDBsum; 6Q6Q; -.
DR   SMR; Q06278; -.
DR   BioGRID; 106813; 10.
DR   DIP; DIP-61698N; -.
DR   IntAct; Q06278; 5.
DR   STRING; 9606.ENSP00000363832; -.
DR   BindingDB; Q06278; -.
DR   ChEMBL; CHEMBL3257; -.
DR   DrugBank; DB00437; Allopurinol.
DR   DrugBank; DB00513; Aminocaproic acid.
DR   DrugBank; DB00484; Brimonidine.
DR   DrugBank; DB11791; Capmatinib.
DR   DrugBank; DB00924; Cyclobenzaprine.
DR   DrugBank; DB03516; Eniluracil.
DR   DrugBank; DB00426; Famciclovir.
DR   DrugBank; DB12466; Favipiravir.
DR   DrugBank; DB09054; Idelalisib.
DR   DrugBank; DB09078; Lenvatinib.
DR   DrugBank; DB00170; Menadione.
DR   DrugBank; DB01033; Mercaptopurine.
DR   DrugBank; DB00563; Methotrexate.
DR   DrugBank; DB08840; N-methylnicotinamide.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB00339; Pyrazinamide.
DR   DrugBank; DB00481; Raloxifene.
DR   DrugBank; DB04827; Urethane.
DR   DrugBank; DB00962; Zaleplon.
DR   DrugBank; DB00246; Ziprasidone.
DR   DrugBank; DB00909; Zonisamide.
DR   DrugCentral; Q06278; -.
DR   iPTMnet; Q06278; -.
DR   PhosphoSitePlus; Q06278; -.
DR   BioMuta; AOX1; -.
DR   DMDM; 215273968; -.
DR   EPD; Q06278; -.
DR   jPOST; Q06278; -.
DR   MassIVE; Q06278; -.
DR   MaxQB; Q06278; -.
DR   PaxDb; Q06278; -.
DR   PeptideAtlas; Q06278; -.
DR   PRIDE; Q06278; -.
DR   ProteomicsDB; 58430; -.
DR   Antibodypedia; 34105; 228 antibodies.
DR   DNASU; 316; -.
DR   Ensembl; ENST00000374700; ENSP00000363832; ENSG00000138356.
DR   GeneID; 316; -.
DR   KEGG; hsa:316; -.
DR   UCSC; uc002uvx.4; human.
DR   CTD; 316; -.
DR   DisGeNET; 316; -.
DR   GeneCards; AOX1; -.
DR   HGNC; HGNC:553; AOX1.
DR   HPA; ENSG00000138356; Tissue enriched (liver).
DR   MIM; 602841; gene.
DR   neXtProt; NX_Q06278; -.
DR   OpenTargets; ENSG00000138356; -.
DR   PharmGKB; PA24842; -.
DR   VEuPathDB; HostDB:ENSG00000138356.13; -.
DR   eggNOG; KOG0430; Eukaryota.
DR   GeneTree; ENSGT00950000183114; -.
DR   HOGENOM; CLU_001681_1_2_1; -.
DR   InParanoid; Q06278; -.
DR   OMA; FRFWHEV; -.
DR   OrthoDB; 48717at2759; -.
DR   PhylomeDB; Q06278; -.
DR   TreeFam; TF353036; -.
DR   BioCyc; MetaCyc:ENSG00000138356-MONOMER; -.
DR   BRENDA; 1.2.3.1; 2681.
DR   PathwayCommons; Q06278; -.
DR   Reactome; R-HSA-964975; Vitamins B6 activation to pyridoxal phosphate.
DR   SABIO-RK; Q06278; -.
DR   BioGRID-ORCS; 316; 5 hits in 988 CRISPR screens.
DR   ChiTaRS; AOX1; human.
DR   GeneWiki; Aldehyde_oxidase_1; -.
DR   GenomeRNAi; 316; -.
DR   Pharos; Q06278; Tbio.
DR   PRO; PR:Q06278; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q06278; protein.
DR   Bgee; ENSG00000138356; Expressed in adrenal gland and 194 other tissues.
DR   ExpressionAtlas; Q06278; baseline and differential.
DR   Genevisible; Q06278; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; IDA:UniProtKB.
DR   GO; GO:0004031; F:aldehyde oxidase activity; IDA:UniProtKB.
DR   GO; GO:0009055; F:electron transfer activity; IEA:InterPro.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0102797; F:geranial:oxygen oxidoreductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102798; F:heptaldehyde:oxygen oxidoreductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005506; F:iron ion binding; IDA:UniProtKB.
DR   GO; GO:0043546; F:molybdopterin cofactor binding; IDA:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0017144; P:drug metabolic process; IDA:UniProtKB.
DR   GO; GO:0042816; P:vitamin B6 metabolic process; TAS:Reactome.
DR   InterPro; IPR002888; 2Fe-2S-bd.
DR   InterPro; IPR036884; 2Fe-2S-bd_dom_sf.
DR   InterPro; IPR036010; 2Fe-2S_ferredoxin-like_sf.
DR   InterPro; IPR001041; 2Fe-2S_ferredoxin-type.
DR   InterPro; IPR006058; 2Fe2S_fd_BS.
DR   InterPro; IPR000674; Ald_Oxase/Xan_DH_a/b.
DR   InterPro; IPR036856; Ald_Oxase/Xan_DH_a/b_sf.
DR   InterPro; IPR016208; Ald_Oxase/xanthine_DH.
DR   InterPro; IPR014313; Aldehyde_oxidase.
DR   InterPro; IPR008274; AldOxase/xan_DH_Mopterin-bd.
DR   InterPro; IPR037165; AldOxase/xan_DH_Mopterin-bd_sf.
DR   InterPro; IPR005107; CO_DH_flav_C.
DR   InterPro; IPR036683; CO_DH_flav_C_dom_sf.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR002346; Mopterin_DH_FAD-bd.
DR   InterPro; IPR022407; OxRdtase_Mopterin_BS.
DR   Pfam; PF01315; Ald_Xan_dh_C; 1.
DR   Pfam; PF02738; Ald_Xan_dh_C2; 1.
DR   Pfam; PF03450; CO_deh_flav_C; 1.
DR   Pfam; PF00941; FAD_binding_5; 1.
DR   Pfam; PF00111; Fer2; 1.
DR   Pfam; PF01799; Fer2_2; 1.
DR   PIRSF; PIRSF000127; Xanthine_DH; 1.
DR   SMART; SM01008; Ald_Xan_dh_C; 1.
DR   SMART; SM01092; CO_deh_flav_C; 1.
DR   SUPFAM; SSF47741; SSF47741; 1.
DR   SUPFAM; SSF54292; SSF54292; 1.
DR   SUPFAM; SSF54665; SSF54665; 1.
DR   SUPFAM; SSF55447; SSF55447; 1.
DR   SUPFAM; SSF56003; SSF56003; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   TIGRFAMs; TIGR02969; mam_aldehyde_ox; 1.
DR   PROSITE; PS00197; 2FE2S_FER_1; 1.
DR   PROSITE; PS51085; 2FE2S_FER_2; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
DR   PROSITE; PS00559; MOLYBDOPTERIN_EUK; 1.
PE   1: Evidence at protein level;
KW   2Fe-2S; 3D-structure; Cytoplasm; FAD; Flavoprotein; Iron; Iron-sulfur;
KW   Metal-binding; Molybdenum; Oxidoreductase; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..1338
FT                   /note="Aldehyde oxidase"
FT                   /id="PRO_0000166104"
FT   DOMAIN          5..92
FT                   /note="2Fe-2S ferredoxin-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00465"
FT   DOMAIN          236..421
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   NP_BIND         264..271
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   REGION          806..807
FT                   /note="Molybdopterin binding"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   REGION          1088..1091
FT                   /note="Molybdopterin binding"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   ACT_SITE        1270
FT                   /note="Proton acceptor; for azaheterocycle hydroxylase
FT                   activity"
FT                   /evidence="ECO:0000250|UniProtKB:O54754"
FT   METAL           44
FT                   /note="Iron-sulfur 1 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0007744|PDB:4UHW"
FT   METAL           49
FT                   /note="Iron-sulfur 1 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   METAL           52
FT                   /note="Iron-sulfur 1 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   METAL           74
FT                   /note="Iron-sulfur 1 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   METAL           114
FT                   /note="Iron-sulfur 2 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   METAL           117
FT                   /note="Iron-sulfur 2 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   METAL           149
FT                   /note="Iron-sulfur 2 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   METAL           151
FT                   /note="Iron-sulfur 2 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   BINDING         113
FT                   /note="Molybdopterin"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0007744|PDB:4UHW, ECO:0007744|PDB:4UHX"
FT   BINDING         151
FT                   /note="Molybdopterin"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   BINDING         345
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0007744|PDB:4UHW, ECO:0007744|PDB:4UHX"
FT   BINDING         354
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   BINDING         358
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:5EPG"
FT   BINDING         367
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   BINDING         411
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   BINDING         1047
FT                   /note="Molybdopterin; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   BINDING         1203
FT                   /note="Molybdopterin"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0000269|PubMed:26842593, ECO:0007744|PDB:4UHW,
FT                   ECO:0007744|PDB:4UHX, ECO:0007744|PDB:5EPG"
FT   BINDING         1268
FT                   /note="Molybdopterin; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:26322824,
FT                   ECO:0007744|PDB:4UHX"
FT   MOD_RES         1068
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   VARIANT         314
FT                   /note="Q -> R (in dbSNP:rs58185012)"
FT                   /id="VAR_061136"
FT   VARIANT         802
FT                   /note="R -> C (decreases homodimerization but nearly no
FT                   effect on kinetic parameters; dbSNP:rs41309768)"
FT                   /evidence="ECO:0000269|PubMed:22279051"
FT                   /id="VAR_047517"
FT   VARIANT         921
FT                   /note="R -> H (increases homodimerization; abolishes
FT                   enzymatic activity on phenanthridine; decreases turnover
FT                   number with benzaldehyde, phtalazine and
FT                   chloroquinazolinone as substrate, while nearly no effect on
FT                   the KM; dbSNP:rs56199635)"
FT                   /evidence="ECO:0000269|PubMed:22279051"
FT                   /id="VAR_070256"
FT   VARIANT         1135
FT                   /note="N -> S (increases homodimerization and turnover
FT                   number with phenanthridine as substrate; nearly no effect
FT                   on kinetic parameters with benzaldehyde, phtalazine and
FT                   chloroquinazolinone as substrate; dbSNP:rs55754655)"
FT                   /evidence="ECO:0000269|PubMed:22279051"
FT                   /id="VAR_070257"
FT   VARIANT         1271
FT                   /note="S -> L (no effect on dimerization; no effect on
FT                   oxidase activity; dbSNP:rs141786030)"
FT                   /evidence="ECO:0000269|PubMed:22279051,
FT                   ECO:0000269|PubMed:26842593"
FT                   /id="VAR_070258"
FT   VARIANT         1297
FT                   /note="H -> R (increases homodimerization and turnover
FT                   number with phenanthridine as substrate; nearly no effect
FT                   on kinetic parameters with benzaldehyde, phtalazine and
FT                   chloroquinazolinone as substrate; dbSNP:rs3731722)"
FT                   /evidence="ECO:0000269|PubMed:22279051"
FT                   /id="VAR_047518"
FT   MUTAGEN         44
FT                   /note="C->W: Disrupts protein stability."
FT                   /evidence="ECO:0000269|PubMed:26842593"
FT   MUTAGEN         1269
FT                   /note="G->R: No effect on dimerization. Loss of oxidase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:26842593"
FT   CONFLICT        41
FT                   /note="K -> P (in Ref. 1; AAA96650 and 2; AAB83966)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        127
FT                   /note="T -> P (in Ref. 1; AAA96650 and 2; AAB83966)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        152
FT                   /note="T -> H (in Ref. 1; AAA96650 and 2; AAB83966)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        227
FT                   /note="E -> D (in Ref. 1; AAA96650 and 2; AAB83966)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        251
FT                   /note="E -> D (in Ref. 1; AAA96650)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        418
FT                   /note="Y -> I (in Ref. 1; AAA96650 and 2; AAB83966)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        501
FT                   /note="V -> L (in Ref. 2; AAB83966)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        627
FT                   /note="I -> N (in Ref. 2; AAB83966)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        929
FT                   /note="A -> V (in Ref. 1; AAA96650 and 2; AAB83966)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1019
FT                   /note="G -> A (in Ref. 1; AAA96650 and 2; AAB83966)"
FT                   /evidence="ECO:0000305"
FT   STRAND          6..11
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          14..20
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           27..33
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          45..49
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          53..60
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   TURN            61..64
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          65..72
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           73..75
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           78..81
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          85..87
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           89..92
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          95..97
FT                   /evidence="ECO:0007829|PDB:4UHX"
FT   HELIX           101..108
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           118..131
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           137..143
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           144..146
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          150..152
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           155..162
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           204..206
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           212..214
FT                   /evidence="ECO:0007829|PDB:4UHX"
FT   HELIX           220..226
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          234..237
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          242..245
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           249..258
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           271..277
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          283..286
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           292..295
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          297..299
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          301..307
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           312..325
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   TURN            328..330
FT                   /evidence="ECO:0007829|PDB:4UHX"
FT   HELIX           332..343
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           347..352
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           355..361
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           369..374
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          378..382
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          387..391
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           394..397
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   TURN            401..403
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          410..417
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          423..430
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          432..437
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          440..448
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          451..453
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          458..469
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           474..480
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          484..486
FT                   /evidence="ECO:0007829|PDB:6Q6Q"
FT   HELIX           487..498
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           512..537
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   TURN            539..541
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   TURN            547..549
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           550..552
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          562..566
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          572..574
FT                   /evidence="ECO:0007829|PDB:4UHX"
FT   HELIX           589..593
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           600..602
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          610..616
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          620..628
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           630..633
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          638..642
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           644..646
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           648..650
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          651..654
FT                   /evidence="ECO:0007829|PDB:6Q6Q"
FT   STRAND          656..663
FT                   /evidence="ECO:0007829|PDB:6Q6Q"
FT   STRAND          666..668
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          674..682
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           683..690
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          694..699
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           709..711
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          721..726
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           728..731
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           732..734
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          736..745
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          756..762
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          769..773
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           778..789
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           793..795
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          796..801
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           812..828
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          832..835
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           838..844
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          851..859
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          865..878
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           884..893
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   TURN            894..897
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          901..911
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   TURN            921..924
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           925..943
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           947..954
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          958..961
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          967..969
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           971..984
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           986..999
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          1001..1016
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          1019..1021
FT                   /evidence="ECO:0007829|PDB:6Q6Q"
FT   HELIX           1022..1024
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          1026..1032
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          1038..1043
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          1047..1049
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           1051..1062
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           1067..1069
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   TURN            1077..1079
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          1088..1090
FT                   /evidence="ECO:0007829|PDB:6Q6Q"
FT   HELIX           1091..1115
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          1118..1120
FT                   /evidence="ECO:0007829|PDB:6Q6Q"
FT   HELIX           1122..1131
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          1137..1142
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          1148..1150
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   TURN            1151..1154
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          1155..1157
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          1160..1174
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   TURN            1175..1177
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          1180..1190
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           1197..1215
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           1232..1234
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           1241..1243
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   STRAND          1246..1252
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           1262..1264
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           1271..1276
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           1277..1293
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           1308..1314
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           1318..1322
FT                   /evidence="ECO:0007829|PDB:4UHW"
FT   HELIX           1328..1330
FT                   /evidence="ECO:0007829|PDB:4UHW"
SQ   SEQUENCE   1338 AA;  147918 MW;  2AB5E543F18C9261 CRC64;
     MDRASELLFY VNGRKVIEKN VDPETMLLPY LRKKLRLTGT KYGCGGGGCG ACTVMISRYN
     PITKRIRHHP ANACLIPICS LYGAAVTTVE GIGSTHTRIH PVQERIAKCH GTQCGFCTPG
     MVMSIYTLLR NHPEPTLDQL TDALGGNLCR CTGYRPIIDA CKTFCKTSGC CQSKENGVCC
     LDQGINGLPE FEEGSKTSPK LFAEEEFLPL DPTQELIFPP ELMIMAEKQS QRTRVFGSER
     MMWFSPVTLK ELLEFKFKYP QAPVIMGNTS VGPEVKFKGV FHPVIISPDR IEELSVVNHA
     YNGLTLGAGL SLAQVKDILA DVVQKLPEEK TQMYHALLKH LGTLAGSQIR NMASLGGHII
     SRHPDSDLNP ILAVGNCTLN LLSKEGKRQI PLNEQFLSKC PNADLKPQEI LVSVNIPYSR
     KWEFVSAFRQ AQRQENALAI VNSGMRVFFG EGDGIIRELC ISYGGVGPAT ICAKNSCQKL
     IGRHWNEQML DIACRLILNE VSLLGSAPGG KVEFKRTLII SFLFKFYLEV SQILKKMDPV
     HYPSLADKYE SALEDLHSKH HCSTLKYQNI GPKQHPEDPI GHPIMHLSGV KHATGEAIYC
     DDMPLVDQEL FLTFVTSSRA HAKIVSIDLS EALSMPGVVD IMTAEHLSDV NSFCFFTEAE
     KFLATDKVFC VGQLVCAVLA DSEVQAKRAA KRVKIVYQDL EPLILTIEES IQHNSSFKPE
     RKLEYGNVDE AFKVVDQILE GEIHMGGQEH FYMETQSMLV VPKGEDQEMD VYVSTQFPKY
     IQDIVASTLK LPANKVMCHV RRVGGAFGGK VLKTGIIAAV TAFAANKHGR AVRCVLERGE
     DMLITGGRHP YLGKYKAGFM NDGRILALDM EHYSNAGASL DESLFVIEMG LLKMDNAYKF
     PNLRCRGWAC RTNLPSNTAF RGFGFPQAAL ITESCITEVA AKCGLSPEKV RIINMYKEID
     QTPYKQEINA KNLIQCWREC MAMSSYSLRK VAVEKFNAEN YWKKKGLAMV PLKFPVGLGS
     RAAGQAAALV HIYLDGSVLV THGGIEMGQG VHTKMIQVVS RELRMPMSNV HLRGTSTETV
     PNANISGGSV VADLNGLAVK DACQTLLKRL EPIISKNPKG TWKDWAQTAF DESINLSAVG
     YFRGYESDMN WEKGEGQPFE YFVYGAACSE VEIDCLTGDH KNIRTDIVMD VGCSINPAID
     IGQIEGAFIQ GMGLYTIEEL NYSPQGILHT RGPDQYKIPA ICDMPTELHI ALLPPSQNSN
     TLYSSKGLGE SGVFLGCSVF FAIHDAVSAA RQERGLHGPL TLNSPLTPEK IRMACEDKFT
     KMIPRDEPGS YVPWNVPI
//
ID   HCRB_THAAR              Reviewed;         324 AA.
AC   O33820;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   02-JUN-2021, entry version 112.
DE   RecName: Full=4-hydroxybenzoyl-CoA reductase subunit beta;
DE            Short=4-HBCR subunit beta;
DE            EC=1.1.7.1 {ECO:0000269|PubMed:9490068};
GN   Name=hcrB;
OS   Thauera aromatica.
OC   Bacteria; Proteobacteria; Betaproteobacteria; Rhodocyclales; Zoogloeaceae;
OC   Thauera.
OX   NCBI_TaxID=59405;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 1-30 AND 169-185,
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, AND SUBUNIT.
RC   STRAIN=DSM 6984 / CIP 107765 / K172;
RX   PubMed=9490068; DOI=10.1046/j.1432-1327.1998.2510916.x;
RA   Breese K., Fuchs G.;
RT   "4-hydroxybenzoyl-CoA reductase (dehydroxylating) from the denitrifying
RT   bacterium Thauera aromatica -- prosthetic groups, electron donor, and genes
RT   of a member of the molybdenum-flavin-iron-sulfur proteins.";
RL   Eur. J. Biochem. 251:916-923(1998).
RN   [2]
RP   COFACTOR, EPR SPECTROSCOPY, AND MOSSBAUER SPECTROSCOPY.
RC   STRAIN=DSM 6984 / CIP 107765 / K172;
RX   PubMed=11602591; DOI=10.1074/jbc.m106766200;
RA   Boll M., Fuchs G., Meier C., Trautwein A., El Kasmi A., Ragsdale S.W.,
RA   Buchanan G., Lowe D.J.;
RT   "Redox centers of 4-hydroxybenzoyl-CoA reductase, a member of the xanthine
RT   oxidase family of molybdenum-containing enzymes.";
RL   J. Biol. Chem. 276:47853-47862(2001).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) IN COMPLEX WITH FAD; [4FE-4S] CLUSTER
RP   AND SUBUNIT ALPHA AND GAMMA, COFACTOR, AND SUBUNIT.
RX   PubMed=15576037; DOI=10.1016/j.str.2004.10.008;
RA   Unciuleac M., Warkentin E., Page C.C., Boll M., Ermler U.;
RT   "Structure of a xanthine oxidase-related 4-hydroxybenzoyl-CoA reductase
RT   with an additional [4Fe-4S] cluster and an inverted electron flow.";
RL   Structure 12:2249-2256(2004).
CC   -!- FUNCTION: Component of a complex that catalyzes the reductive
CC       dehydroxylation of 4-hydroxybenzoyl-CoA to benzoyl-CoA. Reaction is not
CC       reversible. Is a key enzyme in the anaerobic degradation of phenolic
CC       compounds. {ECO:0000269|PubMed:9490068}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=benzoyl-CoA + H2O + oxidized 2[4Fe-4S]-[ferredoxin] = 4-
CC         hydroxybenzoyl-CoA + 2 H(+) + reduced 2[4Fe-4S]-[ferredoxin];
CC         Xref=Rhea:RHEA:29603, Rhea:RHEA-COMP:10002, Rhea:RHEA-COMP:10004,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:33722,
CC         ChEBI:CHEBI:33723, ChEBI:CHEBI:57356, ChEBI:CHEBI:57369; EC=1.1.7.1;
CC         Evidence={ECO:0000269|PubMed:9490068};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC       Note=Binds 1 [4Fe-4S] cluster per subunit.;
CC   -!- ACTIVITY REGULATION: Inactivated by low concentrations of cyanide in
CC       vitro. {ECO:0000269|PubMed:9490068}.
CC   -!- SUBUNIT: Heterohexamer of two alpha, two beta and two gamma subunits.
CC       {ECO:0000269|PubMed:15576037, ECO:0000269|PubMed:9490068}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ001830; CAA05039.1; -; Genomic_DNA.
DR   PDB; 1RM6; X-ray; 1.60 A; B/E=1-324.
DR   PDB; 1SB3; X-ray; 2.20 A; B/E=1-324.
DR   PDBsum; 1RM6; -.
DR   PDBsum; 1SB3; -.
DR   SMR; O33820; -.
DR   DIP; DIP-48467N; -.
DR   IntAct; O33820; 1.
DR   KEGG; ag:CAA05039; -.
DR   BioCyc; MetaCyc:BOHBENREDTHAUERA-MONOMER; -.
DR   EvolutionaryTrace; O33820; -.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0018525; F:4-hydroxybenzoyl-CoA reductase activity; IEA:RHEA.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.465.10; -; 1.
DR   InterPro; IPR017608; 4hydrxbenzoyl-CoA_Rdtase_bsu.
DR   InterPro; IPR005107; CO_DH_flav_C.
DR   InterPro; IPR036683; CO_DH_flav_C_dom_sf.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR016169; FAD-bd_PCMH_sub2.
DR   InterPro; IPR002346; Mopterin_DH_FAD-bd.
DR   Pfam; PF03450; CO_deh_flav_C; 1.
DR   Pfam; PF00941; FAD_binding_5; 1.
DR   SMART; SM01092; CO_deh_flav_C; 1.
DR   SUPFAM; SSF55447; SSF55447; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   TIGRFAMs; TIGR03195; 4hydrxCoA_B; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; 4Fe-4S; Direct protein sequencing; FAD; Flavoprotein; Iron;
KW   Iron-sulfur; Metal-binding; Oxidoreductase.
FT   CHAIN           1..324
FT                   /note="4-hydroxybenzoyl-CoA reductase subunit beta"
FT                   /id="PRO_0000083926"
FT   DOMAIN          2..217
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   NP_BIND         29..36
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15576037"
FT   METAL           122
FT                   /note="Iron-sulfur (4Fe-4S)"
FT   METAL           138
FT                   /note="Iron-sulfur (4Fe-4S)"
FT   METAL           146
FT                   /note="Iron-sulfur (4Fe-4S)"
FT   METAL           155
FT                   /note="Iron-sulfur (4Fe-4S)"
FT   BINDING         111
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15576037"
FT   BINDING         115
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15576037"
FT   BINDING         118
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15576037"
FT   BINDING         162
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15576037"
FT   BINDING         224
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15576037"
FT   CONFLICT        22..30
FT                   /note="LAAEATLPL -> GTVPVAQLF (in Ref. 1; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          8..10
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   HELIX           15..21
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   STRAND          27..32
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   HELIX           36..41
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   STRAND          48..52
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   TURN            57..60
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   STRAND          62..64
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   STRAND          70..73
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   HELIX           78..83
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   HELIX           85..90
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   HELIX           92..100
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   HELIX           104..109
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   HELIX           112..116
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   TURN            123..125
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   HELIX           129..134
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   STRAND          141..144
FT                   /evidence="ECO:0007829|PDB:1SB3"
FT   STRAND          147..149
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   HELIX           163..169
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   STRAND          173..178
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   STRAND          181..186
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   HELIX           187..190
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   STRAND          206..212
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   STRAND          219..225
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   STRAND          227..231
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   STRAND          235..245
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   STRAND          248..262
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   HELIX           269..271
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   HELIX           278..291
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   STRAND          298..300
FT                   /evidence="ECO:0007829|PDB:1RM6"
FT   HELIX           302..322
FT                   /evidence="ECO:0007829|PDB:1RM6"
SQ   SEQUENCE   324 AA;  34374 MW;  C3C5ECAAD093F9DB CRC64;
     MNILTDFRTH RPATLADAVN ALAAEATLPL GAGTDLLPNL RRGLGHPAAL VDLTGIDGLA
     TISTLADGSL RIGAGATLEA IAEHDAIRTT WPALAQAAES VAGPTHRAAA TLGGNLCQDT
     RCTFYNQSEW WRSGNGYCLK YKGDKCHVIV KSDRCYATYH GDVAPALMVL DARAEIVGPA
     GKRTVPVAQL FRESGAEHLT LEKGELLAAI EVPPTGAWSA AYSKVRIRDA VDFPLAGVAA
     ALQRDGDRIA GLRVAITGSN SAPLMVPVDA LLGGNWDDAA AETLAQLVRK TSNVLRTTIT
     GVKYRRRVLL AISRKVVDQL WEAR
//
ID   FSQB_ASPFU              Reviewed;         497 AA.
AC   Q4WD43;
DT   15-FEB-2017, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 1.
DT   02-JUN-2021, entry version 67.
DE   RecName: Full=Amino acid oxidase fsqB {ECO:0000303|PubMed:27065235};
DE            EC=1.5.3.- {ECO:0000269|PubMed:27065235, ECO:0000269|PubMed:30194285};
DE   AltName: Full=Fumipyrrole biosynthesis protein A {ECO:0000303|PubMed:25582336};
DE   AltName: Full=Fumisoquins biosynthesis protein B {ECO:0000303|PubMed:27065235};
GN   Name=fsqB {ECO:0000303|PubMed:27065235};
GN   Synonyms=fmpA {ECO:0000303|PubMed:25582336}; ORFNames=AFUA_6G03440;
OS   Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC
OS   A1100) (Aspergillus fumigatus).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC   Aspergillus subgen. Fumigati.
OX   NCBI_TaxID=330879;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100;
RX   PubMed=16372009; DOI=10.1038/nature04332;
RA   Nierman W.C., Pain A., Anderson M.J., Wortman J.R., Kim H.S., Arroyo J.,
RA   Berriman M., Abe K., Archer D.B., Bermejo C., Bennett J.W., Bowyer P.,
RA   Chen D., Collins M., Coulsen R., Davies R., Dyer P.S., Farman M.L.,
RA   Fedorova N., Fedorova N.D., Feldblyum T.V., Fischer R., Fosker N.,
RA   Fraser A., Garcia J.L., Garcia M.J., Goble A., Goldman G.H., Gomi K.,
RA   Griffith-Jones S., Gwilliam R., Haas B.J., Haas H., Harris D.E.,
RA   Horiuchi H., Huang J., Humphray S., Jimenez J., Keller N., Khouri H.,
RA   Kitamoto K., Kobayashi T., Konzack S., Kulkarni R., Kumagai T., Lafton A.,
RA   Latge J.-P., Li W., Lord A., Lu C., Majoros W.H., May G.S., Miller B.L.,
RA   Mohamoud Y., Molina M., Monod M., Mouyna I., Mulligan S., Murphy L.D.,
RA   O'Neil S., Paulsen I., Penalva M.A., Pertea M., Price C., Pritchard B.L.,
RA   Quail M.A., Rabbinowitsch E., Rawlins N., Rajandream M.A., Reichard U.,
RA   Renauld H., Robson G.D., Rodriguez de Cordoba S., Rodriguez-Pena J.M.,
RA   Ronning C.M., Rutter S., Salzberg S.L., Sanchez M., Sanchez-Ferrero J.C.,
RA   Saunders D., Seeger K., Squares R., Squares S., Takeuchi M., Tekaia F.,
RA   Turner G., Vazquez de Aldana C.R., Weidman J., White O., Woodward J.R.,
RA   Yu J.-H., Fraser C.M., Galagan J.E., Asai K., Machida M., Hall N.,
RA   Barrell B.G., Denning D.W.;
RT   "Genomic sequence of the pathogenic and allergenic filamentous fungus
RT   Aspergillus fumigatus.";
RL   Nature 438:1151-1156(2005).
RN   [2]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=25582336; DOI=10.1111/mmi.12926;
RA   Macheleidt J., Scherlach K., Neuwirth T., Schmidt-Heck W., Strassburger M.,
RA   Spraker J., Baccile J.A., Schroeder F.C., Keller N.P., Hertweck C.,
RA   Heinekamp T., Brakhage A.A.;
RT   "Transcriptome analysis of cyclic AMP-dependent protein kinase A-regulated
RT   genes reveals the production of the novel natural compound fumipyrrole by
RT   Aspergillus fumigatus.";
RL   Mol. Microbiol. 96:148-162(2015).
RN   [3]
RP   FUNCTION, DISRUPTION PHENOTYPE, COFACTOR, CATALYTIC ACTIVITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=27065235; DOI=10.1038/nchembio.2061;
RA   Baccile J.A., Spraker J.E., Le H.H., Brandenburger E., Gomez C., Bok J.W.,
RA   Macheleidt J., Brakhage A.A., Hoffmeister D., Keller N.P., Schroeder F.C.;
RT   "Plant-like biosynthesis of isoquinoline alkaloids in Aspergillus
RT   fumigatus.";
RL   Nat. Chem. Biol. 12:419-424(2016).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) IN COMPLEX WITH FAD, SUBUNIT,
RP   COFACTOR, FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF ARG-63; ARG-66; TYR-121;
RP   LYS-304; ASP-444 AND LYS-448.
RX   PubMed=30194285; DOI=10.1074/jbc.ra118.004227;
RA   Lahham M., Pavkov-Keller T., Fuchs M., Niederhauser J., Chalhoub G.,
RA   Daniel B., Kroutil W., Gruber K., Macheroux P.;
RT   "Oxidative cyclization of N-methyl-dopa by a fungal flavoenzyme of the
RT   amine oxidase family.";
RL   J. Biol. Chem. 293:17021-17032(2018).
CC   -!- FUNCTION: Amino acid oxidase; part of the gene cluster that mediates
CC       the biosynthesis of the isoquinoline alkaloids fumisoquin A, fumisoquin
CC       B and fumisoquin C; as well as small amounts of fumipyrrole as a shunt
CC       metabolite (PubMed:25582336, PubMed:27065235, PubMed:30194285). The
CC       products of the cluster lead to a brown coloration and are important
CC       for growth and conidiation (PubMed:25582336). The nonribosomal peptide
CC       synthetase-like protein fsqF, which lacks a canonical condensation
CC       domain, is required for addition of a serine-derived dehydroalanine
CC       moiety to activated tyrosine but is not essential for the subsequent
CC       steps leading to isoquinoline formation (PubMed:27065235). A different
CC       enzyme, most likely the ATP-grasp enzyme fsqD, is responsible for
CC       activation of tyrosine (Probable). Three additional enzymes encoded by
CC       the fsq cluster, the N-methyltransferase fsqC, the phenol 2-
CC       monooxygenase fsqG and the FAD-dependent oxidase fsqB, catalyze the
CC       formation of the isoquinoline ring system in the fumisoquins
CC       (PubMed:27065235, PubMed:30194285). FsqB converts the fspF thiolation
CC       domain-bound (2S,4S,5S)-2-amino-6-(3,4-dihydroxyphenyl)-4-hydroxy-5-
CC       (methylamino)hexanoyl into isoquinoline (PubMed:27065235,
CC       PubMed:30194285). The cyclization most likely proceeds via a two-step
CC       mechanism, beginning with FAD-dependent oxidation of the methyl group
CC       to an iminium species followed by electrophilic attack on the
CC       deprotonated phenol (Probable). {ECO:0000269|PubMed:25582336,
CC       ECO:0000269|PubMed:27065235, ECO:0000269|PubMed:30194285,
CC       ECO:0000305|PubMed:27065235}.
CC   -!- FUNCTION: Is able to convert N-methyl-3,4-dihydroxy-DL-phenylalanine
CC       (N-methyl-DOPA) directly into cyclic isoquinoline, in vitro
CC       (PubMed:27065235, PubMed:30194285). The absence of the meta-hydroxyl
CC       group, as in L-N-methyl-tyrosine, leads to a 25-fold lower rate of
CC       reduction and the formation of the demethylated product L-tyrosine,
CC       instead of a cyclic product (PubMed:30194285). Does not accept the D-
CC       stereoisomer of N-methyltyrosine, in contrast to N-methyl-DOPA, for
CC       which both stereoisomers are oxidized with similar rates
CC       (PubMed:30194285). {ECO:0000269|PubMed:27065235,
CC       ECO:0000269|PubMed:30194285}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2S,4S,5S)-2-amino-6-(3,4-dihydroxyphenyl)-4-hydroxy-5-
CC         (methylamino)hexanoyl-[peptidyl-carrier protein] + O2 = (2S,4S)-2-
CC         amino-4-[(3S)-7,8-dihydroxy-1,2,3,4-tetrahydroisoquinolin-3-yl]-4-
CC         hydroxybutanoyl-[peptidyl-carrier protein] + H2O2;
CC         Xref=Rhea:RHEA:66628, Rhea:RHEA-COMP:17077, Rhea:RHEA-COMP:17078,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:167304,
CC         ChEBI:CHEBI:167307; Evidence={ECO:0000269|PubMed:27065235};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66629;
CC         Evidence={ECO:0000269|PubMed:27065235};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-methyl-L-dopa + O2 = (3S)-7,8-dihydroxy-1,2,3,4-
CC         tetrahydroisoquinoline-3-carboxylate + H2O2; Xref=Rhea:RHEA:66788,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:167490,
CC         ChEBI:CHEBI:167492; Evidence={ECO:0000269|PubMed:30194285};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66789;
CC         Evidence={ECO:0000269|PubMed:30194285};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-methyl-D-dopa + O2 = (3R)-7,8-dihydroxy-1,2,3,4-
CC         tetrahydroisoquinoline-3-carboxylate + H2O2; Xref=Rhea:RHEA:66792,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:167491,
CC         ChEBI:CHEBI:167493; Evidence={ECO:0000269|PubMed:30194285};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66793;
CC         Evidence={ECO:0000269|PubMed:30194285};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:27065235, ECO:0000269|PubMed:30194285};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=142.5 uM for N-methyl-DOPA {ECO:0000269|PubMed:27065235};
CC         KM=0.16 mM for rac-N-methyl-DOPA {ECO:0000269|PubMed:30194285};
CC         KM=0.25 mM for L-N-methyl-DOPA {ECO:0000269|PubMed:30194285};
CC         KM=2.1 mM for L-N-methyl-tyrosine {ECO:0000269|PubMed:30194285};
CC         KM=1.6 mM for rac-N-methyl-meta-tyrosine
CC         {ECO:0000269|PubMed:30194285};
CC       pH dependence:
CC         Optimum pH is 7.6. {ECO:0000269|PubMed:30194285};
CC   -!- PATHWAY: Secondary metabolite biosynthesis.
CC       {ECO:0000269|PubMed:27065235, ECO:0000269|PubMed:30194285}.
CC   -!- SUBUNIT: Dimer. {ECO:0000269|PubMed:30194285}.
CC   -!- INDUCTION: Expression is positively regulated by the fumisoquins
CC       biosynthesis specific transcription factor fsqA (PubMed:25582336).
CC       {ECO:0000269|PubMed:25582336, ECO:0000269|PubMed:27065235}.
CC   -!- DISRUPTION PHENOTYPE: Leads to complete abolishment of isoquinoline
CC       alkaloid production and accumulation of a series of benzyl pyrroles,
CC       including fumipyrrole. {ECO:0000269|PubMed:27065235}.
CC   -!- SIMILARITY: Belongs to the MSOX/MTOX family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AAHF01000012; EAL85695.1; -; Genomic_DNA.
DR   RefSeq; XP_747733.1; XM_742640.1.
DR   PDB; 6GG2; X-ray; 2.60 A; A=1-497.
DR   PDBsum; 6GG2; -.
DR   SMR; Q4WD43; -.
DR   STRING; 746128.CADAFUBP00009219; -.
DR   EnsemblFungi; EAL85695; EAL85695; AFUA_6G03440.
DR   GeneID; 3505180; -.
DR   KEGG; afm:AFUA_6G03440; -.
DR   VEuPathDB; FungiDB:Afu6g03440; -.
DR   eggNOG; KOG2820; Eukaryota.
DR   HOGENOM; CLU_007884_0_1_1; -.
DR   InParanoid; Q4WD43; -.
DR   OMA; CDHAFKF; -.
DR   OrthoDB; 752680at2759; -.
DR   Proteomes; UP000002530; Chromosome 6.
DR   Proteomes; UP000002530; Unassembled WGS sequence.
DR   GO; GO:0050031; F:L-pipecolate oxidase activity; IBA:GO_Central.
DR   GO; GO:0051699; F:proline oxidase activity; IBA:GO_Central.
DR   GO; GO:0008115; F:sarcosine oxidase activity; IBA:GO_Central.
DR   Gene3D; 3.50.50.60; -; 3.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01266; DAO; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Oxidoreductase; Reference proteome.
FT   CHAIN           1..497
FT                   /note="Amino acid oxidase fsqB"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000438869"
FT   NP_BIND         1..97
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30194285,
FT                   ECO:0007744|PDB:6GG2"
FT   NP_BIND         183..257
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30194285,
FT                   ECO:0007744|PDB:6GG2"
FT   NP_BIND         419..496
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30194285,
FT                   ECO:0007744|PDB:6GG2"
FT   REGION          98..182
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:30194285,
FT                   ECO:0007744|PDB:6GG2"
FT   REGION          259..418
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:30194285,
FT                   ECO:0007744|PDB:6GG2"
FT   BINDING         14
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:30194285,
FT                   ECO:0007744|PDB:6GG2"
FT   BINDING         38
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30194285,
FT                   ECO:0007744|PDB:6GG2"
FT   BINDING         53
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30194285,
FT                   ECO:0007744|PDB:6GG2"
FT   BINDING         57
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:30194285,
FT                   ECO:0007744|PDB:6GG2"
FT   BINDING         58
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30194285,
FT                   ECO:0007744|PDB:6GG2"
FT   BINDING         211
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:30194285,
FT                   ECO:0007744|PDB:6GG2"
FT   BINDING         448
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:30194285,
FT                   ECO:0007744|PDB:6GG2"
FT   MOD_RES         414
FT                   /note="S-8alpha-FAD cysteine"
FT                   /evidence="ECO:0000269|PubMed:30194285,
FT                   ECO:0007744|PDB:6GG2"
FT   MUTAGEN         63
FT                   /note="R->M: Severely compromises enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:30194285"
FT   MUTAGEN         66
FT                   /note="R->M: Severely compromises enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:30194285"
FT   MUTAGEN         121
FT                   /note="Y->F: Severely compromises enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:30194285"
FT   MUTAGEN         304
FT                   /note="K->A: Severely compromises enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:30194285"
FT   MUTAGEN         444
FT                   /note="D->A: Severely compromises enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:30194285"
FT   MUTAGEN         448
FT                   /note="K->A: Impairs interaction with FAD and compromises
FT                   enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:30194285"
FT   STRAND          5..10
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           14..25
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           27..29
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          30..40
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          63..65
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           73..85
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   TURN            86..94
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          95..97
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          100..107
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           120..132
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           136..139
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           146..152
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          161..163
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          173..181
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          183..185
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           187..201
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          205..208
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          211..216
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          218..228
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          233..235
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          237..241
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           244..246
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           247..251
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          258..268
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           271..279
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          284..287
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   TURN            288..291
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          292..295
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          301..307
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           310..319
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           331..337
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   TURN            341..344
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          357..359
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           362..380
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   TURN            382..385
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           398..405
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          410..418
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          420..422
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          425..428
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           430..432
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   STRAND          435..440
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           447..449
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           450..463
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   TURN            464..466
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           480..486
FT                   /evidence="ECO:0007829|PDB:6GG2"
FT   HELIX           491..493
FT                   /evidence="ECO:0007829|PDB:6GG2"
SQ   SEQUENCE   497 AA;  54929 MW;  C4BBC46356D6A74D CRC64;
     MSIPNSFIIV GSGVFGLSLA YALSLDDRFA DKKIILVDRW NFEPPNATGS VHNPAAANAD
     TSRVIRRDYP HGPYASLALE AMKHWRGKFG ENNRYVNQRL LFSGEGSSLT TPPKALETVN
     YIKKAYAISC ELTPGGRDAV QVLDSLDEVR AFLGNTPSHP PHLPVNKDPA ARDLRGYVSN
     DCGWADAGAS IEWLRQEVLR LGRVECVVGE VESLVYSDDQ RAVKGVKLVD GKVLTAELTV
     IAAGARSSHI LGIPKLCDVY SEFVAYIQLT KEEADELRRR QWPILVNCHR GVFAVGPDHD
     NCLKFGHFSY SGIVDVLREA SIQVPTRPDG WEAQQKYWSD PRFAFGGEVK VSALGDVDDY
     ENPAAQRALA DYRLFLLELL GPTGLQGVDT LGLDQSDNLL NNIANRPFTR VRKCWYNDTP
     ALDFVVDYHP SYGKTLFVAT GGCDHAFKFL PIIGEKTLAL ILRNRGDSAV SLPAGVEPSL
     EELSELWRFP VELLQDN
//
ID   HDVD_CLOAM              Reviewed;         490 AA.
AC   P55792; Q9RM87;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 3.
DT   02-JUN-2021, entry version 95.
DE   RecName: Full=4-hydroxybutyryl-CoA dehydratase/vinylacetyl-CoA-Delta-isomerase;
DE            Short=4-BUDH;
DE            EC=4.2.1.120;
DE            EC=5.3.3.3;
DE   AltName: Full=Gamma-aminobutyrate metabolism dehydratase/isomerase;
GN   Name=abfD;
OS   Clostridium aminobutyricum.
OC   Bacteria; Firmicutes; Clostridia; Eubacteriales; Clostridiaceae;
OC   Clostridium.
OX   NCBI_TaxID=33953;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 13726 / DSM 2634;
RX   PubMed=11041350; DOI=10.1007/s002030000195;
RA   Gerhardt A., Cinkaya I., Linder D., Huisman G., Buckel W.;
RT   "Fermentation of 4-aminobutyrate by Clostridium aminobutyricum: cloning of
RT   two genes involved in the formation and dehydration of 4-hydroxybutyryl-
RT   CoA.";
RL   Arch. Microbiol. 174:189-199(2000).
RN   [2]
RP   SEQUENCE REVISION TO 43; 167 AND 357.
RA   Zhang J.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   PROTEIN SEQUENCE OF 1-30, CATALYTIC ACTIVITY, SUBUNIT, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND REACTION MECHANISM.
RC   STRAIN=ATCC 13726 / DSM 2634;
RX   PubMed=8344309; DOI=10.1111/j.1432-1033.1993.tb18049.x;
RA   Scherf U., Buckel W.;
RT   "Purification and properties of an iron-sulfur and FAD-containing 4-
RT   hydroxybutyryl-CoA dehydratase/vinylacetyl-CoA delta 3-delta 2-isomerase
RT   from Clostridium aminobutyricum.";
RL   Eur. J. Biochem. 215:421-429(1993).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) IN COMPLEX WITH IRON-SULFUR AND FAD,
RP   COFACTOR, AND REACTION MECHANISM.
RX   PubMed=15496473; DOI=10.1073/pnas.0403952101;
RA   Martins B.M., Dobbek H., Cinkaya I., Buckel W., Messerschmidt A.;
RT   "Crystal structure of 4-hydroxybutyryl-CoA dehydratase: radical catalysis
RT   involving a [4Fe-4S] cluster and flavin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15645-15649(2004).
CC   -!- FUNCTION: Catalyzes the reversible conversion of 4-hydroxybutyryl-CoA
CC       to crotonyl-CoA. The mechanism of the reaction seems to go through
CC       three steps: (1) the FAD-dependent oxidation of 4-hydroxybutyryl-CoA to
CC       4-hydroxycrotonyl-CoA; (2) the hydroxyl group is substituted by a
CC       hydride derived from the now reduced FAD in an SN2' reaction leading to
CC       vinylacetyl-CoA; (3) isomerization to yield crotonyl-CoA.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-hydroxybutanoyl-CoA = (2E)-butenoyl-CoA + H2O;
CC         Xref=Rhea:RHEA:26530, ChEBI:CHEBI:15377, ChEBI:CHEBI:57332,
CC         ChEBI:CHEBI:58574; EC=4.2.1.120;
CC         Evidence={ECO:0000269|PubMed:8344309};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=vinylacetyl-CoA = (2E)-butenoyl-CoA; Xref=Rhea:RHEA:10572,
CC         ChEBI:CHEBI:57332, ChEBI:CHEBI:57396; EC=5.3.3.3;
CC         Evidence={ECO:0000269|PubMed:8344309};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC       Note=Binds 1 [4Fe-4S] cluster per subunit.;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=50 uM for 4-hydroxybutanoyl-CoA {ECO:0000269|PubMed:8344309};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:15496473,
CC       ECO:0000269|PubMed:8344309}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ250267; CAB60035.2; -; Genomic_DNA.
DR   PIR; S34765; S34765.
DR   PDB; 1U8V; X-ray; 1.60 A; A/B/C/D=1-490.
DR   PDBsum; 1U8V; -.
DR   SMR; P55792; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   PRIDE; P55792; -.
DR   KEGG; ag:CAB60035; -.
DR   BioCyc; MetaCyc:MONOMER-13485; -.
DR   BRENDA; 4.2.1.120; 1455.
DR   EvolutionaryTrace; P55792; -.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0043721; F:4-hydroxybutanoyl-CoA dehydratase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016627; F:oxidoreductase activity, acting on the CH-CH group of donors; IEA:InterPro.
DR   GO; GO:0050393; F:vinylacetyl-CoA delta-isomerase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008152; P:metabolic process; IEA:UniProtKB-KW.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   InterPro; IPR004925; HpaB/PvcC/4-BUDH.
DR   InterPro; IPR024719; HpaB/PvcC/4-BUDH_C.
DR   InterPro; IPR024674; HpaB/PvcC/4-BUDH_N.
DR   PANTHER; PTHR36117; PTHR36117; 1.
DR   Pfam; PF03241; HpaB; 1.
DR   Pfam; PF11794; HpaB_N; 1.
DR   PIRSF; PIRSF000331; HpaA_HpaB; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
PE   1: Evidence at protein level;
KW   3D-structure; 4Fe-4S; Direct protein sequencing; FAD; Flavoprotein; Iron;
KW   Iron-sulfur; Isomerase; Lyase; Metal-binding; Multifunctional enzyme;
KW   Oxidoreductase.
FT   CHAIN           1..490
FT                   /note="4-hydroxybutyryl-CoA dehydratase/vinylacetyl-CoA-
FT                   Delta-isomerase"
FT                   /id="PRO_0000083940"
FT   NP_BIND         149..156
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15496473"
FT   NP_BIND         188..190
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15496473"
FT   NP_BIND         386..390
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15496473"
FT   METAL           99
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:15496473"
FT   METAL           103
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:15496473"
FT   METAL           292
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:15496473"
FT   METAL           299
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:15496473"
FT   BINDING         325
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15496473"
FT   HELIX           5..12
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   STRAND          19..21
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           29..31
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   TURN            33..35
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           36..50
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   TURN            52..54
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           55..58
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   STRAND          59..61
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   TURN            63..65
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   STRAND          66..70
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           71..73
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           79..96
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           103..123
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           127..141
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   STRAND          145..148
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           160..162
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   STRAND          171..175
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   STRAND          177..186
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   STRAND          196..200
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           208..213
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   STRAND          215..220
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   STRAND          226..230
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           236..240
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           246..248
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   STRAND          249..252
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   STRAND          258..268
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           269..271
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   STRAND          272..276
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           278..280
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           281..318
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           324..349
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           363..373
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           376..388
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           391..394
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           398..401
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           414..421
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           430..444
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           449..452
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           454..458
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           463..473
FT                   /evidence="ECO:0007829|PDB:1U8V"
FT   HELIX           476..487
FT                   /evidence="ECO:0007829|PDB:1U8V"
SQ   SEQUENCE   490 AA;  54422 MW;  EDC1E40336806E38 CRC64;
     MLMTAEQYIE SLRKLNTRVY MFGEKIENWV DHPMIRPSIN CVAMTYELAQ DPQYADLMTT
     KSNLIGKTIN RFANLHQSTD DLRKKVKMQR LLGQKTASCF QRCVGMDAFN AVFSTTYEID
     QKYGTNYHKN FTEYLKYIQE NDLIVDGAMT DPKGDRGLAP SAQKDPDLFL RIVEKREDGI
     VVRGAKAHQT GSINSHEHII MPTIAMTEAD KDYAVSFACP SDADGLFMIY GRQSCDTRKM
     EEGADIDLGN KQFGGQEALV VFDNVFIPND RIFLCQEYDF AGMMVERFAG YHRQSYGGCK
     VGVGDVVIGA AALAADYNGA QKASHVKDKL IEMTHLNETL YCCGIACSAE GYPTAAGNYQ
     IDLLLANVCK QNITRFPYEI VRLAEDIAGG LMVTMPSEAD FKSETVVGRD GETIGDFCNK
     FFAAAPTCTT EERMRVLRFL ENICLGASAV GYRTESMHGA GSPQAQRIMI ARQGNINAKK
     ELAKAIAGIK
//
ID   HPAB_THET8              Reviewed;         481 AA.
AC   Q5SJP8;
DT   03-NOV-2009, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   02-JUN-2021, entry version 95.
DE   RecName: Full=4-hydroxyphenylacetate 3-monooxygenase oxygenase component;
DE            EC=1.14.14.9;
DE   AltName: Full=4-HPA 3-hydroxylase;
DE   AltName: Full=4-HPA 3-monooxygenase large component;
GN   OrderedLocusNames=TTHA0960;
OS   Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8).
OC   Bacteria; Deinococcus-Thermus; Deinococci; Thermales; Thermaceae; Thermus.
OX   NCBI_TaxID=300852;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 27634 / DSM 579 / HB8;
RA   Masui R., Kurokawa K., Nakagawa N., Tokunaga F., Koyama Y., Shibata T.,
RA   Oshima T., Yokoyama S., Yasunaga T., Kuramitsu S.;
RT   "Complete genome sequence of Thermus thermophilus HB8.";
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH SUBSTRATE AND FAD,
RP   FUNCTION, CATALYTIC ACTIVITY, REACTION MECHANISM, AND SUBUNIT.
RX   PubMed=17804419; DOI=10.1074/jbc.m703440200;
RA   Kim S.-H., Hisano T., Takeda K., Iwasaki W., Ebihara A., Miki K.;
RT   "Crystal structure of the oxygenase component (hpaB) of the 4-
RT   hydroxyphenylacetate 3-monooxygenase from Thermus thermophilus HB8.";
RL   J. Biol. Chem. 282:33107-33117(2007).
CC   -!- FUNCTION: Utilizes FADH(2) supplied by HpaC, to catalyze the
CC       hydroxylation of 4-hydroxyphenylacetic acid, leading to the production
CC       of 3,4-dihydroxyphenylacetic acid (DHPA).
CC       {ECO:0000269|PubMed:17804419}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-hydroxyphenylacetate + FADH2 + O2 = 3,4-
CC         dihydroxyphenylacetate + FAD + H(+) + H2O; Xref=Rhea:RHEA:30595,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:17612, ChEBI:CHEBI:48999, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307; EC=1.14.14.9;
CC         Evidence={ECO:0000269|PubMed:17804419};
CC   -!- PATHWAY: Aromatic compound metabolism; 4-hydroxyphenylacetate
CC       degradation; pyruvate and succinate semialdehyde from 4-
CC       hydroxyphenylacetate: step 1/7.
CC   -!- SUBUNIT: Homotetramer consisting of a dimer of dimers. 4-HPA 3-
CC       monooxygenase consists of a reductase component HpaC and an oxygenase
CC       component HpaB. {ECO:0000269|PubMed:17804419}.
CC   -!- SIMILARITY: Belongs to the FADH(2)-utilizing monooxygenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AP008226; BAD70783.1; -; Genomic_DNA.
DR   RefSeq; WP_011228328.1; NC_006461.1.
DR   RefSeq; YP_144226.1; NC_006461.1.
DR   PDB; 2YYG; X-ray; 2.00 A; A=1-481.
DR   PDB; 2YYI; X-ray; 1.66 A; A=1-481.
DR   PDB; 2YYJ; X-ray; 1.66 A; A=1-481.
DR   PDB; 2YYK; X-ray; 1.60 A; A=1-481.
DR   PDB; 2YYL; X-ray; 1.75 A; A=1-481.
DR   PDB; 2YYM; X-ray; 1.70 A; A=1-481.
DR   PDBsum; 2YYG; -.
DR   PDBsum; 2YYI; -.
DR   PDBsum; 2YYJ; -.
DR   PDBsum; 2YYK; -.
DR   PDBsum; 2YYL; -.
DR   PDBsum; 2YYM; -.
DR   SMR; Q5SJP8; -.
DR   STRING; 300852.55772342; -.
DR   EnsemblBacteria; BAD70783; BAD70783; BAD70783.
DR   GeneID; 3170066; -.
DR   KEGG; ttj:TTHA0960; -.
DR   PATRIC; fig|300852.9.peg.942; -.
DR   eggNOG; COG2368; Bacteria.
DR   HOGENOM; CLU_023920_2_1_0; -.
DR   OMA; NPQVNRA; -.
DR   PhylomeDB; Q5SJP8; -.
DR   BRENDA; 1.14.14.9; 2305.
DR   UniPathway; UPA00208; UER00416.
DR   EvolutionaryTrace; Q5SJP8; -.
DR   Proteomes; UP000000532; Chromosome.
DR   GO; GO:0052881; F:4-hydroxyphenylacetate 3-monooxygenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0016627; F:oxidoreductase activity, acting on the CH-CH group of donors; IEA:InterPro.
DR   GO; GO:0010124; P:phenylacetate catabolic process; IEA:InterPro.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   InterPro; IPR004925; HpaB/PvcC/4-BUDH.
DR   InterPro; IPR024719; HpaB/PvcC/4-BUDH_C.
DR   InterPro; IPR024674; HpaB/PvcC/4-BUDH_N.
DR   InterPro; IPR012687; HpaB_Deino-type.
DR   PANTHER; PTHR36117; PTHR36117; 1.
DR   Pfam; PF03241; HpaB; 1.
DR   Pfam; PF11794; HpaB_N; 1.
DR   PIRSF; PIRSF000331; HpaA_HpaB; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   TIGRFAMs; TIGR02309; HpaB-1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aromatic hydrocarbons catabolism; FAD; Flavoprotein;
KW   Monooxygenase; Oxidoreductase; Reference proteome.
FT   CHAIN           1..481
FT                   /note="4-hydroxyphenylacetate 3-monooxygenase oxygenase
FT                   component"
FT                   /id="PRO_0000387994"
FT   NP_BIND         142..144
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17804419"
FT   NP_BIND         148..151
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17804419"
FT   NP_BIND         444..447
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17804419"
FT   REGION          100..104
FT                   /note="Substrate binding"
FT   REGION          197..198
FT                   /note="Substrate binding"
FT   BINDING         142
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:17804419"
FT   BINDING         185
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17804419"
FT   HELIX           5..14
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   STRAND          19..21
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   TURN            29..31
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   TURN            33..35
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           36..48
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   TURN            52..54
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           55..58
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   STRAND          59..62
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   STRAND          65..68
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           69..71
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           77..93
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   TURN            94..96
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           103..114
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           116..122
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           123..136
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   STRAND          140..144
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           155..157
FT                   /evidence="ECO:0007829|PDB:2YYI"
FT   STRAND          158..160
FT                   /evidence="ECO:0007829|PDB:2YYI"
FT   STRAND          166..170
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   STRAND          172..185
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   STRAND          189..194
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   STRAND          198..200
FT                   /evidence="ECO:0007829|PDB:2YYJ"
FT   HELIX           205..207
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   STRAND          209..214
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   STRAND          220..224
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   TURN            234..236
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   TURN            238..242
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   STRAND          247..258
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           259..261
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   STRAND          262..266
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           268..278
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           280..309
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           312..314
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           316..341
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           355..380
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           381..384
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           390..394
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           398..404
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   STRAND          408..410
FT                   /evidence="ECO:0007829|PDB:2YYJ"
FT   HELIX           412..424
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   TURN            425..427
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           429..440
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           445..455
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           459..468
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           470..473
FT                   /evidence="ECO:0007829|PDB:2YYK"
FT   HELIX           474..476
FT                   /evidence="ECO:0007829|PDB:2YYK"
SQ   SEQUENCE   481 AA;  54303 MW;  29ED75B3C034FBC0 CRC64;
     MARTGAEYIE ALKTRPPNLW YKGEKVEDPT THPVFRGIVR TMAALYDLQH DPRYREVLTY
     EEEGKRHGMS FLIPKTKEDL KRRGQAYKLW ADQNLGMMGR SPDYLNAVVM AYAASADYFG
     EFAENVRNYY RYLRDQDLAT THALTNPQVN RARPPSGQPD PYIPVGVVKQ TEKGIVVRGA
     RMTATFPLAD EVLIFPSTLL QAGSEKYALA FALPTSTPGL HFVCREALVG GDSPFDHPLS
     SRVEEMDCLV IFDDVLVPWE RVFILGNVEL CNNAYAATGA LNHMAHQVVA LKTAKTEAFL
     GVAALMAEGI GADVYGHVQE KIAEIIVYLE AMRAFWTRAE EEAKENAYGL LVPDRGALDG
     ARNLYPRLYP RIREILEQIG ASGLITLPSE KDFKGPLGPF LEKFLQGAAL EAKERVALFR
     LAWDMTLSGF GARQELYERF FFGDPVRMYQ TLYNVYNKEP YKERIRAFLK ESLKVFEEVQ
     A
//
ID   CRY2_ARATH              Reviewed;         612 AA.
AC   Q96524; B0LQ23; B0LQ24; B0LQ25; B0LQ29; Q42549; Q42603; Q42604; Q56ZL8;
AC   Q696X6; Q696X8; Q696Z7; Q697A2; Q8VWL9; Q8VZY9;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-1998, sequence version 2.
DT   02-JUN-2021, entry version 174.
DE   RecName: Full=Cryptochrome-2 {ECO:0000303|Ref.2};
DE            Short=Atcry2 {ECO:0000303|Ref.2};
DE   AltName: Full=Blue light photoreceptor {ECO:0000303|PubMed:9003312};
DE   AltName: Full=Protein PHR homolog 1 {ECO:0000303|PubMed:9003312};
DE            Short=AtPHH1 {ECO:0000303|PubMed:9003312};
DE   AltName: Full=Protein SUPPRESSOR OF elf3 20 {ECO:0000303|PubMed:21296763};
GN   Name=CRY2 {ECO:0000303|Ref.2};
GN   Synonyms=PHH1 {ECO:0000303|PubMed:9003312},
GN   SEL20 {ECO:0000303|PubMed:21296763};
GN   OrderedLocusNames=At1g04400 {ECO:0000312|Araport:AT1G04400};
GN   ORFNames=F19P19.14 {ECO:0000312|EMBL:AAB70435.1};
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=9003312; DOI=10.1007/s004380050321;
RA   Hoffman P.D., Batschauer A., Hays J.B.;
RT   "PHH1, a novel gene from Arabidopsis thaliana that encodes a protein
RT   similar to plant blue-light photoreceptors and microbial photolyases.";
RL   Mol. Gen. Genet. 253:259-265(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Columbia;
RA   Lin C., Ahmad M., Chan J., Cashmore A.R.;
RT   "CRY2: a second member of the Arabidopsis cryptochrome gene family.";
RL   (er) Plant Gene Register PGR96-001(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   STRAIN=cv. Cvi-0, and cv. Landsberg erecta;
RX   PubMed=11726930; DOI=10.1038/ng767;
RA   El-Din El-Assal S., Alonso-Blanco C., Peeters A.J.M., Raz V., Koornneef M.;
RT   "A QTL for flowering time in Arabidopsis reveals a novel allele of CRY2.";
RL   Nat. Genet. 29:435-440(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS.
RC   STRAIN=cv. Bla-10, cv. Bsch-0, cv. Bu-0, cv. Bu-2, cv. Chi-1, cv. Co-1,
RC   cv. Columbia, cv. Cvi-0, cv. Da(1)-12, cv. Di-G, cv. El-0, cv. Fe-1,
RC   cv. Gr-3, cv. Hn-0, cv. Kon, cv. Kr-0, cv. Landsberg erecta, cv. Le-0,
RC   cv. Li-3, cv. Lip-0, cv. Lz-0, cv. Mrk-0, cv. Mt-0, cv. Mz-0, cv. Ove-0,
RC   cv. PHW-1, cv. PHW-32, cv. PHW-36, cv. Sha, cv. Stw-0, cv. Ta-0, and
RC   cv. Wassilewskija-3;
RX   PubMed=18273534; DOI=10.1007/s00239-007-9063-3;
RA   Moore R.C., Stevens M.H.H.;
RT   "Local patterns of nucleotide polymorphism are highly variable in the
RT   selfing species Arabidopsis thaliana.";
RL   J. Mol. Evol. 66:116-129(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130712; DOI=10.1038/35048500;
RA   Theologis A., Ecker J.R., Palm C.J., Federspiel N.A., Kaul S., White O.,
RA   Alonso J., Altafi H., Araujo R., Bowman C.L., Brooks S.Y., Buehler E.,
RA   Chan A., Chao Q., Chen H., Cheuk R.F., Chin C.W., Chung M.K., Conn L.,
RA   Conway A.B., Conway A.R., Creasy T.H., Dewar K., Dunn P., Etgu P.,
RA   Feldblyum T.V., Feng J.-D., Fong B., Fujii C.Y., Gill J.E., Goldsmith A.D.,
RA   Haas B., Hansen N.F., Hughes B., Huizar L., Hunter J.L., Jenkins J.,
RA   Johnson-Hopson C., Khan S., Khaykin E., Kim C.J., Koo H.L.,
RA   Kremenetskaia I., Kurtz D.B., Kwan A., Lam B., Langin-Hooper S., Lee A.,
RA   Lee J.M., Lenz C.A., Li J.H., Li Y.-P., Lin X., Liu S.X., Liu Z.A.,
RA   Luros J.S., Maiti R., Marziali A., Militscher J., Miranda M., Nguyen M.,
RA   Nierman W.C., Osborne B.I., Pai G., Peterson J., Pham P.K., Rizzo M.,
RA   Rooney T., Rowley D., Sakano H., Salzberg S.L., Schwartz J.R., Shinn P.,
RA   Southwick A.M., Sun H., Tallon L.J., Tambunga G., Toriumi M.J., Town C.D.,
RA   Utterback T., Van Aken S., Vaysberg M., Vysotskaia V.S., Walker M., Wu D.,
RA   Yu G., Fraser C.M., Venter J.C., Davis R.W.;
RT   "Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana.";
RL   Nature 408:816-820(2000).
RN   [6]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J., Southwick A.M.,
RA   Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F., Karlin-Newmann G.,
RA   Liu S.X., Lam B., Sakano H., Wu T., Yu G., Miranda M., Quach H.L.,
RA   Tripp M., Chang C.H., Lee J.M., Toriumi M.J., Chan M.M., Tang C.C.,
RA   Onodera C.S., Deng J.M., Akiyama K., Ansari Y., Arakawa T., Banh J.,
RA   Banno F., Bowser L., Brooks S.Y., Carninci P., Chao Q., Choy N., Enju A.,
RA   Goldsmith A.D., Gurjal M., Hansen N.F., Hayashizaki Y., Johnson-Hopson C.,
RA   Hsuan V.W., Iida K., Karnes M., Khan S., Koesema E., Ishida J., Jiang P.X.,
RA   Jones T., Kawai J., Kamiya A., Meyers C., Nakajima M., Narusaka M.,
RA   Seki M., Sakurai T., Satou M., Tamse R., Vaysberg M., Wallender E.K.,
RA   Wong C., Yamamura Y., Yuan S., Shinozaki K., Davis R.W., Theologis A.,
RA   Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 2-612.
RC   STRAIN=cv. Bla-10, cv. Bsch-0, cv. Bu-0, cv. Bu-2, cv. Chi-1, cv. Co-1,
RC   cv. Cvi-0, cv. Da(1)-12, cv. Di-G, cv. El-0, cv. Fe-1, cv. Gr-3, cv. Hn-0,
RC   cv. Kon, cv. Kr-0, cv. Landsberg erecta, cv. Le-0, cv. Li-3, cv. Lip-0,
RC   cv. Lz-0, cv. Mrk-0, cv. Mt-0, cv. Mz-0, cv. Ove-0, cv. Oy-1, cv. PHW-1,
RC   cv. PHW-33, cv. PHW-36, cv. Sha, cv. Stw-0, and cv. Ta-0;
RX   PubMed=15280248; DOI=10.1534/genetics.103.024950;
RA   Olsen K.M., Halldorsdottir S.S., Stinchcombe J.R., Weinig C., Schmitt J.,
RA   Purugganan M.D.;
RT   "Linkage disequilibrium mapping of Arabidopsis CRY2 flowering time
RT   alleles.";
RL   Genetics 167:1361-1369(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 485-612.
RC   STRAIN=cv. Columbia;
RA   Totoki Y., Seki M., Ishida J., Nakajima M., Enju A., Kamiya A.,
RA   Narusaka M., Shin-i T., Nakagawa M., Sakamoto N., Oishi K., Kohara Y.,
RA   Kobayashi M., Toyoda A., Sakaki Y., Sakurai T., Iida K., Akiyama K.,
RA   Satou M., Toyoda T., Konagaya A., Carninci P., Kawai J., Hayashizaki Y.,
RA   Shinozaki K.;
RT   "Large-scale analysis of RIKEN Arabidopsis full-length (RAFL) cDNAs.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   FUNCTION, AND MUTAGENESIS OF GLY-337.
RX   PubMed=9565033; DOI=10.1038/33701;
RA   Ahmad M., Jarillo J.A., Smirnova O., Cashmore A.R.;
RT   "Cryptochrome blue-light photoreceptors of Arabidopsis implicated in
RT   phototropism.";
RL   Nature 392:720-723(1998).
RN   [11]
RP   PHOSPHORYLATION.
RX   PubMed=9651577; DOI=10.1016/s1097-2765(00)80094-5;
RA   Ahmad M., Jarillo J.A., Smirnova O., Cashmore A.R.;
RT   "The CRY1 blue light photoreceptor of Arabidopsis interacts with
RT   phytochrome A in vitro.";
RL   Mol. Cell 1:939-948(1998).
RN   [12]
RP   FUNCTION.
RX   PubMed=9482948; DOI=10.1073/pnas.95.5.2686;
RA   Lin C., Yang H., Guo H., Mockler T., Chen J., Cashmore A.R.;
RT   "Enhancement of blue-light sensitivity of Arabidopsis seedlings by a blue
RT   light receptor cryptochrome 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:2686-2690(1998).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10476076; DOI=10.1046/j.1365-313x.1999.00535.x;
RA   Kleiner O., Kircher S., Harter K., Batschauer A.;
RT   "Nuclear localization of the Arabidopsis blue light receptor cryptochrome
RT   2.";
RL   Plant J. 19:289-296(1999).
RN   [14]
RP   DOMAINS.
RX   PubMed=11114337; DOI=10.1016/s0092-8674(00)00184-7;
RA   Yang H.-Q., Wu Y.-J., Tang R.-H., Liu D., Liu Y., Cashmore A.R.;
RT   "The C termini of Arabidopsis cryptochromes mediate a constitutive light
RT   response.";
RL   Cell 103:815-827(2000).
RN   [15]
RP   INTERACTION WITH PHYB.
RX   PubMed=11089975; DOI=10.1038/35041583;
RA   Mas P., Devlin P.F., Panda S., Kay S.A.;
RT   "Functional interaction of phytochrome B and cryptochrome 2.";
RL   Nature 408:207-211(2000).
RN   [16]
RP   INDUCTION BY CIRCADIAN CLOCK AND LIGHT, AND TISSUE SPECIFICITY.
RX   PubMed=11743105; DOI=10.1104/pp.010467;
RA   Toth R., Kevei E., Hall A., Millar A.J., Nagy F., Kozma-Bognar L.;
RT   "Circadian clock-regulated expression of phytochrome and cryptochrome genes
RT   in Arabidopsis.";
RL   Plant Physiol. 127:1607-1616(2001).
RN   [17]
RP   INTERACTION WITH COP1.
RX   PubMed=11509693; DOI=10.1126/science.1063630;
RA   Wang H., Ma L.-G., Li J.-M., Zhao H.-Y., Deng X.W.;
RT   "Direct interaction of Arabidopsis cryptochromes with COP1 in light control
RT   development.";
RL   Science 294:154-158(2001).
RN   [18]
RP   PHOSPHORYLATION.
RX   PubMed=12066190; DOI=10.1038/nature00815;
RA   Shalitin D., Yang H., Mockler T.C., Maymon M., Guo H., Whitelam G.C.,
RA   Lin C.;
RT   "Regulation of Arabidopsis cryptochrome 2 by blue-light-dependent
RT   phosphorylation.";
RL   Nature 417:763-767(2002).
RN   [19]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=12857830; DOI=10.1104/pp.102.018481;
RA   Whippo C.W., Hangarter R.P.;
RT   "Second positive phototropism results from coordinated co-action of the
RT   phototropins and cryptochromes.";
RL   Plant Physiol. 132:1499-1507(2003).
RN   [20]
RP   FUNCTION.
RX   PubMed=14605222; DOI=10.1104/pp.103.029819;
RA   El-Din El-Assal S., Alonso-Blanco C., Peeters A.J., Wagemaker C.,
RA   Weller J.L., Koornneef M.;
RT   "The role of cryptochrome 2 in flowering in Arabidopsis.";
RL   Plant Physiol. 133:1504-1516(2003).
RN   [21]
RP   INDUCTION.
RX   PubMed=12578985; DOI=10.1073/pnas.0437826100;
RA   Mockler T., Yang H., Yu X., Parikh D., Cheng Y.C., Dolan S., Lin C.;
RT   "Regulation of photoperiodic flowering by Arabidopsis photoreceptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:2140-2145(2003).
RN   [22]
RP   FUNCTION.
RX   PubMed=16093319; DOI=10.1073/pnas.0501011102;
RA   Mao J., Zhang Y.C., Sang Y., Li Q.H., Yang H.Q.;
RT   "A role for Arabidopsis cryptochromes and COP1 in the regulation of
RT   stomatal opening.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:12270-12275(2005).
RN   [23]
RP   PTM, COFACTOR, AND ATP-BINDING.
RX   PubMed=17073458; DOI=10.1021/bi061556n;
RA   Ozguer S., Sancar A.;
RT   "Analysis of autophosphorylating kinase activities of Arabidopsis and human
RT   cryptochromes.";
RL   Biochemistry 45:13369-13374(2006).
RN   [24]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16703358; DOI=10.1007/s00425-006-0280-6;
RA   Canamero R.C., Bakrim N., Bouly J.-P., Garay A., Dudkin E.E., Habricot Y.,
RA   Ahmad M.;
RT   "Cryptochrome photoreceptors cry1 and cry2 antagonistically regulate
RT   primary root elongation in Arabidopsis thaliana.";
RL   Planta 224:995-1003(2006).
RN   [25]
RP   COFACTOR.
RX   PubMed=17355959; DOI=10.1074/jbc.m700616200;
RA   Banerjee R., Schleicher E., Meier S., Viana R.M., Pokorny R., Ahmad M.,
RA   Bittl R., Batschauer A.;
RT   "The signaling state of Arabidopsis cryptochrome 2 contains flavin
RT   semiquinone.";
RL   J. Biol. Chem. 282:14916-14922(2007).
RN   [26]
RP   FUNCTION.
RX   PubMed=17470059; DOI=10.1111/j.1365-313x.2007.03093.x;
RA   Tessadori F., Schulkes R.K., van Driel R., Fransz P.;
RT   "Light-regulated large-scale reorganization of chromatin during the floral
RT   transition in Arabidopsis.";
RL   Plant J. 50:848-857(2007).
RN   [27]
RP   SUBCELLULAR LOCATION, SUBUNIT, AND PHOSPHORYLATION.
RX   PubMed=17438275; DOI=10.1073/pnas.0701912104;
RA   Yu X., Shalitin D., Liu X., Maymon M., Klejnot J., Yang H., Lopez J.,
RA   Zhao X., Bendehakkalu K.T., Lin C.;
RT   "Derepression of the NC80 motif is critical for the photoactivation of
RT   Arabidopsis CRY2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:7289-7294(2007).
RN   [28]
RP   SUBCELLULAR LOCATION, UBIQUITINATION, AND PHOSPHORYLATION.
RX   PubMed=17965271; DOI=10.1105/tpc.107.053017;
RA   Yu X., Klejnot J., Zhao X., Shalitin D., Maymon M., Yang H., Lee J.,
RA   Liu X., Lopez J., Lin C.;
RT   "Arabidopsis cryptochrome 2 completes its posttranslational life cycle in
RT   the nucleus.";
RL   Plant Cell 19:3146-3156(2007).
RN   [29]
RP   FUNCTION.
RX   PubMed=17259260; DOI=10.1105/tpc.106.048157;
RA   Endo M., Mochizuki N., Suzuki T., Nagatani A.;
RT   "CRYPTOCHROME2 in vascular bundles regulates flowering in Arabidopsis.";
RL   Plant Cell 19:84-93(2007).
RN   [30]
RP   INTERACTION WITH BHLH63/CIB1, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ASP-387.
RX   PubMed=18988809; DOI=10.1126/science.1163927;
RA   Liu H., Yu X., Li K., Klejnot J., Yang H., Lisiero D., Lin C.;
RT   "Photoexcited CRY2 interacts with CIB1 to regulate transcription and floral
RT   initiation in Arabidopsis.";
RL   Science 322:1535-1539(2008).
RN   [31]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=cv. Columbia;
RX   PubMed=19558423; DOI=10.1111/j.1469-8137.2009.02921.x;
RA   Millenaar F.F., van Zanten M., Cox M.C., Pierik R., Voesenek L.A.,
RA   Peeters A.J.;
RT   "Differential petiole growth in Arabidopsis thaliana: photocontrol and
RT   hormonal regulation.";
RL   New Phytol. 184:141-152(2009).
RN   [32]
RP   REVIEW ON CRYPTOCHROMES.
RX   PubMed=21841916; DOI=10.1199/tab.0135;
RA   Yu X., Liu H., Klejnot J., Lin C.;
RT   "The cryptochrome blue light receptors.";
RL   Arabidopsis Book 8:E0135-E0135(2010).
RN   [33]
RP   REVIEW ON PHOTORECEPTORS.
RX   PubMed=20705178; DOI=10.1016/s0070-2153(10)91002-8;
RA   Kami C., Lorrain S., Hornitschek P., Fankhauser C.;
RT   "Light-regulated plant growth and development.";
RL   Curr. Top. Dev. Biol. 91:29-66(2010).
RN   [34]
RP   BIOTECHNOLOGY.
RX   PubMed=21037589; DOI=10.1038/nmeth.1524;
RA   Kennedy M.J., Hughes R.M., Peteya L.A., Schwartz J.W., Ehlers M.D.,
RA   Tucker C.L.;
RT   "Rapid blue-light-mediated induction of protein interactions in living
RT   cells.";
RL   Nat. Methods 7:973-975(2010).
RN   [35]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND INDUCTION BY LOW LIGHT.
RC   STRAIN=cv. Columbia, and cv. Landsberg erecta;
RX   PubMed=20935177; DOI=10.1104/pp.110.164616;
RA   van Zanten M., Tessadori F., McLoughlin F., Smith R., Millenaar F.F.,
RA   van Driel R., Voesenek L.A.C.J., Peeters A.J.M., Fransz P.;
RT   "Photoreceptors CRYTOCHROME2 and phytochrome B control chromatin compaction
RT   in Arabidopsis.";
RL   Plant Physiol. 154:1686-1696(2010).
RN   [36]
RP   FUNCTION, DISRUPTION PHENOTYPE, REGULATION BY BLUE-LIGHT AND DARKNESS,
RP   INTERACTION WITH COP1, AND SUBCELLULAR LOCATION.
RX   PubMed=20624951; DOI=10.1073/pnas.1004529107;
RA   Jeong R.-D., Chandra-Shekara A.C., Barman S.R., Navarre D., Klessig D.F.,
RA   Kachroo A., Kachroo P.;
RT   "Cryptochrome 2 and phototropin 2 regulate resistance protein-mediated
RT   viral defense by negatively regulating an E3 ubiquitin ligase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:13538-13543(2010).
RN   [37]
RP   FUNCTION, INTERACTION WITH SPA1, AND MUTAGENESIS OF ASP-387.
RX   PubMed=21514160; DOI=10.1016/j.cub.2011.03.048;
RA   Zuo Z., Liu H., Liu B., Liu X., Lin C.;
RT   "Blue light-dependent interaction of CRY2 with SPA1 regulates COP1 activity
RT   and floral initiation in Arabidopsis.";
RL   Curr. Biol. 21:841-847(2011).
RN   [38]
RP   FUNCTION, DISRUPTION PHENOTYPE, SUBCELLULAR LOCATION, AND INTERACTION WITH
RP   SPA1.
RC   STRAIN=cv. Columbia;
RX   PubMed=21511872; DOI=10.1101/gad.2025111;
RA   Lian H.-L., He S.-B., Zhang Y.-C., Zhu D.-M., Zhang J.-Y., Jia K.-P.,
RA   Sun S.-X., Li L., Yang H.-Q.;
RT   "Blue-light-dependent interaction of cryptochrome 1 with SPA1 defines a
RT   dynamic signaling mechanism.";
RL   Genes Dev. 25:1023-1028(2011).
RN   [39]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=21296763; DOI=10.1093/jxb/erq450;
RA   Nefissi R., Natsui Y., Miyata K., Oda A., Hase Y., Nakagawa M., Ghorbel A.,
RA   Mizoguchi T.;
RT   "Double loss-of-function mutation in EARLY FLOWERING 3 and CRYPTOCHROME 2
RT   genes delays flowering under continuous light but accelerates it under long
RT   days and short days: an important role for Arabidopsis CRY2 to accelerate
RT   flowering time in continuous light.";
RL   J. Exp. Bot. 62:2731-2744(2011).
RN   [40]
RP   MUTAGENESIS OF TRP-321; TRP-374 AND TRP-397, AND INTERACTION WITH SPA1 AND
RP   BHLH63/CIB1.
RC   STRAIN=cv. Columbia;
RX   PubMed=22139370; DOI=10.1073/pnas.1114579108;
RA   Li X., Wang Q., Yu X., Liu H., Yang H., Zhao C., Liu X., Tan C.,
RA   Klejnot J., Zhong D., Lin C.;
RT   "Arabidopsis cryptochrome 2 (CRY2) functions by the photoactivation
RT   mechanism distinct from the tryptophan (trp) triad-dependent
RT   photoreduction.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:20844-20849(2011).
RN   [41]
RP   MUTAGENESIS OF GLY-377.
RX   PubMed=21765176; DOI=10.1093/mp/ssr052;
RA   Gu N.-N., Zhang Y.-C., Yang H.-Q.;
RT   "Substitution of a conserved glycine in the PHR domain of Arabidopsis
RT   cryptochrome 1 confers a constitutive light response.";
RL   Mol. Plant 5:85-97(2012).
RN   [42]
RP   SUBCELLULAR LOCATION, REGULATION BY BLUE LIGHT, AND MUTAGENESIS OF LYS-541
RP   AND 554-LYS-LYS-555.
RC   STRAIN=cv. Columbia;
RX   PubMed=22311776; DOI=10.1093/mp/sss007;
RA   Zuo Z.-C., Meng Y.-Y., Yu X.-H., Zhang Z.-L., Feng D.-S., Sun S.-F.,
RA   Liu B., Lin C.-T.;
RT   "A study of the blue-light-dependent phosphorylation, degradation, and
RT   photobody formation of Arabidopsis CRY2.";
RL   Mol. Plant 5:726-733(2012).
RN   [43]
RP   INTERACTION WITH SPA1, AND SUBCELLULAR LOCATION.
RX   PubMed=22739826; DOI=10.1105/tpc.112.098210;
RA   Weidler G., Zur Oven-Krockhaus S., Heunemann M., Orth C., Schleifenbaum F.,
RA   Harter K., Hoecker U., Batschauer A.;
RT   "Degradation of Arabidopsis CRY2 is regulated by SPA proteins and
RT   phytochrome A.";
RL   Plant Cell 24:2610-2623(2012).
RN   [44]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=cv. Columbia;
RX   PubMed=22147516; DOI=10.1104/pp.111.187237;
RA   Boccalandro H.E., Giordano C.V., Ploschuk E.L., Piccoli P.N., Bottini R.,
RA   Casal J.J.;
RT   "Phototropins but not cryptochromes mediate the blue light-specific
RT   promotion of stomatal conductance, while both enhance photosynthesis and
RT   transpiration under full sunlight.";
RL   Plant Physiol. 158:1475-1484(2012).
RN   [45]
RP   BIOTECHNOLOGY.
RX   PubMed=22847441; DOI=10.1073/pnas.1211305109;
RA   Idevall-Hagren O., Dickson E.J., Hille B., Toomre D.K., De Camilli P.;
RT   "Optogenetic control of phosphoinositide metabolism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:E2316-E2323(2012).
RN   [46]
RP   SUBCELLULAR LOCATION, AND BIOTECHNOLOGY.
RX   PubMed=23833191; DOI=10.1074/jbc.m113.493361;
RA   Ozkan-Dagliyan I., Chiou Y.-Y., Ye R., Hassan B.H., Ozturk N., Sancar A.;
RT   "Formation of Arabidopsis Cryptochrome 2 photobodies in mammalian nuclei:
RT   application as an optogenetic DNA damage checkpoint switch.";
RL   J. Biol. Chem. 288:23244-23251(2013).
RN   [47]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND INDUCTION BY TEMPERATURE.
RC   STRAIN=cv. Columbia;
RX   PubMed=23511208; DOI=10.1038/msb.2013.7;
RA   Gould P.D., Ugarte N., Domijan M., Costa M., Foreman J., Macgregor D.,
RA   Rose K., Griffiths J., Millar A.J., Finkenstaedt B., Penfield S.,
RA   Rand D.A., Halliday K.J., Hall A.J.W.;
RT   "Network balance via CRY signalling controls the Arabidopsis circadian
RT   clock over ambient temperatures.";
RL   Mol. Syst. Biol. 9:650-650(2013).
RN   [48]
RP   PHOSPHORYLATION AT SER-587 AND THR-603 BY CK1.3 AND CK1.4, AND MUTAGENESIS
RP   OF SER-587 AND THR-603.
RX   PubMed=23897926; DOI=10.1105/tpc.113.114322;
RA   Tan S.-T., Dai C., Liu H.-T., Xue H.-W.;
RT   "Arabidopsis casein kinase1 proteins CK1.3 and CK1.4 phosphorylate
RT   cryptochrome2 to regulate blue light signaling.";
RL   Plant Cell 25:2618-2632(2013).
RN   [49]
RP   FUNCTION.
RC   STRAIN=cv. Landsberg erecta;
RX   PubMed=23398192; DOI=10.1111/tpj.12144;
RA   Herbel V., Orth C., Wenzel R., Ahmad M., Bittl R., Batschauer A.;
RT   "Lifetimes of Arabidopsis cryptochrome signaling states in vivo.";
RL   Plant J. 74:583-592(2013).
RN   [50]
RP   FUNCTION, AND INTERACTION WITH BHLH63/CIB1; BHLH78/CIB2; BHLH74/CIB4 AND
RP   BHLH76/CIB5.
RC   STRAIN=cv. Columbia;
RX   PubMed=24130508; DOI=10.1371/journal.pgen.1003861;
RA   Liu Y., Li X., Li K., Liu H., Lin C.;
RT   "Multiple bHLH proteins form heterodimers to mediate CRY2-dependent
RT   regulation of flowering-time in Arabidopsis.";
RL   PLoS Genet. 9:E1003861-E1003861(2013).
RN   [51]
RP   INTERACTION WITH BHLH63/CIB1.
RX   PubMed=24780222; DOI=10.1016/j.ab.2014.04.023;
RA   Cui Y., Choudhury S.R., Irudayaraj J.;
RT   "Quantitative real-time kinetics of optogenetic proteins CRY2 and CIB1/N
RT   using single-molecule tools.";
RL   Anal. Biochem. 458:58-60(2014).
RN   [52]
RP   BIOTECHNOLOGY.
RX   PubMed=24718798; DOI=10.1007/978-1-4939-0470-9_8;
RA   Idevall-Hagren O., Decamilli P.;
RT   "Manipulation of plasma membrane phosphoinositides using photoinduced
RT   protein-protein interactions.";
RL   Methods Mol. Biol. 1148:109-128(2014).
RN   [53]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=cv. Columbia;
RX   PubMed=24126495; DOI=10.1093/mp/sst093;
RA   Jia K.-P., Luo Q., He S.-B., Lu X.-D., Yang H.-Q.;
RT   "Strigolactone-regulated hypocotyl elongation is dependent on cryptochrome
RT   and phytochrome signaling pathways in Arabidopsis.";
RL   Mol. Plant 7:528-540(2014).
RN   [54]
RP   FUNCTION, COFACTOR, AND MUTAGENESIS OF TRP-321; TRP-331; TRP-374; TRP-376;
RP   TRP-397 AND TYR-399.
RX   PubMed=25428980; DOI=10.1105/tpc.114.129809;
RA   Engelhard C., Wang X., Robles D., Moldt J., Essen L.-O., Batschauer A.,
RA   Bittl R., Ahmad M.;
RT   "Cellular metabolites enhance the light sensitivity of Arabidopsis
RT   cryptochrome through alternate electron transfer pathways.";
RL   Plant Cell 26:4519-4531(2014).
RN   [55]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=26095447; DOI=10.1002/bem.21927;
RA   Xu C., Li Y., Yu Y., Zhang Y., Wei S.;
RT   "Suppression of Arabidopsis flowering by near-null magnetic field is
RT   affected by light.";
RL   Bioelectromagnetics 36:476-479(2015).
RN   [56]
RP   BIOTECHNOLOGY.
RX   PubMed=25963241; DOI=10.1016/j.chembiol.2015.04.014;
RA   Duan L., Che D., Zhang K., Ong Q., Guo S., Cui B.;
RT   "Optogenetic control of molecular motors and organelle distributions in
RT   cells.";
RL   Chem. Biol. 22:671-682(2015).
RN   [57]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-598; SER-599 AND SER-605,
RP   MUTAGENESIS OF 570-SER--SER-575; SER-580; SER-582; SER-584; SER-587;
RP   598-SER-SER-599 AND SER-605, IDENTIFICATION BY MASS SPECTROMETRY,
RP   UBIQUITINATION, AND REGULATION BY BLUE LIGHT.
RX   PubMed=25792146; DOI=10.1016/j.molp.2015.03.005;
RA   Wang Q., Barshop W.D., Bian M., Vashisht A.A., He R., Yu X., Liu B.,
RA   Nguyen P., Liu X., Zhao X., Wohlschlegel J.A., Lin C.;
RT   "The blue light-dependent phosphorylation of the CCE domain determines the
RT   photosensitivity of Arabidopsis CRY2.";
RL   Mol. Plant 8:631-643(2015).
RN   [58]
RP   DOMAINS.
RX   PubMed=25721730; DOI=10.1016/j.molp.2015.02.008;
RA   He S.B., Wang W.X., Zhang J.Y., Xu F., Lian H.L., Li L., Yang H.Q.;
RT   "The CNT1 domain of Arabidopsis CRY1 Alone is sufficient to mediate blue
RT   light inhibition of hypocotyl elongation.";
RL   Mol. Plant 8:822-825(2015).
RN   [59]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=26179959; DOI=10.1080/15592324.2015.1042647;
RA   Jourdan N., Martino C.F., El-Esawi M., Witczak J., Bouchet P.-E.,
RA   d'Harlingue A., Ahmad M.;
RT   "Blue-light dependent ROS formation by Arabidopsis cryptochrome-2 may
RT   contribute toward its signaling role.";
RL   Plant Signal. Behav. 10:E1042647-E1042647(2015).
RN   [60]
RP   FUNCTION, INDUCTION BY LOW BLUE LIGHT, INTERACTION WITH PIF4 AND PIF5, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=26724867; DOI=10.1016/j.cell.2015.12.018;
RA   Pedmale U.V., Huang S.S., Zander M., Cole B.J., Hetzel J., Ljung K.,
RA   Reis P.A., Sridevi P., Nito K., Nery J.R., Ecker J.R., Chory J.;
RT   "Cryptochromes interact directly with PIFs to control plant growth in
RT   limiting blue light.";
RL   Cell 164:233-245(2016).
RN   [61]
RP   INTERACTION WITH BIC1, AND SUBUNIT.
RX   PubMed=27846570; DOI=10.1126/science.aaf9030;
RA   Wang Q., Zuo Z., Wang X., Gu L., Yoshizumi T., Yang Z., Yang L., Liu Q.,
RA   Liu W., Han Y.J., Kim J.I., Liu B., Wohlschlegel J.A., Matsui M., Oka Y.,
RA   Lin C.;
RT   "Photoactivation and inactivation of Arabidopsis cryptochrome 2.";
RL   Science 354:343-347(2016).
RN   [62]
RP   INTERACTION WITH NRP.
RX   PubMed=28633330; DOI=10.1093/jxb/erx192;
RA   Zhou R., Zhu T., Han L., Liu M., Xu M., Liu Y., Han D., Qiu D., Gong Q.,
RA   Liu X.;
RT   "The asparagine-rich protein NRP interacts with the Verticillium effector
RT   PevD1 and regulates the subcellular localization of cryptochrome 2.";
RL   J. Exp. Bot. 68:3427-3440(2017).
RN   [63]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS)IN COMPLEX WITH FAD AND ATP.
RX   PubMed=32398826; DOI=10.1038/s41594-020-0410-z;
RA   Ma L., Wang X., Guan Z., Wang L., Wang Y., Zheng L., Gong Z., Shen C.,
RA   Wang J., Zhang D., Liu Z., Yin P.;
RT   "Structural insights into BIC-mediated inactivation of Arabidopsis
RT   cryptochrome 2.";
RL   Nat. Struct. Mol. Biol. 27:472-479(2020).
CC   -!- FUNCTION: Photoreceptor that mediates primarily blue light inhibition
CC       of hypocotyl elongation and photoperiodic control of floral initiation,
CC       and regulates other light responses, including circadian rhythms,
CC       tropic growth, stomata opening, guard cell development, root
CC       development, bacterial and viral pathogen responses, abiotic stress
CC       responses, cell cycles, programmed cell death, apical dominance, fruit
CC       and ovule development, seed dormancy, and magnetoreception.
CC       Photoexcited cryptochromes interact with signaling partner proteins to
CC       alter gene expression at both transcriptional and post-translational
CC       levels and, consequently, regulate the corresponding metabolic and
CC       developmental programs (PubMed:21841916). Blue-light absorbing
CC       flavoprotein that activates reversible flavin photoreduction via an
CC       electron transport chain comprising a tryptophan triad (W-321, W-374
CC       and W-397), or via an alternative electron transport that involves
CC       small metabolites, including NADPH, NADH, and ATP. The half-life of the
CC       activated signaling state is about 16 minutes (PubMed:25428980,
CC       PubMed:23398192). Perceives low blue light (LBL) and responds by
CC       directly contacting two bHLH transcription factors, PIF4 and PIF5, at
CC       chromatin on E-box variant 5'-CA[CT]GTG-3' to promote their activity
CC       and stimulate specific gene expression to adapt global physiology (e.g.
CC       hypocotyl elongation and hyponastic growth in low blue light)
CC       (PubMed:26724867, PubMed:19558423). In response to blue light, binds to
CC       CIB proteins (e.g. BHLH63/CIB1 and BHLH76/CIB5) to activates
CC       transcription and floral initiation (PubMed:24130508). Mediates blue
CC       light-induced gene expression, floral initiation and hypocotyl
CC       elongation through the interaction with SPA1 that prevents formation of
CC       SPA1/COP1 complex but stimulates COP1 binding, and thus inhibits COP1-
CC       mediated degradation of transcription factors (e.g. CO and HY5)
CC       (PubMed:21514160, PubMed:21511872, PubMed:16093319). Promotes flowering
CC       time in continuous light (LL) (PubMed:21296763). Involved in shortening
CC       the circadian clock period, especially at 27 degrees Celsius, in blue
CC       light (BL). Required to maintain clock genes expression rhythm
CC       (PubMed:23511208). Triggers nuclear accumulation of ROS in response to
CC       blue light illumination (PubMed:26179959). Involved in blue light-
CC       dependent stomatal opening, transpiration and inhibition of stem and
CC       root growth, probably by regulating abscisic acid (ABA)
CC       (PubMed:22147516, PubMed:16093319, PubMed:16703358, PubMed:9482948,
CC       PubMed:9565033). Regulates the timing of flowering by promoting the
CC       expression of 'FLOWERING LOCUS T' (FT) in vascular bundles. Negatively
CC       regulated by 'FLOWERING LOCUS C' (FLC) (PubMed:14605222,
CC       PubMed:17259260). General positive regulator of reversible low light-
CC       induced chromatin decompaction (PubMed:20935177). Involved in
CC       triggering chromatin decondensation during floral transition
CC       (PubMed:17470059). Together with phototropins, involved in phototropism
CC       regulation by various blue light fluence; blue light attenuates
CC       phototropism in high fluence rates (100 umol.m-2.s-1) but enhances
CC       phototropism in low fluence rates (<1.0 umol.m-2.s-1)
CC       (PubMed:12857830). The effect of near-null magnetic field on flowering
CC       is altered by changes of blue light cycle and intensity in a CRY1/CRY2-
CC       dependent manner (PubMed:26095447). Involved in the strigolactone
CC       signaling that regulates hypocotyl growth in response to blue light
CC       (PubMed:24126495). {ECO:0000269|PubMed:12857830,
CC       ECO:0000269|PubMed:14605222, ECO:0000269|PubMed:16093319,
CC       ECO:0000269|PubMed:16703358, ECO:0000269|PubMed:17259260,
CC       ECO:0000269|PubMed:17470059, ECO:0000269|PubMed:19558423,
CC       ECO:0000269|PubMed:20935177, ECO:0000269|PubMed:21296763,
CC       ECO:0000269|PubMed:21511872, ECO:0000269|PubMed:21514160,
CC       ECO:0000269|PubMed:22147516, ECO:0000269|PubMed:23398192,
CC       ECO:0000269|PubMed:23511208, ECO:0000269|PubMed:24126495,
CC       ECO:0000269|PubMed:24130508, ECO:0000269|PubMed:25428980,
CC       ECO:0000269|PubMed:26095447, ECO:0000269|PubMed:26179959,
CC       ECO:0000269|PubMed:26724867, ECO:0000269|PubMed:9482948,
CC       ECO:0000269|PubMed:9565033, ECO:0000303|PubMed:21841916}.
CC   -!- FUNCTION: Confers resistance to turnip crinkle virus (TCV) by
CC       preventing COP1-mediated proteasome-mediated degradation of RPP8/HRT,
CC       thus promoting its stability in light. Exposure to darkness or blue-
CC       light induces degradation of CRY2, and in turn of RPP8/HRT, resulting
CC       in susceptibility to TCV. {ECO:0000269|PubMed:20624951}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:17073458, ECO:0000269|PubMed:17355959};
CC       Note=Binds 1 FAD per subunit. The flavin in the dark is in the oxidized
CC       (bright yellow) redox state, whereas it becomes reduced subsequent to
CC       light activation and formation of the neutral radical (pale yellow).
CC       {ECO:0000269|PubMed:17073458, ECO:0000269|PubMed:17355959,
CC       ECO:0000269|PubMed:25428980};
CC   -!- COFACTOR:
CC       Name=(6R)-5,10-methylene-5,6,7,8-tetrahydrofolate;
CC         Xref=ChEBI:CHEBI:15636; Evidence={ECO:0000250};
CC       Note=Binds 1 5,10-methenyltetrahydrofolate (MTHF) per subunit.
CC       {ECO:0000250};
CC   -!- SUBUNIT: Homodimer (PubMed:11089975, PubMed:11509693, PubMed:17438275,
CC       PubMed:27846570). Blue-light dependent dimerization (PubMed:27846570).
CC       Interacts with COP1 and PHYB in the nucleus (PubMed:11089975,
CC       PubMed:11509693, PubMed:17438275, PubMed:20624951). Binds reversibly to
CC       CIBs proteins such as BHLH63/CIB1, BHLH78/CIB2, BHLH74/CIB4 and
CC       BHLH76/CIB5 after blue light illumination to stimulate their
CC       transcription factor activities (PubMed:18988809, PubMed:22139370,
CC       PubMed:24130508, PubMed:24780222). Interacts with PIF4 and PIF5 in the
CC       nucleus in response to low blue light (LBL) (PubMed:26724867). Binds to
CC       SPA1 in response to blue light, this interaction prevents SPA1/COP1
CC       complex formation but stimulates interaction with COP1, and thus avoid
CC       COP1-dependent degradation of the transcription factors CO and HY5 by
CC       the proteasome and promotes hypocotyl elongation and floral initiation
CC       (PubMed:21514160, PubMed:22139370, PubMed:21511872, PubMed:22739826).
CC       Binding to ATP mediates conformational changes which facilitate flavin
CC       binding (PubMed:17073458). Interacts with BIC1 in both darkness and
CC       light (PubMed:27846570, PubMed:11089975, PubMed:11509693,
CC       PubMed:17073458, PubMed:17438275, PubMed:18988809, PubMed:20624951,
CC       PubMed:21511872, PubMed:21514160, PubMed:22139370, PubMed:22739826,
CC       PubMed:24130508, PubMed:24780222, PubMed:26724867). Interacts with NRP
CC       (PubMed:28633330). {ECO:0000269|PubMed:11089975,
CC       ECO:0000269|PubMed:11509693, ECO:0000269|PubMed:17073458,
CC       ECO:0000269|PubMed:17438275, ECO:0000269|PubMed:18988809,
CC       ECO:0000269|PubMed:20624951, ECO:0000269|PubMed:21511872,
CC       ECO:0000269|PubMed:21514160, ECO:0000269|PubMed:22139370,
CC       ECO:0000269|PubMed:22739826, ECO:0000269|PubMed:24130508,
CC       ECO:0000269|PubMed:24780222, ECO:0000269|PubMed:26724867,
CC       ECO:0000269|PubMed:27846570, ECO:0000269|PubMed:28633330}.
CC   -!- INTERACTION:
CC       Q96524; Q8GY61: BHLH63; NbExp=3; IntAct=EBI-531555, EBI-4469930;
CC       Q96524; P43254: COP1; NbExp=3; IntAct=EBI-531555, EBI-301649;
CC       Q96524; Q96524: CRY2; NbExp=4; IntAct=EBI-531555, EBI-531555;
CC       Q96524; P14713: PHYB; NbExp=3; IntAct=EBI-531555, EBI-300727;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00768,
CC       ECO:0000269|PubMed:10476076, ECO:0000269|PubMed:17438275,
CC       ECO:0000269|PubMed:17965271, ECO:0000269|PubMed:18988809,
CC       ECO:0000269|PubMed:20624951, ECO:0000269|PubMed:22311776,
CC       ECO:0000269|PubMed:22739826, ECO:0000269|PubMed:25792146,
CC       ECO:0000269|PubMed:26179959, ECO:0000269|PubMed:26724867}. Nucleus, PML
CC       body {ECO:0000269|PubMed:21511872, ECO:0000269|PubMed:23833191}.
CC       Cytoplasm {ECO:0000269|PubMed:26179959}. Note=Present in nuclear bodies
CC       (NBs) in blue light (e.g. photobodies) (PubMed:21511872,
CC       PubMed:23833191, PubMed:22311776). Translocates from the cytosol to the
CC       nucleus in response to blue light illumination (PubMed:26179959).
CC       {ECO:0000269|PubMed:21511872, ECO:0000269|PubMed:22311776,
CC       ECO:0000269|PubMed:23833191, ECO:0000269|PubMed:26179959}.
CC   -!- TISSUE SPECIFICITY: Mostly expressed in the shoot meristems and root
CC       tips, and, to a lower extent, in the cotyledons, hypocotyls, and roots.
CC       {ECO:0000269|PubMed:11743105}.
CC   -!- INDUCTION: Daily oscillation of protein abundance in plants grown in
CC       short days (SD) but not in long days (LD) (PubMed:12578985). Expression
CC       levels display circadian oscillations under constant conditions, with a
CC       low amplitude and a late phase, with maximal expression around the end
CC       of the light phase. Repressed by light (PubMed:11743105). In response
CC       to blue light and darkness, phosphorylated, ubiquitinated, and
CC       subsequently degraded (at protein level) in a SPA proteins-dependent
CC       manner (PubMed:20624951, PubMed:25792146, PubMed:22739826,
CC       PubMed:22311776). Transcripts levels oscillate weakly and
CC       proportionally to temperature, but protein levels are stable
CC       (PubMed:23511208). Accumulates in response to low blue light (LBL) and
CC       in low light (PubMed:26724867, PubMed:20935177).
CC       {ECO:0000269|PubMed:11743105, ECO:0000269|PubMed:12578985,
CC       ECO:0000269|PubMed:20624951, ECO:0000269|PubMed:20935177,
CC       ECO:0000269|PubMed:22311776, ECO:0000269|PubMed:22739826,
CC       ECO:0000269|PubMed:23511208, ECO:0000269|PubMed:25792146,
CC       ECO:0000269|PubMed:26724867}.
CC   -!- DOMAIN: The NC80 domain (486-565) contains a major active site
CC       responsible for the signal transduction processes regulating both
CC       hypocotyl inhibition and floral promotion. The C-terminal tail (564-
CC       612) is not required for physiological activity of the protein.
CC   -!- PTM: Phosphorylated by CK1.3 and CK1.4; in response to blue light.
CC       Required for degradation (PubMed:12066190, PubMed:17438275,
CC       PubMed:17965271, PubMed:9651577, PubMed:25792146, PubMed:23897926).
CC       Adopts an open conformation when phosphorylated upon photoexcitation
CC       and thus interacts with signaling partner proteins (PubMed:21841916).
CC       Not autophosphorylated, even in complex with FAD cofactor
CC       (PubMed:17073458). {ECO:0000269|PubMed:12066190,
CC       ECO:0000269|PubMed:17073458, ECO:0000269|PubMed:17438275,
CC       ECO:0000269|PubMed:17965271, ECO:0000269|PubMed:23897926,
CC       ECO:0000269|PubMed:25792146, ECO:0000269|PubMed:9651577,
CC       ECO:0000303|PubMed:21841916}.
CC   -!- PTM: Ubiquitinated; in response to blue light.
CC       {ECO:0000269|PubMed:17965271, ECO:0000269|PubMed:25792146}.
CC   -!- DISRUPTION PHENOTYPE: Plants show increased root elongation in blue
CC       light (PubMed:16703358, PubMed:21511872). Reduced attenuating effect of
CC       high fluence rates of blue light in the cry1 cry2 double mutant. Slow
CC       rate of curvature at low fluence rates of blue light in cry1 cry2
CC       (PubMed:12857830). The double mutant cry1 cry2 exhibits a reduced
CC       impact of near-null magnetic field on flowering in lower blue light
CC       intensity and short days (PubMed:26095447). Little detectable phenotype
CC       on circadian clock in blue light (BL). The double mutant cry1 cry2 is
CC       impaired in blue light signaling, resulting in long-period, lower-
CC       amplitude oscillations at 12 and 17 degrees Celsius and completely
CC       abolishing rhythms at 27 degrees Celsius (PubMed:23511208). Reduced
CC       hyponastic growth (differential growth-driven upward leaf movement) in
CC       low blue light fluence (PubMed:19558423). The double mutant cry1 cry2
CC       is hyposensitive to the strigolactone analog GR24 (PubMed:24126495).
CC       The mutant cry2 exposed to a background of red light show severely
CC       impaired stomatal opening responses to blue light. The double mutant
CC       cry1 cry2 has reduced stomatal conductance, transpiration, and
CC       photosynthesis, particularly under the high irradiance of full sunlight
CC       at midday, associated with elevated abscisic acid levels
CC       (PubMed:22147516). Mutation sel20 suppresses the inhibitory effect of
CC       continuous light (LL) on the hypocotyl elongation of elf3-1. The double
CC       mutant elf3 sel20 exhibits a late-flowering phenotype
CC       (PubMed:21296763). Impaired chromatin decondensation during the floral
CC       transition and in low light conditions (PubMed:20935177). Increased
CC       sensitivity to turnip crinkle virus (TCV) and associated with reduced
CC       HRT levels and stability, and characterized by hypersensitive response
CC       (HR) symptoms (PubMed:20624951). {ECO:0000269|PubMed:12857830,
CC       ECO:0000269|PubMed:16703358, ECO:0000269|PubMed:19558423,
CC       ECO:0000269|PubMed:20624951, ECO:0000269|PubMed:20935177,
CC       ECO:0000269|PubMed:21296763, ECO:0000269|PubMed:21511872,
CC       ECO:0000269|PubMed:22147516, ECO:0000269|PubMed:23511208,
CC       ECO:0000269|PubMed:24126495, ECO:0000269|PubMed:26095447}.
CC   -!- BIOTECHNOLOGY: The rapid blue light-mediated reversible interaction
CC       between CRY2 and BHLH63/CIB1 is used to design an optogenetic control
CC       of target proteins or organelles. {ECO:0000269|PubMed:21037589,
CC       ECO:0000269|PubMed:22847441, ECO:0000269|PubMed:23833191,
CC       ECO:0000269|PubMed:24718798, ECO:0000269|PubMed:25963241}.
CC   -!- MISCELLANEOUS: Phosphorylation of the C-terminal tail and resulting
CC       derepression of NC80 domain may both depend on homodimerization.
CC   -!- SIMILARITY: Belongs to the DNA photolyase class-1 family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to be a DNA photolyase.
CC       {ECO:0000305|PubMed:9003312}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAT80593.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80594.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80595.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80596.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80597.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80598.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80599.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80600.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80601.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80602.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80603.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80604.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80605.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80606.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80607.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80608.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80609.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80610.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80611.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80612.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80613.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80614.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80615.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80616.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80617.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80618.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80619.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80620.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80621.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80622.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAT80623.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAD94467.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U62549; AAB04996.1; -; mRNA.
DR   EMBL; U62550; AAB04997.1; -; mRNA.
DR   EMBL; X99061; CAA67508.1; -; Genomic_DNA.
DR   EMBL; U43397; AAD09837.1; -; mRNA.
DR   EMBL; AY057440; AAL16377.1; -; mRNA.
DR   EMBL; AY057441; AAL16378.1; -; Genomic_DNA.
DR   EMBL; AY057442; AAL16379.1; -; Genomic_DNA.
DR   EMBL; EU351967; ABY77601.1; -; Genomic_DNA.
DR   EMBL; EU351968; ABY77602.1; -; Genomic_DNA.
DR   EMBL; EU351969; ABY77603.1; -; Genomic_DNA.
DR   EMBL; EU351970; ABY77604.1; -; Genomic_DNA.
DR   EMBL; EU351971; ABY77605.1; -; Genomic_DNA.
DR   EMBL; EU351972; ABY77606.1; -; Genomic_DNA.
DR   EMBL; EU351973; ABY77607.1; -; Genomic_DNA.
DR   EMBL; EU351974; ABY77608.1; -; Genomic_DNA.
DR   EMBL; EU351975; ABY77609.1; -; Genomic_DNA.
DR   EMBL; EU351976; ABY77610.1; -; Genomic_DNA.
DR   EMBL; EU351977; ABY77611.1; -; Genomic_DNA.
DR   EMBL; EU351978; ABY77612.1; -; Genomic_DNA.
DR   EMBL; EU351979; ABY77613.1; -; Genomic_DNA.
DR   EMBL; EU351980; ABY77614.1; -; Genomic_DNA.
DR   EMBL; EU351981; ABY77615.1; -; Genomic_DNA.
DR   EMBL; EU351982; ABY77616.1; -; Genomic_DNA.
DR   EMBL; EU351983; ABY77617.1; -; Genomic_DNA.
DR   EMBL; EU351984; ABY77618.1; -; Genomic_DNA.
DR   EMBL; EU351985; ABY77619.1; -; Genomic_DNA.
DR   EMBL; EU351986; ABY77620.1; -; Genomic_DNA.
DR   EMBL; EU351987; ABY77621.1; -; Genomic_DNA.
DR   EMBL; EU351988; ABY77622.1; -; Genomic_DNA.
DR   EMBL; EU351989; ABY77623.1; -; Genomic_DNA.
DR   EMBL; EU351990; ABY77624.1; -; Genomic_DNA.
DR   EMBL; EU351991; ABY77625.1; -; Genomic_DNA.
DR   EMBL; EU351993; ABY77627.1; -; Genomic_DNA.
DR   EMBL; EU351992; ABY77626.1; -; Genomic_DNA.
DR   EMBL; EU351994; ABY77628.1; -; Genomic_DNA.
DR   EMBL; EU351995; ABY77629.1; -; Genomic_DNA.
DR   EMBL; EU351996; ABY77630.1; -; Genomic_DNA.
DR   EMBL; EU351997; ABY77631.1; -; Genomic_DNA.
DR   EMBL; EU351998; ABY77632.1; -; Genomic_DNA.
DR   EMBL; AC000104; AAB70435.1; -; Genomic_DNA.
DR   EMBL; CP002684; AEE27692.1; -; Genomic_DNA.
DR   EMBL; CP002684; AEE27693.1; -; Genomic_DNA.
DR   EMBL; BT008576; AAP40403.1; -; mRNA.
DR   EMBL; BT008648; AAP40463.1; -; mRNA.
DR   EMBL; AY576241; AAT80593.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576242; AAT80594.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576243; AAT80595.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576244; AAT80596.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576245; AAT80597.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576246; AAT80598.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576247; AAT80599.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576248; AAT80600.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576249; AAT80601.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576250; AAT80602.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576251; AAT80603.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576252; AAT80604.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576253; AAT80605.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576254; AAT80606.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576255; AAT80607.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576256; AAT80608.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576257; AAT80609.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576258; AAT80610.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576259; AAT80611.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576260; AAT80612.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576261; AAT80613.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576262; AAT80614.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576263; AAT80615.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576264; AAT80616.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576265; AAT80617.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576266; AAT80618.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576267; AAT80619.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576268; AAT80620.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576269; AAT80621.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576270; AAT80622.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY576271; AAT80623.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AK220946; BAD94467.1; ALT_INIT; mRNA.
DR   PIR; A86176; A86176.
DR   PIR; S71221; S71221.
DR   RefSeq; NP_171935.1; NM_100320.4.
DR   RefSeq; NP_849588.1; NM_179257.2.
DR   PDB; 6K8I; X-ray; 2.70 A; A/B=1-612.
DR   PDB; 6K8K; X-ray; 2.50 A; A/B/D/G=1-612.
DR   PDB; 6M79; EM; 3.10 A; A/B/C/D=1-612.
DR   PDB; 6X24; X-ray; 3.25 A; A/B/C/D=1-498.
DR   PDBsum; 6K8I; -.
DR   PDBsum; 6K8K; -.
DR   PDBsum; 6M79; -.
DR   PDBsum; 6X24; -.
DR   SMR; Q96524; -.
DR   BioGRID; 24764; 11.
DR   DIP; DIP-33589N; -.
DR   IntAct; Q96524; 13.
DR   STRING; 3702.AT1G04400.1; -.
DR   iPTMnet; Q96524; -.
DR   PaxDb; Q96524; -.
DR   PRIDE; Q96524; -.
DR   ProteomicsDB; 224501; -.
DR   EnsemblPlants; AT1G04400.1; AT1G04400.1; AT1G04400.
DR   EnsemblPlants; AT1G04400.2; AT1G04400.2; AT1G04400.
DR   GeneID; 839529; -.
DR   Gramene; AT1G04400.1; AT1G04400.1; AT1G04400.
DR   Gramene; AT1G04400.2; AT1G04400.2; AT1G04400.
DR   KEGG; ath:AT1G04400; -.
DR   Araport; AT1G04400; -.
DR   TAIR; locus:2018254; AT1G04400.
DR   eggNOG; KOG0133; Eukaryota.
DR   HOGENOM; CLU_010348_5_0_1; -.
DR   InParanoid; Q96524; -.
DR   OMA; VFTPYHK; -.
DR   OrthoDB; 378952at2759; -.
DR   PhylomeDB; Q96524; -.
DR   PRO; PR:Q96524; -.
DR   Proteomes; UP000006548; Chromosome 1.
DR   ExpressionAtlas; Q96524; baseline and differential.
DR   Genevisible; Q96524; AT.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell.
DR   GO; GO:0005773; C:vacuole; IDA:TAIR.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0009882; F:blue light photoreceptor activity; ISS:TAIR.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0009785; P:blue light signaling pathway; IGI:TAIR.
DR   GO; GO:0006325; P:chromatin organization; IMP:TAIR.
DR   GO; GO:0006338; P:chromatin remodeling; IMP:TAIR.
DR   GO; GO:0010617; P:circadian regulation of calcium ion oscillation; IMP:TAIR.
DR   GO; GO:0032922; P:circadian regulation of gene expression; IBA:GO_Central.
DR   GO; GO:0007623; P:circadian rhythm; IEP:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; IMP:UniProtKB.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; IBA:GO_Central.
DR   GO; GO:0072387; P:flavin adenine dinucleotide metabolic process; IMP:UniProtKB.
DR   GO; GO:0048574; P:long-day photoperiodism, flowering; IMP:UniProtKB.
DR   GO; GO:0016310; P:phosphorylation; IEA:GOC.
DR   GO; GO:0009638; P:phototropism; IMP:UniProtKB.
DR   GO; GO:0009911; P:positive regulation of flower development; IMP:TAIR.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IDA:UniProtKB.
DR   GO; GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IMP:UniProtKB.
DR   GO; GO:0009909; P:regulation of flower development; IDA:TAIR.
DR   GO; GO:1901371; P:regulation of leaf morphogenesis; IMP:UniProtKB.
DR   GO; GO:0010075; P:regulation of meristem growth; IGI:TAIR.
DR   GO; GO:2000028; P:regulation of photoperiodism, flowering; IDA:UniProtKB.
DR   GO; GO:0009646; P:response to absence of light; IEP:UniProtKB.
DR   GO; GO:0009637; P:response to blue light; IDA:UniProtKB.
DR   GO; GO:0009416; P:response to light stimulus; IMP:UniProtKB.
DR   GO; GO:0010244; P:response to low fluence blue light stimulus by blue low-fluence system; IMP:UniProtKB.
DR   GO; GO:1902347; P:response to strigolactone; IMP:UniProtKB.
DR   GO; GO:0009414; P:response to water deprivation; IGI:TAIR.
DR   GO; GO:0010118; P:stomatal movement; IGI:TAIR.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR036134; Crypto/Photolyase_FAD-like_sf.
DR   InterPro; IPR036155; Crypto/Photolyase_N_sf.
DR   InterPro; IPR005101; Cryptochr/Photolyase_FAD-bd.
DR   InterPro; IPR002081; Cryptochrome/DNA_photolyase_1.
DR   InterPro; IPR014134; Cryptochrome_pln.
DR   InterPro; IPR018394; DNA_photolyase_1_CS_C.
DR   InterPro; IPR006050; DNA_photolyase_N.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00875; DNA_photolyase; 1.
DR   Pfam; PF03441; FAD_binding_7; 1.
DR   PRINTS; PR00147; DNAPHOTLYASE.
DR   SUPFAM; SSF48173; SSF48173; 1.
DR   SUPFAM; SSF52425; SSF52425; 1.
DR   TIGRFAMs; TIGR02766; crypt_chrom_pln; 1.
DR   PROSITE; PS00394; DNA_PHOTOLYASES_1_1; 1.
DR   PROSITE; PS00691; DNA_PHOTOLYASES_1_2; 1.
DR   PROSITE; PS51645; PHR_CRY_ALPHA_BETA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Chromatin regulator; Chromophore; Cytoplasm;
KW   FAD; Flavoprotein; Magnesium; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Photoreceptor protein; Plant defense; Receptor;
KW   Reference proteome; Sensory transduction; Ubl conjugation.
FT   CHAIN           1..612
FT                   /note="Cryptochrome-2"
FT                   /id="PRO_0000085122"
FT   DOMAIN          5..134
FT                   /note="Photolyase/cryptochrome alpha/beta"
FT                   /evidence="ECO:0000255"
FT   NP_BIND         244..248
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32398826,
FT                   ECO:0007744|PDB:6K8I, ECO:0007744|PDB:6K8K"
FT   NP_BIND         356..357
FT                   /note="ATP"
FT                   /evidence="ECO:0000269|PubMed:32398826,
FT                   ECO:0007744|PDB:6K8K"
FT   NP_BIND         387..389
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32398826,
FT                   ECO:0007744|PDB:6K8I, ECO:0007744|PDB:6K8K"
FT   REGION          1..485
FT                   /note="CNT2, binds chromophores to sense blue light and
FT                   mediate CRY dimerization"
FT                   /evidence="ECO:0000303|PubMed:25721730"
FT   REGION          486..612
FT                   /note="CCT2/CCE2, mediates blue light signaling"
FT                   /evidence="ECO:0000269|PubMed:11114337,
FT                   ECO:0000303|PubMed:25721730"
FT   REGION          539..576
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          590..612
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           541..555
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00768"
FT   COMPBIAS        540..564
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   METAL           235
FT                   /note="Magnesium 1; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:Q43125"
FT   METAL           243
FT                   /note="Magnesium 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q43125"
FT   METAL           355
FT                   /note="Magnesium 1; via tele nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:Q43125"
FT   BINDING         232
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32398826,
FT                   ECO:0007744|PDB:6K8I, ECO:0007744|PDB:6K8K"
FT   BINDING         356
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32398826,
FT                   ECO:0007744|PDB:6K8I, ECO:0007744|PDB:6K8K"
FT   BINDING         406
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:Q43125"
FT   SITE            321
FT                   /note="Involved in electron transfer from the protein
FT                   surface to the FAD cofactor"
FT                   /evidence="ECO:0000269|PubMed:25428980"
FT   SITE            374
FT                   /note="Involved in electron transfer from the protein
FT                   surface to the FAD cofactor"
FT                   /evidence="ECO:0000269|PubMed:25428980"
FT   SITE            397
FT                   /note="Involved in electron transfer from the protein
FT                   surface to the FAD cofactor"
FT                   /evidence="ECO:0000269|PubMed:25428980"
FT   MOD_RES         587
FT                   /note="Phosphoserine; by CK1"
FT                   /evidence="ECO:0000269|PubMed:23897926"
FT   MOD_RES         598
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:25792146"
FT   MOD_RES         599
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:25792146"
FT   MOD_RES         603
FT                   /note="Phosphothreonine; by CK1"
FT                   /evidence="ECO:0000269|PubMed:23897926"
FT   MOD_RES         605
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:25792146"
FT   VARIANT         83
FT                   /note="I -> V (in strain: cv. Chi-1, cv. Co-1, cv. Kon, cv.
FT                   PHW-1 and cv. Sha)"
FT                   /evidence="ECO:0000305|PubMed:18273534"
FT   VARIANT         127
FT                   /note="Q -> S (in strain: cv. Bu-0, cv. Da(1)-12, cv. Di-G,
FT                   cv. Landsberg erecta, cv. Le-0, cv. Lip-0, cv. Mrk-0, cv.
FT                   Stw-0 and cv. Ta-0)"
FT                   /evidence="ECO:0000305|PubMed:18273534"
FT   VARIANT         326
FT                   /note="D -> E (in strain: cv. Chi-1, cv. Co-1, cv. Kon, cv.
FT                   PHW-1 and cv. Sha)"
FT                   /evidence="ECO:0000305|PubMed:18273534"
FT   VARIANT         367
FT                   /note="V -> M (in strain: cv. Cvi-0)"
FT                   /evidence="ECO:0000305|PubMed:18273534"
FT   VARIANT         476
FT                   /note="T -> I (in strain: cv. Cvi-0)"
FT                   /evidence="ECO:0000305|PubMed:18273534"
FT   VARIANT         482
FT                   /note="A -> G (in strain: cv. Chi-1, cv. Co-1, cv. Kon, cv.
FT                   PHW-1 and cv. Sha)"
FT                   /evidence="ECO:0000305|PubMed:18273534"
FT   VARIANT         498
FT                   /note="A -> S (in strain: cv. Chi-1, cv. Co-1, cv. Kon, cv.
FT                   PHW-1 and cv. Sha)"
FT                   /evidence="ECO:0000305|PubMed:18273534"
FT   VARIANT         507
FT                   /note="F -> L (in strain: cv. Chi-1, cv. Co-1, cv. Kon, cv.
FT                   PHW-1 and cv. Sha)"
FT                   /evidence="ECO:0000305|PubMed:18273534"
FT   VARIANT         511
FT                   /note="G -> E (in strain: cv. Chi-1, cv. Co-1, cv. Kon, cv.
FT                   PHW-1 and cv. Sha)"
FT                   /evidence="ECO:0000305|PubMed:18273534"
FT   VARIANT         543
FT                   /note="V -> L (in strain: cv. Chi-1, cv. Co-1, cv. Kon, cv.
FT                   PHW-1 and cv. Sha)"
FT                   /evidence="ECO:0000305|PubMed:18273534"
FT   VARIANT         611
FT                   /note="C -> Y (in strain: cv. Chi-1, cv. Co-1, cv. Kon, cv.
FT                   PHW-1 and cv. Sha)"
FT                   /evidence="ECO:0000305|PubMed:18273534"
FT   MUTAGEN         321
FT                   /note="W->A,F: Photochemically inactive in vitro. Undergo
FT                   robust light-dependent photoreduction in an in vivo context
FT                   via an alternative electron transport involving small
FT                   molecule activators including ATP, NADH, and NADPH."
FT                   /evidence="ECO:0000269|PubMed:22139370,
FT                   ECO:0000269|PubMed:25428980"
FT   MUTAGEN         331
FT                   /note="W->A: Decreased light sensitivity. Enhanced
FT                   photoreduction in the presence of added ATP."
FT                   /evidence="ECO:0000269|PubMed:25428980"
FT   MUTAGEN         337
FT                   /note="G->E: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:9565033"
FT   MUTAGEN         374
FT                   /note="W->A: Photochemically inactive in vitro. Undergo
FT                   robust light-dependent photoreduction in an in vivo context
FT                   via an alternative electron transport involving small
FT                   molecule activators including ATP, NADH, and NADPH.
FT                   Enhanced photoreduction in the presence of added ATP.
FT                   Constitutive interaction with SPA1 and BHLH63/CIB1."
FT                   /evidence="ECO:0000269|PubMed:22139370,
FT                   ECO:0000269|PubMed:25428980"
FT   MUTAGEN         374
FT                   /note="W->F: Photochemically inactive in vitro. Undergo
FT                   robust light-dependent photoreduction in an in vivo context
FT                   via an alternative electron transport involving small
FT                   molecule activators including ATP, NADH, and NADPH.
FT                   Enhanced photoreduction in the presence of added ATP."
FT                   /evidence="ECO:0000269|PubMed:22139370,
FT                   ECO:0000269|PubMed:25428980"
FT   MUTAGEN         376
FT                   /note="W->A: Decreased light sensitivity. Enhanced
FT                   photoreduction in the presence of added ATP."
FT                   /evidence="ECO:0000269|PubMed:25428980"
FT   MUTAGEN         377
FT                   /note="G->R: Constitutive light response."
FT                   /evidence="ECO:0000269|PubMed:21765176"
FT   MUTAGEN         387
FT                   /note="D->A: Impaired FAD-binding leading to impaired blue
FT                   light-mediated inhibition of hypocotyl elongation and loss
FT                   of blue light-induced degradation. Disturbed BHLH63/CIB1
FT                   and SPA1 interactions."
FT                   /evidence="ECO:0000269|PubMed:18988809,
FT                   ECO:0000269|PubMed:21514160"
FT   MUTAGEN         397
FT                   /note="W->A: Photochemically inactive in vitro. Undergo
FT                   robust light-dependent photoreduction in an in vivo context
FT                   via an alternative electron transport involving small
FT                   molecule activators including ATP, NADH, and NADPH."
FT                   /evidence="ECO:0000269|PubMed:22139370,
FT                   ECO:0000269|PubMed:25428980"
FT   MUTAGEN         397
FT                   /note="W->F: Photochemically inactive both in vitro and in
FT                   vivo."
FT                   /evidence="ECO:0000269|PubMed:22139370,
FT                   ECO:0000269|PubMed:25428980"
FT   MUTAGEN         399
FT                   /note="Y->A,F: Impaired ATP-mediated enhanced
FT                   photoreduction and decreased affinity for ATP."
FT                   /evidence="ECO:0000269|PubMed:25428980"
FT   MUTAGEN         541
FT                   /note="K->R: Impaired nuclear importation leading to
FT                   reduced phosphorylation, physiological activities, and
FT                   degradation in response to blue light. Forms protein bodies
FT                   (photobodies) in both the nucleus and cytosol in response
FT                   to blue light."
FT                   /evidence="ECO:0000269|PubMed:22311776"
FT   MUTAGEN         554..555
FT                   /note="KK->RR: Impaired nuclear importation leading to
FT                   reduced phosphorylation, physiological activities, and
FT                   degradation in response to blue light. Forms protein bodies
FT                   (photobodies) in both the nucleus and cytosol in response
FT                   to blue light."
FT                   /evidence="ECO:0000269|PubMed:22311776"
FT   MUTAGEN         570..575
FT                   /note="SSSSSS->AAAAAA: Reduced blue light-mediated
FT                   phosphorylation and impaired blue light-dependent
FT                   proteolysis and hypocotyl inhibition response; when
FT                   associated with A-580, A-582, A-584, A-587, 598-A-A-599 and
FT                   A-605."
FT                   /evidence="ECO:0000269|PubMed:25792146"
FT   MUTAGEN         570..575
FT                   /note="SSSSSS->DDDDDD: Reduced blue light-mediated
FT                   phosphorylation and impaired blue light-dependent
FT                   proteolysis and hypocotyl inhibition response; when
FT                   associated with D-580, D-582, D-584, D-587, 598-D-D-599 and
FT                   D-605."
FT                   /evidence="ECO:0000269|PubMed:25792146"
FT   MUTAGEN         580
FT                   /note="S->A: Reduced blue light-mediated phosphorylation
FT                   and impaired blue light-dependent proteolysis and hypocotyl
FT                   inhibition response; when associated with 570-A--A-573, A-
FT                   582, A-584, A-587, 598-A-A-599 and A-605."
FT                   /evidence="ECO:0000269|PubMed:25792146"
FT   MUTAGEN         580
FT                   /note="S->D: Reduced blue light-mediated phosphorylation
FT                   and impaired blue light-dependent proteolysis and hypocotyl
FT                   inhibition response; when associated with 570-D--D-573, D-
FT                   582, D-584, D-587, 598-D-D-599 and D-605."
FT                   /evidence="ECO:0000269|PubMed:25792146"
FT   MUTAGEN         582
FT                   /note="S->A: Reduced blue light-mediated phosphorylation
FT                   and impaired blue light-dependent proteolysis and hypocotyl
FT                   inhibition response; when associated with 570-A--A-573, A-
FT                   580, A-584, A-587, 598-A-A-599 and A-605."
FT                   /evidence="ECO:0000269|PubMed:25792146"
FT   MUTAGEN         582
FT                   /note="S->D: Reduced blue light-mediated phosphorylation
FT                   and impaired blue light-dependent proteolysis and hypocotyl
FT                   inhibition response; when associated with 570-D--D-573, D-
FT                   580, D-584, D-587, 598-D-D-599 and D-605."
FT                   /evidence="ECO:0000269|PubMed:25792146"
FT   MUTAGEN         584
FT                   /note="S->A: Reduced blue light-mediated phosphorylation
FT                   and impaired blue light-dependent proteolysis and hypocotyl
FT                   inhibition response; when associated with 570-A--A-573, A-
FT                   580, A-582, A-587, 598-A-A-599 and A-605."
FT                   /evidence="ECO:0000269|PubMed:25792146"
FT   MUTAGEN         584
FT                   /note="S->D: Reduced blue light-mediated phosphorylation
FT                   and impaired blue light-dependent proteolysis and hypocotyl
FT                   inhibition response; when associated with 570-D--D-573, D-
FT                   580, D-582, D-587, 598-D-D-599 and D-605."
FT                   /evidence="ECO:0000269|PubMed:25792146"
FT   MUTAGEN         587
FT                   /note="S->A: Impaired regulation of hypocotyl growth in
FT                   blue light. Phosphorylated by CK1 proteins CK1.3 and CK1.4.
FT                   Reduced phosphorylation by CK1 proteins CK1.3 and CK1.4;
FT                   when associated with A-603. Reduced blue light-mediated
FT                   phosphorylation and impaired blue light-dependent
FT                   proteolysis and hypocotyl inhibition response; when
FT                   associated with 570-A--A-573, A-580, A-582, A-584, 598-A-A-
FT                   599 and A-605."
FT                   /evidence="ECO:0000269|PubMed:23897926,
FT                   ECO:0000269|PubMed:25792146"
FT   MUTAGEN         587
FT                   /note="S->D: Constitutive regulation of hypocotyl growth in
FT                   blue light. Reduced blue light-mediated phosphorylation and
FT                   impaired blue light-dependent proteolysis and hypocotyl
FT                   inhibition response; when associated with 570-D--D-573, D-
FT                   580, D-582, D-584, 598-D-D-599 and D-605."
FT                   /evidence="ECO:0000269|PubMed:23897926,
FT                   ECO:0000269|PubMed:25792146"
FT   MUTAGEN         598..599
FT                   /note="SS->AA: Reduced blue light-mediated phosphorylation
FT                   and impaired blue light-dependent proteolysis and hypocotyl
FT                   inhibition response; when associated with 570-A--A-573, A-
FT                   580, A-582, A-584, A-587 and A-605."
FT                   /evidence="ECO:0000269|PubMed:25792146"
FT   MUTAGEN         598..599
FT                   /note="SS->DD: Reduced blue light-mediated phosphorylation
FT                   and impaired blue light-dependent proteolysis and hypocotyl
FT                   inhibition response; when associated with 570-D--D-573, D-
FT                   580, D-582, D-584, D-587 and D-605."
FT                   /evidence="ECO:0000269|PubMed:25792146"
FT   MUTAGEN         603
FT                   /note="T->A: Impaired regulation of hypocotyl growth in
FT                   blue light. Phosphorylated by CK1 proteins CK1.3 and CK1.4.
FT                   Reduced phosphorylation by CK1 proteins CK1.3 and CK1.4;
FT                   when associated with A-587."
FT                   /evidence="ECO:0000269|PubMed:23897926"
FT   MUTAGEN         603
FT                   /note="T->D: Constitutive regulation of hypocotyl growth in
FT                   blue light."
FT                   /evidence="ECO:0000269|PubMed:23897926"
FT   MUTAGEN         605
FT                   /note="S->A: Reduced blue light-mediated phosphorylation
FT                   and impaired blue light-dependent proteolysis and hypocotyl
FT                   inhibition response; when associated with 570-A--A-573, A-
FT                   580, A-582, A-584, A-587 and 598-A-A-599."
FT                   /evidence="ECO:0000269|PubMed:25792146"
FT   MUTAGEN         605
FT                   /note="S->D: Reduced blue light-mediated phosphorylation
FT                   and impaired blue light-dependent proteolysis and hypocotyl
FT                   inhibition response; when associated with 570-D--D-573, D-
FT                   580, D-582, D-584, D-587 and 598-D-D-599."
FT                   /evidence="ECO:0000269|PubMed:25792146"
FT   CONFLICT        78
FT                   /note="K -> Q (in Ref. 1; AAB04996/AAB04997)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        95
FT                   /note="A -> P (in Ref. 1; AAB04996/AAB04997)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        188
FT                   /note="S -> L (in Ref. 3; AAL16379)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        366
FT                   /note="A -> G (in Ref. 1; AAB04996)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        534
FT                   /note="A -> V (in Ref. 1; AAB04996/AAB04997)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        590
FT                   /note="K -> E (in Ref. 1; CAA67508)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        612
FT                   /note="K -> Q (in Ref. 1; CAA67508)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..13
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           21..29
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   STRAND          30..38
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           40..43
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           44..46
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           50..69
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   STRAND          75..78
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           82..93
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   STRAND          96..101
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           106..121
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   STRAND          125..129
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   STRAND          143..145
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           151..159
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   TURN            181..185
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           190..192
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           197..199
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           200..209
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           214..227
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           229..231
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           232..235
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   STRAND          239..242
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           248..252
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           258..274
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           278..303
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   TURN            315..318
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           325..332
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           339..351
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           356..368
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           374..384
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           390..400
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   STRAND          404..407
FT                   /evidence="ECO:0007829|PDB:6M79"
FT   HELIX           416..423
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           428..433
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           435..437
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   TURN            442..446
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           448..450
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           453..458
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   TURN            463..465
FT                   /evidence="ECO:0007829|PDB:6K8K"
FT   HELIX           474..494
FT                   /evidence="ECO:0007829|PDB:6K8K"
SQ   SEQUENCE   612 AA;  69457 MW;  082E311301465904 CRC64;
     MKMDKKTIVW FRRDLRIEDN PALAAAAHEG SVFPVFIWCP EEEGQFYPGR ASRWWMKQSL
     AHLSQSLKAL GSDLTLIKTH NTISAILDCI RVTGATKVVF NHLYDPVSLV RDHTVKEKLV
     ERGISVQSYN GDLLYEPWEI YCEKGKPFTS FNSYWKKCLD MSIESVMLPP PWRLMPITAA
     AEAIWACSIE ELGLENEAEK PSNALLTRAW SPGWSNADKL LNEFIEKQLI DYAKNSKKVV
     GNSTSLLSPY LHFGEISVRH VFQCARMKQI IWARDKNSEG EESADLFLRG IGLREYSRYI
     CFNFPFTHEQ SLLSHLRFFP WDADVDKFKA WRQGRTGYPL VDAGMRELWA TGWMHNRIRV
     IVSSFAVKFL LLPWKWGMKY FWDTLLDADL ECDILGWQYI SGSIPDGHEL DRLDNPALQG
     AKYDPEGEYI RQWLPELARL PTEWIHHPWD APLTVLKASG VELGTNYAKP IVDIDTAREL
     LAKAISRTRE AQIMIGAAPD EIVADSFEAL GANTIKEPGL CPSVSSNDQQ VPSAVRYNGS
     KRVKPEEEEE RDMKKSRGFD ERELFSTAES SSSSSVFFVS QSCSLASEGK NLEGIQDSSD
     QITTSLGKNG CK
//
ID   CDR_STAA8               Reviewed;         438 AA.
AC   O52582; Q2FZT2;
DT   01-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-JUN-2021, entry version 128.
DE   RecName: Full=Coenzyme A disulfide reductase;
DE            Short=CoA-disulfide reductase;
DE            Short=CoADR;
DE            EC=1.8.1.14;
GN   Name=cdr; OrderedLocusNames=SAOUHSC_00908;
OS   Staphylococcus aureus (strain NCTC 8325 / PS 47).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC   Staphylococcus.
OX   NCBI_TaxID=93061;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 2-15 AND
RP   193-208.
RX   PubMed=9488708; DOI=10.1074/jbc.273.10.5752;
RA   delCardayre S.B., Davies J.E.;
RT   "Staphylococcus aureus coenzyme A disulfide reductase, a new subfamily of
RT   pyridine nucleotide-disulfide oxidoreductase. Sequence, expression, and
RT   analysis of cdr.";
RL   J. Biol. Chem. 273:5752-5757(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NCTC 8325 / PS 47;
RA   Gillaspy A.F., Worrell V., Orvis J., Roe B.A., Dyer D.W., Iandolo J.J.;
RT   "The Staphylococcus aureus NCTC 8325 genome.";
RL   (In) Fischetti V., Novick R., Ferretti J., Portnoy D., Rood J. (eds.);
RL   Gram positive pathogens, 2nd edition, pp.381-412, ASM Press, Washington
RL   D.C. (2006).
RN   [3]
RP   CHARACTERIZATION.
RX   PubMed=9488707; DOI=10.1074/jbc.273.10.5744;
RA   delCardayre S.B., Stock K.P., Newton G.L., Fahey R.C., Davies J.E.;
RT   "Coenzyme A disulfide reductase, the primary low molecular weight disulfide
RT   reductase from Staphylococcus aureus. Purification and characterization of
RT   the native enzyme.";
RL   J. Biol. Chem. 273:5744-5751(1998).
RN   [4]
RP   CHARACTERIZATION, ACTIVE SITE, MUTAGENESIS OF CYS-43, AND MASS
RP   SPECTROMETRY.
RX   PubMed=10052943; DOI=10.1021/bi9825899;
RA   Luba J., Charrier V., Claiborne A.;
RT   "Coenzyme A-disulfide reductase from Staphylococcus aureus: evidence for
RT   asymmetric behavior on interaction with pyridine nucleotides.";
RL   Biochemistry 38:2725-2737(1999).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.54 ANGSTROMS) IN COMPLEX WITH FAD AND SUBSTRATE,
RP   COFACTOR, SUBUNIT, AND MUTAGENESIS OF TYR-361 AND TYR-419.
RX   PubMed=16981688; DOI=10.1021/bi061139a;
RA   Mallett T.C., Wallen J.R., Karplus P.A., Sakai H., Tsukihara T.,
RA   Claiborne A.;
RT   "Structure of coenzyme A-disulfide reductase from Staphylococcus aureus at
RT   1.54 A resolution.";
RL   Biochemistry 45:11278-11289(2006).
CC   -!- FUNCTION: Catalyzes specifically the NADPH-dependent reduction of
CC       coenzyme A disulfide. Is also active with other disulfide substrates
CC       containing at least one 4'-phosphopantethienyl moiety such as 4,4'-
CC       diphosphopantethine, but is not able to reduce oxidized glutathione,
CC       cystine, pantethine, or H(2)O(2).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 CoA + NADP(+) = CoA-disulfide + H(+) + NADPH;
CC         Xref=Rhea:RHEA:14705, ChEBI:CHEBI:15378, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:62209; EC=1.8.1.14;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:16981688};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:16981688};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2 uM for NADPH;
CC         KM=11 uM for CoA disulfide;
CC         KM=140 uM for 3'-dephospho-CoA disulfide;
CC         KM=80 uM for 4,4'-diphosphopantethine;
CC         KM=1100 uM for CoA glutathione mixed disulfide;
CC       pH dependence:
CC         Optimum pH is 7.0-8.0.;
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:16981688}.
CC   -!- DOMAIN: Contains 2 FAD binding domains and a single NADPH binding
CC       domain.
CC   -!- MASS SPECTROMETRY: Mass=49153; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:10052943};
CC   -!- MISCELLANEOUS: Reduction of disulfides occurs by a thiol-disulfide
CC       exchange reaction, but involves only a single catalytic cysteine
CC       residue that forms a stable mixed disulfide with CoA during catalysis.
CC   -!- SIMILARITY: Belongs to the class-III pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF041467; AAB97073.1; -; Genomic_DNA.
DR   EMBL; CP000253; ABD30033.1; -; Genomic_DNA.
DR   RefSeq; YP_499461.1; NC_007795.1.
DR   PDB; 1YQZ; X-ray; 1.54 A; A/B=1-438.
DR   PDBsum; 1YQZ; -.
DR   SMR; O52582; -.
DR   STRING; 1280.SAXN108_0965; -.
DR   EnsemblBacteria; ABD30033; ABD30033; SAOUHSC_00908.
DR   GeneID; 3920795; -.
DR   KEGG; sao:SAOUHSC_00908; -.
DR   PATRIC; fig|93061.5.peg.829; -.
DR   eggNOG; COG0446; Bacteria.
DR   HOGENOM; CLU_003291_1_3_9; -.
DR   BRENDA; 1.8.1.14; 3352.
DR   SABIO-RK; O52582; -.
DR   EvolutionaryTrace; O52582; -.
DR   Proteomes; UP000008816; Chromosome.
DR   GO; GO:0050451; F:CoA-disulfide reductase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0050661; F:NADP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003756; F:protein disulfide isomerase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   Gene3D; 3.50.50.60; -; 3.
DR   HAMAP; MF_01608; CoA_diS_reduct; 1.
DR   InterPro; IPR017758; CoA_disulphide_reductase.
DR   InterPro; IPR023536; CoA_disulphide_reductase_staph.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
DR   TIGRFAMs; TIGR03385; CoA_CoA_reduc; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; FAD; Flavoprotein; NADP;
KW   Oxidoreductase; Redox-active center; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:9488708"
FT   CHAIN           2..438
FT                   /note="Coenzyme A disulfide reductase"
FT                   /id="PRO_0000184688"
FT   NP_BIND         8..33
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16981688"
FT   NP_BIND         151..166
FT                   /note="NADP"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         267..277
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16981688"
FT   ACT_SITE        43
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000269|PubMed:10052943"
FT   ACT_SITE        43
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:10052943"
FT   BINDING         15
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:16981688"
FT   BINDING         19
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:16981688"
FT   BINDING         22
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:16981688"
FT   BINDING         39
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:16981688"
FT   BINDING         42
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:16981688"
FT   BINDING         71
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:16981688"
FT   BINDING         299
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:16981688"
FT   BINDING         419
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:16981688"
FT   BINDING         427
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:16981688"
FT   MUTAGEN         43
FT                   /note="C->S: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:10052943"
FT   MUTAGEN         361
FT                   /note="Y->F: Reduces activity by 92%. Loss of activity;
FT                   when associated with F-419."
FT                   /evidence="ECO:0000269|PubMed:16981688"
FT   MUTAGEN         419
FT                   /note="Y->F: Reduces activity by 80%. Loss of activity;
FT                   when associated with F-361."
FT                   /evidence="ECO:0000269|PubMed:16981688"
FT   STRAND          4..7
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           13..23
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          25..27
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          29..36
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          38..40
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           42..44
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           45..49
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           56..59
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           64..71
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          74..77
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          79..85
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   TURN            86..89
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          90..95
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   TURN            96..99
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          100..105
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          107..111
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          115..117
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           133..146
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          150..154
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           158..170
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          173..181
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           189..192
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           193..201
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          206..209
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          212..216
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          219..222
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          227..229
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          231..235
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          239..242
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           244..246
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          272..274
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           276..278
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          279..290
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           295..310
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          324..328
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          331..338
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           340..345
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          348..358
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          362..364
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          367..375
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   TURN            376..378
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   STRAND          380..391
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           392..404
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           410..414
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   TURN            421..423
FT                   /evidence="ECO:0007829|PDB:1YQZ"
FT   HELIX           429..435
FT                   /evidence="ECO:0007829|PDB:1YQZ"
SQ   SEQUENCE   438 AA;  49241 MW;  3A9B643BD8D44402 CRC64;
     MPKIVVVGAV AGGATCASQI RRLDKESDII IFEKDRDMSF ANCALPYVIG EVVEDRRYAL
     AYTPEKFYDR KQITVKTYHE VIAINDERQT VSVLNRKTNE QFEESYDKLI LSPGASANSL
     GFESDITFTL RNLEDTDAID QFIKANQVDK VLVVGAGYVS LEVLENLNER GLHPTLIHRS
     DKINKLMDAD MNQPILDELD KREIPYRLNE EINAINGNEI TFKSGKVEHY DMIIEGVGTH
     PNSKFIESSN IKLDRKGFIP VNDKFETNVP NIYAIGDIAT SHYRHVDLPA SVPLAWGAHR
     AASIVAEQIA GNDTIEFKGF LGNNIVKFFD YTFASVGVKP NELKQFDYKM VEVTQGAHAN
     YYPGNSPLHL RVYYDTSNRQ ILRAAAVGKE GADKRIDVLS MAMMNQLTVD ELTEFEVAYA
     PPYSHPKDLI NMIGYKAK
//
ID   AIDB_ECOLI              Reviewed;         541 AA.
AC   P33224; P33223; Q2M6B8;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 3.
DT   02-JUN-2021, entry version 162.
DE   RecName: Full=Putative acyl-CoA dehydrogenase AidB;
DE            EC=1.3.99.-;
GN   Name=aidB; OrderedLocusNames=b4187, JW5867;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND INDUCTION.
RC   STRAIN=K12 / MV1161;
RX   PubMed=7961409; DOI=10.1128/jb.176.21.6583-6589.1994;
RA   Landini P., Hajec L.I., Volkert M.R.;
RT   "Structure and transcriptional regulation of the Escherichia coli adaptive
RT   response gene aidB.";
RL   J. Bacteriol. 176:6583-6589(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=7610040; DOI=10.1093/nar/23.12.2105;
RA   Burland V.D., Plunkett G. III, Sofia H.J., Daniels D.L., Blattner F.R.;
RT   "Analysis of the Escherichia coli genome VI: DNA sequence of the region
RT   from 92.8 through 100 minutes.";
RL   Nucleic Acids Res. 23:2105-2119(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   PROTEIN SEQUENCE OF 195-204, FUNCTION, DNA-BINDING, COFACTOR, AND SUBUNIT.
RC   STRAIN=K12;
RX   PubMed=16352838; DOI=10.1128/jb.188.1.223-230.2006;
RA   Rohankhedkar M.S., Mulrooney S.B., Wedemeyer W.J., Hausinger R.P.;
RT   "The AidB component of the Escherichia coli adaptive response to alkylating
RT   agents is a flavin-containing, DNA-binding protein.";
RL   J. Bacteriol. 188:223-230(2006).
RN   [6]
RP   DNA-BINDING, DOMAIN, AUTOREGULATION, AND INDUCTION.
RC   STRAIN=K12;
RX   PubMed=20889740; DOI=10.1128/jb.00858-10;
RA   Rippa V., Amoresano A., Esposito C., Landini P., Volkert M., Duilio A.;
RT   "Specific DNA binding and regulation of its own expression by the AidB
RT   protein in Escherichia coli.";
RL   J. Bacteriol. 192:6136-6142(2010).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH FAD, FUNCTION,
RP   COFACTOR, SUBUNIT, AND MUTAGENESIS OF ARG-437 AND ARG-518.
RX   PubMed=18829440; DOI=10.1073/pnas.0806521105;
RA   Bowles T., Metz A.H., O'Quin J., Wawrzak Z., Eichman B.F.;
RT   "Structure and DNA binding of alkylation response protein AidB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:15299-15304(2008).
CC   -!- FUNCTION: Part of the adaptive DNA-repair response to alkylating
CC       agents. Could prevent alkylation damage by protecting DNA and
CC       destroying alkylating agents that have yet to reach their DNA target.
CC       Binds to double-stranded DNA with a preference for a DNA region that
CC       includes its own promoter. Shows weak isovaleryl-CoA dehydrogenase
CC       activity in vitro. {ECO:0000269|PubMed:16352838,
CC       ECO:0000269|PubMed:18829440, ECO:0000269|PubMed:7961409}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- SUBUNIT: Homotetramer. Dimer of dimers. {ECO:0000269|PubMed:16352838,
CC       ECO:0000269|PubMed:18829440}.
CC   -!- INTERACTION:
CC       P33224; P33224: aidB; NbExp=3; IntAct=EBI-542726, EBI-542726;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- INDUCTION: Regulated by Ada in response to alkylating agents. Also
CC       induced by anaerobiosis or by acetate at pH 6.5, via RpoS. Represses
CC       its own synthesis during normal cell growth.
CC       {ECO:0000269|PubMed:20889740, ECO:0000269|PubMed:7961409}.
CC   -!- DOMAIN: The N-terminal region contains FAD-dependent dehydrogenase
CC       activity and the C-terminal region contains DNA-binding activity.
CC       {ECO:0000269|PubMed:20889740}.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA97083.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAC18889.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L20915; AAC18889.1; ALT_INIT; Genomic_DNA.
DR   EMBL; L20915; AAC18890.1; -; Genomic_DNA.
DR   EMBL; U14003; AAA97083.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U00096; AAC77144.2; -; Genomic_DNA.
DR   EMBL; AP009048; BAE78188.1; -; Genomic_DNA.
DR   PIR; I41124; I41124.
DR   RefSeq; NP_418608.6; NC_000913.3.
DR   RefSeq; WP_001350567.1; NZ_LN832404.1.
DR   PDB; 3DJL; X-ray; 1.70 A; A=1-541.
DR   PDB; 3U33; X-ray; 2.80 A; A/B/C/D/E/F/G/H/I/J/K/L=1-541.
DR   PDBsum; 3DJL; -.
DR   PDBsum; 3U33; -.
DR   SMR; P33224; -.
DR   BioGRID; 4262695; 240.
DR   DIP; DIP-9078N; -.
DR   IntAct; P33224; 32.
DR   STRING; 511145.b4187; -.
DR   jPOST; P33224; -.
DR   PaxDb; P33224; -.
DR   PRIDE; P33224; -.
DR   EnsemblBacteria; AAC77144; AAC77144; b4187.
DR   EnsemblBacteria; BAE78188; BAE78188; BAE78188.
DR   GeneID; 948710; -.
DR   KEGG; ecj:JW5867; -.
DR   KEGG; eco:b4187; -.
DR   PATRIC; fig|1411691.4.peg.2514; -.
DR   EchoBASE; EB1759; -.
DR   eggNOG; COG1960; Bacteria.
DR   HOGENOM; CLU_016513_0_0_6; -.
DR   InParanoid; P33224; -.
DR   PhylomeDB; P33224; -.
DR   BioCyc; EcoCyc:EG11811-MONOMER; -.
DR   BioCyc; MetaCyc:EG11811-MONOMER; -.
DR   EvolutionaryTrace; P33224; -.
DR   PRO; PR:P33224; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IDA:EcoCyc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008470; F:isovaleryl-CoA dehydrogenase activity; IDA:EcoCyc.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:EcoCyc.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEP:EcoCyc.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:EcoCyc.
DR   CDD; cd01154; AidB; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   InterPro; IPR034184; AidB.
DR   InterPro; IPR041504; AidB_N.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF18158; AidB_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Direct protein sequencing; DNA-binding; FAD;
KW   Flavoprotein; Oxidoreductase; Reference proteome; Stress response.
FT   CHAIN           1..541
FT                   /note="Putative acyl-CoA dehydrogenase AidB"
FT                   /id="PRO_0000201192"
FT   NP_BIND         182..191
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18829440"
FT   NP_BIND         216..218
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18829440"
FT   NP_BIND         423..433
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18829440"
FT   REGION          445..541
FT                   /note="dsDNA-binding"
FT   BINDING         185
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18829440"
FT   BINDING         191
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18829440"
FT   BINDING         218
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18829440"
FT   BINDING         429
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18829440"
FT   MUTAGEN         437
FT                   /note="R->Q: Does not affect DNA binding affinity."
FT                   /evidence="ECO:0000269|PubMed:18829440"
FT   MUTAGEN         518
FT                   /note="R->Q: Reduces DNA binding affinity."
FT                   /evidence="ECO:0000269|PubMed:18829440"
FT   TURN            20..23
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           25..33
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           37..39
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           40..50
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           53..64
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   STRAND          68..72
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   STRAND          78..83
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           86..97
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   TURN            98..102
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           103..105
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           113..127
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           132..148
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           151..156
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           157..160
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           172..174
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   STRAND          175..177
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   STRAND          180..183
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   STRAND          189..191
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           193..195
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   STRAND          199..202
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   STRAND          208..218
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   STRAND          222..231
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   STRAND          234..243
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   STRAND          251..257
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   STRAND          260..262
FT                   /evidence="ECO:0007829|PDB:3U33"
FT   STRAND          268..283
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           287..290
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           292..323
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           331..333
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           335..363
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   TURN            364..366
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           368..400
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           401..405
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           411..423
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           424..426
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           427..441
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           445..454
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   TURN            455..458
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           461..473
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           479..481
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           482..501
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           504..515
FT                   /evidence="ECO:0007829|PDB:3DJL"
FT   HELIX           525..534
FT                   /evidence="ECO:0007829|PDB:3DJL"
SQ   SEQUENCE   541 AA;  60590 MW;  D609E364E3A99208 CRC64;
     MHWQTHTVFN QPIPLNNSNL YLSDGALCEA VTREGAGWDS DFLASIGQQL GTAESLELGR
     LANVNPPELL RYDAQGRRLD DVRFHPAWHL LMQALCTNRV HNLAWEEDAR SGAFVARAAR
     FMLHAQVEAG SLCPITMTFA ATPLLLQMLP APFQDWTTPL LSDRYDSHLL PGGQKRGLLI
     GMGMTEKQGG SDVMSNTTRA ERLEDGSYRL VGHKWFFSVP QSDAHLVLAQ TAGGLSCFFV
     PRFLPDGQRN AIRLERLKDK LGNRSNASCE VEFQDAIGWL LGLEGEGIRL ILKMGGMTRF
     DCALGSHAMM RRAFSLAIYH AHQRHVFGNP LIQQPLMRHV LSRMALQLEG QTALLFRLAR
     AWDRRADAKE ALWARLFTPA AKFVICKRGM PFVAEAMEVL GGIGYCEESE LPRLYREMPV
     NSIWEGSGNI MCLDVLRVLN KQAGVYDLLS EAFVEVKGQD RYFDRAVRRL QQQLRKPAEE
     LGREITHQLF LLGCGAQMLK YASPPMAQAW CQVMLDTRGG VRLSEQIQND LLLRATGGVC
     V
//
ID   GLYOX_GEOKA             Reviewed;         377 AA.
AC   Q5L2C2;
DT   07-JUN-2017, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 1.
DT   02-JUN-2021, entry version 88.
DE   RecName: Full=Glycine oxidase {ECO:0000303|PubMed:17894345};
DE            Short=GO;
DE            Short=GOX {ECO:0000303|PubMed:17894345};
DE            EC=1.4.3.19 {ECO:0000269|PubMed:17894345};
DE   AltName: Full=GOXK {ECO:0000303|PubMed:17894345};
GN   Name=thiO {ECO:0000250|UniProtKB:O31616};
GN   OrderedLocusNames=GK0623 {ECO:0000312|EMBL:BAD74908.1};
OS   Geobacillus kaustophilus (strain HTA426).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Geobacillus;
OC   Geobacillus thermoleovorans group.
OX   NCBI_TaxID=235909;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=HTA426;
RX   PubMed=15576355; DOI=10.1093/nar/gkh970;
RA   Takami H., Takaki Y., Chee G.-J., Nishi S., Shimamura S., Suzuki H.,
RA   Matsui S., Uchiyama I.;
RT   "Thermoadaptation trait revealed by the genome sequence of thermophilic
RT   Geobacillus kaustophilus.";
RL   Nucleic Acids Res. 32:6292-6303(2004).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE
RP   SPECIFICITY, COFACTOR, ACTIVITY REGULATION, SUBUNIT, 3D-STRUCTURE MODELING,
RP   AND PATHWAY.
RC   STRAIN=HTA426;
RX   PubMed=17894345; DOI=10.1002/prot.21690;
RA   Martinez-Martinez I., Navarro-Fernandez J., Garcia-Carmona F., Takami H.,
RA   Sanchez-Ferrer A.;
RT   "Characterization and structural modeling of a novel thermostable glycine
RT   oxidase from Geobacillus kaustophilus HTA426.";
RL   Proteins 70:1429-1441(2008).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) IN COMPLEX WITH FAD AND GLYCINE, AND
RP   COFACTOR.
RA   Shiono T., Arai R., Nishiya Y., Nomura T.;
RT   "Crystal structure of glycine oxidase from Geobacillus kaustophilus.";
RL   Submitted (MAR-2015) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes the FAD-dependent oxidative deamination of various
CC       amines and D-amino acids to yield the corresponding alpha-keto acids,
CC       ammonia/amine, and hydrogen peroxide. Oxidizes glycine, sarcosine (N-
CC       methylglycine), N-ethylglycine, D-proline, D-alanine, glycine-ethyl
CC       ester, and some other D-amino acids. Does not act on L-proline
CC       (PubMed:17894345). Is essential for thiamine biosynthesis since the
CC       oxidation of glycine catalyzed by ThiO generates the glycine imine
CC       intermediate (dehydroglycine) required for the biosynthesis of the
CC       thiazole ring of thiamine pyrophosphate (By similarity).
CC       {ECO:0000250|UniProtKB:O31616, ECO:0000269|PubMed:17894345}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycine + H2O + O2 = glyoxylate + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:11532, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:36655,
CC         ChEBI:CHEBI:57305; EC=1.4.3.19;
CC         Evidence={ECO:0000269|PubMed:17894345};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-ethylglycine + O2 = ethylamine + glyoxylate + H2O2;
CC         Xref=Rhea:RHEA:12472, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:36655, ChEBI:CHEBI:57440,
CC         ChEBI:CHEBI:566789; EC=1.4.3.19;
CC         Evidence={ECO:0000269|PubMed:17894345};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O2 + sarcosine = glyoxylate + H2O2 + methylamine;
CC         Xref=Rhea:RHEA:15165, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:36655, ChEBI:CHEBI:57433,
CC         ChEBI:CHEBI:59338; EC=1.4.3.19;
CC         Evidence={ECO:0000269|PubMed:17894345};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-alanine + H2O + O2 = H2O2 + NH4(+) + pyruvate;
CC         Xref=Rhea:RHEA:22688, ChEBI:CHEBI:15361, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:57416; EC=1.4.3.19;
CC         Evidence={ECO:0000269|PubMed:17894345};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:17894345, ECO:0000269|Ref.3};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|Ref.3};
CC   -!- ACTIVITY REGULATION: Is inhibited at high substrate concentration.
CC       {ECO:0000269|PubMed:17894345}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.25 mM for glycine (at pH 8.5 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:17894345};
CC         KM=0.45 mM for sarcosine (at pH 8.5 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:17894345};
CC         KM=0.22 mM for N-ethylglycine (at pH 8.5 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:17894345};
CC         KM=9.30 mM for D-proline (at pH 8.5 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:17894345};
CC         KM=20.60 mM for D-alanine (at pH 8.5 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:17894345};
CC         KM=0.52 mM for glycine-ethyl ester (at pH 8.5 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:17894345};
CC         Note=Vmax with D-proline as substrate is 1.4-, 2.75-, 3.5- and 4.3-
CC         fold higher than with glycine, sarcosine, D-alanine, and N-
CC         ethylglycine, respectively. {ECO:0000269|PubMed:17894345};
CC       pH dependence:
CC         Optimum pH is 8.5. Is stable in the pH 6-9.5 range. A great decrease
CC         in stability is only produced at pH values below pH 4.0.
CC         {ECO:0000269|PubMed:17894345};
CC       Temperature dependence:
CC         Thermostable. Displays a Tm value of 2.5 hours at 60 degrees Celsius,
CC         and 0.6 hour at 80 degrees Celsius. {ECO:0000269|PubMed:17894345};
CC   -!- PATHWAY: Cofactor biosynthesis; thiamine diphosphate biosynthesis.
CC       {ECO:0000250|UniProtKB:O31616, ECO:0000305|PubMed:17894345}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:17894345}.
CC   -!- SIMILARITY: Belongs to the DAO family. ThiO subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BA000043; BAD74908.1; -; Genomic_DNA.
DR   RefSeq; WP_011230127.1; NC_006510.1.
DR   PDB; 4YSH; X-ray; 2.20 A; A/B=1-377.
DR   PDBsum; 4YSH; -.
DR   SMR; Q5L2C2; -.
DR   STRING; 235909.GK0623; -.
DR   EnsemblBacteria; BAD74908; BAD74908; GK0623.
DR   GeneID; 58927348; -.
DR   KEGG; gka:GK0623; -.
DR   eggNOG; COG0665; Bacteria.
DR   HOGENOM; CLU_007884_4_5_9; -.
DR   OMA; GCGTLWL; -.
DR   BRENDA; 1.4.3.19; 8138.
DR   UniPathway; UPA00060; -.
DR   Proteomes; UP000001172; Chromosome.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0043799; F:glycine oxidase activity; IDA:UniProtKB.
DR   GO; GO:0006520; P:cellular amino acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0009228; P:thiamine biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0009229; P:thiamine diphosphate biosynthetic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR012727; Gly_oxidase_ThiO.
DR   Pfam; PF01266; DAO; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR02352; thiamin_ThiO; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Oxidoreductase; Reference proteome;
KW   Thiamine biosynthesis.
FT   CHAIN           1..377
FT                   /note="Glycine oxidase"
FT                   /id="PRO_0000440180"
FT   NP_BIND         14..15
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.3"
FT   NP_BIND         34..35
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.3"
FT   NP_BIND         42..43
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.3"
FT   NP_BIND         47..49
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.3"
FT   NP_BIND         334..340
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.3"
FT   BINDING         180
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|Ref.3"
FT   BINDING         309
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|Ref.3"
FT   BINDING         336
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|Ref.3"
FT   STRAND          4..10
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   HELIX           14..25
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          30..33
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          35..37
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   TURN            38..41
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   HELIX           42..45
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   TURN            52..54
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   HELIX           62..84
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          95..99
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   HELIX           102..112
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   HELIX           114..117
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          123..125
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   HELIX           129..132
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          142..148
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   HELIX           156..169
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          173..175
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          180..184
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          187..194
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          197..206
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   HELIX           209..211
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   HELIX           212..217
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   TURN            218..220
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          225..236
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          243..251
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          253..257
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   TURN            258..260
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          261..265
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   HELIX           279..292
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   HELIX           294..298
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          299..312
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          318..321
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          323..325
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   STRAND          328..332
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   HELIX           338..353
FT                   /evidence="ECO:0007829|PDB:4YSH"
FT   HELIX           363..365
FT                   /evidence="ECO:0007829|PDB:4YSH"
SQ   SEQUENCE   377 AA;  39913 MW;  DE840B80243B9929 CRC64;
     MTHRYDVAIV GGGVIGAAIG FELAKRRHRV AIFEKGTMGS GASSAAAGML GAQSEFSTSS
     PLVPLALQSR ALMPALAEEL RERTGIDIGL VEKGLIKLAT TEEEADDLYR HYTFWRGIGE
     PVQWLTKGEA LEMEPRLAAE ALAGAMYIPG DGQVSAPDLA AALAYAAASA GACLYEYTEV
     FDIRSDSSGH VLDTTGGTFA AEAVVIASGA WAARLGARVG LSLSVYPVKG ECVMVRAPVP
     LLQTTVFAKN GCYIVPKSGN RLLIGATSTP GTFDRRVSAG GVMNLLHRAA HLVPDIEQAE
     WVASWSGIRP QTEDGLPYLG EHPERRGLFV AAGHYRNGIL LSPLTGLLVA DLVERKETAF
     DLAPFSLTRH IGKVGVE
//
ID   DLD_ECOLI               Reviewed;         571 AA.
AC   P06149; Q2MAU6;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-JUN-2021, entry version 179.
DE   RecName: Full=Quinone-dependent D-lactate dehydrogenase {ECO:0000255|HAMAP-Rule:MF_02092, ECO:0000305};
DE            EC=1.1.5.12 {ECO:0000255|HAMAP-Rule:MF_02092, ECO:0000269|PubMed:3013300, ECO:0000269|PubMed:7578233};
DE   AltName: Full=(R)-lactate:quinone 2-oxidoreductase {ECO:0000305};
DE   AltName: Full=D-lactate dehydrogenase {ECO:0000255|HAMAP-Rule:MF_02092, ECO:0000303|PubMed:4575624, ECO:0000303|PubMed:4582730};
DE            Short=D-LDH {ECO:0000255|HAMAP-Rule:MF_02092, ECO:0000303|PubMed:3882663};
DE   AltName: Full=Respiratory D-lactate dehydrogenase {ECO:0000305};
GN   Name=dld {ECO:0000255|HAMAP-Rule:MF_02092, ECO:0000303|PubMed:6386470};
GN   OrderedLocusNames=b2133, JW2121;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=6386470; DOI=10.1111/j.1432-1033.1984.tb08473.x;
RA   Campbell H.D., Rogers B.L., Young I.G.;
RT   "Nucleotide sequence of the respiratory D-lactate dehydrogenase gene of
RT   Escherichia coli.";
RL   Eur. J. Biochem. 144:367-373(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 2-18.
RX   PubMed=3882663; DOI=10.1128/jb.161.3.1059-1068.1985;
RA   Rule G.S., Pratt E.A., Chin C.C.Q., Wold F., Ho C.;
RT   "Overproduction and nucleotide sequence of the respiratory D-lactate
RT   dehydrogenase of Escherichia coli.";
RL   J. Bacteriol. 161:1059-1068(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / BHB2600;
RA   Richterich P., Lakey N., Gryan G., Jaehn L., Mintz L., Robison K.,
RA   Church G.M.;
RT   "Automated multiplex sequencing of the E.coli genome.";
RL   Submitted (OCT-1993) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [6]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R., Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [7]
RP   FUNCTION, COFACTOR, AND SUBCELLULAR LOCATION.
RX   PubMed=4575624; DOI=10.1021/bi00737a016;
RA   Futai M.;
RT   "Membrane D-lactate dehydrogenase from Escherichia coli. Purification and
RT   properties.";
RL   Biochemistry 12:2468-2474(1973).
RN   [8]
RP   FUNCTION, COFACTOR, ACTIVITY REGULATION, AND SUBCELLULAR LOCATION.
RC   STRAIN=ML 308-225;
RX   PubMed=4582730;
RA   Kohn L.D., Kaback H.R.;
RT   "Mechanisms of active transport in isolated bacterial membrane vesicles.
RT   XV. Purification and properties of the membrane-bound D-lactate
RT   dehydrogenase from Escherichia coli.";
RL   J. Biol. Chem. 248:7012-7017(1973).
RN   [9]
RP   SUBCELLULAR LOCATION.
RC   STRAIN=ML 308-225;
RX   PubMed=1092688;
RA   Short S.A., Kaback H.R., Kohn L.D.;
RT   "Localization of D-lactate dehydrogenase in native and reconstituted
RT   Escherichia coli membrane vesicles.";
RL   J. Biol. Chem. 250:4291-4296(1975).
RN   [10]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=3013300; DOI=10.1021/bi00357a004;
RA   Matsushita K., Kaback H.R.;
RT   "D-lactate oxidation and generation of the proton electrochemical gradient
RT   in membrane vesicles from Escherichia coli GR19N and in proteoliposomes
RT   reconstituted with purified D-lactate dehydrogenase and cytochrome o
RT   oxidase.";
RL   Biochemistry 25:2321-2327(1986).
RN   [11]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=2185834; DOI=10.1021/bi00465a017;
RA   Peersen O.B., Pratt E.A., Truong H.T., Ho C., Rule G.S.;
RT   "Site-specific incorporation of 5-fluorotryptophan as a probe of the
RT   structure and function of the membrane-bound D-lactate dehydrogenase of
RT   Escherichia coli: a 19F nuclear magnetic resonance study.";
RL   Biochemistry 29:3256-3262(1990).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, AND COFACTOR.
RX   PubMed=7578233; DOI=10.1016/0167-4838(95)00120-j;
RA   Sun Z.Y., Dowd S.R., Felix C., Hyde J.S., Ho C.;
RT   "Stopped-flow kinetic and biophysical studies of membrane-associated D-
RT   lactate dehydrogenase of Escherichia coli.";
RL   Biochim. Biophys. Acta 1252:269-277(1995).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF MUTANT TRP-368 IN COMPLEX WITH
RP   FAD, COFACTOR, SUBCELLULAR LOCATION, AND DOMAIN.
RX   PubMed=10944213; DOI=10.1073/pnas.97.17.9413;
RA   Dym O., Pratt E.A., Ho C., Eisenberg D.;
RT   "The crystal structure of D-lactate dehydrogenase, a peripheral membrane
RT   respiratory enzyme.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9413-9418(2000).
CC   -!- FUNCTION: Catalyzes the oxidation of D-lactate to pyruvate. Electrons
CC       derived from D-lactate oxidation are transferred to the
CC       ubiquinone/cytochrome electron transfer chain, where they may be used
CC       to provide energy for the active transport of a variety of amino acids
CC       and sugars across the membrane. {ECO:0000269|PubMed:2185834,
CC       ECO:0000269|PubMed:3013300, ECO:0000269|PubMed:4575624,
CC       ECO:0000269|PubMed:4582730, ECO:0000269|PubMed:7578233}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-lactate + a quinone = a quinol + pyruvate;
CC         Xref=Rhea:RHEA:51468, ChEBI:CHEBI:15361, ChEBI:CHEBI:16004,
CC         ChEBI:CHEBI:24646, ChEBI:CHEBI:132124; EC=1.1.5.12;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_02092,
CC         ECO:0000269|PubMed:3013300, ECO:0000269|PubMed:7578233};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_02092,
CC         ECO:0000269|PubMed:10944213, ECO:0000269|PubMed:4575624,
CC         ECO:0000269|PubMed:4582730, ECO:0000269|PubMed:7578233};
CC   -!- ACTIVITY REGULATION: Inhibited by 2-hydroxy-3-butynoic acid, but not by
CC       p-chloromercuribenzoate, n-ethylmaleimide, or 5,5'-dithiobis(2-
CC       nitrobenzoic acid). {ECO:0000269|PubMed:4582730}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.16 mM for D-lactate {ECO:0000269|PubMed:2185834};
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_02092, ECO:0000269|PubMed:1092688, ECO:0000269|PubMed:4575624,
CC       ECO:0000269|PubMed:4582730}; Peripheral membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_02092, ECO:0000269|PubMed:1092688};
CC       Cytoplasmic side {ECO:0000255|HAMAP-Rule:MF_02092,
CC       ECO:0000269|PubMed:1092688}. Note=May bind the membrane through
CC       electrostatic rather than hydrophobic forces.
CC       {ECO:0000305|PubMed:10944213}.
CC   -!- DOMAIN: Contains 3 domains: the flavin adenine dinucleotide (FAD)-
CC       binding domain, the cap domain and the membrane-binding domain.
CC       {ECO:0000269|PubMed:10944213}.
CC   -!- SIMILARITY: Belongs to the quinone-dependent D-lactate dehydrogenase
CC       family. {ECO:0000255|HAMAP-Rule:MF_02092, ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA60530.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M10038; AAA23688.1; -; Genomic_DNA.
DR   EMBL; X01067; CAA25531.1; -; Genomic_DNA.
DR   EMBL; U00007; AAA60530.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U00096; AAC75194.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE76610.1; -; Genomic_DNA.
DR   PIR; A21893; DEECDL.
DR   RefSeq; NP_416637.1; NC_000913.3.
DR   RefSeq; WP_000097403.1; NZ_LN832404.1.
DR   PDB; 1F0X; X-ray; 1.90 A; A/B=1-571.
DR   PDBsum; 1F0X; -.
DR   SMR; P06149; -.
DR   BioGRID; 4260452; 20.
DR   IntAct; P06149; 17.
DR   STRING; 511145.b2133; -.
DR   BindingDB; P06149; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB00756; Hexachlorophene.
DR   DrugCentral; P06149; -.
DR   jPOST; P06149; -.
DR   PaxDb; P06149; -.
DR   PRIDE; P06149; -.
DR   EnsemblBacteria; AAC75194; AAC75194; b2133.
DR   EnsemblBacteria; BAE76610; BAE76610; BAE76610.
DR   GeneID; 946653; -.
DR   KEGG; ecj:JW2121; -.
DR   KEGG; eco:b2133; -.
DR   PATRIC; fig|1411691.4.peg.110; -.
DR   EchoBASE; EB0227; -.
DR   eggNOG; COG0277; Bacteria.
DR   HOGENOM; CLU_034094_0_0_6; -.
DR   InParanoid; P06149; -.
DR   BioCyc; EcoCyc:DLACTDEHYDROGFAD-MONOMER; -.
DR   BioCyc; MetaCyc:DLACTDEHYDROGFAD-MONOMER; -.
DR   BRENDA; 1.1.1.28; 2026.
DR   EvolutionaryTrace; P06149; -.
DR   PRO; PR:P06149; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IDA:EcoCyc.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0005886; C:plasma membrane; IDA:EcoCyc.
DR   GO; GO:0102029; F:D-lactate dehydrogenase (quinone) activity; IEA:UniProtKB-EC.
DR   GO; GO:0009055; F:electron transfer activity; IDA:EcoCyc.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:EcoCyc.
DR   GO; GO:0016901; F:oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor; IDA:EcoCyc.
DR   GO; GO:0048038; F:quinone binding; IEA:UniProtKB-KW.
DR   GO; GO:0009060; P:aerobic respiration; IDA:EcoCyc.
DR   GO; GO:0009061; P:anaerobic respiration; IDA:EcoCyc.
DR   GO; GO:0019516; P:lactate oxidation; IDA:EcoCyc.
DR   GO; GO:0022904; P:respiratory electron transport chain; IDA:EcoCyc.
DR   GO; GO:0055085; P:transmembrane transport; IEA:InterPro.
DR   Gene3D; 3.30.1370.20; -; 1.
DR   Gene3D; 3.30.43.10; -; 1.
DR   Gene3D; 3.30.465.10; -; 1.
DR   Gene3D; 3.30.70.610; -; 2.
DR   HAMAP; MF_02092; DLDH_Dld; 1.
DR   InterPro; IPR016172; D-lactate_DH_C-sub1.
DR   InterPro; IPR016173; D-lactate_DH_C-sub2.
DR   InterPro; IPR012256; D_lactate_DH.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR016167; FAD-bd_PCMH_sub1.
DR   InterPro; IPR016169; FAD-bd_PCMH_sub2.
DR   InterPro; IPR016164; FAD-linked_Oxase-like_C.
DR   InterPro; IPR015409; Lactate_DH_C.
DR   InterPro; IPR006094; Oxid_FAD_bind_N.
DR   Pfam; PF01565; FAD_binding_4; 1.
DR   Pfam; PF09330; Lact-deh-memb; 1.
DR   PIRSF; PIRSF000101; D-lactate_dh; 1.
DR   SUPFAM; SSF55103; SSF55103; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell inner membrane; Cell membrane;
KW   Direct protein sequencing; FAD; Flavoprotein; Membrane; Oxidoreductase;
KW   Quinone; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:3882663"
FT   CHAIN           2..571
FT                   /note="Quinone-dependent D-lactate dehydrogenase"
FT                   /id="PRO_0000079928"
FT   DOMAIN          42..213
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02092"
FT   NP_BIND         76..80
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02092,
FT                   ECO:0000269|PubMed:10944213, ECO:0007744|PDB:1F0X"
FT   NP_BIND         84..85
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02092,
FT                   ECO:0000269|PubMed:10944213, ECO:0007744|PDB:1F0X"
FT   REGION          546..571
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        546..562
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         143
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02092,
FT                   ECO:0000269|PubMed:10944213, ECO:0007744|PDB:1F0X"
FT   BINDING         150
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02092,
FT                   ECO:0000269|PubMed:10944213, ECO:0007744|PDB:1F0X"
FT   BINDING         160
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02092,
FT                   ECO:0000269|PubMed:10944213, ECO:0007744|PDB:1F0X"
FT   BINDING         262
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02092,
FT                   ECO:0000269|PubMed:10944213, ECO:0007744|PDB:1F0X"
FT   HELIX           10..20
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           22..24
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           29..36
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          39..41
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          47..50
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           55..67
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          71..77
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          81..83
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          96..100
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          107..110
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   TURN            111..114
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          115..118
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           124..131
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           132..134
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           143..147
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           151..156
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          174..179
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          185..189
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          191..193
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           199..207
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           213..215
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           228..233
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           247..249
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          259..268
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          277..284
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           286..299
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          305..311
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           312..318
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           379..387
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          389..396
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           400..414
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          418..421
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           424..434
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           437..447
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           449..451
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          452..461
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           475..478
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          481..489
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   TURN            490..493
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          494..502
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           507..520
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   STRAND          527..529
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   TURN            532..534
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   HELIX           539..548
FT                   /evidence="ECO:0007829|PDB:1F0X"
FT   TURN            556..560
FT                   /evidence="ECO:0007829|PDB:1F0X"
SQ   SEQUENCE   571 AA;  64612 MW;  77FB2C467CB4389F CRC64;
     MSSMTTTDNK AFLNELARLV GSSHLLTDPA KTARYRKGFR SGQGDALAVV FPGSLLELWR
     VLKACVTADK IILMQAANTG LTEGSTPNGN DYDRDVVIIS TLRLDKLHVL GKGEQVLAYP
     GTTLYSLEKA LKPLGREPHS VIGSSCIGAS VIGGICNNSG GSLVQRGPAY TEMSLFARIN
     EDGKLTLVNH LGIDLGETPE QILSKLDDDR IKDDDVRHDG RHAHDYDYVH RVRDIEADTP
     ARYNADPDRL FESSGCAGKL AVFAVRLDTF EAEKNQQVFY IGTNQPEVLT EIRRHILANF
     ENLPVAGEYM HRDIYDIAEK YGKDTFLMID KLGTDKMPFF FNLKGRTDAM LEKVKFFRPH
     FTDRAMQKFG HLFPSHLPPR MKNWRDKYEH HLLLKMAGDG VGEAKSWLVD YFKQAEGDFF
     VCTPEEGSKA FLHRFAAAGA AIRYQAVHSD EVEDILALDI ALRRNDTEWY EHLPPEIDSQ
     LVHKLYYGHF MCYVFHQDYI VKKGVDVHAL KEQMLELLQQ RGAQYPAEHN VGHLYKAPET
     LQKFYRENDP TNSMNPGIGK TSKRKNWQEV E
//
ID   FENR_SPIOL              Reviewed;         369 AA.
AC   P00455;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1988, sequence version 1.
DT   02-JUN-2021, entry version 138.
DE   RecName: Full=Ferredoxin--NADP reductase, chloroplastic;
DE            Short=FNR;
DE            EC=1.18.1.2;
DE   Flags: Precursor;
GN   Name=PETH;
OS   Spinacia oleracea (Spinach).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   Caryophyllales; Chenopodiaceae; Chenopodioideae; Anserineae; Spinacia.
OX   NCBI_TaxID=3562;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2969782; DOI=10.1007/bf02427758;
RA   Jansen T., Reilaender H., Steppuhn J., Herrmann R.G.;
RT   "Analysis of cDNA clones encoding the entire precursor-polypeptide for
RT   ferredoxin:NADP+ oxidoreductase from spinach.";
RL   Curr. Genet. 13:517-522(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Alter J.M., Patrie W.J.;
RT   "Cloning and sequencing of the cDNA for precursor ferredoxin-NADP+:
RT   oxidoreductase from spinach.";
RL   Submitted (FEB-1992) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   PROTEIN SEQUENCE OF 56-369.
RX   PubMed=6529571; DOI=10.1021/bi00321a046;
RA   Karplus P.A., Walsh K.A., Herriott J.R.;
RT   "Amino acid sequence of spinach ferredoxin:NADP+ oxidoreductase.";
RL   Biochemistry 23:6576-6583(1984).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-120.
RX   PubMed=8455561; DOI=10.1007/bf00282808;
RA   Oelmueller R., Bolle C., Tyagi A.K., Niekrawietz N., Breit S.;
RT   "Characterization of the promoter from the single-copy gene encoding
RT   ferredoxin-NADP(+)-oxidoreductase from spinach.";
RL   Mol. Gen. Genet. 237:261-272(1993).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH FAD AND
RP   2-PHOSPHO-AMP, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=1986412; DOI=10.1126/science.1986412;
RA   Karplus P.A., Daniels M.J., Herriott J.R.;
RT   "Atomic structure of ferredoxin-NADP+ reductase: prototype for a
RT   structurally novel flavoenzyme family.";
RL   Science 251:60-66(1991).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 74-369 OF MUTANTS ALA/GLN/LEU-367
RP   IN COMPLEX WITH FAD, AND MUTAGENESIS OF GLU-367.
RC   TISSUE=Leaf;
RX   PubMed=9852055; DOI=10.1074/jbc.273.51.34008;
RA   Aliverti A., Deng Z., Ravasi D., Piubelli L., Karplus P.A., Zanetti G.;
RT   "Probing the function of the invariant glutamyl residue 312 in spinach
RT   ferredoxin-NADP+ reductase.";
RL   J. Biol. Chem. 273:34008-34015(1998).
CC   -!- FUNCTION: May play a key role in regulating the relative amounts of
CC       cyclic and non-cyclic electron flow to meet the demands of the plant
CC       for ATP and reducing power.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADP(+) + 2 reduced [2Fe-2S]-[ferredoxin] = NADPH + 2
CC         oxidized [2Fe-2S]-[ferredoxin]; Xref=Rhea:RHEA:20125, Rhea:RHEA-
CC         COMP:10000, Rhea:RHEA-COMP:10001, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:33737, ChEBI:CHEBI:33738, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.18.1.2;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=35 uM for NADPH {ECO:0000269|PubMed:1986412};
CC   -!- PATHWAY: Energy metabolism; photosynthesis.
CC   -!- INTERACTION:
CC       P00455; P00221: PETF; NbExp=3; IntAct=EBI-865079, EBI-864933;
CC   -!- SUBCELLULAR LOCATION: Plastid, chloroplast stroma. Plastid, chloroplast
CC       thylakoid membrane {ECO:0000305}; Peripheral membrane protein
CC       {ECO:0000305}; Stromal side {ECO:0000305}. Note=In the vicinity of the
CC       photosystem I in the non-stacked and fringe portion of the membrane.
CC   -!- MISCELLANEOUS: FNR is probably attached to the membrane by a specific
CC       binding protein.
CC   -!- SIMILARITY: Belongs to the ferredoxin--NADP reductase type 1 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X07981; CAA30791.1; -; mRNA.
DR   EMBL; M86349; AAA34029.1; -; mRNA.
DR   EMBL; X64351; CAA45703.1; -; Genomic_DNA.
DR   PIR; S00438; RDSPXX.
DR   PDB; 1BX0; X-ray; 1.90 A; A=56-369.
DR   PDB; 1BX1; X-ray; 1.90 A; A=56-369.
DR   PDB; 1FNB; X-ray; 1.70 A; A=56-369.
DR   PDB; 1FNC; X-ray; 2.00 A; A=56-369.
DR   PDB; 1FND; X-ray; 1.70 A; A=56-369.
DR   PDB; 1FRN; X-ray; 2.00 A; A=56-369.
DR   PDB; 1FRQ; X-ray; 1.95 A; A=56-369.
DR   PDBsum; 1BX0; -.
DR   PDBsum; 1BX1; -.
DR   PDBsum; 1FNB; -.
DR   PDBsum; 1FNC; -.
DR   PDBsum; 1FND; -.
DR   PDBsum; 1FRN; -.
DR   PDBsum; 1FRQ; -.
DR   SMR; P00455; -.
DR   IntAct; P00455; 2.
DR   PRIDE; P00455; -.
DR   KEGG; ag:CAA30791; -.
DR   BRENDA; 1.18.1.2; 5812.
DR   BRENDA; 1.19.1.1; 5812.
DR   SABIO-RK; P00455; -.
DR   UniPathway; UPA00091; -.
DR   EvolutionaryTrace; P00455; -.
DR   GO; GO:0009570; C:chloroplast stroma; IEA:UniProtKB-SubCell.
DR   GO; GO:0009535; C:chloroplast thylakoid membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004324; F:ferredoxin-NADP+ reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0015979; P:photosynthesis; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.40.50.80; -; 1.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR015701; FNR.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR035442; FNR_plant_Cyanobacteria.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   PIRSF; PIRSF501178; FNR-PetH; 1.
DR   PIRSF; PIRSF000361; Frd-NADP+_RD; 1.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52343; SSF52343; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chloroplast; Direct protein sequencing; Electron transport;
KW   FAD; Flavoprotein; Membrane; NADP; Oxidoreductase; Photosynthesis; Plastid;
KW   Thylakoid; Transit peptide; Transport.
FT   TRANSIT         1..55
FT                   /note="Chloroplast"
FT                   /evidence="ECO:0000269|PubMed:6529571"
FT   CHAIN           56..369
FT                   /note="Ferredoxin--NADP reductase, chloroplastic"
FT                   /id="PRO_0000019412"
FT   DOMAIN          90..212
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   NP_BIND         148..151
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:1986412,
FT                   ECO:0000269|PubMed:9852055"
FT   NP_BIND         169..171
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:1986412,
FT                   ECO:0000269|PubMed:9852055"
FT   NP_BIND         186..188
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:1986412,
FT                   ECO:0000269|PubMed:9852055"
FT   NP_BIND         259..260
FT                   /note="NADP"
FT   NP_BIND         289..290
FT                   /note="NADP"
FT   NP_BIND         299..301
FT                   /note="NADP"
FT   NP_BIND         328..329
FT                   /note="NADP"
FT                   /evidence="ECO:0000250"
FT   BINDING         151
FT                   /note="NADP"
FT                   /evidence="ECO:0000250"
FT   BINDING         171
FT                   /note="NADP"
FT   BINDING         175
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:1986412,
FT                   ECO:0000269|PubMed:9852055"
FT   BINDING         227
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:1986412,
FT                   ECO:0000269|PubMed:9852055"
FT   BINDING         227
FT                   /note="NADP; via amide nitrogen"
FT                   /evidence="ECO:0000250"
FT   BINDING         367
FT                   /note="NADP"
FT                   /evidence="ECO:0000250"
FT   VARIANT         324
FT                   /note="F -> V"
FT   MUTAGEN         367
FT                   /note="E->A: Slightly reduced activity."
FT                   /evidence="ECO:0000269|PubMed:9852055"
FT   MUTAGEN         367
FT                   /note="E->D,Q: Reduced activity."
FT                   /evidence="ECO:0000269|PubMed:9852055"
FT   MUTAGEN         367
FT                   /note="E->L: Reduces activity by 99%."
FT                   /evidence="ECO:0000269|PubMed:9852055"
FT   STRAND          76..78
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          86..88
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          93..102
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          106..110
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          112..118
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          130..134
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          136..138
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          142..144
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          148..151
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          161..163
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          165..171
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          174..176
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          182..184
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   HELIX           186..193
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          199..206
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          219..225
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   HELIX           226..229
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   HELIX           230..240
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          251..261
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   HELIX           262..264
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   HELIX           268..277
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   TURN            279..281
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          282..288
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   TURN            289..291
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   HELIX           302..307
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   HELIX           310..316
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          322..329
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   HELIX           332..345
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   TURN            346..348
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   HELIX           351..360
FT                   /evidence="ECO:0007829|PDB:1FNB"
FT   STRAND          364..369
FT                   /evidence="ECO:0007829|PDB:1FNB"
SQ   SEQUENCE   369 AA;  41188 MW;  1D0432BA47438A28 CRC64;
     MTTAVTAAVS FPSTKTTSLS ARSSSVISPD KISYKKVPLY YRNVSATGKM GPIRAQIASD
     VEAPPPAPAK VEKHSKKMEE GITVNKFKPK TPYVGRCLLN TKITGDDAPG ETWHMVFSHE
     GEIPYREGQS VGVIPDGEDK NGKPHKLRLY SIASSALGDF GDAKSVSLCV KRLIYTNDAG
     ETIKGVCSNF LCDLKPGAEV KLTGPVGKEM LMPKDPNATI IMLGTGTGIA PFRSFLWKMF
     FEKHDDYKFN GLAWLFLGVP TSSSLLYKEE FEKMKEKAPD NFRLDFAVSR EQTNEKGEKM
     YIQTRMAQYA VELWEMLKKD NTYFYMCGLK GMEKGIDDIM VSLAAAEGID WIEYKRQLKK
     AEQWNVEVY
//
ID   AOXC_MOUSE              Reviewed;        1335 AA.
AC   G3X982; B2RSI5; Q8VI15;
DT   19-FEB-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-NOV-2011, sequence version 1.
DT   02-JUN-2021, entry version 72.
DE   RecName: Full=Aldehyde oxidase 3;
DE            EC=1.2.3.1;
DE   AltName: Full=Aldehyde oxidase homolog 1;
DE   AltName: Full=Azaheterocycle hydroxylase 3;
DE            EC=1.17.3.-;
GN   Name=Aox3; Synonyms=Aoh1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], IDENTIFICATION BY MASS SPECTROMETRY,
RP   FUNCTION AS OXIDASE, ACTIVITY REGULATION, KINETIC PARAMETERS, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=129/Sv;
RX   PubMed=11562361; DOI=10.1074/jbc.m105744200;
RA   Terao M., Kurosaki M., Marini M., Vanoni M.A., Saltini G., Bonetto V.,
RA   Bastone A., Federico C., Saccone S., Fanelli R., Salmona M., Garattini E.;
RT   "Purification of the aldehyde oxidase homolog 1 (AOH1) protein and cloning
RT   of the AOH1 and aldehyde oxidase homolog 2 (AOH2) genes. Identification of
RT   a novel molybdo-flavoprotein gene cluster on mouse chromosome 1.";
RL   J. Biol. Chem. 276:46347-46363(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   STRAIN=CD-1; TISSUE=Olfactory epithelium;
RX   PubMed=15383531; DOI=10.1074/jbc.m408734200;
RA   Kurosaki M., Terao M., Barzago M.M., Bastone A., Bernardinello D.,
RA   Salmona M., Garattini E.;
RT   "The aldehyde oxidase gene cluster in mice and rats. Aldehyde oxidase
RT   homologue 3, a novel member of the molybdo-flavoenzyme family with
RT   selective expression in the olfactory mucosa.";
RL   J. Biol. Chem. 279:50482-50498(2004).
RN   [6]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION BY TESTOSTERONE.
RX   PubMed=18981221; DOI=10.1128/mcb.01385-08;
RA   Terao M., Kurosaki M., Barzago M.M., Fratelli M., Bagnati R., Bastone A.,
RA   Giudice C., Scanziani E., Mancuso A., Tiveron C., Garattini E.;
RT   "Role of the molybdoflavoenzyme aldehyde oxidase homolog 2 in the
RT   biosynthesis of retinoic acid: generation and characterization of a
RT   knockout mouse.";
RL   Mol. Cell. Biol. 29:357-377(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver, and Lung;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [8]
RP   CRYSTALLIZATION, FUNCTION AS OXIDASE, SUBSTRATE SPECIFICITY, KINETIC
RP   PARAMETERS, COFACTOR, AND HOMODIMER.
RX   PubMed=21705476; DOI=10.1124/dmd.111.040873;
RA   Mahro M., Coelho C., Trincao J., Rodrigues D., Terao M., Garattini E.,
RA   Saggu M., Lendzian F., Hildebrandt P., Romao M.J., Leimkuhler S.;
RT   "Characterization and crystallization of mouse aldehyde oxidase 3: from
RT   mouse liver to Escherichia coli heterologous protein expression.";
RL   Drug Metab. Dispos. 39:1939-1945(2011).
RN   [9]
RP   IDENTIFICATION OF PARALOGS.
RX   PubMed=23263164; DOI=10.1007/s00018-012-1229-5;
RA   Kurosaki M., Bolis M., Fratelli M., Barzago M.M., Pattini L., Perretta G.,
RA   Terao M., Garattini E.;
RT   "Structure and evolution of vertebrate aldehyde oxidases: from gene
RT   duplication to gene suppression.";
RL   Cell. Mol. Life Sci. 70:1807-1830(2013).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.54 ANGSTROMS) IN COMPLEX WITH FE-S CLUSTERS; FAD
RP   AND MO-MPT, FUNCTION AS OXIDASE, SUBSTRATE SPECIFICITY, COFACTOR, KINETIC
RP   PARAMETERS, HOMODIMER, ACTIVITY REGULATION, REACTION MECHANISM, ACTIVE
RP   SITE, AND MUTAGENESIS OF ALA-807; TYR-885; LYS-889 AND GLU-1266.
RX   PubMed=23019336; DOI=10.1074/jbc.m112.390419;
RA   Coelho C., Mahro M., Trincao J., Carvalho A.T., Ramos M.J., Terao M.,
RA   Garattini E., Leimkuhler S., Romao M.J.;
RT   "The first mammalian aldehyde oxidase crystal structure: insights into
RT   substrate specificity.";
RL   J. Biol. Chem. 287:40690-40702(2012).
CC   -!- FUNCTION: Oxidase with broad substrate specificity, oxidizing aromatic
CC       azaheterocycles, such as N1-methylnicotinamide and phthalazine, as well
CC       as aldehydes, such as benzaldehyde, retinal and pyridoxal. Plays a key
CC       role in the metabolism of xenobiotics and drugs containing aromatic
CC       azaheterocyclic substituents. Is probably involved in the regulation of
CC       reactive oxygen species homeostasis. May be a prominent source of
CC       superoxide generation via the one-electron reduction of molecular
CC       oxygen. Also may catalyze nitric oxide (NO) production via the
CC       reduction of nitrite to NO with NADH or aldehyde as electron donor.
CC       {ECO:0000269|PubMed:11562361, ECO:0000269|PubMed:18981221,
CC       ECO:0000269|PubMed:21705476, ECO:0000269|PubMed:23019336}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an aldehyde + H2O + O2 = a carboxylate + H(+) + H2O2;
CC         Xref=Rhea:RHEA:16829, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:17478,
CC         ChEBI:CHEBI:29067; EC=1.2.3.1;
CC   -!- COFACTOR:
CC       Name=[2Fe-2S] cluster; Xref=ChEBI:CHEBI:49601;
CC         Evidence={ECO:0000269|PubMed:11562361};
CC       Note=Binds 2 [2Fe-2S] clusters per subunit.
CC       {ECO:0000269|PubMed:11562361};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:11562361};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:11562361};
CC   -!- COFACTOR:
CC       Name=Mo-molybdopterin; Xref=ChEBI:CHEBI:71302;
CC         Evidence={ECO:0000269|PubMed:11562361};
CC       Note=Binds 1 Mo-molybdopterin (Mo-MPT) cofactor per subunit.
CC       {ECO:0000269|PubMed:11562361};
CC   -!- ACTIVITY REGULATION: Inhibited by potassium cyanide, menadione,
CC       benzamidine, raloxifene and norharmane. {ECO:0000269|PubMed:11562361,
CC       ECO:0000269|PubMed:23019336}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.3 uM for phthalazine {ECO:0000269|PubMed:11562361,
CC         ECO:0000269|PubMed:21705476, ECO:0000269|PubMed:23019336};
CC         KM=1.4 uM for phthalazine (at 37 degrees Celsius and pH 8)
CC         {ECO:0000269|PubMed:11562361, ECO:0000269|PubMed:21705476,
CC         ECO:0000269|PubMed:23019336};
CC         KM=2.5 uM for benzaldehyde (at 37 degrees Celsius and pH 8)
CC         {ECO:0000269|PubMed:11562361, ECO:0000269|PubMed:21705476,
CC         ECO:0000269|PubMed:23019336};
CC         KM=128.5 uM for N1-methylnicotinamide (at 37 degrees Celsius and pH
CC         8) {ECO:0000269|PubMed:11562361, ECO:0000269|PubMed:21705476,
CC         ECO:0000269|PubMed:23019336};
CC         KM=32.3 uM for phenanthridine (at 37 degrees Celsius and pH 8)
CC         {ECO:0000269|PubMed:11562361, ECO:0000269|PubMed:21705476,
CC         ECO:0000269|PubMed:23019336};
CC         KM=13 uM for benzaldehyde (at 37 degrees Celsius and pH 7.4)
CC         {ECO:0000269|PubMed:11562361, ECO:0000269|PubMed:21705476,
CC         ECO:0000269|PubMed:23019336};
CC         KM=29 uM for butyraldehyde (at 37 degrees Celsius and pH 8)
CC         {ECO:0000269|PubMed:11562361, ECO:0000269|PubMed:21705476,
CC         ECO:0000269|PubMed:23019336};
CC         KM=173 uM for 2-OH-pyrimidine (at 37 degrees Celsius and pH 8)
CC         {ECO:0000269|PubMed:11562361, ECO:0000269|PubMed:21705476,
CC         ECO:0000269|PubMed:23019336};
CC         Note=kcat is 4 sec(-1) for phthalazine oxidation (PubMed:11562361).
CC         kcat is 130 min(-1) for benzaldehyde oxidation, 384 min(-1) for
CC         butyraldehyde oxidation and 1279 min(-1) for 2-OH-pyrimidine
CC         oxidation (PubMed:21705476). kcat is 41.1 min(-1) for phthalazine
CC         oxidation, 41.9 min(-1) for benzaldehyde oxidation, 14.7 min(-1) for
CC         N1-methylnicotinamide oxidation and 51.7 min(-1) for phenanthridine
CC         oxidation (PubMed:23019336). {ECO:0000269|PubMed:11562361,
CC         ECO:0000269|PubMed:21705476, ECO:0000269|PubMed:23019336};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:23019336}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11562361,
CC       ECO:0000269|PubMed:15383531}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver (at protein level). In
CC       liver, the expression is greater in males than females.
CC       {ECO:0000269|PubMed:11562361, ECO:0000269|PubMed:15383531,
CC       ECO:0000269|PubMed:18981221}.
CC   -!- INDUCTION: Induced by testosterone. {ECO:0000269|PubMed:18981221}.
CC   -!- MISCELLANEOUS: AOX genes evolved from a xanthine oxidoreductase
CC       ancestral precursor via a series of gene duplication and
CC       suppression/deletion events. Different animal species contain a
CC       different complement of AOX genes encoding an equivalent number of AOX
CC       isoenzymes. In mammals, the two extremes are represented by certain
CC       rodents such as mice and rats, which are endowed with 4 AOX genes, and
CC       by humans, whose genome is characterized by a single active gene
CC       (PubMed:23263164). {ECO:0000305|PubMed:23263164}.
CC   -!- SIMILARITY: Belongs to the xanthine dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF322178; AAL36596.1; -; Genomic_DNA.
DR   EMBL; AF322144; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322145; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322146; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322147; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322148; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322149; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322150; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322151; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322152; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322153; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322154; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322155; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322156; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322157; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322158; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322159; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322160; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322161; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322162; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322163; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322164; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322165; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322166; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322167; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322168; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322169; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322170; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322171; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322172; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322173; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322174; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322175; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322176; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AF322177; AAL36596.1; JOINED; Genomic_DNA.
DR   EMBL; AC025116; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH466548; EDL00068.1; -; Genomic_DNA.
DR   EMBL; BC138876; AAI38877.1; -; mRNA.
DR   CCDS; CCDS14969.1; -.
DR   RefSeq; NP_076106.2; NM_023617.2.
DR   PDB; 3ZYV; X-ray; 2.54 A; A/B/C/D=1-1335.
DR   PDBsum; 3ZYV; -.
DR   SMR; G3X982; -.
DR   BioGRID; 214883; 1.
DR   STRING; 10090.ENSMUSP00000049391; -.
DR   iPTMnet; G3X982; -.
DR   PhosphoSitePlus; G3X982; -.
DR   SwissPalm; G3X982; -.
DR   jPOST; G3X982; -.
DR   MaxQB; G3X982; -.
DR   PaxDb; G3X982; -.
DR   PeptideAtlas; G3X982; -.
DR   PRIDE; G3X982; -.
DR   ProteomicsDB; 282130; -.
DR   DNASU; 71724; -.
DR   Ensembl; ENSMUST00000040999; ENSMUSP00000049391; ENSMUSG00000064294.
DR   GeneID; 71724; -.
DR   KEGG; mmu:71724; -.
DR   UCSC; uc007bbm.1; mouse.
DR   CTD; 71724; -.
DR   MGI; MGI:1918974; Aox3.
DR   eggNOG; KOG0430; Eukaryota.
DR   GeneTree; ENSGT00950000183114; -.
DR   HOGENOM; CLU_001681_1_2_1; -.
DR   InParanoid; G3X982; -.
DR   OMA; TWEETIE; -.
DR   OrthoDB; 48717at2759; -.
DR   TreeFam; TF353036; -.
DR   BRENDA; 1.2.3.1; 3474.
DR   BioGRID-ORCS; 71724; 0 hits in 53 CRISPR screens.
DR   ChiTaRS; Aox3; mouse.
DR   PRO; PR:G3X982; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; G3X982; protein.
DR   Bgee; ENSMUSG00000064294; Expressed in liver and 119 other tissues.
DR   Genevisible; G3X982; MM.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; ISS:UniProtKB.
DR   GO; GO:0004031; F:aldehyde oxidase activity; IDA:MGI.
DR   GO; GO:0009055; F:electron transfer activity; IDA:MGI.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; ISS:UniProtKB.
DR   GO; GO:0102797; F:geranial:oxygen oxidoreductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102798; F:heptaldehyde:oxygen oxidoreductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005506; F:iron ion binding; ISS:UniProtKB.
DR   GO; GO:0030151; F:molybdenum ion binding; IDA:MGI.
DR   GO; GO:0043546; F:molybdopterin cofactor binding; ISS:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0050250; F:retinal oxidase activity; ISS:UniProtKB.
DR   GO; GO:0017144; P:drug metabolic process; ISS:UniProtKB.
DR   InterPro; IPR002888; 2Fe-2S-bd.
DR   InterPro; IPR036884; 2Fe-2S-bd_dom_sf.
DR   InterPro; IPR036010; 2Fe-2S_ferredoxin-like_sf.
DR   InterPro; IPR001041; 2Fe-2S_ferredoxin-type.
DR   InterPro; IPR006058; 2Fe2S_fd_BS.
DR   InterPro; IPR000674; Ald_Oxase/Xan_DH_a/b.
DR   InterPro; IPR036856; Ald_Oxase/Xan_DH_a/b_sf.
DR   InterPro; IPR016208; Ald_Oxase/xanthine_DH.
DR   InterPro; IPR014313; Aldehyde_oxidase.
DR   InterPro; IPR008274; AldOxase/xan_DH_Mopterin-bd.
DR   InterPro; IPR037165; AldOxase/xan_DH_Mopterin-bd_sf.
DR   InterPro; IPR005107; CO_DH_flav_C.
DR   InterPro; IPR036683; CO_DH_flav_C_dom_sf.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR002346; Mopterin_DH_FAD-bd.
DR   Pfam; PF01315; Ald_Xan_dh_C; 1.
DR   Pfam; PF02738; Ald_Xan_dh_C2; 1.
DR   Pfam; PF03450; CO_deh_flav_C; 1.
DR   Pfam; PF00941; FAD_binding_5; 1.
DR   Pfam; PF00111; Fer2; 1.
DR   Pfam; PF01799; Fer2_2; 1.
DR   PIRSF; PIRSF000127; Xanthine_DH; 1.
DR   SMART; SM01008; Ald_Xan_dh_C; 1.
DR   SMART; SM01092; CO_deh_flav_C; 1.
DR   SUPFAM; SSF47741; SSF47741; 1.
DR   SUPFAM; SSF54292; SSF54292; 1.
DR   SUPFAM; SSF54665; SSF54665; 1.
DR   SUPFAM; SSF55447; SSF55447; 1.
DR   SUPFAM; SSF56003; SSF56003; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   TIGRFAMs; TIGR02969; mam_aldehyde_ox; 1.
DR   PROSITE; PS00197; 2FE2S_FER_1; 1.
DR   PROSITE; PS51085; 2FE2S_FER_2; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
PE   1: Evidence at protein level;
KW   2Fe-2S; 3D-structure; Cytoplasm; FAD; Flavoprotein; Iron; Iron-sulfur;
KW   Metal-binding; Molybdenum; Oxidoreductase; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..1335
FT                   /note="Aldehyde oxidase 3"
FT                   /id="PRO_0000425247"
FT   DOMAIN          8..95
FT                   /note="2Fe-2S ferredoxin-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00465"
FT   DOMAIN          236..421
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   NP_BIND         264..271
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   ACT_SITE        1266
FT                   /note="Proton acceptor; for azaheterocycle hydroxylase
FT                   activity"
FT                   /evidence="ECO:0000305|PubMed:23019336"
FT   METAL           47
FT                   /note="Iron-sulfur 1 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   METAL           52
FT                   /note="Iron-sulfur 1 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   METAL           55
FT                   /note="Iron-sulfur 1 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   METAL           77
FT                   /note="Iron-sulfur 1 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   METAL           117
FT                   /note="Iron-sulfur 2 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   METAL           120
FT                   /note="Iron-sulfur 2 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   METAL           152
FT                   /note="Iron-sulfur 2 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   METAL           154
FT                   /note="Iron-sulfur 2 (2Fe-2S)"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   BINDING         116
FT                   /note="Molybdopterin"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   BINDING         354
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   BINDING         358
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   BINDING         367
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   BINDING         411
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   BINDING         802
FT                   /note="Molybdopterin; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   BINDING         1043
FT                   /note="Molybdopterin; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   BINDING         1199
FT                   /note="Molybdopterin"
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   MOD_RES         320
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5QE80"
FT   MUTAGEN         807
FT                   /note="A->V: No effect on kinetic constants with smaller
FT                   substrates like benzaldehyde or phthalazine. Decreases
FT                   substrate affinity and slightly increases catalytic
FT                   efficiency for bulkier substrates like phenanthridine."
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   MUTAGEN         885
FT                   /note="Y->M: Slightly decreases substrate affinity but no
FT                   effect on activity with smaller substrates like
FT                   benzaldehyde or phthalazine. Increases catalytic efficiency
FT                   with bulkier substrates like phenanthridine or more charged
FT                   substrates like N1-methylnicotinamide."
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   MUTAGEN         889
FT                   /note="K->H: No effect on substrate affinity but decreases
FT                   catalytic efficiency for smaller substrates like
FT                   benzaldehyde or phthalazine. Increases substrate affinity
FT                   and activity for bulkier substrates like phenanthridine."
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   MUTAGEN         1266
FT                   /note="E->Q: Loss of activity with different N-heterocyclic
FT                   compounds as substrates. 60% reduction of activity with
FT                   benzaldehyde."
FT                   /evidence="ECO:0000269|PubMed:23019336"
FT   CONFLICT        308
FT                   /note="A -> T (in Ref. 1; AAL36596)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        541
FT                   /note="K -> R (in Ref. 4; AAI38877)"
FT                   /evidence="ECO:0000305"
FT   STRAND          10..14
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          17..23
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           30..36
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          48..52
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          56..63
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   TURN            64..67
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          68..75
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   TURN            76..78
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           81..83
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          88..90
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           92..95
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           104..111
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           121..134
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           140..147
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          153..155
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           158..165
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           204..206
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           212..214
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           220..226
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          234..237
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          242..245
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           249..258
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           271..275
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          283..286
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           292..294
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          303..307
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           312..323
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   TURN            328..330
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           334..341
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           347..352
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           355..360
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           369..372
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           373..375
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          378..382
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          387..391
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   TURN            394..396
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          410..417
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          423..430
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          432..437
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          440..448
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          457..469
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           478..480
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           490..503
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           512..537
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           547..550
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           551..553
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           589..593
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          610..616
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          618..628
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           630..634
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          638..642
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           644..646
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          662..664
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          670..678
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           679..686
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          690..695
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           703..708
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          713..722
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           724..727
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          730..741
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          753..758
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          765..769
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           774..785
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           789..791
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          792..797
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   TURN            803..806
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           809..824
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          828..831
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           834..840
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          847..855
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          861..871
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           879..889
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   TURN            890..893
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          897..906
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   TURN            917..920
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           921..939
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           943..950
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           969..979
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           982..995
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          997..1011
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           1017..1020
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          1022..1028
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          1034..1036
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          1043..1045
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           1047..1059
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           1063..1065
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          1066..1068
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   TURN            1073..1075
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           1087..1105
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   TURN            1106..1108
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           1109..1112
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           1118..1127
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          1133..1138
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          1144..1146
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   TURN            1147..1150
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          1151..1153
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          1158..1169
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   TURN            1171..1173
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          1176..1185
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           1193..1212
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   TURN            1229..1231
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   TURN            1237..1239
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   STRAND          1242..1248
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           1258..1260
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           1267..1272
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           1273..1289
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   HELIX           1304..1310
FT                   /evidence="ECO:0007829|PDB:3ZYV"
FT   TURN            1314..1316
FT                   /evidence="ECO:0007829|PDB:3ZYV"
SQ   SEQUENCE   1335 AA;  146902 MW;  29683B03DD3E75E9 CRC64;
     MSPSKESDEL IFFVNGKKVT ERNADPEVNL LFYLRKVIRL TGTKYGCGGG DCGACTVMIS
     RYDPISKRIS HFSATACLVP ICSLHGAAVT TVEGIGSTKT RIHPVQERIA KGHGTQCGFC
     TPGMVMSIYT LLRNHPEPST EQIMETLGGN LCRCTGYRPI VESAKSFCPS STCCQMNGEG
     KCCLDEEKNE PERKNSVCTK LYEKKEFQPL DPTQELIFPP ELMRMAEESQ NTVLTFRGER
     TTWIAPGTLN DLLELKMKHP SAPLVIGNTY LGLHMKFTDV SYPIIISPAR ILELFVVTNT
     KQGLTLGAGL SLTQVKNVLS DVVSRLPKEK TQIYCALLKQ LKTLAGQQIR NVASLGGHII
     SRLPTSDLNP ILGIGNCILN VASTEGIQQI PLNDHFLAGV PDAILKPEQV LISVFVPRSS
     KWEFVSAFRQ APRQQNAFAT VNAGMKVVFK EDTNTITDLG ILYGGIGATV ISADKSCRQL
     IGRCWDEEML DDAGKMICEE VSLLMAAPGG MEEYRKTLAI SFLFMFYLDV LKQLKTRDPH
     KYPDISQKLL HILEDFPLTM PYGMQSFQDV DFQQPLQDPI GRPIMHQSGI KHATGEAVFC
     DDMSVLPGEL FLAVVTSSKS HAKIISLDAS EALASLGVVD VVTARDVPGD NGREEESLYA
     QDEVICVGQI VCAVAADSYA HAQQAAKKVK IVYQDIEPMI VTVQDALQYE SFIGPERKLE
     QGNVEEAFQC ADQILEGEVH LGGQEHFYME TQSVRVVPKG EDKEMDIYVS SQDAAFTQEM
     VARTLGIPKN RINCHVKRVG GAFGGKASKP GLLASVAAVA AQKTGRPIRF ILERRDDMLI
     TGGRHPLLGK YKIGFMNNGK IKAADIQLYI NGGCTPDDSE LVIEYALLKL ENAYKIPNLR
     VRGRVCKTNL PSNTAFRGFG FPQGAFVTET CMSAVAAKCR LPPEKVRELN MYRTIDRTIH
     NQEFDPTNLL QCWEACVENS SYYNRKKAVD EFNQQRFWKK RGIAIIPMKF SVGFPKTFYY
     QAAALVQIYT DGSVLVAHGG VELGQGINTK MIQVASRELK IPMSYIHLDE MSTVTVPNTV
     TTGASTGADV NGRAVQNACQ ILMKRLEPII KQNPSGTWEE WVKEAFVQSI SLSATGYFRG
     YQADMDWEKG EGDIFPYFVF GAACSEVEID CLTGAHKNIR TDIVMDGSFS INPAVDIGQI
     EGAFVQGLGL YTLEELKYSP EGVLYTRGPH QYKIASVTDI PEEFHVSLLT PTPNPKAIYS
     SKGLGEAGTF LGCSVFFAIA AAVAAAREER GLSPIWAINS PATAEVIRMA CEDQFTNLVP
     QTDSKCCKPW SIPVA
//
ID   CGOX_MYXXA              Reviewed;         471 AA.
AC   P56601;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-1998, sequence version 1.
DT   02-JUN-2021, entry version 116.
DE   RecName: Full=Coproporphyrinogen III oxidase {ECO:0000250|UniProtKB:P32397};
DE            EC=1.3.3.15 {ECO:0000250|UniProtKB:P32397};
GN   Name=cgoX {ECO:0000250|UniProtKB:P32397}; Synonyms=hemY;
OS   Myxococcus xanthus.
OC   Bacteria; Proteobacteria; Deltaproteobacteria; Myxococcales;
OC   Cystobacterineae; Myxococcaceae; Myxococcus.
OX   NCBI_TaxID=34;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1372277; DOI=10.1101/gad.6.3.401;
RA   Li S., Lee B.U., Shimkets L.J.;
RT   "csgA expression entrains Myxococcus xanthus development.";
RL   Genes Dev. 6:401-410(1992).
RN   [2]
RP   SEQUENCE REVISION TO C-TERMINUS.
RA   Shimkets L.J.;
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, COFACTOR, ACTIVITY REGULATION, AND SUBUNIT.
RX   PubMed=8621504; DOI=10.1074/jbc.271.15.8714;
RA   Dailey H.A., Dailey T.A.;
RT   "Protoporphyrinogen oxidase of Myxococcus xanthus. Expression,
RT   purification, and characterization of the cloned enzyme.";
RL   J. Biol. Chem. 271:8714-8718(1996).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 4-471 IN COMPLEX WITH FAD AND
RP   ACIFLUORFEN, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=17046834; DOI=10.1074/jbc.m606640200;
RA   Corradi H.R., Corrigall A.V., Boix E., Mohan C.G., Sturrock E.D.,
RA   Meissner P.N., Acharya K.R.;
RT   "Crystal structure of protoporphyrinogen oxidase from Myxococcus xanthus
RT   and its complex with the inhibitor acifluorfen.";
RL   J. Biol. Chem. 281:38625-38633(2006).
CC   -!- FUNCTION: Involved in coproporphyrin-dependent heme b biosynthesis (By
CC       similarity). Catalyzes the oxidation of coproporphyrinogen III to
CC       coproporphyrin III (By similarity). Can also oxidize protoporphyrinogen
CC       IX to protoporphyrin-IX (PubMed:8621504).
CC       {ECO:0000250|UniProtKB:P32397, ECO:0000269|PubMed:8621504}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=coproporphyrinogen III + 3 O2 = coproporphyrin III + 3 H2O2;
CC         Xref=Rhea:RHEA:43436, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:57309, ChEBI:CHEBI:131725; EC=1.3.3.15;
CC         Evidence={ECO:0000250|UniProtKB:P32397};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43437;
CC         Evidence={ECO:0000250|UniProtKB:P32397};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:8621504};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:8621504};
CC   -!- ACTIVITY REGULATION: Strongly inhibited by acifluorfen.
CC       {ECO:0000269|PubMed:8621504}.
CC   -!- SUBUNIT: Monomer. Homodimer. {ECO:0000269|PubMed:17046834,
CC       ECO:0000269|PubMed:8621504}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17046834}. Membrane
CC       {ECO:0000269|PubMed:17046834}.
CC   -!- SIMILARITY: Belongs to the protoporphyrinogen/coproporphyrinogen
CC       oxidase family. Coproporphyrinogen III oxidase subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L27429; AAM28643.1; -; Genomic_DNA.
DR   EMBL; AF098938; AAD13609.1; -; Genomic_DNA.
DR   RefSeq; WP_011551410.1; NZ_JABFNQ010000064.1.
DR   PDB; 2IVD; X-ray; 2.30 A; A/B=4-471.
DR   PDB; 2IVE; X-ray; 2.70 A; A/B=4-471.
DR   PDBsum; 2IVD; -.
DR   PDBsum; 2IVE; -.
DR   SMR; P56601; -.
DR   DrugBank; DB07338; Acifluorfen.
DR   GeneID; 41358739; -.
DR   BRENDA; 1.3.3.4; 3551.
DR   SABIO-RK; P56601; -.
DR   EvolutionaryTrace; P56601; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004729; F:oxygen-dependent protoporphyrinogen oxidase activity; IEA:InterPro.
DR   GO; GO:0006783; P:heme biosynthetic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR004572; Protoporphyrinogen_oxidase.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR00562; proto_IX_ox; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; FAD; Flavoprotein; Heme biosynthesis; Membrane;
KW   Oxidoreductase.
FT   CHAIN           1..471
FT                   /note="Coproporphyrinogen III oxidase"
FT                   /id="PRO_0000135267"
FT   NP_BIND         16..21
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17046834"
FT   NP_BIND         39..40
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17046834"
FT   NP_BIND         61..64
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17046834"
FT   NP_BIND         446..448
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17046834"
FT   BINDING         47
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:17046834"
FT   BINDING         251
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:17046834"
FT   BINDING         408
FT                   /note="FAD"
FT                   /evidence="ECO:0000250"
FT   STRAND          12..15
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           19..29
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   TURN            30..32
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          35..38
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          40..45
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          50..53
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          56..61
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           70..78
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           82..84
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          85..87
FT                   /evidence="ECO:0007829|PDB:2IVE"
FT   STRAND          95..99
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          102..105
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           110..114
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          117..119
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           121..128
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           129..132
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           144..151
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           154..159
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           161..169
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   TURN            173..175
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           178..181
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           183..192
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           195..206
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          223..226
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           231..241
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           242..244
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          245..255
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          262..267
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          270..275
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          277..281
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           285..292
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   TURN            293..295
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           297..304
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          311..318
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          328..332
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           335..337
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          343..346
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           347..350
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           352..354
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          360..367
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           372..376
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           379..394
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          401..410
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           419..431
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   STRAND          436..438
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   TURN            441..443
FT                   /evidence="ECO:0007829|PDB:2IVD"
FT   HELIX           448..462
FT                   /evidence="ECO:0007829|PDB:2IVD"
SQ   SEQUENCE   471 AA;  49388 MW;  2E9909D464F81515 CRC64;
     MHHMPRTTGM NVAVVGGGIS GLAVAHHLRS RGTDAVLLES SARLGGAVGT HALAGYLVEQ
     GPNSFLDREP ATRALAAALN LEGRIRAADP AAKRRYVYTR GRLRSVPASP PAFLASDILP
     LGARLRVAGE LFSRRAPEGV DESLAAFGRR HLGHRATQVL LDAVQTGIYA GDVEQLSVAA
     TFPMLVKMER EHRSLILGAI RAQKAQRQAA LPAGTAPKLS GALSTFDGGL QVLIDALAAS
     LGDAAHVGAR VEGLAREDGG WRLIIEEHGR RAELSVAQVV LAAPAHATAK LLRPLDDALA
     ALVAGIAYAP IAVVHLGFDA GTLPAPDGFG FLVPAEEQRR MLGAIHASTT FPFRAEGGRV
     LYSCMVGGAR QPGLVEQDED ALAALAREEL KALAGVTARP SFTRVFRWPL GIPQYNLGHL
     ERVAAIDAAL QRLPGLHLIG NAYKGVGLND CIRNAAQLAD ALVAGNTSHA P
//
ID   ACAD8_HUMAN             Reviewed;         415 AA.
AC   Q9UKU7; B7Z5W4; Q6ZWP6; Q9BUS8;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   02-JUN-2021, entry version 184.
DE   RecName: Full=Isobutyryl-CoA dehydrogenase, mitochondrial;
DE            Short=IBDH {ECO:0000303|PubMed:12359132};
DE            EC=1.3.8.- {ECO:0000269|PubMed:11013134, ECO:0000269|PubMed:12359132, ECO:0000269|PubMed:16857760};
DE   AltName: Full=Activator-recruited cofactor 42 kDa component;
DE            Short=ARC42;
DE   AltName: Full=Acyl-CoA dehydrogenase family member 8;
DE            Short=ACAD-8;
DE   Flags: Precursor;
GN   Name=ACAD8; Synonyms=ARC42, IBD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Skin fibroblast;
RX   PubMed=10524212; DOI=10.1016/s0167-4781(99)00102-5;
RA   Telford E.A.R., Moynihan L.M., Markham A.F., Lench N.J.;
RT   "Isolation and characterisation of a cDNA encoding the precursor for a
RT   novel member of the acyl-CoA dehydrogenase gene family.";
RL   Biochim. Biophys. Acta 1446:371-376(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY,
RP   SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=11013134; DOI=10.1086/303105;
RA   Andresen B.S., Christensen E., Corydon T.J., Bross P., Pilgaard B.,
RA   Wanders R.J.A., Ruiter J.P.N., Simonsen H., Winter V., Knudsen I.,
RA   Schroeder L.D., Gregersen N., Skovby F.;
RT   "Isolated 2-methylbutyrylglycinuria caused by short/branched-chain acyl-CoA
RT   dehydrogenase deficiency: identification of a new enzyme defect, resolution
RT   of its molecular basis, and evidence for distinct acyl-CoA dehydrogenases
RT   in isoleucine and valine metabolism.";
RL   Am. J. Hum. Genet. 67:1095-1103(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain, and Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION IN ARC COMPLEX, AND PROTEIN SEQUENCE OF 50-61; 70-80 AND
RP   345-355.
RX   PubMed=10235267; DOI=10.1038/19789;
RA   Naeaer A.M., Beaurang P.A., Zhou S., Abraham S., Solomon W.B., Tjian R.;
RT   "Composite co-activator ARC mediates chromatin-directed transcriptional
RT   activation.";
RL   Nature 398:828-832(1999).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.77 ANGSTROMS) OF 24-415 IN COMPLEX WITH FAD AND
RP   SUBSTRATE ANALOG, COFACTOR, SUBUNIT, ACTIVE SITE, AND REGION.
RX   PubMed=14752098; DOI=10.1074/jbc.m400034200;
RA   Battaile K.P., Nguyen T.V., Vockley J., Kim J.-J.P.;
RT   "Structures of isobutyryl-CoA dehydrogenase and enzyme-product complex:
RT   comparison with isovaleryl- and short-chain acyl-CoA dehydrogenases.";
RL   J. Biol. Chem. 279:16526-16534(2004).
RN   [10]
RP   VARIANT IBDD GLN-302, CHARACTERIZATION OF VARIANT IBDD GLN-302, INVOLVEMENT
RP   IN IBDD, FUNCTION, CATALYTIC ACTIVITY, PATHWAY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBSTRATE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=12359132; DOI=10.1016/s1096-7192(02)00152-x;
RA   Nguyen T.V., Andresen B.S., Corydon T.J., Ghisla S., Abd El-Razik N.,
RA   Mohsen A.W., Cederbaum S.D., Roe D.S., Roe C.R., Lench N.J., Vockley J.;
RT   "Identification of isobutyryl-CoA dehydrogenase and its deficiency in
RT   humans.";
RL   Mol. Genet. Metab. 77:68-79(2002).
RN   [11]
RP   VARIANTS IBDD ILE-128 AND ILE-203.
RX   PubMed=15505379; DOI=10.1023/b:boli.0000045798.12425.1b;
RA   Sass J.O., Sander S., Zschocke J.;
RT   "Isobutyryl-CoA dehydrogenase deficiency: isobutyrylglycinuria and ACAD8
RT   gene mutations in two infants.";
RL   J. Inherit. Metab. Dis. 27:741-745(2004).
RN   [12]
RP   VARIANTS IBDD TYR-134; ARG-137; THR-152; GLN-302; THR-320; CYS-334 AND
RP   ARG-385, CHARACTERIZATION OF VARIANTS IBDD ARG-137; GLN-302 AND THR-320,
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=16857760; DOI=10.1203/01.pdr.0000233085.72522.04;
RA   Pedersen C.B., Bischoff C., Christensen E., Simonsen H., Lund A.M.,
RA   Young S.P., Koeberl D.D., Millington D.S., Roe C.R., Roe D.S.,
RA   Wanders R.J.A., Ruiter J.P.N., Keppen L.D., Stein Q., Knudsen I.,
RA   Gregersen N., Andresen B.S.;
RT   "Variations in IBD (ACAD8) in children with elevated C4-carnitine detected
RT   by tandem mass spectrometry newborn screening.";
RL   Pediatr. Res. 60:315-320(2006).
CC   -!- FUNCTION: Isobutyryl-CoA dehydrogenase which catalyzes one of the steps
CC       of the valine catabolic pathway (PubMed:11013134, PubMed:12359132,
CC       PubMed:16857760). To a lesser extent, is also able to catalyze the
CC       oxidation of (2S)-2-methylbutanoyl-CoA (PubMed:11013134,
CC       PubMed:12359132). {ECO:0000269|PubMed:11013134,
CC       ECO:0000269|PubMed:12359132, ECO:0000269|PubMed:16857760}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-methylpropanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-2-methylpropenoyl-CoA + reduced [electron-
CC         transfer flavoprotein]; Xref=Rhea:RHEA:44180, Rhea:RHEA-COMP:10685,
CC         Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57338,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:62500;
CC         Evidence={ECO:0000269|PubMed:11013134, ECO:0000269|PubMed:12359132,
CC         ECO:0000269|PubMed:16857760};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44181;
CC         Evidence={ECO:0000269|PubMed:12359132, ECO:0000269|PubMed:16857760};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2S)-2-methylbutanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-2-methylbut-2-enoyl-CoA + reduced [electron-
CC         transfer flavoprotein]; Xref=Rhea:RHEA:48256, Rhea:RHEA-COMP:10685,
CC         Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57337,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:88166;
CC         Evidence={ECO:0000269|PubMed:11013134, ECO:0000269|PubMed:12359132};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48257;
CC         Evidence={ECO:0000305|PubMed:12359132};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + oxidized [electron-transfer flavoprotein] + propanoyl-
CC         CoA = acryloyl-CoA + reduced [electron-transfer flavoprotein];
CC         Xref=Rhea:RHEA:31287, Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57367, ChEBI:CHEBI:57392,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307;
CC         Evidence={ECO:0000269|PubMed:12359132};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31288;
CC         Evidence={ECO:0000305|PubMed:12359132};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:14752098};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.6 uM for 2-methylpropanoyl-CoA {ECO:0000269|PubMed:12359132};
CC         KM=18 uM for (2S)-2-methylbutanoyl-CoA {ECO:0000269|PubMed:12359132};
CC         KM=24 uM for n-propionyl-CoA {ECO:0000269|PubMed:12359132};
CC         Note=kcat is 2.0 sec(-1) for the oxidation of 2-methylpropanoyl-CoA
CC         (PubMed:12359132). kcat is 4.1 sec(-1) for the oxidation of (2S)-
CC         methylbutanoyl-CoA (PubMed:12359132). kcat is 0.83 sec(-1) for the
CC         oxidation of n-propionyl-CoA (PubMed:12359132).
CC         {ECO:0000269|PubMed:12359132};
CC   -!- PATHWAY: Amino-acid degradation; L-valine degradation.
CC       {ECO:0000269|PubMed:12359132, ECO:0000269|PubMed:16857760}.
CC   -!- SUBUNIT: Homotetramer, formed by a dimer of dimers (PubMed:11013134,
CC       PubMed:14752098). May be part of the large multiprotein complex
CC       ARC/DRIP (PubMed:10235267). {ECO:0000269|PubMed:10235267,
CC       ECO:0000269|PubMed:11013134, ECO:0000269|PubMed:14752098}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:11013134,
CC       ECO:0000269|PubMed:12359132}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UKU7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UKU7-2; Sequence=VSP_055780, VSP_055781;
CC       Name=3;
CC         IsoId=Q9UKU7-3; Sequence=VSP_055779, VSP_055782;
CC   -!- TISSUE SPECIFICITY: Detected at comparable levels in all tissues
CC       examined (heart, lung, brain, skeletal muscle, pancreas and placenta).
CC       Weakly expressed in liver and kidney.
CC   -!- DISEASE: Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283]:
CC       An autosomal recessive metabolic disorder characterized by plasma
CC       carnitine deficiency and elevated C4-acylcarnitine. Patients manifest
CC       variable clinical features including failure to thrive, seizures,
CC       anemia, muscular hypotonia and developmental delay. Some patients may
CC       be asymptomatic. {ECO:0000269|PubMed:12359132,
CC       ECO:0000269|PubMed:15505379, ECO:0000269|PubMed:16857760}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF126245; AAF12736.1; -; mRNA.
DR   EMBL; AF260689; AAF97922.1; -; Genomic_DNA.
DR   EMBL; AF260679; AAF97922.1; JOINED; Genomic_DNA.
DR   EMBL; AF260680; AAF97922.1; JOINED; Genomic_DNA.
DR   EMBL; AF260681; AAF97922.1; JOINED; Genomic_DNA.
DR   EMBL; AF260682; AAF97922.1; JOINED; Genomic_DNA.
DR   EMBL; AF260683; AAF97922.1; JOINED; Genomic_DNA.
DR   EMBL; AF260684; AAF97922.1; JOINED; Genomic_DNA.
DR   EMBL; AF260685; AAF97922.1; JOINED; Genomic_DNA.
DR   EMBL; AF260686; AAF97922.1; JOINED; Genomic_DNA.
DR   EMBL; AF260687; AAF97922.1; JOINED; Genomic_DNA.
DR   EMBL; AF260688; AAF97922.1; JOINED; Genomic_DNA.
DR   EMBL; AK000359; BAA91109.1; -; mRNA.
DR   EMBL; AK074640; BAC11107.1; -; mRNA.
DR   EMBL; AK299492; BAH13050.1; -; mRNA.
DR   EMBL; AP000859; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471065; EAW67833.1; -; Genomic_DNA.
DR   EMBL; BC001964; AAH01964.1; -; mRNA.
DR   CCDS; CCDS8498.1; -. [Q9UKU7-1]
DR   RefSeq; NP_055199.1; NM_014384.2. [Q9UKU7-1]
DR   PDB; 1RX0; X-ray; 1.77 A; A/B/C/D=24-415.
DR   PDBsum; 1RX0; -.
DR   SMR; Q9UKU7; -.
DR   BioGRID; 117965; 28.
DR   CORUM; Q9UKU7; -.
DR   IntAct; Q9UKU7; 16.
DR   STRING; 9606.ENSP00000281182; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB01675; Methacrylyl-Coenzyme A.
DR   SwissLipids; SLP:000001420; -.
DR   iPTMnet; Q9UKU7; -.
DR   PhosphoSitePlus; Q9UKU7; -.
DR   BioMuta; ACAD8; -.
DR   DMDM; 26006699; -.
DR   UCD-2DPAGE; Q9UKU7; -.
DR   EPD; Q9UKU7; -.
DR   jPOST; Q9UKU7; -.
DR   MassIVE; Q9UKU7; -.
DR   PaxDb; Q9UKU7; -.
DR   PeptideAtlas; Q9UKU7; -.
DR   PRIDE; Q9UKU7; -.
DR   ProteomicsDB; 6725; -.
DR   ProteomicsDB; 68496; -.
DR   ProteomicsDB; 84879; -. [Q9UKU7-1]
DR   Antibodypedia; 33180; 184 antibodies.
DR   DNASU; 27034; -.
DR   Ensembl; ENST00000281182; ENSP00000281182; ENSG00000151498. [Q9UKU7-1]
DR   Ensembl; ENST00000374752; ENSP00000363884; ENSG00000151498. [Q9UKU7-2]
DR   GeneID; 27034; -.
DR   KEGG; hsa:27034; -.
DR   UCSC; uc001qhk.4; human. [Q9UKU7-1]
DR   CTD; 27034; -.
DR   DisGeNET; 27034; -.
DR   GeneCards; ACAD8; -.
DR   HGNC; HGNC:87; ACAD8.
DR   HPA; ENSG00000151498; Low tissue specificity.
DR   MalaCards; ACAD8; -.
DR   MIM; 604773; gene.
DR   MIM; 611283; phenotype.
DR   neXtProt; NX_Q9UKU7; -.
DR   OpenTargets; ENSG00000151498; -.
DR   Orphanet; 79159; Isobutyryl-CoA dehydrogenase deficiency.
DR   PharmGKB; PA24423; -.
DR   VEuPathDB; HostDB:ENSG00000151498.11; -.
DR   eggNOG; KOG0140; Eukaryota.
DR   GeneTree; ENSGT00940000157590; -.
DR   HOGENOM; CLU_018204_0_2_1; -.
DR   InParanoid; Q9UKU7; -.
DR   OMA; NMATWML; -.
DR   OrthoDB; 819314at2759; -.
DR   PhylomeDB; Q9UKU7; -.
DR   TreeFam; TF105052; -.
DR   PathwayCommons; Q9UKU7; -.
DR   Reactome; R-HSA-70895; Branched-chain amino acid catabolism.
DR   UniPathway; UPA00362; -.
DR   BioGRID-ORCS; 27034; 13 hits in 993 CRISPR screens.
DR   ChiTaRS; ACAD8; human.
DR   EvolutionaryTrace; Q9UKU7; -.
DR   GeneWiki; ACAD8; -.
DR   GenomeRNAi; 27034; -.
DR   Pharos; Q9UKU7; Tbio.
DR   PRO; PR:Q9UKU7; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q9UKU7; protein.
DR   Bgee; ENSG00000151498; Expressed in prostate gland and 223 other tissues.
DR   ExpressionAtlas; Q9UKU7; baseline and differential.
DR   Genevisible; Q9UKU7; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0003995; F:acyl-CoA dehydrogenase activity; TAS:ProtInc.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0006574; P:valine catabolic process; IEA:UniProtKB-UniPathway.
DR   CDD; cd01162; IBD; 1.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   InterPro; IPR034178; IBD.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing;
KW   Branched-chain amino acid catabolism; Direct protein sequencing;
KW   Disease variant; FAD; Flavoprotein; Mitochondrion; Oxidoreductase;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Transit peptide.
FT   TRANSIT         1..22
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..415
FT                   /note="Isobutyryl-CoA dehydrogenase, mitochondrial"
FT                   /id="PRO_0000000522"
FT   NP_BIND         158..167
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:14752098"
FT   NP_BIND         191..193
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:14752098"
FT   NP_BIND         312..313
FT                   /note="FAD; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:14752098"
FT   NP_BIND         371..375
FT                   /note="FAD; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:14752098"
FT   NP_BIND         400..402
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:14752098"
FT   REGION          274..277
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:14752098"
FT   ACT_SITE        398
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:14752098"
FT   BINDING         167
FT                   /note="Substrate; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:14752098"
FT   BINDING         302
FT                   /note="FAD; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:14752098"
FT   BINDING         410
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:14752098"
FT   MOD_RES         50
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D7B6"
FT   MOD_RES         50
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D7B6"
FT   MOD_RES         213
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D7B6"
FT   MOD_RES         231
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D7B6"
FT   VAR_SEQ         1..77
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055779"
FT   VAR_SEQ         37
FT                   /note="P -> R (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055780"
FT   VAR_SEQ         38..164
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055781"
FT   VAR_SEQ         399..415
FT                   /note="GSNEVMRILISRSLLQE -> ELFWQGPGVQSRSFVPFGGPQIALLLPFSSG
FT                   DLREG (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055782"
FT   VARIANT         128
FT                   /note="M -> I (in IBDD; dbSNP:rs374317179)"
FT                   /evidence="ECO:0000269|PubMed:15505379"
FT                   /id="VAR_035071"
FT   VARIANT         134
FT                   /note="D -> Y (in IBDD; dbSNP:rs367857040)"
FT                   /evidence="ECO:0000269|PubMed:16857760"
FT                   /id="VAR_035072"
FT   VARIANT         137
FT                   /note="G -> R (in IBDD; loss of protein solubility;
FT                   complete loss of isobutyryl-CoA dehydrogenase activity;
FT                   dbSNP:rs371449613)"
FT                   /evidence="ECO:0000269|PubMed:16857760"
FT                   /id="VAR_035073"
FT   VARIANT         152
FT                   /note="M -> T (in IBDD; dbSNP:rs121908418)"
FT                   /evidence="ECO:0000269|PubMed:16857760"
FT                   /id="VAR_035074"
FT   VARIANT         203
FT                   /note="V -> I (in IBDD; dbSNP:rs759877257)"
FT                   /evidence="ECO:0000269|PubMed:15505379"
FT                   /id="VAR_035075"
FT   VARIANT         302
FT                   /note="R -> Q (in IBDD; no effect on localization to the
FT                   mitochondrion; complete loss of isobutyryl-CoA
FT                   dehydrogenase activity; loss of protein expression in
FT                   patient cells; dbSNP:rs121908422)"
FT                   /evidence="ECO:0000269|PubMed:12359132,
FT                   ECO:0000269|PubMed:16857760"
FT                   /id="VAR_035076"
FT   VARIANT         320
FT                   /note="A -> T (in IBDD; decreased isobutyryl-CoA
FT                   dehydrogenase activity; less than 20% of wild-type;
FT                   dbSNP:rs200620279)"
FT                   /evidence="ECO:0000269|PubMed:16857760"
FT                   /id="VAR_035077"
FT   VARIANT         334
FT                   /note="R -> C (in IBDD; dbSNP:rs778823613)"
FT                   /evidence="ECO:0000269|PubMed:16857760"
FT                   /id="VAR_035078"
FT   VARIANT         385
FT                   /note="Q -> R (in IBDD; dbSNP:rs367996531)"
FT                   /evidence="ECO:0000269|PubMed:16857760"
FT                   /id="VAR_035079"
FT   CONFLICT        210
FT                   /note="P -> L (in Ref. 6; AAH01964)"
FT                   /evidence="ECO:0000305"
FT   TURN            37..40
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           43..59
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   TURN            60..63
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           64..70
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           75..83
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           93..95
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           102..113
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           117..136
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           139..150
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   STRAND          156..159
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   STRAND          165..168
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           169..171
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   STRAND          175..179
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   STRAND          182..193
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   TURN            194..197
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   STRAND          199..211
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           212..214
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   STRAND          215..221
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   STRAND          227..229
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   STRAND          235..237
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   STRAND          243..254
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           255..257
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   STRAND          258..261
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           265..301
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           309..311
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           313..341
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           347..372
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           373..378
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           384..393
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   TURN            394..396
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   STRAND          397..399
FT                   /evidence="ECO:0007829|PDB:1RX0"
FT   HELIX           401..414
FT                   /evidence="ECO:0007829|PDB:1RX0"
SQ   SEQUENCE   415 AA;  45070 MW;  CAFFE91B74E2362D CRC64;
     MLWSGCRRFG ARLGCLPGGL RVLVQTGHRS LTSCIDPSMG LNEEQKEFQK VAFDFAAREM
     APNMAEWDQK ELFPVDVMRK AAQLGFGGVY IQTDVGGSGL SRLDTSVIFE ALATGCTSTT
     AYISIHNMCA WMIDSFGNEE QRHKFCPPLC TMEKFASYCL TEPGSGSDAA SLLTSAKKQG
     DHYILNGSKA FISGAGESDI YVVMCRTGGP GPKGISCIVV EKGTPGLSFG KKEKKVGWNS
     QPTRAVIFED CAVPVANRIG SEGQGFLIAV RGLNGGRINI ASCSLGAAHA SVILTRDHLN
     VRKQFGEPLA SNQYLQFTLA DMATRLVAAR LMVRNAAVAL QEERKDAVAL CSMAKLFATD
     ECFAICNQAL QMHGGYGYLK DYAVQQYVRD SRVHQILEGS NEVMRILISR SLLQE
//
ID   CRTDH_NONDD             Reviewed;         487 AA.
AC   L7WC64;
DT   08-MAY-2019, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2013, sequence version 1.
DT   02-JUN-2021, entry version 47.
DE   RecName: Full=1-hydroxycarotenoid 3,4-desaturase {ECO:0000303|PubMed:26138397};
DE            EC=1.3.99.27 {ECO:0000250|UniProtKB:Q7WT72};
DE   AltName: Full=1'-hydroxy-gamma-carotene 3,4-desaturase {ECO:0000305};
DE   AltName: Full=1-hydroxycarotenoid 3,4-dehydrogenase {ECO:0000250|UniProtKB:Q7WT72};
GN   Name=crtD {ECO:0000303|PubMed:26138397};
GN   OrderedLocusNames=DDD_2394 {ECO:0000312|EMBL:AGC77521.1};
OS   Nonlabens dokdonensis (strain DSM 17205 / KCTC 12402 / DSW-6) (Donghaeana
OS   dokdonensis).
OC   Bacteria; Bacteroidetes; Flavobacteriia; Flavobacteriales;
OC   Flavobacteriaceae; Nonlabens.
OX   NCBI_TaxID=592029 {ECO:0000312|Proteomes:UP000011173};
RN   [1] {ECO:0000312|Proteomes:UP000011173}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=DSM 17205 / KCTC 12402 / DSW-6 {ECO:0000312|Proteomes:UP000011173};
RX   PubMed=23292138; DOI=10.1093/gbe/evs134;
RA   Kwon S.K., Kim B.K., Song J.Y., Kwak M.J., Lee C.H., Yoon J.H., Oh T.K.,
RA   Kim J.F.;
RT   "Genomic makeup of the marine flavobacterium Nonlabens (Donghaeana)
RT   dokdonensis DSW-6 and identification of a novel class of rhodopsins.";
RL   Genome Biol. Evol. 5:187-187(2013).
RN   [2] {ECO:0007744|PDB:4REP}
RP   X-RAY CRYSTALLOGRAPHY (1.97 ANGSTROMS) IN COMPLEX WITH FAD, AND SUBUNIT.
RX   PubMed=26138397; DOI=10.1016/j.enzmictec.2015.05.005;
RA   Ahn J.W., Kim K.J.;
RT   "Crystal structure of 1'-OH-carotenoid 3,4-desaturase from Nonlabens
RT   dokdonensis DSW-6.";
RL   Enzyme Microb. Technol. 77:29-37(2015).
CC   -!- FUNCTION: Catalyzes the introduction of a C-3,4 double bond into 1'-
CC       hydroxy-gamma-carotene and rhodopin (1-hydroxylycopene) to yield 1'-
CC       hydroxytorulene and (3E)-3,4-didehydrorhodopin, respectively (By
CC       similarity). Can also use 1-hydroxy-all-trans-1,2-dihydro-neurosporene,
CC       1,1'-dihydroxy-1,1',2,2'-tetrahydroneurosporene and 1,1'-dihydroxy-
CC       1,1',2,2'-tetrahydrolycopene (By similarity). Probably involved in the
CC       synthesis of myxol, a gamma-carotene derivative (Probable). May use FAD
CC       as a proton acceptor (Probable). {ECO:0000250|UniProtKB:Q7WT72,
CC       ECO:0000305|PubMed:26138397}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=A + rhodopin = (3E)-3,4-didehydrorhodopin + AH2;
CC         Xref=Rhea:RHEA:30919, ChEBI:CHEBI:13193, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:35331, ChEBI:CHEBI:62481; EC=1.3.99.27;
CC         Evidence={ECO:0000250|UniProtKB:Q7WT72};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1'-hydroxy-gamma-carotene + A = 1'-hydroxytorulene + AH2;
CC         Xref=Rhea:RHEA:59332, ChEBI:CHEBI:13193, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:80133, ChEBI:CHEBI:80134;
CC         Evidence={ECO:0000250|UniProtKB:Q7WT72};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hydroxy-all-trans-1,2-dihydro-neurosporene + A = AH2 +
CC         demethylspheroidene; Xref=Rhea:RHEA:59336, ChEBI:CHEBI:13193,
CC         ChEBI:CHEBI:17499, ChEBI:CHEBI:62505, ChEBI:CHEBI:138077;
CC         Evidence={ECO:0000250|UniProtKB:Q7WT72};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,1'-dihydroxy-1,1',2,2'-tetrahydroneurosporene + A = 1'-
CC         hydroxy-demethylspheroidene + AH2; Xref=Rhea:RHEA:59340,
CC         ChEBI:CHEBI:13193, ChEBI:CHEBI:17499, ChEBI:CHEBI:138076,
CC         ChEBI:CHEBI:143013; Evidence={ECO:0000250|UniProtKB:Q7WT72};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,1'-dihydroxy-1,1',2,2'-tetrahydrolycopene + A = 1,1'-
CC         dihydroxy-3,4-didehydro-1,2-dihydrolycopene + AH2;
CC         Xref=Rhea:RHEA:59444, ChEBI:CHEBI:13193, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:63065, ChEBI:CHEBI:132450;
CC         Evidence={ECO:0000250|UniProtKB:Q7WT72};
CC   -!- PATHWAY: Carotenoid biosynthesis. {ECO:0000255|RuleBase:RU362075}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:26138397}.
CC   -!- SIMILARITY: Belongs to the carotenoid/retinoid oxidoreductase family.
CC       {ECO:0000255|RuleBase:RU362075}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001397; AGC77521.1; -; Genomic_DNA.
DR   RefSeq; WP_015363018.1; NC_020156.1.
DR   PDB; 4REP; X-ray; 1.97 A; A=1-487.
DR   PDBsum; 4REP; -.
DR   SMR; L7WC64; -.
DR   EnsemblBacteria; AGC77521; AGC77521; DDD_2394.
DR   KEGG; ndo:DDD_2394; -.
DR   PATRIC; fig|592029.3.peg.2371; -.
DR   eggNOG; COG1233; Bacteria.
DR   HOGENOM; CLU_019722_2_1_10; -.
DR   OMA; FTMRWVF; -.
DR   OrthoDB; 418913at2; -.
DR   BioCyc; NDOK592029:G1HEG-2334-MONOMER; -.
DR   BRENDA; 1.3.99.27; 14193.
DR   BRENDA; 1.3.99.37; 14193.
DR   Proteomes; UP000011173; Chromosome.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016117; P:carotenoid biosynthetic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR014105; Carotenoid/retinoid_OxRdtase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR02734; crtI_fam; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Carotenoid biosynthesis; FAD; Flavoprotein;
KW   Nucleotide-binding; Oxidoreductase.
FT   CHAIN           1..487
FT                   /note="1-hydroxycarotenoid 3,4-desaturase"
FT                   /id="PRO_0000447219"
FT   NP_BIND         55..56
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26138397,
FT                   ECO:0007744|PDB:4REP"
FT   NP_BIND         468..469
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26138397,
FT                   ECO:0007744|PDB:4REP"
FT   BINDING         12
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:26138397,
FT                   ECO:0007744|PDB:4REP"
FT   BINDING         31
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23292138,
FT                   ECO:0007744|PDB:4REP"
FT   BINDING         39
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23292138,
FT                   ECO:0007744|PDB:4REP"
FT   BINDING         247
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:26138397,
FT                   ECO:0007744|PDB:4REP"
FT   BINDING         275
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26138397,
FT                   ECO:0007744|PDB:4REP"
FT   BINDING         431
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:23292138,
FT                   ECO:0007744|PDB:4REP"
FT   BINDING         461
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:26138397,
FT                   ECO:0007744|PDB:4REP"
FT   STRAND          3..7
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           11..22
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          26..30
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          32..37
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          42..45
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          48..51
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           61..67
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          79..81
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          83..89
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          95..101
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           102..113
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           117..138
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           155..164
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   TURN            165..167
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           170..174
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          177..179
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           180..187
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           188..193
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   TURN            197..199
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           202..206
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           207..212
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          217..219
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           224..236
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          240..242
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          247..253
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          256..262
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          265..268
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          270..274
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           278..283
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           293..297
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          303..313
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          320..324
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           329..337
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          348..352
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           353..355
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           358..360
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          366..374
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           382..401
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           405..407
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          409..415
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           417..424
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           427..429
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          431..434
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          438..440
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           441..444
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          451..454
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          456..458
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   STRAND          463..465
FT                   /evidence="ECO:0007829|PDB:4REP"
FT   HELIX           469..487
FT                   /evidence="ECO:0007829|PDB:4REP"
SQ   SEQUENCE   487 AA;  54767 MW;  D71FA01681C84674 CRC64;
     MKNAIVIGAG IGGLAAALRL RHQGYSVTIF EKNDYAGGKL HAIEKDGYRF DLGPSLFTLP
     HLVENLFALF PEEIIDFGYK SKAISFHYFW DDGTLFKAST DSSQFIEDAS KVFKEEKSTI
     KKYLAKSKSK YELTKSLFLE KSLHKATTYF SLDTVKAIVH APFLGLNNTL NDENSKFKNP
     KLTQLFNRYA TYNGSSPYQT PGIMTMIPHL ELGLGTYYPD GGMHRISQSL FELAQKVGVK
     FRFRESVTNI TTSKNKVTGV ETKNGSYLSD LVVSNMDIVP TYRNLMKDVP APEKTLSQER
     SSSALIFYWG IDREFPELDL HNILFSEDYK TEFEHIFEHK TLAQDPTVYI NITSKESSND
     APAGHENWFV MINAPGDYGQ DWEQLVEESK KQIIAKIKKC LHVDISKHIT TEYILTPQGI
     EKNTSSYRGA LYGAASNNKF AAFLRHPNFN GKIKNLYHVG GSVHPGGGIP LCLLSAQITA
     DLIQKEQ
//
ID   CRY1_DROME              Reviewed;         542 AA.
AC   O77059; Q9TYA0;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   02-JUN-2021, entry version 161.
DE   RecName: Full=Cryptochrome-1;
DE            Short=DmCRY1 {ECO:0000312|EMBL:BAA33787.1};
DE            Short=dcry {ECO:0000312|EMBL:BAA35000.1};
DE   AltName: Full=Blue light photoreceptor {ECO:0000312|EMBL:BAA35000.1};
GN   Name=cry {ECO:0000312|EMBL:AAF55649.1, ECO:0000312|FlyBase:FBgn0025680};
GN   ORFNames=CG3772;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAC83828.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=9845369; DOI=10.1016/s0092-8674(00)81637-2;
RA   Emery P., So W.V., Kaneko M., Hall J.C., Rosbash M.;
RT   "CRY, a Drosophila clock and light-regulated cryptochrome, is a major
RT   contributor to circadian rhythm resetting and photosensitivity.";
RL   Cell 95:669-679(1998).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:BAA33787.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, LACK OF PHOTOLYASE ACTIVITY, TISSUE
RP   SPECIFICITY, AND FAD-BINDING.
RC   STRAIN=Berkeley {ECO:0000269|PubMed:10063806};
RC   TISSUE=Head {ECO:0000269|PubMed:10063806};
RX   PubMed=10063806; DOI=10.1562/0031-8655(1999)069<0108:apblrf>2.3.co;2;
RA   Okano S., Kanno S., Takao M., Eker A.P.M., Isono K., Tsukahara Y.,
RA   Yasui A.;
RT   "A putative blue-light receptor from Drosophila melanogaster.";
RL   Photochem. Photobiol. 69:108-113(1999).
RN   [3] {ECO:0000312|EMBL:BAA35000.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Head {ECO:0000312|EMBL:BAA35000.1};
RA   Todo T., Ishikawa T.;
RL   Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000312|EMBL:AAF55649.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley {ECO:0000269|PubMed:10731132};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAF55649.1}
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [6] {ECO:0000312|EMBL:AAK92938.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley {ECO:0000312|EMBL:AAK92938.1};
RC   TISSUE=Head {ECO:0000269|PubMed:12537569};
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M., George R.A.,
RA   Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H., Rubin G.M.,
RA   Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [7] {ECO:0000305}
RP   PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], FUNCTION, MUTAGENESIS OF
RP   ASP-410, AND DISRUPTION PHENOTYPE.
RX   PubMed=9845370; DOI=10.1016/s0092-8674(00)81638-4;
RA   Stanewsky R., Kaneko M., Emery P., Beretta B., Wager-Smith K., Kay S.A.,
RA   Rosbash M., Hall J.C.;
RT   "The cryb mutation identifies cryptochrome as a circadian photoreceptor in
RT   Drosophila.";
RL   Cell 95:681-692(1998).
RN   [8] {ECO:0000305}
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=10233998; DOI=10.1523/jneurosci.19-10-03665.1999;
RA   Egan E.S., Franklin T.M., Hilderbrand-Chae M.J., McNeil G.P., Roberts M.A.,
RA   Schroeder A.J., Zhang X., Jackson F.R.;
RT   "An extraretinally expressed insect cryptochrome with similarity to the
RT   blue light photoreceptors of mammals and plants.";
RL   J. Neurosci. 19:3665-3673(1999).
RN   [9] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH TIM, AND SUBCELLULAR LOCATION.
RX   PubMed=10417378; DOI=10.1126/science.285.5427.553;
RA   Ceriani M.F., Darlington T.K., Staknis D., Mas P., Petti A.A., Weitz C.J.,
RA   Kay S.A.;
RT   "Light-dependent sequestration of TIMELESS by CRYPTOCHROME.";
RL   Science 285:553-556(1999).
RN   [10]
RP   INTERACTION WITH PER.
RX   PubMed=11448767; DOI=10.1016/s0960-9822(01)00259-7;
RA   Rosato E., Codd V., Mazzotta G., Piccin A., Zordan M., Costa R.,
RA   Kyriacou C.P.;
RT   "Light-dependent interaction between Drosophila CRY and the clock protein
RT   PER mediated by the carboxy terminus of CRY.";
RL   Curr. Biol. 11:909-917(2001).
RN   [11] {ECO:0000305}
RP   SUBCELLULAR LOCATION, AND C-TERMINAL DOMAIN.
RX   PubMed=15258584; DOI=10.1038/nn1285;
RA   Dissel S., Codd V., Fedic R., Garner K.J., Costa R., Kyriacou C.P.,
RA   Rosato E.;
RT   "A constitutively active cryptochrome in Drosophila melanogaster.";
RL   Nat. Neurosci. 7:834-840(2004).
RN   [12] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=16527739; DOI=10.1016/j.cub.2006.01.034;
RA   Collins B., Mazzoni E.O., Stanewsky R., Blau J.;
RT   "Drosophila CRYPTOCHROME is a circadian transcriptional repressor.";
RL   Curr. Biol. 16:441-449(2006).
RN   [13] {ECO:0000305}
RP   FUNCTION, AND FAD-BINDING.
RX   PubMed=17298948; DOI=10.1074/jbc.m608872200;
RA   Berndt A., Kottke T., Breitkreuz H., Dvorsky R., Hennig S., Alexander M.,
RA   Wolf E.;
RT   "A novel photoreaction mechanism for the circadian blue light photoreceptor
RT   Drosophila cryptochrome.";
RL   J. Biol. Chem. 282:13011-13021(2007).
RN   [14] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=18641630; DOI=10.1038/nature07183;
RA   Gegear R.J., Casselman A., Waddell S., Reppert S.M.;
RT   "Cryptochrome mediates light-dependent magnetosensitivity in Drosophila.";
RL   Nature 454:1014-1018(2008).
RN   [15] {ECO:0000305}
RP   FUNCTION, AND FAD-BINDING.
RX   PubMed=18597555; DOI=10.1371/journal.pbio.0060160;
RA   Hoang N., Schleicher E., Kacprzak S., Bouly J.-P., Picot M., Wu W.,
RA   Berndt A., Wolf E., Bittl R., Ahmad M.;
RT   "Human and Drosophila cryptochromes are light activated by flavin
RT   photoreduction in living cells.";
RL   PLoS Biol. 6:E160-E160(2008).
RN   [16]
RP   INTERACTION WITH L(1)G0136.
RX   PubMed=26569474; DOI=10.1038/nmat4484;
RA   Qin S., Yin H., Yang C., Dou Y., Liu Z., Zhang P., Yu H., Huang Y.,
RA   Feng J., Hao J., Hao J., Deng L., Yan X., Dong X., Zhao Z., Jiang T.,
RA   Wang H.W., Luo S.J., Xie C.;
RT   "A magnetic protein biocompass.";
RL   Nat. Mater. 15:217-226(2016).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.34 ANGSTROMS) IN COMPLEX WITH FAD, COFACTOR, AND
RP   MUTAGENESIS OF CYS-337; TRP-397; CYS-416; TRP-420; CYS-523 AND SER-526.
RX   PubMed=23746849; DOI=10.1016/j.cell.2013.05.011;
RA   Czarna A., Berndt A., Singh H.R., Grudziecki A., Ladurner A.G.,
RA   Timinszky G., Kramer A., Wolf E.;
RT   "Structures of Drosophila cryptochrome and mouse cryptochrome1 provide
RT   insight into circadian function.";
RL   Cell 153:1394-1405(2013).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-539 IN COMPLEX WITH FAD.
RX   PubMed=23518567; DOI=10.1038/nature11995;
RA   Levy C., Zoltowski B.D., Jones A.R., Vaidya A.T., Top D., Widom J.,
RA   Young M.W., Scrutton N.S., Crane B.R., Leys D.;
RT   "Updated structure of Drosophila cryptochrome.";
RL   Nature 495:E3-E4(2013).
CC   -!- FUNCTION: Blue light-dependent regulator that is the input of the
CC       circadian feedback loop. Has no photolyase activity for cyclobutane
CC       pyrimidine dimers or 6-4 photoproducts. Regulation of expression by
CC       light suggests a role in photoreception for locomotor activity rhythms.
CC       Functions, together with per, as a transcriptional repressor required
CC       for the oscillation of peripheral circadian clocks and for the correct
CC       specification of clock cells. Genes directly activated by the
CC       transcription factors Clock (Clk) and cycle (cyc) are repressed by cry.
CC       Necessary for light-dependent magnetosensitivity, an intact circadian
CC       system is not required for the magnetoreception mechanism to operate.
CC       Required for both the naive and trained responses to magnetic field,
CC       consistent with the notion that cry is in the input pathway of magnetic
CC       sensing. {ECO:0000269|PubMed:10063806, ECO:0000269|PubMed:10233998,
CC       ECO:0000269|PubMed:10417378, ECO:0000269|PubMed:16527739,
CC       ECO:0000269|PubMed:17298948, ECO:0000269|PubMed:18597555,
CC       ECO:0000269|PubMed:18641630, ECO:0000269|PubMed:9845369,
CC       ECO:0000269|PubMed:9845370}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:10063806, ECO:0000269|PubMed:17298948,
CC         ECO:0000269|PubMed:18597555, ECO:0000269|PubMed:23746849};
CC       Note=Binds 1 FAD per subunit. The bound form of FAD in the inactive
CC       state of cry is oxidized FAD, not reduced. After activation by blue
CC       light the FAD is in an anionic radical state, which would be
CC       paramagnetic. Green light, which reduces levels of radical
CC       intermediate, has an antagonistic effect on function.
CC       {ECO:0000269|PubMed:10063806, ECO:0000269|PubMed:17298948,
CC       ECO:0000269|PubMed:18597555, ECO:0000269|PubMed:23746849};
CC   -!- SUBUNIT: Interacts with tim and per; promoted by light conditions
CC       (PubMed:10417378, PubMed:11448767). Interaction with tim irreversibly
CC       commits tim to proteasomal degradation (PubMed:10417378). Interacts
CC       with l(1)G0136/CG8198 (PubMed:26569474). {ECO:0000269|PubMed:10417378,
CC       ECO:0000269|PubMed:11448767, ECO:0000269|PubMed:23518567,
CC       ECO:0000269|PubMed:23746849, ECO:0000269|PubMed:26569474}.
CC   -!- INTERACTION:
CC       O77059; P18431: sgg; NbExp=2; IntAct=EBI-94117, EBI-242141;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10417378,
CC       ECO:0000269|PubMed:15258584}. Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:10417378, ECO:0000269|PubMed:15258584}. Nucleus
CC       {ECO:0000269|PubMed:10417378, ECO:0000269|PubMed:15258584}.
CC       Note=Nuclear translocation initiates after the perception of a light
CC       signal. Accumulates in the perinuclear region about one hour before
CC       translocation into the nucleus. Translocation occurs through
CC       interaction with other Clock proteins such as tim and per.
CC       {ECO:0000269|PubMed:10417378, ECO:0000269|PubMed:15258584}.
CC   -!- TISSUE SPECIFICITY: Expressed at higher levels in the head than in body
CC       and it is more expressed in antennae than in legs, wings and mouth
CC       appendages. Prominent expression is seen in cells of the lateral brain,
CC       which are close to or coincident with the clock neurons. Abundance
CC       oscillates in a circadian manner. {ECO:0000269|PubMed:10063806,
CC       ECO:0000269|PubMed:10233998, ECO:0000269|PubMed:9845369}.
CC   -!- INDUCTION: Expression is regulated by light and circadian rhythms.
CC       Under circadian regulation, expression is influenced by the clock
CC       pacemaker genes period, timeless, Clock and cycle.
CC       {ECO:0000269|PubMed:9845369}.
CC   -!- DOMAIN: FAD-binding region regulates cry stability, cry-tim
CC       interaction, and circadian photosensitivity.
CC       {ECO:0000269|PubMed:15258584}.
CC   -!- DOMAIN: Photolyase/cryptochrome alpha/beta domain is sufficient for
CC       light detection and phototransduction.
CC   -!- DISRUPTION PHENOTYPE: Flies exhibit poor synchronization to light-dark
CC       cycles and show no response to brief light pulses. Mutant abolishes
CC       rhythmic tim and per expression in photoreceptor and glial cells, but
CC       not within certain pacemaker neurons of adult brain.
CC       {ECO:0000269|PubMed:9845370}.
CC   -!- MISCELLANEOUS: Unstable upon light exposure. Light induces the
CC       degradation of cry, likely due to conformational change in the
CC       photoreceptor leading to targeting to the proteasome.
CC   -!- MISCELLANEOUS: Appears to bind 5,10-methenyltetrahydrofolate at
CC       substoichiometric levels. {ECO:0000269|PubMed:17298948}.
CC   -!- SIMILARITY: Belongs to the DNA photolyase class-1 family.
CC       {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF099734; AAC83828.1; -; mRNA.
DR   EMBL; AB018400; BAA33787.1; -; mRNA.
DR   EMBL; AB019389; BAA35000.1; -; mRNA.
DR   EMBL; AE014297; AAF55649.1; -; Genomic_DNA.
DR   EMBL; AY051514; AAK92938.1; -; mRNA.
DR   RefSeq; NP_732407.1; NM_169852.2.
DR   PDB; 4GU5; X-ray; 2.30 A; A/B=1-539.
DR   PDB; 4JZY; X-ray; 2.34 A; A/B=1-540.
DR   PDB; 4K03; X-ray; 3.20 A; A/B=1-542.
DR   PDBsum; 4GU5; -.
DR   PDBsum; 4JZY; -.
DR   PDBsum; 4K03; -.
DR   SMR; O77059; -.
DR   BioGRID; 67302; 28.
DR   DIP; DIP-29424N; -.
DR   IntAct; O77059; 1.
DR   STRING; 7227.FBpp0083150; -.
DR   PaxDb; O77059; -.
DR   PRIDE; O77059; -.
DR   DNASU; 42305; -.
DR   EnsemblMetazoa; FBtr0083736; FBpp0083150; FBgn0025680.
DR   GeneID; 42305; -.
DR   KEGG; dme:Dmel_CG3772; -.
DR   UCSC; CG3772-RA; d. melanogaster.
DR   CTD; 42305; -.
DR   FlyBase; FBgn0025680; cry.
DR   eggNOG; KOG0133; Eukaryota.
DR   HOGENOM; CLU_010348_3_4_1; -.
DR   InParanoid; O77059; -.
DR   OMA; IWFRHGL; -.
DR   OrthoDB; 378952at2759; -.
DR   PhylomeDB; O77059; -.
DR   Reactome; R-DME-432395; Degradation of TIM.
DR   Reactome; R-DME-432553; Phosphorylation of PER and TIM.
DR   Reactome; R-DME-538864; Degradation of CRY.
DR   BioGRID-ORCS; 42305; 0 hits in 3 CRISPR screens.
DR   ChiTaRS; cry; fly.
DR   GenomeRNAi; 42305; -.
DR   PRO; PR:O77059; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0025680; Expressed in adult Malpighian tubule (Drosophila) and 39 other tissues.
DR   Genevisible; O77059; DM.
DR   GO; GO:0005737; C:cytoplasm; IDA:FlyBase.
DR   GO; GO:0005829; C:cytosol; IDA:FlyBase.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:FlyBase.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0009882; F:blue light photoreceptor activity; IMP:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0008020; F:G protein-coupled photoreceptor activity; ISS:FlyBase.
DR   GO; GO:0009881; F:photoreceptor activity; IDA:FlyBase.
DR   GO; GO:0009785; P:blue light signaling pathway; IMP:FlyBase.
DR   GO; GO:0071482; P:cellular response to light stimulus; IMP:FlyBase.
DR   GO; GO:0048512; P:circadian behavior; IMP:FlyBase.
DR   GO; GO:0032922; P:circadian regulation of gene expression; IMP:FlyBase.
DR   GO; GO:0007623; P:circadian rhythm; IMP:FlyBase.
DR   GO; GO:0050980; P:detection of light stimulus involved in magnetoreception; IMP:UniProtKB.
DR   GO; GO:0009649; P:entrainment of circadian clock; IDA:FlyBase.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; IMP:FlyBase.
DR   GO; GO:0042332; P:gravitaxis; IMP:FlyBase.
DR   GO; GO:0045475; P:locomotor rhythm; IMP:FlyBase.
DR   GO; GO:0050958; P:magnetoreception; IMP:FlyBase.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0007602; P:phototransduction; IMP:FlyBase.
DR   GO; GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IDA:FlyBase.
DR   GO; GO:0045187; P:regulation of circadian sleep/wake cycle, sleep; IMP:FlyBase.
DR   GO; GO:0009637; P:response to blue light; IMP:FlyBase.
DR   GO; GO:0009416; P:response to light stimulus; IMP:FlyBase.
DR   GO; GO:0071000; P:response to magnetism; IMP:FlyBase.
DR   GO; GO:0009588; P:UV-A, blue light phototransduction; ISS:FlyBase.
DR   Gene3D; 3.40.50.620; -; 1.
DR   IDEAL; IID50267; -.
DR   InterPro; IPR036134; Crypto/Photolyase_FAD-like_sf.
DR   InterPro; IPR036155; Crypto/Photolyase_N_sf.
DR   InterPro; IPR005101; Cryptochr/Photolyase_FAD-bd.
DR   InterPro; IPR002081; Cryptochrome/DNA_photolyase_1.
DR   InterPro; IPR006050; DNA_photolyase_N.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00875; DNA_photolyase; 1.
DR   Pfam; PF03441; FAD_binding_7; 1.
DR   PRINTS; PR00147; DNAPHOTLYASE.
DR   SUPFAM; SSF48173; SSF48173; 1.
DR   SUPFAM; SSF52425; SSF52425; 1.
DR   PROSITE; PS51645; PHR_CRY_ALPHA_BETA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Biological rhythms; Chromophore; Cytoplasm; FAD;
KW   Flavoprotein; Nucleotide-binding; Nucleus; Photoreceptor protein; Receptor;
KW   Reference proteome; Repressor; Sensory transduction; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..542
FT                   /note="Cryptochrome-1"
FT                   /id="PRO_0000348597"
FT   DOMAIN          5..140
FT                   /note="Photolyase/cryptochrome alpha/beta"
FT   NP_BIND         410..412
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23518567,
FT                   ECO:0000269|PubMed:23746849"
FT   BINDING         237
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23518567,
FT                   ECO:0000269|PubMed:23746849"
FT   BINDING         265
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23518567,
FT                   ECO:0000269|PubMed:23746849"
FT   BINDING         267
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000250"
FT   BINDING         311
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23518567,
FT                   ECO:0000269|PubMed:23746849"
FT   BINDING         378
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23518567,
FT                   ECO:0000269|PubMed:23746849"
FT   BINDING         416
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23518567,
FT                   ECO:0000269|PubMed:23746849"
FT   BINDING         419
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23518567,
FT                   ECO:0000269|PubMed:23746849"
FT   MUTAGEN         337
FT                   /note="C->A: Accelerates formation and decay of the FAD
FT                   radical."
FT                   /evidence="ECO:0000269|PubMed:23746849"
FT   MUTAGEN         397
FT                   /note="W->F: Abolishes formation of the FAD radical."
FT                   /evidence="ECO:0000269|PubMed:23746849"
FT   MUTAGEN         410
FT                   /note="D->N: In cryb: Loss of accumulation."
FT                   /evidence="ECO:0000269|PubMed:9845370"
FT   MUTAGEN         416
FT                   /note="C->A: Accelerates decay of the FAD radical."
FT                   /evidence="ECO:0000269|PubMed:23746849"
FT   MUTAGEN         420
FT                   /note="W->A: Abolishes formation of the FAD radical."
FT                   /evidence="ECO:0000269|PubMed:23746849"
FT   MUTAGEN         523
FT                   /note="C->A: Accelerates formation and decay of the FAD
FT                   radical."
FT                   /evidence="ECO:0000269|PubMed:23746849"
FT   MUTAGEN         526
FT                   /note="S->A: Slows down the decay of the FAD radical."
FT                   /evidence="ECO:0000269|PubMed:23746849"
FT   CONFLICT        232
FT                   /note="L -> H (in Ref. 3; BAA35000)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        335
FT                   /note="D -> E (in Ref. 3; BAA35000)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        348
FT                   /note="N -> D (in Ref. 3; BAA35000)"
FT                   /evidence="ECO:0000305"
FT   STRAND          6..13
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   STRAND          17..19
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           21..27
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           30..32
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   STRAND          35..42
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   TURN            46..48
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           54..74
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   TURN            75..77
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   STRAND          82..86
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           88..98
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   STRAND          101..107
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           112..114
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           115..128
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   STRAND          131..135
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   STRAND          138..141
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           143..149
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   TURN            150..152
FT                   /evidence="ECO:0007829|PDB:4JZY"
FT   HELIX           158..168
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           190..195
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           205..208
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   STRAND          212..214
FT                   /evidence="ECO:0007829|PDB:4JZY"
FT   HELIX           227..247
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   TURN            252..254
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           267..271
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           277..288
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   STRAND          296..301
FT                   /evidence="ECO:0007829|PDB:4K03"
FT   HELIX           303..305
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           306..322
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   TURN            326..329
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           347..354
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           361..373
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           378..388
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   TURN            389..393
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           397..407
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           413..425
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           430..433
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           435..438
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           440..447
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           452..457
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           459..461
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   STRAND          462..464
FT                   /evidence="ECO:0007829|PDB:4K03"
FT   HELIX           466..469
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           472..474
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           477..482
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   TURN            487..489
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           498..516
FT                   /evidence="ECO:0007829|PDB:4GU5"
FT   HELIX           528..535
FT                   /evidence="ECO:0007829|PDB:4GU5"
SQ   SEQUENCE   542 AA;  62513 MW;  AB0019E5447BF56E CRC64;
     MATRGANVIW FRHGLRLHDN PALLAALADK DQGIALIPVF IFDGESAGTK NVGYNRMRFL
     LDSLQDIDDQ LQAATDGRGR LLVFEGEPAY IFRRLHEQVR LHRICIEQDC EPIWNERDES
     IRSLCRELNI DFVEKVSHTL WDPQLVIETN GGIPPLTYQM FLHTVQIIGL PPRPTADARL
     EDATFVELDP EFCRSLKLFE QLPTPEHFNV YGDNMGFLAK INWRGGETQA LLLLDERLKV
     EQHAFERGFY LPNQALPNIH DSPKSMSAHL RFGCLSVRRF YWSVHDLFKN VQLRACVRGV
     QMTGGAHITG QLIWREYFYT MSVNNPNYDR MEGNDICLSI PWAKPNENLL QSWRLGQTGF
     PLIDGAMRQL LAEGWLHHTL RNTVATFLTR GGLWQSWEHG LQHFLKYLLD ADWSVCAGNW
     MWVSSSAFER LLDSSLVTCP VALAKRLDPD GTYIKQYVPE LMNVPKEFVH EPWRMSAEQQ
     EQYECLIGVH YPERIIDLSM AVKRNMLAMK SLRNSLITPP PHCRPSNEEE VRQFFWLADV
     VV
//
ID   ADRO_BOVIN              Reviewed;         492 AA.
AC   P08165; Q58CY0; Q95KN8;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 3.
DT   02-JUN-2021, entry version 179.
DE   RecName: Full=NADPH:adrenodoxin oxidoreductase, mitochondrial;
DE            Short=AR;
DE            Short=Adrenodoxin reductase;
DE            EC=1.18.1.6 {ECO:0000269|PubMed:7811729};
DE   AltName: Full=Ferredoxin--NADP(+) reductase;
DE            Short=Ferredoxin reductase;
DE   Flags: Precursor;
GN   Name=FDXR; Synonyms=ADXR;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=3448086; DOI=10.1093/oxfordjournals.jbchem.a122178;
RA   Sagara Y., Takata Y., Miyata T., Hara T., Horiuchi T.;
RT   "Cloning and sequence analysis of adrenodoxin reductase cDNA from bovine
RT   adrenal cortex.";
RL   J. Biochem. 102:1333-1336(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3038094; DOI=10.1016/0006-291x(87)91570-1;
RA   Nonaka Y., Murakami H., Yabusaki Y., Kuramitsu S., Kagamiyama H.,
RA   Yamano T., Okamoto M.;
RT   "Molecular cloning and sequence analysis of full-length cDNA for mRNA of
RT   adrenodoxin oxidoreductase from bovine adrenal cortex.";
RL   Biochem. Biophys. Res. Commun. 145:1239-1247(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Adrenal cortex;
RX   PubMed=2924777; DOI=10.1111/j.1432-1033.1989.tb14671.x;
RA   Hanukoglu I., Gutfinger T.;
RT   "cDNA sequence of adrenodoxin reductase. Identification of NADP-binding
RT   sites in oxidoreductases.";
RL   Eur. J. Biochem. 180:479-484(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RX   PubMed=8130767; DOI=10.1248/bpb.16.1200;
RA   Takata Y., Sagara Y., Kono A., Sekimizu K., Horiuchi T.;
RT   "Gene structure of bovine adrenodoxin reductase.";
RL   Biol. Pharm. Bull. 16:1200-1206(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=16305752; DOI=10.1186/1471-2164-6-166;
RA   Harhay G.P., Sonstegard T.S., Keele J.W., Heaton M.P., Clawson M.L.,
RA   Snelling W.M., Wiedmann R.T., Van Tassell C.P., Smith T.P.L.;
RT   "Characterization of 954 bovine full-CDS cDNA sequences.";
RL   BMC Genomics 6:166-166(2005).
RN   [6]
RP   PROTEIN SEQUENCE OF 33-62; 254-276 AND 487-492.
RX   PubMed=3355838; DOI=10.1016/0167-4838(88)90026-x;
RA   Hamamoto I., Kurokohchi K., Tanaka S., Ichikawa Y.;
RT   "Adrenoferredoxin-binding peptide of NADPH-adrenoferredoxin reductase.";
RL   Biochim. Biophys. Acta 953:207-213(1988).
RN   [7]
RP   PROTEIN SEQUENCE OF 33-51 AND 298-320, FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=7811729; DOI=10.1016/0167-4838(94)00178-j;
RA   Warburton R.J., Seybert D.W.;
RT   "Structural and functional characterization of bovine adrenodoxin reductase
RT   by limited proteolysis.";
RL   Biochim. Biophys. Acta 1246:39-46(1995).
RN   [8]
RP   PROTEIN SEQUENCE OF N-TERMINUS, AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Adrenal cortex;
RX   PubMed=3691502; DOI=10.1111/j.1432-1033.1987.tb13632.x;
RA   Hanukoglu I., Gutfinger T., Haniu M., Shively J.E.;
RT   "Isolation of a cDNA for adrenodoxin reductase (ferredoxin-NADP+
RT   reductase). Implications for mitochondrial cytochrome P-450 systems.";
RL   Eur. J. Biochem. 169:449-455(1987).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=3011431; DOI=10.1111/j.1432-1033.1986.tb09633.x;
RA   Hanukoglu I., Hanukoglu Z.;
RT   "Stoichiometry of mitochondrial cytochromes P-450, adrenodoxin and
RT   adrenodoxin reductase in adrenal cortex and corpus luteum. Implications for
RT   membrane organization and gene regulation.";
RL   Eur. J. Biochem. 157:27-31(1986).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 33-492 IN COMPLEX WITH FAD.
RX   PubMed=10369776; DOI=10.1006/jmbi.1999.2807;
RA   Ziegler G.A., Vonrhein C., Hanukoglu I., Schulz G.E.;
RT   "The structure of adrenodoxin reductase of mitochondrial P450 systems:
RT   electron transfer for steroid biosynthesis.";
RL   J. Mol. Biol. 289:981-990(1999).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 33-492 IN COMPLEX WITH NADP.
RX   PubMed=10998235; DOI=10.1021/bi000079k;
RA   Ziegler G.A., Schulz G.E.;
RT   "Crystal structures of adrenodoxin reductase in complex with NADP+ and
RT   NADPH suggesting a mechanism for the electron transfer of an enzyme
RT   family.";
RL   Biochemistry 39:10986-10995(2000).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 33-492 IN COMPLEX WITH FDX1.
RX   PubMed=11053423; DOI=10.1074/jbc.m008501200;
RA   Mueller J.J., Lapko A., Bourenkov G., Ruckpaul K., Heinemann U.;
RT   "Adrenodoxin reductase-adrenodoxin complex structure suggests electron
RT   transfer path in steroid biosynthesis.";
RL   J. Biol. Chem. 276:2786-2789(2001).
CC   -!- FUNCTION: Serves as the first electron transfer protein in all the
CC       mitochondrial P450 systems including cholesterol side chain cleavage in
CC       all steroidogenic tissues, steroid 11-beta hydroxylation in the adrenal
CC       cortex, 25-OH-vitamin D3-24 hydroxylation in the kidney, and sterol C-
CC       27 hydroxylation in the liver. {ECO:0000269|PubMed:7811729}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADP(+) + 2 reduced [adrenodoxin] = NADPH + 2 oxidized
CC         [adrenodoxin]; Xref=Rhea:RHEA:42312, Rhea:RHEA-COMP:9998, Rhea:RHEA-
CC         COMP:9999, ChEBI:CHEBI:15378, ChEBI:CHEBI:33737, ChEBI:CHEBI:33738,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.18.1.6;
CC         Evidence={ECO:0000269|PubMed:7811729};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:10369776};
CC   -!- PATHWAY: Steroid metabolism; cholesterol metabolism.
CC       {ECO:0000269|PubMed:7811729}.
CC   -!- SUBUNIT: Monomer. Interacts directly with FDX1.
CC       {ECO:0000269|PubMed:10369776, ECO:0000269|PubMed:10998235,
CC       ECO:0000269|PubMed:11053423}.
CC   -!- INTERACTION:
CC       P08165; P00257: FDX1; NbExp=2; IntAct=EBI-593948, EBI-593992;
CC       P08165; P0A3E0: isiB; Xeno; NbExp=3; IntAct=EBI-593948, EBI-593907;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000250|UniProtKB:P48360}; Peripheral membrane protein
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Short;
CC         IsoId=P08165-1; Sequence=Displayed;
CC       Name=Long;
CC         IsoId=P08165-2; Sequence=VSP_003415;
CC   -!- TISSUE SPECIFICITY: Detected in adrenal cortex and corpus luteum (at
CC       protein level). {ECO:0000269|PubMed:3011431}.
CC   -!- MISCELLANEOUS: [Isoform Long]: Represents 10-20% of all adrenodoxin
CC       reductase mRNAs and seems to be inactive. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the ferredoxin--NADP reductase type 1 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M17029; AAA30362.1; -; mRNA.
DR   EMBL; D00211; BAA00150.1; -; mRNA.
DR   EMBL; X13736; CAA32002.1; -; mRNA.
DR   EMBL; D83475; BAA11921.1; -; Genomic_DNA.
DR   EMBL; BT021817; AAX46664.1; -; mRNA.
DR   PIR; JT0751; JT0751.
DR   RefSeq; NP_777116.1; NM_174691.1.
DR   PDB; 1CJC; X-ray; 1.70 A; A=33-492.
DR   PDB; 1E1K; X-ray; 1.95 A; A=33-492.
DR   PDB; 1E1L; X-ray; 2.30 A; A=33-492.
DR   PDB; 1E1M; X-ray; 1.85 A; A=33-492.
DR   PDB; 1E1N; X-ray; 2.40 A; A=33-492.
DR   PDB; 1E6E; X-ray; 2.30 A; A/C=33-492.
DR   PDBsum; 1CJC; -.
DR   PDBsum; 1E1K; -.
DR   PDBsum; 1E1L; -.
DR   PDBsum; 1E1M; -.
DR   PDBsum; 1E1N; -.
DR   PDBsum; 1E6E; -.
DR   SMR; P08165; -.
DR   IntAct; P08165; 2.
DR   STRING; 9913.ENSBTAP00000056258; -.
DR   PaxDb; P08165; -.
DR   GeneID; 282604; -.
DR   KEGG; bta:282604; -.
DR   CTD; 2232; -.
DR   eggNOG; KOG1800; Eukaryota.
DR   InParanoid; P08165; -.
DR   OrthoDB; 1324510at2759; -.
DR   BRENDA; 1.18.1.6; 908.
DR   SABIO-RK; P08165; -.
DR   UniPathway; UPA00296; -.
DR   EvolutionaryTrace; P08165; -.
DR   Proteomes; UP000009136; Unplaced.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0050661; F:NADP binding; IDA:UniProtKB.
DR   GO; GO:0015039; F:NADPH-adrenodoxin reductase activity; IDA:UniProtKB.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0022900; P:electron transport chain; IDA:UniProtKB.
DR   GO; GO:0006694; P:steroid biosynthetic process; TAS:UniProtKB.
DR   GO; GO:0006744; P:ubiquinone biosynthetic process; IBA:GO_Central.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR021163; Ferredox_Rdtase_adrenod.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   PIRSF; PIRSF000362; FNR; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cholesterol metabolism;
KW   Direct protein sequencing; Electron transport; FAD; Flavoprotein;
KW   Lipid metabolism; Membrane; Mitochondrion; Mitochondrion inner membrane;
KW   NADP; Oxidoreductase; Phosphoprotein; Reference proteome;
KW   Steroid metabolism; Sterol metabolism; Transit peptide; Transport.
FT   TRANSIT         1..32
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:3355838,
FT                   ECO:0000269|PubMed:3691502, ECO:0000269|PubMed:7811729"
FT   CHAIN           33..492
FT                   /note="NADPH:adrenodoxin oxidoreductase, mitochondrial"
FT                   /id="PRO_0000019419"
FT   NP_BIND         185..188
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:10998235"
FT   NP_BIND         229..230
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:10998235"
FT   NP_BIND         406..408
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10369776"
FT   BINDING         49
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:10369776"
FT   BINDING         70
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10369776"
FT   BINDING         78
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:10369776"
FT   BINDING         114
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:10369776"
FT   BINDING         241
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:10998235"
FT   BINDING         399
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:10369776"
FT   BINDING         406
FT                   /note="NADP; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:10998235"
FT   MOD_RES         311
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P22570"
FT   MOD_RES         318
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P22570"
FT   VAR_SEQ         204
FT                   /note="E -> EVLLLCQ (in isoform Long)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_003415"
FT   CONFLICT        42
FT                   /note="C -> S (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        77
FT                   /note="G -> R (in Ref. 2; AAA30362)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        81..94
FT                   /note="FGVAPDHPEVKNVI -> VWLALTTPRSRMLL (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        124..128
FT                   /note="QDAYH -> RVYRLT (in Ref. 2; AAA30362)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        268
FT                   /note="K -> R (in Ref. 2; AAA30362)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        317..318
FT                   /note="PS -> RL (in Ref. 2; AAA30362)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        323..333
FT                   /note="RAAGIRLAVTR -> ARRSAWQSPE (in Ref. 2; AAA30362)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        341..352
FT                   /note="TRAVPTGDVEDL -> HPGSAHWGCGGP (in Ref. 2; AAA30362)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        488..489
FT                   /note="RL -> TM (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        491
FT                   /note="G -> R (in Ref. 5; AAX46664)"
FT                   /evidence="ECO:0000305"
FT   STRAND          40..44
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           48..60
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   STRAND          65..69
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   STRAND          71..75
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           78..81
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           88..92
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           93..101
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   STRAND          106..111
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   TURN            114..116
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           120..126
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   STRAND          127..132
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   TURN            145..148
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   STRAND          152..154
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           155..162
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           166..168
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   STRAND          177..184
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           187..197
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           200..203
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           210..217
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   STRAND          223..227
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           232..234
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           239..246
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   STRAND          251..254
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           257..260
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           263..266
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   TURN            267..269
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           272..286
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           291..298
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   STRAND          301..307
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   STRAND          309..317
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   STRAND          321..337
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           338..340
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   STRAND          342..353
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   STRAND          355..359
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   TURN            376..379
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   STRAND          394..396
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           399..402
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           408..428
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           439..449
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           456..473
FT                   /evidence="ECO:0007829|PDB:1CJC"
FT   HELIX           483..489
FT                   /evidence="ECO:0007829|PDB:1CJC"
SQ   SEQUENCE   492 AA;  54338 MW;  E68F6F5D18F53131 CRC64;
     MAPRCWRWWP WSSWTRTRLP PSRSIQNFGQ HFSTQEQTPQ ICVVGSGPAG FYTAQHLLKH
     HSRAHVDIYE KQLVPFGLVR FGVAPDHPEV KNVINTFTQT ARSDRCAFYG NVEVGRDVTV
     QELQDAYHAV VLSYGAEDHQ ALDIPGEELP GVFSARAFVG WYNGLPENRE LAPDLSCDTA
     VILGQGNVAL DVARILLTPP DHLEKTDITE AALGALRQSR VKTVWIVGRR GPLQVAFTIK
     ELREMIQLPG TRPMLDPADF LGLQDRIKEA ARPRKRLMEL LLRTATEKPG VEEAARRASA
     SRAWGLRFFR SPQQVLPSPD GRRAAGIRLA VTRLEGIGEA TRAVPTGDVE DLPCGLVLSS
     IGYKSRPIDP SVPFDPKLGV VPNMEGRVVD VPGLYCSGWV KRGPTGVITT TMTDSFLTGQ
     ILLQDLKAGH LPSGPRPGSA FIKALLDSRG VWPVSFSDWE KLDAEEVSRG QASGKPREKL
     LDPQEMLRLL GH
//
ID   APBE_TREPA              Reviewed;         362 AA.
AC   O83774;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   02-JUN-2021, entry version 109.
DE   RecName: Full=FAD:protein FMN transferase {ECO:0000250|UniProtKB:A5F5Y3};
DE            EC=2.7.1.180 {ECO:0000250|UniProtKB:A5F5Y3};
DE   AltName: Full=Flavin transferase {ECO:0000250|UniProtKB:A5F5Y3};
DE   Flags: Precursor;
GN   Name=apbE; OrderedLocusNames=TP_0796;
OS   Treponema pallidum (strain Nichols).
OC   Bacteria; Spirochaetes; Spirochaetales; Spirochaetaceae; Treponema.
OX   NCBI_TaxID=243276;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Nichols;
RX   PubMed=9665876; DOI=10.1126/science.281.5375.375;
RA   Fraser C.M., Norris S.J., Weinstock G.M., White O., Sutton G.G.,
RA   Dodson R.J., Gwinn M.L., Hickey E.K., Clayton R.A., Ketchum K.A.,
RA   Sodergren E., Hardham J.M., McLeod M.P., Salzberg S.L., Peterson J.D.,
RA   Khalak H.G., Richardson D.L., Howell J.K., Chidambaram M., Utterback T.R.,
RA   McDonald L.A., Artiach P., Bowman C., Cotton M.D., Fujii C., Garland S.A.,
RA   Hatch B., Horst K., Roberts K.M., Sandusky M., Weidman J.F., Smith H.O.,
RA   Venter J.C.;
RT   "Complete genome sequence of Treponema pallidum, the syphilis spirochete.";
RL   Science 281:375-388(1998).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (1.43 ANGSTROMS) OF 23-362 IN COMPLEXES WITH ADP;
RP   AMP; FAD AND MAGNESIUM, FUNCTION, COFACTOR, AND SUBUNIT.
RX   PubMed=23447540; DOI=10.1074/jbc.m113.449975;
RA   Deka R.K., Brautigam C.A., Liu W.Z., Tomchick D.R., Norgard M.V.;
RT   "The TP0796 lipoprotein of Treponema pallidum is a bimetal-dependent FAD
RT   pyrophosphatase with a potential role in flavin homeostasis.";
RL   J. Biol. Chem. 288:11106-11121(2013).
CC   -!- FUNCTION: Flavin transferase that catalyzes the transfer of the FMN
CC       moiety of FAD and its covalent binding to the hydroxyl group of a
CC       threonine residue in a target flavoprotein (By similarity). Displays
CC       FAD pyrophosphatase activity in vitro, hydrolyzing FAD into FMN and AMP
CC       (PubMed:23447540). {ECO:0000250|UniProtKB:A5F5Y3,
CC       ECO:0000269|PubMed:23447540}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=FAD + L-threonyl-[protein] = AMP + FMN-L-threonyl-[protein] +
CC         H(+); Xref=Rhea:RHEA:36847, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11061, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:74257, ChEBI:CHEBI:456215; EC=2.7.1.180;
CC         Evidence={ECO:0000250|UniProtKB:A5F5Y3};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:23447540};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:23447540};
CC       Note=Magnesium. Can also use manganese. {ECO:0000269|PubMed:23447540};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:23447540}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane
CC       {ECO:0000250|UniProtKB:P41780, ECO:0000255|PROSITE-ProRule:PRU00303};
CC       Lipid-anchor {ECO:0000250|UniProtKB:P41780, ECO:0000255|PROSITE-
CC       ProRule:PRU00303}; Periplasmic side {ECO:0000250|UniProtKB:P41780}.
CC   -!- SIMILARITY: Belongs to the ApbE family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE000520; AAC65759.1; -; Genomic_DNA.
DR   PIR; C71281; C71281.
DR   RefSeq; WP_010882241.1; NC_000919.1.
DR   PDB; 4IFU; X-ray; 1.83 A; A=23-362.
DR   PDB; 4IFW; X-ray; 2.30 A; A=23-362.
DR   PDB; 4IFX; X-ray; 1.45 A; A=23-362.
DR   PDB; 4IFZ; X-ray; 1.90 A; A=23-362.
DR   PDB; 4IG1; X-ray; 1.43 A; A=23-362.
DR   PDB; 4XDR; X-ray; 1.40 A; A=23-362.
DR   PDB; 4XDT; X-ray; 1.45 A; A=23-362.
DR   PDB; 4XDU; X-ray; 1.35 A; A=23-362.
DR   PDBsum; 4IFU; -.
DR   PDBsum; 4IFW; -.
DR   PDBsum; 4IFX; -.
DR   PDBsum; 4IFZ; -.
DR   PDBsum; 4IG1; -.
DR   PDBsum; 4XDR; -.
DR   PDBsum; 4XDT; -.
DR   PDBsum; 4XDU; -.
DR   SMR; O83774; -.
DR   STRING; 243276.TPANIC_0796; -.
DR   EnsemblBacteria; AAC65759; AAC65759; TP_0796.
DR   KEGG; tpa:TP_0796; -.
DR   eggNOG; COG1477; Bacteria.
DR   HOGENOM; CLU_044403_1_0_12; -.
DR   OMA; MGTFWRV; -.
DR   BRENDA; 2.7.1.180; 6429.
DR   BRENDA; 3.6.1.18; 6429.
DR   Proteomes; UP000000811; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016740; F:transferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0017013; P:protein flavinylation; IEA:InterPro.
DR   Gene3D; 3.10.520.20; -; 1.
DR   InterPro; IPR024932; ApbE.
DR   InterPro; IPR003374; ApbE-like_sf.
DR   InterPro; IPR042159; Ftp_ApbE.
DR   PANTHER; PTHR30040; PTHR30040; 1.
DR   Pfam; PF02424; ApbE; 1.
DR   PIRSF; PIRSF006268; ApbE; 1.
DR   SUPFAM; SSF143631; SSF143631; 1.
DR   PROSITE; PS51257; PROKAR_LIPOPROTEIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell inner membrane; Cell membrane; FAD; Flavoprotein;
KW   Lipoprotein; Magnesium; Membrane; Metal-binding; Palmitate;
KW   Reference proteome; Signal; Transferase.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00303"
FT   CHAIN           23..362
FT                   /note="FAD:protein FMN transferase"
FT                   /id="PRO_0000001751"
FT   NP_BIND         118..120
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23447540"
FT   NP_BIND         278..280
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23447540"
FT   METAL           184
FT                   /note="Magnesium; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:23447540"
FT   METAL           306
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000269|PubMed:23447540"
FT   METAL           310
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000269|PubMed:23447540"
FT   BINDING         181
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23447540"
FT   BINDING         187
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23447540"
FT   LIPID           23
FT                   /note="N-palmitoyl cysteine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00303"
FT   LIPID           23
FT                   /note="S-diacylglycerol cysteine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00303"
FT   STRAND          30..38
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          41..49
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   HELIX           53..74
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          79..81
FT                   /evidence="ECO:0007829|PDB:4XDR"
FT   HELIX           82..88
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   TURN            89..91
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          95..97
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   HELIX           99..114
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   TURN            115..117
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   HELIX           124..136
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   HELIX           142..149
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   HELIX           154..156
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          157..161
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          169..173
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   TURN            183..185
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   HELIX           186..200
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          206..210
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          213..218
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          234..239
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          245..263
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          266..271
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          274..278
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   TURN            282..284
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          285..287
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          293..300
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   HELIX           302..315
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   HELIX           317..324
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          331..335
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          339..343
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   TURN            345..347
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   HELIX           348..350
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          351..355
FT                   /evidence="ECO:0007829|PDB:4XDU"
FT   STRAND          358..360
FT                   /evidence="ECO:0007829|PDB:4XDU"
SQ   SEQUENCE   362 AA;  39064 MW;  E64E2FAFD1A7041C CRC64;
     MKSSCVYWRI GVLVCILCGV GSCGGRARVR EYSRAELVIG TLCRVRVYSK RPAAEVHAAL
     EEVFTLLQQQ EMVLSANRDD SALAALNAQA GSAPVVVDRS LYALLERALF FAEKSGGAFN
     PALGAXVKLW NIGFDRAAVP DPDALKEALT RCDFRQVHLR AGVSVGAPHT VQLAQAGMQL
     DLGAIAKGFL ADKIVQLLTA HALDSALVDL GGNIFALGLK YGDVRSAAAQ RLEWNVGIRD
     PHGTGQKPAL VVSVRDCSVV TSGAYERFFE RDGVRYHHII DPVTGFPAHT DVDSVSIFAP
     RSTDADALAT ACFVLGYEKS CALLREFPGV DALFIFPDKR VRASAGIVDR VRVLDARFVL
     ER
//
ID   DPYD_PIG                Reviewed;        1025 AA.
AC   Q28943;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   02-JUN-2021, entry version 143.
DE   RecName: Full=Dihydropyrimidine dehydrogenase [NADP(+)];
DE            Short=DHPDHase;
DE            Short=DPD;
DE            EC=1.3.1.2;
DE   AltName: Full=Dihydrothymine dehydrogenase;
DE   AltName: Full=Dihydrouracil dehydrogenase;
DE   Flags: Precursor;
GN   Name=DPYD;
OS   Sus scrofa (Pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae; Sus.
OX   NCBI_TaxID=9823;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=8083224;
RA   Yokota H., Fernandez-Salguero P., Furuya H., Lin K., McBride O.W.,
RA   Podschun B., Schnackerz K.D., Gonzalez F.J.;
RT   "cDNA cloning and chromosome mapping of human dihydropyrimidine
RT   dehydrogenase, an enzyme associated with 5-fluorouracil toxicity and
RT   congenital thymine uraciluria.";
RL   J. Biol. Chem. 269:23192-23196(1994).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, COFACTOR, AND MUTAGENESIS OF
RP   CYS-671.
RX   PubMed=9860876; DOI=10.1021/bi9815997;
RA   Rosenbaum K., Jahnke K., Curti B., Hagen W.R., Schnackerz K.D.,
RA   Vanoni M.A.;
RT   "Porcine recombinant dihydropyrimidine dehydrogenase: comparison of the
RT   spectroscopic and catalytic properties of the wild-type and C671A mutant
RT   enzymes.";
RL   Biochemistry 37:17598-17609(1998).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND MUTAGENESIS OF CYS-126;
RP   GLN-156; ARG-235 AND SER-670.
RX   PubMed=20831907; DOI=10.1016/j.bbapap.2010.08.014;
RA   Lohkamp B., Voevodskaya N., Lindqvist Y., Dobritzsch D.;
RT   "Insights into the mechanism of dihydropyrimidine dehydrogenase from site-
RT   directed mutagenesis targeting the active site loop and redox cofactor
RT   coordination.";
RL   Biochim. Biophys. Acta 1804:2198-2206(2010).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEXES WITH 5-FLUOROURACIL;
RP   FAD; FMN; 4FE-4S IRON-SULFUR CLUSTER AND NADP, FUNCTION, SUBUNIT, AND
RP   COFACTOR.
RX   PubMed=11179210; DOI=10.1093/emboj/20.4.650;
RA   Dobritzsch D., Schneider G., Schnackerz K.D., Lindqvist Y.;
RT   "Crystal structure of dihydropyrimidine dehydrogenase, a major determinant
RT   of the pharmacokinetics of the anti-cancer drug 5-fluorouracil.";
RL   EMBO J. 20:650-660(2001).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) IN COMPLEX WITH 5-IODOURACIL; FAD;
RP   FMN; 4FE-4S IRON-SULFUR CLUSTER AND NADP, COFACTOR, AND ACTIVE SITE.
RX   PubMed=11796730; DOI=10.1074/jbc.m111877200;
RA   Dobritzsch D., Ricagno S., Schneider G., Schnackerz K.D., Lindqvist Y.;
RT   "Crystal structure of the productive ternary complex of dihydropyrimidine
RT   dehydrogenase with NADPH and 5-iodouracil. Implications for mechanism of
RT   inhibition and electron transfer.";
RL   J. Biol. Chem. 277:13155-13166(2002).
CC   -!- FUNCTION: Involved in pyrimidine base degradation. Catalyzes the
CC       reduction of uracil and thymine. {ECO:0000269|PubMed:11179210,
CC       ECO:0000269|PubMed:20831907, ECO:0000269|PubMed:9860876}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5,6-dihydrouracil + NADP(+) = H(+) + NADPH + uracil;
CC         Xref=Rhea:RHEA:18093, ChEBI:CHEBI:15378, ChEBI:CHEBI:15901,
CC         ChEBI:CHEBI:17568, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.3.1.2;
CC         Evidence={ECO:0000269|PubMed:20831907, ECO:0000269|PubMed:9860876};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC       Note=Binds 4 [4Fe-4S] clusters. Contains approximately 16 iron atoms
CC       per subunit.;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC   -!- PATHWAY: Amino-acid biosynthesis; beta-alanine biosynthesis.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11179210,
CC       ECO:0000269|PubMed:11796730, ECO:0000269|PubMed:9860876}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- SIMILARITY: Belongs to the dihydropyrimidine dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U09179; AAA57475.1; -; mRNA.
DR   PIR; B54718; B54718.
DR   RefSeq; NP_999209.1; NM_214044.2.
DR   PDB; 1GT8; X-ray; 3.30 A; A/B/C/D=1-1025.
DR   PDB; 1GTE; X-ray; 1.65 A; A/B/C/D=1-1025.
DR   PDB; 1GTH; X-ray; 2.25 A; A/B/C/D=1-1025.
DR   PDB; 1H7W; X-ray; 1.90 A; A/B/C/D=1-1025.
DR   PDB; 1H7X; X-ray; 2.01 A; A/B/C/D=1-1025.
DR   PDBsum; 1GT8; -.
DR   PDBsum; 1GTE; -.
DR   PDBsum; 1GTH; -.
DR   PDBsum; 1H7W; -.
DR   PDBsum; 1H7X; -.
DR   SMR; Q28943; -.
DR   STRING; 9823.ENSSSCP00000007333; -.
DR   PaxDb; Q28943; -.
DR   PeptideAtlas; Q28943; -.
DR   PRIDE; Q28943; -.
DR   GeneID; 397109; -.
DR   KEGG; ssc:397109; -.
DR   CTD; 1806; -.
DR   eggNOG; KOG1799; Eukaryota.
DR   InParanoid; Q28943; -.
DR   OrthoDB; 592753at2759; -.
DR   BRENDA; 1.3.1.2; 6170.
DR   UniPathway; UPA00131; -.
DR   EvolutionaryTrace; Q28943; -.
DR   Proteomes; UP000008227; Unplaced.
DR   Proteomes; UP000314985; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0017113; F:dihydropyrimidine dehydrogenase (NADP+) activity; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0010181; F:FMN binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050661; F:NADP binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0019483; P:beta-alanine biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006214; P:thymidine catabolic process; ISS:UniProtKB.
DR   GO; GO:0006210; P:thymine catabolic process; IEA:InterPro.
DR   GO; GO:0006212; P:uracil catabolic process; ISS:UniProtKB.
DR   Gene3D; 1.10.1060.10; -; 1.
DR   Gene3D; 3.20.20.70; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR017896; 4Fe4S_Fe-S-bd.
DR   InterPro; IPR017900; 4Fe4S_Fe_S_CS.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR005720; Dihydroorotate_DH.
DR   InterPro; IPR028261; DPD_II.
DR   InterPro; IPR044512; DPYD.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR009051; Helical_ferredxn.
DR   PANTHER; PTHR43073; PTHR43073; 1.
DR   Pfam; PF01180; DHO_dh; 1.
DR   Pfam; PF14691; Fer4_20; 1.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF46548; SSF46548; 1.
DR   TIGRFAMs; TIGR01037; pyrD_sub1_fam; 1.
DR   PROSITE; PS00198; 4FE4S_FER_1; 1.
DR   PROSITE; PS51379; 4FE4S_FER_2; 3.
PE   1: Evidence at protein level;
KW   3D-structure; 4Fe-4S; Acetylation; Cytoplasm; Direct protein sequencing;
KW   FAD; Flavoprotein; FMN; Iron; Iron-sulfur; Metal-binding; NADP;
KW   Nucleotide-binding; Oxidoreductase; Reference proteome; Repeat.
FT   PROPEP          1..3
FT                   /id="PRO_0000021116"
FT   CHAIN           4..1025
FT                   /note="Dihydropyrimidine dehydrogenase [NADP(+)]"
FT                   /id="PRO_0000021117"
FT   DOMAIN          69..100
FT                   /note="4Fe-4S ferredoxin-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00711"
FT   DOMAIN          944..976
FT                   /note="4Fe-4S ferredoxin-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00711"
FT   DOMAIN          978..1007
FT                   /note="4Fe-4S ferredoxin-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00711"
FT   NP_BIND         194..198
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   NP_BIND         218..226
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   NP_BIND         340..343
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   NP_BIND         364..365
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   NP_BIND         437..439
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   NP_BIND         480..489
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   NP_BIND         481..487
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   NP_BIND         574..575
FT                   /note="FMN"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   NP_BIND         793..795
FT                   /note="FMN"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   NP_BIND         816..817
FT                   /note="FMN"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   REGION          668..670
FT                   /note="Substrate binding"
FT   REGION          736..737
FT                   /note="Substrate binding"
FT   ACT_SITE        671
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   METAL           79
FT                   /note="Iron-sulfur 1 (4Fe-4S)"
FT   METAL           82
FT                   /note="Iron-sulfur 1 (4Fe-4S)"
FT   METAL           87
FT                   /note="Iron-sulfur 1 (4Fe-4S)"
FT   METAL           91
FT                   /note="Iron-sulfur 2 (4Fe-4S)"
FT   METAL           130
FT                   /note="Iron-sulfur 2 (4Fe-4S)"
FT   METAL           136
FT                   /note="Iron-sulfur 2 (4Fe-4S)"
FT   METAL           140
FT                   /note="Iron-sulfur 1 (4Fe-4S)"
FT   METAL           156
FT                   /note="Iron-sulfur 2 (4Fe-4S)"
FT   METAL           953
FT                   /note="Iron-sulfur 3 (4Fe-4S)"
FT   METAL           956
FT                   /note="Iron-sulfur 3 (4Fe-4S)"
FT   METAL           959
FT                   /note="Iron-sulfur 3 (4Fe-4S)"
FT   METAL           963
FT                   /note="Iron-sulfur 3 (4Fe-4S)"
FT   METAL           986
FT                   /note="Iron-sulfur 4 (4Fe-4S)"
FT   METAL           989
FT                   /note="Iron-sulfur 4 (4Fe-4S)"
FT   METAL           992
FT                   /note="Iron-sulfur 4 (4Fe-4S)"
FT   METAL           996
FT                   /note="Iron-sulfur 4 (4Fe-4S)"
FT   BINDING         129
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   BINDING         235
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   BINDING         261
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   BINDING         371
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   BINDING         550
FT                   /note="FMN"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   BINDING         609
FT                   /note="Substrate"
FT   BINDING         709
FT                   /note="FMN"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   BINDING         767
FT                   /note="FMN; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:11796730"
FT   MOD_RES         384
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q12882"
FT   MUTAGEN         126
FT                   /note="C->A: No effect on enzyme activity. Reduced iron
FT                   content."
FT                   /evidence="ECO:0000269|PubMed:20831907"
FT   MUTAGEN         156
FT                   /note="Q->E: Loss of enzyme activity. Reduces iron
FT                   content."
FT                   /evidence="ECO:0000269|PubMed:20831907"
FT   MUTAGEN         235
FT                   /note="R->A,K: Loss of enzyme activity. Loss of FAD
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:20831907"
FT   MUTAGEN         670
FT                   /note="S->A: Strongly reduced affinity for uracil. Reduces
FT                   enzyme activity by 30%."
FT                   /evidence="ECO:0000269|PubMed:20831907"
FT   MUTAGEN         671
FT                   /note="C->A: Reduces catalytic activity by 99%."
FT                   /evidence="ECO:0000269|PubMed:9860876"
FT   MUTAGEN         673
FT                   /note="H->Q: Reduces activity by 50%."
FT   HELIX           10..15
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   TURN            16..18
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          24..26
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           31..41
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           69..78
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           86..89
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           97..105
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           109..119
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           123..129
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           132..134
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           136..139
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           141..144
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           152..166
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           179..181
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           184..187
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          190..193
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           197..208
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          214..222
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           226..229
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   TURN            233..235
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           238..249
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   TURN            250..252
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          254..258
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           268..273
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          278..281
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           292..294
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   TURN            299..302
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          303..305
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           306..317
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          322..324
FT                   /evidence="ECO:0007829|PDB:1H7X"
FT   STRAND          333..338
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           342..353
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          357..362
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           367..369
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           374..382
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          386..388
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          390..399
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          402..413
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          419..430
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          432..436
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           445..450
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   TURN            451..453
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          460..462
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   TURN            466..468
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          476..478
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           481..483
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           489..510
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           527..530
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          535..537
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          540..548
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           552..554
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           557..566
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          569..572
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           579..581
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          590..592
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          607..609
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           618..631
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          635..641
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           647..659
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          663..668
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          678..680
FT                   /evidence="ECO:0007829|PDB:1H7W"
FT   HELIX           684..686
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           688..701
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          706..710
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           717..727
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          730..734
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          738..740
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          750..752
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   TURN            755..758
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          763..767
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           768..770
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           771..784
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          790..795
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           799..807
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          811..816
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           817..820
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           826..840
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           844..846
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          848..850
FT                   /evidence="ECO:0007829|PDB:1GT8"
FT   STRAND          858..860
FT                   /evidence="ECO:0007829|PDB:1GT8"
FT   TURN            869..873
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           880..899
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           921..924
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   TURN            925..928
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           929..931
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           935..937
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          940..942
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          944..948
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   TURN            950..952
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           958..966
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          971..973
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   TURN            975..977
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          980..982
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   HELIX           991..995
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   TURN            999..1001
FT                   /evidence="ECO:0007829|PDB:1GTE"
FT   STRAND          1002..1006
FT                   /evidence="ECO:0007829|PDB:1GTE"
SQ   SEQUENCE   1025 AA;  111424 MW;  B8D553AD862845D0 CRC64;
     MAPVLSKDVA DIESILALNP RTQSHAALHS TLAKKLDKKH WKRNPDKNCF HCEKLENNFG
     DIKHTTLGER GALREAMRCL KCADAPCQKS CPTHLDIKSF ITSISNKNYY GAAKMIFSDN
     PLGLTCGMVC PTSDLCVGGC NLYATEEGSI NIGGLQQFAS EVFKAMNIPQ IRNPCLPSQE
     KMPEAYSAKI ALLGAGPASI SCASFLARLG YSDITIFEKQ EYVGGLSTSE IPQFRLPYDV
     VNFEIELMKD LGVKIICGKS LSENEITLNT LKEEGYKAAF IGIGLPEPKT DDIFQGLTQD
     QGFYTSKDFL PLVAKSSKAG MCACHSPLPS IRGAVIVLGA GDTAFDCATS ALRCGARRVF
     LVFRKGFVNI RAVPEEVELA KEEKCEFLPF LSPRKVIVKG GRIVAVQFVR TEQDETGKWN
     EDEDQIVHLK ADVVISAFGS VLRDPKVKEA LSPIKFNRWD LPEVDPETMQ TSEPWVFAGG
     DIVGMANTTV ESVNDGKQAS WYIHKYIQAQ YGASVSAKPE LPLFYTPVDL VDISVEMAGL
     KFINPFGLAS AAPTTSSSMI RRAFEAGWGF ALTKTFSLDK DIVTNVSPRI VRGTTSGPMY
     GPGQSSFLNI ELISEKTAAY WCQSVTELKA DFPDNIVIAS IMCSYNKNDW MELSRKAEAS
     GADALELNLS CPHGMGERGM GLACGQDPEL VRNICRWVRQ AVQIPFFAKL TPNVTDIVSI
     ARAAKEGGAD GVTATNTVSG LMGLKADGTP WPAVGAGKRT TYGGVSGTAI RPIALRAVTT
     IARALPGFPI LATGGIDSAE SGLQFLHSGA SVLQVCSAVQ NQDFTVIQDY CTGLKALLYL
     KSIEELQGWD GQSPGTESHQ KGKPVPRIAE LMGKKLPNFG PYLEQRKKII AEEKMRLKEQ
     NAAFPPLERK PFIPKKPIPA IKDVIGKALQ YLGTFGELSN IEQVVAVIDE EMCINCGKCY
     MTCNDSGYQA IQFDPETHLP TVTDTCTGCT LCLSVCPIID CIRMVSRTTP YEPKRGLPLA
     VNPVC
//
ID   CRY1_MOUSE              Reviewed;         606 AA.
AC   P97784;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   02-JUN-2021, entry version 171.
DE   RecName: Full=Cryptochrome-1;
GN   Name=Cry1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain, Keratinocyte, and Liver;
RX   PubMed=9801304; DOI=10.1093/nar/26.22.5086;
RA   Kobayashi K., Kanno S., Smit B., van der Horst G.T.J., Takao M., Yasui A.;
RT   "Characterization of photolyase/blue-light receptor homologs in mouse and
RT   human cells.";
RL   Nucleic Acids Res. 26:5086-5092(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J;
RA   Kume K., Reppert S.M.;
RT   "Analysis of mouse cryptochromes.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Embryo;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and FVB/N;
RC   TISSUE=Brain, Embryonic brain, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=9600923; DOI=10.1073/pnas.95.11.6097;
RA   Miyamoto Y., Sancar A.;
RT   "Vitamin B2-based blue-light photoreceptors in the retinohypothalamic tract
RT   as the photoactive pigments for setting the circadian clock in mammals.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:6097-6102(1998).
RN   [6]
RP   FUNCTION, INTERACTION WITH PER1; PER2; PER3 AND TIMELESS, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=10428031; DOI=10.1016/s0092-8674(00)81014-4;
RA   Kume K., Zylka M.J., Sriram S., Shearman L.P., Weaver D.R., Jin X.,
RA   Maywood E.S., Hastings M.H., Reppert S.M.;
RT   "mCRY1 and mCRY2 are essential components of the negative limb of the
RT   circadian clock feedback loop.";
RL   Cell 98:193-205(1999).
RN   [7]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=10521578; DOI=10.1016/s0169-328x(99)00192-8;
RA   Miyamoto Y., Sancar A.;
RT   "Circadian regulation of cryptochrome genes in the mouse.";
RL   Brain Res. Mol. Brain Res. 71:238-243(1999).
RN   [8]
RP   IDENTIFICATION IN A COMPLEX WITH CLOCK; PER1; PER2; CRY1; CRY2; CSNK1D AND
RP   CSNK1E, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11779462; DOI=10.1016/s0092-8674(01)00610-9;
RA   Lee C., Etchegaray J.-P., Cagampang F.R.A., Loudon A.S.I., Reppert S.M.;
RT   "Posttranslational mechanisms regulate the mammalian circadian clock.";
RL   Cell 107:855-867(2001).
RN   [9]
RP   INTERACTION WITH PER2, SUBCELLULAR LOCATION, AND UBIQUITINATION.
RX   PubMed=11889036; DOI=10.1093/emboj/21.6.1301;
RA   Yagita K., Tamanini F., Yasuda M., Hoeijmakers J.H., van der Horst G.T.,
RA   Okamura H.;
RT   "Nucleocytoplasmic shuttling and mCRY-dependent inhibition of
RT   ubiquitylation of the mPER2 clock protein.";
RL   EMBO J. 21:1301-1314(2002).
RN   [10]
RP   INTERACTION WITH PER1 AND PER2, PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=11875063; DOI=10.1074/jbc.m111466200;
RA   Eide E.J., Vielhaber E.L., Hinz W.A., Virshup D.M.;
RT   "The circadian regulatory proteins BMAL1 and cryptochromes are substrates
RT   of casein kinase Iepsilon.";
RL   J. Biol. Chem. 277:17248-17254(2002).
RN   [11]
RP   PHOSPHORYLATION AT SER-247, AND MUTAGENESIS OF SER-247.
RX   PubMed=15298678; DOI=10.1111/j.1356-9597.2004.00758.x;
RA   Sanada K., Harada Y., Sakai M., Todo T., Fukada Y.;
RT   "Serine phosphorylation of mCRY1 and mCRY2 by mitogen-activated protein
RT   kinase.";
RL   Genes Cells 9:697-708(2004).
RN   [12]
RP   INTERACTION WITH PER1; PER2 AND PER3.
RX   PubMed=14701732; DOI=10.1128/mcb.24.2.584-594.2004;
RA   Lee C., Weaver D.R., Reppert S.M.;
RT   "Direct association between mouse PERIOD and CKIepsilon is critical for a
RT   functioning circadian clock.";
RL   Mol. Cell. Biol. 24:584-594(2004).
RN   [13]
RP   FUNCTION AS TRANSCRIPTION REPRESSOR, AND INTERACTION WITH HDAC1; HDAC2 AND
RP   SIN3B.
RX   PubMed=15226430; DOI=10.1128/mcb.24.14.6278-6287.2004;
RA   Naruse Y., Oh-hashi K., Iijima N., Naruse M., Yoshioka H., Tanaka M.;
RT   "Circadian and light-induced transcription of clock gene Per1 depends on
RT   histone acetylation and deacetylation.";
RL   Mol. Cell. Biol. 24:6278-6287(2004).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16628007; DOI=10.4161/cc.5.8.2684;
RA   Kondratov R.V., Kondratova A.A., Lee C., Gorbacheva V.Y., Chernov M.V.,
RA   Antoch M.P.;
RT   "Post-translational regulation of circadian transcriptional
RT   CLOCK(NPAS2)/BMAL1 complex by CRYPTOCHROMES.";
RL   Cell Cycle 5:890-895(2006).
RN   [15]
RP   INTERACTION WITH EZH2; CLOCK AND ARNTL.
RX   PubMed=16717091; DOI=10.1074/jbc.m603722200;
RA   Etchegaray J.P., Yang X., DeBruyne J.P., Peters A.H., Weaver D.R.,
RA   Jenuwein T., Reppert S.M.;
RT   "The polycomb group protein EZH2 is required for mammalian circadian clock
RT   function.";
RL   J. Biol. Chem. 281:21209-21215(2006).
RN   [16]
RP   FUNCTION, INTERACTION WITH PER1 AND PER2, AND SUBCELLULAR LOCATION.
RX   PubMed=16478995; DOI=10.1128/mcb.26.5.1743-1753.2006;
RA   Chaves I., Yagita K., Barnhoorn S., Okamura H., van der Horst G.T.J.,
RA   Tamanini F.;
RT   "Functional evolution of the photolyase/cryptochrome protein family:
RT   importance of the C terminus of mammalian CRY1 for circadian core
RT   oscillator performance.";
RL   Mol. Cell. Biol. 26:1743-1753(2006).
RN   [17]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=16790549; DOI=10.1073/pnas.0604138103;
RA   Partch C.L., Shields K.F., Thompson C.L., Selby C.P., Sancar A.;
RT   "Posttranslational regulation of the mammalian circadian clock by
RT   cryptochrome and protein phosphatase 5.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:10467-10472(2006).
RN   [18]
RP   INTERACTION WITH FBXL3, AND UBIQUITINATION.
RX   PubMed=17462724; DOI=10.1016/j.cell.2007.04.030;
RA   Siepka S.M., Yoo S.H., Park J., Song W., Kumar V., Hu Y., Lee C.,
RA   Takahashi J.S.;
RT   "Circadian mutant Overtime reveals F-box protein FBXL3 regulation of
RT   cryptochrome and period gene expression.";
RL   Cell 129:1011-1023(2007).
RN   [19]
RP   FUNCTION.
RX   PubMed=17310242; DOI=10.1038/ncb1539;
RA   Zhao W.N., Malinin N., Yang F.C., Staknis D., Gekakis N., Maier B.,
RA   Reischl S., Kramer A., Weitz C.J.;
RT   "CIPC is a mammalian circadian clock protein without invertebrate
RT   homologues.";
RL   Nat. Cell Biol. 9:268-275(2007).
RN   [20]
RP   INTERACTION WITH FBXL21, AND UBIQUITINATION.
RX   PubMed=18953409; DOI=10.1371/journal.pone.0003530;
RA   Dardente H., Mendoza J., Fustin J.M., Challet E., Hazlerigg D.G.;
RT   "Implication of the F-Box Protein FBXL21 in circadian pacemaker function in
RT   mammals.";
RL   PLoS ONE 3:E3530-E3530(2008).
RN   [21]
RP   INTERACTION WITH ARNTL AND CLOCK, AND INDUCTION.
RX   PubMed=19917250; DOI=10.1016/j.molcel.2009.10.012;
RA   Chen R., Schirmer A., Lee Y., Lee H., Kumar V., Yoo S.H., Takahashi J.S.,
RA   Lee C.;
RT   "Rhythmic PER abundance defines a critical nodal point for negative
RT   feedback within the circadian clock mechanism.";
RL   Mol. Cell 36:417-430(2009).
RN   [22]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH MYBBP1A; DOCK7;
RP   HNRNPU; RPL7A; RPL8 AND RPS3.
RX   PubMed=19129230; DOI=10.1093/nar/gkn1013;
RA   Hara Y., Onishi Y., Oishi K., Miyazaki K., Fukamizu A., Ishida N.;
RT   "Molecular characterization of Mybbp1a as a co-repressor on the Period2
RT   promoter.";
RL   Nucleic Acids Res. 37:1115-1126(2009).
RN   [23]
RP   PHOSPHORYLATION AT SER-71 AND SER-280, AND MUTAGENESIS OF SER-71 AND
RP   SER-280.
RX   PubMed=19833968; DOI=10.1126/science.1172156;
RA   Lamia K.A., Sachdeva U.M., DiTacchio L., Williams E.C., Alvarez J.G.,
RA   Egan D.F., Vasquez D.S., Juguilon H., Panda S., Shaw R.J., Thompson C.B.,
RA   Evans R.M.;
RT   "AMPK regulates the circadian clock by cryptochrome phosphorylation and
RT   degradation.";
RL   Science 326:437-440(2009).
RN   [24]
RP   FUNCTION.
RX   PubMed=19299583; DOI=10.1126/science.1171641;
RA   Ramsey K.M., Yoshino J., Brace C.S., Abrassart D., Kobayashi Y.,
RA   Marcheva B., Hong H.K., Chong J.L., Buhr E.D., Lee C., Takahashi J.S.,
RA   Imai S., Bass J.;
RT   "Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis.";
RL   Science 324:651-654(2009).
RN   [25]
RP   INTERACTION WITH PER2.
RX   PubMed=20159955; DOI=10.1101/gad.564110;
RA   Schmutz I., Ripperger J.A., Baeriswyl-Aebischer S., Albrecht U.;
RT   "The mammalian clock component PERIOD2 coordinates circadian output by
RT   interaction with nuclear receptors.";
RL   Genes Dev. 24:345-357(2010).
RN   [26]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=20385766; DOI=10.1128/mcb.01141-09;
RA   Guillaumond F., Grechez-Cassiau A., Subramaniam M., Brangolo S.,
RA   Peteri-Brunback B., Staels B., Fievet C., Spelsberg T.C., Delaunay F.,
RA   Teboul M.;
RT   "Kruppel-like factor KLF10 is a link between the circadian clock and
RT   metabolism in liver.";
RL   Mol. Cell. Biol. 30:3059-3070(2010).
RN   [27]
RP   FUNCTION IN GLUCONEOGENESIS, AND DISRUPTION PHENOTYPE.
RX   PubMed=20852621; DOI=10.1038/nm.2214;
RA   Zhang E.E., Liu Y., Dentin R., Pongsawakul P.Y., Liu A.C., Hirota T.,
RA   Nusinow D.A., Sun X., Landais S., Kodama Y., Brenner D.A., Montminy M.,
RA   Kay S.A.;
RT   "Cryptochrome mediates circadian regulation of cAMP signaling and hepatic
RT   gluconeogenesis.";
RL   Nat. Med. 16:1152-1156(2010).
RN   [28]
RP   FUNCTION IN CIRCADIAN RHYTHMS REGULATION, AND INDUCTION.
RX   PubMed=21236481; DOI=10.1016/j.cell.2010.12.019;
RA   Ukai-Tadenuma M., Yamada R.G., Xu H., Ripperger J.A., Liu A.C., Ueda H.R.;
RT   "Delay in feedback repression by cryptochrome 1 is required for circadian
RT   clock function.";
RL   Cell 144:268-281(2011).
RN   [29]
RP   INTERACTION WITH CLOCK-ARNTL AND PER2.
RX   PubMed=21613214; DOI=10.1074/jbc.m111.254680;
RA   Ye R., Selby C.P., Ozturk N., Annayev Y., Sancar A.;
RT   "Biochemical analysis of the canonical model for the mammalian circadian
RT   clock.";
RL   J. Biol. Chem. 286:25891-25902(2011).
RN   [30]
RP   FUNCTION.
RX   PubMed=21768648; DOI=10.1074/jbc.m111.258970;
RA   Koyanagi S., Hamdan A.M., Horiguchi M., Kusunose N., Okamoto A.,
RA   Matsunaga N., Ohdo S.;
RT   "cAMP-response element (CRE)-mediated transcription by activating
RT   transcription factor-4 (ATF4) is essential for circadian expression of the
RT   Period2 gene.";
RL   J. Biol. Chem. 286:32416-32423(2011).
RN   [31]
RP   FUNCTION AS NR3C1 REPRESSOR, INTERACTION WITH AR; NR1D1; NR3C1; RORA AND
RP   RORC, AND DISRUPTION PHENOTYPE.
RX   PubMed=22170608; DOI=10.1038/nature10700;
RA   Lamia K.A., Papp S.J., Yu R.T., Barish G.D., Uhlenhaut N.H., Jonker J.W.,
RA   Downes M., Evans R.M.;
RT   "Cryptochromes mediate rhythmic repression of the glucocorticoid
RT   receptor.";
RL   Nature 480:552-556(2011).
RN   [32]
RP   FUNCTION, INDUCTION, AND INTERACTION WITH PRMT5.
RX   PubMed=23133559; DOI=10.1371/journal.pone.0048152;
RA   Na J., Lee K., Kim H.G., Shin J.Y., Na W., Jeong H., Lee J.W., Cho S.,
RA   Kim W.S., Ju B.G.;
RT   "Role of type II protein arginine methyltransferase 5 in the regulation of
RT   Circadian Per1 gene.";
RL   PLoS ONE 7:E48152-E48152(2012).
RN   [33]
RP   ACTIVITY REGULATION.
RX   PubMed=22798407; DOI=10.1126/science.1223710;
RA   Hirota T., Lee J.W., St John P.C., Sawa M., Iwaisako K., Noguchi T.,
RA   Pongsawakul P.Y., Sonntag T., Welsh D.K., Brenner D.A., Doyle F.J. III,
RA   Schultz P.G., Kay S.A.;
RT   "Identification of small molecule activators of cryptochrome.";
RL   Science 337:1094-1097(2012).
RN   [34]
RP   FUNCTION IN METABOLISM, AND DISRUPTION PHENOTYPE.
RX   PubMed=23531614; DOI=10.1152/ajpendo.00512.2012;
RA   Barclay J.L., Shostak A., Leliavski A., Tsang A.H., Johren O.,
RA   Muller-Fielitz H., Landgraf D., Naujokat N., van der Horst G.T., Oster H.;
RT   "High-fat diet-induced hyperinsulinemia and tissue-specific insulin
RT   resistance in Cry-deficient mice.";
RL   Am. J. Physiol. 304:E1053-E1063(2013).
RN   [35]
RP   UBIQUITINATION BY THE SCF(FBXL3) AND SCF(FBXL21) COMPLEXES, INTERACTION
RP   WITH FBXL3 AND FBXL21, AND UBIQUITINATION AT LYS-11.
RX   PubMed=23452855; DOI=10.1016/j.cell.2013.01.055;
RA   Yoo S.H., Mohawk J.A., Siepka S.M., Shan Y., Huh S.K., Hong H.K.,
RA   Kornblum I., Kumar V., Koike N., Xu M., Nussbaum J., Liu X., Chen Z.,
RA   Chen Z.J., Green C.B., Takahashi J.S.;
RT   "Competing E3 ubiquitin ligases govern circadian periodicity by degradation
RT   of CRY in nucleus and cytoplasm.";
RL   Cell 152:1091-1105(2013).
RN   [36]
RP   UBIQUITINATION BY THE SCF(FBXL3) AND SCF(FBXL21) COMPLEXES, UBIQUITINATION
RP   AT LYS-107; LYS-159; LYS-329 AND LYS-485, INTERACTION WITH FBXL3 AND
RP   FBXL21, AND MUTAGENESIS OF LYS-107.
RX   PubMed=23452856; DOI=10.1016/j.cell.2013.01.054;
RA   Hirano A., Yumimoto K., Tsunematsu R., Matsumoto M., Oyama M.,
RA   Kozuka-Hata H., Nakagawa T., Lanjakornsiripan D., Nakayama K.I., Fukada Y.;
RT   "FBXL21 regulates oscillation of the circadian clock through ubiquitination
RT   and stabilization of cryptochromes.";
RL   Cell 152:1106-1118(2013).
RN   [37]
RP   FUNCTION IN CIRCADIAN CLOCK, INTERACTION WITH PRKDC, PHOSPHORYLATION AT
RP   SER-588, AND MUTAGENESIS OF SER-551; SER-564 AND SER-588.
RX   PubMed=24158435; DOI=10.1074/jbc.m113.509604;
RA   Gao P., Yoo S.H., Lee K.J., Rosensweig C., Takahashi J.S., Chen B.P.,
RA   Green C.B.;
RT   "Phosphorylation of the cryptochrome 1 C-terminal tail regulates circadian
RT   period length.";
RL   J. Biol. Chem. 288:35277-35286(2013).
RN   [38]
RP   FUNCTION IN CIRCADIAN CLOCK, AND DISRUPTION PHENOTYPE.
RX   PubMed=23616524; DOI=10.1523/jneurosci.4950-12.2013;
RA   Anand S.N., Maywood E.S., Chesham J.E., Joynson G., Banks G.T.,
RA   Hastings M.H., Nolan P.M.;
RT   "Distinct and separable roles for endogenous CRY1 and CRY2 within the
RT   circadian molecular clockwork of the suprachiasmatic nucleus, as revealed
RT   by the Fbxl3(Afh) mutation.";
RL   J. Neurosci. 33:7145-7153(2013).
RN   [39]
RP   FUNCTION IN CIRCADIAN CLOCK.
RX   PubMed=23575670; DOI=10.1038/ncomms2670;
RA   Ono D., Honma S., Honma K.;
RT   "Cryptochromes are critical for the development of coherent circadian
RT   rhythms in the mouse suprachiasmatic nucleus.";
RL   Nat. Commun. 4:1666-1666(2013).
RN   [40]
RP   FUNCTION.
RX   PubMed=24089055; DOI=10.1038/ncomms3545;
RA   Li D.Q., Pakala S.B., Reddy S.D., Peng S., Balasenthil S., Deng C.X.,
RA   Lee C.C., Rea M.A., Kumar R.;
RT   "Metastasis-associated protein 1 is an integral component of the circadian
RT   molecular machinery.";
RL   Nat. Commun. 4:2545-2545(2013).
RN   [41]
RP   INTERACTION WITH TIMELESS AND PER2, AND SUBCELLULAR LOCATION.
RX   PubMed=23418588; DOI=10.1371/journal.pone.0056623;
RA   Engelen E., Janssens R.C., Yagita K., Smits V.A., van der Horst G.T.,
RA   Tamanini F.;
RT   "Mammalian TIMELESS is involved in period determination and DNA damage-
RT   dependent phase advancing of the circadian clock.";
RL   PLoS ONE 8:E56623-E56623(2013).
RN   [42]
RP   REVIEW.
RX   PubMed=23303907; DOI=10.1152/physrev.00016.2012;
RA   Eckel-Mahan K., Sassone-Corsi P.;
RT   "Metabolism and the circadian clock converge.";
RL   Physiol. Rev. 93:107-135(2013).
RN   [43]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=24385426; DOI=10.1074/jbc.m113.534651;
RA   Annayev Y., Adar S., Chiou Y.Y., Lieb J., Sancar A., Ye R.;
RT   "Gene model 129 (Gm129) encodes a novel transcriptional repressor that
RT   modulates circadian gene expression.";
RL   J. Biol. Chem. 289:5013-5024(2014).
RN   [44]
RP   FUNCTION IN GR REPRESSION.
RX   PubMed=24378737; DOI=10.1016/j.mce.2013.12.013;
RA   Han D.H., Lee Y.J., Kim K., Kim C.J., Cho S.;
RT   "Modulation of glucocorticoid receptor induction properties by core
RT   circadian clock proteins.";
RL   Mol. Cell. Endocrinol. 383:170-180(2014).
RN   [45]
RP   FUNCTION IN DNA DAMAGE CHECKPOINT, INTERACTION WITH TIMELESS, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=24489120; DOI=10.1093/nar/gku094;
RA   Kang T.H., Leem S.H.;
RT   "Modulation of ATR-mediated DNA damage checkpoint response by cryptochrome
RT   1.";
RL   Nucleic Acids Res. 42:4427-4434(2014).
RN   [46]
RP   REVIEW.
RX   PubMed=23916625; DOI=10.1016/j.tcb.2013.07.002;
RA   Partch C.L., Green C.B., Takahashi J.S.;
RT   "Molecular architecture of the mammalian circadian clock.";
RL   Trends Cell Biol. 24:90-99(2014).
RN   [47]
RP   FUNCTION, INTERACTION WITH DDB1-CUL4A COMPLEX, UBIQUITINATION AT LYS-585,
RP   AND MUTAGENESIS OF LYS-585.
RX   PubMed=26431207; DOI=10.1371/journal.pone.0139725;
RA   Tong X., Zhang D., Guha A., Arthurs B., Cazares V., Gupta N., Yin L.;
RT   "CUL4-DDB1-CDT2 E3 ligase regulates the molecular clock activity by
RT   promoting ubiquitination-dependent degradation of the mammalian CRY1.";
RL   PLoS ONE 10:E0139725-E0139725(2015).
RN   [48]
RP   UBIQUITINATION AND PROTEASOMAL DEGRADATION, AND INTERACTION WITH HDAC3 AND
RP   ARNTL.
RX   PubMed=26776516; DOI=10.1016/j.celrep.2015.12.076;
RA   Shi G., Xie P., Qu Z., Zhang Z., Dong Z., An Y., Xing L., Liu Z., Dong Y.,
RA   Xu G., Yang L., Liu Y., Xu Y.;
RT   "Distinct roles of HDAC3 in the core circadian negative feedback loop are
RT   critical for clock function.";
RL   Cell Rep. 14:823-834(2016).
RN   [49]
RP   DEUBIQUITINATION BY USP7, AND INTERACTION WITH TRIM28; KCTD5 AND DDB1.
RX   PubMed=27123980; DOI=10.1371/journal.pone.0154263;
RA   Hirano A., Nakagawa T., Yoshitane H., Oyama M., Kozuka-Hata H.,
RA   Lanjakornsiripan D., Fukada Y.;
RT   "USP7 and TDP-43: pleiotropic regulation of cryptochrome protein stability
RT   paces the oscillation of the mammalian circadian clock.";
RL   PLoS ONE 11:E0154263-E0154263(2016).
RN   [50]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND INTERACTION WITH PPARA; PPARD AND
RP   PPARG.
RX   PubMed=28683290; DOI=10.1016/j.cmet.2017.06.002;
RA   Jordan S.D., Kriebs A., Vaughan M., Duglan D., Fan W., Henriksson E.,
RA   Huber A.L., Papp S.J., Nguyen M., Afetian M., Downes M., Yu R.T.,
RA   Kralli A., Evans R.M., Lamia K.A.;
RT   "CRY1/2 selectively repress PPARdelta and limit exercise capacity.";
RL   Cell Metab. 26:243-255(2017).
RN   [51]
RP   FUNCTION, AND INTERACTION WITH FOXO1.
RX   PubMed=28790135; DOI=10.2337/db16-1600;
RA   Tong X., Zhang D., Charney N., Jin E., VanDommelen K., Stamper K.,
RA   Gupta N., Saldate J., Yin L.;
RT   "DDB1-mediated CRY1 degradation promotes FOXO1-driven gluconeogenesis in
RT   liver.";
RL   Diabetes 66:2571-2582(2017).
RN   [52]
RP   FUNCTION, AND INTERACTION WITH NR1I2; NR1I3; NR3C1; PPARD; VDR; AR AND
RP   HNF4A.
RX   PubMed=28751364; DOI=10.1073/pnas.1704955114;
RA   Kriebs A., Jordan S.D., Soto E., Henriksson E., Sandate C.R., Vaughan M.E.,
RA   Chan A.B., Duglan D., Papp S.J., Huber A.L., Afetian M.E., Yu R.T.,
RA   Zhao X., Downes M., Evans R.M., Lamia K.A.;
RT   "Circadian repressors CRY1 and CRY2 broadly interact with nuclear receptors
RT   and modulate transcriptional activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:8776-8781(2017).
RN   [53]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND TISSUE SPECIFICITY.
RX   PubMed=29561690; DOI=10.1096/fj.201701165rr;
RA   Wong J.C.Y., Smyllie N.J., Banks G.T., Pothecary C.A., Barnard A.R.,
RA   Maywood E.S., Jagannath A., Hughes S., van der Horst G.T.J., MacLaren R.E.,
RA   Hankins M.W., Hastings M.H., Nolan P.M., Foster R.G., Peirson S.N.;
RT   "Differential roles for cryptochromes in the mammalian retinal clock.";
RL   FASEB J. 32:4302-4314(2018).
RN   [54]
RP   INTERACTION WITH KDM8; FBXL3 AND PSMD2.
RX   PubMed=30500822; DOI=10.1371/journal.pbio.2006145;
RA   Saran A.R., Kalinowska D., Oh S., Janknecht R., DiTacchio L.;
RT   "JMJD5 links CRY1 function and proteasomal degradation.";
RL   PLoS Biol. 16:E2006145-E2006145(2018).
RN   [55]
RP   FUNCTION, INTERACTION WITH MAP1LC3B, LIR MOTIFS, DEGRADATION VIA AUTOPHAGY,
RP   AND MUTAGENESIS OF TYR-273; VAL-276; TYR-287; LEU-290; TYR-488; LEU-491;
RP   TYR-494 AND LEU-497.
RX   PubMed=29937374; DOI=10.1016/j.cmet.2018.05.023;
RA   Toledo M., Batista-Gonzalez A., Merheb E., Aoun M.L., Tarabra E., Feng D.,
RA   Sarparanta J., Merlo P., Botre F., Schwartz G.J., Pessin J.E., Singh R.;
RT   "Autophagy regulates the liver clock and glucose metabolism by degrading
RT   CRY1.";
RL   Cell Metab. 28:268-281(2018).
RN   [56]
RP   X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF APOPROTEIN, INTERACTION WITH
RP   ARNTL; PER2 AND FBXL3, FUNCTION, FAD-BINDING SITES, AND MUTAGENESIS OF
RP   HIS-224; SER-247; 382-GLU-GLU-383; PHE-405 AND LYS-485.
RX   PubMed=23746849; DOI=10.1016/j.cell.2013.05.011;
RA   Czarna A., Berndt A., Singh H.R., Grudziecki A., Ladurner A.G.,
RA   Timinszky G., Kramer A., Wolf E.;
RT   "Structures of Drosophila cryptochrome and mouse cryptochrome1 provide
RT   insight into circadian function.";
RL   Cell 153:1394-1405(2013).
CC   -!- FUNCTION: Transcriptional repressor which forms a core component of the
CC       circadian clock. The circadian clock, an internal time-keeping system,
CC       regulates various physiological processes through the generation of
CC       approximately 24 hour circadian rhythms in gene expression, which are
CC       translated into rhythms in metabolism and behavior. It is derived from
CC       the Latin roots 'circa' (about) and 'diem' (day) and acts as an
CC       important regulator of a wide array of physiological functions
CC       including metabolism, sleep, body temperature, blood pressure,
CC       endocrine, immune, cardiovascular, and renal function. Consists of two
CC       major components: the central clock, residing in the suprachiasmatic
CC       nucleus (SCN) of the brain, and the peripheral clocks that are present
CC       in nearly every tissue and organ system. Both the central and
CC       peripheral clocks can be reset by environmental cues, also known as
CC       Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the
CC       central clock is light, which is sensed by retina and signals directly
CC       to the SCN. The central clock entrains the peripheral clocks through
CC       neuronal and hormonal signals, body temperature and feeding-related
CC       cues, aligning all clocks with the external light/dark cycle. Circadian
CC       rhythms allow an organism to achieve temporal homeostasis with its
CC       environment at the molecular level by regulating gene expression to
CC       create a peak of protein expression once every 24 hours to control when
CC       a particular physiological process is most active with respect to the
CC       solar day. Transcription and translation of core clock components
CC       (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2, PER1, PER2, PER3, CRY1 and
CC       CRY2) plays a critical role in rhythm generation, whereas delays
CC       imposed by post-translational modifications (PTMs) are important for
CC       determining the period (tau) of the rhythms (tau refers to the period
CC       of a rhythm and is the length, in time, of one complete cycle). A
CC       diurnal rhythm is synchronized with the day/night cycle, while the
CC       ultradian and infradian rhythms have a period shorter and longer than
CC       24 hours, respectively. Disruptions in the circadian rhythms contribute
CC       to the pathology of cardiovascular diseases, cancer, metabolic
CC       syndromes and aging. A transcription/translation feedback loop (TTFL)
CC       forms the core of the molecular circadian clock mechanism.
CC       Transcription factors, CLOCK or NPAS2 and ARNTL/BMAL1 or ARNTL2/BMAL2,
CC       form the positive limb of the feedback loop, act in the form of a
CC       heterodimer and activate the transcription of core clock genes and
CC       clock-controlled genes (involved in key metabolic processes), harboring
CC       E-box elements (5'-CACGTG-3') within their promoters. The core clock
CC       genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form
CC       the negative limb of the feedback loop and interact with the
CC       CLOCK|NPAS2-ARNTL/BMAL1|ARNTL2/BMAL2 heterodimer inhibiting its
CC       activity and thereby negatively regulating their own expression. This
CC       heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G,
CC       which form a second feedback loop and which activate and repress
CC       ARNTL/BMAL1 transcription, respectively. CRY1 and CRY2 have redundant
CC       functions but also differential and selective contributions at least in
CC       defining the pace of the SCN circadian clock and its circadian
CC       transcriptional outputs. More potent transcriptional repressor in
CC       cerebellum and liver than CRY2, though more effective in lengthening
CC       the period of the SCN oscillator. On its side, CRY2 seems to play a
CC       critical role in tuning SCN circadian period by opposing the action of
CC       CRY1. With CRY2, is dispensable for circadian rhythm generation but
CC       necessary for the development of intercellular networks for rhythm
CC       synchrony. Capable of translocating circadian clock core proteins such
CC       as PER proteins to the nucleus. Interacts with CLOCK-ARNTL/BMAL1
CC       independently of PER proteins and is found at CLOCK-ARNTL/BMAL1-bound
CC       sites, suggesting that CRY may act as a molecular gatekeeper to
CC       maintain CLOCK-ARNTL/BMAL1 in a poised and repressed state until the
CC       proper time for transcriptional activation. Represses the CLOCK-
CC       ARNTL/BMAL1 induced transcription of BHLHE40/DEC1, ATF4, MTA1, KLF10
CC       and NAMPT. May repress circadian target genes expression in
CC       collaboration with HDAC1 and HDAC2 through histone deacetylation.
CC       Mediates the clock-control activation of ATR and modulates ATR-mediated
CC       DNA damage checkpoint. In liver, mediates circadian regulation of cAMP
CC       signaling and gluconeogenesis by binding to membrane-coupled G proteins
CC       and blocking glucagon-mediated increases in intracellular cAMP
CC       concentrations and CREB1 phosphorylation. Inhibits hepatic
CC       gluconeogenesis by decreasing nuclear FOXO1 levels that downregulates
CC       gluconeogenic gene expression. Besides its role in the maintenance of
CC       the circadian clock, is also involved in the regulation of other
CC       processes. Represses glucocorticoid receptor NR3C1/GR-induced
CC       transcriptional activity by binding to glucocorticoid response elements
CC       (GREs). Plays a key role in glucose and lipid metabolism modulation, in
CC       part, through the transcriptional regulation of genes involved in these
CC       pathways, such as LEP or ACSL4. Represses PPARD and its target genes in
CC       the skeletal muscle and limits exercise capacity (PubMed:28683290).
CC       Plays an essential role in the generation of circadian rhythms in the
CC       retina (PubMed:29561690). Represses the transcriptional activity of
CC       NR1I2 (PubMed:28751364). {ECO:0000269|PubMed:10428031,
CC       ECO:0000269|PubMed:15226430, ECO:0000269|PubMed:16478995,
CC       ECO:0000269|PubMed:16628007, ECO:0000269|PubMed:17310242,
CC       ECO:0000269|PubMed:19129230, ECO:0000269|PubMed:19299583,
CC       ECO:0000269|PubMed:20385766, ECO:0000269|PubMed:20852621,
CC       ECO:0000269|PubMed:21236481, ECO:0000269|PubMed:21768648,
CC       ECO:0000269|PubMed:22170608, ECO:0000269|PubMed:23133559,
CC       ECO:0000269|PubMed:23531614, ECO:0000269|PubMed:23575670,
CC       ECO:0000269|PubMed:23616524, ECO:0000269|PubMed:23746849,
CC       ECO:0000269|PubMed:24089055, ECO:0000269|PubMed:24158435,
CC       ECO:0000269|PubMed:24378737, ECO:0000269|PubMed:24385426,
CC       ECO:0000269|PubMed:24489120, ECO:0000269|PubMed:26431207,
CC       ECO:0000269|PubMed:28683290, ECO:0000269|PubMed:28751364,
CC       ECO:0000269|PubMed:28790135, ECO:0000269|PubMed:29561690,
CC       ECO:0000269|PubMed:29937374}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:23746849};
CC       Note=Binds 1 FAD per subunit. Only a minority of the protein molecules
CC       contain bound FAD. Contrary to the situation in photolyases, the FAD is
CC       bound in a shallow, surface-exposed pocket.
CC       {ECO:0000269|PubMed:23746849};
CC   -!- COFACTOR:
CC       Name=(6R)-5,10-methylene-5,6,7,8-tetrahydrofolate;
CC         Xref=ChEBI:CHEBI:15636; Evidence={ECO:0000250};
CC       Note=Binds 1 5,10-methenyltetrahydrofolate (MTHF) non-covalently per
CC       subunit. {ECO:0000250};
CC   -!- ACTIVITY REGULATION: KL001 (N-[3-(9H-carbazol-9-yl)-2-hydroxypropyl]-N-
CC       (2-furanylmethyl)-methanesulfonamide) binds to CRY1 and stabilizes it
CC       by inhibiting FBXL3- and ubiquitin-dependent degradation of CRY1
CC       resulting in lengthening of the circadian periods. KL001-mediated CRY1
CC       stabilization can inhibit glucagon-induced gluconeogenesis in primary
CC       hepatocytes. {ECO:0000269|PubMed:22798407}.
CC   -!- SUBUNIT: Component of the circadian core oscillator, which includes the
CC       CRY proteins, CLOCK or NPAS2, ARNTL/BMAL1 or ARNTL2/BMAL2, CSNK1D
CC       and/or CSNK1E, TIMELESS, and the PER proteins (PubMed:11779462).
CC       Interacts directly with TIMELESS (PubMed:10428031, PubMed:24489120,
CC       PubMed:23418588). Interacts directly with PER1 and PER2; interaction
CC       with PER2 inhibits its ubiquitination and vice versa (PubMed:10428031,
CC       PubMed:11889036, PubMed:11875063, PubMed:14701732, PubMed:16478995,
CC       PubMed:23746849, PubMed:23418588, PubMed:21613214, PubMed:20159955).
CC       Interacts with PER3 (PubMed:10428031, PubMed:14701732). Interacts with
CC       FBXL21 (PubMed:18953409, PubMed:23452855, PubMed:23452856). Interacts
CC       with FBXL3 (PubMed:17462724, PubMed:23746849, PubMed:23452855,
CC       PubMed:23452856, PubMed:30500822). Interacts with PPP5C (via TPR
CC       repeats) (By similarity). Interacts with CLOCK-ARNTL/BMAL1
CC       independently of PER2 and DNA (PubMed:21613214). Interacts with HDAC1,
CC       HDAC2 and SIN3B (PubMed:15226430). Interacts with nuclear receptors AR,
CC       NR1D1, NR3C1/GR, RORA and RORC; the interaction with at least NR3C1/GR
CC       is ligand dependent (PubMed:22170608, PubMed:28751364). Interacts with
CC       PRKDC (PubMed:24158435). Interacts with the G protein subunit alpha
CC       GNAS; the interaction may block GPCR-mediated regulation of cAMP
CC       concentrations (By similarity). Interacts with PRMT5 (PubMed:23133559).
CC       Interacts with EZH2 (PubMed:16717091). Interacts with MYBBP1A, DOCK7,
CC       HNRNPU, RPL7A, RPL8 and RPS3 (PubMed:19129230). Interacts with MAP1LC3B
CC       (PubMed:29937374). Interacts with CLOCK (PubMed:16717091,
CC       PubMed:19917250). Interacts with ARNTL/BMAL1 (PubMed:26776516,
CC       PubMed:16717091, PubMed:19917250, PubMed:23746849). Interacts weakly
CC       with HDAC3; this interaction is enhanced in the presence of FBXL3
CC       (PubMed:26776516). Interacts with TRIM28, KCTD5 and DDB1
CC       (PubMed:27123980). Interacts with DTL (By similarity). Interacts with
CC       DDB1-CUL4A complex (PubMed:26431207). Interacts with FOXO1
CC       (PubMed:28790135). Interacts with PSMD2 in a KDM8-dependent manner
CC       (PubMed:30500822). Interacts with KDM8 in a FBXL3-dependent manner
CC       (PubMed:30500822). Interacts with PPARA (PubMed:28683290). Interacts
CC       with PPARG in a ligand-dependent manner (PubMed:28683290). Interacts
CC       with PPARD (via domain NR LBD) in a ligand-dependent manner
CC       (PubMed:28683290, PubMed:28751364). Interacts with NR1I2 (via domain NR
CC       LBD) in a ligand-dependent manner (PubMed:28751364). Interacts with
CC       NR1I3, VDR and HNF4A (PubMed:28751364). {ECO:0000250|UniProtKB:Q16526,
CC       ECO:0000269|PubMed:10428031, ECO:0000269|PubMed:11779462,
CC       ECO:0000269|PubMed:11875063, ECO:0000269|PubMed:11889036,
CC       ECO:0000269|PubMed:14701732, ECO:0000269|PubMed:15226430,
CC       ECO:0000269|PubMed:16478995, ECO:0000269|PubMed:16717091,
CC       ECO:0000269|PubMed:17462724, ECO:0000269|PubMed:18953409,
CC       ECO:0000269|PubMed:19129230, ECO:0000269|PubMed:19917250,
CC       ECO:0000269|PubMed:20159955, ECO:0000269|PubMed:21613214,
CC       ECO:0000269|PubMed:22170608, ECO:0000269|PubMed:23133559,
CC       ECO:0000269|PubMed:23418588, ECO:0000269|PubMed:23452855,
CC       ECO:0000269|PubMed:23452856, ECO:0000269|PubMed:23746849,
CC       ECO:0000269|PubMed:24158435, ECO:0000269|PubMed:24489120,
CC       ECO:0000269|PubMed:26431207, ECO:0000269|PubMed:26776516,
CC       ECO:0000269|PubMed:27123980, ECO:0000269|PubMed:28683290,
CC       ECO:0000269|PubMed:28751364, ECO:0000269|PubMed:28790135,
CC       ECO:0000269|PubMed:29937374, ECO:0000269|PubMed:30500822}.
CC   -!- INTERACTION:
CC       P97784; Q9WTL8: Arntl; NbExp=23; IntAct=EBI-1266607, EBI-644534;
CC       P97784; Q9WTL8-2: Arntl; NbExp=4; IntAct=EBI-1266607, EBI-644559;
CC       P97784; Q9WTL8-4: Arntl; NbExp=4; IntAct=EBI-1266607, EBI-644568;
CC       P97784; Q2VPD4: Arntl2; NbExp=3; IntAct=EBI-1266607, EBI-9696862;
CC       P97784; O08785: Clock; NbExp=10; IntAct=EBI-1266607, EBI-79859;
CC       P97784; P67871: Csnk2b; NbExp=4; IntAct=EBI-1266607, EBI-348179;
CC       P97784; Q8BFZ4: Fbxl21; NbExp=10; IntAct=EBI-1266607, EBI-6898235;
CC       P97784; Q8C4V4: Fbxl3; NbExp=12; IntAct=EBI-1266607, EBI-1266589;
CC       P97784; P06537-1: Nr3c1; NbExp=3; IntAct=EBI-1266607, EBI-15959147;
CC       P97784; O35973: Per1; NbExp=3; IntAct=EBI-1266607, EBI-1266764;
CC       P97784; O54943: Per2; NbExp=22; IntAct=EBI-1266607, EBI-1266779;
CC       P97784; Q8CIG8: Prmt5; NbExp=2; IntAct=EBI-1266607, EBI-2527009;
CC       P97784; P67870: CSNK2B; Xeno; NbExp=2; IntAct=EBI-1266607, EBI-348169;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11779462}. Nucleus
CC       {ECO:0000269|PubMed:11779462, ECO:0000269|PubMed:19129230}.
CC       Note=Transloctaed to the nucleus through interaction with other clock
CC       proteins such as PER2 or ARNTL/BMAL1.
CC   -!- TISSUE SPECIFICITY: Expressed in cones, amacrine cells, and retinal
CC       ganglion cells of the retina (at protein level) (PubMed:29561690).
CC       Expressed in all tissues examined including heart, brain, spleen, lung,
CC       liver, skeletal muscle, kidney and testis. Higher levels in brain,
CC       liver and testis. In the retina, highly expressed in the ganglion cell
CC       layer (GCL) and in the inner nuclear layer (INL). Evenly distributed in
CC       central and peripheral retina. In the brain, highly expressed in the
CC       suprachiasmatic nucleus (SCN). High levels in cerebral cortical layers
CC       particularly in the pyramidial cell layer of the hippocampus, the
CC       granular cell layer of the dentate gyrus (DG) and the pyramidal cell
CC       layer of the piriform cortex (PFC). {ECO:0000269|PubMed:10428031,
CC       ECO:0000269|PubMed:10521578, ECO:0000269|PubMed:11779462,
CC       ECO:0000269|PubMed:16790549, ECO:0000269|PubMed:29561690,
CC       ECO:0000269|PubMed:9600923, ECO:0000269|PubMed:9801304}.
CC   -!- INDUCTION: Oscillates diurnally, rhythmic expression in the early night
CC       is critical for clock function (at protein level). In SCN, exhibits
CC       circadian rhythm expression with highest levels during the light phase
CC       at CT10. No detectable expression after 8 hours in the dark. Circadian
CC       oscillations also observed in liver, skeletal muscle and cerebellum,
CC       but not in testis. {ECO:0000269|PubMed:10428031,
CC       ECO:0000269|PubMed:10521578, ECO:0000269|PubMed:16790549,
CC       ECO:0000269|PubMed:19917250, ECO:0000269|PubMed:20385766,
CC       ECO:0000269|PubMed:21236481, ECO:0000269|PubMed:23133559,
CC       ECO:0000269|PubMed:9600923}.
CC   -!- DOMAIN: The LIR motifs (LC3-interacting region) 3 and 5 are required
CC       for its interaction with MAP1LC3B and for its autophagy-mediated
CC       degradation. {ECO:0000269|PubMed:29937374}.
CC   -!- PTM: Phosphorylation on Ser-247 by MAPK is important for the inhibition
CC       of CLOCK-ARNTL/BMAL1-mediated transcriptional activity. Phosphorylation
CC       by CSNK1E requires interaction with PER1 or PER2. Phosphorylation at
CC       Ser-71 and Ser-280 by AMPK decreases protein stability. Phosphorylation
CC       at Ser-588 exhibits a robust circadian rhythm with a peak at CT8,
CC       increases protein stability, prevents SCF(FBXL3)-mediated degradation
CC       and is antagonized by interaction with PRKDC.
CC       {ECO:0000269|PubMed:11875063, ECO:0000269|PubMed:15298678,
CC       ECO:0000269|PubMed:19833968, ECO:0000269|PubMed:24158435}.
CC   -!- PTM: Ubiquitinated by the SCF(FBXL3) and SCF(FBXL21) complexes,
CC       regulating the balance between degradation and stabilization. The
CC       SCF(FBXL3) complex is mainly nuclear and mediates ubiquitination and
CC       subsequent degradation of CRY1. In contrast, cytoplasmic SCF(FBXL21)
CC       complex-mediated ubiquitination leads to stabilize CRY1 and counteract
CC       the activity of the SCF(FBXL3) complex. The SCF(FBXL3) and SCF(FBXL21)
CC       complexes probably mediate ubiquitination at different Lys residues.
CC       Ubiquitination at Lys-11 and Lys-107 are specifically ubiquitinated by
CC       the SCF(FBXL21) complex but not by the SCF(FBXL3) complex.
CC       Ubiquitination may be inhibited by PER2. Deubiquitinated by USP7
CC       (PubMed:27123980). {ECO:0000269|PubMed:11889036,
CC       ECO:0000269|PubMed:17462724, ECO:0000269|PubMed:18953409,
CC       ECO:0000269|PubMed:23452855, ECO:0000269|PubMed:23452856,
CC       ECO:0000269|PubMed:26776516, ECO:0000269|PubMed:27123980}.
CC   -!- PTM: Undergoes autophagy-mediated degradation in the liver in a time-
CC       dependent manner. Autophagic degradation of CRY1 (an inhibitor of
CC       gluconeogenesis) occurs during periods of reduced feeding allowing
CC       induction of gluconeogenesis and maintenance of blood glucose levels.
CC       {ECO:0000269|PubMed:29937374}.
CC   -!- DISRUPTION PHENOTYPE: Mice show an advanced phase shift (around 4
CC       hours) in the expression of DBP, NR1D1 and PER1 genes in the liver.
CC       Double knockouts of CRY1 and CRY2 show slightly decrease body weight
CC       and lose the cycling rhythmicity of feeding behavior, energy
CC       expenditure and glucocorticoids expression. Glucose homeostasis is
CC       severely disrupted and animals exhibit elevated blood glucose in
CC       response to acute feeding after an overnight fast as well as severely
CC       impaired glucose clearance in a glucose tolerance test. When challenged
CC       with high-fat diet, animals rapidly gain weight and surpass that of
CC       wild-type mice, despite displaying hypophagia. They exhibit
CC       hyperinsulinemia and selective insulin resistance in the liver and
CC       muscle but show high insulin sensitivity in adipose tissue and
CC       consequent increased lipid uptake. Mice display enlarged gonadal,
CC       subcutaneous and perirenal fat deposits with adipocyte hypertrophy and
CC       increased lipied accumulation in liver. Mice show loss of circadian
CC       rhythms in photopic ERG b-wave amplitudes, visual contrast sensitivity
CC       and pupillary light responses, with reduced robustness and stability of
CC       bioluminescent rhythms (PubMed:29561690). Both single CRY1 knockout and
CC       double CRY1 and CRY2 knockout mice show increased exercise performance
CC       and increased mitochondrial reserve capacity in primary myotubes
CC       (PubMed:28683290). {ECO:0000269|PubMed:20852621,
CC       ECO:0000269|PubMed:22170608, ECO:0000269|PubMed:23531614,
CC       ECO:0000269|PubMed:23616524, ECO:0000269|PubMed:24385426,
CC       ECO:0000269|PubMed:28683290, ECO:0000269|PubMed:29561690}.
CC   -!- SIMILARITY: Belongs to the DNA photolyase class-1 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB000777; BAA19175.1; -; mRNA.
DR   EMBL; AF156986; AAD39548.1; -; mRNA.
DR   EMBL; AK162460; BAE36931.1; -; mRNA.
DR   EMBL; BC022174; AAH22174.1; -; mRNA.
DR   EMBL; BC085499; AAH85499.1; -; mRNA.
DR   CCDS; CCDS24089.1; -.
DR   RefSeq; NP_031797.1; NM_007771.3.
DR   PDB; 4CT0; X-ray; 2.45 A; A=1-496.
DR   PDB; 4K0R; X-ray; 2.65 A; A=1-606.
DR   PDB; 5T5X; X-ray; 1.84 A; A=1-491.
DR   PDB; 6KX4; X-ray; 2.00 A; A=1-496.
DR   PDB; 6KX5; X-ray; 2.00 A; A=1-496.
DR   PDB; 6KX6; X-ray; 2.00 A; A/B=1-496.
DR   PDB; 6KX7; X-ray; 2.10 A; A=1-496.
DR   PDB; 6LUE; X-ray; 2.10 A; A/B=1-496.
DR   PDB; 6OF7; X-ray; 3.11 A; A=1-491.
DR   PDB; 7D19; X-ray; 2.35 A; A/B=1-496.
DR   PDB; 7D1C; X-ray; 1.91 A; A=1-496.
DR   PDBsum; 4CT0; -.
DR   PDBsum; 4K0R; -.
DR   PDBsum; 5T5X; -.
DR   PDBsum; 6KX4; -.
DR   PDBsum; 6KX5; -.
DR   PDBsum; 6KX6; -.
DR   PDBsum; 6KX7; -.
DR   PDBsum; 6LUE; -.
DR   PDBsum; 6OF7; -.
DR   PDBsum; 7D19; -.
DR   PDBsum; 7D1C; -.
DR   SMR; P97784; -.
DR   BioGRID; 198906; 35.
DR   ComplexPortal; CPX-3209; Cry1-Per2 complex.
DR   ComplexPortal; CPX-3216; Cry1-Per1 complex.
DR   ComplexPortal; CPX-3217; Cry1-Per3 complex.
DR   CORUM; P97784; -.
DR   DIP; DIP-38515N; -.
DR   IntAct; P97784; 49.
DR   MINT; P97784; -.
DR   STRING; 10090.ENSMUSP00000020227; -.
DR   iPTMnet; P97784; -.
DR   PhosphoSitePlus; P97784; -.
DR   EPD; P97784; -.
DR   MaxQB; P97784; -.
DR   PaxDb; P97784; -.
DR   PeptideAtlas; P97784; -.
DR   PRIDE; P97784; -.
DR   ProteomicsDB; 284026; -.
DR   Antibodypedia; 3122; 282 antibodies.
DR   DNASU; 12952; -.
DR   Ensembl; ENSMUST00000020227; ENSMUSP00000020227; ENSMUSG00000020038.
DR   GeneID; 12952; -.
DR   KEGG; mmu:12952; -.
DR   UCSC; uc007gle.1; mouse.
DR   CTD; 1407; -.
DR   MGI; MGI:1270841; Cry1.
DR   eggNOG; KOG0133; Eukaryota.
DR   GeneTree; ENSGT00940000155455; -.
DR   HOGENOM; CLU_010348_3_4_1; -.
DR   InParanoid; P97784; -.
DR   OMA; WQWSASS; -.
DR   OrthoDB; 378952at2759; -.
DR   PhylomeDB; P97784; -.
DR   TreeFam; TF323191; -.
DR   BioGRID-ORCS; 12952; 1 hit in 52 CRISPR screens.
DR   ChiTaRS; Cry1; mouse.
DR   PRO; PR:P97784; -.
DR   Proteomes; UP000000589; Chromosome 10.
DR   RNAct; P97784; protein.
DR   Bgee; ENSMUSG00000020038; Expressed in secondary oocyte and 304 other tissues.
DR   Genevisible; P97784; MM.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0070888; F:E-box binding; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IBA:GO_Central.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:UniProtKB.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0035257; F:nuclear hormone receptor binding; IPI:UniProtKB.
DR   GO; GO:0019902; F:phosphatase binding; ISO:MGI.
DR   GO; GO:0009881; F:photoreceptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0032922; P:circadian regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; IDA:MGI.
DR   GO; GO:0006975; P:DNA damage induced protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; IMP:UniProtKB.
DR   GO; GO:0006094; P:gluconeogenesis; IMP:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; IGI:UniProtKB.
DR   GO; GO:0019915; P:lipid storage; IGI:UniProtKB.
DR   GO; GO:0042754; P:negative regulation of circadian rhythm; IDA:UniProtKB.
DR   GO; GO:0045744; P:negative regulation of G protein-coupled receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:2000323; P:negative regulation of glucocorticoid receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:2000850; P:negative regulation of glucocorticoid secretion; IGI:UniProtKB.
DR   GO; GO:0045721; P:negative regulation of gluconeogenesis; IMP:UniProtKB.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IMP:UniProtKB.
DR   GO; GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IMP:UniProtKB.
DR   GO; GO:2000001; P:regulation of DNA damage checkpoint; IDA:UniProtKB.
DR   GO; GO:0014823; P:response to activity; IMP:UniProtKB.
DR   GO; GO:0033762; P:response to glucagon; IMP:UniProtKB.
DR   GO; GO:0032868; P:response to insulin; IGI:UniProtKB.
DR   GO; GO:0009416; P:response to light stimulus; IMP:UniProtKB.
DR   Gene3D; 3.40.50.620; -; 1.
DR   IDEAL; IID50287; -.
DR   InterPro; IPR036134; Crypto/Photolyase_FAD-like_sf.
DR   InterPro; IPR036155; Crypto/Photolyase_N_sf.
DR   InterPro; IPR005101; Cryptochr/Photolyase_FAD-bd.
DR   InterPro; IPR006050; DNA_photolyase_N.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00875; DNA_photolyase; 1.
DR   Pfam; PF03441; FAD_binding_7; 1.
DR   SUPFAM; SSF48173; SSF48173; 1.
DR   SUPFAM; SSF52425; SSF52425; 1.
DR   PROSITE; PS51645; PHR_CRY_ALPHA_BETA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Biological rhythms; Chromophore; Cytoplasm; FAD;
KW   Flavoprotein; Isopeptide bond; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Photoreceptor protein; Receptor; Reference proteome; Repressor;
KW   Sensory transduction; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..606
FT                   /note="Cryptochrome-1"
FT                   /id="PRO_0000261142"
FT   DOMAIN          3..132
FT                   /note="Photolyase/cryptochrome alpha/beta"
FT   NP_BIND         387..389
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23746849"
FT   REGION          371..470
FT                   /note="Required for inhibition of CLOCK-ARNTL/BMAL1-
FT                   mediated transcription"
FT                   /evidence="ECO:0000269|PubMed:16478995"
FT   REGION          471..493
FT                   /note="Interaction with TIMELESS"
FT                   /evidence="ECO:0000269|PubMed:23418588"
FT   REGION          559..606
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           50..54
FT                   /note="LIR 1"
FT                   /evidence="ECO:0000305|PubMed:29937374"
FT   MOTIF           82..87
FT                   /note="LIR 2"
FT                   /evidence="ECO:0000305|PubMed:29937374"
FT   MOTIF           151..156
FT                   /note="LIR 3"
FT                   /evidence="ECO:0000305|PubMed:29937374"
FT   MOTIF           255..260
FT                   /note="LIR 4"
FT                   /evidence="ECO:0000305|PubMed:29937374"
FT   MOTIF           271..276
FT                   /note="LIR 5"
FT                   /evidence="ECO:0000305|PubMed:29937374"
FT   MOTIF           285..290
FT                   /note="LIR 6"
FT                   /evidence="ECO:0000305|PubMed:29937374"
FT   MOTIF           335..339
FT                   /note="LIR 7"
FT                   /evidence="ECO:0000305|PubMed:29937374"
FT   MOTIF           379..384
FT                   /note="LIR 8"
FT                   /evidence="ECO:0000305|PubMed:29937374"
FT   MOTIF           395..400
FT                   /note="LIR 9"
FT                   /evidence="ECO:0000305|PubMed:29937374"
FT   MOTIF           411..416
FT                   /note="LIR 10"
FT                   /evidence="ECO:0000305|PubMed:29937374"
FT   MOTIF           430..435
FT                   /note="LIR 11"
FT                   /evidence="ECO:0000305|PubMed:29937374"
FT   MOTIF           486..491
FT                   /note="LIR 12"
FT                   /evidence="ECO:0000305|PubMed:29937374"
FT   MOTIF           492..497
FT                   /note="LIR 13"
FT                   /evidence="ECO:0000305|PubMed:29937374"
FT   BINDING         252
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:23746849"
FT   BINDING         289
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23746849"
FT   BINDING         355
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23746849"
FT   MOD_RES         71
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:19833968"
FT   MOD_RES         247
FT                   /note="Phosphoserine; by MAPK"
FT                   /evidence="ECO:0000269|PubMed:15298678"
FT   MOD_RES         280
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:19833968"
FT   MOD_RES         588
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:24158435"
FT   CROSSLNK        11
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000305|PubMed:23452855"
FT   CROSSLNK        107
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:23452856"
FT   CROSSLNK        159
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:23452856"
FT   CROSSLNK        329
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:23452856"
FT   CROSSLNK        485
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:23452856"
FT   CROSSLNK        585
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:26431207"
FT   MUTAGEN         71
FT                   /note="S->A: Phosphomimetic mutant that leads to
FT                   stabilization of the protein; when associated with A-280."
FT                   /evidence="ECO:0000269|PubMed:19833968"
FT   MUTAGEN         71
FT                   /note="S->D: Phosphomimetic mutant that leads to
FT                   destabilization of the protein and abolishes ability to
FT                   bind PER2; when associated with D-280."
FT                   /evidence="ECO:0000269|PubMed:19833968"
FT   MUTAGEN         107
FT                   /note="K->R: Sensitive to FBXL3-ediated degradation but noz
FT                   affected by expression of FBXL21."
FT                   /evidence="ECO:0000269|PubMed:23452856"
FT   MUTAGEN         224
FT                   /note="H->E: Reduces affinity for FBXL3."
FT                   /evidence="ECO:0000269|PubMed:23746849"
FT   MUTAGEN         247
FT                   /note="S->A: Reduced MAPK-catalyzed in vitro
FT                   phosphorylation. No effect on inhibition of CLOCK-
FT                   ARNTL/BMAL1-mediated transcriptional activity."
FT                   /evidence="ECO:0000269|PubMed:15298678,
FT                   ECO:0000269|PubMed:23746849"
FT   MUTAGEN         247
FT                   /note="S->D: Reduced inhibition of CLOCK-ARNTL/BMAL1-
FT                   mediated transcriptional activity."
FT                   /evidence="ECO:0000269|PubMed:15298678,
FT                   ECO:0000269|PubMed:23746849"
FT   MUTAGEN         273
FT                   /note="Y->A: Reduced interaction with MAP1LC3B and
FT                   significant decrease in its autophagy-mediated degradation;
FT                   when associated with A-276."
FT                   /evidence="ECO:0000269|PubMed:29937374"
FT   MUTAGEN         276
FT                   /note="V->A: Reduced interaction with MAP1LC3B and
FT                   significant decrease in its autophagy-mediated degradation;
FT                   when associated with A-273."
FT                   /evidence="ECO:0000269|PubMed:29937374"
FT   MUTAGEN         280
FT                   /note="S->A: Phosphomimetic mutant that leads to
FT                   stabilization of the protein; when associated with A-71."
FT                   /evidence="ECO:0000269|PubMed:19833968"
FT   MUTAGEN         280
FT                   /note="S->D: Phosphomimetic mutant that leads to
FT                   destabilization of the protein and abolishes ability to
FT                   bind PER2; when associated with D-71."
FT                   /evidence="ECO:0000269|PubMed:19833968"
FT   MUTAGEN         287
FT                   /note="Y->A: No effect on its interaction with MAP1LC3B and
FT                   moderate decrease in its autophagy-mediated degradation;
FT                   when associated with A-290."
FT                   /evidence="ECO:0000269|PubMed:29937374"
FT   MUTAGEN         290
FT                   /note="L->A: No effect on its interaction with MAP1LC3B and
FT                   moderate decrease in its autophagy-mediated degradation;
FT                   when associated with A-287."
FT                   /evidence="ECO:0000269|PubMed:29937374"
FT   MUTAGEN         336
FT                   /note="G->D: Abolishes transcriptional repression of target
FT                   genes. Abolishes interaction with PER2."
FT   MUTAGEN         382..383
FT                   /note="EE->RR: Decreases transcriptional repression of
FT                   target genes. Decreases FBXL3 binding. Increases PER2
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:23746849"
FT   MUTAGEN         405
FT                   /note="F->A: Decreases affinity for FBXL3. Slightly
FT                   increases affinity for PER2."
FT                   /evidence="ECO:0000269|PubMed:23746849"
FT   MUTAGEN         485
FT                   /note="K->D,E: Strongly reduces FBXL3 binding. Reduces PER2
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:23746849"
FT   MUTAGEN         488
FT                   /note="Y->A: No efect on its interaction with MAP1LC3B and
FT                   moderate decrease in its autophagy-mediated degradation;
FT                   when associated with A-491."
FT                   /evidence="ECO:0000269|PubMed:29937374"
FT   MUTAGEN         491
FT                   /note="L->A: No effect on its interaction with MAP1LC3B and
FT                   moderate decrease in its autophagy-mediated degradation;
FT                   when associated with A-488."
FT                   /evidence="ECO:0000269|PubMed:29937374"
FT   MUTAGEN         494
FT                   /note="Y->A: Loss of interaction with MAP1LC3B and
FT                   significant decrease in its autophagy-mediated degradation;
FT                   when associated with A-497."
FT                   /evidence="ECO:0000269|PubMed:29937374"
FT   MUTAGEN         497
FT                   /note="L->A: Loss of interaction with MAP1LC3B and
FT                   significant decrease in its autophagy-mediated degradation;
FT                   when associated with A-494."
FT                   /evidence="ECO:0000269|PubMed:29937374"
FT   MUTAGEN         551
FT                   /note="S->A: No effect on circadian period length and
FT                   protein stability."
FT                   /evidence="ECO:0000269|PubMed:24158435"
FT   MUTAGEN         551
FT                   /note="S->D: No effect on circadian period length and
FT                   protein stability."
FT                   /evidence="ECO:0000269|PubMed:24158435"
FT   MUTAGEN         564
FT                   /note="S->A: No effect on circadian period length and
FT                   protein stability."
FT                   /evidence="ECO:0000269|PubMed:24158435"
FT   MUTAGEN         564
FT                   /note="S->D: No effect on circadian period length and
FT                   protein stability."
FT                   /evidence="ECO:0000269|PubMed:24158435"
FT   MUTAGEN         585
FT                   /note="K->A: Loss of ubiquitination. No loss of interaction
FT                   with DDB1-CUL4A complex."
FT                   /evidence="ECO:0000269|PubMed:26431207"
FT   MUTAGEN         588
FT                   /note="S->A: No effect on circadian period length and
FT                   protein stability."
FT                   /evidence="ECO:0000269|PubMed:24158435"
FT   MUTAGEN         588
FT                   /note="S->D: Lengthen circadian period. No effect on
FT                   repressive activity. Increases protein stability."
FT                   /evidence="ECO:0000269|PubMed:24158435"
FT   STRAND          4..11
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   STRAND          14..17
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           19..25
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   STRAND          29..37
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           39..41
FT                   /evidence="ECO:0007829|PDB:6KX7"
FT   TURN            42..44
FT                   /evidence="ECO:0007829|PDB:6KX7"
FT   HELIX           49..67
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   TURN            68..70
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   STRAND          73..78
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           80..91
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   STRAND          93..99
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           104..119
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   STRAND          123..127
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   STRAND          130..133
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           135..141
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           150..158
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   TURN            174..177
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           186..190
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   TURN            195..199
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           214..229
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           241..244
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           252..256
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           262..277
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           284..287
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           288..300
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   TURN            304..307
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           324..332
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           338..350
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           355..365
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   TURN            366..370
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           374..384
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           390..400
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   STRAND          403..405
FT                   /evidence="ECO:0007829|PDB:6KX7"
FT   HELIX           417..422
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           427..432
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           434..436
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   TURN            441..445
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           447..449
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           452..457
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   TURN            462..464
FT                   /evidence="ECO:0007829|PDB:5T5X"
FT   HELIX           473..487
FT                   /evidence="ECO:0007829|PDB:5T5X"
SQ   SEQUENCE   606 AA;  68001 MW;  2F2B8DD53F0A9AF9 CRC64;
     MGVNAVHWFR KGLRLHDNPA LKECIQGADT IRCVYILDPW FAGSSNVGIN RWRFLLQCLE
     DLDANLRKLN SRLFVIRGQP ADVFPRLFKE WNITKLSIEY DSEPFGKERD AAIKKLATEA
     GVEVIVRISH TLYDLDKIIE LNGGQPPLTY KRFQTLVSKM EPLEMPADTI TSDVIGKCMT
     PLSDDHDEKY GVPSLEELGF DTDGLSSAVW PGGETEALTR LERHLERKAW VANFERPRMN
     ANSLLASPTG LSPYLRFGCL SCRLFYFKLT DLYKKVKKNS SPPLSLYGQL LWREFFYTAA
     TNNPRFDKME GNPICVQIPW DKNPEALAKW AEGRTGFPWI DAIMTQLRQE GWIHHLARHA
     VACFLTRGDL WISWEEGMKV FEELLLDADW SINAGSWMWL SCSSFFQQFF HCYCPVGFGR
     RTDPNGDYIR RYLPVLRGFP AKYIYDPWNA PEGIQKVAKC LIGVNYPKPM VNHAEASRLN
     IERMKQIYQQ LSRYRGLGLL ASVPSNSNGN GGLMGYAPGE NVPSCSSSGN GGLMGYAPGE
     NVPSCSGGNC SQGSGILHYA HGDSQQTHSL KQGRSSAGTG LSSGKRPSQE EDAQSVGPKV
     QRQSSN
//
ID   ACD11_HUMAN             Reviewed;         780 AA.
AC   Q709F0; Q08AF0; Q658N9; Q658Y2; Q6ZND2; Q8WUT6; Q9H9R3;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   12-SEP-2018, sequence version 3.
DT   02-JUN-2021, entry version 156.
DE   RecName: Full=Acyl-CoA dehydrogenase family member 11;
DE            Short=ACAD-11;
DE            EC=1.3.8.- {ECO:0000269|PubMed:21237683};
GN   Name=ACAD11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Mahieu V., Van Veldhoven P.P.;
RT   "Presence of an acyl-CoA dehydrogenase in mammalian peroxisomes ?";
RL   Submitted (NOV-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 35-780 (ISOFORM 1).
RC   TISSUE=Lymph node, and Stomach;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-563 (ISOFORM 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 343-780 (ISOFORM 1).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=21237683; DOI=10.1016/j.ymgme.2010.12.005;
RA   He M., Pei Z., Mohsen A.W., Watkins P., Murdoch G., Van Veldhoven P.P.,
RA   Ensenauer R., Vockley J.;
RT   "Identification and characterization of new long chain acyl-CoA
RT   dehydrogenases.";
RL   Mol. Genet. Metab. 102:418-429(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 355-780 IN COMPLEX WITH FAD,
RP   COFACTOR, AND SUBUNIT.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human acyl-CoA dehydrogenase 11.";
RL   Submitted (MAY-2009) to the PDB data bank.
CC   -!- FUNCTION: Acyl-CoA dehydrogenase, that exhibits maximal activity
CC       towards saturated C22-CoA (PubMed:21237683). Probably participates in
CC       beta-oxydation and energy production but could also play a role in the
CC       metabolism of specific fatty acids to control fatty acids composition
CC       of cellular lipids in brain (Probable). {ECO:0000269|PubMed:21237683,
CC       ECO:0000305|PubMed:21237683}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2,3-saturated acyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = a (2E)-enoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:44704, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:58856, ChEBI:CHEBI:65111;
CC         Evidence={ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44705;
CC         Evidence={ECO:0000305|PubMed:21237683};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=docosanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-docosenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47228, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:65059, ChEBI:CHEBI:74692;
CC         Evidence={ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47229;
CC         Evidence={ECO:0000305|PubMed:21237683};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + oxidized [electron-transfer flavoprotein] +
CC         tetracosanoyl-CoA = (2E)-tetracosenoyl-CoA + reduced [electron-
CC         transfer flavoprotein]; Xref=Rhea:RHEA:47232, Rhea:RHEA-COMP:10685,
CC         Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:65052, ChEBI:CHEBI:74693;
CC         Evidence={ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47233;
CC         Evidence={ECO:0000305|PubMed:21237683};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=eicosanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-eicosenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47236, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57380, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:74691;
CC         Evidence={ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47237;
CC         Evidence={ECO:0000305|PubMed:21237683};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hexacosanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] = (2E)-hexacosenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:48216, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:64868, ChEBI:CHEBI:74281;
CC         Evidence={ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48217;
CC         Evidence={ECO:0000305|PubMed:21237683};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + oxidized [electron-transfer flavoprotein] +
CC         tricosanoyl-CoA = (2E)-tricosenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:48220, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:90118, ChEBI:CHEBI:90119;
CC         Evidence={ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48221;
CC         Evidence={ECO:0000305|PubMed:21237683};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|Ref.9};
CC   -!- PATHWAY: Lipid metabolism; fatty acid beta-oxidation.
CC       {ECO:0000305|PubMed:21237683}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|Ref.9}.
CC   -!- INTERACTION:
CC       Q709F0; O95400: CD2BP2; NbExp=4; IntAct=EBI-2880718, EBI-768015;
CC   -!- SUBCELLULAR LOCATION: Peroxisome {ECO:0000250|UniProtKB:Q80XL6}.
CC       Mitochondrion membrane {ECO:0000269|PubMed:21237683}. Note=Has been
CC       detected associated with mitochondrial membrane, but no matrix, in
CC       kidney and cerebellum, as well as in a neuroblastoma cell line, but not
CC       in skin fibroblasts, where it is observed in cytoplasmic vesicles
CC       (PubMed:21237683). No mitochondrial targeting signals could be
CC       predicted for any known isoform, including a putative isoform starting
CC       at Met-316. {ECO:0000269|PubMed:21237683}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q709F0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q709F0-2; Sequence=VSP_021188;
CC       Name=3;
CC         IsoId=Q709F0-3; Sequence=VSP_021187;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in brain
CC       followed by liver, heart and kidney. {ECO:0000269|PubMed:21237683}.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14158.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ608287; CAE55233.1; -; mRNA.
DR   EMBL; AL833721; CAH56228.1; -; mRNA.
DR   EMBL; AL832873; CAH56354.1; -; mRNA.
DR   EMBL; AK022654; BAB14158.1; ALT_INIT; mRNA.
DR   EMBL; AK131265; BAD18443.1; -; mRNA.
DR   EMBL; AC020632; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF457683; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF457684; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC019607; AAH19607.2; -; mRNA.
DR   EMBL; BC125204; AAI25205.1; -; mRNA.
DR   CCDS; CCDS3074.1; -. [Q709F0-1]
DR   RefSeq; NP_115545.3; NM_032169.4. [Q709F0-1]
DR   PDB; 2WBI; X-ray; 2.80 A; A/B=355-780.
DR   PDBsum; 2WBI; -.
DR   SMR; Q709F0; -.
DR   BioGRID; 123902; 73.
DR   IntAct; Q709F0; 48.
DR   MINT; Q709F0; -.
DR   STRING; 9606.ENSP00000264990; -.
DR   ChEMBL; CHEMBL4105707; -.
DR   SwissLipids; SLP:000001326; -.
DR   iPTMnet; Q709F0; -.
DR   PhosphoSitePlus; Q709F0; -.
DR   BioMuta; ACAD11; -.
DR   DMDM; 117949774; -.
DR   EPD; Q709F0; -.
DR   jPOST; Q709F0; -.
DR   MassIVE; Q709F0; -.
DR   MaxQB; Q709F0; -.
DR   PaxDb; Q709F0; -.
DR   PeptideAtlas; Q709F0; -.
DR   PRIDE; Q709F0; -.
DR   ProteomicsDB; 68516; -. [Q709F0-1]
DR   ProteomicsDB; 68517; -. [Q709F0-2]
DR   ProteomicsDB; 68518; -. [Q709F0-3]
DR   Antibodypedia; 34898; 99 antibodies.
DR   DNASU; 84129; -.
DR   Ensembl; ENST00000264990; ENSP00000264990; ENSG00000240303. [Q709F0-1]
DR   GeneID; 84129; -.
DR   KEGG; hsa:84129; -.
DR   UCSC; uc003eov.5; human. [Q709F0-1]
DR   CTD; 84129; -.
DR   DisGeNET; 84129; -.
DR   GeneCards; ACAD11; -.
DR   HGNC; HGNC:30211; ACAD11.
DR   HPA; ENSG00000240303; Tissue enhanced (kidney, liver).
DR   MIM; 614288; gene.
DR   neXtProt; NX_Q709F0; -.
DR   OpenTargets; ENSG00000240303; -.
DR   PharmGKB; PA142672658; -.
DR   VEuPathDB; HostDB:ENSG00000240303.7; -.
DR   eggNOG; KOG1469; Eukaryota.
DR   GeneTree; ENSGT00940000160993; -.
DR   HOGENOM; CLU_007526_3_1_1; -.
DR   InParanoid; Q709F0; -.
DR   OMA; SPQRWHT; -.
DR   OrthoDB; 1028522at2759; -.
DR   PhylomeDB; Q709F0; -.
DR   TreeFam; TF333953; -.
DR   PathwayCommons; Q709F0; -.
DR   Reactome; R-HSA-77289; Mitochondrial Fatty Acid Beta-Oxidation.
DR   UniPathway; UPA00659; -.
DR   BioGRID-ORCS; 84129; 4 hits in 998 CRISPR screens.
DR   EvolutionaryTrace; Q709F0; -.
DR   GenomeRNAi; 84129; -.
DR   Pharos; Q709F0; Tbio.
DR   PRO; PR:Q709F0; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q709F0; protein.
DR   Bgee; ENSG00000240303; Expressed in liver and 115 other tissues.
DR   ExpressionAtlas; Q709F0; baseline and differential.
DR   Genevisible; Q709F0; HS.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0031966; C:mitochondrial membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; ISS:HGNC.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0004466; F:long-chain-acyl-CoA dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0070991; F:medium-chain-acyl-CoA dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0017099; F:very-long-chain-acyl-CoA dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome.
DR   GO; GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; IDA:UniProtKB.
DR   CDD; cd05154; ACAD10_11_N-like; 1.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR041726; ACAD10_11_N.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   InterPro; IPR002575; Aminoglycoside_PTrfase.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   Pfam; PF01636; APH; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; FAD;
KW   Fatty acid metabolism; Flavoprotein; Lipid metabolism; Membrane;
KW   Mitochondrion; Oxidoreductase; Peroxisome; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..780
FT                   /note="Acyl-CoA dehydrogenase family member 11"
FT                   /id="PRO_0000254145"
FT   NP_BIND         504..514
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.9"
FT   NP_BIND         538..540
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.9"
FT   NP_BIND         727..731
FT                   /note="FAD; shared with dimeric partner"
FT                   /evidence="ECO:0000269|Ref.9"
FT   NP_BIND         756..758
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.9"
FT   REGION          629..632
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250"
FT   BINDING         514
FT                   /note="Substrate; via carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   BINDING         657
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.9"
FT   BINDING         657
FT                   /note="FAD; shared with dimeric partner"
FT                   /evidence="ECO:0000269|Ref.9"
FT   BINDING         727
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.9"
FT   BINDING         755
FT                   /note="Substrate; via amide nitrogen"
FT   MOD_RES         177
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80XL6"
FT   MOD_RES         324
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80XL6"
FT   MOD_RES         391
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80XL6"
FT   VAR_SEQ         1..120
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_021187"
FT   VAR_SEQ         564..667
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_021188"
FT   VARIANT         362
FT                   /note="V -> L (in dbSNP:rs6776576)"
FT                   /id="VAR_028826"
FT   CONFLICT        414
FT                   /note="K -> T (in Ref. 2; CAH56354)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        549
FT                   /note="I -> V (in Ref. 1; CAE55233 and 3; BAB14158)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        562
FT                   /note="S -> SRLT (in Ref. 2; CAH56228)"
FT                   /evidence="ECO:0000305"
FT   HELIX           377..392
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           394..402
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           404..408
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           419..430
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           439..442
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           446..456
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           462..465
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           472..482
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           485..490
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           492..497
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   STRAND          499..505
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           516..518
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   STRAND          522..526
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   STRAND          529..540
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   TURN            541..543
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   STRAND          547..555
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           563..565
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   STRAND          567..573
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   STRAND          579..584
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           593..595
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   STRAND          598..609
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           610..612
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           620..656
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           664..666
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           668..702
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           704..728
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           730..734
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           740..750
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   TURN            751..754
FT                   /evidence="ECO:0007829|PDB:2WBI"
FT   HELIX           757..776
FT                   /evidence="ECO:0007829|PDB:2WBI"
SQ   SEQUENCE   780 AA;  87264 MW;  E4DC30F6ABE70463 CRC64;
     MKPGATGESD LAEVLPQHKF DSKSLEAYLN QHLSGFGAER EATLTIAQYR AGKSNPTFYL
     QKGFQTYVLR KKPPGSLLPK AHQIDREFKV QKALFSIGFP VPKPILYCSD TSVIGTEFYV
     MEHVQGRIFR DLTIPGLSPA ERSAIYVATV ETLAQLHSLN IQSLQLEGYG IGAGYCKRQV
     STWTKQYQAA AHQDIPAMQQ LSEWLMKNLP DNDNEENLIH GDFRLDNIVF HPKECRVIAV
     LDWELSTIGH PLSDLAHFSL FYFWPRTVPM INQGSYSENS GIPSMEELIS IYCRCRGINS
     ILPNWNFFLA LSYFKMAGIA QGVYSRYLLG NNSSEDSFLF ANIVQPLAET GLQLSKRTFS
     TVLPQIDTTG QLFVQTRKGQ EVLIKVKHFM KQHILPAEKE VTEFYVQNEN SVDKWGKPLV
     IDKLKEMAKV EGLWNLFLPA VSGLSHVDYA LIAEETGKCF FAPDVFNCQA PDTGNMEVLH
     LYGSEEQKKQ WLEPLLQGNI TSCFCMTEPD VASSDATNIE CSIQRDEDSY VINGKKWWSS
     GAGNPKCKIA IVLGRTQNTS LSRHKQHSMI LVPMNTPGVK IIRPLSVFGY TDNFHGGHFE
     IHFNQVRVPA TNLILGEGRG FEISQGRLGP GRIHHCMRTV GLAERALQIM CERATQRIAF
     KKKLYAHEVV AHWIAESRIA IEKIRLLTLK AAHSMDTLGS AGAKKEIAMI KVAAPRAVSK
     IVDWAIQVCG GAGVSQDYPL ANMYAITRVL RLADGPDEVH LSAIATMELR DQAKRLTAKI
//
ID   ACADS_HUMAN             Reviewed;         412 AA.
AC   P16219; P78331;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   02-JUN-2021, entry version 216.
DE   RecName: Full=Short-chain specific acyl-CoA dehydrogenase, mitochondrial;
DE            Short=SCAD;
DE            EC=1.3.8.1 {ECO:0000269|PubMed:21237683};
DE   AltName: Full=Butyryl-CoA dehydrogenase;
DE   Flags: Precursor;
GN   Name=ACADS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2565344; DOI=10.1172/jci114058;
RA   Naito E., Ozasa H., Ikeda Y., Tanaka K.;
RT   "Molecular cloning and nucleotide sequence of complementary DNAs encoding
RT   human short chain acyl-coenzyme A dehydrogenase and the study of the
RT   molecular basis of human short chain acyl-coenzyme A dehydrogenase
RT   deficiency.";
RL   J. Clin. Invest. 83:1605-1613(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9383286; DOI=10.1007/s003359900612;
RA   Corydon M.J., Andresen B.S., Bross P., Kjeldsen M., Andreasen P.H.,
RA   Eiberg H., Koelvraa S., Gregersen N.;
RT   "Structural organization of the human short-chain acyl-CoA dehydrogenase
RT   gene.";
RL   Mamm. Genome 8:922-926(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Yamagata K., Oda N., Furuta H., Vaxillaire M., Southam L., Boriraj V.,
RA   Chen X., Oda Y., Takeda J., Yamada S., Nishigori H., Lebeau M.M.,
RA   Lathrop M., Cox R.D., Bell G.I.;
RT   "Transcription map of the 5cM region surrounding the hepatocyte nuclear
RT   factor-1a/MODY3 gene on chromosome 12.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Retinal pigment epithelium;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 25-34.
RC   TISSUE=Liver;
RX   PubMed=1286669; DOI=10.1002/elps.11501301201;
RA   Hochstrasser D.F., Frutiger S., Paquet N., Bairoch A., Ravier F.,
RA   Pasquali C., Sanchez J.-C., Tissot J.-D., Bjellqvist B., Vargas R.,
RA   Appel R.D., Hughes G.J.;
RT   "Human liver protein map: a reference database established by
RT   microsequencing and gel comparison.";
RL   Electrophoresis 13:992-1001(1992).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBSTRATE SPECIFICITY.
RX   PubMed=21237683; DOI=10.1016/j.ymgme.2010.12.005;
RA   He M., Pei Z., Mohsen A.W., Watkins P., Murdoch G., Van Veldhoven P.P.,
RA   Ensenauer R., Vockley J.;
RT   "Identification and characterization of new long chain acyl-CoA
RT   dehydrogenases.";
RL   Mol. Genet. Metab. 102:418-429(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 30-412 IN COMPLEX WITH FAD AND
RP   SUBSTRATE ANALOG, AND COFACTOR.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human RAB14.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [11]
RP   VARIANTS ACADSD.
RX   PubMed=1692038; DOI=10.1172/jci114607;
RA   Naito E., Indo Y., Tanaka K.;
RT   "Identification of two variant short chain acyl-coenzyme A dehydrogenase
RT   alleles, each containing a different point mutation in a patient with short
RT   chain acyl-coenzyme A dehydrogenase deficiency.";
RL   J. Clin. Invest. 85:1575-1582(1990).
RN   [12]
RP   VARIANTS ACADSD CYS-92; ARG-177 AND CYS-383, AND VARIANTS TRP-171 AND
RP   SER-209.
RX   PubMed=9499414; DOI=10.1093/hmg/7.4.619;
RA   Gregersen N., Winter V.S., Corydon M.J., Corydon T.J., Rinaldo P.,
RA   Ribes A., Martinez G., Bennett M.J., Vianey-Saban C., Bhala A., Hale D.E.,
RA   Lehnert W., Kmoch S., Roig M., Riudor E., Eiberg H., Andresen B.S.,
RA   Bross P., Bolund L.A., Koelvraa S.;
RT   "Identification of four new mutations in the short-chain acyl-CoA
RT   dehydrogenase (SCAD) gene in two patients: one of the variant alleles,
RT   511C-->T, is present at an unexpectedly high frequency in the general
RT   population, as was the case for 625G-->A, together conferring
RT   susceptibility to ethylmalonic aciduria.";
RL   Hum. Mol. Genet. 7:619-627(1998).
RN   [13]
RP   VARIANTS ACADSD SER-90; GLU-104 DEL; VAL-192; TRP-325; LEU-353 AND TRP-380,
RP   VARIANTS TRP-171 AND SER-209, CHARACTERIZATION OF VARIANTS ACADSD SER-90;
RP   GLU-104 DEL; VAL-192; TRP-325; LEU-353 AND TRP-380, CHARACTERIZATION OF
RP   VARIANTS TRP-171 AND SER-209, FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=11134486; DOI=10.1203/00006450-200101000-00008;
RA   Corydon M.J., Vockley J., Rinaldo P., Rhead W.J., Kjeldsen M., Winter V.S.,
RA   Riggs C., Babovic-Vuksanovic D., Smeitink J., De Jong J., Levy H.,
RA   Sewell A.C., Roe C., Matern D., Dasouki M., Gregersen N.;
RT   "Role of common gene variations in the molecular pathogenesis of short-
RT   chain acyl-CoA dehydrogenase deficiency.";
RL   Pediatr. Res. 49:18-23(2001).
CC   -!- FUNCTION: Short-chain specific acyl-CoA dehydrogenase is one of the
CC       acyl-CoA dehydrogenases that catalyze the first step of mitochondrial
CC       fatty acid beta-oxidation, an aerobic process breaking down fatty acids
CC       into acetyl-CoA and allowing the production of energy from fats (By
CC       similarity). The first step of fatty acid beta-oxidation consists in
CC       the removal of one hydrogen from C-2 and C-3 of the straight-chain
CC       fatty acyl-CoA thioester, resulting in the formation of trans-2-enoyl-
CC       CoA (By similarity). Among the different mitochondrial acyl-CoA
CC       dehydrogenases, short-chain specific acyl-CoA dehydrogenase acts
CC       specifically on acyl-CoAs with saturated 4 to 6 carbons long primary
CC       chains (PubMed:21237683, PubMed:11134486).
CC       {ECO:0000250|UniProtKB:P15651, ECO:0000269|PubMed:11134486,
CC       ECO:0000269|PubMed:21237683}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a short-chain 2,3-saturated fatty acyl-CoA + H(+) + oxidized
CC         [electron-transfer flavoprotein] = a short-chain (2E)-enoyl-CoA +
CC         reduced [electron-transfer flavoprotein]; Xref=Rhea:RHEA:47196,
CC         Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:87487,
CC         ChEBI:CHEBI:87488; EC=1.3.8.1;
CC         Evidence={ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47197;
CC         Evidence={ECO:0000305|PubMed:11134486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=butanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-butenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:24004, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57332, ChEBI:CHEBI:57371,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307; EC=1.3.8.1;
CC         Evidence={ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24005;
CC         Evidence={ECO:0000305|PubMed:11134486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + oxidized [electron-transfer flavoprotein] + pentanoyl-
CC         CoA = (2E)-pentenoyl-CoA + reduced [electron-transfer flavoprotein];
CC         Xref=Rhea:RHEA:43456, Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57389, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:86160;
CC         Evidence={ECO:0000250|UniProtKB:Q3ZBF6};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43457;
CC         Evidence={ECO:0000305|PubMed:11134486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hexanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] = (2E)-hexenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:43464, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:62077, ChEBI:CHEBI:62620;
CC         Evidence={ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43465;
CC         Evidence={ECO:0000305|PubMed:11134486};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|Ref.10};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|Ref.10};
CC   -!- PATHWAY: Lipid metabolism; mitochondrial fatty acid beta-oxidation.
CC       {ECO:0000305|PubMed:11134486}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|Ref.10}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000250|UniProtKB:Q3ZBF6}.
CC   -!- DISEASE: Acyl-CoA dehydrogenase short-chain deficiency (ACADSD)
CC       [MIM:201470]: An inborn error of mitochondrial fatty acid beta-
CC       oxidation resulting in acute acidosis and muscle weakness in infants,
CC       and a form of lipid-storage myopathy in adults.
CC       {ECO:0000269|PubMed:11134486, ECO:0000269|PubMed:1692038,
CC       ECO:0000269|PubMed:9499414}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Butyryl-CoA dehydrogenase entry;
CC       URL="https://en.wikipedia.org/wiki/Butyryl_CoA_dehydrogenase";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M26393; AAA60307.1; -; mRNA.
DR   EMBL; Z80345; CAB02492.1; -; Genomic_DNA.
DR   EMBL; Z80347; CAB02492.1; JOINED; Genomic_DNA.
DR   EMBL; U83992; AAD00552.1; -; Genomic_DNA.
DR   EMBL; U83991; AAD00552.1; JOINED; Genomic_DNA.
DR   EMBL; BC025963; AAH25963.1; -; mRNA.
DR   CCDS; CCDS9207.1; -.
DR   PIR; A30605; A30605.
DR   RefSeq; NP_000008.1; NM_000017.3.
DR   RefSeq; NP_001289483.1; NM_001302554.1.
DR   PDB; 2VIG; X-ray; 1.90 A; A/B/C/D/E/F/G/H=30-412.
DR   PDBsum; 2VIG; -.
DR   SMR; P16219; -.
DR   BioGRID; 106553; 16.
DR   IntAct; P16219; 12.
DR   MINT; P16219; -.
DR   STRING; 9606.ENSP00000242592; -.
DR   DrugBank; DB03059; Acetoacetyl-CoA.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB00157; NADH.
DR   SwissLipids; SLP:000001403; -.
DR   iPTMnet; P16219; -.
DR   MetOSite; P16219; -.
DR   PhosphoSitePlus; P16219; -.
DR   BioMuta; ACADS; -.
DR   DMDM; 113019; -.
DR   DOSAC-COBS-2DPAGE; P16219; -.
DR   SWISS-2DPAGE; P16219; -.
DR   UCD-2DPAGE; P16219; -.
DR   EPD; P16219; -.
DR   jPOST; P16219; -.
DR   MassIVE; P16219; -.
DR   MaxQB; P16219; -.
DR   PaxDb; P16219; -.
DR   PeptideAtlas; P16219; -.
DR   PRIDE; P16219; -.
DR   ProteomicsDB; 53323; -.
DR   Antibodypedia; 1579; 269 antibodies.
DR   DNASU; 35; -.
DR   Ensembl; ENST00000242592; ENSP00000242592; ENSG00000122971.
DR   GeneID; 35; -.
DR   KEGG; hsa:35; -.
DR   UCSC; uc001tza.5; human.
DR   CTD; 35; -.
DR   DisGeNET; 35; -.
DR   GeneCards; ACADS; -.
DR   GeneReviews; ACADS; -.
DR   HGNC; HGNC:90; ACADS.
DR   HPA; ENSG00000122971; Tissue enhanced (liver, skeletal muscle).
DR   MalaCards; ACADS; -.
DR   MIM; 201470; phenotype.
DR   MIM; 606885; gene.
DR   neXtProt; NX_P16219; -.
DR   OpenTargets; ENSG00000122971; -.
DR   Orphanet; 26792; Short chain acyl-CoA dehydrogenase deficiency.
DR   PharmGKB; PA24426; -.
DR   VEuPathDB; HostDB:ENSG00000122971.8; -.
DR   eggNOG; KOG0139; Eukaryota.
DR   GeneTree; ENSGT00940000158866; -.
DR   HOGENOM; CLU_018204_0_2_1; -.
DR   InParanoid; P16219; -.
DR   OMA; LVPEQWG; -.
DR   OrthoDB; 589058at2759; -.
DR   PhylomeDB; P16219; -.
DR   TreeFam; TF105019; -.
DR   BioCyc; MetaCyc:HS04619-MONOMER; -.
DR   PathwayCommons; P16219; -.
DR   Reactome; R-HSA-77350; Beta oxidation of hexanoyl-CoA to butanoyl-CoA.
DR   Reactome; R-HSA-77352; Beta oxidation of butanoyl-CoA to acetyl-CoA.
DR   SABIO-RK; P16219; -.
DR   UniPathway; UPA00660; -.
DR   BioGRID-ORCS; 35; 5 hits in 992 CRISPR screens.
DR   ChiTaRS; ACADS; human.
DR   EvolutionaryTrace; P16219; -.
DR   GenomeRNAi; 35; -.
DR   Pharos; P16219; Tbio.
DR   PRO; PR:P16219; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P16219; protein.
DR   Bgee; ENSG00000122971; Expressed in right lobe of liver and 204 other tissues.
DR   ExpressionAtlas; P16219; baseline and differential.
DR   Genevisible; P16219; HS.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005759; C:mitochondrial matrix; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0003995; F:acyl-CoA dehydrogenase activity; IDA:BHF-UCL.
DR   GO; GO:0004085; F:butyryl-CoA dehydrogenase activity; ISS:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0046359; P:butyrate catabolic process; IBA:GO_Central.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome.
DR   GO; GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; IDA:BHF-UCL.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Direct protein sequencing; Disease variant; FAD;
KW   Fatty acid metabolism; Flavoprotein; Lipid metabolism; Mitochondrion;
KW   Oxidoreductase; Phosphoprotein; Reference proteome; Transit peptide.
FT   TRANSIT         1..24
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:1286669"
FT   CHAIN           25..412
FT                   /note="Short-chain specific acyl-CoA dehydrogenase,
FT                   mitochondrial"
FT                   /id="PRO_0000000498"
FT   NP_BIND         152..161
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.10"
FT   NP_BIND         185..187
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.10"
FT   NP_BIND         365..369
FT                   /note="FAD; shared with dimeric partner"
FT                   /evidence="ECO:0000269|Ref.10"
FT   NP_BIND         394..396
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.10"
FT   REGION          269..272
FT                   /note="Substrate binding"
FT   ACT_SITE        392
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P15651"
FT   BINDING         161
FT                   /note="Substrate; via carbonyl oxygen"
FT   BINDING         297
FT                   /note="FAD; shared with dimeric partner"
FT                   /evidence="ECO:0000269|Ref.10"
FT   BINDING         308
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.10"
FT   BINDING         393
FT                   /note="Substrate; via amide nitrogen"
FT   MOD_RES         27
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         51
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         51
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         72
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         129
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         129
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         208
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         262
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         262
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         306
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         306
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   VARIANT         46
FT                   /note="R -> W (in ACADSD; dbSNP:rs121908003)"
FT                   /id="VAR_000310"
FT   VARIANT         90
FT                   /note="G -> S (in ACADSD; loss of acyl-CoA dehydrogenase
FT                   activity; dbSNP:rs121908005)"
FT                   /evidence="ECO:0000269|PubMed:11134486"
FT                   /id="VAR_013565"
FT   VARIANT         92
FT                   /note="G -> C (in ACADSD; dbSNP:rs121908004)"
FT                   /evidence="ECO:0000269|PubMed:9499414"
FT                   /id="VAR_000311"
FT   VARIANT         104
FT                   /note="Missing (in ACADSD; loss of acyl-CoA dehydrogenase
FT                   activity; dbSNP:rs387906308)"
FT                   /evidence="ECO:0000269|PubMed:11134486"
FT                   /id="VAR_013566"
FT   VARIANT         107
FT                   /note="R -> C (in ACADSD; dbSNP:rs61732144)"
FT                   /id="VAR_000312"
FT   VARIANT         171
FT                   /note="R -> W (69% of wild-type acyl-CoA dehydrogenase
FT                   activity; confers susceptibility to ethylmalonicaciduria;
FT                   dbSNP:rs1800556)"
FT                   /evidence="ECO:0000269|PubMed:11134486,
FT                   ECO:0000269|PubMed:9499414"
FT                   /id="VAR_013567"
FT   VARIANT         177
FT                   /note="W -> R (in ACADSD; dbSNP:rs57443665)"
FT                   /evidence="ECO:0000269|PubMed:9499414"
FT                   /id="VAR_000314"
FT   VARIANT         192
FT                   /note="A -> V (in ACADSD; loss of acyl-CoA dehydrogenase
FT                   activity; dbSNP:rs28940874)"
FT                   /evidence="ECO:0000269|PubMed:11134486"
FT                   /id="VAR_013568"
FT   VARIANT         209
FT                   /note="G -> S (86% of wild-type acyl-CoA dehydrogenase
FT                   activity; confers susceptibility to ethylmalonicaciduria;
FT                   dbSNP:rs1799958)"
FT                   /evidence="ECO:0000269|PubMed:11134486,
FT                   ECO:0000269|PubMed:9499414"
FT                   /id="VAR_000315"
FT   VARIANT         325
FT                   /note="R -> W (in ACADSD; loss of acyl-CoA dehydrogenase
FT                   activity; dbSNP:rs121908006)"
FT                   /evidence="ECO:0000269|PubMed:11134486"
FT                   /id="VAR_013569"
FT   VARIANT         353
FT                   /note="S -> L (in ACADSD; loss of acyl-CoA dehydrogenase
FT                   activity; dbSNP:rs28941773)"
FT                   /evidence="ECO:0000269|PubMed:11134486"
FT                   /id="VAR_013570"
FT   VARIANT         380
FT                   /note="R -> W (in ACADSD; loss of acyl-CoA dehydrogenase
FT                   activity; dbSNP:rs28940875)"
FT                   /evidence="ECO:0000269|PubMed:11134486"
FT                   /id="VAR_013571"
FT   VARIANT         383
FT                   /note="R -> C (in ACADSD; dbSNP:rs28940872)"
FT                   /evidence="ECO:0000269|PubMed:9499414"
FT                   /id="VAR_000316"
FT   VARIANT         383
FT                   /note="R -> H (in dbSNP:rs35233375)"
FT                   /id="VAR_033458"
FT   HELIX           36..52
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   TURN            53..56
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           57..63
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           68..77
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   TURN            78..80
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           86..88
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           95..108
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           110..121
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           124..130
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           133..139
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           141..143
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   STRAND          144..147
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   STRAND          150..153
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   STRAND          159..162
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           163..165
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   STRAND          169..173
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   STRAND          176..187
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   TURN            188..191
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   STRAND          193..200
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   STRAND          203..205
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   STRAND          210..218
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   STRAND          222..224
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   STRAND          230..232
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   STRAND          238..249
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           250..252
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   STRAND          253..256
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           260..296
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           304..306
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           308..336
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           342..367
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           368..372
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           378..388
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   TURN            389..392
FT                   /evidence="ECO:0007829|PDB:2VIG"
FT   HELIX           395..411
FT                   /evidence="ECO:0007829|PDB:2VIG"
SQ   SEQUENCE   412 AA;  44297 MW;  3E946ADFC3DA3C0E CRC64;
     MAAALLARAS GPARRALCPR AWRQLHTIYQ SVELPETHQM LLQTCRDFAE KELFPIAAQV
     DKEHLFPAAQ VKKMGGLGLL AMDVPEELGG AGLDYLAYAI AMEEISRGCA STGVIMSVNN
     SLYLGPILKF GSKEQKQAWV TPFTSGDKIG CFALSEPGNG SDAGAASTTA RAEGDSWVLN
     GTKAWITNAW EASAAVVFAS TDRALQNKGI SAFLVPMPTP GLTLGKKEDK LGIRGSSTAN
     LIFEDCRIPK DSILGEPGMG FKIAMQTLDM GRIGIASQAL GIAQTALDCA VNYAENRMAF
     GAPLTKLQVI QFKLADMALA LESARLLTWR AAMLKDNKKP FIKEAAMAKL AASEAATAIS
     HQAIQILGGM GYVTEMPAER HYRDARITEI YEGTSEIQRL VIAGHLLRSY RS
//
ID   APRA_DESGG              Reviewed;         666 AA.
AC   T2G6Z9; D2YW42; S5WDB4;
DT   14-OCT-2015, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2013, sequence version 1.
DT   02-JUN-2021, entry version 40.
DE   RecName: Full=Adenylylsulfate reductase subunit alpha {ECO:0000303|PubMed:19820092, ECO:0000303|PubMed:2158885, ECO:0000312|EMBL:AGS82785.1, ECO:0000312|EMBL:AGW12370.1, ECO:0000312|PDB:3GYX};
DE            Short=AdoPSO(4) reductase subunit A {ECO:0000303|PubMed:2158885};
DE            EC=1.8.99.2 {ECO:0000269|PubMed:19820092, ECO:0000269|PubMed:2158885, ECO:0000269|PubMed:7240092};
DE   AltName: Full=Adenosine 5'-phosphosulfate reductase subunit alpha {ECO:0000303|PubMed:19820092};
DE            Short=APSR subunit A {ECO:0000303|PubMed:19820092};
GN   Name=aprA {ECO:0000303|PubMed:19820092, ECO:0000312|EMBL:AGS82785.1,
GN   ECO:0000312|EMBL:AGW12370.1};
GN   ORFNames=DGI_0457 {ECO:0000312|EMBL:AGW12370.1};
OS   Desulfovibrio gigas (strain ATCC 19364 / DSM 1382 / NCIMB 9332 / VKM
OS   B-1759).
OC   Bacteria; Proteobacteria; Deltaproteobacteria; Desulfovibrionales;
OC   Desulfovibrionaceae; Desulfovibrio.
OX   NCBI_TaxID=1121448;
RN   [1] {ECO:0000312|EMBL:AGS82785.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 19364 / DSM 1382 / NCIMB 9332 / VKM B-1759
RC   {ECO:0000312|EMBL:AGS82785.1};
RX   PubMed=23974026; DOI=10.1128/jb.00411-13;
RA   Morais-Silva F.O., Santos C.I., Rodrigues R., Pereira I.A.,
RA   Rodrigues-Pousada C.;
RT   "Roles of HynAB and Ech, the only two hydrogenases found in the model
RT   sulfate reducer Desulfovibrio gigas.";
RL   J. Bacteriol. 195:4753-4760(2013).
RN   [2] {ECO:0000312|EMBL:AGW12370.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 19364 / DSM 1382 / NCIMB 9332 / VKM B-1759
RC   {ECO:0000312|EMBL:AGW12370.1};
RA   Morais-Silva F.O., Rezende A.M., Pimentel C., Resende D.M., Santos C.I.,
RA   Clemente C., de Oliveira L.M., da Silva S.M., Costa D.A., Varela-Raposo A.,
RA   Horacio E.C.A., Matos M., Flores O., Ruiz J.C., Rodrigues-Pousada C.;
RL   Submitted (JUL-2013) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000312|PDB:3GYX, ECO:0007744|PDB:3GYX}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 3-664, X-RAY CRYSTALLOGRAPHY (3.20
RP   ANGSTROMS) IN COMPLEX WITH FAD AND APRB, FUNCTION, CATALYTIC ACTIVITY OF
RP   THE ADENYLYLSULFATE REDUCTASE, COFACTOR, SUBUNIT, DOMAINS, AND SITES.
RC   STRAIN=ATCC 19364 / DSM 1382 / NCIMB 9332 / VKM B-1759
RC   {ECO:0000303|PubMed:19820092};
RX   PubMed=19820092; DOI=10.1128/jb.00583-09;
RA   Chiang Y.L., Hsieh Y.C., Fang J.Y., Liu E.H., Huang Y.C., Chuankhayan P.,
RA   Jeyakanthan J., Liu M.Y., Chan S.I., Chen C.J.;
RT   "Crystal structure of Adenylylsulfate reductase from Desulfovibrio gigas
RT   suggests a potential self-regulation mechanism involving the C terminus of
RT   the beta-subunit.";
RL   J. Bacteriol. 191:7597-7608(2009).
RN   [4]
RP   CATALYTIC ACTIVITY OF THE ADENYLYLSULFATE REDUCTASE, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=7240092; DOI=10.1128/jb.147.1.161-169.1981;
RA   Odom J.M., Peck H.D. Jr.;
RT   "Localization of dehydrogenases, reductases, and electron transfer
RT   components in the sulfate-reducing bacterium Desulfovibrio gigas.";
RL   J. Bacteriol. 147:161-169(1981).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY OF THE ADENYLYLSULFATE REDUCTASE, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND EPR AND MOESSBAUER SPECTROSCOPY
RP   OF THE ADENYLYLSULFATE REDUCTASE.
RC   STRAIN=ATCC 19364 / DSM 1382 / NCIMB 9332 / VKM B-1759
RC   {ECO:0000303|PubMed:2158885};
RX   PubMed=2158885; DOI=10.1111/j.1432-1033.1990.tb15447.x;
RA   Lampreia J., Moura I., Teixeira M., Peck H.D. Jr., Legall J., Huynh B.H.,
RA   Moura J.J.;
RT   "The active centers of adenylylsulfate reductase from Desulfovibrio gigas.
RT   Characterization and spectroscopic studies.";
RL   Eur. J. Biochem. 188:653-664(1990).
CC   -!- FUNCTION: Catalytic subunit of the adenylylsulfate reductase which
CC       catalyzes reversibly the reduction of adenosine 5'-phosphosulfate (APS)
CC       to sulfite and AMP during dissimilatory sulfate reduction.
CC       {ECO:0000269|PubMed:19820092, ECO:0000269|PubMed:2158885}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=A + AMP + 2 H(+) + sulfite = adenosine 5'-phosphosulfate +
CC         AH2; Xref=Rhea:RHEA:24240, ChEBI:CHEBI:13193, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17359, ChEBI:CHEBI:17499, ChEBI:CHEBI:58243,
CC         ChEBI:CHEBI:456215; EC=1.8.99.2;
CC         Evidence={ECO:0000269|PubMed:19820092, ECO:0000269|PubMed:2158885,
CC         ECO:0000269|PubMed:7240092};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:19820092, ECO:0000269|PubMed:2158885};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.34 mM for sulfite {ECO:0000269|PubMed:2158885};
CC         KM=0.16 mM for AMP {ECO:0000269|PubMed:2158885};
CC       pH dependence:
CC         Optimum pH is 7.4 for the adenylylsulfate reductase.
CC         {ECO:0000269|PubMed:2158885};
CC   -!- SUBUNIT: Heterodimer composed of AprA and AprB (PubMed:19820092,
CC       PubMed:2158885). The heterodimers can dimerize to form heterotetramers
CC       (PubMed:2158885). {ECO:0000269|PubMed:19820092,
CC       ECO:0000269|PubMed:2158885}.
CC   -!- INTERACTION:
CC       T2G6Z9; T2G899: aprB; NbExp=3; IntAct=EBI-6409227, EBI-6409220;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:7240092}.
CC   -!- DOMAIN: Consists of three sections from the N- to the C-terminus: FAD-
CC       binding domain, capping domain and helical domain. The FAD-binding
CC       domain and the capping domain slightly overlap and form a channel that
CC       may transport the substrate. {ECO:0000269|PubMed:19820092}.
CC   -!- SIMILARITY: Belongs to the FAD-dependent oxidoreductase 2 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KF113859; AGS82785.1; -; Genomic_DNA.
DR   EMBL; CP006585; AGW12370.1; -; Genomic_DNA.
DR   RefSeq; WP_021759000.1; NZ_AUBO01000012.1.
DR   PDB; 3GYX; X-ray; 3.20 A; A/C/E/G/I/K=3-663.
DR   PDBsum; 3GYX; -.
DR   SMR; T2G6Z9; -.
DR   IntAct; T2G6Z9; 1.
DR   PRIDE; T2G6Z9; -.
DR   KEGG; dgg:DGI_0457; -.
DR   PATRIC; fig|1121448.10.peg.454; -.
DR   HOGENOM; CLU_014312_8_3_7; -.
DR   SABIO-RK; T2G6Z9; -.
DR   Proteomes; UP000016587; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0009973; F:adenylyl-sulfate reductase activity; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0019420; P:dissimilatory sulfate reduction; IDA:UniProtKB.
DR   GO; GO:0051290; P:protein heterotetramerization; IDA:UniProtKB.
DR   Gene3D; 3.90.700.10; -; 1.
DR   InterPro; IPR011803; AprA.
DR   InterPro; IPR003953; FAD-binding_2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR037099; Fum_R/Succ_DH_flav-like_C_sf.
DR   InterPro; IPR011280; Succ_DH/Fum_Rdt_flav_su.
DR   InterPro; IPR027477; Succ_DH/fumarate_Rdtase_cat_sf.
DR   PANTHER; PTHR11632:SF53; PTHR11632:SF53; 1.
DR   Pfam; PF00890; FAD_binding_2; 1.
DR   SUPFAM; SSF46977; SSF46977; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF56425; SSF56425; 1.
DR   TIGRFAMs; TIGR02061; aprA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; FAD; Flavoprotein; Nucleotide-binding;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN           1..666
FT                   /note="Adenylylsulfate reductase subunit alpha"
FT                   /id="PRO_0000434041"
FT   NP_BIND         32..35
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19820092"
FT   NP_BIND         60..61
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19820092,
FT                   ECO:0007744|PDB:3GYX"
FT   NP_BIND         67..69
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19820092"
FT   NP_BIND         461..462
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19820092,
FT                   ECO:0007744|PDB:3GYX"
FT   BINDING         78
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19820092"
FT   BINDING         193
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:19820092"
FT   BINDING         259
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19820092,
FT                   ECO:0007744|PDB:3GYX"
FT   BINDING         417
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19820092,
FT                   ECO:0007744|PDB:3GYX"
FT   BINDING         472
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19820092,
FT                   ECO:0007744|PDB:3GYX"
FT   SITE            160
FT                   /note="Important for interaction with AprB and for the
FT                   recognition of substrate at the substrate channel entrance"
FT                   /evidence="ECO:0000269|PubMed:19820092"
FT   SITE            282
FT                   /note="Important for interaction with AprB and for the
FT                   binding of substrate at the substrate channel entrance"
FT                   /evidence="ECO:0000269|PubMed:19820092"
FT   SITE            300
FT                   /note="Important for interaction with AprB and for the
FT                   binding of substrate at the substrate channel entrance"
FT                   /evidence="ECO:0000269|PubMed:19820092"
FT   CONFLICT        664
FT                   /note="T -> D (in Ref. 3; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   HELIX           5..7
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          21..24
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          26..30
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           34..50
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          56..59
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   TURN            64..66
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   TURN            69..72
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          74..77
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           86..96
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   TURN            97..99
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           103..123
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          132..134
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           139..145
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   TURN            149..152
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          163..169
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           170..182
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          186..188
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          190..193
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          200..202
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          205..217
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          219..223
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          225..229
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          236..238
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           245..248
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           259..265
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   TURN            266..268
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          270..272
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          281..283
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   TURN            284..286
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           291..297
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           309..312
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           314..317
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           318..321
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   TURN            322..324
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   TURN            327..329
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           333..336
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           338..345
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           355..362
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   TURN            363..365
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           368..383
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           387..395
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   TURN            400..402
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          405..409
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          416..419
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           436..438
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          453..455
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          461..464
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           471..492
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           504..511
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           513..521
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           522..524
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          526..530
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          532..535
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           537..551
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   TURN            555..559
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           563..579
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           580..582
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   HELIX           588..613
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   TURN            620..622
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   TURN            633..635
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          638..645
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   TURN            646..649
FT                   /evidence="ECO:0007829|PDB:3GYX"
FT   STRAND          650..656
FT                   /evidence="ECO:0007829|PDB:3GYX"
SQ   SEQUENCE   666 AA;  74880 MW;  7FD12237BFBF6FBC CRC64;
     MPKIPSKETP RGVAIAEPII VEHSVDLLMV GGGMGNCGAA FEAVRWADKY APEAKILLVD
     KASLERSGAV AQGLSAINTY LGDNNADDYV RMVRTDLMGL VREDLIYDLG RHVDDSVHLF
     EEWGLPVWIK DEHGHNLDGA QAKAAGKSLR NGDKPVRSGR WQIMINGESY KVIVAEAAKN
     ALGQDRIIER IFIVKLLLDK NTPNRIAGAV GFNLRANEVH IFKANAMVVA CGGAVNVYRP
     RSVGEGMGRA WYPVWNAGST YTMCAQVGAE MTMMENRFVP ARFKDGYGPV GAWFLLFKAK
     ATNCKGEDYC ATNRAMLKPY EERGYAKGHV IPTCLRNHMM LREMREGRGP IYMDTKTALQ
     TSFATMSPAQ QKHLEAEAWE DFLDMCVGQA NLWAATNCAP EERGSEIMPT EPYLLGSHSG
     CCGIWASGPD EAWVPEDYKV RAANGKVYNR MTTVEGLWTC ADGVGASGHK FSSGSHAEGR
     IVGKQMVRWY LDHKDFKPEF VETAEELKTL IYRPYYNYEK GKGASTCPVV NPEYISPKNF
     MMRLIKCTDE YGGGVGTYYN TSKALLDTGF WLMEMLEEDS LKLAARDLHE LLRCWENYHR
     LWTVRLHMQH IAFREESRYP GFYYRADFLG LDDSKWKCFV NSKYDPAKKE TKIFKKPYYQ
     IIPTDA
//
ID   CRY2_MOUSE              Reviewed;         592 AA.
AC   Q9R194; O08706; Q6A024;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   02-JUN-2021, entry version 159.
DE   RecName: Full=Cryptochrome-2;
GN   Name=Cry2; Synonyms=Kiaa0658;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, INDUCTION, AND
RP   INTERACTION WITH PER1; PER2; PER3 AND TIMELESS.
RC   STRAIN=C57BL/6J;
RX   PubMed=10428031; DOI=10.1016/s0092-8674(00)81014-4;
RA   Kume K., Zylka M.J., Sriram S., Shearman L.P., Weaver D.R., Jin X.,
RA   Maywood E.S., Hastings M.H., Reppert S.M.;
RT   "mCRY1 and mCRY2 are essential components of the negative limb of the
RT   circadian clock feedback loop.";
RL   Cell 98:193-205(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Embryo, Fetal brain, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and CD-1; TISSUE=Brain, and Neural stem cell;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 9-592.
RC   TISSUE=Fetal brain;
RX   PubMed=15368895; DOI=10.1093/dnares/11.3.205;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Seino S., Nishimura M., Kaisho T., Hoshino K., Kitamura H.,
RA   Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: IV.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 11:205-218(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-592, TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Liver;
RX   PubMed=9801304; DOI=10.1093/nar/26.22.5086;
RA   Kobayashi K., Kanno S., Smit B., van der Horst G.T.J., Takao M., Yasui A.;
RT   "Characterization of photolyase/blue-light receptor homologs in mouse and
RT   human cells.";
RL   Nucleic Acids Res. 26:5086-5092(1998).
RN   [6]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=10521578; DOI=10.1016/s0169-328x(99)00192-8;
RA   Miyamoto Y., Sancar A.;
RT   "Circadian regulation of cryptochrome genes in the mouse.";
RL   Brain Res. Mol. Brain Res. 71:238-243(1999).
RN   [7]
RP   IDENTIFICATION IN A COMPLEX WITH CLOCK; PER1; PER2; CRY1; CRY2; CSNK1D AND
RP   CSNK1E, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11779462; DOI=10.1016/s0092-8674(01)00610-9;
RA   Lee C., Etchegaray J.-P., Cagampang F.R.A., Loudon A.S.I., Reppert S.M.;
RT   "Posttranslational mechanisms regulate the mammalian circadian clock.";
RL   Cell 107:855-867(2001).
RN   [8]
RP   PHOSPHORYLATION AT SER-265 AND SER-557, AND MUTAGENESIS OF SER-265 AND
RP   SER-557.
RX   PubMed=15298678; DOI=10.1111/j.1356-9597.2004.00758.x;
RA   Sanada K., Harada Y., Sakai M., Todo T., Fukada Y.;
RT   "Serine phosphorylation of mCRY1 and mCRY2 by mitogen-activated protein
RT   kinase.";
RL   Genes Cells 9:697-708(2004).
RN   [9]
RP   INTERACTION WITH PER1 AND PER2, PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=11875063; DOI=10.1074/jbc.m111466200;
RA   Eide E.J., Vielhaber E.L., Hinz W.A., Virshup D.M.;
RT   "The circadian regulatory proteins BMAL1 and cryptochromes are substrates
RT   of casein kinase Iepsilon.";
RL   J. Biol. Chem. 277:17248-17254(2002).
RN   [10]
RP   INTERACTION WITH PER1; PER2 AND PER3.
RX   PubMed=14701732; DOI=10.1128/mcb.24.2.584-594.2004;
RA   Lee C., Weaver D.R., Reppert S.M.;
RT   "Direct association between mouse PERIOD and CKIepsilon is critical for a
RT   functioning circadian clock.";
RL   Mol. Cell. Biol. 24:584-594(2004).
RN   [11]
RP   PHOSPHORYLATION AT SER-557, AND SUBCELLULAR LOCATION.
RX   PubMed=15980066; DOI=10.1074/jbc.m506225200;
RA   Harada Y., Sakai M., Kurabayashi N., Hirota T., Fukada Y.;
RT   "Ser-557-phosphorylated mCRY2 is degraded upon synergistic phosphorylation
RT   by glycogen synthase kinase-3 beta.";
RL   J. Biol. Chem. 280:31714-31721(2005).
RN   [12]
RP   INTERACTION WITH CLOCK-ARNTL COMPLEX, AND FUNCTION.
RX   PubMed=16628007; DOI=10.4161/cc.5.8.2684;
RA   Kondratov R.V., Kondratova A.A., Lee C., Gorbacheva V.Y., Chernov M.V.,
RA   Antoch M.P.;
RT   "Post-translational regulation of circadian transcriptional
RT   CLOCK(NPAS2)/BMAL1 complex by CRYPTOCHROMES.";
RL   Cell Cycle 5:890-895(2006).
RN   [13]
RP   INTERACTION WITH CLOCK AND ARNTL.
RX   PubMed=16717091; DOI=10.1074/jbc.m603722200;
RA   Etchegaray J.P., Yang X., DeBruyne J.P., Peters A.H., Weaver D.R.,
RA   Jenuwein T., Reppert S.M.;
RT   "The polycomb group protein EZH2 is required for mammalian circadian clock
RT   function.";
RL   J. Biol. Chem. 281:21209-21215(2006).
RN   [14]
RP   INTERACTION WITH NFIL3.
RX   PubMed=17274955; DOI=10.1016/j.bbrc.2007.01.084;
RA   Ohno T., Onishi Y., Ishida N.;
RT   "The negative transcription factor E4BP4 is associated with circadian clock
RT   protein PERIOD2.";
RL   Biochem. Biophys. Res. Commun. 354:1010-1015(2007).
RN   [15]
RP   INTERACTION WITH FBXL3, AND UBIQUITINATION.
RX   PubMed=17462724; DOI=10.1016/j.cell.2007.04.030;
RA   Siepka S.M., Yoo S.H., Park J., Song W., Kumar V., Hu Y., Lee C.,
RA   Takahashi J.S.;
RT   "Circadian mutant Overtime reveals F-box protein FBXL3 regulation of
RT   cryptochrome and period gene expression.";
RL   Cell 129:1011-1023(2007).
RN   [16]
RP   FUNCTION.
RX   PubMed=17310242; DOI=10.1038/ncb1539;
RA   Zhao W.N., Malinin N., Yang F.C., Staknis D., Gekakis N., Maier B.,
RA   Reischl S., Kramer A., Weitz C.J.;
RT   "CIPC is a mammalian circadian clock protein without invertebrate
RT   homologues.";
RL   Nat. Cell Biol. 9:268-275(2007).
RN   [17]
RP   INTERACTION WITH ARNTL AND CLOCK, AND INDUCTION.
RX   PubMed=19917250; DOI=10.1016/j.molcel.2009.10.012;
RA   Chen R., Schirmer A., Lee Y., Lee H., Kumar V., Yoo S.H., Takahashi J.S.,
RA   Lee C.;
RT   "Rhythmic PER abundance defines a critical nodal point for negative
RT   feedback within the circadian clock mechanism.";
RL   Mol. Cell 36:417-430(2009).
RN   [18]
RP   FUNCTION.
RX   PubMed=19299583; DOI=10.1126/science.1171641;
RA   Ramsey K.M., Yoshino J., Brace C.S., Abrassart D., Kobayashi Y.,
RA   Marcheva B., Hong H.K., Chong J.L., Buhr E.D., Lee C., Takahashi J.S.,
RA   Imai S., Bass J.;
RT   "Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis.";
RL   Science 324:651-654(2009).
RN   [19]
RP   INTERACTION WITH ARNTL AND PER2, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ARG-501 AND LYS-503.
RX   PubMed=20840750; DOI=10.1186/1471-2199-11-69;
RA   Ozber N., Baris I., Tatlici G., Gur I., Kilinc S., Unal E.B., Kavakli I.H.;
RT   "Identification of two amino acids in the C-terminal domain of mouse CRY2
RT   essential for PER2 interaction.";
RL   BMC Mol. Biol. 11:69-69(2010).
RN   [20]
RP   PHOSPHORYLATION AT SER-553 AND SER-557, AND MUTAGENESIS OF SER-553 AND
RP   SER-557.
RX   PubMed=20123978; DOI=10.1128/mcb.01047-09;
RA   Kurabayashi N., Hirota T., Sakai M., Sanada K., Fukada Y.;
RT   "DYRK1A and glycogen synthase kinase 3beta, a dual-kinase mechanism
RT   directing proteasomal degradation of CRY2 for circadian timekeeping.";
RL   Mol. Cell. Biol. 30:1757-1768(2010).
RN   [21]
RP   FUNCTION IN GLUCONEOGENESIS, AND DISRUPTION PHENOTYPE.
RX   PubMed=20852621; DOI=10.1038/nm.2214;
RA   Zhang E.E., Liu Y., Dentin R., Pongsawakul P.Y., Liu A.C., Hirota T.,
RA   Nusinow D.A., Sun X., Landais S., Kodama Y., Brenner D.A., Montminy M.,
RA   Kay S.A.;
RT   "Cryptochrome mediates circadian regulation of cAMP signaling and hepatic
RT   gluconeogenesis.";
RL   Nat. Med. 16:1152-1156(2010).
RN   [22]
RP   FUNCTION AS NR3C1 REPRESSOR, INTERACTION WITH AR AND NR3C1, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=22170608; DOI=10.1038/nature10700;
RA   Lamia K.A., Papp S.J., Yu R.T., Barish G.D., Uhlenhaut N.H., Jonker J.W.,
RA   Downes M., Evans R.M.;
RT   "Cryptochromes mediate rhythmic repression of the glucocorticoid
RT   receptor.";
RL   Nature 480:552-556(2011).
RN   [23]
RP   ACTIVITY REGULATION.
RX   PubMed=22798407; DOI=10.1126/science.1223710;
RA   Hirota T., Lee J.W., St John P.C., Sawa M., Iwaisako K., Noguchi T.,
RA   Pongsawakul P.Y., Sonntag T., Welsh D.K., Brenner D.A., Doyle F.J. III,
RA   Schultz P.G., Kay S.A.;
RT   "Identification of small molecule activators of cryptochrome.";
RL   Science 337:1094-1097(2012).
RN   [24]
RP   FUNCTION AS TRANSCRIPTIONAL REPRESSOR, INTERACTION WITH PER1, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=24154698; DOI=10.1152/ajprenal.00472.2013;
RA   Richards J., Cheng K.Y., All S., Skopis G., Jeffers L., Lynch I.J.,
RA   Wingo C.S., Gumz M.L.;
RT   "A role for the circadian clock protein Per1 in the regulation of
RT   aldosterone levels and renal Na+ retention.";
RL   Am. J. Physiol. 305:F1697-F1704(2013).
RN   [25]
RP   FUNCTION IN METABOLISM, AND DISRUPTION PHENOTYPE.
RX   PubMed=23531614; DOI=10.1152/ajpendo.00512.2012;
RA   Barclay J.L., Shostak A., Leliavski A., Tsang A.H., Johren O.,
RA   Muller-Fielitz H., Landgraf D., Naujokat N., van der Horst G.T., Oster H.;
RT   "High-fat diet-induced hyperinsulinemia and tissue-specific insulin
RT   resistance in Cry-deficient mice.";
RL   Am. J. Physiol. 304:E1053-E1063(2013).
RN   [26]
RP   UBIQUITINATION BY THE SCF(FBXL3) AND SCF(FBXL21) COMPLEXES, AND INTERACTION
RP   WITH FBXL3 AND FBXL21.
RX   PubMed=23452855; DOI=10.1016/j.cell.2013.01.055;
RA   Yoo S.H., Mohawk J.A., Siepka S.M., Shan Y., Huh S.K., Hong H.K.,
RA   Kornblum I., Kumar V., Koike N., Xu M., Nussbaum J., Liu X., Chen Z.,
RA   Chen Z.J., Green C.B., Takahashi J.S.;
RT   "Competing E3 ubiquitin ligases govern circadian periodicity by degradation
RT   of CRY in nucleus and cytoplasm.";
RL   Cell 152:1091-1105(2013).
RN   [27]
RP   UBIQUITINATION BY THE SCF(FBXL3) AND SCF(FBXL21) COMPLEXES, UBIQUITINATION
RP   AT LYS-125; LYS-241; LYS-347; LYS-474 AND LYS-503, AND INTERACTION WITH
RP   FBXL3 AND FBXL21.
RX   PubMed=23452856; DOI=10.1016/j.cell.2013.01.054;
RA   Hirano A., Yumimoto K., Tsunematsu R., Matsumoto M., Oyama M.,
RA   Kozuka-Hata H., Nakagawa T., Lanjakornsiripan D., Nakayama K.I., Fukada Y.;
RT   "FBXL21 regulates oscillation of the circadian clock through ubiquitination
RT   and stabilization of cryptochromes.";
RL   Cell 152:1106-1118(2013).
RN   [28]
RP   INTERACTION WITH PRKDC.
RX   PubMed=24158435; DOI=10.1074/jbc.m113.509604;
RA   Gao P., Yoo S.H., Lee K.J., Rosensweig C., Takahashi J.S., Chen B.P.,
RA   Green C.B.;
RT   "Phosphorylation of the cryptochrome 1 C-terminal tail regulates circadian
RT   period length.";
RL   J. Biol. Chem. 288:35277-35286(2013).
RN   [29]
RP   FUNCTION IN CIRCADIAN CLOCK, AND DISRUPTION PHENOTYPE.
RX   PubMed=23616524; DOI=10.1523/jneurosci.4950-12.2013;
RA   Anand S.N., Maywood E.S., Chesham J.E., Joynson G., Banks G.T.,
RA   Hastings M.H., Nolan P.M.;
RT   "Distinct and separable roles for endogenous CRY1 and CRY2 within the
RT   circadian molecular clockwork of the suprachiasmatic nucleus, as revealed
RT   by the Fbxl3(Afh) mutation.";
RL   J. Neurosci. 33:7145-7153(2013).
RN   [30]
RP   FUNCTION IN CIRCADIAN RHYTHM MAINTENANCE.
RX   PubMed=23575670; DOI=10.1038/ncomms2670;
RA   Ono D., Honma S., Honma K.;
RT   "Cryptochromes are critical for the development of coherent circadian
RT   rhythms in the mouse suprachiasmatic nucleus.";
RL   Nat. Commun. 4:1666-1666(2013).
RN   [31]
RP   REVIEW.
RX   PubMed=23303907; DOI=10.1152/physrev.00016.2012;
RA   Eckel-Mahan K., Sassone-Corsi P.;
RT   "Metabolism and the circadian clock converge.";
RL   Physiol. Rev. 93:107-135(2013).
RN   [32]
RP   INTERACTION WITH CIART.
RX   PubMed=24736997; DOI=10.1371/journal.pbio.1001839;
RA   Goriki A., Hatanaka F., Myung J., Kim J.K., Yoritaka T., Tanoue S., Abe T.,
RA   Kiyonari H., Fujimoto K., Kato Y., Todo T., Matsubara A., Forger D.,
RA   Takumi T.;
RT   "A novel protein, CHRONO, functions as a core component of the mammalian
RT   circadian clock.";
RL   PLoS Biol. 12:E1001839-E1001839(2014).
RN   [33]
RP   REVIEW.
RX   PubMed=23916625; DOI=10.1016/j.tcb.2013.07.002;
RA   Partch C.L., Green C.B., Takahashi J.S.;
RT   "Molecular architecture of the mammalian circadian clock.";
RL   Trends Cell Biol. 24:90-99(2014).
RN   [34]
RP   UBIQUITINATION AND PROTEASOMAL DEGRADATION.
RX   PubMed=26776516; DOI=10.1016/j.celrep.2015.12.076;
RA   Shi G., Xie P., Qu Z., Zhang Z., Dong Z., An Y., Xing L., Liu Z., Dong Y.,
RA   Xu G., Yang L., Liu Y., Xu Y.;
RT   "Distinct roles of HDAC3 in the core circadian negative feedback loop are
RT   critical for clock function.";
RL   Cell Rep. 14:823-834(2016).
RN   [35]
RP   DEUBIQUITINATION BY USP7, AND INTERACTION WITH DDB1; USP7 AND TARDBP.
RX   PubMed=27123980; DOI=10.1371/journal.pone.0154263;
RA   Hirano A., Nakagawa T., Yoshitane H., Oyama M., Kozuka-Hata H.,
RA   Lanjakornsiripan D., Fukada Y.;
RT   "USP7 and TDP-43: pleiotropic regulation of cryptochrome protein stability
RT   paces the oscillation of the mammalian circadian clock.";
RL   PLoS ONE 11:E0154263-E0154263(2016).
RN   [36]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND INTERACTION WITH PPARA; PPARD AND
RP   PPARG.
RX   PubMed=28683290; DOI=10.1016/j.cmet.2017.06.002;
RA   Jordan S.D., Kriebs A., Vaughan M., Duglan D., Fan W., Henriksson E.,
RA   Huber A.L., Papp S.J., Nguyen M., Afetian M., Downes M., Yu R.T.,
RA   Kralli A., Evans R.M., Lamia K.A.;
RT   "CRY1/2 selectively repress PPARdelta and limit exercise capacity.";
RL   Cell Metab. 26:243-255(2017).
RN   [37]
RP   FUNCTION, INTERACTION WITH NR1I2; NR1I3; NR3C1; PPARD; VDR; AR AND HNF4A,
RP   AND MUTAGENESIS OF GLY-351; GLY-354; SER-394; VAL-396 AND ARG-397.
RX   PubMed=28751364; DOI=10.1073/pnas.1704955114;
RA   Kriebs A., Jordan S.D., Soto E., Henriksson E., Sandate C.R., Vaughan M.E.,
RA   Chan A.B., Duglan D., Papp S.J., Huber A.L., Afetian M.E., Yu R.T.,
RA   Zhao X., Downes M., Evans R.M., Lamia K.A.;
RT   "Circadian repressors CRY1 and CRY2 broadly interact with nuclear receptors
RT   and modulate transcriptional activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:8776-8781(2017).
RN   [38]
RP   DISRUPTION PHENOTYPE, AND TISSUE SPECIFICITY.
RX   PubMed=29561690; DOI=10.1096/fj.201701165rr;
RA   Wong J.C.Y., Smyllie N.J., Banks G.T., Pothecary C.A., Barnard A.R.,
RA   Maywood E.S., Jagannath A., Hughes S., van der Horst G.T.J., MacLaren R.E.,
RA   Hankins M.W., Hastings M.H., Nolan P.M., Foster R.G., Peirson S.N.;
RT   "Differential roles for cryptochromes in the mammalian retinal clock.";
RL   FASEB J. 32:4302-4314(2018).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) OF 1-512 IN COMPLEX WITH UBIQUITIN
RP   LIGASE SYNTHETIC INHIBITOR.
RX   PubMed=24080726; DOI=10.1038/cr.2013.136;
RA   Nangle S., Xing W., Zheng N.;
RT   "Crystal structure of mammalian cryptochrome in complex with a small
RT   molecule competitor of its ubiquitin ligase.";
RL   Cell Res. 23:1417-1419(2013).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-512 IN COMPLEXES WITH FAD; SKP1
RP   AND FBXL3, IDENTIFICATION IN A COMPLEX WITH SKP1 AND FBXL3, COFACTOR,
RP   IDENTIFICATION BY MASS SPECTROMETRY, FAD-BINDING SITES, AND MUTAGENESIS OF
RP   TRP-310; ASP-339; ARG-376; PHE-428; ILE-499 AND LEU-517.
RX   PubMed=23503662; DOI=10.1038/nature11964;
RA   Xing W., Busino L., Hinds T.R., Marionni S.T., Saifee N.H., Bush M.F.,
RA   Pagano M., Zheng N.;
RT   "SCF(FBXL3) ubiquitin ligase targets cryptochromes at their cofactor
RT   pocket.";
RL   Nature 496:64-68(2013).
CC   -!- FUNCTION: Transcriptional repressor which forms a core component of the
CC       circadian clock. The circadian clock, an internal time-keeping system,
CC       regulates various physiological processes through the generation of
CC       approximately 24 hour circadian rhythms in gene expression, which are
CC       translated into rhythms in metabolism and behavior. It is derived from
CC       the Latin roots 'circa' (about) and 'diem' (day) and acts as an
CC       important regulator of a wide array of physiological functions
CC       including metabolism, sleep, body temperature, blood pressure,
CC       endocrine, immune, cardiovascular, and renal function. Consists of two
CC       major components: the central clock, residing in the suprachiasmatic
CC       nucleus (SCN) of the brain, and the peripheral clocks that are present
CC       in nearly every tissue and organ system. Both the central and
CC       peripheral clocks can be reset by environmental cues, also known as
CC       Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the
CC       central clock is light, which is sensed by retina and signals directly
CC       to the SCN. The central clock entrains the peripheral clocks through
CC       neuronal and hormonal signals, body temperature and feeding-related
CC       cues, aligning all clocks with the external light/dark cycle. Circadian
CC       rhythms allow an organism to achieve temporal homeostasis with its
CC       environment at the molecular level by regulating gene expression to
CC       create a peak of protein expression once every 24 hours to control when
CC       a particular physiological process is most active with respect to the
CC       solar day. Transcription and translation of core clock components
CC       (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2, PER1, PER2, PER3, CRY1 and
CC       CRY2) plays a critical role in rhythm generation, whereas delays
CC       imposed by post-translational modifications (PTMs) are important for
CC       determining the period (tau) of the rhythms (tau refers to the period
CC       of a rhythm and is the length, in time, of one complete cycle). A
CC       diurnal rhythm is synchronized with the day/night cycle, while the
CC       ultradian and infradian rhythms have a period shorter and longer than
CC       24 hours, respectively. Disruptions in the circadian rhythms contribute
CC       to the pathology of cardiovascular diseases, cancer, metabolic
CC       syndromes and aging. A transcription/translation feedback loop (TTFL)
CC       forms the core of the molecular circadian clock mechanism.
CC       Transcription factors, CLOCK or NPAS2 and ARNTL/BMAL1 or ARNTL2/BMAL2,
CC       form the positive limb of the feedback loop, act in the form of a
CC       heterodimer and activate the transcription of core clock genes and
CC       clock-controlled genes (involved in key metabolic processes), harboring
CC       E-box elements (5'-CACGTG-3') within their promoters. The core clock
CC       genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form
CC       the negative limb of the feedback loop and interact with the
CC       CLOCK|NPAS2-ARNTL/BMAL1|ARNTL2/BMAL2 heterodimer inhibiting its
CC       activity and thereby negatively regulating their own expression. This
CC       heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G,
CC       which form a second feedback loop and which activate and repress
CC       ARNTL/BMAL1 transcription, respectively. CRY1 and CRY2 have redundant
CC       functions but also differential and selective contributions at least in
CC       defining the pace of the SCN circadian clock and its circadian
CC       transcriptional outputs. Less potent transcriptional repressor in
CC       cerebellum and liver than CRY1, though less effective in lengthening
CC       the period of the SCN oscillator. Seems to play a critical role in
CC       tuning SCN circadian period by opposing the action of CRY1. With CRY1,
CC       dispensable for circadian rhythm generation but necessary for the
CC       development of intercellular networks for rhythm synchrony. May mediate
CC       circadian regulation of cAMP signaling and gluconeogenesis by blocking
CC       glucagon-mediated increases in intracellular cAMP concentrations and in
CC       CREB1 phosphorylation. Besides its role in the maintenance of the
CC       circadian clock, is also involved in the regulation of other processes.
CC       Plays a key role in glucose and lipid metabolism modulation, in part,
CC       through the transcriptional regulation of genes involved in these
CC       pathways, such as LEP or ACSL4. Represses glucocorticoid receptor
CC       NR3C1/GR-induced transcriptional activity by binding to glucocorticoid
CC       response elements (GREs). Represses the CLOCK-ARNTL/BMAL1 induced
CC       transcription of BHLHE40/DEC1 and NAMPT. Represses PPARD and its target
CC       genes in the skeletal muscle and limits exercise capacity
CC       (PubMed:28683290). Represses the transcriptional activity of NR1I2
CC       (PubMed:28751364). {ECO:0000269|PubMed:10428031,
CC       ECO:0000269|PubMed:16628007, ECO:0000269|PubMed:17310242,
CC       ECO:0000269|PubMed:19299583, ECO:0000269|PubMed:20852621,
CC       ECO:0000269|PubMed:22170608, ECO:0000269|PubMed:23531614,
CC       ECO:0000269|PubMed:23575670, ECO:0000269|PubMed:23616524,
CC       ECO:0000269|PubMed:24154698, ECO:0000269|PubMed:28683290,
CC       ECO:0000269|PubMed:28751364}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:23503662};
CC       Note=Binds 1 FAD per subunit. Only a minority of the protein molecules
CC       contain bound FAD. Contrary to the situation in photolyases, the FAD is
CC       bound in a shallow, surface-exposed pocket.
CC       {ECO:0000269|PubMed:23503662};
CC   -!- COFACTOR:
CC       Name=(6R)-5,10-methylene-5,6,7,8-tetrahydrofolate;
CC         Xref=ChEBI:CHEBI:15636; Evidence={ECO:0000250};
CC       Note=Binds 1 5,10-methenyltetrahydrofolate (MTHF) non-covalently per
CC       subunit. {ECO:0000250};
CC   -!- ACTIVITY REGULATION: KL001 (N-[3-(9H-carbazol-9-yl)-2-hydroxypropyl]-N-
CC       (2-furanylmethyl)-methanesulfonamide) binds to CRY1 and stabilizes it
CC       by inhibiting FBXL3- and ubiquitin-dependent degradation of CRY1
CC       resulting in lengthening of the circadian periods. KL001-mediated CRY1
CC       stabilization can inhibit glucagon-induced gluconeogenesis in primary
CC       hepatocytes. {ECO:0000269|PubMed:22798407}.
CC   -!- SUBUNIT: Component of the circadian core oscillator, which includes the
CC       CRY proteins, CLOCK or NPAS2, ARNTL/BMAL1 or ARNTL2/BMAL2, CSNK1D
CC       and/or CSNK1E, TIMELESS, and the PER proteins (PubMed:11779462).
CC       Interacts with TIMELESS (PubMed:10428031). Interacts directly with
CC       PER1, PER2 and PER3; interaction with PER2 inhibits its ubiquitination
CC       and vice versa (PubMed:10428031, PubMed:11875063, PubMed:14701732,
CC       PubMed:20840750, PubMed:24154698). Interacts with CLOCK-ARNTL/BMAL1
CC       (PubMed:16628007). Interacts with ARNTL/BMAL1 (PubMed:16717091,
CC       PubMed:19917250, PubMed:20840750). Interacts with CLOCK
CC       (PubMed:16717091, PubMed:19917250). Interacts with NFIL3
CC       (PubMed:17274955). Interacts with FBXL3 and FBXL21 (PubMed:17462724,
CC       PubMed:23452855, PubMed:23452856). FBXL3, PER2 and the cofactor FAD
CC       compete for overlapping binding sites (PubMed:24080726,
CC       PubMed:23503662). FBXL3 cannot bind CRY2 that interacts already with
CC       PER2 or that contains bound FAD (PubMed:23503662). Interacts with PPP5C
CC       (via TPR repeats); the interaction downregulates the PPP5C phosphatase
CC       activity on CSNK1E (By similarity). Interacts with nuclear receptors AR
CC       and NR3C1/GR; the interaction is ligand dependent (PubMed:22170608,
CC       PubMed:28751364). Interacts with PRKDC (PubMed:24158435). Interacts
CC       with CIART (PubMed:24736997). Interacts with DDB1, USP7 and TARDBP
CC       (PubMed:27123980). Interacts with HNF4A (PubMed:28751364). Interacts
CC       with PPARA (PubMed:28683290). Interacts with PPARG in a ligand-
CC       dependent manner (PubMed:28683290). Interacts with PPARD (via domain NR
CC       LBD) in a ligand-dependent manner (PubMed:28683290, PubMed:28751364).
CC       Interacts with NR1I2 (via domain NR LBD) in a ligand-dependent manner
CC       (PubMed:28751364). Interacts with NR1I3 and VDR in a ligand-dependent
CC       manner (PubMed:28751364). {ECO:0000250|UniProtKB:Q49AN0,
CC       ECO:0000269|PubMed:10428031, ECO:0000269|PubMed:11779462,
CC       ECO:0000269|PubMed:11875063, ECO:0000269|PubMed:14701732,
CC       ECO:0000269|PubMed:16628007, ECO:0000269|PubMed:16717091,
CC       ECO:0000269|PubMed:17274955, ECO:0000269|PubMed:17462724,
CC       ECO:0000269|PubMed:19917250, ECO:0000269|PubMed:20840750,
CC       ECO:0000269|PubMed:22170608, ECO:0000269|PubMed:23452855,
CC       ECO:0000269|PubMed:23452856, ECO:0000269|PubMed:23503662,
CC       ECO:0000269|PubMed:24080726, ECO:0000269|PubMed:24154698,
CC       ECO:0000269|PubMed:24158435, ECO:0000269|PubMed:24736997,
CC       ECO:0000269|PubMed:27123980, ECO:0000269|PubMed:28683290,
CC       ECO:0000269|PubMed:28751364}.
CC   -!- INTERACTION:
CC       Q9R194; Q9WTL8: Arntl; NbExp=12; IntAct=EBI-1266619, EBI-644534;
CC       Q9R194; Q3TQ03: Ciart; NbExp=2; IntAct=EBI-1266619, EBI-16101489;
CC       Q9R194; P67871: Csnk2b; NbExp=3; IntAct=EBI-1266619, EBI-348179;
CC       Q9R194; Q8BFZ4: Fbxl21; NbExp=4; IntAct=EBI-1266619, EBI-6898235;
CC       Q9R194; Q8C4V4: Fbxl3; NbExp=6; IntAct=EBI-1266619, EBI-1266589;
CC       Q9R194; P06537-1: Nr3c1; NbExp=3; IntAct=EBI-1266619, EBI-15959147;
CC       Q9R194; O35973: Per1; NbExp=3; IntAct=EBI-1266619, EBI-1266764;
CC       Q9R194; O54943: Per2; NbExp=8; IntAct=EBI-1266619, EBI-1266779;
CC       Q9R194; Q9UKT7: FBXL3; Xeno; NbExp=13; IntAct=EBI-1266619, EBI-2557269;
CC       Q9R194; O15534: PER1; Xeno; NbExp=3; IntAct=EBI-1266619, EBI-2557276;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11779462}. Nucleus
CC       {ECO:0000269|PubMed:11779462}. Note=Translocated to the nucleus through
CC       interaction with other Clock proteins such as PER2 or ARNTL.
CC       {ECO:0000269|PubMed:11779462}.
CC   -!- TISSUE SPECIFICITY: Expression in the retina is restricted to the
CC       photoreceptor layer (at protein level) (PubMed:29561690). Expressed in
CC       all tissues examined including heart, brain, spleen, lung, liver,
CC       skeletal muscle, kidney and testis. Weak expression in spleen.
CC       {ECO:0000269|PubMed:10521578, ECO:0000269|PubMed:11779462,
CC       ECO:0000269|PubMed:24154698, ECO:0000269|PubMed:29561690,
CC       ECO:0000269|PubMed:9801304}.
CC   -!- INDUCTION: Shows no clear circadian oscillation pattern in testis,
CC       cerebellum nor liver. In skeletal muscle, under constant darkness and
CC       12 hours light:12 hours dark conditions, levels peak between ZT6 and
CC       ZT9. {ECO:0000269|PubMed:10428031, ECO:0000269|PubMed:10521578,
CC       ECO:0000269|PubMed:19917250}.
CC   -!- PTM: Phosphorylation on Ser-265 by MAPK is important for the inhibition
CC       of CLOCK-ARNTL-mediated transcriptional activity. Phosphorylation by
CC       CSKNE requires interaction with PER1 or PER2. Phosphorylated in a
CC       circadian manner at Ser-553 and Ser-557 in the suprachiasmatic nucleus
CC       (SCN) and liver. Phosphorylation at Ser-557 by DYRK1A promotes
CC       subsequent phosphorylation at Ser-553 by GSK3-beta: the two-step
CC       phosphorylation at the neighboring Ser residues leads to its
CC       proteasomal degradation. {ECO:0000269|PubMed:11875063,
CC       ECO:0000269|PubMed:15298678, ECO:0000269|PubMed:15980066,
CC       ECO:0000269|PubMed:20123978}.
CC   -!- PTM: Ubiquitinated by the SCF(FBXL3) and SCF(FBXL21) complexes,
CC       regulating the balance between degradation and stabilization. The
CC       SCF(FBXL3) complex is mainly nuclear and mediates ubiquitination and
CC       subsequent degradation of CRY2. In contrast, cytoplasmic SCF(FBXL21)
CC       complex-mediated ubiquitination leads to stabilize CRY2 and counteract
CC       the activity of the SCF(FBXL3) complex. The SCF(FBXL3) and SCF(FBXL21)
CC       complexes probably mediate ubiquitination at different Lys residues.
CC       The SCF(FBXL3) complex recognizes and binds CRY2 phosphorylated at Ser-
CC       553 and Ser-557. Ubiquitination may be inhibited by PER2.
CC       Deubiquitinated by USP7 (PubMed:27123980).
CC       {ECO:0000269|PubMed:15298678, ECO:0000269|PubMed:15980066,
CC       ECO:0000269|PubMed:17462724, ECO:0000269|PubMed:20123978,
CC       ECO:0000269|PubMed:23452855, ECO:0000269|PubMed:23452856,
CC       ECO:0000269|PubMed:26776516, ECO:0000269|PubMed:27123980}.
CC   -!- DISRUPTION PHENOTYPE: Animals show longer circadian periods. Double
CC       knockouts of CRY1 and CRY2 show slightly decrease body weight and lose
CC       the cycling rhythmicity of feeding behavior, energy expenditure and
CC       glucocorticorids expression. Glucose homeostasis is severely disrupted
CC       and animals exhibit elevated blood glucose in response to acute feeding
CC       after an overnight fast as well as severely impaired glucose clearance
CC       in a glucose tolerance test. When challenged with high-fat diet,
CC       animals rapidly gain weight and surpass that of wild-type mice, despite
CC       displaying hypophagia. They exhibit hyperinsulinemia and selective
CC       insulin resistance in the liver and muscle but show high insulin
CC       sensitivity in adipose tissue and consequent increased lipid uptake.
CC       Mice display enlarged gonadal, subcutaneous and perirenal fat deposits
CC       with adipocyte hypertrophy and increased lipied accumulation in liver.
CC       Mice show attentuated circadian rhythms in photopic ERG b-wave
CC       amplitudes (PubMed:29561690). Both single CRY1 knockout and double CRY1
CC       and CRY2 knockout mice show increased exercise performance and
CC       increased mitochondrial reserve capacity in primary myotubes
CC       (PubMed:28683290). {ECO:0000269|PubMed:20852621,
CC       ECO:0000269|PubMed:22170608, ECO:0000269|PubMed:23531614,
CC       ECO:0000269|PubMed:23616524, ECO:0000269|PubMed:28683290,
CC       ECO:0000269|PubMed:29561690}.
CC   -!- SIMILARITY: Belongs to the DNA photolyase class-1 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF156987; AAD46561.1; -; mRNA.
DR   EMBL; AK041696; BAC31037.1; -; mRNA.
DR   EMBL; AK133781; BAE21836.1; -; mRNA.
DR   EMBL; BC054794; AAH54794.1; -; mRNA.
DR   EMBL; BC066799; AAH66799.1; -; mRNA.
DR   EMBL; AK172994; BAD32272.1; -; mRNA.
DR   EMBL; AB003433; BAA19864.1; -; mRNA.
DR   CCDS; CCDS16447.1; -.
DR   RefSeq; NP_034093.1; NM_009963.4.
DR   RefSeq; XP_017170770.1; XM_017315281.1.
DR   PDB; 4I6E; X-ray; 2.70 A; A=1-512.
DR   PDB; 4I6G; X-ray; 2.20 A; A/B=1-512.
DR   PDB; 4I6J; X-ray; 2.70 A; A=1-544.
DR   PDB; 4MLP; X-ray; 1.94 A; A/B/C/D=1-512.
DR   PDB; 4U8H; X-ray; 2.80 A; A/C=1-510.
DR   PDB; 6KX8; X-ray; 2.25 A; A/B=1-512.
DR   PDBsum; 4I6E; -.
DR   PDBsum; 4I6G; -.
DR   PDBsum; 4I6J; -.
DR   PDBsum; 4MLP; -.
DR   PDBsum; 4U8H; -.
DR   PDBsum; 6KX8; -.
DR   SMR; Q9R194; -.
DR   BioGRID; 198907; 16.
DR   ComplexPortal; CPX-3210; Cry2-Per2 complex.
DR   ComplexPortal; CPX-3214; Cry2-Per1 complex.
DR   ComplexPortal; CPX-3218; Cry2-Per3 complex.
DR   CORUM; Q9R194; -.
DR   DIP; DIP-38517N; -.
DR   IntAct; Q9R194; 25.
DR   MINT; Q9R194; -.
DR   STRING; 10090.ENSMUSP00000088047; -.
DR   iPTMnet; Q9R194; -.
DR   PhosphoSitePlus; Q9R194; -.
DR   EPD; Q9R194; -.
DR   jPOST; Q9R194; -.
DR   MaxQB; Q9R194; -.
DR   PaxDb; Q9R194; -.
DR   PeptideAtlas; Q9R194; -.
DR   PRIDE; Q9R194; -.
DR   ProteomicsDB; 284176; -.
DR   Antibodypedia; 26186; 246 antibodies.
DR   Ensembl; ENSMUST00000090559; ENSMUSP00000088047; ENSMUSG00000068742.
DR   Ensembl; ENSMUST00000111278; ENSMUSP00000106909; ENSMUSG00000068742.
DR   GeneID; 12953; -.
DR   KEGG; mmu:12953; -.
DR   UCSC; uc008kxy.2; mouse.
DR   CTD; 1408; -.
DR   MGI; MGI:1270859; Cry2.
DR   eggNOG; KOG0133; Eukaryota.
DR   GeneTree; ENSGT00940000159073; -.
DR   HOGENOM; CLU_010348_3_4_1; -.
DR   InParanoid; Q9R194; -.
DR   OMA; HEAACNI; -.
DR   OrthoDB; 378952at2759; -.
DR   PhylomeDB; Q9R194; -.
DR   TreeFam; TF323191; -.
DR   BioGRID-ORCS; 12953; 1 hit in 53 CRISPR screens.
DR   PRO; PR:Q9R194; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; Q9R194; protein.
DR   Bgee; ENSMUSG00000068742; Expressed in blood and 308 other tissues.
DR   Genevisible; Q9R194; MM.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; ISO:MGI.
DR   GO; GO:0003677; F:DNA binding; ISO:MGI.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0035257; F:nuclear hormone receptor binding; IPI:UniProtKB.
DR   GO; GO:0019902; F:phosphatase binding; ISO:MGI.
DR   GO; GO:0009881; F:photoreceptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0003697; F:single-stranded DNA binding; ISO:MGI.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0032922; P:circadian regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; IMP:UniProtKB.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; IMP:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; IGI:UniProtKB.
DR   GO; GO:0019915; P:lipid storage; IGI:UniProtKB.
DR   GO; GO:0042754; P:negative regulation of circadian rhythm; IDA:UniProtKB.
DR   GO; GO:2000323; P:negative regulation of glucocorticoid receptor signaling pathway; IGI:UniProtKB.
DR   GO; GO:2000850; P:negative regulation of glucocorticoid secretion; IGI:UniProtKB.
DR   GO; GO:0032515; P:negative regulation of phosphoprotein phosphatase activity; ISO:MGI.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:MGI.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006606; P:protein import into nucleus; IPI:MGI.
DR   GO; GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IMP:UniProtKB.
DR   GO; GO:0014823; P:response to activity; IMP:UniProtKB.
DR   GO; GO:0032868; P:response to insulin; IGI:UniProtKB.
DR   GO; GO:0009416; P:response to light stimulus; IMP:UniProtKB.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR036134; Crypto/Photolyase_FAD-like_sf.
DR   InterPro; IPR036155; Crypto/Photolyase_N_sf.
DR   InterPro; IPR005101; Cryptochr/Photolyase_FAD-bd.
DR   InterPro; IPR006050; DNA_photolyase_N.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00875; DNA_photolyase; 1.
DR   Pfam; PF03441; FAD_binding_7; 1.
DR   SUPFAM; SSF48173; SSF48173; 1.
DR   SUPFAM; SSF52425; SSF52425; 1.
DR   PROSITE; PS51645; PHR_CRY_ALPHA_BETA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Biological rhythms; Chromophore; Cytoplasm; FAD;
KW   Flavoprotein; Isopeptide bond; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Photoreceptor protein; Receptor; Reference proteome; Repressor;
KW   Sensory transduction; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..592
FT                   /note="Cryptochrome-2"
FT                   /id="PRO_0000261149"
FT   DOMAIN          21..150
FT                   /note="Photolyase/cryptochrome alpha/beta"
FT   NP_BIND         405..407
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23503662"
FT   REGION          389..488
FT                   /note="Required for inhibition of CLOCK-ARNTL-mediated
FT                   transcription"
FT                   /evidence="ECO:0000250|UniProtKB:P97784"
FT   REGION          532..592
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        535..552
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        560..579
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         270
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:23503662"
FT   BINDING         307
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:P97784"
FT   BINDING         373
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23503662"
FT   MOD_RES         89
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P97784"
FT   MOD_RES         265
FT                   /note="Phosphoserine; by MAPK"
FT                   /evidence="ECO:0000269|PubMed:11875063,
FT                   ECO:0000269|PubMed:15298678"
FT   MOD_RES         298
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P97784"
FT   MOD_RES         553
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000269|PubMed:11875063,
FT                   ECO:0000269|PubMed:20123978"
FT   MOD_RES         557
FT                   /note="Phosphoserine; by DYRK1A and MAPK"
FT                   /evidence="ECO:0000269|PubMed:11875063,
FT                   ECO:0000269|PubMed:15298678, ECO:0000269|PubMed:15980066,
FT                   ECO:0000269|PubMed:20123978"
FT   CROSSLNK        29
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P97784"
FT   CROSSLNK        125
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:23452856"
FT   CROSSLNK        241
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:23452856"
FT   CROSSLNK        347
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:23452856"
FT   CROSSLNK        474
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:23452856"
FT   CROSSLNK        503
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:23452856"
FT   MUTAGEN         265
FT                   /note="S->A: Reduced in vitro MAPK-catalyzed
FT                   phosphorylation. No effect on inhibition of CLOCK-ARNTL-
FT                   mediated transcriptional activity. Very little in vitro
FT                   MAPK-catalyzed phosphorylation; when associated with A-
FT                   557."
FT                   /evidence="ECO:0000269|PubMed:15298678"
FT   MUTAGEN         265
FT                   /note="S->D: Reduced inhibition of CLOCK-ARNTL-mediated
FT                   transcriptional activity. No effect on nuclear localization
FT                   nor on protein stability."
FT                   /evidence="ECO:0000269|PubMed:15298678"
FT   MUTAGEN         310
FT                   /note="W->A: Decreases FBXL3 binding. Strongly decreases
FT                   CRY2 degradation."
FT                   /evidence="ECO:0000269|PubMed:23503662"
FT   MUTAGEN         339
FT                   /note="D->R: Strongly reduces PER1 binding."
FT                   /evidence="ECO:0000269|PubMed:23503662"
FT   MUTAGEN         351
FT                   /note="G->D: Loss of ability to inhibit CLOCK-ARNTL-
FT                   mediated transcriptional activity. No loss of ability to
FT                   inhibit NR1I2 transcriptional activity."
FT                   /evidence="ECO:0000269|PubMed:28751364"
FT   MUTAGEN         354
FT                   /note="G->D: Loss of ability to inhibit CLOCK-ARNTL-
FT                   mediated transcriptional activity. No loss of ability to
FT                   inhibit NR1I2 transcriptional activity."
FT                   /evidence="ECO:0000269|PubMed:28751364"
FT   MUTAGEN         376
FT                   /note="R->A: Impairs protein folding. Abolishes binding of
FT                   ARNTL, PER1 and FBXL3. Strongly reduces SKP1 binding."
FT                   /evidence="ECO:0000269|PubMed:23503662"
FT   MUTAGEN         394
FT                   /note="S->E: Reduced interaction with NR1I2 and NR1I3.
FT                   Significant decrease in interaction with NR1I2 and NR1I3;
FT                   when associated with M-396 and K-397."
FT                   /evidence="ECO:0000269|PubMed:28751364"
FT   MUTAGEN         396
FT                   /note="V->M: Reduced interaction with NR1I2 and NR1I3.
FT                   Significant decrease in interaction with NR1I2 and NR1I3;
FT                   when associated with E-394 and K-397."
FT                   /evidence="ECO:0000269|PubMed:28751364"
FT   MUTAGEN         397
FT                   /note="R->K: Reduced interaction with NR1I2 and NR1I3.
FT                   Significant decrease in interaction with NR1I2 and NR1I3;
FT                   when associated with E-394 and M-396."
FT                   /evidence="ECO:0000269|PubMed:28751364"
FT   MUTAGEN         428
FT                   /note="F->D: Abolishes binding of FBXL3 and SKP1. Strongly
FT                   decreases CRY2 degradation."
FT                   /evidence="ECO:0000269|PubMed:23503662"
FT   MUTAGEN         499
FT                   /note="I->D: Abolishes binding of FBXL3 and SKP1. Strongly
FT                   decreases CRY2 degradation."
FT                   /evidence="ECO:0000269|PubMed:23503662"
FT   MUTAGEN         501
FT                   /note="R->Q: Inhibits interaction with PER2. Does not
FT                   suppress its nuclear localization. Inhibits its repression
FT                   activity on CLOCK|NPAS2-ARNTL-driven transcription."
FT                   /evidence="ECO:0000269|PubMed:20840750"
FT   MUTAGEN         503
FT                   /note="K->R: Inhibits interaction with PER2. Does not
FT                   suppress its nuclear localization. Inhibits its repression
FT                   activity on CLOCK|NPAS2-ARNTL-driven transcription."
FT                   /evidence="ECO:0000269|PubMed:20840750"
FT   MUTAGEN         517
FT                   /note="L->D: Decreases FBXL3 binding. Strongly decreases
FT                   CRY2 degradation."
FT                   /evidence="ECO:0000269|PubMed:23503662"
FT   MUTAGEN         553
FT                   /note="S->A: Shorter circadian rhythm; when associated with
FT                   A-557."
FT                   /evidence="ECO:0000269|PubMed:20123978"
FT   MUTAGEN         557
FT                   /note="S->A: Reduced in vitro MAPK-catalyzed
FT                   phosphorylation. No effect on inhibition of CLOCK-ARNTL-
FT                   mediated transcriptional activity. Very little in vitro
FT                   MAPK-catalyzed phosphorylation; when associated with A-265.
FT                   Shorter circadian rhythm; when associated with A-553."
FT                   /evidence="ECO:0000269|PubMed:15298678,
FT                   ECO:0000269|PubMed:20123978"
FT   MUTAGEN         557
FT                   /note="S->D: Reduced inhibition of CLOCK-ARNTL-mediated
FT                   transcriptional activity. No effect on nuclear localization
FT                   nor on protein stability."
FT                   /evidence="ECO:0000269|PubMed:15298678,
FT                   ECO:0000269|PubMed:20123978"
FT   CONFLICT        191..192
FT                   /note="QQ -> SR (in Ref. 5; BAA19864)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        202
FT                   /note="E -> K (in Ref. 5; BAA19864)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        327
FT                   /note="M -> V (in Ref. 5; BAA19864)"
FT                   /evidence="ECO:0000305"
FT   STRAND          22..26
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   STRAND          32..35
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           37..43
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   STRAND          47..55
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           59..61
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           67..85
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   TURN            86..88
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   STRAND          91..96
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           98..109
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   STRAND          113..117
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           122..137
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   STRAND          141..145
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   STRAND          148..151
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           153..159
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   TURN            160..162
FT                   /evidence="ECO:0007829|PDB:4I6E"
FT   HELIX           168..176
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           190..194
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           204..208
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   TURN            213..217
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           232..242
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           245..251
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           259..262
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           270..274
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           280..294
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   STRAND          295..297
FT                   /evidence="ECO:0007829|PDB:4I6G"
FT   HELIX           302..305
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           306..318
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   TURN            322..325
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           342..350
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           356..368
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           373..383
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   TURN            384..388
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           392..402
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           408..418
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   STRAND          421..423
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           435..440
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           445..450
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           452..454
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           459..462
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           465..467
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           470..475
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   TURN            480..482
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   HELIX           491..507
FT                   /evidence="ECO:0007829|PDB:4MLP"
FT   STRAND          517..521
FT                   /evidence="ECO:0007829|PDB:4I6J"
SQ   SEQUENCE   592 AA;  66850 MW;  4D6E7B199C392CBB CRC64;
     MAAAAVVAAT VPAQSMGADG ASSVHWFRKG LRLHDNPALL AAVRGARCVR CVYILDPWFA
     ASSSVGINRW RFLLQSLEDL DTSLRKLNSR LFVVRGQPAD VFPRLFKEWG VTRLTFEYDS
     EPFGKERDAA IMKMAKEAGV EVVTENSHTL YDLDRIIELN GQKPPLTYKR FQALISRMEL
     PKKPAVAVSS QQMESCRAEI QENHDDTYGV PSLEELGFPT EGLGPAVWQG GETEALARLD
     KHLERKAWVA NYERPRMNAN SLLASPTGLS PYLRFGCLSC RLFYYRLWDL YKKVKRNSTP
     PLSLFGQLLW REFFYTAATN NPRFDRMEGN PICIQIPWDR NPEALAKWAE GKTGFPWIDA
     IMTQLRQEGW IHHLARHAVA CFLTRGDLWV SWESGVRVFD ELLLDADFSV NAGSWMWLSC
     SAFFQQFFHC YCPVGFGRRT DPSGDYIRRY LPKLKGFPSR YIYEPWNAPE SVQKAAKCII
     GVDYPRPIVN HAETSRLNIE RMKQIYQQLS RYRGLCLLAS VPSCVEDLSH PVAEPGSSQA
     GSISNTGPRA LSSGPASPKR KLEAAEEPPG EELTKRARVT EMPTQEPASK DS
//
ID   GGR_SULAC               Reviewed;         452 AA.
AC   Q4JA33;
DT   07-OCT-2020, integrated into UniProtKB/Swiss-Prot.
DT   02-AUG-2005, sequence version 1.
DT   02-JUN-2021, entry version 98.
DE   RecName: Full=Digeranylgeranylglycerophospholipid reductase;
DE            Short=DGGGPL reductase;
DE            EC=1.3.-.- {ECO:0000269|PubMed:18375567, ECO:0000269|PubMed:24954619};
DE   AltName: Full=2,3-bis-O-geranylgeranylglyceryl phosphate reductase;
DE   AltName: Full=Geranylgeranyl diphosphate reductase;
DE            Short=GGPP reductase;
DE   AltName: Full=Geranylgeranyl reductase {ECO:0000303|PubMed:18375567};
DE            Short=GGR {ECO:0000303|PubMed:18375567};
GN   OrderedLocusNames=Saci_0986 {ECO:0000312|EMBL:AAY80347.1};
OS   Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC
OS   15157 / NCIMB 11770).
OC   Archaea; Crenarchaeota; Thermoprotei; Sulfolobales; Sulfolobaceae;
OC   Sulfolobus.
OX   NCBI_TaxID=330779;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770;
RX   PubMed=15995215; DOI=10.1128/jb.187.14.4992-4999.2005;
RA   Chen L., Bruegger K., Skovgaard M., Redder P., She Q., Torarinsson E.,
RA   Greve B., Awayez M., Zibat A., Klenk H.-P., Garrett R.A.;
RT   "The genome of Sulfolobus acidocaldarius, a model organism of the
RT   Crenarchaeota.";
RL   J. Bacteriol. 187:4992-4999(2005).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, FLAVIN-BINDING, COFACTOR, AND PATHWAY.
RX   PubMed=18375567; DOI=10.1128/jb.00082-08;
RA   Sato S., Murakami M., Yoshimura T., Hemmi H.;
RT   "Specific partial reduction of geranylgeranyl diphosphate by an enzyme from
RT   the thermoacidophilic archaeon Sulfolobus acidocaldarius yields a reactive
RT   prenyl donor, not a dead-end product.";
RL   J. Bacteriol. 190:3923-3929(2008).
RN   [3] {ECO:0007744|PDB:3ATQ, ECO:0007744|PDB:3ATR}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH FADH2, FUNCTION,
RP   COFACTOR, DISULFIDE BOND, SUBUNIT, AND MUTAGENESIS OF CYS-47; TYR-215;
RP   TRP-217 AND PHE-219.
RX   PubMed=21515284; DOI=10.1016/j.jmb.2011.04.002;
RA   Sasaki D., Fujihashi M., Iwata Y., Murakami M., Yoshimura T., Hemmi H.,
RA   Miki K.;
RT   "Structure and mutation analysis of archaeal geranylgeranyl reductase.";
RL   J. Mol. Biol. 409:543-557(2011).
RN   [4] {ECO:0007744|PDB:4OPC, ECO:0007744|PDB:4OPD, ECO:0007744|PDB:4OPG, ECO:0007744|PDB:4OPI, ECO:0007744|PDB:4OPL, ECO:0007744|PDB:4OPT, ECO:0007744|PDB:4OPU}
RP   X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) OF WILD-TYPE AND MUTANTS HIS-91;
RP   PHE-206; LEU-219; HIS-377 AND PHE-206/HIS-377 IN COMPLEXES WITH FAD;
RP   GERANYLGERANYL PYROPHOSPHATE AND PHOSPHATIDYLGLYCEROL, FUNCTION, CATALYTIC
RP   ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, DISULFIDE BOND,
RP   MUTAGENESIS OF GLY-91; ILE-206; PHE-219 AND LEU-377, AND REACTION
RP   MECHANISM.
RX   PubMed=24954619; DOI=10.1016/j.str.2014.05.007;
RA   Kung Y., McAndrew R.P., Xie X., Liu C.C., Pereira J.H., Adams P.D.,
RA   Keasling J.D.;
RT   "Constructing tailored isoprenoid products by structure-guided modification
RT   of geranylgeranyl reductase.";
RL   Structure 22:1028-1036(2014).
CC   -!- FUNCTION: Is involved in the reduction of 2,3-
CC       digeranylgeranylglycerophospholipids (unsaturated archaeols) into 2,3-
CC       diphytanylglycerophospholipids (saturated archaeols) in the
CC       biosynthesis of archaeal membrane lipids. Catalyzes the formation of
CC       archaetidic acid (2,3-di-O-phytanyl-sn-glyceryl phosphate) from 2,3-di-
CC       O-geranylgeranylglyceryl phosphate (DGGGP) via the hydrogenation of
CC       each double bond of the isoprenoid chains. Is not active with NADPH or
CC       NADH as an electron donor; the physiological reducing agent is unknown.
CC       Is also active on the more upstream precursors of membrane lipid
CC       biosynthesis, catalyzing the complete reduction of 3-O-
CC       geranylgeranylglyceryl phosphate (GGGP) to 3-O-phytanylglyceryl
CC       phosphate, and the partial reduction of geranylgeranyl diphosphate
CC       (GGPP) to phytyl diphosphate, thus reducing three of four GGPP double
CC       bonds and preserving the allylic double bond (at position 2). This
CC       reaction product is a reactive prenyl donor, which can be used as a
CC       substrate by archaeal prenyltransferases such as GGGP synthases.
CC       {ECO:0000269|PubMed:18375567, ECO:0000269|PubMed:21515284,
CC       ECO:0000269|PubMed:24954619}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=8 A + a 2,3-bis-O-phytanyl-sn-glycerol 1-phospholipid = a 2,3-
CC         bis-O-(geranylgeranyl)-sn-glycerol 1-phospholipid + 8 AH2;
CC         Xref=Rhea:RHEA:64376, ChEBI:CHEBI:13193, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:138139, ChEBI:CHEBI:138140;
CC         Evidence={ECO:0000305|PubMed:18375567, ECO:0000305|PubMed:24954619};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:64378;
CC         Evidence={ECO:0000305|PubMed:18375567};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2,3-bis-O-(phytanyl)-sn-glycerol 1-phosphate + 8 A = 2,3-bis-
CC         O-(geranylgeranyl)-sn-glycerol 1-phosphate + 8 AH2;
CC         Xref=Rhea:RHEA:64368, ChEBI:CHEBI:13193, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:58837, ChEBI:CHEBI:73125;
CC         Evidence={ECO:0000269|PubMed:18375567};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:64370;
CC         Evidence={ECO:0000305|PubMed:18375567};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4 A + sn-3-O-phytanylglycerol 1-phosphate = 4 AH2 + sn-3-O-
CC         (geranylgeranyl)glycerol 1-phosphate; Xref=Rhea:RHEA:64388,
CC         ChEBI:CHEBI:13193, ChEBI:CHEBI:17499, ChEBI:CHEBI:57677,
CC         ChEBI:CHEBI:152569; Evidence={ECO:0000269|PubMed:18375567};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:64390;
CC         Evidence={ECO:0000305|PubMed:18375567};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3 A + phytyl diphosphate = (2E,6E,10E)-geranylgeranyl
CC         diphosphate + 3 AH2; Xref=Rhea:RHEA:64380, ChEBI:CHEBI:13193,
CC         ChEBI:CHEBI:17499, ChEBI:CHEBI:58756, ChEBI:CHEBI:75434;
CC         Evidence={ECO:0000269|PubMed:18375567, ECO:0000269|PubMed:24954619};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:64382;
CC         Evidence={ECO:0000305|PubMed:18375567};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:21515284, ECO:0000269|PubMed:24954619,
CC         ECO:0000305|PubMed:18375567};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:21515284,
CC       ECO:0000269|PubMed:24954619};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=kcat is 0.40 min(-1) for the reduction of GGPP to the hexahydro-
CC         product H(6)GGPP. {ECO:0000269|PubMed:24954619};
CC       pH dependence:
CC         Optimum pH is 5.5 for the reduction of GGPP to the hexahydro-product
CC         H(6)GGPP. {ECO:0000269|PubMed:24954619};
CC       Temperature dependence:
CC         Optimum temperature is 55 degrees Celsius for the reduction of GGPP
CC         to the hexahydro-product H(6)GGPP. {ECO:0000269|PubMed:24954619};
CC   -!- PATHWAY: Membrane lipid metabolism; glycerophospholipid metabolism.
CC       {ECO:0000305|PubMed:18375567}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:21515284}.
CC   -!- SIMILARITY: Belongs to the geranylgeranyl reductase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000077; AAY80347.1; -; Genomic_DNA.
DR   RefSeq; WP_011277849.1; NC_007181.1.
DR   PDB; 3ATQ; X-ray; 1.85 A; A=1-452.
DR   PDB; 3ATR; X-ray; 1.80 A; A=1-452.
DR   PDB; 4OPC; X-ray; 1.40 A; A=1-452.
DR   PDB; 4OPD; X-ray; 1.81 A; A/B=1-452.
DR   PDB; 4OPG; X-ray; 2.07 A; A=1-452.
DR   PDB; 4OPI; X-ray; 2.24 A; A=1-452.
DR   PDB; 4OPL; X-ray; 2.51 A; A=1-452.
DR   PDB; 4OPT; X-ray; 2.60 A; A=1-452.
DR   PDB; 4OPU; X-ray; 2.70 A; A=1-452.
DR   PDBsum; 3ATQ; -.
DR   PDBsum; 3ATR; -.
DR   PDBsum; 4OPC; -.
DR   PDBsum; 4OPD; -.
DR   PDBsum; 4OPG; -.
DR   PDBsum; 4OPI; -.
DR   PDBsum; 4OPL; -.
DR   PDBsum; 4OPT; -.
DR   PDBsum; 4OPU; -.
DR   SMR; Q4JA33; -.
DR   STRING; 330779.Saci_0986; -.
DR   EnsemblBacteria; AAY80347; AAY80347; Saci_0986.
DR   GeneID; 3473654; -.
DR   KEGG; sai:Saci_0986; -.
DR   PATRIC; fig|330779.12.peg.946; -.
DR   eggNOG; arCOG00570; Archaea.
DR   eggNOG; COG0644; LUCA.
DR   HOGENOM; CLU_024648_0_0_2; -.
DR   OMA; YFPRTET; -.
DR   BioCyc; SACI330779:G1G4L-965-MONOMER; -.
DR   BRENDA; 1.3.7.11; 6160.
DR   UniPathway; UPA00940; -.
DR   EvolutionaryTrace; Q4JA33; -.
DR   Proteomes; UP000001018; Chromosome.
DR   GO; GO:0016628; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; IEA:InterPro.
DR   GO; GO:0006650; P:glycerophospholipid metabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR011777; Geranylgeranyl_Rdtase_fam.
DR   Pfam; PF01266; DAO; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR02032; GG-red-SF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; FAD; Flavoprotein; Lipid biosynthesis;
KW   Lipid metabolism; Oxidoreductase; Phospholipid biosynthesis;
KW   Phospholipid metabolism; Reference proteome.
FT   CHAIN           1..452
FT                   /note="Digeranylgeranylglycerophospholipid reductase"
FT                   /id="PRO_0000450802"
FT   NP_BIND         15..16
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21515284,
FT                   ECO:0000269|PubMed:24954619, ECO:0007744|PDB:3ATQ,
FT                   ECO:0007744|PDB:4OPC"
FT   NP_BIND         35..36
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21515284,
FT                   ECO:0000269|PubMed:24954619, ECO:0007744|PDB:3ATQ,
FT                   ECO:0007744|PDB:4OPC"
FT   NP_BIND         45..50
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21515284,
FT                   ECO:0000269|PubMed:24954619, ECO:0007744|PDB:3ATQ,
FT                   ECO:0007744|PDB:4OPC"
FT   NP_BIND         300..301
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21515284,
FT                   ECO:0000269|PubMed:24954619, ECO:0007744|PDB:3ATQ,
FT                   ECO:0007744|PDB:4OPC"
FT   BINDING         55
FT                   /note="a 2,3-bis-O-phytanyl-sn-glycerol 1-phospholipid"
FT                   /evidence="ECO:0000305|PubMed:24954619,
FT                   ECO:0007744|PDB:4OPC"
FT   BINDING         122
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:21515284,
FT                   ECO:0000269|PubMed:24954619, ECO:0007744|PDB:3ATQ,
FT                   ECO:0007744|PDB:4OPC"
FT   BINDING         288
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21515284,
FT                   ECO:0000269|PubMed:24954619, ECO:0007744|PDB:3ATQ,
FT                   ECO:0007744|PDB:4OPC"
FT   BINDING         297
FT                   /note="a 2,3-bis-O-phytanyl-sn-glycerol 1-phospholipid"
FT                   /evidence="ECO:0000305|PubMed:24954619,
FT                   ECO:0007744|PDB:4OPC"
FT   BINDING         340
FT                   /note="a 2,3-bis-O-phytanyl-sn-glycerol 1-phospholipid"
FT                   /evidence="ECO:0000305|PubMed:24954619,
FT                   ECO:0007744|PDB:4OPC"
FT   DISULFID        310..335
FT                   /evidence="ECO:0000269|PubMed:21515284,
FT                   ECO:0000269|PubMed:24954619, ECO:0007744|PDB:3ATQ,
FT                   ECO:0007744|PDB:3ATR, ECO:0007744|PDB:4OPC"
FT   MUTAGEN         47
FT                   /note="C->A,M: Almost loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:21515284"
FT   MUTAGEN         47
FT                   /note="C->S: Seems to be able to reduce only one double
FT                   bond of GGGP."
FT                   /evidence="ECO:0000269|PubMed:21515284"
FT   MUTAGEN         91
FT                   /note="G->H: Halts the reduction of GGPP at H(2)GGPP."
FT                   /evidence="ECO:0000269|PubMed:24954619"
FT   MUTAGEN         206
FT                   /note="I->F: Increases reduction rate of GGPP to H(6)GGPP."
FT                   /evidence="ECO:0000269|PubMed:24954619"
FT   MUTAGEN         215
FT                   /note="Y->F,L: Moderate decrease in catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:21515284"
FT   MUTAGEN         217
FT                   /note="W->L: Large decrease in catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:21515284"
FT   MUTAGEN         219
FT                   /note="F->L: Halts the reduction of GGPP at H(4)GGPP."
FT                   /evidence="ECO:0000269|PubMed:24954619"
FT   MUTAGEN         219
FT                   /note="F->L: Slight decrease in catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:21515284"
FT   MUTAGEN         377
FT                   /note="L->H: Increases reduction rate of GGPP to H(6)GGPP."
FT                   /evidence="ECO:0000269|PubMed:24954619"
FT   STRAND          2..5
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          7..11
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           15..24
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          25..28
FT                   /evidence="ECO:0007829|PDB:3ATR"
FT   STRAND          31..34
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           39..41
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          50..52
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           53..59
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           66..68
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          69..79
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          86..96
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           98..111
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          115..128
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          131..139
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   TURN            140..143
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          144..149
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          151..155
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           158..160
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           164..166
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           172..174
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           179..181
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          182..194
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   TURN            197..200
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          201..205
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   TURN            208..210
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          214..236
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           241..252
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          256..270
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          278..280
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          283..285
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           287..290
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   TURN            295..297
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           301..321
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           326..329
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           331..339
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           341..356
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           359..367
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           373..382
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           387..396
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   TURN            397..399
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           405..408
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           409..424
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           430..432
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           433..451
FT                   /evidence="ECO:0007829|PDB:4OPC"
SQ   SEQUENCE   452 AA;  50623 MW;  1C94FC2B23BA3CDF CRC64;
     MKELKYDVLI IGGGFAGSSA AYQLSRRGLK ILLVDSKPWN RIGDKPCGDA VSKAHFDKLG
     MPYPKGEELE NKINGIKLYS PDMQTVWTVN GEGFELNAPL YNQRVLKEAQ DRGVEIWDLT
     TAMKPIFEDG YVKGAVLFNR RTNEELTVYS KVVVEATGYS RSFRSKLPPE LPITEDLDDK
     DADVAYREVL LTKEDIEDHD YLRIFIDQET SPGGYWWYFP KGKNKVNVGL GIQGGMGYPS
     IHEYYKKYLD KYAPDVDKSK LLVKGGALVP TRRPLYTMAW NGIIVIGDSG FTVNPVHGGG
     KGSAMISGYC AAKAILSAFE TGDFSASGLW DMNICYVNEY GAKQASLDIF RRFLQKLSND
     DINYGMKKKI IKEEDLLEAS EKGDLHLSVA DKAMRVISGL GRPSLLFKLK AVAESMKKIK
     ELYLNYPRSP SSLGSWRREV DNVLTEFNKS LS
//
ID   ACX11_CAEEL             Reviewed;         674 AA.
AC   O62140; Q2L6T9; Q7JK62;
DT   07-APR-2021, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   02-JUN-2021, entry version 148.
DE   RecName: Full=Acyl-coenzyme A oxidase acox-1.1 {ECO:0000305};
DE            EC=1.3.3.- {ECO:0000269|PubMed:25775534, ECO:0000269|PubMed:27551084, ECO:0000269|PubMed:29537254, ECO:0000269|PubMed:29863473};
DE            EC=1.3.3.6 {ECO:0000269|PubMed:25775534, ECO:0000269|PubMed:27551084, ECO:0000269|PubMed:29537254, ECO:0000269|PubMed:29863473};
GN   Name=acox-1.1 {ECO:0000312|WormBase:F08A8.1a};
GN   Synonyms=acox-1 {ECO:0000312|WormBase:F08A8.1a};
GN   ORFNames=F08A8.1 {ECO:0000312|WormBase:F08A8.1a};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [2] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INDUCTION, AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=20610393; DOI=10.1074/jbc.m110.122663;
RA   Joo H.J., Kim K.Y., Yim Y.H., Jin Y.X., Kim H., Kim M.Y., Paik Y.K.;
RT   "Contribution of the peroxisomal acox gene to the dynamic balance of
RT   daumone production in Caenorhabditis elegans.";
RL   J. Biol. Chem. 285:29319-29325(2010).
RN   [3] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, PATHWAY,
RP   SUBUNIT, AND INTERACTION WITH ACOX-1.2 AND ACOX-1.3.
RX   PubMed=25775534; DOI=10.1073/pnas.1423951112;
RA   Zhang X., Feng L., Chinta S., Singh P., Wang Y., Nunnery J.K.,
RA   Butcher R.A.;
RT   "Acyl-CoA oxidase complexes control the chemical message produced by
RT   Caenorhabditis elegans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:3955-3960(2015).
RN   [4] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF HIS-396 AND GLU-434.
RX   PubMed=29537254; DOI=10.1021/acschembio.7b01021;
RA   Zhang X., Wang Y., Perez D.H., Jones Lipinski R.A., Butcher R.A.;
RT   "Acyl-CoA Oxidases Fine-Tune the Production of Ascaroside Pheromones with
RT   Specific Side Chain Lengths.";
RL   ACS Chem. Biol. 13:1048-1056(2018).
RN   [5] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF GLU-434.
RX   PubMed=29863473; DOI=10.7554/elife.33286;
RA   Zhou Y., Wang Y., Zhang X., Bhar S., Jones Lipinski R.A., Han J., Feng L.,
RA   Butcher R.A.;
RT   "Biosynthetic tailoring of existing ascaroside pheromones alters their
RT   biological function in C. elegans.";
RL   Elife 7:0-0(2018).
RN   [6] {ECO:0007744|PDB:5K3G, ECO:0007744|PDB:5K3H, ECO:0007744|PDB:5K3I}
RP   X-RAY CRYSTALLOGRAPHY (2.48 ANGSTROMS) OF APO FORM AND MUTANT ALA-434 IN
RP   COMPLEX WITH ATP AND FAD, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ACTIVITY
RP   REGULATION, PATHWAY, SUBUNIT, SUBSTRATE SPECIFICITY, AND MUTAGENESIS OF
RP   VAL-118; TRP-189; TYR-245; GLY-301; GLN-340; LYS-391; HIS-396; GLU-434;
RP   ASN-437; ARG-533 AND ARG-536.
RX   PubMed=27551084; DOI=10.1073/pnas.1608262113;
RA   Zhang X., Li K., Jones R.A., Bruner S.D., Butcher R.A.;
RT   "Structural characterization of acyl-CoA oxidases reveals a direct link
RT   between pheromone biosynthesis and metabolic state in Caenorhabditis
RT   elegans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:10055-10060(2016).
CC   -!- FUNCTION: Involved in the first step of peroxisomal beta-oxidation by
CC       catalyzing the desaturation of fatty acid-derived side chains
CC       (PubMed:25775534, PubMed:29537254, PubMed:27551084). Specifically,
CC       catalyzes the desaturation of fatty acids heptanoyl-CoA (C7), nonanoyl-
CC       CoA (C9), dodecanoyl-CoA (C12) and to a lesser extent pentanoyl-CoA
CC       (C5) and hexadecanoyl-CoA (C16), and hydroxylated fatty acid
CC       hydroxynonanoyl-CoA (PubMed:25775534, PubMed:29537254,
CC       PubMed:27551084). Also, catalyzes the desaturation fatty acid-derived
CC       side chains of ascaroside pheromones, which regulates development and
CC       behavior (PubMed:20610393, PubMed:25775534, PubMed:29537254,
CC       PubMed:29863473, PubMed:27551084). Specifically, shortens ascaroside
CC       with 5-carbon omega side chain (asc-omega-C5), 7-carbon side chain
CC       (asc-C7), 9-carbon side chain (asc-C9), 11-carbon side chain (asc-C11),
CC       13-carbon side chain (asc-C13), 15-carbon side chain (asc-C15) and to a
CC       lesser extent ascarosides with 7-omega-carbon side chain (asc-omega-C7)
CC       (PubMed:25775534, PubMed:29537254, PubMed:27551084). Also shortens
CC       indol-3-carbonyl(IC)-ascarosides with 7-carbon side chain (IC-asc-C7)
CC       and to a lesser extent (IC)-ascarosides with 9-carbon side chain (IC-
CC       asc-C9) (PubMed:29863473). May associate and regulate the folding
CC       and/or the catalytic activity of other acyl-coenzyme A oxidases
CC       including acox-1.2, acox-1.3, acox-1.4 and acox-3 modulating the type
CC       of ascarosides produced (PubMed:25775534, PubMed:29537254,
CC       PubMed:29863473). In association with acox-1.3, catalyzes the
CC       desaturation of asc-C7-CoA but not of fatty acids or hydroxylated fatty
CC       acids (PubMed:25775534). Involved in the biosynthesis of asc-C6-MK
CC       (daumone 2) and asc-delta-C9 (daumone 3) but not asc-C7 (daumone 1);
CC       daumones are pheromones produced during unfavourable growth conditions
CC       which promote entry into the dauer stage (PubMed:20610393).
CC       {ECO:0000269|PubMed:20610393, ECO:0000269|PubMed:25775534,
CC       ECO:0000269|PubMed:27551084, ECO:0000269|PubMed:29537254,
CC       ECO:0000269|PubMed:29863473}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=nonanoyl-CoA + O2 = (2E)-nonenoyl-CoA + H2O2;
CC         Xref=Rhea:RHEA:38987, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:76291, ChEBI:CHEBI:76292;
CC         Evidence={ECO:0000269|PubMed:25775534, ECO:0000269|PubMed:29537254,
CC         ECO:0000269|PubMed:29863473};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoyl-CoA + O2 = (2E)-dodecenoyl-CoA + H2O2;
CC         Xref=Rhea:RHEA:40171, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:57330, ChEBI:CHEBI:57375;
CC         Evidence={ECO:0000269|PubMed:27551084, ECO:0000269|PubMed:29537254,
CC         ECO:0000269|PubMed:29863473};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2,3-saturated acyl-CoA + O2 = a (2E)-enoyl-CoA + H2O2;
CC         Xref=Rhea:RHEA:38959, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:58856, ChEBI:CHEBI:65111; EC=1.3.3.6;
CC         Evidence={ECO:0000269|PubMed:25775534, ECO:0000269|PubMed:27551084,
CC         ECO:0000269|PubMed:29537254, ECO:0000269|PubMed:29863473};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=heptanoyl-CoA + O2 = (2E)-heptenoyl-CoA + H2O2;
CC         Xref=Rhea:RHEA:66204, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:78811, ChEBI:CHEBI:166980;
CC         Evidence={ECO:0000269|PubMed:25775534, ECO:0000269|PubMed:27551084};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(8R)-8-hydroxynonanoyl-CoA + O2 = (2E,8R)-8-hydroxynonenoyl-
CC         CoA + H2O2; Xref=Rhea:RHEA:66208, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:166978, ChEBI:CHEBI:166979;
CC         Evidence={ECO:0000269|PubMed:25775534};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + pentanoyl-CoA = (2E)-pentenoyl-CoA + H2O2;
CC         Xref=Rhea:RHEA:66200, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:57389, ChEBI:CHEBI:86160;
CC         Evidence={ECO:0000269|PubMed:25775534, ECO:0000269|PubMed:27551084};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexadecanoyl-CoA + O2 = (2E)-hexadecenoyl-CoA + H2O2;
CC         Xref=Rhea:RHEA:40167, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:57379, ChEBI:CHEBI:61526;
CC         Evidence={ECO:0000269|PubMed:27551084};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=IC-asc-C7-CoA + O2 = H2O2 + IC-asc-DeltaC7-CoA;
CC         Xref=Rhea:RHEA:66232, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:166976, ChEBI:CHEBI:166977;
CC         Evidence={ECO:0000269|PubMed:29863473};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=IC-asc-C9-CoA + O2 = H2O2 + IC-asc-DeltaC9-CoA;
CC         Xref=Rhea:RHEA:66236, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:166973, ChEBI:CHEBI:166974;
CC         Evidence={ECO:0000269|PubMed:29863473};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=asc-omegaC5-CoA + O2 = asc-omegaDeltaC5-CoA + H2O2;
CC         Xref=Rhea:RHEA:66212, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:140060, ChEBI:CHEBI:166969;
CC         Evidence={ECO:0000269|PubMed:25775534};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=asc-C7-CoA + O2 = asc-DeltaC7-CoA + H2O2;
CC         Xref=Rhea:RHEA:66216, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:139646, ChEBI:CHEBI:139712;
CC         Evidence={ECO:0000269|PubMed:25775534, ECO:0000269|PubMed:27551084};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=asc-omegaC7-CoA + O2 = asc-omegaDeltaC7-CoA + H2O2;
CC         Xref=Rhea:RHEA:66220, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:139994, ChEBI:CHEBI:140057;
CC         Evidence={ECO:0000269|PubMed:27551084};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=asc-C9-CoA + O2 = asc-DeltaC9-CoA + H2O2;
CC         Xref=Rhea:RHEA:66224, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:139617, ChEBI:CHEBI:139706;
CC         Evidence={ECO:0000269|PubMed:25775534, ECO:0000269|PubMed:27551084,
CC         ECO:0000269|PubMed:29863473};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=asc-C13-CoA + O2 = asc-DeltaC13-CoA + H2O2;
CC         Xref=Rhea:RHEA:66228, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:139652, ChEBI:CHEBI:139655;
CC         Evidence={ECO:0000269|PubMed:29863473};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:27551084};
CC   -!- ACTIVITY REGULATION: Activated by ATP (PubMed:27551084). ATP binding
CC       leads to a conformational change that promotes FAD cofactor binding and
CC       enzyme activity (PubMed:27551084). ATP binding likely occurs during
CC       acox-1.1 folding and/or dimer formation (PubMed:27551084).
CC       {ECO:0000269|PubMed:27551084}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=42.7 uM for asc-C9-CoA (at 30 degrees Celsius and pH 7.4)
CC         {ECO:0000269|PubMed:25775534};
CC         KM=60 uM for asc-C7-CoA (at 30 degrees Celsius, pH 7.4 and in complex
CC         with acox-1.3) {ECO:0000269|PubMed:25775534};
CC         KM=152 uM for asc-omega-C5-CoA (at 30 degrees Celsius, pH 7.4 and in
CC         complex with acox-1.2) {ECO:0000269|PubMed:25775534};
CC         Note=kcat is 252 sec(-1) with asc-C9-CoA (at 30 degrees Celsius and
CC         pH 7.4) (PubMed:25775534). kcat is 144 sec(-1) with asc-C7-CoA (at 30
CC         degrees Celsius, pH 7.4 and in complex with acox-1.3)
CC         (PubMed:25775534). kcat is 478 sec(-1) with asc-omega-C5-CoA (at 30
CC         degrees Celsius, pH 7.4 and in complex with acox-1.2)
CC         (PubMed:25775534). {ECO:0000269|PubMed:25775534};
CC   -!- PATHWAY: Lipid metabolism; peroxisomal fatty acid beta-oxidation.
CC       {ECO:0000269|PubMed:25775534, ECO:0000269|PubMed:27551084,
CC       ECO:0000269|PubMed:29537254}.
CC   -!- SUBUNIT: Homodimer (Probable). Forms a heterodimer with acox-1.2
CC       (PubMed:25775534). Forms a heterodimer with acox-1.3; the interaction
CC       may be important for the stability of acox-1.3 (PubMed:25775534).
CC       {ECO:0000269|PubMed:25775534, ECO:0000305|PubMed:27551084}.
CC   -!- SUBCELLULAR LOCATION: Peroxisome {ECO:0000269|PubMed:20610393,
CC       ECO:0000269|PubMed:29537254, ECO:0000269|PubMed:29863473}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=a {ECO:0000312|WormBase:F08A8.1a};
CC         IsoId=O62140-1; Sequence=Displayed;
CC       Name=b {ECO:0000312|WormBase:F08A8.1b};
CC         IsoId=O62140-2; Sequence=VSP_060949;
CC       Name=c {ECO:0000312|WormBase:F08A8.1c};
CC         IsoId=O62140-3; Sequence=VSP_060950;
CC   -!- TISSUE SPECIFICITY: Expressed in hypodermis and intestine.
CC       {ECO:0000269|PubMed:20610393, ECO:0000269|PubMed:29863473}.
CC   -!- INDUCTION: Induced by high temperatures (25 degrees Celsius).
CC       {ECO:0000269|PubMed:20610393}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown abolishes production of
CC       dauer pheromone daumone 2, severely reduces production of daumone 3 and
CC       increases production of daumone 1. {ECO:0000269|PubMed:20610393}.
CC   -!- SIMILARITY: Belongs to the acyl-CoA oxidase family.
CC       {ECO:0000255|PIRNR:PIRNR000168}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX284601; CAB16867.1; -; Genomic_DNA.
DR   EMBL; BX284601; CAE54894.1; -; Genomic_DNA.
DR   EMBL; BX284601; CAJ58493.1; -; Genomic_DNA.
DR   PIR; T20571; T20571.
DR   RefSeq; NP_001021089.1; NM_001025918.4. [O62140-1]
DR   RefSeq; NP_001021090.1; NM_001025919.3. [O62140-2]
DR   RefSeq; NP_001040649.1; NM_001047184.2. [O62140-3]
DR   PDB; 5K3G; X-ray; 2.86 A; A/B/C/D=1-674.
DR   PDB; 5K3H; X-ray; 2.48 A; A/B/C/D/E/F/G/H=1-674.
DR   PDB; 5K3I; X-ray; 2.68 A; A/B/C/D/E/F/G/H=1-674.
DR   PDBsum; 5K3G; -.
DR   PDBsum; 5K3H; -.
DR   PDBsum; 5K3I; -.
DR   SMR; O62140; -.
DR   IntAct; O62140; 1.
DR   MINT; O62140; -.
DR   STRING; 6239.F08A8.1a.2; -.
DR   EPD; O62140; -.
DR   PaxDb; O62140; -.
DR   PeptideAtlas; O62140; -.
DR   EnsemblMetazoa; F08A8.1a.1; F08A8.1a.1; WBGene00008564. [O62140-1]
DR   EnsemblMetazoa; F08A8.1a.2; F08A8.1a.2; WBGene00008564. [O62140-1]
DR   EnsemblMetazoa; F08A8.1b.1; F08A8.1b.1; WBGene00008564. [O62140-2]
DR   EnsemblMetazoa; F08A8.1b.2; F08A8.1b.2; WBGene00008564. [O62140-2]
DR   EnsemblMetazoa; F08A8.1c.1; F08A8.1c.1; WBGene00008564. [O62140-3]
DR   EnsemblMetazoa; F08A8.1c.2; F08A8.1c.2; WBGene00008564. [O62140-3]
DR   GeneID; 173162; -.
DR   KEGG; cel:CELE_F08A8.1; -.
DR   UCSC; F08A8.1b.4; c. elegans. [O62140-1]
DR   CTD; 173162; -.
DR   WormBase; F08A8.1a; CE17633; WBGene00008564; acox-1.1.
DR   WormBase; F08A8.1b; CE36125; WBGene00008564; acox-1.1.
DR   WormBase; F08A8.1c; CE39570; WBGene00008564; acox-1.1.
DR   eggNOG; KOG0136; Eukaryota.
DR   GeneTree; ENSGT00940000168827; -.
DR   HOGENOM; CLU_014629_3_1_1; -.
DR   InParanoid; O62140; -.
DR   OMA; MASVNQG; -.
DR   OrthoDB; 416859at2759; -.
DR   PhylomeDB; O62140; -.
DR   BRENDA; 1.3.3.6; 1045.
DR   Reactome; R-CEL-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-CEL-389887; Beta-oxidation of pristanoyl-CoA.
DR   Reactome; R-CEL-9033241; Peroxisomal protein import.
DR   UniPathway; UPA00661; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00008564; Expressed in multi-cellular organism and 4 other tissues.
DR   ExpressionAtlas; O62140; baseline and differential.
DR   GO; GO:0005782; C:peroxisomal matrix; IDA:WormBase.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0003997; F:acyl-CoA oxidase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0005504; F:fatty acid binding; IBA:GO_Central.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:1904070; P:ascaroside biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; IDA:UniProtKB.
DR   GO; GO:0055088; P:lipid homeostasis; IBA:GO_Central.
DR   GO; GO:0042811; P:pheromone biosynthetic process; IMP:UniProtKB.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR029320; Acyl-CoA_ox_N.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR012258; Acyl-CoA_oxidase.
DR   InterPro; IPR002655; Acyl-CoA_oxidase_C.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF01756; ACOX; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF14749; Acyl-CoA_ox_N; 1.
DR   PIRSF; PIRSF000168; Acyl-CoA_oxidase; 1.
DR   SUPFAM; SSF47203; SSF47203; 2.
DR   SUPFAM; SSF56645; SSF56645; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; FAD;
KW   Fatty acid metabolism; Flavoprotein; Lipid metabolism; Nucleotide-binding;
KW   Oxidoreductase; Peroxisome; Reference proteome.
FT   CHAIN           1..674
FT                   /note="Acyl-coenzyme A oxidase acox-1.1"
FT                   /id="PRO_0000452302"
FT   NP_BIND         149..152
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3I"
FT   NP_BIND         157..158
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3I"
FT   NP_BIND         340..343
FT                   /note="FAD; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3I"
FT   NP_BIND         533..536
FT                   /note="ATP"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3I"
FT   REGION          285..288
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:O62137"
FT   REGION          433..434
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:O62137"
FT   MOTIF           672..674
FT                   /note="Microbody targeting signal"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        434
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PIRSR:PIRSR000168-1"
FT   BINDING         191
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000255|PIRSR:PIRSR000168-2,
FT                   ECO:0000269|PubMed:27551084, ECO:0007744|PDB:5K3I"
FT   BINDING         295
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:O62137"
FT   BINDING         320
FT                   /note="FAD; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3I"
FT   BINDING         342
FT                   /note="ATP; via tele nitrogen; shared with dimeric partner"
FT                   /evidence="ECO:0000250|UniProtKB:O62137"
FT   BINDING         392
FT                   /note="ATP; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3I"
FT   BINDING         396
FT                   /note="ATP"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3I"
FT   BINDING         404
FT                   /note="ATP; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3I"
FT   BINDING         411
FT                   /note="FAD; via amide nitrogen; shared with dimeric
FT                   partner"
FT                   /evidence="ECO:0000250|UniProtKB:O62137"
FT   BINDING         436
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:O62137"
FT   BINDING         581
FT                   /note="ATP"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3I"
FT   VAR_SEQ         1..112
FT                   /note="Missing (in isoform b)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_060949"
FT   VAR_SEQ         1..29
FT                   /note="Missing (in isoform c)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_060950"
FT   MUTAGEN         118
FT                   /note="V->A: Shows catalytic activity toward asc-omega-C5-
FT                   CoA without affecting activity toward asc-C9-CoA, asc-
FT                   omega-C7-CoA or fatty acyl-CoA; when associated with F-245
FT                   and E-301."
FT                   /evidence="ECO:0000269|PubMed:27551084"
FT   MUTAGEN         189
FT                   /note="W->A: Loss of ATP and FAD binding."
FT                   /evidence="ECO:0000269|PubMed:27551084"
FT   MUTAGEN         245
FT                   /note="Y->F: Shows catalytic activity toward asc-omega-C5-
FT                   CoA without affecting activity toward asc-C9-CoA, asc-
FT                   omega-C7-CoA or fatty acyl-CoA; when associated with A-118
FT                   and E-301."
FT                   /evidence="ECO:0000269|PubMed:27551084"
FT   MUTAGEN         301
FT                   /note="G->E: Reduced catalytic activity toward ascaroside
FT                   asc-C9-CoA, but not toward fatty acyl-CoA substrates. Has a
FT                   slight activity toward asc-omega-C5-CoA. Shows catalytic
FT                   activity toward asc-omega-C5-CoA without affecting activity
FT                   toward asc-C9-CoA, asc-omega-C7-CoA or fatty acyl-CoA; when
FT                   associated with A-118 and F-245."
FT                   /evidence="ECO:0000269|PubMed:27551084"
FT   MUTAGEN         340
FT                   /note="Q->A: Loss of ATP and FAD binding."
FT                   /evidence="ECO:0000269|PubMed:27551084"
FT   MUTAGEN         391
FT                   /note="K->A: Loss of ATP binding and severe reduction in
FT                   FAD binding."
FT                   /evidence="ECO:0000269|PubMed:27551084"
FT   MUTAGEN         396
FT                   /note="H->G: Loss of ATP and FAD binding. Severe loss of
FT                   catalytic activity toward ascaroside-CoA and fatty acyl-CoA
FT                   substrates. Defects in the processing of ascarosides with
FT                   13-, 11-, 9-, and 7-carbon side chains. No defect in
FT                   subcellular location."
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0000269|PubMed:29537254"
FT   MUTAGEN         434
FT                   /note="E->A: In reb2; severe reduction in catalytic
FT                   activity toward fatty-acid CoA and ascaroside-CoA.
FT                   Increases ATP and FAD binding. No defect in the production
FT                   of various ascarosides apart from a slight accumulation of
FT                   asc-C11. Accumulation of indol-3-carbonyl (IC)-asc-C7.
FT                   Enhances accumulation of IC-asc-C7 and IC-asc-C9 in a acox-
FT                   1.4 (reb6) and acox-3 (tm4033) mutant background."
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0000269|PubMed:29537254, ECO:0000269|PubMed:29863473"
FT   MUTAGEN         437
FT                   /note="N->A: Loss of ATP binding and severe reduction in
FT                   FAD binding."
FT                   /evidence="ECO:0000269|PubMed:27551084"
FT   MUTAGEN         533
FT                   /note="R->E: Loss of ATP binding."
FT                   /evidence="ECO:0000269|PubMed:27551084"
FT   MUTAGEN         536
FT                   /note="R->E: Loss of ATP binding."
FT                   /evidence="ECO:0000269|PubMed:27551084"
SQ   SEQUENCE   674 AA;  76074 MW;  FED79A75F936FECD CRC64;
     MVHLNKTIQE GDNPDLTAER LTATFDTHAM AAQIYGGEMR ARRRREITAK LAEIPELHDS
     MPLPYMTREE KIMESARKLT VLTQRMSEII DPTDAGELYH LNNEVLGIEG NPMALHGVMF
     IPALNAQASD EQQAKWLIRA LRREIIGTYA QTEMGHGTNL QNLETTATYD IGTQEFVLHT
     PKITALKWWP GNLGKSSNYA VVVAHMYIKG KNFGPHTFMV PLRDEKTHKP LPGITIGDIG
     PKMAYNIVDN GFLGFNNYRI PRTNLLMRHT KVEADGTYIK PPHAKINYSA MVHVRSYMLT
     GQAIMLSYAL NIATRYSAVR RQGQIDKNEP EVKVLEYQTQ QHRLFPFIAR AYAFQFAGAE
     TVKLYERVLK EMKSGNVSLM ADLHALTSGL KSVVTHQTGE GIEQARMACG GHGYSMASYI
     SEIYGVAIGG CTYEGENMVM LLQLARYLVK SAALVKSGKA SQLGPLVAYL GARSEPTSLI
     DRVPNGGITE YIKTFQHIAK RQTLKAANKF FGLMENGEKR EIAWNKSSVE LNRASRLHTR
     LFIVEAFARR VNEIGDITIK EALSDLLHLH VNYELLDVAT YALEDGFMSS TQLDYVRDQL
     YFYLQKIRPN AVSLLDSWEF SDRELRSVLG RRDGHVYENL FKWAKESPLN KTDVLPSVDT
     YLKPMMEKAR QSKL
//
ID   ACDSB_HUMAN             Reviewed;         432 AA.
AC   P45954; B4DQ51; Q5SQN6; Q96CX7;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   02-JUN-2021, entry version 210.
DE   RecName: Full=Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial {ECO:0000305|PubMed:7698750};
DE            Short=SBCAD {ECO:0000303|PubMed:7698750};
DE            EC=1.3.8.5 {ECO:0000269|PubMed:10832746, ECO:0000269|PubMed:21430231};
DE   AltName: Full=2-methyl branched chain acyl-CoA dehydrogenase;
DE            Short=2-MEBCAD;
DE   AltName: Full=2-methylbutyryl-coenzyme A dehydrogenase;
DE            Short=2-methylbutyryl-CoA dehydrogenase;
DE   Flags: Precursor;
GN   Name=ACADSB {ECO:0000312|HGNC:HGNC:91};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   SUBSTRATE SPECIFICITY, AND TRANSIT PEPTIDE.
RC   TISSUE=Liver;
RX   PubMed=7698750; DOI=10.1006/geno.1994.1617;
RA   Rozen R., Vockley J., Zhou L., Milos R., Willard J., Fu K., Vicanek C.,
RA   Low-Nang L., Torban E., Fournier B.;
RT   "Isolation and expression of a cDNA encoding the precursor for a novel
RT   member (ACADSB) of the acyl-CoA dehydrogenase gene family.";
RL   Genomics 24:280-287(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, PATHWAY,
RP   INVOLVEMENT IN SBCADD, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=11013134; DOI=10.1086/303105;
RA   Andresen B.S., Christensen E., Corydon T.J., Bross P., Pilgaard B.,
RA   Wanders R.J.A., Ruiter J.P.N., Simonsen H., Winter V., Knudsen I.,
RA   Schroeder L.D., Gregersen N., Skovby F.;
RT   "Isolated 2-methylbutyrylglycinuria caused by short/branched-chain acyl-CoA
RT   dehydrogenase deficiency: identification of a new enzyme defect, resolution
RT   of its molecular basis, and evidence for distinct acyl-CoA dehydrogenases
RT   in isoleucine and valine metabolism.";
RL   Am. J. Hum. Genet. 67:1095-1103(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Esophagus, and Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT LYS-13.
RC   TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 6-432 (ISOFORM 1), AND VARIANTS
RP   LYS-13 AND VAL-316.
RC   TISSUE=Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY.
RX   PubMed=8660691; DOI=10.1006/abbi.1996.0290;
RA   Willard J., Vicanek C., Battaile K.P., van Veldhoven P.P., Fauq A.H.,
RA   Rozen R., Vockley J.;
RT   "Cloning of a cDNA for short/branched chain acyl-Coenzyme A dehydrogenase
RT   from rat and characterization of its tissue expression and substrate
RT   specificity.";
RL   Arch. Biochem. Biophys. 331:127-133(1996).
RN   [9]
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF
RP   VAL-137; PHE-138; SER-210 AND ALA-416.
RX   PubMed=12855692; DOI=10.1074/jbc.m306882200;
RA   He M., Burghardt T.P., Vockley J.;
RT   "A novel approach to the characterization of substrate specificity in
RT   short/branched chain Acyl-CoA dehydrogenase.";
RL   J. Biol. Chem. 278:37974-37986(2003).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-284, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND ACTIVITY REGULATION.
RX   PubMed=21430231; DOI=10.1124/dmd.110.037606;
RA   Luis P.B., Ruiter J.P., Ijlst L., Tavares de Almeida I., Duran M.,
RA   Mohsen A.W., Vockley J., Wanders R.J., Silva M.F.;
RT   "Role of isovaleryl-CoA dehydrogenase and short branched-chain acyl-CoA
RT   dehydrogenase in the metabolism of valproic acid: implications for the
RT   branched-chain amino acid oxidation pathway.";
RL   Drug Metab. Dispos. 39:1155-1160(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 52-432 IN COMPLEX WITH FAD AND
RP   SUBSTRATE ANALOG, COFACTOR, SUBUNIT, AND ACTIVE SITE.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human short-branched chain acyl-CoA dehydrogenase.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [16]
RP   VARIANT SBCADD PHE-255, CHARACTERIZATION OF VARIANT SBCADD PHE-255,
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=10832746; DOI=10.1203/00006450-200006000-00025;
RA   Gibson K.M., Burlingame T.G., Hogema B., Jakobs C., Schutgens R.B.H.,
RA   Millington D., Roe C.R., Roe D.S., Sweetman L., Steiner R.D., Linck L.,
RA   Pohowalla P., Sacks M., Kiss D., Rinaldo P., Vockley J.;
RT   "2-methylbutyryl-coenzyme A dehydrogenase deficiency: a new inborn error of
RT   L-isoleucine metabolism.";
RL   Pediatr. Res. 47:830-833(2000).
RN   [17]
RP   VARIANT SBCADD PHE-255.
RX   PubMed=16317551; DOI=10.1007/s00439-005-0070-4;
RA   Madsen P.P., Kibaek M., Roca X., Sachidanandam R., Krainer A.R.,
RA   Christensen E., Steiner R.D., Gibson K.M., Corydon T.J., Knudsen I.,
RA   Wanders R.J., Ruiter J.P.N., Gregersen N., Andresen B.S.;
RT   "Short/branched-chain acyl-CoA dehydrogenase deficiency due to an IVS3+3A>G
RT   mutation that causes exon skipping.";
RL   Hum. Genet. 118:680-690(2006).
CC   -!- FUNCTION: Short and branched chain specific acyl-CoA dehydrogenase that
CC       catalyzes the removal of one hydrogen from C-2 and C-3 of the fatty
CC       acyl-CoA thioester, resulting in the formation of trans-2-enoyl-CoA
CC       (PubMed:7698750, PubMed:11013134, PubMed:21430231, PubMed:10832746).
CC       Among the different mitochondrial acyl-CoA dehydrogenases, acts
CC       specifically on short and branched chain acyl-CoA derivatives such as
CC       (S)-2-methylbutyryl-CoA as well as short straight chain acyl-CoAs such
CC       as butyryl-CoA (PubMed:7698750, PubMed:11013134, PubMed:21430231,
CC       PubMed:10832746). Plays an important role in the metabolism of L-
CC       isoleucine by catalyzing the dehydrogenation of 2-methylbutyryl-CoA,
CC       one of the steps of the L-isoleucine catabolic pathway
CC       (PubMed:11013134, PubMed:10832746). Can also act on valproyl-CoA, a
CC       metabolite of valproic acid, an antiepileptic drug (PubMed:8660691).
CC       {ECO:0000269|PubMed:10832746, ECO:0000269|PubMed:11013134,
CC       ECO:0000269|PubMed:21430231, ECO:0000269|PubMed:7698750,
CC       ECO:0000269|PubMed:8660691}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-methylbutanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-2-methylbut-2-enoyl-CoA + reduced [electron-
CC         transfer flavoprotein]; Xref=Rhea:RHEA:43780, Rhea:RHEA-COMP:10685,
CC         Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57336,
CC         ChEBI:CHEBI:57337, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307; EC=1.3.8.5;
CC         Evidence={ECO:0000269|PubMed:10832746, ECO:0000269|PubMed:21430231};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43781;
CC         Evidence={ECO:0000269|PubMed:10832746};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2S)-2-methylbutanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-2-methylbut-2-enoyl-CoA + reduced [electron-
CC         transfer flavoprotein]; Xref=Rhea:RHEA:48256, Rhea:RHEA-COMP:10685,
CC         Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57337,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:88166;
CC         Evidence={ECO:0000269|PubMed:11013134, ECO:0000269|PubMed:12855692,
CC         ECO:0000269|PubMed:7698750};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48257;
CC         Evidence={ECO:0000305|PubMed:7698750};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2R)-2-methylbutanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = ethylacryloyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:65296, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:156439, ChEBI:CHEBI:156440;
CC         Evidence={ECO:0000250|UniProtKB:P70584};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65297;
CC         Evidence={ECO:0000250|UniProtKB:P70584};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=butanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-butenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:24004, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57332, ChEBI:CHEBI:57371,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307;
CC         Evidence={ECO:0000269|PubMed:7698750};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24005;
CC         Evidence={ECO:0000305|PubMed:7698750};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-methylpropanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-2-methylpropenoyl-CoA + reduced [electron-
CC         transfer flavoprotein]; Xref=Rhea:RHEA:44180, Rhea:RHEA-COMP:10685,
CC         Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57338,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:62500;
CC         Evidence={ECO:0000269|PubMed:7698750};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44181;
CC         Evidence={ECO:0000305|PubMed:7698750};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hexanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] = (2E)-hexenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:43464, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:62077, ChEBI:CHEBI:62620;
CC         Evidence={ECO:0000269|PubMed:12855692, ECO:0000269|PubMed:7698750};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43465;
CC         Evidence={ECO:0000305|PubMed:7698750};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-methylhexanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = 2-methylhexenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:48272, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:90156, ChEBI:CHEBI:90157;
CC         Evidence={ECO:0000269|PubMed:7698750};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48273;
CC         Evidence={ECO:0000305|PubMed:7698750};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + oxidized [electron-transfer flavoprotein] + valproyl-
CC         CoA = (2E)-2-propylpent-2-enoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:65344, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:156457, ChEBI:CHEBI:156458;
CC         Evidence={ECO:0000269|PubMed:8660691};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65345;
CC         Evidence={ECO:0000305|PubMed:8660691};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|Ref.15};
CC   -!- ACTIVITY REGULATION: Competitively inhibited by valproyl-CoA.
CC       {ECO:0000269|PubMed:21430231}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=12 uM for 2-methylbutanoyl-CoA (at pH 8.0 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:21430231};
CC         KM=2.7 uM for (2S)-2-methylbutanoyl-CoA (at 32 degrees Celsius)
CC         {ECO:0000269|PubMed:12855692};
CC         KM=36 uM for hexanoyl-CoA (at 32 degrees Celsius)
CC         {ECO:0000269|PubMed:12855692};
CC         KM=130 uM for 2-methylpropanoyl-CoA (at 32 degrees Celsius)
CC         {ECO:0000269|PubMed:12855692};
CC         Vmax=12 umol/min/mg enzyme with 2-methylbutanoyl-CoA as substrate (at
CC         pH 8.0 and 37 degrees Celsius) {ECO:0000269|PubMed:21430231};
CC         Note=kcat is 9700 sec(-1) for the dehydrogenation of (2S)-2-
CC         methylbutanoyl-CoA (PubMed:12855692). kcat is 7600 sec(-1) for the
CC         dehydrogenation of hexanoyl-CoA (PubMed:12855692). kcat is 2900 sec(-
CC         1) for the dehydrogenation of hexanoyl-CoA (PubMed:12855692).
CC         {ECO:0000269|PubMed:12855692};
CC   -!- PATHWAY: Lipid metabolism; mitochondrial fatty acid beta-oxidation.
CC       {ECO:0000269|PubMed:11013134}.
CC   -!- PATHWAY: Amino-acid degradation; L-isoleucine degradation.
CC       {ECO:0000269|PubMed:11013134}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:11013134,
CC       ECO:0000269|Ref.15}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000305|PubMed:11013134}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P45954-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P45954-2; Sequence=VSP_055778;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:8660691}.
CC   -!- DISEASE: Short/branched-chain acyl-CoA dehydrogenase deficiency
CC       (SBCADD) [MIM:610006]: Autosomal recessive disorder and consists of a
CC       defect in catabolism of L-isoleucine which is characterized by an
CC       increase of 2-methylbutyrylglycine and 2-methylbutyrylcarnitine in
CC       blood and urine. Affected individuals have seizures and psychomotor
CC       delay as the main clinical features. {ECO:0000269|PubMed:10832746,
CC       ECO:0000269|PubMed:11013134, ECO:0000269|PubMed:16317551}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U12778; AAA74424.1; -; mRNA.
DR   EMBL; AF260678; AAF97921.1; -; Genomic_DNA.
DR   EMBL; AF260668; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260669; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260670; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260671; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260672; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260673; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260674; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260675; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260676; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260677; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AK298638; BAG60813.1; -; mRNA.
DR   EMBL; AK314241; BAG36909.1; -; mRNA.
DR   EMBL; AC012391; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073585; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL731666; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49291.1; -; Genomic_DNA.
DR   EMBL; BC013756; AAH13756.1; -; mRNA.
DR   EMBL; AL831821; CAD38535.2; -; mRNA.
DR   CCDS; CCDS7634.1; -. [P45954-1]
DR   CCDS; CCDS81518.1; -. [P45954-2]
DR   PIR; A55680; A55680.
DR   RefSeq; NP_001317103.1; NM_001330174.1. [P45954-2]
DR   RefSeq; NP_001600.1; NM_001609.3. [P45954-1]
DR   PDB; 2JIF; X-ray; 2.00 A; A/B/C/D=52-432.
DR   PDBsum; 2JIF; -.
DR   SMR; P45954; -.
DR   BioGRID; 106554; 41.
DR   IntAct; P45954; 17.
DR   STRING; 9606.ENSP00000357873; -.
DR   DrugBank; DB00167; Isoleucine.
DR   DrugBank; DB00313; Valproic acid.
DR   SwissLipids; SLP:000001415; -.
DR   iPTMnet; P45954; -.
DR   PhosphoSitePlus; P45954; -.
DR   SwissPalm; P45954; -.
DR   BioMuta; ACADSB; -.
DR   DMDM; 1168283; -.
DR   EPD; P45954; -.
DR   jPOST; P45954; -.
DR   MassIVE; P45954; -.
DR   PaxDb; P45954; -.
DR   PeptideAtlas; P45954; -.
DR   PRIDE; P45954; -.
DR   ProteomicsDB; 4844; -.
DR   ProteomicsDB; 55690; -. [P45954-1]
DR   Antibodypedia; 19074; 152 antibodies.
DR   DNASU; 36; -.
DR   Ensembl; ENST00000358776; ENSP00000357873; ENSG00000196177. [P45954-1]
DR   Ensembl; ENST00000368869; ENSP00000357862; ENSG00000196177. [P45954-2]
DR   GeneID; 36; -.
DR   KEGG; hsa:36; -.
DR   UCSC; uc001lhb.4; human. [P45954-1]
DR   CTD; 36; -.
DR   DisGeNET; 36; -.
DR   GeneCards; ACADSB; -.
DR   HGNC; HGNC:91; ACADSB.
DR   HPA; ENSG00000196177; Group enriched (kidney, liver).
DR   MalaCards; ACADSB; -.
DR   MIM; 600301; gene.
DR   MIM; 610006; phenotype.
DR   neXtProt; NX_P45954; -.
DR   OpenTargets; ENSG00000196177; -.
DR   Orphanet; 79157; 2-methylbutyryl-CoA dehydrogenase deficiency.
DR   PharmGKB; PA24427; -.
DR   VEuPathDB; HostDB:ENSG00000196177.12; -.
DR   eggNOG; KOG0139; Eukaryota.
DR   GeneTree; ENSGT00940000156525; -.
DR   HOGENOM; CLU_018204_0_0_1; -.
DR   InParanoid; P45954; -.
DR   OMA; LYREAPM; -.
DR   OrthoDB; 663893at2759; -.
DR   PhylomeDB; P45954; -.
DR   TreeFam; TF105055; -.
DR   PathwayCommons; P45954; -.
DR   Reactome; R-HSA-70895; Branched-chain amino acid catabolism.
DR   UniPathway; UPA00364; -.
DR   UniPathway; UPA00660; -.
DR   BioGRID-ORCS; 36; 8 hits in 992 CRISPR screens.
DR   ChiTaRS; ACADSB; human.
DR   EvolutionaryTrace; P45954; -.
DR   GenomeRNAi; 36; -.
DR   Pharos; P45954; Tbio.
DR   PRO; PR:P45954; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; P45954; protein.
DR   Bgee; ENSG00000196177; Expressed in liver and 230 other tissues.
DR   ExpressionAtlas; P45954; baseline and differential.
DR   Genevisible; P45954; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0003853; F:2-methylacyl-CoA dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0102035; F:isobutyryl-CoA:FAD oxidoreductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016937; F:short-branched-chain-acyl-CoA dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome.
DR   GO; GO:0006631; P:fatty acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0006550; P:isoleucine catabolic process; IMP:UniProtKB.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Disease variant; FAD;
KW   Fatty acid metabolism; Flavoprotein; Lipid metabolism; Mitochondrion;
KW   Oxidoreductase; Phosphoprotein; Reference proteome; Transit peptide.
FT   TRANSIT         1..33
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:7698750"
FT   CHAIN           34..432
FT                   /note="Short/branched chain specific acyl-CoA
FT                   dehydrogenase, mitochondrial"
FT                   /id="PRO_0000000519"
FT   NP_BIND         174..183
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.15"
FT   NP_BIND         207..209
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.15"
FT   NP_BIND         387..391
FT                   /note="FAD; shared with dimeric partner"
FT                   /evidence="ECO:0000269|Ref.15"
FT   NP_BIND         416..418
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.15"
FT   REGION          291..294
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|Ref.15"
FT   ACT_SITE        414
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|Ref.15"
FT   BINDING         183
FT                   /note="Substrate; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|Ref.15"
FT   BINDING         229
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|Ref.15"
FT   BINDING         283
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|Ref.15"
FT   BINDING         319
FT                   /note="FAD; shared with dimeric partner"
FT                   /evidence="ECO:0000269|Ref.15"
FT   BINDING         330
FT                   /note="FAD; shared with dimeric partner"
FT                   /evidence="ECO:0000269|Ref.15"
FT   MOD_RES         70
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBL1"
FT   MOD_RES         70
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBL1"
FT   MOD_RES         183
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         284
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         284
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBL1"
FT   MOD_RES         426
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBL1"
FT   VAR_SEQ         1..102
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055778"
FT   VARIANT         13
FT                   /note="R -> K (in dbSNP:rs12263012)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17974005"
FT                   /id="VAR_048177"
FT   VARIANT         209
FT                   /note="S -> G (in dbSNP:rs1799823)"
FT                   /id="VAR_014749"
FT   VARIANT         255
FT                   /note="L -> F (in SBCADD; loss of protein expression; loss
FT                   of 2-methylbutyryl-CoA dehydrogenase activity;
FT                   dbSNP:rs137852649)"
FT                   /evidence="ECO:0000269|PubMed:10832746,
FT                   ECO:0000269|PubMed:16317551"
FT                   /id="VAR_013010"
FT   VARIANT         316
FT                   /note="I -> V (in dbSNP:rs1131430)"
FT                   /evidence="ECO:0000269|PubMed:17974005"
FT                   /id="VAR_048178"
FT   VARIANT         376
FT                   /note="E -> G (in dbSNP:rs12357783)"
FT                   /id="VAR_048179"
FT   MUTAGEN         137
FT                   /note="V->L: Decreased acyl-CoA dehydrogenase activity."
FT                   /evidence="ECO:0000269|PubMed:12855692"
FT   MUTAGEN         138
FT                   /note="F->L: Increased acyl-CoA dehydrogenase activity. No
FT                   effect on substrate specificity."
FT                   /evidence="ECO:0000269|PubMed:12855692"
FT   MUTAGEN         210
FT                   /note="S->N: Increased acyl-CoA dehydrogenase activity.
FT                   Changed substrate specificity."
FT                   /evidence="ECO:0000269|PubMed:12855692"
FT   MUTAGEN         416
FT                   /note="A->T: Increased acyl-CoA dehydrogenase activity. No
FT                   effect on substrate specificity."
FT                   /evidence="ECO:0000269|PubMed:12855692"
FT   HELIX           59..75
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           77..79
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           80..86
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           91..99
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   TURN            100..103
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   STRAND          104..107
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           109..111
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           118..129
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           133..144
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           146..153
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           156..168
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   STRAND          172..175
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   STRAND          181..184
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           185..187
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   STRAND          191..195
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   STRAND          198..209
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   TURN            210..213
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   STRAND          215..223
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           225..231
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   STRAND          232..238
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   STRAND          244..246
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   STRAND          252..254
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   STRAND          260..271
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           272..274
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   STRAND          275..278
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           282..318
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           326..328
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           330..358
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           364..389
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           390..394
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           400..407
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           408..411
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   TURN            412..414
FT                   /evidence="ECO:0007829|PDB:2JIF"
FT   HELIX           417..431
FT                   /evidence="ECO:0007829|PDB:2JIF"
SQ   SEQUENCE   432 AA;  47485 MW;  1EB5F894B1944E99 CRC64;
     MEGLAVRLLR GSRLLRRNFL TCLSSWKIPP HVSKSSQSEA LLNITNNGIH FAPLQTFTDE
     EMMIKSSVKK FAQEQIAPLV STMDENSKME KSVIQGLFQQ GLMGIEVDPE YGGTGASFLS
     TVLVIEELAK VDASVAVFCE IQNTLINTLI RKHGTEEQKA TYLPQLTTEK VGSFCLSEAG
     AGSDSFALKT RADKEGDYYV LNGSKMWISS AEHAGLFLVM ANVDPTIGYK GITSFLVDRD
     TPGLHIGKPE NKLGLRASST CPLTFENVKV PEANILGQIG HGYKYAIGSL NEGRIGIAAQ
     MLGLAQGCFD YTIPYIKERI QFGKRLFDFQ GLQHQVAHVA TQLEAARLLT YNAARLLEAG
     KPFIKEASMA KYYASEIAGQ TTSKCIEWMG GVGYTKDYPV EKYFRDAKIG TIYEGASNIQ
     LNTIAKHIDA EY
//
ID   FADE5_MYCTU             Reviewed;         611 AA.
AC   O53666; I6Y372; Q7DA67;
DT   07-APR-2021, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   02-JUN-2021, entry version 146.
DE   RecName: Full=Broad-specificity linear acyl-CoA dehydrogenase FadE5 {ECO:0000305};
DE   AltName: Full=Long-chain-acyl-CoA dehydrogenase {ECO:0000305};
DE            EC=1.3.8.8 {ECO:0000269|PubMed:32601219};
DE   AltName: Full=Medium-chain-acyl-CoA dehydrogenase {ECO:0000305};
DE            EC=1.3.8.7 {ECO:0000269|PubMed:32601219};
DE   AltName: Full=Short-chain-acyl-CoA dehydrogenase {ECO:0000305};
DE            EC=1.3.8.1 {ECO:0000269|PubMed:32601219};
GN   Name=fadE5 {ECO:0000303|PubMed:32601219};
GN   OrderedLocusNames=Rv0244c {ECO:0000312|EMBL:CCP42973.1};
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [3] {ECO:0007744|PDB:6KSE}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF MUTANT ALA-447 IN COMPLEX WITH
RP   FAD AND OCTADECANOYL-COA, FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, PATHWAY, SUBUNIT, ACTIVE SITE, AND
RP   MUTAGENESIS OF SER-171; LYS-225; PHE-294; ARG-301; GLU-447 AND ARG-460.
RC   STRAIN=H37Rv;
RX   PubMed=32601219; DOI=10.1073/pnas.2002835117;
RA   Chen X., Chen J., Yan B., Zhang W., Guddat L.W., Liu X., Rao Z.;
RT   "Structural basis for the broad substrate specificity of two acyl-CoA
RT   dehydrogenases FadE5 from mycobacteria.";
RL   Proc. Natl. Acad. Sci. U.S.A. 117:16324-16332(2020).
CC   -!- FUNCTION: Acyl-CoA dehydrogenase that exhibits broad specificity for
CC       linear acyl-CoA substrates, with a preference for long-chain
CC       substrates. {ECO:0000269|PubMed:32601219}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a long-chain 2,3-saturated fatty acyl-CoA + H(+) + oxidized
CC         [electron-transfer flavoprotein] = a long-chain (2E)-enoyl-CoA +
CC         reduced [electron-transfer flavoprotein]; Xref=Rhea:RHEA:17721,
CC         Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:83721,
CC         ChEBI:CHEBI:83727; EC=1.3.8.8;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a medium-chain 2,3-saturated fatty acyl-CoA + H(+) + oxidized
CC         [electron-transfer flavoprotein] = a medium-chain trans-(2E)-enoyl-
CC         CoA + reduced [electron-transfer flavoprotein]; Xref=Rhea:RHEA:14477,
CC         Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:83723,
CC         ChEBI:CHEBI:83726; EC=1.3.8.7;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a short-chain 2,3-saturated fatty acyl-CoA + H(+) + oxidized
CC         [electron-transfer flavoprotein] = a short-chain (2E)-enoyl-CoA +
CC         reduced [electron-transfer flavoprotein]; Xref=Rhea:RHEA:47196,
CC         Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:87487,
CC         ChEBI:CHEBI:87488; EC=1.3.8.1;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + octadecanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] = (2E)-octadecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47240, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57394, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:71412;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hexadecanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] = (2E)-hexadecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:43448, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57379, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:61526;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-dodecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47296, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57330, ChEBI:CHEBI:57375,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=decanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-decenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:48176, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:61406, ChEBI:CHEBI:61430;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hexanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] = (2E)-hexenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:43464, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:62077, ChEBI:CHEBI:62620;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=butanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-butenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:24004, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57332, ChEBI:CHEBI:57371,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307;
CC         Evidence={ECO:0000269|PubMed:32601219};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000305|PubMed:32601219};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=358.7 uM for butanoyl-CoA {ECO:0000269|PubMed:32601219};
CC         KM=353.0 uM for hexanoyl-CoA {ECO:0000269|PubMed:32601219};
CC         KM=162.5 uM for octadecanoyl-CoA {ECO:0000269|PubMed:32601219};
CC         Note=kcat is 1.07 sec(-1) with butanoyl-CoA as substrate. kcat is
CC         0.80 sec(-1) with hexanoyl-CoA as substrate. kcat is 0.61 sec(-1)
CC         with octadecanoyl-CoA as substrate. {ECO:0000269|PubMed:32601219};
CC   -!- PATHWAY: Lipid metabolism; fatty acid metabolism.
CC       {ECO:0000305|PubMed:32601219}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:32601219}.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP42973.1; -; Genomic_DNA.
DR   RefSeq; NP_214758.1; NC_000962.3.
DR   RefSeq; WP_003401312.1; NZ_NVQJ01000001.1.
DR   PDB; 6KSE; X-ray; 2.00 A; A/B=1-611.
DR   PDBsum; 6KSE; -.
DR   SMR; O53666; -.
DR   STRING; 83332.Rv0244c; -.
DR   PaxDb; O53666; -.
DR   PRIDE; O53666; -.
DR   DNASU; 886698; -.
DR   GeneID; 886698; -.
DR   KEGG; mtu:Rv0244c; -.
DR   PATRIC; fig|83332.111.peg.277; -.
DR   TubercuList; Rv0244c; -.
DR   eggNOG; COG1960; Bacteria.
DR   OMA; IEHARMM; -.
DR   BioCyc; MetaCyc:G185E-4366-MONOMER; -.
DR   UniPathway; UPA00199; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0005576; C:extracellular region; HDA:MTBBASE.
DR   GO; GO:0005886; C:plasma membrane; HDA:MTBBASE.
DR   GO; GO:0004085; F:butyryl-CoA dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0004466; F:long-chain-acyl-CoA dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0052572; P:response to host immune response; IEP:MTBBASE.
DR   CDD; cd01153; ACAD_fadE5; 1.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR034188; ACAD_FadE5.
DR   InterPro; IPR025878; Acyl-CoA_dh-like_C_dom.
DR   InterPro; IPR020953; Acyl-CoA_DH_N_bac.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF12806; Acyl-CoA_dh_C; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF12418; AcylCoA_DH_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Fatty acid metabolism; Flavoprotein; Lipid metabolism;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN           1..611
FT                   /note="Broad-specificity linear acyl-CoA dehydrogenase
FT                   FadE5"
FT                   /id="PRO_0000452498"
FT   NP_BIND         162..165
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   NP_BIND         420..424
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   REGION          224..225
FT                   /note="A 2,3-saturated acyl-CoA binding"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   REGION          460..461
FT                   /note="A 2,3-saturated acyl-CoA binding"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   ACT_SITE        447
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:32601219"
FT   BINDING         171
FT                   /note="A 2,3-saturated acyl-CoA"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         171
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         198
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         301
FT                   /note="A 2,3-saturated acyl-CoA"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         326
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         338
FT                   /note="A 2,3-saturated acyl-CoA"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         447
FT                   /note="A 2,3-saturated acyl-CoA"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         449
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   BINDING         456
FT                   /note="A 2,3-saturated acyl-CoA"
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   MUTAGEN         171
FT                   /note="S->A: Decreases affinity for eicosanoyl-CoA; when
FT                   associated with A-447."
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   MUTAGEN         225
FT                   /note="K->A: Decreases affinity for eicosanoyl-CoA; when
FT                   associated with A-447."
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   MUTAGEN         294
FT                   /note="F->A: Increases affinity for eicosanoyl-CoA; when
FT                   associated with A-447."
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   MUTAGEN         301
FT                   /note="R->A: Increases affinity for eicosanoyl-CoA; when
FT                   associated with A-447."
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   MUTAGEN         447
FT                   /note="E->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:32601219"
FT   MUTAGEN         460
FT                   /note="R->A: Decreases affinity for eicosanoyl-CoA; when
FT                   associated with A-447."
FT                   /evidence="ECO:0000269|PubMed:32601219"
SQ   SEQUENCE   611 AA;  66046 MW;  768532A48AD4875C CRC64;
     MSHYRSNVRD QVFNLFEVLG VDKALGHGEF SDVDVDTARD MLAEVSRLAE GPVAESFVEG
     DRNPPVFDPK THSVMLPESF KKSVNAMLEA GWDKVGIDEA LGGMPMPKAV VWALHEHILG
     ANPAVWMYAG GAGFAQILYH LGTEEQKKWA VLAAERGWGS TMVLTEPDAG SDVGAARTKA
     VQQADGSWHI DGVKRFITSG DSGDLFENIF HLVLARPEGA GPGTKGLSLY FVPKFLFDVE
     TGEPGERNGV FVTNVEHKMG LKVSATCELA FGQHGVPAKG WLVGEVHNGI AQMFEVIEQA
     RMMVGTKAIA TLSTGYLNAL QYAKSRVQGA DLTQMTDKTA PRVTITHHPD VRRSLMTQKA
     YAEGLRALYL YTATFQDAAV AEVVHGVDAK LAVKVNDLML PVVKGVGSEQ AYAKLTESLQ
     TLGGSGFLQD YPIEQYIRDA KIDSLYEGTT AIQAQDFFFR KIVRDKGVAL AHVSGQIQEF
     VDSGAGNGRL KTERALLAKA LTDVQGMAAA LTGYLMAAQQ DVTSLYKVGL GSVRFLMSVG
     DLIIGWLLQR QAAVAVAALD AGATGDERSF YEGKVAVASF FAKNFLPLLT STREVIETLD
     NDIMELDEAA F
//
ID   FENR_PLAF7              Reviewed;         371 AA.
AC   C6KT68;
DT   05-OCT-2016, integrated into UniProtKB/Swiss-Prot.
DT   01-SEP-2009, sequence version 1.
DT   02-JUN-2021, entry version 91.
DE   RecName: Full=Ferredoxin--NADP reductase, apicoplast {ECO:0000303|PubMed:17251200, ECO:0000303|PubMed:17258767, ECO:0000303|PubMed:19736991};
DE            EC=1.18.1.2 {ECO:0000305|PubMed:16289098, ECO:0000305|PubMed:17251200, ECO:0000305|PubMed:17258767, ECO:0000305|PubMed:19736991};
DE   Flags: Precursor;
GN   Name=FNR {ECO:0000303|PubMed:16289098};
GN   ORFNames=PF3D7_0623200 {ECO:0000312|EMBL:CAG25044.1};
OS   Plasmodium falciparum (isolate 3D7).
OC   Eukaryota; Sar; Alveolata; Apicomplexa; Aconoidasida; Haemosporida;
OC   Plasmodiidae; Plasmodium; Plasmodium (Laverania).
OX   NCBI_TaxID=36329 {ECO:0000312|EMBL:CAG25044.1};
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=3D7;
RX   PubMed=12368864; DOI=10.1038/nature01097;
RA   Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W.,
RA   Carlton J.M., Pain A., Nelson K.E., Bowman S., Paulsen I.T., James K.D.,
RA   Eisen J.A., Rutherford K.M., Salzberg S.L., Craig A., Kyes S., Chan M.-S.,
RA   Nene V., Shallom S.J., Suh B., Peterson J., Angiuoli S., Pertea M.,
RA   Allen J., Selengut J., Haft D., Mather M.W., Vaidya A.B., Martin D.M.A.,
RA   Fairlamb A.H., Fraunholz M.J., Roos D.S., Ralph S.A., McFadden G.I.,
RA   Cummings L.M., Subramanian G.M., Mungall C., Venter J.C., Carucci D.J.,
RA   Hoffman S.L., Newbold C., Davis R.W., Fraser C.M., Barrell B.G.;
RT   "Genome sequence of the human malaria parasite Plasmodium falciparum.";
RL   Nature 419:498-511(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=3D7;
RX   PubMed=12368867; DOI=10.1038/nature01095;
RA   Hall N., Pain A., Berriman M., Churcher C.M., Harris B., Harris D.,
RA   Mungall K.L., Bowman S., Atkin R., Baker S., Barron A., Brooks K.,
RA   Buckee C.O., Burrows C., Cherevach I., Chillingworth C., Chillingworth T.,
RA   Christodoulou Z., Clark L., Clark R., Corton C., Cronin A., Davies R.M.,
RA   Davis P., Dear P., Dearden F., Doggett J., Feltwell T., Goble A.,
RA   Goodhead I., Gwilliam R., Hamlin N., Hance Z., Harper D., Hauser H.,
RA   Hornsby T., Holroyd S., Horrocks P., Humphray S., Jagels K., James K.D.,
RA   Johnson D., Kerhornou A., Knights A., Konfortov B., Kyes S., Larke N.,
RA   Lawson D., Lennard N., Line A., Maddison M., Mclean J., Mooney P.,
RA   Moule S., Murphy L., Oliver K., Ormond D., Price C., Quail M.A.,
RA   Rabbinowitsch E., Rajandream M.A., Rutter S., Rutherford K.M., Sanders M.,
RA   Simmonds M., Seeger K., Sharp S., Smith R., Squares R., Squares S.,
RA   Stevens K., Taylor K., Tivey A., Unwin L., Whitehead S., Woodward J.R.,
RA   Sulston J.E., Craig A., Newbold C., Barrell B.G.;
RT   "Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13.";
RL   Nature 419:527-531(2002).
RN   [3]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=16289098; DOI=10.1016/j.febslet.2005.10.037;
RA   Roehrich R.C., Englert N., Troschke K., Reichenberg A., Hintz M.,
RA   Seeber F., Balconi E., Aliverti A., Zanetti G., Koehler U., Pfeiffer M.,
RA   Beck E., Jomaa H., Wiesner J.;
RT   "Reconstitution of an apicoplast-localised electron transfer pathway
RT   involved in the isoprenoid biosynthesis of Plasmodium falciparum.";
RL   FEBS Lett. 579:6433-6438(2005).
RN   [4]
RP   CATALYTIC ACTIVITY, AND COFACTOR.
RX   PubMed=17251200; DOI=10.1093/jb/mvm046;
RA   Kimata-Ariga Y., Kurisu G., Kusunoki M., Aoki S., Sato D., Kobayashi T.,
RA   Kita K., Horii T., Hase T.;
RT   "Cloning and characterization of ferredoxin and ferredoxin-NADP+ reductase
RT   from human malaria parasite.";
RL   J. Biochem. 141:421-428(2007).
RN   [5] {ECO:0007744|PDB:2OK7, ECO:0007744|PDB:2OK8}
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 56-371 IN COMPLEX WITH FAD AND
RP   THE NADP ANALOG ADENOSINE-2'-5'-DIPHOSPHATE, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=17258767; DOI=10.1016/j.jmb.2007.01.005;
RA   Milani M., Balconi E., Aliverti A., Mastrangelo E., Seeber F.,
RA   Bolognesi M., Zanetti G.;
RT   "Ferredoxin-NADP+ reductase from Plasmodium falciparum undergoes NADP+-
RT   dependent dimerization and inactivation: functional and crystallographic
RT   analysis.";
RL   J. Mol. Biol. 367:501-513(2007).
RN   [6] {ECO:0007744|PDB:3JQP, ECO:0007744|PDB:3JQQ, ECO:0007744|PDB:3JQR}
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 56-371 IN COMPLEX WITH FAD AND
RP   THE NADP ANALOG ADENOSINE-2'-5'-DIPHOSPHATE, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, SUBUNIT, MUTAGENESIS OF LYS-304
RP   AND HIS-341, AND DISULFIDE BOND.
RX   PubMed=19736991; DOI=10.1021/bi9013209;
RA   Crobu D., Canevari G., Milani M., Pandini V., Vanoni M.A., Bolognesi M.,
RA   Zanetti G., Aliverti A.;
RT   "Plasmodium falciparum ferredoxin-NADP+ reductase His286 plays a dual role
RT   in NADP(H) binding and catalysis.";
RL   Biochemistry 48:9525-9533(2009).
CC   -!- FUNCTION: May play a role in the terminal step of the DOXP/MEP pathway
CC       for isoprenoid precursor biosynthesis. {ECO:0000269|PubMed:16289098}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADP(+) + 2 reduced [2Fe-2S]-[ferredoxin] = NADPH + 2
CC         oxidized [2Fe-2S]-[ferredoxin]; Xref=Rhea:RHEA:20125, Rhea:RHEA-
CC         COMP:10000, Rhea:RHEA-COMP:10001, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:33737, ChEBI:CHEBI:33738, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.18.1.2;
CC         Evidence={ECO:0000305|PubMed:16289098, ECO:0000305|PubMed:17251200,
CC         ECO:0000305|PubMed:17258767, ECO:0000305|PubMed:19736991};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:17251200, ECO:0000269|PubMed:17258767,
CC         ECO:0000269|PubMed:19736991};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=36 uM for NADPH {ECO:0000269|PubMed:17258767,
CC         ECO:0000269|PubMed:19736991};
CC         KM=720 uM for NADH {ECO:0000269|PubMed:17258767};
CC   -!- SUBUNIT: Monomer (PubMed:17258767). Homodimer; disulfide linked
CC       (PubMed:17258767, PubMed:19736991). NADP binding accelerates formation
CC       of an inactive, disulfide-linked homodimer when the protein is exposed
CC       to air for 24 h or more (in vitro); the physiological relevance of this
CC       is uncertain (PubMed:17258767). {ECO:0000269|PubMed:17258767,
CC       ECO:0000269|PubMed:19736991}.
CC   -!- INTERACTION:
CC       C6KT68; C6KT68: PF3D7_0623200; NbExp=2; IntAct=EBI-7046197, EBI-7046197;
CC       C6KT68; Q8IED5: PF3D7_1318100; NbExp=3; IntAct=EBI-7046197, EBI-7046314;
CC   -!- SUBCELLULAR LOCATION: Plastid, apicoplast {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the ferredoxin--NADP reductase type 1 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL844505; CAG25044.1; -; Genomic_DNA.
DR   RefSeq; XP_966214.1; XM_961121.1.
DR   PDB; 2OK7; X-ray; 2.70 A; A/B/C/D/E/F=56-371.
DR   PDB; 2OK8; X-ray; 2.40 A; A/B/C/D=56-371.
DR   PDB; 3JQP; X-ray; 3.00 A; A/B/C/D/E/F=56-371.
DR   PDB; 3JQQ; X-ray; 2.20 A; A/B/C/D/E/F=56-371.
DR   PDB; 3JQR; X-ray; 2.30 A; A=56-371.
DR   PDBsum; 2OK7; -.
DR   PDBsum; 2OK8; -.
DR   PDBsum; 3JQP; -.
DR   PDBsum; 3JQQ; -.
DR   PDBsum; 3JQR; -.
DR   SMR; C6KT68; -.
DR   IntAct; C6KT68; 1.
DR   MINT; C6KT68; -.
DR   DrugBank; DB06608; Tafenoquine.
DR   PRIDE; C6KT68; -.
DR   EnsemblProtists; CAG25044; CAG25044; PF3D7_0623200.
DR   GeneDB; PF3D7_0623200.1:pep; -.
DR   GeneID; 3885862; -.
DR   KEGG; pfa:PF3D7_0623200; -.
DR   VEuPathDB; PlasmoDB:PF3D7_0623200; -.
DR   HOGENOM; CLU_755410_0_0_1; -.
DR   InParanoid; C6KT68; -.
DR   OMA; RPRHVNK; -.
DR   PhylomeDB; C6KT68; -.
DR   BRENDA; 1.18.1.2; 4889.
DR   SABIO-RK; C6KT68; -.
DR   EvolutionaryTrace; C6KT68; -.
DR   Proteomes; UP000001450; Chromosome 6.
DR   GO; GO:0020011; C:apicoplast; IDA:GeneDB.
DR   GO; GO:0009055; F:electron transfer activity; IDA:GeneDB.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0008937; F:ferredoxin-NAD(P) reductase activity; IDA:UniProtKB.
DR   GO; GO:0004324; F:ferredoxin-NADP+ reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0010322; P:regulation of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway; IDA:UniProtKB.
DR   Gene3D; 3.40.50.80; -; 1.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52343; SSF52343; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apicoplast; Disulfide bond; Electron transport; FAD;
KW   Flavoprotein; NADP; Nucleotide-binding; Oxidoreductase; Plastid;
KW   Reference proteome; Transit peptide; Transport.
FT   TRANSIT         1..18
FT                   /note="Apicoplast"
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..371
FT                   /note="Ferredoxin--NADP reductase, apicoplast"
FT                   /id="PRO_5002968039"
FT   DOMAIN          68..218
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   NP_BIND         155..159
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17258767,
FT                   ECO:0000269|PubMed:19736991, ECO:0007744|PDB:2OK7,
FT                   ECO:0007744|PDB:2OK8, ECO:0007744|PDB:3JQP,
FT                   ECO:0007744|PDB:3JQQ, ECO:0007744|PDB:3JQR"
FT   NP_BIND         172..179
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17258767,
FT                   ECO:0000269|PubMed:19736991, ECO:0007744|PDB:2OK7,
FT                   ECO:0007744|PDB:2OK8, ECO:0007744|PDB:3JQP,
FT                   ECO:0007744|PDB:3JQQ, ECO:0007744|PDB:3JQR"
FT   NP_BIND         192..194
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17258767,
FT                   ECO:0000269|PubMed:19736991, ECO:0007744|PDB:2OK7,
FT                   ECO:0007744|PDB:2OK8, ECO:0007744|PDB:3JQP,
FT                   ECO:0007744|PDB:3JQQ, ECO:0007744|PDB:3JQR"
FT   NP_BIND         272..273
FT                   /note="NADP"
FT                   /evidence="ECO:0000305|PubMed:17258767,
FT                   ECO:0000305|PubMed:19736991, ECO:0007744|PDB:2OK7,
FT                   ECO:0007744|PDB:3JQP"
FT   NP_BIND         313..315
FT                   /note="NADP"
FT                   /evidence="ECO:0000305|PubMed:17258767,
FT                   ECO:0000305|PubMed:19736991, ECO:0007744|PDB:2OK7,
FT                   ECO:0007744|PDB:3JQP, ECO:0007744|PDB:3JQQ"
FT   NP_BIND         341..343
FT                   /note="NADP"
FT                   /evidence="ECO:0000305|PubMed:17258767,
FT                   ECO:0000305|PubMed:19736991, ECO:0007744|PDB:2OK7,
FT                   ECO:0007744|PDB:3JQP, ECO:0007744|PDB:3JQQ"
FT   BINDING         68
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17258767,
FT                   ECO:0007744|PDB:2OK8"
FT   BINDING         174
FT                   /note="NADP"
FT                   /evidence="ECO:0000305|PubMed:17258767,
FT                   ECO:0000305|PubMed:19736991, ECO:0007744|PDB:2OK7,
FT                   ECO:0007744|PDB:3JQP, ECO:0007744|PDB:3JQQ"
FT   BINDING         235
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19736991,
FT                   ECO:0007744|PDB:3JQP"
FT   BINDING         302
FT                   /note="NADP"
FT                   /evidence="ECO:0000305|PubMed:17258767,
FT                   ECO:0000305|PubMed:19736991, ECO:0007744|PDB:2OK7,
FT                   ECO:0007744|PDB:3JQP, ECO:0007744|PDB:3JQQ"
FT   BINDING         342
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19736991,
FT                   ECO:0007744|PDB:3JQQ"
FT   BINDING         371
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17258767,
FT                   ECO:0000269|PubMed:19736991, ECO:0007744|PDB:2OK7,
FT                   ECO:0007744|PDB:2OK8, ECO:0007744|PDB:3JQP,
FT                   ECO:0007744|PDB:3JQQ, ECO:0007744|PDB:3JQR"
FT   DISULFID        154
FT                   /note="Interchain"
FT                   /evidence="ECO:0000269|PubMed:17258767,
FT                   ECO:0000269|PubMed:19736991, ECO:0007744|PDB:2OK7,
FT                   ECO:0007744|PDB:2OK8, ECO:0007744|PDB:3JQP,
FT                   ECO:0007744|PDB:3JQR"
FT   MUTAGEN         304
FT                   /note="K->A: Slightly decreases affinity for NADPH."
FT                   /evidence="ECO:0000269|PubMed:19736991"
FT   MUTAGEN         341
FT                   /note="H->A,L: Strongly decreases affinity for NADPH."
FT                   /evidence="ECO:0000269|PubMed:19736991"
FT   MUTAGEN         341
FT                   /note="H->K: Strongly decreases catalytic activity.
FT                   Abolishes NADPH binding."
FT                   /evidence="ECO:0000269|PubMed:19736991"
FT   MUTAGEN         341
FT                   /note="H->Q: Increases catalytic activity. Slightly
FT                   decreases affinity for NADPH."
FT                   /evidence="ECO:0000269|PubMed:19736991"
FT   STRAND          67..69
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   STRAND          71..80
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   STRAND          90..96
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   STRAND          108..111
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   STRAND          156..160
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   STRAND          166..174
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   HELIX           192..198
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   STRAND          205..212
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   HELIX           221..224
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   STRAND          228..233
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   HELIX           234..237
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   HELIX           238..247
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   HELIX           252..254
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   STRAND          266..274
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   HELIX           275..277
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   HELIX           281..290
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   TURN            292..294
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   STRAND          295..301
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   HELIX           302..304
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   STRAND          305..308
FT                   /evidence="ECO:0007829|PDB:2OK7"
FT   HELIX           314..320
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   HELIX           322..331
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   STRAND          335..340
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   HELIX           344..353
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   HELIX           360..363
FT                   /evidence="ECO:0007829|PDB:3JQQ"
FT   STRAND          366..370
FT                   /evidence="ECO:0007829|PDB:3JQQ"
SQ   SEQUENCE   371 AA;  43779 MW;  971B66E201FB352D CRC64;
     MKIRFVFILS VLISGVCCIS KNVSRRVANR MTAHSRFLFV HDKYKRNKNF KLKNNKEENN
     FINLYTVKNP LKCKIVDKIN LVRPNSPNEV YHLEINHNGL FKYLEGHTCG IIPYYNELDN
     NPNNQINKDH NIINTTNHTN HNNIALSHIK KQRCARLYSI SSSNNMENLS VAIKIHKYEQ
     TENAPNITNY GYCSGFIKNL KINDDIYLTG AHGYFNLPND AIQKNTNFIF IATGTGISPY
     ISFLKKLFAY DKNNLYNRNS NYTGYITIYY GVYNEDSILY LNELEYFQKM YPNNINIHYV
     FSYKQNSDAT SFYVQDEIYK RKTEFLNLFN NYKCELYICG HKSIRYKVMD ILKSHDQFDE
     KKKKRVHVEV Y
//
ID   DLDH_MYCTU              Reviewed;         464 AA.
AC   P9WHH9; L0T3N4; O53747; P66004;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   02-JUN-2021, entry version 48.
DE   RecName: Full=Dihydrolipoyl dehydrogenase;
DE            Short=LPD;
DE            EC=1.8.1.4;
DE   AltName: Full=Component of peroxynitrite reductase/peroxidase complex;
DE            Short=Component of PNR/P;
DE   AltName: Full=Dihydrolipoamide dehydrogenase;
DE   AltName: Full=E3 component of alpha-ketoacid dehydrogenase complexes;
GN   Name=lpdC; Synonyms=lpd; OrderedLocusNames=Rv0462; ORFNames=MTV038.06;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, KINETIC PARAMETERS,
RP   COFACTOR, GENE NAME, SUBUNIT, AND REACTION MECHANISM.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=11560483; DOI=10.1021/bi010575o;
RA   Argyrou A., Blanchard J.S.;
RT   "Mycobacterium tuberculosis lipoamide dehydrogenase is encoded by Rv0462
RT   and not by the lpdA or lpdB genes.";
RL   Biochemistry 40:11353-11363(2001).
RN   [3]
RP   FUNCTION AS AN ANTIOXIDANT, AND SUBUNIT.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=11799204; DOI=10.1126/science.1067798;
RA   Bryk R., Lima C.D., Erdjument-Bromage H., Tempst P., Nathan C.;
RT   "Metabolic enzymes of mycobacteria linked to antioxidant defense by a
RT   thioredoxin-like protein.";
RL   Science 295:1073-1077(2002).
RN   [4]
RP   FUNCTION AS A PDH COMPONENT, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   IDENTIFICATION IN THE PDH COMPLEX.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=16045627; DOI=10.1111/j.1365-2958.2005.04741.x;
RA   Tian J., Bryk R., Shi S., Erdjument-Bromage H., Tempst P., Nathan C.;
RT   "Mycobacterium tuberculosis appears to lack alpha-ketoglutarate
RT   dehydrogenase and encodes pyruvate dehydrogenase in widely separated
RT   genes.";
RL   Mol. Microbiol. 57:859-868(2005).
RN   [5]
RP   FUNCTION AS A BCKADH COMPONENT, ROLE IN VIRULENCE, DISRUPTION PHENOTYPE,
RP   AND IDENTIFICATION IN THE BCKADH COMPLEX.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21238944; DOI=10.1016/j.chom.2010.12.004;
RA   Venugopal A., Bryk R., Shi S., Rhee K., Rath P., Schnappinger D., Ehrt S.,
RA   Nathan C.;
RT   "Virulence of Mycobacterium tuberculosis depends on lipoamide
RT   dehydrogenase, a member of three multienzyme complexes.";
RL   Cell Host Microbe 9:21-31(2011).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH FAD, DISULFIDE BOND,
RP   SUBUNIT, FUNCTION, AND MUTAGENESIS OF ASP-5; ASN-43; ARG-93; LYS-103;
RP   HIS-386 AND PHE-464.
RX   PubMed=16093239; DOI=10.1074/jbc.m507466200;
RA   Rajashankar K.R., Bryk R., Kniewel R., Buglino J.A., Nathan C.F.,
RA   Lima C.D.;
RT   "Crystal structure and functional analysis of lipoamide dehydrogenase from
RT   Mycobacterium tuberculosis.";
RL   J. Biol. Chem. 280:33977-33983(2005).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.42 ANGSTROMS) IN COMPLEX WITH INHIBITOR AND FAD,
RP   ACTIVITY REGULATION, AND INHIBITORS.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=20078138; DOI=10.1021/bi9016186;
RA   Bryk R., Arango N., Venugopal A., Warren J.D., Park Y.H., Patel M.S.,
RA   Lima C.D., Nathan C.;
RT   "Triazaspirodimethoxybenzoyls as selective inhibitors of mycobacterial
RT   lipoamide dehydrogenase.";
RL   Biochemistry 49:1616-1627(2010).
CC   -!- FUNCTION: Lipoamide dehydrogenase is an essential component of the
CC       alpha-ketoacid dehydrogenase complexes, namely the pyruvate
CC       dehydrogenase (PDH) complex, the branched-chain alpha-ketoacid
CC       dehydrogenase (BCKADH) complex, and likely also the 2-oxoglutarate
CC       dehydrogenase (ODH) complex. Catalyzes the reoxidation of dihydrolipoyl
CC       groups which are covalently attached to the lipoate acyltransferase
CC       components (E2) of the complexes. Is also able to catalyze the
CC       transhydrogenation of NADH and thio-NAD(+) in the absence of D,L-
CC       lipoamide, and the NADH-dependent reduction of quinones in vitro.
CC   -!- FUNCTION: Together with AhpC, AhpD and DlaT, Lpd constitutes an NADH-
CC       dependent peroxidase active against hydrogen and alkyl peroxides as
CC       well as serving as a peroxynitrite reductase, thus protecting the
CC       bacterium against reactive nitrogen intermediates and oxidative stress
CC       generated by the host immune system.
CC   -!- FUNCTION: Appears to be essential for Mtb pathogenesis.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-N(6)-dihydrolipoyl-L-lysyl-[protein] + NAD(+) = (R)-N(6)-
CC         lipoyl-L-lysyl-[protein] + H(+) + NADH; Xref=Rhea:RHEA:15045,
CC         Rhea:RHEA-COMP:10474, Rhea:RHEA-COMP:10475, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:83099,
CC         ChEBI:CHEBI:83100; EC=1.8.1.4;
CC         Evidence={ECO:0000269|PubMed:11560483};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:11560483};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:11560483};
CC   -!- ACTIVITY REGULATION: Triazaspirodimethoxybenzoyls are high-nanomolar
CC       inhibitors of M.tuberculosis Lpd and are non-competitive versus NADH,
CC       NAD(+), and lipoamide and >100-fold selective compared to human Lpd.
CC       {ECO:0000269|PubMed:20078138}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=66 uM for NAD(+) {ECO:0000269|PubMed:11560483,
CC         ECO:0000269|PubMed:16045627};
CC         KM=7.3 uM for NADH {ECO:0000269|PubMed:11560483,
CC         ECO:0000269|PubMed:16045627};
CC         KM=110 uM for thio-NADH {ECO:0000269|PubMed:11560483,
CC         ECO:0000269|PubMed:16045627};
CC         KM=16 mM for D,L-lipoamide {ECO:0000269|PubMed:11560483,
CC         ECO:0000269|PubMed:16045627};
CC         KM=120 mM for D,L-lipoate {ECO:0000269|PubMed:11560483,
CC         ECO:0000269|PubMed:16045627};
CC       pH dependence:
CC         Optimum pH is 8.0 for PDH complex activity. Half-maximal activity is
CC         observed at pH 7.0 and pH 9.0. Activity is abolished at pH < 5.
CC         {ECO:0000269|PubMed:16045627};
CC   -!- SUBUNIT: Homodimer. Identified in a complex with AhpC, AhpD and DlaT.
CC       Also is part of the PDH complex, consisting of multiple copies of AceE
CC       (E1), DlaT (E2) and Lpd (E3), and of the BCKADH complex, consisting of
CC       multiple copies of BkdA/BkdB (E1), BkdC (E2) and Lpd (E3).
CC       {ECO:0000269|PubMed:11560483, ECO:0000269|PubMed:11799204,
CC       ECO:0000269|PubMed:16045627, ECO:0000269|PubMed:16093239,
CC       ECO:0000269|PubMed:20078138, ECO:0000269|PubMed:21238944}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene grow, albeit poorly, in
CC       standard medium with dextrose, glycerol, and fatty acids as carbon
CC       sources, but fail to grow on carbohydrates. They are less resistant
CC       than wild-type to exposition to mildly acidified nitrite, but are more
CC       resistant to oxidative stress in the form of H(2)O(2) in vitro. Lpd-
CC       deficient strains are severely attenuated in wild-type and
CC       immunodeficient mice. In contrast to wild-type or DlaT lacking strains,
CC       strains lacking Lpd are unable to grow on leucine or isoleucine.
CC       Disruption of this gene also leads to extraordinary accumulations of
CC       pyruvate and branched chain amino and keto acids.
CC       {ECO:0000269|PubMed:21238944}.
CC   -!- MISCELLANEOUS: The active site is a redox-active disulfide bond.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP43195.1; -; Genomic_DNA.
DR   PIR; B70828; B70828.
DR   RefSeq; NP_214976.1; NC_000962.3.
DR   RefSeq; WP_003402301.1; NZ_NVQJ01000002.1.
DR   PDB; 2A8X; X-ray; 2.40 A; A/B=1-464.
DR   PDB; 3II4; X-ray; 2.42 A; A/B=1-464.
DR   PDB; 4M52; X-ray; 2.40 A; A/B/C/D=1-464.
DR   PDB; 7KMY; X-ray; 2.21 A; A/B/C/D/I/J/M/N=1-464.
DR   PDBsum; 2A8X; -.
DR   PDBsum; 3II4; -.
DR   PDBsum; 4M52; -.
DR   PDBsum; 7KMY; -.
DR   SMR; P9WHH9; -.
DR   STRING; 83332.Rv0462; -.
DR   BindingDB; P9WHH9; -.
DR   ChEMBL; CHEMBL3988585; -.
DR   PaxDb; P9WHH9; -.
DR   DNASU; 886300; -.
DR   GeneID; 45424424; -.
DR   GeneID; 886300; -.
DR   KEGG; mtu:Rv0462; -.
DR   TubercuList; Rv0462; -.
DR   eggNOG; COG1249; Bacteria.
DR   OMA; TMSEAVM; -.
DR   PhylomeDB; P9WHH9; -.
DR   BRENDA; 1.8.1.4; 3445.
DR   Reactome; R-HSA-1222541; Cell redox homeostasis.
DR   Reactome; R-HSA-9636383; Prevention of phagosomal-lysosomal fusion.
DR   PHI-base; PHI:7582; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0005829; C:cytosol; HDA:MTBBASE.
DR   GO; GO:0005576; C:extracellular region; IDA:CAFA.
DR   GO; GO:0005886; C:plasma membrane; HDA:MTBBASE.
DR   GO; GO:0045254; C:pyruvate dehydrogenase complex; IDA:MTBBASE.
DR   GO; GO:0016209; F:antioxidant activity; IEA:UniProtKB-KW.
DR   GO; GO:0004148; F:dihydrolipoyl dehydrogenase activity; IDA:MTBBASE.
DR   GO; GO:0015036; F:disulfide oxidoreductase activity; IDA:MTBBASE.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:MTBBASE.
DR   GO; GO:0070404; F:NADH binding; IDA:MTBBASE.
DR   GO; GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; IDA:MTBBASE.
DR   GO; GO:0035375; F:zymogen binding; IPI:CAFA.
DR   GO; GO:0045454; P:cell redox homeostasis; IDA:MTBBASE.
DR   GO; GO:0006096; P:glycolytic process; IEA:UniProtKB-KW.
DR   GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0052170; P:suppression by symbiont of host innate immune response; TAS:Reactome.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR006258; Lipoamide_DH.
DR   InterPro; IPR001100; Pyr_nuc-diS_OxRdtase.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   InterPro; IPR012999; Pyr_OxRdtase_I_AS.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   PIRSF; PIRSF000350; Mercury_reductase_MerA; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
DR   TIGRFAMs; TIGR01350; lipoamide_DH; 1.
DR   PROSITE; PS00076; PYRIDINE_REDOX_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antioxidant; Cytoplasm; Disulfide bond; FAD; Flavoprotein;
KW   Glycolysis; NAD; Oxidoreductase; Redox-active center; Reference proteome;
KW   Tricarboxylic acid cycle; Virulence.
FT   CHAIN           1..464
FT                   /note="Dihydrolipoyl dehydrogenase"
FT                   /id="PRO_0000068034"
FT   NP_BIND         33..41
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16093239,
FT                   ECO:0000269|PubMed:20078138"
FT   NP_BIND         178..182
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         266..269
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        443
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         50
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16093239,
FT                   ECO:0000269|PubMed:20078138"
FT   BINDING         113
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   BINDING         201
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   BINDING         309
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16093239,
FT                   ECO:0000269|PubMed:20078138"
FT   BINDING         317
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:16093239,
FT                   ECO:0000269|PubMed:20078138"
FT   DISULFID        41..46
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:16093239"
FT   MUTAGEN         5
FT                   /note="D->A: Reduces lipoamide dehydrogenase activity by
FT                   95%."
FT                   /evidence="ECO:0000269|PubMed:16093239"
FT   MUTAGEN         43
FT                   /note="N->A: Reduces lipoamide dehydrogenase activity by
FT                   89%."
FT                   /evidence="ECO:0000269|PubMed:16093239"
FT   MUTAGEN         93
FT                   /note="R->A: Reduces lipoamide dehydrogenase activity by
FT                   94%."
FT                   /evidence="ECO:0000269|PubMed:16093239"
FT   MUTAGEN         93
FT                   /note="R->E: Reduces lipoamide dehydrogenase activity by
FT                   96%."
FT                   /evidence="ECO:0000269|PubMed:16093239"
FT   MUTAGEN         103
FT                   /note="K->E: Reduces lipoamide dehydrogenase activity by
FT                   82%."
FT                   /evidence="ECO:0000269|PubMed:16093239"
FT   MUTAGEN         386
FT                   /note="H->K: Reduces lipoamide dehydrogenase activity by
FT                   91%."
FT                   /evidence="ECO:0000269|PubMed:16093239"
FT   MUTAGEN         464
FT                   /note="F->A: Reduces lipoamide dehydrogenase activity by
FT                   95%."
FT                   /evidence="ECO:0000269|PubMed:16093239"
FT   STRAND          2..9
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           13..24
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          29..32
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           39..44
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           46..65
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   TURN            66..70
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          71..73
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           79..103
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          107..109
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          111..125
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          131..140
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          144..146
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           161..165
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          172..177
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           181..192
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          196..200
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          202..207
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           212..225
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          228..230
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          234..240
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          245..253
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          255..265
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          269..271
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          274..276
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           278..281
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          289..291
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          304..306
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           308..311
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           317..332
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           342..344
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          347..349
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          351..359
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           362..367
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          372..378
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           379..381
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           383..388
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          394..400
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   TURN            401..404
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   STRAND          405..413
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           416..419
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           420..428
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           433..436
FT                   /evidence="ECO:0007829|PDB:2A8X"
FT   HELIX           448..458
FT                   /evidence="ECO:0007829|PDB:2A8X"
SQ   SEQUENCE   464 AA;  49239 MW;  DD93D95DC6F76B22 CRC64;
     MTHYDVVVLG AGPGGYVAAI RAAQLGLSTA IVEPKYWGGV CLNVGCIPSK ALLRNAELVH
     IFTKDAKAFG ISGEVTFDYG IAYDRSRKVA EGRVAGVHFL MKKNKITEIH GYGTFADANT
     LLVDLNDGGT ESVTFDNAII ATGSSTRLVP GTSLSANVVT YEEQILSREL PKSIIIAGAG
     AIGMEFGYVL KNYGVDVTIV EFLPRALPNE DADVSKEIEK QFKKLGVTIL TATKVESIAD
     GGSQVTVTVT KDGVAQELKA EKVLQAIGFA PNVEGYGLDK AGVALTDRKA IGVDDYMRTN
     VGHIYAIGDV NGLLQLAHVA EAQGVVAAET IAGAETLTLG DHRMLPRATF CQPNVASFGL
     TEQQARNEGY DVVVAKFPFT ANAKAHGVGD PSGFVKLVAD AKHGELLGGH LVGHDVAELL
     PELTLAQRWD LTASELARNV HTHPTMSEAL QECFHGLVGH MINF
//
ID   DLDH_PEA                Reviewed;         501 AA.
AC   P31023;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2001, sequence version 2.
DT   02-JUN-2021, entry version 140.
DE   RecName: Full=Dihydrolipoyl dehydrogenase, mitochondrial;
DE            EC=1.8.1.4;
DE   AltName: Full=Dihydrolipoamide dehydrogenase;
DE   AltName: Full=Glycine cleavage system L protein;
DE   AltName: Full=Pyruvate dehydrogenase complex E3 subunit;
DE            Short=E3;
DE            Short=PDC-E3;
DE   Flags: Precursor;
GN   Name=LPD;
OS   Pisum sativum (Garden pea).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; fabids; Fabales; Fabaceae; Papilionoideae; 50 kb inversion clade;
OC   NPAAA clade; Hologalegina; IRL clade; Fabeae; Pisum.
OX   NCBI_TaxID=3888;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Leaf;
RX   PubMed=1541297; DOI=10.1111/j.1432-1033.1992.tb16706.x;
RA   Bourguignon J., Macherel D., Neuburger M., Douce R.;
RT   "Isolation, characterization, and sequence analysis of a cDNA clone
RT   encoding L-protein, the dihydrolipoamide dehydrogenase component of the
RT   glycine cleavage system from pea-leaf mitochondria.";
RL   Eur. J. Biochem. 204:865-873(1992).
RN   [2]
RP   SEQUENCE REVISION TO 480.
RA   Bourguignon J.;
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Birte; TISSUE=Leaf;
RX   PubMed=1560008;
RA   Turner S.R., Ireland R., Rawsthorne S.;
RT   "Purification and primary amino acid sequence of the L subunit of glycine
RT   decarboxylase. Evidence for a single lipoamide dehydrogenase in plant
RT   mitochondria.";
RL   J. Biol. Chem. 267:7745-7750(1992).
RN   [4]
RP   SEQUENCE REVISION TO 499-501.
RA   Rawsthorne S.;
RL   Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   PROTEIN SEQUENCE OF 32-61 AND 493-501, AND MASS SPECTROMETRY.
RX   PubMed=8546688; DOI=10.1042/bj3130229;
RA   Bourguignon J., Merand V., Rawsthorne S., Forest E., Douce R.;
RT   "Glycine decarboxylase and pyruvate dehydrogenase complexes share the same
RT   dihydrolipoamide dehydrogenase in pea leaf mitochondria: evidence from mass
RT   spectrometry and primary-structure analysis.";
RL   Biochem. J. 313:229-234(1996).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (3.15 ANGSTROMS) OF 32-501 IN COMPLEX WITH FAD,
RP   SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=10806386; DOI=10.1046/j.1432-1033.2000.01330.x;
RA   Faure M., Bourguignon J., Neuburger M., MacHerel D., Sieker L., Ober R.,
RA   Kahn R., Cohen-Addad C., Douce R.;
RT   "Interaction between the lipoamide-containing H-protein and the lipoamide
RT   dehydrogenase (L-protein) of the glycine decarboxylase multienzyme system
RT   2. Crystal structures of H- and L-proteins.";
RL   Eur. J. Biochem. 267:2890-2898(2000).
RN   [7]
RP   ERRATUM OF PUBMED:10806386.
RA   Faure M., Bourguignon J., Neuburger M., MacHerel D., Sieker L., Ober R.,
RA   Kahn R., Cohen-Addad C., Douce R.;
RL   Eur. J. Biochem. 267:3914-3914(2000).
CC   -!- FUNCTION: Lipoamide dehydrogenase is a component of the glycine
CC       cleavage system as well as of the alpha-ketoacid dehydrogenase
CC       complexes. The pyruvate dehydrogenase complex contains multiple copies
CC       of three enzymatic components: pyruvate dehydrogenase (E1),
CC       dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase
CC       (E3).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-N(6)-dihydrolipoyl-L-lysyl-[protein] + NAD(+) = (R)-N(6)-
CC         lipoyl-L-lysyl-[protein] + H(+) + NADH; Xref=Rhea:RHEA:15045,
CC         Rhea:RHEA-COMP:10474, Rhea:RHEA-COMP:10475, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:83099,
CC         ChEBI:CHEBI:83100; EC=1.8.1.4;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:10806386}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- MASS SPECTROMETRY: Mass=49753; Mass_error=5; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:8546688};
CC   -!- MISCELLANEOUS: The active site is a redox-active disulfide bond.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X63464; CAA45066.2; -; mRNA.
DR   EMBL; X62995; CAA44729.1; -; mRNA.
DR   PIR; S22384; S22384.
DR   PDB; 1DXL; X-ray; 3.15 A; A/B/C/D=32-501.
DR   PDBsum; 1DXL; -.
DR   SMR; P31023; -.
DR   IntAct; P31023; 1.
DR   PRIDE; P31023; -.
DR   SABIO-RK; P31023; -.
DR   EvolutionaryTrace; P31023; -.
DR   GO; GO:0005960; C:glycine cleavage complex; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:CACAO.
DR   GO; GO:0004148; F:dihydrolipoyl dehydrogenase activity; IDA:CACAO.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR006258; Lipoamide_DH.
DR   InterPro; IPR001100; Pyr_nuc-diS_OxRdtase.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   InterPro; IPR012999; Pyr_OxRdtase_I_AS.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   PIRSF; PIRSF000350; Mercury_reductase_MerA; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
DR   TIGRFAMs; TIGR01350; lipoamide_DH; 1.
DR   PROSITE; PS00076; PYRIDINE_REDOX_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Disulfide bond; FAD; Flavoprotein;
KW   Mitochondrion; NAD; Oxidoreductase; Redox-active center; Transit peptide.
FT   TRANSIT         1..31
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:8546688"
FT   CHAIN           32..501
FT                   /note="Dihydrolipoyl dehydrogenase, mitochondrial"
FT                   /id="PRO_0000030299"
FT   NP_BIND         67..76
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10806386"
FT   NP_BIND         178..180
FT                   /note="FAD"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         215..222
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         354..357
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10806386"
FT   ACT_SITE        480
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         85
FT                   /note="FAD"
FT                   /evidence="ECO:0000250"
FT   BINDING         149
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:10806386"
FT   BINDING         238
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   BINDING         272
FT                   /note="NAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   BINDING         307
FT                   /note="NAD; via amide nitrogen"
FT                   /evidence="ECO:0000250"
FT   BINDING         348
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10806386"
FT   DISULFID        76..81
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:10806386"
FT   STRAND          40..43
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   HELIX           47..58
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          63..67
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          69..72
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   HELIX           76..79
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   HELIX           81..99
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   HELIX           102..104
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          106..109
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   HELIX           115..140
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          143..147
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          149..153
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          156..159
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          162..164
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          167..170
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          172..176
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          180..182
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          192..196
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   HELIX           198..201
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          209..214
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   HELIX           218..230
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          233..237
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          239..244
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   HELIX           249..261
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          269..276
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          278..291
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          295..303
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          308..310
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   TURN            318..321
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          326..328
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          343..345
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          350..352
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   HELIX           356..370
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          384..386
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          388..396
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   HELIX           399..404
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          409..415
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   HELIX           416..418
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   HELIX           420..425
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          431..437
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   TURN            438..440
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   STRAND          442..450
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   HELIX           453..465
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   HELIX           470..474
FT                   /evidence="ECO:0007829|PDB:1DXL"
FT   HELIX           485..495
FT                   /evidence="ECO:0007829|PDB:1DXL"
SQ   SEQUENCE   501 AA;  53310 MW;  639D2D6368589FCE CRC64;
     MAMANLARRK GYSLLSSETL RYSFSLRSRA FASGSDENDV VIIGGGPGGY VAAIKAAQLG
     FKTTCIEKRG ALGGTCLNVG CIPSKALLHS SHMYHEAKHS FANHGVKVSN VEIDLAAMMG
     QKDKAVSNLT RGIEGLFKKN KVTYVKGYGK FVSPSEISVD TIEGENTVVK GKHIIIATGS
     DVKSLPGVTI DEKKIVSSTG ALALSEIPKK LVVIGAGYIG LEMGSVWGRI GSEVTVVEFA
     SEIVPTMDAE IRKQFQRSLE KQGMKFKLKT KVVGVDTSGD GVKLTVEPSA GGEQTIIEAD
     VVLVSAGRTP FTSGLNLDKI GVETDKLGRI LVNERFSTNV SGVYAIGDVI PGPMLAHKAE
     EDGVACVEYL AGKVGHVDYD KVPGVVYTNP EVASVGKTEE QVKETGVEYR VGKFPFMANS
     RAKAIDNAEG LVKIIAEKET DKILGVHIMA PNAGELIHEA AIALQYDASS EDIARVCHAH
     PTMSEAIKEA AMATYDKPIH I
//
ID   ERV1_ARATH              Reviewed;         191 AA.
AC   Q8GXX0; Q8LC15; Q9C6C6;
DT   30-NOV-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   02-JUN-2021, entry version 100.
DE   RecName: Full=FAD-linked sulfhydryl oxidase ERV1;
DE            Short=AtErv1;
DE            EC=1.8.3.2;
DE   AltName: Full=Mitochondrial sulfhydryl oxidase ERV1;
GN   Name=ERV1; OrderedLocusNames=At1g49880; ORFNames=F10F5.3;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, COFACTOR, SUBUNIT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=14996837; DOI=10.1074/jbc.m312877200;
RA   Levitan A., Danon A., Lisowsky T.;
RT   "Unique features of plant mitochondrial sulfhydryl oxidase.";
RL   J. Biol. Chem. 279:20002-20008(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130712; DOI=10.1038/35048500;
RA   Theologis A., Ecker J.R., Palm C.J., Federspiel N.A., Kaul S., White O.,
RA   Alonso J., Altafi H., Araujo R., Bowman C.L., Brooks S.Y., Buehler E.,
RA   Chan A., Chao Q., Chen H., Cheuk R.F., Chin C.W., Chung M.K., Conn L.,
RA   Conway A.B., Conway A.R., Creasy T.H., Dewar K., Dunn P., Etgu P.,
RA   Feldblyum T.V., Feng J.-D., Fong B., Fujii C.Y., Gill J.E., Goldsmith A.D.,
RA   Haas B., Hansen N.F., Hughes B., Huizar L., Hunter J.L., Jenkins J.,
RA   Johnson-Hopson C., Khan S., Khaykin E., Kim C.J., Koo H.L.,
RA   Kremenetskaia I., Kurtz D.B., Kwan A., Lam B., Langin-Hooper S., Lee A.,
RA   Lee J.M., Lenz C.A., Li J.H., Li Y.-P., Lin X., Liu S.X., Liu Z.A.,
RA   Luros J.S., Maiti R., Marziali A., Militscher J., Miranda M., Nguyen M.,
RA   Nierman W.C., Osborne B.I., Pai G., Peterson J., Pham P.K., Rizzo M.,
RA   Rooney T., Rowley D., Sakano H., Salzberg S.L., Schwartz J.R., Shinn P.,
RA   Southwick A.M., Sun H., Tallon L.J., Tambunga G., Toriumi M.J., Town C.D.,
RA   Utterback T., Van Aken S., Vaysberg M., Vysotskaia V.S., Walker M., Wu D.,
RA   Yu G., Fraser C.M., Venter J.C., Davis R.W.;
RT   "Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana.";
RL   Nature 408:816-820(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11910074; DOI=10.1126/science.1071006;
RA   Seki M., Narusaka M., Kamiya A., Ishida J., Satou M., Sakurai T.,
RA   Nakajima M., Enju A., Akiyama K., Oono Y., Muramatsu M., Hayashizaki Y.,
RA   Kawai J., Carninci P., Itoh M., Ishii Y., Arakawa T., Shibata K.,
RA   Shinagawa A., Shinozaki K.;
RT   "Functional annotation of a full-length Arabidopsis cDNA collection.";
RL   Science 296:141-145(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J., Southwick A.M.,
RA   Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F., Karlin-Newmann G.,
RA   Liu S.X., Lam B., Sakano H., Wu T., Yu G., Miranda M., Quach H.L.,
RA   Tripp M., Chang C.H., Lee J.M., Toriumi M.J., Chan M.M., Tang C.C.,
RA   Onodera C.S., Deng J.M., Akiyama K., Ansari Y., Arakawa T., Banh J.,
RA   Banno F., Bowser L., Brooks S.Y., Carninci P., Chao Q., Choy N., Enju A.,
RA   Goldsmith A.D., Gurjal M., Hansen N.F., Hayashizaki Y., Johnson-Hopson C.,
RA   Hsuan V.W., Iida K., Karnes M., Khan S., Koesema E., Ishida J., Jiang P.X.,
RA   Jones T., Kawai J., Kamiya A., Meyers C., Nakajima M., Narusaka M.,
RA   Seki M., Sakurai T., Satou M., Tamse R., Vaysberg M., Wallender E.K.,
RA   Wong C., Yamamura Y., Yuan S., Shinozaki K., Davis R.W., Theologis A.,
RA   Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Brover V.V., Troukhan M.E., Alexandrov N.A., Lu Y.-P., Flavell R.B.,
RA   Feldmann K.A.;
RT   "Full-length cDNA from Arabidopsis thaliana.";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=20829360; DOI=10.1074/jbc.m110.121202;
RA   Carrie C., Giraud E., Duncan O., Xu L., Wang Y., Huang S., Clifton R.,
RA   Murcha M., Filipovska A., Rackham O., Vrielink A., Whelan J.;
RT   "Conserved and novel functions for Arabidopsis thaliana MIA40 in assembly
RT   of proteins in mitochondria and peroxisomes.";
RL   J. Biol. Chem. 285:36138-36148(2010).
RN   [8]
RP   DISULFIDE BONDS.
RX   PubMed=19017646; DOI=10.1074/jbc.m806316200;
RA   Farver O., Vitu E., Wherland S., Fass D., Pecht I.;
RT   "Electron transfer reactivity of the Arabidopsis thaliana sulfhydryl
RT   oxidase AtErv1.";
RL   J. Biol. Chem. 284:2098-2105(2009).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 71-191 IN COMPLEX WITH FAD,
RP   SUBUNIT, DISULFIDE BONDS, AND MUTAGENESIS OF CYS-177 AND CYS-182.
RX   PubMed=16893552; DOI=10.1016/j.jmb.2006.06.070;
RA   Vitu E., Bentzur M., Lisowsky T., Kaiser C.A., Fass D.;
RT   "Gain of function in an ERV/ALR sulfhydryl oxidase by molecular engineering
RT   of the shuttle disulfide.";
RL   J. Mol. Biol. 362:89-101(2006).
CC   -!- FUNCTION: FAD-dependent sulfhydryl oxidase that catalyzes disulfide
CC       bond formation (By similarity) (PubMed:14996837). Oxidizes thioredoxin
CC       in vitro (PubMed:14996837). Required for the import and folding of
CC       small cysteine-containing proteins in the mitochondrial intermembrane
CC       space. Forms a redox cycle with MIA40 that involves a disulfide relay
CC       system. Important for maintaining the cysteine residues in MIA40 in an
CC       oxidized state (By similarity). {ECO:0000250|UniProtKB:P27882,
CC       ECO:0000255|PROSITE-ProRule:PRU00654, ECO:0000269|PubMed:14996837}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + 2 R'C(R)SH = H2O2 + R'C(R)S-S(R)CR';
CC         Xref=Rhea:RHEA:17357, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:16520, ChEBI:CHEBI:17412; EC=1.8.3.2;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00654,
CC         ECO:0000269|PubMed:14996837};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:14996837,
CC       ECO:0000269|PubMed:16893552}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:14996837}.
CC   -!- PTM: Contains three disulfide bonds; one catalytic disulfide (Cys-119
CC       to Cys-122), one structural disulfide (Cys-148 to Cys-165), and one
CC       shuttle disulfide (Cys-177 to Cys-182). {ECO:0000269|PubMed:19017646}.
CC   -!- DISRUPTION PHENOTYPE: Embryonic lethality when homozygous.
CC       {ECO:0000269|PubMed:16893552}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG51780.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ551263; CAD83013.1; -; mRNA.
DR   EMBL; AC079674; AAG51780.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002684; AEE32487.1; -; Genomic_DNA.
DR   EMBL; AK117991; BAC42626.1; -; mRNA.
DR   EMBL; BT003718; AAO39946.1; -; mRNA.
DR   EMBL; AY086861; AAM63908.1; -; mRNA.
DR   PIR; G96535; G96535.
DR   RefSeq; NP_564557.1; NM_103875.4.
DR   PDB; 2HJ3; X-ray; 2.50 A; A/B=71-191.
DR   PDBsum; 2HJ3; -.
DR   SMR; Q8GXX0; -.
DR   BioGRID; 26636; 1.
DR   STRING; 3702.AT1G49880.1; -.
DR   PaxDb; Q8GXX0; -.
DR   PRIDE; Q8GXX0; -.
DR   ProteomicsDB; 220643; -.
DR   EnsemblPlants; AT1G49880.1; AT1G49880.1; AT1G49880.
DR   GeneID; 841411; -.
DR   Gramene; AT1G49880.1; AT1G49880.1; AT1G49880.
DR   KEGG; ath:AT1G49880; -.
DR   Araport; AT1G49880; -.
DR   TAIR; locus:2007283; AT1G49880.
DR   eggNOG; KOG3355; Eukaryota.
DR   HOGENOM; CLU_105631_0_0_1; -.
DR   InParanoid; Q8GXX0; -.
DR   OMA; CEQKACE; -.
DR   OrthoDB; 1537996at2759; -.
DR   PhylomeDB; Q8GXX0; -.
DR   BioCyc; ARA:AT1G49880-MONOMER; -.
DR   BRENDA; 1.8.3.2; 399.
DR   EvolutionaryTrace; Q8GXX0; -.
DR   PRO; PR:Q8GXX0; -.
DR   Proteomes; UP000006548; Chromosome 1.
DR   ExpressionAtlas; Q8GXX0; baseline and differential.
DR   Genevisible; Q8GXX0; AT.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0016971; F:flavin-linked sulfhydryl oxidase activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0015035; F:protein disulfide oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0016972; F:thiol oxidase activity; IDA:UniProtKB.
DR   Gene3D; 1.20.120.310; -; 1.
DR   InterPro; IPR039799; ALR/ERV.
DR   InterPro; IPR036774; ERV/ALR_sulphydryl_oxid_sf.
DR   InterPro; IPR017905; ERV/ALR_sulphydryl_oxidase.
DR   PANTHER; PTHR12645; PTHR12645; 1.
DR   Pfam; PF04777; Evr1_Alr; 1.
DR   SUPFAM; SSF69000; SSF69000; 1.
DR   PROSITE; PS51324; ERV_ALR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; FAD; Flavoprotein; Mitochondrion;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN           1..191
FT                   /note="FAD-linked sulfhydryl oxidase ERV1"
FT                   /id="PRO_0000401377"
FT   DOMAIN          72..172
FT                   /note="ERV/ALR sulfhydryl oxidase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654"
FT   NP_BIND         81..84
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16893552"
FT   NP_BIND         121..125
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16893552"
FT   NP_BIND         148..155
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16893552"
FT   NP_BIND         171..172
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16893552"
FT   MOTIF           177..182
FT                   /note="Required for dimerization and substrate specificity"
FT   BINDING         76
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16893552"
FT   BINDING         160
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16893552"
FT   DISULFID        119..122
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000269|PubMed:19017646"
FT   DISULFID        148..165
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000269|PubMed:16893552, ECO:0000269|PubMed:19017646"
FT   DISULFID        177..182
FT                   /evidence="ECO:0000269|PubMed:16893552,
FT                   ECO:0000269|PubMed:19017646"
FT   MUTAGEN         177
FT                   /note="C->A: Loss the capacity to oxidize thioredoxin; when
FT                   associated with A-182."
FT                   /evidence="ECO:0000269|PubMed:16893552"
FT   MUTAGEN         182
FT                   /note="C->A: Loss the capacity to oxidize thioredoxin; when
FT                   associated with A-177."
FT                   /evidence="ECO:0000269|PubMed:16893552"
FT   CONFLICT        35..36
FT                   /note="PS -> R (in Ref. 6; AAM63908)"
FT                   /evidence="ECO:0000305"
FT   HELIX           76..93
FT                   /evidence="ECO:0007829|PDB:2HJ3"
FT   HELIX           100..116
FT                   /evidence="ECO:0007829|PDB:2HJ3"
FT   HELIX           120..132
FT                   /evidence="ECO:0007829|PDB:2HJ3"
FT   HELIX           140..157
FT                   /evidence="ECO:0007829|PDB:2HJ3"
FT   HELIX           168..171
FT                   /evidence="ECO:0007829|PDB:2HJ3"
SQ   SEQUENCE   191 AA;  21600 MW;  7CC7FEA44C0D4B38 CRC64;
     MGEKPWQPLL QSFEKLSNCV QTHLSNFIGI KNTPPSSQST IQNPIISLDS SPPIATNSSS
     LQKLPLKDKS TGPVTKEDLG RATWTFLHTL AAQYPEKPTR QQKKDVKELM TILSRMYPCR
     ECADHFKEIL RSNPAQAGSQ EEFSQWLCHV HNTVNRSLGK LVFPCERVDA RWGKLECEQK
     SCDLHGTSMD F
//
ID   CKX7_ARATH              Reviewed;         524 AA.
AC   Q9FUJ1;
DT   24-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   02-JUN-2021, entry version 126.
DE   RecName: Full=Cytokinin dehydrogenase 7;
DE            EC=1.5.99.12;
DE   AltName: Full=Cytokinin oxidase 7;
DE            Short=AtCKX5;
DE            Short=AtCKX7;
DE            Short=CKO7;
GN   Name=CKX7; Synonyms=CKX5; OrderedLocusNames=At5g21482; ORFNames=F13M11;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11154345; DOI=10.1104/pp.125.1.378;
RA   Bilyeu K.D., Cole J.L., Laskey J.G., Riekhof W.R., Esparza T.J.,
RA   Kramer M.D., Morris R.O.;
RT   "Molecular and biochemical characterization of a cytokinin oxidase from
RT   maize.";
RL   Plant Physiol. 125:378-386(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130714; DOI=10.1038/35048507;
RA   Tabata S., Kaneko T., Nakamura Y., Kotani H., Kato T., Asamizu E.,
RA   Miyajima N., Sasamoto S., Kimura T., Hosouchi T., Kawashima K., Kohara M.,
RA   Matsumoto M., Matsuno A., Muraki A., Nakayama S., Nakazaki N., Naruo K.,
RA   Okumura S., Shinpo S., Takeuchi C., Wada T., Watanabe A., Yamada M.,
RA   Yasuda M., Sato S., de la Bastide M., Huang E., Spiegel L., Gnoj L.,
RA   O'Shaughnessy A., Preston R., Habermann K., Murray J., Johnson D.,
RA   Rohlfing T., Nelson J., Stoneking T., Pepin K., Spieth J., Sekhon M.,
RA   Armstrong J., Becker M., Belter E., Cordum H., Cordes M., Courtney L.,
RA   Courtney W., Dante M., Du H., Edwards J., Fryman J., Haakensen B.,
RA   Lamar E., Latreille P., Leonard S., Meyer R., Mulvaney E., Ozersky P.,
RA   Riley A., Strowmatt C., Wagner-McPherson C., Wollam A., Yoakum M., Bell M.,
RA   Dedhia N., Parnell L., Shah R., Rodriguez M., Hoon See L., Vil D.,
RA   Baker J., Kirchoff K., Toth K., King L., Bahret A., Miller B., Marra M.A.,
RA   Martienssen R., McCombie W.R., Wilson R.K., Murphy G., Bancroft I.,
RA   Volckaert G., Wambutt R., Duesterhoeft A., Stiekema W., Pohl T.,
RA   Entian K.-D., Terryn N., Hartley N., Bent E., Johnson S., Langham S.-A.,
RA   McCullagh B., Robben J., Grymonprez B., Zimmermann W., Ramsperger U.,
RA   Wedler H., Balke K., Wedler E., Peters S., van Staveren M., Dirkse W.,
RA   Mooijman P., Klein Lankhorst R., Weitzenegger T., Bothe G., Rose M.,
RA   Hauf J., Berneiser S., Hempel S., Feldpausch M., Lamberth S.,
RA   Villarroel R., Gielen J., Ardiles W., Bents O., Lemcke K., Kolesov G.,
RA   Mayer K.F.X., Rudd S., Schoof H., Schueller C., Zaccaria P., Mewes H.-W.,
RA   Bevan M., Fransz P.F.;
RT   "Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana.";
RL   Nature 408:823-826(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [4]
RP   REVIEW, AND NOMENCLATURE.
RX   PubMed=12721786; DOI=10.1007/s10265-003-0096-4;
RA   Schmuelling T., Werner T., Riefler M., Krupkova E., Bartrina y Manns I.;
RT   "Structure and function of cytokinin oxidase/dehydrogenase genes of maize,
RT   rice, Arabidopsis and other species.";
RL   J. Plant Res. 116:241-252(2003).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 2-524 IN COMPLEX WITH FAD.
RX   PubMed=17850744; DOI=10.1016/j.str.2007.06.019;
RA   Levin E.J., Kondrashov D.A., Wesenberg G.E., Phillips G.N. Jr.;
RT   "Ensemble refinement of protein crystal structures: validation and
RT   application.";
RL   Structure 15:1040-1052(2007).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 2-524.
RG   Center for eukaryotic structural genomics (CESG);
RT   "X-ray structure of cytokinin oxidase/dehydrogenase (CKX) from Arabidopsis
RT   thaliana At5g21482.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes the oxidation of cytokinins, a family of N(6)-
CC       substituted adenine derivatives that are plant hormones, where the
CC       substituent is an isopentenyl group. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=A + H2O + N(6)-dimethylallyladenine = 3-methyl-2-butenal +
CC         adenine + AH2; Xref=Rhea:RHEA:13625, ChEBI:CHEBI:13193,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15825, ChEBI:CHEBI:16708,
CC         ChEBI:CHEBI:17499, ChEBI:CHEBI:17660; EC=1.5.99.12;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- SIMILARITY: Belongs to the oxygen-dependent FAD-linked oxidoreductase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF303981; AAG30908.1; -; mRNA.
DR   EMBL; AC140977; AAO73882.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED92951.1; -; Genomic_DNA.
DR   RefSeq; NP_850863.1; NM_180532.3.
DR   PDB; 2EXR; X-ray; 1.70 A; A=2-524.
DR   PDB; 2Q4W; X-ray; 1.70 A; A=2-524.
DR   PDBsum; 2EXR; -.
DR   PDBsum; 2Q4W; -.
DR   SMR; Q9FUJ1; -.
DR   STRING; 3702.AT5G21482.1; -.
DR   PaxDb; Q9FUJ1; -.
DR   PRIDE; Q9FUJ1; -.
DR   ProteomicsDB; 222095; -.
DR   DNASU; 832248; -.
DR   EnsemblPlants; AT5G21482.1; AT5G21482.1; AT5G21482.
DR   GeneID; 832248; -.
DR   Gramene; AT5G21482.1; AT5G21482.1; AT5G21482.
DR   KEGG; ath:AT5G21482; -.
DR   Araport; AT5G21482; -.
DR   TAIR; locus:1005716173; AT5G21482.
DR   eggNOG; KOG1231; Eukaryota.
DR   HOGENOM; CLU_024955_1_0_1; -.
DR   InParanoid; Q9FUJ1; -.
DR   OMA; YDYKIYF; -.
DR   OrthoDB; 350817at2759; -.
DR   PhylomeDB; Q9FUJ1; -.
DR   BioCyc; ARA:AT5G21482-MONOMER; -.
DR   BRENDA; 1.5.99.12; 399.
DR   EvolutionaryTrace; Q9FUJ1; -.
DR   PRO; PR:Q9FUJ1; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; Q9FUJ1; baseline and differential.
DR   GO; GO:0019139; F:cytokinin dehydrogenase activity; TAS:TAIR.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0009823; P:cytokinin catabolic process; TAS:TAIR.
DR   Gene3D; 3.30.43.10; -; 1.
DR   Gene3D; 3.30.465.10; -; 1.
DR   Gene3D; 3.40.462.10; -; 1.
DR   InterPro; IPR016170; Cytok_DH_C_sf.
DR   InterPro; IPR015345; Cytokinin_DH_FAD/cytokin-bd.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR016167; FAD-bd_PCMH_sub1.
DR   InterPro; IPR016169; FAD-bd_PCMH_sub2.
DR   InterPro; IPR016164; FAD-linked_Oxase-like_C.
DR   InterPro; IPR006094; Oxid_FAD_bind_N.
DR   Pfam; PF09265; Cytokin-bind; 1.
DR   Pfam; PF01565; FAD_binding_4; 1.
DR   SUPFAM; SSF55103; SSF55103; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Oxidoreductase; Reference proteome.
FT   CHAIN           1..524
FT                   /note="Cytokinin dehydrogenase 7"
FT                   /id="PRO_0000128156"
FT   DOMAIN          58..238
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   NP_BIND         91..95
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17850744"
FT   NP_BIND         96..97
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17850744"
FT   NP_BIND         173..177
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17850744"
FT   NP_BIND         514..517
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17850744"
FT   BINDING         101
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:17850744"
FT   BINDING         162
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:17850744"
FT   BINDING         167
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17850744"
FT   BINDING         228
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:17850744"
FT   BINDING         479
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17850744"
FT   MOD_RES         96
FT                   /note="Pros-8alpha-FAD histidine"
FT   STRAND          37..41
FT                   /evidence="ECO:0007829|PDB:2EXR"
FT   HELIX           44..49
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          63..66
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           71..83
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          84..86
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          89..95
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          98..100
FT                   /evidence="ECO:0007829|PDB:2EXR"
FT   STRAND          107..111
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           112..118
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          120..124
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          127..130
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          132..137
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           142..153
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          154..156
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          165..167
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           168..172
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           181..184
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           187..190
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          191..198
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          203..206
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           212..218
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          224..237
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          240..250
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           252..263
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   TURN            267..269
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          272..276
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          279..282
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   TURN            285..287
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           289..291
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           302..304
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          311..322
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           328..339
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          349..355
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           356..360
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           363..373
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          376..378
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          383..388
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           389..398
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           399..403
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   TURN            404..406
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          412..418
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           419..421
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          435..442
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           452..471
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   STRAND          476..480
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           486..493
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           494..496
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           497..507
FT                   /evidence="ECO:0007829|PDB:2Q4W"
FT   HELIX           515..517
FT                   /evidence="ECO:0007829|PDB:2Q4W"
SQ   SEQUENCE   524 AA;  57976 MW;  9ADB3BE97A7F063C CRC64;
     MIAYIEPYFL ENDAEAASAA TAAGKSTDGV SESLNIQGEI LCGGAAADIA GRDFGGMNCV
     KPLAVVRPVG PEDIAGAVKA ALRSDKLTVA ARGNGHSING QAMAEGGLVV DMSTTAENHF
     EVGYLSGGDA TAFVDVSGGA LWEDVLKRCV SEYGLAPRSW TDYLGLTVGG TLSNAGVSGQ
     AFRYGPQTSN VTELDVVTGN GDVVTCSEIE NSELFFSVLG GLGQFGIITR ARVLLQPAPD
     MVRWIRVVYT EFDEFTQDAE WLVSQKNESS FDYVEGFVFV NGADPVNGWP TVPLHPDHEF
     DPTRLPQSCG SVLYCLELGL HYRDSDSNST IDKRVERLIG RLRFNEGLRF EVDLPYVDFL
     LRVKRSEEIA KENGTWETPH PWLNLFVSKR DIGDFNRTVF KELVKNGVNG PMLVYPLLRS
     RWDDRTSVVI PEEGEIFYIV ALLRFVPPCA KVSSVEKMVA QNQEIVHWCV KNGIDYKLYL
     PHYKSQEEWI RHFGNRWSRF VDRKAMFDPM AILSPGQKIF NRSL
//
ID   DLDH1_GEOSE             Reviewed;         470 AA.
AC   P11959;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1991, sequence version 2.
DT   02-JUN-2021, entry version 144.
DE   RecName: Full=Dihydrolipoyl dehydrogenase;
DE            EC=1.8.1.4;
DE   AltName: Full=Dihydrolipoamide dehydrogenase;
DE   AltName: Full=E3 component of pyruvate complex;
GN   Name=pdhD;
OS   Geobacillus stearothermophilus (Bacillus stearothermophilus).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Geobacillus.
OX   NCBI_TaxID=1422;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=ATCC 29609 / DSM 2027 / NCA 1503 / NCIMB 8924;
RX   PubMed=2200674; DOI=10.1111/j.1432-1033.1990.tb19128.x;
RA   Hawkins C.F., Borges A., Perham R.N.;
RT   "Cloning and sequence analysis of the genes encoding the alpha and beta
RT   subunits of the E1 component of the pyruvate dehydrogenase multienzyme
RT   complex of Bacillus stearothermophilus.";
RL   Eur. J. Biochem. 191:337-346(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 29609 / DSM 2027 / NCA 1503 / NCIMB 8924;
RX   PubMed=2253629; DOI=10.1111/j.1432-1033.1990.tb19432.x;
RA   Borges A., Hawkins C.F., Packman L.C., Perham R.N.;
RT   "Cloning and sequence analysis of the genes encoding the dihydrolipoamide
RT   acetyltransferase and dihydrolipoamide dehydrogenase components of the
RT   pyruvate dehydrogenase multienzyme complex of Bacillus
RT   stearothermophilus.";
RL   Eur. J. Biochem. 194:95-102(1990).
RN   [3]
RP   PROTEIN SEQUENCE OF 41-56.
RX   PubMed=6896188; DOI=10.1016/0014-5793(82)80839-9;
RA   Packman L.C., Perham R.N.;
RT   "An amino acid sequence in the active site of lipoamide dehydrogenase from
RT   Bacillus stearothermophilus.";
RL   FEBS Lett. 139:155-158(1982).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH FAD, AND SUBUNIT.
RX   PubMed=8805537; DOI=10.1016/s0969-2126(96)00032-9;
RA   Mande S.S., Sarfaty S., Allen M.D., Perham R.N., Hol W.G.J.;
RT   "Protein-protein interactions in the pyruvate dehydrogenase multienzyme
RT   complex: dihydrolipoamide dehydrogenase complexed with the binding domain
RT   of dihydrolipoamide acetyltransferase.";
RL   Structure 4:277-286(1996).
CC   -!- FUNCTION: Lipoamide dehydrogenase is a component of the alpha-ketoacid
CC       dehydrogenase complexes.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-N(6)-dihydrolipoyl-L-lysyl-[protein] + NAD(+) = (R)-N(6)-
CC         lipoyl-L-lysyl-[protein] + H(+) + NADH; Xref=Rhea:RHEA:15045,
CC         Rhea:RHEA-COMP:10474, Rhea:RHEA-COMP:10475, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:83099,
CC         ChEBI:CHEBI:83100; EC=1.8.1.4;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- SUBUNIT: Homodimer. Identified in a complex with PdhC.
CC       {ECO:0000269|PubMed:8805537}.
CC   -!- INTERACTION:
CC       P11959; P11961: pdhC; NbExp=3; IntAct=EBI-9021392, EBI-1040691;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- MISCELLANEOUS: The active site is a redox-active disulfide bond.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X53560; CAA37631.1; -; Genomic_DNA.
DR   PIR; S13839; S13839.
DR   PDB; 1EBD; X-ray; 2.60 A; A/B=7-461.
DR   PDBsum; 1EBD; -.
DR   SMR; P11959; -.
DR   DIP; DIP-6155N; -.
DR   IntAct; P11959; 1.
DR   BRENDA; 1.8.1.4; 623.
DR   EvolutionaryTrace; P11959; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004148; F:dihydrolipoyl dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:0006096; P:glycolytic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR006258; Lipoamide_DH.
DR   InterPro; IPR001100; Pyr_nuc-diS_OxRdtase.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   InterPro; IPR012999; Pyr_OxRdtase_I_AS.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   PIRSF; PIRSF000350; Mercury_reductase_MerA; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
DR   TIGRFAMs; TIGR01350; lipoamide_DH; 1.
DR   PROSITE; PS00076; PYRIDINE_REDOX_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Direct protein sequencing; Disulfide bond; FAD;
KW   Flavoprotein; Glycolysis; NAD; Oxidoreductase; Redox-active center.
FT   CHAIN           1..470
FT                   /note="Dihydrolipoyl dehydrogenase"
FT                   /id="PRO_0000068015"
FT   NP_BIND         39..47
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8805537"
FT   NP_BIND         183..187
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         271..274
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        446
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         56
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8805537"
FT   BINDING         119
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   BINDING         206
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   BINDING         314
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8805537"
FT   BINDING         322
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:8805537"
FT   DISULFID        47..52
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000250"
FT   STRAND          11..15
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           19..30
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          35..41
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           45..49
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           52..69
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           72..74
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           85..108
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   TURN            109..111
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          113..123
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          126..131
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          134..139
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          141..145
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          149..151
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          161..164
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           166..170
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          177..182
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           186..197
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          201..212
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           217..229
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          233..246
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          249..256
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          259..270
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          274..277
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          279..282
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   TURN            283..287
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          309..311
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           313..315
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          316..318
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           322..336
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          350..352
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          354..356
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          358..362
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           365..369
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   TURN            370..372
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          375..381
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           382..384
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           386..391
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          397..403
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   TURN            404..406
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   STRAND          408..416
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           419..432
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           436..441
FT                   /evidence="ECO:0007829|PDB:1EBD"
FT   HELIX           451..459
FT                   /evidence="ECO:0007829|PDB:1EBD"
SQ   SEQUENCE   470 AA;  49356 MW;  C9C05F21A3EE4CB7 CRC64;
     MVVGDFAIET ETLVVGAGPG GYVAAIRAAQ LGQKVTIVEK GNLGGVCLNV GCIPSKALIS
     ASHRYEQAKH SEEMGIKAEN VTIDFAKVQE WKASVVKKLT GGVEGLLKGN KVEIVKGEAY
     FVDANTVRVV NGDSAQTYTF KNAIIATGSR PIELPNFKFS NRILDSTGAL NLGEVPKSLV
     VIGGGYIGIE LGTAYANFGT KVTILEGAGE ILSGFEKQMA AIIKKRLKKK GVEVVTNALA
     KGAEEREDGV TVTYEANGET KTIDADYVLV TVGRRPNTDE LGLEQIGIKM TNRGLIEVDQ
     QCRTSVPNIF AIGDIVPGPA LAHKASYEGK VAAEAIAGHP SAVDYVAIPA VVFSDPECAS
     VGYFEQQAKD EGIDVIAAKF PFAANGRALA LNDTDGFLKL VVRKEDGVII GAQIIGPNAS
     DMIAELGLAI EAGMTAEDIA LTIHAHPTLG EIAMEAAEVA LGTPIHIITK
//
ID   CYND4_CYNDA             Reviewed;         522 AA.
AC   Q5QJ60;
DT   11-DEC-2019, integrated into UniProtKB/Swiss-Prot.
DT   04-JAN-2005, sequence version 1.
DT   02-JUN-2021, entry version 69.
DE   RecName: Full=Berberine bridge enzyme-like Cyn d 4 {ECO:0000305};
DE   AltName: Full=60 kDa pollen antigen {ECO:0000303|PubMed:8828524, ECO:0000303|PubMed:8900140};
DE            Short=BG60 {ECO:0000303|PubMed:20080962, ECO:0000303|PubMed:8828524, ECO:0000303|PubMed:8900140};
DE   AltName: Full=Cyn d BG60 {ECO:0000303|PubMed:20080962};
DE   AltName: Full=FAD-linked oxidoreductase BG60 {ECO:0000312|EMBL:AAS02108.1};
DE            EC=1.-.-.- {ECO:0000305};
DE   AltName: Full=Pollen isoallergen BG60 {ECO:0000303|PubMed:10479622, ECO:0000303|PubMed:11162583, ECO:0000303|PubMed:22993084};
DE   AltName: Allergen=Cyn d 4 {ECO:0000303|PubMed:22993084};
DE   Flags: Precursor;
OS   Cynodon dactylon (Bermuda grass) (Panicum dactylon).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; Liliopsida; Poales; Poaceae; PACMAD clade;
OC   Chloridoideae; Cynodonteae; Eleusininae; Cynodon.
OX   NCBI_TaxID=28909 {ECO:0000312|EMBL:AAS02108.1};
RN   [1] {ECO:0000312|EMBL:AAS02108.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Chuang J.-G., Chow L.-P., Su S.-N.;
RT   "Molecular cloning and expression of an allergen BG60 from Bermuda grass
RT   (Cynodon dactylon).";
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   PROTEIN SEQUENCE OF 76-86; 195-218; 347-365 AND 464-476, COFACTOR, TISSUE
RP   SPECIFICITY, PTM, AND CIRCULAR DICHROISM ANALYSIS.
RX   PubMed=11162583; DOI=10.1006/bbrc.2000.4203;
RA   Liaw S., Lee D.Y., Chow L.P., Lau G.X., Su S.N., Chow L.;
RT   "Structural characterization of the 60-kDa bermuda grass pollen
RT   isoallergens, a covalent flavoprotein.";
RL   Biochem. Biophys. Res. Commun. 280:738-743(2001).
RN   [3]
RP   TISSUE SPECIFICITY, PTM, GLYCOSYLATION, AND ALLERGEN.
RX   PubMed=8828524; DOI=10.1016/s0091-6749(96)70080-5;
RA   Su S.N., Shu P., Lau G.X., Yang S.Y., Huang S.W., Lee Y.C.;
RT   "Immunologic and physicochemical studies of Bermuda grass pollen antigen
RT   BG60.";
RL   J. Allergy Clin. Immunol. 98:486-494(1996).
RN   [4]
RP   TISSUE SPECIFICITY, AND GLYCOSYLATION.
RX   PubMed=8900140; DOI=10.1074/jbc.271.43.26653;
RA   Ohsuga H., Su S.N., Takahashi N., Yang S.Y., Nakagawa H., Shimada I.,
RA   Arata Y., Lee Y.C.;
RT   "The carbohydrate moiety of the bermuda grass antigen BG60. New
RT   oligosaccharides of plant origin.";
RL   J. Biol. Chem. 271:26653-26658(1996).
RN   [5]
RP   CRYSTALLIZATION, SUBUNIT, TISSUE SPECIFICITY, AND PTM.
RX   PubMed=10479622; DOI=10.1006/jsbi.1999.4133;
RA   Liaw S.H., Lee D.Y., Yang S.Y., Su S.N.;
RT   "Crystallization and preliminary diffraction data of 60-kDa glycosylated
RT   pollen isoallergens from Bermuda grass.";
RL   J. Struct. Biol. 127:83-87(1999).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, TISSUE SPECIFICITY, PTM,
RP   GLYCOSYLATION, AND ALLERGEN.
RX   PubMed=16121337; DOI=10.1002/pmic.200401229;
RA   Kao S.H., Su S.N., Huang S.W., Tsai J.J., Chow L.P.;
RT   "Sub-proteome analysis of novel IgE-binding proteins from Bermuda grass
RT   pollen.";
RL   Proteomics 5:3805-3813(2005).
RN   [7]
RP   ALLERGEN.
RX   PubMed=20080962; DOI=10.1074/jbc.m109.058370;
RA   Hsu S.C., Chen C.H., Tsai S.H., Kawasaki H., Hung C.H., Chu Y.T.,
RA   Chang H.W., Zhou Y., Fu J., Plunkett B., Su S.N., Vieths S., Lee R.T.,
RA   Lee Y.C., Huang S.K.;
RT   "Functional interaction of common allergens and a C-type lectin receptor,
RT   dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN), on human
RT   dendritic cells.";
RL   J. Biol. Chem. 285:7903-7910(2010).
RN   [8] {ECO:0007744|PDB:4DNS}
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 26-522 IN COMPLEX WITH FAD,
RP   COFACTOR, SUBUNIT, TISSUE SPECIFICITY, DISULFIDE BONDS, AND GLYCOSYLATION
RP   AT ASN-88 AND ASN-325.
RX   PubMed=22993084; DOI=10.1107/s0907444912027552;
RA   Huang T.H., Peng H.J., Su S.N., Liaw S.H.;
RT   "Various cross-reactivity of the grass pollen group 4 allergens:
RT   crystallographic study of the Bermuda grass isoallergen Cyn d 4.";
RL   Acta Crystallogr. D 68:1303-1310(2012).
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:11162583, ECO:0000269|PubMed:22993084};
CC       Note=Binds 1 FAD per subunit in a bicovalent manner.
CC       {ECO:0000269|PubMed:22993084};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:10479622,
CC       ECO:0000269|PubMed:22993084}.
CC   -!- TISSUE SPECIFICITY: Expressed in pollen (at protein level).
CC       {ECO:0000269|PubMed:10479622, ECO:0000269|PubMed:11162583,
CC       ECO:0000269|PubMed:16121337, ECO:0000269|PubMed:22993084,
CC       ECO:0000269|PubMed:8828524, ECO:0000269|PubMed:8900140}.
CC   -!- PTM: The FAD cofactor is bound via a bicovalent 6-S-cysteinyl, 8alpha-
CC       N1-histidyl FAD linkage. {ECO:0000269|PubMed:22993084}.
CC   -!- PTM: The N-terminus is blocked. {ECO:0000269|PubMed:10479622,
CC       ECO:0000269|PubMed:11162583, ECO:0000269|PubMed:16121337,
CC       ECO:0000269|PubMed:8828524}.
CC   -!- PTM: Glycosylated (PubMed:16121337). N-glycosylated (PubMed:8828524,
CC       PubMed:8900140). Contains fucose, N-acetylglucosamine, and mannose as
CC       main carbohydrates (in a ratio of approximately 3:2:1), and a minute
CC       amount of xylose (PubMed:8828524). The two most abundant
CC       oligosaccharides are Fuc(1)GlcNAc(2)Man(3) and Fuc(1)GlcNAc(2)Man(2),
CC       together comprising about 80% of the total carbohydrate content. They
CC       are structurally unusual in having a L-Fuc alpha-(1,3)-linked to Asn-
CC       linked GlcNAc without a Xyl beta-(1,2)-linked to the branching Man. The
CC       other oligosaccharides make up only 9% of the total carbohydrate
CC       content and are characterized by the presence of Xyl beta-(1,2)-linked
CC       to the branching Man (PubMed:8900140). {ECO:0000269|PubMed:16121337,
CC       ECO:0000269|PubMed:8828524, ECO:0000269|PubMed:8900140}.
CC   -!- ALLERGEN: Causes an allergic reaction in human. Binds to IgE of
CC       patients allergic to Bermuda grass pollen (BGP) (PubMed:8828524,
CC       PubMed:16121337). Binds to IgE in all 18 patients tested
CC       (PubMed:8828524). Binds to IgE in 50% of the 10 patients tested
CC       (PubMed:16121337). Periodate oxidation decreases the binding activity
CC       to IgE from 20% to 65% as the concentration of periodate increases from
CC       1 mmol/L to 10 mmol/L, indicating the involvement of the carbohydrate
CC       moiety of this protein in immune responses (PubMed:8828524). The
CC       fucosylated glycan structures of this protein can bind the human C-type
CC       lectin receptors CD209 (DC-SIGN) and its related receptor CLEC4M (L-
CC       SIGN). The interaction provokes an immune response leading to the
CC       activation of RAF1 and ERK kinases and to the induction of tumor
CC       necrosis factor (TNF)-alpha expression in human THP-1 cells and
CC       monocyte-derived dendritic cells (MDDCs) (PubMed:20080962).
CC       {ECO:0000269|PubMed:16121337, ECO:0000269|PubMed:20080962,
CC       ECO:0000269|PubMed:8828524}.
CC   -!- SIMILARITY: Belongs to the oxygen-dependent FAD-linked oxidoreductase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY451241; AAS02108.1; -; mRNA.
DR   PDB; 4DNS; X-ray; 2.15 A; A/B=26-522.
DR   PDBsum; 4DNS; -.
DR   SMR; Q5QJ60; -.
DR   Allergome; 819; Cyn d 4.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0016491; F:oxidoreductase activity; IC:UniProtKB.
DR   Gene3D; 3.30.43.10; -; 1.
DR   InterPro; IPR012951; BBE.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR016167; FAD-bd_PCMH_sub1.
DR   InterPro; IPR006094; Oxid_FAD_bind_N.
DR   Pfam; PF08031; BBE; 1.
DR   Pfam; PF01565; FAD_binding_4; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allergen; Direct protein sequencing; Disulfide bond; FAD;
KW   Flavoprotein; Glycoprotein; Nucleotide-binding; Oxidoreductase; Signal.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..522
FT                   /note="Berberine bridge enzyme-like Cyn d 4"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_5004261372"
FT   DOMAIN          76..252
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   NP_BIND         108..114
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22993084,
FT                   ECO:0007744|PDB:4DNS"
FT   NP_BIND         176..177
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22993084,
FT                   ECO:0007744|PDB:4DNS"
FT   NP_BIND         181..185
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22993084,
FT                   ECO:0007744|PDB:4DNS"
FT   NP_BIND         461..465
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22993084,
FT                   ECO:0007744|PDB:4DNS"
FT   BINDING         119
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22993084,
FT                   ECO:0007744|PDB:4DNS"
FT   BINDING         152
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22993084,
FT                   ECO:0007744|PDB:4DNS"
FT   BINDING         191
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:22993084,
FT                   ECO:0007744|PDB:4DNS"
FT   BINDING         237
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:22993084,
FT                   ECO:0007744|PDB:4DNS"
FT   BINDING         242
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:22993084,
FT                   ECO:0007744|PDB:4DNS"
FT   CARBOHYD        88
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498,
FT                   ECO:0000269|PubMed:22993084, ECO:0007744|PDB:4DNS"
FT   CARBOHYD        325
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498,
FT                   ECO:0000269|PubMed:22993084, ECO:0007744|PDB:4DNS"
FT   CARBOHYD        354
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        477
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   DISULFID        41..98
FT                   /evidence="ECO:0000269|PubMed:22993084,
FT                   ECO:0007744|PDB:4DNS"
FT   DISULFID        308..329
FT                   /evidence="ECO:0000269|PubMed:22993084,
FT                   ECO:0007744|PDB:4DNS"
FT   CROSSLNK        113..177
FT                   /note="6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-
FT                   Cys)"
FT                   /evidence="ECO:0000269|PubMed:22993084,
FT                   ECO:0007744|PDB:4DNS"
FT   HELIX           38..43
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           48..50
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          51..53
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           59..64
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           70..72
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          74..78
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          81..84
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           89..101
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          105..111
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   TURN            118..120
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          122..124
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          128..132
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           133..135
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          139..141
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   TURN            143..145
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          147..151
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           156..166
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           182..187
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           195..198
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           202..204
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          205..211
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           220..223
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           225..230
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   TURN            231..233
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          241..248
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          256..264
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           265..267
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           269..279
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   TURN            280..282
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          287..294
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          297..306
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           308..318
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           320..322
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          330..332
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           334..343
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           349..353
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          361..370
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           376..384
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           385..387
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          393..398
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           401..405
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          410..412
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   STRAND          421..430
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           432..434
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           436..449
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   TURN            450..452
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           467..469
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           481..492
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           493..495
FT                   /evidence="ECO:0007829|PDB:4DNS"
FT   HELIX           496..506
FT                   /evidence="ECO:0007829|PDB:4DNS"
SQ   SEQUENCE   522 AA;  57413 MW;  3C781F7FC155B33F CRC64;
     MARSRAFAFA LLICAVAASC HVALSAPPPY AKQVERDFLT CLTKDIPPRQ LYAKSSPAYA
     SVWSSTVRNI KFLSDKTVKP LYIITPTNAS HIQAAVVCGR RHGMRIRVRS GGHDYEGLSY
     RSEKPEPFAV VDMNKMRAVS IDGKAATAWV DSGAQLGDLY YGIAKASPKL GFPAGVCTTI
     GVGGHFSGGG FGMLLRKYGT AADNVIDAKV VDAQGRLLDR KAMGEDHFWA IRGGGGESFG
     IVASWQVKLL PVPPKVTVFQ VHKGIKEGAI DLVTKWQTVA PALPDDLMIR IMAMGQGAMF
     EALYLGTCKD LVLLMTARFP ELGMNATHCK EMTWIESVPY IPMGPKGTVR DLLNRTSNIK
     AFGKYKSDYV LEPIPKSDWE KIFTWLVKPG AGVMIMDPYG GGIASVPESA TPFPRRSGVL
     FNIQYVVYWF GEGAAALPTQ WTRDIYDFMT PYVSKNPRQA YVNYRDLDLG VNQVVGNVST
     YASGKVWGEK YFKGNFERLA RTKGKIDPED YFRNEQSIPP LL
//
ID   AIFM1_MOUSE             Reviewed;         612 AA.
AC   Q9Z0X1; Q1L6K5;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   02-JUN-2021, entry version 186.
DE   RecName: Full=Apoptosis-inducing factor 1, mitochondrial {ECO:0000305};
DE            EC=1.6.99.- {ECO:0000269|PubMed:19447115};
DE   AltName: Full=Programmed cell death protein 8;
DE   Flags: Precursor;
GN   Name=Aifm1 {ECO:0000312|MGI:MGI:1349419}; Synonyms=Aif, Pdcd8;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF N-TERMINUS, PROTEIN
RP   SEQUENCE OF 322-336, FUNCTION, COFACTOR, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=9989411; DOI=10.1038/17135;
RA   Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M.,
RA   Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N.,
RA   Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., Kroemer G.;
RT   "Molecular characterization of mitochondrial apoptosis-inducing factor.";
RL   Nature 397:441-446(1999).
RN   [2] {ECO:0000312|EMBL:AAY84740.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION (ISOFORM 2),
RP   AND TISSUE SPECIFICITY (ISOFORM 2).
RC   STRAIN=C57BL/6J;
RX   PubMed=16644725; DOI=10.1074/jbc.m601751200;
RA   Delettre C., Yuste V.J., Moubarak R.S., Bras M., Robert N., Susin S.A.;
RT   "Identification and characterization of AIFsh2, a mitochondrial apoptosis-
RT   inducing factor (AIF) isoform with NADH oxidase activity.";
RL   J. Biol. Chem. 281:18507-18518(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 378-386, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=OF1; TISSUE=Hippocampus;
RA   Lubec G., Sunyer B., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   SUCCINYLATION [LARGE SCALE ANALYSIS] AT LYS-108, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-387 AND LYS-592, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=23576753; DOI=10.1073/pnas.1302961110;
RA   Rardin M.J., Newman J.C., Held J.M., Cusack M.P., Sorensen D.J., Li B.,
RA   Schilling B., Mooney S.D., Kahn C.R., Verdin E., Gibson B.W.;
RT   "Label-free quantitative proteomics of the lysine acetylome in mitochondria
RT   identifies substrates of SIRT3 in metabolic pathways.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:6601-6606(2013).
RN   [8]
RP   FUNCTION.
RX   PubMed=26004228; DOI=10.1016/j.molcel.2015.04.020;
RA   Hangen E., Feraud O., Lachkar S., Mou H., Doti N., Fimia G.M., Lam N.V.,
RA   Zhu C., Godin I., Muller K., Chatzi A., Nuebel E., Ciccosanti F.,
RA   Flamant S., Benit P., Perfettini J.L., Sauvat A., Bennaceur-Griscelli A.,
RA   Ser-Le Roux K., Gonin P., Tokatlidis K., Rustin P., Piacentini M., Ruvo M.,
RA   Blomgren K., Kroemer G., Modjtahedi N.;
RT   "Interaction between AIF and CHCHD4 Regulates Respiratory Chain
RT   Biogenesis.";
RL   Mol. Cell 58:1001-1014(2015).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 108-610 IN COMPLEX WITH FAD,
RP   NAD-BINDING, AND MUTAGENESIS OF LYS-176 AND GLU-313.
RX   PubMed=11967568; DOI=10.1038/nsb793;
RA   Mate M.J., Ortiz-Lombardia M., Boitel B., Haouz A., Tello D., Susin S.A.,
RA   Penninger J., Kroemer G., Alzari P.M.;
RT   "The crystal structure of the mouse apoptosis-inducing factor AIF.";
RL   Nat. Struct. Biol. 9:442-446(2002).
RN   [10] {ECO:0007744|PDB:3GD3, ECO:0007744|PDB:3GD4}
RP   X-RAY CRYSTALLOGRAPHY (2.24 ANGSTROMS) OF 78-612 IN COMPLEX WITH FAD AND
RP   NAD, FAD-BINDING, NAD-BINDING, MUTAGENESIS OF TRP-195, SUBUNIT, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND CATALYTIC ACTIVITY.
RX   PubMed=19447115; DOI=10.1016/j.jmb.2009.05.013;
RA   Sevrioukova I.F.;
RT   "Redox-linked conformational dynamics in apoptosis-inducing factor.";
RL   J. Mol. Biol. 390:924-938(2009).
CC   -!- FUNCTION: Functions both as NADH oxidoreductase and as regulator of
CC       apoptosis (By similarity). In response to apoptotic stimuli, it is
CC       released from the mitochondrion intermembrane space into the cytosol
CC       and to the nucleus, where it functions as a proapoptotic factor in a
CC       caspase-independent pathway. The soluble form (AIFsol) found in the
CC       nucleus induces 'parthanatos' i.e. caspase-independent fragmentation of
CC       chromosomal DNA (PubMed:9989411). Binds to DNA in a sequence-
CC       independent manner. Interacts with EIF3G, and thereby inhibits the EIF3
CC       machinery and protein synthesis, and activates caspase-7 to amplify
CC       apoptosis. Plays a critical role in caspase-independent, pyknotic cell
CC       death in hydrogen peroxide-exposed cells (By similarity). In contrast,
CC       participates in normal mitochondrial metabolism. Plays an important
CC       role in the regulation of respiratory chain biogenesis by interacting
CC       with CHCHD4 and controlling CHCHD4 mitochondrial import
CC       (PubMed:19447115). {ECO:0000250|UniProtKB:O95831,
CC       ECO:0000269|PubMed:19447115, ECO:0000269|PubMed:9989411}.
CC   -!- FUNCTION: [Isoform 2]: Has NADH oxidoreductase activity. Does not
CC       induce nuclear apoptosis. {ECO:0000250|UniProtKB:O95831}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=A + H(+) + NADH = AH2 + NAD(+); Xref=Rhea:RHEA:11356,
CC         ChEBI:CHEBI:13193, ChEBI:CHEBI:15378, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         Evidence={ECO:0000269|PubMed:19447115};
CC   -!- CATALYTIC ACTIVITY: [Isoform 2]:
CC       Reaction=A + H(+) + NADH = AH2 + NAD(+); Xref=Rhea:RHEA:11356,
CC         ChEBI:CHEBI:13193, ChEBI:CHEBI:15378, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         Evidence={ECO:0000250|UniProtKB:O95831};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:19447115, ECO:0000269|PubMed:9989411};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=kcat is 48 min(-1) for dichlorophenolindophenol and 34 min(-1)
CC         for cytochrome c. {ECO:0000269|PubMed:19447115};
CC   -!- SUBUNIT: Monomer (oxidized form). Homodimer (reduced form). Upon
CC       reduction with NADH, undergoes dimerization and forms tight, long-lived
CC       FADH2-NAD charge transfer complexes (CTC) resistant to oxidation
CC       (PubMed:19447115). Also dimerizes with isoform 3 preventing its release
CC       from mitochondria. Interacts with XIAP/BIRC4. Interacts (via N-
CC       terminus) with EIF3G (via C-terminus). Interacts with PRELID1.
CC       Interacts with CHCHD4; the interaction increases in presence of NADH
CC       (By similarity). {ECO:0000250|UniProtKB:O95831,
CC       ECO:0000269|PubMed:19447115}.
CC   -!- INTERACTION:
CC       Q9Z0X1; P27661: H2ax; NbExp=3; IntAct=EBI-773597, EBI-495621;
CC       Q9Z0X1; Q9EQN3: Tsc22d4; NbExp=4; IntAct=EBI-773597, EBI-7821198;
CC       PRO_0000022031; P16104: H2AX; Xeno; NbExp=2; IntAct=EBI-5326677, EBI-494830;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion intermembrane space
CC       {ECO:0000269|PubMed:9989411}. Mitochondrion inner membrane
CC       {ECO:0000250|UniProtKB:O95831}. Cytoplasm
CC       {ECO:0000250|UniProtKB:O95831}. Nucleus {ECO:0000250|UniProtKB:O95831}.
CC       Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:O95831}.
CC       Note=Proteolytic cleavage during or just after translocation into the
CC       mitochondrial intermembrane space (IMS) results in the formation of an
CC       inner-membrane-anchored mature form (AIFmit). During apoptosis, further
CC       proteolytic processing leads to a mature form, which is confined to the
CC       mitochondrial IMS in a soluble form (AIFsol). AIFsol is released to the
CC       cytoplasm in response to specific death signals, and translocated to
CC       the nucleus, where it induces nuclear apoptosis. Colocalizes with EIF3G
CC       in the nucleus and perinuclear region. {ECO:0000250|UniProtKB:O95831}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Mitochondrion
CC       {ECO:0000269|PubMed:16644725}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:O95831}. Note=In pro-apoptotic conditions, is
CC       released from mitochondria to cytosol in a calpain/cathepsin-dependent
CC       manner. {ECO:0000250|UniProtKB:O95831}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Z0X1-1; Sequence=Displayed;
CC       Name=2; Synonyms=AIFsh2 {ECO:0000303|PubMed:16644725};
CC         IsoId=Q9Z0X1-2; Sequence=VSP_060486, VSP_060487;
CC   -!- TISSUE SPECIFICITY: [Isoform 2]: Expressed in liver (at protein level).
CC       {ECO:0000269|PubMed:16644725}.
CC   -!- PTM: Under normal conditions, a 54-residue N-terminal segment is first
CC       proteolytically removed during or just after translocation into the
CC       mitochondrial intermembrane space (IMS) by the mitochondrial processing
CC       peptidase (MPP) to form the inner-membrane-anchored mature form
CC       (AIFmit). During apoptosis, it is further proteolytically processed at
CC       amino-acid position 101 leading to the generation of the mature form,
CC       which is confined to the mitochondrial IMS in a soluble form (AIFsol).
CC       AIFsol is released to the cytoplasm in response to specific death
CC       signals, and translocated to the nucleus, where it induces nuclear
CC       apoptosis in a caspase-independent manner.
CC       {ECO:0000250|UniProtKB:O95831}.
CC   -!- PTM: Ubiquitination by XIAP/BIRC4 does not lead to proteasomal
CC       degradation. Ubiquitination at Lys-254 by XIAP/BIRC4 blocks its ability
CC       to bind DNA and induce chromatin degradation, thereby inhibiting its
CC       ability to induce cell death. {ECO:0000250|UniProtKB:O95831}.
CC   -!- SIMILARITY: Belongs to the FAD-dependent oxidoreductase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF100927; AAD16435.1; -; mRNA.
DR   EMBL; DQ016499; AAY84740.1; -; mRNA.
DR   EMBL; BC003292; AAH03292.1; -; mRNA.
DR   CCDS; CCDS30109.1; -. [Q9Z0X1-1]
DR   RefSeq; NP_001277293.1; NM_001290364.1.
DR   RefSeq; NP_036149.1; NM_012019.3. [Q9Z0X1-1]
DR   PDB; 1GV4; X-ray; 2.00 A; A/B=122-610.
DR   PDB; 3GD3; X-ray; 2.95 A; A/B/C/D=78-612.
DR   PDB; 3GD4; X-ray; 2.24 A; A/B=102-612.
DR   PDB; 5MIU; X-ray; 3.50 A; A/B=78-612.
DR   PDB; 5MIV; X-ray; 3.10 A; A/C=78-612.
DR   PDBsum; 1GV4; -.
DR   PDBsum; 3GD3; -.
DR   PDBsum; 3GD4; -.
DR   PDBsum; 5MIU; -.
DR   PDBsum; 5MIV; -.
DR   SMR; Q9Z0X1; -.
DR   BioGRID; 205067; 29.
DR   IntAct; Q9Z0X1; 29.
DR   MINT; Q9Z0X1; -.
DR   STRING; 10090.ENSMUSP00000041104; -.
DR   iPTMnet; Q9Z0X1; -.
DR   PhosphoSitePlus; Q9Z0X1; -.
DR   SwissPalm; Q9Z0X1; -.
DR   EPD; Q9Z0X1; -.
DR   jPOST; Q9Z0X1; -.
DR   MaxQB; Q9Z0X1; -.
DR   PaxDb; Q9Z0X1; -.
DR   PeptideAtlas; Q9Z0X1; -.
DR   PRIDE; Q9Z0X1; -.
DR   ProteomicsDB; 296004; -. [Q9Z0X1-1]
DR   Antibodypedia; 3528; 845 antibodies.
DR   DNASU; 26926; -.
DR   Ensembl; ENSMUST00000037349; ENSMUSP00000041104; ENSMUSG00000036932. [Q9Z0X1-1]
DR   GeneID; 26926; -.
DR   KEGG; mmu:26926; -.
DR   UCSC; uc009tcg.1; mouse. [Q9Z0X1-1]
DR   CTD; 9131; -.
DR   MGI; MGI:1349419; Aifm1.
DR   eggNOG; KOG1346; Eukaryota.
DR   GeneTree; ENSGT00940000156455; -.
DR   HOGENOM; CLU_003291_5_3_1; -.
DR   InParanoid; Q9Z0X1; -.
DR   OrthoDB; 830428at2759; -.
DR   PhylomeDB; Q9Z0X1; -.
DR   TreeFam; TF314028; -.
DR   SABIO-RK; Q9Z0X1; -.
DR   BioGRID-ORCS; 26926; 9 hits in 52 CRISPR screens.
DR   ChiTaRS; Aifm1; mouse.
DR   EvolutionaryTrace; Q9Z0X1; -.
DR   PRO; PR:Q9Z0X1; -.
DR   Proteomes; UP000000589; Chromosome X.
DR   RNAct; Q9Z0X1; protein.
DR   Bgee; ENSMUSG00000036932; Expressed in cortex of kidney and 308 other tissues.
DR   ExpressionAtlas; Q9Z0X1; baseline and differential.
DR   Genevisible; Q9Z0X1; MM.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; ISS:UniProtKB.
DR   GO; GO:0005741; C:mitochondrial outer membrane; TAS:MGI.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0004174; F:electron-transferring-flavoprotein dehydrogenase activity; TAS:MGI.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0016174; F:NAD(P)H oxidase H2O2-forming activity; IDA:UniProtKB.
DR   GO; GO:0003954; F:NADH dehydrogenase activity; IEA:RHEA.
DR   GO; GO:0016651; F:oxidoreductase activity, acting on NAD(P)H; ISO:MGI.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB.
DR   GO; GO:0008637; P:apoptotic mitochondrial changes; TAS:MGI.
DR   GO; GO:0006915; P:apoptotic process; ISO:MGI.
DR   GO; GO:1904045; P:cellular response to aldosterone; IEA:Ensembl.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEA:Ensembl.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0071732; P:cellular response to nitric oxide; IEA:Ensembl.
DR   GO; GO:0090650; P:cellular response to oxygen-glucose deprivation; IEA:Ensembl.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IMP:UniProtKB.
DR   GO; GO:0033108; P:mitochondrial respiratory chain complex assembly; IMP:UniProtKB.
DR   GO; GO:0032981; P:mitochondrial respiratory chain complex I assembly; ISO:MGI.
DR   GO; GO:0051402; P:neuron apoptotic process; IGI:MGI.
DR   GO; GO:0030182; P:neuron differentiation; ISO:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0010942; P:positive regulation of cell death; IMP:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISO:MGI.
DR   GO; GO:0045041; P:protein import into mitochondrial intermembrane space; IMP:UniProtKB.
DR   GO; GO:1902510; P:regulation of apoptotic DNA fragmentation; IGI:MGI.
DR   GO; GO:0002931; P:response to ischemia; IEA:Ensembl.
DR   GO; GO:1902065; P:response to L-glutamate; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; TAS:UniProtKB.
DR   GO; GO:0009636; P:response to toxic substance; IEA:Ensembl.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR029324; AIF_C.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   Pfam; PF14721; AIF_C; 1.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF51905; SSF51905; 2.
DR   SUPFAM; SSF55424; SSF55424; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis; Cytoplasm;
KW   Direct protein sequencing; DNA-binding; FAD; Flavoprotein; Isopeptide bond;
KW   Membrane; Mitochondrion; Mitochondrion inner membrane; NAD; Nucleus;
KW   Oxidoreductase; Phosphoprotein; Reference proteome; Transit peptide;
KW   Ubl conjugation.
FT   TRANSIT         1..54
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000250"
FT   PROPEP          55..101
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000269|PubMed:9989411"
FT                   /id="PRO_0000401936"
FT   CHAIN           102..612
FT                   /note="Apoptosis-inducing factor 1, mitochondrial"
FT                   /id="PRO_0000022031"
FT   NP_BIND         137..141
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11967568,
FT                   ECO:0000269|PubMed:19447115, ECO:0007744|PDB:3GD3,
FT                   ECO:0007744|PDB:3GD4"
FT   NP_BIND         163..164
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11967568,
FT                   ECO:0000269|PubMed:19447115, ECO:0007744|PDB:3GD4"
FT   NP_BIND         307..310
FT                   /note="NAD 1"
FT                   /evidence="ECO:0000269|PubMed:19447115,
FT                   ECO:0007744|PDB:3GD4"
FT   NP_BIND         452..453
FT                   /note="NAD 1"
FT                   /evidence="ECO:0000269|PubMed:19447115,
FT                   ECO:0007744|PDB:3GD4"
FT   NP_BIND         453..454
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11967568,
FT                   ECO:0000269|PubMed:19447115, ECO:0007744|PDB:3GD4"
FT   REGION          133..482
FT                   /note="FAD-dependent oxidoreductase"
FT   REGION          512..551
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           1..30
FT                   /note="Mitochondrial localization signal"
FT                   /evidence="ECO:0000305|PubMed:9989411"
FT   MOTIF           62..88
FT                   /note="Mitochondrial localization signal"
FT                   /evidence="ECO:0000305|PubMed:9989411"
FT   MOTIF           445..450
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        513..540
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         171
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11967568,
FT                   ECO:0000269|PubMed:19447115, ECO:0007744|PDB:3GD3,
FT                   ECO:0007744|PDB:3GD4"
FT   BINDING         176
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11967568,
FT                   ECO:0000269|PubMed:19447115, ECO:0007744|PDB:3GD3"
FT   BINDING         195
FT                   /note="NAD 2"
FT                   /evidence="ECO:0000250|UniProtKB:O95831"
FT   BINDING         232
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:11967568,
FT                   ECO:0000269|PubMed:19447115, ECO:0007744|PDB:3GD3,
FT                   ECO:0007744|PDB:3GD4"
FT   BINDING         284
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11967568,
FT                   ECO:0000269|PubMed:19447115, ECO:0007744|PDB:3GD3,
FT                   ECO:0007744|PDB:3GD4"
FT   BINDING         335
FT                   /note="NAD 1"
FT                   /evidence="ECO:0000269|PubMed:19447115,
FT                   ECO:0007744|PDB:3GD4"
FT   BINDING         341
FT                   /note="NAD 1"
FT                   /evidence="ECO:0000269|PubMed:19447115,
FT                   ECO:0007744|PDB:3GD4"
FT   BINDING         398
FT                   /note="NAD 1; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:19447115,
FT                   ECO:0007744|PDB:3GD4"
FT   BINDING         437
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19447115,
FT                   ECO:0007744|PDB:3GD3, ECO:0007744|PDB:3GD4"
FT   BINDING         482
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:11967568,
FT                   ECO:0000269|PubMed:19447115, ECO:0007744|PDB:3GD3,
FT                   ECO:0007744|PDB:3GD4"
FT   BINDING         482
FT                   /note="NAD 1; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:19447115,
FT                   ECO:0007744|PDB:3GD4"
FT   BINDING         492
FT                   /note="NAD 2"
FT                   /evidence="ECO:0000250|UniProtKB:O95831"
FT   BINDING         582
FT                   /note="NAD 2"
FT                   /evidence="ECO:0000250|UniProtKB:O95831"
FT   MOD_RES         108
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         115
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95831"
FT   MOD_RES         267
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95831"
FT   MOD_RES         370
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95831"
FT   MOD_RES         387
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23576753"
FT   MOD_RES         520
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O95831"
FT   MOD_RES         523
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95831"
FT   MOD_RES         529
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95831"
FT   MOD_RES         592
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23576753"
FT   CROSSLNK        254
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:O95831"
FT   VAR_SEQ         322..324
FT                   /note="SQA -> CEY (in isoform 2)"
FT                   /id="VSP_060486"
FT   VAR_SEQ         325..612
FT                   /note="Missing (in isoform 2)"
FT                   /id="VSP_060487"
FT   MUTAGEN         176
FT                   /note="K->A: Increases catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:11967568"
FT   MUTAGEN         195
FT                   /note="W->A: Increases redox potential, reacts faster to
FT                   NADH and forms two-fold longer-lived CTC."
FT                   /evidence="ECO:0000269|PubMed:19447115"
FT   MUTAGEN         313
FT                   /note="E->A: Increases catalytic efficiency 30-fold.
FT                   Increases affinity for NADH 20-fold."
FT                   /evidence="ECO:0000269|PubMed:11967568"
FT   STRAND          129..137
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           140..152
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          157..166
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           172..175
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           177..179
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           186..189
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          191..193
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          199..205
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           207..209
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           213..218
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          223..229
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          232..236
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   TURN            237..240
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          241..244
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          249..257
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          261..263
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           267..270
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           274..277
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          280..282
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           286..296
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          300..305
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           309..325
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          328..332
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          334..337
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   TURN            338..342
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           345..356
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   TURN            357..359
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          361..363
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          368..374
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          377..382
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          387..395
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          399..401
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           404..406
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   TURN            407..410
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   TURN            415..417
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          419..421
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          426..429
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          432..434
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           436..438
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          439..443
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   TURN            444..446
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          447..449
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           454..468
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   TURN            469..471
FT                   /evidence="ECO:0007829|PDB:3GD3"
FT   STRAND          480..486
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          490..495
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          499..501
FT                   /evidence="ECO:0007829|PDB:5MIU"
FT   STRAND          503..508
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           516..523
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           528..532
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          539..542
FT                   /evidence="ECO:0007829|PDB:3GD4"
FT   HELIX           556..558
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   STRAND          561..579
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           584..593
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           600..604
FT                   /evidence="ECO:0007829|PDB:1GV4"
FT   HELIX           605..607
FT                   /evidence="ECO:0007829|PDB:1GV4"
SQ   SEQUENCE   612 AA;  66765 MW;  A17EDFD5CF77BB85 CRC64;
     MFRCGGLAGA FKQKLVPLVR TVYVQRPKQR NRLPGNLFQQ WRVPLELQMA RQMASSGSSG
     GKMDNSVLVL IVGLSTIGAG AYAYKTIKED QKRYNERVMG LGLSPEEKQR RAIASATEGG
     SVPQIRAPSH VPFLLIGGGT AAFAAARSIR ARDPGARVLI VSEDPELPYM RPPLSKELWF
     SDDPNVTKTL QFRQWNGKER SIYFQPPSFY VSAQDLPNIE NGGVAVLTGK KVVHLDVRGN
     MVKLNDGSQI TFEKCLIATG GTPRSLSAID RAGAEVKSRT TLFRKIGDFR ALEKISREVK
     SITVIGGGFL GSELACALGR KSQASGIEVI QLFPEKGNMG KILPQYLSNW TMEKVKREGV
     KVMPNAIVQS VGVSGGRLLI KLKDGRKVET DHIVTAVGLE PNVELAKTGG LEIDSDFGGF
     RVNAELQARS NIWVAGDAAC FYDIKLGRRR VEHHDHAVVS GRLAGENMTG AAKPYWHQSM
     FWSDLGPDVG YEAIGLVDSS LPTVGVFAKA TAQDNPKSAT EQSGTGIRSE SETESEASEI
     TIPPSAPAVP QVPVEGEDYG KGVIFYLRDK VVVGIVLWNV FNRMPIARKI IKDGEQHEDL
     NEVAKLFNIH ED
//
ID   ACX12_CAEEL             Reviewed;         661 AA.
AC   O62137;
DT   07-APR-2021, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 2.
DT   02-JUN-2021, entry version 152.
DE   RecName: Full=Acyl-coenzyme A oxidase acox-1.2 {ECO:0000305};
DE            EC=1.3.3.- {ECO:0000269|PubMed:25775534, ECO:0000269|PubMed:27551084};
GN   Name=acox-1.2 {ECO:0000312|WormBase:F08A8.2};
GN   Synonyms=acox-2 {ECO:0000312|WormBase:F08A8.2};
GN   ORFNames=F08A8.2 {ECO:0000312|WormBase:F08A8.2};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [2] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, PATHWAY,
RP   SUBUNIT, INTERACTION WITH ACOX-1.1, INDUCTION, AND MUTAGENESIS OF
RP   496-TRP--LEU-661.
RX   PubMed=25775534; DOI=10.1073/pnas.1423951112;
RA   Zhang X., Feng L., Chinta S., Singh P., Wang Y., Nunnery J.K.,
RA   Butcher R.A.;
RT   "Acyl-CoA oxidase complexes control the chemical message produced by
RT   Caenorhabditis elegans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:3955-3960(2015).
RN   [3] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=29863473; DOI=10.7554/elife.33286;
RA   Zhou Y., Wang Y., Zhang X., Bhar S., Jones Lipinski R.A., Han J., Feng L.,
RA   Butcher R.A.;
RT   "Biosynthetic tailoring of existing ascaroside pheromones alters their
RT   biological function in C. elegans.";
RL   Elife 7:0-0(2018).
RN   [4] {ECO:0007744|PDB:5K3J}
RP   X-RAY CRYSTALLOGRAPHY (2.68 ANGSTROMS) OF MUTANT ALA-432 IN COMPLEX WITH
RP   ATP; FAD AND ASCAROSIDE-OMEGA-C5-COA, FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, ACTIVITY REGULATION, PATHWAY, SUBUNIT, AND MUTAGENESIS OF
RP   GLU-432.
RX   PubMed=27551084; DOI=10.1073/pnas.1608262113;
RA   Zhang X., Li K., Jones R.A., Bruner S.D., Butcher R.A.;
RT   "Structural characterization of acyl-CoA oxidases reveals a direct link
RT   between pheromone biosynthesis and metabolic state in Caenorhabditis
RT   elegans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:10055-10060(2016).
CC   -!- FUNCTION: Involved in the first step of peroxisomal beta-oxidation by
CC       catalyzing the desaturation of fatty acid-derived side chains of
CC       ascaroside pheromones, which regulates development and behavior
CC       (PubMed:25775534, PubMed:27551084). Specifically, shortens ascarosides
CC       with 5-carbon omega side chain (asc-omega-C5) (PubMed:25775534,
CC       PubMed:27551084). Does not shorten indol-3-carbonyl(IC)-ascaroside with
CC       7-carbon or 9-carbon side chains (PubMed:29863473). Does not catalyze
CC       the desaturation of fatty acids or hydroxylated fatty acids
CC       (PubMed:25775534, PubMed:27551084). {ECO:0000269|PubMed:25775534,
CC       ECO:0000269|PubMed:27551084, ECO:0000269|PubMed:29863473}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=asc-omegaC5-CoA + O2 = asc-omegaDeltaC5-CoA + H2O2;
CC         Xref=Rhea:RHEA:66212, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:140060, ChEBI:CHEBI:166969;
CC         Evidence={ECO:0000269|PubMed:25775534, ECO:0000269|PubMed:27551084};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:27551084};
CC   -!- ACTIVITY REGULATION: Activated by ATP (PubMed:27551084). ATP binding
CC       leads to a conformational change that promotes FAD cofactor binding and
CC       enzyme activity (PubMed:27551084). ATP binding likely occurs during
CC       acox-1.2 folding and/or dimer formation (PubMed:27551084). The
CC       preference for processing substrates with shorter fatty acid chains is
CC       likely due to the closed conformation of the active site
CC       (PubMed:27551084). {ECO:0000269|PubMed:27551084}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=175 uM for asc-omega-C5-CoA (at 30 degrees Celsius and pH 7.4)
CC         {ECO:0000269|PubMed:25775534};
CC         KM=152 uM for asc-omega-C5-CoA (at 30 degrees Celsius, pH 7.4 and in
CC         complex with acox-1.1) {ECO:0000269|PubMed:25775534};
CC         Note=kcat is 364 sec(-1) with asc-omega-C5-CoA (at 30 degrees Celsius
CC         and pH 7.4) (PubMed:25775534). kcat is 478 sec(-1) with asc-omega-C5-
CC         CoA (at 30 degrees Celsius, pH 7.4 and in complex with acox-1.1)
CC         (PubMed:25775534). {ECO:0000269|PubMed:25775534};
CC   -!- PATHWAY: Lipid metabolism; peroxisomal fatty acid beta-oxidation.
CC       {ECO:0000269|PubMed:25775534, ECO:0000269|PubMed:27551084}.
CC   -!- SUBUNIT: Homodimer (Probable) (PubMed:27551084). Forms a heterodimer
CC       with acox-1.1 (PubMed:25775534). {ECO:0000269|PubMed:25775534,
CC       ECO:0000269|PubMed:27551084, ECO:0000305|PubMed:25775534}.
CC   -!- SUBCELLULAR LOCATION: Peroxisome {ECO:0000250|UniProtKB:O62140}.
CC   -!- INDUCTION: Induced by high temperatures (25 degrees Celsius)
CC       (PubMed:25775534). Down-regulated in dauer conditions
CC       (PubMed:25775534). {ECO:0000269|PubMed:25775534}.
CC   -!- SIMILARITY: Belongs to the acyl-CoA oxidase family.
CC       {ECO:0000255|PIRNR:PIRNR000168}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX284601; CAB16864.2; -; Genomic_DNA.
DR   RefSeq; NP_493262.2; NM_060861.3.
DR   PDB; 5K3J; X-ray; 2.68 A; A/B=1-661.
DR   PDBsum; 5K3J; -.
DR   SMR; O62137; -.
DR   STRING; 6239.F08A8.2; -.
DR   EPD; O62137; -.
DR   PaxDb; O62137; -.
DR   PeptideAtlas; O62137; -.
DR   EnsemblMetazoa; F08A8.2.1; F08A8.2.1; WBGene00008565.
DR   GeneID; 173163; -.
DR   KEGG; cel:CELE_F08A8.2; -.
DR   UCSC; F08A8.2; c. elegans.
DR   CTD; 173163; -.
DR   WormBase; F08A8.2; CE43421; WBGene00008565; acox-1.2.
DR   eggNOG; KOG0136; Eukaryota.
DR   GeneTree; ENSGT00940000168827; -.
DR   HOGENOM; CLU_014629_3_1_1; -.
DR   InParanoid; O62137; -.
DR   OMA; GRRFFTM; -.
DR   OrthoDB; 416859at2759; -.
DR   PhylomeDB; O62137; -.
DR   BRENDA; 1.3.3.6; 1045.
DR   Reactome; R-CEL-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-CEL-389887; Beta-oxidation of pristanoyl-CoA.
DR   Reactome; R-CEL-9033241; Peroxisomal protein import.
DR   UniPathway; UPA00661; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00008565; Expressed in multi-cellular organism and 3 other tissues.
DR   GO; GO:0005777; C:peroxisome; IBA:GO_Central.
DR   GO; GO:0003997; F:acyl-CoA oxidase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0005504; F:fatty acid binding; IBA:GO_Central.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:1904070; P:ascaroside biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; IDA:UniProtKB.
DR   GO; GO:0055088; P:lipid homeostasis; IBA:GO_Central.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR029320; Acyl-CoA_ox_N.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR012258; Acyl-CoA_oxidase.
DR   InterPro; IPR002655; Acyl-CoA_oxidase_C.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF01756; ACOX; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF14749; Acyl-CoA_ox_N; 1.
DR   PIRSF; PIRSF000168; Acyl-CoA_oxidase; 1.
DR   SUPFAM; SSF47203; SSF47203; 2.
DR   SUPFAM; SSF56645; SSF56645; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; FAD; Fatty acid metabolism; Flavoprotein;
KW   Lipid metabolism; Nucleotide-binding; Oxidoreductase; Peroxisome;
KW   Reference proteome.
FT   CHAIN           1..661
FT                   /note="Acyl-coenzyme A oxidase acox-1.2"
FT                   /id="PRO_0000452303"
FT   NP_BIND         147..150
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3J"
FT   NP_BIND         155..156
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3J"
FT   NP_BIND         338..341
FT                   /note="FAD; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3J"
FT   NP_BIND         525..528
FT                   /note="ATP"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3J"
FT   REGION          283..286
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3J"
FT   REGION          431..432
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3J"
FT   MOTIF           659..661
FT                   /note="Microbody targeting signal"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        432
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PIRSR:PIRSR000168-1"
FT   BINDING         189
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000255|PIRSR:PIRSR000168-2,
FT                   ECO:0000269|PubMed:27551084, ECO:0007744|PDB:5K3J"
FT   BINDING         293
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3J"
FT   BINDING         318
FT                   /note="FAD; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3J"
FT   BINDING         340
FT                   /note="ATP; via tele nitrogen; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3J"
FT   BINDING         390
FT                   /note="ATP; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:O62140"
FT   BINDING         394
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:O62140"
FT   BINDING         402
FT                   /note="ATP; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3J"
FT   BINDING         409
FT                   /note="FAD; via amide nitrogen; shared with dimeric
FT                   partner"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3J"
FT   BINDING         434
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3J"
FT   BINDING         573
FT                   /note="ATP"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0007744|PDB:5K3J"
FT   SITE            299
FT                   /note="Important for asc-omega-C5-CoA binding and thus
FT                   substrate specificity"
FT                   /evidence="ECO:0000269|PubMed:27551084,
FT                   ECO:0000312|PDB:5K3J"
FT   MUTAGEN         432
FT                   /note="E->A: Increases ATP and FAD binding."
FT                   /evidence="ECO:0000269|PubMed:27551084"
FT   MUTAGEN         496..661
FT                   /note="Missing: In gk386052; increases production of asc-
FT                   omega-C5 and reduces the production of asc-omega-C3."
FT                   /evidence="ECO:0000269|PubMed:25775534"
SQ   SEQUENCE   661 AA;  75091 MW;  EF005188A6A87472 CRC64;
     MANRSIRDGD NPELLEERRM ATFDTDKMAA VIYGSEEFAR RRREITDAVS KIPELADIKP
     YPFLTREEKV TEGTRKISIL TKYLNQLIDR DNEEESLHLH REVIGYEGHP FALHDALFIP
     TLQSQASDEQ QEKWLERARR REIIGCYAQT ELGHGSNLRN LETTAVYDIA SQEFVLHTPT
     TTALKWWPGA LGKSCNYALV VAELIIKRNN YGPHFFMVQL RDEKTHIPLK GVTVGDIGPK
     MNFNAADNGY LGLNNLRVPR TNLLMRHCKV EADGTYVKPP HAKIGYSGMV KIRSQMAMEQ
     GLFLAHALTI AARYSAVRRQ GHLDDKQVEV KVLDYQTQQH RLFPSLARAY AFIFTGFETI
     HLYSQLLKDV DMGNTSGMAD LHALTSGLKS VVAHETGEGI EQARMACGGH GYSMASYISV
     VYGIAIGGCT YEGENMVMLL QLARYLVKSV ELIKAGKAKK LGPVASYLAD KSDETDLTSL
     NGYVKMFENM ARRQAWKATE KFLKLMESGE SREVAWNKSA VELTRASRLH TRLFIIEAFM
     RRVSRIEDIP VKEVLTDLLH LHVNYELLDV ATYALEFMSF TQLDYVRDQL YLYLEKIRPN
     AVSLVDSFQI SDMQLRSVLG RRDGHVYENL FKWAKSSPLN NADVLPSVEK YLKPMMEKAK
     L
//
ID   ACADS_RAT               Reviewed;         412 AA.
AC   P15651;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   02-JUN-2021, entry version 177.
DE   RecName: Full=Short-chain specific acyl-CoA dehydrogenase, mitochondrial;
DE            Short=SCAD;
DE            EC=1.3.8.1 {ECO:0000269|PubMed:3968063};
DE   AltName: Full=Butyryl-CoA dehydrogenase;
DE   Flags: Precursor;
GN   Name=Acads;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 25-51; 235-250; 314-325
RP   AND 350-379.
RX   PubMed=2777793;
RA   Matsubara Y., Indo Y., Naito E., Ozasa H., Glassberg R., Vockley J.,
RA   Ikeda Y., Kraus J., Tanaka K.;
RT   "Molecular cloning and nucleotide sequence of cDNAs encoding the precursors
RT   of rat long chain acyl-coenzyme A, short chain acyl-coenzyme A, and
RT   isovaleryl-coenzyme A dehydrogenases. Sequence homology of four enzymes of
RT   the acyl-CoA dehydrogenase family.";
RL   J. Biol. Chem. 264:16321-16331(1989).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, COFACTOR, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBSTRATE SPECIFICITY, AND PATHWAY.
RX   PubMed=3968063;
RA   Ikeda Y., Okamura-Ikeda K., Tanaka K.;
RT   "Purification and characterization of short-chain, medium-chain, and long-
RT   chain acyl-CoA dehydrogenases from rat liver mitochondria. Isolation of the
RT   holo- and apoenzymes and conversion of the apoenzyme to the holoenzyme.";
RL   J. Biol. Chem. 260:1311-1325(1985).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 25-412 IN COMPLEX WITH THE
RP   SUBSTRATE ANALOG ACETOACETYL-COA AND FAD, COFACTOR, SUBUNIT, AND ACTIVE
RP   SITE.
RX   PubMed=11812788; DOI=10.1074/jbc.m111296200;
RA   Battaile K.P., Molin-Case J., Paschke R., Wang M., Bennett D., Vockley J.,
RA   Kim J.-J.P.;
RT   "Crystal structure of rat short chain acyl-CoA dehydrogenase complexed with
RT   acetoacetyl-CoA: comparison with other acyl-CoA dehydrogenases.";
RL   J. Biol. Chem. 277:12200-12207(2002).
CC   -!- FUNCTION: Short-chain specific acyl-CoA dehydrogenase is one of the
CC       acyl-CoA dehydrogenases that catalyze the first step of mitochondrial
CC       fatty acid beta-oxidation, an aerobic process breaking down fatty acids
CC       into acetyl-CoA and allowing the production of energy from fats
CC       (PubMed:3968063). The first step of fatty acid beta-oxidation consists
CC       in the removal of one hydrogen from C-2 and C-3 of the straight-chain
CC       fatty acyl-CoA thioester, resulting in the formation of trans-2-enoyl-
CC       CoA (PubMed:3968063). Among the different mitochondrial acyl-CoA
CC       dehydrogenases, short-chain specific acyl-CoA dehydrogenase acts
CC       specifically on acyl-CoAs with saturated 4 to 6 carbons long primary
CC       chains (PubMed:3968063). {ECO:0000269|PubMed:3968063,
CC       ECO:0000303|PubMed:3968063}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a short-chain 2,3-saturated fatty acyl-CoA + H(+) + oxidized
CC         [electron-transfer flavoprotein] = a short-chain (2E)-enoyl-CoA +
CC         reduced [electron-transfer flavoprotein]; Xref=Rhea:RHEA:47196,
CC         Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:87487,
CC         ChEBI:CHEBI:87488; EC=1.3.8.1; Evidence={ECO:0000269|PubMed:3968063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=butanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-butenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:24004, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57332, ChEBI:CHEBI:57371,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307; EC=1.3.8.1;
CC         Evidence={ECO:0000269|PubMed:3968063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24005;
CC         Evidence={ECO:0000305|PubMed:3968063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + oxidized [electron-transfer flavoprotein] + pentanoyl-
CC         CoA = (2E)-pentenoyl-CoA + reduced [electron-transfer flavoprotein];
CC         Xref=Rhea:RHEA:43456, Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57389, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:86160;
CC         Evidence={ECO:0000269|PubMed:3968063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43457;
CC         Evidence={ECO:0000305|PubMed:3968063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hexanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] = (2E)-hexenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:43464, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:62077, ChEBI:CHEBI:62620;
CC         Evidence={ECO:0000269|PubMed:3968063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43465;
CC         Evidence={ECO:0000305|PubMed:3968063};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:11812788, ECO:0000269|PubMed:3968063};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:11812788,
CC       ECO:0000269|PubMed:3968063};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=10.7 uM for butanoyl-CoA {ECO:0000269|PubMed:3968063};
CC         KM=32.9 uM for pentanoyl-CoA {ECO:0000269|PubMed:3968063};
CC         KM=285 uM for hexanoyl-CoA {ECO:0000269|PubMed:3968063};
CC   -!- PATHWAY: Lipid metabolism; mitochondrial fatty acid beta-oxidation.
CC       {ECO:0000305|PubMed:3968063}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:11812788,
CC       ECO:0000269|PubMed:3968063}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000250|UniProtKB:Q3ZBF6}.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA40669.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J05030; AAA40669.1; ALT_INIT; mRNA.
DR   PIR; B34252; B34252.
DR   RefSeq; NP_071957.1; NM_022512.2.
DR   PDB; 1JQI; X-ray; 2.25 A; A/B=25-412.
DR   PDBsum; 1JQI; -.
DR   SMR; P15651; -.
DR   BioGRID; 249019; 3.
DR   IntAct; P15651; 15.
DR   STRING; 10116.ENSRNOP00000001556; -.
DR   ChEMBL; CHEMBL2176825; -.
DR   CarbonylDB; P15651; -.
DR   iPTMnet; P15651; -.
DR   PhosphoSitePlus; P15651; -.
DR   jPOST; P15651; -.
DR   PaxDb; P15651; -.
DR   PRIDE; P15651; -.
DR   GeneID; 64304; -.
DR   KEGG; rno:64304; -.
DR   UCSC; RGD:620514; rat.
DR   CTD; 35; -.
DR   RGD; 620514; Acads.
DR   eggNOG; KOG0139; Eukaryota.
DR   InParanoid; P15651; -.
DR   OrthoDB; 589058at2759; -.
DR   BRENDA; 1.3.8.1; 5301.
DR   Reactome; R-RNO-77350; Beta oxidation of hexanoyl-CoA to butanoyl-CoA.
DR   Reactome; R-RNO-77352; Beta oxidation of butanoyl-CoA to acetyl-CoA.
DR   SABIO-RK; P15651; -.
DR   UniPathway; UPA00660; -.
DR   EvolutionaryTrace; P15651; -.
DR   PRO; PR:P15651; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:BHF-UCL.
DR   GO; GO:0031966; C:mitochondrial membrane; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:RGD.
DR   GO; GO:0003995; F:acyl-CoA dehydrogenase activity; IDA:RGD.
DR   GO; GO:0004085; F:butyryl-CoA dehydrogenase activity; IDA:RGD.
DR   GO; GO:0000062; F:fatty-acyl-CoA binding; IDA:RGD.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0046359; P:butyrate catabolic process; IDA:RGD.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; TAS:RGD.
DR   GO; GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; IDA:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0042594; P:response to starvation; IEP:RGD.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Direct protein sequencing; FAD;
KW   Fatty acid metabolism; Flavoprotein; Lipid metabolism; Mitochondrion;
KW   Oxidoreductase; Phosphoprotein; Reference proteome; Transit peptide.
FT   TRANSIT         1..24
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:2777793"
FT   CHAIN           25..412
FT                   /note="Short-chain specific acyl-CoA dehydrogenase,
FT                   mitochondrial"
FT                   /id="PRO_0000000501"
FT   NP_BIND         152..161
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11812788"
FT   NP_BIND         185..187
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11812788"
FT   NP_BIND         365..369
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11812788"
FT   NP_BIND         394..396
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11812788"
FT   REGION          269..272
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:11812788"
FT   ACT_SITE        392
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000269|PubMed:11812788"
FT   BINDING         161
FT                   /note="Substrate; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:11812788"
FT   BINDING         297
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11812788"
FT   MOD_RES         27
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         51
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         51
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         72
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         129
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         129
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         208
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         262
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         262
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         292
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         306
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   MOD_RES         306
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07417"
FT   HELIX           36..52
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   TURN            53..56
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           57..63
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           68..77
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   TURN            78..80
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   STRAND          81..84
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           86..88
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           95..108
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           110..121
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           124..130
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           133..139
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           141..143
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   STRAND          144..147
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   STRAND          150..153
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   STRAND          159..162
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   STRAND          169..172
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   STRAND          174..187
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   TURN            188..191
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   STRAND          193..201
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           203..208
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   STRAND          209..218
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   STRAND          222..224
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   STRAND          230..232
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   STRAND          238..249
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           250..252
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   STRAND          253..256
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           260..296
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   STRAND          298..303
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           304..306
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           308..336
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           342..367
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           368..371
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           378..385
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           386..389
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   TURN            390..392
FT                   /evidence="ECO:0007829|PDB:1JQI"
FT   HELIX           395..410
FT                   /evidence="ECO:0007829|PDB:1JQI"
SQ   SEQUENCE   412 AA;  44765 MW;  3E4A052FC99B8E14 CRC64;
     MAAALLARAG GSLGRALRAR DWRRLHTVYQ SVELPETHQM LRQTCRDFAE KELVPIAAQL
     DKEHLFPTSQ VKKMGELGLL AMDVPEELSG AGLDYLAYSI ALEEISRGCA STGVIMSVNN
     SLYLGPILKF GSSQQKQQWI TPFTNGDKIG CFALSEPGNG SDAGAASTTA REEGDSWVLN
     GTKAWITNSW EASATVVFAS TDRSRQNKGI SAFLVPMPTP GLTLGKKEDK LGIRASSTAN
     LIFEDCRIPK ENLLGEPGMG FKIAMQTLDM GRIGIASQAL GIAQASLDCA VKYAENRHAF
     GAPLTKLQNI QFKLADMALA LESARLLTWR AAMLKDNKKP FTKESAMAKL AASEAATAIS
     HQAIQILGGM GYVTEMPAER YYRDARITEI YEGTSEIQRL VIAGHLLRSY RS
//
ID   CHSE4_MYCTU             Reviewed;         400 AA.
AC   I6YCA3;
DT   30-NOV-2016, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2012, sequence version 1.
DT   02-JUN-2021, entry version 71.
DE   RecName: Full=Acyl-CoA dehydrogenase FadE26 {ECO:0000303|PubMed:26161441};
DE            Short=ACAD {ECO:0000303|PubMed:26161441};
DE            EC=1.3.99.- {ECO:0000269|PubMed:26161441};
DE   AltName: Full=3-oxocholest-4-en-26-oyl-CoA dehydrogenase alpha subunit {ECO:0000305|PubMed:26161441};
GN   Name=fadE26; OrderedLocusNames=Rv3504;
GN   ORFNames=LH57_19105 {ECO:0000312|EMBL:AIR16298.1};
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 27294 / TMC 102 / H37Rv;
RA   Hazbon M.H., Riojas M.A., Damon A.M., Alalade R.O., Cantwell B.J.,
RA   Monaco A., King S., Sohrabi A.;
RT   "Phylogenetic analysis of Mycobacterial species using whole genome
RT   sequences.";
RL   Submitted (SEP-2014) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   INDUCTION.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=17635188; DOI=10.1111/j.1365-2958.2007.05827.x;
RA   Kendall S.L., Withers M., Soffair C.N., Moreland N.J., Gurcha S.,
RA   Sidders B., Frita R., Ten Bokum A., Besra G.S., Lott J.S., Stoker N.G.;
RT   "A highly conserved transcriptional repressor controls a large regulon
RT   involved in lipid degradation in Mycobacterium smegmatis and Mycobacterium
RT   tuberculosis.";
RL   Mol. Microbiol. 65:684-699(2007).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [5]
RP   FUNCTION, AND SUBSTRATE SPECIFICITY.
RX   PubMed=26348625; DOI=10.1021/acs.biochem.5b00911;
RA   Lu R., Schmitz W., Sampson N.S.;
RT   "Alpha-methyl acyl CoA racemase provides Mycobacterium tuberculosis
RT   catabolic access to cholesterol esters.";
RL   Biochemistry 54:5669-5672(2015).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.99 ANGSTROMS) IN COMPLEX WITH FAD, FUNCTION,
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, ACTIVITY
RP   REGULATION, ACTIVE SITE, MUTAGENESIS OF GLU-247, PATHWAY, SUBSTRATE
RP   SPECIFICITY, AND SUBUNIT.
RX   PubMed=26161441; DOI=10.1021/id500033m;
RA   Yang M., Lu R., Guja K.E., Wipperman M.F., St Clair J.R., Bonds A.C.,
RA   Garcia-Diaz M., Sampson N.S.;
RT   "Unraveling cholesterol catabolism in Mycobacterium tuberculosis: ChsE4-
RT   ChsE5 alpha2beta2 acyl-CoA dehydrogenase initiates beta-oxidation of 3-oxo-
RT   cholest-4-en-26-oyl CoA.";
RL   ACS Infect. Dis. 1:110-125(2015).
CC   -!- FUNCTION: Involved in the first cycle of side chain dehydrogenation in
CC       the beta-oxidation of cholesterol catabolism (PubMed:26161441). It
CC       contributes partly to the virulence by increasing the efficiency of
CC       beta-oxidation. Catalyzes the dehydrogenation of acyl-CoA ester side
CC       chains of (25S)-3-oxo-cholest-4-en-26-oyl-CoA (3-OCS-CoA) to yield
CC       (24E)-3-oxo-cholest-4,24-dien-26-oyl-CoA (PubMed:26348625,
CC       PubMed:26161441). Also able to dehydrogenate steroyl-CoA such as 3-oxo-
CC       chol-4-en-24-oyl-CoA (3-OCO-CoA) as well as 3-oxo-4-pregnene-20-
CC       carboxyl-CoA (3-OPC-CoA) (PubMed:26161441). It dehydrogenates only
CC       (25S)-OCS-CoA diastereomer (Probable). {ECO:0000269|PubMed:26161441,
CC       ECO:0000269|PubMed:26348625}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(25S)-3-oxocholest-4-en-26-oyl-CoA + A = 3-oxo-cholest-4,24-
CC         dien-26-oyl-CoA + AH2; Xref=Rhea:RHEA:46688, ChEBI:CHEBI:13193,
CC         ChEBI:CHEBI:17499, ChEBI:CHEBI:83819, ChEBI:CHEBI:86414;
CC         Evidence={ECO:0000269|PubMed:26161441};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:26161441};
CC       Note=Binds 1 FAD per heterodimer. {ECO:0000269|PubMed:26161441};
CC   -!- ACTIVITY REGULATION: Uncompetitively inhibited by high concentration of
CC       3-OCS-CoA. {ECO:0000269|PubMed:26161441}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.6 uM for 3-OCO-CoA (at pH 8.5 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:26161441};
CC         KM=3.3 uM for 3-OPC-CoA (at pH 8.5 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:26161441};
CC         KM=3.4 uM for 3-OCS-CoA (at pH 8.5 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:26161441};
CC         KM=4.1 uM for octanoyl-CoA (at pH 8.5 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:26161441};
CC         Note=Kcat is 2.7 sec(-1) for 3-OCS-CoA as substrate (at pH 8.5 and 25
CC         degrees Celsius). Kcat is 1.5 sec(-1) for 3-OPC-CoA as substrate (at
CC         pH 8.5 and 25 degrees Celsius). Kcat is 0.48 sec(-1) for 3-OCO-CoA as
CC         substrate (at pH 8.5 and 25 degrees Celsius). Kcat is 0.042 sec(-1)
CC         for octanoyl-CoA as substrate (at pH 8.5 and 25 degrees Celsius).
CC         {ECO:0000269|PubMed:26161441};
CC   -!- PATHWAY: Steroid metabolism; cholesterol degradation.
CC       {ECO:0000305|PubMed:26161441}.
CC   -!- SUBUNIT: Heterotetramer (dimer of heterodimers) composed of FadE26 and
CC       FadE27. {ECO:0000269|PubMed:26161441}.
CC   -!- INDUCTION: Induced by cholesterol and repressed by KstR.
CC       {ECO:0000269|PubMed:17635188}.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP009480; AIR16298.1; -; Genomic_DNA.
DR   EMBL; AL123456; CCP46326.1; -; Genomic_DNA.
DR   RefSeq; NP_218021.1; NC_000962.3.
DR   RefSeq; WP_003418997.1; NZ_NVQJ01000042.1.
DR   PDB; 4X28; X-ray; 1.99 A; A/B=1-400.
DR   PDBsum; 4X28; -.
DR   SMR; I6YCA3; -.
DR   STRING; 83332.Rv3504; -.
DR   PaxDb; I6YCA3; -.
DR   PRIDE; I6YCA3; -.
DR   DNASU; 887722; -.
DR   GeneID; 887722; -.
DR   KEGG; mtu:Rv3504; -.
DR   PATRIC; fig|83332.111.peg.3902; -.
DR   TubercuList; Rv3504; -.
DR   eggNOG; COG1960; Bacteria.
DR   HOGENOM; CLU_018204_9_0_11; -.
DR   OMA; APTIMHF; -.
DR   PhylomeDB; I6YCA3; -.
DR   BioCyc; MetaCyc:G185E-7781-MONOMER; -.
DR   UniPathway; UPA01058; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0016627; F:oxidoreductase activity, acting on the CH-CH group of donors; IEA:InterPro.
DR   GO; GO:0006707; P:cholesterol catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cholesterol metabolism; FAD; Flavoprotein; Lipid degradation;
KW   Lipid metabolism; Oxidoreductase; Reference proteome; Steroid metabolism;
KW   Sterol metabolism; Virulence.
FT   CHAIN           1..400
FT                   /note="Acyl-CoA dehydrogenase FadE26"
FT                   /id="PRO_0000438520"
FT   NP_BIND         127..130
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26161441,
FT                   ECO:0007744|PDB:4X28"
FT   NP_BIND         380..382
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26161441,
FT                   ECO:0007744|PDB:4X28"
FT   ACT_SITE        247
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:26161441"
FT   BINDING         136
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26161441,
FT                   ECO:0007744|PDB:4X28"
FT   BINDING         162
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:26161441,
FT                   ECO:0007744|PDB:4X28"
FT   MUTAGEN         247
FT                   /note="E->A: Loss of dehydrogenase activity."
FT                   /evidence="ECO:0000269|PubMed:26161441"
FT   HELIX           7..23
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           26..32
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           44..54
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   TURN            58..61
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           64..66
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           73..86
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           92..96
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           98..105
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           108..119
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   STRAND          125..128
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   STRAND          134..136
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           138..140
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   STRAND          144..148
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   STRAND          151..159
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           164..166
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   STRAND          168..176
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           178..180
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           184..186
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   STRAND          189..195
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   STRAND          201..206
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   STRAND          208..211
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   STRAND          214..225
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           226..228
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   STRAND          229..232
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           237..240
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   TURN            241..244
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           255..269
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           279..281
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           283..308
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           320..345
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           346..348
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           360..362
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           363..370
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           372..376
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   STRAND          377..379
FT                   /evidence="ECO:0007829|PDB:4X28"
FT   HELIX           381..393
FT                   /evidence="ECO:0007829|PDB:4X28"
SQ   SEQUENCE   400 AA;  43785 MW;  2B25B8A76861F271 CRC64;
     MRISYTPQQE ELRRELRSYF ATLMTPERRE ALSSVQGEYG VGNVYRETIA QMGRDGWLAL
     GWPKEYGGQG RSAMDQLIFT DEAAIAGAPV PFLTINSVAP TIMAYGTDEQ KRFFLPRIAA
     GDLHFSIGYS EPGAGTDLAN LRTTAVRDGD DYVVNGQKMW TSLIQYADYV WLAVRTNPES
     SGAKKHRGIS VLIVPTTAEG FSWTPVHTMA GPDTSATYYS DVRVPVANRV GEENAGWKLV
     TNQLNHERVA LVSPAPIFGC LREVREWAQN TKDAGGTRLI DSEWVQLNLA RVHAKAEVLK
     LINWELASSQ SGPKDAGPSP ADASAAKVFG TELATEAYRL LMEVLGTAAT LRQNSPGALL
     RGRVERMHRA CLILTFGGGT NEVQRDIIGM VALGLPRANR
//
ID   CYSJ_ECOLI              Reviewed;         599 AA.
AC   P38038; P14782; Q2MA65;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   02-JUN-2021, entry version 189.
DE   RecName: Full=Sulfite reductase [NADPH] flavoprotein alpha-component {ECO:0000255|HAMAP-Rule:MF_01541};
DE            Short=SiR-FP {ECO:0000255|HAMAP-Rule:MF_01541};
DE            EC=1.8.1.2 {ECO:0000255|HAMAP-Rule:MF_01541, ECO:0000269|PubMed:10860732};
GN   Name=cysJ {ECO:0000255|HAMAP-Rule:MF_01541};
GN   OrderedLocusNames=b2764, JW2734;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=B;
RX   PubMed=2550423;
RA   Ostrowski J., Barber M.J., Rueger D.C., Miller B.E., Siegel L.M.,
RA   Kredich N.M.;
RT   "Characterization of the flavoprotein moieties of NADPH-sulfite reductase
RT   from Salmonella typhimurium and Escherichia coli. Physicochemical and
RT   catalytic properties, amino acid sequence deduced from DNA sequence of
RT   cysJ, and comparison with NADPH-cytochrome P-450 reductase.";
RL   J. Biol. Chem. 264:15796-15808(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 594-599.
RC   STRAIN=B;
RX   PubMed=2670946;
RA   Ostrowski J., Wu J.-Y., Rueger D.C., Miller B.E., Siegel L.M.,
RA   Kredich N.M.;
RT   "Characterization of the cysJIH regions of Salmonella typhimurium and
RT   Escherichia coli B. DNA sequences of cysI and cysH and a model for the
RT   siroheme-Fe4S4 active center of sulfite reductase hemoprotein based on
RT   amino acid homology with spinach nitrite reductase.";
RL   J. Biol. Chem. 264:15726-15737(1989).
RN   [5]
RP   CHARACTERIZATION OF FAD AND FMN DOMAINS.
RX   PubMed=7589518; DOI=10.1016/0014-5793(95)01081-o;
RA   Eschenbrenner M., Coves J., Fontecave M.;
RT   "NADPH-sulfite reductase flavoprotein from Escherichia coli: contribution
RT   to the flavin content and subunit interaction.";
RL   FEBS Lett. 374:82-84(1995).
RN   [6]
RP   CHARACTERIZATION AS A NADPH:FLAVIN OXIDOREDUCTASE.
RX   PubMed=7657631; DOI=10.1074/jbc.270.35.20550;
RA   Eschenbrenner M., Coves J., Fontecave M.;
RT   "The flavin reductase activity of the flavoprotein component of sulfite
RT   reductase from Escherichia coli. A new model for the protein structure.";
RL   J. Biol. Chem. 270:20550-20555(1995).
RN   [7]
RP   CHARACTERIZATION OF FMN DOMAIN 1-220.
RX   PubMed=9153434; DOI=10.1021/bi9623744;
RA   Coves J., Zeghouf M., Macherel D., Guigliarelli B., Asso M., Fontecave M.;
RT   "Flavin mononucleotide-binding domain of the flavoprotein component of the
RT   sulfite reductase from Escherichia coli.";
RL   Biochemistry 36:5921-5928(1997).
RN   [8]
RP   CHARACTERIZATION AS A NADPH-CYTOCHROME P450 REDUCTASE.
RX   PubMed=9618257; DOI=10.1006/bbrc.1998.8671;
RA   Zeghouf M., Defaye G., Fontecave M., Coves J.;
RT   "The flavoprotein component of the Escherichia coli sulfite reductase can
RT   act as a cytochrome P450c17 reductase.";
RL   Biochem. Biophys. Res. Commun. 246:602-605(1998).
RN   [9]
RP   CHARACTERIZATION.
RX   PubMed=9558350; DOI=10.1021/bi9728699;
RA   Zeghouf M., Fontecave M., Macherel D., Coves J.;
RT   "The flavoprotein component of the Escherichia coli sulfite reductase:
RT   expression, purification, and spectral and catalytic properties of a
RT   monomeric form containing both the flavin adenine dinucleotide and the
RT   flavin mononucleotide cofactors.";
RL   Biochemistry 37:6114-6123(1998).
RN   [10]
RP   CHARACTERIZATION OF FAD DOMAIN.
RX   PubMed=10455035; DOI=10.1042/bj3420465;
RA   Coves J., Lebrun C., Gervasi G., Dalbon P., Fontecave M.;
RT   "Overexpression of the FAD-binding domain of the sulphite reductase
RT   flavoprotein component from Escherichia coli and its inhibition by iodonium
RT   diphenyl chloride.";
RL   Biochem. J. 342:465-472(1999).
RN   [11]
RP   CHARACTERIZATION, AND STRUCTURE BY NMR OF 53-220.
RX   PubMed=11888295; DOI=10.1021/bi016008i;
RA   Champier L., Sibille N., Bersch B., Brutscher B., Blackledge M., Coves J.;
RT   "Reactivity, secondary structure, and molecular topology of the Escherichia
RT   coli sulfite reductase flavodoxin-like domain.";
RL   Biochemistry 41:3770-3780(2002).
RN   [12]
RP   QUATERNARY STRUCTURE.
RX   PubMed=10984484; DOI=10.1074/jbc.m005619200;
RA   Zeghouf M., Fontecave M., Coves J.;
RT   "A simplified functional version of the Escherichia coli sulfite
RT   reductase.";
RL   J. Biol. Chem. 275:37651-37656(2000).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.01 ANGSTROMS) OF 226-599 IN COMPLEXES WITH FAD AND
RP   NADP, COFACTOR, IDENTIFICATION BY MASS SPECTROMETRY, PARTIAL PROTEIN
RP   SEQUENCE, AND CATALYTIC ACTIVITY.
RX   PubMed=10860732; DOI=10.1006/jmbi.2000.3748;
RA   Gruez A., Pignol D., Zeghouf M., Coves J., Fontecave M., Ferrer J.-L.,
RA   Fontecilla-Camps J.-C.;
RT   "Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite
RT   reductase indicate a disordered flavodoxin-like module.";
RL   J. Mol. Biol. 299:199-212(2000).
RN   [14]
RP   STRUCTURE BY NMR OF 53-218 IN COMPLEX WITH FMN.
RX   PubMed=15966732; DOI=10.1021/bi050437p;
RA   Sibille N., Blackledge M., Brutscher B., Coves J., Bersch B.;
RT   "Solution structure of the sulfite reductase flavodoxin-like domain from
RT   Escherichia coli.";
RL   Biochemistry 44:9086-9095(2005).
CC   -!- FUNCTION: Component of the sulfite reductase complex that catalyzes the
CC       6-electron reduction of sulfite to sulfide. This is one of several
CC       activities required for the biosynthesis of L-cysteine from sulfate.
CC       The flavoprotein component catalyzes the electron flow from NADPH ->
CC       FAD -> FMN to the hemoprotein component. {ECO:0000255|HAMAP-
CC       Rule:MF_01541}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3 H2O + hydrogen sulfide + 3 NADP(+) = 4 H(+) + 3 NADPH +
CC         sulfite; Xref=Rhea:RHEA:13801, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17359, ChEBI:CHEBI:29919, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.8.1.2; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_01541, ECO:0000269|PubMed:10860732};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01541,
CC         ECO:0000269|PubMed:10860732};
CC       Note=Binds 1 FAD per subunit. {ECO:0000255|HAMAP-Rule:MF_01541,
CC       ECO:0000269|PubMed:10860732};
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01541,
CC         ECO:0000269|PubMed:10860732};
CC       Note=Binds 1 FMN per subunit. {ECO:0000255|HAMAP-Rule:MF_01541,
CC       ECO:0000269|PubMed:10860732};
CC   -!- PATHWAY: Sulfur metabolism; hydrogen sulfide biosynthesis; hydrogen
CC       sulfide from sulfite (NADPH route): step 1/1. {ECO:0000255|HAMAP-
CC       Rule:MF_01541}.
CC   -!- SUBUNIT: Alpha(8)-beta(8). The alpha component is a flavoprotein, the
CC       beta component is a hemoprotein. {ECO:0000255|HAMAP-Rule:MF_01541,
CC       ECO:0000269|PubMed:10984484, ECO:0000269|PubMed:15966732}.
CC   -!- INTERACTION:
CC       P38038; P75863: ycbX; NbExp=5; IntAct=EBI-544440, EBI-544422;
CC   -!- SIMILARITY: Belongs to the NADPH-dependent sulphite reductase
CC       flavoprotein subunit CysJ family. {ECO:0000255|HAMAP-Rule:MF_01541}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the flavodoxin
CC       family. {ECO:0000255|HAMAP-Rule:MF_01541}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the flavoprotein
CC       pyridine nucleotide cytochrome reductase family. {ECO:0000255|HAMAP-
CC       Rule:MF_01541}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M23008; AAA23650.1; -; Genomic_DNA.
DR   EMBL; U29579; AAA69274.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC75806.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE76841.1; -; Genomic_DNA.
DR   PIR; H65057; H65057.
DR   RefSeq; NP_417244.1; NC_000913.3.
DR   RefSeq; WP_000211913.1; NZ_LN832404.1.
DR   PDB; 1DDG; X-ray; 2.01 A; A/B=226-599.
DR   PDB; 1DDI; X-ray; 2.51 A; A=226-599.
DR   PDB; 1YKG; NMR; -; A=53-219.
DR   PDBsum; 1DDG; -.
DR   PDBsum; 1DDI; -.
DR   PDBsum; 1YKG; -.
DR   BMRB; P38038; -.
DR   SASBDB; P38038; -.
DR   SMR; P38038; -.
DR   BioGRID; 4262283; 220.
DR   BioGRID; 851569; 2.
DR   ComplexPortal; CPX-5629; Sulfite reductase [NADPH] complex.
DR   DIP; DIP-9381N; -.
DR   IntAct; P38038; 4.
DR   STRING; 511145.b2764; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB03461; Nicotinamide adenine dinucleotide phosphate.
DR   jPOST; P38038; -.
DR   PaxDb; P38038; -.
DR   PRIDE; P38038; -.
DR   EnsemblBacteria; AAC75806; AAC75806; b2764.
DR   EnsemblBacteria; BAE76841; BAE76841; BAE76841.
DR   GeneID; 947239; -.
DR   KEGG; ecj:JW2734; -.
DR   KEGG; eco:b2764; -.
DR   PATRIC; fig|1411691.4.peg.3973; -.
DR   EchoBASE; EB0188; -.
DR   eggNOG; COG0369; Bacteria.
DR   HOGENOM; CLU_001570_17_7_6; -.
DR   InParanoid; P38038; -.
DR   PhylomeDB; P38038; -.
DR   BioCyc; EcoCyc:ALPHACOMP-MONOMER; -.
DR   BioCyc; MetaCyc:ALPHACOMP-MONOMER; -.
DR   BRENDA; 1.8.1.2; 2026.
DR   UniPathway; UPA00140; UER00207.
DR   EvolutionaryTrace; P38038; -.
DR   PRO; PR:P38038; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0009337; C:sulfite reductase complex (NADPH); IDA:EcoCyc.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:EcoCyc.
DR   GO; GO:0010181; F:FMN binding; IDA:EcoCyc.
DR   GO; GO:0070401; F:NADP+ binding; IMP:CAFA.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0042602; F:riboflavin reductase (NADPH) activity; IDA:EcoCyc.
DR   GO; GO:0004783; F:sulfite reductase (NADPH) activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0019344; P:cysteine biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0070814; P:hydrogen sulfide biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0000103; P:sulfate assimilation; IEA:UniProtKB-UniRule.
DR   DisProt; DP00190; -.
DR   Gene3D; 1.20.990.10; -; 1.
DR   Gene3D; 3.40.50.360; -; 1.
DR   Gene3D; 3.40.50.80; -; 1.
DR   HAMAP; MF_01541; CysJ; 1.
DR   InterPro; IPR010199; CysJ.
DR   InterPro; IPR003097; CysJ-like_FAD-binding.
DR   InterPro; IPR029758; CysJ_Proteobact.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001094; Flavdoxin-like.
DR   InterPro; IPR008254; Flavodoxin/NO_synth.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR023173; NADPH_Cyt_P450_Rdtase_alpha.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF00667; FAD_binding_1; 1.
DR   Pfam; PF00258; Flavodoxin_1; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   PIRSF; PIRSF000207; SiR-FP_CysJ; 1.
DR   PRINTS; PR00369; FLAVODOXIN.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52218; SSF52218; 1.
DR   SUPFAM; SSF52343; SSF52343; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   TIGRFAMs; TIGR01931; cysJ; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
DR   PROSITE; PS50902; FLAVODOXIN_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Amino-acid biosynthesis; Cysteine biosynthesis;
KW   Direct protein sequencing; Electron transport; FAD; Flavoprotein; FMN;
KW   NADP; Oxidoreductase; Reference proteome; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT   CHAIN           2..599
FT                   /note="Sulfite reductase [NADPH] flavoprotein alpha-
FT                   component"
FT                   /id="PRO_0000199923"
FT   DOMAIN          64..202
FT                   /note="Flavodoxin-like"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01541"
FT   DOMAIN          234..448
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01541"
FT   NP_BIND         70..75
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01541,
FT                   ECO:0000269|PubMed:15966732"
FT   NP_BIND         117..120
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01541,
FT                   ECO:0000269|PubMed:15966732"
FT   NP_BIND         153..162
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01541,
FT                   ECO:0000269|PubMed:15966732"
FT   NP_BIND         386..389
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01541,
FT                   ECO:0000269|PubMed:10860732"
FT   NP_BIND         404..406
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01541,
FT                   ECO:0000269|PubMed:10860732"
FT   NP_BIND         419..422
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01541,
FT                   ECO:0000269|PubMed:10860732"
FT   NP_BIND         519..520
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01541,
FT                   ECO:0000269|PubMed:10860732"
FT   NP_BIND         525..529
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01541,
FT                   ECO:0000269|PubMed:10860732"
FT   BINDING         322
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01541,
FT                   ECO:0000269|PubMed:10860732"
FT   BINDING         356
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01541,
FT                   ECO:0000269|PubMed:10860732"
FT   BINDING         410
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01541,
FT                   ECO:0000269|PubMed:10860732"
FT   BINDING         561
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01541,
FT                   ECO:0000269|PubMed:10860732"
FT   BINDING         599
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01541,
FT                   ECO:0000269|PubMed:10860732"
FT   CONFLICT        156
FT                   /note="S -> T (in Ref. 1; AAA23650)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        268
FT                   /note="M -> L (in Ref. 1; AAA23650)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        508
FT                   /note="D -> E (in Ref. 1; AAA23650)"
FT                   /evidence="ECO:0000305"
FT   STRAND          65..69
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   STRAND          71..73
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   HELIX           74..89
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   STRAND          94..97
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   HELIX           98..100
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   HELIX           103..108
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   STRAND          110..117
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   HELIX           120..122
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   HELIX           126..128
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   HELIX           129..135
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   STRAND          147..153
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   STRAND          158..160
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   HELIX           163..175
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   STRAND          178..181
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   STRAND          184..186
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   HELIX           191..206
FT                   /evidence="ECO:0007829|PDB:1YKG"
FT   STRAND          233..235
FT                   /evidence="ECO:0007829|PDB:1DDI"
FT   STRAND          237..246
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   STRAND          253..262
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   STRAND          275..278
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           284..293
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   STRAND          300..304
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   STRAND          307..310
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           311..318
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           326..336
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   TURN            339..341
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           342..344
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           349..357
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           360..366
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           373..379
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   STRAND          386..390
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   TURN            394..396
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   STRAND          399..407
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   STRAND          409..412
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   STRAND          415..418
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           420..427
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   STRAND          434..440
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   STRAND          455..458
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           461..464
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           465..477
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   STRAND          483..490
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           492..495
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           499..507
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   STRAND          513..518
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   STRAND          521..524
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           528..534
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           536..544
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   STRAND          548..554
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   TURN            555..557
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           558..572
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   TURN            573..575
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   HELIX           578..590
FT                   /evidence="ECO:0007829|PDB:1DDG"
FT   STRAND          594..599
FT                   /evidence="ECO:0007829|PDB:1DDG"
SQ   SEQUENCE   599 AA;  66270 MW;  6B39EF5C25265113 CRC64;
     MTTQVPPSAL LPLNPEQLAR LQAATTDLTP TQLAWVSGYF WGVLNQQPAA LAATPAPAAE
     MPGITIISAS QTGNARRVAE ALRDDLLAAK LNVKLVNAGD YKFKQIASEK LLIVVTSTQG
     EGEPPEEAVA LHKFLFSKKA PKLENTAFAV FSLGDSSYEF FCQSGKDFDS KLAELGGERL
     LDRVDADVEY QAAASEWRAR VVDALKSRAP VAAPSQSVAT GAVNEIHTSP YSKDAPLVAS
     LSVNQKITGR NSEKDVRHIE IDLGDSGMRY QPGDALGVWY QNDPALVKEL VELLWLKGDE
     PVTVEGKTLP LNEALQWHFE LTVNTANIVE NYATLTRSET LLPLVGDKAK LQHYAATTPI
     VDMVRFSPAQ LDAEALINLL RPLTPRLYSI ASSQAEVENE VHVTVGVVRY DVEGRARAGG
     ASSFLADRVE EEGEVRVFIE HNDNFRLPAN PETPVIMIGP GTGIAPFRAF MQQRAADEAP
     GKNWLFFGNP HFTEDFLYQV EWQRYVKDGV LTRIDLAWSR DQKEKVYVQD KLREQGAELW
     RWINDGAHIY VCGDANRMAK DVEQALLEVI AEFGGMDTEA ADEFLSELRV ERRYQRDVY
//
ID   ACOX4_ARATH             Reviewed;         436 AA.
AC   Q96329;
DT   29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   02-JUN-2021, entry version 149.
DE   RecName: Full=Acyl-coenzyme A oxidase 4, peroxisomal {ECO:0000305};
DE            Short=AOX 4 {ECO:0000305};
DE            EC=1.3.3.6 {ECO:0000269|PubMed:10212254};
DE   AltName: Full=G6p {ECO:0000312|EMBL:AAB18129.1};
DE   AltName: Full=Short-chain acyl-CoA oxidase {ECO:0000303|PubMed:10212254};
DE            Short=AtCX4 {ECO:0000303|PubMed:12682048};
DE            Short=AtG6 {ECO:0000312|EMBL:AAB18129.1};
DE            Short=SAOX {ECO:0000305};
GN   Name=ACX4 {ECO:0000303|PubMed:12682048};
GN   Synonyms=G6 {ECO:0000312|EMBL:AAB18129.1};
GN   OrderedLocusNames=At3g51840 {ECO:0000312|Araport:AT3G51840};
GN   ORFNames=ATEM1.9 {ECO:0000312|EMBL:AAC14411.1};
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Columbia;
RA   Grellet F., Gaubier P., Wu H.-J., Laudie M., Berger C., Delseny M.;
RT   "Structure of the Arabidopsis thaliana Em1 locus.";
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   SUBCELLULAR LOCATION, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY,
RP   AND DEVELOPMENTAL STAGE.
RC   STRAIN=cv. Columbia;
RX   PubMed=10212254; DOI=10.1074/jbc.274.18.12715;
RA   Hayashi H., De Bellis L., Ciurli A., Kondo M., Hayashi M., Nishimura M.;
RT   "A novel acyl-CoA oxidase that can oxidize short-chain acyl-CoA in plant
RT   peroxisomes.";
RL   J. Biol. Chem. 274:12715-12721(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10645728; DOI=10.1023/a:1006395324818;
RA   Comella P., Wu H.-J., Laudie M., Berger C., Cooke R., Delseny M.,
RA   Grellet F.;
RT   "Fine sequence analysis of 60 kb around the Arabidopsis thaliana AtEm1
RT   locus on chromosome III.";
RL   Plant Mol. Biol. 41:687-700(1999).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J., Southwick A.M.,
RA   Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F., Karlin-Newmann G.,
RA   Liu S.X., Lam B., Sakano H., Wu T., Yu G., Miranda M., Quach H.L.,
RA   Tripp M., Chang C.H., Lee J.M., Toriumi M.J., Chan M.M., Tang C.C.,
RA   Onodera C.S., Deng J.M., Akiyama K., Ansari Y., Arakawa T., Banh J.,
RA   Banno F., Bowser L., Brooks S.Y., Carninci P., Chao Q., Choy N., Enju A.,
RA   Goldsmith A.D., Gurjal M., Hansen N.F., Hayashizaki Y., Johnson-Hopson C.,
RA   Hsuan V.W., Iida K., Karnes M., Khan S., Koesema E., Ishida J., Jiang P.X.,
RA   Jones T., Kawai J., Kamiya A., Meyers C., Nakajima M., Narusaka M.,
RA   Seki M., Sakurai T., Satou M., Tamse R., Vaysberg M., Wallender E.K.,
RA   Wong C., Yamamura Y., Yuan S., Shinozaki K., Davis R.W., Theologis A.,
RA   Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Brover V.V., Troukhan M.E., Alexandrov N.A., Lu Y.-P., Flavell R.B.,
RA   Feldmann K.A.;
RT   "Full-length cDNA from Arabidopsis thaliana.";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   FUNCTION.
RX   PubMed=12682048; DOI=10.1074/jbc.m300826200;
RA   Rylott E.L., Rogers C.A., Gilday A.D., Edgell T., Larson T.R., Graham I.A.;
RT   "Arabidopsis mutants in short- and medium-chain acyl-CoA oxidase activities
RT   accumulate acyl-CoAs and reveal that fatty acid beta-oxidation is essential
RT   for embryo development.";
RL   J. Biol. Chem. 278:21370-21377(2003).
RN   [8]
RP   INDUCTION.
RX   PubMed=15141068; DOI=10.1104/pp.104.039925;
RA   Cruz-Castillo M., Martinez C., Buchala A., Metraux J.-P., Leon J.;
RT   "Gene-specific involvement of beta-oxidation in wound-activated responses
RT   in Arabidopsis.";
RL   Plant Physiol. 135:85-94(2004).
RN   [9]
RP   FUNCTION.
RX   PubMed=15743450; DOI=10.1111/j.1365-313x.2005.02343.x;
RA   Adham A.R., Zolman B.K., Millius A., Bartel B.;
RT   "Mutations in Arabidopsis acyl-CoA oxidase genes reveal distinct and
RT   overlapping roles in beta-oxidation.";
RL   Plant J. 41:859-874(2005).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17951448; DOI=10.1105/tpc.107.050989;
RA   Reumann S., Babujee L., Ma C., Wienkoop S., Siemsen T., Antonicelli G.E.,
RA   Rasche N., Lueder F., Weckwerth W., Jahn O.;
RT   "Proteome analysis of Arabidopsis leaf peroxisomes reveals novel targeting
RT   peptides, metabolic pathways, and defense mechanisms.";
RL   Plant Cell 19:3170-3193(2007).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=31064880; DOI=10.1073/pnas.1904143116;
RA   Wang L., Wang C., Liu X., Cheng J., Li S., Zhu J.K., Gong Z.;
RT   "Peroxisomal beta-oxidation regulates histone acetylation and DNA
RT   methylation in Arabidopsis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 116:10576-10585(2019).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) IN COMPLEX WITH FAD AND ACYL-COA,
RP   AND SUBUNIT.
RX   PubMed=16887802; DOI=10.1074/jbc.m603405200;
RA   Mackenzie J., Pedersen L., Arent S., Henriksen A.;
RT   "Controlling electron transfer in acyl-CoA oxidases and dehydrogenases: a
RT   structural view.";
RL   J. Biol. Chem. 281:31012-31020(2006).
CC   -!- FUNCTION: Catalyzes the desaturation of short-chain acyl-CoAs to 2-
CC       trans-enoyl-CoAs (PubMed:10212254, PubMed:15743450). Active on butyryl-
CC       CoA (C4), hexanoyl-CoA (C6), and octanoyl-CoA (C8) (PubMed:10212254).
CC       Has no activity as acyl-CoA dehydrogenase or on crotonyl-CoA (an
CC       unsaturated C4:1 carbocyclic ester) or glutaryl-CoA (a dicarboxylic
CC       ester) (PubMed:10212254). Peroxisomal fatty acid beta-oxidation is
CC       essential for embryo development (PubMed:12682048). Acts as a
CC       suppressor of transcriptional silencing (PubMed:31064880). Required for
CC       nuclear histone acetylation and DNA demethylation at some endogenous
CC       genomic loci (PubMed:31064880). {ECO:0000269|PubMed:10212254,
CC       ECO:0000269|PubMed:12682048, ECO:0000269|PubMed:15743450,
CC       ECO:0000269|PubMed:31064880}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2,3-saturated acyl-CoA + O2 = a (2E)-enoyl-CoA + H2O2;
CC         Xref=Rhea:RHEA:38959, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:58856, ChEBI:CHEBI:65111; EC=1.3.3.6;
CC         Evidence={ECO:0000269|PubMed:10212254};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38960;
CC         Evidence={ECO:0000269|PubMed:10212254};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=butanoyl-CoA + O2 = (2E)-butenoyl-CoA + H2O2;
CC         Xref=Rhea:RHEA:41964, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:57332, ChEBI:CHEBI:57371;
CC         Evidence={ECO:0000269|PubMed:10212254};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41965;
CC         Evidence={ECO:0000269|PubMed:10212254};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexanoyl-CoA + O2 = (2E)-hexenoyl-CoA + H2O2;
CC         Xref=Rhea:RHEA:40311, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:62077, ChEBI:CHEBI:62620;
CC         Evidence={ECO:0000269|PubMed:10212254};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40312;
CC         Evidence={ECO:0000269|PubMed:10212254};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:10212254};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=8.3 uM for hexanoyl-CoA {ECO:0000269|PubMed:10212254};
CC       pH dependence:
CC         Optimum pH is 8.5-9.0. {ECO:0000269|PubMed:10212254};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:16887802}.
CC   -!- SUBCELLULAR LOCATION: Glyoxysome {ECO:0000269|PubMed:10212254}.
CC       Peroxisome {ECO:0000269|PubMed:10212254, ECO:0000269|PubMed:31064880}.
CC   -!- TISSUE SPECIFICITY: Particularly abundant in etiolated cotyledons. Also
CC       present in flowers, roots and siliques, but not detected in green
CC       cotyledons, rosette leaves and stems. {ECO:0000269|PubMed:10212254}.
CC   -!- DEVELOPMENTAL STAGE: Induced by seed imbibition with a peak at day 5 to
CC       7. Decreases after illumination but still detectable 5 days after
CC       illumination (PubMed:10212254). {ECO:0000269|PubMed:10212254}.
CC   -!- INDUCTION: Induced by dehydration and abscisic acid (ABA).
CC       {ECO:0000269|PubMed:15141068}.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U72505; AAB18129.1; -; mRNA.
DR   EMBL; AB017643; BAA82478.1; -; mRNA.
DR   EMBL; AF049236; AAC14411.1; -; Genomic_DNA.
DR   EMBL; CP002686; AEE78851.1; -; Genomic_DNA.
DR   EMBL; AY094441; AAM19813.1; -; mRNA.
DR   EMBL; AY125536; AAM78046.1; -; mRNA.
DR   EMBL; AY087793; AAM65329.1; -; mRNA.
DR   PIR; T46895; T46895.
DR   RefSeq; NP_190752.1; NM_115043.3.
DR   PDB; 2IX5; X-ray; 2.70 A; A/B/C/D=1-436.
DR   PDB; 2IX6; X-ray; 3.90 A; A/B/C/D/E/F=1-436.
DR   PDBsum; 2IX5; -.
DR   PDBsum; 2IX6; -.
DR   SMR; Q96329; -.
DR   BioGRID; 9665; 1.
DR   STRING; 3702.AT3G51840.1; -.
DR   SwissLipids; SLP:000000862; -.
DR   iPTMnet; Q96329; -.
DR   PaxDb; Q96329; -.
DR   PRIDE; Q96329; -.
DR   ProteomicsDB; 244351; -.
DR   EnsemblPlants; AT3G51840.1; AT3G51840.1; AT3G51840.
DR   GeneID; 824347; -.
DR   Gramene; AT3G51840.1; AT3G51840.1; AT3G51840.
DR   KEGG; ath:AT3G51840; -.
DR   Araport; AT3G51840; -.
DR   TAIR; locus:2074403; AT3G51840.
DR   eggNOG; KOG0138; Eukaryota.
DR   HOGENOM; CLU_018204_8_2_1; -.
DR   InParanoid; Q96329; -.
DR   OMA; QERMLPR; -.
DR   OrthoDB; 589058at2759; -.
DR   PhylomeDB; Q96329; -.
DR   BioCyc; ARA:AT3G51840-MONOMER; -.
DR   BioCyc; MetaCyc:AT3G51840-MONOMER; -.
DR   BRENDA; 1.3.3.6; 399.
DR   EvolutionaryTrace; Q96329; -.
DR   PRO; PR:Q96329; -.
DR   Proteomes; UP000006548; Chromosome 3.
DR   ExpressionAtlas; Q96329; baseline and differential.
DR   Genevisible; Q96329; AT.
DR   GO; GO:0005829; C:cytosol; HDA:TAIR.
DR   GO; GO:0009514; C:glyoxysome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005777; C:peroxisome; IDA:TAIR.
DR   GO; GO:0003995; F:acyl-CoA dehydrogenase activity; IEA:InterPro.
DR   GO; GO:0003997; F:acyl-CoA oxidase activity; IDA:TAIR.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0009793; P:embryo development ending in seed dormancy; IGI:TAIR.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IDA:TAIR.
DR   GO; GO:0046459; P:short-chain fatty acid metabolic process; TAS:TAIR.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; FAD; Fatty acid metabolism; Flavoprotein;
KW   Glyoxysome; Lipid metabolism; Oxidoreductase; Peroxisome;
KW   Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22223895"
FT   CHAIN           2..436
FT                   /note="Acyl-coenzyme A oxidase 4, peroxisomal"
FT                   /id="PRO_0000201211"
FT   NP_BIND         172..175
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16887802,
FT                   ECO:0007744|PDB:2IX5, ECO:0007744|PDB:2IX6"
FT   NP_BIND         313..315
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16887802,
FT                   ECO:0007744|PDB:2IX5, ECO:0007744|PDB:2IX6"
FT   NP_BIND         410..412
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16887802,
FT                   ECO:0007744|PDB:2IX5, ECO:0007744|PDB:2IX6"
FT   REGION          181..184
FT                   /note="Acyl-CoA binding"
FT                   /evidence="ECO:0000269|PubMed:16887802,
FT                   ECO:0007744|PDB:2IX5"
FT   MOTIF           434..436
FT                   /note="Microbody targeting signal"
FT                   /evidence="ECO:0000255"
FT   BINDING         181
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16887802,
FT                   ECO:0007744|PDB:2IX5, ECO:0007744|PDB:2IX6"
FT   BINDING         207
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:16887802,
FT                   ECO:0007744|PDB:2IX5"
FT   BINDING         288
FT                   /note="Acyl-CoA"
FT                   /evidence="ECO:0000269|PubMed:16887802,
FT                   ECO:0007744|PDB:2IX5"
FT   BINDING         324
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16887802,
FT                   ECO:0007744|PDB:2IX5"
FT   BINDING         381
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:16887802,
FT                   ECO:0007744|PDB:2IX5, ECO:0007744|PDB:2IX6"
FT   BINDING         385
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:16887802,
FT                   ECO:0007744|PDB:2IX5, ECO:0007744|PDB:2IX6"
FT   BINDING         409
FT                   /note="Acyl-CoA; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:16887802,
FT                   ECO:0007744|PDB:2IX5"
FT   BINDING         428
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:16887802,
FT                   ECO:0007744|PDB:2IX5, ECO:0007744|PDB:2IX6"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:22223895"
FT   STRAND          19..23
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           28..31
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           51..54
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           57..73
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           75..84
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           89..91
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           92..96
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   TURN            97..99
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   TURN            101..104
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           115..128
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           130..140
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           143..150
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           153..164
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   STRAND          170..173
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   STRAND          179..181
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           183..185
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   STRAND          189..193
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   STRAND          196..207
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   TURN            208..211
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   STRAND          213..221
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   TURN            222..224
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   STRAND          225..233
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   STRAND          239..243
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   STRAND          247..250
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   STRAND          255..266
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           267..269
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           277..312
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           320..322
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           324..352
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           358..382
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           383..388
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           390..392
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           394..406
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   STRAND          407..409
FT                   /evidence="ECO:0007829|PDB:2IX5"
FT   HELIX           411..423
FT                   /evidence="ECO:0007829|PDB:2IX5"
SQ   SEQUENCE   436 AA;  47557 MW;  B6050262D9482C6D CRC64;
     MAVLSSADRA SNEKKVKSSY FDLPPMEMSV AFPQATPAST FPPCTSDYYH FNDLLTPEEQ
     AIRKKVRECM EKEVAPIMTE YWEKAEFPFH ITPKLGAMGV AGGSIKGYGC PGLSITANAI
     ATAEIARVDA SCSTFILVHS SLGMLTIALC GSEAQKEKYL PSLAQLNTVA CWALTEPDNG
     SDASGLGTTA TKVEGGWKIN GQKRWIGNST FADLLIIFAR NTTTNQINGF IVKKDAPGLK
     ATKIPNKIGL RMVQNGDILL QNVFVPDEDR LPGVNSFQDT SKVLAVSRVM VAWQPIGISM
     GIYDMCHRYL KERKQFGAPL AAFQLNQQKL VQMLGNVQAM FLMGWRLCKL YETGQMTPGQ
     ASLGKAWISS KARETASLGR ELLGGNGILA DFLVAKAFCD LEPIYTYEGT YDINTLVTGR
     EVTGIASFKP ATRSRL
//
ID   ACD_DESML               Reviewed;         389 AA.
AC   C3UVB0;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   16-JUN-2009, sequence version 1.
DT   02-JUN-2021, entry version 59.
DE   RecName: Full=Glutaryl-CoA dehydrogenase;
DE            Short=GDH(Des);
DE            EC=1.3.99.32;
GN   Name=Acd;
OS   Desulfococcus multivorans.
OC   Bacteria; Proteobacteria; Deltaproteobacteria; Desulfobacterales;
OC   Desulfobacteraceae; Desulfococcus.
OX   NCBI_TaxID=897;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, SUBUNIT,
RP   PATHWAY, COFACTOR, AND ACTIVITY REGULATION.
RC   STRAIN=ATCC 33890 / DSM 2059 / Goettingen / 1be1;
RX   PubMed=19395484; DOI=10.1128/jb.00205-09;
RA   Wischgoll S., Taubert M., Peters F., Jehmlich N., von Bergen M., Boll M.;
RT   "Decarboxylating and nondecarboxylating glutaryl-coenzyme A dehydrogenases
RT   in the aromatic metabolism of obligately anaerobic bacteria.";
RL   J. Bacteriol. 191:4401-4409(2009).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) IN COMPLEX WITH FAD AND SUBSTRATE,
RP   COFACTOR, AND MUTAGENESIS OF ALA-80; VAL-88 AND VAL-366.
RC   STRAIN=ATCC 33890 / DSM 2059 / Goettingen / 1be1;
RX   PubMed=20486657; DOI=10.1021/bi100317m;
RA   Wischgoll S., Demmer U., Warkentin E., Gunther R., Boll M., Ermler U.;
RT   "Structural basis for promoting and preventing decarboxylation in glutaryl-
RT   coenzyme A dehydrogenases.";
RL   Biochemistry 49:5350-5357(2010).
CC   -!- FUNCTION: Catalyzes the dehydrogenation of Glutaryl-CoA to glutaconyl-
CC       CoA. {ECO:0000269|PubMed:19395484}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=A + glutaryl-CoA = (2E)-glutaconyl-CoA + AH2;
CC         Xref=Rhea:RHEA:47420, ChEBI:CHEBI:13193, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:57353, ChEBI:CHEBI:57378; EC=1.3.99.32;
CC         Evidence={ECO:0000269|PubMed:19395484};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:19395484, ECO:0000269|PubMed:20486657};
CC   -!- ACTIVITY REGULATION: Inhibited by glutaconyl-CoA.
CC       {ECO:0000269|PubMed:19395484}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=25 uM for glutaryl-CoA;
CC         Vmax=11 mmol/min/mg enzyme;
CC   -!- PATHWAY: Aromatic compound metabolism; benzoyl-CoA degradation.
CC       {ECO:0000269|PubMed:19395484}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:19395484,
CC       ECO:0000269|PubMed:20486657}.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FJ688103; ACP50614.1; -; Genomic_DNA.
DR   RefSeq; WP_070962329.1; NZ_CP019913.2.
DR   PDB; 3MPI; X-ray; 2.05 A; A/B/C/D=1-389.
DR   PDB; 3MPJ; X-ray; 2.10 A; A/B/D/E/F/G=1-389.
DR   PDBsum; 3MPI; -.
DR   PDBsum; 3MPJ; -.
DR   SMR; C3UVB0; -.
DR   KEGG; ag:ACP50614; -.
DR   KEGG; dml:Dmul_25030; -.
DR   KEGG; dml:Dmul_34900; -.
DR   PATRIC; fig|897.4.peg.2846; -.
DR   OrthoDB; 760677at2; -.
DR   BRENDA; 1.3.99.32; 1889.
DR   UniPathway; UPA00739; -.
DR   EvolutionaryTrace; C3UVB0; -.
DR   GO; GO:0003995; F:acyl-CoA dehydrogenase activity; IEA:InterPro.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aromatic hydrocarbons catabolism; FAD; Flavoprotein;
KW   Nucleotide-binding; Oxidoreductase.
FT   CHAIN           1..389
FT                   /note="Glutaryl-CoA dehydrogenase"
FT                   /id="PRO_0000418764"
FT   NP_BIND         126..129
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   NP_BIND         159..161
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   NP_BIND         281..284
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   NP_BIND         367..371
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   ACT_SITE        367
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305"
FT   BINDING         87
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   BINDING         91
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   BINDING         135
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   BINDING         135
FT                   /note="Substrate; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   BINDING         181
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   BINDING         271
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   BINDING         340
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   BINDING         344
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   BINDING         385
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   MUTAGEN         80
FT                   /note="A->E: Loses the FAD cofactor and dehydrogenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   MUTAGEN         88
FT                   /note="V->S: A residual dehydrogenase activity is
FT                   observed."
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   MUTAGEN         366
FT                   /note="V->Y: Loses the FAD cofactor but a residual
FT                   dehydrogenase activity is observed."
FT                   /evidence="ECO:0000269|PubMed:20486657"
FT   HELIX           7..23
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   TURN            24..27
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           28..34
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   TURN            39..42
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           43..48
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   TURN            49..52
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   STRAND          54..56
FT                   /evidence="ECO:0007829|PDB:3MPJ"
FT   HELIX           58..60
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           68..82
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           84..93
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   TURN            94..97
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           98..104
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           107..118
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   STRAND          133..135
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           137..139
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   STRAND          143..146
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   STRAND          148..161
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   TURN            162..165
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   STRAND          167..175
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           177..182
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   STRAND          183..189
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   TURN            191..193
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   STRAND          197..201
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   STRAND          212..223
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           224..226
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   STRAND          227..230
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   TURN            231..233
FT                   /evidence="ECO:0007829|PDB:3MPJ"
FT   HELIX           234..270
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           278..280
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           282..310
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           317..342
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           343..347
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           352..359
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           362..365
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   STRAND          366..368
FT                   /evidence="ECO:0007829|PDB:3MPI"
FT   HELIX           370..381
FT                   /evidence="ECO:0007829|PDB:3MPI"
SQ   SEQUENCE   389 AA;  42382 MW;  F479601F35A96975 CRC64;
     MDFNLSKELQ MLQKEVRNFV NKKIVPFADQ WDNENHFPYE EAVRPMGELG FFGTVIPEEY
     GGEGMDQGWL AAMIVTEEIA RGSSALRVQL NMEVLGCAYT ILTYGSEALK KKYVPKLSSA
     EFLGGFGITE PDAGSDVMAM SSTAEDKGDH WLLNGSKTWI SNAAQADVLI YYAYTDKAAG
     SRGLSAFVIE PRNFPGIKTS NLEKLGSHAS PTGELFLDNV KVPKENILGK PGDGARIVFG
     SLNHTRLSAA AGGVGLAQAC LDAAIKYCNE RRQFGKPIGD FQMNQDMIAQ MAVEVEAARL
     LAYKAAAAKD EGRLNNGLDV AMAKYAAGEA VSKCANYAMR ILGAYGYSTE YPVARFYRDA
     PTYYMVEGSA NICKMIIALD QLGVRKANR
//
ID   DLDH_YEAST              Reviewed;         499 AA.
AC   P09624; D6VTL1;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   02-JUN-2021, entry version 214.
DE   RecName: Full=Dihydrolipoyl dehydrogenase, mitochondrial;
DE            EC=1.8.1.4;
DE   AltName: Full=Dihydrolipoamide dehydrogenase;
DE   AltName: Full=Glycine decarboxylase complex subunit L;
DE   AltName: Full=Lipoamide dehydrogenase component of pyruvate dehydrogenase complex;
DE   AltName: Full=Pyruvate dehydrogenase complex E3 component;
DE   Flags: Precursor;
GN   Name=LPD1; Synonyms=DHLP1; OrderedLocusNames=YFL018C;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3279419; DOI=10.1073/pnas.85.6.1831;
RA   Browning K.S., Uhlinger D.J., Reed L.J.;
RT   "Nucleotide sequence for yeast dihydrolipoamide dehydrogenase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:1831-1834(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3058861; DOI=10.1099/00221287-134-5-1131;
RA   Ross J., Reid G.A., Dawes I.W.;
RT   "The nucleotide sequence of the LPD1 gene encoding lipoamide dehydrogenase
RT   in Saccharomyces cerevisiae: comparison between eukaryotic and prokaryotic
RT   sequences for related enzymes and identification of potential upstream
RT   control sites.";
RL   J. Gen. Microbiol. 134:1131-1139(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=7670463; DOI=10.1038/ng0795-261;
RA   Murakami Y., Naitou M., Hagiwara H., Shibata T., Ozawa M., Sasanuma S.,
RA   Sasanuma M., Tsuchiya Y., Soeda E., Yokoyama K., Yamazaki M., Tashiro H.,
RA   Eki T.;
RT   "Analysis of the nucleotide sequence of chromosome VI from Saccharomyces
RT   cerevisiae.";
RL   Nat. Genet. 10:261-268(1995).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204511 / S288c / AB972;
RA   Barrell B.G., Churcher C., Rajandream M.A.;
RL   Submitted (SEP-1994) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   IDENTIFICATION IN GLYCINE DECARBOXYLASE COMPLEX.
RX   PubMed=7498764;
RA   Sinclair D.A., Dawes I.W.;
RT   "Genetics of the synthesis of serine from glycine and the utilization of
RT   glycine as sole nitrogen source by Saccharomyces cerevisiae.";
RL   Genetics 140:1213-1222(1995).
RN   [7]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH FAD, ACTIVE SITE, AND
RP   DISULFIDE BOND.
RX   PubMed=9538259; DOI=10.1093/oxfordjournals.jbchem.a021989;
RA   Toyoda T., Suzuki K., Sekiguchi T., Reed L.J., Takenaka A.;
RT   "Crystal structure of eucaryotic E3, lipoamide dehydrogenase from yeast.";
RL   J. Biochem. 123:668-674(1998).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH FAD AND NAD.
RA   Adachi W., Suzuki K., Tsunoda M., Sekiguchi T., Reed L.J., Takenaka A.;
RT   "Crystal structure of yeast lipoamide dehydrogenase complexed with NAD+.";
RL   Submitted (FEB-2005) to the PDB data bank.
CC   -!- FUNCTION: Lipoamide dehydrogenase is a component of the alpha-ketoacid
CC       dehydrogenase complexes. This includes the pyruvate dehydrogenase
CC       complex, which catalyzes the overall conversion of pyruvate to acetyl-
CC       CoA and CO(2). Acts also as component of the glycine cleavage system
CC       (glycine decarboxylase complex), which catalyzes the degradation of
CC       glycine.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-N(6)-dihydrolipoyl-L-lysyl-[protein] + NAD(+) = (R)-N(6)-
CC         lipoyl-L-lysyl-[protein] + H(+) + NADH; Xref=Rhea:RHEA:15045,
CC         Rhea:RHEA-COMP:10474, Rhea:RHEA-COMP:10475, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:83099,
CC         ChEBI:CHEBI:83100; EC=1.8.1.4;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000250};
CC       Note=Binds 1 FAD per subunit. {ECO:0000250};
CC   -!- SUBUNIT: LPD1 is a homodimer. Eukaryotic pyruvate dehydrogenase (PDH)
CC       complexes are organized as a core consisting of the oligomeric
CC       dihydrolipoamide acetyl-transferase (E2), around which are arranged
CC       multiple copies of pyruvate dehydrogenase (E1), dihydrolipoamide
CC       dehydrogenase (E3) and protein X (E3BP) bound by non-covalent bonds.
CC       LPD1 is a component of the glycine decarboxylase complex (GDC), which
CC       is composed of four proteins: P, T, L and H.
CC       {ECO:0000269|PubMed:7498764, ECO:0000269|PubMed:9538259,
CC       ECO:0000269|Ref.9}.
CC   -!- INTERACTION:
CC       P09624; P19262: KGD2; NbExp=4; IntAct=EBI-5940, EBI-12464;
CC       P09624; P19955: YMR31; NbExp=5; IntAct=EBI-5940, EBI-16295;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- MISCELLANEOUS: The active site is a redox-active disulfide bond.
CC   -!- MISCELLANEOUS: Present with 24600 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J03645; AAA34565.1; -; mRNA.
DR   EMBL; M20880; AAB63974.1; -; Genomic_DNA.
DR   EMBL; D50617; BAA09220.1; -; Genomic_DNA.
DR   EMBL; Z46255; CAA86354.1; -; Genomic_DNA.
DR   EMBL; BK006940; DAA12421.1; -; Genomic_DNA.
DR   PIR; A30151; A30151.
DR   RefSeq; NP_116635.1; NM_001179948.1.
DR   PDB; 1JEH; X-ray; 2.40 A; A/B=22-499.
DR   PDB; 1V59; X-ray; 2.20 A; A/B=22-499.
DR   PDBsum; 1JEH; -.
DR   PDBsum; 1V59; -.
DR   SMR; P09624; -.
DR   BioGRID; 31128; 456.
DR   ComplexPortal; CPX-1268; Glycine decarboxylase multienzyme complex.
DR   ComplexPortal; CPX-1293; Mitochondrial 2-oxoglutarate dehydrogenase complex.
DR   ComplexPortal; CPX-3207; Mitochondrial pyruvate dehydrogenase complex.
DR   DIP; DIP-41N; -.
DR   IntAct; P09624; 59.
DR   MINT; P09624; -.
DR   STRING; 4932.YFL018C; -.
DR   iPTMnet; P09624; -.
DR   UCD-2DPAGE; P09624; -.
DR   MaxQB; P09624; -.
DR   PaxDb; P09624; -.
DR   PRIDE; P09624; -.
DR   EnsemblFungi; YFL018C_mRNA; YFL018C; YFL018C.
DR   GeneID; 850527; -.
DR   KEGG; sce:YFL018C; -.
DR   SGD; S000001876; LPD1.
DR   VEuPathDB; FungiDB:YFL018C; -.
DR   eggNOG; KOG1335; Eukaryota.
DR   GeneTree; ENSGT00550000074844; -.
DR   HOGENOM; CLU_016755_0_1_1; -.
DR   InParanoid; P09624; -.
DR   OMA; TMSEAVM; -.
DR   Reactome; R-SCE-389661; Glyoxylate metabolism and glycine degradation.
DR   Reactome; R-SCE-6783984; Glycine degradation.
DR   Reactome; R-SCE-70268; Pyruvate metabolism.
DR   Reactome; R-SCE-71064; Lysine catabolism.
DR   Reactome; R-SCE-71403; Citric acid cycle (TCA cycle).
DR   EvolutionaryTrace; P09624; -.
DR   PRO; PR:P09624; -.
DR   Proteomes; UP000002311; Chromosome VI.
DR   RNAct; P09624; protein.
DR   GO; GO:0005960; C:glycine cleavage complex; IMP:SGD.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:SGD.
DR   GO; GO:0009353; C:mitochondrial oxoglutarate dehydrogenase complex; IDA:SGD.
DR   GO; GO:0005967; C:mitochondrial pyruvate dehydrogenase complex; IDA:SGD.
DR   GO; GO:0005739; C:mitochondrion; HDA:SGD.
DR   GO; GO:0045252; C:oxoglutarate dehydrogenase complex; IBA:GO_Central.
DR   GO; GO:0004148; F:dihydrolipoyl dehydrogenase activity; IDA:SGD.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:0004375; F:glycine dehydrogenase (decarboxylating) activity; IMP:SGD.
DR   GO; GO:0004591; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; IMP:SGD.
DR   GO; GO:0004738; F:pyruvate dehydrogenase activity; IMP:SGD.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; IMP:SGD.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:0006546; P:glycine catabolic process; IMP:SGD.
DR   GO; GO:0042743; P:hydrogen peroxide metabolic process; IMP:SGD.
DR   GO; GO:0006550; P:isoleucine catabolic process; IMP:SGD.
DR   GO; GO:0006564; P:L-serine biosynthetic process; IMP:SGD.
DR   GO; GO:0006552; P:leucine catabolic process; IMP:SGD.
DR   GO; GO:0006090; P:pyruvate metabolic process; IMP:SGD.
DR   GO; GO:0006574; P:valine catabolic process; IMP:SGD.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR006258; Lipoamide_DH.
DR   InterPro; IPR001100; Pyr_nuc-diS_OxRdtase.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   InterPro; IPR012999; Pyr_OxRdtase_I_AS.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   PIRSF; PIRSF000350; Mercury_reductase_MerA; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
DR   TIGRFAMs; TIGR01350; lipoamide_DH; 1.
DR   PROSITE; PS00076; PYRIDINE_REDOX_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; FAD; Flavoprotein; Mitochondrion; NAD;
KW   Oxidoreductase; Redox-active center; Reference proteome; Transit peptide.
FT   TRANSIT         1..21
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:3279419"
FT   CHAIN           22..499
FT                   /note="Dihydrolipoyl dehydrogenase, mitochondrial"
FT                   /id="PRO_0000030301"
FT   NP_BIND         56..65
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9538259, ECO:0000269|Ref.9"
FT   NP_BIND         174..176
FT                   /note="FAD"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         211..218
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         352..355
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9538259, ECO:0000269|Ref.9"
FT   ACT_SITE        478
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000269|PubMed:9538259"
FT   BINDING         74
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9538259, ECO:0000269|Ref.9"
FT   BINDING         139
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:9538259, ECO:0000269|Ref.9"
FT   BINDING         234
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   BINDING         268
FT                   /note="NAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   BINDING         305
FT                   /note="NAD; via amide nitrogen"
FT                   /evidence="ECO:0000250"
FT   BINDING         346
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9538259, ECO:0000269|Ref.9"
FT   DISULFID        65..70
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:9538259"
FT   STRAND          23..32
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           36..47
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          52..62
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           63..68
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           70..88
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           91..93
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          95..97
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          101..103
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           105..129
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          133..150
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          153..156
FT                   /evidence="ECO:0007829|PDB:1JEH"
FT   STRAND          163..172
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          176..178
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          188..192
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           194..197
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          205..210
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           214..225
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          229..233
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          235..243
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           245..257
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          261..263
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          265..274
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   TURN            275..278
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          279..286
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   TURN            287..290
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          291..302
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          306..308
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   TURN            311..313
FT                   /evidence="ECO:0007829|PDB:1JEH"
FT   TURN            315..319
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          341..343
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           345..347
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          348..350
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           354..370
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           377..379
FT                   /evidence="ECO:0007829|PDB:1JEH"
FT   STRAND          382..384
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          386..394
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           397..402
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          407..413
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           414..416
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           418..422
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          429..435
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   TURN            436..438
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   STRAND          440..448
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           451..463
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           468..472
FT                   /evidence="ECO:0007829|PDB:1V59"
FT   HELIX           483..493
FT                   /evidence="ECO:0007829|PDB:1V59"
SQ   SEQUENCE   499 AA;  54010 MW;  986A370F2E079DBC CRC64;
     MLRIRSLLNN KRAFSSTVRT LTINKSHDVV IIGGGPAGYV AAIKAAQLGF NTACVEKRGK
     LGGTCLNVGC IPSKALLNNS HLFHQMHTEA QKRGIDVNGD IKINVANFQK AKDDAVKQLT
     GGIELLFKKN KVTYYKGNGS FEDETKIRVT PVDGLEGTVK EDHILDVKNI IVATGSEVTP
     FPGIEIDEEK IVSSTGALSL KEIPKRLTII GGGIIGLEMG SVYSRLGSKV TVVEFQPQIG
     ASMDGEVAKA TQKFLKKQGL DFKLSTKVIS AKRNDDKNVV EIVVEDTKTN KQENLEAEVL
     LVAVGRRPYI AGLGAEKIGL EVDKRGRLVI DDQFNSKFPH IKVVGDVTFG PMLAHKAEEE
     GIAAVEMLKT GHGHVNYNNI PSVMYSHPEV AWVGKTEEQL KEAGIDYKIG KFPFAANSRA
     KTNQDTEGFV KILIDSKTER ILGAHIIGPN AGEMIAEAGL ALEYGASAED VARVCHAHPT
     LSEAFKEANM AAYDKAIHC
//
ID   ERG1_HUMAN              Reviewed;         574 AA.
AC   Q14534; Q9UEK6; Q9UNR6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   02-JUN-2021, entry version 180.
DE   RecName: Full=Squalene monooxygenase;
DE            EC=1.14.14.17 {ECO:0000269|PubMed:10666321, ECO:0000269|PubMed:30626872};
DE   AltName: Full=Squalene epoxidase {ECO:0000303|PubMed:9286711};
DE            Short=SE;
GN   Name=SQLE; Synonyms=ERG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9286711; DOI=10.1006/geno.1997.4825;
RA   Nagai M., Sakakibara J., Wakui K., Fukushima Y., Igarashi S., Tsuji S.,
RA   Arakawa M., Ono T.;
RT   "Localization of the squalene epoxidase gene (SQLE) to human chromosome
RT   region 8q24.1.";
RL   Genomics 44:141-143(1997).
RN   [2] {ECO:0000312|EMBL:AAD10823.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, ACTIVITY
RP   REGULATION, COFACTOR, AND PATHWAY.
RC   TISSUE=Liver {ECO:0000312|EMBL:AAD10823.1};
RX   PubMed=10666321; DOI=10.1006/abbi.1999.1629;
RA   Laden B.P., Tang Y., Porter T.D.;
RT   "Cloning, heterologous expression, and enzymological characterization of
RT   human squalene monooxygenase.";
RL   Arch. Biochem. Biophys. 374:381-388(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary {ECO:0000312|EMBL:BAG36182.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon endothelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon {ECO:0000312|EMBL:AAH17033.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 187-535.
RC   TISSUE=Liver;
RX   PubMed=8626488; DOI=10.1074/jbc.271.14.8053;
RA   Nakamura Y., Sakakibara J., Izumi T., Shibata A., Ono T.;
RT   "Transcriptional regulation of squalene epoxidase by sterols and inhibitors
RT   in HeLa cells.";
RL   J. Biol. Chem. 271:8053-8056(1996).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   DOMAIN, INTERACTION WITH MARCHF6, UBIQUITINATION, AND PATHWAY.
RX   PubMed=24449766; DOI=10.1128/mcb.01140-13;
RA   Zelcer N., Sharpe L.J., Loregger A., Kristiana I., Cook E.C., Phan L.,
RA   Stevenson J., Brown A.J.;
RT   "The E3 ubiquitin ligase MARCH6 degrades squalene monooxygenase and affects
RT   3-hydroxy-3-methyl-glutaryl coenzyme A reductase and the cholesterol
RT   synthesis pathway.";
RL   Mol. Cell. Biol. 34:1262-1270(2014).
RN   [11]
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND DOMAIN.
RX   PubMed=26434806; DOI=10.1074/jbc.m115.675181;
RA   Howe V., Chua N.K., Stevenson J., Brown A.J.;
RT   "The Regulatory Domain of Squalene Monooxygenase Contains a Re-entrant Loop
RT   and Senses Cholesterol via a Conformational Change.";
RL   J. Biol. Chem. 290:27533-27544(2015).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   DOMAIN, SUBCELLULAR LOCATION, TOPOLOGY, AND MUTAGENESIS OF PHE-35; SER-37;
RP   62-GLN--LEU-73; LEU-65 AND ILE-69.
RX   PubMed=28972164; DOI=10.1074/jbc.m117.794230;
RA   Chua N.K., Howe V., Jatana N., Thukral L., Brown A.J.;
RT   "A conserved degron containing an amphipathic helix regulates the
RT   cholesterol-mediated turnover of human squalene monooxygenase, a rate-
RT   limiting enzyme in cholesterol synthesis.";
RL   J. Biol. Chem. 292:19959-19973(2017).
RN   [14]
RP   INTERACTION WITH SMIM22.
RX   PubMed=29765154; DOI=10.1038/s41388-018-0281-5;
RA   Polycarpou-Schwarz M., Gross M., Mestdagh P., Schott J., Grund S.E.,
RA   Hildenbrand C., Rom J., Aulmann S., Sinn H.P., Vandesompele J.,
RA   Diederichs S.;
RT   "The cancer-associated microprotein CASIMO1 controls cell proliferation and
RT   interacts with squalene epoxidase modulating lipid droplet formation.";
RL   Oncogene 37:4750-4768(2018).
RN   [15] {ECO:0007744|PDB:6C6N, ECO:0007744|PDB:6C6P, ECO:0007744|PDB:6C6R}
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 118-574 IN COMPLEXES WITH FAD AND
RP   SYNTHETIC INHIBITORS, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, COFACTOR, PATHWAY, TISSUE SPECIFICITY, SUBCELLULAR LOCATION,
RP   ACTIVITY REGULATION, MUTAGENESIS OF TYR-195, AND DOMAIN.
RX   PubMed=30626872; DOI=10.1038/s41467-018-07928-x;
RA   Padyana A.K., Gross S., Jin L., Cianchetta G., Narayanaswamy R., Wang F.,
RA   Wang R., Fang C., Lv X., Biller S.A., Dang L., Mahoney C.E., Nagaraja N.,
RA   Pirman D., Sui Z., Popovici-Muller J., Smolen G.A.;
RT   "Structure and inhibition mechanism of the catalytic domain of human
RT   squalene epoxidase.";
RL   Nat. Commun. 10:97-97(2019).
CC   -!- FUNCTION: Catalyzes the stereospecific oxidation of squalene to (S)-
CC       2,3-epoxysqualene, and is considered to be a rate-limiting enzyme in
CC       steroid biosynthesis. {ECO:0000269|PubMed:10666321,
CC       ECO:0000269|PubMed:30626872}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + reduced [NADPH--hemoprotein reductase] + squalene = (S)-
CC         2,3-epoxysqualene + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:25282, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:15440, ChEBI:CHEBI:15441, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210; EC=1.14.14.17;
CC         Evidence={ECO:0000269|PubMed:10666321, ECO:0000269|PubMed:30626872};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:10666321, ECO:0000269|PubMed:30626872};
CC   -!- ACTIVITY REGULATION: Inhibited by NB-598 ((E)N-ethyl-N-(6,6-dimethyl-2-
CC       hepten-4-ynyl)-3-[(3,3'-bi-thiophen-5-yl)methoxy]benzene-methanamine).
CC       Contrary to fungal enzymes, the mammalian enzyme is only slightly
CC       inhibited by terbinafine (PubMed:30626872). Inhibited by tellurite,
CC       tellurium dioxide, selenite, and selenium dioxide (PubMed:10666321).
CC       {ECO:0000269|PubMed:10666321, ECO:0000269|PubMed:30626872}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.9 uM for squalene {ECO:0000269|PubMed:30626872};
CC         KM=9.6 uM for FAD {ECO:0000269|PubMed:30626872};
CC   -!- PATHWAY: Terpene metabolism; lanosterol biosynthesis; lanosterol from
CC       farnesyl diphosphate: step 2/3. {ECO:0000269|PubMed:24449766,
CC       ECO:0000305|PubMed:10666321, ECO:0000305|PubMed:30626872}.
CC   -!- SUBUNIT: Interacts (via N-terminal domain) with MARCHF6. Interacts with
CC       SMIM22; this interaction modulates lipid droplet formation
CC       (PubMed:29765154). {ECO:0000269|PubMed:24449766,
CC       ECO:0000269|PubMed:29765154}.
CC   -!- INTERACTION:
CC       Q14534; Q96BA8: CREB3L1; NbExp=3; IntAct=EBI-3905171, EBI-6942903;
CC       Q14534; Q9H6H4: REEP4; NbExp=3; IntAct=EBI-3905171, EBI-7545592;
CC       Q14534; Q9NUH8: TMEM14B; NbExp=3; IntAct=EBI-3905171, EBI-8638294;
CC   -!- SUBCELLULAR LOCATION: Microsome membrane {ECO:0000269|PubMed:26434806,
CC       ECO:0000269|PubMed:28972164, ECO:0000269|PubMed:30626872}; Peripheral
CC       membrane protein {ECO:0000269|PubMed:26434806,
CC       ECO:0000269|PubMed:28972164}. Endoplasmic reticulum membrane
CC       {ECO:0000305|PubMed:26434806}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:26434806, ECO:0000269|PubMed:28972164}.
CC   -!- TISSUE SPECIFICITY: Detected in liver (at protein level).
CC       {ECO:0000269|PubMed:30626872}.
CC   -!- DOMAIN: The C-terminal hydrophobic region contains two helices that
CC       mediate interaction with membranes. Contrary to predictions, this
CC       region does not contain transmembrane helices.
CC       {ECO:0000269|PubMed:30626872}.
CC   -!- DOMAIN: The N-terminal region mediates interaction with MARCHF6,
CC       leading to SQLE ubiquitination and proteasomal degradation when
CC       cholosterol levels are high (PubMed:24449766, PubMed:26434806,
CC       PubMed:28972164). The first part of the N-terminal region contains a
CC       hydrophobic region that inserts into the membrane; contrary to
CC       predictions, there are no transmembrane helices (PubMed:26434806). The
CC       second part contains a region that can form an amphipathic region that
CC       associates with membranes. This region is ejected from the membrane by
CC       high cholesterol levels and becomes disordered in an aqueous
CC       environment. This is critical for cholesterol-dependent proteasomal
CC       degradation. Additional parts of the N-terminal region are predicted to
CC       be disordered and contribute to flagging the protein for proteasomal
CC       degradation already under basal conditions (PubMed:28972164).
CC       {ECO:0000269|PubMed:24449766, ECO:0000269|PubMed:26434806,
CC       ECO:0000269|PubMed:28972164}.
CC   -!- PTM: Ubiquitinated by MARCHF6 in response to high cholesterol levels in
CC       intracellular membranes, leading to proteasomal degradation.
CC       {ECO:0000269|PubMed:24449766}.
CC   -!- SIMILARITY: Belongs to the squalene monooxygenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D78130; BAA22372.1; -; mRNA.
DR   EMBL; AF098865; AAD10823.1; -; mRNA.
DR   EMBL; AK313384; BAG36182.1; -; mRNA.
DR   EMBL; BX647400; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC009908; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471060; EAW92079.1; -; Genomic_DNA.
DR   EMBL; BC017033; AAH17033.1; -; mRNA.
DR   EMBL; FJ695197; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; D78129; BAA11209.1; -; mRNA.
DR   CCDS; CCDS47918.1; -.
DR   RefSeq; NP_003120.2; NM_003129.3.
DR   PDB; 6C6N; X-ray; 2.30 A; A/B=118-574.
DR   PDB; 6C6P; X-ray; 2.50 A; A/B=118-574.
DR   PDB; 6C6R; X-ray; 3.00 A; A/B=118-574.
DR   PDBsum; 6C6N; -.
DR   PDBsum; 6C6P; -.
DR   PDBsum; 6C6R; -.
DR   SMR; Q14534; -.
DR   BioGRID; 112591; 25.
DR   IntAct; Q14534; 20.
DR   MINT; Q14534; -.
DR   STRING; 9606.ENSP00000265896; -.
DR   BindingDB; Q14534; -.
DR   ChEMBL; CHEMBL3592; -.
DR   DrugBank; DB01091; Butenafine.
DR   DrugBank; DB08846; Ellagic acid.
DR   DrugBank; DB00735; Naftifine.
DR   DrugBank; DB00857; Terbinafine.
DR   DrugCentral; Q14534; -.
DR   GuidetoPHARMACOLOGY; 2433; -.
DR   SwissLipids; SLP:000001243; -.
DR   iPTMnet; Q14534; -.
DR   PhosphoSitePlus; Q14534; -.
DR   SwissPalm; Q14534; -.
DR   BioMuta; SQLE; -.
DR   DMDM; 296439362; -.
DR   EPD; Q14534; -.
DR   jPOST; Q14534; -.
DR   MassIVE; Q14534; -.
DR   PaxDb; Q14534; -.
DR   PeptideAtlas; Q14534; -.
DR   PRIDE; Q14534; -.
DR   ProteomicsDB; 60034; -.
DR   Antibodypedia; 27121; 156 antibodies.
DR   DNASU; 6713; -.
DR   Ensembl; ENST00000265896; ENSP00000265896; ENSG00000104549.
DR   GeneID; 6713; -.
DR   KEGG; hsa:6713; -.
DR   UCSC; uc011liq.3; human.
DR   CTD; 6713; -.
DR   DisGeNET; 6713; -.
DR   GeneCards; SQLE; -.
DR   HGNC; HGNC:11279; SQLE.
DR   HPA; ENSG00000104549; Low tissue specificity.
DR   MIM; 602019; gene.
DR   neXtProt; NX_Q14534; -.
DR   OpenTargets; ENSG00000104549; -.
DR   PharmGKB; PA36108; -.
DR   VEuPathDB; HostDB:ENSG00000104549.11; -.
DR   eggNOG; KOG1298; Eukaryota.
DR   GeneTree; ENSGT00390000011759; -.
DR   InParanoid; Q14534; -.
DR   OMA; LILWKAC; -.
DR   OrthoDB; 583514at2759; -.
DR   PhylomeDB; Q14534; -.
DR   TreeFam; TF331056; -.
DR   BioCyc; MetaCyc:HS02595-MONOMER; -.
DR   BRENDA; 1.14.14.17; 2681.
DR   PathwayCommons; Q14534; -.
DR   Reactome; R-HSA-191273; Cholesterol biosynthesis.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   SABIO-RK; Q14534; -.
DR   UniPathway; UPA00767; UER00752.
DR   BioGRID-ORCS; 6713; 46 hits in 999 CRISPR screens.
DR   ChiTaRS; SQLE; human.
DR   GeneWiki; Squalene_monooxygenase; -.
DR   GenomeRNAi; 6713; -.
DR   Pharos; Q14534; Tchem.
DR   PRO; PR:Q14534; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q14534; protein.
DR   Bgee; ENSG00000104549; Expressed in adrenal tissue and 238 other tissues.
DR   ExpressionAtlas; Q14534; baseline and differential.
DR   Genevisible; Q14534; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0004506; F:squalene monooxygenase activity; IDA:UniProtKB.
DR   GO; GO:0006725; P:cellular aromatic compound metabolic process; IEA:Ensembl.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome.
DR   GO; GO:0008203; P:cholesterol metabolic process; IBA:GO_Central.
DR   GO; GO:0140042; P:lipid droplet formation; IMP:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IMP:UniProtKB.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; TAS:Reactome.
DR   GO; GO:0010033; P:response to organic substance; IEA:Ensembl.
DR   GO; GO:0016126; P:sterol biosynthetic process; IDA:UniProtKB.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR013698; Squalene_epoxidase.
DR   InterPro; IPR040125; Squalene_monox.
DR   PANTHER; PTHR10835; PTHR10835; 1.
DR   Pfam; PF08491; SE; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Endoplasmic reticulum; FAD; Flavoprotein; Membrane;
KW   Microsome; Oxidoreductase; Reference proteome; Ubl conjugation.
FT   CHAIN           1..574
FT                   /note="Squalene monooxygenase"
FT                   /id="PRO_0000209838"
FT   TOPO_DOM        1..20
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:26434806"
FT   INTRAMEM        21..41
FT                   /evidence="ECO:0000305|PubMed:26434806"
FT   TOPO_DOM        42..574
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   NP_BIND         133..134
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30626872,
FT                   ECO:0007744|PDB:6C6N"
FT   NP_BIND         153..154
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30626872,
FT                   ECO:0007744|PDB:6C6N"
FT   REGION          1..100
FT                   /note="Interaction with MARCHF6"
FT                   /evidence="ECO:0000269|PubMed:24449766"
FT   REGION          62..73
FT                   /note="Required for degradation in response to high
FT                   membrane cholesterol levels"
FT                   /evidence="ECO:0000269|PubMed:28972164"
FT   REGION          118..574
FT                   /note="Sufficient for enzyme activity"
FT                   /evidence="ECO:0000269|PubMed:10666321,
FT                   ECO:0000269|PubMed:30626872"
FT   REGION          516..574
FT                   /note="Hydrophobic; mediates interaction with membranes"
FT                   /evidence="ECO:0000269|PubMed:30626872"
FT   BINDING         161
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30626872,
FT                   ECO:0007744|PDB:6C6N"
FT   BINDING         166
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:30626872,
FT                   ECO:0007744|PDB:6C6N"
FT   BINDING         234
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30626872,
FT                   ECO:0007744|PDB:6C6N"
FT   BINDING         250
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:30626872,
FT                   ECO:0007744|PDB:6C6N"
FT   BINDING         408
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:30626872,
FT                   ECO:0007744|PDB:6C6N"
FT   BINDING         421
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:30626872,
FT                   ECO:0007744|PDB:6C6N"
FT   SITE            195
FT                   /note="Important for enzyme activity"
FT                   /evidence="ECO:0000269|PubMed:30626872"
FT   MUTAGEN         35
FT                   /note="F->A: Increased expression levels and decreased
FT                   degradation in response to high membrane cholesterol
FT                   levels; when associated with A-37; A-65 and A-69."
FT                   /evidence="ECO:0000269|PubMed:28972164"
FT   MUTAGEN         37
FT                   /note="S->A: Increased expression levels and decreased
FT                   degradation in response to high membrane cholesterol
FT                   levels; when associated with A-35; A-65 and A-69."
FT                   /evidence="ECO:0000269|PubMed:28972164"
FT   MUTAGEN         62..73
FT                   /note="Missing: Abolishes degradation in response to high
FT                   membrane cholesterol levels."
FT                   /evidence="ECO:0000269|PubMed:28972164"
FT   MUTAGEN         65
FT                   /note="L->A: Increased expression levels and decreased
FT                   degradation in response to high membrane cholesterol
FT                   levels; when associated with A-35; A-37 and A-69."
FT                   /evidence="ECO:0000269|PubMed:28972164"
FT   MUTAGEN         69
FT                   /note="I->A: Increased expression levels and decreased
FT                   degradation in response to high membrane cholesterol
FT                   levels; when associated with A-35; A-37 and A-65."
FT                   /evidence="ECO:0000269|PubMed:28972164"
FT   MUTAGEN         195
FT                   /note="Y->A,F: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:30626872"
FT   CONFLICT        43
FT                   /note="S -> F (in Ref. 3; BX647400)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        58
FT                   /note="Q -> R (in Ref. 1; BAA22372)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        94
FT                   /note="E -> G (in Ref. 1; BAA22372)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        139
FT                   /note="A -> V (in Ref. 1; BAA22372)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        247
FT                   /note="E -> G (in Ref. 8; BAA11209)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        334
FT                   /note="I -> T (in Ref. 3; BX647400)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        336
FT                   /note="Q -> R (in Ref. 1; BAA22372)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        379..380
FT                   /note="AT -> VA (in Ref. 3; BX647400)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        389
FT                   /note="P -> L (in Ref. 1; BAA22372)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        451
FT                   /note="K -> N (in Ref. 1; BAA22372)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        518
FT                   /note="V -> A (in Ref. 1; BAA22372)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        551
FT                   /note="G -> S (in Ref. 1; BAA22372)"
FT                   /evidence="ECO:0000305"
FT   STRAND          125..129
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           133..144
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          149..154
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          162..164
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           169..177
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           181..184
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          190..192
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          194..199
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   TURN            200..203
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          204..209
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          221..223
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           226..238
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          243..267
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   TURN            268..270
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          273..277
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          279..283
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           286..288
FT                   /evidence="ECO:0007829|PDB:6C6R"
FT   HELIX           292..295
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          301..313
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          321..326
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          328..330
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          332..336
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          338..348
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           356..362
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           365..367
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           370..372
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           373..382
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          386..393
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   STRAND          403..405
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           407..409
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           415..417
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           420..436
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           444..459
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           462..477
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           482..496
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           500..509
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           516..537
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           540..544
FT                   /evidence="ECO:0007829|PDB:6C6N"
FT   HELIX           545..566
FT                   /evidence="ECO:0007829|PDB:6C6N"
SQ   SEQUENCE   574 AA;  63923 MW;  6957F5CF1F1624C8 CRC64;
     MWTFLGIATF TYFYKKFGDF ITLANREVLL CVLVFLSLGL VLSYRCRHRN GGLLGRQQSG
     SQFALFSDIL SGLPFIGFFW AKSPPESENK EQLEARRRRK GTNISETSLI GTAACTSTSS
     QNDPEVIIVG AGVLGSALAA VLSRDGRKVT VIERDLKEPD RIVGEFLQPG GYHVLKDLGL
     GDTVEGLDAQ VVNGYMIHDQ ESKSEVQIPY PLSENNQVQS GRAFHHGRFI MSLRKAAMAE
     PNAKFIEGVV LQLLEEDDVV MGVQYKDKET GDIKELHAPL TVVADGLFSK FRKSLVSNKV
     SVSSHFVGFL MKNAPQFKAN HAELILANPS PVLIYQISSS ETRVLVDIRG EMPRNLREYM
     VEKIYPQIPD HLKEPFLEAT DNSHLRSMPA SFLPPSSVKK RGVLLLGDAY NMRHPLTGGG
     MTVAFKDIKL WRKLLKGIPD LYDDAAIFEA KKSFYWARKT SHSFVVNILA QALYELFSAT
     DDSLHQLRKA CFLYFKLGGE CVAGPVGLLS VLSPNPLVLI GHFFAVAIYA VYFCFKSEPW
     ITKPRALLSS GAVLYKACSV IFPLIYSEMK YMVH
//
ID   DLDH_AZOVI              Reviewed;         477 AA.
AC   P18925;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   02-JUN-2021, entry version 140.
DE   RecName: Full=Dihydrolipoyl dehydrogenase;
DE            EC=1.8.1.4;
DE   AltName: Full=Dihydrolipoamide dehydrogenase;
DE   AltName: Full=E3 component of pyruvate complex;
OS   Azotobacter vinelandii.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Azotobacter.
OX   NCBI_TaxID=354;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2832161; DOI=10.1111/j.1432-1033.1988.tb13887.x;
RA   Westphal A.H., de Kok A.;
RT   "Lipoamide dehydrogenase from Azotobacter vinelandii. Molecular cloning,
RT   organization and sequence analysis of the gene.";
RL   Eur. J. Biochem. 172:299-305(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-21, AND DISULFIDE BOND.
RX   PubMed=2404760; DOI=10.1111/j.1432-1033.1990.tb15300.x;
RA   Westphal A.H., de Kok A.;
RT   "The 2-oxoglutarate dehydrogenase complex from Azotobacter vinelandii. 2.
RT   Molecular cloning and sequence analysis of the gene encoding the
RT   succinyltransferase component.";
RL   Eur. J. Biochem. 187:235-239(1990).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH FAD.
RX   PubMed=1880807; DOI=10.1016/0022-2836(91)90367-f;
RA   Mattevi A., Schierbeek A.J., Hol W.G.J.;
RT   "Refined crystal structure of lipoamide dehydrogenase from Azotobacter
RT   vinelandii at 2.2-A resolution. A comparison with the structure of
RT   glutathione reductase.";
RL   J. Mol. Biol. 220:975-994(1991).
CC   -!- FUNCTION: The pyruvate dehydrogenase complex catalyzes the overall
CC       conversion of pyruvate to acetyl-CoA and CO(2). It contains multiple
CC       copies of three enzymatic components: pyruvate dehydrogenase (E1),
CC       dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase
CC       (E3).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-N(6)-dihydrolipoyl-L-lysyl-[protein] + NAD(+) = (R)-N(6)-
CC         lipoyl-L-lysyl-[protein] + H(+) + NADH; Xref=Rhea:RHEA:15045,
CC         Rhea:RHEA-COMP:10474, Rhea:RHEA-COMP:10475, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:83099,
CC         ChEBI:CHEBI:83100; EC=1.8.1.4;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:1880807}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- MISCELLANEOUS: The active site is a redox-active disulfide bond.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M37307; AAA22139.1; -; Genomic_DNA.
DR   EMBL; X52432; CAA36679.1; -; Genomic_DNA.
DR   PIR; S00360; DEAVHL.
DR   RefSeq; WP_012701528.1; NZ_FPKM01000019.1.
DR   PDB; 3LAD; X-ray; 2.20 A; A/B=2-477.
DR   PDBsum; 3LAD; -.
DR   SMR; P18925; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   PRIDE; P18925; -.
DR   SABIO-RK; P18925; -.
DR   EvolutionaryTrace; P18925; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004148; F:dihydrolipoyl dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:0006096; P:glycolytic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR006258; Lipoamide_DH.
DR   InterPro; IPR001100; Pyr_nuc-diS_OxRdtase.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   InterPro; IPR012999; Pyr_OxRdtase_I_AS.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   PIRSF; PIRSF000350; Mercury_reductase_MerA; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
DR   TIGRFAMs; TIGR01350; lipoamide_DH; 1.
DR   PROSITE; PS00076; PYRIDINE_REDOX_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Disulfide bond; FAD; Flavoprotein; Glycolysis;
KW   NAD; Oxidoreductase; Redox-active center.
FT   CHAIN           1..477
FT                   /note="Dihydrolipoyl dehydrogenase"
FT                   /id="PRO_0000068014"
FT   NP_BIND         34..49
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:1880807"
FT   NP_BIND         188..192
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         276..279
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        451
FT                   /note="Proton acceptor"
FT   BINDING         58
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:1880807"
FT   BINDING         122
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   BINDING         211
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   BINDING         245
FT                   /note="NAD; via amide nitrogen"
FT                   /evidence="ECO:0000250"
FT   BINDING         319
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:1880807"
FT   BINDING         327
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:1880807"
FT   DISULFID        49..54
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:1880807,
FT                   ECO:0000269|PubMed:2404760"
FT   STRAND          6..10
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           14..26
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          30..34
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          41..43
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           47..52
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           54..71
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           75..77
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           88..113
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          116..124
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          130..133
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          139..142
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          147..149
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          153..155
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          165..170
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           171..174
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          182..187
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           191..202
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          206..217
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           222..234
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          237..241
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          244..250
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          255..275
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          279..281
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          314..316
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           318..320
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          321..323
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           327..343
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          355..357
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          359..367
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           370..375
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          380..386
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           387..389
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           391..396
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          402..408
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   TURN            409..411
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   STRAND          413..421
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           424..436
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           441..445
FT                   /evidence="ECO:0007829|PDB:3LAD"
FT   HELIX           455..465
FT                   /evidence="ECO:0007829|PDB:3LAD"
SQ   SEQUENCE   477 AA;  49567 MW;  4219A8EA4DAFCAD0 CRC64;
     MSQKFDVIVI GAGPGGYVAA IKSAQLGLKT ALIEKYKGKE GKTALGGTCL NVGCIPSKAL
     LDSSYKFHEA HESFKLHGIS TGEVAIDVPT MIARKDQIVR NLTGGVASLI KANGVTLFEG
     HGKLLAGKKV EVTAADGSSQ VLDTENVILA SGSKPVEIPP APVDQDVIVD STGALDFQNV
     PGKLGVIGAG VIGLELGSVW ARLGAEVTVL EAMDKFLPAV DEQVAKEAQK ILTKQGLKIL
     LGARVTGTEV KNKQVTVKFV DAEGEKSQAF DKLIVAVGRR PVTTDLLAAD SGVTLDERGF
     IYVDDYCATS VPGVYAIGDV VRGAMLAHKA SEEGVVVAER IAGHKAQMNY DLIPAVIYTH
     PEIAGVGKTE QALKAEGVAI NVGVFPFAAS GRAMAANDTA GFVKVIADAK TDRVLGVHVI
     GPSAAELVQQ GAIAMEFGTS AEDLGMMVFA HPALSEALHE AALAVSGHAI HVANRKK
//
ID   FRDA_SHEON              Reviewed;         596 AA.
AC   P83223;
DT   27-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2002, sequence version 2.
DT   02-JUN-2021, entry version 143.
DE   RecName: Full=Fumarate reductase flavoprotein subunit;
DE            EC=1.3.5.4;
DE   AltName: Full=Flavocytochrome c;
DE            Short=FL cyt;
DE   Flags: Precursor;
GN   OrderedLocusNames=SO_0970;
OS   Shewanella oneidensis (strain MR-1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Alteromonadales;
OC   Shewanellaceae; Shewanella.
OX   NCBI_TaxID=211586;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND INDUCTION.
RC   STRAIN=MR-1;
RX   PubMed=11425747; DOI=10.1128/aem.67.7.3236-3244.2001;
RA   Tsapin A.I., Vandenberghe I., Nealson K.H., Scott J.H., Meyer T.E.,
RA   Cusanovich M.A., Harada E., Kaizu T., Akutsu H., Leys D., Van Beeumen J.J.;
RT   "Identification of a small tetraheme cytochrome c and a flavocytochrome c
RT   as two of the principal soluble cytochromes c in Shewanella oneidensis
RT   strain MR1.";
RL   Appl. Environ. Microbiol. 67:3236-3244(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=MR-1;
RX   PubMed=12368813; DOI=10.1038/nbt749;
RA   Heidelberg J.F., Paulsen I.T., Nelson K.E., Gaidos E.J., Nelson W.C.,
RA   Read T.D., Eisen J.A., Seshadri R., Ward N.L., Methe B.A., Clayton R.A.,
RA   Meyer T., Tsapin A., Scott J., Beanan M.J., Brinkac L.M., Daugherty S.C.,
RA   DeBoy R.T., Dodson R.J., Durkin A.S., Haft D.H., Kolonay J.F., Madupu R.,
RA   Peterson J.D., Umayam L.A., White O., Wolf A.M., Vamathevan J.J.,
RA   Weidman J.F., Impraim M., Lee K., Berry K.J., Lee C., Mueller J.,
RA   Khouri H.M., Gill J., Utterback T.R., McDonald L.A., Feldblyum T.V.,
RA   Smith H.O., Venter J.C., Nealson K.H., Fraser C.M.;
RT   "Genome sequence of the dissimilatory metal ion-reducing bacterium
RT   Shewanella oneidensis.";
RL   Nat. Biotechnol. 20:1118-1123(2002).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEXES WITH FAD; HEMES;
RP   FUMARATE AND SUCCINATE.
RC   STRAIN=MR-1;
RX   PubMed=10581551; DOI=10.1038/70051;
RA   Leys D., Tsapin A.S., Nealson K.H., Meyer T.E., Cusanovich M.A.,
RA   Van Beeumen J.J.;
RT   "Structure and mechanism of the flavocytochrome c fumarate reductase of
RT   Shewanella putrefaciens MR-1.";
RL   Nat. Struct. Biol. 6:1113-1117(1999).
CC   -!- FUNCTION: Catalyzes fumarate reduction using artificial electron donors
CC       such as methyl viologen. The physiological reductant is unknown, but
CC       evidence indicates that flavocytochrome c participates in electron
CC       transfer from formate to fumarate and possibly also to trimethylamine
CC       oxide (TMAO). This enzyme is essentially unidirectional (By
CC       similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + succinate = a quinol + fumarate;
CC         Xref=Rhea:RHEA:40523, ChEBI:CHEBI:24646, ChEBI:CHEBI:29806,
CC         ChEBI:CHEBI:30031, ChEBI:CHEBI:132124; EC=1.3.5.4;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:10581551}.
CC   -!- SUBCELLULAR LOCATION: Periplasm {ECO:0000250}.
CC   -!- INDUCTION: By anaerobiosis and fumarate. {ECO:0000269|PubMed:11425747}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the FAD-dependent
CC       oxidoreductase 2 family. FRD/SDH subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE014299; AAN54044.1; -; Genomic_DNA.
DR   RefSeq; NP_716599.1; NC_004347.2.
DR   RefSeq; WP_011071245.1; NZ_CP053946.1.
DR   PDB; 1D4C; X-ray; 2.90 A; A/B/C/D=25-596.
DR   PDB; 1D4D; X-ray; 2.50 A; A=25-596.
DR   PDB; 1D4E; X-ray; 2.80 A; A=25-596.
DR   PDBsum; 1D4C; -.
DR   PDBsum; 1D4D; -.
DR   PDBsum; 1D4E; -.
DR   SMR; P83223; -.
DR   STRING; 211586.SO_0970; -.
DR   DrugBank; DB00518; Albendazole.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB01677; Fumaric Acid.
DR   PaxDb; P83223; -.
DR   KEGG; son:SO_0970; -.
DR   PATRIC; fig|211586.12.peg.930; -.
DR   eggNOG; COG1053; Bacteria.
DR   HOGENOM; CLU_011398_4_5_6; -.
DR   OMA; GKMWENG; -.
DR   OrthoDB; 153138at2; -.
DR   PhylomeDB; P83223; -.
DR   BioCyc; SONE211586:G1GMP-903-MONOMER; -.
DR   EvolutionaryTrace; P83223; -.
DR   Proteomes; UP000008186; Chromosome.
DR   GO; GO:0042597; C:periplasmic space; IEA:UniProtKB-SubCell.
DR   GO; GO:0102040; F:fumarate reductase (menaquinone); IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000104; F:succinate dehydrogenase activity; ISS:TIGR.
DR   GO; GO:0009061; P:anaerobic respiration; ISS:TIGR.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; ISS:TIGR.
DR   Gene3D; 3.50.50.60; -; 1.
DR   Gene3D; 3.90.700.10; -; 1.
DR   InterPro; IPR003953; FAD-binding_2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR010960; Flavocytochrome_c.
DR   InterPro; IPR011031; Multihaem_cyt.
DR   InterPro; IPR036280; Multihaem_cyt_sf.
DR   InterPro; IPR027477; Succ_DH/fumarate_Rdtase_cat_sf.
DR   InterPro; IPR012286; Tetrahaem_cytochrome.
DR   Pfam; PF14537; Cytochrom_c3_2; 1.
DR   Pfam; PF00890; FAD_binding_2; 1.
DR   SUPFAM; SSF48695; SSF48695; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF56425; SSF56425; 1.
DR   TIGRFAMs; TIGR01813; flavo_cyto_c; 1.
DR   PROSITE; PS51008; MULTIHEME_CYTC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Electron transport; FAD; Flavoprotein; Heme; Iron;
KW   Metal-binding; Oxidoreductase; Periplasm; Reference proteome; Signal;
KW   Transport.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000305"
FT   CHAIN           26..596
FT                   /note="Fumarate reductase flavoprotein subunit"
FT                   /id="PRO_0000010345"
FT   NP_BIND         180..181
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10581551,
FT                   ECO:0007744|PDB:1D4D"
FT   NP_BIND         188..195
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10581551,
FT                   ECO:0007744|PDB:1D4D"
FT   NP_BIND         574..575
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10581551,
FT                   ECO:0007744|PDB:1D4D"
FT   REGION          142..596
FT                   /note="Flavoprotein-like"
FT   REGION          401..402
FT                   /note="Fumarate binding"
FT                   /evidence="ECO:0000269|PubMed:10581551,
FT                   ECO:0007744|PDB:1D4E"
FT   REGION          401..402
FT                   /note="Succinate binding"
FT                   /evidence="ECO:0000269|PubMed:10581551,
FT                   ECO:0007744|PDB:1D4D"
FT   ACT_SITE        426
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P0C278"
FT   METAL           34
FT                   /note="Iron (heme 2 axial ligand)"
FT   METAL           44
FT                   /note="Iron (heme 1 axial ligand)"
FT   METAL           67
FT                   /note="Iron (heme 2 axial ligand)"
FT   METAL           85
FT                   /note="Iron (heme 3 axial ligand)"
FT   METAL           88
FT                   /note="Iron (heme 4 axial ligand)"
FT   METAL           99
FT                   /note="Iron (heme 3 axial ligand)"
FT   METAL           102
FT                   /note="Iron (heme 1 axial ligand)"
FT   METAL           113
FT                   /note="Iron (heme 4 axial ligand)"
FT   BINDING         40
FT                   /note="Heme 1; covalent"
FT   BINDING         43
FT                   /note="Heme 1; covalent"
FT   BINDING         63
FT                   /note="Heme 2; covalent"
FT   BINDING         66
FT                   /note="Heme 2; covalent"
FT   BINDING         95
FT                   /note="Heme 3; covalent"
FT   BINDING         98
FT                   /note="Heme 3; covalent"
FT   BINDING         109
FT                   /note="Heme 4; covalent"
FT   BINDING         112
FT                   /note="Heme 4; covalent"
FT   BINDING         161
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:10581551,
FT                   ECO:0007744|PDB:1D4D"
FT   BINDING         302
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:10581551,
FT                   ECO:0007744|PDB:1D4D"
FT   BINDING         389
FT                   /note="Succinate"
FT                   /evidence="ECO:0000269|PubMed:10581551,
FT                   ECO:0007744|PDB:1D4D"
FT   BINDING         528
FT                   /note="Fumarate"
FT                   /evidence="ECO:0000269|PubMed:10581551,
FT                   ECO:0007744|PDB:1D4E"
FT   BINDING         528
FT                   /note="Succinate"
FT                   /evidence="ECO:0000269|PubMed:10581551,
FT                   ECO:0007744|PDB:1D4D"
FT   BINDING         559
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10581551,
FT                   ECO:0007744|PDB:1D4D"
FT   BINDING         569
FT                   /note="Fumarate"
FT                   /evidence="ECO:0000269|PubMed:10581551,
FT                   ECO:0007744|PDB:1D4E"
FT   BINDING         569
FT                   /note="Succinate"
FT                   /evidence="ECO:0000269|PubMed:10581551,
FT                   ECO:0007744|PDB:1D4D"
FT   CONFLICT        71
FT                   /note="K -> E (in Ref. 1)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        282
FT                   /note="A -> S (in Ref. 1)"
FT                   /evidence="ECO:0000305"
FT   HELIX           30..33
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   TURN            34..38
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   TURN            41..43
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          44..48
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           57..67
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           70..76
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          79..81
FT                   /evidence="ECO:0007829|PDB:1D4C"
FT   STRAND          86..88
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           95..97
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          101..103
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           108..111
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   TURN            132..135
FT                   /evidence="ECO:0007829|PDB:1D4C"
FT   HELIX           136..144
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          152..156
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           160..170
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          171..173
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          176..179
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          181..185
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           189..191
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          200..202
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           205..207
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           214..223
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   TURN            224..226
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           230..238
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           240..249
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          256..258
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          268..271
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   TURN            272..274
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           277..291
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          295..307
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          309..311
FT                   /evidence="ECO:0007829|PDB:1D4C"
FT   STRAND          313..320
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   TURN            321..323
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          324..329
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          331..335
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           344..350
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           352..354
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          359..361
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           368..375
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          386..393
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   TURN            394..397
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           403..406
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          410..412
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           426..434
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           437..439
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          441..445
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           447..450
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           455..461
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          466..470
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           471..478
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           482..495
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   TURN            502..504
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          515..530
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          533..536
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   STRAND          541..556
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           558..560
FT                   /evidence="ECO:0007829|PDB:1D4C"
FT   STRAND          561..563
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   TURN            564..567
FT                   /evidence="ECO:0007829|PDB:1D4D"
FT   HELIX           573..591
FT                   /evidence="ECO:0007829|PDB:1D4D"
SQ   SEQUENCE   596 AA;  62448 MW;  74CB81FE89790463 CRC64;
     MFTRKIQKTA LAMLISGAMA GTAYAAPEVL ADFHGEMGGC DSCHVSDKGG VTNDNLTHEN
     GQCVSCHGDL KELAAAAPKD KVSPHKSHLI GEIACTSCHK GHEKSVAYCD ACHSFGFDMP
     FGGKWERKFV PVDADKAAQD KAIAAGVKET TDVVIIGSGG AGLAAAVSAR DAGAKVILLE
     KEPIPGGNTK LAAGGMNAAE TKPQAKLGIE DKKQIMIDDT MKGGRNINDP ELVKVLANNS
     SDSIDWLTSM GADMTDVGRM GGASVNRSHR PTGGAGVGAH VAQVLWDNAV KRGTDIRLNS
     RVVRILEDAS GKVTGVLVKG EYTGYYVIKA DAVVIAAGGF AKNNERVSKY DPKLKGFKAT
     NHPGATGDGL DVALQAGAAT RDLEYIQAHP TYSPAGGVMI TEAVRGNGAI VVNREGNRFM
     NEITTRDKAS AAILQQKGES AYLVFDDSIR KSLKAIEGYV HLNIVKEGKT IEELAKQIDV
     PAAELAKTVT AYNGFVKSGK DAQFERPDLP RELVVAPFYA LEIAPAVHHT MGGLVIDTKA
     EVKSEKTGKP ITGLYAAGEV TGGVHGANRL GGNAISDIVT YGRIAGASAA KFAKDN
//
ID   FADH_ECOLI              Reviewed;         672 AA.
AC   P42593; Q2M9C5;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-JUN-2021, entry version 177.
DE   RecName: Full=2,4-dienoyl-CoA reductase [(2E)-enoyl-CoA-producing] {ECO:0000303|PubMed:10933894, ECO:0000303|PubMed:9346310};
DE            Short=DCR {ECO:0000303|PubMed:12840019};
DE            EC=1.3.1.34 {ECO:0000269|PubMed:18171025, ECO:0000269|PubMed:6363415, ECO:0000269|PubMed:9346310};
DE   AltName: Full=2,4-dienoyl-coenzyme A reductase [NADPH] {ECO:0000305|PubMed:6363415};
GN   Name=fadH {ECO:0000303|PubMed:9346310}; Synonyms=ygjL;
GN   OrderedLocusNames=b3081, JW3052;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-31, FUNCTION,
RP   CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   STRAIN=K12;
RX   PubMed=9346310; DOI=10.1111/j.1432-1033.1997.00516.x;
RA   He X.-Y., Yang S.-Y., Schulz H.;
RT   "Cloning and expression of the fadH gene and characterization of the gene
RT   product 2,4-dienoyl coenzyme A reductase from Escherichia coli.";
RL   Eur. J. Biochem. 248:516-520(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR,
RP   ACTIVITY REGULATION, SUBUNIT, INDUCTION, AND PATHWAY.
RX   PubMed=6363415;
RA   Dommes V., Kunau W.H.;
RT   "2,4-Dienoyl coenzyme A reductases from bovine liver and Escherichia coli.
RT   Comparison of properties.";
RL   J. Biol. Chem. 259:1781-1788(1984).
RN   [5]
RP   FUNCTION, COFACTOR, AND PATHWAY.
RC   STRAIN=K12;
RX   PubMed=10933894; DOI=10.1006/abbi.2000.1941;
RA   Liang X., Thorpe C., Schulz H.;
RT   "2,4-Dienoyl-CoA reductase from Escherichia coli is a novel iron-sulfur
RT   flavoprotein that functions in fatty acid beta-oxidation.";
RL   Arch. Biochem. Biophys. 380:373-379(2000).
RN   [6]
RP   CATALYTIC ACTIVITY, REACTION MECHANISM, ACTIVE SITE, AND MUTAGENESIS OF
RP   GLU-165; TYR-167; HIS-253 AND CYS-338.
RC   STRAIN=K12;
RX   PubMed=18171025; DOI=10.1021/bi701235t;
RA   Tu X., Hubbard P.A., Kim J.J., Schulz H.;
RT   "Two distinct proton donors at the active site of Escherichia coli 2,4-
RT   dienoyl-CoA reductase are responsible for the formation of different
RT   products.";
RL   Biochemistry 47:1167-1175(2008).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 2-672 IN COMPLEX WITH
RP   5-MERCAPTOETHANOL-2-DECENOYL-COENZYME A; FAD; FMN; IRON-SULFUR (4FE-4S) AND
RP   NADP, COFACTOR, DOMAIN, REACTION MECHANISM, AND ACTIVE SITE.
RC   STRAIN=K12;
RX   PubMed=12840019; DOI=10.1074/jbc.m304642200;
RA   Hubbard P.A., Liang X., Schulz H., Kim J.J.;
RT   "The crystal structure and reaction mechanism of Escherichia coli 2,4-
RT   dienoyl-CoA reductase.";
RL   J. Biol. Chem. 278:37553-37560(2003).
CC   -!- FUNCTION: Functions as an auxiliary enzyme in the beta-oxidation of
CC       unsaturated fatty acids with double bonds at even carbon positions.
CC       Catalyzes the NADPH-dependent reduction of the C4-C5 double bond of the
CC       acyl chain of 2,4-dienoyl-CoA to yield 2-trans-enoyl-CoA
CC       (PubMed:9346310, PubMed:6363415). Acts on both isomers, 2-trans,4-
CC       cis- and 2-trans,4-trans-decadienoyl-CoA, with almost equal efficiency
CC       (PubMed:6363415). Is not active with NADH instead of NADPH
CC       (PubMed:6363415). Does not show cis->trans isomerase activity
CC       (PubMed:10933894). {ECO:0000269|PubMed:10933894,
CC       ECO:0000269|PubMed:6363415, ECO:0000269|PubMed:9346310}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 4,5-saturated-(2E)-enoyl-CoA + NADP(+) = a (2E,4E)-dienoyl-
CC         CoA + H(+) + NADPH; Xref=Rhea:RHEA:12136, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:85100,
CC         ChEBI:CHEBI:85101; EC=1.3.1.34;
CC         Evidence={ECO:0000269|PubMed:18171025, ECO:0000269|PubMed:6363415,
CC         ECO:0000269|PubMed:9346310};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a (2E,4Z)-dienoyl-CoA + H(+) + NADPH = a 4,5-saturated-(2E)-
CC         enoyl-CoA + NADP(+); Xref=Rhea:RHEA:45232, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:85099,
CC         ChEBI:CHEBI:85100; EC=1.3.1.34;
CC         Evidence={ECO:0000269|PubMed:6363415};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-decenoyl-CoA + NADP(+) = (2E,4E)-decadienoyl-CoA + H(+) +
CC         NADPH; Xref=Rhea:RHEA:53296, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:61406, ChEBI:CHEBI:62244;
CC         Evidence={ECO:0000269|PubMed:18171025, ECO:0000269|PubMed:6363415,
CC         ECO:0000269|PubMed:9346310};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-decenoyl-CoA + NADP(+) = (2E,4Z)-decadienoyl-CoA + H(+) +
CC         NADPH; Xref=Rhea:RHEA:53708, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:61406, ChEBI:CHEBI:137593;
CC         Evidence={ECO:0000269|PubMed:6363415};
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000269|PubMed:10933894, ECO:0000269|PubMed:12840019};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:10933894, ECO:0000269|PubMed:12840019,
CC         ECO:0000269|PubMed:6363415};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000269|PubMed:10933894, ECO:0000269|PubMed:12840019};
CC   -!- ACTIVITY REGULATION: Is non-competitively inhibited by NADH.
CC       {ECO:0000269|PubMed:6363415}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=50 uM for NADPH {ECO:0000269|PubMed:9346310};
CC         KM=10.1 uM for NADPH {ECO:0000269|PubMed:6363415};
CC         KM=2.3 uM for (2E,4E)-decadienoyl-CoA {ECO:0000269|PubMed:9346310};
CC         KM=8.8 uM for (2E,4E)-decadienoyl-CoA {ECO:0000269|PubMed:6363415};
CC         KM=4.1 uM for (2E,4Z)-decadienoyl-CoA {ECO:0000269|PubMed:6363415};
CC         Note=kcat is 16 sec(-1) for the NADPH-reduction of (2E,4E)-
CC         decadienoyl-CoA. {ECO:0000269|PubMed:9346310};
CC   -!- PATHWAY: Lipid metabolism; fatty acid beta-oxidation.
CC       {ECO:0000305|PubMed:10933894, ECO:0000305|PubMed:6363415}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:6363415}.
CC   -!- INTERACTION:
CC       P42593; P11349: narH; NbExp=3; IntAct=EBI-561933, EBI-555067;
CC       P42593; P19318: narY; NbExp=3; IntAct=EBI-561933, EBI-555059;
CC   -!- INDUCTION: Induced when cells are grown on oleate as sole carbon
CC       source. Repressed by glucose. {ECO:0000269|PubMed:6363415}.
CC   -!- DOMAIN: Is composed of three domains: an N-terminal TIM barrel
CC       (residues 1-368) which binds FMN, the 4Fe-4S cluster, and the
CC       substrate; a flavodoxin-like fold (residues 369-467 and 626-671) which
CC       binds FAD; and an NADP(H)-binding domain (residues 468-625).
CC       {ECO:0000269|PubMed:12840019}.
CC   -!- MISCELLANEOUS: The overall reaction mechanism can be divided into three
CC       stages: initially, reduction of FAD by NADPH, then electron transfer
CC       from FAD to FMN via the 4Fe-4S cluster, and finally reduction of
CC       substrate. {ECO:0000305|PubMed:12840019}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the NADH:flavin
CC       oxidoreductase/NADH oxidase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U93405; AAB82738.1; -; Genomic_DNA.
DR   EMBL; U18997; AAA57882.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76116.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77131.1; -; Genomic_DNA.
DR   PIR; F65096; F65096.
DR   RefSeq; NP_417552.1; NC_000913.3.
DR   RefSeq; WP_000121433.1; NZ_LN832404.1.
DR   PDB; 1PS9; X-ray; 2.20 A; A=2-672.
DR   PDBsum; 1PS9; -.
DR   SMR; P42593; -.
DR   BioGRID; 4261984; 17.
DR   BioGRID; 851910; 4.
DR   DIP; DIP-9562N; -.
DR   IntAct; P42593; 10.
DR   STRING; 511145.b3081; -.
DR   DrugBank; DB03698; 5-Mercaptoethanol-2-decenoyl-coenzyme A.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB03247; Flavin mononucleotide.
DR   DrugBank; DB03461; Nicotinamide adenine dinucleotide phosphate.
DR   SwissLipids; SLP:000001817; -.
DR   jPOST; P42593; -.
DR   PaxDb; P42593; -.
DR   PRIDE; P42593; -.
DR   EnsemblBacteria; AAC76116; AAC76116; b3081.
DR   EnsemblBacteria; BAE77131; BAE77131; BAE77131.
DR   GeneID; 947594; -.
DR   KEGG; ecj:JW3052; -.
DR   KEGG; eco:b3081; -.
DR   PATRIC; fig|511145.12.peg.3176; -.
DR   EchoBASE; EB2582; -.
DR   eggNOG; COG0446; Bacteria.
DR   eggNOG; COG1902; Bacteria.
DR   HOGENOM; CLU_012153_1_1_6; -.
DR   InParanoid; P42593; -.
DR   PhylomeDB; P42593; -.
DR   BioCyc; EcoCyc:DIENOYLCOAREDUCT-MONOMER; -.
DR   BioCyc; MetaCyc:DIENOYLCOAREDUCT-MONOMER; -.
DR   BRENDA; 1.3.1.34; 2026.
DR   UniPathway; UPA00659; -.
DR   EvolutionaryTrace; P42593; -.
DR   PRO; PR:P42593; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0008670; F:2,4-dienoyl-CoA reductase (NADPH) activity; IDA:EcoCyc.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IDA:EcoCyc.
DR   GO; GO:0071949; F:FAD binding; IDA:EcoCyc.
DR   GO; GO:0010181; F:FMN binding; IDA:EcoCyc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0033543; P:fatty acid beta-oxidation, unsaturated, even number, reductase/isomerase pathway; IMP:EcoCyc.
DR   Gene3D; 3.20.20.70; -; 1.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR001155; OxRdtase_FMN_N.
DR   Pfam; PF00724; Oxidored_FMN; 1.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; 4Fe-4S; Direct protein sequencing; FAD; Flavoprotein; FMN;
KW   Iron; Iron-sulfur; Metal-binding; NADP; Oxidoreductase; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:9346310"
FT   CHAIN           2..672
FT                   /note="2,4-dienoyl-CoA reductase [(2E)-enoyl-CoA-
FT                   producing]"
FT                   /id="PRO_0000194482"
FT   NP_BIND         25..27
FT                   /note="FMN"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   NP_BIND         311..312
FT                   /note="FMN"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   NP_BIND         563..564
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   NP_BIND         654..656
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   NP_BIND         656..658
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   REGION          253..256
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000305|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   ACT_SITE        167
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000305|PubMed:12840019,
FT                   ECO:0000305|PubMed:18171025"
FT   METAL           335
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   METAL           338
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   METAL           342
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   METAL           354
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         59
FT                   /note="FMN; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         101
FT                   /note="FMN"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         176
FT                   /note="Substrate"
FT                   /evidence="ECO:0000305|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         215
FT                   /note="FMN"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         289
FT                   /note="FMN; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         340
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         340
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         385
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         404
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         412
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         422
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         449
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         567
FT                   /note="Substrate"
FT                   /evidence="ECO:0000305|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         578
FT                   /note="Substrate"
FT                   /evidence="ECO:0000305|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         649
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   SITE            253
FT                   /note="Important for catalytic activity, assists active
FT                   site Tyr in protonation of C4"
FT                   /evidence="ECO:0000305|PubMed:12840019,
FT                   ECO:0000305|PubMed:18171025"
FT   MUTAGEN         165
FT                   /note="E->A: Exhibits 1.3% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:18171025"
FT   MUTAGEN         165
FT                   /note="E->Q: Loss of enzyme activity; when associated with
FT                   Ala-167."
FT                   /evidence="ECO:0000269|PubMed:18171025"
FT   MUTAGEN         167
FT                   /note="Y->F: Forms 3-enoyl-CoA as the product of the
FT                   reaction instead of 2-enoyl-CoA, at a rate which is 26% of
FT                   wild-type. 2-fold increase in substrate affinity. Loss of
FT                   enzyme activity; when associated with Gln-165."
FT                   /evidence="ECO:0000269|PubMed:18171025"
FT   MUTAGEN         253
FT                   /note="H->A: 1000-fold reduction in enzyme activity. Forms
FT                   both 3-enoyl-CoA and 2-enoyl-CoA as products of the
FT                   reaction."
FT                   /evidence="ECO:0000269|PubMed:18171025"
FT   MUTAGEN         253
FT                   /note="H->F: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:18171025"
FT   MUTAGEN         338
FT                   /note="C->A: 1000-fold reduction in enzyme activity. Highly
FT                   affects iron-sulfur cluster binding."
FT                   /evidence="ECO:0000269|PubMed:18171025"
FT   TURN            4..7
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          16..23
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           36..49
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          53..64
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           78..80
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           81..93
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          98..102
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           106..108
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          109..111
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          115..119
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           134..153
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          157..163
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           168..173
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            175..177
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          185..187
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           188..206
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          208..219
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           228..241
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          244..250
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          259..261
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            266..269
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           270..276
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          284..286
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           293..301
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          306..311
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           313..316
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           320..325
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           329..331
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            340..342
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           343..347
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            358..361
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            363..365
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          376..380
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           384..394
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            395..397
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          399..409
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           413..416
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           425..439
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          442..446
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          451..454
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          457..462
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          466..468
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            475..477
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          481..483
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           484..488
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          496..501
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           504..514
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           521..523
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           525..531
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           541..543
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          555..561
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            568..571
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            574..576
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           577..586
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          590..592
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          596..601
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          604..609
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          612..616
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          619..623
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          627..629
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           634..638
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            639..641
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          644..646
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           648..650
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           658..671
FT                   /evidence="ECO:0007829|PDB:1PS9"
SQ   SEQUENCE   672 AA;  72678 MW;  B26C7CAAACE760C3 CRC64;
     MSYPSLFAPL DLGFTTLKNR VLMGSMHTGL EEYPDGAERL AAFYAERARH GVALIVSGGI
     APDLTGVGME GGAMLNDASQ IPHHRTITEA VHQEGGKIAL QILHTGRYSY QPHLVAPSAL
     QAPINRFVPH ELSHEEILQL IDNFARCAQL AREAGYDGVE VMGSEGYLIN EFLTLRTNQR
     SDQWGGDYRN RMRFAVEVVR AVRERVGNDF IIIYRLSMLD LVEDGGTFAE TVELAQAIEA
     AGATIINTGI GWHEARIPTI ATPVPRGAFS WVTRKLKGHV SLPLVTTNRI NDPQVADDIL
     SRGDADMVSM ARPFLADAEL LSKAQSGRAD EINTCIGCNQ ACLDQIFVGK VTSCLVNPRA
     CHETKMPILP AVQKKNLAVV GAGPAGLAFA INAAARGHQV TLFDAHSEIG GQFNIAKQIP
     GKEEFYETLR YYRRMIEVTG VTLKLNHTVT ADQLQAFDET ILASGIVPRT PPIDGIDHPK
     VLSYLDVLRD KAPVGNKVAI IGCGGIGFDT AMYLSQPGES TSQNIAGFCN EWGIDSSLQQ
     AGGLSPQGMQ IPRSPRQIVM LQRKASKPGQ GLGKTTGWIH RTTLLSRGVK MIPGVSYQKI
     DDDGLHVVIN GETQVLAVDN VVICAGQEPN RALAQPLIDS GKTVHLIGGC DVAMELDARR
     AIAQGTRLAL EI
//
ID   ETFA_METME              Reviewed;         321 AA.
AC   P53571;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   02-JUN-2021, entry version 100.
DE   RecName: Full=Electron transfer flavoprotein subunit alpha;
DE            Short=Alpha-ETF;
DE   AltName: Full=Electron transfer flavoprotein large subunit;
DE            Short=ETFLS;
GN   Name=etfA;
OS   Methylophilus methylotrophus (Bacterium W3A1).
OC   Bacteria; Proteobacteria; Betaproteobacteria; Nitrosomonadales;
OC   Methylophilaceae; Methylophilus.
OX   NCBI_TaxID=17;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-33, MASS
RP   SPECTROMETRY, FUNCTION, AND COFACTOR.
RX   PubMed=7798207;
RA   Chen D., Swenson R.P.;
RT   "Cloning, sequence analysis, and expression of the genes encoding the two
RT   subunits of the methylotrophic bacterium W3A1 electron transfer
RT   flavoprotein.";
RL   J. Biol. Chem. 269:32120-32130(1994).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH FAD AND TMADH.
RX   PubMed=12567183; DOI=10.1038/nsb894;
RA   Leys D., Basran J., Talfournier F., Sutcliffe M.J., Scrutton N.S.;
RT   "Extensive conformational sampling in a ternary electron transfer
RT   complex.";
RL   Nat. Struct. Biol. 10:219-225(2003).
CC   -!- FUNCTION: Heterodimeric electron transfer flavoprotein that accepts
CC       electrons from trimethylamine dehydrogenase (PubMed:7798207). It
CC       transfers the electrons to the main respiratory chain via ETF-
CC       ubiquinone oxidoreductase (ETF dehydrogenase) (Probable).
CC       {ECO:0000269|PubMed:7798207, ECO:0000305}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:12567183, ECO:0000269|PubMed:7798207};
CC       Note=Binds 1 FAD per dimer. {ECO:0000269|PubMed:12567183};
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit.
CC       {ECO:0000269|PubMed:12567183, ECO:0000269|PubMed:7798207}.
CC   -!- MASS SPECTROMETRY: Mass=33672; Mass_error=34; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:7798207};
CC   -!- SIMILARITY: Belongs to the ETF alpha-subunit/FixB family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U17242; AAA64953.1; -; Genomic_DNA.
DR   PIR; T47206; T47206.
DR   PDB; 1E11; Model; -; A=1-321.
DR   PDB; 1O94; X-ray; 2.00 A; D/F=2-321.
DR   PDB; 1O95; X-ray; 3.70 A; D/F=2-321.
DR   PDB; 1O96; X-ray; 3.10 A; B/D/F/Z=2-321.
DR   PDB; 1O97; X-ray; 1.60 A; D=2-321.
DR   PDB; 3CLR; X-ray; 1.90 A; D=1-321.
DR   PDB; 3CLS; X-ray; 1.65 A; D=1-321.
DR   PDB; 3CLT; X-ray; 2.00 A; D=1-321.
DR   PDB; 3CLU; X-ray; 1.80 A; D=1-321.
DR   PDBsum; 1E11; -.
DR   PDBsum; 1O94; -.
DR   PDBsum; 1O95; -.
DR   PDBsum; 1O96; -.
DR   PDBsum; 1O97; -.
DR   PDBsum; 3CLR; -.
DR   PDBsum; 3CLS; -.
DR   PDBsum; 3CLT; -.
DR   PDBsum; 3CLU; -.
DR   SMR; P53571; -.
DR   MINT; P53571; -.
DR   EvolutionaryTrace; P53571; -.
DR   GO; GO:0009055; F:electron transfer activity; IEA:InterPro.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   CDD; cd01715; ETF_alpha; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR029035; DHS-like_NAD/FAD-binding_dom.
DR   InterPro; IPR014730; ETF_a/b_N.
DR   InterPro; IPR001308; ETF_a/FixB.
DR   InterPro; IPR033947; ETF_alpha_N.
DR   InterPro; IPR014731; ETF_asu_C.
DR   InterPro; IPR018206; ETF_asu_C_CS.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF01012; ETF; 1.
DR   Pfam; PF00766; ETF_alpha; 1.
DR   PIRSF; PIRSF000089; Electra_flavoP_a; 1.
DR   SMART; SM00893; ETF; 1.
DR   SUPFAM; SSF52467; SSF52467; 1.
DR   PROSITE; PS00696; ETF_ALPHA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Electron transport; FAD;
KW   Flavoprotein; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:7798207"
FT   CHAIN           2..321
FT                   /note="Electron transfer flavoprotein subunit alpha"
FT                   /id="PRO_0000167851"
FT   NP_BIND         236..237
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12567183,
FT                   ECO:0007744|PDB:1O96, ECO:0007744|PDB:3CLR,
FT                   ECO:0007744|PDB:3CLS, ECO:0007744|PDB:3CLU"
FT   NP_BIND         250..254
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12567183,
FT                   ECO:0007744|PDB:1O96, ECO:0007744|PDB:3CLR,
FT                   ECO:0007744|PDB:3CLS, ECO:0007744|PDB:3CLU"
FT   NP_BIND         268..275
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12567183,
FT                   ECO:0007744|PDB:1O96, ECO:0007744|PDB:3CLR,
FT                   ECO:0007744|PDB:3CLS, ECO:0007744|PDB:3CLU"
FT   NP_BIND         307..308
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12567183,
FT                   ECO:0007744|PDB:1O96, ECO:0007744|PDB:3CLR,
FT                   ECO:0007744|PDB:3CLS, ECO:0007744|PDB:3CLU"
FT   BINDING         211
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12567183,
FT                   ECO:0007744|PDB:1O96, ECO:0007744|PDB:3CLR,
FT                   ECO:0007744|PDB:3CLS, ECO:0007744|PDB:3CLU"
FT   BINDING         289
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12567183,
FT                   ECO:0007744|PDB:1O96, ECO:0007744|PDB:3CLR,
FT                   ECO:0007744|PDB:3CLS, ECO:0007744|PDB:3CLU"
FT   STRAND          3..7
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   HELIX           18..29
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   STRAND          36..43
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   HELIX           46..49
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   HELIX           50..53
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   STRAND          59..65
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   HELIX           73..87
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   STRAND          90..95
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   HELIX           98..101
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   HELIX           104..109
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   STRAND          114..119
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   STRAND          121..125
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   STRAND          128..135
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   TURN            136..139
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   STRAND          140..145
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   STRAND          152..156
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   STRAND          158..161
FT                   /evidence="ECO:0007829|PDB:1O96"
FT   STRAND          171..176
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   STRAND          183..190
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   HELIX           200..202
FT                   /evidence="ECO:0007829|PDB:3CLU"
FT   STRAND          203..209
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   HELIX           211..213
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   HELIX           216..218
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   HELIX           219..229
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   STRAND          232..235
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   HELIX           237..241
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   HELIX           247..249
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   STRAND          250..252
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   STRAND          262..268
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   HELIX           273..279
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   STRAND          283..288
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   HELIX           295..298
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   STRAND          301..304
FT                   /evidence="ECO:0007829|PDB:1O97"
FT   HELIX           308..318
FT                   /evidence="ECO:0007829|PDB:1O97"
SQ   SEQUENCE   321 AA;  33723 MW;  25A566407E7F42E9 CRC64;
     MSKILVIAEH RRNDLRPVSL ELIGAANGLK KSGEDKVVVA VIGSQADAFV PALSVNGVDE
     LVVVKGSSID FDPDVFEASV SALIAAHNPS VVLLPHSVDS LGYASSLASK TGYGFATDVY
     IVEYQGDELV ATRGGYNQKV NVEVDFPGKS TVVLTIRPSV FKPLEGAGSP VVSNVDAPSV
     QSRSQNKDYV EVGGGNDIDI TTVDFIMSIG RGIGEETNVE QFRELADEAG ATLCCSRPIA
     DAGWLPKSRQ VGQSGKVVGS CKLYVAMGIS GSIQHMAGMK HVPTIIAVNT DPGASIFTIA
     KYGIVADIFD IEEELKAQLA A
//
ID   ALR_RAT                 Reviewed;         198 AA.
AC   Q63042;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   02-JUN-2021, entry version 136.
DE   RecName: Full=FAD-linked sulfhydryl oxidase ALR;
DE            EC=1.8.3.2;
DE   AltName: Full=Augmenter of liver regeneration;
GN   Name=Gfer; Synonyms=Alr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION IN LIVER REGENERATION.
RC   STRAIN=Fischer 344; TISSUE=Liver;
RX   PubMed=8058770; DOI=10.1073/pnas.91.17.8142;
RA   Hagiya M., Francavilla A., Polimeno L., Ihara I., Sakai H., Seki T.,
RA   Shimonishi M., Porter K.A., Starzl T.E.;
RT   "Cloning and sequence analysis of the rat augmenter of liver regeneration
RT   (ALR) gene: expression of biologically active recombinant ALR and
RT   demonstration of tissue distribution.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:8142-8146(1994).
RN   [2]
RP   ERRATUM OF PUBMED:8058770.
RX   PubMed=7708779; DOI=10.1073/pnas.92.7.3076d;
RA   Hagiya M., Francavilla A., Polimeno L., Ihara I., Sakai H., Seki T.,
RA   Shimonishi M., Porter K.A., Starzl T.E.;
RL   Proc. Natl. Acad. Sci. U.S.A. 92:3076-3076(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Wistar;
RX   PubMed=12906155;
RA   Dong J., Cheng J., Wang Q., Shi S., Wang G., Si C.;
RT   "Cloning and analysis of the genomic DNA sequence of augmenter of liver
RT   regeneration from rat.";
RL   Chin. Med. Sci. J. 17:63-67(2002).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH FAD, SUBUNIT,
RP   COFACTOR, AND DISULFIDE BONDS.
RX   PubMed=12717032; DOI=10.1110/ps.0238103;
RA   Wu C.-K., Dailey T.A., Dailey H.A., Wang B.-C., Rose J.P.;
RT   "The crystal structure of augmenter of liver regeneration: a mammalian FAD-
RT   dependent sulfhydryl oxidase.";
RL   Protein Sci. 12:1109-1118(2003).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 74-198 IN COMPLEX WITH FAD, AND
RP   SUBUNIT.
RX   PubMed=22948913; DOI=10.1107/s0907444912022561;
RA   Florence Q., Wu C.K., Habel J., Swindell J.T. II, Wang B.C., Rose J.P.;
RT   "The structure of augmenter of liver regeneration crystallized in the
RT   presence of 50 mM CdCl2 reveals a novel Cd2Cl4O6 cluster that aids in
RT   crystal packing.";
RL   Acta Crystallogr. D 68:1128-1133(2012).
CC   -!- FUNCTION: FAD-dependent sulfhydryl oxidase that regenerates the redox-
CC       active disulfide bonds in CHCHD4/MIA40, a chaperone essential for
CC       disulfide bond formation and protein folding in the mitochondrial
CC       intermembrane space. The reduced form of CHCHD4/MIA40 forms a transient
CC       intermolecular disulfide bridge with GFER/ERV1, resulting in
CC       regeneration of the essential disulfide bonds in CHCHD4/MIA40, while
CC       GFER/ERV1 becomes re-oxidized by donating electrons to cytochrome c or
CC       molecular oxygen. May have a function in liver regeneration and
CC       spermatogenesis. {ECO:0000269|PubMed:8058770}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + 2 R'C(R)SH = H2O2 + R'C(R)S-S(R)CR';
CC         Xref=Rhea:RHEA:17357, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:16520, ChEBI:CHEBI:17412; EC=1.8.3.2;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00654,
CC         ECO:0000269|PubMed:12717032};
CC   -!- SUBUNIT: Homodimer; disulfide-linked (PubMed:12717032,
CC       PubMed:22948913). Interacts with CHCHD4/MIA40 (By similarity).
CC       {ECO:0000250|UniProtKB:P55789, ECO:0000269|PubMed:12717032,
CC       ECO:0000269|PubMed:22948913}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion intermembrane space
CC       {ECO:0000250|UniProtKB:P55789}. Mitochondrion
CC       {ECO:0000250|UniProtKB:P55789}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF12808.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA06399.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D30735; BAA06399.1; ALT_INIT; mRNA.
DR   EMBL; AF197192; AAF12808.1; ALT_INIT; Genomic_DNA.
DR   PIR; I80184; I80184.
DR   RefSeq; NP_037354.2; NM_013222.2.
DR   PDB; 1OQC; X-ray; 1.80 A; A/B/C/D=74-198.
DR   PDB; 3R7C; X-ray; 2.40 A; A/B/C/D=74-198.
DR   PDBsum; 1OQC; -.
DR   PDBsum; 3R7C; -.
DR   SMR; Q63042; -.
DR   STRING; 10116.ENSRNOP00000017917; -.
DR   PaxDb; Q63042; -.
DR   PRIDE; Q63042; -.
DR   Ensembl; ENSRNOT00000017917; ENSRNOP00000017917; ENSRNOG00000013370.
DR   GeneID; 27100; -.
DR   KEGG; rno:27100; -.
DR   UCSC; RGD:61845; rat.
DR   CTD; 2671; -.
DR   RGD; 61845; Gfer.
DR   eggNOG; KOG3355; Eukaryota.
DR   GeneTree; ENSGT00390000001979; -.
DR   HOGENOM; CLU_070631_1_1_1; -.
DR   InParanoid; Q63042; -.
DR   OMA; KPCRSCT; -.
DR   OrthoDB; 1537996at2759; -.
DR   PhylomeDB; Q63042; -.
DR   TreeFam; TF105271; -.
DR   BRENDA; 1.8.3.2; 5301.
DR   EvolutionaryTrace; Q63042; -.
DR   PRO; PR:Q63042; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000013370; Expressed in testis and 22 other tissues.
DR   Genevisible; Q63042; RN.
DR   GO; GO:0005829; C:cytosol; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:RGD.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; ISS:UniProtKB.
DR   GO; GO:0016971; F:flavin-linked sulfhydryl oxidase activity; IDA:RGD.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0015035; F:protein disulfide oxidoreductase activity; ISS:UniProtKB.
DR   GO; GO:0072717; P:cellular response to actinomycin D; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0097237; P:cellular response to toxic substance; IEP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0001889; P:liver development; IBA:GO_Central.
DR   GO; GO:0097421; P:liver regeneration; IMP:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0045953; P:negative regulation of natural killer cell mediated cytotoxicity; IDA:RGD.
DR   GO; GO:1903204; P:negative regulation of oxidative stress-induced neuron death; IDA:RGD.
DR   GO; GO:2000573; P:positive regulation of DNA biosynthetic process; IDA:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   Gene3D; 1.20.120.310; -; 1.
DR   InterPro; IPR039799; ALR/ERV.
DR   InterPro; IPR036774; ERV/ALR_sulphydryl_oxid_sf.
DR   InterPro; IPR017905; ERV/ALR_sulphydryl_oxidase.
DR   PANTHER; PTHR12645; PTHR12645; 1.
DR   Pfam; PF04777; Evr1_Alr; 1.
DR   SUPFAM; SSF69000; SSF69000; 1.
DR   PROSITE; PS51324; ERV_ALR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; FAD; Flavoprotein; Growth factor;
KW   Mitochondrion; Oxidoreductase; Reference proteome.
FT   CHAIN           1..198
FT                   /note="FAD-linked sulfhydryl oxidase ALR"
FT                   /id="PRO_0000208550"
FT   DOMAIN          88..188
FT                   /note="ERV/ALR sulfhydryl oxidase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654"
FT   NP_BIND         92..100
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12717032,
FT                   ECO:0000269|PubMed:22948913"
FT   NP_BIND         164..176
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12717032,
FT                   ECO:0000269|PubMed:22948913"
FT   NP_BIND         187..188
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12717032,
FT                   ECO:0000269|PubMed:22948913"
FT   REGION          1..59
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        29..45
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         104
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12717032,
FT                   ECO:0000269|PubMed:22948913"
FT   BINDING         133
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12717032,
FT                   ECO:0000269|PubMed:22948913"
FT   DISULFID        88
FT                   /note="Interchain (with C-197)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000269|PubMed:12717032"
FT   DISULFID        135..138
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000269|PubMed:12717032"
FT   DISULFID        164..181
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000269|PubMed:12717032"
FT   DISULFID        197
FT                   /note="Interchain (with C-88)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00654,
FT                   ECO:0000269|PubMed:12717032"
FT   HELIX           92..108
FT                   /evidence="ECO:0007829|PDB:1OQC"
FT   HELIX           116..132
FT                   /evidence="ECO:0007829|PDB:1OQC"
FT   HELIX           136..148
FT                   /evidence="ECO:0007829|PDB:1OQC"
FT   HELIX           156..173
FT                   /evidence="ECO:0007829|PDB:1OQC"
FT   HELIX           181..183
FT                   /evidence="ECO:0007829|PDB:1OQC"
FT   HELIX           184..188
FT                   /evidence="ECO:0007829|PDB:1OQC"
SQ   SEQUENCE   198 AA;  22837 MW;  46AD9BEC2EF0C393 CRC64;
     MAAPSEPAGF PRGSRFSFLP GGAHSEMTDD LVTDARGRGA RHRKDNAPAA APAPKGLEHG
     KRPCRACVDF KSWMRTQQKR DIKFREDCPQ DREELGRNTW AFLHTLAAYY PDMPTPEQQQ
     DMAQFIHIFS KFYPCEECAE DIRKRIDRSQ PDTSTRVSFS QWLCRLHNEV NRKLGKPDFD
     CSRVDERWRD GWKDGSCD
//
ID   FRDA_WOLSU              Reviewed;         656 AA.
AC   P17412;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2003, sequence version 3.
DT   02-JUN-2021, entry version 160.
DE   RecName: Full=Fumarate reductase flavoprotein subunit;
DE            EC=1.3.5.4;
DE   AltName: Full=Quinol-fumarate reductase flavoprotein subunit {ECO:0000303|PubMed:10586875};
DE            Short=QFR flavoprotein subunit {ECO:0000303|PubMed:10586875};
GN   Name=frdA; OrderedLocusNames=WS0831;
OS   Wolinella succinogenes (strain ATCC 29543 / DSM 1740 / LMG 7466 / NCTC
OS   11488 / FDC 602W) (Vibrio succinogenes).
OC   Bacteria; Proteobacteria; Epsilonproteobacteria; Campylobacterales;
OC   Helicobacteraceae; Wolinella.
OX   NCBI_TaxID=273121;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2244791; DOI=10.1007/bf00276536;
RA   Lauterbach F., Koertner C., Albracht S.P., Unden G., Kroeger A.;
RT   "The fumarate reductase operon of Wolinella succinogenes. Sequence and
RT   expression of the frdA and frdB genes.";
RL   Arch. Microbiol. 154:386-393(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RX   PubMed=9492313; DOI=10.1046/j.1432-1327.1998.2510418.x;
RA   Simon J., Gross R., Ringel M., Schmidt E., Kroeger A.;
RT   "Deletion and site-directed mutagenesis of the Wolinella succinogenes
RT   fumarate reductase operon.";
RL   Eur. J. Biochem. 251:418-426(1998).
RN   [3]
RP   SEQUENCE REVISION TO 281-289; 490 AND 593.
RA   Simon J.;
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 29543 / DSM 1740 / LMG 7466 / NCTC 11488 / FDC 602W;
RX   PubMed=14500908; DOI=10.1073/pnas.1932838100;
RA   Baar C., Eppinger M., Raddatz G., Simon J., Lanz C., Klimmek O.,
RA   Nandakumar R., Gross R., Rosinus A., Keller H., Jagtap P., Linke B.,
RA   Meyer F., Lederer H., Schuster S.C.;
RT   "Complete genome sequence and analysis of Wolinella succinogenes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:11690-11695(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-25.
RX   PubMed=3609021; DOI=10.1111/j.1432-1033.1987.tb13536.x;
RA   Lauterbach F., Kortner C., Tripier D., Unden G.;
RT   "Cloning and expression of the genes of two fumarate reductase subunits
RT   from Wolinella succinogenes.";
RL   Eur. J. Biochem. 166:447-452(1987).
RN   [6] {ECO:0007744|PDB:1QLB}
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH FAD, SEQUENCE
RP   REVISION TO 281-289, COFACTOR, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=10586875; DOI=10.1038/46483;
RA   Lancaster C.R.D., Kroeger A., Auer M., Michel H.;
RT   "Structure of fumarate reductase from Wolinella succinogenes at 2.2 A
RT   resolution.";
RL   Nature 402:377-385(1999).
RN   [7] {ECO:0007744|PDB:1E7P}
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) IN COMPLEX WITH FAD, FUNCTION,
RP   COFACTOR, SUBUNIT, AND MUTAGENESIS OF ARG-301.
RX   PubMed=11248702; DOI=10.1046/j.1432-1033.2001.02053.x;
RA   Lancaster C.R.D., Gross R., Simon J.;
RT   "A third crystal form of Wolinella succinogenes quinol:fumarate reductase
RT   reveals domain closure at the site of fumarate reduction.";
RL   Eur. J. Biochem. 268:1820-1827(2001).
CC   -!- FUNCTION: The fumarate reductase enzyme complex is required for
CC       fumarate respiration using formate or sulfide as electron donor.
CC       {ECO:0000269|PubMed:11248702, ECO:0000269|PubMed:9492313}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + succinate = a quinol + fumarate;
CC         Xref=Rhea:RHEA:40523, ChEBI:CHEBI:24646, ChEBI:CHEBI:29806,
CC         ChEBI:CHEBI:30031, ChEBI:CHEBI:132124; EC=1.3.5.4;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:10586875, ECO:0000269|PubMed:11248702};
CC       Note=Binds 1 FAD covalently per subunit. {ECO:0000269|PubMed:10586875,
CC       ECO:0000269|PubMed:11248702};
CC   -!- SUBUNIT: Part of an enzyme complex containing three subunits: a
CC       flavoprotein (frdA), an iron-sulfur protein (frdB), and diheme
CC       cytochrome b (frdC). {ECO:0000269|PubMed:10586875,
CC       ECO:0000269|PubMed:11248702}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000305}; Peripheral
CC       membrane protein {ECO:0000305|PubMed:10586875}; Cytoplasmic side
CC       {ECO:0000305|PubMed:10586875}.
CC   -!- SIMILARITY: Belongs to the FAD-dependent oxidoreductase 2 family.
CC       FRD/SDH subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ000662; CAA04214.2; -; Genomic_DNA.
DR   EMBL; BX571659; CAE09942.1; -; Genomic_DNA.
DR   EMBL; M28294; AAA27586.1; -; Genomic_DNA.
DR   PIR; B44954; B44954.
DR   RefSeq; WP_011138739.1; NC_005090.1.
DR   PDB; 1E7P; X-ray; 3.10 A; A/D/G/J=1-656.
DR   PDB; 1QLB; X-ray; 2.33 A; A/D=1-656.
DR   PDB; 2BS2; X-ray; 1.78 A; A/D=1-656.
DR   PDB; 2BS3; X-ray; 2.19 A; A/D=1-656.
DR   PDB; 2BS4; X-ray; 2.76 A; A/D=1-656.
DR   PDBsum; 1E7P; -.
DR   PDBsum; 1QLB; -.
DR   PDBsum; 2BS2; -.
DR   PDBsum; 2BS3; -.
DR   PDBsum; 2BS4; -.
DR   SMR; P17412; -.
DR   STRING; 273121.WS0831; -.
DR   DrugBank; DB07669; 2,3-Dimethyl-1,4-naphthoquinone.
DR   TCDB; 3.D.10.1.3; the prokaryotic succinate dehydrogenase (sdh) family.
DR   PRIDE; P17412; -.
DR   EnsemblBacteria; CAE09942; CAE09942; WS0831.
DR   KEGG; wsu:WS0831; -.
DR   eggNOG; COG1053; Bacteria.
DR   HOGENOM; CLU_014312_6_2_7; -.
DR   OMA; HRAESCG; -.
DR   OrthoDB; 153138at2; -.
DR   BioCyc; WSUC273121:G1GTD-799-MONOMER; -.
DR   BRENDA; 1.3.5.4; 6642.
DR   EvolutionaryTrace; P17412; -.
DR   Proteomes; UP000000422; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070469; C:respirasome; IEA:UniProtKB-KW.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0102040; F:fumarate reductase (menaquinone); IEA:UniProtKB-EC.
DR   GO; GO:0022900; P:electron transport chain; IEA:InterPro.
DR   Gene3D; 3.50.50.60; -; 1.
DR   Gene3D; 3.90.700.10; -; 1.
DR   InterPro; IPR003953; FAD-binding_2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR003952; FRD_SDH_FAD_BS.
DR   InterPro; IPR037099; Fum_R/Succ_DH_flav-like_C_sf.
DR   InterPro; IPR015939; Fum_Rdtase/Succ_DH_flav-like_C.
DR   InterPro; IPR027477; Succ_DH/fumarate_Rdtase_cat_sf.
DR   InterPro; IPR014006; Succ_Dhase_FrdA_Gneg.
DR   Pfam; PF00890; FAD_binding_2; 1.
DR   Pfam; PF02910; Succ_DH_flav_C; 1.
DR   SUPFAM; SSF46977; SSF46977; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF56425; SSF56425; 1.
DR   TIGRFAMs; TIGR01812; sdhA_frdA_Gneg; 1.
DR   PROSITE; PS00504; FRD_SDH_FAD_BINDING; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell inner membrane; Cell membrane; Electron transport; FAD;
KW   Flavoprotein; Membrane; Oxidoreductase; Reference proteome;
KW   Respiratory chain; Transport.
FT   CHAIN           1..656
FT                   /note="Fumarate reductase flavoprotein subunit"
FT                   /id="PRO_0000158667"
FT   NP_BIND         13..16
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10586875,
FT                   ECO:0000269|PubMed:11248702, ECO:0007744|PDB:1E7P,
FT                   ECO:0007744|PDB:1QLB, ECO:0007744|PDB:2BS2,
FT                   ECO:0007744|PDB:2BS3, ECO:0007744|PDB:2BS4"
FT   NP_BIND         42..44
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10586875,
FT                   ECO:0000269|PubMed:11248702, ECO:0007744|PDB:1E7P,
FT                   ECO:0007744|PDB:1QLB, ECO:0007744|PDB:2BS2,
FT                   ECO:0007744|PDB:2BS3, ECO:0007744|PDB:2BS4"
FT   NP_BIND         49..50
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10586875,
FT                   ECO:0000269|PubMed:11248702, ECO:0007744|PDB:1E7P,
FT                   ECO:0007744|PDB:1QLB, ECO:0007744|PDB:2BS2,
FT                   ECO:0007744|PDB:2BS3, ECO:0007744|PDB:2BS4"
FT   NP_BIND         409..410
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10586875,
FT                   ECO:0000269|PubMed:11248702, ECO:0007744|PDB:1E7P,
FT                   ECO:0007744|PDB:1QLB, ECO:0007744|PDB:2BS2,
FT                   ECO:0007744|PDB:2BS3, ECO:0007744|PDB:2BS4"
FT   ACT_SITE        257
FT                   /evidence="ECO:0000250|UniProtKB:P00363"
FT   ACT_SITE        273
FT                   /evidence="ECO:0000250|UniProtKB:P00363"
FT   BINDING         235
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10586875,
FT                   ECO:0000269|PubMed:11248702, ECO:0007744|PDB:1E7P,
FT                   ECO:0007744|PDB:1QLB, ECO:0007744|PDB:2BS2,
FT                   ECO:0007744|PDB:2BS3, ECO:0007744|PDB:2BS4"
FT   BINDING         393
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10586875,
FT                   ECO:0007744|PDB:1QLB, ECO:0007744|PDB:2BS2,
FT                   ECO:0007744|PDB:2BS3, ECO:0007744|PDB:2BS4"
FT   MOD_RES         43
FT                   /note="Tele-8alpha-FAD histidine"
FT                   /evidence="ECO:0000269|PubMed:10586875,
FT                   ECO:0000269|PubMed:11248702, ECO:0007744|PDB:1E7P,
FT                   ECO:0007744|PDB:1QLB, ECO:0007744|PDB:2BS2,
FT                   ECO:0007744|PDB:2BS3"
FT   MUTAGEN         301
FT                   /note="R->E: No growth on fumarate, loss of FAD cofactor,
FT                   no enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:11248702"
FT   MUTAGEN         301
FT                   /note="R->K: No growth on fumarate, retains FAD cofactor,
FT                   15-fold decreased enzmye activity in vitro."
FT                   /evidence="ECO:0000269|PubMed:11248702"
FT   STRAND          3..5
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          7..11
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           15..25
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   TURN            26..28
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          31..34
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           39..41
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           43..46
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           59..61
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           66..76
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   TURN            77..79
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           83..102
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          112..116
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          119..122
FT                   /evidence="ECO:0007829|PDB:1QLB"
FT   STRAND          125..128
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           130..132
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           156..171
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          174..176
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          178..187
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          190..198
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   TURN            199..201
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          204..208
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          210..214
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           220..222
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          223..228
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           235..241
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          244..246
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          254..258
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   TURN            262..264
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           271..275
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          278..280
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          282..285
FT                   /evidence="ECO:0007829|PDB:1E7P"
FT   HELIX           288..291
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   TURN            293..295
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           296..298
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           301..313
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   TURN            314..316
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          317..320
FT                   /evidence="ECO:0007829|PDB:2BS4"
FT   STRAND          325..329
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           331..333
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           335..341
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           343..351
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   TURN            357..359
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          362..364
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          367..371
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          374..376
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          384..386
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          388..390
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           392..394
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           408..430
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          434..436
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           437..456
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           463..477
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          478..482
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           484..501
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          511..513
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           515..539
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          547..549
FT                   /evidence="ECO:0007829|PDB:1E7P"
FT   STRAND          554..556
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   TURN            557..559
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          562..567
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          570..572
FT                   /evidence="ECO:0007829|PDB:1E7P"
FT   STRAND          577..582
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           585..587
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   STRAND          596..598
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           607..625
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           630..637
FT                   /evidence="ECO:0007829|PDB:2BS2"
FT   HELIX           644..646
FT                   /evidence="ECO:0007829|PDB:2BS2"
SQ   SEQUENCE   656 AA;  72719 MW;  BFEE6E8316F7F618 CRC64;
     MKVQYCDSLV IGGGLAGLRA AVATQQKGLS TIVLSLIPVK RSHSAAAQGG MQASLGNSKM
     SDGDNEDLHF MDTVKGSDWG CDQKVARMFV NTAPKAIREL AAWGVPWTRI HKGDRMAIIN
     AQKTTITEED FRHGLIHSRD FGGTKKWRTC YTADATGHTM LFAVANECLK LGVSIQDRKE
     AIALIHQDGK CYGAVVRDLV TGDIIAYVAK GTLIATGGYG RIYKNTTNAV VCEGTGTAIA
     LETGIAQLGN MEAVQFHPTP LFPSGILLTE GCRGDGGILR DVDGHRFMPD YEPEKKELAS
     RDVVSRRMIE HIRKGKGVQS PYGQHLWLDI SILGRKHIET NLRDVQEICE YFAGIDPAEK
     WAPVLPMQHY SMGGIRTDYR GEAKLKGLFS AGEAACWDMH GFNRLGGNSV SEAVVAGMIV
     GEYFAEHCAN TQVDLETKTL EKFVKGQEAY MKSLVESKGT EDVFKIKNRM KDVMDDNVGI
     FRDGPHLEKA VKELEELYKK SKNVGIKNKR LHANPELEEA YRVPMMLKVA LCVAKGALDR
     TESRGAHNRE DYPKRDDINW LNRTLASWPN PEQTLPTLEY EALDVNEMEI APGYRGYGAK
     GNYIENPLSV KRQEEIDKIQ SELEAAGKDR HAIQEALMPY ELPAKYKARN ERLGDK
//
ID   HPAC_THET8              Reviewed;         149 AA.
AC   Q5SJP7;
DT   03-NOV-2009, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   02-JUN-2021, entry version 89.
DE   RecName: Full=4-hydroxyphenylacetate 3-monooxygenase, reductase component {ECO:0000303|PubMed:17729270};
DE            EC=1.5.1.36 {ECO:0000269|PubMed:17729270};
DE   AltName: Full=4-HPA 3-monooxygenase small component;
DE   AltName: Full=Flavin:NADH reductase;
GN   OrderedLocusNames=TTHA0961;
OS   Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8).
OC   Bacteria; Deinococcus-Thermus; Deinococci; Thermales; Thermaceae; Thermus.
OX   NCBI_TaxID=300852;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 27634 / DSM 579 / HB8;
RA   Masui R., Kurokawa K., Nakagawa N., Tokunaga F., Koyama Y., Shibata T.,
RA   Oshima T., Yokoyama S., Yasunaga T., Kuramitsu S.;
RT   "Complete genome sequence of Thermus thermophilus HB8.";
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) IN COMPLEX WITH FAD AND NAD,
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, PATHWAY,
RP   SUBUNIT, AND SUBSTRATE SPECIFICITY.
RX   PubMed=17729270; DOI=10.1002/prot.21534;
RA   Kim S.-H., Hisano T., Iwasaki W., Ebihara A., Miki K.;
RT   "Crystal structure of the flavin reductase component (hpaC) of 4-
RT   hydroxyphenylacetate 3-monooxygenase from Thermus thermophilus HB8:
RT   Structural basis for the flavin affinity.";
RL   Proteins 70:718-730(2008).
CC   -!- FUNCTION: Catalyzes the reduction of free flavins (FMN, FAD and
CC       riboflavin) by NADH. Subsequently, the reduced flavins diffuse to the
CC       large HpaB component. It utilizes NADH, but not NADPH as an electron
CC       donor, and both FAD and FMN as electron acceptors.
CC       {ECO:0000269|PubMed:17729270}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a reduced flavin + NAD(+) = an oxidized flavin + 2 H(+) +
CC         NADH; Xref=Rhea:RHEA:31303, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:60531, ChEBI:CHEBI:62787; EC=1.5.1.36;
CC         Evidence={ECO:0000269|PubMed:17729270};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=8.9 uM for FAD (at 30 degrees Celsius and pH 7.0)
CC         {ECO:0000269|PubMed:17729270};
CC         KM=36.8 uM for FMN (at 30 degrees Celsius and pH 7.0)
CC         {ECO:0000269|PubMed:17729270};
CC   -!- PATHWAY: Aromatic compound metabolism; 4-hydroxyphenylacetate
CC       degradation; pyruvate and succinate semialdehyde from 4-
CC       hydroxyphenylacetate: step 1/7. {ECO:0000305|PubMed:17729270}.
CC   -!- SUBUNIT: Homodimer. 4-HPA 3-monooxygenase consists of a reductase
CC       component HpaC and an oxygenase component HpaB.
CC       {ECO:0000269|PubMed:17729270}.
CC   -!- SIMILARITY: Belongs to the non-flavoprotein flavin reductase family.
CC       HpaC subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AP008226; BAD70784.1; -; Genomic_DNA.
DR   RefSeq; WP_011228329.1; NC_006461.1.
DR   RefSeq; YP_144227.1; NC_006461.1.
DR   PDB; 2ECR; X-ray; 1.60 A; A/B=1-149.
DR   PDB; 2ECU; X-ray; 1.30 A; A/B=1-149.
DR   PDB; 2ED4; X-ray; 1.85 A; A/B=1-149.
DR   PDBsum; 2ECR; -.
DR   PDBsum; 2ECU; -.
DR   PDBsum; 2ED4; -.
DR   SMR; Q5SJP7; -.
DR   STRING; 300852.55772343; -.
DR   EnsemblBacteria; BAD70784; BAD70784; BAD70784.
DR   GeneID; 3170068; -.
DR   KEGG; ttj:TTHA0961; -.
DR   PATRIC; fig|300852.9.peg.943; -.
DR   eggNOG; COG1853; Bacteria.
DR   HOGENOM; CLU_059021_1_4_0; -.
DR   OMA; WFDRGYH; -.
DR   PhylomeDB; Q5SJP7; -.
DR   SABIO-RK; Q5SJP7; -.
DR   UniPathway; UPA00208; UER00416.
DR   EvolutionaryTrace; Q5SJP7; -.
DR   Proteomes; UP000000532; Chromosome.
DR   GO; GO:0036382; F:flavin reductase (NADH) activity; IEA:UniProtKB-EC.
DR   GO; GO:0010181; F:FMN binding; IEA:InterPro.
DR   GO; GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-KW.
DR   Gene3D; 2.30.110.10; -; 1.
DR   InterPro; IPR002563; Flavin_Rdtase-like_dom.
DR   InterPro; IPR012349; Split_barrel_FMN-bd.
DR   Pfam; PF01613; Flavin_Reduct; 1.
DR   SMART; SM00903; Flavin_Reduct; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aromatic hydrocarbons catabolism; FAD; Flavoprotein; FMN;
KW   NAD; Oxidoreductase; Reference proteome.
FT   CHAIN           1..149
FT                   /note="4-hydroxyphenylacetate 3-monooxygenase, reductase
FT                   component"
FT                   /id="PRO_0000387997"
FT   NP_BIND         27..34
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17729270,
FT                   ECO:0007744|PDB:2ED4"
FT   NP_BIND         48..50
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17729270,
FT                   ECO:0007744|PDB:2ED4"
FT   NP_BIND         54..55
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17729270,
FT                   ECO:0007744|PDB:2ED4"
FT   NP_BIND         137..140
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:17729270,
FT                   ECO:0007744|PDB:2ED4"
FT   BINDING         37
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:17729270,
FT                   ECO:0007744|PDB:2ED4"
FT   BINDING         80
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17729270,
FT                   ECO:0007744|PDB:2ED4"
FT   BINDING         116
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:17729270,
FT                   ECO:0007744|PDB:2ED4"
FT   HELIX           3..10
FT                   /evidence="ECO:0007829|PDB:2ECU"
FT   STRAND          17..23
FT                   /evidence="ECO:0007829|PDB:2ECU"
FT   STRAND          26..33
FT                   /evidence="ECO:0007829|PDB:2ECU"
FT   STRAND          35..39
FT                   /evidence="ECO:0007829|PDB:2ECU"
FT   TURN            40..43
FT                   /evidence="ECO:0007829|PDB:2ECU"
FT   STRAND          44..50
FT                   /evidence="ECO:0007829|PDB:2ECU"
FT   HELIX           55..62
FT                   /evidence="ECO:0007829|PDB:2ECU"
FT   STRAND          64..69
FT                   /evidence="ECO:0007829|PDB:2ECU"
FT   HELIX           75..80
FT                   /evidence="ECO:0007829|PDB:2ECU"
FT   TURN            81..83
FT                   /evidence="ECO:0007829|PDB:2ECU"
FT   STRAND          100..113
FT                   /evidence="ECO:0007829|PDB:2ECU"
FT   STRAND          116..128
FT                   /evidence="ECO:0007829|PDB:2ECU"
FT   STRAND          139..143
FT                   /evidence="ECO:0007829|PDB:2ECU"
SQ   SEQUENCE   149 AA;  16111 MW;  CD963ADB68B1D66A CRC64;
     MKEAFKEALA RFASGVTVVA ARLGEEERGM TATAFMSLSL EPPLVALAVS ERAKLLPVLE
     GAGAFTVSLL REGQEAVSEH FAGRPKEGIA LEEGRVKGAL AVLRCRLHAL YPGGDHRIVV
     GLVEEVELGE EGPPLVYFQR GYRRLVWPS
//
ID   FENR1_PEA               Reviewed;         360 AA.
AC   P10933;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   02-JUN-2021, entry version 142.
DE   RecName: Full=Ferredoxin--NADP reductase, leaf isozyme, chloroplastic;
DE            Short=FNR;
DE            EC=1.18.1.2;
DE   Flags: Precursor;
GN   Name=PETH;
OS   Pisum sativum (Garden pea).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; fabids; Fabales; Fabaceae; Papilionoideae; 50 kb inversion clade;
OC   NPAAA clade; Hologalegina; IRL clade; Fabeae; Pisum.
OX   NCBI_TaxID=3888;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Little Marvel; TISSUE=Leaf;
RX   AGRICOLA=IND92000035; DOI=10.1007/BF00033606;
RA   Newman B.J., Gray J.C.;
RT   "Characterisation of a full-length cDNA clone for pea ferredoxin-NADP+
RT   reductase.";
RL   Plant Mol. Biol. 10:511-520(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 270-360, AND MUTAGENESIS OF TYR-360.
RX   PubMed=8366077;
RA   Orellano E.G., Calcaterra N.B., Carrillo N., Ceccarelli E.A.;
RT   "Probing the role of the carboxyl-terminal region of ferredoxin-NADP+
RT   reductase by site-directed mutagenesis and deletion analysis.";
RL   J. Biol. Chem. 268:19267-19273(1993).
RN   [3]
RP   INTERACTION WITH TIC62.
RX   PubMed=12426385; DOI=10.1093/emboj/cdf621;
RA   Kuechler M., Decker S., Hoermann F., Soll J., Heins L.;
RT   "Protein import into chloroplasts involves redox-regulated proteins.";
RL   EMBO J. 21:6136-6145(2002).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH FAD AND NADP.
RX   PubMed=10467097; DOI=10.1038/12307;
RA   Deng Z., Aliverti A., Zanetti G., Arakaki A.K., Ottado J., Orellano E.G.,
RA   Calcaterra N.B., Ceccarelli E.A., Carrillo N., Karplus P.A.;
RT   "A productive NADP+ binding mode of ferredoxin-NADP + reductase revealed by
RT   protein engineering and crystallographic studies.";
RL   Nat. Struct. Biol. 6:847-853(1999).
CC   -!- FUNCTION: May play a key role in regulating the relative amounts of
CC       cyclic and non-cyclic electron flow to meet the demands of the plant
CC       for ATP and reducing power.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADP(+) + 2 reduced [2Fe-2S]-[ferredoxin] = NADPH + 2
CC         oxidized [2Fe-2S]-[ferredoxin]; Xref=Rhea:RHEA:20125, Rhea:RHEA-
CC         COMP:10000, Rhea:RHEA-COMP:10001, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:33737, ChEBI:CHEBI:33738, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.18.1.2;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- PATHWAY: Energy metabolism; photosynthesis.
CC   -!- SUBUNIT: Monomer. Interacts with TIC62 (via C-terminus).
CC       {ECO:0000269|PubMed:10467097, ECO:0000269|PubMed:12426385}.
CC   -!- INTERACTION:
CC       P10933; P09911: PETF; NbExp=3; IntAct=EBI-931306, EBI-931449;
CC       P10933; Q8SKU2: TIC62; NbExp=5; IntAct=EBI-931306, EBI-15606082;
CC   -!- SUBCELLULAR LOCATION: Plastid, chloroplast stroma. Plastid, chloroplast
CC       thylakoid membrane {ECO:0000305}; Peripheral membrane protein
CC       {ECO:0000305}; Stromal side {ECO:0000305}. Note=In the vicinity of the
CC       photosystem I in the non-stacked and fringe portion of the membrane.
CC   -!- MISCELLANEOUS: FNR is probably attached to the membrane by a specific
CC       binding protein.
CC   -!- SIMILARITY: Belongs to the ferredoxin--NADP reductase type 1 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X12446; CAA30978.1; -; mRNA.
DR   EMBL; L15565; AAB59349.1; -; mRNA.
DR   EMBL; L15567; AAB59303.1; -; mRNA.
DR   EMBL; L15569; AAB59304.1; -; mRNA.
DR   PIR; S04030; S04030.
DR   PDB; 1QFY; X-ray; 1.80 A; A/B=53-360.
DR   PDB; 1QFZ; X-ray; 1.70 A; A/B=53-360.
DR   PDB; 1QG0; X-ray; 2.50 A; A/B=53-360.
DR   PDB; 1QGA; X-ray; 2.00 A; A/B=53-360.
DR   PDB; 2XNC; X-ray; 2.90 A; A/B=53-360.
DR   PDB; 3MHP; X-ray; 1.70 A; A/B=66-360.
DR   PDB; 4AF6; X-ray; 2.90 A; A/B=53-360.
DR   PDB; 4AF7; X-ray; 2.85 A; A/B=53-360.
DR   PDBsum; 1QFY; -.
DR   PDBsum; 1QFZ; -.
DR   PDBsum; 1QG0; -.
DR   PDBsum; 1QGA; -.
DR   PDBsum; 2XNC; -.
DR   PDBsum; 3MHP; -.
DR   PDBsum; 4AF6; -.
DR   PDBsum; 4AF7; -.
DR   SMR; P10933; -.
DR   DIP; DIP-35575N; -.
DR   IntAct; P10933; 3.
DR   PRIDE; P10933; -.
DR   BRENDA; 1.18.1.2; 4872.
DR   BRENDA; 1.19.1.1; 4872.
DR   SABIO-RK; P10933; -.
DR   UniPathway; UPA00091; -.
DR   EvolutionaryTrace; P10933; -.
DR   GO; GO:0009570; C:chloroplast stroma; IEA:UniProtKB-SubCell.
DR   GO; GO:0009535; C:chloroplast thylakoid membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004324; F:ferredoxin-NADP+ reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0015979; P:photosynthesis; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.40.50.80; -; 1.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR015701; FNR.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR035442; FNR_plant_Cyanobacteria.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   PIRSF; PIRSF501178; FNR-PetH; 1.
DR   PIRSF; PIRSF000361; Frd-NADP+_RD; 1.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52343; SSF52343; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chloroplast; Electron transport; FAD; Flavoprotein; Membrane;
KW   NADP; Oxidoreductase; Photosynthesis; Plastid; Thylakoid; Transit peptide;
KW   Transport.
FT   TRANSIT         1..52
FT                   /note="Chloroplast"
FT   CHAIN           53..360
FT                   /note="Ferredoxin--NADP reductase, leaf isozyme,
FT                   chloroplastic"
FT                   /id="PRO_0000019411"
FT   DOMAIN          81..203
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   NP_BIND         139..142
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10467097"
FT   NP_BIND         160..162
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10467097"
FT   NP_BIND         177..179
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10467097"
FT   NP_BIND         250..251
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:10467097"
FT   NP_BIND         280..281
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:10467097"
FT   NP_BIND         319..320
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:10467097"
FT   BINDING         142
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:10467097"
FT   BINDING         162
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:10467097"
FT   BINDING         166
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10467097"
FT   BINDING         218
FT                   /note="FAD"
FT                   /evidence="ECO:0000250"
FT   BINDING         218
FT                   /note="NADP; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:10467097"
FT   BINDING         290
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:10467097"
FT   BINDING         358
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:10467097"
FT   MUTAGEN         360
FT                   /note="Y->F: Results in a 2.0-fold reduction in kcat for
FT                   the diaphorase reaction."
FT                   /evidence="ECO:0000269|PubMed:8366077"
FT   MUTAGEN         360
FT                   /note="Y->G: Results in a 302-fold reduction in kcat for
FT                   the diaphorase reaction."
FT                   /evidence="ECO:0000269|PubMed:8366077"
FT   MUTAGEN         360
FT                   /note="Y->S: Results in a 22-fold reduction in kcat for the
FT                   diaphorase reaction."
FT                   /evidence="ECO:0000269|PubMed:8366077"
FT   MUTAGEN         360
FT                   /note="Y->W: Results in a 2.2-fold reduction in kcat for
FT                   the diaphorase reaction."
FT                   /evidence="ECO:0000269|PubMed:8366077"
FT   STRAND          67..69
FT                   /evidence="ECO:0007829|PDB:1QFY"
FT   STRAND          77..79
FT                   /evidence="ECO:0007829|PDB:3MHP"
FT   STRAND          80..82
FT                   /evidence="ECO:0007829|PDB:2XNC"
FT   STRAND          84..93
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   STRAND          99..101
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   STRAND          103..109
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   STRAND          121..125
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   STRAND          127..129
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   STRAND          133..135
FT                   /evidence="ECO:0007829|PDB:3MHP"
FT   STRAND          139..143
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   STRAND          152..154
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   STRAND          156..162
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   STRAND          165..167
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   STRAND          173..175
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   HELIX           177..184
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   STRAND          190..197
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   STRAND          199..201
FT                   /evidence="ECO:0007829|PDB:4AF7"
FT   STRAND          210..216
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   HELIX           217..220
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   HELIX           221..231
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   STRAND          242..252
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   HELIX           253..255
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   HELIX           259..268
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   TURN            270..272
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   STRAND          273..279
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   TURN            280..282
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   HELIX           293..297
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   HELIX           298..300
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   HELIX           301..309
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   STRAND          313..320
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   HELIX           323..337
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   HELIX           342..351
FT                   /evidence="ECO:0007829|PDB:1QFZ"
FT   STRAND          355..360
FT                   /evidence="ECO:0007829|PDB:1QFZ"
SQ   SEQUENCE   360 AA;  40194 MW;  7F1CC10DEBBA7B24 CRC64;
     MAAAVTAAVS LPYSNSTSLP IRTSIVAPER LVFKKVSLNN VSISGRVGTI RAQVTTEAPA
     KVVKHSKKQD ENIVVNKFKP KEPYVGRCLL NTKITGDDAP GETWHMVFST EGEVPYREGQ
     SIGIVPDGID KNGKPHKLRL YSIASSAIGD FGDSKTVSLC VKRLVYTNDA GEVVKGVCSN
     FLCDLKPGSE VKITGPVGKE MLMPKDPNAT VIMLGTGTGI APFRSFLWKM FFEKHEDYQF
     NGLAWLFLGV PTSSSLLYKE EFEKMKEKAP ENFRLDFAVS REQVNDKGEK MYIQTRMAQY
     AEELWELLKK DNTFVYMCGL KGMEKGIDDI MVSLAAKDGI DWIEYKRTLK KAEQWNVEVY
//
ID   HPXO_KLEP7              Reviewed;         384 AA.
AC   A6T923;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   21-AUG-2007, sequence version 1.
DT   02-JUN-2021, entry version 73.
DE   RecName: Full=FAD-dependent urate hydroxylase {ECO:0000305|PubMed:19260710};
DE            EC=1.14.13.113 {ECO:0000269|PubMed:19260710};
DE   AltName: Full=FAD-dependent urate oxidase {ECO:0000303|PubMed:19260710};
GN   Name=hpxO {ECO:0000303|PubMed:19260710}; OrderedLocusNames=KPN78578_16330;
GN   ORFNames=KPN_01663;
OS   Klebsiella pneumoniae subsp. pneumoniae (strain ATCC 700721 / MGH 78578).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Klebsiella.
OX   NCBI_TaxID=272620;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700721 / MGH 78578;
RG   The Klebsiella pneumonia Genome Sequencing Project;
RA   McClelland M., Sanderson E.K., Spieth J., Clifton W.S., Latreille P.,
RA   Sabo A., Pepin K., Bhonagiri V., Porwollik S., Ali J., Wilson R.K.;
RL   Submitted (SEP-2006) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   PATHWAY.
RC   STRAIN=ATCC 700721 / MGH 78578;
RX   PubMed=19260710; DOI=10.1021/bi900160b;
RA   O'Leary S.E., Hicks K.A., Ealick S.E., Begley T.P.;
RT   "Biochemical characterization of the HpxO enzyme from Klebsiella
RT   pneumoniae, a novel FAD-dependent urate oxidase.";
RL   Biochemistry 48:3033-3035(2009).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.97 ANGSTROMS) OF WILD-TYPE AND MUTANT GLN-204 IN
RP   COMPLEXES WITH URATE AND FAD, SUBUNIT, REACTION MECHANISM, AND MUTAGENESIS
RP   OF ARG-204 AND TYR-216.
RC   STRAIN=ATCC 700721 / MGH 78578;
RX   PubMed=23259842; DOI=10.1021/bi301262p;
RA   Hicks K.A., O'Leary S.E., Begley T.P., Ealick S.E.;
RT   "Structural and mechanistic studies of HpxO, a novel flavin adenine
RT   dinucleotide-dependent urate oxidase from Klebsiella pneumoniae.";
RL   Biochemistry 52:477-487(2013).
CC   -!- FUNCTION: Catalyzes the hydroxylation of urate to 5-hydroxyisourate
CC       (HIU). {ECO:0000269|PubMed:19260710}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADH + O2 + urate = 5-hydroxyisourate + H2O + NAD(+);
CC         Xref=Rhea:RHEA:27329, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:17775, ChEBI:CHEBI:18072,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.14.13.113;
CC         Evidence={ECO:0000269|PubMed:19260710};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:19260710};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=42 uM for urate {ECO:0000269|PubMed:19260710};
CC         Note=kcat is 42 sec(-1). {ECO:0000269|PubMed:19260710};
CC   -!- PATHWAY: Purine metabolism; urate degradation.
CC       {ECO:0000269|PubMed:19260710}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:23259842}.
CC   -!- SIMILARITY: Belongs to the FAD-dependent urate hydroxylase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000647; ABR77094.1; -; Genomic_DNA.
DR   RefSeq; WP_002904783.1; NC_009648.1.
DR   PDB; 3RP6; X-ray; 2.20 A; A=1-384.
DR   PDB; 3RP7; X-ray; 2.04 A; A=1-384.
DR   PDB; 3RP8; X-ray; 1.97 A; A=1-384.
DR   PDBsum; 3RP6; -.
DR   PDBsum; 3RP7; -.
DR   PDBsum; 3RP8; -.
DR   SMR; A6T923; -.
DR   EnsemblBacteria; ABR77094; ABR77094; KPN_01663.
DR   KEGG; kpn:KPN_01663; -.
DR   HOGENOM; CLU_009665_19_5_6; -.
DR   OMA; AMVPYMS; -.
DR   BioCyc; KPNE272620:G1G8J-1790-MONOMER; -.
DR   BRENDA; 1.14.13.113; 2814.
DR   UniPathway; UPA00394; -.
DR   Proteomes; UP000000265; Chromosome.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0102099; F:FAD-dependent urate hydroxylase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; IDA:UniProtKB.
DR   GO; GO:0004846; F:urate oxidase activity; IDA:CACAO.
DR   GO; GO:0006144; P:purine nucleobase metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0019628; P:urate catabolic process; IDA:UniProtKB.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Monooxygenase; NAD; Oxidoreductase;
KW   Purine metabolism; Reference proteome.
FT   CHAIN           1..384
FT                   /note="FAD-dependent urate hydroxylase"
FT                   /id="PRO_0000418845"
FT   NP_BIND         30..31
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23259842,
FT                   ECO:0007744|PDB:3RP6, ECO:0007744|PDB:3RP7,
FT                   ECO:0007744|PDB:3RP8"
FT   NP_BIND         295..299
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23259842,
FT                   ECO:0007744|PDB:3RP6, ECO:0007744|PDB:3RP7,
FT                   ECO:0007744|PDB:3RP8"
FT   REGION          216..218
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:23259842,
FT                   ECO:0007744|PDB:3RP7"
FT   BINDING         11
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:23259842,
FT                   ECO:0007744|PDB:3RP6, ECO:0007744|PDB:3RP7,
FT                   ECO:0007744|PDB:3RP8"
FT   BINDING         43
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23259842,
FT                   ECO:0007744|PDB:3RP6, ECO:0007744|PDB:3RP7,
FT                   ECO:0007744|PDB:3RP8"
FT   BINDING         125
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:23259842,
FT                   ECO:0007744|PDB:3RP6, ECO:0007744|PDB:3RP7,
FT                   ECO:0007744|PDB:3RP8"
FT   BINDING         178
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:23259842,
FT                   ECO:0007744|PDB:3RP7"
FT   BINDING         204
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:23259842,
FT                   ECO:0007744|PDB:3RP7"
FT   BINDING         285
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23259842,
FT                   ECO:0007744|PDB:3RP6, ECO:0007744|PDB:3RP7,
FT                   ECO:0007744|PDB:3RP8"
FT   SITE            204
FT                   /note="Involved in substrate activation for the transfer of
FT                   oxygen from the flavin hydroperoxide"
FT                   /evidence="ECO:0000305|PubMed:23259842"
FT   MUTAGEN         204
FT                   /note="R->Q: 160-fold decrease in catalytic activity.
FT                   Results in the uncoupling of the NADH oxidation and urate
FT                   hydroxylation reactions."
FT                   /evidence="ECO:0000269|PubMed:23259842"
FT   MUTAGEN         216
FT                   /note="Y->F: 5-fold decrease in catalytic activity. 2-fold
FT                   decrease in affinity for urate and increase in affinity for
FT                   NADH."
FT                   /evidence="ECO:0000269|PubMed:23259842"
FT   STRAND          2..6
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           10..21
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   STRAND          25..33
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   STRAND          41..44
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           46..54
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           58..64
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   STRAND          70..75
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   TURN            76..78
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   STRAND          81..86
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           88..94
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   STRAND          99..102
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           103..114
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           116..118
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   STRAND          119..122
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   STRAND          125..131
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   STRAND          134..139
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   STRAND          144..152
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           161..165
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   STRAND          172..184
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   TURN            187..189
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   STRAND          194..200
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   STRAND          203..210
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   TURN            211..213
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   STRAND          214..222
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   TURN            231..233
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           234..241
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   TURN            242..244
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           247..255
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           258..260
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   STRAND          262..268
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   STRAND          280..282
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           284..286
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           292..294
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           297..313
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           318..347
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   TURN            348..351
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           352..363
FT                   /evidence="ECO:0007829|PDB:3RP8"
FT   HELIX           368..379
FT                   /evidence="ECO:0007829|PDB:3RP8"
SQ   SEQUENCE   384 AA;  42107 MW;  4B656520269C3535 CRC64;
     MKAIVIGAGI GGLSAAVALK QSGIDCDVYE AVKEIKPVGA AISVWPNGVK CMAHLGMGDI
     METFGGPLRR MAYRDFRSGE NMTQFSLAPL IERTGSRPCP VSRAELQREM LDYWGRDSVQ
     FGKRVTRCEE DADGVTVWFT DGSSASGDLL IAADGSHSAL RPWVLGFTPQ RRYAGYVNWN
     GLVEIDEALA PGDQWTTFVG EGKRVSLMPV SAGRFYFFFD VPLPAGLAED RDTLRADLSR
     YFAGWAPPVQ KLIAALDPQT TNRIEIHDIE PFSRLVRGRV ALLGDAGHST TPDIGQGGCA
     AMEDAVVLGA VFRQTRDIAA ALREYEAQRC DRVRDLVLKA RKRCDITHGK DMQLTEAWYQ
     ELREETGERI INGMCDTILS GPLG
//
ID   DPRE1_MYCS2             Reviewed;         460 AA.
AC   A0R607; I7FMU1;
DT   01-APR-2015, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-2015, sequence version 2.
DT   02-JUN-2021, entry version 101.
DE   RecName: Full=Decaprenylphosphoryl-beta-D-ribose oxidase {ECO:0000305};
DE            EC=1.1.98.3 {ECO:0000269|PubMed:22188377};
DE   AltName: Full=Decaprenylphospho-beta-D-ribofuranose 2-dehydrogenase {ECO:0000305|PubMed:22956199};
DE   AltName: Full=Decaprenylphosphoryl-beta-D-ribofuranose 2'-epimerase subunit DprE1 {ECO:0000305|PubMed:22188377};
DE            Short=Decaprenyl-phosphoribose 2'-epimerase subunit 1 {ECO:0000305|PubMed:22188377};
DE   AltName: Full=Decaprenylphosphoryl-beta-D-ribofuranose 2'-oxidase {ECO:0000303|PubMed:22188377};
DE   AltName: Full=Decaprenylphosphoryl-beta-D-ribose 2-epimerase flavoprotein subunit {ECO:0000305};
DE   AltName: Full=FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase {ECO:0000305|PubMed:22188377};
GN   Name=dprE1 {ECO:0000303|PubMed:22188377};
GN   OrderedLocusNames=MSMEG_6382, MSMEI_6214; ORFNames=LJ00_31545;
OS   Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) (Mycobacterium
OS   smegmatis).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycolicibacterium.
OX   NCBI_TaxID=246196;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700084 / mc(2)155;
RA   Fleischmann R.D., Dodson R.J., Haft D.H., Merkel J.S., Nelson W.C.,
RA   Fraser C.M.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=17295914; DOI=10.1186/gb-2007-8-2-r20;
RA   Deshayes C., Perrodou E., Gallien S., Euphrasie D., Schaeffer C.,
RA   Van-Dorsselaer A., Poch O., Lecompte O., Reyrat J.-M.;
RT   "Interrupted coding sequences in Mycobacterium smegmatis: authentic
RT   mutations or sequencing errors?";
RL   Genome Biol. 8:R20.1-R20.9(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=18955433; DOI=10.1101/gr.081901.108;
RA   Gallien S., Perrodou E., Carapito C., Deshayes C., Reyrat J.-M.,
RA   Van Dorsselaer A., Poch O., Schaeffer C., Lecompte O.;
RT   "Ortho-proteogenomics: multiple proteomes investigation through orthology
RT   and a new MS-based protocol.";
RL   Genome Res. 19:128-135(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=25657281; DOI=10.1128/genomea.01520-14;
RA   Mohan A., Padiadpu J., Baloni P., Chandra N.;
RT   "Complete genome sequences of a Mycobacterium smegmatis laboratory strain
RT   (MC2 155) and isoniazid-resistant (4XR1/R2) mutant strains.";
RL   Genome Announc. 3:E01520-E01520(2015).
RN   [5]
RP   ACTIVITY REGULATION, DRUG TARGET, AND BTZ043-RESISTANT VARIANTS MN47 AND
RP   MN84.
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=19299584; DOI=10.1126/science.1171583;
RA   Makarov V., Manina G., Mikusova K., Mollmann U., Ryabova O.,
RA   Saint-Joanis B., Dhar N., Pasca M.R., Buroni S., Lucarelli A.P., Milano A.,
RA   De Rossi E., Belanova M., Bobovska A., Dianiskova P., Kordulakova J.,
RA   Sala C., Fullam E., Schneider P., McKinney J.D., Brodin P., Christophe T.,
RA   Waddell S., Butcher P., Albrethsen J., Rosenkrands I., Brosch R., Nandi V.,
RA   Bharath S., Gaonkar S., Shandil R.K., Balasubramanian V., Balganesh T.,
RA   Tyagi S., Grosset J., Riccardi G., Cole S.T.;
RT   "Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan
RT   synthesis.";
RL   Science 324:801-804(2009).
RN   [6]
RP   DISRUPTION PHENOTYPE, AND PATHWAY.
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=21346818; DOI=10.1371/journal.pone.0016869;
RA   Crellin P.K., Brammananth R., Coppel R.L.;
RT   "Decaprenylphosphoryl-beta-D-ribose 2'-epimerase, the target of
RT   benzothiazinones and dinitrobenzamides, is an essential enzyme in
RT   Mycobacterium smegmatis.";
RL   PLoS ONE 6:E16869-E16869(2011).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF CYS-386, ACTIVITY REGULATION,
RP   AND SUBSTRATE SPECIFICITY.
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=22188377; DOI=10.1021/ja211042r;
RA   Trefzer C., Skovierova H., Buroni S., Bobovska A., Nenci S., Molteni E.,
RA   Pojer F., Pasca M.R., Makarov V., Cole S.T., Riccardi G., Mikusova K.,
RA   Johnsson K.;
RT   "Benzothiazinones are suicide inhibitors of mycobacterial
RT   decaprenylphosphoryl-beta-D-ribofuranose 2'-oxidase DprE1.";
RL   J. Am. Chem. Soc. 134:912-915(2012).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEXES WITH FAD AND THE
RP   BENZOTHIAZINONE BTZ043 INHIBITOR, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   MUTAGENESIS OF GLN-335; CYS-386 AND LYS-417, ACTIVITY REGULATION, AND
RP   SUBUNIT.
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=22956199; DOI=10.1126/scitranslmed.3004395;
RA   Neres J., Pojer F., Molteni E., Chiarelli L.R., Dhar N., Boy-Rottger S.,
RA   Buroni S., Fullam E., Degiacomi G., Lucarelli A.P., Read R.J., Zanoni G.,
RA   Edmondson D.E., De Rossi E., Pasca M.R., McKinney J.D., Dyson P.J.,
RA   Riccardi G., Mattevi A., Cole S.T., Binda C.;
RT   "Structural basis for benzothiazinone-mediated killing of Mycobacterium
RT   tuberculosis.";
RL   Sci. Transl. Med. 4:150RA121-150RA121(2012).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 58-460.
RC   STRAIN=ATCC 607 / DSM 43465 / JCM 20379 / NBRC 3207 / NRRL B-692;
RX   PubMed=23184707; DOI=10.1002/prot.24220;
RA   Li H., Jogl G.;
RT   "Crystal structure of decaprenylphosphoryl-beta- D-ribose 2'-epimerase from
RT   Mycobacterium smegmatis.";
RL   Proteins 81:538-543(2013).
CC   -!- FUNCTION: Component of the DprE1-DprE2 complex that catalyzes the 2-
CC       step epimerization of decaprenyl-phospho-ribose (DPR) to decaprenyl-
CC       phospho-arabinose (DPA), a key precursor that serves as the arabinose
CC       donor required for the synthesis of cell-wall arabinans
CC       (PubMed:22188377). DprE1 catalyzes the first step of epimerization,
CC       namely FAD-dependent oxidation of the C2' hydroxyl of DPR to yield the
CC       keto intermediate decaprenyl-phospho-2'-keto-D-arabinose (DPX)
CC       (PubMed:22188377). The intermediate DPX is then transferred to DprE2
CC       subunit of the epimerase complex, most probably through a 'substrate
CC       channel' at the interface of DprE1-DprE2 complex (By similarity). Can
CC       also use farnesyl-phosphoryl-beta-D-ribofuranose (FPR) as substrate in
CC       vitro (PubMed:22188377, PubMed:22956199). Appears to be essential for
CC       the growth of M.smegmatis (PubMed:21346818).
CC       {ECO:0000250|UniProtKB:P9WJF1, ECO:0000269|PubMed:21346818,
CC       ECO:0000269|PubMed:22188377, ECO:0000269|PubMed:22956199}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=FAD + H(+) + trans,octa-cis-decaprenylphospho-beta-D-
CC         ribofuranose = FADH2 + trans,octa-cis-decaprenylphospho-beta-D-
CC         erythro-pentofuranosid-2-ulose; Xref=Rhea:RHEA:33899,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:65067, ChEBI:CHEBI:66881; EC=1.1.98.3;
CC         Evidence={ECO:0000269|PubMed:22188377};
CC   -!- ACTIVITY REGULATION: Is inhibited by 8-nitro-benzothiazinones (BTZs)
CC       such as BTZ043; BTZs are a new class of antimycobacterial agents that
CC       block formation of both cell-wall lipoarabinomannan and arabinogalactan
CC       via inhibition of decaprenyl-phospho-arabinose (DPA) synthesis
CC       (PubMed:19299584, PubMed:22188377). BTZs are suicide inhibitors that
CC       act via covalent modification of DprE1; the essential nitro group of
CC       these compounds is reduced by DprE1 to a nitroso group, which then
CC       specifically reacts with Cys-386 of DprE1 to form an irreversible
CC       semimercaptal adduct (PubMed:22188377, PubMed:22956199). Other
CC       compounds with diverse scaffolds (dinitrobenzamides and
CC       nitrobenzoquinoxalines) also act as covalent DprE1 inhibitors
CC       (PubMed:22956199). {ECO:0000269|PubMed:19299584,
CC       ECO:0000269|PubMed:22188377, ECO:0000269|PubMed:22956199}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.11 mM for FPR (at pH 8.5 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:22956199};
CC         Note=kcat is 12.7 min(-1) for epimerase activity with FPR as
CC         substrate (at pH 8.5 and 25 degrees Celsius).
CC         {ECO:0000269|PubMed:22956199};
CC   -!- PATHWAY: Cell wall biogenesis; cell wall polysaccharide biosynthesis.
CC       {ECO:0000305|PubMed:21346818}.
CC   -!- SUBUNIT: Monomer (PubMed:22956199). Interacts with DprE2 to form an
CC       epimerase complex (By similarity). {ECO:0000250|UniProtKB:P9WJF1,
CC       ECO:0000269|PubMed:22956199}.
CC   -!- SUBCELLULAR LOCATION: Periplasm {ECO:0000250|UniProtKB:P9WJF1}.
CC   -!- DISRUPTION PHENOTYPE: Disruption of this gene is only possible in the
CC       presence of a plasmid-encoded copy of the gene. Curing of this 'rescue'
CC       plasmid from the bacterial population results in a cessation of growth,
CC       demonstrating gene essentiality. {ECO:0000269|PubMed:21346818}.
CC   -!- SIMILARITY: Belongs to the DprE1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=ABK72795.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000480; ABK72795.1; ALT_INIT; Genomic_DNA.
DR   EMBL; CP001663; AFP42640.1; -; Genomic_DNA.
DR   EMBL; CP009494; AIU11363.1; -; Genomic_DNA.
DR   RefSeq; WP_003897792.1; NZ_SIJM01000013.1.
DR   RefSeq; YP_890595.1; NC_008596.1.
DR   PDB; 4AUT; X-ray; 2.10 A; A=1-460.
DR   PDB; 4F4Q; X-ray; 2.62 A; A=1-460.
DR   PDB; 4G3T; X-ray; 2.35 A; A=58-460.
DR   PDB; 4G3U; X-ray; 2.69 A; A/B=58-460.
DR   PDBsum; 4AUT; -.
DR   PDBsum; 4F4Q; -.
DR   PDBsum; 4G3T; -.
DR   PDBsum; 4G3U; -.
DR   SMR; A0R607; -.
DR   STRING; 246196.MSMEI_6214; -.
DR   ChEMBL; CHEMBL3797019; -.
DR   PRIDE; A0R607; -.
DR   EnsemblBacteria; ABK72795; ABK72795; MSMEG_6382.
DR   EnsemblBacteria; AFP42640; AFP42640; MSMEI_6214.
DR   KEGG; msb:LJ00_31545; -.
DR   KEGG; msg:MSMEI_6214; -.
DR   KEGG; msm:MSMEG_6382; -.
DR   PATRIC; fig|246196.19.peg.6209; -.
DR   eggNOG; COG0277; Bacteria.
DR   HOGENOM; CLU_032465_0_0_11; -.
DR   BioCyc; MetaCyc:MONOMER-17534; -.
DR   BioCyc; MSME246196:G1H7P-6349-MONOMER; -.
DR   BRENDA; 1.1.98.3; 3512.
DR   UniPathway; UPA00963; -.
DR   Proteomes; UP000000757; Chromosome.
DR   Proteomes; UP000006158; Chromosome.
DR   GO; GO:0016020; C:membrane; IEA:InterPro.
DR   GO; GO:0042597; C:periplasmic space; IEA:UniProtKB-SubCell.
DR   GO; GO:0003885; F:D-arabinono-1,4-lactone oxidase activity; IEA:InterPro.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0045227; P:capsule polysaccharide biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.43.10; -; 1.
DR   Gene3D; 3.30.465.10; -; 1.
DR   InterPro; IPR007173; ALO.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR016167; FAD-bd_PCMH_sub1.
DR   InterPro; IPR016169; FAD-bd_PCMH_sub2.
DR   InterPro; IPR006094; Oxid_FAD_bind_N.
DR   Pfam; PF04030; ALO; 1.
DR   Pfam; PF01565; FAD_binding_4; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic resistance; Cell wall biogenesis/degradation; FAD;
KW   Flavoprotein; Nucleotide-binding; Oxidoreductase; Periplasm;
KW   Reference proteome.
FT   CHAIN           1..460
FT                   /note="Decaprenylphosphoryl-beta-D-ribose oxidase"
FT                   /id="PRO_0000432471"
FT   DOMAIN          19..193
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   NP_BIND         52..62
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22956199,
FT                   ECO:0007744|PDB:4AUT, ECO:0007744|PDB:4F4Q"
FT   NP_BIND         121..124
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22956199,
FT                   ECO:0007744|PDB:4AUT, ECO:0007744|PDB:4F4Q"
FT   NP_BIND         128..131
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22956199,
FT                   ECO:0007744|PDB:4AUT, ECO:0007744|PDB:4F4Q"
FT   BINDING         116
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:22956199,
FT                   ECO:0007744|PDB:4AUT, ECO:0007744|PDB:4F4Q"
FT   BINDING         183
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:22956199,
FT                   ECO:0007744|PDB:4AUT, ECO:0007744|PDB:4F4Q"
FT   BINDING         414
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22956199,
FT                   ECO:0007744|PDB:4AUT, ECO:0007744|PDB:4F4Q"
FT   VARIANT         386
FT                   /note="C -> G (in strain: MN47; BTZ043-resistant)"
FT                   /evidence="ECO:0000269|PubMed:19299584"
FT   VARIANT         386
FT                   /note="C -> S (in strain: MN84; BTZ043-resistant)"
FT                   /evidence="ECO:0000269|PubMed:19299584"
FT   MUTAGEN         335
FT                   /note="Q->A: 10-fold decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:22956199"
FT   MUTAGEN         386
FT                   /note="C->G: 14-fold decrease in catalytic efficiency.
FT                   Reduces BTZs to inert metabolites while avoiding covalent
FT                   inactivation."
FT                   /evidence="ECO:0000269|PubMed:22188377,
FT                   ECO:0000269|PubMed:22956199"
FT   MUTAGEN         417
FT                   /note="K->A: Loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:22956199"
FT   STRAND          8..13
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          22..27
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           32..40
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           42..45
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          50..55
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          58..61
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          68..72
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           73..75
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          79..83
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   TURN            84..87
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          88..92
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           97..104
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           105..107
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           122..127
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           135..138
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           141..144
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          145..151
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          157..160
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          162..164
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           167..173
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   TURN            177..180
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          182..189
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          196..204
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           208..216
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           219..222
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          224..230
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          232..234
FT                   /evidence="ECO:0007829|PDB:4G3T"
FT   TURN            236..240
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          242..249
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           252..254
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           257..261
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          302..308
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           309..313
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   TURN            314..317
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          331..339
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           343..356
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          361..368
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   STRAND          381..390
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           395..408
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           415..417
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           423..429
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           433..443
FT                   /evidence="ECO:0007829|PDB:4AUT"
FT   HELIX           452..456
FT                   /evidence="ECO:0007829|PDB:4AUT"
SQ   SEQUENCE   460 AA;  50377 MW;  2F19107D18638FC0 CRC64;
     MSTTEFPTTT KRLMGWGRTA PTVASVLSTS DPEVIVRAVT RAAEEGGRGV IARGLGRSYG
     DNAQNGGGLV IDMPALNRIH SIDSGTRLVD VDAGVSLDQL MKAALPHGLW VPVLPGTRQV
     TVGGAIGCDI HGKNHHSAGS FGNHVRSMEL LTANGEVRHL TPAGPDSDLF WATVGGNGLT
     GIILRATIEM TPTETAYFIA DGDVTGSLDE TIAFHSDGSE ANYTYSSAWF DAISKPPKLG
     RAAISRGSLA KLDQLPSKLQ KDPLKFDAPQ LLTLPDIFPN GLANKFTFMP IGELWYRKSG
     TYRNKVQNLT QFYHPLDMFG EWNRAYGSAG FLQYQFVVPT EAVEEFKSII VDIQRSGHYS
     FLNVFKLFGP GNQAPLSFPI PGWNVCVDFP IKAGLHEFVT ELDRRVLEFG GRLYTAKDSR
     TTAETFHAMY PRIDEWIRIR RSVDPDGVFA SDMARRLQLL
//
ID   GLF_MYCTU               Reviewed;         399 AA.
AC   P9WIQ1; F2GDG8; L0TDM1; O06934; Q7ARQ0; Q7D4U3;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   02-JUN-2021, entry version 39.
DE   RecName: Full=UDP-galactopyranose mutase;
DE            Short=UGM;
DE            EC=5.4.99.9;
DE   AltName: Full=UDP-GALP mutase;
DE   AltName: Full=Uridine 5-diphosphate galactopyranose mutase;
GN   Name=glf; OrderedLocusNames=Rv3809c;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9692181; DOI=10.1016/s0962-8479(98)80005-1;
RA   Weston A., Stern R.J., Lee R.E., Nassau P.M., Monsey D., Martin S.L.,
RA   Scherman M.S., Besra G.S., Duncan K., McNeil M.R.;
RT   "Biosynthetic origin of mycobacterial cell wall galactofuranosyl
RT   residues.";
RL   Tuber. Lung Dis. 78:123-131(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9784509; DOI=10.1128/iai.66.11.5099-5106.1998;
RA   Chen P., Bishai W.R.;
RT   "Novel selection for isoniazid (INH) resistance genes supports a role for
RT   NAD+-binding proteins in mycobacterial INH resistance.";
RL   Infect. Immun. 66:5099-5106(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) IN COMPLEX WITH FAD, COFACTOR, AND
RP   SUBUNIT.
RX   PubMed=15843027; DOI=10.1016/j.jmb.2005.02.057;
RA   Beis K., Srikannathasan V., Liu H., Fullerton S.W., Bamford V.A.,
RA   Sanders D.A., Whitfield C., McNeil M.R., Naismith J.H.;
RT   "Crystal structures of Mycobacteria tuberculosis and Klebsiella pneumoniae
RT   UDP-galactopyranose mutase in the oxidised state and Klebsiella pneumoniae
RT   UDP-galactopyranose mutase in the (active) reduced state.";
RL   J. Mol. Biol. 348:971-982(2005).
CC   -!- FUNCTION: Catalyzes the interconversion through a 2-keto intermediate
CC       of uridine diphosphogalactopyranose (UDP-GalP) into uridine
CC       diphosphogalactofuranose (UDP-GalF) which is a key building block for
CC       cell wall construction in Mycobacterium tuberculosis.
CC       {ECO:0000269|PubMed:9692181}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=UDP-alpha-D-galactose = UDP-alpha-D-galactofuranose;
CC         Xref=Rhea:RHEA:24132, ChEBI:CHEBI:66914, ChEBI:CHEBI:66915;
CC         EC=5.4.99.9;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:15843027};
CC   -!- PATHWAY: Cell wall biogenesis; cell wall polysaccharide biosynthesis.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:15843027}.
CC   -!- SIMILARITY: Belongs to the UDP-galactopyranose/dTDP-fucopyranose mutase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U96128; AAC46190.1; -; Genomic_DNA.
DR   EMBL; AF026540; AAC69358.1; -; Genomic_DNA.
DR   EMBL; AL123456; CCP46638.1; -; Genomic_DNA.
DR   PIR; E70888; E70888.
DR   RefSeq; NP_218326.1; NC_000962.3.
DR   RefSeq; WP_003420798.1; NZ_NVQJ01000022.1.
DR   PDB; 1V0J; X-ray; 2.25 A; A/B/C/D=1-399.
DR   PDB; 4RPG; X-ray; 2.40 A; A/B/C=1-399.
DR   PDB; 4RPH; X-ray; 2.60 A; A/B/C=1-399.
DR   PDB; 4RPJ; X-ray; 2.50 A; A/B/C=1-399.
DR   PDB; 4RPK; X-ray; 2.55 A; A/B/C=1-399.
DR   PDB; 4RPL; X-ray; 2.25 A; A/B/C=1-399.
DR   PDBsum; 1V0J; -.
DR   PDBsum; 4RPG; -.
DR   PDBsum; 4RPH; -.
DR   PDBsum; 4RPJ; -.
DR   PDBsum; 4RPK; -.
DR   PDBsum; 4RPL; -.
DR   SMR; P9WIQ1; -.
DR   STRING; 83332.Rv3809c; -.
DR   BindingDB; P9WIQ1; -.
DR   ChEMBL; CHEMBL4450; -.
DR   DrugBank; DB03709; Bicine.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugCentral; P9WIQ1; -.
DR   PaxDb; P9WIQ1; -.
DR   DNASU; 886142; -.
DR   GeneID; 886142; -.
DR   KEGG; mtu:Rv3809c; -.
DR   PATRIC; fig|83332.111.peg.4234; -.
DR   TubercuList; Rv3809c; -.
DR   eggNOG; COG0562; Bacteria.
DR   OMA; INVHKYG; -.
DR   PhylomeDB; P9WIQ1; -.
DR   BioCyc; MetaCyc:G185E-8105-MONOMER; -.
DR   BRENDA; 5.4.99.9; 3445.
DR   UniPathway; UPA00963; -.
DR   PRO; PR:P9WIQ1; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0005618; C:cell wall; HDA:MTBBASE.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; HDA:MTBBASE.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:0008767; F:UDP-galactopyranose mutase activity; IDA:MTBBASE.
DR   GO; GO:0071766; P:Actinobacterium-type cell wall biogenesis; IDA:MTBBASE.
DR   GO; GO:0045227; P:capsule polysaccharide biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   InterPro; IPR004379; UDP-GALP_mutase.
DR   InterPro; IPR015899; UDP-GalPyranose_mutase_C.
DR   Pfam; PF03275; GLF; 1.
DR   TIGRFAMs; TIGR00031; UDP-GALP_mutase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell wall biogenesis/degradation; FAD; Flavoprotein;
KW   Isomerase; Reference proteome.
FT   CHAIN           1..399
FT                   /note="UDP-galactopyranose mutase"
FT                   /id="PRO_0000420735"
FT   NP_BIND         224..225
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15843027"
FT   NP_BIND         367..369
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15843027"
FT   BINDING         18
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:15843027"
FT   BINDING         38
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15843027"
FT   BINDING         46
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:15843027"
FT   BINDING         66
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:15843027"
FT   BINDING         157
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   BINDING         162
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   BINDING         166
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   BINDING         191
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   BINDING         282
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   BINDING         292
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   BINDING         328
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   BINDING         360
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15843027"
FT   BINDING         366
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   STRAND          9..13
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           17..29
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          34..37
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          39..44
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           45..47
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          49..51
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   TURN            53..55
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          58..60
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          67..69
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           72..78
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   TURN            79..81
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          91..95
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          98..101
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          103..105
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           106..113
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           119..129
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   TURN            130..132
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           135..137
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           141..149
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           151..157
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           159..166
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           170..172
FT                   /evidence="ECO:0007829|PDB:1V0J"
FT   HELIX           175..177
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   TURN            178..180
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          185..187
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          195..198
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           204..211
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          217..220
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           225..235
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          241..243
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           247..250
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   TURN            251..253
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          260..273
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          275..283
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          291..295
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           296..299
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          310..319
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          322..324
FT                   /evidence="ECO:0007829|PDB:4RPG"
FT   HELIX           333..353
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   STRAND          355..357
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           359..363
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           369..382
FT                   /evidence="ECO:0007829|PDB:4RPL"
FT   HELIX           384..390
FT                   /evidence="ECO:0007829|PDB:4RPL"
SQ   SEQUENCE   399 AA;  45814 MW;  3D475965C213C18E CRC64;
     MQPMTARFDL FVVGSGFFGL TIAERVATQL DKRVLVLERR PHIGGNAYSE AEPQTGIEVH
     KYGAHLFHTS NKRVWDYVRQ FTDFTDYRHR VFAMHNGQAY QFPMGLGLVS QFFGKYFTPE
     QARQLIAEQA AEIDTADAQN LEEKAISLIG RPLYEAFVKG YTAKQWQTDP KELPAANITR
     LPVRYTFDNR YFSDTYEGLP TDGYTAWLQN MAADHRIEVR LNTDWFDVRG QLRPGSPAAP
     VVYTGPLDRY FDYAEGRLGW RTLDFEVEVL PIGDFQGTAV MNYNDLDVPY TRIHEFRHFH
     PERDYPTDKT VIMREYSRFA EDDDEPYYPI NTEADRALLA TYRARAKSET ASSKVLFGGR
     LGTYQYLDMH MAIASALNMY DNVLAPHLRD GVPLLQDGA
//
ID   FENR_RHOCA              Reviewed;         270 AA.
AC   Q9L6V3;
DT   25-OCT-2017, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2017, sequence version 2.
DT   02-JUN-2021, entry version 83.
DE   RecName: Full=Flavodoxin/ferredoxin--NADP reductase {ECO:0000305};
DE            EC=1.18.1.2 {ECO:0000269|PubMed:14572660, ECO:0000269|PubMed:24016470};
DE            EC=1.19.1.1 {ECO:0000269|PubMed:14572660, ECO:0000269|PubMed:16128574, ECO:0000269|PubMed:24016470};
DE   AltName: Full=Ferredoxin (flavodoxin):NADP(+) oxidoreductase {ECO:0000305};
DE   AltName: Full=Ferredoxin--NADP reductase {ECO:0000305};
DE            Short=FNR {ECO:0000305};
DE   AltName: Full=Flavodoxin--NADP reductase {ECO:0000305};
DE            Short=FLDR {ECO:0000305};
GN   Name=fpr {ECO:0000303|PubMed:14572660};
OS   Rhodobacter capsulatus (Rhodopseudomonas capsulata).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Rhodobacterales;
OC   Rhodobacteraceae; Rhodobacter.
OX   NCBI_TaxID=1061;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-6, FUNCTION,
RP   CATALYTIC ACTIVITY, COFACTOR, SUBUNIT, SUBCELLULAR LOCATION, AND INDUCTION.
RC   STRAIN=DSM 938 / 37b4;
RX   PubMed=14572660; DOI=10.1016/s0014-5793(03)01075-5;
RA   Bittel C., Tabares L.C., Armesto M., Carrillo N., Cortez N.;
RT   "The oxidant-responsive diaphorase of Rhodobacter capsulatus is a
RT   ferredoxin (flavodoxin)-NADP(H) reductase.";
RL   FEBS Lett. 553:408-412(2003).
RN   [2] {ECO:0007744|PDB:2BGI, ECO:0007744|PDB:2BGJ}
RP   X-RAY CRYSTALLOGRAPHY (1.68 ANGSTROMS) IN COMPLEX WITH FAD, FUNCTION,
RP   CATALYTIC ACTIVITY, AND COFACTOR.
RC   STRAIN=DSM 938 / 37b4;
RX   PubMed=16128574; DOI=10.1021/bi0508183;
RA   Nogues I., Perez-Dorado I., Frago S., Bittel C., Mayhew S.G.,
RA   Gomez-Moreno C., Hermoso J.A., Medina M., Cortez N., Carrillo N.;
RT   "The ferredoxin-NADP(H) reductase from Rhodobacter capsulatus: molecular
RT   structure and catalytic mechanism.";
RL   Biochemistry 44:11730-11740(2005).
RN   [3] {ECO:0007744|PDB:2VNH, ECO:0007744|PDB:2VNI, ECO:0007744|PDB:2VNJ, ECO:0007744|PDB:2VNK}
RP   X-RAY CRYSTALLOGRAPHY (1.93 ANGSTROMS) IN COMPLEX WITH FAD AND NADP, AND
RP   COFACTOR.
RX   PubMed=18973834; DOI=10.1016/j.bbapap.2008.09.013;
RA   Bortolotti A., Perez-Dorado I., Goni G., Medina M., Hermoso J.A.,
RA   Carrillo N., Cortez N.;
RT   "Coenzyme binding and hydride transfer in Rhodobacter capsulatus
RT   ferredoxin/flavodoxin NADP(H) oxidoreductase.";
RL   Biochim. Biophys. Acta 1794:199-210(2009).
RN   [4] {ECO:0007744|PDB:4K1X}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 14-264 IN COMPLEX WITH FAD,
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF ALA-264.
RX   PubMed=24016470; DOI=10.1016/j.bbabio.2013.08.008;
RA   Bortolotti A., Sanchez-Azqueta A., Maya C.M., Velazquez-Campoy A.,
RA   Hermoso J.A., Medina M., Cortez N.;
RT   "The C-terminal extension of bacterial flavodoxin-reductases: involvement
RT   in the hydride transfer mechanism from the coenzyme.";
RL   Biochim. Biophys. Acta 1837:33-43(2014).
CC   -!- FUNCTION: Transports electrons between flavodoxin or ferredoxin and
CC       NADPH. {ECO:0000269|PubMed:14572660, ECO:0000269|PubMed:16128574,
CC       ECO:0000269|PubMed:24016470}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADP(+) + 2 reduced [2Fe-2S]-[ferredoxin] = NADPH + 2
CC         oxidized [2Fe-2S]-[ferredoxin]; Xref=Rhea:RHEA:20125, Rhea:RHEA-
CC         COMP:10000, Rhea:RHEA-COMP:10001, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:33737, ChEBI:CHEBI:33738, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.18.1.2;
CC         Evidence={ECO:0000269|PubMed:14572660, ECO:0000269|PubMed:24016470};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADP(+) + reduced [flavodoxin] = 2 H(+) + NADPH + oxidized
CC         [flavodoxin]; Xref=Rhea:RHEA:50756, Rhea:RHEA-COMP:10622, Rhea:RHEA-
CC         COMP:10623, ChEBI:CHEBI:15378, ChEBI:CHEBI:57618, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58210, ChEBI:CHEBI:58349; EC=1.19.1.1;
CC         Evidence={ECO:0000269|PubMed:14572660, ECO:0000269|PubMed:16128574,
CC         ECO:0000269|PubMed:24016470};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:14572660, ECO:0000269|PubMed:16128574,
CC         ECO:0000269|PubMed:18973834, ECO:0000269|PubMed:24016470};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=93 uM for NADPH (in the presence of K(3)Fe(CN)(6))
CC         {ECO:0000269|PubMed:24016470};
CC         KM=85 uM for NADPH (in the presence of 2,6-dichlorophenolindophenol)
CC         {ECO:0000269|PubMed:24016470};
CC         Note=kcat is 222 sec(-1) with K(3)Fe(CN)(6) as substrate. kcat is 20
CC         sec(-1) with 2,6-dichlorophenolindophenol as substrate.
CC         {ECO:0000269|PubMed:24016470};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:14572660}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305|PubMed:14572660}.
CC   -!- INDUCTION: Induced under oxidative stress conditions.
CC       {ECO:0000269|PubMed:14572660}.
CC   -!- SIMILARITY: Belongs to the ferredoxin--NADP reductase type 1 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF35905.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF232063; AAF35905.1; ALT_INIT; Genomic_DNA.
DR   PDB; 2BGI; X-ray; 1.68 A; A=1-270.
DR   PDB; 2BGJ; X-ray; 2.10 A; A/B/C/D=1-270.
DR   PDB; 2VNH; X-ray; 2.27 A; A=1-270.
DR   PDB; 2VNI; X-ray; 2.24 A; A=1-270.
DR   PDB; 2VNJ; X-ray; 2.13 A; A=1-270.
DR   PDB; 2VNK; X-ray; 1.93 A; A/B/C/D=1-270.
DR   PDB; 4K1X; X-ray; 1.70 A; A/B=14-264.
DR   PDBsum; 2BGI; -.
DR   PDBsum; 2BGJ; -.
DR   PDBsum; 2VNH; -.
DR   PDBsum; 2VNI; -.
DR   PDBsum; 2VNJ; -.
DR   PDBsum; 2VNK; -.
DR   PDBsum; 4K1X; -.
DR   SMR; Q9L6V3; -.
DR   DrugBank; DB04450; Heptyl 1-Thiohexopyranoside.
DR   BRENDA; 1.18.1.2; 5381.
DR   BRENDA; 1.19.1.1; 5381.
DR   EvolutionaryTrace; Q9L6V3; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004324; F:ferredoxin-NADP+ reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   CDD; cd06195; FNR1; 1.
DR   Gene3D; 3.40.50.80; -; 1.
DR   InterPro; IPR008333; Cbr1-like_FAD-bd_dom.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR033892; FNR_bac.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF00970; FAD_binding_6; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52343; SSF52343; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Direct protein sequencing; FAD; Flavoprotein;
KW   NADP; Nucleotide-binding; Oxidoreductase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305|PubMed:14572660"
FT   CHAIN           2..270
FT                   /note="Flavodoxin/ferredoxin--NADP reductase"
FT                   /id="PRO_0000441750"
FT   DOMAIN          12..113
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   NP_BIND         62..65
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16128574,
FT                   ECO:0000269|PubMed:18973834, ECO:0000269|PubMed:24016470"
FT   NP_BIND         78..80
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16128574,
FT                   ECO:0000269|PubMed:18973834, ECO:0000269|PubMed:24016470"
FT   NP_BIND         86..88
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16128574,
FT                   ECO:0000269|PubMed:18973834, ECO:0000269|PubMed:24016470"
FT   NP_BIND         192..193
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:18973834"
FT   NP_BIND         264..270
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16128574,
FT                   ECO:0000269|PubMed:18973834"
FT   BINDING         126
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:18973834"
FT   BINDING         128
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16128574,
FT                   ECO:0000269|PubMed:18973834, ECO:0000269|PubMed:24016470"
FT   BINDING         156
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:18973834"
FT   BINDING         201
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:18973834"
FT   BINDING         238
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:18973834"
FT   MUTAGEN         264
FT                   /note="A->Y: 3-fold decrease in kcat."
FT                   /evidence="ECO:0000269|PubMed:24016470"
FT   STRAND          15..26
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   STRAND          29..35
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   STRAND          47..53
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   STRAND          59..65
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   STRAND          73..80
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   HELIX           88..91
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   STRAND          99..107
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   HELIX           112..114
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   STRAND          119..126
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   HELIX           127..130
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   HELIX           131..136
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   HELIX           140..143
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   STRAND          147..158
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   HELIX           159..161
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   HELIX           162..173
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   TURN            175..179
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   TURN            182..184
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   STRAND          185..194
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   STRAND          197..199
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   HELIX           202..207
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   HELIX           210..215
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   TURN            222..224
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   STRAND          225..231
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   HELIX           233..244
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   TURN            245..247
FT                   /evidence="ECO:0007829|PDB:2BGI"
FT   TURN            252..254
FT                   /evidence="ECO:0007829|PDB:4K1X"
FT   STRAND          257..268
FT                   /evidence="ECO:0007829|PDB:2BGI"
SQ   SEQUENCE   270 AA;  30233 MW;  12DE6B7A75D03D10 CRC64;
     MNETTPIAPA KVLPDAQTVT SVRHWTDTLF SFRVTRPQTL RFRSGEFVMI GLLDDNGKPI
     MRAYSIASPA WDEELEFYSI KVPDGPLTSR LQHIKVGEQI ILRPKPVGTL VIDALLPGKR
     LWFLATGTGI APFASLMREP EAYEKFDEVI MMHACRTVAE LEYGRQLVEA LQEDPLIGEL
     VEGKLKYYPT TTREEFHHMG RITDNLASGK VFEDLGIAPM NPETDRAMVC GSLAFNVDVM
     KVLESYGLRE GANSEPREFV VEKAFVGEGI
//
ID   FMO1_SCHPO              Reviewed;         447 AA.
AC   Q9HFE4;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   02-JUN-2021, entry version 129.
DE   RecName: Full=Thiol-specific monooxygenase;
DE            EC=1.14.13.-;
DE   AltName: Full=Flavin-dependent monooxygenase;
GN   Name=fmo1; ORFNames=SPBP16F5.08c;
OS   Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Taphrinomycotina;
OC   Schizosaccharomycetes; Schizosaccharomycetales; Schizosaccharomycetaceae;
OC   Schizosaccharomyces.
OX   NCBI_TaxID=284812;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=972 / ATCC 24843;
RX   PubMed=11859360; DOI=10.1038/nature724;
RA   Wood V., Gwilliam R., Rajandream M.A., Lyne M.H., Lyne R., Stewart A.,
RA   Sgouros J.G., Peat N., Hayles J., Baker S.G., Basham D., Bowman S.,
RA   Brooks K., Brown D., Brown S., Chillingworth T., Churcher C.M., Collins M.,
RA   Connor R., Cronin A., Davis P., Feltwell T., Fraser A., Gentles S.,
RA   Goble A., Hamlin N., Harris D.E., Hidalgo J., Hodgson G., Holroyd S.,
RA   Hornsby T., Howarth S., Huckle E.J., Hunt S., Jagels K., James K.D.,
RA   Jones L., Jones M., Leather S., McDonald S., McLean J., Mooney P.,
RA   Moule S., Mungall K.L., Murphy L.D., Niblett D., Odell C., Oliver K.,
RA   O'Neil S., Pearson D., Quail M.A., Rabbinowitsch E., Rutherford K.M.,
RA   Rutter S., Saunders D., Seeger K., Sharp S., Skelton J., Simmonds M.N.,
RA   Squares R., Squares S., Stevens K., Taylor K., Taylor R.G., Tivey A.,
RA   Walsh S.V., Warren T., Whitehead S., Woodward J.R., Volckaert G., Aert R.,
RA   Robben J., Grymonprez B., Weltjens I., Vanstreels E., Rieger M.,
RA   Schaefer M., Mueller-Auer S., Gabel C., Fuchs M., Duesterhoeft A.,
RA   Fritzc C., Holzer E., Moestl D., Hilbert H., Borzym K., Langer I., Beck A.,
RA   Lehrach H., Reinhardt R., Pohl T.M., Eger P., Zimmermann W., Wedler H.,
RA   Wambutt R., Purnelle B., Goffeau A., Cadieu E., Dreano S., Gloux S.,
RA   Lelaure V., Mottier S., Galibert F., Aves S.J., Xiang Z., Hunt C.,
RA   Moore K., Hurst S.M., Lucas M., Rochet M., Gaillardin C., Tallada V.A.,
RA   Garzon A., Thode G., Daga R.R., Cruzado L., Jimenez J., Sanchez M.,
RA   del Rey F., Benito J., Dominguez A., Revuelta J.L., Moreno S.,
RA   Armstrong J., Forsburg S.L., Cerutti L., Lowe T., McCombie W.R.,
RA   Paulsen I., Potashkin J., Shpakovski G.V., Ussery D., Barrell B.G.,
RA   Nurse P.;
RT   "The genome sequence of Schizosaccharomyces pombe.";
RL   Nature 415:871-880(2002).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 1-447 IN COMPLEX WITH FAD; NADPH
RP   AND METHIMAZOLE.
RX   PubMed=16777962; DOI=10.1073/pnas.0602398103;
RA   Eswaramoorthy S., Bonanno J.B., Burley S.K., Swaminathan S.;
RT   "Mechanism of action of a flavin-containing monooxygenase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:9832-9837(2006).
CC   -!- FUNCTION: Flavin-dependent oxidation of thiol-containing compounds.
CC       Probably required for the correct folding of disulfide-bonded proteins
CC       (By similarity). {ECO:0000250}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the FMO family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CU329671; CAC08547.1; -; Genomic_DNA.
DR   RefSeq; NP_595782.1; NM_001021682.2.
DR   PDB; 1VQW; X-ray; 2.40 A; A/B=2-447.
DR   PDB; 2GV8; X-ray; 2.10 A; A/B=1-447.
DR   PDB; 2GVC; X-ray; 2.22 A; A/B/D/E=1-447.
DR   PDBsum; 1VQW; -.
DR   PDBsum; 2GV8; -.
DR   PDBsum; 2GVC; -.
DR   SMR; Q9HFE4; -.
DR   BioGRID; 277742; 8.
DR   STRING; 4896.SPBP16F5.08c.1; -.
DR   iPTMnet; Q9HFE4; -.
DR   MaxQB; Q9HFE4; -.
DR   PaxDb; Q9HFE4; -.
DR   DNASU; 2541228; -.
DR   EnsemblFungi; SPBP16F5.08c.1; SPBP16F5.08c.1:pep; SPBP16F5.08c.
DR   GeneID; 2541228; -.
DR   KEGG; spo:SPBP16F5.08c; -.
DR   PomBase; SPBP16F5.08c; fmo1.
DR   VEuPathDB; FungiDB:SPBP16F5.08c; -.
DR   eggNOG; KOG1399; Eukaryota.
DR   HOGENOM; CLU_006909_5_0_1; -.
DR   InParanoid; Q9HFE4; -.
DR   OMA; FMEWEHH; -.
DR   PhylomeDB; Q9HFE4; -.
DR   BRENDA; 1.14.13.8; 5613.
DR   EvolutionaryTrace; Q9HFE4; -.
DR   PRO; PR:Q9HFE4; -.
DR   Proteomes; UP000002485; Chromosome II.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISO:PomBase.
DR   GO; GO:0005739; C:mitochondrion; HDA:PomBase.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; ISM:PomBase.
DR   GO; GO:0004499; F:N,N-dimethylaniline monooxygenase activity; ISM:PomBase.
DR   GO; GO:0050661; F:NADP binding; ISM:PomBase.
DR   GO; GO:0034975; P:protein folding in endoplasmic reticulum; IC:PomBase.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR000960; Flavin_mOase.
DR   InterPro; IPR020946; Flavin_mOase-like.
DR   Pfam; PF00743; FMO-like; 2.
DR   PIRSF; PIRSF000332; FMO; 1.
DR   PRINTS; PR00370; FMOXYGENASE.
DR   SUPFAM; SSF51905; SSF51905; 2.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Monooxygenase; NADP; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN           1..447
FT                   /note="Thiol-specific monooxygenase"
FT                   /id="PRO_0000314653"
FT   NP_BIND         13..17
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16777962,
FT                   ECO:0007744|PDB:1VQW, ECO:0007744|PDB:2GV8,
FT                   ECO:0007744|PDB:2GVC"
FT   NP_BIND         46..47
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16777962,
FT                   ECO:0007744|PDB:1VQW, ECO:0007744|PDB:2GV8,
FT                   ECO:0007744|PDB:2GVC"
FT   NP_BIND         90..91
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:16777962,
FT                   ECO:0007744|PDB:2GV8"
FT   NP_BIND         91..92
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16777962,
FT                   ECO:0007744|PDB:1VQW, ECO:0007744|PDB:2GV8,
FT                   ECO:0007744|PDB:2GVC"
FT   NP_BIND         137..138
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16777962,
FT                   ECO:0007744|PDB:1VQW, ECO:0007744|PDB:2GV8,
FT                   ECO:0007744|PDB:2GVC"
FT   NP_BIND         223..226
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:16777962,
FT                   ECO:0007744|PDB:2GV8"
FT   BINDING         38
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16777962,
FT                   ECO:0007744|PDB:1VQW, ECO:0007744|PDB:2GV8,
FT                   ECO:0007744|PDB:2GVC"
FT   STRAND          8..12
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           16..26
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   TURN            27..29
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          32..37
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          39..44
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           45..47
FT                   /evidence="ECO:0007829|PDB:2GVC"
FT   STRAND          59..61
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          71..73
FT                   /evidence="ECO:0007829|PDB:2GVC"
FT   STRAND          74..76
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           94..97
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           114..125
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           126..131
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          135..144
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          147..156
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          161..171
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          175..179
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           187..193
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          197..200
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           201..203
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           207..210
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          215..218
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           222..231
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   TURN            232..234
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          237..242
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          252..257
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          260..264
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   TURN            265..268
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          269..272
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   TURN            273..275
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          276..278
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          282..286
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           297..300
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   TURN            305..307
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          311..315
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          318..320
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   TURN            321..323
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          331..335
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          338..340
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           342..357
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           366..380
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           384..386
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   STRAND          387..389
FT                   /evidence="ECO:0007829|PDB:1VQW"
FT   TURN            391..393
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           394..407
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           424..431
FT                   /evidence="ECO:0007829|PDB:2GV8"
FT   HELIX           433..440
FT                   /evidence="ECO:0007829|PDB:2GV8"
SQ   SEQUENCE   447 AA;  49889 MW;  4392F5D9791C406F CRC64;
     MCLPTIRKIA IIGAGPSGLV TAKALLAEKA FDQVTLFERR GSPGGVWNYT STLSNKLPVP
     STNPILTTEP IVGPAALPVY PSPLYRDLQT NTPIELMGYC DQSFKPQTLQ FPHRHTIQEY
     QRIYAQPLLP FIKLATDVLD IEKKDGSWVV TYKGTKAGSP ISKDIFDAVS ICNGHYEVPY
     IPNIKGLDEY AKAVPGSVLH SSLFREPELF VGESVLVVGG ASSANDLVRH LTPVAKHPIY
     QSLLGGGDIQ NESLQQVPEI TKFDPTTREI YLKGGKVLSN IDRVIYCTGY LYSVPFPSLA
     KLKSPETKLI DDGSHVHNVY QHIFYIPDPT LAFVGLALHV VPFPTSQAQA AFLARVWSGR
     LKLPSKEEQL KWQDELMFSL SGANNMYHSL DYPKDATYIN KLHDWCKQAT PVLEEEFPSP
     YWGEKERSIR ENMWSIRAKF FGIEPPK
//
ID   GLF1_KLEPN              Reviewed;         384 AA.
AC   Q48485;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   02-JUN-2021, entry version 110.
DE   RecName: Full=UDP-galactopyranose mutase;
DE            Short=UGM;
DE            EC=5.4.99.9;
DE   AltName: Full=UDP-GALP mutase;
DE   AltName: Full=Uridine 5-diphosphate galactopyranose mutase;
DE   Flags: Precursor;
GN   Name=rfbD;
OS   Klebsiella pneumoniae.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Klebsiella.
OX   NCBI_TaxID=573;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K20 / Serotype O1;
RX   PubMed=7559323; DOI=10.1128/jb.177.19.5411-5418.1995;
RA   Clarke B.R., Bronner D., Keenleyside W.J., Severn W.B., Richards J.C.,
RA   Whitfield C.;
RT   "Role of Rfe and RfbF in the initiation of biosynthesis of D-galactan I,
RT   the lipopolysaccharide O antigen from Klebsiella pneumoniae serotype O1.";
RL   J. Bacteriol. 177:5411-5418(1995).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, DISRUPTION PHENOTYPE, COFACTOR, AND SUBUNIT.
RC   STRAIN=K20 / Serotype O1;
RX   PubMed=9020123; DOI=10.1074/jbc.272.7.4121;
RA   Koplin R., Brisson J.R., Whitfield C.;
RT   "UDP-galactofuranose precursor required for formation of the
RT   lipopolysaccharide O antigen of Klebsiella pneumoniae serotype O1 is
RT   synthesized by the product of the rfbDKPO1 gene.";
RL   J. Biol. Chem. 272:4121-4128(1997).
RN   [3]
RP   REACTION MECHANISM.
RC   STRAIN=K20 / Serotype O1;
RX   PubMed=15133501; DOI=10.1038/nsmb772;
RA   Soltero-Higgin M., Carlson E.E., Gruber T.D., Kiessling L.L.;
RT   "A unique catalytic mechanism for UDP-galactopyranose mutase.";
RL   Nat. Struct. Mol. Biol. 11:539-543(2004).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) IN COMPLEX WITH FAD, COFACTOR, AND
RP   SUBUNIT.
RX   PubMed=15843027; DOI=10.1016/j.jmb.2005.02.057;
RA   Beis K., Srikannathasan V., Liu H., Fullerton S.W., Bamford V.A.,
RA   Sanders D.A., Whitfield C., McNeil M.R., Naismith J.H.;
RT   "Crystal structures of Mycobacteria tuberculosis and Klebsiella pneumoniae
RT   UDP-galactopyranose mutase in the oxidised state and Klebsiella pneumoniae
RT   UDP-galactopyranose mutase in the (active) reduced state.";
RL   J. Mol. Biol. 348:971-982(2005).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-383 IN COMPLEX WITH FAD AND
RP   SUBSTRATE, COFACTOR, AND SUBUNIT.
RX   PubMed=19719175; DOI=10.1021/bi901437v;
RA   Gruber T.D., Westler W.M., Kiessling L.L., Forest K.T.;
RT   "X-ray crystallography reveals a reduced substrate complex of UDP-
RT   galactopyranose mutase poised for covalent catalysis by flavin.";
RL   Biochemistry 48:9171-9173(2009).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 1-383 IN COMPLEX WITH FAD AND
RP   SUBSTRATE, AND COFACTOR.
RX   PubMed=19500588; DOI=10.1016/j.jmb.2009.05.081;
RA   Gruber T.D., Borrok M.J., Westler W.M., Forest K.T., Kiessling L.L.;
RT   "Ligand binding and substrate discrimination by UDP-galactopyranose
RT   mutase.";
RL   J. Mol. Biol. 391:327-340(2009).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1-383 IN COMPLEX WITH FAD,
RP   COFACTOR, AND SUBUNIT.
RA   Gruber T.D., Dimond M.C., Kiessling L.L., Forest K.T.;
RT   "Structure of UDP-galactopyranose mutase bound to flavin mononucleotide.";
RL   Submitted (DEC-2009) to the PDB data bank.
CC   -!- FUNCTION: Involved in the biosynthesis of the galactose-containing O-
CC       side-chain polysaccharide backbone structure of D-galactan I which is a
CC       key component of lipopolysaccharide (LPS). Catalyzes the
CC       interconversion through a 2-keto intermediate of uridine
CC       diphosphogalactopyranose (UDP-GalP) into uridine
CC       diphosphogalactofuranose (UDP-GalF) which is the biosynthetic precursor
CC       of galactofuranosyl residues. {ECO:0000269|PubMed:9020123}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=UDP-alpha-D-galactose = UDP-alpha-D-galactofuranose;
CC         Xref=Rhea:RHEA:24132, ChEBI:CHEBI:66914, ChEBI:CHEBI:66915;
CC         EC=5.4.99.9; Evidence={ECO:0000269|PubMed:9020123};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:15843027, ECO:0000269|PubMed:19500588,
CC         ECO:0000269|PubMed:19719175, ECO:0000269|PubMed:9020123,
CC         ECO:0000269|Ref.7};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:15843027,
CC       ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
CC       ECO:0000269|PubMed:9020123, ECO:0000269|Ref.7};
CC   -!- PATHWAY: Bacterial outer membrane biogenesis; LPS O-antigen
CC       biosynthesis.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:15843027,
CC       ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
CC       ECO:0000269|PubMed:9020123, ECO:0000269|Ref.7}.
CC   -!- DISRUPTION PHENOTYPE: Abolishes lipopolysaccharide (LPS) biosynthesis.
CC       {ECO:0000269|PubMed:9020123}.
CC   -!- SIMILARITY: Belongs to the UDP-galactopyranose/dTDP-fucopyranose mutase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L31762; AAC98417.1; -; Genomic_DNA.
DR   RefSeq; WP_023284018.1; NZ_WTCT01000132.1.
DR   PDB; 1WAM; X-ray; 2.35 A; A=1-384.
DR   PDB; 2BI7; X-ray; 2.00 A; A=1-384.
DR   PDB; 2BI8; X-ray; 2.35 A; A=1-384.
DR   PDB; 3GF4; X-ray; 2.45 A; A/B=1-384.
DR   PDB; 3INR; X-ray; 2.30 A; A/B=1-383.
DR   PDB; 3INT; X-ray; 2.51 A; A/B=1-384.
DR   PDB; 3KYB; X-ray; 2.30 A; A/B=1-384.
DR   PDBsum; 1WAM; -.
DR   PDBsum; 2BI7; -.
DR   PDBsum; 2BI8; -.
DR   PDBsum; 3GF4; -.
DR   PDBsum; 3INR; -.
DR   PDBsum; 3INT; -.
DR   PDBsum; 3KYB; -.
DR   SMR; Q48485; -.
DR   BRENDA; 5.4.99.9; 2814.
DR   UniPathway; UPA00281; -.
DR   EvolutionaryTrace; Q48485; -.
DR   GO; GO:0008767; F:UDP-galactopyranose mutase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009243; P:O antigen biosynthetic process; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR004379; UDP-GALP_mutase.
DR   InterPro; IPR015899; UDP-GalPyranose_mutase_C.
DR   Pfam; PF03275; GLF; 1.
DR   TIGRFAMs; TIGR00031; UDP-GALP_mutase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Isomerase;
KW   Lipopolysaccharide biosynthesis; Signal.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..384
FT                   /note="UDP-galactopyranose mutase"
FT                   /id="PRO_0000087506"
FT   NP_BIND         33..34
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15843027,
FT                   ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
FT                   ECO:0000269|Ref.7"
FT   NP_BIND         60..61
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15843027,
FT                   ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
FT                   ECO:0000269|Ref.7"
FT   NP_BIND         350..355
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15843027,
FT                   ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
FT                   ECO:0000269|Ref.7"
FT   BINDING         14
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15843027,
FT                   ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
FT                   ECO:0000269|Ref.7"
FT   BINDING         41
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:15843027,
FT                   ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
FT                   ECO:0000269|Ref.7"
FT   BINDING         84
FT                   /note="UDP-GalP"
FT   BINDING         151
FT                   /note="UDP-GalP; via carbonyl oxygen"
FT   BINDING         156
FT                   /note="UDP-GalP"
FT   BINDING         160
FT                   /note="UDP-GalP"
FT   BINDING         185
FT                   /note="UDP-GalP"
FT   BINDING         219
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:15843027,
FT                   ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
FT                   ECO:0000269|Ref.7"
FT   BINDING         270
FT                   /note="UDP-GalP"
FT   BINDING         280
FT                   /note="UDP-GalP"
FT   BINDING         314
FT                   /note="UDP-GalP"
FT   BINDING         343
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15843027,
FT                   ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
FT                   ECO:0000269|Ref.7"
FT   BINDING         349
FT                   /note="UDP-GalP"
FT   STRAND          5..9
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           13..23
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   TURN            24..26
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          28..39
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           40..42
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          44..46
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   TURN            48..50
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          53..55
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          62..65
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           67..74
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          79..81
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          86..90
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          93..98
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           101..107
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           114..124
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           135..143
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           145..151
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           153..160
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           164..166
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           169..171
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          179..181
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          189..194
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           197..206
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          211..216
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           221..226
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          227..232
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           236..239
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   TURN            240..244
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          249..261
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          263..271
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          276..283
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           284..287
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          294..305
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           319..332
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          336..340
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           342..345
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           352..371
FT                   /evidence="ECO:0007829|PDB:2BI7"
SQ   SEQUENCE   384 AA;  44457 MW;  B74EC65EA5B751AB CRC64;
     MKSKKILIVG AGFSGAVIGR QLAEKGHQVH IIDQRDHIGG NSYDARDSET NVMVHVYGPH
     IFHTDNETVW NYVNKHAEMM PYVNRVKATV NGQVFSLPIN LHTINQFFSK TCSPDEARAL
     IAEKGDSTIA DPQTFEEQAL RFIGKELYEA FFKGYTIKQW GMQPSELPAS ILKRLPVRFN
     YDDNYFNHKF QGMPKCGYTQ MIKSILNHEN IKVDLQREFI VEERTHYDHV FYSGPLDAFY
     GYQYGRLGYR TLDFKKFTYQ GDYQGCAVMN YCSVDVPYTR ITEHKYFSPW EQHDGSVCYK
     EYSRACEEND IPYYPIRQMG EMALLEKYLS LAENETNITF VGRLGTYRYL DMDVTIAEAL
     KTAEVYLNSL TENQPMPVFT VSVR
//
ID   APBE_SALTY              Reviewed;         350 AA.
AC   P41780; O06948;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-1998, sequence version 2.
DT   02-JUN-2021, entry version 116.
DE   RecName: Full=FAD:protein FMN transferase {ECO:0000250|UniProtKB:A5F5Y3};
DE            EC=2.7.1.180 {ECO:0000250|UniProtKB:A5F5Y3};
DE   AltName: Full=Flavin transferase {ECO:0000250|UniProtKB:A5F5Y3};
DE   Flags: Precursor;
GN   Name=apbE {ECO:0000303|PubMed:9473043}; OrderedLocusNames=STM2266;
OS   Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Salmonella.
OX   NCBI_TaxID=99287;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], DISRUPTION PHENOTYPE, AND SUBCELLULAR
RP   LOCATION.
RC   STRAIN=LT2;
RX   PubMed=9473043; DOI=10.1128/jb.180.4.885-891.1998;
RA   Beck B.J., Downs D.M.;
RT   "The apbE gene encodes a lipoprotein involved in thiamine synthesis in
RT   Salmonella typhimurium.";
RL   J. Bacteriol. 180:885-891(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 29595 / ST1;
RA   Beck G., Blat Y., Eisenbach M.;
RL   Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=LT2 / SGSC1412 / ATCC 700720;
RX   PubMed=11677609; DOI=10.1038/35101614;
RA   McClelland M., Sanderson K.E., Spieth J., Clifton S.W., Latreille P.,
RA   Courtney L., Porwollik S., Ali J., Dante M., Du F., Hou S., Layman D.,
RA   Leonard S., Nguyen C., Scott K., Holmes A., Grewal N., Mulvaney E.,
RA   Ryan E., Sun H., Florea L., Miller W., Stoneking T., Nhan M., Waterston R.,
RA   Wilson R.K.;
RT   "Complete genome sequence of Salmonella enterica serovar Typhimurium LT2.";
RL   Nature 413:852-856(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 337-350.
RX   PubMed=1904855; DOI=10.1128/jb.173.12.3663-3672.1991;
RA   Hakura A., Morimoto K., Sofuni T., Nohmi T.;
RT   "Cloning and characterization of the Salmonella typhimurium ada gene, which
RT   encodes O6-methylguanine-DNA methyltransferase.";
RL   J. Bacteriol. 173:3663-3672(1991).
RN   [5]
RP   SUBCELLULAR LOCATION.
RC   STRAIN=LT2;
RX   PubMed=10572132; DOI=10.1128/jb.181.23.7285-7290.1999;
RA   Beck B.J., Downs D.M.;
RT   "A periplasmic location is essential for the role of the ApbE lipoprotein
RT   in thiamine synthesis in Salmonella typhimurium.";
RL   J. Bacteriol. 181:7285-7290(1999).
RN   [6]
RP   DISRUPTION PHENOTYPE.
RC   STRAIN=LT2;
RX   PubMed=12486045; DOI=10.1128/jb.185.1.98-106.2003;
RA   Skovran E., Downs D.M.;
RT   "Lack of the ApbC or ApbE protein results in a defect in Fe-S cluster
RT   metabolism in Salmonella enterica serovar Typhimurium.";
RL   J. Bacteriol. 185:98-106(2003).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 21-350 IN COMPLEX WITH FAD,
RP   SUBUNIT, AND MUTAGENESIS OF TYR-78.
RC   STRAIN=LT2;
RX   PubMed=21148731; DOI=10.1128/jb.00730-10;
RA   Boyd J.M., Endrizzi J.A., Hamilton T.L., Christopherson M.R., Mulder D.W.,
RA   Downs D.M., Peters J.W.;
RT   "FAD binding by ApbE protein from Salmonella enterica: a new class of FAD-
RT   binding proteins.";
RL   J. Bacteriol. 193:887-895(2011).
CC   -!- FUNCTION: Flavin transferase that catalyzes the transfer of the FMN
CC       moiety of FAD and its covalent binding to the hydroxyl group of a
CC       threonine residue in a target flavoprotein such as NqrB and NqrC, two
CC       subunits of the NQR complex. {ECO:0000250|UniProtKB:A5F5Y3}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=FAD + L-threonyl-[protein] = AMP + FMN-L-threonyl-[protein] +
CC         H(+); Xref=Rhea:RHEA:36847, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11061, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:74257, ChEBI:CHEBI:456215; EC=2.7.1.180;
CC         Evidence={ECO:0000250|UniProtKB:A5F5Y3};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:A5F5Y3};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:21148731}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|PROSITE-
CC       ProRule:PRU00303, ECO:0000269|PubMed:10572132,
CC       ECO:0000269|PubMed:9473043}; Lipid-anchor {ECO:0000255|PROSITE-
CC       ProRule:PRU00303, ECO:0000269|PubMed:9473043}; Periplasmic side
CC       {ECO:0000269|PubMed:10572132}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene are conditional thiamine
CC       auxotrophs, and display phenotypic behaviors similar to those of
CC       strains lacking isc (iron-sulfur [Fe-S] cluster biosynthesis) operon
CC       functions. {ECO:0000269|PubMed:12486045, ECO:0000269|PubMed:9473043}.
CC   -!- SIMILARITY: Belongs to the ApbE family. {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to be involved in synthesis of the
CC       pyrimidine moiety of thiamine and/or in metabolism of Fe-S clusters.
CC       {ECO:0000303|PubMed:12486045, ECO:0000303|PubMed:21148731,
CC       ECO:0000303|PubMed:9473043}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF035376; AAC46116.1; -; Genomic_DNA.
DR   EMBL; U90324; AAB50407.1; -; Genomic_DNA.
DR   EMBL; AE006468; AAL21168.1; -; Genomic_DNA.
DR   EMBL; D90221; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_461209.1; NC_003197.2.
DR   RefSeq; WP_000784307.1; NC_003197.2.
DR   PDB; 3PND; X-ray; 2.75 A; A/B/C/D=21-350.
DR   PDBsum; 3PND; -.
DR   SMR; P41780; -.
DR   PaxDb; P41780; -.
DR   DNASU; 1253788; -.
DR   EnsemblBacteria; AAL21168; AAL21168; STM2266.
DR   GeneID; 1253788; -.
DR   KEGG; stm:STM2266; -.
DR   PATRIC; fig|99287.12.peg.2400; -.
DR   HOGENOM; CLU_044403_0_0_6; -.
DR   OMA; MGTFWRV; -.
DR   PhylomeDB; P41780; -.
DR   Proteomes; UP000001014; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0071949; F:FAD binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016740; F:transferase activity; IBA:GO_Central.
DR   GO; GO:0017013; P:protein flavinylation; IBA:GO_Central.
DR   Gene3D; 3.10.520.20; -; 1.
DR   InterPro; IPR024932; ApbE.
DR   InterPro; IPR003374; ApbE-like_sf.
DR   InterPro; IPR042159; Ftp_ApbE.
DR   PANTHER; PTHR30040; PTHR30040; 1.
DR   Pfam; PF02424; ApbE; 1.
DR   PIRSF; PIRSF006268; ApbE; 1.
DR   SUPFAM; SSF143631; SSF143631; 1.
DR   PROSITE; PS51257; PROKAR_LIPOPROTEIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell inner membrane; Cell membrane; FAD; Flavoprotein;
KW   Lipoprotein; Magnesium; Membrane; Metal-binding; Palmitate;
KW   Reference proteome; Signal; Transferase.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00303"
FT   CHAIN           20..350
FT                   /note="FAD:protein FMN transferase"
FT                   /id="PRO_0000001750"
FT   NP_BIND         119..121
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21148731"
FT   METAL           184
FT                   /note="Magnesium; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB85"
FT   METAL           298
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000250|UniProtKB:O83774"
FT   METAL           301
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB85"
FT   METAL           302
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000250|UniProtKB:O83774"
FT   BINDING         41
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:21148731"
FT   BINDING         78
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21148731"
FT   BINDING         181
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21148731"
FT   BINDING         187
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21148731"
FT   BINDING         272
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:21148731"
FT   LIPID           20
FT                   /note="N-palmitoyl cysteine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00303"
FT   LIPID           20
FT                   /note="S-diacylglycerol cysteine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00303"
FT   MUTAGEN         78
FT                   /note="Y->A: Unable to grow in minimal glucose medium;
FT                   requires thiamine for growth. Is defective in FAD binding."
FT                   /evidence="ECO:0000269|PubMed:21148731"
FT   CONFLICT        215
FT                   /note="S -> N (in Ref. 2; AAB50407)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        321..350
FT                   /note="LAVFMIMKEGEGFKTWMSPQFKTFLVSDKN -> WRYL (in Ref. 2;
FT                   AAB50407)"
FT                   /evidence="ECO:0000305"
FT   STRAND          34..40
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   STRAND          43..52
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   HELIX           54..75
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   HELIX           83..88
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   STRAND          96..98
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   HELIX           100..115
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   TURN            116..118
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   HELIX           125..130
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   STRAND          134..136
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   HELIX           145..152
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   HELIX           157..159
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   STRAND          160..165
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   STRAND          168..174
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   HELIX           183..200
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   STRAND          205..210
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   STRAND          213..219
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   STRAND          223..225
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   STRAND          228..231
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   STRAND          241..244
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   STRAND          249..255
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   HELIX           257..263
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   TURN            274..277
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   STRAND          283..293
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   HELIX           294..307
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   HELIX           309..319
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   STRAND          322..329
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   STRAND          332..337
FT                   /evidence="ECO:0007829|PDB:3PND"
FT   HELIX           339..342
FT                   /evidence="ECO:0007829|PDB:3PND"
SQ   SEQUENCE   350 AA;  38149 MW;  40AA62CB4D04F913 CRC64;
     MKMTFCRAVC LAAAFLLMGC DEAPETTTAS PAAQVLEGKT MGTLWRVSVV GIDAKRAAEL
     QTKIQTQLDA DDWLLSTYKN DSALMRFNHS RSLAPWPVSE AMADIVTSAL RIGAKTDGAM
     DITVGPLVNL WGFGPDRQPL HIPTPAQIDA AKAKTGLQHL QVIDRAGHQF LQKDLPDLYV
     DLSTVGEGYA ADHLARLMEQ EGIARYLVSV GGALSSRGMN AQGQPWRVAI QKPTDRENAV
     QAIVDINGHG ISTSGSYRNY YELDGKRVSH VIDPQTGRPI EHNLVSVTVI APTALEADGW
     DTGLMVLGTQ KAQEVVRREG LAVFMIMKEG EGFKTWMSPQ FKTFLVSDKN
//
ID   DMGO_ARTGO              Reviewed;         830 AA.
AC   Q9AGP8;
DT   14-MAY-2014, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   02-JUN-2021, entry version 95.
DE   RecName: Full=Dimethylglycine oxidase;
DE            Short=DMGO;
DE            EC=1.5.3.10;
GN   Name=dmg;
OS   Arthrobacter globiformis.
OC   Bacteria; Actinobacteria; Micrococcales; Micrococcaceae; Arthrobacter.
OX   NCBI_TaxID=1665;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   STRAIN=NRRL B-2979;
RX   PubMed=11422368; DOI=10.1046/j.1432-1327.2001.02239.x;
RA   Meskys R., Harris R.J., Casaite V., Basran J., Scrutton N.S.;
RT   "Organization of the genes involved in dimethylglycine and sarcosine
RT   degradation in Arthrobacter spp.: implications for glycine betaine
RT   catabolism.";
RL   Eur. J. Biochem. 268:3390-3398(2001).
RN   [2]
RP   PROTEIN SEQUENCE OF 27-58, FUNCTION, AND FAD-BINDING AT HIS-48.
RC   STRAIN=NRRL B-2979;
RX   PubMed=11926836; DOI=10.1021/bi025519h;
RA   Basran J., Bhanji N., Basran A., Nietlispach D., Mistry S., Meskys R.,
RA   Scrutton N.S.;
RT   "Mechanistic aspects of the covalent flavoprotein dimethylglycine oxidase
RT   of Arthrobacter globiformis studied by stopped-flow spectrophotometry.";
RL   Biochemistry 41:4733-4743(2002).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.61 ANGSTROMS) IN COMPLEX WITH FAD AND
RP   TETRAHYDROFOLATE, FUNCTION, AND MUTAGENESIS OF HIS-225 AND TYR-259.
RC   STRAIN=NRRL B-2979;
RX   PubMed=12912903; DOI=10.1093/emboj/cdg395;
RA   Leys D., Basran J., Scrutton N.S.;
RT   "Channelling and formation of 'active' formaldehyde in dimethylglycine
RT   oxidase.";
RL   EMBO J. 22:4038-4048(2003).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 4-830 IN COMPLEX WITH FAD AND
RP   TETRAHYDROFOLATE, FUNCTION, AND MUTAGENESIS OF ASP-552.
RC   STRAIN=NRRL B-2979;
RX   PubMed=19369258; DOI=10.1074/jbc.m109.006262;
RA   Tralau T., Lafite P., Levy C., Combe J.P., Scrutton N.S., Leys D.;
RT   "An internal reaction chamber in dimethylglycine oxidase provides efficient
RT   protection from exposure to toxic formaldehyde.";
RL   J. Biol. Chem. 284:17826-17834(2009).
CC   -!- FUNCTION: Catalyzes the oxidative demethylation of N,N-dimethylglycine
CC       to yield sarcosine, formaldehyde and hydrogen peroxide. The oxidation
CC       of dimethylglycine is coupled to the synthesis of 5,10-
CC       methylenetetrahydrofolate through an unusual substrate channeling
CC       mechanism. This channeling occurs by nonbiased diffusion of the iminium
CC       intermediate through a large solvent cavity connecting active site 1
CC       (N-terminus) and active site 2 (C-terminus). The synthesis of 5,10-
CC       methylenetetrahydrofolate (at active site 2) prevents the accumulation
CC       of formaldehyde, formed by hydrolysis of the iminium intermediate
CC       product (at active site 1). Does not oxidize sarcosine.
CC       {ECO:0000269|PubMed:11422368, ECO:0000269|PubMed:11926836,
CC       ECO:0000269|PubMed:12912903, ECO:0000269|PubMed:19369258}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N,N-dimethylglycine + O2 = formaldehyde + H2O2 +
CC         sarcosine; Xref=Rhea:RHEA:17077, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:16842,
CC         ChEBI:CHEBI:57433, ChEBI:CHEBI:58251; EC=1.5.3.10;
CC         Evidence={ECO:0000269|PubMed:11422368};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6S)-5,6,7,8-tetrahydrofolate + N,N-dimethylglycine + O2 =
CC         (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate + H2O2 + sarcosine;
CC         Xref=Rhea:RHEA:45756, ChEBI:CHEBI:15379, ChEBI:CHEBI:15636,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:57433, ChEBI:CHEBI:57453,
CC         ChEBI:CHEBI:58251; Evidence={ECO:0000269|PubMed:11422368};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:11422368, ECO:0000269|PubMed:11926836};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:11422368,
CC       ECO:0000269|PubMed:11926836};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2 mM for N,N-dimethylglycine {ECO:0000269|PubMed:11422368};
CC       pH dependence:
CC         Optimum pH is 8.0-10.0. {ECO:0000269|PubMed:11422368};
CC   -!- SIMILARITY: Belongs to the GcvT family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF329477; AAK16482.1; -; Genomic_DNA.
DR   PDB; 1PJ5; X-ray; 1.61 A; A=1-830.
DR   PDB; 1PJ6; X-ray; 1.65 A; A=1-830.
DR   PDB; 1PJ7; X-ray; 2.10 A; A=1-830.
DR   PDB; 3GSI; X-ray; 2.00 A; A=4-830.
DR   PDBsum; 1PJ5; -.
DR   PDBsum; 1PJ6; -.
DR   PDBsum; 1PJ7; -.
DR   PDBsum; 3GSI; -.
DR   SMR; Q9AGP8; -.
DR   DrugBank; DB03256; (6R)-Folinic acid.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   PRIDE; Q9AGP8; -.
DR   KEGG; ag:AAK16482; -.
DR   BRENDA; 1.5.3.10; 444.
DR   SABIO-RK; Q9AGP8; -.
DR   EvolutionaryTrace; Q9AGP8; -.
DR   GO; GO:0047866; F:dimethylglycine oxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.1360.120; -; 1.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR032503; FAO_M.
DR   InterPro; IPR013977; GCV_T_C.
DR   InterPro; IPR006222; GCV_T_N.
DR   InterPro; IPR029043; GcvT/YgfZ_C.
DR   InterPro; IPR027266; TrmE/GcvT_dom1.
DR   Pfam; PF01266; DAO; 1.
DR   Pfam; PF16350; FAO_M; 1.
DR   Pfam; PF01571; GCV_T; 1.
DR   Pfam; PF08669; GCV_T_C; 1.
DR   SUPFAM; SSF101790; SSF101790; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; FAD; Flavoprotein;
KW   Nucleotide-binding; Oxidoreductase.
FT   CHAIN           1..830
FT                   /note="Dimethylglycine oxidase"
FT                   /id="PRO_0000428956"
FT   NP_BIND         14..15
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12912903,
FT                   ECO:0000269|PubMed:19369258"
FT   NP_BIND         35..36
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12912903,
FT                   ECO:0000269|PubMed:19369258"
FT   NP_BIND         45..48
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12912903,
FT                   ECO:0000269|PubMed:19369258"
FT   NP_BIND         360..363
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12912903,
FT                   ECO:0000269|PubMed:19369258"
FT   REGION          658..660
FT                   /note="Tetrahydrofolate binding"
FT   ACT_SITE        225
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        259
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        552
FT                   /note="For 5,10-methylenetetrahydrofolate synthesis
FT                   activity"
FT                   /evidence="ECO:0000255"
FT   BINDING         52
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:12912903,
FT                   ECO:0000269|PubMed:19369258"
FT   BINDING         174
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:12912903,
FT                   ECO:0000269|PubMed:19369258"
FT   BINDING         259
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12912903,
FT                   ECO:0000269|PubMed:19369258"
FT   BINDING         539
FT                   /note="Tetrahydrofolate"
FT                   /evidence="ECO:0000269|PubMed:19369258"
FT   BINDING         554
FT                   /note="Tetrahydrofolate"
FT   BINDING         566
FT                   /note="Tetrahydrofolate; via carbonyl oxygen"
FT   SITE            225
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000269|PubMed:12912903"
FT   SITE            259
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000269|PubMed:12912903"
FT   SITE            552
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000269|PubMed:19369258,
FT                   ECO:0000305|PubMed:12912903"
FT   MOD_RES         48
FT                   /note="Pros-8alpha-FAD histidine"
FT   MUTAGEN         225
FT                   /note="H->Q: Reduces catalytic efficiency 3-fold and
FT                   substrate affinity 30-fold."
FT                   /evidence="ECO:0000269|PubMed:12912903"
FT   MUTAGEN         259
FT                   /note="Y->F: Reduces catalytic efficiency 225-fold and
FT                   substrate affinity 25-fold."
FT                   /evidence="ECO:0000269|PubMed:12912903"
FT   MUTAGEN         552
FT                   /note="D->A: No effect on the activity."
FT                   /evidence="ECO:0000269|PubMed:19369258"
FT   MUTAGEN         552
FT                   /note="D->N: Reduces activity 3-fold."
FT                   /evidence="ECO:0000269|PubMed:19369258"
FT   STRAND          7..10
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           14..25
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          31..34
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           45..47
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           60..75
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          81..85
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          89..95
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           96..112
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          117..119
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           121..127
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           133..135
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          138..142
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          146..148
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           150..163
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          167..169
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          174..180
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          183..189
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          192..195
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          197..201
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           204..206
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           207..212
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   TURN            213..215
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          221..231
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           234..236
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   TURN            237..239
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   TURN            242..244
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          250..253
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           254..256
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          258..263
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          266..271
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           281..283
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           289..291
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           305..318
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           320..324
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          327..337
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          344..347
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          349..352
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          354..359
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           362..364
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           365..378
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   TURN            386..388
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           390..392
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           395..398
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           400..412
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   TURN            413..415
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          425..427
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           436..441
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          444..449
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          452..458
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           459..467
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           470..472
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           479..482
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           488..498
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          501..504
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          510..515
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           518..525
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          526..528
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          536..543
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          549..559
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          562..566
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           570..586
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          594..597
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           599..601
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          602..609
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           612..616
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   TURN            617..619
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   TURN            626..628
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          633..639
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          642..647
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          653..662
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           663..677
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           678..680
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          683..685
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           687..696
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   TURN            702..704
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   TURN            712..716
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           718..720
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   HELIX           731..734
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   TURN            739..741
FT                   /evidence="ECO:0007829|PDB:3GSI"
FT   STRAND          743..751
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          763..766
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          769..773
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          776..780
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   TURN            781..784
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          785..793
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          801..806
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   STRAND          809..816
FT                   /evidence="ECO:0007829|PDB:1PJ5"
FT   TURN            826..828
FT                   /evidence="ECO:0007829|PDB:1PJ5"
SQ   SEQUENCE   830 AA;  89985 MW;  13DE3C4B3DF325DA CRC64;
     MASTPRIVII GAGIVGTNLA DELVTRGWNN ITVLDQGPLN MPGGSTSHAP GLVFQTNPSK
     TMASFAKYTV EKLLSLTEDG VSCFNQVGGL EVATTETRLA DLKRKLGYAA AWGIEGRLLS
     PAECQELYPL LDGENILGGL HVPSDGLASA ARAVQLLIKR TESAGVTYRG STTVTGIEQS
     GGRVTGVQTA DGVIPADIVV SCAGFWGAKI GAMIGMAVPL LPLAHQYVKT TPVPAQQGRN
     DQPNGARLPI LRHQDQDLYY REHGDRYGIG SYAHRPMPVD VDTLGAYAPE TVSEHHMPSR
     LDFTLEDFLP AWEATKQLLP ALADSEIEDG FNGIFSFTPD GGPLLGESKE LDGFYVAEAV
     WVTHSAGVAK AMAELLTTGR SETDLGECDI TRFEDVQLTP EYVSETSQQN FVEIYDVLHP
     LQPRLSPRNL RVSPFHARHK ELGAFFLEAG GWERPYWFEA NAALLKEMPA EWLPPARDAW
     SGMFSSPIAA AEAWKTRTAV AMYDMTPLKR LEVSGPGALK LLQELTTADL AKKPGAVTYT
     LLLDHAGGVR SDITVARLSE DTFQLGANGN IDTAYFERAA RHQTQSGSAT DWVQVRDTTG
     GTCCIGLWGP LARDLVSKVS DDDFTNDGLK YFRAKNVVIG GIPVTAMRLS YVGELGWELY
     TSADNGQRLW DALWQAGQPF GVIAAGRAAF SSLRLEKGYR SWGTDMTTEH DPFEAGLGFA
     VKMAKESFIG KGALEGRTEE ASARRLRCLT IDDGRSIVLG KEPVFYKEQA VGYVTSAAYG
     YTVAKPIAYS YLPGTVSVGD SVDIEYFGRR ITATVTEDPL YDPKMTRLRG
//
ID   DPRE1_MYCTU             Reviewed;         461 AA.
AC   P9WJF1; L0TDT1; P72056; Q7D4V3;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   02-JUN-2021, entry version 57.
DE   RecName: Full=Decaprenylphosphoryl-beta-D-ribose oxidase {ECO:0000303|PubMed:19299584, ECO:0000303|PubMed:25427196, ECO:0000303|PubMed:25789990};
DE            EC=1.1.98.3 {ECO:0000269|PubMed:22733761};
DE   AltName: Full=Decaprenylphospho-beta-D-ribofuranose 2-dehydrogenase {ECO:0000303|PubMed:20828197};
DE   AltName: Full=Decaprenylphosphoryl-beta-D-ribofuranose 2'-epimerase subunit DprE1 {ECO:0000305|PubMed:25789990};
DE            Short=Decaprenyl-phosphoribose 2'-epimerase subunit 1 {ECO:0000305|PubMed:25789990};
DE   AltName: Full=Decaprenylphosphoryl-beta-D-ribofuranose 2'-oxidase {ECO:0000305};
DE   AltName: Full=Decaprenylphosphoryl-beta-D-ribose 2-epimerase flavoprotein subunit {ECO:0000303|PubMed:24500695};
DE   AltName: Full=FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase {ECO:0000303|PubMed:20828197};
GN   Name=dprE1 {ECO:0000303|PubMed:19299584, ECO:0000303|PubMed:20828197};
GN   OrderedLocusNames=Rv3790;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=12657046; DOI=10.1046/j.1365-2958.2003.03425.x;
RA   Sassetti C.M., Boyd D.H., Rubin E.J.;
RT   "Genes required for mycobacterial growth defined by high density
RT   mutagenesis.";
RL   Mol. Microbiol. 48:77-84(2003).
RN   [3]
RP   FUNCTION IN DPR EPIMERIZATION, AND PATHWAY.
RC   STRAIN=H37Rv;
RX   PubMed=16291675; DOI=10.1128/jb.187.23.8020-8025.2005;
RA   Mikusova K., Huang H., Yagi T., Holsters M., Vereecke D., D'Haeze W.,
RA   Scherman M.S., Brennan P.J., McNeil M.R., Crick D.C.;
RT   "Decaprenylphosphoryl arabinofuranose, the donor of the D-arabinofuranosyl
RT   residues of mycobacterial arabinan, is formed via a two-step epimerization
RT   of decaprenylphosphoryl ribose.";
RL   J. Bacteriol. 187:8020-8025(2005).
RN   [4]
RP   IDENTIFICATION AS A DRUG TARGET [LARGE SCALE ANALYSIS].
RX   PubMed=19099550; DOI=10.1186/1752-0509-2-109;
RA   Raman K., Yeturu K., Chandra N.;
RT   "targetTB: a target identification pipeline for Mycobacterium tuberculosis
RT   through an interactome, reactome and genome-scale structural analysis.";
RL   BMC Syst. Biol. 2:109-109(2008).
RN   [5]
RP   ACTIVITY REGULATION, AND INHIBITOR SCREENING.
RC   STRAIN=H37Rv;
RX   PubMed=19876393; DOI=10.1371/journal.ppat.1000645;
RA   Christophe T., Jackson M., Jeon H.K., Fenistein D., Contreras-Dominguez M.,
RA   Kim J., Genovesio A., Carralot J.P., Ewann F., Kim E.H., Lee S.Y., Kang S.,
RA   Seo M.J., Park E.J., Skovierova H., Pham H., Riccardi G., Nam J.Y.,
RA   Marsollier L., Kempf M., Joly-Guillou M.L., Oh T., Shin W.K., No Z.,
RA   Nehrbass U., Brosch R., Cole S.T., Brodin P.;
RT   "High content screening identifies decaprenyl-phosphoribose 2' epimerase as
RT   a target for intracellular antimycobacterial inhibitors.";
RL   PLoS Pathog. 5:E1000645-E1000645(2009).
RN   [6]
RP   FUNCTION IN DPR EPIMERIZATION, ACTIVITY REGULATION, DRUG TARGET, AND
RP   BTZ043-RESISTANT VARIANTS NTB1 AND NTB9.
RC   STRAIN=H37Rv;
RX   PubMed=19299584; DOI=10.1126/science.1171583;
RA   Makarov V., Manina G., Mikusova K., Mollmann U., Ryabova O.,
RA   Saint-Joanis B., Dhar N., Pasca M.R., Buroni S., Lucarelli A.P., Milano A.,
RA   De Rossi E., Belanova M., Bobovska A., Dianiskova P., Kordulakova J.,
RA   Sala C., Fullam E., Schneider P., McKinney J.D., Brodin P., Christophe T.,
RA   Waddell S., Butcher P., Albrethsen J., Rosenkrands I., Brosch R., Nandi V.,
RA   Bharath S., Gaonkar S., Shandil R.K., Balasubramanian V., Balganesh T.,
RA   Tyagi S., Grosset J., Riccardi G., Cole S.T.;
RT   "Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan
RT   synthesis.";
RL   Science 324:801-804(2009).
RN   [7]
RP   REVIEW, AND DRUG TARGET.
RX   PubMed=20629622; DOI=10.2174/092986710791959693;
RA   Manina G., Pasca M.R., Buroni S., De Rossi E., Riccardi G.;
RT   "Decaprenylphosphoryl-beta-D-ribose 2'-epimerase from Mycobacterium
RT   tuberculosis is a magic drug target.";
RL   Curr. Med. Chem. 17:3099-3108(2010).
RN   [8]
RP   ACTIVITY REGULATION, MECHANISM OF ACTION OF BENZOTHIAZINONES, MUTAGENESIS
RP   OF CYS-387, AND 3D-STRUCTURE MODELING.
RX   PubMed=20828197; DOI=10.1021/ja106357w;
RA   Trefzer C., Rengifo-Gonzalez M., Hinner M.J., Schneider P., Makarov V.,
RA   Cole S.T., Johnsson K.;
RT   "Benzothiazinones: prodrugs that covalently modify the
RT   decaprenylphosphoryl-beta-D-ribose 2'-epimerase DprE1 of Mycobacterium
RT   tuberculosis.";
RL   J. Am. Chem. Soc. 132:13663-13665(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [10]
RP   REVIEW, AND DRUG TARGET.
RX   PubMed=24037308; DOI=10.1007/s00253-013-5218-x;
RA   Riccardi G., Pasca M.R., Chiarelli L.R., Manina G., Mattevi A., Binda C.;
RT   "The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium
RT   tuberculosis.";
RL   Appl. Microbiol. Biotechnol. 97:8841-8848(2013).
RN   [11]
RP   ACTIVITY REGULATION.
RX   PubMed=24215368; DOI=10.1021/jm401382v;
RA   Shirude P.S., Shandil R., Sadler C., Naik M., Hosagrahara V., Hameed S.,
RA   Shinde V., Bathula C., Humnabadkar V., Kumar N., Reddy J., Panduga V.,
RA   Sharma S., Ambady A., Hegde N., Whiteaker J., McLaughlin R.E., Gardner H.,
RA   Madhavapeddi P., Ramachandran V., Kaur P., Narayan A., Guptha S.,
RA   Awasthy D., Narayan C., Mahadevaswamy J., Vishwas K.G., Ahuja V.,
RA   Srivastava A., Prabhakar K.R., Bharath S., Kale R., Ramaiah M.,
RA   Choudhury N.R., Sambandamurthy V.K., Solapure S., Iyer P.S., Narayanan S.,
RA   Chatterji M.;
RT   "Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts,
RT   kill Mycobacterium tuberculosis and are efficacious in vivo.";
RL   J. Med. Chem. 56:9701-9708(2013).
RN   [12]
RP   REVIEW, AND DRUG TARGET.
RX   PubMed=24245764; DOI=10.2174/138161282027140630122724;
RA   Mikusova K., Makarov V., Neres J.;
RT   "DprE1--from the discovery to the promising tuberculosis drug target.";
RL   Curr. Pharm. Des. 20:4379-4403(2014).
RN   [13]
RP   ACTIVITY REGULATION.
RX   PubMed=24818517; DOI=10.1021/jm5002937;
RA   Panda M., Ramachandran S., Ramachandran V., Shirude P.S., Humnabadkar V.,
RA   Nagalapur K., Sharma S., Kaur P., Guptha S., Narayan A., Mahadevaswamy J.,
RA   Ambady A., Hegde N., Rudrapatna S.S., Hosagrahara V.P.,
RA   Sambandamurthy V.K., Raichurkar A.;
RT   "Discovery of pyrazolopyridones as a novel class of noncovalent DprE1
RT   inhibitor with potent anti-mycobacterial activity.";
RL   J. Med. Chem. 57:4761-4771(2014).
RN   [14]
RP   DISRUPTION PHENOTYPE, AND PATHWAY.
RC   STRAIN=H37Rv;
RX   PubMed=24517327; DOI=10.1111/mmi.12546;
RA   Kolly G.S., Boldrin F., Sala C., Dhar N., Hartkoorn R.C., Ventura M.,
RA   Serafini A., McKinney J.D., Manganelli R., Cole S.T.;
RT   "Assessing the essentiality of the decaprenyl-phospho-D-arabinofuranose
RT   pathway in Mycobacterium tuberculosis using conditional mutants.";
RL   Mol. Microbiol. 92:194-211(2014).
RN   [15]
RP   SUBCELLULAR LOCATION.
RC   STRAIN=H37Rv;
RX   PubMed=25906160; DOI=10.1021/acschembio.5b00237;
RA   Brecik M., Centarova I., Mukherjee R., Kolly G.S., Huszar S., Bobovska A.,
RA   Kilacskova E., Mokosova V., Svetlikova Z., Sarkan M., Neres J.,
RA   Kordulakova J., Cole S.T., Mikusova K.;
RT   "DprE1 is a vulnerable tuberculosis drug target due to its cell wall
RT   localization.";
RL   ACS Chem. Biol. 10:1631-1636(2015).
RN   [16]
RP   ACTIVITY REGULATION.
RC   STRAIN=H37Rv;
RX   PubMed=25987616; DOI=10.1128/aac.00778-15;
RA   Makarov V., Neres J., Hartkoorn R.C., Ryabova O.B., Kazakova E., Sarkan M.,
RA   Huszar S., Piton J., Kolly G.S., Vocat A., Conroy T.M., Mikusova K.,
RA   Cole S.T.;
RT   "The 8-pyrrole-benzothiazinones are noncovalent inhibitors of DprE1 from
RT   Mycobacterium tuberculosis.";
RL   Antimicrob. Agents Chemother. 59:4446-4452(2015).
RN   [17]
RP   INTERACTION WITH DPRE2.
RX   PubMed=25789990; DOI=10.1371/journal.pone.0119771;
RA   Bhutani I., Loharch S., Gupta P., Madathil R., Parkesh R.;
RT   "Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb)
RT   DprE1 and DprE2 examined by molecular modeling, simulation, and
RT   electrostatic studies.";
RL   PLoS ONE 10:E0119771-E0119771(2015).
RN   [18]
RP   MUTAGENESIS OF CYS-387.
RC   STRAIN=H37Rv;
RX   PubMed=27527085; DOI=10.1128/aac.01523-16;
RA   Foo C.S., Lechartier B., Kolly G.S., Boy-Roettger S., Neres J.,
RA   Rybniker J., Lupien A., Sala C., Piton J., Cole S.T.;
RT   "Characterization of DprE1-mediated benzothiazinone resistance in
RT   Mycobacterium tuberculosis.";
RL   Antimicrob. Agents Chemother. 60:6451-6459(2016).
RN   [19]
RP   REVIEW, AND ACTIVITY REGULATION.
RX   PubMed=27666194; DOI=10.1016/j.drudis.2016.09.014;
RA   Piton J., Foo C.S., Cole S.T.;
RT   "Structural studies of Mycobacterium tuberculosis DprE1 interacting with
RT   its inhibitors.";
RL   Drug Discov. Today 22:526-533(2017).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.04 ANGSTROMS) IN COMPLEXES WITH FAD AND
RP   BENZOTHIAZINONE INHIBITORS, FUNCTION, CATALYTIC ACTIVITY, ACTIVITY
RP   REGULATION, AND SUBUNIT.
RX   PubMed=22733761; DOI=10.1073/pnas.1205735109;
RA   Batt S.M., Jabeen T., Bhowruth V., Quill L., Lund P.A., Eggeling L.,
RA   Alderwick L.J., Futterer K., Besra G.S.;
RT   "Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by
RT   benzothiazinone inhibitors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:11354-11359(2012).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.61 ANGSTROMS) IN COMPLEX WITH TCA1 INHIBITOR AND
RP   FAD, INHIBITOR SCREENING, ACTIVITY REGULATION, AND TCA1-RESISTANT VARIANT
RP   CYS-314.
RX   PubMed=23776209; DOI=10.1073/pnas.1309171110;
RA   Wang F., Sambandan D., Halder R., Wang J., Batt S.M., Weinrick B.,
RA   Ahmad I., Yang P., Zhang Y., Kim J., Hassani M., Huszar S., Trefzer C.,
RA   Ma Z., Kaneko T., Mdluli K.E., Franzblau S., Chatterjee A.K., Johnsson K.,
RA   Johnson K., Mikusova K., Besra G.S., Futterer K., Robbins S.H.,
RA   Barnes S.W., Walker J.R., Jacobs W.R. Jr., Schultz P.G.;
RT   "Identification of a small molecule with activity against drug-resistant
RT   and persistent tuberculosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:E2510-E2517(2013).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.88 ANGSTROMS) IN COMPLEX WITH FAD AND THE
RP   BENZOTHIAZINONE PBTZ169 INHIBITOR, AND ACTIVITY REGULATION.
RX   PubMed=24500695; DOI=10.1002/emmm.201303575;
RA   Makarov V., Lechartier B., Zhang M., Neres J., van der Sar A.M.,
RA   Raadsen S.A., Hartkoorn R.C., Ryabova O.B., Vocat A., Decosterd L.A.,
RA   Widmer N., Buclin T., Bitter W., Andries K., Pojer F., Dyson P.J.,
RA   Cole S.T.;
RT   "Towards a new combination therapy for tuberculosis with next generation
RT   benzothiazinones.";
RL   EMBO Mol. Med. 6:372-383(2014).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.79 ANGSTROMS) IN COMPLEXES WITH FAD AND DIFFERENT
RP   QUINOXALINE INHIBITORS, ACTIVITY REGULATION, INHIBITOR SCREENING,
RP   TY38C-RESISTANT VARIANTS TRC11 AND TRC12, FUNCTION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND MUTAGENESIS OF GLY-17 AND LEU-368.
RX   PubMed=25427196; DOI=10.1021/cb5007163;
RA   Neres J., Hartkoorn R.C., Chiarelli L.R., Gadupudi R., Pasca M.R., Mori G.,
RA   Venturelli A., Savina S., Makarov V., Kolly G.S., Molteni E., Binda C.,
RA   Dhar N., Ferrari S., Brodin P., Delorme V., Landry V.,
RA   de Jesus Lopes Ribeiro A.L., Farina D., Saxena P., Pojer F., Carta A.,
RA   Luciani R., Porta A., Zanoni G., De Rossi E., Costi M.P., Riccardi G.,
RA   Cole S.T.;
RT   "2-Carboxyquinoxalines kill Mycobacterium tuberculosis through noncovalent
RT   inhibition of DprE1.";
RL   ACS Chem. Biol. 10:705-714(2015).
CC   -!- FUNCTION: Component of the DprE1-DprE2 complex that catalyzes the 2-
CC       step epimerization of decaprenyl-phospho-ribose (DPR) to decaprenyl-
CC       phospho-arabinose (DPA), a key precursor that serves as the arabinose
CC       donor required for the synthesis of cell-wall arabinans
CC       (PubMed:16291675, PubMed:19299584). DprE1 catalyzes the first step of
CC       epimerization, namely FAD-dependent oxidation of the C2' hydroxyl of
CC       DPR to yield the keto intermediate decaprenyl-phospho-2'-keto-D-
CC       arabinose (DPX) (PubMed:22733761). The intermediate DPX is then
CC       transferred to DprE2 subunit of the epimerase complex, most probably
CC       through a 'substrate channel' at the interface of DprE1-DprE2 complex
CC       (PubMed:25789990). Can also use farnesyl-phosphoryl-beta-D-ribofuranose
CC       (FPR) as substrate in vitro (PubMed:25427196). Appears to be essential
CC       for the growth and survival of M.tuberculosis (PubMed:12657046,
CC       PubMed:24517327). {ECO:0000269|PubMed:12657046,
CC       ECO:0000269|PubMed:16291675, ECO:0000269|PubMed:19299584,
CC       ECO:0000269|PubMed:22733761, ECO:0000269|PubMed:24517327,
CC       ECO:0000269|PubMed:25427196, ECO:0000305|PubMed:25789990}.
CC   -!- FUNCTION: DprE1 is a highly vulnerable and fully validated tuberculosis
CC       drug target. {ECO:0000303|PubMed:20629622, ECO:0000303|PubMed:24037308,
CC       ECO:0000303|PubMed:24245764}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=FAD + H(+) + trans,octa-cis-decaprenylphospho-beta-D-
CC         ribofuranose = FADH2 + trans,octa-cis-decaprenylphospho-beta-D-
CC         erythro-pentofuranosid-2-ulose; Xref=Rhea:RHEA:33899,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:65067, ChEBI:CHEBI:66881; EC=1.1.98.3;
CC         Evidence={ECO:0000269|PubMed:22733761};
CC   -!- ACTIVITY REGULATION: Is inhibited by 8-nitro-benzothiazinones (BTZs)
CC       such as BTZ043 and PBTZ169; BTZs are a new class of antimycobacterial
CC       agents that kill M.tuberculosis in vitro, ex vivo, and in mouse models
CC       of tuberculosis (PubMed:20828197, PubMed:19299584, PubMed:22733761,
CC       PubMed:24500695). Is also inhibited by dinitrobenzamide derivatives
CC       (DNBs), which thus block formation of both cell-wall lipoarabinomannan
CC       and arabinogalactan via inhibition of decaprenyl-phospho-arabinose
CC       (DPA) synthesis; DNBs show high activity against intracellular growth
CC       of M.tuberculosis inside macrophages, including extensively drug
CC       resistant (XDR) strains (PubMed:19876393). BTZs and DNBs are suicide
CC       inhibitors that act via covalent modification of DprE1; the essential
CC       nitro group of these compounds is reduced by DprE1 to a nitroso group,
CC       which then specifically reacts with Cys-387 of DprE1 to form an
CC       irreversible semimercaptal adduct (PubMed:20828197, PubMed:22733761,
CC       PubMed:24500695). Many other compounds with diverse scaffolds were
CC       found to act as either covalent (e.g. nitroquinoxalines,
CC       nitroimidazoles) or non-covalent (e.g. the benzothiazole derivative
CC       TCA1, the 2-carboxyquinoxaline Ty38C, 8-pyrrole-benzothiazinones, 1,4-
CC       azaindoles, pyrazolopyridones, 4-aminoquinolone piperidine amides)
CC       DprE1 inhibitors (PubMed:23776209, PubMed:25427196, PubMed:25987616,
CC       PubMed:24215368, PubMed:24818517, PubMed:27666194).
CC       {ECO:0000269|PubMed:19299584, ECO:0000269|PubMed:19876393,
CC       ECO:0000269|PubMed:20828197, ECO:0000269|PubMed:22733761,
CC       ECO:0000269|PubMed:23776209, ECO:0000269|PubMed:24215368,
CC       ECO:0000269|PubMed:24500695, ECO:0000269|PubMed:24818517,
CC       ECO:0000269|PubMed:25427196, ECO:0000269|PubMed:25987616,
CC       ECO:0000303|PubMed:27666194}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=kcat is 4.1 min(-1) with farnesyl-phosphoryl-beta-D-ribofuranose
CC         as substrate (at pH 8 and 30 degrees Celsius).
CC         {ECO:0000269|PubMed:25427196};
CC   -!- PATHWAY: Cell wall biogenesis; cell wall polysaccharide biosynthesis.
CC       {ECO:0000305|PubMed:16291675, ECO:0000305|PubMed:24517327}.
CC   -!- SUBUNIT: Monomer. Although forming apparent dimer in crystals, DprE1
CC       does not dimerize appreciably in solution (PubMed:22733761). Interacts
CC       with DprE2 to form an epimerase complex (PubMed:25789990).
CC       {ECO:0000269|PubMed:22733761, ECO:0000269|PubMed:25789990}.
CC   -!- SUBCELLULAR LOCATION: Periplasm {ECO:0000269|PubMed:25906160}.
CC   -!- DISRUPTION PHENOTYPE: Traditional knockout mutant with dprE1 disruption
CC       could not be achieved, suggesting this gene is essential
CC       (PubMed:24517327). Conditional knock-down mutant of dprE1 show that
CC       down-regulation of DprE1 results in rapid in vitro growth arrest,
CC       swelling of the bacteria, cell wall damage, stop of cell division or
CC       lysis, decreased survival in macrophages and virulence attenuation
CC       (PubMed:24517327). Cells lacking this gene display impaired growth
CC       (PubMed:12657046). {ECO:0000269|PubMed:12657046,
CC       ECO:0000269|PubMed:24517327}.
CC   -!- MISCELLANEOUS: Was identified as a high-confidence drug target.
CC       {ECO:0000269|PubMed:19099550}.
CC   -!- SIMILARITY: Belongs to the DprE1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP46619.1; -; Genomic_DNA.
DR   PIR; B70697; B70697.
DR   RefSeq; NP_218307.1; NC_000962.3.
DR   RefSeq; WP_003420630.1; NZ_NVQJ01000009.1.
DR   PDB; 4FDN; X-ray; 2.40 A; A=1-461.
DR   PDB; 4FDO; X-ray; 2.40 A; A=1-461.
DR   PDB; 4FDP; X-ray; 2.23 A; A/B=1-461.
DR   PDB; 4FEH; X-ray; 2.04 A; A=1-461.
DR   PDB; 4FF6; X-ray; 2.60 A; A/B=1-461.
DR   PDB; 4KW5; X-ray; 2.61 A; A/B=1-461.
DR   PDB; 4NCR; X-ray; 1.88 A; A/B=1-461.
DR   PDB; 4P8C; X-ray; 1.95 A; A/B=1-461.
DR   PDB; 4P8H; X-ray; 3.00 A; A/B=1-461.
DR   PDB; 4P8K; X-ray; 2.49 A; A/B=1-461.
DR   PDB; 4P8L; X-ray; 2.02 A; A/B=1-461.
DR   PDB; 4P8M; X-ray; 2.09 A; A/B=1-461.
DR   PDB; 4P8N; X-ray; 1.79 A; A/B=1-461.
DR   PDB; 4P8P; X-ray; 2.20 A; A/B=1-461.
DR   PDB; 4P8T; X-ray; 2.55 A; A/B=1-461.
DR   PDB; 4P8Y; X-ray; 2.01 A; A/B=1-461.
DR   PDB; 4PFA; X-ray; 2.56 A; A/B=1-461.
DR   PDB; 4PFD; X-ray; 2.30 A; A/B=1-461.
DR   PDB; 5OEP; X-ray; 2.35 A; A/B=1-461.
DR   PDB; 5OEQ; X-ray; 2.25 A; A/B=1-461.
DR   PDB; 6HEZ; X-ray; 2.30 A; A/B=1-461.
DR   PDB; 6HF0; X-ray; 2.38 A; A/B=1-461.
DR   PDB; 6HF3; X-ray; 2.20 A; A/B=1-461.
DR   PDB; 6HFV; X-ray; 2.05 A; A/B=1-461.
DR   PDB; 6HFW; X-ray; 2.47 A; A/B=1-461.
DR   PDBsum; 4FDN; -.
DR   PDBsum; 4FDO; -.
DR   PDBsum; 4FDP; -.
DR   PDBsum; 4FEH; -.
DR   PDBsum; 4FF6; -.
DR   PDBsum; 4KW5; -.
DR   PDBsum; 4NCR; -.
DR   PDBsum; 4P8C; -.
DR   PDBsum; 4P8H; -.
DR   PDBsum; 4P8K; -.
DR   PDBsum; 4P8L; -.
DR   PDBsum; 4P8M; -.
DR   PDBsum; 4P8N; -.
DR   PDBsum; 4P8P; -.
DR   PDBsum; 4P8T; -.
DR   PDBsum; 4P8Y; -.
DR   PDBsum; 4PFA; -.
DR   PDBsum; 4PFD; -.
DR   PDBsum; 5OEP; -.
DR   PDBsum; 5OEQ; -.
DR   PDBsum; 6HEZ; -.
DR   PDBsum; 6HF0; -.
DR   PDBsum; 6HF3; -.
DR   PDBsum; 6HFV; -.
DR   PDBsum; 6HFW; -.
DR   SMR; P9WJF1; -.
DR   STRING; 83332.Rv3790; -.
DR   BindingDB; P9WJF1; -.
DR   ChEMBL; CHEMBL3804751; -.
DR   PaxDb; P9WJF1; -.
DR   DNASU; 886125; -.
DR   GeneID; 886125; -.
DR   KEGG; mtu:Rv3790; -.
DR   TubercuList; Rv3790; -.
DR   eggNOG; COG0277; Bacteria.
DR   OMA; ADVHGKN; -.
DR   PhylomeDB; P9WJF1; -.
DR   BioCyc; MetaCyc:G185E-8086-MONOMER; -.
DR   BRENDA; 1.1.98.3; 3445.
DR   UniPathway; UPA00963; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0042597; C:periplasmic space; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; HDA:MTBBASE.
DR   GO; GO:0003885; F:D-arabinono-1,4-lactone oxidase activity; IEA:InterPro.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0035884; P:arabinan biosynthetic process; IDA:MTBBASE.
DR   GO; GO:0045227; P:capsule polysaccharide biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   GO; GO:0070592; P:cell wall polysaccharide biosynthetic process; IDA:MTBBASE.
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.465.10; -; 1.
DR   InterPro; IPR007173; ALO.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR016169; FAD-bd_PCMH_sub2.
DR   InterPro; IPR006094; Oxid_FAD_bind_N.
DR   Pfam; PF04030; ALO; 1.
DR   Pfam; PF01565; FAD_binding_4; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic resistance; Cell wall biogenesis/degradation; FAD;
KW   Flavoprotein; Oxidoreductase; Periplasm; Reference proteome.
FT   CHAIN           1..461
FT                   /note="Decaprenylphosphoryl-beta-D-ribose oxidase"
FT                   /id="PRO_0000390891"
FT   DOMAIN          19..194
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   NP_BIND         53..63
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22733761,
FT                   ECO:0000269|PubMed:23776209, ECO:0000269|PubMed:24500695,
FT                   ECO:0000269|PubMed:25427196, ECO:0007744|PDB:4FDP,
FT                   ECO:0007744|PDB:4NCR"
FT   NP_BIND         122..125
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22733761,
FT                   ECO:0000269|PubMed:23776209, ECO:0000269|PubMed:24500695,
FT                   ECO:0000269|PubMed:25427196, ECO:0007744|PDB:4FDP,
FT                   ECO:0007744|PDB:4KW5, ECO:0007744|PDB:4NCR"
FT   NP_BIND         129..132
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22733761,
FT                   ECO:0000269|PubMed:23776209, ECO:0000269|PubMed:24500695,
FT                   ECO:0000269|PubMed:25427196, ECO:0007744|PDB:4FDP,
FT                   ECO:0007744|PDB:4KW5, ECO:0007744|PDB:4NCR"
FT   BINDING         117
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:22733761,
FT                   ECO:0000269|PubMed:23776209, ECO:0000269|PubMed:24500695,
FT                   ECO:0000269|PubMed:25427196, ECO:0007744|PDB:4FDP,
FT                   ECO:0007744|PDB:4KW5, ECO:0007744|PDB:4NCR"
FT   BINDING         184
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:22733761,
FT                   ECO:0000269|PubMed:23776209, ECO:0000269|PubMed:24500695,
FT                   ECO:0000269|PubMed:25427196, ECO:0007744|PDB:4FDP,
FT                   ECO:0007744|PDB:4KW5, ECO:0007744|PDB:4NCR"
FT   BINDING         415
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:22733761,
FT                   ECO:0000269|PubMed:23776209, ECO:0000269|PubMed:24500695,
FT                   ECO:0000269|PubMed:25427196, ECO:0007744|PDB:4FDP,
FT                   ECO:0007744|PDB:4KW5, ECO:0007744|PDB:4NCR"
FT   VARIANT         17
FT                   /note="G -> C (in strain: TRC11; Ty38c-resistant mutant
FT                   strain lacking Rv3406, but sensitive to moxifloxacin)"
FT                   /evidence="ECO:0000269|PubMed:25427196"
FT   VARIANT         314
FT                   /note="Y -> C (in a spontaneous TCA1-resistant mutant
FT                   strain, but sensitive to BTZ)"
FT                   /evidence="ECO:0000269|PubMed:23776209"
FT   VARIANT         368
FT                   /note="L -> P (in strain: TRC12; Ty38c-resistant mutant
FT                   strain lacking Rv3406, but sensitive to moxifloxacin)"
FT                   /evidence="ECO:0000269|PubMed:25427196"
FT   VARIANT         387
FT                   /note="C -> G (in strain: NTB9; BTZ043-resistant)"
FT                   /evidence="ECO:0000269|PubMed:19299584"
FT   VARIANT         387
FT                   /note="C -> S (in strain: NTB1; BTZ043-resistant)"
FT                   /evidence="ECO:0000269|PubMed:19299584"
FT   MUTAGEN         17
FT                   /note="G->C: Significantly less susceptible to Ty38c
FT                   inhibition. 34-fold reduction in catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:25427196"
FT   MUTAGEN         368
FT                   /note="L->P: Significantly less susceptible to Ty38c
FT                   inhibition. 7-fold reduction in catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:25427196"
FT   MUTAGEN         387
FT                   /note="C->A,S,T: Confers resistance to BTZ043 and PBTZ169.
FT                   Decreases M.tuberculosis cytotoxicity in macrophages. Does
FT                   not affect binding affinity of the substrate to the enzyme,
FT                   and only slightly affects catalytic efficiency. Is only
FT                   partially inhibited by PBTZ169 at high concentrations,
FT                   while totally inhibited by the non-covalent inhibitor
FT                   Ty38c."
FT                   /evidence="ECO:0000269|PubMed:27527085"
FT   MUTAGEN         387
FT                   /note="C->G: Confers resistance to BTZ043 and PBTZ169. Loss
FT                   of covalent modification with BTZ043. Decreases
FT                   M.tuberculosis cytotoxicity in macrophages. Does not affect
FT                   binding affinity of the substrate to the enzyme, but
FT                   reduces catalytic efficiency by 4-fold. Is only partially
FT                   inhibited by PBTZ169 at high concentrations, while nearly
FT                   totally inhibited by the non-covalent inhibitor Ty38c."
FT                   /evidence="ECO:0000269|PubMed:20828197,
FT                   ECO:0000269|PubMed:27527085"
FT   MUTAGEN         387
FT                   /note="C->N: Confers resistance to BTZ043 and PBTZ169.
FT                   Decreases M.tuberculosis cytotoxicity in macrophages. Does
FT                   not affect binding affinity of the substrate to the enzyme,
FT                   but reduces catalytic efficiency by 4-fold. Is only
FT                   partially inhibited by PBTZ169 at high concentrations,
FT                   while totally inhibited by the non-covalent inhibitor
FT                   Ty38c."
FT                   /evidence="ECO:0000269|PubMed:27527085"
FT   STRAND          7..13
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          22..28
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           32..44
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          47..49
FT                   /evidence="ECO:0007829|PDB:4PFA"
FT   STRAND          51..54
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          59..62
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          69..73
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          80..84
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   TURN            85..87
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          89..93
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           98..105
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           106..108
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          117..119
FT                   /evidence="ECO:0007829|PDB:6HFW"
FT   HELIX           123..129
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           136..139
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           142..145
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          146..152
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          158..161
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          163..165
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           168..174
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   TURN            178..181
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          183..190
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          197..205
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           209..217
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           220..223
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          225..231
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          233..235
FT                   /evidence="ECO:0007829|PDB:5OEQ"
FT   TURN            237..241
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          243..250
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           253..255
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           258..260
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          261..263
FT                   /evidence="ECO:0007829|PDB:6HEZ"
FT   HELIX           275..278
FT                   /evidence="ECO:0007829|PDB:4P8T"
FT   HELIX           285..288
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           291..300
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          303..310
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   TURN            311..313
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   TURN            315..322
FT                   /evidence="ECO:0007829|PDB:4FDO"
FT   HELIX           324..327
FT                   /evidence="ECO:0007829|PDB:4FEH"
FT   TURN            328..330
FT                   /evidence="ECO:0007829|PDB:4FEH"
FT   STRAND          332..340
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           341..343
FT                   /evidence="ECO:0007829|PDB:4FDN"
FT   HELIX           344..356
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          365..369
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   STRAND          382..391
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           396..409
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           416..418
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           424..430
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           434..444
FT                   /evidence="ECO:0007829|PDB:4NCR"
FT   HELIX           453..457
FT                   /evidence="ECO:0007829|PDB:4NCR"
SQ   SEQUENCE   461 AA;  50163 MW;  B9B770002E5FE81C CRC64;
     MLSVGATTTA TRLTGWGRTA PSVANVLRTP DAEMIVKAVA RVAESGGGRG AIARGLGRSY
     GDNAQNGGGL VIDMTPLNTI HSIDADTKLV DIDAGVNLDQ LMKAALPFGL WVPVLPGTRQ
     VTVGGAIACD IHGKNHHSAG SFGNHVRSMD LLTADGEIRH LTPTGEDAEL FWATVGGNGL
     TGIIMRATIE MTPTSTAYFI ADGDVTASLD ETIALHSDGS EARYTYSSAW FDAISAPPKL
     GRAAVSRGRL ATVEQLPAKL RSEPLKFDAP QLLTLPDVFP NGLANKYTFG PIGELWYRKS
     GTYRGKVQNL TQFYHPLDMF GEWNRAYGPA GFLQYQFVIP TEAVDEFKKI IGVIQASGHY
     SFLNVFKLFG PRNQAPLSFP IPGWNICVDF PIKDGLGKFV SELDRRVLEF GGRLYTAKDS
     RTTAETFHAM YPRVDEWISV RRKVDPLRVF ASDMARRLEL L
//
ID   DHPH_PAENI              Reviewed;         397 AA.
AC   Q93NG3;
DT   03-SEP-2014, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   02-JUN-2021, entry version 102.
DE   RecName: Full=2,6-dihydroxypyridine 3-monooxygenase;
DE            Short=2,6-DHPH;
DE            EC=1.14.13.10;
GN   Name=dhpH;
OS   Paenarthrobacter nicotinovorans (Arthrobacter nicotinovorans).
OG   Plasmid pAO1.
OC   Bacteria; Actinobacteria; Micrococcales; Micrococcaceae; Paenarthrobacter.
OX   NCBI_TaxID=29320;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES, AND PATHWAY.
RC   STRAIN=ATCC 49919 / DSM 420 / JCM 3874 / NBRC 15511; PLASMID=pAO1;
RX   PubMed=11514508; DOI=10.1128/jb.183.18.5262-5267.2001;
RA   Baitsch D., Sandu C., Brandsch R., Igloi G.L.;
RT   "Gene cluster on pAO1 of Arthrobacter nicotinovorans involved in
RT   degradation of the plant alkaloid nicotine: cloning, purification, and
RT   characterization of 2,6-dihydroxypyridine 3-hydroxylase.";
RL   J. Bacteriol. 183:5262-5267(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 49919 / DSM 420 / JCM 3874 / NBRC 15511; PLASMID=pAO1;
RX   PubMed=12618462; DOI=10.1128/jb.185.6.1976-1986.2003;
RA   Igloi G.L., Brandsch R.;
RT   "Sequence of the 165-kilobase catabolic plasmid pAO1 from Arthrobacter
RT   nicotinovorans and identification of a pAO1-dependent nicotine uptake
RT   system.";
RL   J. Bacteriol. 185:1976-1986(2003).
RN   [3]
RP   IDENTIFICATION.
RX   PubMed=24826896; DOI=10.1371/journal.pone.0097250;
RA   Shearer A.G., Altman T., Rhee C.D.;
RT   "Finding sequences for over 270 orphan enzymes.";
RL   PLoS ONE 9:E97250-E97250(2014).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) IN COMPLEX WITH FAD, AND MUTAGENESIS
RP   OF CYS-323.
RX   PubMed=18440023; DOI=10.1016/j.jmb.2008.03.032;
RA   Treiber N., Schulz G.E.;
RT   "Structure of 2,6-dihydroxypyridine 3-hydroxylase from a nicotine-degrading
RT   pathway.";
RL   J. Mol. Biol. 379:94-104(2008).
CC   -!- FUNCTION: Catalyzes the conversion of 2,6-dihydroxypyridine into 2,3,6-
CC       trihydroxypyridine in the nicotine degradation pathway.
CC       {ECO:0000269|PubMed:11514508}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2,6-dihydroxypyridine + H(+) + NADH + O2 = 2,3,6-
CC         trihydroxypyridine + H2O + NAD(+); Xref=Rhea:RHEA:16917,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16683, ChEBI:CHEBI:17681, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.14.13.10;
CC         Evidence={ECO:0000269|PubMed:11514508};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:11514508};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.0000083 M for 2,6-dihydroxypyridine
CC         {ECO:0000269|PubMed:11514508};
CC       pH dependence:
CC         Optimum pH is 8.0. {ECO:0000269|PubMed:11514508};
CC       Temperature dependence:
CC         Optimum temperature is 20 degrees Celsius.
CC         {ECO:0000269|PubMed:11514508};
CC   -!- PATHWAY: Alkaloid degradation; nicotine degradation.
CC       {ECO:0000269|PubMed:11514508}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11514508,
CC       ECO:0000269|PubMed:18440023}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF373840; AAK64255.1; -; Genomic_DNA.
DR   EMBL; AJ507836; CAD47937.1; -; Genomic_DNA.
DR   RefSeq; WP_016359448.1; NC_021229.1.
DR   RefSeq; YP_007988763.1; NC_021229.1.
DR   PDB; 2VOU; X-ray; 2.60 A; A/B/C=1-397.
DR   PDBsum; 2VOU; -.
DR   SMR; Q93NG3; -.
DR   KEGG; ag:AAK64255; -.
DR   BioCyc; MetaCyc:MONOMER-1001; -.
DR   BRENDA; 1.14.13.10; 449.
DR   SABIO-RK; Q93NG3; -.
DR   UniPathway; UPA00106; -.
DR   EvolutionaryTrace; Q93NG3; -.
DR   GO; GO:0018663; F:2,6-dihydroxypyridine 3-monooxygenase activity; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0019608; P:nicotine catabolic process; IDA:UniProtKB.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; NAD; Nucleotide-binding; Oxidoreductase;
KW   Plasmid.
FT   CHAIN           1..397
FT                   /note="2,6-dihydroxypyridine 3-monooxygenase"
FT                   /id="PRO_0000430255"
FT   NP_BIND         14..16
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18440023"
FT   NP_BIND         35..36
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18440023"
FT   NP_BIND         316..320
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18440023"
FT   BINDING         49
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:18440023"
FT   BINDING         120
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:18440023"
FT   BINDING         306
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18440023"
FT   MUTAGEN         323
FT                   /note="C->S: Does not cause structural disturbance."
FT                   /evidence="ECO:0000269|PubMed:18440023"
FT   STRAND          6..11
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   HELIX           15..26
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          30..34
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          36..40
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          47..49
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   HELIX           52..60
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   HELIX           65..67
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          74..79
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   TURN            80..82
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          85..90
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          95..97
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   HELIX           98..109
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          120..125
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          130..134
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          139..147
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   HELIX           154..160
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          165..176
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   HELIX           183..189
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          192..198
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          201..208
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          218..226
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   HELIX           231..236
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          246..249
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   HELIX           251..253
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   HELIX           256..266
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   HELIX           271..279
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          284..291
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          296..298
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          301..303
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   HELIX           305..307
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   HELIX           313..315
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   HELIX           318..335
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   HELIX           339..368
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   TURN            369..371
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   HELIX           379..381
FT                   /evidence="ECO:0007829|PDB:2VOU"
FT   STRAND          382..384
FT                   /evidence="ECO:0007829|PDB:2VOU"
SQ   SEQUENCE   397 AA;  43400 MW;  D257CDC11D516CBE CRC64;
     MSPTTDRIAV VGGSISGLTA ALMLRDAGVD VDVYERSPQP LSGFGTGIVV QPELVHYLLE
     QGVELDSISV PSSSMEYVDA LTGERVGSVP ADWRFTSYDS IYGGLYELFG PERYHTSKCL
     VGLSQDSETV QMRFSDGTKA EANWVIGADG GASVVRKRLL GIEPTYAGYV TWRGVLQPGE
     VADDVWNYFN DKFTYGLLDD GHLIAYPIPG RENAESPRLN FQWYWNVAEG PDLDELMTDV
     RGIRLPTSVH NNSLNPHNLR QFHSKGESLF KPFRDLVLNA SSPFVTVVAD ATVDRMVHGR
     VLLIGDAAVT PRPHAAAGGA KACDDARTLA EVFTKNHDLR GSLQSWETRQ LQQGHAYLNK
     VKKMASRLQH GGSFEPGNPA FAFGLPKVDE PSVVTNS
//
ID   DLDH1_PSEPU             Reviewed;         459 AA.
AC   P09063;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1988, sequence version 1.
DT   02-JUN-2021, entry version 156.
DE   RecName: Full=Dihydrolipoyl dehydrogenase;
DE            EC=1.8.1.4;
DE   AltName: Full=Dihydrolipoamide dehydrogenase;
DE   AltName: Full=E3 component of branched-chain alpha-keto acid dehydrogenase complex;
DE   AltName: Full=LPD-Val;
GN   Name=lpdV;
OS   Pseudomonas putida (Arthrobacter siderocapsulatus).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=303;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=G2;
RX   PubMed=3046941; DOI=10.1111/j.1432-1033.1988.tb14264.x;
RA   Burns G., Brown T., Hatter K., Sokatch J.R.;
RT   "Comparison of the amino acid sequences of the transacylase components of
RT   branched chain oxoacid dehydrogenase of Pseudomonas putida, and the
RT   pyruvate and 2-oxoglutarate dehydrogenases of Escherichia coli.";
RL   Eur. J. Biochem. 176:165-169(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=G2;
RX   PubMed=2917566; DOI=10.1111/j.1432-1033.1989.tb14521.x;
RA   Burns G., Brown T., Hatter K., Sokatch J.R.;
RT   "Sequence analysis of the lpdV gene for lipoamide dehydrogenase of
RT   branched-chain-oxoacid dehydrogenase of Pseudomonas putida.";
RL   Eur. J. Biochem. 179:61-69(1989).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) IN COMPLEX WITH NAD AND FAD,
RP   SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=1325638; DOI=10.1002/prot.340130406;
RA   Mattevi A., Obmolova G., Sokatsch J.R., Betzel C., Hol W.G.J.;
RT   "The refined crystal structure of Pseudomonas putida lipoamide
RT   dehydrogenase complexed with NAD+ at 2.45-A resolution.";
RL   Proteins 13:336-351(1992).
CC   -!- FUNCTION: The branched-chain alpha-keto dehydrogenase complex catalyzes
CC       the overall conversion of alpha-keto acids to acyl-CoA and CO(2). It
CC       contains multiple copies of 3 enzymatic components: branched-chain
CC       alpha-keto acid decarboxylase (E1), lipoamide acyltransferase (E2) and
CC       lipoamide dehydrogenase (E3).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-N(6)-dihydrolipoyl-L-lysyl-[protein] + NAD(+) = (R)-N(6)-
CC         lipoyl-L-lysyl-[protein] + H(+) + NADH; Xref=Rhea:RHEA:15045,
CC         Rhea:RHEA-COMP:10474, Rhea:RHEA-COMP:10475, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:83099,
CC         ChEBI:CHEBI:83100; EC=1.8.1.4;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000250};
CC       Note=Binds 1 FAD per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:1325638}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- MISCELLANEOUS: The active site is a redox-active disulfide bond.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M57613; AAA65618.1; -; Genomic_DNA.
DR   PIR; S02139; DEPSLP.
DR   RefSeq; WP_027609417.1; NZ_AP022324.1.
DR   PDB; 1LVL; X-ray; 2.45 A; A=2-459.
DR   PDBsum; 1LVL; -.
DR   SMR; P09063; -.
DR   STRING; 1240350.AMZE01000027_gene4715; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   eggNOG; COG1249; Bacteria.
DR   EvolutionaryTrace; P09063; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004148; F:dihydrolipoyl dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:0006096; P:glycolytic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR006258; Lipoamide_DH.
DR   InterPro; IPR001100; Pyr_nuc-diS_OxRdtase.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   InterPro; IPR012999; Pyr_OxRdtase_I_AS.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   PIRSF; PIRSF000350; Mercury_reductase_MerA; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
DR   TIGRFAMs; TIGR01350; lipoamide_DH; 1.
DR   PROSITE; PS00076; PYRIDINE_REDOX_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Direct protein sequencing; Disulfide bond; FAD;
KW   Flavoprotein; Glycolysis; NAD; Oxidoreductase; Redox-active center.
FT   CHAIN           1..459
FT                   /note="Dihydrolipoyl dehydrogenase"
FT                   /id="PRO_0000068038"
FT   NP_BIND         36..44
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:1325638"
FT   NP_BIND         179..183
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:1325638"
FT   NP_BIND         264..267
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:1325638"
FT   ACT_SITE        438
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         53
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:1325638"
FT   BINDING         119
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:1325638"
FT   BINDING         142
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:1325638"
FT   BINDING         182
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:1325638"
FT   BINDING         202
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:1325638"
FT   BINDING         236
FT                   /note="NAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:1325638"
FT   BINDING         306
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:1325638"
FT   BINDING         312
FT                   /note="NAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:1325638"
FT   BINDING         314
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:1325638"
FT   DISULFID        44..49
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:1325638"
FT   STRAND          8..12
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           16..28
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          32..35
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           42..47
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           49..67
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           85..109
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          113..115
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          119..123
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          126..129
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          132..135
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          137..141
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          145..147
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           162..165
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          173..178
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           182..194
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          197..201
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          203..208
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           213..226
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          229..231
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          235..240
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          243..247
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          249..251
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          261..263
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          267..269
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          272..275
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           276..278
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          301..303
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           305..308
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           314..328
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          342..344
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          346..354
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           357..362
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          367..373
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           374..376
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           378..382
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          389..395
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   TURN            396..398
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   STRAND          400..408
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           411..413
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           414..424
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           428..432
FT                   /evidence="ECO:0007829|PDB:1LVL"
FT   HELIX           443..452
FT                   /evidence="ECO:0007829|PDB:1LVL"
SQ   SEQUENCE   459 AA;  48159 MW;  3D60A7DE167D0586 CRC64;
     MQQTIQTTLL IIGGGPGGYV AAIRAGQLGI PTVLVEGQAL GGTCLNIGCI PSKALIHVAE
     QFHQASRFTE PSPLGISVAS PRLDIGQSVA WKDGIVDRLT TGVAALLKKH GVKVVHGWAK
     VLDGKQVEVD GQRIQCEHLL LATGSSSVEL PMLPLGGPVI SSTEALAPKA LPQHLVVVGG
     GYIGLELGIA YRKLGAQVSV VEARERILPT YDSELTAPVA ESLKKLGIAL HLGHSVEGYE
     NGCLLANDGK GGQLRLEADR VLVAVGRRPR TKGFNLECLD LKMNGAAIAI DERCQTSMHN
     VWAIGDVAGE PMLAHRAMAQ GEMVAEIIAG KARRFEPAAI AAVCFTDPEV VVVGKTPEQA
     SQQGLDCIVA QFPFAANGRA MSLESKSGFV RVVARRDNHL ILGWQAVGVA VSELSTAFAQ
     SLEMGACLED VAGTIHAHPT LGEAVQEAAL RALGHALHI
//
ID   AIFM1_HUMAN             Reviewed;         613 AA.
AC   O95831; A4QPB4; B1ALN1; B2RB08; D3DTE9; E9PRR0; Q1L6K4; Q1L6K6; Q2QKE4;
AC   Q5JUZ7; Q6I9X6; Q9Y3I3; Q9Y3I4;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   02-JUN-2021, entry version 215.
DE   RecName: Full=Apoptosis-inducing factor 1, mitochondrial {ECO:0000305};
DE            EC=1.6.99.- {ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:24914854, ECO:0000269|PubMed:27178839};
DE   AltName: Full=Programmed cell death protein 8;
DE   Flags: Precursor;
GN   Name=AIFM1 {ECO:0000312|HGNC:HGNC:8768}; Synonyms=AIF, PDCD8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9989411; DOI=10.1038/17135;
RA   Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M.,
RA   Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N.,
RA   Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., Kroemer G.;
RT   "Molecular characterization of mitochondrial apoptosis-inducing factor.";
RL   Nature 397:441-446(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), PROTEIN SEQUENCE OF N-TERMINUS,
RP   SUBCELLULAR LOCATION (ISOFORM 5), TISSUE SPECIFICITY (ISOFORM 5), FUNCTION
RP   (ISOFORM 5), AND INDUCTION BY GAMMA-IRRADIATION (ISOFORM 5).
RX   PubMed=16365034; DOI=10.1074/jbc.m509884200;
RA   Delettre C., Yuste V.J., Moubarak R.S., Bras M., Lesbordes-Brion J.-C.,
RA   Petres S., Bellalou J., Susin S.A.;
RT   "AIFsh, a novel apoptosis-inducing factor (AIF) pro-apoptotic isoform with
RT   potential pathological relevance in human cancer.";
RL   J. Biol. Chem. 281:6413-6427(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4 AND 6), ALTERNATIVE SPLICING,
RP   FUNCTION (ISOFORM 4), SUBCELLULAR LOCATION (ISOFORM 4), AND TISSUE
RP   SPECIFICITY (ISOFORMS 4 AND 6).
RX   PubMed=16644725; DOI=10.1074/jbc.m601751200;
RA   Delettre C., Yuste V.J., Moubarak R.S., Bras M., Robert N., Susin S.A.;
RT   "Identification and characterization of AIFsh2, a mitochondrial apoptosis-
RT   inducing factor (AIF) isoform with NADH oxidase activity.";
RL   J. Biol. Chem. 281:18507-18518(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RA   Rhodes S.;
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 55-59, SUBCELLULAR LOCATION, AND PROTEOLYTIC CLEAVAGE.
RX   PubMed=15775970; DOI=10.1038/sj.emboj.7600614;
RA   Otera H., Ohsakaya S., Nagaura Z., Ishihara N., Mihara K.;
RT   "Export of mitochondrial AIF in response to proapoptotic stimuli depends on
RT   processing at the intermembrane space.";
RL   EMBO J. 24:1375-1386(2005).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 171-613.
RC   TISSUE=Brain;
RA   Mei G., Yu W., Gibbs R.A.;
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   REVIEW.
RX   PubMed=10913597; DOI=10.1016/s0014-5793(00)01731-2;
RA   Daugas E., Nochy D., Ravagnan L., Loeffler M., Susin S.A., Zamzami N.,
RA   Kroemer G.;
RT   "Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase
RT   involved in apoptosis.";
RL   FEBS Lett. 476:118-123(2000).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH EIF3G.
RX   PubMed=17094969; DOI=10.1016/j.febslet.2006.10.049;
RA   Kim J.T., Kim K.D., Song E.Y., Lee H.G., Kim J.W., Kim J.W., Chae S.K.,
RA   Kim E., Lee M.S., Yang Y., Lim J.S.;
RT   "Apoptosis-inducing factor (AIF) inhibits protein synthesis by interacting
RT   with the eukaryotic translation initiation factor 3 subunit p44 (eIF3g).";
RL   FEBS Lett. 580:6375-6383(2006).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-105, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [15]
RP   UBIQUITINATION BY XIAP/BIRC4, AND INTERACTION WITH XIAP/BIRC4.
RX   PubMed=17967870; DOI=10.1128/mcb.01065-07;
RA   Wilkinson J.C., Wilkinson A.S., Galban S., Csomos R.A., Duckett C.S.;
RT   "Apoptosis-inducing factor is a target for ubiquitination through
RT   interaction with XIAP.";
RL   Mol. Cell. Biol. 28:237-247(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   FUNCTION.
RX   PubMed=19418225; DOI=10.1007/s10495-009-0353-7;
RA   Son Y.O., Jang Y.S., Heo J.S., Chung W.T., Choi K.C., Lee J.C.;
RT   "Apoptosis-inducing factor plays a critical role in caspase-independent,
RT   pyknotic cell death in hydrogen peroxide-exposed cells.";
RL   Apoptosis 14:796-808(2009).
RN   [18]
RP   ALTERNATIVE SPLICING (ISOFORM 3), SUBCELLULAR LOCATION (ISOFORM 3), AND
RP   SUBUNIT.
RX   PubMed=20111043; DOI=10.1038/cdd.2009.211;
RA   Hangen E., De Zio D., Bordi M., Zhu C., Dessen P., Caffin F., Lachkar S.,
RA   Perfettini J.L., Lazar V., Benard J., Fimia G.M., Piacentini M., Harper F.,
RA   Pierron G., Vicencio J.M., Benit P., de Andrade A., Hoglinger G.,
RA   Culmsee C., Rustin P., Blomgren K., Cecconi F., Kroemer G., Modjtahedi N.;
RT   "A brain-specific isoform of mitochondrial apoptosis-inducing factor:
RT   AIF2.";
RL   Cell Death Differ. 17:1155-1166(2010).
RN   [19]
RP   INTERACTION WITH PRELID1.
RX   PubMed=21364629; DOI=10.1038/cddis.2009.19;
RA   McKeller M.R., Herrera-Rodriguez S., Ma W., Ortiz-Quintero B., Rangel R.,
RA   Cande C., Sims-Mourtada J.C., Melnikova V., Kashi C., Phan L.M., Chen Z.,
RA   Huang P., Dunner K. Jr., Kroemer G., Singh K.K., Martinez-Valdez H.;
RT   "Vital function of PRELI and essential requirement of its LEA motif.";
RL   Cell Death Dis. 1:E21-E21(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   UBIQUITINATION AT LYS-255 BY XIAP/BIRC4.
RX   PubMed=22103349; DOI=10.1021/bi201483g;
RA   Lewis E.M., Wilkinson A.S., Davis N.Y., Horita D.A., Wilkinson J.C.;
RT   "Nondegradative ubiquitination of apoptosis inducing factor (AIF) by X-
RT   linked inhibitor of apoptosis at a residue critical for AIF-mediated
RT   chromatin degradation.";
RL   Biochemistry 50:11084-11096(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-105; SER-116; SER-268 AND
RP   SER-292, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116; SER-118; SER-268;
RP   SER-371; THR-521; SER-524 AND SER-530, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   FUNCTION, INTERACTION WITH CHCHD4, SUBCELLULAR LOCATION, CHARACTERIZATION
RP   OF VARIANT COXPD6 GLU-308, AND CHARACTERIZATION OF VARIANT CMTX4 VAL-493.
RX   PubMed=26004228; DOI=10.1016/j.molcel.2015.04.020;
RA   Hangen E., Feraud O., Lachkar S., Mou H., Doti N., Fimia G.M., Lam N.V.,
RA   Zhu C., Godin I., Muller K., Chatzi A., Nuebel E., Ciccosanti F.,
RA   Flamant S., Benit P., Perfettini J.L., Sauvat A., Bennaceur-Griscelli A.,
RA   Ser-Le Roux K., Gonin P., Tokatlidis K., Rustin P., Piacentini M., Ruvo M.,
RA   Blomgren K., Kroemer G., Modjtahedi N.;
RT   "Interaction between AIF and CHCHD4 Regulates Respiratory Chain
RT   Biogenesis.";
RL   Mol. Cell 58:1001-1014(2015).
RN   [25]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER MET-54, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 121-613 IN COMPLEX WITH FAD,
RP   SUBCELLULAR LOCATION, AND DNA-BINDING.
RX   PubMed=12198487; DOI=10.1038/nsb836;
RA   Ye H., Cande C., Stephanou N.C., Jiang S., Gurbuxani S., Larochette N.,
RA   Daugas E., Garrido C., Kroemer G., Wu H.;
RT   "DNA binding is required for the apoptogenic action of apoptosis inducing
RT   factor.";
RL   Nat. Struct. Biol. 9:680-684(2002).
RN   [27] {ECO:0007744|PDB:4BUR, ECO:0007744|PDB:4BV6}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 121-613 IN COMPLEX WITH FAD AND
RP   NAD, SUBUNIT, MUTAGENESIS OF 413-GLU--ARG-430, SUBCELLULAR LOCATION,
RP   COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, FAD-BINDING, NAD-BINDING, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=24914854; DOI=10.1021/bi500343r;
RA   Ferreira P., Villanueva R., Martinez-Julvez M., Herguedas B., Marcuello C.,
RA   Fernandez-Silva P., Cabon L., Hermoso J.A., Lostao A., Susin S.A.,
RA   Medina M.;
RT   "Structural insights into the coenzyme mediated monomer-dimer transition of
RT   the pro-apoptotic apoptosis inducing factor.";
RL   Biochemistry 53:4204-4215(2014).
RN   [28] {ECO:0007744|PDB:5FS6, ECO:0007744|PDB:5FS7, ECO:0007744|PDB:5FS8, ECO:0007744|PDB:5FS9}
RP   X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) OF 103-613 IN COMPLEX WITH FAD,
RP   CHARACTERIZATION OF VARIANT SER-262, CHARACTERIZATION OF VARIANTS COXPD6
RP   LEU-243; GLU-308 AND GLU-338, FUNCTION, DNA-BINDING, FAD-BINDING, CATALYTIC
RP   ACTIVITY, AND COFACTOR.
RX   PubMed=27178839; DOI=10.1016/j.jmb.2016.05.004;
RA   Sevrioukova I.F.;
RT   "Structure/Function Relations in AIFM1 Variants Associated with
RT   Neurodegenerative Disorders.";
RL   J. Mol. Biol. 428:3650-3665(2016).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 103-613 IN COMPLEX WITH FAD,
RP   FUNCTION, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, DNA-BINDING, SUBUNIT,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, VARIANT CMTX4 VAL-493,
RP   CHARACTERIZATION OF VARIANT CMTX4 VAL-493, AND CATALYTIC ACTIVITY.
RX   PubMed=23217327; DOI=10.1016/j.ajhg.2012.10.008;
RA   Rinaldi C., Grunseich C., Sevrioukova I.F., Schindler A.,
RA   Horkayne-Szakaly I., Lamperti C., Landoure G., Kennerson M.L.,
RA   Burnett B.G., Boennemann C., Biesecker L.G., Ghezzi D., Zeviani M.,
RA   Fischbeck K.H.;
RT   "Cowchock syndrome is associated with a mutation in apoptosis-inducing
RT   factor.";
RL   Am. J. Hum. Genet. 91:1095-1102(2012).
RN   [30] {ECO:0007744|PDB:5KVH, ECO:0007744|PDB:5KVI}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 78-613 IN COMPLEX WITH FAD,
RP   SUBUNIT, MUTAGENESIS OF TRP-196; 443-TYR--ILE-445; HIS-454; TRP-477;
RP   SER-480; ASP-485; ARG-529; GLU-531; GLU-533 AND GLU-535, COFACTOR, AND
RP   FAD-BINDING.
RX   PubMed=27818101; DOI=10.1016/j.str.2016.09.012;
RA   Brosey C.A., Ho C., Long W.Z., Singh S., Burnett K., Hura G.L., Nix J.C.,
RA   Bowman G.R., Ellenberger T., Tainer J.A.;
RT   "Defining NADH-Driven Allostery Regulating Apoptosis-Inducing Factor.";
RL   Structure 24:2067-2079(2016).
RN   [31]
RP   VARIANT COXPD6 ARG-201 DEL, CHARACTERIZATION OF VARIANT COXPD6 ARG-201 DEL,
RP   AND FUNCTION.
RX   PubMed=20362274; DOI=10.1016/j.ajhg.2010.03.002;
RA   Ghezzi D., Sevrioukova I., Invernizzi F., Lamperti C., Mora M., D'Adamo P.,
RA   Novara F., Zuffardi O., Uziel G., Zeviani M.;
RT   "Severe X-linked mitochondrial encephalomyopathy associated with a mutation
RT   in apoptosis-inducing factor.";
RL   Am. J. Hum. Genet. 86:639-649(2010).
RN   [32]
RP   VARIANT COXPD6 GLU-308.
RX   PubMed=22019070; DOI=10.1016/j.ymgme.2011.09.020;
RA   Berger I., Ben-Neriah Z., Dor-Wolman T., Shaag A., Saada A., Zenvirt S.,
RA   Raas-Rothschild A., Nadjari M., Kaestner K.H., Elpeleg O.;
RT   "Early prenatal ventriculomegaly due to an AIFM1 mutation identified by
RT   linkage analysis and whole exome sequencing.";
RL   Mol. Genet. Metab. 104:517-520(2011).
RN   [33]
RP   INVOLVEMENT IN DFNX5, AND VARIANTS DFNX5 ALA-260; PHE-344; ARG-360;
RP   GLN-422; TRP-422; CYS-430; GLN-451; VAL-472; LEU-475; MET-498 AND MET-591.
RX   PubMed=25986071; DOI=10.1136/jmedgenet-2014-102961;
RA   Zong L., Guan J., Ealy M., Zhang Q., Wang D., Wang H., Zhao Y., Shen Z.,
RA   Campbell C.A., Wang F., Yang J., Sun W., Lan L., Ding D., Xie L., Qi Y.,
RA   Lou X., Huang X., Shi Q., Chang S., Xiong W., Yin Z., Yu N., Zhao H.,
RA   Wang J., Wang J., Salvi R.J., Petit C., Smith R.J., Wang Q.;
RT   "Mutations in apoptosis-inducing factor cause X-linked recessive auditory
RT   neuropathy spectrum disorder.";
RL   J. Med. Genet. 52:523-531(2015).
RN   [34]
RP   VARIANT COXPD6 LEU-243, AND CHARACTERIZATION OF VARIANT COXPD6 LEU-243.
RX   PubMed=25583628; DOI=10.1016/j.mito.2015.01.001;
RA   Kettwig M., Schubach M., Zimmermann F.A., Klinge L., Mayr J.A., Biskup S.,
RA   Sperl W., Gaertner J., Huppke P.;
RT   "From ventriculomegaly to severe muscular atrophy: Expansion of the
RT   clinical spectrum related to mutations in AIFM1.";
RL   Mitochondrion 21C:12-18(2015).
RN   [35]
RP   VARIANT SER-262, AND CHARACTERIZATION OF VARIANT SER-262.
RX   PubMed=25934856; DOI=10.1212/wnl.0000000000001613;
RA   Ardissone A., Piscosquito G., Legati A., Langella T., Lamantea E.,
RA   Garavaglia B., Salsano E., Farina L., Moroni I., Pareyson D., Ghezzi D.;
RT   "A slowly progressive mitochondrial encephalomyopathy widens the spectrum
RT   of AIFM1 disorders.";
RL   Neurology 84:2193-2195(2015).
RN   [36]
RP   VARIANT COXPD6 GLU-338, AND CHARACTERIZATION OF VARIANT COXPD6 GLU-338.
RX   PubMed=26173962; DOI=10.1038/ejhg.2015.141;
RA   Diodato D., Tasca G., Verrigni D., D'Amico A., Rizza T., Tozzi G.,
RA   Martinelli D., Verardo M., Invernizzi F., Nasca A., Bellacchio E.,
RA   Ghezzi D., Piemonte F., Dionisi-Vici C., Carrozzo R., Bertini E.;
RT   "A novel AIFM1 mutation expands the phenotype to an infantile motor neuron
RT   disease.";
RL   Eur. J. Hum. Genet. 24:463-466(2016).
RN   [37]
RP   VARIANTS SEMDHL HIS-235; GLY-237 AND VAL-237, CHARACTERIZATION OF VARIANT
RP   SEMDHL HIS-235, INVOLVEMENT IN SEMDHL, AND TISSUE SPECIFICITY.
RX   PubMed=28842795; DOI=10.1007/s10048-017-0520-x;
RA   Miyake N., Wolf N.I., Cayami F.K., Crawford J., Bley A., Bulas D.,
RA   Conant A., Bent S.J., Gripp K.W., Hahn A., Humphray S., Kimura-Ohba S.,
RA   Kingsbury Z., Lajoie B.R., Lal D., Micha D., Pizzino A., Sinke R.J.,
RA   Sival D., Stolte-Dijkstra I., Superti-Furga A., Ulrick N., Taft R.J.,
RA   Ogata T., Ozono K., Matsumoto N., Neubauer B.A., Simons C., Vanderver A.;
RT   "X-linked hypomyelination with spondylometaphyseal dysplasia (H-SMD)
RT   associated with mutations in AIFM1.";
RL   Neurogenetics 18:185-194(2017).
CC   -!- FUNCTION: Functions both as NADH oxidoreductase and as regulator of
CC       apoptosis (PubMed:20362274, PubMed:23217327, PubMed:17094969). In
CC       response to apoptotic stimuli, it is released from the mitochondrion
CC       intermembrane space into the cytosol and to the nucleus, where it
CC       functions as a proapoptotic factor in a caspase-independent pathway.
CC       The soluble form (AIFsol) found in the nucleus induces 'parthanatos'
CC       i.e. caspase-independent fragmentation of chromosomal DNA (By
CC       similarity). Binds to DNA in a sequence-independent manner
CC       (PubMed:27178839). Interacts with EIF3G, and thereby inhibits the EIF3
CC       machinery and protein synthesis, and activates caspase-7 to amplify
CC       apoptosis (PubMed:17094969). Plays a critical role in caspase-
CC       independent, pyknotic cell death in hydrogen peroxide-exposed cells
CC       (PubMed:19418225). In contrast, participates in normal mitochondrial
CC       metabolism. Plays an important role in the regulation of respiratory
CC       chain biogenesis by interacting with CHCHD4 and controlling CHCHD4
CC       mitochondrial import (PubMed:26004228). {ECO:0000250|UniProtKB:Q9Z0X1,
CC       ECO:0000269|PubMed:17094969, ECO:0000269|PubMed:19418225,
CC       ECO:0000269|PubMed:20362274, ECO:0000269|PubMed:23217327,
CC       ECO:0000269|PubMed:26004228, ECO:0000269|PubMed:27178839}.
CC   -!- FUNCTION: [Isoform 4]: Has NADH oxidoreductase activity. Does not
CC       induce nuclear apoptosis. {ECO:0000269|PubMed:16644725}.
CC   -!- FUNCTION: [Isoform 5]: Pro-apoptotic isoform.
CC       {ECO:0000269|PubMed:16365034}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=A + H(+) + NADH = AH2 + NAD(+); Xref=Rhea:RHEA:11356,
CC         ChEBI:CHEBI:13193, ChEBI:CHEBI:15378, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         Evidence={ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:24914854,
CC         ECO:0000269|PubMed:27178839};
CC   -!- CATALYTIC ACTIVITY: [Isoform 4]:
CC       Reaction=A + H(+) + NADH = AH2 + NAD(+); Xref=Rhea:RHEA:11356,
CC         ChEBI:CHEBI:13193, ChEBI:CHEBI:15378, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         Evidence={ECO:0000269|PubMed:16644725};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:24914854,
CC         ECO:0000269|PubMed:27178839, ECO:0000269|PubMed:27818101};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.53 mM for NADH {ECO:0000269|PubMed:23217327};
CC         KM=26 uM for cytochrome c (at pH 7.4 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:27178839};
CC         KM=138 uM for dichlorophenolindophenol (at pH 7.4 and 25 degrees
CC         Celsius) {ECO:0000269|PubMed:27178839};
CC         KM=0.51 mM for NADH (at pH 7.4 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:27178839};
CC         KM=896 uM for NADPH {ECO:0000269|PubMed:24914854};
CC         Note=kcat is 86 min(-1) for dichlorophenolindophenol reduction and 24
CC         min(-1) for cytochrom c reduction (PubMed:27178839). kcat is 1.5
CC         sec(-1) for dichlorophenolindophenol reduction, 3.1 sec(-1) for
CC         ferricyanide and 0.6 sec(-1) for cytochrom c reduction
CC         (PubMed:24914854). {ECO:0000269|PubMed:24914854,
CC         ECO:0000269|PubMed:27178839};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES: [Isoform 4]:
CC       Kinetic parameters:
CC         KM=102.6 uM for NADH {ECO:0000269|PubMed:16644725};
CC         KM=45.3 uM for NADPH {ECO:0000269|PubMed:16644725};
CC   -!- SUBUNIT: Monomer (oxidized form). Homodimer (reduced form). Upon
CC       reduction with NADH, undergoes dimerization and forms tight, long-lived
CC       FADH2-NAD charge transfer complexes (CTC) resistant to oxidation
CC       (PubMed:24914854, PubMed:20111043, PubMed:23217327, PubMed:27818101).
CC       Also dimerizes with isoform 3 preventing its release from mitochondria
CC       (PubMed:20111043). Interacts with XIAP/BIRC4 (PubMed:17967870).
CC       Interacts (via N-terminus) with EIF3G (via C-terminus)
CC       (PubMed:17094969). Interacts with PRELID1 (PubMed:21364629). Interacts
CC       with CHCHD4; the interaction increases in presence of NADH
CC       (PubMed:26004228). {ECO:0000269|PubMed:17094969,
CC       ECO:0000269|PubMed:17967870, ECO:0000269|PubMed:20111043,
CC       ECO:0000269|PubMed:21364629, ECO:0000269|PubMed:23217327,
CC       ECO:0000269|PubMed:24914854, ECO:0000269|PubMed:26004228,
CC       ECO:0000269|PubMed:27818101}.
CC   -!- INTERACTION:
CC       O95831; O75821: EIF3G; NbExp=9; IntAct=EBI-356440, EBI-366632;
CC       O95831; Q63ZY3: KANK2; NbExp=2; IntAct=EBI-356440, EBI-2556193;
CC       O95831; Q63ZY3-2: KANK2; NbExp=4; IntAct=EBI-356440, EBI-6244894;
CC       O95831; Q9Y3Q8: TSC22D4; NbExp=2; IntAct=EBI-356440, EBI-739485;
CC       O95831; Q5EP34: PA; Xeno; NbExp=8; IntAct=EBI-356440, EBI-25772799;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion intermembrane space
CC       {ECO:0000269|PubMed:15775970, ECO:0000269|PubMed:24914854,
CC       ECO:0000269|PubMed:26004228}. Mitochondrion inner membrane. Cytoplasm
CC       {ECO:0000269|PubMed:15775970}. Nucleus {ECO:0000269|PubMed:15775970,
CC       ECO:0000269|PubMed:17094969}. Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:17094969}. Note=Proteolytic cleavage during or just
CC       after translocation into the mitochondrial intermembrane space (IMS)
CC       results in the formation of an inner-membrane-anchored mature form
CC       (AIFmit). During apoptosis, further proteolytic processing leads to a
CC       mature form, which is confined to the mitochondrial IMS in a soluble
CC       form (AIFsol). AIFsol is released to the cytoplasm in response to
CC       specific death signals, and translocated to the nucleus, where it
CC       induces nuclear apoptosis (PubMed:15775970). Colocalizes with EIF3G in
CC       the nucleus and perinuclear region (PubMed:17094969).
CC       {ECO:0000269|PubMed:15775970, ECO:0000269|PubMed:17094969}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Mitochondrion intermembrane space
CC       {ECO:0000269|PubMed:20111043}. Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:20111043}. Note=Has a stronger membrane anchorage
CC       than isoform 1. {ECO:0000269|PubMed:20111043}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Mitochondrion
CC       {ECO:0000269|PubMed:16644725}. Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:16644725}. Note=In pro-apoptotic conditions, is
CC       released from mitochondria to cytosol in a calpain/cathepsin-dependent
CC       manner. {ECO:0000269|PubMed:16644725}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 5]: Cytoplasm
CC       {ECO:0000269|PubMed:16365034}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=AIF;
CC         IsoId=O95831-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95831-2; Sequence=VSP_004357;
CC       Name=3; Synonyms=AIF-exB, AIF2;
CC         IsoId=O95831-3; Sequence=VSP_022953;
CC       Name=4; Synonyms=AIFsh2 {ECO:0000303|PubMed:16644725};
CC         IsoId=O95831-4; Sequence=VSP_043637, VSP_043638;
CC       Name=5; Synonyms=AIFsh;
CC         IsoId=O95831-5; Sequence=VSP_046248;
CC       Name=6; Synonyms=AIFsh3 {ECO:0000303|PubMed:16644725};
CC         IsoId=O95831-6; Sequence=VSP_060785, VSP_060786;
CC   -!- TISSUE SPECIFICITY: Expressed in all tested tissues (PubMed:16644725).
CC       Detected in muscle and skin fibroblasts (at protein level)
CC       (PubMed:23217327). Expressed in osteoblasts (at protein level)
CC       (PubMed:28842795). {ECO:0000269|PubMed:16644725,
CC       ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:28842795}.
CC   -!- TISSUE SPECIFICITY: [Isoform 3]: Brain specific.
CC       {ECO:0000269|PubMed:20111043}.
CC   -!- TISSUE SPECIFICITY: [Isoform 4]: Expressed in all tested tissues except
CC       brain. {ECO:0000269|PubMed:16644725}.
CC   -!- TISSUE SPECIFICITY: [Isoform 5]: Isoform 5 is frequently down-regulated
CC       in human cancers. {ECO:0000269|PubMed:16365034}.
CC   -!- INDUCTION: [Isoform 5]: Strongly down-regulated in many tumor cells,
CC       up-regulated by gamma-irradiation. {ECO:0000269|PubMed:16365034}.
CC   -!- PTM: Under normal conditions, a 54-residue N-terminal segment is first
CC       proteolytically removed during or just after translocation into the
CC       mitochondrial intermembrane space (IMS) by the mitochondrial processing
CC       peptidase (MPP) to form the inner-membrane-anchored mature form
CC       (AIFmit). During apoptosis, it is further proteolytically processed at
CC       amino-acid position 101 leading to the generation of the mature form,
CC       which is confined to the mitochondrial IMS in a soluble form (AIFsol).
CC       AIFsol is released to the cytoplasm in response to specific death
CC       signals, and translocated to the nucleus, where it induces nuclear
CC       apoptosis in a caspase-independent manner.
CC       {ECO:0000269|PubMed:15775970}.
CC   -!- PTM: Ubiquitination by XIAP/BIRC4 does not lead to proteasomal
CC       degradation. Ubiquitination at Lys-255 by XIAP/BIRC4 blocks its ability
CC       to bind DNA and induce chromatin degradation, thereby inhibiting its
CC       ability to induce cell death. {ECO:0000269|PubMed:17967870,
CC       ECO:0000269|PubMed:22103349}.
CC   -!- DISEASE: Combined oxidative phosphorylation deficiency 6 (COXPD6)
CC       [MIM:300816]: A mitochondrial disease resulting in a neurodegenerative
CC       disorder characterized by psychomotor delay, hypotonia, areflexia,
CC       muscle weakness and wasting. Some patients manifest prenatal
CC       ventriculomegaly and severe postnatal encephalomyopathy.
CC       {ECO:0000269|PubMed:20362274, ECO:0000269|PubMed:22019070,
CC       ECO:0000269|PubMed:25583628, ECO:0000269|PubMed:26004228,
CC       ECO:0000269|PubMed:26173962, ECO:0000269|PubMed:27178839}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Charcot-Marie-Tooth disease, X-linked recessive, 4, with or
CC       without cerebellar ataxia (CMTX4) [MIM:310490]: A neuromuscular
CC       disorder characterized by progressive sensorimotor axonal neuropathy,
CC       distal sensory impairment, difficulty walking due to peripheral
CC       neuropathy and/or cerebellar ataxia, and deafness due to auditory
CC       neuropathy. Additional features include cognitive impairment,
CC       cerebellar atrophy, dysarthria, abnormal extraocular movements, tremor,
CC       dysmetria and spasticity. The age at onset ranges from infancy to young
CC       adulthood. {ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:26004228}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- DISEASE: Deafness, X-linked, 5, with peripheral neuropathy (DFNX5)
CC       [MIM:300614]: A form of hearing loss characterized by absent or
CC       severely abnormal auditory brainstem response, abnormal middle ear
CC       reflexes, abnormal speech discrimination, loss of outer hair cell
CC       function, and cochlear nerve hypoplasia. DFNX5 patients manifest
CC       auditory neuropathy with childhood onset, associated with distal
CC       sensory impairment affecting the peripheral nervous system.
CC       {ECO:0000269|PubMed:25986071}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Spondyloepimetaphyseal dysplasia, X-linked, with
CC       hypomyelinating leukodystrophy (SEMDHL) [MIM:300232]: An X-linked
CC       recessive developmental disorder characterized by slowly progressive
CC       skeletal and neurologic abnormalities, including short stature, large
CC       and deformed joints, significant motor impairment, visual defects, and
CC       sometimes cognitive deficits. Affected individuals typically have
CC       normal early development in the first year or so of life, followed by
CC       development regression and the development of symptoms. Brain imaging
CC       shows white matter abnormalities consistent with hypomyelinating
CC       leukodystrophy. {ECO:0000269|PubMed:28842795}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: [Isoform 6]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the FAD-dependent oxidoreductase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAY84741.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AIFM1ID44053chXq25.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF100928; AAD16436.1; -; mRNA.
DR   EMBL; DQ016496; AAY84737.1; -; mRNA.
DR   EMBL; DQ016498; AAY84739.1; -; mRNA.
DR   EMBL; DQ016500; AAY84741.1; ALT_SEQ; mRNA.
DR   EMBL; AL049703; CAB41267.1; -; mRNA.
DR   EMBL; AL049704; CAB41268.1; -; mRNA.
DR   EMBL; AK314446; BAG37055.1; -; mRNA.
DR   EMBL; CR457379; CAG33660.1; -; mRNA.
DR   EMBL; AL139234; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF459397; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF510638; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471107; EAX11811.1; -; Genomic_DNA.
DR   EMBL; CH471107; EAX11812.1; -; Genomic_DNA.
DR   EMBL; CH471107; EAX11810.1; -; Genomic_DNA.
DR   EMBL; BC111065; AAI11066.1; -; mRNA.
DR   EMBL; BC139738; AAI39739.1; -; mRNA.
DR   EMBL; AF131759; AAD20036.1; -; mRNA.
DR   CCDS; CCDS14618.1; -. [O95831-1]
DR   CCDS; CCDS14619.1; -. [O95831-3]
DR   CCDS; CCDS48167.1; -. [O95831-4]
DR   RefSeq; NP_001124318.2; NM_001130846.3.
DR   RefSeq; NP_001124319.1; NM_001130847.3. [O95831-4]
DR   RefSeq; NP_004199.1; NM_004208.3. [O95831-1]
DR   RefSeq; NP_665811.1; NM_145812.2. [O95831-3]
DR   PDB; 1M6I; X-ray; 1.80 A; A=121-613.
DR   PDB; 4BUR; X-ray; 2.88 A; A/B/C/D=103-613.
DR   PDB; 4BV6; X-ray; 1.80 A; A=121-613.
DR   PDB; 4FDC; X-ray; 2.40 A; B=103-613.
DR   PDB; 4LII; X-ray; 1.88 A; A=100-611.
DR   PDB; 5FMH; X-ray; 1.80 A; A=104-613.
DR   PDB; 5FS6; X-ray; 1.90 A; A/B=103-613.
DR   PDB; 5FS7; X-ray; 1.85 A; A/B=103-613.
DR   PDB; 5FS8; X-ray; 1.40 A; A=103-613.
DR   PDB; 5FS9; X-ray; 1.75 A; A/B=103-613.
DR   PDB; 5KVH; X-ray; 2.27 A; A/B=78-613.
DR   PDB; 5KVI; X-ray; 2.00 A; A=78-613.
DR   PDBsum; 1M6I; -.
DR   PDBsum; 4BUR; -.
DR   PDBsum; 4BV6; -.
DR   PDBsum; 4FDC; -.
DR   PDBsum; 4LII; -.
DR   PDBsum; 5FMH; -.
DR   PDBsum; 5FS6; -.
DR   PDBsum; 5FS7; -.
DR   PDBsum; 5FS8; -.
DR   PDBsum; 5FS9; -.
DR   PDBsum; 5KVH; -.
DR   PDBsum; 5KVI; -.
DR   SMR; O95831; -.
DR   BioGRID; 114579; 388.
DR   CORUM; O95831; -.
DR   DIP; DIP-32975N; -.
DR   IntAct; O95831; 278.
DR   MINT; O95831; -.
DR   STRING; 9606.ENSP00000287295; -.
DR   ChEMBL; CHEMBL4295688; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB05282; MCC.
DR   CarbonylDB; O95831; -.
DR   iPTMnet; O95831; -.
DR   MetOSite; O95831; -.
DR   PhosphoSitePlus; O95831; -.
DR   SwissPalm; O95831; -.
DR   BioMuta; AIFM1; -.
DR   REPRODUCTION-2DPAGE; IPI00157908; -.
DR   UCD-2DPAGE; O95831; -.
DR   EPD; O95831; -.
DR   jPOST; O95831; -.
DR   MassIVE; O95831; -.
DR   MaxQB; O95831; -.
DR   PaxDb; O95831; -.
DR   PeptideAtlas; O95831; -.
DR   PRIDE; O95831; -.
DR   ProteomicsDB; 23386; -.
DR   ProteomicsDB; 51073; -. [O95831-1]
DR   ProteomicsDB; 51074; -. [O95831-2]
DR   ProteomicsDB; 51075; -. [O95831-3]
DR   ProteomicsDB; 51076; -. [O95831-4]
DR   ProteomicsDB; 61222; -.
DR   ProteomicsDB; 61439; -.
DR   ABCD; O95831; 1 sequenced antibody.
DR   Antibodypedia; 3528; 845 antibodies.
DR   DNASU; 9131; -.
DR   Ensembl; ENST00000287295; ENSP00000287295; ENSG00000156709. [O95831-1]
DR   Ensembl; ENST00000346424; ENSP00000316320; ENSG00000156709. [O95831-2]
DR   Ensembl; ENST00000527892; ENSP00000435955; ENSG00000156709. [O95831-6]
DR   Ensembl; ENST00000535724; ENSP00000446113; ENSG00000156709. [O95831-4]
DR   Ensembl; ENST00000674997; ENSP00000502124; ENSG00000156709. [O95831-6]
DR   Ensembl; ENST00000675050; ENSP00000502606; ENSG00000156709. [O95831-3]
DR   Ensembl; ENST00000675774; ENSP00000502690; ENSG00000156709. [O95831-6]
DR   Ensembl; ENST00000676229; ENSP00000502184; ENSG00000156709. [O95831-3]
DR   GeneID; 9131; -.
DR   KEGG; hsa:9131; -.
DR   UCSC; uc004evg.4; human. [O95831-1]
DR   CTD; 9131; -.
DR   DisGeNET; 9131; -.
DR   GeneCards; AIFM1; -.
DR   GeneReviews; AIFM1; -.
DR   HGNC; HGNC:8768; AIFM1.
DR   HPA; ENSG00000156709; Tissue enhanced (kidney).
DR   MalaCards; AIFM1; -.
DR   MIM; 300169; gene.
DR   MIM; 300232; phenotype.
DR   MIM; 300614; phenotype.
DR   MIM; 300816; phenotype.
DR   MIM; 310490; phenotype.
DR   neXtProt; NX_O95831; -.
DR   OpenTargets; ENSG00000156709; -.
DR   Orphanet; 83629; Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome.
DR   Orphanet; 238329; Severe X-linked mitochondrial encephalomyopathy.
DR   Orphanet; 101078; X-linked Charcot-Marie-Tooth disease type 4.
DR   Orphanet; 139583; X-linked hereditary sensory and autonomic neuropathy with deafness.
DR   PharmGKB; PA162376129; -.
DR   VEuPathDB; HostDB:ENSG00000156709.13; -.
DR   eggNOG; KOG1346; Eukaryota.
DR   GeneTree; ENSGT00940000156455; -.
DR   HOGENOM; CLU_1059750_0_0_1; -.
DR   InParanoid; O95831; -.
DR   OMA; EVRYERC; -.
DR   OrthoDB; 830428at2759; -.
DR   PhylomeDB; O95831; -.
DR   TreeFam; TF314028; -.
DR   BRENDA; 7.1.1.2; 2681.
DR   PathwayCommons; O95831; -.
DR   SABIO-RK; O95831; -.
DR   SignaLink; O95831; -.
DR   SIGNOR; O95831; -.
DR   BioGRID-ORCS; 9131; 146 hits in 637 CRISPR screens.
DR   ChiTaRS; AIFM1; human.
DR   EvolutionaryTrace; O95831; -.
DR   GeneWiki; AIFM1; -.
DR   GenomeRNAi; 9131; -.
DR   Pharos; O95831; Tbio.
DR   PRO; PR:O95831; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; O95831; protein.
DR   Bgee; ENSG00000156709; Expressed in adult mammalian kidney and 228 other tissues.
DR   ExpressionAtlas; O95831; baseline and differential.
DR   Genevisible; O95831; HS.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:UniProtKB.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0016174; F:NAD(P)H oxidase H2O2-forming activity; IDA:UniProtKB.
DR   GO; GO:0003954; F:NADH dehydrogenase activity; IEA:RHEA.
DR   GO; GO:0016651; F:oxidoreductase activity, acting on NAD(P)H; IDA:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IMP:UniProtKB.
DR   GO; GO:0030261; P:chromosome condensation; TAS:UniProtKB.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   GO; GO:0033108; P:mitochondrial respiratory chain complex assembly; IMP:UniProtKB.
DR   GO; GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB.
DR   GO; GO:0030182; P:neuron differentiation; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0045041; P:protein import into mitochondrial intermembrane space; IMP:UniProtKB.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR029324; AIF_C.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   Pfam; PF14721; AIF_C; 1.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF51905; SSF51905; 2.
DR   SUPFAM; SSF55424; SSF55424; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis;
KW   Charcot-Marie-Tooth disease; Cytoplasm; Deafness;
KW   Direct protein sequencing; Disease variant; DNA-binding; Dwarfism; FAD;
KW   Flavoprotein; Isopeptide bond; Membrane; Mental retardation; Mitochondrion;
KW   Mitochondrion inner membrane; NAD; Neurodegeneration; Neuropathy; Nucleus;
KW   Oxidoreductase; Phosphoprotein; Primary mitochondrial disease;
KW   Reference proteome; Transit peptide; Ubl conjugation.
FT   TRANSIT         1..54
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:15775970,
FT                   ECO:0000269|PubMed:16365034, ECO:0007744|PubMed:25944712"
FT   PROPEP          55..101
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000269|PubMed:16365034"
FT                   /id="PRO_0000401935"
FT   CHAIN           102..613
FT                   /note="Apoptosis-inducing factor 1, mitochondrial"
FT                   /id="PRO_0000022030"
FT   NP_BIND         138..142
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12198487,
FT                   ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:24914854,
FT                   ECO:0000269|PubMed:27178839, ECO:0000269|PubMed:27818101,
FT                   ECO:0007744|PDB:4BUR, ECO:0007744|PDB:4BV6,
FT                   ECO:0007744|PDB:5FS7, ECO:0007744|PDB:5FS8,
FT                   ECO:0007744|PDB:5FS9, ECO:0007744|PDB:5KVI"
FT   NP_BIND         164..165
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12198487,
FT                   ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:24914854,
FT                   ECO:0000269|PubMed:27178839, ECO:0000269|PubMed:27818101,
FT                   ECO:0007744|PDB:4BUR, ECO:0007744|PDB:4BV6,
FT                   ECO:0007744|PDB:5FS7, ECO:0007744|PDB:5FS8,
FT                   ECO:0007744|PDB:5FS9, ECO:0007744|PDB:5KVH,
FT                   ECO:0007744|PDB:5KVI"
FT   NP_BIND         308..311
FT                   /note="NAD 1"
FT                   /evidence="ECO:0000269|PubMed:24914854,
FT                   ECO:0007744|PDB:4BUR"
FT   NP_BIND         453..454
FT                   /note="NAD 1"
FT                   /evidence="ECO:0000269|PubMed:24914854,
FT                   ECO:0007744|PDB:4BUR"
FT   NP_BIND         454..455
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12198487,
FT                   ECO:0000269|PubMed:24914854, ECO:0000269|PubMed:27178839,
FT                   ECO:0000269|PubMed:27818101, ECO:0007744|PDB:4BUR,
FT                   ECO:0007744|PDB:4BV6, ECO:0007744|PDB:5FS7,
FT                   ECO:0007744|PDB:5FS8, ECO:0007744|PDB:5FS9,
FT                   ECO:0007744|PDB:5KVH, ECO:0007744|PDB:5KVI"
FT   REGION          100..127
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          134..483
FT                   /note="FAD-dependent oxidoreductase"
FT                   /evidence="ECO:0000250"
FT   REGION          513..554
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           1..31
FT                   /note="Mitochondrial localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0X1"
FT   MOTIF           63..89
FT                   /note="Mitochondrial localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0X1"
FT   MOTIF           446..451
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        514..546
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         172
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12198487,
FT                   ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:24914854,
FT                   ECO:0000269|PubMed:27178839, ECO:0000269|PubMed:27818101,
FT                   ECO:0007744|PDB:4BUR, ECO:0007744|PDB:4BV6,
FT                   ECO:0007744|PDB:5FS7, ECO:0007744|PDB:5FS8,
FT                   ECO:0007744|PDB:5FS9, ECO:0007744|PDB:5KVH,
FT                   ECO:0007744|PDB:5KVI"
FT   BINDING         177
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12198487,
FT                   ECO:0000269|PubMed:24914854, ECO:0000269|PubMed:27178839,
FT                   ECO:0000269|PubMed:27818101, ECO:0007744|PDB:4BUR,
FT                   ECO:0007744|PDB:4BV6, ECO:0007744|PDB:5FS7,
FT                   ECO:0007744|PDB:5FS8, ECO:0007744|PDB:5FS9,
FT                   ECO:0007744|PDB:5KVI"
FT   BINDING         196
FT                   /note="NAD 2"
FT                   /evidence="ECO:0000269|PubMed:24914854,
FT                   ECO:0007744|PDB:4BUR"
FT   BINDING         233
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:12198487,
FT                   ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:24914854,
FT                   ECO:0000269|PubMed:27178839, ECO:0000269|PubMed:27818101,
FT                   ECO:0007744|PDB:4BUR, ECO:0007744|PDB:4BV6,
FT                   ECO:0007744|PDB:5FS7, ECO:0007744|PDB:5FS8,
FT                   ECO:0007744|PDB:5FS9, ECO:0007744|PDB:5KVH,
FT                   ECO:0007744|PDB:5KVI"
FT   BINDING         285
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12198487,
FT                   ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:24914854,
FT                   ECO:0000269|PubMed:27178839, ECO:0000269|PubMed:27818101,
FT                   ECO:0007744|PDB:4BUR, ECO:0007744|PDB:4BV6,
FT                   ECO:0007744|PDB:5FS7, ECO:0007744|PDB:5FS8,
FT                   ECO:0007744|PDB:5FS9, ECO:0007744|PDB:5KVH"
FT   BINDING         336
FT                   /note="NAD 1"
FT                   /evidence="ECO:0000269|PubMed:24914854,
FT                   ECO:0007744|PDB:4BUR"
FT   BINDING         342
FT                   /note="NAD 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0X1"
FT   BINDING         399
FT                   /note="NAD 1; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:24914854,
FT                   ECO:0007744|PDB:4BUR"
FT   BINDING         438
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12198487,
FT                   ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:24914854,
FT                   ECO:0000269|PubMed:27178839, ECO:0000269|PubMed:27818101,
FT                   ECO:0007744|PDB:4BUR, ECO:0007744|PDB:4BV6,
FT                   ECO:0007744|PDB:5FS7, ECO:0007744|PDB:5FS8,
FT                   ECO:0007744|PDB:5FS9, ECO:0007744|PDB:5KVH,
FT                   ECO:0007744|PDB:5KVI"
FT   BINDING         483
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:12198487,
FT                   ECO:0000269|PubMed:23217327, ECO:0000269|PubMed:24914854,
FT                   ECO:0000269|PubMed:27178839, ECO:0000269|PubMed:27818101,
FT                   ECO:0007744|PDB:4BUR, ECO:0007744|PDB:4BV6,
FT                   ECO:0007744|PDB:5FS7, ECO:0007744|PDB:5FS8,
FT                   ECO:0007744|PDB:5FS9, ECO:0007744|PDB:5KVH,
FT                   ECO:0007744|PDB:5KVI"
FT   BINDING         483
FT                   /note="NAD 1; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:24914854,
FT                   ECO:0007744|PDB:4BUR, ECO:0007744|PDB:4BV6"
FT   BINDING         493
FT                   /note="NAD 2"
FT                   /evidence="ECO:0000269|PubMed:24914854,
FT                   ECO:0007744|PDB:4BUR"
FT   BINDING         583
FT                   /note="NAD 2"
FT                   /evidence="ECO:0000269|PubMed:24914854,
FT                   ECO:0007744|PDB:4BUR"
FT   MOD_RES         105
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         109
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0X1"
FT   MOD_RES         116
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         118
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         268
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         292
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         371
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         388
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0X1"
FT   MOD_RES         521
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         524
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         530
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         593
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0X1"
FT   CROSSLNK        255
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:22103349"
FT   VAR_SEQ         1..352
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:16365034"
FT                   /id="VSP_046248"
FT   VAR_SEQ         36..322
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_004357"
FT   VAR_SEQ         36..82
FT                   /note="GNLFQRWHVPLELQMTRQMASSGASGGKIDNSVLVLIVGLSTVGAGA -> V
FT                   VQSHHLGSPSRSLASTGASGKDGSNLVYFLIVGATVTGAGVY (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.4"
FT                   /id="VSP_022953"
FT   VAR_SEQ         37..43
FT                   /note="NLFQRWH -> LQDYERG (in isoform 6)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_060785"
FT   VAR_SEQ         44..613
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_060786"
FT   VAR_SEQ         323..324
FT                   /note="AR -> DI (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:16644725"
FT                   /id="VSP_043637"
FT   VAR_SEQ         325..613
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:16644725"
FT                   /id="VSP_043638"
FT   VARIANT         201
FT                   /note="Missing (in COXPD6; higher DNA binding affinity,
FT                   partially impaired flavin binding and association with
FT                   increased parthanatos-linked cell death;
FT                   dbSNP:rs387906500)"
FT                   /evidence="ECO:0000269|PubMed:20362274"
FT                   /id="VAR_063827"
FT   VARIANT         235
FT                   /note="Q -> H (in SEMDHL; severe decrease of protein
FT                   expression; dbSNP:rs377527583)"
FT                   /evidence="ECO:0000269|PubMed:28842795"
FT                   /id="VAR_083739"
FT   VARIANT         237
FT                   /note="D -> G (in SEMDHL; dbSNP:rs1202786652)"
FT                   /evidence="ECO:0000269|PubMed:28842795"
FT                   /id="VAR_083740"
FT   VARIANT         237
FT                   /note="D -> V (in SEMDHL; dbSNP:rs1202786652)"
FT                   /evidence="ECO:0000269|PubMed:28842795"
FT                   /id="VAR_083741"
FT   VARIANT         243
FT                   /note="V -> L (in COXPD6; reduced protein amount in muscle
FT                   compared to controls; no effect on reduction with NADH;
FT                   strongly decreased NADH oxidase activity; no effect on
FT                   dimerization; no effect on DNA-binding;
FT                   dbSNP:rs1603225138)"
FT                   /evidence="ECO:0000269|PubMed:25583628,
FT                   ECO:0000269|PubMed:27178839"
FT                   /id="VAR_072791"
FT   VARIANT         260
FT                   /note="T -> A (in DFNX5; dbSNP:rs863225432)"
FT                   /evidence="ECO:0000269|PubMed:25986071"
FT                   /id="VAR_076211"
FT   VARIANT         262
FT                   /note="G -> S (probable disease-associated variant found in
FT                   patient with mitochondrial encephalomyopathy with moderate
FT                   clinical severity and slow progressive course despite early
FT                   onset as well as and cerebellar involvement; decreased
FT                   protein level; strongly decreased redox potential; strongly
FT                   decreased NADH oxidase activity; no effect on DNA-binding;
FT                   dbSNP:rs1603224817)"
FT                   /evidence="ECO:0000269|PubMed:25934856,
FT                   ECO:0000269|PubMed:27178839"
FT                   /id="VAR_083067"
FT   VARIANT         308
FT                   /note="G -> E (in COXPD6; with prenatal ventriculomegaly
FT                   and severe postnatal encephalomyopathy; no effect on redox
FT                   potential; slowered reduction with NADH; strongly decreased
FT                   NADH oxidase activity; strongly decreased NADH oxidase
FT                   activity; no effect on DNA-binding; decreased interaction
FT                   with CHCHDE; dbSNP:rs1603224226)"
FT                   /evidence="ECO:0000269|PubMed:22019070,
FT                   ECO:0000269|PubMed:26004228, ECO:0000269|PubMed:27178839"
FT                   /id="VAR_067334"
FT   VARIANT         338
FT                   /note="G -> E (in COXPD6; with early-onset severe motor
FT                   neuron involvement; decreased protein levels; decreased
FT                   oxidoreductase activity on cytochrome C; slowered reduction
FT                   with NADH; strongly decreased NADH oxidase activity;
FT                   strongly decreased NADH oxidase activity; no effect on DNA-
FT                   binding; dbSNP:rs1603223152)"
FT                   /evidence="ECO:0000269|PubMed:26173962,
FT                   ECO:0000269|PubMed:27178839"
FT                   /id="VAR_083068"
FT   VARIANT         344
FT                   /note="L -> F (in DFNX5; unknown pathological significance;
FT                   dbSNP:rs184474885)"
FT                   /evidence="ECO:0000269|PubMed:25986071"
FT                   /id="VAR_076212"
FT   VARIANT         360
FT                   /note="G -> R (in DFNX5; unknown pathological significance;
FT                   dbSNP:rs724160026)"
FT                   /evidence="ECO:0000269|PubMed:25986071"
FT                   /id="VAR_076213"
FT   VARIANT         422
FT                   /note="R -> Q (in DFNX5; dbSNP:rs724160021)"
FT                   /evidence="ECO:0000269|PubMed:25986071"
FT                   /id="VAR_076214"
FT   VARIANT         422
FT                   /note="R -> W (in DFNX5; dbSNP:rs724160020)"
FT                   /evidence="ECO:0000269|PubMed:25986071"
FT                   /id="VAR_076215"
FT   VARIANT         430
FT                   /note="R -> C (in DFNX5; unknown pathological significance;
FT                   dbSNP:rs1223488720)"
FT                   /evidence="ECO:0000269|PubMed:25986071"
FT                   /id="VAR_076216"
FT   VARIANT         451
FT                   /note="R -> Q (in DFNX5; dbSNP:rs863225431)"
FT                   /evidence="ECO:0000269|PubMed:25986071"
FT                   /id="VAR_076217"
FT   VARIANT         472
FT                   /note="A -> V (in DFNX5; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:25986071"
FT                   /id="VAR_076218"
FT   VARIANT         475
FT                   /note="P -> L (in DFNX5; unknown pathological significance;
FT                   dbSNP:rs724160022)"
FT                   /evidence="ECO:0000269|PubMed:25986071"
FT                   /id="VAR_076219"
FT   VARIANT         493
FT                   /note="E -> V (in CMTX4; increases affinity for NADH and
FT                   electron transfer activity; increases affinity for DNA,
FT                   resulting in increased apoptosis; no effect on interaction
FT                   with CHCHD4; dbSNP:rs281864468)"
FT                   /evidence="ECO:0000269|PubMed:23217327,
FT                   ECO:0000269|PubMed:26004228"
FT                   /id="VAR_069468"
FT   VARIANT         498
FT                   /note="V -> M (in DFNX5; unknown pathological significance;
FT                   dbSNP:rs724160023)"
FT                   /evidence="ECO:0000269|PubMed:25986071"
FT                   /id="VAR_076220"
FT   VARIANT         591
FT                   /note="I -> M (in DFNX5; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:25986071"
FT                   /id="VAR_076221"
FT   MUTAGEN         196
FT                   /note="W->A: Increases protein dimerization at lower NADH
FT                   levels."
FT                   /evidence="ECO:0000269|PubMed:27818101"
FT   MUTAGEN         413..430
FT                   /note="EIDSDFGGFRVNAELQAR->AIDSDFGGFAVNAELQAA: Disrupts
FT                   dimerization. Lower efficiency in stabilizing charge-
FT                   transfer complexes upon coenzyme reduction."
FT                   /evidence="ECO:0000269|PubMed:24914854"
FT   MUTAGEN         443..445
FT                   /note="YDI->ADA: Disrupts dimerization. Disrupts
FT                   dimerization; when associated with A-477."
FT                   /evidence="ECO:0000269|PubMed:27818101"
FT   MUTAGEN         454
FT                   /note="H->A: Allows dimerization in absence of NADH."
FT                   /evidence="ECO:0000269|PubMed:27818101"
FT   MUTAGEN         477
FT                   /note="W->A: Disrupts dimerization; when associated with A-
FT                   443--445-A."
FT                   /evidence="ECO:0000269|PubMed:27818101"
FT   MUTAGEN         480
FT                   /note="S->A: Allows dimerization in absence of NADH."
FT                   /evidence="ECO:0000269|PubMed:27818101"
FT   MUTAGEN         485
FT                   /note="D->A: Increases protein dimerization at lower NADH
FT                   levels."
FT                   /evidence="ECO:0000269|PubMed:27818101"
FT   MUTAGEN         529
FT                   /note="R->A: Increases protein dimerization at lower NADH
FT                   levels."
FT                   /evidence="ECO:0000269|PubMed:27818101"
FT   MUTAGEN         531
FT                   /note="E->A: Increases protein dimerization at lower NADH
FT                   levels."
FT                   /evidence="ECO:0000269|PubMed:27818101"
FT   MUTAGEN         533
FT                   /note="E->A: Increases protein dimerization at lower NADH
FT                   levels."
FT                   /evidence="ECO:0000269|PubMed:27818101"
FT   MUTAGEN         535
FT                   /note="E->A: Increases protein dimerization at lower NADH
FT                   levels."
FT                   /evidence="ECO:0000269|PubMed:27818101"
FT   STRAND          130..138
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           141..153
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          158..162
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          164..167
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           173..176
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           178..180
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           187..190
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          192..194
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          200..206
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           208..210
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   TURN            214..219
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          224..228
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          233..237
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   TURN            238..241
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          242..245
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          250..258
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          262..264
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           268..271
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           275..279
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          281..283
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           287..299
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          301..306
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           310..326
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          329..333
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          335..338
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   TURN            339..343
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           346..358
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          362..364
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          369..375
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          378..383
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          388..396
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          400..402
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           407..410
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   TURN            416..418
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          420..422
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          427..430
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          433..435
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           437..439
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          440..444
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   TURN            445..447
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          448..450
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           455..468
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   TURN            469..471
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          481..487
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          491..496
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          504..509
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          513..515
FT                   /evidence="ECO:0007829|PDB:4BUR"
FT   HELIX           517..524
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           529..533
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          538..542
FT                   /evidence="ECO:0007829|PDB:5KVI"
FT   STRAND          562..569
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   STRAND          572..580
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           585..594
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           601..605
FT                   /evidence="ECO:0007829|PDB:5FS8"
FT   HELIX           606..608
FT                   /evidence="ECO:0007829|PDB:5FS8"
SQ   SEQUENCE   613 AA;  66901 MW;  A156762BC64E6340 CRC64;
     MFRCGGLAAG ALKQKLVPLV RTVCVRSPRQ RNRLPGNLFQ RWHVPLELQM TRQMASSGAS
     GGKIDNSVLV LIVGLSTVGA GAYAYKTMKE DEKRYNERIS GLGLTPEQKQ KKAALSASEG
     EEVPQDKAPS HVPFLLIGGG TAAFAAARSI RARDPGARVL IVSEDPELPY MRPPLSKELW
     FSDDPNVTKT LRFKQWNGKE RSIYFQPPSF YVSAQDLPHI ENGGVAVLTG KKVVQLDVRD
     NMVKLNDGSQ ITYEKCLIAT GGTPRSLSAI DRAGAEVKSR TTLFRKIGDF RSLEKISREV
     KSITIIGGGF LGSELACALG RKARALGTEV IQLFPEKGNM GKILPEYLSN WTMEKVRREG
     VKVMPNAIVQ SVGVSSGKLL IKLKDGRKVE TDHIVAAVGL EPNVELAKTG GLEIDSDFGG
     FRVNAELQAR SNIWVAGDAA CFYDIKLGRR RVEHHDHAVV SGRLAGENMT GAAKPYWHQS
     MFWSDLGPDV GYEAIGLVDS SLPTVGVFAK ATAQDNPKSA TEQSGTGIRS ESETESEASE
     ITIPPSTPAV PQAPVQGEDY GKGVIFYLRD KVVVGIVLWN IFNRMPIARK IIKDGEQHED
     LNEVAKLFNI HED
//
ID   FPRA_MYCTU              Reviewed;         456 AA.
AC   P9WIQ3; L0TBK5; O05783;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   02-JUN-2021, entry version 42.
DE   RecName: Full=NADPH-ferredoxin reductase FprA;
DE            Short=NFR;
DE            EC=1.18.1.2;
GN   Name=fprA; OrderedLocusNames=Rv3106; ORFNames=MTCY164.16;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   PROTEIN SEQUENCE OF 1-21, AND CHARACTERIZATION.
RX   PubMed=12071965; DOI=10.1046/j.1432-1033.2002.02989.x;
RA   Fischer F., Raimondi D., Aliverti A., Zanetti G.;
RT   "Mycobacterium tuberculosis FprA, a novel bacterial NADPH-ferredoxin
RT   reductase.";
RL   Eur. J. Biochem. 269:3005-3013(2002).
RN   [3]
RP   ENZYME KINETICS, REDOX POTENTIOMETRY, ABSORPTION SPECTROSCOPY, CIRCULAR
RP   DICHROISM ANALYSIS, AND EPR SPECTROSCOPY.
RX   PubMed=12614197; DOI=10.1042/bj20021692;
RA   McLean K.J., Scrutton N.S., Munro A.W.;
RT   "Kinetic, spectroscopic and thermodynamic characterization of the
RT   Mycobacterium tuberculosis adrenodoxin reductase homologue FprA.";
RL   Biochem. J. 372:317-327(2003).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.05 ANGSTROMS) IN COMPLEX WITH NADP, AND SUBUNIT.
RX   PubMed=12102623; DOI=10.1021/bi025858a;
RA   Bossi R.T., Aliverti A., Raimondi D., Fischer F., Zanetti G., Ferrari D.,
RA   Tahallah N., Maier C.S., Heck A.J., Rizzi M., Mattevi A.;
RT   "A covalent modification of NADP+ revealed by the atomic resolution
RT   structure of FprA, a Mycobacterium tuberculosis oxidoreductase.";
RL   Biochemistry 41:8807-8818(2002).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF MUTANT GLN-57 IN COMPLEX WITH FAD
RP   AND NADPH, AND SUBUNIT.
RX   PubMed=16846214; DOI=10.1021/bi060369m;
RA   Pennati A., Razeto A., de Rosa M., Pandini V., Vanoni M.A., Mattevi A.,
RA   Coda A., Aliverti A., Zanetti G.;
RT   "Role of the His57-Glu214 ionic couple located in the active site of
RT   Mycobacterium tuberculosis FprA.";
RL   Biochemistry 45:8712-8720(2006).
CC   -!- FUNCTION: May serve as electron transfer protein and supply electrons
CC       to P450 systems.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADP(+) + 2 reduced [2Fe-2S]-[ferredoxin] = NADPH + 2
CC         oxidized [2Fe-2S]-[ferredoxin]; Xref=Rhea:RHEA:20125, Rhea:RHEA-
CC         COMP:10000, Rhea:RHEA-COMP:10001, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:33737, ChEBI:CHEBI:33738, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.18.1.2;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:12102623,
CC       ECO:0000269|PubMed:16846214}.
CC   -!- SIMILARITY: Belongs to the ferredoxin--NADP reductase type 1 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP45916.1; -; Genomic_DNA.
DR   PIR; A70920; A70920.
DR   RefSeq; NP_217622.1; NC_000962.3.
DR   RefSeq; WP_003900632.1; NZ_NVQJ01000011.1.
DR   PDB; 1LQT; X-ray; 1.05 A; A/B=1-456.
DR   PDB; 1LQU; X-ray; 1.25 A; A/B=1-456.
DR   PDB; 2C7G; X-ray; 1.80 A; A=1-456.
DR   PDBsum; 1LQT; -.
DR   PDBsum; 1LQU; -.
DR   PDBsum; 2C7G; -.
DR   SMR; P9WIQ3; -.
DR   STRING; 83332.Rv3106; -.
DR   DrugBank; DB01753; 4-oxo-nicotinamide-adenine dinucleotide phosphate.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   PaxDb; P9WIQ3; -.
DR   DNASU; 888839; -.
DR   GeneID; 888839; -.
DR   KEGG; mtu:Rv3106; -.
DR   TubercuList; Rv3106; -.
DR   eggNOG; COG0493; Bacteria.
DR   OMA; MRPYHVA; -.
DR   PhylomeDB; P9WIQ3; -.
DR   BRENDA; 1.18.1.6; 3445.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0005618; C:cell wall; HDA:MTBBASE.
DR   GO; GO:0008860; F:ferredoxin-NAD+ reductase activity; IDA:MTBBASE.
DR   GO; GO:0004324; F:ferredoxin-NADP+ reductase activity; IDA:MTBBASE.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:MTBBASE.
DR   GO; GO:0070401; F:NADP+ binding; IDA:MTBBASE.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR021163; Ferredox_Rdtase_adrenod.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   PIRSF; PIRSF000362; FNR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; FAD; Flavoprotein; NADP;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN           1..456
FT                   /note="NADPH-ferredoxin reductase FprA"
FT                   /id="PRO_0000087329"
FT   NP_BIND         155..158
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:12102623,
FT                   ECO:0000269|PubMed:16846214"
FT   NP_BIND         199..200
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:12102623,
FT                   ECO:0000269|PubMed:16846214"
FT   NP_BIND         366..368
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16846214"
FT   BINDING         14
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:16846214"
FT   BINDING         40
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16846214"
FT   BINDING         48
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:16846214"
FT   BINDING         84
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:16846214"
FT   BINDING         110
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:12102623,
FT                   ECO:0000269|PubMed:16846214"
FT   BINDING         211
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:12102623,
FT                   ECO:0000269|PubMed:16846214"
FT   BINDING         359
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:16846214"
FT   BINDING         366
FT                   /note="NADP; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:12102623,
FT                   ECO:0000269|PubMed:16846214"
FT   MUTAGEN         57
FT                   /note="H->A,Q: Reduces activity 4-fold."
FT   MUTAGEN         214
FT                   /note="E->A: No effect on activity. Decreases Km for NADP
FT                   2-fold."
FT   STRAND          4..9
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           13..28
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   STRAND          34..44
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           48..51
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           59..63
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           64..71
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   STRAND          76..81
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   TURN            84..86
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           90..96
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   STRAND          97..102
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   TURN            115..118
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   STRAND          122..124
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           125..132
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           136..138
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   STRAND          147..153
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           157..167
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           170..173
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           180..186
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   STRAND          193..197
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           202..204
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           209..214
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           215..217
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   STRAND          221..224
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           227..230
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           235..241
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           243..256
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   STRAND          264..270
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   STRAND          272..279
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   STRAND          281..283
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   STRAND          286..296
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   STRAND          298..314
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   STRAND          316..320
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   TURN            336..339
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   STRAND          352..356
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           359..362
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           368..370
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           371..391
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           402..413
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           420..434
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           435..437
FT                   /evidence="ECO:0007829|PDB:1LQT"
FT   HELIX           447..454
FT                   /evidence="ECO:0007829|PDB:1LQT"
SQ   SEQUENCE   456 AA;  49341 MW;  74D91282BD78BFB9 CRC64;
     MRPYYIAIVG SGPSAFFAAA SLLKAADTTE DLDMAVDMLE MLPTPWGLVR SGVAPDHPKI
     KSISKQFEKT AEDPRFRFFG NVVVGEHVQP GELSERYDAV IYAVGAQSDR MLNIPGEDLP
     GSIAAVDFVG WYNAHPHFEQ VSPDLSGARA VVIGNGNVAL DVARILLTDP DVLARTDIAD
     HALESLRPRG IQEVVIVGRR GPLQAAFTTL ELRELADLDG VDVVIDPAEL DGITDEDAAA
     VGKVCKQNIK VLRGYADREP RPGHRRMVFR FLTSPIEIKG KRKVERIVLG RNELVSDGSG
     RVAAKDTGER EELPAQLVVR SVGYRGVPTP GLPFDDQSGT IPNVGGRING SPNEYVVGWI
     KRGPTGVIGT NKKDAQDTVD TLIKNLGNAK EGAECKSFPE DHADQVADWL AARQPKLVTS
     AHWQVIDAFE RAAGEPHGRP RVKLASLAEL LRIGLG
//
ID   ACADV_HUMAN             Reviewed;         655 AA.
AC   P49748; B4DEB6; F5H2A9; O76056; Q8WUL0;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   02-JUN-2021, entry version 212.
DE   RecName: Full=Very long-chain specific acyl-CoA dehydrogenase, mitochondrial {ECO:0000305|PubMed:7668252};
DE            Short=VLCAD {ECO:0000303|PubMed:7668252};
DE            EC=1.3.8.9 {ECO:0000269|PubMed:17374501, ECO:0000269|PubMed:21237683, ECO:0000269|PubMed:7668252, ECO:0000269|PubMed:9461620, ECO:0000269|PubMed:9599005, ECO:0000269|PubMed:9839948};
DE   Flags: Precursor;
GN   Name=ACADVL {ECO:0000312|HGNC:HGNC:92};
GN   Synonyms=VLCAD {ECO:0000303|PubMed:7668252};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, FUNCTION,
RP   CATALYTIC ACTIVITY, PATHWAY, INVOLVEMENT IN ACADVLD, AND TRANSIT PEPTIDE.
RX   PubMed=7668252;
RA   Aoyama T., Souri M., Ueno I., Kamijo T., Yamaguchi S., Rhead W.J.,
RA   Tanaka K., Hashimoto T.;
RT   "Cloning of human very-long-chain acyl-coenzyme A dehydrogenase and
RT   molecular characterization of its deficiency in two patients.";
RL   Am. J. Hum. Genet. 57:273-283(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND VARIANTS
RP   ACADVLD MET-260; ASP-281; ALA-283; ALA-317; CYS-366; GLU-381 DEL; ASP-441
RP   AND ILE-602.
RC   TISSUE=Placenta;
RX   PubMed=8845838; DOI=10.1093/hmg/5.4.461;
RA   Andresen B.S., Bross P., Vianey-Saban C., Divry P., Zabot M.-T., Roe C.R.,
RA   Nada M.A., Byskov A., Kruse T.A., Neve S., Kristiansen K., Knudsen I.,
RA   Corydon M.J., Gregersen N.;
RT   "Cloning and characterization of human very-long-chain acyl-CoA
RT   dehydrogenase cDNA, chromosomal assignment of the gene and identification
RT   in four patients of nine different mutations within the VLCAD gene.";
RL   Hum. Mol. Genet. 5:461-472(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Peripheral blood;
RX   PubMed=8554625; DOI=10.1006/bbrc.1995.2867;
RA   Orii K.O., Aoyama T., Souri M., Orii K.E., Kondo N., Orii T., Hashimoto T.;
RT   "Genomic DNA organization of human mitochondrial very-long-chain acyl-CoA
RT   dehydrogenase and mutation analysis.";
RL   Biochem. Biophys. Res. Commun. 217:987-992(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Liver, Lung, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   CHARACTERIZATION.
RX   PubMed=7769092; DOI=10.1172/jci117947;
RA   Aoyama T., Souri M., Ushikubo S., Kamijo T., Yamaguchi S., Kelley R.I.,
RA   Rhead W.J., Uetake K., Tanaka K., Hashimoto T.;
RT   "Purification of human very-long-chain acyl-coenzyme A dehydrogenase and
RT   characterization of its deficiency in seven patients.";
RL   J. Clin. Invest. 95:2465-2473(1995).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES,
RP   SUBUNIT, SUBCELLULAR LOCATION, MUTAGENESIS OF PHE-458 AND GLU-462, ACTIVE
RP   SITE, AND CHARACTERIZATION OF VARIANT ACADVLD LEU-458.
RX   PubMed=9461620; DOI=10.1074/jbc.273.7.4227;
RA   Souri M., Aoyama T., Cox G.F., Hashimoto T.;
RT   "Catalytic and FAD-binding residues of mitochondrial very long chain acyl-
RT   coenzyme A dehydrogenase.";
RL   J. Biol. Chem. 273:4227-4231(1998).
RN   [9]
RP   VARIANTS ACADVLD MET-260; ALA-283; TRP-469; PRO-502 AND TRP-613.
RX   PubMed=9973285; DOI=10.1086/302261;
RA   Andresen B.S., Olpin S., Poorthuis B.J.H.M., Scholte H.R., Vianey-Saban C.,
RA   Wanders R., Ijlst L., Morris A., Pourfarzam M., Bartlett K.,
RA   Baumgartner E.R., de Klerk J.B.C., Schroeder L.D., Corydon T.J., Lund H.,
RA   Winter V., Bross P., Bolund L., Gregersen N.;
RT   "Clear correlation of genotype with disease phenotype in very-long-chain
RT   acyl-CoA dehydrogenase deficiency.";
RL   Am. J. Hum. Genet. 64:479-494(1999).
RN   [10]
RP   CATALYTIC ACTIVITY (ISOFORM 2), SUBCELLULAR LOCATION (ISOFORM 2), TOPOLOGY
RP   (ISOFORM 2), AND CHARACTERIZATION OF VARIANT ACADVLD MET-260; ALA-283;
RP   TRP-469; PRO-490; PRO-502 AND TRP-613.
RX   PubMed=17374501; DOI=10.1016/j.ymgme.2007.01.013;
RA   Goetzman E.S., Wang Y., He M., Mohsen A.W., Ninness B.K., Vockley J.;
RT   "Expression and characterization of mutations in human very long-chain
RT   acyl-CoA dehydrogenase using a prokaryotic system.";
RL   Mol. Genet. Metab. 91:138-147(2007).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-239 AND LYS-331, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   CATALYTIC ACTIVITY, AND SUBSTRATE SPECIFICITY.
RX   PubMed=21237683; DOI=10.1016/j.ymgme.2010.12.005;
RA   He M., Pei Z., Mohsen A.W., Watkins P., Murdoch G., Van Veldhoven P.P.,
RA   Ensenauer R., Vockley J.;
RT   "Identification and characterization of new long chain acyl-CoA
RT   dehydrogenases.";
RL   Mol. Genet. Metab. 102:418-429(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-517 AND SER-522, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER TYR-40, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17] {ECO:0007744|PDB:2UXW}
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 69-655 IN COMPLEX WITH FAD AND
RP   SUBSTRATE ANALOG.
RA   Pike A.C.W., Hozjan V., Smee C., Berridge G., Burgess N., Salah E.,
RA   Bunkoczi G., Uppenberg J., Ugochukwu E., von Delft F., Arrowsmith C.H.,
RA   Edwards A., Weigelt J., Sundstrom M., Oppermann U.;
RT   "Crystal Structure of Human Very Long Chain Acyl- Coa Dehydrogenase
RT   (Acadvl).";
RL   Submitted (MAR-2007) to the PDB data bank.
RN   [18] {ECO:0007744|PDB:3B96}
RP   X-RAY CRYSTALLOGRAPHY (1.91 ANGSTROMS) OF 69-655 IN COMPLEX WITH
RP   TETRADECANOYL-COA AND FAD, FUNCTION, SUBUNIT, COFACTOR, AND ACTIVE SITE.
RX   PubMed=18227065; DOI=10.1074/jbc.m709135200;
RA   McAndrew R.P., Wang Y., Mohsen A.W., He M., Vockley J., Kim J.J.;
RT   "Structural basis for substrate fatty acyl chain specificity: crystal
RT   structure of human very-long-chain acyl-CoA dehydrogenase.";
RL   J. Biol. Chem. 283:9435-9443(2008).
RN   [19]
RP   VARIANTS ACADVLD GLU-130 DEL; LYS-299 DEL; GLN-382 AND TRP-613.
RX   PubMed=8554073;
RA   Souri M., Aoyama T., Orii K., Yamaguchi S., Hashimoto T.;
RT   "Mutation analysis of very-long-chain acyl-coenzyme A dehydrogenase (VLCAD)
RT   deficiency: identification and characterization of mutant VLCAD cDNAs from
RT   four patients.";
RL   Am. J. Hum. Genet. 58:97-106(1996).
RN   [20]
RP   VARIANT ACADVLD HIS-450.
RX   PubMed=9546340; DOI=10.1002/ana.410430422;
RA   Smelt A.H., Poorthuis B.J.H.M., Onkenhout W., Scholte H.R., Andresen B.S.,
RA   van Duinen S.G., Gregersen N., Wintzen A.R.;
RT   "Very long chain acyl-coenzyme A dehydrogenase deficiency with adult
RT   onset.";
RL   Ann. Neurol. 43:540-544(1998).
RN   [21]
RP   VARIANT ACADVLD PRO-490, CHARACTERIZATION OF VARIANT ACADVLD PRO-490,
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBSTRATE SPECIFICITY, AND
RP   MUTAGENESIS OF ALA-490.
RX   PubMed=9839948; DOI=10.1046/j.1432-1327.1998.2570592.x;
RA   Souri M., Aoyama T., Yamaguchi S., Hashimoto T.;
RT   "Relationship between structure and substrate-chain-length specificity of
RT   mitochondrial very-long-chain acyl-coenzyme A dehydrogenase.";
RL   Eur. J. Biochem. 257:592-598(1998).
RN   [22]
RP   VARIANT ACADVLD TRP-583, CHARACTERIZATION OF VARIANT ACADVLD TRP-583,
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBUNIT, SUBCELLULAR LOCATION, AND
RP   TOPOLOGY.
RX   PubMed=9599005; DOI=10.1016/s0014-5793(98)00343-3;
RA   Souri M., Aoyama T., Hoganson G., Hashimoto T.;
RT   "Very-long-chain acyl-CoA dehydrogenase subunit assembles to the dimer form
RT   on mitochondrial inner membrane.";
RL   FEBS Lett. 426:187-190(1998).
RN   [23]
RP   VARIANTS ACADVLD GLU-130 DEL; PRO-213; GLU-247; MET-260; LYS-278 DEL;
RP   ALA-283; ASP-441; LEU-458; PRO-490; LYS-534; TRP-613 AND GLN-615.
RX   PubMed=10077518; DOI=10.1161/01.cir.99.10.1337;
RA   Mathur A., Sims H.F., Gopalakrishnan D., Gibson B., Rinaldo P., Vockley J.,
RA   Hug G., Strauss A.W.;
RT   "Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase
RT   deficiency causing pediatric cardiomyopathy and sudden death.";
RL   Circulation 99:1337-1343(1999).
CC   -!- FUNCTION: Very long-chain specific acyl-CoA dehydrogenase is one of the
CC       acyl-CoA dehydrogenases that catalyze the first step of mitochondrial
CC       fatty acid beta-oxidation, an aerobic process breaking down fatty acids
CC       into acetyl-CoA and allowing the production of energy from fats
CC       (PubMed:7668252, PubMed:9461620, PubMed:18227065, PubMed:9839948,
CC       PubMed:9599005). The first step of fatty acid beta-oxidation consists
CC       in the removal of one hydrogen from C-2 and C-3 of the straight-chain
CC       fatty acyl-CoA thioester, resulting in the formation of trans-2-enoyl-
CC       CoA (PubMed:7668252, PubMed:9461620, PubMed:18227065, PubMed:9839948).
CC       Among the different mitochondrial acyl-CoA dehydrogenases, very long-
CC       chain specific acyl-CoA dehydrogenase acts specifically on acyl-CoAs
CC       with saturated 12 to 24 carbons long primary chains (PubMed:21237683,
CC       PubMed:9839948). {ECO:0000269|PubMed:18227065,
CC       ECO:0000269|PubMed:21237683, ECO:0000269|PubMed:7668252,
CC       ECO:0000269|PubMed:9461620, ECO:0000269|PubMed:9599005,
CC       ECO:0000269|PubMed:9839948}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a very-long-chain 2,3-saturated fatty acyl-CoA + H(+) +
CC         oxidized [electron-transfer flavoprotein] = a very-long-chain (2E)-
CC         enoyl-CoA + reduced [electron-transfer flavoprotein];
CC         Xref=Rhea:RHEA:19181, Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:83724, ChEBI:CHEBI:83728; EC=1.3.8.9;
CC         Evidence={ECO:0000269|PubMed:17374501, ECO:0000269|PubMed:21237683,
CC         ECO:0000269|PubMed:7668252, ECO:0000269|PubMed:9461620,
CC         ECO:0000269|PubMed:9599005, ECO:0000269|PubMed:9839948};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19182;
CC         Evidence={ECO:0000269|PubMed:7668252};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=decanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-decenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:48176, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:61406, ChEBI:CHEBI:61430;
CC         Evidence={ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48177;
CC         Evidence={ECO:0000305|PubMed:21237683};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-dodecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47296, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57330, ChEBI:CHEBI:57375,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307;
CC         Evidence={ECO:0000269|PubMed:21237683, ECO:0000269|PubMed:9839948};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47297;
CC         Evidence={ECO:0000269|PubMed:9839948};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + oxidized [electron-transfer flavoprotein] +
CC         tetradecanoyl-CoA = (2E)-tetradecenoyl-CoA + reduced [electron-
CC         transfer flavoprotein]; Xref=Rhea:RHEA:47316, Rhea:RHEA-COMP:10685,
CC         Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57385,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:61405;
CC         Evidence={ECO:0000269|PubMed:21237683, ECO:0000269|PubMed:9839948};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47317;
CC         Evidence={ECO:0000269|PubMed:9839948};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hexadecanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] = (2E)-hexadecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:43448, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57379, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:61526;
CC         Evidence={ECO:0000269|PubMed:21237683, ECO:0000269|PubMed:7668252,
CC         ECO:0000269|PubMed:9461620, ECO:0000269|PubMed:9599005,
CC         ECO:0000269|PubMed:9839948};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43449;
CC         Evidence={ECO:0000269|PubMed:7668252};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + octadecanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] = (2E)-octadecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47240, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57394, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:71412;
CC         Evidence={ECO:0000269|PubMed:21237683, ECO:0000269|PubMed:9839948};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47241;
CC         Evidence={ECO:0000269|PubMed:9839948};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=eicosanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-eicosenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47236, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57380, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:74691;
CC         Evidence={ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47237;
CC         Evidence={ECO:0000305|PubMed:21237683};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=docosanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-docosenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47228, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:65059, ChEBI:CHEBI:74692;
CC         Evidence={ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47229;
CC         Evidence={ECO:0000305|PubMed:21237683};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + oxidized [electron-transfer flavoprotein] +
CC         tetracosanoyl-CoA = (2E)-tetracosenoyl-CoA + reduced [electron-
CC         transfer flavoprotein]; Xref=Rhea:RHEA:47232, Rhea:RHEA-COMP:10685,
CC         Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:65052, ChEBI:CHEBI:74693;
CC         Evidence={ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47233;
CC         Evidence={ECO:0000305|PubMed:21237683};
CC   -!- CATALYTIC ACTIVITY: [Isoform 2]:
CC       Reaction=a very-long-chain 2,3-saturated fatty acyl-CoA + H(+) +
CC         oxidized [electron-transfer flavoprotein] = a very-long-chain (2E)-
CC         enoyl-CoA + reduced [electron-transfer flavoprotein];
CC         Xref=Rhea:RHEA:19181, Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:83724, ChEBI:CHEBI:83728; EC=1.3.8.9;
CC         Evidence={ECO:0000269|PubMed:17374501};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19182;
CC         Evidence={ECO:0000305|PubMed:17374501};
CC   -!- CATALYTIC ACTIVITY: [Isoform 2]:
CC       Reaction=H(+) + oxidized [electron-transfer flavoprotein] +
CC         tetradecanoyl-CoA = (2E)-tetradecenoyl-CoA + reduced [electron-
CC         transfer flavoprotein]; Xref=Rhea:RHEA:47316, Rhea:RHEA-COMP:10685,
CC         Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57385,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:61405;
CC         Evidence={ECO:0000269|PubMed:17374501};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47317;
CC         Evidence={ECO:0000305|PubMed:17374501};
CC   -!- CATALYTIC ACTIVITY: [Isoform 2]:
CC       Reaction=H(+) + hexadecanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] = (2E)-hexadecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:43448, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57379, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:61526;
CC         Evidence={ECO:0000269|PubMed:17374501};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43449;
CC         Evidence={ECO:0000305|PubMed:17374501};
CC   -!- CATALYTIC ACTIVITY: [Isoform 2]:
CC       Reaction=(9Z)-hexadecenoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E,9Z)-hexadecadienoyl-CoA + reduced [electron-
CC         transfer flavoprotein]; Xref=Rhea:RHEA:47304, Rhea:RHEA-COMP:10685,
CC         Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:61540, ChEBI:CHEBI:77549;
CC         Evidence={ECO:0000269|PubMed:17374501};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47305;
CC         Evidence={ECO:0000305|PubMed:17374501};
CC   -!- CATALYTIC ACTIVITY: [Isoform 2]:
CC       Reaction=H(+) + octadecanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] = (2E)-octadecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47240, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57394, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:71412;
CC         Evidence={ECO:0000269|PubMed:17374501};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47241;
CC         Evidence={ECO:0000305|PubMed:17374501};
CC   -!- CATALYTIC ACTIVITY: [Isoform 2]:
CC       Reaction=(9Z)-octadecenoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E,9Z)-octadecadienoyl-CoA + reduced [electron-
CC         transfer flavoprotein]; Xref=Rhea:RHEA:47300, Rhea:RHEA-COMP:10685,
CC         Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:77553;
CC         Evidence={ECO:0000269|PubMed:17374501};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47301;
CC         Evidence={ECO:0000305|PubMed:17374501};
CC   -!- CATALYTIC ACTIVITY: [Isoform 2]:
CC       Reaction=eicosanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-eicosenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47236, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57380, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:74691;
CC         Evidence={ECO:0000269|PubMed:17374501};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47237;
CC         Evidence={ECO:0000305|PubMed:17374501};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:18227065, ECO:0000269|PubMed:9461620};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.4 uM for hexadecanoyl-CoA {ECO:0000269|PubMed:9461620};
CC   -!- PATHWAY: Lipid metabolism; mitochondrial fatty acid beta-oxidation.
CC       {ECO:0000269|PubMed:7668252, ECO:0000269|PubMed:9599005,
CC       ECO:0000269|PubMed:9839948}.
CC   -!- SUBUNIT: Homodimer (PubMed:9461620, PubMed:18227065, PubMed:9599005).
CC       Homodimerizes after import into the mitochondrion (PubMed:9599005).
CC       {ECO:0000269|PubMed:18227065, ECO:0000269|PubMed:9461620,
CC       ECO:0000269|PubMed:9599005}.
CC   -!- INTERACTION:
CC       P49748; Q53T94: TAF1B; NbExp=3; IntAct=EBI-727618, EBI-1560239;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:9461620, ECO:0000269|PubMed:9599005}; Peripheral
CC       membrane protein {ECO:0000269|PubMed:9599005}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:17374501}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:17374501}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P49748-1; Sequence=Displayed;
CC       Name=2; Synonyms=DeltaEx3 VLCAD {ECO:0000303|PubMed:17374501};
CC         IsoId=P49748-2; Sequence=VSP_007734;
CC       Name=3;
CC         IsoId=P49748-3; Sequence=VSP_046031;
CC   -!- PTM: S-nitrosylation at Cys-237 in liver improves catalytic efficiency.
CC       {ECO:0000250|UniProtKB:P50544}.
CC   -!- DISEASE: Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD)
CC       [MIM:201475]: An inborn error of mitochondrial fatty acid beta-
CC       oxidation which leads to impaired long-chain fatty acid beta-oxidation.
CC       It is clinically heterogeneous, with three major phenotypes: a severe
CC       childhood form characterized by early onset, high mortality and high
CC       incidence of cardiomyopathy; a milder childhood form with later onset,
CC       characterized by hypoketotic hypoglycemia, low mortality and rare
CC       cardiomyopathy; an adult form, with isolated skeletal muscle
CC       involvement, rhabdomyolysis and myoglobinuria, usually triggered by
CC       exercise or fasting. {ECO:0000269|PubMed:10077518,
CC       ECO:0000269|PubMed:17374501, ECO:0000269|PubMed:7668252,
CC       ECO:0000269|PubMed:8554073, ECO:0000269|PubMed:8845838,
CC       ECO:0000269|PubMed:9461620, ECO:0000269|PubMed:9546340,
CC       ECO:0000269|PubMed:9599005, ECO:0000269|PubMed:9839948,
CC       ECO:0000269|PubMed:9973285}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D43682; BAA07781.1; -; mRNA.
DR   EMBL; L46590; AAA79002.1; -; Genomic_DNA.
DR   EMBL; X86556; CAA60253.1; -; mRNA.
DR   EMBL; D78298; BAA29057.1; -; Genomic_DNA.
DR   EMBL; AK293549; BAG57027.1; -; mRNA.
DR   EMBL; AC120057; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000399; AAH00399.1; -; mRNA.
DR   EMBL; BC012912; AAH12912.1; -; mRNA.
DR   EMBL; BC020218; AAH20218.1; -; mRNA.
DR   CCDS; CCDS11090.1; -. [P49748-1]
DR   CCDS; CCDS42249.1; -. [P49748-2]
DR   CCDS; CCDS58509.1; -. [P49748-3]
DR   PIR; S54183; S54183.
DR   RefSeq; NP_000009.1; NM_000018.3. [P49748-1]
DR   RefSeq; NP_001029031.1; NM_001033859.2. [P49748-2]
DR   RefSeq; NP_001257376.1; NM_001270447.1. [P49748-3]
DR   PDB; 2UXW; X-ray; 1.45 A; A=72-655.
DR   PDB; 3B96; X-ray; 1.91 A; A=69-655.
DR   PDBsum; 2UXW; -.
DR   PDBsum; 3B96; -.
DR   SASBDB; P49748; -.
DR   SMR; P49748; -.
DR   BioGRID; 106555; 96.
DR   IntAct; P49748; 40.
DR   MINT; P49748; -.
DR   STRING; 9606.ENSP00000438689; -.
DR   ChEMBL; CHEMBL4105892; -.
DR   SwissLipids; SLP:000001330; -. [P49748-2]
DR   SwissLipids; SLP:000001332; -.
DR   CarbonylDB; P49748; -.
DR   iPTMnet; P49748; -.
DR   PhosphoSitePlus; P49748; -.
DR   SwissPalm; P49748; -.
DR   BioMuta; ACADVL; -.
DR   DMDM; 1703068; -.
DR   CPTAC; CPTAC-454; -.
DR   CPTAC; CPTAC-455; -.
DR   EPD; P49748; -.
DR   jPOST; P49748; -.
DR   MassIVE; P49748; -.
DR   MaxQB; P49748; -.
DR   PaxDb; P49748; -.
DR   PeptideAtlas; P49748; -.
DR   PRIDE; P49748; -.
DR   ProteomicsDB; 25916; -.
DR   ProteomicsDB; 56061; -. [P49748-1]
DR   ProteomicsDB; 56062; -. [P49748-2]
DR   Antibodypedia; 11798; 294 antibodies.
DR   DNASU; 37; -.
DR   Ensembl; ENST00000350303; ENSP00000344152; ENSG00000072778. [P49748-2]
DR   Ensembl; ENST00000356839; ENSP00000349297; ENSG00000072778. [P49748-1]
DR   Ensembl; ENST00000543245; ENSP00000438689; ENSG00000072778. [P49748-3]
DR   GeneID; 37; -.
DR   KEGG; hsa:37; -.
DR   UCSC; uc002gev.5; human. [P49748-1]
DR   CTD; 37; -.
DR   DisGeNET; 37; -.
DR   GeneCards; ACADVL; -.
DR   GeneReviews; ACADVL; -.
DR   HGNC; HGNC:92; ACADVL.
DR   HPA; ENSG00000072778; Low tissue specificity.
DR   MalaCards; ACADVL; -.
DR   MIM; 201475; phenotype.
DR   MIM; 609575; gene.
DR   neXtProt; NX_P49748; -.
DR   OpenTargets; ENSG00000072778; -.
DR   Orphanet; 26793; Very long chain acyl-CoA dehydrogenase deficiency.
DR   PharmGKB; PA24428; -.
DR   VEuPathDB; HostDB:ENSG00000072778.19; -.
DR   eggNOG; KOG0137; Eukaryota.
DR   GeneTree; ENSGT00940000158535; -.
DR   HOGENOM; CLU_018204_11_2_1; -.
DR   InParanoid; P49748; -.
DR   OMA; NAFMGLR; -.
DR   OrthoDB; 819314at2759; -.
DR   PhylomeDB; P49748; -.
DR   TreeFam; TF105053; -.
DR   BioCyc; MetaCyc:ENSG00000072778-MONOMER; -.
DR   BRENDA; 1.3.8.8; 2681.
DR   BRENDA; 1.3.8.9; 2681.
DR   PathwayCommons; P49748; -.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   Reactome; R-HSA-77305; Beta oxidation of palmitoyl-CoA to myristoyl-CoA.
DR   UniPathway; UPA00660; -.
DR   BioGRID-ORCS; 37; 7 hits in 996 CRISPR screens.
DR   ChiTaRS; ACADVL; human.
DR   EvolutionaryTrace; P49748; -.
DR   GenomeRNAi; 37; -.
DR   Pharos; P49748; Tbio.
DR   PRO; PR:P49748; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; P49748; protein.
DR   Bgee; ENSG00000072778; Expressed in left lobe of thyroid gland and 248 other tissues.
DR   ExpressionAtlas; P49748; baseline and differential.
DR   Genevisible; P49748; HS.
DR   GO; GO:0031314; C:extrinsic component of mitochondrial inner membrane; IMP:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0031966; C:mitochondrial membrane; IDA:BHF-UCL.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003995; F:acyl-CoA dehydrogenase activity; IMP:UniProtKB.
DR   GO; GO:0000062; F:fatty-acyl-CoA binding; IBA:GO_Central.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0004466; F:long-chain-acyl-CoA dehydrogenase activity; IDA:BHF-UCL.
DR   GO; GO:0017099; F:very-long-chain-acyl-CoA dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0015980; P:energy derivation by oxidation of organic compounds; TAS:ProtInc.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEP:UniProtKB.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome.
DR   GO; GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; IDA:BHF-UCL.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0045717; P:negative regulation of fatty acid biosynthetic process; ISS:BHF-UCL.
DR   GO; GO:0046322; P:negative regulation of fatty acid oxidation; ISS:BHF-UCL.
DR   GO; GO:0090181; P:regulation of cholesterol metabolic process; ISS:BHF-UCL.
DR   GO; GO:0009409; P:response to cold; IEA:Ensembl.
DR   GO; GO:0001659; P:temperature homeostasis; ISS:BHF-UCL.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cardiomyopathy;
KW   Direct protein sequencing; Disease variant; FAD; Fatty acid metabolism;
KW   Flavoprotein; Lipid metabolism; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; S-nitrosylation; Transit peptide.
FT   TRANSIT         1..40
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:7668252,
FT                   ECO:0007744|PubMed:25944712"
FT   CHAIN           41..655
FT                   /note="Very long-chain specific acyl-CoA dehydrogenase,
FT                   mitochondrial"
FT                   /id="PRO_0000000515"
FT   NP_BIND         214..223
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18227065,
FT                   ECO:0007744|PDB:2UXW, ECO:0007744|PDB:3B96"
FT   NP_BIND         249..251
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18227065,
FT                   ECO:0007744|PDB:2UXW, ECO:0007744|PDB:3B96"
FT   NP_BIND         464..466
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18227065,
FT                   ECO:0007744|PDB:2UXW, ECO:0007744|PDB:3B96"
FT   REGION          23..42
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          41..482
FT                   /note="Catalytic"
FT                   /evidence="ECO:0000305|PubMed:18227065"
FT   REGION          461..463
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:18227065,
FT                   ECO:0007744|PDB:2UXW, ECO:0007744|PDB:3B96"
FT   REGION          483..516
FT                   /note="Membrane-anchoring"
FT                   /evidence="ECO:0000305|PubMed:18227065"
FT   ACT_SITE        462
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000269|PubMed:18227065,
FT                   ECO:0000269|PubMed:9461620, ECO:0007744|PDB:2UXW,
FT                   ECO:0007744|PDB:3B96"
FT   BINDING         562
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18227065,
FT                   ECO:0007744|PDB:2UXW, ECO:0007744|PDB:3B96"
FT   MOD_RES         51
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         71
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         71
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         195
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         237
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         239
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         239
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         276
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         276
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         278
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         278
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         298
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         331
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         331
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         372
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         482
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         482
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         517
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         522
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         550
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         556
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         556
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   MOD_RES         639
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P50544"
FT   VAR_SEQ         1..20
FT                   /note="MQAARMAASLGRQLLRLGGG -> MLGGLAAAAGTRIMGKEIEAEAQRPLRQ
FT                   TWRPGQPPAMTAKTM (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046031"
FT   VAR_SEQ         47..68
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_007734"
FT   VARIANT         17
FT                   /note="L -> F (in dbSNP:rs2230179)"
FT                   /id="VAR_029286"
FT   VARIANT         43
FT                   /note="G -> D (in dbSNP:rs2230178)"
FT                   /id="VAR_000330"
FT   VARIANT         65
FT                   /note="P -> L (in dbSNP:rs28934585)"
FT                   /id="VAR_048176"
FT   VARIANT         130
FT                   /note="Missing (in ACADVLD; dbSNP:rs387906251)"
FT                   /evidence="ECO:0000269|PubMed:10077518,
FT                   ECO:0000269|PubMed:8554073"
FT                   /id="VAR_000331"
FT   VARIANT         158
FT                   /note="T -> N (in ACADVLD)"
FT                   /id="VAR_000332"
FT   VARIANT         159
FT                   /note="Q -> R (in ACADVLD; dbSNP:rs746688190)"
FT                   /id="VAR_000333"
FT   VARIANT         174
FT                   /note="V -> M (in ACADVLD; dbSNP:rs369560930)"
FT                   /id="VAR_000334"
FT   VARIANT         185
FT                   /note="G -> S (in ACADVLD; dbSNP:rs545215807)"
FT                   /id="VAR_000335"
FT   VARIANT         213
FT                   /note="A -> P (in ACADVLD; dbSNP:rs140629318)"
FT                   /evidence="ECO:0000269|PubMed:10077518"
FT                   /id="VAR_010101"
FT   VARIANT         218
FT                   /note="E -> K (in ACADVLD; dbSNP:rs1432183079)"
FT                   /id="VAR_000336"
FT   VARIANT         243
FT                   /note="L -> R (in ACADVLD)"
FT                   /id="VAR_000337"
FT   VARIANT         247
FT                   /note="K -> E (in ACADVLD; dbSNP:rs387906253)"
FT                   /evidence="ECO:0000269|PubMed:10077518"
FT                   /id="VAR_010102"
FT   VARIANT         247
FT                   /note="K -> T (in ACADVLD)"
FT                   /id="VAR_000338"
FT   VARIANT         260
FT                   /note="T -> M (in ACADVLD; decreased protein abundance;
FT                   loss of fatty acid beta-oxidation; dbSNP:rs113994168)"
FT                   /evidence="ECO:0000269|PubMed:10077518,
FT                   ECO:0000269|PubMed:17374501, ECO:0000269|PubMed:8845838,
FT                   ECO:0000269|PubMed:9973285"
FT                   /id="VAR_000339"
FT   VARIANT         278
FT                   /note="Missing (in ACADVLD)"
FT                   /evidence="ECO:0000269|PubMed:10077518"
FT                   /id="VAR_000340"
FT   VARIANT         281
FT                   /note="A -> D (in ACADVLD)"
FT                   /evidence="ECO:0000269|PubMed:8845838"
FT                   /id="VAR_000341"
FT   VARIANT         283
FT                   /note="V -> A (in ACADVLD; decreased protein abundance;
FT                   decreased fatty acid beta-oxidation; dbSNP:rs113994167)"
FT                   /evidence="ECO:0000269|PubMed:10077518,
FT                   ECO:0000269|PubMed:17374501, ECO:0000269|PubMed:8845838,
FT                   ECO:0000269|PubMed:9973285"
FT                   /id="VAR_000342"
FT   VARIANT         290
FT                   /note="G -> D (in ACADVLD; dbSNP:rs866464446)"
FT                   /id="VAR_000343"
FT   VARIANT         294
FT                   /note="G -> E (in ACADVLD; dbSNP:rs200573371)"
FT                   /id="VAR_000344"
FT   VARIANT         299
FT                   /note="K -> N (in ACADVLD; dbSNP:rs774716484)"
FT                   /id="VAR_000345"
FT   VARIANT         299
FT                   /note="Missing (in ACADVLD)"
FT                   /evidence="ECO:0000269|PubMed:8554073"
FT                   /id="VAR_000346"
FT   VARIANT         317
FT                   /note="V -> A (in ACADVLD; dbSNP:rs398123095)"
FT                   /evidence="ECO:0000269|PubMed:8845838"
FT                   /id="VAR_000347"
FT   VARIANT         352
FT                   /note="M -> V (in ACADVLD)"
FT                   /id="VAR_000348"
FT   VARIANT         359
FT                   /note="A -> S (in dbSNP:rs1051701)"
FT                   /id="VAR_011990"
FT   VARIANT         366
FT                   /note="R -> C (in ACADVLD; dbSNP:rs771874163)"
FT                   /evidence="ECO:0000269|PubMed:8845838"
FT                   /id="VAR_000349"
FT   VARIANT         366
FT                   /note="R -> H (in ACADVLD; dbSNP:rs112406105)"
FT                   /id="VAR_000350"
FT   VARIANT         381
FT                   /note="Missing (in ACADVLD; dbSNP:rs1057517281)"
FT                   /evidence="ECO:0000269|PubMed:8845838"
FT                   /id="VAR_000351"
FT   VARIANT         382
FT                   /note="K -> Q (in ACADVLD; dbSNP:rs118204015)"
FT                   /evidence="ECO:0000269|PubMed:8554073"
FT                   /id="VAR_000352"
FT   VARIANT         405
FT                   /note="D -> H (in ACADVLD)"
FT                   /id="VAR_000353"
FT   VARIANT         441
FT                   /note="G -> D (in ACADVLD; dbSNP:rs2309689)"
FT                   /evidence="ECO:0000269|PubMed:10077518,
FT                   ECO:0000269|PubMed:8845838"
FT                   /id="VAR_000354"
FT   VARIANT         450
FT                   /note="R -> H (in ACADVLD; dbSNP:rs118204016)"
FT                   /evidence="ECO:0000269|PubMed:9546340"
FT                   /id="VAR_000355"
FT   VARIANT         453
FT                   /note="R -> Q (in ACADVLD; dbSNP:rs138058572)"
FT                   /id="VAR_000356"
FT   VARIANT         454
FT                   /note="D -> N (in ACADVLD; dbSNP:rs1419606204)"
FT                   /id="VAR_000357"
FT   VARIANT         456
FT                   /note="R -> H (in ACADVLD; dbSNP:rs794727112)"
FT                   /id="VAR_000358"
FT   VARIANT         458
FT                   /note="F -> L (in ACADVLD; loss of acyl-CoA dehydrogenase
FT                   activity; Loss of FAD cofactor-binding; dbSNP:rs118204017)"
FT                   /evidence="ECO:0000269|PubMed:10077518,
FT                   ECO:0000269|PubMed:9461620"
FT                   /id="VAR_010103"
FT   VARIANT         459
FT                   /note="R -> W (in ACADVLD; dbSNP:rs766742117)"
FT                   /id="VAR_000359"
FT   VARIANT         463
FT                   /note="G -> E (in ACADVLD; dbSNP:rs200366828)"
FT                   /id="VAR_000360"
FT   VARIANT         469
FT                   /note="R -> Q (in ACADVLD; dbSNP:rs398123083)"
FT                   /id="VAR_000361"
FT   VARIANT         469
FT                   /note="R -> W (in ACADVLD; decreased protein abundance;
FT                   loss of fatty acid beta-oxidation; dbSNP:rs113994170)"
FT                   /evidence="ECO:0000269|PubMed:17374501,
FT                   ECO:0000269|PubMed:9973285"
FT                   /id="VAR_000362"
FT   VARIANT         490
FT                   /note="A -> P (in ACADVLD; decreased association with
FT                   mitochondrial inner membrane; could change substrate
FT                   specificity with decreased affinity for tetradecanoyl-CoA
FT                   and hexadecanoyl-CoA; dbSNP:rs759775666)"
FT                   /evidence="ECO:0000269|PubMed:10077518,
FT                   ECO:0000269|PubMed:17374501, ECO:0000269|PubMed:9839948"
FT                   /id="VAR_010104"
FT   VARIANT         502
FT                   /note="L -> P (in ACADVLD; decreased association with
FT                   mitochondrial inner membrane; no effect on acyl-CoA
FT                   dehydrogenase activity)"
FT                   /evidence="ECO:0000269|PubMed:17374501,
FT                   ECO:0000269|PubMed:9973285"
FT                   /id="VAR_000363"
FT   VARIANT         534
FT                   /note="E -> K (in ACADVLD; unknown pathological
FT                   significance; dbSNP:rs2230180)"
FT                   /evidence="ECO:0000269|PubMed:10077518"
FT                   /id="VAR_010105"
FT   VARIANT         583
FT                   /note="S -> W (in ACADVLD; Loss of homodimerization; loss
FT                   of localization to mitochondrial inner membrane;
FT                   dbSNP:rs1085307648)"
FT                   /evidence="ECO:0000269|PubMed:9599005"
FT                   /id="VAR_083892"
FT   VARIANT         602
FT                   /note="L -> I (in ACADVLD)"
FT                   /evidence="ECO:0000269|PubMed:8845838"
FT                   /id="VAR_000364"
FT   VARIANT         613
FT                   /note="R -> W (in ACADVLD; loss of protein expression;
FT                   dbSNP:rs118204014)"
FT                   /evidence="ECO:0000269|PubMed:10077518,
FT                   ECO:0000269|PubMed:8554073, ECO:0000269|PubMed:9973285"
FT                   /id="VAR_000365"
FT   VARIANT         615
FT                   /note="R -> Q (in ACADVLD; dbSNP:rs148584617)"
FT                   /evidence="ECO:0000269|PubMed:10077518"
FT                   /id="VAR_010106"
FT   VARIANT         623
FT                   /note="S -> F (in dbSNP:rs13383)"
FT                   /id="VAR_011991"
FT   MUTAGEN         458
FT                   /note="F->T: Decreased acyl-CoA dehydrogenase activity.
FT                   Decreased affinity for acyl-CoA. No effect on FAD cofactor-
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:9461620"
FT   MUTAGEN         458
FT                   /note="F->V: Loss of acyl-CoA dehydrogenase activity. Loss
FT                   of FAD cofactor-binding."
FT                   /evidence="ECO:0000269|PubMed:9461620"
FT   MUTAGEN         458
FT                   /note="F->Y: Decreased acyl-CoA dehydrogenase activity. No
FT                   effect on affinity for acyl-CoA. Decreased FAD cofactor-
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:9461620"
FT   MUTAGEN         462
FT                   /note="E->D: Decreased acyl-CoA dehydrogenase activity. No
FT                   effect on affinity for acyl-CoA. No effect on FAD cofactor-
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:9461620"
FT   MUTAGEN         462
FT                   /note="E->Q: Loss of acyl-CoA dehydrogenase activity. No
FT                   effect on FAD cofactor-binding."
FT                   /evidence="ECO:0000269|PubMed:9461620"
FT   MUTAGEN         490
FT                   /note="A->G,V,S,D,H: Changed substrate specificity with
FT                   decreased affinity for tetradecanoyl-CoA and hexadecanoyl-
FT                   CoA."
FT                   /evidence="ECO:0000269|PubMed:9839948"
FT   CONFLICT        193
FT                   /note="G -> C (in Ref. 3; BAA29057)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        200
FT                   /note="K -> E (in Ref. 4; BAG57027)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        541
FT                   /note="E -> K (in Ref. 4; BAG57027)"
FT                   /evidence="ECO:0000305"
FT   HELIX           73..77
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   TURN            78..80
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   TURN            85..87
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           96..115
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           119..125
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           130..138
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   TURN            139..142
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           148..150
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           157..170
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           172..182
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   TURN            183..186
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           187..192
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           195..206
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   STRAND          212..215
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   STRAND          221..223
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           225..227
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   STRAND          231..234
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   STRAND          238..251
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   TURN            252..255
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   STRAND          257..268
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   TURN            270..272
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   STRAND          275..285
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           286..288
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   STRAND          289..293
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   STRAND          307..318
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           319..321
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   STRAND          322..325
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           329..365
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           373..375
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           377..405
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           412..437
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           439..442
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           448..455
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           456..459
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   STRAND          461..463
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           465..485
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           486..488
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   TURN            522..524
FT                   /evidence="ECO:0007829|PDB:3B96"
FT   HELIX           527..529
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           530..554
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           555..560
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           562..591
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           596..622
FT                   /evidence="ECO:0007829|PDB:2UXW"
FT   HELIX           627..644
FT                   /evidence="ECO:0007829|PDB:2UXW"
SQ   SEQUENCE   655 AA;  70390 MW;  A5594D1EA7911D19 CRC64;
     MQAARMAASL GRQLLRLGGG SSRLTALLGQ PRPGPARRPY AGGAAQLALD KSDSHPSDAL
     TRKKPAKAES KSFAVGMFKG QLTTDQVFPY PSVLNEEQTQ FLKELVEPVS RFFEEVNDPA
     KNDALEMVEE TTWQGLKELG AFGLQVPSEL GGVGLCNTQY ARLVEIVGMH DLGVGITLGA
     HQSIGFKGIL LFGTKAQKEK YLPKLASGET VAAFCLTEPS SGSDAASIRT SAVPSPCGKY
     YTLNGSKLWI SNGGLADIFT VFAKTPVTDP ATGAVKEKIT AFVVERGFGG ITHGPPEKKM
     GIKASNTAEV FFDGVRVPSE NVLGEVGSGF KVAMHILNNG RFGMAAALAG TMRGIIAKAV
     DHATNRTQFG EKIHNFGLIQ EKLARMVMLQ YVTESMAYMV SANMDQGATD FQIEAAISKI
     FGSEAAWKVT DECIQIMGGM GFMKEPGVER VLRDLRIFRI FEGTNDILRL FVALQGCMDK
     GKELSGLGSA LKNPFGNAGL LLGEAGKQLR RRAGLGSGLS LSGLVHPELS RSGELAVRAL
     EQFATVVEAK LIKHKKGIVN EQFLLQRLAD GAIDLYAMVV VLSRASRSLS EGHPTAQHEK
     MLCDTWCIEA AARIREGMAA LQSDPWQQEL YRNFKSISKA LVERGGVVTS NPLGF
//
ID   CGOX_BACSU              Reviewed;         470 AA.
AC   P32397;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 1.
DT   02-JUN-2021, entry version 153.
DE   RecName: Full=Coproporphyrinogen III oxidase {ECO:0000305};
DE            EC=1.3.3.15 {ECO:0000269|PubMed:7928957, ECO:0000269|PubMed:8288631, ECO:0000269|PubMed:9217019, ECO:0000269|PubMed:9784236};
GN   Name=cgoX {ECO:0000303|PubMed:28123057};
GN   Synonyms=hemG {ECO:0000303|PubMed:8288631},
GN   hemY {ECO:0000303|PubMed:1459957}; OrderedLocusNames=BSU10140;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PATHWAY.
RX   PubMed=1459957; DOI=10.1128/jb.174.24.8081-8093.1992;
RA   Hansson M., Hederstedt L.;
RT   "Cloning and characterization of the Bacillus subtilis hemEHY gene cluster,
RT   which encodes protoheme IX biosynthetic enzymes.";
RL   J. Bacteriol. 174:8081-8093(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9579061; DOI=10.1099/00221287-144-4-859;
RA   Noback M.A., Holsappel S., Kiewiet R., Terpstra P., Wambutt R., Wedler H.,
RA   Venema G., Bron S.;
RT   "The 172 kb prkA-addAB region from 83 degrees to 97 degrees of the Bacillus
RT   subtilis chromosome contains several dysfunctional genes, the glyB marker,
RT   many genes encoding transporter proteins, and the ubiquitous hit gene.";
RL   Microbiology 144:859-875(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V.,
RA   Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R.,
RA   Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S.,
RA   Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K.,
RA   Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F.,
RA   Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D.,
RA   Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M.,
RA   Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P.,
RA   Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K.,
RA   Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S.,
RA   Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y.,
RA   Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G.,
RA   Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M.,
RA   Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y.,
RA   Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J.,
RA   Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A.,
RA   Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M.,
RA   Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S.,
RA   Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E.,
RA   Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-8, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, PATHWAY, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=7928957; DOI=10.1128/jb.176.19.5962-5970.1994;
RA   Hansson M., Hederstedt L.;
RT   "Bacillus subtilis HemY is a peripheral membrane protein essential for
RT   protoheme IX synthesis which can oxidize coproporphyrinogen III and
RT   protoporphyrinogen IX.";
RL   J. Bacteriol. 176:5962-5970(1994).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY
RP   REGULATION, SUBUNIT, SUBCELLULAR LOCATION, AND COFACTOR.
RX   PubMed=8288631;
RA   Dailey T.A., Meissner P., Dailey H.A.;
RT   "Expression of a cloned protoporphyrinogen oxidase.";
RL   J. Biol. Chem. 269:813-815(1994).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND COFACTOR.
RX   PubMed=9217019; DOI=10.1016/s0167-4838(97)00030-7;
RA   Hansson M., Gustafsson M.C., Kannangara C.G., Hederstedt L.;
RT   "Isolated Bacillus subtilis HemY has coproporphyrinogen III to
RT   coproporphyrin III oxidase activity.";
RL   Biochim. Biophys. Acta 1340:97-104(1997).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ACTIVITY REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=9784236; DOI=10.1006/abbi.1998.0834;
RA   Corrigall A.V., Siziba K.B., Maneli M.H., Shephard E.G., Ziman M.,
RA   Dailey T.A., Dailey H.A., Kirsch R.E., Meissner P.N.;
RT   "Purification of and kinetic studies on a cloned protoporphyrinogen oxidase
RT   from the aerobic bacterium Bacillus subtilis.";
RL   Arch. Biochem. Biophys. 358:251-256(1998).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF TYR-366.
RX   PubMed=19266155; DOI=10.1007/s00726-009-0256-5;
RA   Sun L., Wen X., Tan Y., Li H., Yang X., Zhao Y., Wang B., Cao Q., Niu C.,
RA   Xi Z.;
RT   "Site-directed mutagenesis and computational study of the Y366 active site
RT   in Bacillus subtilis protoporphyrinogen oxidase.";
RL   Amino Acids 37:523-530(2009).
RN   [9]
RP   PATHWAY, AND REVIEW.
RX   PubMed=25711532; DOI=10.1016/j.abb.2015.02.017;
RA   Dailey H.A., Gerdes S.;
RT   "HemQ: An iron-coproporphyrin oxidative decarboxylase for protoheme
RT   synthesis in Firmicutes and Actinobacteria.";
RL   Arch. Biochem. Biophys. 574:27-35(2015).
RN   [10]
RP   NOMENCLATURE, AND REVIEW.
RX   PubMed=28123057; DOI=10.1128/mmbr.00048-16;
RA   Dailey H.A., Dailey T.A., Gerdes S., Jahn D., Jahn M., O'Brian M.R.,
RA   Warren M.J.;
RT   "Prokaryotic heme biosynthesis: multiple pathways to a common essential
RT   product.";
RL   Microbiol. Mol. Biol. Rev. 81:e00048-e00048(2017).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) IN COMPLEX WITH FAD AND THE INHIBITOR
RP   ACIFLUORFEN, FUNCTION, COFACTOR, ACTIVITY REGULATION, MUTAGENESIS OF
RP   PRO-64; LYS-71; ILE-176 AND PHE-227, AND SUBUNIT.
RX   PubMed=19944166; DOI=10.1016/j.jsb.2009.11.012;
RA   Qin X., Sun L., Wen X., Yang X., Tan Y., Jin H., Cao Q., Zhou W., Xi Z.,
RA   Shen Y.;
RT   "Structural insight into unique properties of protoporphyrinogen oxidase
RT   from Bacillus subtilis.";
RL   J. Struct. Biol. 170:76-82(2010).
CC   -!- FUNCTION: Involved in coproporphyrin-dependent heme b biosynthesis
CC       (PubMed:7928957, PubMed:9217019). Catalyzes the oxidation of
CC       coproporphyrinogen III to coproporphyrin III (PubMed:8288631,
CC       PubMed:7928957, PubMed:9217019, PubMed:9784236). Can also oxidize
CC       protoporphyrinogen IX to protoporphyrin-IX (PubMed:8288631,
CC       PubMed:7928957, PubMed:9217019, PubMed:9784236, PubMed:19944166). The
CC       specific activity for the oxidation of coproporphyrinogen III is much
CC       higher than that for the oxidation of protoporphyrinogen IX
CC       (PubMed:7928957, PubMed:9217019). Can also oxidize mesoporphyrinogen
CC       IX, but not uroporphyrinogen III (PubMed:8288631, PubMed:9784236,
CC       PubMed:7928957). {ECO:0000269|PubMed:19944166,
CC       ECO:0000269|PubMed:7928957, ECO:0000269|PubMed:8288631,
CC       ECO:0000269|PubMed:9217019, ECO:0000269|PubMed:9784236}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=coproporphyrinogen III + 3 O2 = coproporphyrin III + 3 H2O2;
CC         Xref=Rhea:RHEA:43436, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:57309, ChEBI:CHEBI:131725; EC=1.3.3.15;
CC         Evidence={ECO:0000269|PubMed:7928957, ECO:0000269|PubMed:8288631,
CC         ECO:0000269|PubMed:9217019, ECO:0000269|PubMed:9784236};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43437;
CC         Evidence={ECO:0000269|PubMed:7928957, ECO:0000269|PubMed:8288631,
CC         ECO:0000269|PubMed:9217019, ECO:0000269|PubMed:9784236};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:19944166, ECO:0000269|PubMed:8288631,
CC         ECO:0000269|PubMed:9217019, ECO:0000269|PubMed:9784236};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:19944166};
CC   -!- ACTIVITY REGULATION: Only weakly inhibited by acifluorfen, in contrast
CC       to eukaryotic family members (PubMed:8288631, PubMed:9784236,
CC       PubMed:19944166). Weakly inhibited by methylacifluorfen
CC       (PubMed:9784236). Bilirubin, biliverdin and hemin are all competitive
CC       inhibitors (PubMed:9784236). {ECO:0000269|PubMed:19944166,
CC       ECO:0000269|PubMed:8288631, ECO:0000269|PubMed:9784236}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.56 uM for coproporphyrinogen III {ECO:0000269|PubMed:7928957};
CC         KM=5.29 uM for coproporphyrinogen III {ECO:0000269|PubMed:9784236};
CC         KM=0.95 uM for protoporphyrinogen IX {ECO:0000269|PubMed:7928957};
CC         KM=10.4 uM for protoporphyrinogen IX {ECO:0000269|PubMed:8288631};
CC         KM=1.0 uM for protoporphyrinogen IX {ECO:0000269|PubMed:9784236};
CC         KM=21.1 uM for mesoporphyrinogen IX {ECO:0000269|PubMed:8288631};
CC         KM=4.92 uM for mesoporphyrinogen IX {ECO:0000269|PubMed:9784236};
CC         Vmax=7.0 nmol/min/mg enzyme with coproporphyrinogen III as substrate
CC         {ECO:0000269|PubMed:7928957};
CC         Vmax=0.98 nmol/min/mg enzyme with coproporphyrinogen III as substrate
CC         {ECO:0000269|PubMed:9784236};
CC         Vmax=0.85 nmol/min/mg enzyme with protoporphyrinogen IX as substrate
CC         {ECO:0000269|PubMed:7928957};
CC         Vmax=3.7 nmol/min/mg enzyme with protoporphyrinogen IX as substrate
CC         {ECO:0000269|PubMed:9784236};
CC         Vmax=45 nmol/min/mg enzyme with mesoporphyrinogen IX as substrate
CC         {ECO:0000269|PubMed:9784236};
CC         Note=kcat is 0.05 min(-1) with coproporphyrinogen III as substrate
CC         (PubMed:9784236). kcat is 0.19 min(-1) with protoporphyrinogen IX as
CC         substrate (PubMed:9784236). kcat is 2.69 min(-1) with
CC         mesoporphyrinogen IX as substrate (PubMed:9784236).
CC         {ECO:0000269|PubMed:9784236};
CC       pH dependence:
CC         Optimum pH is 8.7 (for protoporphyrinogen oxidation).
CC         {ECO:0000269|PubMed:9784236};
CC   -!- PATHWAY: Porphyrin-containing compound metabolism; protoheme
CC       biosynthesis. {ECO:0000269|PubMed:1459957, ECO:0000269|PubMed:7928957,
CC       ECO:0000305|PubMed:25711532}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:19944166,
CC       ECO:0000269|PubMed:8288631, ECO:0000269|PubMed:9784236}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:8288631}. Cell
CC       membrane {ECO:0000269|PubMed:7928957}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:7928957}.
CC   -!- DISRUPTION PHENOTYPE: Mutations cause the accumulation of
CC       coproporphyrinogen III or coproporphyrin III in the growth medium and
CC       the accumulation of trace amounts of other porphyrinogens or porphyrins
CC       intracellularly. {ECO:0000269|PubMed:7928957}.
CC   -!- SIMILARITY: Belongs to the protoporphyrinogen/coproporphyrinogen
CC       oxidase family. Coproporphyrinogen III oxidase subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M97208; AAA22519.1; -; Genomic_DNA.
DR   EMBL; Y14083; CAA74520.1; -; Genomic_DNA.
DR   EMBL; AL009126; CAB12854.1; -; Genomic_DNA.
DR   PIR; D47045; D47045.
DR   RefSeq; NP_388895.1; NC_000964.3.
DR   RefSeq; WP_003245394.1; NZ_JNCM01000035.1.
DR   PDB; 3I6D; X-ray; 2.90 A; A/B=1-470.
DR   PDBsum; 3I6D; -.
DR   SMR; P32397; -.
DR   STRING; 224308.BSU10140; -.
DR   BindingDB; P32397; -.
DR   ChEMBL; CHEMBL1075048; -.
DR   DrugBank; DB07338; Acifluorfen.
DR   jPOST; P32397; -.
DR   PaxDb; P32397; -.
DR   PRIDE; P32397; -.
DR   DNASU; 936311; -.
DR   EnsemblBacteria; CAB12854; CAB12854; BSU_10140.
DR   GeneID; 936311; -.
DR   KEGG; bsu:BSU10140; -.
DR   PATRIC; fig|224308.179.peg.1090; -.
DR   eggNOG; COG1232; Bacteria.
DR   InParanoid; P32397; -.
DR   OMA; IFDSCCF; -.
DR   PhylomeDB; P32397; -.
DR   BioCyc; BSUB:BSU10140-MONOMER; -.
DR   BioCyc; MetaCyc:BSU10140-MONOMER; -.
DR   BRENDA; 1.3.3.15; 658.
DR   BRENDA; 1.3.3.4; 658.
DR   SABIO-RK; P32397; -.
DR   UniPathway; UPA00252; -.
DR   EvolutionaryTrace; P32397; -.
DR   PRO; PR:P32397; -.
DR   Proteomes; UP000001570; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0004729; F:oxygen-dependent protoporphyrinogen oxidase activity; IEA:InterPro.
DR   GO; GO:0006783; P:heme biosynthetic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR004572; Protoporphyrinogen_oxidase.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR00562; proto_IX_ox; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Cytoplasm; Direct protein sequencing; FAD;
KW   Flavoprotein; Heme biosynthesis; Membrane; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN           1..470
FT                   /note="Coproporphyrinogen III oxidase"
FT                   /id="PRO_0000135263"
FT   NP_BIND         12..17
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19944166"
FT   NP_BIND         41..42
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19944166"
FT   NP_BIND         63..66
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19944166"
FT   NP_BIND         448..450
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19944166"
FT   BINDING         49
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:19944166"
FT   BINDING         256
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:P56601"
FT   BINDING         409
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19944166"
FT   MUTAGEN         64
FT                   /note="P->A: Decreased affinity for protoporphyrinogen-IX."
FT                   /evidence="ECO:0000269|PubMed:19944166"
FT   MUTAGEN         71
FT                   /note="K->A: Strongly decreased catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:19944166"
FT   MUTAGEN         176
FT                   /note="I->A: Strongly decreased catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:19944166"
FT   MUTAGEN         227
FT                   /note="F->R: Decreased affinity for protoporphyrinogen-IX."
FT                   /evidence="ECO:0000269|PubMed:19944166"
FT   MUTAGEN         366
FT                   /note="Y->A,H: Reduces protoporphyrinogen oxidation by
FT                   90%."
FT                   /evidence="ECO:0000269|PubMed:19266155"
FT   MUTAGEN         366
FT                   /note="Y->E: Reduces protoporphyrinogen oxidation by 99%."
FT                   /evidence="ECO:0000269|PubMed:19266155"
FT   STRAND          6..11
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           15..28
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   TURN            29..32
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          34..40
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          42..46
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          60..63
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           73..80
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          87..89
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          95..98
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          103..105
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           133..140
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          145..148
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           152..159
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           162..167
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           169..175
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   TURN            181..183
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           186..189
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           191..193
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          227..230
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           235..243
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          247..251
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          256..261
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          263..273
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          275..283
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           287..293
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   TURN            294..296
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           300..304
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          307..320
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          329..334
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          341..347
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           348..351
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           353..355
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          361..367
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           374..376
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           380..391
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           392..394
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          402..415
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           420..434
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   STRAND          438..440
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   TURN            443..445
FT                   /evidence="ECO:0007829|PDB:3I6D"
FT   HELIX           450..468
FT                   /evidence="ECO:0007829|PDB:3I6D"
SQ   SEQUENCE   470 AA;  51203 MW;  95CC4E5847686D2E CRC64;
     MSDGKKHVVI IGGGITGLAA AFYMEKEIKE KNLPLELTLV EASPRVGGKI QTVKKDGYII
     ERGPDSFLER KKSAPQLVKD LGLEHLLVNN ATGQSYVLVN RTLHPMPKGA VMGIPTKIAP
     FVSTGLFSLS GKARAAMDFI LPASKTKDDQ SLGEFFRRRV GDEVVENLIE PLLSGIYAGD
     IDKLSLMSTF PQFYQTEQKH RSLILGMKKT RPQGSGQQLT AKKQGQFQTL STGLQTLVEE
     IEKQLKLTKV YKGTKVTKLS HSGSCYSLEL DNGVTLDADS VIVTAPHKAA AGMLSELPAI
     SHLKNMHSTS VANVALGFPE GSVQMEHEGT GFVISRNSDF AITACTWTNK KWPHAAPEGK
     TLLRAYVGKA GDESIVDLSD NDIINIVLED LKKVMNINGE PEMTCVTRWH ESMPQYHVGH
     KQRIKELREA LASAYPGVYM TGASFEGVGI PDCIDQGKAA VSDALTYLFS
//
ID   DAUA_PSEAE              Reviewed;         375 AA.
AC   Q9HXE3;
DT   27-MAY-2015, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   02-JUN-2021, entry version 109.
DE   RecName: Full=FAD-dependent catabolic D-arginine dehydrogenase DauA {ECO:0000303|PubMed:20809650};
DE            EC=1.4.99.6 {ECO:0000269|PubMed:19139398, ECO:0000269|PubMed:19850617, ECO:0000269|PubMed:20809650, ECO:0000269|PubMed:3141581};
DE   AltName: Full=D-arginine dehydrogenase {ECO:0000303|PubMed:19139398};
DE            Short=DADH {ECO:0000303|PubMed:19139398};
DE   AltName: Full=D-arginine utilization protein A {ECO:0000303|PubMed:19139398};
DE            Short=Dau {ECO:0000303|PubMed:19139398};
GN   Name=dauA {ECO:0000303|PubMed:19139398}; OrderedLocusNames=PA3863;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, INDUCTION, AND SUBSTRATE SPECIFICITY.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=3141581; DOI=10.1099/00221287-134-9-2633;
RA   Jann A., Matsumoto H., Haas D.;
RT   "The fourth arginine catabolic pathway of Pseudomonas aeruginosa.";
RL   J. Gen. Microbiol. 134:1043-1053(1988).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, INDUCTION, DISRUPTION PHENOTYPE, AND SUBUNIT.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=19139398; DOI=10.1073/pnas.0808269106;
RA   Li C., Lu C.D.;
RT   "Arginine racemization by coupled catabolic and anabolic dehydrogenases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:906-911(2009).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, DISRUPTION
RP   PHENOTYPE, ACTIVITY REGULATION, INDUCTION, AND SUBSTRATE SPECIFICITY.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=19850617; DOI=10.1099/mic.0.033282-0;
RA   Li C., Yao X., Lu C.D.;
RT   "Regulation of the dauBAR operon and characterization of D-amino acid
RT   dehydrogenase DauA in arginine and lysine catabolism of Pseudomonas
RT   aeruginosa PAO1.";
RL   Microbiology 156:60-71(2010).
RN   [5]
RP   FUNCTION IN VIRULENCE.
RX   PubMed=24011342; DOI=10.1139/cjm-2013-0289;
RA   Oliver K.E., Silo-Suh L.;
RT   "Impact of D-amino acid dehydrogenase on virulence factor production by a
RT   Pseudomonas aeruginosa.";
RL   Can. J. Microbiol. 59:598-603(2013).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.06 ANGSTROMS) OF 2-375 IN COMPLEX WITH FAD,
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, AND
RP   SUBSTRATE SPECIFICITY.
RX   PubMed=20809650; DOI=10.1021/bi1005865;
RA   Fu G., Yuan H., Li C., Lu C.D., Gadda G., Weber I.T.;
RT   "Conformational changes and substrate recognition in Pseudomonas aeruginosa
RT   D-arginine dehydrogenase.";
RL   Biochemistry 49:8535-8545(2010).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.07 ANGSTROMS) OF 2-375 IN COMPLEX WITH FAD ANALOG,
RP   AND COFACTOR.
RX   PubMed=21707047; DOI=10.1021/bi200831a;
RA   Fu G., Yuan H., Wang S., Gadda G., Weber I.T.;
RT   "Atomic-resolution structure of an N5 flavin adduct in D-arginine
RT   dehydrogenase.";
RL   Biochemistry 50:6292-6294(2011).
CC   -!- FUNCTION: DauA is highly expressed within the cystic fibrosis (CF)
CC       lung, and it is required for virulence via the optimal production of
CC       hydrogen cyanide, pyocyanine, pyoverdine, rhamnolipid and alginate
CC       during biofilm formation (PubMed:24011342). Involved in the catabolism
CC       of D-lysine and D-arginine. Under aerobic conditions, the arginine
CC       succinyltransferase (AST) and arginine transaminase (ATA) pathways are
CC       2 major routes for L-arginine utilization as the sole source of carbon
CC       and nitrogen. The D-to-L racemization of arginine by DauA and DauB is
CC       necessary, before to be channeled into the AST and/or ATA pathways.
CC       DauA catalyzes the flavin-dependent oxidative deamination of D-arginine
CC       into 2-ketoarginine (2-KA) and ammonia (PubMed:3141581,
CC       PubMed:19139398, PubMed:19850617, PubMed:20809650). It has also
CC       dehydrogenase activity towards D-lysine, D-tyrosine, D-methionine, D-
CC       phenylalanine, D-ornithine, D-histidine and D-leucine as substrates
CC       (PubMed:19850617, PubMed:20809650). {ECO:0000269|PubMed:19139398,
CC       ECO:0000269|PubMed:19850617, ECO:0000269|PubMed:20809650,
CC       ECO:0000269|PubMed:24011342, ECO:0000269|PubMed:3141581}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=A + D-arginine + H2O = 5-guanidino-2-oxopentanoate + AH2 +
CC         NH4(+); Xref=Rhea:RHEA:43572, ChEBI:CHEBI:13193, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:17499, ChEBI:CHEBI:28938, ChEBI:CHEBI:32689,
CC         ChEBI:CHEBI:58489; EC=1.4.99.6;
CC         Evidence={ECO:0000269|PubMed:19139398, ECO:0000269|PubMed:19850617,
CC         ECO:0000269|PubMed:20809650, ECO:0000269|PubMed:3141581};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=A + a D-alpha-amino acid + H2O = a 2-oxocarboxylate + AH2 +
CC         NH4(+); Xref=Rhea:RHEA:18125, ChEBI:CHEBI:13193, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:17499, ChEBI:CHEBI:28938, ChEBI:CHEBI:35179,
CC         ChEBI:CHEBI:59871; Evidence={ECO:0000269|PubMed:19850617,
CC         ECO:0000269|PubMed:20809650};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:20809650, ECO:0000269|PubMed:21707047};
CC   -!- ACTIVITY REGULATION: Inhibited by D-arginine and D-lysine at high
CC       concentration. {ECO:0000269|PubMed:19850617}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.06 mM for D-arginine (at pH 8.7 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:20809650};
CC         KM=0.08 mM for D-arginine (at pH 8.7 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:19850617};
CC         KM=0.19 mM for D-lysine (at pH 8.7 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:19850617};
CC         KM=0.26 mM for D-lysine (at pH 8.7 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:20809650};
CC         KM=0.4 mM for D-tyrosine (at pH 8.7 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:19850617};
CC         KM=0.8 mM for D-tyrosine (at pH 8.7 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:20809650};
CC         KM=1.13 mM for D-phenylalanine (at pH 8.7 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:19850617};
CC         KM=1.43 mM for D-methionine (at pH 8.7 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:19850617};
CC         KM=1.48 mM for D-ornithine (at pH 8.7 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:19850617};
CC         KM=3.52 mM for D-histidine (at pH 8.7 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:19850617};
CC         KM=10 mM for D-methionine (at pH 8.7 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:20809650};
CC         KM=11 mM for D-phenylalanine (at pH 8.7 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:20809650};
CC         KM=11 mM for D-histidine (at pH 8.7 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:20809650};
CC         KM=12 mM for D-leucine (at pH 8.7 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:20809650};
CC         Note=Kcat is 204 sec(-1) for dehydrogenase activity with D-arginine
CC         as substrate (at pH 8.7 and 25 degrees Celsius). Kcat is 154 sec(-1)
CC         for dehydrogenase activity with D-methionine as substrate (at pH 8.7
CC         and 25 degrees Celsius). Kcat is 141 sec(-1) for dehydrogenase
CC         activity with D-lysine as substrate (at pH 8.7 and 25 degrees
CC         Celsius). Kcat is 75 sec(-1) for dehydrogenase activity with D-
CC         phenylalanine as substrate (at pH 8.7 and 25 degrees Celsius). Kcat
CC         is 35 sec(-1) for dehydrogenase activity with D-histidine as
CC         substrate (at pH 8.7 and 25 degrees Celsius). Kcat is 23 sec(-1) for
CC         dehydrogenase activity with D-tyrosine as substrate (at pH 8.7 and 25
CC         degrees Celsius). Kcat is 11.1 sec(-1) for dehydrogenase activity
CC         with D-arginine as substrate (at pH 8.7 and 37 degrees Celsius). Kcat
CC         is 9.2 sec(-1) for dehydrogenase activity with D-lysine as substrate
CC         (at pH 8.7 and 37 degrees Celsius). Kcat is 6.8 sec(-1) for
CC         dehydrogenase activity with D-methionine as substrate (at pH 8.7 and
CC         37 degrees Celsius). Kcat is 6.4 sec(-1) for dehydrogenase activity
CC         with D-leucine as substrate (at pH 8.7 and 25 degrees Celsius). Kcat
CC         is 6.2 sec(-1) for dehydrogenase activity with D-ornithine as
CC         substrate (at pH 8.7 and 37 degrees Celsius). Kcat is 5.3 sec(-1) for
CC         dehydrogenase activity with D-phenylalanine as substrate (at pH 8.7
CC         and 37 degrees Celsius). Kcat is 3.6 sec(-1) for dehydrogenase
CC         activity with D-histidine and D-tyrosine as substrates (at pH 8.7 and
CC         37 degrees Celsius). {ECO:0000269|PubMed:19850617,
CC         ECO:0000269|PubMed:20809650};
CC       pH dependence:
CC         Optimum pH is 8.7. {ECO:0000269|PubMed:19850617};
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius.
CC         {ECO:0000269|PubMed:19850617};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:19139398}.
CC   -!- INDUCTION: Induced by growth on D-arginine, D-lysine and 2-ketoarginine
CC       (2-KA), but not on L-arginine (PubMed:3141581, PubMed:19139398).
CC       Repressed by DauR. ArgR could be a transcriptional activator of the
CC       dauBAR operon in response to the presence of L-Arg (PubMed:19850617).
CC       {ECO:0000269|PubMed:19139398, ECO:0000269|PubMed:19850617,
CC       ECO:0000269|PubMed:3141581}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene are unable to grow on D-
CC       arginine or D-lysine as sole nitrogen source.
CC       {ECO:0000269|PubMed:19139398, ECO:0000269|PubMed:19850617}.
CC   -!- MISCELLANEOUS: In vitro, it is essential to include phenazine
CC       methosulfate (PMS) or iodonitrotetrazolium chloride (INT) as the
CC       artificial electron acceptor in the reaction to ensure DauA remains
CC       active with FAD. {ECO:0000269|PubMed:19139398,
CC       ECO:0000269|PubMed:3141581}.
CC   -!- SIMILARITY: Belongs to the FAD-dependent glycerol-3-phosphate
CC       dehydrogenase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE004091; AAG07250.1; -; Genomic_DNA.
DR   PIR; E83163; E83163.
DR   RefSeq; NP_252552.1; NC_002516.2.
DR   RefSeq; WP_003113780.1; NZ_QZGE01000001.1.
DR   PDB; 3NYC; X-ray; 1.06 A; A=2-375.
DR   PDB; 3NYE; X-ray; 1.30 A; A=2-375.
DR   PDB; 3NYF; X-ray; 1.30 A; A=2-375.
DR   PDB; 3SM8; X-ray; 1.07 A; A=2-375.
DR   PDB; 6P9D; X-ray; 1.33 A; A=1-375.
DR   PDB; 6PLD; X-ray; 1.55 A; A=1-375.
DR   PDBsum; 3NYC; -.
DR   PDBsum; 3NYE; -.
DR   PDBsum; 3NYF; -.
DR   PDBsum; 3SM8; -.
DR   PDBsum; 6P9D; -.
DR   PDBsum; 6PLD; -.
DR   SMR; Q9HXE3; -.
DR   PaxDb; Q9HXE3; -.
DR   PRIDE; Q9HXE3; -.
DR   DNASU; 879806; -.
DR   EnsemblBacteria; AAG07250; AAG07250; PA3863.
DR   GeneID; 879806; -.
DR   KEGG; pae:PA3863; -.
DR   PATRIC; fig|208964.12.peg.4045; -.
DR   PseudoCAP; PA3863; -.
DR   HOGENOM; CLU_007884_4_2_6; -.
DR   InParanoid; Q9HXE3; -.
DR   OMA; FMESYGT; -.
DR   PhylomeDB; Q9HXE3; -.
DR   BioCyc; MetaCyc:MONOMER-11563; -.
DR   BioCyc; PAER208964:G1FZ6-3934-MONOMER; -.
DR   BRENDA; 1.4.99.6; 5087.
DR   EvolutionaryTrace; Q9HXE3; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0008718; F:D-amino-acid dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0006527; P:arginine catabolic process; IDA:UniProtKB.
DR   GO; GO:0006525; P:arginine metabolic process; IDA:UniProtKB.
DR   GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01266; DAO; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Nucleotide-binding; Oxidoreductase;
KW   Reference proteome; Virulence.
FT   CHAIN           1..375
FT                   /note="FAD-dependent catabolic D-arginine dehydrogenase
FT                   DauA"
FT                   /id="PRO_0000433131"
FT   NP_BIND         32..33
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20809650,
FT                   ECO:0000269|PubMed:21707047"
FT   NP_BIND         41..48
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20809650,
FT                   ECO:0000269|PubMed:21707047"
FT   NP_BIND         331..336
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:20809650,
FT                   ECO:0000269|PubMed:21707047"
FT   BINDING         14
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:20809650,
FT                   ECO:0000269|PubMed:21707047"
FT   BINDING         171
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:20809650,
FT                   ECO:0000269|PubMed:21707047"
FT   SITE            87
FT                   /note="Important for specificity toward positively charged
FT                   susbtrates"
FT                   /evidence="ECO:0000269|PubMed:20809650"
FT   STRAND          5..9
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   HELIX           13..22
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   TURN            23..25
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          28..31
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          33..36
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   HELIX           41..43
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          51..54
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   HELIX           56..70
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          81..84
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          87..90
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   HELIX           96..109
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          114..116
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   HELIX           118..124
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   HELIX           130..132
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          136..139
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          143..145
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   HELIX           147..160
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          164..168
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          173..177
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          180..184
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          186..197
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   HELIX           200..202
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   HELIX           203..210
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          218..227
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          240..243
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          249..253
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          256..260
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   HELIX           276..289
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          298..307
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          314..317
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   STRAND          324..328
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   TURN            334..337
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   HELIX           338..349
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   HELIX           356..359
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   TURN            360..362
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   HELIX           365..368
FT                   /evidence="ECO:0007829|PDB:3NYC"
FT   HELIX           370..373
FT                   /evidence="ECO:0007829|PDB:3NYC"
SQ   SEQUENCE   375 AA;  40567 MW;  655001CB24FF13DE CRC64;
     MIEADYLVIG AGIAGASTGY WLSAHGRVVV LEREAQPGYH STGRSAAHYT VAYGTPQVRA
     LTAASRAFFD NPPAGFCEHP LLSPRPEMVV DFSDDPEELR RQYESGKALV PQMRLLDAEQ
     ACSIVPVLRR DKVFGATYDP TGADIDTDAL HQGYLRGIRR NQGQVLCNHE ALEIRRVDGA
     WEVRCDAGSY RAAVLVNAAG AWCDAIAGLA GVRPLGLQPK RRSAFIFAPP PGIDCHDWPM
     LVSLDESFYL KPDAGMLLGS PANADPVEAH DVQPEQLDIA TGMYLIEEAT TLTIRRPEHT
     WAGLRSFVAD GDLVAGYAAN AEGFFWVAAQ GGYGIQTSAA MGEASAALIR HQPLPAHLRE
     HGLDEAMLSP RRLSP
//
ID   GLYOX_BACSU             Reviewed;         369 AA.
AC   O31616;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   02-JUN-2021, entry version 144.
DE   RecName: Full=Glycine oxidase {ECO:0000303|PubMed:11744710, ECO:0000303|PubMed:9827558};
DE            Short=GO {ECO:0000303|PubMed:11744710};
DE            EC=1.4.3.19 {ECO:0000269|PubMed:11744710, ECO:0000269|PubMed:19864430, ECO:0000269|PubMed:9827558};
GN   Name=thiO {ECO:0000303|PubMed:12627963};
GN   Synonyms=goxB {ECO:0000303|PubMed:9827558},
GN   yjbR {ECO:0000303|PubMed:9827558}; OrderedLocusNames=BSU11670;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V.,
RA   Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R.,
RA   Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S.,
RA   Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K.,
RA   Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F.,
RA   Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D.,
RA   Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M.,
RA   Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P.,
RA   Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K.,
RA   Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S.,
RA   Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y.,
RA   Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G.,
RA   Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M.,
RA   Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y.,
RA   Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J.,
RA   Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A.,
RA   Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M.,
RA   Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S.,
RA   Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E.,
RA   Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND SUBUNIT.
RC   STRAIN=MT-2;
RX   PubMed=9827558; DOI=10.1016/s0014-5793(98)01313-1;
RA   Nishiya Y., Imanaka T.;
RT   "Purification and characterization of a novel glycine oxidase from Bacillus
RT   subtilis.";
RL   FEBS Lett. 438:263-266(1998).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, COFACTOR, AND ACTIVITY
RP   REGULATION.
RX   PubMed=11744710; DOI=10.1074/jbc.m111095200;
RA   Job V., Marcone G.L., Pilone M.S., Pollegioni L.;
RT   "Glycine oxidase from Bacillus subtilis. Characterization of a new
RT   flavoprotein.";
RL   J. Biol. Chem. 277:6985-6993(2002).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH FAD AND
RP   N-ACETYLGLYCINE, FUNCTION IN THIAMINE BIOSYNTHESIS, PATHWAY, DISRUPTION
RP   PHENOTYPE, AND SUBUNIT.
RX   PubMed=12627963; DOI=10.1021/bi026916v;
RA   Settembre E.C., Dorrestein P.C., Park J.-H., Augustine A.M., Begley T.P.,
RA   Ealick S.E.;
RT   "Structural and mechanistic studies on ThiO, a glycine oxidase essential
RT   for thiamin biosynthesis in Bacillus subtilis.";
RL   Biochemistry 42:2971-2981(2003).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEXES WITH GLYCOLATE AND FAD,
RP   AND SUBUNIT.
RX   PubMed=15105420; DOI=10.1074/jbc.m401224200;
RA   Moertl M., Diederichs K., Welte W., Molla G., Motteran L., Andriolo G.,
RA   Pilone M.S., Pollegioni L.;
RT   "Structure-function correlation in glycine oxidase from Bacillus
RT   subtilis.";
RL   J. Biol. Chem. 279:29718-29727(2004).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF MUTANT SER-51/ARG-54/ALA-244 IN
RP   COMPLEX WITH GLYCOLATE AND FAD, FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE
RP   SPECIFICITY, KINETIC PARAMETERS, SUBUNIT, BIOTECHNOLOGY, AND MUTAGENESIS OF
RP   GLY-51; ALA-54 AND HIS-244.
RX   PubMed=19864430; DOI=10.1074/jbc.m109.051631;
RA   Pedotti M., Rosini E., Molla G., Moschetti T., Savino C., Vallone B.,
RA   Pollegioni L.;
RT   "Glyphosate resistance by engineering the flavoenzyme glycine oxidase.";
RL   J. Biol. Chem. 284:36415-36423(2009).
CC   -!- FUNCTION: Catalyzes the FAD-dependent oxidative deamination of various
CC       amines and D-amino acids to yield the corresponding alpha-keto acids,
CC       ammonia/amine, and hydrogen peroxide. Oxidizes sarcosine (N-
CC       methylglycine), N-ethylglycine and glycine (PubMed:9827558,
CC       PubMed:11744710, PubMed:19864430). Can also oxidize the herbicide
CC       glyphosate (N-phosphonomethylglycine) (PubMed:19864430). Displays lower
CC       activities on D-alanine, D-valine, D-proline and D-methionine
CC       (PubMed:9827558, PubMed:11744710). Does not act on L-amino acids and
CC       other D-amino acids (PubMed:9827558). Is essential for thiamine
CC       biosynthesis since the oxidation of glycine catalyzed by ThiO generates
CC       the glycine imine intermediate (dehydroglycine) required for the
CC       biosynthesis of the thiazole ring of thiamine pyrophosphate
CC       (PubMed:12627963). {ECO:0000269|PubMed:11744710,
CC       ECO:0000269|PubMed:12627963, ECO:0000269|PubMed:19864430,
CC       ECO:0000269|PubMed:9827558}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycine + H2O + O2 = glyoxylate + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:11532, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:36655,
CC         ChEBI:CHEBI:57305; EC=1.4.3.19;
CC         Evidence={ECO:0000269|PubMed:11744710, ECO:0000269|PubMed:19864430,
CC         ECO:0000269|PubMed:9827558};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-ethylglycine + O2 = ethylamine + glyoxylate + H2O2;
CC         Xref=Rhea:RHEA:12472, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:36655, ChEBI:CHEBI:57440,
CC         ChEBI:CHEBI:566789; EC=1.4.3.19;
CC         Evidence={ECO:0000269|PubMed:11744710, ECO:0000269|PubMed:19864430,
CC         ECO:0000269|PubMed:9827558};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O2 + sarcosine = glyoxylate + H2O2 + methylamine;
CC         Xref=Rhea:RHEA:15165, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:36655, ChEBI:CHEBI:57433,
CC         ChEBI:CHEBI:59338; EC=1.4.3.19;
CC         Evidence={ECO:0000269|PubMed:11744710, ECO:0000269|PubMed:19864430,
CC         ECO:0000269|PubMed:9827558};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-alanine + H2O + O2 = H2O2 + NH4(+) + pyruvate;
CC         Xref=Rhea:RHEA:22688, ChEBI:CHEBI:15361, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:57416; EC=1.4.3.19;
CC         Evidence={ECO:0000269|PubMed:11744710, ECO:0000269|PubMed:19864430,
CC         ECO:0000269|PubMed:9827558};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glyphosate + H2O + O2 = aminomethylphosphonate + glyoxylate +
CC         H(+) + H2O2; Xref=Rhea:RHEA:52740, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:36655, ChEBI:CHEBI:133673, ChEBI:CHEBI:133674;
CC         Evidence={ECO:0000269|PubMed:19864430};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:11744710};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:11744710};
CC   -!- ACTIVITY REGULATION: Is competitively inhibited by glycolate.
CC       {ECO:0000269|PubMed:11744710}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.22 mM for sarcosine (at pH 8.0) {ECO:0000269|PubMed:9827558};
CC         KM=0.66 mM for N-ethylglycine (at pH 8.0)
CC         {ECO:0000269|PubMed:9827558};
CC         KM=0.99 mM for glycine (at pH 8.0) {ECO:0000269|PubMed:9827558};
CC         KM=46 mM for D-proline (at pH 8.0) {ECO:0000269|PubMed:9827558};
CC         KM=81 mM for D-alanine (at pH 8.0) {ECO:0000269|PubMed:9827558};
CC         KM=0.7 mM for glycine (at pH 8.5 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:19864430};
CC         KM=87 mM for glyphosate (at pH 8.5 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:19864430};
CC         Note=kcat is 1.3 sec(-1) with glycine as substrate. kcat is 1.6 sec(-
CC         1) with sarcosine as substrate. kcat is 1.4 sec(-1) with N-
CC         ethylglycine as substrate. kcat is 1.3 sec(-1) with D-proline as
CC         substrate. kcat is 1.1 sec(-1) with D-alanine as substrate (at pH
CC         8.0) (PubMed:9827558). kcat is 0.60 sec(-1) with glycine as
CC         substrate. kcat is 0.91 sec(-1) with glyphosate as substrate (at pH
CC         8.5 and 37 degrees Celsius) (PubMed:19864430).
CC         {ECO:0000269|PubMed:19864430, ECO:0000269|PubMed:9827558};
CC       pH dependence:
CC         Optimum pH is 8.0. {ECO:0000269|PubMed:9827558};
CC       Temperature dependence:
CC         Optimum temperature is 45 degrees Celsius.
CC         {ECO:0000269|PubMed:9827558};
CC   -!- PATHWAY: Cofactor biosynthesis; thiamine diphosphate biosynthesis.
CC       {ECO:0000269|PubMed:12627963}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:12627963,
CC       ECO:0000269|PubMed:15105420, ECO:0000269|PubMed:19864430,
CC       ECO:0000269|PubMed:9827558}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene have an absolute
CC       requirement for the thiazole alcohol for growth.
CC       {ECO:0000269|PubMed:12627963}.
CC   -!- BIOTECHNOLOGY: Introducing the gene coding for the glycine oxidase
CC       mutant Ser-51/Arg-54/Ala-244 in plants may be an effective alternative
CC       mechanism for glyphosate tolerance in transgenic crops. In addition,
CC       transgenic plants that are able to oxidize glyphosate may represent an
CC       innovative bioremediation system for the soil treated with this
CC       herbicide. {ECO:0000305|PubMed:19864430}.
CC   -!- SIMILARITY: Belongs to the DAO family. ThiO subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL009126; CAB13024.1; -; Genomic_DNA.
DR   PIR; B69845; B69845.
DR   RefSeq; NP_389049.1; NC_000964.3.
DR   RefSeq; WP_003245044.1; NZ_JNCM01000035.1.
DR   PDB; 1NG3; X-ray; 2.60 A; A/B=1-369.
DR   PDB; 1NG4; X-ray; 2.30 A; A/B=1-369.
DR   PDB; 1RYI; X-ray; 1.80 A; A/B/C/D=1-367.
DR   PDB; 3IF9; X-ray; 2.60 A; A/B/C/D=1-369.
DR   PDBsum; 1NG3; -.
DR   PDBsum; 1NG4; -.
DR   PDBsum; 1RYI; -.
DR   PDBsum; 3IF9; -.
DR   SMR; O31616; -.
DR   STRING; 224308.BSU11670; -.
DR   DrugBank; DB02713; Acetylamino-Acetic Acid.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   PaxDb; O31616; -.
DR   EnsemblBacteria; CAB13024; CAB13024; BSU_11670.
DR   GeneID; 939377; -.
DR   KEGG; bsu:BSU11670; -.
DR   PATRIC; fig|224308.179.peg.1256; -.
DR   eggNOG; COG0665; Bacteria.
DR   InParanoid; O31616; -.
DR   OMA; GCGTLWL; -.
DR   PhylomeDB; O31616; -.
DR   BioCyc; BSUB:BSU11670-MONOMER; -.
DR   BioCyc; MetaCyc:BSU11670-MONOMER; -.
DR   BRENDA; 1.4.3.19; 658.
DR   SABIO-RK; O31616; -.
DR   UniPathway; UPA00060; -.
DR   EvolutionaryTrace; O31616; -.
DR   Proteomes; UP000001570; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0043799; F:glycine oxidase activity; IDA:UniProtKB.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0006520; P:cellular amino acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0009635; P:response to herbicide; IEA:UniProtKB-KW.
DR   GO; GO:0009228; P:thiamine biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0009229; P:thiamine diphosphate biosynthetic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR012727; Gly_oxidase_ThiO.
DR   Pfam; PF01266; DAO; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR02352; thiamin_ThiO; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; FAD; Flavoprotein; Herbicide resistance;
KW   Oxidoreductase; Reference proteome; Thiamine biosynthesis.
FT   CHAIN           1..369
FT                   /note="Glycine oxidase"
FT                   /id="PRO_0000162773"
FT   NP_BIND         14..15
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12627963,
FT                   ECO:0000269|PubMed:15105420, ECO:0000269|PubMed:19864430"
FT   NP_BIND         34..35
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12627963,
FT                   ECO:0000269|PubMed:15105420, ECO:0000269|PubMed:19864430"
FT   NP_BIND         42..43
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12627963,
FT                   ECO:0000269|PubMed:15105420, ECO:0000269|PubMed:19864430"
FT   NP_BIND         47..49
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12627963,
FT                   ECO:0000269|PubMed:15105420, ECO:0000269|PubMed:19864430"
FT   NP_BIND         327..333
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12627963,
FT                   ECO:0000269|PubMed:15105420, ECO:0000269|PubMed:19864430"
FT   BINDING         174
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:12627963,
FT                   ECO:0000269|PubMed:15105420, ECO:0000269|PubMed:19864430"
FT   BINDING         302
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:12627963"
FT   BINDING         329
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:12627963"
FT   MUTAGEN         51
FT                   /note="G->R: 130-fold decrease in catalytic efficiency on
FT                   glycine and 28-fold increase in that on glyphosate."
FT                   /evidence="ECO:0000269|PubMed:19864430"
FT   MUTAGEN         51
FT                   /note="G->S: 60-fold decrease in catalytic efficiency on
FT                   glycine and 210-fold increase in that on glyphosate; when
FT                   associated with R-54 and A-244."
FT                   /evidence="ECO:0000269|PubMed:19864430"
FT   MUTAGEN         54
FT                   /note="A->R: 20-fold decrease in catalytic efficiency on
FT                   glycine and 34-fold increase in that on glyphosate. 60-fold
FT                   decrease in catalytic efficiency on glycine and 210-fold
FT                   increase in that on glyphosate; when associated with S-51
FT                   and A-244."
FT                   /evidence="ECO:0000269|PubMed:19864430"
FT   MUTAGEN         244
FT                   /note="H->A: 2-fold decrease in catalytic efficiency on
FT                   glycine and similar catalytic efficiency on glyphosate. 60-
FT                   fold decrease in catalytic efficiency on glycine and 210-
FT                   fold increase in that on glyphosate; when associated with
FT                   S-51 and R-54."
FT                   /evidence="ECO:0000269|PubMed:19864430"
FT   STRAND          3..10
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   HELIX           14..25
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          30..33
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          35..37
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   TURN            38..41
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   HELIX           42..45
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   HELIX           52..54
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   HELIX           61..72
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   TURN            73..75
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   HELIX           76..84
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          95..101
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   HELIX           102..109
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   TURN            110..113
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          117..121
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   HELIX           122..128
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          138..142
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   HELIX           150..163
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          167..169
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          176..178
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          180..188
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          191..200
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   HELIX           203..206
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   HELIX           207..212
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          220..230
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          232..234
FT                   /evidence="ECO:0007829|PDB:3IF9"
FT   STRAND          238..242
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          245..249
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          253..258
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   HELIX           272..285
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   HELIX           287..291
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          292..304
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          306..308
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          311..315
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   STRAND          318..325
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   TURN            331..334
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   HELIX           335..346
FT                   /evidence="ECO:0007829|PDB:1RYI"
FT   HELIX           353..358
FT                   /evidence="ECO:0007829|PDB:1RYI"
SQ   SEQUENCE   369 AA;  40937 MW;  7A9466117AC0A76A CRC64;
     MKRHYEAVVI GGGIIGSAIA YYLAKENKNT ALFESGTMGG RTTSAAAGML GAHAECEERD
     AFFDFAMHSQ RLYKGLGEEL YALSGVDIRQ HNGGMFKLAF SEEDVLQLRQ MDDLDSVSWY
     SKEEVLEKEP YASGDIFGAS FIQDDVHVEP YFVCKAYVKA AKMLGAEIFE HTPVLHVERD
     GEALFIKTPS GDVWANHVVV ASGVWSGMFF KQLGLNNAFL PVKGECLSVW NDDIPLTKTL
     YHDHCYIVPR KSGRLVVGAT MKPGDWSETP DLGGLESVMK KAKTMLPAIQ NMKVDRFWAG
     LRPGTKDGKP YIGRHPEDSR ILFAAGHFRN GILLAPATGA LISDLIMNKE VNQDWLHAFR
     IDRKEAVQI
//
ID   GLIT_ASPFU              Reviewed;         334 AA.
AC   E9RAH5; Q4WMI9; Q5MBU7;
DT   02-NOV-2016, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 1.
DT   02-JUN-2021, entry version 53.
DE   RecName: Full=Thioredoxin reductase gliT {ECO:0000303|PubMed:15979823};
DE            EC=1.8.1.- {ECO:0000269|PubMed:20548963};
DE   AltName: Full=Gliotoxin biosynthesis protein T {ECO:0000303|PubMed:15979823};
GN   Name=gliT {ECO:0000303|PubMed:15979823}; ORFNames=AFUA_6G09740;
OS   Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC
OS   A1100) (Aspergillus fumigatus).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC   Aspergillus subgen. Fumigati.
OX   NCBI_TaxID=330879;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RC   STRAIN=ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100;
RX   PubMed=15979823; DOI=10.1016/j.femsle.2005.05.046;
RA   Gardiner D.M., Howlett B.J.;
RT   "Bioinformatic and expression analysis of the putative gliotoxin
RT   biosynthetic gene cluster of Aspergillus fumigatus.";
RL   FEMS Microbiol. Lett. 248:241-248(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100;
RX   PubMed=16372009; DOI=10.1038/nature04332;
RA   Nierman W.C., Pain A., Anderson M.J., Wortman J.R., Kim H.S., Arroyo J.,
RA   Berriman M., Abe K., Archer D.B., Bermejo C., Bennett J.W., Bowyer P.,
RA   Chen D., Collins M., Coulsen R., Davies R., Dyer P.S., Farman M.L.,
RA   Fedorova N., Fedorova N.D., Feldblyum T.V., Fischer R., Fosker N.,
RA   Fraser A., Garcia J.L., Garcia M.J., Goble A., Goldman G.H., Gomi K.,
RA   Griffith-Jones S., Gwilliam R., Haas B.J., Haas H., Harris D.E.,
RA   Horiuchi H., Huang J., Humphray S., Jimenez J., Keller N., Khouri H.,
RA   Kitamoto K., Kobayashi T., Konzack S., Kulkarni R., Kumagai T., Lafton A.,
RA   Latge J.-P., Li W., Lord A., Lu C., Majoros W.H., May G.S., Miller B.L.,
RA   Mohamoud Y., Molina M., Monod M., Mouyna I., Mulligan S., Murphy L.D.,
RA   O'Neil S., Paulsen I., Penalva M.A., Pertea M., Price C., Pritchard B.L.,
RA   Quail M.A., Rabbinowitsch E., Rawlins N., Rajandream M.A., Reichard U.,
RA   Renauld H., Robson G.D., Rodriguez de Cordoba S., Rodriguez-Pena J.M.,
RA   Ronning C.M., Rutter S., Salzberg S.L., Sanchez M., Sanchez-Ferrero J.C.,
RA   Saunders D., Seeger K., Squares R., Squares S., Takeuchi M., Tekaia F.,
RA   Turner G., Vazquez de Aldana C.R., Weidman J., White O., Woodward J.R.,
RA   Yu J.-H., Fraser C.M., Galagan J.E., Asai K., Machida M., Hall N.,
RA   Barrell B.G., Denning D.W.;
RT   "Genomic sequence of the pathogenic and allergenic filamentous fungus
RT   Aspergillus fumigatus.";
RL   Nature 438:1151-1156(2005).
RN   [3]
RP   FUNCTION.
RX   PubMed=17154540; DOI=10.1021/bi061845b;
RA   Balibar C.J., Walsh C.T.;
RT   "GliP, a multimodular nonribosomal peptide synthetase in Aspergillus
RT   fumigatus, makes the diketopiperazine scaffold of gliotoxin.";
RL   Biochemistry 45:15029-15038(2006).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, DISRUPTION PHENOTYPE, AND INDUCTION.
RX   PubMed=20548963; DOI=10.1371/journal.ppat.1000952;
RA   Schrettl M., Carberry S., Kavanagh K., Haas H., Jones G.W., O'Brien J.,
RA   Nolan A., Stephens J., Fenelon O., Doyle S.;
RT   "Self-protection against gliotoxin--a component of the gliotoxin
RT   biosynthetic cluster, GliT, completely protects Aspergillus fumigatus
RT   against exogenous gliotoxin.";
RL   PLoS Pathog. 6:E1000952-E1000952(2010).
RN   [5]
RP   FUNCTION.
RX   PubMed=21513890; DOI=10.1016/j.chembiol.2010.12.022;
RA   Davis C., Carberry S., Schrettl M., Singh I., Stephens J.C., Barry S.M.,
RA   Kavanagh K., Challis G.L., Brougham D., Doyle S.;
RT   "The role of glutathione S-transferase GliG in gliotoxin biosynthesis in
RT   Aspergillus fumigatus.";
RL   Chem. Biol. 18:542-552(2011).
RN   [6]
RP   FUNCTION.
RX   PubMed=21612254; DOI=10.1021/ja2029987;
RA   Forseth R.R., Fox E.M., Chung D., Howlett B.J., Keller N.P.,
RA   Schroeder F.C.;
RT   "Identification of cryptic products of the gliotoxin gene cluster using
RT   NMR-based comparative metabolomics and a model for gliotoxin
RT   biosynthesis.";
RL   J. Am. Chem. Soc. 133:9678-9681(2011).
RN   [7]
RP   FUNCTION.
RX   PubMed=21749092; DOI=10.1021/ja201311d;
RA   Scharf D.H., Remme N., Habel A., Chankhamjon P., Scherlach K.,
RA   Heinekamp T., Hortschansky P., Brakhage A.A., Hertweck C.;
RT   "A dedicated glutathione S-transferase mediates carbon-sulfur bond
RT   formation in gliotoxin biosynthesis.";
RL   J. Am. Chem. Soc. 133:12322-12325(2011).
RN   [8]
RP   FUNCTION.
RX   PubMed=22936680; DOI=10.1002/anie.201205041;
RA   Scharf D.H., Chankhamjon P., Scherlach K., Heinekamp T., Roth M.,
RA   Brakhage A.A., Hertweck C.;
RT   "Epidithiol formation by an unprecedented twin carbon-sulfur lyase in the
RT   gliotoxin pathway.";
RL   Angew. Chem. Int. Ed. 51:10064-10068(2012).
RN   [9]
RP   FUNCTION.
RX   PubMed=22903976; DOI=10.1128/ec.00113-12;
RA   Gallagher L., Owens R.A., Dolan S.K., O'Keeffe G., Schrettl M.,
RA   Kavanagh K., Jones G.W., Doyle S.;
RT   "The Aspergillus fumigatus protein GliK protects against oxidative stress
RT   and is essential for gliotoxin biosynthesis.";
RL   Eukaryot. Cell 11:1226-1238(2012).
RN   [10]
RP   FUNCTION.
RX   PubMed=24039048; DOI=10.1002/anie.201305059;
RA   Scharf D.H., Chankhamjon P., Scherlach K., Heinekamp T., Willing K.,
RA   Brakhage A.A., Hertweck C.;
RT   "Epidithiodiketopiperazine biosynthesis: a four-enzyme cascade converts
RT   glutathione conjugates into transannular disulfide bridges.";
RL   Angew. Chem. Int. Ed. 52:11092-11095(2013).
RN   [11]
RP   FUNCTION.
RX   PubMed=23434416; DOI=10.1016/j.bmcl.2013.01.099;
RA   Chang S.L., Chiang Y.M., Yeh H.H., Wu T.K., Wang C.C.;
RT   "Reconstitution of the early steps of gliotoxin biosynthesis in Aspergillus
RT   nidulans reveals the role of the monooxygenase GliC.";
RL   Bioorg. Med. Chem. Lett. 23:2155-2157(2013).
RN   [12]
RP   INDUCTION.
RX   PubMed=23671611; DOI=10.1371/journal.pone.0062591;
RA   Sekonyela R., Palmer J.M., Bok J.W., Jain S., Berthier E., Forseth R.,
RA   Schroeder F., Keller N.P.;
RT   "RsmA regulates Aspergillus fumigatus gliotoxin cluster metabolites
RT   including cyclo(L-Phe-L-Ser), a potential new diagnostic marker for
RT   invasive aspergillosis.";
RL   PLoS ONE 8:E62591-E62591(2013).
RN   [13]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=25311525; DOI=10.1186/1471-2164-15-894;
RA   O'Keeffe G., Hammel S., Owens R.A., Keane T.M., Fitzpatrick D.A.,
RA   Jones G.W., Doyle S.;
RT   "RNA-seq reveals the pan-transcriptomic impact of attenuating the gliotoxin
RT   self-protection mechanism in Aspergillus fumigatus.";
RL   BMC Genomics 15:894-894(2014).
RN   [14]
RP   FUNCTION.
RX   PubMed=25062268; DOI=10.1021/ja5033106;
RA   Scharf D.H., Habel A., Heinekamp T., Brakhage A.A., Hertweck C.;
RT   "Opposed effects of enzymatic gliotoxin N- and S-methylations.";
RL   J. Am. Chem. Soc. 136:11674-11679(2014).
RN   [15]
RP   INDUCTION.
RX   PubMed=26032501; DOI=10.1016/j.bbrc.2015.05.090;
RA   Shin K.S., Kim Y.H., Yu J.H.;
RT   "Proteomic analyses reveal the key roles of BrlA and AbaA in biogenesis of
RT   gliotoxin in Aspergillus fumigatus.";
RL   Biochem. Biophys. Res. Commun. 463:428-433(2015).
RN   [16]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=26150413; DOI=10.1128/ec.00055-15;
RA   Owens R.A., O'Keeffe G., Smith E.B., Dolan S.K., Hammel S., Sheridan K.J.,
RA   Fitzpatrick D.A., Keane T.M., Jones G.W., Doyle S.;
RT   "Interplay between gliotoxin resistance, secretion, and the
RT   methyl/methionine cycle in Aspergillus fumigatus.";
RL   Eukaryot. Cell 14:941-957(2015).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH FAD, SUBUNIT,
RP   COFACTOR, AND DISULFIDE BOND.
RX   PubMed=24446392; DOI=10.1002/anie.201309302;
RA   Scharf D.H., Groll M., Habel A., Heinekamp T., Hertweck C., Brakhage A.A.,
RA   Huber E.M.;
RT   "Flavoenzyme-catalyzed formation of disulfide bonds in natural products.";
RL   Angew. Chem. Int. Ed. 53:2221-2224(2014).
CC   -!- FUNCTION: Thioredoxin reductase; part of the gene cluster that mediates
CC       the biosynthesis of gliotoxin, a member of the
CC       epipolythiodioxopiperazine (ETP) class of toxins characterized by a
CC       disulfide bridged cyclic dipeptide (PubMed:15979823, PubMed:21612254).
CC       The first step in gliotoxin biosynthesis is the condensation of serine
CC       and phenylalanine to form the cyclo-L-phenylalanyl-L-serine
CC       diketopiperazine (DKP) by the NRPS gliP (PubMed:17154540,
CC       PubMed:21612254). GliP is also able to produce the DKP cyclo-L-
CC       tryptophanyl-L-serine, suggesting that the substrate specificity of the
CC       first adenylation (A) domain in gliP is sufficiently relaxed to
CC       accommodate both L-Phe and L-Trp (PubMed:23434416). The cytochrome P450
CC       monooxygenase gliC has been shown to catalyze the subsequent
CC       hydroxylation of the alpha-carbon of L-Phe in cyclo-L-phenylalanyl-L-
CC       serine whereas the second cytochrome P450 enzyme, gliF, is presumably
CC       involved in the modification of the DKP side chain (PubMed:24039048,
CC       PubMed:23434416). The glutathione S-transferase (GST) gliG then forms a
CC       bis-glutathionylated biosynthetic intermediate which is responsible for
CC       the sulfurization of gliotoxin (PubMed:21513890, PubMed:21749092). This
CC       bis-glutathionylated intermediate is subsequently processed by the
CC       gamma-glutamyl cyclotransferase gliK to remove both gamma-glutamyl
CC       moieties (PubMed:22903976, PubMed:24039048). Subsequent processing via
CC       gliI yields a biosynthetic intermediate, which is N-methylated via the
CC       N-methyltransferase gliN, before the gliotoxin oxidoreductase gliT-
CC       mediated disulfide bridge closure (PubMed:20548963, PubMed:22936680,
CC       PubMed:24039048, PubMed:25062268). GliN-mediated amide methylation
CC       confers stability to ETP, damping the spontaneous formation of tri- and
CC       tetrasulfides (PubMed:25062268). Intracellular dithiol gliotoxin
CC       oxidized by gliT is subsequently effluxed by gliA (PubMed:26150413).
CC       GliT is required for self-protection against gliotoxin
CC       (PubMed:20548963, PubMed:26150413). GliT plays a role in preventing
CC       dysregulation of the methyl/methionine cycle to control intracellular
CC       S-adenosylmethionine (SAM) depletion and S-adenosylhomocysteine (SAH)
CC       homeostasis during gliotoxin biosynthesis and exposure
CC       (PubMed:26150413). {ECO:0000269|PubMed:17154540,
CC       ECO:0000269|PubMed:20548963, ECO:0000269|PubMed:21513890,
CC       ECO:0000269|PubMed:21612254, ECO:0000269|PubMed:21749092,
CC       ECO:0000269|PubMed:22903976, ECO:0000269|PubMed:22936680,
CC       ECO:0000269|PubMed:23434416, ECO:0000269|PubMed:24039048,
CC       ECO:0000269|PubMed:25062268, ECO:0000269|PubMed:26150413}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:24446392};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:24446392};
CC   -!- PATHWAY: Mycotoxin biosynthesis. {ECO:0000269|PubMed:20548963}.
CC   -!- SUBUNIT: Homodimer (PubMed:24446392). {ECO:0000269|PubMed:24446392}.
CC   -!- INDUCTION: Expression is induced by gliotoxin, but appears to be
CC       independently regulated compared to all other cluster components
CC       (PubMed:20548963). Expression is positively regulated by the brlA and
CC       abaA transcription factors (PubMed:26032501). Expression is also
CC       regulated by rsmA (PubMed:23671611). {ECO:0000269|PubMed:20548963,
CC       ECO:0000269|PubMed:23671611, ECO:0000269|PubMed:26032501}.
CC   -!- DISRUPTION PHENOTYPE: Impairs gliotoxin oxidation, leading to unchecked
CC       methylation and subsequent significant S-adenosylmethionine (SAM)
CC       depletion and S-adenosylhomocysteine (SAH) overproduction which in turn
CC       significantly contributes to hypersensitivity to gliotoxin of gliT-
CC       deficient A.fumigatus (PubMed:26150413). Results in altered expression
CC       of over 200 genes involved in many functions (PubMed:25311525).
CC       {ECO:0000269|PubMed:25311525, ECO:0000269|PubMed:26150413}.
CC   -!- SIMILARITY: Belongs to the class-II pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY838877; AAW03299.1; -; Genomic_DNA.
DR   EMBL; AAHF01000006; EAL88825.1; -; Genomic_DNA.
DR   RefSeq; XP_750863.1; XM_745770.1.
DR   PDB; 4NTC; X-ray; 1.90 A; A/B=1-334.
DR   PDBsum; 4NTC; -.
DR   SMR; E9RAH5; -.
DR   STRING; 746128.CADAFUBP00007383; -.
DR   EnsemblFungi; EAL88825; EAL88825; AFUA_6G09740.
DR   GeneID; 3508168; -.
DR   KEGG; afm:AFUA_6G09740; -.
DR   VEuPathDB; FungiDB:Afu6g09740; -.
DR   eggNOG; ENOG502QQDE; Eukaryota.
DR   HOGENOM; CLU_031864_5_0_1; -.
DR   InParanoid; E9RAH5; -.
DR   OMA; LFCDGYE; -.
DR   OrthoDB; 1133476at2759; -.
DR   BioCyc; MetaCyc:MONOMER-18853; -.
DR   Proteomes; UP000002530; Chromosome 6.
DR   Proteomes; UP000002530; Unassembled WGS sequence.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:AspGD.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   GO; GO:0036146; P:cellular response to mycotoxin; IMP:AspGD.
DR   GO; GO:2001310; P:gliotoxin biosynthetic process; IMP:AspGD.
DR   GO; GO:0043386; P:mycotoxin biosynthetic process; IDA:AspGD.
DR   GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; FAD; Flavoprotein; NADP; Oxidoreductase;
KW   Redox-active center; Reference proteome; Virulence.
FT   CHAIN           1..334
FT                   /note="Thioredoxin reductase gliT"
FT                   /id="PRO_0000437710"
FT   NP_BIND         21..24
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:24446392"
FT   NP_BIND         43..48
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:24446392"
FT   NP_BIND         301..302
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:24446392"
FT   BINDING         56
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:24446392"
FT   BINDING         91
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:24446392"
FT   BINDING         121
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:24446392"
FT   BINDING         294
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:24446392"
FT   DISULFID        145..148
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:24446392"
FT   STRAND          3..6
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          12..19
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   HELIX           23..34
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          39..42
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   TURN            48..51
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   HELIX           66..79
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          83..87
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          91..98
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   TURN            99..101
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          102..107
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          112..120
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          124..126
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          130..132
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   HELIX           134..137
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   TURN            139..141
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          142..144
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   TURN            146..148
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   HELIX           151..153
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          155..162
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   HELIX           165..167
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   HELIX           170..180
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   TURN            181..183
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          184..190
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   HELIX           195..207
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          208..210
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          215..218
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          222..227
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          234..238
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   TURN            239..241
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          242..247
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          255..260
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   HELIX           261..264
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   TURN            279..282
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   STRAND          289..291
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   HELIX           293..296
FT                   /evidence="ECO:0007829|PDB:4NTC"
FT   HELIX           302..322
FT                   /evidence="ECO:0007829|PDB:4NTC"
SQ   SEQUENCE   334 AA;  36004 MW;  6744C7C4CF119B84 CRC64;
     MSIGKLLSNG ALLVDVLIIG AGPAGLSTAT GLARQLHTAV VFDSGVYRNA KTQHMHNVLG
     WDHRNPAELR AAGRADLTTR YSTIQFQNST IEAIRQVETN QLFEARDNEG HSWYGRKVVL
     ATGVRDIPLD IEGYSECWAN GIYHCLFCDG YEERGQETVG VLALGPIANP ARALHLARMA
     LRLSESVTIY TNGNEQLAKE IQQAAEESPV GASGLKFEAR PIRRFEKGDV AKTVIVHLGE
     SESKTEGFLV YNPQTEVNGP FAKQLALNMT EGGDILTTPP FYETSVPGVF AVGDCATPLK
     AVTPAVSMGS LAAGGLVAQL QAQALPEFRL DQEL
//
ID   IVD_HUMAN               Reviewed;         426 AA.
AC   P26440; B2RCV5; B3KVI7; J3KR54; Q53XZ9; Q96AF6;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   12-SEP-2018, sequence version 2.
DT   02-JUN-2021, entry version 211.
DE   RecName: Full=Isovaleryl-CoA dehydrogenase, mitochondrial {ECO:0000305};
DE            Short=IVD;
DE            EC=1.3.8.4 {ECO:0000269|PubMed:7640268};
DE   AltName: Full=Butyryl-CoA dehydrogenase;
DE            EC=1.3.8.1 {ECO:0000269|PubMed:7640268};
DE   Flags: Precursor;
GN   Name=IVD {ECO:0000312|HGNC:HGNC:6186};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2318964; DOI=10.1172/jci114536;
RA   Matsubara Y., Ito M., Glassberg R., Satyabhama S., Ikeda Y., Tanaka K.;
RT   "Nucleotide sequence of messenger RNA encoding human isovaleryl-coenzyme A
RT   dehydrogenase and its expression in isovaleric acidemia fibroblasts.";
RL   J. Clin. Invest. 85:1058-1064(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10677295; DOI=10.1086/302751;
RA   Vockley J., Rogan P.K., Anderson B.D., Willard J., Seelan R.S., Smith D.I.,
RA   Liu W.;
RT   "Exon skipping in IVD RNA processing in isovaleric acidemia caused by point
RT   mutations in the coding region of the IVD gene.";
RL   Am. J. Hum. Genet. 66:356-367(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Pericardium, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-426 (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 384-426.
RX   PubMed=8468053; DOI=10.1006/geno.1993.1111;
RA   Parimoo B., Tanaka K.;
RT   "Structural organization of the human isovaleryl-CoA dehydrogenase gene.";
RL   Genomics 15:582-590(1993).
RN   [9]
RP   PROTEIN SEQUENCE OF N-TERMINUS.
RX   PubMed=1310317;
RA   Vockley J., Nagao M., Parimoo B., Tanaka K.;
RT   "The variant human isovaleryl-CoA dehydrogenase gene responsible for type
RT   II isovaleric acidemia determines an RNA splicing error, leading to the
RT   deletion of the entire second coding exon and the production of a truncated
RT   precursor protein that interacts poorly with mitochondrial import
RT   receptors.";
RL   J. Biol. Chem. 267:2494-2501(1992).
RN   [10]
RP   PROTEIN SEQUENCE OF 33-50.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [11]
RP   ACTIVE SITE, MUTAGENESIS OF GLU-286 AND ALA-407, CATALYTIC ACTIVITY,
RP   FUNCTION, AND SUBSTRATE SPECIFICITY.
RX   PubMed=7640268; DOI=10.1021/bi00032a007;
RA   Mohsen A.W., Vockley J.;
RT   "Identification of the active site catalytic residue in human isovaleryl-
RT   CoA dehydrogenase.";
RL   Biochemistry 34:10146-10152(1995).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-78, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER ALA-32, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 33-426 IN COMPLEX WITH FAD AND
RP   SUBSTRATE ANALOG, AND COFACTOR.
RX   PubMed=9214289; DOI=10.1021/bi970422u;
RA   Tiffany K.A., Roberts D.L., Wang M., Paschke R., Mohsen A.W., Vockley J.,
RA   Kim J.-J.P.;
RT   "Structure of human isovaleryl-CoA dehydrogenase at 2.6-A resolution:
RT   structural basis for substrate specificity.";
RL   Biochemistry 36:8455-8464(1997).
RN   [17]
RP   VARIANTS IVA PRO-45 AND VAL-202.
RX   PubMed=2063866;
RA   Vockley J., Parimoo B., Tanaka K.;
RT   "Molecular characterization of four different classes of mutations in the
RT   isovaleryl-CoA dehydrogenase gene responsible for isovaleric acidemia.";
RL   Am. J. Hum. Genet. 49:147-157(1991).
RN   [18]
RP   VARIANTS IVA PRO-53; ASN-72; VAL-314; ARG-360; ALA-374; CYS-395 AND
RP   LEU-414.
RX   PubMed=9665741; DOI=10.1021/bi973096r;
RA   Mohsen A.-W.A., Anderson B.D., Volchenboum S.L., Battaile K.P.,
RA   Tiffany K.A., Roberts D.L., Kim J.-J.P., Vockley J.;
RT   "Characterization of molecular defects in isovaleryl-CoA dehydrogenase in
RT   patients with isovaleric acidemia.";
RL   Biochemistry 37:10325-10335(1998).
RN   [19]
RP   VARIANTS IVA GLY-97; ARG-123; PRO-279 AND CYS-403.
RX   PubMed=22004070; DOI=10.1111/j.1442-200x.2011.03488.x;
RA   Vatanavicharn N., Liammongkolkul S., Sakamoto O., Sathienkijkanchai A.,
RA   Wasant P.;
RT   "Phenotypic and mutation spectrums of Thai patients with isovaleric
RT   acidemia.";
RL   Pediatr. Int. 53:990-994(2011).
RN   [20]
RP   VARIANT IVA ARG-123.
RX   PubMed=22350545; DOI=10.1007/s10545-012-9457-2;
RA   Dercksen M., Duran M., Ijlst L., Mienie L.J., Reinecke C.J., Ruiter J.P.,
RA   Waterham H.R., Wanders R.J.;
RT   "Clinical variability of isovaleric acidemia in a genetically homogeneous
RT   population.";
RL   J. Inherit. Metab. Dis. 35:1021-1029(2012).
RN   [21]
RP   VARIANT IVA MET-199.
RX   PubMed=23587913; DOI=10.1016/j.gene.2013.03.139;
RA   Bei F., Sun J.H., Yu Y.G., Jia J., Zheng Z.J., Fu Q.H., Cai W.;
RT   "Two novel isovaleryl-CoA dehydrogenase gene mutations in a Chinese
RT   infant.";
RL   Gene 524:396-400(2013).
RN   [22]
RP   VARIANTS IVA ALA-250; VAL-291; THR-379; GLN-398 AND ASN-403.
RX   PubMed=28535199; DOI=10.1093/hmg/ddx195;
RA   Zaki O.K., Priya Doss C.G., Ali S.A., Murad G.G., Elashi S.A.,
RA   Ebnou M.S.A., Kumar D T., Khalifa O., Gamal R., El Abd H.S.A., Nasr B.N.,
RA   Zayed H.;
RT   "Genotype-phenotype correlation in patients with isovaleric acidaemia:
RT   comparative structural modelling and computational analysis of novel
RT   variants.";
RL   Hum. Mol. Genet. 26:3105-3115(2017).
CC   -!- FUNCTION: Catalyzes the conversion of isovaleryl-CoA/3-methylbutanoyl-
CC       CoA to 3-methylbut-2-enoyl-CoA as an intermediate step in the leucine
CC       (Leu) catabolic pathway (PubMed:7640268). To a lesser extent, is also
CC       able to catalyze the oxidation of other saturated short-chain acyl-CoA
CC       thioesters as pentanoyl-CoA, hexenoyl-CoA and butenoyl-CoA
CC       (PubMed:7640268). {ECO:0000269|PubMed:7640268}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-methylbutanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = 3-methyl-(2E)-butenoyl-CoA + reduced [electron-
CC         transfer flavoprotein]; Xref=Rhea:RHEA:12276, Rhea:RHEA-COMP:10685,
CC         Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57344,
CC         ChEBI:CHEBI:57345, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307; EC=1.3.8.4;
CC         Evidence={ECO:0000269|PubMed:7640268};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + oxidized [electron-transfer flavoprotein] + pentanoyl-
CC         CoA = (2E)-pentenoyl-CoA + reduced [electron-transfer flavoprotein];
CC         Xref=Rhea:RHEA:43456, Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57389, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:86160;
CC         Evidence={ECO:0000269|PubMed:7640268};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hexanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] = (2E)-hexenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:43464, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:62077, ChEBI:CHEBI:62620;
CC         Evidence={ECO:0000269|PubMed:7640268};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=butanoyl-CoA + H(+) + oxidized [electron-transfer
CC         flavoprotein] = (2E)-butenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:24004, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57332, ChEBI:CHEBI:57371,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307; EC=1.3.8.1;
CC         Evidence={ECO:0000269|PubMed:7640268};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:9214289};
CC   -!- PATHWAY: Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-
CC       3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:9214289}.
CC   -!- INTERACTION:
CC       P26440; Q08043: ACTN3; NbExp=3; IntAct=EBI-2866408, EBI-2880652;
CC       P26440; Q9Y4H4: GPSM3; NbExp=3; IntAct=EBI-2866408, EBI-347538;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000250|UniProtKB:P12007}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P26440-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P26440-2; Sequence=VSP_045193;
CC   -!- DISEASE: Isovaleric acidemia (IVA) [MIM:243500]: A metabolic disorder
CC       characterized by retarded psychomotor development, a peculiar odor
CC       resembling sweaty feet, an aversion to dietary protein, and pernicious
CC       vomiting, leading to acidosis and coma. The acute neonatal form leads
CC       to massive metabolic acidosis from the first days of life and rapid
CC       death. {ECO:0000269|PubMed:2063866, ECO:0000269|PubMed:22004070,
CC       ECO:0000269|PubMed:22350545, ECO:0000269|PubMed:23587913,
CC       ECO:0000269|PubMed:28535199, ECO:0000269|PubMed:9665741}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-4 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA52711.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAB92584.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH17202.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAG37702.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M34192; AAA52711.1; ALT_INIT; mRNA.
DR   EMBL; AF191218; AAF20182.1; -; Genomic_DNA.
DR   EMBL; AF191214; AAF20182.1; JOINED; Genomic_DNA.
DR   EMBL; AF191215; AAF20182.1; JOINED; Genomic_DNA.
DR   EMBL; AF191216; AAF20182.1; JOINED; Genomic_DNA.
DR   EMBL; AF191217; AAF20182.1; JOINED; Genomic_DNA.
DR   EMBL; AK122922; BAG53799.1; -; mRNA.
DR   EMBL; AK315296; BAG37702.1; ALT_INIT; mRNA.
DR   EMBL; AC013356; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471125; EAW92413.1; -; Genomic_DNA.
DR   EMBL; CH471125; EAW92414.1; -; Genomic_DNA.
DR   EMBL; CH471125; EAW92415.1; -; Genomic_DNA.
DR   EMBL; BC017202; AAH17202.1; ALT_INIT; mRNA.
DR   EMBL; AF038318; AAB92584.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BT007145; AAP35809.1; -; mRNA.
DR   PIR; A37033; A37033.
DR   RefSeq; NP_001152980.1; NM_001159508.1.
DR   RefSeq; NP_002216.2; NM_002225.3.
DR   PDB; 1IVH; X-ray; 2.60 A; A/B/C/D=33-426.
DR   PDBsum; 1IVH; -.
DR   SMR; P26440; -.
DR   BioGRID; 109916; 35.
DR   IntAct; P26440; 19.
DR   STRING; 9606.ENSP00000418397; -.
DR   DrugBank; DB04036; Coenzyme A persulfide.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   SwissLipids; SLP:000000936; -.
DR   iPTMnet; P26440; -.
DR   PhosphoSitePlus; P26440; -.
DR   SwissPalm; P26440; -.
DR   BioMuta; IVD; -.
DR   DMDM; 125051; -.
DR   REPRODUCTION-2DPAGE; IPI00645805; -.
DR   UCD-2DPAGE; P26440; -.
DR   EPD; P26440; -.
DR   jPOST; P26440; -.
DR   MassIVE; P26440; -.
DR   MaxQB; P26440; -.
DR   PaxDb; P26440; -.
DR   PeptideAtlas; P26440; -.
DR   PRIDE; P26440; -.
DR   ProteomicsDB; 3759; -.
DR   ProteomicsDB; 54348; -. [P26440-1]
DR   Antibodypedia; 23079; 213 antibodies.
DR   DNASU; 3712; -.
DR   Ensembl; ENST00000650656; ENSP00000498731; ENSG00000128928. [P26440-2]
DR   Ensembl; ENST00000651168; ENSP00000499074; ENSG00000128928. [P26440-1]
DR   GeneID; 3712; -.
DR   KEGG; hsa:3712; -.
DR   UCSC; uc001zlq.3; human. [P26440-1]
DR   CTD; 3712; -.
DR   DisGeNET; 3712; -.
DR   GeneCards; IVD; -.
DR   HGNC; HGNC:6186; IVD.
DR   HPA; ENSG00000128928; Low tissue specificity.
DR   MalaCards; IVD; -.
DR   MIM; 243500; phenotype.
DR   MIM; 607036; gene.
DR   neXtProt; NX_P26440; -.
DR   OpenTargets; ENSG00000128928; -.
DR   Orphanet; 33; Isovaleric acidemia.
DR   PharmGKB; PA29984; -.
DR   VEuPathDB; HostDB:ENSG00000128928.8; -.
DR   eggNOG; KOG0141; Eukaryota.
DR   GeneTree; ENSGT00940000158100; -.
DR   HOGENOM; CLU_018204_3_5_1; -.
DR   InParanoid; P26440; -.
DR   OMA; CFITNSG; -.
DR   OrthoDB; 589058at2759; -.
DR   PhylomeDB; P26440; -.
DR   TreeFam; TF105050; -.
DR   BRENDA; 1.3.8.4; 2681.
DR   PathwayCommons; P26440; -.
DR   Reactome; R-HSA-70895; Branched-chain amino acid catabolism.
DR   SABIO-RK; P26440; -.
DR   UniPathway; UPA00363; UER00860.
DR   BioGRID-ORCS; 3712; 3 hits in 997 CRISPR screens.
DR   ChiTaRS; IVD; human.
DR   EvolutionaryTrace; P26440; -.
DR   GenomeRNAi; 3712; -.
DR   Pharos; P26440; Tbio.
DR   PRO; PR:P26440; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; P26440; protein.
DR   Bgee; ENSG00000128928; Expressed in left lobe of thyroid gland and 222 other tissues.
DR   ExpressionAtlas; P26440; baseline and differential.
DR   Genevisible; P26440; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; ISS:BHF-UCL.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:Ensembl.
DR   GO; GO:0004085; F:butyryl-CoA dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0008470; F:isovaleryl-CoA dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0009083; P:branched-chain amino acid catabolic process; IDA:UniProtKB.
DR   GO; GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; IDA:BHF-UCL.
DR   GO; GO:0006552; P:leucine catabolic process; IDA:UniProtKB.
DR   CDD; cd01156; IVD; 1.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   InterPro; IPR034183; IVD.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Direct protein sequencing;
KW   Disease variant; FAD; Fatty acid metabolism; Flavoprotein;
KW   Lipid metabolism; Mitochondrion; Oxidoreductase; Reference proteome;
KW   Transit peptide.
FT   TRANSIT         1..32
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:12665801,
FT                   ECO:0000269|PubMed:1310317, ECO:0007744|PubMed:25944712"
FT   CHAIN           33..426
FT                   /note="Isovaleryl-CoA dehydrogenase, mitochondrial"
FT                   /id="PRO_0000000531"
FT   NP_BIND         165..174
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9214289,
FT                   ECO:0007744|PDB:1IVH"
FT   NP_BIND         198..200
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9214289,
FT                   ECO:0007744|PDB:1IVH"
FT   NP_BIND         380..384
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9214289,
FT                   ECO:0007744|PDB:1IVH"
FT   NP_BIND         409..411
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9214289,
FT                   ECO:0007744|PDB:1IVH"
FT   REGION          222..223
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:9214289,
FT                   ECO:0007744|PDB:1IVH"
FT   REGION          284..287
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:9214289,
FT                   ECO:0007744|PDB:1IVH"
FT   REGION          407..408
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:9214289,
FT                   ECO:0007744|PDB:1IVH"
FT   ACT_SITE        286
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000269|PubMed:7640268,
FT                   ECO:0007744|PDB:1IVH"
FT   BINDING         174
FT                   /note="Substrate; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:9214289,
FT                   ECO:0007744|PDB:1IVH"
FT   BINDING         277
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:9214289,
FT                   ECO:0007744|PDB:1IVH"
FT   BINDING         312
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9214289,
FT                   ECO:0007744|PDB:1IVH"
FT   BINDING         323
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9214289,
FT                   ECO:0007744|PDB:1IVH"
FT   MOD_RES         58
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JHI5"
FT   MOD_RES         58
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JHI5"
FT   MOD_RES         67
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JHI5"
FT   MOD_RES         67
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JHI5"
FT   MOD_RES         78
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         78
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JHI5"
FT   MOD_RES         241
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JHI5"
FT   MOD_RES         262
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JHI5"
FT   MOD_RES         262
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JHI5"
FT   MOD_RES         318
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JHI5"
FT   VAR_SEQ         52..81
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045193"
FT   VARIANT         45
FT                   /note="L -> P (in IVA; dbSNP:rs121434284)"
FT                   /evidence="ECO:0000269|PubMed:2063866"
FT                   /id="VAR_000423"
FT   VARIANT         53
FT                   /note="R -> P (in IVA; dbSNP:rs2229311)"
FT                   /evidence="ECO:0000269|PubMed:9665741"
FT                   /id="VAR_015960"
FT   VARIANT         72
FT                   /note="D -> N (in IVA; dbSNP:rs747273828)"
FT                   /evidence="ECO:0000269|PubMed:9665741"
FT                   /id="VAR_015961"
FT   VARIANT         97
FT                   /note="A -> G (in IVA)"
FT                   /evidence="ECO:0000269|PubMed:22004070"
FT                   /id="VAR_070061"
FT   VARIANT         123
FT                   /note="G -> R (in IVA; dbSNP:rs142761835)"
FT                   /evidence="ECO:0000269|PubMed:22004070,
FT                   ECO:0000269|PubMed:22350545"
FT                   /id="VAR_070062"
FT   VARIANT         199
FT                   /note="I -> M (in IVA)"
FT                   /evidence="ECO:0000269|PubMed:23587913"
FT                   /id="VAR_070063"
FT   VARIANT         202
FT                   /note="G -> V (in IVA; dbSNP:rs121434285)"
FT                   /evidence="ECO:0000269|PubMed:2063866"
FT                   /id="VAR_000424"
FT   VARIANT         250
FT                   /note="G -> A (in IVA; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:28535199"
FT                   /id="VAR_079552"
FT   VARIANT         279
FT                   /note="L -> P (in IVA)"
FT                   /evidence="ECO:0000269|PubMed:22004070"
FT                   /id="VAR_070064"
FT   VARIANT         291
FT                   /note="A -> V (in IVA; unknown pathological significance;
FT                   dbSNP:rs886042098)"
FT                   /evidence="ECO:0000269|PubMed:28535199"
FT                   /id="VAR_079553"
FT   VARIANT         314
FT                   /note="A -> V (in IVA; dbSNP:rs28940889)"
FT                   /evidence="ECO:0000269|PubMed:9665741"
FT                   /id="VAR_015962"
FT   VARIANT         360
FT                   /note="C -> R (in IVA; dbSNP:rs760822119)"
FT                   /evidence="ECO:0000269|PubMed:9665741"
FT                   /id="VAR_015963"
FT   VARIANT         374
FT                   /note="V -> A (in IVA; dbSNP:rs754600862)"
FT                   /evidence="ECO:0000269|PubMed:9665741"
FT                   /id="VAR_015964"
FT   VARIANT         379
FT                   /note="I -> T (in IVA; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:28535199"
FT                   /id="VAR_079554"
FT   VARIANT         395
FT                   /note="R -> C (in IVA; dbSNP:rs371427844)"
FT                   /evidence="ECO:0000269|PubMed:9665741"
FT                   /id="VAR_015965"
FT   VARIANT         398
FT                   /note="R -> Q (in IVA; unknown pathological significance;
FT                   dbSNP:rs1477527791)"
FT                   /evidence="ECO:0000269|PubMed:28535199"
FT                   /id="VAR_079555"
FT   VARIANT         403
FT                   /note="Y -> C (in IVA; dbSNP:rs773560012)"
FT                   /evidence="ECO:0000269|PubMed:22004070"
FT                   /id="VAR_070065"
FT   VARIANT         403
FT                   /note="Y -> N (in IVA; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:28535199"
FT                   /id="VAR_079556"
FT   VARIANT         414
FT                   /note="R -> L (in IVA)"
FT                   /evidence="ECO:0000269|PubMed:9665741"
FT                   /id="VAR_015966"
FT   MUTAGEN         286
FT                   /note="E->D: Residual isovaleryl-CoA dehydrogenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:7640268"
FT   MUTAGEN         286
FT                   /note="E->G: Loss of isovaleryl-CoA dehydrogenase activity.
FT                   Does not affect isovaleryl-CoA dehydrogenase activity; when
FT                   associated with 407-E."
FT                   /evidence="ECO:0000269|PubMed:7640268"
FT   MUTAGEN         286
FT                   /note="E->Q: Loss of isovaleryl-CoA dehydrogenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:7640268"
FT   MUTAGEN         407
FT                   /note="A->E: Does not affect isovaleryl-CoA dehydrogenase
FT                   activity; when associated with 286-D."
FT                   /evidence="ECO:0000269|PubMed:7640268"
FT   CONFLICT        13
FT                   /note="W -> C (in Ref. 7; AAP35809 and 6; AAH17202)"
FT                   /evidence="ECO:0000305"
FT   HELIX           41..43
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           47..63
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   TURN            64..67
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           68..74
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           80..90
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   TURN            93..96
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           99..101
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           108..121
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           123..133
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   TURN            134..136
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           137..143
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           146..157
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   STRAND          163..166
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   STRAND          172..175
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           176..178
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   STRAND          182..185
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   STRAND          187..200
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           202..204
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   STRAND          206..214
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           221..224
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   STRAND          225..231
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   STRAND          237..239
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   STRAND          245..247
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   STRAND          253..264
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           265..267
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   STRAND          268..270
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           275..290
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           292..309
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           319..321
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           323..351
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           357..382
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           383..387
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           393..402
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   TURN            403..407
FT                   /evidence="ECO:0007829|PDB:1IVH"
FT   HELIX           410..422
FT                   /evidence="ECO:0007829|PDB:1IVH"
SQ   SEQUENCE   426 AA;  46651 MW;  D744DA85752BF307 CRC64;
     MAEMATATRL LGWRVASWRL RPPLAGFVSQ RAHSLLPVDD AINGLSEEQR QLRQTMAKFL
     QEHLAPKAQE IDRSNEFKNL REFWKQLGNL GVLGITAPVQ YGGSGLGYLE HVLVMEEISR
     ASGAVGLSYG AHSNLCINQL VRNGNEAQKE KYLPKLISGE YIGALAMSEP NAGSDVVSMK
     LKAEKKGNHY ILNGNKFWIT NGPDADVLIV YAKTDLAAVP ASRGITAFIV EKGMPGFSTS
     KKLDKLGMRG SNTCELIFED CKIPAANILG HENKGVYVLM SGLDLERLVL AGGPLGLMQA
     VLDHTIPYLH VREAFGQKIG HFQLMQGKMA DMYTRLMACR QYVYNVAKAC DEGHCTAKDC
     AGVILYSAEC ATQVALDGIQ CFGGNGYIND FPMGRFLRDA KLYEIGAGTS EVRRLVIGRA
     FNADFH
//
ID   FAP_CHLVA               Reviewed;         654 AA.
AC   A0A248QE08; A0A2D0TC92; E1ZTE9;
DT   17-JUN-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-NOV-2017, sequence version 1.
DT   02-JUN-2021, entry version 17.
DE   RecName: Full=Fatty acid photodecarboxylase, chloroplastic {ECO:0000303|PubMed:28860382};
DE            Short=CvFAP {ECO:0000303|PubMed:28860382};
DE            EC=4.1.1.106 {ECO:0000269|PubMed:28860382};
DE   Flags: Precursor;
GN   Name=FAP {ECO:0000303|PubMed:28860382};
GN   ORFNames=CHLNCDRAFT_28598 {ECO:0000312|EMBL:EFN50890.1};
OS   Chlorella variabilis (Green alga).
OC   Eukaryota; Viridiplantae; Chlorophyta; core chlorophytes; Trebouxiophyceae;
OC   Chlorellales; Chlorellaceae; Chlorella clade; Chlorella.
OX   NCBI_TaxID=554065;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], X-RAY CRYSTALLOGRAPHY (3.12 ANGSTROMS) OF
RP   62-654 IN COMPLEX WITH FAD AND PALMITATE, FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   BIOTECHNOLOGY.
RC   STRAIN=NC64A;
RX   PubMed=28860382; DOI=10.1126/science.aan6349;
RA   Sorigue D., Legeret B., Cuine S., Blangy S., Moulin S., Billon E.,
RA   Richaud P., Brugiere S., Coute Y., Nurizzo D., Mueller P., Brettel K.,
RA   Pignol D., Arnoux P., Li-Beisson Y., Peltier G., Beisson F.;
RT   "An algal photoenzyme converts fatty acids to hydrocarbons.";
RL   Science 357:903-907(2017).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NC64A;
RX   PubMed=20852019; DOI=10.1105/tpc.110.076406;
RA   Blanc G., Duncan G., Agarkova I., Borodovsky M., Gurnon J., Kuo A.,
RA   Lindquist E., Lucas S., Pangilinan J., Polle J., Salamov A., Terry A.,
RA   Yamada T., Dunigan D.D., Grigoriev I.V., Claverie J.M., Van Etten J.L.;
RT   "The Chlorella variabilis NC64A genome reveals adaptation to
RT   photosymbiosis, coevolution with viruses, and cryptic sex.";
RL   Plant Cell 22:2943-2955(2010).
RN   [3]
RP   FUNCTION.
RX   PubMed=30106504; DOI=10.1002/anie.201807119;
RA   Huijbers M.M.E., Zhang W., Tonin F., Hollmann F.;
RT   "Light-driven enzymatic decarboxylation of fatty acids.";
RL   Angew. Chem. Int. Ed. 57:13648-13651(2018).
RN   [4]
RP   BIOTECHNOLOGY.
RX   PubMed=31462926; DOI=10.1186/s13068-019-1542-4;
RA   Bruder S., Moldenhauer E.J., Lemke R.D., Ledesma-Amaro R., Kabisch J.;
RT   "Drop-in biofuel production using fatty acid photodecarboxylase from
RT   Chlorella variabilis in the oleaginous yeast Yarrowia lipolytica.";
RL   Biotechnol. Biofuels 12:202-202(2019).
RN   [5]
RP   FUNCTION.
RX   PubMed=30673222; DOI=10.1021/jacs.8b12282;
RA   Zhang W., Ma M., Huijbers M.M.E., Filonenko G.A., Pidko E.A., van Schie M.,
RA   de Boer S., Burek B.O., Bloh J.Z., van Berkel W.J.H., Smith W.A.,
RA   Hollmann F.;
RT   "Hydrocarbon synthesis via photoenzymatic decarboxylation of carboxylic
RT   acids.";
RL   J. Am. Chem. Soc. 141:3116-3120(2019).
CC   -!- FUNCTION: Catalyzes the decarboxylation of free fatty acids to n-
CC       alkanes or n-alkenes in response to blue light (PubMed:28860382,
CC       PubMed:30106504, PubMed:30673222). Substrate preference is toward fatty
CC       acids with C16 or C17 chains (PubMed:28860382, PubMed:30106504,
CC       PubMed:30673222). Saturated fatty acids are converted to alkanes, not
CC       alkenes (PubMed:28860382). The decarboxylation is initiated through
CC       electron abstraction from the fatty acid by the photo-excited FAD
CC       (PubMed:28860382). {ECO:0000269|PubMed:28860382,
CC       ECO:0000269|PubMed:30106504, ECO:0000269|PubMed:30673222}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a long-chain fatty acid + H(+) + hnu = a long-chain alkane +
CC         CO2; Xref=Rhea:RHEA:18969, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:30212, ChEBI:CHEBI:57560, ChEBI:CHEBI:83563;
CC         EC=4.1.1.106; Evidence={ECO:0000269|PubMed:28860382};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18970;
CC         Evidence={ECO:0000269|PubMed:28860382};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hexadecanoate + hnu = CO2 + pentadecane;
CC         Xref=Rhea:RHEA:56060, ChEBI:CHEBI:7896, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:28897, ChEBI:CHEBI:30212;
CC         EC=4.1.1.106; Evidence={ECO:0000269|PubMed:28860382};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:56061;
CC         Evidence={ECO:0000269|PubMed:28860382};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:28860382};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:28860382};
CC   -!- ACTIVITY REGULATION: Activated by blue light and repressed by red
CC       light. {ECO:0000269|PubMed:28860382}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 8.5 (with palmitate as substrate).
CC         {ECO:0000269|PubMed:28860382};
CC   -!- SUBCELLULAR LOCATION: Plastid, chloroplast {ECO:0000255}.
CC   -!- BIOTECHNOLOGY: May be used in light-driven, bio-based production of
CC       hydrocarbons (PubMed:28860382). The oleaginous yeast Yarrowia
CC       lipolytica expressing FAP from Chlorella variabilis under blue light
CC       conditions produces odd-numbered alkanes and alkenes, which could be
CC       used as drop-in biofuel (PubMed:31462926).
CC       {ECO:0000269|PubMed:28860382, ECO:0000269|PubMed:31462926}.
CC   -!- SIMILARITY: Belongs to the GMC oxidoreductase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=EFN50890.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KY511411; ASM79489.1; -; mRNA.
DR   EMBL; GL433871; EFN50890.1; ALT_SEQ; Genomic_DNA.
DR   RefSeq; XP_005842992.1; XM_005842930.1.
DR   PDB; 5NCC; X-ray; 3.12 A; A/B/C/D/E/F=62-654.
DR   PDBsum; 5NCC; -.
DR   SMR; A0A248QE08; -.
DR   GeneID; 17350319; -.
DR   KEGG; cvr:CHLNCDRAFT_28598; -.
DR   eggNOG; KOG1238; Eukaryota.
DR   OMA; TSRLNYM; -.
DR   BioCyc; MetaCyc:MONOMER-20386; -.
DR   Proteomes; UP000008141; Unassembled WGS sequence.
DR   GO; GO:0009507; C:chloroplast; IEA:UniProtKB-SubCell.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016614; F:oxidoreductase activity, acting on CH-OH group of donors; IEA:InterPro.
DR   Gene3D; 3.50.50.60; -; 1.
DR   Gene3D; 4.10.450.10; -; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR027424; Glucose_Oxidase_domain_2.
DR   InterPro; IPR012132; GMC_OxRdtase.
DR   InterPro; IPR000172; GMC_OxRdtase_N.
DR   InterPro; IPR007867; GMC_OxRtase_C.
DR   PANTHER; PTHR11552; PTHR11552; 1.
DR   Pfam; PF05199; GMC_oxred_C; 1.
DR   Pfam; PF00732; GMC_oxred_N; 1.
DR   PIRSF; PIRSF000137; Alcohol_oxidase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   PROSITE; PS00624; GMC_OXRED_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chloroplast; FAD; Flavoprotein; Lyase; Plastid;
KW   Reference proteome; Transit peptide.
FT   TRANSIT         1..62
FT                   /note="Chloroplast"
FT                   /evidence="ECO:0000255"
FT   CHAIN           63..654
FT                   /note="Fatty acid photodecarboxylase, chloroplastic"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000450329"
FT   NP_BIND         93..94
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28860382,
FT                   ECO:0007744|PDB:5NCC"
FT   NP_BIND         170..173
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28860382,
FT                   ECO:0007744|PDB:5NCC"
FT   BINDING         114
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28860382,
FT                   ECO:0007744|PDB:5NCC"
FT   BINDING         162
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28860382,
FT                   ECO:0007744|PDB:5NCC"
FT   BINDING         166
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28860382,
FT                   ECO:0007744|PDB:5NCC"
FT   BINDING         298
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28860382,
FT                   ECO:0007744|PDB:5NCC"
FT   BINDING         432
FT                   /note="Palmitate"
FT                   /evidence="ECO:0000269|PubMed:28860382,
FT                   ECO:0007744|PDB:5NCC"
FT   BINDING         451
FT                   /note="Palmitate"
FT                   /evidence="ECO:0000269|PubMed:28860382,
FT                   ECO:0007744|PDB:5NCC"
FT   BINDING         466
FT                   /note="Palmitate"
FT                   /evidence="ECO:0000269|PubMed:28860382,
FT                   ECO:0007744|PDB:5NCC"
FT   BINDING         486
FT                   /note="Palmitate"
FT                   /evidence="ECO:0000269|PubMed:28860382,
FT                   ECO:0007744|PDB:5NCC"
FT   BINDING         622
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:28860382,
FT                   ECO:0007744|PDB:5NCC"
FT   HELIX           66..70
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           71..74
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          83..89
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           93..104
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          110..116
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           122..125
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           127..129
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           130..133
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           148..150
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           165..168
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           179..183
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           192..200
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          217..219
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           232..241
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          242..244
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          260..263
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          266..269
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           276..280
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   TURN            281..284
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          290..295
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          297..303
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          311..318
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   TURN            319..322
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          327..331
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          337..339
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           342..353
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   TURN            358..361
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           362..364
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   TURN            373..376
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          383..393
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          397..399
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           400..402
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           415..418
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   TURN            419..421
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          434..438
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          448..455
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          458..461
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           462..470
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          473..475
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          482..491
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          496..498
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          501..503
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           522..538
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           541..546
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           560..569
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   STRAND          605..607
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           610..612
FT                   /evidence="ECO:0007829|PDB:5NCC"
FT   HELIX           622..636
FT                   /evidence="ECO:0007829|PDB:5NCC"
SQ   SEQUENCE   654 AA;  68824 MW;  0CC56D0FA3D1B4DA CRC64;
     MASITSRASA RASCSQANTR AGRVALSGGA LLRPARPARS FVPARKQQQG AVRRGGALSA
     RASAVEDIRK VLSDSSSPVA GQKYDYILVG GGTAACVLAN RLSADGSKRV LVLEAGPDNT
     SRDVKIPAAI TRLFRSPLDW NLFSELQEQL AERQIYMARG RLLGGSSATN ATLYHRGAAG
     DYDAWGVEGW SSEDVLSWFV QAETNADFGP GAYHGSGGPM RVENPRYTNK QLHTAFFKAA
     EEVGLTPNSD FNDWSHDHAG YGTFQVMQDK GTRADMYRQY LKPVLGRRNL QVLTGAAVTK
     VNIDQAAGKA QALGVEFSTD GPTGERLSAE LAPGGEVIMC AGAVHTPFLL KHSGVGPSAE
     LKEFGIPVVS NLAGVGQNLQ DQPACLTAAP VKEKYDGIAI SDHIYNEKGQ IRKRAIASYL
     LGGRGGLTST GCDRGAFVRT AGQALPDLQV RFVPGMALDP DGVSTYVRFA KFQSQGLKWP
     SGITMQLIAC RPQSTGSVGL KSADPFAPPK LSPGYLTDKD GADLATLRKG IHWARDVARS
     SALSEYLDGE LFPGSGVVSD DQIDEYIRRS IHSSNAITGT CKMGNAGDSS SVVDNQLRVH
     GVEGLRVVDA SVVPKIPGGQ TGAPVVMIAE RAAALLTGKA TIGASAAAPA TVAA
//
ID   KMO_HUMAN               Reviewed;         486 AA.
AC   O15229; A2A2U8; A2A2U9; A2A2V0; Q5SY07; Q5SY08; Q5SY09;
DT   04-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 2.
DT   02-JUN-2021, entry version 169.
DE   RecName: Full=Kynurenine 3-monooxygenase {ECO:0000255|HAMAP-Rule:MF_03018};
DE            EC=1.14.13.9 {ECO:0000255|HAMAP-Rule:MF_03018};
DE   AltName: Full=Kynurenine 3-hydroxylase {ECO:0000255|HAMAP-Rule:MF_03018};
GN   Name=KMO {ECO:0000255|HAMAP-Rule:MF_03018, ECO:0000312|HGNC:HGNC:6381};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:CAA73613.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   AND VARIANT CYS-452.
RC   TISSUE=Liver {ECO:0000312|EMBL:CAA73613.1};
RX   PubMed=9237672; DOI=10.1016/s0014-5793(97)00627-3;
RA   Alberati-Giani D., Cesura A.M., Broger C., Warren W.D., Rover S.,
RA   Malherbe P.;
RT   "Cloning and functional expression of human kynurenine 3-monooxygenase.";
RL   FEBS Lett. 410:407-412(1997).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAC62615.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CATALYTIC ACTIVITY, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND VARIANT CYS-452.
RC   TISSUE=Liver {ECO:0000269|PubMed:10672018};
RX   PubMed=10672018; DOI=10.1046/j.1432-1327.2000.01104.x;
RA   Breton J., Avanzi N., Magagnin S., Covini N., Magistrelli G., Cozzi L.,
RA   Isacchi A.;
RT   "Functional characterization and mechanism of action of recombinant human
RT   kynurenine 3-hydroxylase.";
RL   Eur. J. Biochem. 267:1092-1099(2000).
RN   [3] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4] {ECO:0000305}
RP   REVIEW.
RX   PubMed=12402501; DOI=10.1038/nrd870;
RA   Stone T.W., Darlington L.G.;
RT   "Endogenous kynurenines as targets for drug discovery and development.";
RL   Nat. Rev. Drug Discov. 1:609-620(2002).
RN   [5]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=23575632; DOI=10.1038/nature12039;
RA   Amaral M., Levy C., Heyes D.J., Lafite P., Outeiro T.F., Giorgini F.,
RA   Leys D., Scrutton N.S.;
RT   "Structural basis of kynurenine 3-monooxygenase inhibition.";
RL   Nature 496:382-385(2013).
RN   [6]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=26752518; DOI=10.1038/nm.4020;
RA   Mole D.J., Webster S.P., Uings I., Zheng X., Binnie M., Wilson K.,
RA   Hutchinson J.P., Mirguet O., Walker A., Beaufils B., Ancellin N.,
RA   Trottet L., Beneton V., Mowat C.G., Wilkinson M., Rowland P., Haslam C.,
RA   McBride A., Homer N.Z., Baily J.E., Sharp M.G., Garden O.J., Hughes J.,
RA   Howie S.E., Holmes D.S., Liddle J., Iredale J.P.;
RT   "Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in
RT   rodent models of acute pancreatitis.";
RL   Nat. Med. 22:202-209(2016).
RN   [7]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND FUNCTION.
RX   PubMed=28604669; DOI=10.1038/ncomms15827;
RA   Hutchinson J.P., Rowland P., Taylor M.R.D., Christodoulou E.M., Haslam C.,
RA   Hobbs C.I., Holmes D.S., Homes P., Liddle J., Mole D.J., Uings I.,
RA   Walker A.L., Webster S.P., Mowat C.G., Chung C.W.;
RT   "Structural and mechanistic basis of differentiated inhibitors of the acute
RT   pancreatitis target kynurenine-3-monooxygenase.";
RL   Nat. Commun. 8:15827-15827(2017).
RN   [8]
RP   FUNCTION, DOMAIN, GLYCOSYLATION AT ASN-465, AND MUTAGENESIS OF ARG-85;
RP   TYR-99; ASN-363; GLU-366; MET-367; TYR-398 AND ASN-465.
RX   PubMed=29208702; DOI=10.1096/fj.201700397rr;
RA   Gao J., Yao L., Xia T., Liao X., Zhu D., Xiang Y.;
RT   "Biochemistry and structural studies of kynurenine 3-monooxygenase reveal
RT   allosteric inhibition by Ro 61-8048.";
RL   FASEB J. 32:2036-2045(2018).
RN   [9] {ECO:0007744|PDB:5X68}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 1-374 IN COMPLEX WITH FAD,
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, GLYCOSYLATION AT ASN-465, AND
RP   MUTAGENESIS OF 312-PHE-PHE-313; PHE-312 AND PHE-313.
RX   PubMed=29429898; DOI=10.1016/j.chembiol.2018.01.008;
RA   Kim H.T., Na B.K., Chung J., Kim S., Kwon S.K., Cha H., Son J., Cho J.M.,
RA   Hwang K.Y.;
RT   "Structural Basis for Inhibitor-Induced Hydrogen Peroxide Production by
RT   Kynurenine 3-Monooxygenase.";
RL   Cell Chem. Biol. 0:0-0(2018).
CC   -!- FUNCTION: Catalyzes the hydroxylation of L-kynurenine (L-Kyn) to form
CC       3-hydroxy-L-kynurenine (L-3OHKyn) (PubMed:29429898, PubMed:23575632,
CC       PubMed:26752518, PubMed:28604669, PubMed:29208702). Required for
CC       synthesis of quinolinic acid, a neurotoxic NMDA receptor antagonist and
CC       potential endogenous inhibitor of NMDA receptor signaling in axonal
CC       targeting, synaptogenesis and apoptosis during brain development.
CC       Quinolinic acid may also affect NMDA receptor signaling in pancreatic
CC       beta cells, osteoblasts, myocardial cells, and the gastrointestinal
CC       tract (Probable). {ECO:0000269|PubMed:23575632,
CC       ECO:0000269|PubMed:26752518, ECO:0000269|PubMed:28604669,
CC       ECO:0000269|PubMed:29208702, ECO:0000269|PubMed:29429898,
CC       ECO:0000305|PubMed:12402501}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + L-kynurenine + NADPH + O2 = 3-hydroxy-L-kynurenine +
CC         H2O + NADP(+); Xref=Rhea:RHEA:20545, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:57959, ChEBI:CHEBI:58125, ChEBI:CHEBI:58349;
CC         EC=1.14.13.9; Evidence={ECO:0000255|HAMAP-Rule:MF_03018,
CC         ECO:0000269|PubMed:10672018, ECO:0000269|PubMed:29429898,
CC         ECO:0000269|PubMed:9237672};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03018,
CC         ECO:0000269|PubMed:10672018, ECO:0000269|PubMed:29429898};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=24.1 uM for L-kynurenine {ECO:0000269|PubMed:10672018,
CC         ECO:0000269|PubMed:23575632, ECO:0000269|PubMed:9237672};
CC         KM=2 uM for L-kynurenine {ECO:0000269|PubMed:26752518};
CC         KM=78 uM for L-kynurenine {ECO:0000269|PubMed:26752518};
CC         Vmax=8.5 umol/min/mg enzyme {ECO:0000269|PubMed:10672018,
CC         ECO:0000269|PubMed:9237672};
CC         Note=Kcat is 0.24 sec(-1) for L-kynurenine.
CC         {ECO:0000269|PubMed:28604669};
CC       pH dependence:
CC         Optimum pH is 7.5. {ECO:0000269|PubMed:10672018,
CC         ECO:0000269|PubMed:9237672};
CC   -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; quinolinate from
CC       L-kynurenine: step 1/3. {ECO:0000255|HAMAP-Rule:MF_03018}.
CC   -!- INTERACTION:
CC       O15229-2; P42858: HTT; NbExp=3; IntAct=EBI-21870540, EBI-466029;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000255|HAMAP-
CC       Rule:MF_03018, ECO:0000269|PubMed:9237672}; Multi-pass membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_03018, ECO:0000269|PubMed:9237672}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1 {ECO:0000269|PubMed:10672018, ECO:0000269|PubMed:9237672};
CC         IsoId=O15229-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:16710414};
CC         IsoId=O15229-2; Sequence=VSP_051973;
CC       Name=3 {ECO:0000269|PubMed:16710414};
CC         IsoId=O15229-3; Sequence=VSP_051972;
CC   -!- TISSUE SPECIFICITY: Highest levels in placenta and liver. Detectable in
CC       kidney. {ECO:0000269|PubMed:9237672}.
CC   -!- DOMAIN: Transmembrane domains are required for enzymatic activity.
CC       {ECO:0000269|PubMed:29208702, ECO:0000269|PubMed:29429898}.
CC   -!- MISCELLANEOUS: Increased in neuroinflammatory conditions. Inhibitors
CC       are investigated as potential neuroprotective drugs since they lead to
CC       an increased level of kynurenic acid, a neuroprotective NMDA receptor
CC       agonist. {ECO:0000269|PubMed:9237672}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Gene model based on mouse cDNA data.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the aromatic-ring hydroxylase family. KMO
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_03018}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y13153; CAA73613.1; -; mRNA.
DR   EMBL; AF056032; AAC62615.1; -; mRNA.
DR   EMBL; AL133390; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FO393423; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS1618.1; -. [O15229-1]
DR   RefSeq; NP_003670.2; NM_003679.4. [O15229-1]
DR   PDB; 5X68; X-ray; 2.10 A; A/B=1-374.
DR   PDBsum; 5X68; -.
DR   SMR; O15229; -.
DR   BioGRID; 114133; 5.
DR   IntAct; O15229; 4.
DR   STRING; 9606.ENSP00000355517; -.
DR   BindingDB; O15229; -.
DR   ChEMBL; CHEMBL2145; -.
DR   GuidetoPHARMACOLOGY; 2886; -.
DR   GlyGen; O15229; 1 site.
DR   iPTMnet; O15229; -.
DR   PhosphoSitePlus; O15229; -.
DR   BioMuta; KMO; -.
DR   jPOST; O15229; -.
DR   MassIVE; O15229; -.
DR   MaxQB; O15229; -.
DR   PaxDb; O15229; -.
DR   PeptideAtlas; O15229; -.
DR   PRIDE; O15229; -.
DR   ProteomicsDB; 48519; -. [O15229-1]
DR   ProteomicsDB; 48520; -. [O15229-2]
DR   ProteomicsDB; 48521; -. [O15229-3]
DR   Antibodypedia; 34702; 187 antibodies.
DR   DNASU; 8564; -.
DR   Ensembl; ENST00000366557; ENSP00000355515; ENSG00000117009. [O15229-3]
DR   Ensembl; ENST00000366558; ENSP00000355516; ENSG00000117009. [O15229-2]
DR   Ensembl; ENST00000366559; ENSP00000355517; ENSG00000117009. [O15229-1]
DR   GeneID; 8564; -.
DR   KEGG; hsa:8564; -.
DR   UCSC; uc001hyy.4; human. [O15229-1]
DR   CTD; 8564; -.
DR   DisGeNET; 8564; -.
DR   GeneCards; KMO; -.
DR   HGNC; HGNC:6381; KMO.
DR   HPA; ENSG00000117009; Tissue enhanced (blood, liver, placenta).
DR   MIM; 603538; gene.
DR   neXtProt; NX_O15229; -.
DR   OpenTargets; ENSG00000117009; -.
DR   PharmGKB; PA30172; -.
DR   VEuPathDB; HostDB:ENSG00000117009.11; -.
DR   eggNOG; KOG2614; Eukaryota.
DR   GeneTree; ENSGT00390000000747; -.
DR   HOGENOM; CLU_023210_0_0_1; -.
DR   InParanoid; O15229; -.
DR   OMA; NLAMSNR; -.
DR   OrthoDB; 462247at2759; -.
DR   PhylomeDB; O15229; -.
DR   TreeFam; TF312990; -.
DR   BioCyc; MetaCyc:HS04082-MONOMER; -.
DR   BRENDA; 1.14.13.9; 2681.
DR   PathwayCommons; O15229; -.
DR   Reactome; R-HSA-71240; Tryptophan catabolism.
DR   SABIO-RK; O15229; -.
DR   UniPathway; UPA00253; UER00328.
DR   BioGRID-ORCS; 8564; 6 hits in 985 CRISPR screens.
DR   ChiTaRS; KMO; human.
DR   GeneWiki; KMO_(gene); -.
DR   GenomeRNAi; 8564; -.
DR   Pharos; O15229; Tchem.
DR   PRO; PR:O15229; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O15229; protein.
DR   Bgee; ENSG00000117009; Expressed in placenta and 150 other tissues.
DR   ExpressionAtlas; O15229; baseline and differential.
DR   Genevisible; O15229; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISS:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0004502; F:kynurenine 3-monooxygenase activity; IDA:UniProtKB.
DR   GO; GO:0016174; F:NAD(P)H oxidase H2O2-forming activity; IDA:UniProtKB.
DR   GO; GO:0034354; P:'de novo' NAD biosynthetic process from tryptophan; IEA:UniProtKB-UniRule.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0043420; P:anthranilate metabolic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0034276; P:kynurenic acid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0070189; P:kynurenine metabolic process; IDA:UniProtKB.
DR   GO; GO:0097052; P:L-kynurenine metabolic process; IEA:Ensembl.
DR   GO; GO:0019674; P:NAD metabolic process; IDA:UniProtKB.
DR   GO; GO:1903296; P:positive regulation of glutamate secretion, neurotransmission; IEA:Ensembl.
DR   GO; GO:1901216; P:positive regulation of neuron death; IEA:Ensembl.
DR   GO; GO:0019805; P:quinolinate biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0009651; P:response to salt stress; IDA:UniProtKB.
DR   GO; GO:0006569; P:tryptophan catabolic process; TAS:Reactome.
DR   Gene3D; 3.50.50.60; -; 1.
DR   HAMAP; MF_01971; Kynurenine_monooxygenase; 1.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR027545; Kynurenine_monooxygenase.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; FAD; Flavoprotein; Glycoprotein;
KW   Membrane; Mitochondrion; Mitochondrion outer membrane; Monooxygenase; NADP;
KW   Oxidoreductase; Pyridine nucleotide biosynthesis; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..486
FT                   /note="Kynurenine 3-monooxygenase"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000229742"
FT   TRANSMEM        385..404
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03018"
FT   TRANSMEM        425..445
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03018"
FT   NP_BIND         37..40
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29429898,
FT                   ECO:0007744|PDB:5X68"
FT   NP_BIND         317..318
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29429898,
FT                   ECO:0007744|PDB:5X68"
FT   BINDING         19
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:29429898,
FT                   ECO:0007744|PDB:5X68"
FT   BINDING         57
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:29429898,
FT                   ECO:0007744|PDB:5X68"
FT   BINDING         85
FT                   /note="L-kynurenine"
FT                   /evidence="ECO:0000250|UniProtKB:Q84HF5"
FT   BINDING         99
FT                   /note="L-kynurenine"
FT                   /evidence="ECO:0000250|UniProtKB:Q84HF5"
FT   BINDING         111
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29429898,
FT                   ECO:0007744|PDB:5X68"
FT   BINDING         136
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:29429898,
FT                   ECO:0007744|PDB:5X68"
FT   BINDING         172
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:29429898,
FT                   ECO:0007744|PDB:5X68"
FT   BINDING         304
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:29429898,
FT                   ECO:0007744|PDB:5X68"
FT   BINDING         363
FT                   /note="L-kynurenine"
FT                   /evidence="ECO:0000250|UniProtKB:Q84HF5"
FT   BINDING         398
FT                   /note="L-kynurenine"
FT                   /evidence="ECO:0000250|UniProtKB:Q84HF5"
FT   CARBOHYD        465
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:29429898"
FT   VAR_SEQ         367..400
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16710414"
FT                   /id="VSP_051972"
FT   VAR_SEQ         367..379
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16710414"
FT                   /id="VSP_051973"
FT   VARIANT         452
FT                   /note="R -> C (in dbSNP:rs1053230)"
FT                   /evidence="ECO:0000269|PubMed:10672018,
FT                   ECO:0000269|PubMed:9237672"
FT                   /id="VAR_030845"
FT   MUTAGEN         85
FT                   /note="R->A,K: Abolishes kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         99
FT                   /note="Y->A: Abolishes kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         99
FT                   /note="Y->F: Strongly decreases kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         312..313
FT                   /note="FF->AA: Abolishes NADPH oxidase activity."
FT                   /evidence="ECO:0000269|PubMed:29429898"
FT   MUTAGEN         312
FT                   /note="F->A: Decreases to 30% NADPH oxidase activity."
FT                   /evidence="ECO:0000269|PubMed:29429898"
FT   MUTAGEN         313
FT                   /note="F->A: Decreases to 50% NADPH oxidase activity."
FT                   /evidence="ECO:0000269|PubMed:29429898"
FT   MUTAGEN         363
FT                   /note="N->A: Strongly decreases kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         363
FT                   /note="N->D: Abolishes kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         366
FT                   /note="E->A,Q: Strongly decreases kynurenine 3-
FT                   monooxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         367
FT                   /note="M->A: Strongly decreases kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         367
FT                   /note="M->L: Strongly decreases kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         398
FT                   /note="Y->A,F: Abolishes kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         465
FT                   /note="N->A: Not glycosylted. Reduces to 80% kynurenine 3-
FT                   monooxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   STRAND          10..14
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   HELIX           18..28
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   TURN            29..31
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          33..37
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   TURN            43..45
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          55..58
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   HELIX           60..68
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   HELIX           72..76
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          80..82
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          84..88
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          94..98
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   HELIX           102..104
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          106..110
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   HELIX           111..123
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          128..131
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          138..140
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   TURN            141..144
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          145..148
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          156..159
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          161..165
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   HELIX           172..177
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          189..199
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          202..205
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          212..217
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          222..227
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          233..240
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   HELIX           241..244
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   HELIX           250..260
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   HELIX           264..268
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   HELIX           270..277
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          283..286
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          288..290
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          293..295
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   TURN            296..298
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          299..301
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   HELIX           303..305
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   TURN            311..313
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   HELIX           316..333
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   TURN            334..336
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   HELIX           338..349
FT                   /evidence="ECO:0007829|PDB:5X68"
FT   STRAND          363..365
FT                   /evidence="ECO:0007829|PDB:5X68"
SQ   SEQUENCE   486 AA;  55810 MW;  164870D52E62A08A CRC64;
     MDSSVIQRKK VAVIGGGLVG SLQACFLAKR NFQIDVYEAR EDTRVATFTR GRSINLALSH
     RGRQALKAVG LEDQIVSQGI PMRARMIHSL SGKKSAIPYG TKSQYILSVS RENLNKDLLT
     AAEKYPNVKM HFNHRLLKCN PEEGMITVLG SDKVPKDVTC DLIVGCDGAY STVRSHLMKK
     PRFDYSQQYI PHGYMELTIP PKNGDYAMEP NYLHIWPRNT FMMIALPNMN KSFTCTLFMP
     FEEFEKLLTS NDVVDFFQKY FPDAIPLIGE KLLVQDFFLL PAQPMISVKC SSFHFKSHCV
     LLGDAAHAIV PFFGQGMNAG FEDCLVFDEL MDKFSNDLSL CLPVFSRLRI PDDHAISDLS
     MYNYIEMRAH VNSSWFIFQK NMERFLHAIM PSTFIPLYTM VTFSRIRYHE AVQRWHWQKK
     VINKGLFFLG SLIAISSTYL LIHYMSPRSF LRLRRPWNWI AHFRNTTCFP AKAVDSLEQI
     SNLISR
//
ID   MNMG_CHLTE              Reviewed;         621 AA.
AC   Q8KA85;
DT   09-MAY-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   02-JUN-2021, entry version 104.
DE   RecName: Full=tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG;
DE   AltName: Full=Glucose-inhibited division protein A;
GN   Name=mnmG; Synonyms=gidA; OrderedLocusNames=CT2283;
OS   Chlorobaculum tepidum (strain ATCC 49652 / DSM 12025 / NBRC 103806 / TLS)
OS   (Chlorobium tepidum).
OC   Bacteria; Chlorobi; Chlorobia; Chlorobiales; Chlorobiaceae; Chlorobaculum.
OX   NCBI_TaxID=194439;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 49652 / DSM 12025 / NBRC 103806 / TLS;
RX   PubMed=12093901; DOI=10.1073/pnas.132181499;
RA   Eisen J.A., Nelson K.E., Paulsen I.T., Heidelberg J.F., Wu M., Dodson R.J.,
RA   DeBoy R.T., Gwinn M.L., Nelson W.C., Haft D.H., Hickey E.K., Peterson J.D.,
RA   Durkin A.S., Kolonay J.F., Yang F., Holt I.E., Umayam L.A., Mason T.M.,
RA   Brenner M., Shea T.P., Parksey D.S., Nierman W.C., Feldblyum T.V.,
RA   Hansen C.L., Craven M.B., Radune D., Vamathevan J.J., Khouri H.M.,
RA   White O., Gruber T.M., Ketchum K.A., Venter J.C., Tettelin H., Bryant D.A.,
RA   Fraser C.M.;
RT   "The complete genome sequence of Chlorobium tepidum TLS, a photosynthetic,
RT   anaerobic, green-sulfur bacterium.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:9509-9514(2002).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) IN COMPLEX WITH FAD, AND SUBUNIT.
RX   PubMed=18565343; DOI=10.1016/j.jmb.2008.04.072;
RA   Meyer S., Scrima A., Versees W., Wittinghofer A.;
RT   "Crystal structures of the conserved tRNA-modifying enzyme GidA:
RT   implications for its interaction with MnmE and substrate.";
RL   J. Mol. Biol. 380:532-547(2008).
CC   -!- FUNCTION: NAD-binding protein involved in the addition of a
CC       carboxymethylaminomethyl (cmnm) group at the wobble position (U34) of
CC       certain tRNAs, forming tRNA-cmnm(5)s(2)U34. {ECO:0000250}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- SUBUNIT: Homodimer. Heterotetramer of two MnmE and two MnmG subunits
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the MnmG family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE006470; AAM73496.1; -; Genomic_DNA.
DR   RefSeq; NP_663154.1; NC_002932.3.
DR   RefSeq; WP_010933931.1; NC_002932.3.
DR   PDB; 3CP8; X-ray; 3.20 A; A/B/C/D=1-621.
DR   PDBsum; 3CP8; -.
DR   SMR; Q8KA85; -.
DR   STRING; 194439.CT2283; -.
DR   EnsemblBacteria; AAM73496; AAM73496; CT2283.
DR   KEGG; cte:CT2283; -.
DR   PATRIC; fig|194439.7.peg.2076; -.
DR   eggNOG; COG0445; Bacteria.
DR   HOGENOM; CLU_007831_2_2_10; -.
DR   OMA; FRPGYAI; -.
DR   OrthoDB; 146811at2; -.
DR   BioCyc; CTEP194439:G1FZE-2332-MONOMER; -.
DR   EvolutionaryTrace; Q8KA85; -.
DR   Proteomes; UP000001007; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0002098; P:tRNA wobble uridine modification; IEA:InterPro.
DR   Gene3D; 3.50.50.60; -; 2.
DR   HAMAP; MF_00129; MnmG_GidA; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR026904; GidA-assoc_3.
DR   InterPro; IPR004416; MnmG.
DR   InterPro; IPR002218; MnmG-rel.
DR   InterPro; IPR020595; MnmG-rel_CS.
DR   InterPro; IPR040131; MnmG_N.
DR   PANTHER; PTHR11806; PTHR11806; 1.
DR   PANTHER; PTHR11806:SF0; PTHR11806:SF0; 1.
DR   Pfam; PF01134; GIDA; 1.
DR   Pfam; PF13932; GIDA_assoc; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR00136; gidA; 1.
DR   PROSITE; PS01280; GIDA_1; 1.
DR   PROSITE; PS01281; GIDA_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; FAD; Flavoprotein; NAD; Reference proteome;
KW   tRNA processing.
FT   CHAIN           1..621
FT                   /note="tRNA uridine 5-carboxymethylaminomethyl modification
FT                   enzyme MnmG"
FT                   /id="PRO_0000117086"
FT   NP_BIND         8..13
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18565343"
FT   NP_BIND         269..283
FT                   /note="NAD"
FT                   /evidence="ECO:0000255"
FT   BINDING         120
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:18565343"
FT   BINDING         366
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18565343"
FT   STRAND          2..7
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           11..22
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          27..32
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           34..36
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          44..47
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           49..61
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           65..72
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          73..79
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          81..83
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   TURN            85..87
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          89..94
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           96..108
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          113..117
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          120..126
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          129..135
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          140..148
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          157..160
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          163..166
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          168..170
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           179..185
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          190..197
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          200..202
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           203..205
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   TURN            208..210
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          211..214
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          223..226
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           231..233
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          238..242
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           245..252
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   TURN            253..257
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           277..282
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          290..297
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          302..306
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           314..321
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          332..334
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          337..344
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           346..348
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          353..359
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          361..363
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           366..368
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           373..392
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   TURN            401..403
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           405..415
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   TURN            424..426
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           433..435
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           437..439
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           440..450
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           456..478
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           483..493
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           505..508
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          509..512
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           515..519
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           523..528
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           531..534
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           536..547
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           549..565
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   STRAND          572..574
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           586..593
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           598..601
FT                   /evidence="ECO:0007829|PDB:3CP8"
FT   HELIX           609..616
FT                   /evidence="ECO:0007829|PDB:3CP8"
SQ   SEQUENCE   621 AA;  68097 MW;  752ED5CA7F9A38BF CRC64;
     MYDVIVVGAG HAGCEAALAV ARGGLHCLLI TSDLSAVARM SCNPAIGGVA KGQITREIDA
     LGGEMGKAID ATGIQFRMLN RSKGPAMHSP RAQADKTQYS LYMRRIVEHE PNIDLLQDTV
     IGVSANSGKF SSVTVRSGRA IQAKAAILAC GTFLNGLIHI GMDHFPGGRS TAEPPVEGLT
     ESLASLGFSF GRLKTGTPPR IDSRSVDYTI VTEQPGDVDP VPFSFSSTSV ANRNLVSCYL
     TKTTEKTHDI LRTGFDRSPL FTGKVQGVGP RYCPSIEDKI SRFPDKSSHH IFLEPEGTDT
     VEMYVNGFST SLPEDIQIAG LRSIPGLEEA KMIRPGYAIE YDFFHPWQIR STMETRPVEN
     LFFAGQINGT SGYEEAAAQG LMAGINAVRK ILGKELIVLG RDQAYIGVLI DDLITKETKE
     PYRMFTSSAE HRLILRHDNA DLRLRKIGYD CNLVSSDDLH RTESIIKRVQ HCLEVMKTAK
     VTPAEINTLL MNKGLQELKT PARALSLIKR PGISLQDILE HSLSVRSAAE ELCNDPRVAE
     QVQIEIKYEG YIKREQLVAD RIARLDSLHI PDNFNYDSLN SLSSEGREKL LKHRPATIGQ
     ASRILGVSPS DVSILMIRLG R
//
ID   ILVB_ARATH              Reviewed;         670 AA.
AC   P17597; A0A174; Q5FV34; Q8L7Y7; Q94B64;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1990, sequence version 1.
DT   02-JUN-2021, entry version 185.
DE   RecName: Full=Acetolactate synthase, chloroplastic;
DE            Short=AtALS;
DE            EC=2.2.1.6;
DE   AltName: Full=Acetohydroxy-acid synthase;
DE   AltName: Full=Protein CHLORSULFURON RESISTANT 1;
DE   Flags: Precursor;
GN   Name=ALS; Synonyms=AHAS, CSR1, TZP5; OrderedLocusNames=At3g48560;
GN   ORFNames=T8P19.70;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RX   PubMed=16665813; DOI=10.1104/pp.85.4.1110;
RA   Mazur B.J., Chui C.F., Smith J.K.;
RT   "Isolation and characterization of plant genes coding for acetolactate
RT   synthase, the target enzyme for two classes of herbicides.";
RL   Plant Physiol. 85:1110-1117(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], MUTAGENESIS OF SER-653, AND FUNCTION.
RC   STRAIN=cv. Columbia;
RX   PubMed=2336405; DOI=10.1093/nar/18.8.2188;
RA   Sathasivan K., Haughn G.W., Murai N.;
RT   "Nucleotide sequence of a mutant acetolactate synthase gene from an
RT   imidazolinone-resistant Arabidopsis thaliana var. Columbia.";
RL   Nucleic Acids Res. 18:2188-2188(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130713; DOI=10.1038/35048706;
RA   Salanoubat M., Lemcke K., Rieger M., Ansorge W., Unseld M., Fartmann B.,
RA   Valle G., Bloecker H., Perez-Alonso M., Obermaier B., Delseny M.,
RA   Boutry M., Grivell L.A., Mache R., Puigdomenech P., De Simone V.,
RA   Choisne N., Artiguenave F., Robert C., Brottier P., Wincker P.,
RA   Cattolico L., Weissenbach J., Saurin W., Quetier F., Schaefer M.,
RA   Mueller-Auer S., Gabel C., Fuchs M., Benes V., Wurmbach E., Drzonek H.,
RA   Erfle H., Jordan N., Bangert S., Wiedelmann R., Kranz H., Voss H.,
RA   Holland R., Brandt P., Nyakatura G., Vezzi A., D'Angelo M., Pallavicini A.,
RA   Toppo S., Simionati B., Conrad A., Hornischer K., Kauer G., Loehnert T.-H.,
RA   Nordsiek G., Reichelt J., Scharfe M., Schoen O., Bargues M., Terol J.,
RA   Climent J., Navarro P., Collado C., Perez-Perez A., Ottenwaelder B.,
RA   Duchemin D., Cooke R., Laudie M., Berger-Llauro C., Purnelle B., Masuy D.,
RA   de Haan M., Maarse A.C., Alcaraz J.-P., Cottet A., Casacuberta E.,
RA   Monfort A., Argiriou A., Flores M., Liguori R., Vitale D., Mannhaupt G.,
RA   Haase D., Schoof H., Rudd S., Zaccaria P., Mewes H.-W., Mayer K.F.X.,
RA   Kaul S., Town C.D., Koo H.L., Tallon L.J., Jenkins J., Rooney T., Rizzo M.,
RA   Walts A., Utterback T., Fujii C.Y., Shea T.P., Creasy T.H., Haas B.,
RA   Maiti R., Wu D., Peterson J., Van Aken S., Pai G., Militscher J.,
RA   Sellers P., Gill J.E., Feldblyum T.V., Preuss D., Lin X., Nierman W.C.,
RA   Salzberg S.L., White O., Venter J.C., Fraser C.M., Kaneko T., Nakamura Y.,
RA   Sato S., Kato T., Asamizu E., Sasamoto S., Kimura T., Idesawa K.,
RA   Kawashima K., Kishida Y., Kiyokawa C., Kohara M., Matsumoto M., Matsuno A.,
RA   Muraki A., Nakayama S., Nakazaki N., Shinpo S., Takeuchi C., Wada T.,
RA   Watanabe A., Yamada M., Yasuda M., Tabata S.;
RT   "Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana.";
RL   Nature 408:820-822(2000).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=cv. Landsberg erecta;
RA   Jander G., Baerson S.R., Hudak J.A., Gonzalez K.A., Gruys K.J., Last R.L.;
RT   "Saturation mutagenesis in Arabidopsis to determine frequency of herbicide
RT   resistance.";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J., Southwick A.M.,
RA   Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F., Karlin-Newmann G.,
RA   Liu S.X., Lam B., Sakano H., Wu T., Yu G., Miranda M., Quach H.L.,
RA   Tripp M., Chang C.H., Lee J.M., Toriumi M.J., Chan M.M., Tang C.C.,
RA   Onodera C.S., Deng J.M., Akiyama K., Ansari Y., Arakawa T., Banh J.,
RA   Banno F., Bowser L., Brooks S.Y., Carninci P., Chao Q., Choy N., Enju A.,
RA   Goldsmith A.D., Gurjal M., Hansen N.F., Hayashizaki Y., Johnson-Hopson C.,
RA   Hsuan V.W., Iida K., Karnes M., Khan S., Koesema E., Ishida J., Jiang P.X.,
RA   Jones T., Kawai J., Kamiya A., Meyers C., Nakajima M., Narusaka M.,
RA   Seki M., Sakurai T., Satou M., Tamse R., Vaysberg M., Wallender E.K.,
RA   Wong C., Yamamura Y., Yuan S., Shinozaki K., Davis R.W., Theologis A.,
RA   Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RA   Cheuk R.F., Chen H., Kim C.J., Shinn P., Ecker J.R.;
RT   "Arabidopsis ORF clones.";
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Jiang L., Xiang W., Wang X., Wang X., Zhang J., Xi D., Gao A.;
RT   "Cloning of Arabidopsis thaliana acetolactate synthase catalytic subunit.";
RL   Submitted (SEP-2006) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   FUNCTION, AND MUTAGENESIS OF PRO-197.
RC   STRAIN=cv. Columbia;
RA   Haughn G.W., Smith J.K., Mazur B.J., Somerville C.;
RT   "Transformation with a mutant Arabidopsis acetolactate synthase gene
RT   renders tobacco resistant to sulfonylurea herbicides.";
RL   Mol. Gen. Genet. 211:266-271(1988).
RN   [10]
RP   FUNCTION.
RX   PubMed=16667374; DOI=10.1104/pp.92.4.1081;
RA   Haughn G.W., Somerville C.R.;
RT   "A mutation causing imidazolinone resistance maps to the csr1 locus of
RT   Arabidopsis thaliana.";
RL   Plant Physiol. 92:1081-1085(1990).
RN   [11]
RP   FUNCTION, AND MUTAGENESIS OF SER-653.
RC   STRAIN=cv. Columbia;
RX   PubMed=16668488; DOI=10.1104/pp.97.3.1044;
RA   Sathasivan K., Haughn G.W., Murai N.;
RT   "Molecular basis of imidazolinone herbicide resistance in Arabidopsis
RT   thaliana var Columbia.";
RL   Plant Physiol. 97:1044-1050(1991).
RN   [12]
RP   3D-STRUCTURE MODELING, FUNCTION, AND MUTAGENESIS OF MET-124 AND ARG-199.
RX   PubMed=8913312; DOI=10.1006/jmbi.1996.0580;
RA   Ott K.H., Kwagh J.G., Stockton G.W., Sidorov V., Kakefuda G.;
RT   "Rational molecular design and genetic engineering of herbicide resistant
RT   crops by structure modeling and site-directed mutagenesis of
RT   acetohydroxyacid synthase.";
RL   J. Mol. Biol. 263:359-368(1996).
RN   [13]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, ACTIVITY REGULATION, AND
RP   SUBUNIT.
RX   PubMed=9355748; DOI=10.1042/bj3270161;
RA   Chang A.K., Duggleby R.G.;
RT   "Expression, purification and characterization of Arabidopsis thaliana
RT   acetohydroxyacid synthase.";
RL   Biochem. J. 327:161-169(1997).
RN   [14]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, AND MUTAGENESIS OF
RP   ALA-122; TRP-574 AND SER-653.
RX   PubMed=9677339; DOI=10.1042/bj3330765;
RA   Chang A.K., Duggleby R.G.;
RT   "Herbicide-resistant forms of Arabidopsis thaliana acetohydroxyacid
RT   synthase: characterization of the catalytic properties and sensitivity to
RT   inhibitors of four defined mutants.";
RL   Biochem. J. 333:765-777(1998).
RN   [15]
RP   FUNCTION, AND MUTAGENESIS OF SER-653.
RX   PubMed=10386618; DOI=10.1016/s0014-5793(99)00668-7;
RA   Lee Y.T., Chang A.K., Duggleby R.G.;
RT   "Effect of mutagenesis at serine 653 of Arabidopsis thaliana
RT   acetohydroxyacid synthase on the sensitivity to imidazolinone and
RT   sulfonylurea herbicides.";
RL   FEBS Lett. 452:341-345(1999).
RN   [16]
RP   3D-STRUCTURE MODELING, AND ACTIVITY REGULATION.
RX   PubMed=19342247; DOI=10.1016/j.bmc.2009.03.018;
RA   Chen C.N., Lv L.L., Ji F.Q., Chen Q., Xu H., Niu C.W., Xi Z., Yang G.F.;
RT   "Design and synthesis of N-2,6-difluorophenyl-5-methoxyl-1,2,4-
RT   triazolo[1,5-a]-pyrimidine-2-sulfonamide as acetohydroxyacid synthase
RT   inhibitor.";
RL   Bioorg. Med. Chem. 17:3011-3017(2009).
RN   [17]
RP   3D-STRUCTURE MODELING, AND ACTIVITY REGULATION.
RX   PubMed=20598554; DOI=10.1016/j.bmc.2010.06.015;
RA   Chen C.N., Chen Q., Liu Y.C., Zhu X.L., Niu C.W., Xi Z., Yang G.F.;
RT   "Syntheses and herbicidal activity of new triazolopyrimidine-2-sulfonamides
RT   as acetohydroxyacid synthase inhibitor.";
RL   Bioorg. Med. Chem. 18:4897-4904(2010).
RN   [18]
RP   3D-STRUCTURE MODELING, AND ACTIVITY REGULATION.
RX   PubMed=21838297; DOI=10.1021/jf2021607;
RA   Wang J., Tan H., Li Y., Ma Y., Li Z., Guddat L.W.;
RT   "Chemical synthesis, in vitro acetohydroxyacid synthase (AHAS) inhibition,
RT   herbicidal activity, and computational studies of isatin derivatives.";
RL   J. Agric. Food Chem. 59:9892-9900(2011).
RN   [19]
RP   3D-STRUCTURE MODELING, AND ACTIVITY REGULATION.
RX   PubMed=22905906; DOI=10.1021/jf302206x;
RA   Shang J., Wang W.M., Li Y.H., Song H.B., Li Z.M., Wang J.G.;
RT   "Synthesis, crystal structure, in vitro acetohydroxyacid synthase
RT   inhibition, in vivo herbicidal activity, and 3D-QSAR of new asymmetric aryl
RT   disulfides.";
RL   J. Agric. Food Chem. 60:8286-8293(2012).
RN   [20]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=22430369; DOI=10.1007/s11248-012-9597-z;
RA   Schnell J., Labbe H., Kovinich N., Manabe Y., Miki B.;
RT   "Comparability of imazapyr-resistant Arabidopsis created by transgenesis
RT   and mutagenesis.";
RL   Transgenic Res. 21:1255-1264(2012).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 86-667 IN COMPLEX WITH FAD;
RP   MAGNESIUM; THIAMINE PYROPHOSPHATE AND HERBICIDES, OXIDATION AT CYS-340, AND
RP   SUBUNIT.
RX   PubMed=16407096; DOI=10.1073/pnas.0508701103;
RA   McCourt J.A., Pang S.S., King-Scott J., Guddat L.W., Duggleby R.G.;
RT   "Herbicide-binding sites revealed in the structure of plant
RT   acetohydroxyacid synthase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:569-573(2006).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 87-670 IN COMPLEX WITH MAGNESIUM
RP   AND SULFONYLUREA HERBICIDES, AND OXIDATION AT CYS-340.
RX   PubMed=19187232; DOI=10.1111/j.1742-4658.2009.06863.x;
RA   Wang J.G., Lee P.K., Dong Y.H., Pang S.S., Duggleby R.G., Li Z.M.,
RA   Guddat L.W.;
RT   "Crystal structures of two novel sulfonylurea herbicides in complex with
RT   Arabidopsis thaliana acetohydroxyacid synthase.";
RL   FEBS J. 276:1282-1290(2009).
CC   -!- FUNCTION: Catalyzes the formation of acetolactate from pyruvate, the
CC       first step in valine and isoleucine biosynthesis.
CC       {ECO:0000269|PubMed:10386618, ECO:0000269|PubMed:16665813,
CC       ECO:0000269|PubMed:16667374, ECO:0000269|PubMed:16668488,
CC       ECO:0000269|PubMed:2336405, ECO:0000269|PubMed:8913312,
CC       ECO:0000269|PubMed:9355748, ECO:0000269|PubMed:9677339,
CC       ECO:0000269|Ref.9}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + 2 pyruvate = (2S)-2-acetolactate + CO2;
CC         Xref=Rhea:RHEA:25249, ChEBI:CHEBI:15361, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:58476; EC=2.2.1.6;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Binds 1 Mg(2+) ion per subunit.;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- COFACTOR:
CC       Name=thiamine diphosphate; Xref=ChEBI:CHEBI:58937;
CC       Note=Binds 1 thiamine pyrophosphate per subunit.;
CC   -!- ACTIVITY REGULATION: Inhibited by asymmetric aryl disulfides,
CC       triazolopyrimidine sulfonanilide compounds, isatin derivatives, and
CC       sulfonylurea and imidazolinone herbicides. Insensitive to feed-back
CC       inhibition by branched-chain amino acids. {ECO:0000269|PubMed:19342247,
CC       ECO:0000269|PubMed:20598554, ECO:0000269|PubMed:21838297,
CC       ECO:0000269|PubMed:22905906, ECO:0000269|PubMed:9355748}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 7.0-7.5. {ECO:0000269|PubMed:9355748,
CC         ECO:0000269|PubMed:9677339};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-isoleucine biosynthesis; L-
CC       isoleucine from 2-oxobutanoate: step 1/4.
CC   -!- PATHWAY: Amino-acid biosynthesis; L-valine biosynthesis; L-valine from
CC       pyruvate: step 1/4.
CC   -!- SUBUNIT: Homodimer or homotetramer. The acetolactate synthase complex
CC       contains both large catalytic subunits and small regulatory subunits.
CC       {ECO:0000269|PubMed:16407096, ECO:0000269|PubMed:19187232,
CC       ECO:0000269|PubMed:9355748}.
CC   -!- SUBCELLULAR LOCATION: Plastid, chloroplast {ECO:0000305}.
CC   -!- DISRUPTION PHENOTYPE: Lethal when homozygous.
CC       {ECO:0000269|PubMed:22430369}.
CC   -!- BIOTECHNOLOGY: Introduced by genetic manipulation and expressed in
CC       sulfonylurea resistant plants.
CC   -!- SIMILARITY: Belongs to the TPP enzyme family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X51514; CAA35887.1; -; Genomic_DNA.
DR   EMBL; AL133315; CAB62345.1; -; Genomic_DNA.
DR   EMBL; CP002686; AEE78430.1; -; Genomic_DNA.
DR   EMBL; AY124092; AAM92569.1; -; Genomic_DNA.
DR   EMBL; AY042819; AAK68759.1; -; mRNA.
DR   EMBL; BT020540; AAW70386.1; -; mRNA.
DR   EMBL; DQ991161; ABJ80681.1; -; mRNA.
DR   PIR; S09502; YCMU.
DR   RefSeq; NP_190425.1; NM_114714.3.
DR   PDB; 1YBH; X-ray; 2.50 A; A=86-667.
DR   PDB; 1YHY; X-ray; 2.70 A; A=86-667.
DR   PDB; 1YHZ; X-ray; 2.70 A; A=86-667.
DR   PDB; 1YI0; X-ray; 2.70 A; A=86-667.
DR   PDB; 1YI1; X-ray; 2.90 A; A=86-667.
DR   PDB; 1Z8N; X-ray; 2.80 A; A=86-667.
DR   PDB; 3E9Y; X-ray; 3.00 A; A=87-670.
DR   PDB; 3EA4; X-ray; 2.80 A; A=87-670.
DR   PDB; 5K2O; X-ray; 2.87 A; A=86-667.
DR   PDB; 5K3S; X-ray; 2.87 A; A=86-667.
DR   PDB; 5K6Q; X-ray; 2.95 A; A=86-667.
DR   PDB; 5K6R; X-ray; 2.73 A; A=86-667.
DR   PDB; 5K6T; X-ray; 2.76 A; A=86-667.
DR   PDB; 5WJ1; X-ray; 2.52 A; A=86-667.
DR   PDB; 6U9H; EM; 3.80 A; A/B/H/I/L/M/P/Q=86-670.
DR   PDB; 6VZ8; EM; 3.45 A; D/E/H/I/L/M/P/Q=86-670.
DR   PDBsum; 1YBH; -.
DR   PDBsum; 1YHY; -.
DR   PDBsum; 1YHZ; -.
DR   PDBsum; 1YI0; -.
DR   PDBsum; 1YI1; -.
DR   PDBsum; 1Z8N; -.
DR   PDBsum; 3E9Y; -.
DR   PDBsum; 3EA4; -.
DR   PDBsum; 5K2O; -.
DR   PDBsum; 5K3S; -.
DR   PDBsum; 5K6Q; -.
DR   PDBsum; 5K6R; -.
DR   PDBsum; 5K6T; -.
DR   PDBsum; 5WJ1; -.
DR   PDBsum; 6U9H; -.
DR   PDBsum; 6VZ8; -.
DR   SMR; P17597; -.
DR   BioGRID; 9334; 1.
DR   DIP; DIP-61092N; -.
DR   STRING; 3702.AT3G48560.1; -.
DR   BindingDB; P17597; -.
DR   ChEMBL; CHEMBL4263; -.
DR   MetOSite; P17597; -.
DR   PaxDb; P17597; -.
DR   PRIDE; P17597; -.
DR   ProteomicsDB; 228865; -.
DR   EnsemblPlants; AT3G48560.1; AT3G48560.1; AT3G48560.
DR   GeneID; 824015; -.
DR   Gramene; AT3G48560.1; AT3G48560.1; AT3G48560.
DR   KEGG; ath:AT3G48560; -.
DR   Araport; AT3G48560; -.
DR   TAIR; locus:2114525; AT3G48560.
DR   eggNOG; KOG4166; Eukaryota.
DR   HOGENOM; CLU_013748_1_2_1; -.
DR   InParanoid; P17597; -.
DR   OMA; MRSYNPV; -.
DR   OrthoDB; 1132247at2759; -.
DR   PhylomeDB; P17597; -.
DR   BioCyc; ARA:AT3G48560-MONOMER; -.
DR   BRENDA; 2.2.1.6; 399.
DR   SABIO-RK; P17597; -.
DR   UniPathway; UPA00047; UER00055.
DR   UniPathway; UPA00049; UER00059.
DR   EvolutionaryTrace; P17597; -.
DR   PRO; PR:P17597; -.
DR   Proteomes; UP000006548; Chromosome 3.
DR   ExpressionAtlas; P17597; baseline and differential.
DR   Genevisible; P17597; AT.
DR   GO; GO:0005948; C:acetolactate synthase complex; IBA:GO_Central.
DR   GO; GO:0009507; C:chloroplast; IDA:TAIR.
DR   GO; GO:0009570; C:chloroplast stroma; IDA:TAIR.
DR   GO; GO:0003984; F:acetolactate synthase activity; IDA:TAIR.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0030976; F:thiamine pyrophosphate binding; IEA:InterPro.
DR   GO; GO:0009097; P:isoleucine biosynthetic process; IBA:GO_Central.
DR   GO; GO:0009635; P:response to herbicide; IEA:UniProtKB-KW.
DR   GO; GO:0009099; P:valine biosynthetic process; IDA:TAIR.
DR   CDD; cd02015; TPP_AHAS; 1.
DR   InterPro; IPR012846; Acetolactate_synth_lsu.
DR   InterPro; IPR039368; AHAS_TPP.
DR   InterPro; IPR029035; DHS-like_NAD/FAD-binding_dom.
DR   InterPro; IPR029061; THDP-binding.
DR   InterPro; IPR012000; Thiamin_PyroP_enz_cen_dom.
DR   InterPro; IPR012001; Thiamin_PyroP_enz_TPP-bd_dom.
DR   InterPro; IPR000399; TPP-bd_CS.
DR   InterPro; IPR011766; TPP_enzyme-bd_C.
DR   Pfam; PF02775; TPP_enzyme_C; 1.
DR   Pfam; PF00205; TPP_enzyme_M; 1.
DR   Pfam; PF02776; TPP_enzyme_N; 1.
DR   SUPFAM; SSF52467; SSF52467; 1.
DR   SUPFAM; SSF52518; SSF52518; 2.
DR   TIGRFAMs; TIGR00118; acolac_lg; 1.
DR   PROSITE; PS00187; TPP_ENZYMES; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Amino-acid biosynthesis;
KW   Branched-chain amino acid biosynthesis; Chloroplast; Coiled coil; FAD;
KW   Flavoprotein; Genetically modified food; Herbicide resistance; Magnesium;
KW   Metal-binding; Oxidation; Plastid; Reference proteome;
KW   Thiamine pyrophosphate; Transferase; Transit peptide.
FT   TRANSIT         1..55
FT                   /note="Chloroplast"
FT                   /evidence="ECO:0000255"
FT   CHAIN           56..670
FT                   /note="Acetolactate synthase, chloroplastic"
FT                   /id="PRO_0000035655"
FT   NP_BIND         331..332
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16407096"
FT   NP_BIND         349..352
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16407096"
FT   NP_BIND         371..375
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16407096"
FT   NP_BIND         395..396
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16407096"
FT   NP_BIND         414..415
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16407096"
FT   NP_BIND         508..509
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16407096"
FT   REGION          1..94
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          376..377
FT                   /note="Sulfonylurea herbicides binding"
FT   REGION          487..488
FT                   /note="Thiamine pyrophosphate binding"
FT   REGION          511..513
FT                   /note="Thiamine pyrophosphate binding"
FT   REGION          538..540
FT                   /note="Thiamine pyrophosphate binding"
FT   REGION          565..570
FT                   /note="Thiamine pyrophosphate binding"
FT   COILED          414..446
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1..84
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   METAL           538
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000269|PubMed:16407096,
FT                   ECO:0000269|PubMed:19187232"
FT   METAL           565
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000269|PubMed:16407096,
FT                   ECO:0000269|PubMed:19187232"
FT   METAL           567
FT                   /note="Magnesium; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:16407096,
FT                   ECO:0000269|PubMed:19187232"
FT   BINDING         144
FT                   /note="Thiamine pyrophosphate"
FT                   /evidence="ECO:0000269|PubMed:16407096"
FT   BINDING         207
FT                   /note="Thiamine pyrophosphate"
FT                   /evidence="ECO:0000269|PubMed:16407096"
FT   BINDING         220
FT                   /note="Imidazolinone herbicides"
FT   BINDING         246
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16407096"
FT   BINDING         246
FT                   /note="Imidazolinone herbicides; via amide nitrogen"
FT   BINDING         256
FT                   /note="Sulfonylurea herbicides"
FT                   /evidence="ECO:0000269|PubMed:19187232"
FT   BINDING         308
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:16407096"
FT   BINDING         377
FT                   /note="Imidazolinone and sulfonylurea herbicides"
FT   BINDING         574
FT                   /note="Sulfonylurea herbicides"
FT                   /evidence="ECO:0000269|PubMed:19187232"
FT   BINDING         653
FT                   /note="Sulfonylurea herbicides"
FT                   /evidence="ECO:0000269|PubMed:19187232"
FT   MOD_RES         340
FT                   /note="Cysteine sulfinic acid (-SO2H)"
FT                   /evidence="ECO:0000269|PubMed:16407096,
FT                   ECO:0000269|PubMed:19187232"
FT   MUTAGEN         122
FT                   /note="A->V: Reduced catalytic activity. Resistant to
FT                   imidazolinone herbicides but not to sulfonylurea
FT                   herbicides."
FT                   /evidence="ECO:0000269|PubMed:9677339"
FT   MUTAGEN         124
FT                   /note="M->E: Reduced catalytic activity. Resistant to
FT                   imidazolinone herbicides and reduced sensitivity to
FT                   sulfonylurea herbicides."
FT                   /evidence="ECO:0000269|PubMed:8913312"
FT   MUTAGEN         124
FT                   /note="M->I: No effect on catalytic activity. Increased
FT                   resistance to imidazolinone herbicides."
FT                   /evidence="ECO:0000269|PubMed:8913312"
FT   MUTAGEN         197
FT                   /note="P->S: In csr1-1/GH50; resistant to sulfonylurea but
FT                   not to imidazolinone herbicides."
FT                   /evidence="ECO:0000269|Ref.9"
FT   MUTAGEN         199
FT                   /note="R->A,E: No effect on catalytic activity. Resistant
FT                   to imidazolinone herbicides but not to sulfonylurea
FT                   herbicides."
FT                   /evidence="ECO:0000269|PubMed:8913312"
FT   MUTAGEN         574
FT                   /note="W->L: Increased catalytic activity. Resistant to
FT                   imidazolinone and sulfonylurea herbicides."
FT                   /evidence="ECO:0000269|PubMed:9677339"
FT   MUTAGEN         574
FT                   /note="W->S: Slightly decreased catalytic activity.
FT                   Resistant to imidazolinone and sulfonylurea herbicides."
FT                   /evidence="ECO:0000269|PubMed:9677339"
FT   MUTAGEN         653
FT                   /note="S->A: No effect on catalytic activity or sensitivity
FT                   to herbicides."
FT                   /evidence="ECO:0000269|PubMed:10386618,
FT                   ECO:0000269|PubMed:16668488, ECO:0000269|PubMed:2336405,
FT                   ECO:0000269|PubMed:9677339"
FT   MUTAGEN         653
FT                   /note="S->F: No effect on catalytic activity. Resistant to
FT                   imidazolinone herbicides and also slightly sulfonylurea-
FT                   resistant."
FT                   /evidence="ECO:0000269|PubMed:10386618,
FT                   ECO:0000269|PubMed:16668488, ECO:0000269|PubMed:2336405,
FT                   ECO:0000269|PubMed:9677339"
FT   MUTAGEN         653
FT                   /note="S->N: In csr1-2/GH90; no effect on catalytic
FT                   activity. Resistant to imidazolinone but not to
FT                   sulfonylurea herbicides."
FT                   /evidence="ECO:0000269|PubMed:10386618,
FT                   ECO:0000269|PubMed:16668488, ECO:0000269|PubMed:2336405,
FT                   ECO:0000269|PubMed:9677339"
FT   MUTAGEN         653
FT                   /note="S->T: No effect on catalytic activity. Resistant to
FT                   imidazolinone herbicides but not to sulfonylurea
FT                   herbicides."
FT                   /evidence="ECO:0000269|PubMed:10386618,
FT                   ECO:0000269|PubMed:16668488, ECO:0000269|PubMed:2336405,
FT                   ECO:0000269|PubMed:9677339"
FT   CONFLICT        104
FT                   /note="V -> A (in Ref. 8; ABJ80681)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        161
FT                   /note="P -> S (in Ref. 8; ABJ80681)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        208
FT                   /note="E -> G (in Ref. 8; ABJ80681)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        466
FT                   /note="Y -> H (in Ref. 8; ABJ80681)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        555
FT                   /note="N -> Q (in Ref. 5; AAM92569)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        560
FT                   /note="V -> I (in Ref. 5; AAM92569)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        575
FT                   /note="E -> Q (in Ref. 6; AAK68759)"
FT                   /evidence="ECO:0000305"
FT   HELIX           99..108
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   TURN            109..111
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          114..117
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           121..123
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           124..132
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           144..158
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          162..166
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           170..173
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           176..185
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          189..195
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           198..200
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   TURN            201..204
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           211..215
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           216..218
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          219..224
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           228..230
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           231..243
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          244..246
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          249..255
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           256..260
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           274..279
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           286..298
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          300..306
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           308..310
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           314..324
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          328..330
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   TURN            332..336
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          340..342
FT                   /evidence="ECO:0007829|PDB:1YHZ"
FT   STRAND          345..348
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           355..363
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          365..371
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           376..379
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           382..384
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   TURN            385..388
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          389..396
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   TURN            398..402
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          403..405
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          408..413
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           415..428
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           430..433
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           438..450
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           464..475
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          480..483
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           487..494
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          503..505
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           516..526
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          532..537
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           538..543
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           544..546
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           547..553
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          558..564
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           569..578
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           591..593
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           601..607
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          612..615
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   HELIX           618..630
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          631..633
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          635..640
FT                   /evidence="ECO:0007829|PDB:1YBH"
FT   STRAND          648..650
FT                   /evidence="ECO:0007829|PDB:5WJ1"
FT   HELIX           657..659
FT                   /evidence="ECO:0007829|PDB:1YBH"
SQ   SEQUENCE   670 AA;  72585 MW;  DA697A8DD155F160 CRC64;
     MAAATTTTTT SSSISFSTKP SPSSSKSPLP ISRFSLPFSL NPNKSSSSSR RRGIKSSSPS
     SISAVLNTTT NVTTTPSPTK PTKPETFISR FAPDQPRKGA DILVEALERQ GVETVFAYPG
     GASMEIHQAL TRSSSIRNVL PRHEQGGVFA AEGYARSSGK PGICIATSGP GATNLVSGLA
     DALLDSVPLV AITGQVPRRM IGTDAFQETP IVEVTRSITK HNYLVMDVED IPRIIEEAFF
     LATSGRPGPV LVDVPKDIQQ QLAIPNWEQA MRLPGYMSRM PKPPEDSHLE QIVRLISESK
     KPVLYVGGGC LNSSDELGRF VELTGIPVAS TLMGLGSYPC DDELSLHMLG MHGTVYANYA
     VEHSDLLLAF GVRFDDRVTG KLEAFASRAK IVHIDIDSAE IGKNKTPHVS VCGDVKLALQ
     GMNKVLENRA EELKLDFGVW RNELNVQKQK FPLSFKTFGE AIPPQYAIKV LDELTDGKAI
     ISTGVGQHQM WAAQFYNYKK PRQWLSSGGL GAMGFGLPAA IGASVANPDA IVVDIDGDGS
     FIMNVQELAT IRVENLPVKV LLLNNQHLGM VMQWEDRFYK ANRAHTFLGD PAQEDEIFPN
     MLLFAAACGI PAARVTKKAD LREAIQTMLD TPGPYLLDVI CPHQEHVLPM IPSGGTFNDV
     ITEGDGRIKY
//
ID   NQO1_MOUSE              Reviewed;         274 AA.
AC   Q64669;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-JUN-2021, entry version 170.
DE   RecName: Full=NAD(P)H dehydrogenase [quinone] 1;
DE            EC=1.6.5.2;
DE   AltName: Full=Azoreductase;
DE   AltName: Full=DT-diaphorase;
DE            Short=DTD;
DE   AltName: Full=Menadione reductase;
DE   AltName: Full=NAD(P)H:quinone oxidoreductase 1;
DE   AltName: Full=Phylloquinone reductase;
DE   AltName: Full=Quinone reductase 1;
DE            Short=QR1;
GN   Name=Nqo1; Synonyms=Dia4, Nmo1, Nmor1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6 X CBA; TISSUE=Liver;
RX   PubMed=7704040;
RA   Vasiliou V., Theurer M.J., Puga A., Reuter S.F., Nebert D.W.;
RT   "Mouse dioxin-inducible NAD(P)H: menadione oxidoreductase: NMO1 cDNA
RT   sequence and genetic differences in mRNA levels.";
RL   Pharmacogenetics 4:341-348(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, CLEAVAGE OF INITIATOR
RP   METHIONINE, AND ACETYLATION AT ALA-2.
RC   TISSUE=Liver;
RX   PubMed=7527260; DOI=10.1002/pro.5560030816;
RA   Chen S., Clarke P.E., Martino P.A., Deng P.S., Yeh C.H., Lee T.D.,
RA   Prochaska H.J., Talalay P.;
RT   "Mouse liver NAD(P)H:quinone acceptor oxidoreductase: protein sequence
RT   analysis by tandem mass spectrometry, cDNA cloning, expression in
RT   Escherichia coli, and enzyme activity analysis.";
RL   Protein Sci. 3:1296-1304(1994).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Heart, Kidney, Liver, Lung, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH FAD, AND SUBUNIT.
RX   PubMed=10706635; DOI=10.1073/pnas.97.7.3177;
RA   Faig M., Bianchet M.A., Talalay P., Chen S., Winski S., Ross D.,
RA   Amzel L.M.;
RT   "Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases:
RT   species comparison and structural changes with substrate binding and
RT   release.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:3177-3182(2000).
CC   -!- FUNCTION: The enzyme apparently serves as a quinone reductase in
CC       connection with conjugation reactions of hydroquinons involved in
CC       detoxification pathways as well as in biosynthetic processes such as
CC       the vitamin K-dependent gamma-carboxylation of glutamate residues in
CC       prothrombin synthesis. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADH = a quinol + NAD(+);
CC         Xref=Rhea:RHEA:46160, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:132124; EC=1.6.5.2;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADPH = a quinol + NADP(+);
CC         Xref=Rhea:RHEA:46164, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:132124; EC=1.6.5.2;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:10706635}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- INDUCTION: By polycyclic hydrocarbons such as dioxin (Governed by the
CC       aromatic hydrocarbon-responsive (AH) locus).
CC   -!- SIMILARITY: Belongs to the NAD(P)H dehydrogenase (quinone) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U12961; AAA80184.1; -; mRNA.
DR   EMBL; S75951; AAB32718.1; -; mRNA.
DR   CCDS; CCDS40465.1; -.
DR   PIR; A57691; A57691.
DR   RefSeq; NP_032732.3; NM_008706.5.
DR   PDB; 1DXQ; X-ray; 2.80 A; A/B/C/D=2-274.
DR   PDBsum; 1DXQ; -.
DR   SMR; Q64669; -.
DR   BioGRID; 201790; 3.
DR   STRING; 10090.ENSMUSP00000003947; -.
DR   ChEMBL; CHEMBL5611; -.
DR   iPTMnet; Q64669; -.
DR   PhosphoSitePlus; Q64669; -.
DR   CPTAC; non-CPTAC-4052; -.
DR   jPOST; Q64669; -.
DR   MaxQB; Q64669; -.
DR   PaxDb; Q64669; -.
DR   PRIDE; Q64669; -.
DR   ProteomicsDB; 293965; -.
DR   Antibodypedia; 1549; 803 antibodies.
DR   DNASU; 18104; -.
DR   Ensembl; ENSMUST00000003947; ENSMUSP00000003947; ENSMUSG00000003849.
DR   GeneID; 18104; -.
DR   KEGG; mmu:18104; -.
DR   UCSC; uc009nhq.1; mouse.
DR   CTD; 1728; -.
DR   MGI; MGI:103187; Nqo1.
DR   eggNOG; ENOG502QQMI; Eukaryota.
DR   GeneTree; ENSGT00940000159150; -.
DR   HOGENOM; CLU_058643_2_0_1; -.
DR   InParanoid; Q64669; -.
DR   OMA; WFERVLV; -.
DR   OrthoDB; 1394543at2759; -.
DR   PhylomeDB; Q64669; -.
DR   TreeFam; TF300296; -.
DR   BRENDA; 1.6.5.2; 3474.
DR   Reactome; R-MMU-350562; Regulation of ornithine decarboxylase (ODC).
DR   BioGRID-ORCS; 18104; 1 hit in 52 CRISPR screens.
DR   ChiTaRS; Nqo1; mouse.
DR   EvolutionaryTrace; Q64669; -.
DR   PRO; PR:Q64669; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   RNAct; Q64669; protein.
DR   Bgee; ENSMUSG00000003849; Expressed in stomach and 212 other tissues.
DR   ExpressionAtlas; Q64669; baseline and differential.
DR   Genevisible; Q64669; MM.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0030425; C:dendrite; ISO:MGI.
DR   GO; GO:0043025; C:neuronal cell body; ISO:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; IDA:MGI.
DR   GO; GO:0050136; F:NADH dehydrogenase (quinone) activity; IEA:RHEA.
DR   GO; GO:0008753; F:NADPH dehydrogenase (quinone) activity; IEA:RHEA.
DR   GO; GO:0004784; F:superoxide dismutase activity; ISO:MGI.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:Ensembl.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISO:MGI.
DR   GO; GO:0071248; P:cellular response to metal ion; IEA:Ensembl.
DR   GO; GO:0006116; P:NADH oxidation; ISO:MGI.
DR   GO; GO:0070995; P:NADPH oxidation; ISO:MGI.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:MGI.
DR   GO; GO:0043086; P:negative regulation of catalytic activity; IDA:MGI.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISO:MGI.
DR   GO; GO:0043279; P:response to alkaloid; IEA:Ensembl.
DR   GO; GO:0014075; P:response to amine; ISO:MGI.
DR   GO; GO:0009743; P:response to carbohydrate; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0051602; P:response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:1905395; P:response to flavonoid; IEA:Ensembl.
DR   GO; GO:0009725; P:response to hormone; IEA:Ensembl.
DR   GO; GO:1904880; P:response to hydrogen sulfide; IEA:Ensembl.
DR   GO; GO:0002931; P:response to ischemia; IEA:Ensembl.
DR   GO; GO:1904844; P:response to L-glutamine; ISO:MGI.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:MGI.
DR   GO; GO:0033574; P:response to testosterone; IEA:Ensembl.
DR   GO; GO:1904772; P:response to tetrachloromethane; IEA:Ensembl.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:MGI.
DR   GO; GO:0006801; P:superoxide metabolic process; ISO:MGI.
DR   Gene3D; 3.40.50.360; -; 1.
DR   InterPro; IPR003680; Flavodoxin_fold.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   Pfam; PF02525; Flavodoxin_2; 1.
DR   SUPFAM; SSF52218; SSF52218; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing; FAD;
KW   Flavoprotein; Isopeptide bond; NAD; NADP; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:7527260"
FT   CHAIN           2..274
FT                   /note="NAD(P)H dehydrogenase [quinone] 1"
FT                   /id="PRO_0000071623"
FT   NP_BIND         18..19
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10706635"
FT   NP_BIND         104..107
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10706635"
FT   NP_BIND         148..151
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10706635"
FT   REGION          126..128
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250"
FT   BINDING         12
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10706635"
FT   BINDING         67
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10706635"
FT   BINDING         156
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10706635"
FT   BINDING         201
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10706635"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:7527260"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15559"
FT   CROSSLNK        251
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P15559"
FT   STRAND          5..10
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   HELIX           18..32
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   STRAND          36..41
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   HELIX           42..45
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   HELIX           68..77
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   HELIX           83..94
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   STRAND          96..103
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   HELIX           111..120
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   TURN            123..125
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   STRAND          129..131
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   HELIX           133..135
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   TURN            137..140
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   STRAND          141..151
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   HELIX           153..156
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   STRAND          160..162
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   HELIX           165..173
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   TURN            174..176
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   HELIX           177..180
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   STRAND          188..191
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   TURN            193..195
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   HELIX           198..212
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   HELIX           213..217
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   HELIX           226..228
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   TURN            233..236
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   STRAND          237..239
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   HELIX           241..247
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   STRAND          254..256
FT                   /evidence="ECO:0007829|PDB:1DXQ"
FT   TURN            268..270
FT                   /evidence="ECO:0007829|PDB:1DXQ"
SQ   SEQUENCE   274 AA;  30960 MW;  68F380922FD72965 CRC64;
     MAARRALIVL AHSEKTSFNY AMKEAAVEAL KKRGWEVLES DLYAMNFNPI ISRNDITGEL
     KDSKNFQYPS ESSLAYKEGR LSPDIVAEHK KLEAADLVIF QFPLQWFGVP AILKGWFERV
     LVAGFAYTYA AMYDNGPFQN KKTLLSITTG GSGSMYSLQG VHGDMNVILW PIQSGILRFC
     GFQVLEPQLV YSIGHTPPDA RMQILEGWKK RLETVWEETP LYFAPSSLFD LNFQAGFLMK
     KEVQEEQKKN KFGLSVGHHL GKSIPADNQI KARK
//
ID   NQO1_RAT                Reviewed;         274 AA.
AC   P05982; Q63478;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   02-JUN-2021, entry version 175.
DE   RecName: Full=NAD(P)H dehydrogenase [quinone] 1;
DE            EC=1.6.5.2 {ECO:0000269|PubMed:1703398, ECO:0000269|PubMed:7862630};
DE   AltName: Full=Azoreductase;
DE   AltName: Full=DT-diaphorase;
DE            Short=DTD;
DE   AltName: Full=Menadione reductase;
DE   AltName: Full=NAD(P)H:quinone oxidoreductase 1;
DE   AltName: Full=Phylloquinone reductase;
DE   AltName: Full=Quinone reductase 1;
DE            Short=QR1;
GN   Name=Nqo1; Synonyms=Nmor1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=3536915;
RA   Robertson J.A., Chen H.-C., Nebert D.W.;
RT   "NAD(P)H:menadione oxidoreductase. Novel purification of enzyme cDNA and
RT   complete amino acid sequence, and gene regulation.";
RL   J. Biol. Chem. 261:15794-15799(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE.
RA   Robertson J.A., Nebert D.W., Hankinson O.;
RT   "Autoregulation plus positive and negative elements controlling
RT   transcription of genes in the [Ah] battery.";
RL   Chem. Scr. 27:83-87(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=3100515;
RA   Bayney R.M., Rodkey J.A., Bennett C.D., Lu A.Y.H., Pickett C.B.;
RT   "Rat liver NAD(P)H: quinone reductase nucleotide sequence analysis of a
RT   quinone reductase cDNA clone and prediction of the amino acid sequence of
RT   the corresponding protein.";
RL   J. Biol. Chem. 262:572-575(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=2480957;
RA   Bayney R.M., Morton M.R., Favreau L.V., Pickett C.B.;
RT   "Rat liver NAD(P)H:quinone reductase. Regulation of quinone reductase gene
RT   expression by planar aromatic compounds and determination of the exon
RT   structure of the quinone reductase structural gene.";
RL   J. Biol. Chem. 264:21793-21797(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-274, CLEAVAGE OF INITIATOR METHIONINE, AND
RP   ACETYLATION AT ALA-2.
RX   PubMed=3143406; DOI=10.1021/bi00418a033;
RA   Haniu M., Yuan H., Chen S.A., Iyanagi T., Lee T.D., Shively J.E.;
RT   "Structure-function relationship of NAD(P)H:quinone reductase:
RT   characterization of NH2-terminal blocking group and essential tyrosine and
RT   lysine residues.";
RL   Biochemistry 27:6877-6883(1988).
RN   [7]
RP   NUCLEOTIDE SEQUENCE OF 1-57.
RX   PubMed=2963593; DOI=10.1016/0003-9861(88)90516-4;
RA   Bayney R.M., Pickett C.B.;
RT   "Rat liver NAD(P)H:quinone reductase: isolation of a quinone reductase
RT   structural gene and prediction of the NH2 terminal sequence of the protein
RT   by double-stranded sequencing of exons 1 and 2.";
RL   Arch. Biochem. Biophys. 260:847-850(1988).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-21, FUNCTION, COFACTOR, SUBCELLULAR LOCATION, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=1703398; DOI=10.1016/0003-9861(90)90648-i;
RA   Ma Q., Wang R., Yang C.S., Lu A.Y.H.;
RT   "Expression of mammalian DT-diaphorase in Escherichia coli: purification
RT   and characterization of the expressed protein.";
RL   Arch. Biochem. Biophys. 283:311-317(1990).
RN   [9]
RP   PROTEIN SEQUENCE OF 24-131 AND 156-270.
RX   PubMed=3144286; DOI=10.1016/0006-2952(88)90336-x;
RA   Knox R.J., Boland M.P., Friedlos F., Coles B., Southan C., Roberts J.J.;
RT   "The nitroreductase enzyme in Walker cells that activates 5-(aziridin-1-
RT   yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-yl)-4-hydroxylamino-2-
RT   nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC
RT   1.6.99.2).";
RL   Biochem. Pharmacol. 37:4671-4677(1988).
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 80-274.
RX   PubMed=2504488;
RA   Dear T.N., McDonald D.A., Kefford R.F.;
RT   "Transcriptional down-regulation of a rat gene, WDNM2, in metastatic DMBA-8
RT   cells.";
RL   Cancer Res. 49:5323-5328(1989).
RN   [11]
RP   PROTEIN SEQUENCE OF 147-156 AND 263-271.
RX   PubMed=2499768;
RA   Liu X.F., Yuan H., Haniu M., Iyanagi T., Shively J.E., Chen S.A.;
RT   "Reaction of rat liver DT-diaphorase (NAD(P)H:quinone acceptor reductase)
RT   with 5'-[p-(fluorosulfonyl)benzoyl]-adenosine.";
RL   Mol. Pharmacol. 35:818-822(1989).
RN   [12]
RP   MUTAGENESIS.
RX   PubMed=2141979; DOI=10.1016/0006-291x(90)92006-l;
RA   Forrest G.L., Qian J., Ma J.-X., Kaplan W.D., Akman S., Doroshow J.,
RA   Chen S.A.;
RT   "Rat liver NAD(P)H:quinone oxidoreductase: cDNA expression and site-
RT   directed mutagenesis.";
RL   Biochem. Biophys. Res. Commun. 169:1087-1093(1990).
RN   [13]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF HIS-195.
RX   PubMed=7862630; DOI=10.1073/pnas.92.4.1043;
RA   Cui K., Lu A.Y., Yang C.S.;
RT   "Subunit functional studies of NAD(P)H:quinone oxidoreductase with a
RT   heterodimer approach.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:1043-1047(1995).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH FAD AND DUROQUINONE,
RP   AND SUBUNIT.
RC   TISSUE=Liver;
RX   PubMed=7568029; DOI=10.1073/pnas.92.19.8846;
RA   Li R., Bianchet M.A., Talalay P., Amzel L.M.;
RT   "The three-dimensional structure of NAD(P)H:quinone reductase, a
RT   flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism
RT   of the two-electron reduction.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:8846-8850(1995).
RN   [15]
RP   ERRATUM OF PUBMED:7568029.
RA   Li R., Bianchet M.A., Talalay P., Amzel L.M.;
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10815-10815(1995).
CC   -!- FUNCTION: The enzyme apparently serves as a quinone reductase in
CC       connection with conjugation reactions of hydroquinons involved in
CC       detoxification pathways as well as in biosynthetic processes such as
CC       the vitamin K-dependent gamma-carboxylation of glutamate residues in
CC       prothrombin synthesis. {ECO:0000269|PubMed:1703398,
CC       ECO:0000269|PubMed:7862630}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADH = a quinol + NAD(+);
CC         Xref=Rhea:RHEA:46160, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:132124; EC=1.6.5.2;
CC         Evidence={ECO:0000269|PubMed:1703398, ECO:0000269|PubMed:7862630};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADPH = a quinol + NADP(+);
CC         Xref=Rhea:RHEA:46164, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:132124; EC=1.6.5.2;
CC         Evidence={ECO:0000269|PubMed:1703398, ECO:0000269|PubMed:7862630};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:1703398};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=85 uM for NADH {ECO:0000269|PubMed:7862630};
CC         KM=39 uM for NADPH {ECO:0000269|PubMed:7862630};
CC         Note=kcat is 0.075 min(-1) NADH with as substrate. kcat is 0.074
CC         min(-1) with NADPH as substrate. {ECO:0000269|PubMed:7862630};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:7568029}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:1703398}.
CC   -!- INDUCTION: By polycyclic hydrocarbons (Governed by the aromatic
CC       hydrocarbon-responsive (AH) locus).
CC   -!- MISCELLANEOUS: Quinone reductase accepts electrons from both NADH and
CC       NADPH with equal efficiency.
CC   -!- MISCELLANEOUS: This protein is inhibited by dicoumarol.
CC   -!- SIMILARITY: Belongs to the NAD(P)H dehydrogenase (quinone) family.
CC       {ECO:0000305}.
CC   -!- CAUTION: PubMed:2480957 sequence seems incorrectly to be attributed to
CC       a mouse sequence while it really seems to correspond to the rat
CC       sequence. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA41988.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J02608; AAA41716.1; -; mRNA.
DR   EMBL; J02679; AAA41715.1; -; mRNA.
DR   EMBL; M36660; AAA39829.1; -; mRNA.
DR   EMBL; J02640; AAA41988.1; ALT_INIT; mRNA.
DR   EMBL; M31805; AAA41989.1; -; Genomic_DNA.
DR   EMBL; M31801; AAA41989.1; JOINED; Genomic_DNA.
DR   EMBL; M31802; AAA41989.1; JOINED; Genomic_DNA.
DR   EMBL; M31804; AAA41989.1; JOINED; Genomic_DNA.
DR   EMBL; M33039; AAA41990.1; -; Genomic_DNA.
DR   EMBL; M33038; AAA41990.1; JOINED; Genomic_DNA.
DR   EMBL; BC083542; AAH83542.1; -; mRNA.
DR   EMBL; X17464; -; NOT_ANNOTATED_CDS; mRNA.
DR   PIR; A34162; A34162.
DR   RefSeq; NP_058696.2; NM_017000.3.
DR   PDB; 1QRD; X-ray; 2.40 A; A/B=2-274.
DR   PDBsum; 1QRD; -.
DR   SMR; P05982; -.
DR   IntAct; P05982; 2.
DR   STRING; 10116.ENSRNOP00000017175; -.
DR   BindingDB; P05982; -.
DR   ChEMBL; CHEMBL3091269; -.
DR   iPTMnet; P05982; -.
DR   PhosphoSitePlus; P05982; -.
DR   World-2DPAGE; 0004:P05982; -.
DR   jPOST; P05982; -.
DR   PaxDb; P05982; -.
DR   PRIDE; P05982; -.
DR   Ensembl; ENSRNOT00000017174; ENSRNOP00000017175; ENSRNOG00000012772.
DR   GeneID; 24314; -.
DR   KEGG; rno:24314; -.
DR   UCSC; RGD:2503; rat.
DR   CTD; 1728; -.
DR   RGD; 2503; Nqo1.
DR   eggNOG; ENOG502QQMI; Eukaryota.
DR   GeneTree; ENSGT00940000159150; -.
DR   HOGENOM; CLU_058643_2_0_1; -.
DR   InParanoid; P05982; -.
DR   OMA; WFERVLV; -.
DR   OrthoDB; 1394543at2759; -.
DR   PhylomeDB; P05982; -.
DR   TreeFam; TF300296; -.
DR   BRENDA; 1.6.5.2; 5301.
DR   Reactome; R-RNO-350562; Regulation of ornithine decarboxylase (ODC).
DR   EvolutionaryTrace; P05982; -.
DR   PRO; PR:P05982; -.
DR   Proteomes; UP000002494; Chromosome 19.
DR   Bgee; ENSRNOG00000012772; Expressed in stomach and 22 other tissues.
DR   Genevisible; P05982; RN.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; IDA:RGD.
DR   GO; GO:0050136; F:NADH dehydrogenase (quinone) activity; IEA:RHEA.
DR   GO; GO:0008753; F:NADPH dehydrogenase (quinone) activity; IEA:RHEA.
DR   GO; GO:0004784; F:superoxide dismutase activity; IMP:RGD.
DR   GO; GO:0007568; P:aging; IEP:RGD.
DR   GO; GO:0045454; P:cell redox homeostasis; ISO:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IDA:RGD.
DR   GO; GO:0071248; P:cellular response to metal ion; IEP:RGD.
DR   GO; GO:0006116; P:NADH oxidation; IDA:RGD.
DR   GO; GO:0070995; P:NADPH oxidation; IDA:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:RGD.
DR   GO; GO:0043086; P:negative regulation of catalytic activity; ISO:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0043279; P:response to alkaloid; IEP:RGD.
DR   GO; GO:0014075; P:response to amine; IDA:RGD.
DR   GO; GO:0009743; P:response to carbohydrate; IEP:RGD.
DR   GO; GO:0042493; P:response to drug; IEP:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:1905395; P:response to flavonoid; IEP:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:1904880; P:response to hydrogen sulfide; IEP:RGD.
DR   GO; GO:0002931; P:response to ischemia; IEP:RGD.
DR   GO; GO:1904844; P:response to L-glutamine; IDA:RGD.
DR   GO; GO:1901698; P:response to nitrogen compound; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0010033; P:response to organic substance; IEP:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IEP:RGD.
DR   GO; GO:0033574; P:response to testosterone; IEP:RGD.
DR   GO; GO:1904772; P:response to tetrachloromethane; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IDA:RGD.
DR   GO; GO:0006801; P:superoxide metabolic process; IMP:RGD.
DR   Gene3D; 3.40.50.360; -; 1.
DR   InterPro; IPR003680; Flavodoxin_fold.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   Pfam; PF02525; Flavodoxin_2; 1.
DR   SUPFAM; SSF52218; SSF52218; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing; FAD;
KW   Flavoprotein; Isopeptide bond; NAD; NADP; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:1703398,
FT                   ECO:0000269|PubMed:3143406"
FT   CHAIN           2..274
FT                   /note="NAD(P)H dehydrogenase [quinone] 1"
FT                   /id="PRO_0000071625"
FT   NP_BIND         18..19
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7568029"
FT   NP_BIND         104..107
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7568029"
FT   NP_BIND         148..151
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7568029"
FT   REGION          126..128
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250"
FT   BINDING         12
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7568029"
FT   BINDING         67
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7568029"
FT   BINDING         156
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7568029"
FT   BINDING         201
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7568029"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:3143406"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15559"
FT   CROSSLNK        251
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P15559"
FT   MUTAGEN         117..118
FT                   /note="FE->KK: Destroys enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:2141979"
FT   MUTAGEN         161
FT                   /note="V->D: Destroys enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:2141979"
FT   MUTAGEN         164
FT                   /note="D->Q: Destroys enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:2141979"
FT   MUTAGEN         195
FT                   /note="H->A: Induces a very low catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:7862630"
FT   CONFLICT        31
FT                   /note="Missing (in Ref. 9; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        80
FT                   /note="R -> G (in Ref. 10; X17464)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        135
FT                   /note="K -> Q (in Ref. 3; AAA41988)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        216
FT                   /note="W -> E (in Ref. 9; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        227
FT                   /note="S -> E (in Ref. 9; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        263
FT                   /note="S -> I (in Ref. 9; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        269
FT                   /note="Q -> E (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..10
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   HELIX           18..32
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   STRAND          36..41
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   TURN            42..46
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   HELIX           53..55
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   HELIX           68..78
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   HELIX           83..94
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   STRAND          96..103
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   HELIX           111..120
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   TURN            123..125
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   HELIX           133..135
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   TURN            137..140
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   STRAND          142..148
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   HELIX           153..156
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   HELIX           165..173
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   HELIX           174..178
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   TURN            179..181
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   STRAND          188..190
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   HELIX           193..195
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   HELIX           198..212
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   HELIX           215..217
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   HELIX           226..228
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   TURN            233..236
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   HELIX           241..247
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   STRAND          254..256
FT                   /evidence="ECO:0007829|PDB:1QRD"
FT   TURN            266..270
FT                   /evidence="ECO:0007829|PDB:1QRD"
SQ   SEQUENCE   274 AA;  30947 MW;  40E8801320A20F09 CRC64;
     MAVRRALIVL AHAERTSFNY AMKEAAVEAL KKKGWEVVES DLYAMNFNPL ISRNDITGEP
     KDSENFQYPV ESSLAYKEGR LSPDIVAEQK KLEAADLVIF QFPLYWFGVP AILKGWFERV
     LVAGFAYTYA TMYDKGPFQN KKTLLSITTG GSGSMYSLQG VHGDMNVILW PIQSGILRFC
     GFQVLEPQLV YSIGHTPPDA RVQVLEGWKK RLETVWEESP LYFAPSSLFD LNFQAGFLLK
     KEVQEEQKKN KFGLSVGHHL GKSIPADNQI KARK
//
ID   DLDH_PSEFL              Reviewed;         478 AA.
AC   P14218;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-JUN-2021, entry version 141.
DE   RecName: Full=Dihydrolipoyl dehydrogenase;
DE            EC=1.8.1.4;
DE   AltName: Full=Dihydrolipoamide dehydrogenase;
DE   AltName: Full=E3 component of 2-oxoglutarate dehydrogenase complex;
GN   Name=lpd;
OS   Pseudomonas fluorescens.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=294;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 2-23.
RX   PubMed=2515251; DOI=10.1099/00221287-135-7-1787;
RA   Benen J.A.E., van Berkel W.J.H., van Dongen W.M.A.M., Mueller F.,
RA   de Kok A.;
RT   "Molecular cloning and sequence determination of the lpd gene encoding
RT   lipoamide dehydrogenase from Pseudomonas fluorescens.";
RL   J. Gen. Microbiol. 135:1787-1797(1989).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH FAD, SUBUNIT, AND
RP   DISULFIDE BOND.
RX   PubMed=8487301; DOI=10.1006/jmbi.1993.1236;
RA   Mattevi A., Obmolova G., Kalk K.H., van Berkel W.J.H., Hol W.G.J.;
RT   "Three-dimensional structure of lipoamide dehydrogenase from Pseudomonas
RT   fluorescens at 2.8-A resolution. Analysis of redox and thermostability
RT   properties.";
RL   J. Mol. Biol. 230:1200-1215(1993).
CC   -!- FUNCTION: The branched-chain alpha-keto dehydrogenase complex catalyzes
CC       the overall conversion of alpha-keto acids to acyl-CoA and CO(2). It
CC       contains multiple copies of 3 enzymatic components: branched-chain
CC       alpha-keto acid decarboxylase (E1), lipoamide acyltransferase (E2) and
CC       lipoamide dehydrogenase (E3).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-N(6)-dihydrolipoyl-L-lysyl-[protein] + NAD(+) = (R)-N(6)-
CC         lipoyl-L-lysyl-[protein] + H(+) + NADH; Xref=Rhea:RHEA:15045,
CC         Rhea:RHEA-COMP:10474, Rhea:RHEA-COMP:10475, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:83099,
CC         ChEBI:CHEBI:83100; EC=1.8.1.4;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:8487301}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- MISCELLANEOUS: The active site is a redox-active disulfide bond.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M28356; AAA99234.1; -; Genomic_DNA.
DR   PDB; 1LPF; X-ray; 2.80 A; A/B=2-478.
DR   PDBsum; 1LPF; -.
DR   SMR; P14218; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   EvolutionaryTrace; P14218; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004148; F:dihydrolipoyl dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:0006096; P:glycolytic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR006258; Lipoamide_DH.
DR   InterPro; IPR001100; Pyr_nuc-diS_OxRdtase.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   InterPro; IPR012999; Pyr_OxRdtase_I_AS.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   PIRSF; PIRSF000350; Mercury_reductase_MerA; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
DR   TIGRFAMs; TIGR01350; lipoamide_DH; 1.
DR   PROSITE; PS00076; PYRIDINE_REDOX_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Direct protein sequencing; Disulfide bond; FAD;
KW   Flavoprotein; Glycolysis; NAD; Oxidoreductase; Redox-active center.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:2515251"
FT   CHAIN           2..478
FT                   /note="Dihydrolipoyl dehydrogenase"
FT                   /id="PRO_0000068037"
FT   NP_BIND         34..49
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8487301"
FT   NP_BIND         188..192
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         276..279
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        451
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         58
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8487301"
FT   BINDING         122
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:8487301"
FT   BINDING         211
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   BINDING         245
FT                   /note="NAD; via amide nitrogen"
FT                   /evidence="ECO:0000250"
FT   BINDING         319
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:8487301"
FT   BINDING         327
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:8487301"
FT   DISULFID        49..54
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:8487301"
FT   STRAND          4..10
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           14..25
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          30..34
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          39..43
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           47..52
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           54..72
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           75..77
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          79..86
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           88..113
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          115..124
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           126..128
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          129..134
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          139..149
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          153..155
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   TURN            165..167
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           171..174
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          182..187
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           191..202
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          206..210
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          212..217
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           222..235
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          238..240
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          244..247
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          254..260
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          265..271
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          273..275
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          279..281
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   TURN            284..286
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          308..311
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          314..316
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           318..320
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          321..323
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           327..341
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           350..352
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          355..357
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          359..367
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           370..375
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          380..386
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           387..389
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           391..396
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          402..411
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   STRAND          413..421
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           424..436
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           441..445
FT                   /evidence="ECO:0007829|PDB:1LPF"
FT   HELIX           455..465
FT                   /evidence="ECO:0007829|PDB:1LPF"
SQ   SEQUENCE   478 AA;  50151 MW;  B23EB31268C69EC7 CRC64;
     MSQKFDVVVI GAGPGGYVAA IRAAQLGLKT ACIEKYIGKE GKVALGGTCL NVGCIPSKAL
     LDSSYKYHEA KEAFKVHGIE AKGVTIDVPA MVARKANIVK NLTGGIATLF KANGVTSFEG
     HGKLLANKQV EVTGLDGKTQ VLEAENVIIA SGSRPVEIPP APLSDDIIVD STGALEFQAV
     PKKLGVIGAG VIGLELGSVW ARLGAEVTVL EALDKFLPAA DEQIAKEALK VLTKQGLNIR
     LGARVTASEV KKKQVTVTFT DANGEQKETF DKLIVAVGRR PVTTDLLAAD SGVTLDERGF
     IYVDDHCKTS VPGVFAIGDV VRGAMLAHKA SEEGVMVAER IAGHKAQMNY DLIPSVIYTH
     PEIAWVGKTE QTLKAEGVEV NVGTFPFAAS GRAMAANDTT GLVKVIADAK TDRVLGVHVI
     GPSAAELVQQ GAIGMEFGTS AEDLGMMVFS HPTLSEALHE AALAVNGHAI HIANRKKR
//
ID   DNRF_STREF              Reviewed;         535 AA.
AC   Q54530;
DT   19-MAR-2014, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-JUN-2021, entry version 95.
DE   RecName: Full=Aklavinone 12-hydroxylase RdmE;
DE            EC=1.14.13.180;
DE   AltName: Full=Aklavinone 11-hydroxylase;
GN   Name=rdmE;
OS   Streptomyces purpurascens.
OC   Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC   Streptomyces.
OX   NCBI_TaxID=1924;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 25489 / DSM 40310 / JCM 4509 / NBRC 13077 / Maria 515;
RX   PubMed=8081500; DOI=10.1099/00221287-140-6-1351;
RA   Niemi J., Ylihonko K., Hakala J., Parssinen R., Kopio A., Mantsala P.;
RT   "Hybrid anthracycline antibiotics: production of new anthracyclines by
RT   cloned genes from Streptomyces purpurascens in Streptomyces galilaeus.";
RL   Microbiology 140:1351-1358(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 25489 / DSM 40310 / JCM 4509 / NBRC 13077 / Maria 515;
RA   Halo L., Wang Y., Mantsala P., Hakala J., Ylihonko K.;
RT   "Characterization of the gene cluster involved in rhodomycin
RT   biosynthesis.";
RL   Submitted (AUG-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 25489 / DSM 40310 / JCM 4509 / NBRC 13077 / Maria 515;
RX   PubMed=7751313; DOI=10.1128/jb.177.10.2942-2945.1995;
RA   Niemi J., Mantsala P.;
RT   "Nucleotide sequences and expression of genes from Streptomyces
RT   purpurascens that cause the production of new anthracyclines in
RT   Streptomyces galilaeus.";
RL   J. Bacteriol. 177:2942-2945(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 25489 / DSM 40310 / JCM 4509 / NBRC 13077 / Maria 515;
RA   Halo L., Wang Y., Mantsala P., Hakala J., Ylihonko K.;
RL   Submitted (OCT-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   PROTEIN SEQUENCE OF 2-13, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBSTRATE SPECIFICITY, ACTIVITY REGULATION, AND SUBUNIT.
RX   PubMed=10082933; DOI=10.1016/s0167-4838(98)00265-9;
RA   Niemi J., Wang Y., Airas K., Ylihonko K., Hakala J., Mantsala P.;
RT   "Characterization of aklavinone-11-hydroxylase from Streptomyces
RT   purpurascens.";
RL   Biochim. Biophys. Acta 1430:57-64(1999).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.49 ANGSTROMS) IN COMPLEX WITH FAD AND AKLAVINONE,
RP   FUNCTION, ACTIVE SITE, MUTAGENESIS OF TYR-224 AND ARG-373, SUBSTRATE
RP   SPECIFICITY, REACTION MECHANISM, COFACTOR, AND SUBUNIT.
RX   PubMed=19744497; DOI=10.1016/j.jmb.2009.09.003;
RA   Lindqvist Y., Koskiniemi H., Jansson A., Sandalova T., Schnell R., Liu Z.,
RA   Mantsala P., Niemi J., Schneider G.;
RT   "Structural basis for substrate recognition and specificity in aklavinone-
RT   11-hydroxylase from rhodomycin biosynthesis.";
RL   J. Mol. Biol. 393:966-977(2009).
CC   -!- FUNCTION: Involved in the biosynthesis of the anthracyclines
CC       carminomycin, rhodomycin and daunorubicin (daunomycin) which are
CC       aromatic polyketide antibiotics that exhibit high cytotoxicity and are
CC       widely applied in the chemotherapy of a variety of cancers. Catalyzes
CC       the incorporation of a hydroxyl group at position C-11 of aklavinone,
CC       resulting in epsilon-rhodomycinone. It cannot accept substrates
CC       glycosylated at position C-7 and is specific for the C-9R configuration
CC       of anthracyclines. It can use both NAD or NADP but it is slowly
CC       inactivated in the presence of NADH. {ECO:0000269|PubMed:10082933,
CC       ECO:0000269|PubMed:19744497}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=aklavinone + H(+) + NADPH + O2 = epsilon-rhodomycinone + H2O +
CC         NADP(+); Xref=Rhea:RHEA:37835, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:31181, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:75291; EC=1.14.13.180;
CC         Evidence={ECO:0000269|PubMed:10082933};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:19744497};
CC   -!- ACTIVITY REGULATION: Inhibited by phenylglyoxal and 2,3-butanedione.
CC       NADP provides a partial protection against inhibition by phenylglyoxal.
CC       Increasing the methanol concentration in the assay causes inhibition of
CC       the enzyme. {ECO:0000269|PubMed:10082933}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2 uM for NAD (at pH 7.5) {ECO:0000269|PubMed:10082933};
CC         KM=10 uM for aklavinone (at pH 7.5) {ECO:0000269|PubMed:10082933};
CC         KM=2 mM for NADP (at pH 7.5) {ECO:0000269|PubMed:10082933};
CC       pH dependence:
CC         Optimum pH is near 7.4. {ECO:0000269|PubMed:10082933};
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius.
CC         {ECO:0000269|PubMed:10082933};
CC   -!- PATHWAY: Antibiotic biosynthesis; daunorubicin biosynthesis.
CC   -!- PATHWAY: Antibiotic biosynthesis; carminomycin biosynthesis.
CC   -!- PATHWAY: Antibiotic biosynthesis; rhodomycin biosynthesis.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:10082933,
CC       ECO:0000269|PubMed:19744497}.
CC   -!- SIMILARITY: Belongs to the PheA/TfdB FAD monooxygenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U10405; AAA83424.1; -; Genomic_DNA.
DR   PDB; 3IHG; X-ray; 2.49 A; A/B/C=1-535.
DR   PDBsum; 3IHG; -.
DR   SMR; Q54530; -.
DR   KEGG; ag:AAA83424; -.
DR   BRENDA; 1.14.13.180; 6079.
DR   UniPathway; UPA00054; -.
DR   UniPathway; UPA01040; -.
DR   UniPathway; UPA01042; -.
DR   EvolutionaryTrace; Q54530; -.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; IDA:UniProtKB.
DR   GO; GO:1901771; P:daunorubicin biosynthetic process; IDA:UniProtKB.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic biosynthesis; Direct protein sequencing; FAD;
KW   Flavoprotein; NAD; NADP; Nucleotide-binding; Oxidoreductase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:10082933"
FT   CHAIN           2..535
FT                   /note="Aklavinone 12-hydroxylase RdmE"
FT                   /id="PRO_0000425675"
FT   NP_BIND         15..16
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19744497"
FT   ACT_SITE        224
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000269|PubMed:19744497"
FT   BINDING         35
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19744497"
FT   BINDING         119
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19744497"
FT   BINDING         143
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:19744497"
FT   BINDING         308
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19744497"
FT   BINDING         317
FT                   /note="Aklavinone; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:19744497"
FT   MUTAGEN         224
FT                   /note="Y->F: Loss of hydroxylase activity."
FT                   /evidence="ECO:0000269|PubMed:19744497"
FT   MUTAGEN         373
FT                   /note="R->A: Hydroxylase activity similar as the wild-type
FT                   enzyme."
FT                   /evidence="ECO:0000269|PubMed:19744497"
FT   MUTAGEN         373
FT                   /note="R->M: Hydroxylase activity similar as the wild-type
FT                   enzyme."
FT                   /evidence="ECO:0000269|PubMed:19744497"
FT   MUTAGEN         373
FT                   /note="R->Q: Hydroxylase activity similar as the wild-type
FT                   enzyme."
FT                   /evidence="ECO:0000269|PubMed:19744497"
FT   STRAND          5..11
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           15..25
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   TURN            26..28
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          31..34
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          36..39
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           51..59
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           63..68
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          80..89
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          91..97
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           99..104
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           107..109
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           119..132
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          136..140
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          142..149
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           151..153
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          155..163
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          166..177
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           184..188
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          193..208
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           211..213
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          221..226
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          231..236
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          242..249
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   TURN            251..254
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           257..259
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           262..273
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          281..296
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          298..300
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          303..305
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   TURN            307..310
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           320..339
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           347..373
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           376..378
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   TURN            379..381
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           388..392
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          430..433
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          436..439
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           440..443
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          445..452
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           457..470
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          474..479
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   TURN            480..482
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           490..493
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   TURN            497..499
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          501..504
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   STRAND          508..516
FT                   /evidence="ECO:0007829|PDB:3IHG"
FT   HELIX           521..532
FT                   /evidence="ECO:0007829|PDB:3IHG"
SQ   SEQUENCE   535 AA;  57437 MW;  969CAAB6FEB6AD4F CRC64;
     MNDHEVDVLV VGAGLGGLST AMFLARQGVR VLVVERRPGL SPYPRAAGQN PRTMELLRIG
     GVADEVVRAD DIRGTQGDFV IRLAESVRGE ILRTVSESFD DMVAATEPCT PAGWAMLSQD
     KLEPILLAQA RKHGGAIRFG TRLLSFRQHD DDAGAGVTAR LAGPDGEYDL RAGYLVGADG
     NRSLVRESLG IGRYGHGTLT HMVGVIFDAD LSGIMEPGTT GWYYLHHPEF KGTFGPTDRP
     DRHTLFVEYD PDEGERPEDF TPQRCVELIG LALDAPEVKP ELVDIQGWEM AARIAERWRE
     GRVFLAGDAA KVTPPTGGMS GNAAVADGFD LAWKLAAVLQ GQAGAGLLDT YEDERKVAAE
     LVVAEALAIY AQRMAPHMAE VWDKSVGYPE TLLGFRYRSS AVLATDDDPA RVENPLTPSG
     RPGFRGPHVL VSRHGERLST VDLFGDGWTL LAGELGADWV AAAEAVSAEL GVPVRAYRVG
     AGLTDPESAV SERYGIGKAG ASLVRPDGIV AWRTDEAAAD AAQTLEGVLR RVLDR
//
ID   M2GD_RAT                Reviewed;         857 AA.
AC   Q63342;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-JUN-2021, entry version 138.
DE   RecName: Full=Dimethylglycine dehydrogenase, mitochondrial;
DE            EC=1.5.8.4 {ECO:0000269|PubMed:2417560, ECO:0000269|PubMed:24858690};
DE   AltName: Full=ME2GLYDH;
DE   Flags: Precursor;
GN   Name=Dmgdh;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=1710985; DOI=10.1111/j.1432-1033.1991.tb16083.x;
RA   Lang H., Polster M., Brandsch R.;
RT   "Rat liver dimethylglycine dehydrogenase. Flavinylation of the enzyme in
RT   hepatocytes in primary culture and characterization of a cDNA clone.";
RL   Eur. J. Biochem. 198:793-799(1991).
RN   [2]
RP   PROTEIN SEQUENCE OF 75-99, COFACTOR, AND FAD-BINDING.
RC   TISSUE=Liver;
RX   PubMed=4055729;
RA   Cook R.J., Misono K.S., Wagner C.;
RT   "The amino acid sequences of the flavin-peptides of dimethylglycine
RT   dehydrogenase and sarcosine dehydrogenase from rat liver mitochondria.";
RL   J. Biol. Chem. 260:12998-13002(1985).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME KINETICS, AND SUBCELLULAR LOCATION.
RX   PubMed=2417560; DOI=10.1016/0003-9861(85)90516-8;
RA   Porter D.H., Cook R.J., Wagner C.;
RT   "Enzymatic properties of dimethylglycine dehydrogenase and sarcosine
RT   dehydrogenase from rat liver.";
RL   Arch. Biochem. Biophys. 243:396-407(1985).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 2-857 IN COMPLEXES WITH FAD AND
RP   TETRAHYDROFOLATE, CATALYTIC ACTIVITY, COFACTOR, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=24858690; DOI=10.1016/j.bbrc.2014.05.064;
RA   Luka Z., Pakhomova S., Loukachevitch L.V., Newcomer M.E., Wagner C.;
RT   "Folate in demethylation: the crystal structure of the rat dimethylglycine
RT   dehydrogenase complexed with tetrahydrofolate.";
RL   Biochem. Biophys. Res. Commun. 449:392-398(2014).
CC   -!- FUNCTION: Catalyzes the demethylation of N,N-dimethylglycine to
CC       sarcosine. Also has activity with sarcosine in vitro.
CC       {ECO:0000269|PubMed:2417560}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6S)-5,6,7,8-tetrahydrofolyl-(gamma-L-Glu)n + H(+) + N,N-
CC         dimethylglycine + oxidized [electron-transfer flavoprotein] = (6R)-
CC         5,10-methylenetetrahydrofolyl-(gamma-L-Glu)(n) + reduced [electron-
CC         transfer flavoprotein] + sarcosine; Xref=Rhea:RHEA:52856, Rhea:RHEA-
CC         COMP:10685, Rhea:RHEA-COMP:10686, Rhea:RHEA-COMP:13257, Rhea:RHEA-
CC         COMP:14738, ChEBI:CHEBI:15378, ChEBI:CHEBI:57433, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58251, ChEBI:CHEBI:58307, ChEBI:CHEBI:136572,
CC         ChEBI:CHEBI:141005; EC=1.5.8.4; Evidence={ECO:0000269|PubMed:2417560,
CC         ECO:0000269|PubMed:24858690};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:24858690, ECO:0000269|PubMed:4055729};
CC       Note=Binds 1 FAD covalently per monomer. {ECO:0000269|PubMed:24858690,
CC       ECO:0000269|PubMed:4055729};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=760 uM for N,N-dimethylglycine for precursor enzyme
CC         {ECO:0000269|PubMed:24858690};
CC         KM=580 uM for N,N-dimethylglycine for mature enzyme
CC         {ECO:0000269|PubMed:24858690};
CC         Note=kcat is 1.43-1.48 sec(1-). {ECO:0000269|PubMed:24858690};
CC   -!- PATHWAY: Amine and polyamine degradation; betaine degradation;
CC       sarcosine from betaine: step 2/2.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:2417560}.
CC   -!- SIMILARITY: Belongs to the GcvT family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X55995; CAA39468.1; -; mRNA.
DR   PIR; S16133; S16133.
DR   PDB; 4P9S; X-ray; 2.32 A; A/B=22-857.
DR   PDB; 4PAA; X-ray; 2.26 A; A/B=22-857.
DR   PDB; 4PAB; X-ray; 1.85 A; A/B=2-857.
DR   PDBsum; 4P9S; -.
DR   PDBsum; 4PAA; -.
DR   PDBsum; 4PAB; -.
DR   SMR; Q63342; -.
DR   IntAct; Q63342; 1.
DR   STRING; 10116.ENSRNOP00000030481; -.
DR   iPTMnet; Q63342; -.
DR   PhosphoSitePlus; Q63342; -.
DR   PaxDb; Q63342; -.
DR   PRIDE; Q63342; -.
DR   UCSC; RGD:620453; rat.
DR   RGD; 620453; Dmgdh.
DR   eggNOG; KOG2844; Eukaryota.
DR   InParanoid; Q63342; -.
DR   PhylomeDB; Q63342; -.
DR   BioCyc; MetaCyc:MONOMER-16117; -.
DR   BRENDA; 1.5.8.4; 5301.
DR   Reactome; R-RNO-6798163; Choline catabolism.
DR   UniPathway; UPA00291; UER00433.
DR   PRO; PR:Q63342; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005759; C:mitochondrial matrix; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:RGD.
DR   GO; GO:0047865; F:dimethylglycine dehydrogenase activity; IDA:RGD.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:RGD.
DR   GO; GO:0005542; F:folic acid binding; IDA:RGD.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0006579; P:amino-acid betaine catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0042426; P:choline catabolic process; ISO:RGD.
DR   GO; GO:0019695; P:choline metabolic process; TAS:RGD.
DR   GO; GO:0035999; P:tetrahydrofolate interconversion; IDA:RGD.
DR   Gene3D; 3.30.1360.120; -; 1.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR032503; FAO_M.
DR   InterPro; IPR013977; GCV_T_C.
DR   InterPro; IPR006222; GCV_T_N.
DR   InterPro; IPR029043; GcvT/YgfZ_C.
DR   InterPro; IPR027266; TrmE/GcvT_dom1.
DR   Pfam; PF01266; DAO; 1.
DR   Pfam; PF16350; FAO_M; 1.
DR   Pfam; PF01571; GCV_T; 1.
DR   Pfam; PF08669; GCV_T_C; 1.
DR   SUPFAM; SSF101790; SSF101790; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Direct protein sequencing; FAD; Flavoprotein;
KW   Mitochondrion; Oxidoreductase; Reference proteome; Transit peptide.
FT   TRANSIT         1..43
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           44..857
FT                   /note="Dimethylglycine dehydrogenase, mitochondrial"
FT                   /id="PRO_0000010769"
FT   NP_BIND         52..53
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:24858690,
FT                   ECO:0007744|PDB:4P9S, ECO:0007744|PDB:4PAA,
FT                   ECO:0007744|PDB:4PAB"
FT   NP_BIND         73..74
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:24858690,
FT                   ECO:0007744|PDB:4P9S, ECO:0007744|PDB:4PAA,
FT                   ECO:0007744|PDB:4PAB"
FT   NP_BIND         80..88
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:24858690,
FT                   ECO:0007744|PDB:4P9S, ECO:0007744|PDB:4PAA,
FT                   ECO:0007744|PDB:4PAB"
FT   NP_BIND         390..395
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:24858690,
FT                   ECO:0007744|PDB:4P9S, ECO:0007744|PDB:4PAA,
FT                   ECO:0007744|PDB:4PAB"
FT   REGION          15..39
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          573..575
FT                   /note="Tetrahydrofolate binding"
FT                   /evidence="ECO:0000269|PubMed:24858690,
FT                   ECO:0007744|PDB:4PAA, ECO:0007744|PDB:4PAB"
FT   REGION          676..678
FT                   /note="Tetrahydrofolate binding"
FT                   /evidence="ECO:0000269|PubMed:24858690,
FT                   ECO:0007744|PDB:4PAA, ECO:0007744|PDB:4PAB"
FT   BINDING         212
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:24858690,
FT                   ECO:0007744|PDB:4P9S, ECO:0007744|PDB:4PAA,
FT                   ECO:0007744|PDB:4PAB"
FT   BINDING         244
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:24858690,
FT                   ECO:0007744|PDB:4P9S, ECO:0007744|PDB:4PAB"
FT   BINDING         669
FT                   /note="Tetrahydrofolate"
FT                   /evidence="ECO:0000269|PubMed:24858690,
FT                   ECO:0007744|PDB:4PAA"
FT   BINDING         737
FT                   /note="Tetrahydrofolate"
FT                   /evidence="ECO:0000269|PubMed:24858690,
FT                   ECO:0007744|PDB:4PAA, ECO:0007744|PDB:4PAB"
FT   MOD_RES         84
FT                   /note="Tele-8alpha-FAD histidine"
FT                   /evidence="ECO:0000269|PubMed:24858690,
FT                   ECO:0000269|PubMed:4055729, ECO:0007744|PDB:4P9S,
FT                   ECO:0007744|PDB:4PAA, ECO:0007744|PDB:4PAB"
FT   MOD_RES         107
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         141
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         141
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         161
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         216
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         310
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         312
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         328
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         353
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         427
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         427
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         469
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         469
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         516
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         516
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         648
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         648
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         757
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         786
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         786
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         788
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   STRAND          41..48
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           52..63
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          68..72
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          74..76
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   TURN            77..81
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           82..84
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          94..96
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           98..116
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          127..131
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           134..147
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          150..152
FT                   /evidence="ECO:0007829|PDB:4PAA"
FT   STRAND          155..157
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           159..165
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          176..180
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           188..201
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          205..209
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          214..217
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          223..227
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          230..239
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           242..244
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           245..250
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   TURN            251..253
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          259..268
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           272..275
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          283..286
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   TURN            287..290
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          291..296
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          299..304
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   TURN            308..310
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           315..320
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           336..338
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           339..348
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           350..353
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          357..367
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          374..377
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          384..388
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           393..410
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           418..420
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           422..424
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           431..443
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   TURN            444..446
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           467..471
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   TURN            472..474
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          475..480
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          483..489
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           508..520
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          523..526
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          530..537
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           540..547
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          548..550
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          557..564
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          570..580
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          583..588
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           590..592
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           593..606
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          612..615
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   TURN            617..619
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          620..627
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           630..635
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   TURN            644..646
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          651..657
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          660..665
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          671..680
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           681..683
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           684..694
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   TURN            695..699
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           705..714
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   TURN            720..722
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   TURN            730..734
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           736..738
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          743..745
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           750..759
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          762..770
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          782..785
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          788..799
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   TURN            800..803
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          804..812
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           813..815
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          821..826
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   STRAND          829..835
FT                   /evidence="ECO:0007829|PDB:4PAB"
FT   HELIX           844..857
FT                   /evidence="ECO:0007829|PDB:4PAB"
SQ   SEQUENCE   857 AA;  96048 MW;  A6FED946B8AB9878 CRC64;
     MLRLGALRLR GLALRSSQGR PSSAGLREGQ ESPPSPPEWK DRAETVIIGG GCVGVSLAYH
     LAKAGMRDVV LLEKSELTAG STWHAAGLTT YFHPGINLKK IHYDSIKLYE RLEEETGQVV
     GFHQPGSIRL ATTPERVDEF KYQMTRTNWH ATEQYIIEPE KIHELFPLLN MDKILAGLYN
     PGDGHIDPYS LTMALATGAR KYGVLLKYPA PVTSLKPRPD GTWDVETPQG SVRANRIVNA
     AGFWAREVGK MIGLDHPLIP VQHQYVVTST IPEVKALKRE LPVLRDLEGS YYLRQERDGL
     LFGPYESQEK MKLQASWVAH GVPPGFGKEL FESDLDRITE HVEAAMEMVP VLKKADIINI
     VNGPITYSPD ILPMVGPHQG VRNYWVAIGF GYGIIHAGGV GKYLSDWILH GEPPFDLIEL
     DPNRYGKWTT TQYTEAKARE SYGFNNIVGY PKEERFAGRP TQRVSGLYKI LESKCSMGFH
     AGWEQPHWFY KPGQDTQYRP SFRRTNWFRP VGSEYKQVMQ RVGVIDLSPF GKFNIKGQDS
     TQLLDHLCAN VIPKVGFTNI SHMLTPRGRV YAELTVSHQS PGEFLLITGS GSELHDLRWI
     EEAAVRGGYD VEIRNITDEL GVLGVAGPYA RRVLQKLTSE DLSDDVFKFL QTKSLKISDI
     PVTAIRISYT GELGWELYHR REDSAALYER IMNAGQEEGI DNFGTYALNA LRLEKAFRAW
     GSEMNCDTNP LEAGLDYFIK LNKPADFTGK QALKQIKAKG LKRRLVCLTL ATDDVDPEGN
     ESVWYKGKVI GNTTSGSYSY SIQKSLAFAY VPVELSEVGQ QVEVELLGKN YPATIIQEPL
     VLTEPTRTRL QKDGRKS
//
ID   FENR_ECOLI              Reviewed;         248 AA.
AC   P28861; P11007; Q2M8M0;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   02-JUN-2021, entry version 173.
DE   RecName: Full=Flavodoxin/ferredoxin--NADP reductase {ECO:0000305};
DE            EC=1.18.1.2 {ECO:0000269|PubMed:12234497, ECO:0000269|PubMed:21306142, ECO:0000269|PubMed:8449868};
DE            EC=1.19.1.1 {ECO:0000269|PubMed:12234497, ECO:0000269|PubMed:9839946};
DE   AltName: Full=Ferredoxin (flavodoxin):NADP(+) oxidoreductase {ECO:0000303|PubMed:12234497};
DE   AltName: Full=Ferredoxin--NADP reductase {ECO:0000303|PubMed:8449868};
DE            Short=FNR {ECO:0000303|PubMed:8449868};
DE   AltName: Full=Flavodoxin--NADP reductase {ECO:0000305};
DE            Short=FLDR {ECO:0000303|PubMed:9839946};
DE   AltName: Full=Methyl viologen resistance protein A {ECO:0000303|PubMed:2834327};
DE   AltName: Full=dA1 {ECO:0000303|PubMed:8449868};
GN   Name=fpr {ECO:0000303|PubMed:8449868};
GN   Synonyms=mvrA {ECO:0000303|PubMed:2834327};
GN   OrderedLocusNames=b3924, JW3895;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-26, FUNCTION,
RP   CATALYTIC ACTIVITY, AND COFACTOR.
RC   STRAIN=K12 / C600 / CR34 / ATCC 23724 / DSM 3925 / LMG 3041 / NCIB 10222;
RX   PubMed=8449868; DOI=10.1128/jb.175.6.1590-1595.1993;
RA   Bianchi V., Reichard P., Eliasson R., Pontis E., Krook M., Joernvall H.,
RA   Haggaard-Ljungquist E.;
RT   "Escherichia coli ferredoxin NADP+ reductase: activation of E. coli
RT   anaerobic ribonucleotide reduction, cloning of the gene (fpr), and
RT   overexpression of the protein.";
RL   J. Bacteriol. 175:1590-1595(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=8346018; DOI=10.1093/nar/21.15.3391;
RA   Plunkett G. III, Burland V., Daniels D.L., Blattner F.R.;
RT   "Analysis of the Escherichia coli genome. III. DNA sequence of the region
RT   from 87.2 to 89.2 minutes.";
RL   Nucleic Acids Res. 21:3391-3398(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   PRELIMINARY NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-135.
RC   STRAIN=K12 / MC4100 / ATCC 35695 / DSM 6574;
RX   PubMed=1400248; DOI=10.1128/jb.174.21.6981-6991.1992;
RA   Truniger V., Boos W., Sweet G.;
RT   "Molecular analysis of the glpFKX regions of Escherichia coli and Shigella
RT   flexneri.";
RL   J. Bacteriol. 174:6981-6991(1992).
RN   [6]
RP   PRELIMINARY NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-129, AND DISRUPTION
RP   PHENOTYPE.
RC   STRAIN=K12;
RX   PubMed=2834327; DOI=10.1128/jb.170.5.2136-2142.1988;
RA   Morimyo M.;
RT   "Isolation and characterization of methyl viologen-sensitive mutants of
RT   Escherichia coli K-12.";
RL   J. Bacteriol. 170:2136-2142(1988).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-14, AND SUBCELLULAR LOCATION.
RX   PubMed=7961651;
RA   Jenkins C.M., Waterman M.R.;
RT   "Flavodoxin and NADPH-flavodoxin reductase from Escherichia coli support
RT   bovine cytochrome P450c17 hydroxylase activities.";
RL   J. Biol. Chem. 269:27401-27408(1994).
RN   [8]
RP   FUNCTION.
RX   PubMed=7042345;
RA   Blaschkowski H.P., Neuer G., Ludwig-Festl M., Knappe J.;
RT   "Routes of flavodoxin and ferredoxin reduction in Escherichia coli. CoA-
RT   acylating pyruvate: flavodoxin and NADPH: flavodoxin oxidoreductases
RT   participating in the activation of pyruvate formate-lyase.";
RL   Eur. J. Biochem. 123:563-569(1982).
RN   [9]
RP   FUNCTION.
RX   PubMed=8267617; DOI=10.1006/bbrc.1993.2548;
RA   Bianchi V., Eliasson R., Fontecave M., Mulliez E., Hoover D.M.,
RA   Matthews R.G., Reichard P.;
RT   "Flavodoxin is required for the activation of the anaerobic ribonucleotide
RT   reductase.";
RL   Biochem. Biophys. Res. Commun. 197:792-797(1993).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9839946; DOI=10.1046/j.1432-1327.1998.2570577.x;
RA   McIver L., Leadbeater C., Campopiano D.J., Baxter R.L., Daff S.N.,
RA   Chapman S.K., Munro A.W.;
RT   "Characterisation of flavodoxin NADP+ oxidoreductase and flavodoxin; key
RT   components of electron transfer in Escherichia coli.";
RL   Eur. J. Biochem. 257:577-585(1998).
RN   [11]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF ARG-144; ARG-174 AND
RP   ARG-184.
RX   PubMed=11085917; DOI=10.1042/bj3520257;
RA   Leadbeater C., McIver L., Campopiano D.J., Webster S.P., Baxter R.L.,
RA   Kelly S.M., Price N.C., Lysek D.A., Noble M.A., Chapman S.K., Munro A.W.;
RT   "Probing the NADPH-binding site of Escherichia coli flavodoxin
RT   oxidoreductase.";
RL   Biochem. J. 352:257-266(2000).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=12234497; DOI=10.1016/s0003-9861(02)00421-6;
RA   Wan J.T., Jarrett J.T.;
RT   "Electron acceptor specificity of ferredoxin (flavodoxin):NADP+
RT   oxidoreductase from Escherichia coli.";
RL   Arch. Biochem. Biophys. 406:116-126(2002).
RN   [13] {ECO:0007744|PDB:1FDR}
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH FAD, AND SUBUNIT.
RX   PubMed=9149148; DOI=10.1006/jmbi.1997.0957;
RA   Ingelman M., Blanchi V., Eklund H.;
RT   "The three-dimensional structure of flavodoxin reductase from Escherichia
RT   coli at 1.7-A resolution.";
RL   J. Mol. Biol. 268:147-157(1997).
RN   [14] {ECO:0007744|PDB:2XNJ}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 2-247 IN COMPLEX WITH FAD AND
RP   NADP, FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=21306142; DOI=10.1021/bi101772a;
RA   Musumeci M.A., Botti H., Buschiazzo A., Ceccarelli E.A.;
RT   "Swapping FAD binding motifs between plastidic and bacterial ferredoxin-
RT   NADP(H) reductases.";
RL   Biochemistry 50:2111-2122(2011).
CC   -!- FUNCTION: Transports electrons between flavodoxin or ferredoxin and
CC       NADPH (PubMed:8449868, PubMed:9839946, PubMed:12234497,
CC       PubMed:21306142). Reduces flavodoxin 1, flavodoxin 2 and ferredoxin,
CC       ferredoxin being the kinetically and thermodynamically preferred
CC       partner (PubMed:12234497). Required for the activation of several
CC       enzymes such as pyruvate formate-lyase, anaerobic ribonucleotide
CC       reductase and cobalamin-dependent methionine synthase (PubMed:7042345,
CC       PubMed:8267617). {ECO:0000269|PubMed:12234497,
CC       ECO:0000269|PubMed:21306142, ECO:0000269|PubMed:7042345,
CC       ECO:0000269|PubMed:8267617, ECO:0000269|PubMed:8449868,
CC       ECO:0000269|PubMed:9839946}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADP(+) + 2 reduced [2Fe-2S]-[ferredoxin] = NADPH + 2
CC         oxidized [2Fe-2S]-[ferredoxin]; Xref=Rhea:RHEA:20125, Rhea:RHEA-
CC         COMP:10000, Rhea:RHEA-COMP:10001, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:33737, ChEBI:CHEBI:33738, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.18.1.2;
CC         Evidence={ECO:0000269|PubMed:12234497, ECO:0000269|PubMed:21306142,
CC         ECO:0000269|PubMed:8449868};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADP(+) + reduced [flavodoxin] = 2 H(+) + NADPH + oxidized
CC         [flavodoxin]; Xref=Rhea:RHEA:50756, Rhea:RHEA-COMP:10622, Rhea:RHEA-
CC         COMP:10623, ChEBI:CHEBI:15378, ChEBI:CHEBI:57618, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58210, ChEBI:CHEBI:58349; EC=1.19.1.1;
CC         Evidence={ECO:0000269|PubMed:12234497, ECO:0000269|PubMed:9839946};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:12234497, ECO:0000269|PubMed:8449868};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.85 uM for NADPH {ECO:0000269|PubMed:9839946};
CC         KM=3.9 uM for NADPH {ECO:0000269|PubMed:11085917};
CC         KM=2.04 mM for NADH {ECO:0000269|PubMed:11085917};
CC         KM=12.0 uM for ferredoxin {ECO:0000269|PubMed:12234497};
CC         KM=7.6 uM for flavodoxin 1 {ECO:0000269|PubMed:12234497};
CC         KM=4.0 uM for flavodoxin 2 {ECO:0000269|PubMed:12234497};
CC         KM=6.84 uM for flavodoxin {ECO:0000269|PubMed:9839946};
CC         KM=17.6 uM for cytochrome c {ECO:0000269|PubMed:9839946};
CC         KM=23.6 uM for potassium ferricyanide {ECO:0000269|PubMed:9839946};
CC         Note=kcat is 338.9 min(-1) with NADPH as the donor. kcat is 33 min(-
CC         1) with NADP as the donor (PubMed:11085917). kcat is 0.15 sec(-1)
CC         with ferredoxin as substrate. kcat is 0.0042 sec(-1) with flavodoxin
CC         1 as substrate. kcat is 0.0039 sec(-1) with flavodoxin 2 as substrate
CC         (PubMed:12234497). {ECO:0000269|PubMed:11085917,
CC         ECO:0000269|PubMed:12234497};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:9149148}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:7961651}.
CC   -!- DISRUPTION PHENOTYPE: Mutant is highly sensitive to methyl viologen.
CC       {ECO:0000269|PubMed:2834327}.
CC   -!- SIMILARITY: Belongs to the ferredoxin--NADP reductase type 1 family.
CC       {ECO:0000305}.
CC   -!- CAUTION: PubMed:2834327 authors incorrectly assigned the protein to be
CC       part of FPR, the C-terminal of GlpX. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=Z11767; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L04757; AAA23805.1; -; Genomic_DNA.
DR   EMBL; L19201; AAB03056.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76906.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77386.1; -; Genomic_DNA.
DR   EMBL; Z11767; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M19644; AAA24189.1; ALT_SEQ; Genomic_DNA.
DR   PIR; S40867; S40867.
DR   RefSeq; NP_418359.1; NC_000913.3.
DR   RefSeq; WP_000796332.1; NZ_SSZK01000014.1.
DR   PDB; 1FDR; X-ray; 1.70 A; A=1-248.
DR   PDB; 2XNJ; X-ray; 1.90 A; A/B=2-247.
DR   PDBsum; 1FDR; -.
DR   PDBsum; 2XNJ; -.
DR   SMR; P28861; -.
DR   BioGRID; 4261115; 4.
DR   IntAct; P28861; 6.
DR   STRING; 511145.b3924; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   jPOST; P28861; -.
DR   PaxDb; P28861; -.
DR   PRIDE; P28861; -.
DR   EnsemblBacteria; AAC76906; AAC76906; b3924.
DR   EnsemblBacteria; BAE77386; BAE77386; BAE77386.
DR   GeneID; 948414; -.
DR   KEGG; ecj:JW3895; -.
DR   KEGG; eco:b3924; -.
DR   PATRIC; fig|1411691.4.peg.2781; -.
DR   EchoBASE; EB1480; -.
DR   eggNOG; COG1018; Bacteria.
DR   HOGENOM; CLU_003827_3_0_6; -.
DR   InParanoid; P28861; -.
DR   PhylomeDB; P28861; -.
DR   BioCyc; EcoCyc:FLAVONADPREDUCT-MONOMER; -.
DR   BioCyc; MetaCyc:FLAVONADPREDUCT-MONOMER; -.
DR   BRENDA; 1.18.1.2; 2026.
DR   BRENDA; 1.19.1.1; 2026.
DR   EvolutionaryTrace; P28861; -.
DR   PRO; PR:P28861; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0071949; F:FAD binding; IDA:EcoCyc.
DR   GO; GO:0004324; F:ferredoxin-NADP+ reductase activity; IDA:EcoCyc.
DR   GO; GO:0016226; P:iron-sulfur cluster assembly; IDA:EcoCyc.
DR   GO; GO:0042493; P:response to drug; IMP:EcoliWiki.
DR   GO; GO:0000303; P:response to superoxide; IMP:EcoCyc.
DR   CDD; cd06195; FNR1; 1.
DR   Gene3D; 3.40.50.80; -; 1.
DR   InterPro; IPR008333; Cbr1-like_FAD-bd_dom.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR033892; FNR_bac.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF00970; FAD_binding_6; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   SUPFAM; SSF52343; SSF52343; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Direct protein sequencing; FAD; Flavoprotein;
KW   NADP; Nucleotide-binding; Oxidoreductase; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:7961651,
FT                   ECO:0000269|PubMed:8449868"
FT   CHAIN           2..248
FT                   /note="Flavodoxin/ferredoxin--NADP reductase"
FT                   /id="PRO_0000167643"
FT   DOMAIN          2..101
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   NP_BIND         50..53
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21306142,
FT                   ECO:0000269|PubMed:9149148, ECO:0007744|PDB:1FDR,
FT                   ECO:0007744|PDB:2XNJ"
FT   NP_BIND         74..76
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21306142,
FT                   ECO:0000269|PubMed:9149148, ECO:0007744|PDB:1FDR,
FT                   ECO:0007744|PDB:2XNJ"
FT   NP_BIND         143..144
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:21306142,
FT                   ECO:0007744|PDB:2XNJ"
FT   NP_BIND         173..174
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:21306142,
FT                   ECO:0007744|PDB:2XNJ"
FT   NP_BIND         214..216
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:21306142,
FT                   ECO:0007744|PDB:2XNJ"
FT   NP_BIND         247..248
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9149148,
FT                   ECO:0007744|PDB:1FDR"
FT   BINDING         17
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:21306142,
FT                   ECO:0007744|PDB:2XNJ"
FT   BINDING         66
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:21306142,
FT                   ECO:0000269|PubMed:9149148, ECO:0007744|PDB:1FDR,
FT                   ECO:0007744|PDB:2XNJ"
FT   BINDING         116
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:9149148,
FT                   ECO:0007744|PDB:1FDR"
FT   BINDING         184
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:21306142,
FT                   ECO:0007744|PDB:2XNJ"
FT   BINDING         220
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:21306142,
FT                   ECO:0007744|PDB:2XNJ"
FT   MUTAGEN         144
FT                   /note="R->A: Increases Km for NADPH. 2-fold decrease in
FT                   catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:11085917"
FT   MUTAGEN         174
FT                   /note="R->A: Increases Km for NADPH. 13-fold decrease in
FT                   catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:11085917"
FT   MUTAGEN         184
FT                   /note="R->A: Increases Km for NADPH. 15-fold decrease in
FT                   catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:11085917"
FT   STRAND          4..14
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   STRAND          16..25
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   STRAND          36..41
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   STRAND          48..53
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   STRAND          61..68
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   HELIX           76..80
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   STRAND          87..93
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   HELIX           100..102
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   STRAND          107..114
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   HELIX           115..118
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   HELIX           119..127
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   STRAND          135..145
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   HELIX           146..148
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   HELIX           152..161
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   TURN            162..164
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   STRAND          165..175
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   STRAND          180..183
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   HELIX           185..190
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   HELIX           193..198
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   TURN            204..206
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   STRAND          207..213
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   HELIX           215..229
FT                   /evidence="ECO:0007829|PDB:1FDR"
FT   STRAND          236..238
FT                   /evidence="ECO:0007829|PDB:2XNJ"
FT   STRAND          241..246
FT                   /evidence="ECO:0007829|PDB:1FDR"
SQ   SEQUENCE   248 AA;  27751 MW;  CBF46435A95709E4 CRC64;
     MADWVTGKVT KVQNWTDALF SLTVHAPVLP FTAGQFTKLG LEIDGERVQR AYSYVNSPDN
     PDLEFYLVTV PDGKLSPRLA ALKPGDEVQV VSEAAGFFVL DEVPHCETLW MLATGTAIGP
     YLSILQLGKD LDRFKNLVLV HAARYAADLS YLPLMQELEK RYEGKLRIQT VVSRETAAGS
     LTGRIPALIE SGELESTIGL PMNKETSHVM LCGNPQMVRD TQQLLKETRQ MTKHLRRRPG
     HMTAEHYW
//
ID   GLF_ECOLI               Reviewed;         367 AA.
AC   P37747;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1994, sequence version 1.
DT   02-JUN-2021, entry version 169.
DE   RecName: Full=UDP-galactopyranose mutase;
DE            Short=UGM;
DE            EC=5.4.99.9;
DE   AltName: Full=UDP-GALP mutase;
DE   AltName: Full=Uridine 5-diphosphate galactopyranose mutase;
GN   Name=glf; Synonyms=yefE; OrderedLocusNames=b2036, JW2021;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=7517390; DOI=10.1128/jb.176.13.4133-4143.1994;
RA   Yao Z., Valvano M.A.;
RT   "Genetic analysis of the O-specific lipopolysaccharide biosynthesis region
RT   (rfb) of Escherichia coli K-12 W3110: identification of genes that confer
RT   group 6 specificity to Shigella flexneri serotypes Y and 4a.";
RL   J. Bacteriol. 176:4133-4143(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12 / WG1;
RX   PubMed=7517391; DOI=10.1128/jb.176.13.4144-4156.1994;
RA   Stevenson G., Neal B., Liu D., Hobbs M., Packer N.H., Batley M.,
RA   Redmond J.W., Lindquist L., Reeves P.R.;
RT   "Structure of the O antigen of Escherichia coli K-12 and the sequence of
RT   its rfb gene cluster.";
RL   J. Bacteriol. 176:4144-4156(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9097040; DOI=10.1093/dnares/3.6.379;
RA   Itoh T., Aiba H., Baba T., Fujita K., Hayashi K., Inada T., Isono K.,
RA   Kasai H., Kimura S., Kitakawa M., Kitagawa M., Makino K., Miki T.,
RA   Mizobuchi K., Mori H., Mori T., Motomura K., Nakade S., Nakamura Y.,
RA   Nashimoto H., Nishio Y., Oshima T., Saito N., Sampei G., Seki Y.,
RA   Sivasundaram S., Tagami H., Takeda J., Takemoto K., Wada C., Yamamoto Y.,
RA   Horiuchi T.;
RT   "A 460-kb DNA sequence of the Escherichia coli K-12 genome corresponding to
RT   the 40.1-50.0 min region on the linkage map.";
RL   DNA Res. 3:379-392(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-15, FUNCTION, CATALYTIC ACTIVITY, MASS SPECTROMETRY,
RP   COFACTOR, AND NOMENCLATURE.
RX   PubMed=8576037; DOI=10.1128/jb.178.4.1047-1052.1996;
RA   Nassau P.M., Martin S.L., Brown R.E., Weston A., Monsey D., McNeil M.R.,
RA   Duncan K.;
RT   "Galactofuranose biosynthesis in Escherichia coli K-12: identification and
RT   cloning of UDP-galactopyranose mutase.";
RL   J. Bacteriol. 178:1047-1052(1996).
RN   [7]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11448178; DOI=10.1021/ja010473l;
RA   Zhang Q., Liu H.;
RT   "Mechanistic investigation of UDP-galactopyranose mutase from Escherichia
RT   coli using 2- and 3-fluorinated UDP-galactofuranose as probes.";
RL   J. Am. Chem. Soc. 123:6756-6766(2001).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH FAD, MUTAGENESIS OF
RP   TYR-151; TRP-156; TYR-181; TYR-311 AND TYR-346, AND SUBUNIT.
RX   PubMed=11573090; DOI=10.1038/nsb1001-858;
RA   Sanders D.A., Staines A.G., McMahon S.A., McNeil M.R., Whitfield C.,
RA   Naismith J.H.;
RT   "UDP-galactopyranose mutase has a novel structure and mechanism.";
RL   Nat. Struct. Biol. 8:858-863(2001).
CC   -!- FUNCTION: Catalyzes the interconversion through a 2-keto intermediate
CC       of uridine diphosphogalactopyranose (UDP-GalP) into uridine
CC       diphosphogalactofuranose (UDP-GalF). {ECO:0000250,
CC       ECO:0000269|PubMed:11448178, ECO:0000269|PubMed:8576037}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=UDP-alpha-D-galactose = UDP-alpha-D-galactofuranose;
CC         Xref=Rhea:RHEA:24132, ChEBI:CHEBI:66914, ChEBI:CHEBI:66915;
CC         EC=5.4.99.9; Evidence={ECO:0000269|PubMed:8576037};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:8576037};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:8576037};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=194 uM for UDP-GalF {ECO:0000269|PubMed:11448178};
CC         Note=Kcat is 1.5 (sec-1) for UDP-GalF.;
CC   -!- PATHWAY: Bacterial outer membrane biogenesis; lipopolysaccharide
CC       biosynthesis.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11573090}.
CC   -!- INTERACTION:
CC       P37747; P11868: tdcD; NbExp=2; IntAct=EBI-558730, EBI-553884;
CC   -!- MASS SPECTROMETRY: Mass=42960; Mass_error=8; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:8576037};
CC   -!- SIMILARITY: Belongs to the UDP-galactopyranose/dTDP-fucopyranose mutase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U03041; AAC31632.1; -; Genomic_DNA.
DR   EMBL; U09876; AAB88403.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC75097.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA15878.1; -; Genomic_DNA.
DR   PIR; I69653; I69653.
DR   RefSeq; NP_416540.1; NC_000913.3.
DR   RefSeq; WP_000272486.1; NZ_LN832404.1.
DR   PDB; 1I8T; X-ray; 2.40 A; A/B=1-367.
DR   PDBsum; 1I8T; -.
DR   SMR; P37747; -.
DR   BioGRID; 4260648; 105.
DR   DIP; DIP-6863N; -.
DR   IntAct; P37747; 4.
DR   STRING; 511145.b2036; -.
DR   ChEMBL; CHEMBL1075076; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   jPOST; P37747; -.
DR   PaxDb; P37747; -.
DR   PRIDE; P37747; -.
DR   EnsemblBacteria; AAC75097; AAC75097; b2036.
DR   EnsemblBacteria; BAA15878; BAA15878; BAA15878.
DR   GeneID; 945235; -.
DR   KEGG; ecj:JW2021; -.
DR   KEGG; eco:b2036; -.
DR   PATRIC; fig|1411691.4.peg.215; -.
DR   EchoBASE; EB1924; -.
DR   eggNOG; COG0562; Bacteria.
DR   HOGENOM; CLU_042118_0_0_6; -.
DR   InParanoid; P37747; -.
DR   PhylomeDB; P37747; -.
DR   BioCyc; EcoCyc:GALPMUT-MONOMER; -.
DR   BioCyc; MetaCyc:GALPMUT-MONOMER; -.
DR   BRENDA; 5.4.99.9; 2026.
DR   UniPathway; UPA00030; -.
DR   EvolutionaryTrace; P37747; -.
DR   PRO; PR:P37747; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:EcoCyc.
DR   GO; GO:0008767; F:UDP-galactopyranose mutase activity; IDA:EcoCyc.
DR   GO; GO:0009103; P:lipopolysaccharide biosynthetic process; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR004379; UDP-GALP_mutase.
DR   InterPro; IPR015899; UDP-GalPyranose_mutase_C.
DR   Pfam; PF03275; GLF; 1.
DR   TIGRFAMs; TIGR00031; UDP-GALP_mutase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; FAD; Flavoprotein; Isomerase;
KW   Lipopolysaccharide biosynthesis; Reference proteome.
FT   CHAIN           1..367
FT                   /note="UDP-galactopyranose mutase"
FT                   /id="PRO_0000087508"
FT   NP_BIND         31..32
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11573090"
FT   NP_BIND         56..57
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11573090"
FT   NP_BIND         212..213
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11573090"
FT   NP_BIND         347..352
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:11573090"
FT   BINDING         12
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:11573090"
FT   BINDING         12
FT                   /note="UDP-GalP; via amide nitrogen"
FT                   /evidence="ECO:0000250"
FT   BINDING         39
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:11573090"
FT   BINDING         80
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   BINDING         152
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   BINDING         156
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   BINDING         181
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   BINDING         268
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   BINDING         278
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   BINDING         311
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   BINDING         340
FT                   /note="FAD"
FT                   /evidence="ECO:0000250"
FT   BINDING         346
FT                   /note="UDP-GalP"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         151
FT                   /note="Y->F: 3-fold decrease in the mutase activity."
FT                   /evidence="ECO:0000269|PubMed:11573090"
FT   MUTAGEN         156
FT                   /note="W->A: Loss of mutase activity."
FT                   /evidence="ECO:0000269|PubMed:11573090"
FT   MUTAGEN         156
FT                   /note="W->Y: 2-fold decrease in the mutase activity."
FT                   /evidence="ECO:0000269|PubMed:11573090"
FT   MUTAGEN         181
FT                   /note="Y->F: Increase in the mutase activity."
FT                   /evidence="ECO:0000269|PubMed:11573090"
FT   MUTAGEN         311
FT                   /note="Y->F: Loss of mutase activity."
FT                   /evidence="ECO:0000269|PubMed:11573090"
FT   MUTAGEN         346
FT                   /note="Y->F: Loss of mutase activity."
FT                   /evidence="ECO:0000269|PubMed:11573090"
FT   STRAND          2..7
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           11..20
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           21..23
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          27..30
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          32..37
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           38..40
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          42..45
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          48..51
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          58..61
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           63..70
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          83..86
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          89..96
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           97..104
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           109..119
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   TURN            120..123
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           131..147
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           149..156
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           160..162
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          175..177
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          185..188
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           194..202
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          205..208
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           213..215
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           217..221
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          224..229
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           233..236
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   TURN            237..241
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          246..259
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          261..269
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          277..281
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           282..285
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          293..302
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           316..331
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   STRAND          335..337
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   TURN            340..344
FT                   /evidence="ECO:0007829|PDB:1I8T"
FT   HELIX           349..364
FT                   /evidence="ECO:0007829|PDB:1I8T"
SQ   SEQUENCE   367 AA;  42966 MW;  C62F67A4682B2A06 CRC64;
     MYDYIIVGSG LFGAVCANEL KKLNKKVLVI EKRNHIGGNA YTEDCEGIQI HKYGAHIFHT
     NDKYIWDYVN DLVEFNRFTN SPLAIYKDKL FNLPFNMNTF HQMWGVKDPQ EAQNIINAQK
     KKYGDKVPEN LEEQAISLVG EDLYQALIKG YTEKQWGRSA KELPAFIIKR IPVRFTFDNN
     YFSDRYQGIP VGGYTKLIEK MLEGVDVKLG IDFLKDKDSL ASKAHRIIYT GPIDQYFDYR
     FGALEYRSLK FETERHEFPN FQGNAVINFT DANVPYTRII EHKHFDYVET KHTVVTKEYP
     LEWKVGDEPY YPVNDNKNME LFKKYRELAS REDKVIFGGR LAEYKYYDMH QVISAALYQV
     KNIMSTD
//
ID   METF_ECOLI              Reviewed;         296 AA.
AC   P0AEZ1; P00394; Q2M8N7;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   02-JUN-2021, entry version 126.
DE   RecName: Full=5,10-methylenetetrahydrofolate reductase;
DE            EC=1.5.1.20;
GN   Name=metF; OrderedLocusNames=b3941, JW3913;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=6356036; DOI=10.1093/nar/11.19.6723;
RA   Saint-Girons I., Duchange N., Zakin M.M., Park I., Margarita D.,
RA   Ferrara P., Cohen G.N.;
RT   "Nucleotide sequence of metF, the E. coli structural gene for 5-10
RT   methylene tetrahydrofolate reductase and of its control region.";
RL   Nucleic Acids Res. 11:6723-6732(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=8346018; DOI=10.1093/nar/21.15.3391;
RA   Plunkett G. III, Burland V., Daniels D.L., Blattner F.R.;
RT   "Analysis of the Escherichia coli genome. III. DNA sequence of the region
RT   from 87.2 to 89.2 minutes.";
RL   Nucleic Acids Res. 21:3391-3398(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   INDUCTION, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   COFACTOR.
RX   PubMed=14275142;
RA   Katzen H.M., Buchanan J.M.;
RT   "Enzymatic synthesis of the methyl group of methionine. 8. Repression-
RT   derepression, purification, and properties of 5,10-
RT   methylenetetrahydrofolate reductase from Escherichia coli.";
RL   J. Biol. Chem. 240:825-835(1965).
RN   [6]
RP   IDENTIFICATION.
RX   PubMed=6219268; DOI=10.1007/bf00384390;
RA   Zakin M.M., Greene R.C., Dautry-Varsat A., Duchange N., Ferrara P.,
RA   Py M.C., Margarita D., Cohen G.N.;
RT   "Construction and physical mapping of plasmids containing the metJBLF gene
RT   cluster of E. coli K12.";
RL   Mol. Gen. Genet. 187:101-106(1982).
RN   [7]
RP   CATALYTIC ACTIVITY, COFACTOR, ACTIVE SITE, AND MUTAGENESIS OF GLU-28 AND
RP   ASP-120.
RX   PubMed=11371182; DOI=10.1021/bi002790v;
RA   Trimmer E.E., Ballou D.P., Ludwig M.L., Matthews R.G.;
RT   "Folate activation and catalysis in methylenetetrahydrofolate reductase
RT   from Escherichia coli: roles for aspartate 120 and glutamate 28.";
RL   Biochemistry 40:6216-6226(2001).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 21-294 IN COMPLEX WITH FAD,
RP   BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, SUBUNIT, AND MUTAGENESIS OF
RP   ALA-177.
RX   PubMed=10201405; DOI=10.1038/7594;
RA   Guenther B.D., Sheppard C.A., Tran P., Rozen R., Matthews R.G.,
RA   Ludwig M.L.;
RT   "The structure and properties of methylenetetrahydrofolate reductase from
RT   Escherichia coli suggest how folate ameliorates human
RT   hyperhomocysteinemia.";
RL   Nat. Struct. Biol. 6:359-365(1999).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF WILD TYPE AND MUTANT GLN-28 IN
RP   COMPLEXES WITH 5-METHYL-5,6,7,8-TETRAHYDROFOLATE; FAD AND NAD, COFACTOR,
RP   SUBUNIT, MUTAGENESIS OF GLU-28, AND ACTIVE SITE.
RX   PubMed=16114881; DOI=10.1021/bi050533q;
RA   Pejchal R., Sargeant R., Ludwig M.L.;
RT   "Structures of NADH and CH3-H4folate complexes of Escherichia coli
RT   methylenetetrahydrofolate reductase reveal a spartan strategy for a ping-
RT   pong reaction.";
RL   Biochemistry 44:11447-11457(2005).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF MUTANT VAL-177 IN COMPLEX WITH
RP   SUBSTRATE ANALOG LY309887 AND FAD, COFACTOR, AND SUBUNIT.
RX   PubMed=16605249; DOI=10.1021/bi052294c;
RA   Pejchal R., Campbell E., Guenther B.D., Lennon B.W., Matthews R.G.,
RA   Ludwig M.L.;
RT   "Structural perturbations in the Ala --> Val polymorphism of
RT   methylenetetrahydrofolate reductase: how binding of folates may protect
RT   against inactivation.";
RL   Biochemistry 45:4808-4818(2006).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) ON MUTANTS GLN-28 AND LEU-223 IN
RP   COMPLEXES WITH 5-METHYL-5,6,7,8-TETRAHYDROFOLATE AND FAD, CATALYTIC
RP   ACTIVITY, MUTAGENESIS OF PHE-223, AND COFACTOR.
RX   PubMed=19610625; DOI=10.1021/bi9007325;
RA   Lee M.N., Takawira D., Nikolova A.P., Ballou D.P., Furtado V.C.,
RA   Phung N.L., Still B.R., Thorstad M.K., Tanner J.J., Trimmer E.E.;
RT   "Functional role for the conformationally mobile phenylalanine 223 in the
RT   reaction of methylenetetrahydrofolate reductase from Escherichia coli.";
RL   Biochemistry 48:7673-7685(2009).
CC   -!- FUNCTION: Methylenetetrahydrofolate reductase required to generate the
CC       methyl groups necessary for methionine synthetase to convert
CC       homocysteine to methionine. {ECO:0000269|PubMed:14275142}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6S)-5-methyl-5,6,7,8-tetrahydrofolate + NADP(+) = (6R)-5,10-
CC         methylene-5,6,7,8-tetrahydrofolate + H(+) + NADPH;
CC         Xref=Rhea:RHEA:19817, ChEBI:CHEBI:15378, ChEBI:CHEBI:15636,
CC         ChEBI:CHEBI:18608, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.5.1.20;
CC         Evidence={ECO:0000269|PubMed:11371182, ECO:0000269|PubMed:14275142,
CC         ECO:0000269|PubMed:19610625};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6S)-5-methyl-5,6,7,8-tetrahydrofolate + NAD(+) = (6R)-5,10-
CC         methylene-5,6,7,8-tetrahydrofolate + H(+) + NADH;
CC         Xref=Rhea:RHEA:19821, ChEBI:CHEBI:15378, ChEBI:CHEBI:15636,
CC         ChEBI:CHEBI:18608, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.5.1.20;
CC         Evidence={ECO:0000269|PubMed:11371182, ECO:0000269|PubMed:14275142,
CC         ECO:0000269|PubMed:19610625};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:10201405, ECO:0000269|PubMed:11371182,
CC         ECO:0000269|PubMed:14275142, ECO:0000269|PubMed:16114881,
CC         ECO:0000269|PubMed:16605249, ECO:0000269|PubMed:19610625};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=17 uM for NADPH {ECO:0000269|PubMed:10201405,
CC         ECO:0000269|PubMed:14275142};
CC         KM=3.9 uM for 5,10-methylenetetrahydrofolate
CC         {ECO:0000269|PubMed:10201405, ECO:0000269|PubMed:14275142};
CC       pH dependence:
CC         Optimum pH is 6.3-6.4. {ECO:0000269|PubMed:10201405,
CC         ECO:0000269|PubMed:14275142};
CC   -!- PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:10201405,
CC       ECO:0000269|PubMed:16114881, ECO:0000269|PubMed:16605249}.
CC   -!- INDUCTION: Repressed by methionine. {ECO:0000269|PubMed:14275142}.
CC   -!- SIMILARITY: Belongs to the methylenetetrahydrofolate reductase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; V01502; CAA24747.1; -; Genomic_DNA.
DR   EMBL; L19201; AAB03073.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76923.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77369.1; -; Genomic_DNA.
DR   PIR; A00462; RDECMH.
DR   RefSeq; NP_418376.1; NC_000913.3.
DR   RefSeq; WP_000007523.1; NZ_STEB01000037.1.
DR   PDB; 1B5T; X-ray; 2.50 A; A/B/C=21-294.
DR   PDB; 1ZP3; X-ray; 1.85 A; A/B/C=1-296.
DR   PDB; 1ZP4; X-ray; 1.85 A; A/B/C=1-296.
DR   PDB; 1ZPT; X-ray; 1.95 A; A/B/C=1-296.
DR   PDB; 1ZRQ; X-ray; 2.20 A; A/B/C=1-296.
DR   PDB; 2FMN; X-ray; 2.05 A; A/B/C=1-296.
DR   PDB; 2FMO; X-ray; 2.25 A; A/B/C=1-296.
DR   PDB; 3FST; X-ray; 1.65 A; A/C/E=1-296.
DR   PDB; 3FSU; X-ray; 1.70 A; A/C/E=1-296.
DR   PDB; 6PEY; X-ray; 2.88 A; A/B/C=1-296.
DR   PDBsum; 1B5T; -.
DR   PDBsum; 1ZP3; -.
DR   PDBsum; 1ZP4; -.
DR   PDBsum; 1ZPT; -.
DR   PDBsum; 1ZRQ; -.
DR   PDBsum; 2FMN; -.
DR   PDBsum; 2FMO; -.
DR   PDBsum; 3FST; -.
DR   PDBsum; 3FSU; -.
DR   PDBsum; 6PEY; -.
DR   SMR; P0AEZ1; -.
DR   BioGRID; 4263063; 24.
DR   DIP; DIP-6848N; -.
DR   IntAct; P0AEZ1; 4.
DR   STRING; 511145.b3941; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   PaxDb; P0AEZ1; -.
DR   PRIDE; P0AEZ1; -.
DR   EnsemblBacteria; AAC76923; AAC76923; b3941.
DR   EnsemblBacteria; BAE77369; BAE77369; BAE77369.
DR   GeneID; 61754803; -.
DR   GeneID; 948432; -.
DR   KEGG; ecj:JW3913; -.
DR   KEGG; eco:b3941; -.
DR   PATRIC; fig|1411691.4.peg.2763; -.
DR   EchoBASE; EB0580; -.
DR   eggNOG; COG0685; Bacteria.
DR   HOGENOM; CLU_025841_0_0_6; -.
DR   InParanoid; P0AEZ1; -.
DR   PhylomeDB; P0AEZ1; -.
DR   BioCyc; EcoCyc:METHYLENETHFREDUCT-MONOMER; -.
DR   BioCyc; MetaCyc:METHYLENETHFREDUCT-MONOMER; -.
DR   BRENDA; 1.5.1.20; 2026.
DR   UniPathway; UPA00193; -.
DR   EvolutionaryTrace; P0AEZ1; -.
DR   PRO; PR:P0AEZ1; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; IDA:EcoCyc.
DR   GO; GO:0071949; F:FAD binding; IDA:EcoCyc.
DR   GO; GO:0004489; F:methylenetetrahydrofolate reductase (NAD(P)H) activity; IDA:EcoCyc.
DR   GO; GO:0106312; F:methylenetetrahydrofolate reductase NADH activity; IEA:RHEA.
DR   GO; GO:0106313; F:methylenetetrahydrofolate reductase NADPH activity; IEA:RHEA.
DR   GO; GO:0009086; P:methionine biosynthetic process; IBA:GO_Central.
DR   GO; GO:0046654; P:tetrahydrofolate biosynthetic process; IDA:EcoCyc.
DR   GO; GO:0035999; P:tetrahydrofolate interconversion; IBA:GO_Central.
DR   CDD; cd00537; MTHFR; 1.
DR   InterPro; IPR029041; FAD-linked_oxidoreductase-like.
DR   InterPro; IPR003171; Mehydrof_redctse-like.
DR   InterPro; IPR004620; MTHF_reductase_bac.
DR   Pfam; PF02219; MTHFR; 1.
DR   SUPFAM; SSF51730; SSF51730; 1.
DR   TIGRFAMs; TIGR00676; fadh2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Amino-acid biosynthesis; FAD; Flavoprotein;
KW   Methionine biosynthesis; NAD; NADP; Oxidoreductase; Reference proteome.
FT   CHAIN           1..296
FT                   /note="5,10-methylenetetrahydrofolate reductase"
FT                   /id="PRO_0000190261"
FT   NP_BIND         28..33
FT                   /note="NAD"
FT   NP_BIND         59..62
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10201405,
FT                   ECO:0000269|PubMed:16605249"
FT   NP_BIND         59..60
FT                   /note="NAD"
FT   NP_BIND         118..120
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10201405,
FT                   ECO:0000269|PubMed:16605249"
FT   NP_BIND         131..132
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10201405,
FT                   ECO:0000269|PubMed:16605249"
FT   NP_BIND         156..159
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10201405,
FT                   ECO:0000269|PubMed:16605249"
FT   NP_BIND         165..172
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10201405,
FT                   ECO:0000269|PubMed:16605249"
FT   ACT_SITE        28
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000269|PubMed:11371182,
FT                   ECO:0000269|PubMed:16114881"
FT   BINDING         88
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10201405,
FT                   ECO:0000269|PubMed:16605249"
FT   BINDING         120
FT                   /note="Substrate"
FT   BINDING         152
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10201405,
FT                   ECO:0000269|PubMed:16605249"
FT   BINDING         183
FT                   /note="Substrate"
FT   BINDING         219
FT                   /note="Substrate"
FT   BINDING         223
FT                   /note="Substrate"
FT   BINDING         275
FT                   /note="Substrate"
FT   BINDING         279
FT                   /note="Substrate"
FT   MUTAGEN         28
FT                   /note="E->Q: Abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:11371182,
FT                   ECO:0000269|PubMed:16114881"
FT   MUTAGEN         120
FT                   /note="D->N: Strongly reduces enzyme activity. Strongly
FT                   reduces affinity for 5-methyltetrahydrofolate."
FT                   /evidence="ECO:0000269|PubMed:11371182"
FT   MUTAGEN         177
FT                   /note="A->V: Increases the propensity to lose its essential
FT                   flavin cofactor."
FT                   /evidence="ECO:0000269|PubMed:10201405"
FT   MUTAGEN         223
FT                   /note="F->A: Strongly decreases substrate and NADH
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:19610625"
FT   MUTAGEN         223
FT                   /note="F->L: Slightly reduced enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:19610625"
FT   HELIX           4..17
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   TURN            18..21
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   STRAND          24..29
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   HELIX           35..49
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   STRAND          54..58
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   HELIX           67..81
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   STRAND          85..91
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   HELIX           96..108
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   STRAND          113..117
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   STRAND          123..125
FT                   /evidence="ECO:0007829|PDB:1B5T"
FT   HELIX           132..142
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   STRAND          146..151
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   HELIX           162..175
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   STRAND          179..182
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   HELIX           188..200
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   STRAND          207..211
FT                   /evidence="ECO:0007829|PDB:1B5T"
FT   HELIX           217..226
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   HELIX           233..239
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   HELIX           246..266
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   STRAND          271..275
FT                   /evidence="ECO:0007829|PDB:3FST"
FT   HELIX           281..289
FT                   /evidence="ECO:0007829|PDB:3FST"
SQ   SEQUENCE   296 AA;  33103 MW;  B702702D2BE9521E CRC64;
     MSFFHASQRD ALNQSLAEVQ GQINVSFEFF PPRTSEMEQT LWNSIDRLSS LKPKFVSVTY
     GANSGERDRT HSIIKGIKDR TGLEAAPHLT CIDATPDELR TIARDYWNNG IRHIVALRGD
     LPPGSGKPEM YASDLVTLLK EVADFDISVA AYPEVHPEAK SAQADLLNLK RKVDAGANRA
     ITQFFFDVES YLRFRDRCVS AGIDVEIIPG ILPVSNFKQA KKFADMTNVR IPAWMAQMFD
     GLDDDAETRK LVGANIAMDM VKILSREGVK DFHFYTLNRA EMSYAICHTL GVRPGL
//
ID   PAOB_ECOLI              Reviewed;         318 AA.
AC   P77324; Q2MCD7;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   02-JUN-2021, entry version 146.
DE   RecName: Full=Aldehyde oxidoreductase FAD-binding subunit PaoB {ECO:0000305};
DE            EC=1.2.99.6 {ECO:0000269|PubMed:19368556, ECO:0000269|PubMed:21081498};
GN   Name=paoB {ECO:0000303|PubMed:21081498}; Synonyms=yagS;
GN   OrderedLocusNames=b0285, JW0279;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RA   Chung E., Allen E., Araujo R., Aparicio A.M., Davis K., Duncan M.,
RA   Federspiel N., Hyman R., Kalman S., Komp C., Kurdi O., Lew H., Lin D.,
RA   Namath A., Oefner P., Roberts D., Schramm S., Davis R.W.;
RT   "Sequence of minutes 4-25 of Escherichia coli.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ACTIVITY REGULATION, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=19368556; DOI=10.1111/j.1742-4658.2009.07000.x;
RA   Neumann M., Mittelstaedt G., Iobbi-Nivol C., Saggu M., Lendzian F.,
RA   Hildebrandt P., Leimkuehler S.;
RT   "A periplasmic aldehyde oxidoreductase represents the first molybdopterin
RT   cytosine dinucleotide cofactor containing molybdo-flavoenzyme from
RT   Escherichia coli.";
RL   FEBS J. 276:2762-2774(2009).
RN   [5]
RP   CATALYTIC ACTIVITY, AND NOMENCLATURE.
RX   PubMed=21081498; DOI=10.1074/jbc.m110.155671;
RA   Neumann M., Seduk F., Iobbi-Nivol C., Leimkuhler S.;
RT   "Molybdopterin dinucleotide biosynthesis in Escherichia coli:
RT   identification of amino acid residues of molybdopterin dinucleotide
RT   transferases that determine specificity for binding of guanine or cytosine
RT   nucleotides.";
RL   J. Biol. Chem. 286:1400-1408(2011).
RN   [6]
RP   CRYSTALLIZATION, AND SUBUNIT.
RX   PubMed=24492481; DOI=10.3390/ijms15022223;
RA   Otrelo-Cardoso A.R., da Silva Correia M.A., Schwuchow V., Svergun D.I.,
RA   Romao M.J., Leimkuehler S., Santos-Silva T.;
RT   "Structural data on the periplasmic aldehyde oxidoreductase PaoABC from
RT   Escherichia coli: SAXS and preliminary X-ray crystallography analysis.";
RL   Int. J. Mol. Sci. 15:2223-2236(2014).
RN   [7] {ECO:0007744|PDB:5G5G, ECO:0007744|PDB:5G5H}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) IN COMPLEX WITH FAD AND IRON-SULFUR
RP   (4FE-4S), COFACTOR, AND SUBUNIT.
RX   PubMed=27622978; DOI=10.1021/acschembio.6b00572;
RA   Correia M.A., Otrelo-Cardoso A.R., Schwuchow V., Sigfridsson Clauss K.G.,
RA   Haumann M., Romao M.J., Leimkuhler S., Santos-Silva T.;
RT   "The Escherichia coli periplasmic aldehyde oxidoreductase is an exceptional
RT   member of the xanthine oxidase family of molybdoenzymes.";
RL   ACS Chem. Biol. 11:2923-2935(2016).
CC   -!- FUNCTION: Oxidizes aldehydes to the corresponding carboxylic acids with
CC       a preference for aromatic aldehydes. It might play a role in the
CC       detoxification of aldehydes to avoid cell damage.
CC       {ECO:0000269|PubMed:19368556}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=A + an aldehyde + H2O = a carboxylate + AH2 + H(+);
CC         Xref=Rhea:RHEA:56856, ChEBI:CHEBI:13193, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17478, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:29067; EC=1.2.99.6;
CC         Evidence={ECO:0000269|PubMed:19368556, ECO:0000269|PubMed:21081498};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:19368556, ECO:0000269|PubMed:27622978};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000269|PubMed:27622978};
CC   -!- ACTIVITY REGULATION: The complex requires PaoD for activity.
CC       {ECO:0000269|PubMed:19368556}.
CC   -!- SUBUNIT: Heterotrimer composed of PaoA, PaoB and PaoC.
CC       {ECO:0000269|PubMed:19368556, ECO:0000269|PubMed:24492481,
CC       ECO:0000269|PubMed:27622978}.
CC   -!- SUBCELLULAR LOCATION: Periplasm {ECO:0000305|PubMed:19368556}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U73857; AAB18014.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC73388.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE76069.1; -; Genomic_DNA.
DR   PIR; E64754; E64754.
DR   RefSeq; NP_414819.1; NC_000913.3.
DR   RefSeq; WP_000643333.1; NZ_SSZK01000048.1.
DR   PDB; 5G5G; X-ray; 1.70 A; B=1-318.
DR   PDB; 5G5H; X-ray; 2.30 A; B=1-318.
DR   PDBsum; 5G5G; -.
DR   PDBsum; 5G5H; -.
DR   SMR; P77324; -.
DR   BioGRID; 4259785; 121.
DR   ComplexPortal; CPX-4281; PaoABC periplasmic aldehyde oxidoreductase.
DR   IntAct; P77324; 8.
DR   STRING; 511145.b0285; -.
DR   jPOST; P77324; -.
DR   PaxDb; P77324; -.
DR   PRIDE; P77324; -.
DR   EnsemblBacteria; AAC73388; AAC73388; b0285.
DR   EnsemblBacteria; BAE76069; BAE76069; BAE76069.
DR   GeneID; 61754905; -.
DR   GeneID; 945710; -.
DR   KEGG; ecj:JW0279; -.
DR   KEGG; eco:b0285; -.
DR   PATRIC; fig|1411691.4.peg.1993; -.
DR   EchoBASE; EB3328; -.
DR   eggNOG; COG1319; Bacteria.
DR   HOGENOM; CLU_058050_1_0_6; -.
DR   InParanoid; P77324; -.
DR   PhylomeDB; P77324; -.
DR   BioCyc; EcoCyc:G6156-MONOMER; -.
DR   BioCyc; MetaCyc:G6156-MONOMER; -.
DR   BRENDA; 1.17.1.4; 2026.
DR   PRO; PR:P77324; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0042597; C:periplasmic space; NAS:EcoCyc.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0047770; F:carboxylate reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:EcoCyc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016903; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors; IDA:EcoCyc.
DR   Gene3D; 3.30.465.10; -; 1.
DR   InterPro; IPR005107; CO_DH_flav_C.
DR   InterPro; IPR036683; CO_DH_flav_C_dom_sf.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR016169; FAD-bd_PCMH_sub2.
DR   InterPro; IPR002346; Mopterin_DH_FAD-bd.
DR   Pfam; PF03450; CO_deh_flav_C; 1.
DR   Pfam; PF00941; FAD_binding_5; 1.
DR   SMART; SM01092; CO_deh_flav_C; 1.
DR   SUPFAM; SSF55447; SSF55447; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; 4Fe-4S; FAD; Flavoprotein; Iron; Iron-sulfur; Metal-binding;
KW   Oxidoreductase; Periplasm; Reference proteome.
FT   CHAIN           1..318
FT                   /note="Aldehyde oxidoreductase FAD-binding subunit PaoB"
FT                   /id="PRO_0000166094"
FT   DOMAIN          1..223
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   NP_BIND         26..34
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27622978,
FT                   ECO:0007744|PDB:5G5G, ECO:0007744|PDB:5G5H"
FT   METAL           119
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:27622978,
FT                   ECO:0007744|PDB:5G5G, ECO:0007744|PDB:5G5H"
FT   METAL           129
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:27622978,
FT                   ECO:0007744|PDB:5G5G, ECO:0007744|PDB:5G5H"
FT   METAL           138
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:27622978,
FT                   ECO:0007744|PDB:5G5G, ECO:0007744|PDB:5G5H"
FT   METAL           157
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000269|PubMed:27622978,
FT                   ECO:0007744|PDB:5G5G, ECO:0007744|PDB:5G5H"
FT   BINDING         108
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27622978,
FT                   ECO:0007744|PDB:5G5G, ECO:0007744|PDB:5G5H"
FT   BINDING         164
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27622978,
FT                   ECO:0007744|PDB:5G5G, ECO:0007744|PDB:5G5H"
FT   BINDING         213
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:27622978,
FT                   ECO:0007744|PDB:5G5G, ECO:0007744|PDB:5G5H"
FT   BINDING         230
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27622978,
FT                   ECO:0007744|PDB:5G5G, ECO:0007744|PDB:5G5H"
FT   STRAND          5..7
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   HELIX           12..21
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   STRAND          25..30
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   HELIX           34..39
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   STRAND          46..50
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   STRAND          59..61
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   STRAND          65..70
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   HELIX           75..80
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   HELIX           82..87
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   HELIX           89..96
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   HELIX           101..106
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   HELIX           109..113
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   HELIX           120..123
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   TURN            130..132
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   TURN            140..142
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   STRAND          150..152
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   HELIX           165..171
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   STRAND          175..179
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   STRAND          185..189
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   HELIX           190..192
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   STRAND          212..218
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   STRAND          224..231
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   STRAND          233..238
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   STRAND          241..248
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   STRAND          254..264
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   HELIX           269..272
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   HELIX           273..277
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   HELIX           279..286
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   TURN            287..289
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   TURN            294..297
FT                   /evidence="ECO:0007829|PDB:5G5G"
FT   HELIX           298..315
FT                   /evidence="ECO:0007829|PDB:5G5G"
SQ   SEQUENCE   318 AA;  33858 MW;  7D51C2B30C9BB222 CRC64;
     MKAFTYERVN TPAEAALSAQ RVPGAKFIAG GTNLLDLMKL EIETPTHLID VNGLGLDKIE
     VTDAGGLRIG ALVRNTDLAA HERVRRDYAV LSRALLAGAS GQLRNQATTA GNLLQRTRCP
     YFYDTNQPCN KRLPGSGCAA LEGFSRQHAV VGVSEACIAT HPSDMAVAMR LLDAVVETIT
     PEGKTRSITL ADFYHPPGKT PHIETALLPG ELIVAVTLPP PLGGKHIYRK VRDRASYAFA
     LVSVAAIIQP DGSGRVALGG VAHKPWRIEA ADAQLSQGAQ AVYDTLFASA HPTAENTFKL
     LLAKRTLASV LAEARAQA
//
ID   MDAR3_ORYSJ             Reviewed;         435 AA.
AC   Q652L6; Q9XFZ3;
DT   25-OCT-2017, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2004, sequence version 1.
DT   02-JUN-2021, entry version 137.
DE   RecName: Full=Monodehydroascorbate reductase 3, cytosolic {ECO:0000305};
DE            Short=OsMDAR3 {ECO:0000303|PubMed:25546583};
DE            Short=OsMDHAR3 {ECO:0000303|PubMed:25546583};
DE            EC=1.6.5.4 {ECO:0000269|PubMed:24376554, ECO:0000269|PubMed:27652777};
GN   Name=MDAR3 {ECO:0000303|PubMed:25546583};
GN   Synonyms=MDHAR3 {ECO:0000303|PubMed:25546583};
GN   OrderedLocusNames=Os09g0567300 {ECO:0000312|EMBL:BAF25874.1},
GN   LOC_Os09g39380 {ECO:0000305};
GN   ORFNames=OJ1155_H10.27 {ECO:0000312|EMBL:BAD46251.1};
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Nipponbare;
RA   Kaminaka H., Morita S., Tokumoto M., Masumura T., Tanaka K.;
RT   "Molecular cloning and characterization of a cDNA encoding
RT   monodehydroascorbate reductase from rice.";
RL   Submitted (JUN-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=18089549; DOI=10.1093/nar/gkm978;
RG   The rice annotation project (RAP);
RT   "The rice annotation project database (RAP-DB): 2008 update.";
RL   Nucleic Acids Res. 36:D1028-D1033(2008).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H., McCombie W.R.,
RA   Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S., Childs K.L.,
RA   Davidson R.M., Lin H., Quesada-Ocampo L., Vaillancourt B., Sakai H.,
RA   Lee S.S., Kim J., Numa H., Itoh T., Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using next
RT   generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
RN   [5]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=24376554; DOI=10.1371/journal.pone.0082611;
RA   Wang X., Hargrove M.S.;
RT   "Nitric oxide in plants: the roles of ascorbate and hemoglobin.";
RL   PLoS ONE 8:E82611-E82611(2013).
RN   [6]
RP   INDUCTION.
RX   PubMed=25546583; DOI=10.1016/j.jplph.2014.09.020;
RA   Li Z., Su D., Lei B., Wang F., Geng W., Pan G., Cheng F.;
RT   "Transcriptional profile of genes involved in ascorbate glutathione cycle
RT   in senescing leaves for an early senescence leaf (esl) rice mutant.";
RL   J. Plant Physiol. 176:1-15(2015).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 4-435 IN COMPLEX WITH ASCORBATE;
RP   FAD; NAD AND NADP, CATALYTIC ACTIVITY, COFACTOR, AND MUTAGENESIS OF CYS-70;
RP   GLY-72; GLU-196; ARG-320; TYR-349 AND ARG-351.
RX   PubMed=27652777; DOI=10.1038/srep33903;
RA   Park A.K., Kim I.S., Do H., Jeon B.W., Lee C.W., Roh S.J., Shin S.C.,
RA   Park H., Kim Y.S., Kim Y.H., Yoon H.S., Lee J.H., Kim H.W.;
RT   "Structure and catalytic mechanism of monodehydroascorbate reductase,
RT   MDHAR, from Oryza sativa L. japonica.";
RL   Sci. Rep. 6:33903-33903(2016).
CC   -!- FUNCTION: Catalyzes the conversion of monodehydroascorbate to
CC       ascorbate, oxidizing NADH in the process. Ascorbate is a major
CC       antioxidant against reactive oxygen species (ROS) and nitric oxide (NO)
CC       (PubMed:24376554, PubMed:27652777). Can use NADPH as electron donor,
CC       but possesses lower activity compared to NADH as electron donor
CC       (PubMed:27652777). {ECO:0000269|PubMed:24376554,
CC       ECO:0000269|PubMed:27652777}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + 2 monodehydro-L-ascorbate radical + NADH = 2 L-
CC         ascorbate + NAD(+); Xref=Rhea:RHEA:14581, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:38290, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:59513; EC=1.6.5.4; Evidence={ECO:0000269|PubMed:24376554,
CC         ECO:0000269|PubMed:27652777};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:27652777};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- INDUCTION: Down-regulated during senescence.
CC       {ECO:0000269|PubMed:25546583}.
CC   -!- SIMILARITY: Belongs to the FAD-dependent oxidoreductase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D85764; BAA77214.1; -; mRNA.
DR   EMBL; AP005558; BAD46251.1; -; Genomic_DNA.
DR   EMBL; AP008215; BAF25874.1; -; Genomic_DNA.
DR   EMBL; AP014965; BAT09471.1; -; Genomic_DNA.
DR   RefSeq; XP_015611766.1; XM_015756280.1.
DR   PDB; 5JCI; X-ray; 1.70 A; A=4-435.
DR   PDB; 5JCK; X-ray; 2.00 A; A=1-435.
DR   PDB; 5JCL; X-ray; 1.80 A; A/B=4-435.
DR   PDB; 5JCM; X-ray; 1.90 A; A/B=4-435.
DR   PDB; 5JCN; X-ray; 2.29 A; A/B=1-435.
DR   PDBsum; 5JCI; -.
DR   PDBsum; 5JCK; -.
DR   PDBsum; 5JCL; -.
DR   PDBsum; 5JCM; -.
DR   PDBsum; 5JCN; -.
DR   SMR; Q652L6; -.
DR   STRING; 4530.OS09T0567300-01; -.
DR   PaxDb; Q652L6; -.
DR   PRIDE; Q652L6; -.
DR   EnsemblPlants; Os09t0567300-01; Os09t0567300-01; Os09g0567300.
DR   GeneID; 4347885; -.
DR   Gramene; Os09t0567300-01; Os09t0567300-01; Os09g0567300.
DR   KEGG; osa:4347885; -.
DR   eggNOG; KOG1336; Eukaryota.
DR   HOGENOM; CLU_003291_4_1_1; -.
DR   InParanoid; Q652L6; -.
DR   OMA; GAQLRYC; -.
DR   OrthoDB; 405030at2759; -.
DR   BRENDA; 1.6.5.4; 8948.
DR   Proteomes; UP000000763; Chromosome 9.
DR   Proteomes; UP000059680; Chromosome 9.
DR   GO; GO:0048046; C:apoplast; IEA:EnsemblPlants.
DR   GO; GO:0009507; C:chloroplast; IEA:EnsemblPlants.
DR   GO; GO:0005782; C:peroxisomal matrix; IEA:EnsemblPlants.
DR   GO; GO:0005886; C:plasma membrane; IEA:EnsemblPlants.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0016656; F:monodehydroascorbate reductase (NADH) activity; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IEA:EnsemblPlants.
DR   GO; GO:0098869; P:cellular oxidant detoxification; IDA:UniProtKB.
DR   GO; GO:0046686; P:response to cadmium ion; IEA:EnsemblPlants.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; FAD; Flavoprotein; NAD; NADP; Nucleotide-binding;
KW   Oxidoreductase; Redox-active center; Reference proteome.
FT   CHAIN           1..435
FT                   /note="Monodehydroascorbate reductase 3, cytosolic"
FT                   /id="PRO_0000442021"
FT   NP_BIND         14..17
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCI"
FT   NP_BIND         147..148
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCI"
FT   NP_BIND         172..178
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCK"
FT   NP_BIND         174..178
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCL"
FT   NP_BIND         314..315
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCK"
FT   NP_BIND         314..315
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCL"
FT   BINDING         41
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCI"
FT   BINDING         48
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCI"
FT   BINDING         53
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCI"
FT   BINDING         96
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCI"
FT   BINDING         196
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCK"
FT   BINDING         202
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCK"
FT   BINDING         202
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCL"
FT   BINDING         261
FT                   /note="NAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCK"
FT   BINDING         261
FT                   /note="NADP; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCL"
FT   BINDING         298
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCI"
FT   BINDING         316
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCI"
FT   BINDING         320
FT                   /note="Ascorbate"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCN"
FT   BINDING         349
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCI"
FT   BINDING         349
FT                   /note="NAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCK"
FT   BINDING         349
FT                   /note="NADP; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCL"
FT   BINDING         351
FT                   /note="Ascorbate"
FT                   /evidence="ECO:0000269|PubMed:27652777,
FT                   ECO:0007744|PDB:5JCN"
FT   MUTAGEN         70
FT                   /note="C->A: No effect on catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:27652777"
FT   MUTAGEN         70
FT                   /note="C->S: Slight reduction of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:27652777"
FT   MUTAGEN         72
FT                   /note="G->N: Slight reduction of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:27652777"
FT   MUTAGEN         196
FT                   /note="E->A: Reduces catalytic activity 2-fold."
FT                   /evidence="ECO:0000269|PubMed:27652777"
FT   MUTAGEN         320
FT                   /note="R->A: Reduces catalytic activity 5-fold."
FT                   /evidence="ECO:0000269|PubMed:27652777"
FT   MUTAGEN         349
FT                   /note="Y->A,F,W: Abolishes catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:27652777"
FT   MUTAGEN         351
FT                   /note="R->A: No effect on catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:27652777"
FT   CONFLICT        257
FT                   /note="V -> G (in Ref. 1; BAA77214)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..12
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           16..27
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          34..38
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          40..43
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           48..52
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           54..56
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          58..60
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   TURN            64..67
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           71..73
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           80..85
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          89..91
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          96..100
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   TURN            101..104
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          105..108
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          109..111
FT                   /evidence="ECO:0007829|PDB:5JCN"
FT   STRAND          113..121
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          125..127
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           130..133
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   TURN            137..139
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          143..145
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           149..161
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   TURN            162..164
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          165..170
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           174..185
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          189..200
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   TURN            201..203
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           206..218
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          222..226
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          229..234
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          238..245
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          250..252
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          254..258
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          262..264
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           267..269
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   TURN            270..272
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          279..281
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          293..295
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           297..299
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          300..304
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           305..307
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          309..311
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           316..335
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          347..352
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          355..361
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          365..372
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          377..379
FT                   /evidence="ECO:0007829|PDB:5JCL"
FT   STRAND          381..388
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   STRAND          391..399
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           402..414
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           421..426
FT                   /evidence="ECO:0007829|PDB:5JCI"
FT   HELIX           428..434
FT                   /evidence="ECO:0007829|PDB:5JCI"
SQ   SEQUENCE   435 AA;  46673 MW;  E0771D77F9A2D36E CRC64;
     MASEKHFKYV ILGGGVAAGY AAREFAKQGV KPGELAIISK EAVAPYERPA LSKGYLFPQN
     AARLPGFHVC VGSGGERLLP EWYSEKGIEL ILSTEIVKAD LASKTLTSAV GATFTYEILI
     IATGSSVIKL SDFGTQGADS NNILYLREVD DADKLVAAIQ AKKGGKAVIV GGGYIGLELS
     AALKINDFDV TMVFPEPWCM PRLFTADIAA FYESYYTNKG VKIVKGTVAV GFDADANGDV
     TAVNLKNGSV LEADIVVVGV GGRPLTTLFK GQVAEEKGGI KTDAFFETSV PGVYAVGDVA
     TFPMKMYNEL RRVEHVDHAR KSAEQAVKAI KGKESGESVV EYDYLPYFYS RSFDLGWQFY
     GDNVGDTILF GDSDPTSAKP KFGSYWIKDG KVLGAFLEGG SPDENKAIAK VAKTQPPVAN
     IEELKKEGLQ FASKI
//
ID   KMO_PSEFL               Reviewed;         461 AA.
AC   Q84HF5;
DT   10-FEB-2009, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   02-JUN-2021, entry version 79.
DE   RecName: Full=Kynurenine 3-monooxygenase {ECO:0000255|HAMAP-Rule:MF_01971};
DE            Short=PfKMO;
DE            EC=1.14.13.9 {ECO:0000255|HAMAP-Rule:MF_01971};
DE   AltName: Full=Kynurenine 3-hydroxylase {ECO:0000255|HAMAP-Rule:MF_01971};
GN   Name=kmo {ECO:0000255|HAMAP-Rule:MF_01971}; Synonyms=qbsG;
OS   Pseudomonas fluorescens.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=294;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROBABLE FUNCTION, AND PATHWAY.
RC   STRAIN=ATCC 17400;
RX   PubMed=15066027; DOI=10.1111/j.1365-2958.2004.03999.x;
RA   Matthijs S., Baysse C., Koedam N., Tehrani K.A., Verheyden L.,
RA   Budzikiewicz H., Schaefer M., Hoorelbeke B., Meyer J.-M., De Greve H.,
RA   Cornelis P.;
RT   "The Pseudomonas siderophore quinolobactin is synthesized from xanthurenic
RT   acid, an intermediate of the kynurenine pathway.";
RL   Mol. Microbiol. 52:371-384(2004).
RN   [2]
RP   CATALYTIC ACTIVITY, COFACTOR, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   STRAIN=17400;
RX   PubMed=16973376; DOI=10.1016/j.pep.2006.07.024;
RA   Crozier K.R., Moran G.R.;
RT   "Heterologous expression and purification of kynurenine-3-monooxygenase
RT   from Pseudomonas fluorescens strain 17400.";
RL   Protein Expr. Purif. 51:324-333(2007).
RN   [3] {ECO:0007744|PDB:5FN0}
RP   X-RAY CRYSTALLOGRAPHY (3.19 ANGSTROMS) IN COMPLEX WITH FAD AND INHIBITOR.
RX   PubMed=26752518; DOI=10.1038/nm.4020;
RA   Mole D.J., Webster S.P., Uings I., Zheng X., Binnie M., Wilson K.,
RA   Hutchinson J.P., Mirguet O., Walker A., Beaufils B., Ancellin N.,
RA   Trottet L., Beneton V., Mowat C.G., Wilkinson M., Rowland P., Haslam C.,
RA   McBride A., Homer N.Z., Baily J.E., Sharp M.G., Garden O.J., Hughes J.,
RA   Howie S.E., Holmes D.S., Liddle J., Iredale J.P.;
RT   "Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in
RT   rodent models of acute pancreatitis.";
RL   Nat. Med. 22:202-209(2016).
RN   [4] {ECO:0007744|PDB:5N7T}
RP   X-RAY CRYSTALLOGRAPHY (1.81 ANGSTROMS)IN COMPLEX WITH FAD AND INHIBITOR.
RX   PubMed=28336141; DOI=10.1016/j.bmcl.2017.02.078;
RA   Liddle J., Beaufils B., Binnie M., Bouillot A., Denis A.A., Hann M.M.,
RA   Haslam C.P., Holmes D.S., Hutchinson J.P., Kranz M., McBride A.,
RA   Mirguet O., Mole D.J., Mowat C.G., Pal S., Rowland P., Trottet L.,
RA   Uings I.J., Walker A.L., Webster S.P.;
RT   "The discovery of potent and selective kynurenine 3-monooxygenase
RT   inhibitors for the treatment of acute pancreatitis.";
RL   Bioorg. Med. Chem. Lett. 27:2023-2028(2017).
RN   [5] {ECO:0007744|PDB:5MZC, ECO:0007744|PDB:5MZI, ECO:0007744|PDB:5MZK}
RP   X-RAY CRYSTALLOGRAPHY (1.71 ANGSTROMS) IN COMPLEX WITH FAD AND INHIBITOR.
RX   PubMed=28398044; DOI=10.1021/acs.jmedchem.7b00055;
RA   Walker A.L., Ancellin N., Beaufils B., Bergeal M., Binnie M., Bouillot A.,
RA   Clapham D., Denis A., Haslam C.P., Holmes D.S., Hutchinson J.P., Liddle J.,
RA   McBride A., Mirguet O., Mowat C.G., Rowland P., Tiberghien N., Trottet L.,
RA   Uings I., Webster S.P., Zheng X., Mole D.J.;
RT   "Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading
RT   to a Clinical Candidate for the Treatment of Acute Pancreatitis.";
RL   J. Med. Chem. 60:3383-3404(2017).
RN   [6] {ECO:0007744|PDB:5NA5, ECO:0007744|PDB:5NAB, ECO:0007744|PDB:5NAE, ECO:0007744|PDB:5NAG, ECO:0007744|PDB:5NAH, ECO:0007744|PDB:5NAK}
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) IN COMPLEX WITH FAD AND INHIBITORS,
RP   COFACTOR, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND FUNCTION.
RX   PubMed=28604669; DOI=10.1038/ncomms15827;
RA   Hutchinson J.P., Rowland P., Taylor M.R.D., Christodoulou E.M., Haslam C.,
RA   Hobbs C.I., Holmes D.S., Homes P., Liddle J., Mole D.J., Uings I.,
RA   Walker A.L., Webster S.P., Mowat C.G., Chung C.W.;
RT   "Structural and mechanistic basis of differentiated inhibitors of the acute
RT   pancreatitis target kynurenine-3-monooxygenase.";
RL   Nat. Commun. 8:15827-15827(2017).
RN   [7] {ECO:0007744|PDB:5X6P, ECO:0007744|PDB:5X6Q}
RP   X-RAY CRYSTALLOGRAPHY (1.78 ANGSTROMS) IN COMPLEX WITH FAD AND INHIBITOR,
RP   CATALYTIC ACTIVITY, COFACTOR, AND MUTAGENESIS OF 319-PHE-HIS-320 AND
RP   HIS-320.
RX   PubMed=29429898; DOI=10.1016/j.chembiol.2018.01.008;
RA   Kim H.T., Na B.K., Chung J., Kim S., Kwon S.K., Cha H., Son J., Cho J.M.,
RA   Hwang K.Y.;
RT   "Structural Basis for Inhibitor-Induced Hydrogen Peroxide Production by
RT   Kynurenine 3-Monooxygenase.";
RL   Cell Chem. Biol. 0:0-0(2018).
RN   [8] {ECO:0007744|PDB:5Y66, ECO:0007744|PDB:5Y77, ECO:0007744|PDB:5Y7A}
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 2-461 IN COMPLEX WITH FAD;
RP   L-KYNURENINE AND INHIBITOR, FUNCTION, MUTAGENESIS OF ARG-84; TYR-98;
RP   ASN-369; GLU-372; MET-373 AND TYR-404, AND COFACTOR.
RX   PubMed=29208702; DOI=10.1096/fj.201700397rr;
RA   Gao J., Yao L., Xia T., Liao X., Zhu D., Xiang Y.;
RT   "Biochemistry and structural studies of kynurenine 3-monooxygenase reveal
RT   allosteric inhibition by Ro 61-8048.";
RL   FASEB J. 32:2036-2045(2018).
CC   -!- FUNCTION: Catalyzes the hydroxylation of L-kynurenine (L-Kyn) to form
CC       3-hydroxy-L-kynurenine (L-3OHKyn). Probably required for the synthesis
CC       of quinolinic acid and the siderophore quinolobactin.
CC       {ECO:0000269|PubMed:28604669, ECO:0000269|PubMed:29208702}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + L-kynurenine + NADPH + O2 = 3-hydroxy-L-kynurenine +
CC         H2O + NADP(+); Xref=Rhea:RHEA:20545, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:57959, ChEBI:CHEBI:58125, ChEBI:CHEBI:58349;
CC         EC=1.14.13.9; Evidence={ECO:0000255|HAMAP-Rule:MF_01971,
CC         ECO:0000269|PubMed:16973376, ECO:0000269|PubMed:28604669,
CC         ECO:0000269|PubMed:29429898};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01971,
CC         ECO:0000269|PubMed:16973376, ECO:0000269|PubMed:28604669,
CC         ECO:0000269|PubMed:29429898};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=11.8 uM for L-kynurenine (at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:16973376};
CC         KM=7 uM for L-kynurenine {ECO:0000269|PubMed:28604669};
CC         KM=8.5 uM for NADPH (at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:16973376};
CC         KM=34.2 uM for oxygen (at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:16973376};
CC         Note=Kcat is 2.3 sec(-) for L-kynurenine.
CC         {ECO:0000269|PubMed:28604669};
CC       pH dependence:
CC         Optimum pH is 8.5. {ECO:0000269|PubMed:16973376};
CC   -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; quinolinate from
CC       L-kynurenine: step 1/3. {ECO:0000255|HAMAP-Rule:MF_01971,
CC       ECO:0000269|PubMed:15066027}.
CC   -!- PATHWAY: Siderophore biosynthesis; quinolobactin biosynthesis.
CC       {ECO:0000269|PubMed:15066027}.
CC   -!- SIMILARITY: Belongs to the aromatic-ring hydroxylase family. KMO
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_01971}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY271621; AAL65289.1; -; Genomic_DNA.
DR   RefSeq; WP_029293793.1; NZ_JENC01000007.1.
DR   PDB; 5FN0; X-ray; 3.19 A; A/B/C/D=1-460.
DR   PDB; 5MZC; X-ray; 1.82 A; A/B=1-461.
DR   PDB; 5MZI; X-ray; 1.71 A; A/B=1-461.
DR   PDB; 5MZK; X-ray; 1.82 A; A/B=1-461.
DR   PDB; 5N7T; X-ray; 1.81 A; A/B=1-461.
DR   PDB; 5NA5; X-ray; 1.94 A; A/B=1-461.
DR   PDB; 5NAB; X-ray; 1.63 A; A/B=1-461.
DR   PDB; 5NAE; X-ray; 1.76 A; A/B=1-461.
DR   PDB; 5NAG; X-ray; 1.68 A; A/B=1-461.
DR   PDB; 5NAH; X-ray; 1.75 A; A/B=1-461.
DR   PDB; 5NAK; X-ray; 1.50 A; A/B=1-461.
DR   PDB; 5X6P; X-ray; 1.78 A; A/B=1-461.
DR   PDB; 5X6Q; X-ray; 1.90 A; A=1-461.
DR   PDB; 5Y66; X-ray; 2.34 A; A=2-461.
DR   PDB; 5Y77; X-ray; 1.60 A; A/B=2-461.
DR   PDB; 5Y7A; X-ray; 1.85 A; A=2-461.
DR   PDB; 6FOX; X-ray; 1.90 A; A/B=2-460.
DR   PDB; 6FOY; X-ray; 1.65 A; A/B=2-460.
DR   PDB; 6FOZ; X-ray; 2.15 A; A/B=2-461.
DR   PDB; 6FP0; X-ray; 2.03 A; A/B=2-460.
DR   PDB; 6FP1; X-ray; 1.97 A; A/B=2-460.
DR   PDB; 6FPH; X-ray; 2.00 A; A/B=2-461.
DR   PDBsum; 5FN0; -.
DR   PDBsum; 5MZC; -.
DR   PDBsum; 5MZI; -.
DR   PDBsum; 5MZK; -.
DR   PDBsum; 5N7T; -.
DR   PDBsum; 5NA5; -.
DR   PDBsum; 5NAB; -.
DR   PDBsum; 5NAE; -.
DR   PDBsum; 5NAG; -.
DR   PDBsum; 5NAH; -.
DR   PDBsum; 5NAK; -.
DR   PDBsum; 5X6P; -.
DR   PDBsum; 5X6Q; -.
DR   PDBsum; 5Y66; -.
DR   PDBsum; 5Y77; -.
DR   PDBsum; 5Y7A; -.
DR   PDBsum; 6FOX; -.
DR   PDBsum; 6FOY; -.
DR   PDBsum; 6FOZ; -.
DR   PDBsum; 6FP0; -.
DR   PDBsum; 6FP1; -.
DR   PDBsum; 6FPH; -.
DR   SMR; Q84HF5; -.
DR   BindingDB; Q84HF5; -.
DR   ChEMBL; CHEMBL4105840; -.
DR   BRENDA; 1.14.13.9; 5121.
DR   UniPathway; UPA00253; UER00328.
DR   UniPathway; UPA00981; -.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0004502; F:kynurenine 3-monooxygenase activity; IDA:UniProtKB.
DR   GO; GO:0016174; F:NAD(P)H oxidase H2O2-forming activity; IDA:UniProtKB.
DR   GO; GO:0034354; P:'de novo' NAD biosynthetic process from tryptophan; IEA:UniProtKB-UniRule.
DR   GO; GO:0043420; P:anthranilate metabolic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0070189; P:kynurenine metabolic process; IDA:UniProtKB.
DR   GO; GO:0019674; P:NAD metabolic process; IDA:UniProtKB.
DR   GO; GO:0019805; P:quinolinate biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0006569; P:tryptophan catabolic process; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.50.50.60; -; 1.
DR   HAMAP; MF_01971; Kynurenine_monooxygenase; 1.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR027545; Kynurenine_monooxygenase.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Monooxygenase; NADP; Oxidoreductase;
KW   Pyridine nucleotide biosynthesis.
FT   CHAIN           1..461
FT                   /note="Kynurenine 3-monooxygenase"
FT                   /id="PRO_0000361942"
FT   NP_BIND         17..18
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28336141,
FT                   ECO:0000269|PubMed:28398044, ECO:0000269|PubMed:28604669,
FT                   ECO:0000269|PubMed:29208702, ECO:0000269|PubMed:29429898,
FT                   ECO:0007744|PDB:5FN0, ECO:0007744|PDB:5MZC,
FT                   ECO:0007744|PDB:5MZI, ECO:0007744|PDB:5MZK,
FT                   ECO:0007744|PDB:5N7T, ECO:0007744|PDB:5NA5,
FT                   ECO:0007744|PDB:5NAB, ECO:0007744|PDB:5NAE,
FT                   ECO:0007744|PDB:5NAG, ECO:0007744|PDB:5NAH,
FT                   ECO:0007744|PDB:5NAK, ECO:0007744|PDB:5X6P,
FT                   ECO:0007744|PDB:5X6Q, ECO:0007744|PDB:5Y66,
FT                   ECO:0007744|PDB:5Y77, ECO:0007744|PDB:5Y7A"
FT   NP_BIND         37..39
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28336141,
FT                   ECO:0000269|PubMed:28398044, ECO:0000269|PubMed:28604669,
FT                   ECO:0000269|PubMed:29208702, ECO:0000269|PubMed:29429898,
FT                   ECO:0007744|PDB:5FN0, ECO:0007744|PDB:5MZC,
FT                   ECO:0007744|PDB:5MZI, ECO:0007744|PDB:5MZK,
FT                   ECO:0007744|PDB:5N7T, ECO:0007744|PDB:5NA5,
FT                   ECO:0007744|PDB:5NAB, ECO:0007744|PDB:5NAE,
FT                   ECO:0007744|PDB:5NAG, ECO:0007744|PDB:5NAH,
FT                   ECO:0007744|PDB:5NAK, ECO:0007744|PDB:5X6P,
FT                   ECO:0007744|PDB:5X6Q, ECO:0007744|PDB:5Y66,
FT                   ECO:0007744|PDB:5Y77, ECO:0007744|PDB:5Y7A"
FT   NP_BIND         324..325
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28336141,
FT                   ECO:0000269|PubMed:28398044, ECO:0000269|PubMed:28604669,
FT                   ECO:0000269|PubMed:29208702, ECO:0000269|PubMed:29429898,
FT                   ECO:0007744|PDB:5FN0, ECO:0007744|PDB:5MZC,
FT                   ECO:0007744|PDB:5MZI, ECO:0007744|PDB:5MZK,
FT                   ECO:0007744|PDB:5N7T, ECO:0007744|PDB:5NA5,
FT                   ECO:0007744|PDB:5NAB, ECO:0007744|PDB:5NAE,
FT                   ECO:0007744|PDB:5NAG, ECO:0007744|PDB:5NAH,
FT                   ECO:0007744|PDB:5NAK, ECO:0007744|PDB:5X6P,
FT                   ECO:0007744|PDB:5X6Q, ECO:0007744|PDB:5Y66,
FT                   ECO:0007744|PDB:5Y77, ECO:0007744|PDB:5Y7A"
FT   BINDING         56
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28336141,
FT                   ECO:0000269|PubMed:28398044, ECO:0000269|PubMed:28604669,
FT                   ECO:0000269|PubMed:29208702, ECO:0000269|PubMed:29429898,
FT                   ECO:0007744|PDB:5FN0, ECO:0007744|PDB:5MZC,
FT                   ECO:0007744|PDB:5MZI, ECO:0007744|PDB:5MZK,
FT                   ECO:0007744|PDB:5N7T, ECO:0007744|PDB:5NA5,
FT                   ECO:0007744|PDB:5NAB, ECO:0007744|PDB:5NAE,
FT                   ECO:0007744|PDB:5NAG, ECO:0007744|PDB:5NAH,
FT                   ECO:0007744|PDB:5NAK, ECO:0007744|PDB:5X6P,
FT                   ECO:0007744|PDB:5X6Q, ECO:0007744|PDB:5Y66,
FT                   ECO:0007744|PDB:5Y77, ECO:0007744|PDB:5Y7A"
FT   BINDING         84
FT                   /note="L-kynurenine"
FT                   /evidence="ECO:0000269|PubMed:29208702,
FT                   ECO:0007744|PDB:5Y66, ECO:0007744|PDB:5Y77"
FT   BINDING         98
FT                   /note="L-kynurenine"
FT                   /evidence="ECO:0000269|PubMed:29208702,
FT                   ECO:0007744|PDB:5Y77"
FT   BINDING         111
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28336141,
FT                   ECO:0000269|PubMed:28398044, ECO:0000269|PubMed:28604669,
FT                   ECO:0000269|PubMed:29208702, ECO:0000269|PubMed:29429898,
FT                   ECO:0007744|PDB:5FN0, ECO:0007744|PDB:5MZC,
FT                   ECO:0007744|PDB:5MZI, ECO:0007744|PDB:5MZK,
FT                   ECO:0007744|PDB:5N7T, ECO:0007744|PDB:5NA5,
FT                   ECO:0007744|PDB:5NAB, ECO:0007744|PDB:5NAE,
FT                   ECO:0007744|PDB:5NAG, ECO:0007744|PDB:5NAH,
FT                   ECO:0007744|PDB:5NAK, ECO:0007744|PDB:5X6P,
FT                   ECO:0007744|PDB:5X6Q, ECO:0007744|PDB:5Y66,
FT                   ECO:0007744|PDB:5Y77, ECO:0007744|PDB:5Y7A"
FT   BINDING         135
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28336141,
FT                   ECO:0000269|PubMed:28398044, ECO:0000269|PubMed:28604669,
FT                   ECO:0000269|PubMed:29208702, ECO:0000269|PubMed:29429898,
FT                   ECO:0007744|PDB:5FN0, ECO:0007744|PDB:5MZC,
FT                   ECO:0007744|PDB:5MZI, ECO:0007744|PDB:5MZK,
FT                   ECO:0007744|PDB:5N7T, ECO:0007744|PDB:5NA5,
FT                   ECO:0007744|PDB:5NAB, ECO:0007744|PDB:5NAE,
FT                   ECO:0007744|PDB:5NAG, ECO:0007744|PDB:5NAH,
FT                   ECO:0007744|PDB:5NAK, ECO:0007744|PDB:5X6P,
FT                   ECO:0007744|PDB:5X6Q, ECO:0007744|PDB:5Y66,
FT                   ECO:0007744|PDB:5Y77, ECO:0007744|PDB:5Y7A"
FT   BINDING         311
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:28336141,
FT                   ECO:0000269|PubMed:28398044, ECO:0000269|PubMed:28604669,
FT                   ECO:0000269|PubMed:29208702, ECO:0000269|PubMed:29429898,
FT                   ECO:0007744|PDB:5FN0, ECO:0007744|PDB:5MZC,
FT                   ECO:0007744|PDB:5MZI, ECO:0007744|PDB:5MZK,
FT                   ECO:0007744|PDB:5N7T, ECO:0007744|PDB:5NA5,
FT                   ECO:0007744|PDB:5NAB, ECO:0007744|PDB:5NAE,
FT                   ECO:0007744|PDB:5NAG, ECO:0007744|PDB:5NAH,
FT                   ECO:0007744|PDB:5NAK, ECO:0007744|PDB:5X6P,
FT                   ECO:0007744|PDB:5X6Q, ECO:0007744|PDB:5Y66,
FT                   ECO:0007744|PDB:5Y77, ECO:0007744|PDB:5Y7A"
FT   BINDING         369
FT                   /note="L-kynurenine"
FT                   /evidence="ECO:0000269|PubMed:29208702,
FT                   ECO:0007744|PDB:5Y66, ECO:0007744|PDB:5Y77,
FT                   ECO:0007744|PDB:5Y7A"
FT   BINDING         404
FT                   /note="L-kynurenine"
FT                   /evidence="ECO:0000269|PubMed:29208702,
FT                   ECO:0007744|PDB:5Y66, ECO:0007744|PDB:5Y77,
FT                   ECO:0007744|PDB:5Y7A"
FT   MUTAGEN         84
FT                   /note="R->A: Abolishes kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         98
FT                   /note="Y->A,F: Abolishes kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         319..320
FT                   /note="FH->AA: Abolishes NADPH oxidase activity."
FT                   /evidence="ECO:0000269|PubMed:29429898"
FT   MUTAGEN         320
FT                   /note="H->A: Slightly decreases NADPH oxidase activity."
FT                   /evidence="ECO:0000269|PubMed:29429898"
FT   MUTAGEN         369
FT                   /note="N->A: Decreases kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         369
FT                   /note="N->D: Abolishes kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         372
FT                   /note="E->A,Q: Strongly decreases kynurenine 3-
FT                   monooxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         373
FT                   /note="M->A: Abolishes kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         373
FT                   /note="M->L: Decreases kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         404
FT                   /note="Y->A: Abolishes kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   MUTAGEN         404
FT                   /note="Y->F: Decreases kynurenine 3-monooxygenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29208702"
FT   STRAND          9..13
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           18..28
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          32..36
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   TURN            42..44
FT                   /evidence="ECO:0007829|PDB:5FN0"
FT   STRAND          54..57
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           59..67
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           71..75
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          79..81
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          83..86
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          89..91
FT                   /evidence="ECO:0007829|PDB:5X6P"
FT   STRAND          94..97
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          99..101
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          106..110
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           111..124
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          128..130
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          134..139
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   TURN            140..143
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          144..148
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          150..152
FT                   /evidence="ECO:0007829|PDB:5Y7A"
FT   STRAND          154..158
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          160..164
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           171..176
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   TURN            177..179
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          185..188
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          190..198
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           200..205
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          212..218
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          221..227
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          233..242
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          245..247
FT                   /evidence="ECO:0007829|PDB:5X6P"
FT   HELIX           253..255
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           259..269
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   TURN            271..273
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           274..276
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           280..286
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          293..296
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          300..302
FT                   /evidence="ECO:0007829|PDB:5Y7A"
FT   TURN            303..305
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          306..308
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           310..312
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           318..320
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           323..340
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   STRAND          341..343
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           344..374
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           376..378
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           380..395
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   TURN            397..399
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           403..409
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           414..432
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           438..440
FT                   /evidence="ECO:0007829|PDB:5NAK"
FT   HELIX           443..453
FT                   /evidence="ECO:0007829|PDB:5NAK"
SQ   SEQUENCE   461 AA;  50712 MW;  6515A55FFE8987F4 CRC64;
     MTATDNARQV TIIGAGLAGT LVARLLARNG WQVNLFERRP DPRIETGARG RSINLALAER
     GAHALRLAGL EREVLAEAVM MRGRMVHVPG TPPNLQPYGR DDSEVIWSIN RDRLNRILLD
     GAEAAGASIH FNLGLDSVDF ARQRLTLSNV SGERLEKRFH LLIGADGCNS AVRQAMASVV
     DLGEHLETQP HGYKELQITP EASAQFNLEP NALHIWPHGD YMCIALPNLD RSFTVTLFLH
     HQSPAAQPAS PCFAQLVDGH AARRFFQRQF PDLSPMLDSL EQDFEHHPTG KLATLRLTTW
     HVGGQAVLLG DAAHPMVPFH GQGMNCALED AVALAEHLQS AADNASALAA FTAQRQPDAL
     AIQAMALENY VEMSSKVASP TYLLERELGQ IMAQRQPTRF IPRYSMVTFS RLPYAQAMAR
     GQIQEQLLKF AVANHSDLTS INLDAVEHEV TRCLPPLSHL C
//
ID   NCPR_RAT                Reviewed;         678 AA.
AC   P00388;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-JUN-2021, entry version 195.
DE   RecName: Full=NADPH--cytochrome P450 reductase {ECO:0000255|HAMAP-Rule:MF_03212};
DE            Short=CPR {ECO:0000255|HAMAP-Rule:MF_03212};
DE            Short=P450R {ECO:0000255|HAMAP-Rule:MF_03212};
DE            EC=1.6.2.4 {ECO:0000255|HAMAP-Rule:MF_03212};
GN   Name=Por {ECO:0000255|HAMAP-Rule:MF_03212};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3919392; DOI=10.1073/pnas.82.4.973;
RA   Porter T.D., Kasper C.B.;
RT   "Coding nucleotide sequence of rat NADPH-cytochrome P-450 oxidoreductase
RT   cDNA and identification of flavin-binding domains.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:973-977(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3082610; DOI=10.1089/dna.1986.5.1;
RA   Murakami H., Yabusaki Y., Ohkawa H.;
RT   "Expression of rat NADPH-cytochrome P-450 reductase cDNA in Saccharomyces
RT   cerevisiae.";
RL   DNA 5:1-10(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=2125483; DOI=10.1021/bi00494a009;
RA   Porter T.D., Beck T.W., Kasper C.B.;
RT   "NADPH-cytochrome P-450 oxidoreductase gene organization correlates with
RT   structural domains of the protein.";
RL   Biochemistry 29:9814-9818(1990).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 64-678 IN COMPLEX WITH FAD; FMN
RP   AND NADP.
RX   PubMed=9237990; DOI=10.1073/pnas.94.16.8411;
RA   Wang M., Roberts D.L., Paschke R., Shea T.M., Masters B.S.S., Kim J.-J.P.;
RT   "Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype
RT   for FMN- and FAD-containing enzymes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:8411-8416(1997).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 57-678 IN COMPLEX WITH FAD; FMN
RP   AND NADP.
RX   PubMed=11371558; DOI=10.1074/jbc.m101731200;
RA   Hubbard P.A., Shen A.L., Paschke R., Kasper C.B., Kim J.-J.P.;
RT   "NADPH-cytochrome P450 oxidoreductase. Structural basis for hydride and
RT   electron transfer.";
RL   J. Biol. Chem. 276:29163-29170(2001).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (3.40 ANGSTROMS) OF 57-678 IN COMPLEX WITH FAD; FMN
RP   AND NADP.
RX   PubMed=19171935; DOI=10.1074/jbc.m807868200;
RA   Hamdane D., Xia C., Im S.C., Zhang H., Kim J.J., Waskell L.;
RT   "Structure and function of an NADPH-cytochrome P450 oxidoreductase in an
RT   open conformation capable of reducing cytochrome P450.";
RL   J. Biol. Chem. 284:11374-11384(2009).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 57-678.
RX   PubMed=21345800; DOI=10.1074/jbc.m111.230532;
RA   Xia C., Hamdane D., Shen A.L., Choi V., Kasper C.B., Pearl N.M., Zhang H.,
RA   Im S.C., Waskell L., Kim J.J.;
RT   "Conformational changes of NADPH-cytochrome P450 oxidoreductase are
RT   essential for catalysis and cofactor binding.";
RL   J. Biol. Chem. 286:16246-16260(2011).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (4.30 ANGSTROMS) OF 58-678 IN COMPLEX WITH FAD; FMN
RP   AND NADP.
RA   Sugishima M., Sato H., Higashimoto Y., Harada J., Wada K., Fukuyama K.,
RA   Noguchi M.;
RT   "Structural basis for the electron transfer from an open form of NADPH-
RT   cytochrome P450 oxidoreductase to heme oxygenase.";
RL   Submitted (OCT-2013) to the PDB data bank.
CC   -!- FUNCTION: This enzyme is required for electron transfer from NADP to
CC       cytochrome P450 in microsomes. It can also provide electron transfer to
CC       heme oxygenase and cytochrome B5. {ECO:0000255|HAMAP-Rule:MF_03212}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADPH + 2 oxidized [cytochrome P450] = H(+) + NADP(+) + 2
CC         reduced [cytochrome P450]; Xref=Rhea:RHEA:24040, Rhea:RHEA-
CC         COMP:14627, Rhea:RHEA-COMP:14628, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:55376, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:60344; EC=1.6.2.4; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_03212};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03212,
CC         ECO:0000269|PubMed:9237990};
CC       Note=Binds 1 FAD per monomer. {ECO:0000255|HAMAP-Rule:MF_03212,
CC       ECO:0000269|PubMed:9237990};
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03212,
CC         ECO:0000269|PubMed:9237990};
CC       Note=Binds 1 FMN per monomer. {ECO:0000255|HAMAP-Rule:MF_03212,
CC       ECO:0000269|PubMed:9237990};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000255|HAMAP-Rule:MF_03212}; Single-pass membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_03212}; Cytoplasmic side {ECO:0000255|HAMAP-
CC       Rule:MF_03212}.
CC   -!- SIMILARITY: Belongs to the NADPH--cytochrome P450 reductase family.
CC       {ECO:0000255|HAMAP-Rule:MF_03212}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the flavodoxin
CC       family. {ECO:0000255|HAMAP-Rule:MF_03212}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the flavoprotein
CC       pyridine nucleotide cytochrome reductase family. {ECO:0000255|HAMAP-
CC       Rule:MF_03212}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M10068; AAA41064.1; -; mRNA.
DR   EMBL; M12516; AAA41067.1; -; mRNA.
DR   EMBL; M58937; AAA41683.1; -; Genomic_DNA.
DR   EMBL; M58932; AAA41683.1; JOINED; Genomic_DNA.
DR   EMBL; M58933; AAA41683.1; JOINED; Genomic_DNA.
DR   EMBL; M58934; AAA41683.1; JOINED; Genomic_DNA.
DR   EMBL; M58935; AAA41683.1; JOINED; Genomic_DNA.
DR   EMBL; M58936; AAA41683.1; JOINED; Genomic_DNA.
DR   PIR; A36073; RDRTO4.
DR   RefSeq; NP_113764.1; NM_031576.1.
DR   PDB; 1AMO; X-ray; 2.60 A; A/B=64-678.
DR   PDB; 1J9Z; X-ray; 2.70 A; A/B=57-676.
DR   PDB; 1JA0; X-ray; 2.60 A; A/B=57-676.
DR   PDB; 1JA1; X-ray; 1.80 A; A/B=57-678.
DR   PDB; 3ES9; X-ray; 3.40 A; A/B/C=57-678.
DR   PDB; 3OJW; X-ray; 2.20 A; A=57-678.
DR   PDB; 3OJX; X-ray; 2.50 A; A=57-678.
DR   PDB; 3WKT; X-ray; 4.30 A; A/B=58-678.
DR   PDB; 4Y7C; X-ray; 2.20 A; A/B=57-678.
DR   PDB; 4Y9R; X-ray; 2.40 A; A/B=57-678.
DR   PDB; 4Y9U; X-ray; 1.95 A; A/B=57-678.
DR   PDB; 4YAF; X-ray; 1.91 A; A/B=57-678.
DR   PDB; 4YAL; X-ray; 1.88 A; A/B=57-678.
DR   PDB; 4YAO; X-ray; 2.50 A; A/B=57-678.
DR   PDB; 4YAU; X-ray; 2.20 A; A/B=57-678.
DR   PDB; 4YAW; X-ray; 2.00 A; A/B=57-678.
DR   PDB; 5URD; X-ray; 1.90 A; A/B=57-678.
DR   PDB; 5URE; X-ray; 2.30 A; A/B=57-678.
DR   PDB; 5URG; X-ray; 2.30 A; A/B=57-678.
DR   PDB; 5URH; X-ray; 2.50 A; A/B=57-678.
DR   PDB; 5URI; X-ray; 2.70 A; A/B=57-678.
DR   PDB; 6J79; X-ray; 3.33 A; A/B=59-678.
DR   PDB; 6J7A; X-ray; 3.27 A; A/B=59-678.
DR   PDB; 6J7I; X-ray; 3.30 A; A/B=59-678.
DR   PDB; 6NJR; X-ray; 2.70 A; A/B=57-678.
DR   PDB; 7L18; X-ray; 2.54 A; AAA/BBB=57-678.
DR   PDBsum; 1AMO; -.
DR   PDBsum; 1J9Z; -.
DR   PDBsum; 1JA0; -.
DR   PDBsum; 1JA1; -.
DR   PDBsum; 3ES9; -.
DR   PDBsum; 3OJW; -.
DR   PDBsum; 3OJX; -.
DR   PDBsum; 3WKT; -.
DR   PDBsum; 4Y7C; -.
DR   PDBsum; 4Y9R; -.
DR   PDBsum; 4Y9U; -.
DR   PDBsum; 4YAF; -.
DR   PDBsum; 4YAL; -.
DR   PDBsum; 4YAO; -.
DR   PDBsum; 4YAU; -.
DR   PDBsum; 4YAW; -.
DR   PDBsum; 5URD; -.
DR   PDBsum; 5URE; -.
DR   PDBsum; 5URG; -.
DR   PDBsum; 5URH; -.
DR   PDBsum; 5URI; -.
DR   PDBsum; 6J79; -.
DR   PDBsum; 6J7A; -.
DR   PDBsum; 6J7I; -.
DR   PDBsum; 6NJR; -.
DR   PDBsum; 7L18; -.
DR   SMR; P00388; -.
DR   BioGRID; 248088; 1.
DR   IntAct; P00388; 1.
DR   STRING; 10116.ENSRNOP00000001961; -.
DR   ChEMBL; CHEMBL2817; -.
DR   iPTMnet; P00388; -.
DR   PhosphoSitePlus; P00388; -.
DR   jPOST; P00388; -.
DR   PaxDb; P00388; -.
DR   PRIDE; P00388; -.
DR   Ensembl; ENSRNOT00000001961; ENSRNOP00000001961; ENSRNOG00000001442.
DR   GeneID; 29441; -.
DR   KEGG; rno:29441; -.
DR   UCSC; RGD:68335; rat.
DR   CTD; 5447; -.
DR   RGD; 68335; Por.
DR   eggNOG; KOG1158; Eukaryota.
DR   GeneTree; ENSGT00940000156847; -.
DR   HOGENOM; CLU_001570_17_3_1; -.
DR   InParanoid; P00388; -.
DR   OMA; QKRYQRD; -.
DR   OrthoDB; 318396at2759; -.
DR   PhylomeDB; P00388; -.
DR   TreeFam; TF105719; -.
DR   BioCyc; MetaCyc:MONOMER-14290; -.
DR   BRENDA; 1.6.2.4; 5301.
DR   SABIO-RK; P00388; -.
DR   EvolutionaryTrace; P00388; -.
DR   PRO; PR:P00388; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000001442; Expressed in liver and 21 other tissues.
DR   Genevisible; P00388; RN.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:RGD.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0005739; C:mitochondrion; IDA:RGD.
DR   GO; GO:0004128; F:cytochrome-b5 reductase activity, acting on NAD(P)H; IDA:RGD.
DR   GO; GO:0009055; F:electron transfer activity; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; IDA:RGD.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IMP:RGD.
DR   GO; GO:0010181; F:FMN binding; IMP:RGD.
DR   GO; GO:0016787; F:hydrolase activity; IDA:RGD.
DR   GO; GO:0047726; F:iron-cytochrome-c reductase activity; IDA:RGD.
DR   GO; GO:0050661; F:NADP binding; IDA:RGD.
DR   GO; GO:0003958; F:NADPH-hemoprotein reductase activity; IDA:BHF-UCL.
DR   GO; GO:0008941; F:nitric oxide dioxygenase activity; IDA:RGD.
DR   GO; GO:0016491; F:oxidoreductase activity; ISO:RGD.
DR   GO; GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; IBA:GO_Central.
DR   GO; GO:0009437; P:carnitine metabolic process; IEP:RGD.
DR   GO; GO:0090346; P:cellular organofluorine metabolic process; ISO:RGD.
DR   GO; GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEP:RGD.
DR   GO; GO:0071371; P:cellular response to gonadotropin stimulus; IEP:RGD.
DR   GO; GO:0071375; P:cellular response to peptide hormone stimulus; IEP:RGD.
DR   GO; GO:0070988; P:demethylation; IDA:RGD.
DR   GO; GO:0019395; P:fatty acid oxidation; IDA:RGD.
DR   GO; GO:0009812; P:flavonoid metabolic process; IEP:RGD.
DR   GO; GO:0018393; P:internal peptidyl-lysine acetylation; IDA:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:RGD.
DR   GO; GO:0060192; P:negative regulation of lipase activity; IDA:RGD.
DR   GO; GO:0043602; P:nitrate catabolic process; IDA:RGD.
DR   GO; GO:0046210; P:nitric oxide catabolic process; IDA:RGD.
DR   GO; GO:0045542; P:positive regulation of cholesterol biosynthetic process; IMP:RGD.
DR   GO; GO:0032332; P:positive regulation of chondrocyte differentiation; IMP:RGD.
DR   GO; GO:0032770; P:positive regulation of monooxygenase activity; ISO:RGD.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; IMP:RGD.
DR   GO; GO:0090031; P:positive regulation of steroid hormone biosynthetic process; IDA:RGD.
DR   GO; GO:0090181; P:regulation of cholesterol metabolic process; IMP:RGD.
DR   GO; GO:0003420; P:regulation of growth plate cartilage chondrocyte proliferation; IMP:RGD.
DR   GO; GO:0042493; P:response to drug; IEP:RGD.
DR   GO; GO:0009725; P:response to hormone; IBA:GO_Central.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   Gene3D; 1.20.990.10; -; 2.
DR   Gene3D; 3.40.50.360; -; 1.
DR   Gene3D; 3.40.50.80; -; 1.
DR   HAMAP; MF_03212; NCPR; 1.
DR   InterPro; IPR003097; CysJ-like_FAD-binding.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001094; Flavdoxin-like.
DR   InterPro; IPR008254; Flavodoxin/NO_synth.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR023173; NADPH_Cyt_P450_Rdtase_alpha.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR023208; P450R.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF00667; FAD_binding_1; 1.
DR   Pfam; PF00258; Flavodoxin_1; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   PIRSF; PIRSF000208; P450R; 1.
DR   PRINTS; PR00369; FLAVODOXIN.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52218; SSF52218; 1.
DR   SUPFAM; SSF52343; SSF52343; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
DR   PROSITE; PS50902; FLAVODOXIN_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Endoplasmic reticulum; FAD; Flavoprotein; FMN;
KW   Membrane; NADP; Oxidoreductase; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P16435"
FT   CHAIN           2..678
FT                   /note="NADPH--cytochrome P450 reductase"
FT                   /id="PRO_0000167600"
FT   TOPO_DOM        2..22
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212"
FT   TRANSMEM        23..43
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212"
FT   TOPO_DOM        44..678
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212"
FT   DOMAIN          80..224
FT                   /note="Flavodoxin-like"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212"
FT   DOMAIN          279..521
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212"
FT   NP_BIND         86..91
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:11371558, ECO:0000269|PubMed:19171935,
FT                   ECO:0000269|PubMed:21345800, ECO:0000269|PubMed:9237990,
FT                   ECO:0000269|Ref.8"
FT   NP_BIND         138..141
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:11371558, ECO:0000269|PubMed:19171935,
FT                   ECO:0000269|PubMed:21345800, ECO:0000269|PubMed:9237990,
FT                   ECO:0000269|Ref.8"
FT   NP_BIND         173..182
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:11371558, ECO:0000269|PubMed:19171935,
FT                   ECO:0000269|PubMed:21345800, ECO:0000269|PubMed:9237990,
FT                   ECO:0000269|Ref.8"
FT   NP_BIND         454..457
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:11371558, ECO:0000269|PubMed:19171935,
FT                   ECO:0000269|PubMed:21345800, ECO:0000269|PubMed:9237990,
FT                   ECO:0000269|Ref.8"
FT   NP_BIND         472..474
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:11371558, ECO:0000269|PubMed:19171935,
FT                   ECO:0000269|PubMed:9237990, ECO:0000269|Ref.8"
FT   NP_BIND         488..491
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:11371558, ECO:0000269|PubMed:19171935,
FT                   ECO:0000269|PubMed:21345800, ECO:0000269|PubMed:9237990,
FT                   ECO:0000269|Ref.8"
FT   NP_BIND         596..597
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:11371558, ECO:0000269|PubMed:19171935,
FT                   ECO:0000269|PubMed:21345800, ECO:0000269|PubMed:9237990,
FT                   ECO:0000269|Ref.8"
FT   NP_BIND         602..606
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:11371558, ECO:0000269|PubMed:19171935,
FT                   ECO:0000269|PubMed:21345800, ECO:0000269|PubMed:9237990,
FT                   ECO:0000269|Ref.8"
FT   BINDING         208
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:11371558, ECO:0000269|PubMed:21345800,
FT                   ECO:0000269|PubMed:9237990"
FT   BINDING         298
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:11371558, ECO:0000269|PubMed:19171935,
FT                   ECO:0000269|PubMed:21345800, ECO:0000269|PubMed:9237990"
FT   BINDING         424
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:11371558, ECO:0000269|PubMed:19171935,
FT                   ECO:0000269|PubMed:21345800, ECO:0000269|Ref.8"
FT   BINDING         478
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:11371558, ECO:0000269|PubMed:19171935,
FT                   ECO:0000269|PubMed:21345800, ECO:0000269|PubMed:9237990,
FT                   ECO:0000269|Ref.8"
FT   BINDING         535
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:11371558, ECO:0000269|PubMed:19171935,
FT                   ECO:0000269|PubMed:21345800, ECO:0000269|PubMed:9237990,
FT                   ECO:0000269|Ref.8"
FT   BINDING         639
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:11371558, ECO:0000269|PubMed:19171935,
FT                   ECO:0000269|PubMed:21345800, ECO:0000269|PubMed:9237990"
FT   BINDING         677
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:11371558, ECO:0000269|PubMed:19171935,
FT                   ECO:0000269|PubMed:21345800, ECO:0000269|PubMed:9237990,
FT                   ECO:0000269|Ref.8"
FT   MOD_RES         2
FT                   /note="N-acetylglycine"
FT                   /evidence="ECO:0000250|UniProtKB:P16435"
FT   CONFLICT        255
FT                   /note="V -> A (in Ref. 3; AAA41683)"
FT                   /evidence="ECO:0000305"
FT   HELIX           69..76
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          80..85
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          87..89
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           90..101
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           102..105
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          109..112
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           114..116
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           119..127
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          132..140
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   TURN            141..143
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           147..149
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           150..158
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          167..174
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          176..180
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           183..194
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          198..201
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          204..207
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   TURN            208..210
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           212..231
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          244..249
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           255..257
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          258..261
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          263..265
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   TURN            266..270
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          277..280
FT                   /evidence="ECO:0007829|PDB:5URD"
FT   STRAND          282..291
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          294..298
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          300..306
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   TURN            308..311
FT                   /evidence="ECO:0007829|PDB:5URG"
FT   STRAND          319..322
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           328..337
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          345..351
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          360..366
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           367..373
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           383..389
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           390..392
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          393..395
FT                   /evidence="ECO:0007829|PDB:3OJX"
FT   HELIX           396..403
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           404..406
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          408..410
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           411..419
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   TURN            420..424
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           427..433
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           441..447
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          454..457
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   TURN            462..464
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          468..474
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          477..479
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          483..487
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           489..496
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          508..514
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          528..531
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           534..537
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           538..552
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          560..567
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   TURN            569..571
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           576..584
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          587..595
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          598..601
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           605..611
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           613..621
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          626..632
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   TURN            633..635
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           636..651
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   HELIX           656..668
FT                   /evidence="ECO:0007829|PDB:1JA1"
FT   STRAND          671..677
FT                   /evidence="ECO:0007829|PDB:1JA1"
SQ   SEQUENCE   678 AA;  76963 MW;  AF3087E4D7A352D6 CRC64;
     MGDSHEDTSA TMPEAVAEEV SLFSTTDMVL FSLIVGVLTY WFIFRKKKEE IPEFSKIQTT
     APPVKESSFV EKMKKTGRNI IVFYGSQTGT AEEFANRLSK DAHRYGMRGM SADPEEYDLA
     DLSSLPEIDK SLVVFCMATY GEGDPTDNAQ DFYDWLQETD VDLTGVKFAV FGLGNKTYEH
     FNAMGKYVDQ RLEQLGAQRI FELGLGDDDG NLEEDFITWR EQFWPAVCEF FGVEATGEES
     SIRQYELVVH EDMDVAKVYT GEMGRLKSYE NQKPPFDAKN PFLAAVTANR KLNQGTERHL
     MHLELDISDS KIRYESGDHV AVYPANDSAL VNQIGEILGA DLDVIMSLNN LDEESNKKHP
     FPCPTTYRTA LTYYLDITNP PRTNVLYELA QYASEPSEQE HLHKMASSSG EGKELYLSWV
     VEARRHILAI LQDYPSLRPP IDHLCELLPR LQARYYSIAS SSKVHPNSVH ICAVAVEYEA
     KSGRVNKGVA TSWLRAKEPA GENGGRALVP MFVRKSQFRL PFKSTTPVIM VGPGTGIAPF
     MGFIQERAWL REQGKEVGET LLYYGCRRSD EDYLYREELA RFHKDGALTQ LNVAFSREQA
     HKVYVQHLLK RDREHLWKLI HEGGAHIYVC GDARNMAKDV QNTFYDIVAE FGPMEHTQAV
     DYVKKLMTKG RYSLDVWS
//
ID   MDL2_PRUDU              Reviewed;         563 AA.
AC   Q945K2;
DT   28-NOV-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   02-JUN-2021, entry version 88.
DE   RecName: Full=(R)-mandelonitrile lyase 2;
DE            EC=4.1.2.10;
DE   AltName: Full=Hydroxynitrile lyase 2;
DE            Short=(R)-oxynitrilase 2;
DE            Short=PaHNL1;
DE   AltName: Full=R-oxynitrile lyase isoenzyme 2;
DE   Flags: Precursor;
GN   Name=MDL2; Synonyms=HNL1;
OS   Prunus dulcis (Almond) (Amygdalus dulcis).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; fabids; Rosales; Rosaceae; Amygdaloideae; Amygdaleae; Prunus.
OX   NCBI_TaxID=3755;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, X-RAY CRYSTALLOGRAPHY (1.47
RP   ANGSTROMS) OF 28-563, GLYCOSYLATION AT ASN-145; ASN-162; ASN-379 AND
RP   ASN-419, AND DISULFIDE BOND.
RC   TISSUE=Seed;
RX   PubMed=11566130; DOI=10.1016/s0969-2126(01)00639-6;
RA   Dreveny I., Gruber K., Glieder A., Thompson A., Kratky C.;
RT   "The hydroxynitrile lyase from almond: a lyase that looks like an
RT   oxidoreductase.";
RL   Structure 9:803-815(2001).
RN   [2]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=6246955; DOI=10.1016/0005-2744(80)90206-5;
RA   Jorns M.S.;
RT   "Studies on the kinetics of cyanohydrin synthesis and cleavage by the the
RT   flavoenzyme oxynitrilase.";
RL   Biochim. Biophys. Acta 613:203-209(1980).
RN   [3]
RP   3D-STRUCTURE MODELING.
RX   PubMed=11790839; DOI=10.1110/ps.38102;
RA   Dreveny I., Kratky C., Gruber K.;
RT   "The active site of hydroxynitrile lyase from Prunus amygdalus: modeling
RT   studies provide new insights into the mechanism of cyanogenesis.";
RL   Protein Sci. 11:292-300(2002).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.57 ANGSTROMS) OF 28-548 IN COMPLEX WITH FAD AND
RP   BENZALDEHYDE, SUBUNIT, CATALYTIC ACTIVITY, GLYCOSYLATION AT ASN-145;
RP   ASN-162; ASN-379 AND ASN-419, DISULFIDE BOND, MUTAGENESIS OF HIS-486 AND
RP   HIS-524, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19256550; DOI=10.1021/bi802162s;
RA   Dreveny I., Andryushkova A.S., Glieder A., Gruber K., Kratky C.;
RT   "Substrate binding in the FAD-dependent hydroxynitrile lyase from almond
RT   provides insight into the mechanism of cyanohydrin formation and explains
RT   the absence of dehydrogenation activity.";
RL   Biochemistry 48:3370-3377(2009).
CC   -!- FUNCTION: Involved in cyanogenesis, the release of HCN from injured
CC       tissues. Catalyzes the stereospecific addition of HCN to a variety of
CC       aldehydes in vitro. Has no oxidase activity. The redox properties of
CC       the FAD cofactor appear to be unimportant for catalysis.
CC       {ECO:0000269|PubMed:11566130, ECO:0000269|PubMed:6246955}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-mandelonitrile = benzaldehyde + hydrogen cyanide;
CC         Xref=Rhea:RHEA:18313, ChEBI:CHEBI:17169, ChEBI:CHEBI:18407,
CC         ChEBI:CHEBI:18450; EC=4.1.2.10;
CC         Evidence={ECO:0000269|PubMed:19256550, ECO:0000269|PubMed:6246955};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 5.5. {ECO:0000269|PubMed:19256550};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:19256550}.
CC   -!- PTM: Glycosylated. Deglycosylation does not affect the enzymatic
CC       activity. {ECO:0000269|PubMed:11566130, ECO:0000269|PubMed:19256550}.
CC   -!- SIMILARITY: Belongs to the GMC oxidoreductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF412329; AAL11514.1; -; Genomic_DNA.
DR   PDB; 1JU2; X-ray; 1.47 A; A/B=28-563.
DR   PDB; 3GDN; X-ray; 1.67 A; A/B=28-548.
DR   PDB; 3GDP; X-ray; 1.57 A; A/B=28-548.
DR   PDBsum; 1JU2; -.
DR   PDBsum; 3GDN; -.
DR   PDBsum; 3GDP; -.
DR   SMR; Q945K2; -.
DR   Allergome; 12337; Pru du 10.
DR   iPTMnet; Q945K2; -.
DR   EvolutionaryTrace; Q945K2; -.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0046593; F:mandelonitrile lyase activity; TAS:UniProtKB.
DR   GO; GO:0016614; F:oxidoreductase activity, acting on CH-OH group of donors; IEA:InterPro.
DR   GO; GO:0050898; P:nitrile metabolic process; TAS:UniProtKB.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR012132; GMC_OxRdtase.
DR   InterPro; IPR000172; GMC_OxRdtase_N.
DR   InterPro; IPR007867; GMC_OxRtase_C.
DR   Pfam; PF05199; GMC_oxred_C; 1.
DR   Pfam; PF00732; GMC_oxred_N; 1.
DR   PIRSF; PIRSF000137; Alcohol_oxidase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   PROSITE; PS00623; GMC_OXRED_1; 1.
DR   PROSITE; PS00624; GMC_OXRED_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; FAD; Flavoprotein; Glycoprotein; Lyase;
KW   Signal.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000255"
FT   CHAIN           28..563
FT                   /note="(R)-mandelonitrile lyase 2"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_5000061321"
FT   NP_BIND         63..64
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19256550"
FT   NP_BIND         82..83
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19256550"
FT   NP_BIND         137..140
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19256550"
FT   NP_BIND         485..486
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19256550"
FT   NP_BIND         525..526
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19256550"
FT   ACT_SITE        486
FT                   /note="Proton donor"
FT   ACT_SITE        524
FT                   /note="Proton acceptor"
FT   BINDING         129
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:19256550"
FT   BINDING         133
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19256550"
FT   BINDING         244
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:19256550"
FT   BINDING         355
FT                   /note="Substrate"
FT   BINDING         484
FT                   /note="Substrate"
FT   BINDING         514
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:19256550"
FT   CARBOHYD        145
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:11566130,
FT                   ECO:0000269|PubMed:19256550"
FT   CARBOHYD        162
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:11566130,
FT                   ECO:0000269|PubMed:19256550"
FT   CARBOHYD        379
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:11566130,
FT                   ECO:0000269|PubMed:19256550"
FT   CARBOHYD        419
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:11566130,
FT                   ECO:0000269|PubMed:19256550"
FT   DISULFID        426..477
FT                   /evidence="ECO:0000269|PubMed:11566130,
FT                   ECO:0000269|PubMed:19256550"
FT   MUTAGEN         486
FT                   /note="H->N: Loss of 95% of the catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:19256550"
FT   MUTAGEN         524
FT                   /note="H->N: Loss of 95% of the catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:19256550"
FT   CONFLICT        373
FT                   /note="A -> S (in Ref. 4; No nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   HELIX           37..41
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          42..44
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           45..47
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          50..59
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           65..72
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   TURN            73..75
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          78..81
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          83..85
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           87..89
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           91..94
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           96..98
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           99..104
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          109..117
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          123..127
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           132..135
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          152..154
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           158..172
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           180..191
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          197..200
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          206..210
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          212..215
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          219..221
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           224..230
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   TURN            233..235
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          236..241
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          243..249
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          252..254
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          256..263
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          269..282
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           285..295
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           301..306
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          312..314
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   TURN            316..319
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          320..323
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          326..332
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          345..348
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          350..359
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          370..373
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          382..391
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          396..399
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           420..437
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           440..445
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   TURN            452..455
FT                   /evidence="ECO:0007829|PDB:3GDP"
FT   STRAND          458..461
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           470..480
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          488..491
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   TURN            494..496
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          501..503
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          509..511
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           514..516
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   STRAND          521..524
FT                   /evidence="ECO:0007829|PDB:1JU2"
FT   HELIX           526..547
FT                   /evidence="ECO:0007829|PDB:1JU2"
SQ   SEQUENCE   563 AA;  61158 MW;  E0F53C236F4B001C CRC64;
     MEKSTMSAIL LVLYIFVLHL QYSEVHSLAT TSDHDFSYLS FAYDATDLEL EGSYDYVIVG
     GGTSGCPLAA TLSEKYKVLV LERGSLPTAY PNVLTADGFV YNLQQEDDGK TPVERFVSED
     GIDNVRGRVL GGTSIINAGV YARANTSIYS ASGVDWDMDL VNQTYEWVED TIVYKPNSQS
     WQSVTKTAFL EAGVHPNHGF SLDHEEGTRI TGSTFDNKGT RHAADELLNK GNSNNLRVGV
     HASVEKIIFS NAPGLTATGV IYRDSNGTPH QAFVRSKGEV IVSAGTIGTP QLLLLSGVGP
     ESYLSSLNIP VVLSHPYVGQ FLHDNPRNFI NILPPNPIEP TIVTVLGISN DFYQCSFSSL
     PFTTPPFGFF PSASYPLPNS TFAHFASKVA GPLSYGSLTL KSSSNVRVSP NVKFNYYSNL
     TDLSHCVSGM KKIGELLSTD ALKPYKVEDL PGVEGFNILG IPLPKDQTDD AAFETFCRES
     VASYWHYHGG CLVGKVLDGD FRVTGINALR VVDGSTFPYT PASHPQGFYL MLGRYVGIKI
     LQERSASDLK ILDSLKSAAS LVL
//
ID   ILVB_YEAST              Reviewed;         687 AA.
AC   P07342; D6VZT1;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1988, sequence version 1.
DT   02-JUN-2021, entry version 223.
DE   RecName: Full=Acetolactate synthase catalytic subunit, mitochondrial;
DE            EC=2.2.1.6;
DE   AltName: Full=Acetohydroxy-acid synthase catalytic subunit;
DE            Short=AHAS;
DE            Short=ALS;
DE   Flags: Precursor;
GN   Name=ILV2; Synonyms=SMR1; OrderedLocusNames=YMR108W; ORFNames=YM9718.07;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2989783; DOI=10.1093/nar/13.11.4011;
RA   Falco S.C., Dumas K.S., Livak K.J.;
RT   "Nucleotide sequence of the yeast ILV2 gene which encodes acetolactate
RT   synthase.";
RL   Nucleic Acids Res. 13:4011-4027(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169872;
RA   Bowman S., Churcher C.M., Badcock K., Brown D., Chillingworth T.,
RA   Connor R., Dedman K., Devlin K., Gentles S., Hamlin N., Hunt S., Jagels K.,
RA   Lye G., Moule S., Odell C., Pearson D., Rajandream M.A., Rice P.,
RA   Skelton J., Walsh S.V., Whitehead S., Barrell B.G.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XIII.";
RL   Nature 387:90-93(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A., Raphael J.,
RA   Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F., Williamson J.,
RA   Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G., Kolodner R.D.,
RA   LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-encoding
RT   clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [5]
RP   RECONSTITUTION OF THE ACETOLACTATE SYNTHASE COMPLEX, AND ACTIVITY
RP   REGULATION.
RX   PubMed=10213630; DOI=10.1021/bi983013m;
RA   Pang S.S., Duggleby R.G.;
RT   "Expression, purification, characterization, and reconstitution of the
RT   large and small subunits of yeast acetohydroxyacid synthase.";
RL   Biochemistry 38:5222-5231(1999).
RN   [6]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 58-687.
RX   PubMed=11902841; DOI=10.1006/jmbi.2001.5419;
RA   Pang S.S., Duggleby R.G., Guddat L.W.;
RT   "Crystal structure of yeast acetohydroxyacid synthase: a target for
RT   herbicidal inhibitors.";
RL   J. Mol. Biol. 317:249-262(2002).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 60-687 IN COMPLEX WITH FAD;
RP   HERBICIDE AND THIAMINE DIPHOSPHATE.
RX   PubMed=12496246; DOI=10.1074/jbc.m211648200;
RA   Pang S.S., Guddat L.W., Duggleby R.G.;
RT   "Molecular basis of sulfonylurea herbicide inhibition of acetohydroxyacid
RT   synthase.";
RL   J. Biol. Chem. 278:7639-7644(2003).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + 2 pyruvate = (2S)-2-acetolactate + CO2;
CC         Xref=Rhea:RHEA:25249, ChEBI:CHEBI:15361, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:58476; EC=2.2.1.6;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000250};
CC   -!- COFACTOR:
CC       Name=thiamine diphosphate; Xref=ChEBI:CHEBI:58937;
CC         Evidence={ECO:0000250};
CC       Note=Binds 1 thiamine pyrophosphate per subunit. {ECO:0000250};
CC   -!- ACTIVITY REGULATION: The regulatory subunit ILV6 stimulates enzymatic
CC       activity seven- to tenfold and confers sensitivity to inhibition by
CC       valine and activation by ATP. {ECO:0000269|PubMed:10213630}.
CC   -!- PATHWAY: Amino-acid biosynthesis; L-isoleucine biosynthesis; L-
CC       isoleucine from 2-oxobutanoate: step 1/4.
CC   -!- PATHWAY: Amino-acid biosynthesis; L-valine biosynthesis; L-valine from
CC       pyruvate: step 1/4.
CC   -!- SUBUNIT: Homodimer. The acetolactate synthase complex contains the
CC       catalytic regulatory subunit ILV2 and the regulatory small subunit
CC       ILV6. {ECO:0000269|PubMed:12496246}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- MISCELLANEOUS: Contains 1 molecule of FAD per monomer. The role of this
CC       cofactor is not clear considering that the reaction does not involve
CC       redox chemistry.
CC   -!- MISCELLANEOUS: Present with 31900 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the TPP enzyme family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X02549; CAA26400.1; -; Genomic_DNA.
DR   EMBL; Z49702; CAA89744.1; -; Genomic_DNA.
DR   EMBL; AY692995; AAT93014.1; -; Genomic_DNA.
DR   EMBL; BK006946; DAA10005.1; -; Genomic_DNA.
DR   PIR; A23808; YCBYI.
DR   RefSeq; NP_013826.1; NM_001182608.1.
DR   PDB; 1JSC; X-ray; 2.60 A; A/B=58-687.
DR   PDB; 1N0H; X-ray; 2.80 A; A/B=58-687.
DR   PDB; 1T9A; X-ray; 2.59 A; A/B=58-687.
DR   PDB; 1T9B; X-ray; 2.20 A; A/B=58-687.
DR   PDB; 1T9C; X-ray; 2.34 A; A/B=58-687.
DR   PDB; 1T9D; X-ray; 2.30 A; A/B/C/D=58-687.
DR   PDB; 5FEM; X-ray; 2.17 A; A/B=58-687.
DR   PDB; 5IMS; X-ray; 1.98 A; A/B=58-687.
DR   PDB; 5WKC; X-ray; 2.33 A; A/B/D/E=58-687.
DR   PDB; 6BD3; X-ray; 2.28 A; A/B=58-687.
DR   PDB; 6BD9; X-ray; 1.98 A; A/B=58-687.
DR   PDB; 6U9D; X-ray; 3.19 A; A/B/E/F/I/J/M/N/Q/R/U/V=58-687.
DR   PDBsum; 1JSC; -.
DR   PDBsum; 1N0H; -.
DR   PDBsum; 1T9A; -.
DR   PDBsum; 1T9B; -.
DR   PDBsum; 1T9C; -.
DR   PDBsum; 1T9D; -.
DR   PDBsum; 5FEM; -.
DR   PDBsum; 5IMS; -.
DR   PDBsum; 5WKC; -.
DR   PDBsum; 6BD3; -.
DR   PDBsum; 6BD9; -.
DR   PDBsum; 6U9D; -.
DR   SMR; P07342; -.
DR   BioGRID; 35284; 53.
DR   ComplexPortal; CPX-3034; Acetolactate synthase complex.
DR   DIP; DIP-1104N; -.
DR   IntAct; P07342; 73.
DR   MINT; P07342; -.
DR   STRING; 4932.YMR108W; -.
DR   BindingDB; P07342; -.
DR   ChEMBL; CHEMBL1075095; -.
DR   CarbonylDB; P07342; -.
DR   iPTMnet; P07342; -.
DR   MaxQB; P07342; -.
DR   PaxDb; P07342; -.
DR   PRIDE; P07342; -.
DR   EnsemblFungi; YMR108W_mRNA; YMR108W; YMR108W.
DR   GeneID; 855135; -.
DR   KEGG; sce:YMR108W; -.
DR   SGD; S000004714; ILV2.
DR   VEuPathDB; FungiDB:YMR108W; -.
DR   eggNOG; KOG4166; Eukaryota.
DR   GeneTree; ENSGT00940000176650; -.
DR   HOGENOM; CLU_013748_1_2_1; -.
DR   InParanoid; P07342; -.
DR   OMA; MRSYNPV; -.
DR   BRENDA; 2.2.1.6; 984.
DR   UniPathway; UPA00047; UER00055.
DR   UniPathway; UPA00049; UER00059.
DR   EvolutionaryTrace; P07342; -.
DR   PRO; PR:P07342; -.
DR   Proteomes; UP000002311; Chromosome XIII.
DR   RNAct; P07342; protein.
DR   GO; GO:0005948; C:acetolactate synthase complex; IDA:SGD.
DR   GO; GO:0005739; C:mitochondrion; HDA:SGD.
DR   GO; GO:0003984; F:acetolactate synthase activity; IDA:SGD.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:SGD.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0030976; F:thiamine pyrophosphate binding; IEA:InterPro.
DR   GO; GO:0009082; P:branched-chain amino acid biosynthetic process; IDA:SGD.
DR   GO; GO:0009097; P:isoleucine biosynthetic process; IBA:GO_Central.
DR   GO; GO:0009099; P:valine biosynthetic process; IBA:GO_Central.
DR   CDD; cd02015; TPP_AHAS; 1.
DR   DisProt; DP00398; -.
DR   InterPro; IPR012846; Acetolactate_synth_lsu.
DR   InterPro; IPR039368; AHAS_TPP.
DR   InterPro; IPR029035; DHS-like_NAD/FAD-binding_dom.
DR   InterPro; IPR029061; THDP-binding.
DR   InterPro; IPR012000; Thiamin_PyroP_enz_cen_dom.
DR   InterPro; IPR012001; Thiamin_PyroP_enz_TPP-bd_dom.
DR   InterPro; IPR000399; TPP-bd_CS.
DR   InterPro; IPR011766; TPP_enzyme-bd_C.
DR   Pfam; PF02775; TPP_enzyme_C; 1.
DR   Pfam; PF00205; TPP_enzyme_M; 1.
DR   Pfam; PF02776; TPP_enzyme_N; 1.
DR   SUPFAM; SSF52467; SSF52467; 1.
DR   SUPFAM; SSF52518; SSF52518; 2.
DR   TIGRFAMs; TIGR00118; acolac_lg; 1.
DR   PROSITE; PS00187; TPP_ENZYMES; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Amino-acid biosynthesis;
KW   Branched-chain amino acid biosynthesis; Magnesium; Metal-binding;
KW   Mitochondrion; Reference proteome; Thiamine pyrophosphate; Transferase;
KW   Transit peptide.
FT   TRANSIT         1..90
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           91..687
FT                   /note="Acetolactate synthase catalytic subunit,
FT                   mitochondrial"
FT                   /id="PRO_0000035664"
FT   NP_BIND         355..376
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12496246"
FT   NP_BIND         407..426
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12496246"
FT   REGION          43..68
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          499..579
FT                   /note="Thiamine pyrophosphate binding"
FT   METAL           550
FT                   /note="Magnesium"
FT   METAL           577
FT                   /note="Magnesium"
FT   METAL           579
FT                   /note="Magnesium; via carbonyl oxygen"
FT   BINDING         139
FT                   /note="Thiamine pyrophosphate"
FT   BINDING         241
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12496246"
FT   TURN            88..91
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           94..104
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          109..112
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           116..118
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           119..127
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          132..134
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           139..153
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          157..161
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           165..168
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           171..180
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          184..190
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           193..195
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   TURN            196..199
FT                   /evidence="ECO:0007829|PDB:5IMS"
FT   HELIX           206..209
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           211..213
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          214..219
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           223..225
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           226..237
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          239..241
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          244..250
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           251..255
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           264..267
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          272..275
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           281..298
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          300..306
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           308..312
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           316..327
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          331..333
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           335..337
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          348..351
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           358..366
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          368..374
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           379..382
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           385..387
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           390..397
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          402..408
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           410..412
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          415..417
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          420..425
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           427..435
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           445..457
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          467..469
FT                   /evidence="ECO:0007829|PDB:1JSC"
FT   HELIX           473..486
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          491..495
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           499..507
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          512..514
FT                   /evidence="ECO:0007829|PDB:5IMS"
FT   HELIX           528..538
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          542..549
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           550..556
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           557..559
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           560..566
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          571..576
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          582..587
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          589..591
FT                   /evidence="ECO:0007829|PDB:5IMS"
FT   STRAND          594..596
FT                   /evidence="ECO:0007829|PDB:5IMS"
FT   HELIX           605..612
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          614..619
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           622..624
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   HELIX           625..634
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          639..645
FT                   /evidence="ECO:0007829|PDB:6BD9"
FT   STRAND          652..654
FT                   /evidence="ECO:0007829|PDB:5FEM"
FT   HELIX           669..682
FT                   /evidence="ECO:0007829|PDB:5FEM"
FT   TURN            683..685
FT                   /evidence="ECO:0007829|PDB:5FEM"
SQ   SEQUENCE   687 AA;  74937 MW;  B03C4D0F38AA1362 CRC64;
     MIRQSTLKNF AIKRCFQHIA YRNTPAMRSV ALAQRFYSSS SRYYSASPLP ASKRPEPAPS
     FNVDPLEQPA EPSKLAKKLR AEPDMDTSFV GLTGGQIFNE MMSRQNVDTV FGYPGGAILP
     VYDAIHNSDK FNFVLPKHEQ GAGHMAEGYA RASGKPGVVL VTSGPGATNV VTPMADAFAD
     GIPMVVFTGQ VPTSAIGTDA FQEADVVGIS RSCTKWNVMV KSVEELPLRI NEAFEIATSG
     RPGPVLVDLP KDVTAAILRN PIPTKTTLPS NALNQLTSRA QDEFVMQSIN KAADLINLAK
     KPVLYVGAGI LNHADGPRLL KELSDRAQIP VTTTLQGLGS FDQEDPKSLD MLGMHGCATA
     NLAVQNADLI IAVGARFDDR VTGNISKFAP EARRAAAEGR GGIIHFEVSP KNINKVVQTQ
     IAVEGDATTN LGKMMSKIFP VKERSEWFAQ INKWKKEYPY AYMEETPGSK IKPQTVIKKL
     SKVANDTGRH VIVTTGVGQH QMWAAQHWTW RNPHTFITSG GLGTMGYGLP AAIGAQVAKP
     ESLVIDIDGD ASFNMTLTEL SSAVQAGTPV KILILNNEEQ GMVTQWQSLF YEHRYSHTHQ
     LNPDFIKLAE AMGLKGLRVK KQEELDAKLK EFVSTKGPVL LEVEVDKKVP VLPMVAGGSG
     LDEFINFDPE VERQQTELRH KRTGGKH
//
ID   MICA1_MOUSE             Reviewed;        1048 AA.
AC   Q8VDP3; D3Z4C6; E9PXR1; Q3TB77; Q3TBH9; Q3TX89;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   02-JUN-2021, entry version 162.
DE   RecName: Full=[F-actin]-monooxygenase MICAL1 {ECO:0000305};
DE            EC=1.14.13.225 {ECO:0000269|PubMed:23911929};
DE   AltName: Full=Molecule interacting with CasL protein 1;
DE            Short=MICAL-1;
DE            Short=mMical1;
DE   AltName: Full=NEDD9-interacting protein with calponin homology and LIM domains;
GN   Name=Mical1; Synonyms=Mical, Nical;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J, and NOD;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH RAB8A.
RX   PubMed=18094055; DOI=10.1091/mbc.e07-06-0551;
RA   Yamamura R., Nishimura N., Nakatsuji H., Arase S., Sasaki T.;
RT   "The interaction of JRAB/MICAL-L2 with Rab8 and Rab13 coordinates the
RT   assembly of tight junctions and adherens junctions.";
RL   Mol. Biol. Cell 19:971-983(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-777 AND SER-781, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Heart, Lung, Pancreas, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH STK38 AND STK38L.
RX   PubMed=21730291; DOI=10.1128/mcb.01389-10;
RA   Zhou Y., Adolfs Y., Pijnappel W.W., Fuller S.J., Van der Schors R.C.,
RA   Li K.W., Sugden P.H., Smit A.B., Hergovich A., Pasterkamp R.J.;
RT   "MICAL-1 is a negative regulator of MST-NDR kinase signaling and
RT   apoptosis.";
RL   Mol. Cell. Biol. 31:3603-3615(2011).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, AND CAUTION.
RX   PubMed=23911929; DOI=10.1016/j.molcel.2013.06.019;
RA   Lee B.C., Peterfi Z., Hoffmann F.W., Moore R.E., Kaya A., Avanesov A.,
RA   Tarrago L., Zhou Y., Weerapana E., Fomenko D.E., Hoffmann P.R.,
RA   Gladyshev V.N.;
RT   "MsrB1 and MICALs regulate actin assembly and macrophage function via
RT   reversible stereoselective methionine oxidation.";
RL   Mol. Cell 51:397-404(2013).
RN   [8]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=25007825; DOI=10.1038/ncomms5317;
RA   Van Battum E.Y., Gunput R.A., Lemstra S., Groen E.J., Yu K.L., Adolfs Y.,
RA   Zhou Y., Hoogenraad C.C., Yoshida Y., Schachner M., Akhmanova A.,
RA   Pasterkamp R.J.;
RT   "The intracellular redox protein MICAL-1 regulates the development of
RT   hippocampal mossy fibre connections.";
RL   Nat. Commun. 5:4317-4317(2014).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 1-489 IN COMPLEX WITH FAD, AND
RP   COFACTOR.
RX   PubMed=16275925; DOI=10.1073/pnas.0504997102;
RA   Siebold C., Berrow N., Walter T.S., Harlos K., Owens R.J., Stuart D.I.,
RA   Terman J.R., Kolodkin A.L., Pasterkamp R.J., Jones E.Y.;
RT   "High-resolution structure of the catalytic region of MICAL (molecule
RT   interacting with CasL), a multidomain flavoenzyme-signaling molecule.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:16836-16841(2005).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.31 ANGSTROMS) OF 2-615 IN COMPLEX WITH FAD,
RP   COFACTOR, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   CAUTION.
RX   PubMed=26935886; DOI=10.1038/srep22176;
RA   Alqassim S.S., Urquiza M., Borgnia E., Nagib M., Amzel L.M., Bianchet M.A.;
RT   "Modulation of MICAL monooxygenase activity by its calponin homology
RT   domain: structural and mechanistic insights.";
RL   Sci. Rep. 6:22176-22176(2016).
CC   -!- FUNCTION: Monooxygenase that promotes depolymerization of F-actin by
CC       mediating oxidation of specific methionine residues on actin to form
CC       methionine-sulfoxide, resulting in actin filament disassembly and
CC       preventing repolymerization. In the absence of actin, it also functions
CC       as a NADPH oxidase producing H(2)O(2) (By similarity). Acts as a
CC       cytoskeletal regulator that connects NEDD9 to intermediate filaments.
CC       Also acts as a negative regulator of apoptosis via its interaction with
CC       STK38 and STK38L; acts by antagonizing STK38 and STK38L activation by
CC       MST1/STK4. Involved in regulation of lamina-specific connectivity in
CC       the nervous system such as the development of lamina-restricted
CC       hippocampal connections. Through redox regulation of the actin
CC       cytoskeleton controls the intracellular distribution of secretory
CC       vesicles containing L1/neurofascin/NgCAM family proteins in neurons,
CC       thereby regulating their cell surface levels. May act as Rab effector
CC       protein and play a role in vesicle trafficking.
CC       {ECO:0000250|UniProtKB:Q8TDZ2, ECO:0000269|PubMed:21730291,
CC       ECO:0000269|PubMed:23911929, ECO:0000269|PubMed:25007825,
CC       ECO:0000269|PubMed:26935886}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + L-methionyl-[F-actin] + NADPH + O2 = H2O + L-methionyl-
CC         (R)-S-oxide-[F-actin] + NADP(+); Xref=Rhea:RHEA:51308, Rhea:RHEA-
CC         COMP:12953, Rhea:RHEA-COMP:12956, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16044,
CC         ChEBI:CHEBI:45764, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         EC=1.14.13.225; Evidence={ECO:0000269|PubMed:23911929,
CC         ECO:0000269|PubMed:26935886};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:16275925};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=9.3 uM for actin (for a monooxygenase domain construct)
CC         {ECO:0000269|PubMed:26935886};
CC         KM=28.8 uM for NADPH (for a monooxygenase domain construct)
CC         {ECO:0000269|PubMed:26935886};
CC   -!- SUBUNIT: Associates with the SH3 domain of NEDD9. Interacts with VIM
CC       and PLXNA3. Interacts with RAB1B, RAB8A, RAB10, RAB13 and RAB15 (in
CC       their GTP-bound forms); binding to RAB1B is of low affinity compared to
CC       other Rab proteins; at least in case of RAB8A and RAB10 can bind 2
CC       molecules of the Rab proteins simultaneously (By similarity). Interacts
CC       with STK38 and STK38L. {ECO:0000250, ECO:0000250|UniProtKB:Q8TDZ2,
CC       ECO:0000269|PubMed:16275925, ECO:0000269|PubMed:18094055,
CC       ECO:0000269|PubMed:21730291}.
CC   -!- INTERACTION:
CC       Q8VDP3; Q91VJ4: Stk38; NbExp=9; IntAct=EBI-4394891, EBI-2527046;
CC       Q8VDP3; A4GW50: Stk38l; Xeno; NbExp=2; IntAct=EBI-4394891, EBI-4404035;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q8TDZ2}.
CC       Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q8TDZ2}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8VDP3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8VDP3-2; Sequence=VSP_042591;
CC       Name=3;
CC         IsoId=Q8VDP3-3; Sequence=VSP_042592;
CC   -!- TISSUE SPECIFICITY: Expressed in the postnatal and adult hippocampus;
CC       found in dentate gyrus, the polymorphic layer, cornu ammonis (CA) 1-3
CC       and in mossy fibers of the striatum lucidum. In adult hippocampus
CC       strongly expressed in CA3 pyramidial neurons.
CC       {ECO:0000269|PubMed:25007825}.
CC   -!- DOMAIN: The C-terminal coiled coil part contains the plexin-interacting
CC       region.
CC   -!- DOMAIN: The bivalent Mical/EHBP Rab binding (bMERB) domain, mediates
CC       binding to predominantly Rab8, Rab10, Rab10, Rab13 and Rab15 (in their
CC       GTP-bound forms). {ECO:0000250|UniProtKB:Q8TDZ2}.
CC   -!- SIMILARITY: Belongs to the Mical family. {ECO:0000305}.
CC   -!- CAUTION: The reaction mechanism is subject to discussion. Some work
CC       suggest MICAL enzymes directly oxidize actin methionine residues to
CC       produce methionine-(R)-S-oxide. Other publications suggest that the
CC       enzyme functions as a NADPH oxidase producing H(2)O(2) (EC 1.6.3.1) and
CC       that it is the produced H(2)O(2) that is responsible for the
CC       methionine-(R)-S-oxide production. {ECO:0000250|UniProtKB:Q86BA1,
CC       ECO:0000250|UniProtKB:Q8TDZ2, ECO:0000269|PubMed:23911929,
CC       ECO:0000269|PubMed:26935886}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK159369; BAE35027.1; -; mRNA.
DR   EMBL; AK170881; BAE42090.1; -; mRNA.
DR   EMBL; AK171234; BAE42330.1; -; mRNA.
DR   EMBL; AK171411; BAE42437.1; -; mRNA.
DR   EMBL; AK171429; BAE42447.1; -; mRNA.
DR   EMBL; AK171479; BAE42481.1; -; mRNA.
DR   EMBL; AC153360; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC021477; AAH21477.1; -; mRNA.
DR   EMBL; BC034682; AAH34682.1; -; mRNA.
DR   CCDS; CCDS35888.1; -. [Q8VDP3-1]
DR   CCDS; CCDS48547.1; -. [Q8VDP3-2]
DR   RefSeq; NP_001157905.1; NM_001164433.1. [Q8VDP3-2]
DR   RefSeq; NP_612188.1; NM_138315.2. [Q8VDP3-1]
DR   RefSeq; XP_011241439.1; XM_011243137.2. [Q8VDP3-1]
DR   PDB; 2BRA; X-ray; 2.00 A; A/B=1-484.
DR   PDB; 2BRY; X-ray; 1.45 A; A/B=1-489.
DR   PDB; 2C4C; X-ray; 2.90 A; A/B=1-489.
DR   PDB; 4TXI; X-ray; 2.31 A; A=2-615.
DR   PDB; 4TXK; X-ray; 2.88 A; A=2-615.
DR   PDBsum; 2BRA; -.
DR   PDBsum; 2BRY; -.
DR   PDBsum; 2C4C; -.
DR   PDBsum; 4TXI; -.
DR   PDBsum; 4TXK; -.
DR   SMR; Q8VDP3; -.
DR   BioGRID; 228624; 10.
DR   IntAct; Q8VDP3; 4.
DR   STRING; 10090.ENSMUSP00000097519; -.
DR   iPTMnet; Q8VDP3; -.
DR   PhosphoSitePlus; Q8VDP3; -.
DR   jPOST; Q8VDP3; -.
DR   PaxDb; Q8VDP3; -.
DR   PeptideAtlas; Q8VDP3; -.
DR   PRIDE; Q8VDP3; -.
DR   ProteomicsDB; 295663; -. [Q8VDP3-1]
DR   ProteomicsDB; 295664; -. [Q8VDP3-2]
DR   ProteomicsDB; 295665; -. [Q8VDP3-3]
DR   Antibodypedia; 32258; 259 antibodies.
DR   DNASU; 171580; -.
DR   Ensembl; ENSMUST00000019967; ENSMUSP00000019967; ENSMUSG00000019823. [Q8VDP3-1]
DR   Ensembl; ENSMUST00000099934; ENSMUSP00000097519; ENSMUSG00000019823. [Q8VDP3-2]
DR   Ensembl; ENSMUST00000119962; ENSMUSP00000113783; ENSMUSG00000019823. [Q8VDP3-3]
DR   GeneID; 171580; -.
DR   KEGG; mmu:171580; -.
DR   UCSC; uc007exn.2; mouse. [Q8VDP3-1]
DR   UCSC; uc007exp.2; mouse. [Q8VDP3-2]
DR   CTD; 64780; -.
DR   MGI; MGI:2385847; Mical1.
DR   eggNOG; KOG1700; Eukaryota.
DR   GeneTree; ENSGT00940000159117; -.
DR   HOGENOM; CLU_000329_0_0_1; -.
DR   InParanoid; Q8VDP3; -.
DR   OrthoDB; 430978at2759; -.
DR   TreeFam; TF324129; -.
DR   BRENDA; 1.14.13.225; 3474.
DR   BioGRID-ORCS; 171580; 0 hits in 52 CRISPR screens.
DR   ChiTaRS; Mical1; mouse.
DR   EvolutionaryTrace; Q8VDP3; -.
DR   PRO; PR:Q8VDP3; -.
DR   Proteomes; UP000000589; Chromosome 10.
DR   RNAct; Q8VDP3; protein.
DR   Bgee; ENSMUSG00000019823; Expressed in granulocyte and 275 other tissues.
DR   Genevisible; Q8VDP3; MM.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:1990026; C:hippocampal mossy fiber expansion; IMP:UniProtKB.
DR   GO; GO:0045171; C:intercellular bridge; ISO:MGI.
DR   GO; GO:0030496; C:midbody; ISO:MGI.
DR   GO; GO:0003779; F:actin binding; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004497; F:monooxygenase activity; IMP:MGI.
DR   GO; GO:0016174; F:NAD(P)H oxidase H2O2-forming activity; ISO:MGI.
DR   GO; GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IDA:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; ISS:UniProtKB.
DR   GO; GO:0031267; F:small GTPase binding; IPI:UniProtKB.
DR   GO; GO:0030042; P:actin filament depolymerization; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:1903305; P:regulation of regulated secretory pathway; IMP:UniProtKB.
DR   GO; GO:0019417; P:sulfur oxidation; IDA:UniProtKB.
DR   CDD; cd00014; CH; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   InterPro; IPR022735; bMERB_dom.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00307; CH; 1.
DR   Pfam; PF12130; DUF3585; 1.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   SMART; SM00033; CH; 1.
DR   SMART; SM00132; LIM; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   PROSITE; PS51848; BMERB; 1.
DR   PROSITE; PS50021; CH; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 1.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Actin-binding; Alternative splicing; Coiled coil; Cytoplasm;
KW   Cytoskeleton; FAD; Flavoprotein; LIM domain; Metal-binding; Monooxygenase;
KW   NADP; Oxidoreductase; Phosphoprotein; Reference proteome; Zinc.
FT   CHAIN           1..1048
FT                   /note="[F-actin]-monooxygenase MICAL1"
FT                   /id="PRO_0000075843"
FT   DOMAIN          507..611
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   DOMAIN          681..743
FT                   /note="LIM zinc-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          905..1048
FT                   /note="bMERB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01195"
FT   NP_BIND         114..116
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16275925,
FT                   ECO:0007744|PDB:4TXI, ECO:0007744|PDB:4TXK"
FT   NP_BIND         121..123
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16275925,
FT                   ECO:0007744|PDB:4TXI, ECO:0007744|PDB:4TXK"
FT   REGION          1..489
FT                   /note="Monooxygenase domain"
FT   REGION          488..508
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          643..676
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          741..787
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          805..825
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          839..873
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          847..867
FT                   /evidence="ECO:0000255"
FT   COILED          906..949
FT                   /evidence="ECO:0000255"
FT   COILED          974..1031
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        656..672
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        749..770
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        850..872
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   METAL           683
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   METAL           686
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   METAL           704
FT                   /note="Zinc 1; via pros nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   METAL           707
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   METAL           710
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   METAL           713
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   METAL           733
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   METAL           736
FT                   /note="Zinc 2; via pros nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   BINDING         95
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16275925,
FT                   ECO:0007744|PDB:4TXI, ECO:0007744|PDB:4TXK"
FT   BINDING         181
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:16275925,
FT                   ECO:0007744|PDB:4TXI, ECO:0007744|PDB:4TXK"
FT   BINDING         293
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16275925,
FT                   ECO:0007744|PDB:4TXI, ECO:0007744|PDB:4TXK"
FT   BINDING         393
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16275925,
FT                   ECO:0007744|PDB:4TXI, ECO:0007744|PDB:4TXK"
FT   MOD_RES         475
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:D3ZBP4"
FT   MOD_RES         616
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   MOD_RES         777
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         781
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   VAR_SEQ         87..159
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_042591"
FT   VAR_SEQ         192
FT                   /note="S -> D (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_042592"
FT   CONFLICT        871
FT                   /note="P -> H (in Ref. 1; BAE35027)"
FT                   /evidence="ECO:0000305"
FT   HELIX           9..19
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           23..37
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           44..53
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   TURN            58..60
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           61..71
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           74..79
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   TURN            80..84
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          86..90
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           94..105
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          109..115
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          124..126
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           129..136
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   TURN            137..139
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           140..143
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   TURN            145..148
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          154..156
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           157..170
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          174..178
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          180..185
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          194..200
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           204..207
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          211..216
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          228..233
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          238..245
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           250..253
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          258..262
FT                   /evidence="ECO:0007829|PDB:4TXK"
FT   TURN            263..266
FT                   /evidence="ECO:0007829|PDB:2BRA"
FT   HELIX           269..277
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          281..298
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           300..305
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          308..311
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           316..319
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   TURN            322..324
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           327..341
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   TURN            342..346
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          357..359
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          361..365
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          367..373
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          375..381
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          384..390
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           392..394
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           400..402
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           405..424
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           429..440
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           441..445
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   TURN            448..450
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           455..457
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           462..464
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          466..468
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           476..482
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   STRAND          483..485
FT                   /evidence="ECO:0007829|PDB:2BRY"
FT   HELIX           508..520
FT                   /evidence="ECO:0007829|PDB:4TXI"
FT   TURN            521..523
FT                   /evidence="ECO:0007829|PDB:4TXI"
FT   STRAND          531..533
FT                   /evidence="ECO:0007829|PDB:4TXI"
FT   HELIX           534..536
FT                   /evidence="ECO:0007829|PDB:4TXI"
FT   HELIX           540..549
FT                   /evidence="ECO:0007829|PDB:4TXI"
FT   HELIX           564..579
FT                   /evidence="ECO:0007829|PDB:4TXI"
FT   HELIX           587..592
FT                   /evidence="ECO:0007829|PDB:4TXI"
FT   HELIX           596..610
FT                   /evidence="ECO:0007829|PDB:4TXI"
SQ   SEQUENCE   1048 AA;  116785 MW;  C31A392A4AE222FC CRC64;
     MASPASTNPA HDHFETFVQA QLCQDVLSSF QGLCRALGVE SGGGLSQYHK IKAQLNYWSA
     KSLWAKLDKR ASQPVYQQGQ ACTNTKCLVV GAGPCGLRAA VELALLGARV VLVEKRIKFS
     RHNVLHLWPF TIHDLRALGA KKFYGRFCTG TLDHISIRQL QLLLLKVALL LGVEIHWGVK
     FTGLQPPPRK GSGWRAQLQP NPPAQLASYE FDVLISAAGG KFVPEGFTIR EMRGKLAIGI
     TANFVNGRTV EETQVPEISG VARIYNQKFF QSLLKATGID LENIVYYKDE THYFVMTAKK
     QCLLRLGVLR QDLSETDQLL GKANVVPEAL QRFARAAADF ATHGKLGKLE FAQDARGRPD
     VAAFDFTSMM RAESSARVQE KHGARLLLGL VGDCLVEPFW PLGTGVARGF LAAFDAAWMV
     KRWAEGAGPL EVLAERESLY QLLSQTSPEN MHRNVAQYGL DPATRYPNLN LRAVTPNQVQ
     DLYDMMDKEH AQRKSDEPDS RKTTTGSAGT EELLHWCQEQ TAGFPGVHVT DFSSSWADGL
     ALCALVHHLQ PGLLEPSELQ GMGALEATTW ALRVAEHELG ITPVLSAQAV MAGSDPLGLI
     AYLSHFHSAF KNTSHSSGLV SQPSGTPSAI LFLGKLQRSL QRTRAKVDEE TPSTEEPPVS
     EPSMSPNTPE LSEHQEAGAE ELCELCGKHL YILERFCVDG HFFHRSCFCC HTCEATLWPG
     GYGQHPGDGH FYCLQHLPQE DQKEADNNGS LESQELPTPG DSNMQPDPSS PPVTRVSPVP
     SPSQPARRLI RLSSLERLRL SSLNIIPDSG AEPPPKPPRS CSDLARESLK SSFVGWGVPV
     QAPQVPEAIE KGDDEEEEEE EEEEEEEPLP PLEPELEQTL LTLAKNPGAM TKYPTWRRTL
     MRRAKEEEMK RFCKAQAIQR RLNEIEATMR ELEAEGTKLE LALRKESSSP EQQKKLWLDQ
     LLRLIQKKNS LVTEEAELMI TVQELDLEEK QRQLDHELRG YMNREETMKT EADLQSENQV
     LRKLLEVVNQ RDALIQFQEE RRLREMPA
//
ID   MNMG_AQUAE              Reviewed;         617 AA.
AC   O66962;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   02-JUN-2021, entry version 122.
DE   RecName: Full=tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG;
DE   AltName: Full=Glucose-inhibited division protein A;
GN   Name=mnmG; Synonyms=gidA; OrderedLocusNames=aq_761;
OS   Aquifex aeolicus (strain VF5).
OC   Bacteria; Aquificae; Aquificales; Aquificaceae; Aquifex.
OX   NCBI_TaxID=224324;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=VF5;
RX   PubMed=9537320; DOI=10.1038/32831;
RA   Deckert G., Warren P.V., Gaasterland T., Young W.G., Lenox A.L.,
RA   Graham D.E., Overbeek R., Snead M.A., Keller M., Aujay M., Huber R.,
RA   Feldman R.A., Short J.M., Olsen G.J., Swanson R.V.;
RT   "The complete genome of the hyperthermophilic bacterium Aquifex aeolicus.";
RL   Nature 392:353-358(1998).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) IN COMPLEX WITH FAD, AND SUBUNIT.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Crystal structure of gidA from Aquifex aeolicus.";
RL   Submitted (JAN-2008) to the PDB data bank.
CC   -!- FUNCTION: NAD-binding protein involved in the addition of a
CC       carboxymethylaminomethyl (cmnm) group at the wobble position (U34) of
CC       certain tRNAs, forming tRNA-cmnm(5)s(2)U34. {ECO:0000250}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- SUBUNIT: Homodimer. Heterotetramer of two MnmE and two MnmG subunits
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the MnmG family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE000657; AAC06917.1; -; Genomic_DNA.
DR   PIR; G70366; G70366.
DR   RefSeq; NP_213523.1; NC_000918.1.
DR   RefSeq; WP_010880461.1; NC_000918.1.
DR   PDB; 2ZXH; X-ray; 3.20 A; A/B=1-617.
DR   PDB; 2ZXI; X-ray; 2.30 A; A/B/C/D=1-617.
DR   PDBsum; 2ZXH; -.
DR   PDBsum; 2ZXI; -.
DR   SMR; O66962; -.
DR   DIP; DIP-48311N; -.
DR   STRING; 224324.aq_761; -.
DR   EnsemblBacteria; AAC06917; AAC06917; aq_761.
DR   KEGG; aae:aq_761; -.
DR   PATRIC; fig|224324.8.peg.606; -.
DR   eggNOG; COG0445; Bacteria.
DR   HOGENOM; CLU_007831_2_2_0; -.
DR   InParanoid; O66962; -.
DR   OMA; FRPGYAI; -.
DR   OrthoDB; 146811at2; -.
DR   BioCyc; AAEO224324:G1G15-544-MONOMER; -.
DR   EvolutionaryTrace; O66962; -.
DR   Proteomes; UP000000798; Chromosome.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:0030488; P:tRNA methylation; IBA:GO_Central.
DR   GO; GO:0002098; P:tRNA wobble uridine modification; IBA:GO_Central.
DR   Gene3D; 3.50.50.60; -; 2.
DR   HAMAP; MF_00129; MnmG_GidA; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR026904; GidA-assoc_3.
DR   InterPro; IPR004416; MnmG.
DR   InterPro; IPR002218; MnmG-rel.
DR   InterPro; IPR020595; MnmG-rel_CS.
DR   InterPro; IPR040131; MnmG_N.
DR   PANTHER; PTHR11806; PTHR11806; 1.
DR   PANTHER; PTHR11806:SF0; PTHR11806:SF0; 1.
DR   Pfam; PF01134; GIDA; 1.
DR   Pfam; PF13932; GIDA_assoc; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR00136; gidA; 1.
DR   PROSITE; PS01280; GIDA_1; 1.
DR   PROSITE; PS01281; GIDA_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; FAD; Flavoprotein; NAD; Reference proteome;
KW   tRNA processing.
FT   CHAIN           1..617
FT                   /note="tRNA uridine 5-carboxymethylaminomethyl modification
FT                   enzyme MnmG"
FT                   /id="PRO_0000117046"
FT   NP_BIND         14..19
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.2"
FT   NP_BIND         280..294
FT                   /note="NAD"
FT                   /evidence="ECO:0000255"
FT   BINDING         126
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|Ref.2"
FT   BINDING         181
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.2"
FT   BINDING         377
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|Ref.2"
FT   HELIX           4..6
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          9..13
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           17..28
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          33..38
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           40..42
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          50..53
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           57..67
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           71..78
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          79..86
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           91..93
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          95..100
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           102..114
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          119..124
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          126..141
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          146..148
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          150..154
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          163..166
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          169..172
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           184..190
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          196..202
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          205..207
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           208..210
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          216..219
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          230..234
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          249..253
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           256..264
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           265..268
FT                   /evidence="ECO:0007829|PDB:2ZXH"
FT   TURN            281..283
FT                   /evidence="ECO:0007829|PDB:2ZXH"
FT   HELIX           287..293
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          301..306
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          313..317
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           325..332
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          343..345
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          348..354
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           357..359
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          364..370
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          372..374
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           376..379
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           384..402
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   TURN            412..414
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           416..427
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           435..437
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   TURN            441..445
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           451..461
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          463..465
FT                   /evidence="ECO:0007829|PDB:2ZXH"
FT   HELIX           467..487
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          491..496
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   STRAND          499..504
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           505..508
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   TURN            509..512
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           515..522
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           530..552
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           554..560
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           570..572
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           578..587
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           592..595
FT                   /evidence="ECO:0007829|PDB:2ZXI"
FT   HELIX           603..612
FT                   /evidence="ECO:0007829|PDB:2ZXI"
SQ   SEQUENCE   617 AA;  69644 MW;  1DAB1BDFEFCBA6DD CRC64;
     MAWVVDEFDV VVIGGGHAGI EAALAAARMG AKTAMFVLNA DTIGQMSCNP AIGGIAKGIV
     VREIDALGGE MGKAIDQTGI QFKMLNTRKG KAVQSPRAQA DKKRYREYMK KVCENQENLY
     IKQEEVVDII VKNNQVVGVR TNLGVEYKTK AVVVTTGTFL NGVIYIGDKM IPGGRLGEPR
     SEGLSDFYRR FDFPLIRFKT GTPARLDKRT IDFSALEVAP GDDPPPKFSF WTEPVGSYWF
     PKGKEQVNCW ITYTTPKTHE IIRKNLHRTA LYGGLIKGIG PRYCPSIEDK IVKFPDKERH
     QIFLEPEGLD TIEIYPNGLS TSLPEEVQWE MYRSIPGLEN VVLIRPAYAI EYDVVPPTEL
     YPTLETKKIR GLFHAGNFNG TTGYEEAAGQ GIVAGINAAL RAFGKEPIYL RRDESYIGVM
     IDDLTTKGVT EPYRLFTSRS EYRLYIRQDN AILRLAKLGR ELGLLSEEQY KLVKELEREI
     EKWKEFYKSE RVSVAVGGDT RSYSVATLMT MNYTLDDVKE KFGYEVPQHP YVKEEVEIQL
     KYEPYIERER KLNEKLKKLE DTKIPPDIDY DKIPGLTKEA REKLKKFKPI TVGQASRIDG
     ITPAAITALL VYLGKLD
//
ID   LPDA_MYCTU              Reviewed;         493 AA.
AC   P9WHH7; L0TC51; O53355; Q8VJ36;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   02-JUN-2021, entry version 46.
DE   RecName: Full=NAD(P)H dehydrogenase (quinone);
DE            EC=1.6.5.2;
DE   AltName: Full=NAD(P)H quinone reductase;
DE   AltName: Full=NAD(P)H: menadione oxidoreductase;
DE   AltName: Full=NADH-menadione reductase;
GN   Name=lpdA; Synonyms=lpdA-2; OrderedLocusNames=Rv3303c;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17097323; DOI=10.1016/j.micinf.2006.09.004;
RA   Akhtar P., Srivastava S., Srivastava A., Srivastava M., Srivastava B.S.,
RA   Srivastava R.;
RT   "Rv3303c of Mycobacterium tuberculosis protects tubercle bacilli against
RT   oxidative stress in vivo and contributes to virulence in mice.";
RL   Microbes Infect. 8:2855-2862(2006).
RN   [3]
RP   IDENTIFICATION AS A DRUG TARGET [LARGE SCALE ANALYSIS].
RX   PubMed=19099550; DOI=10.1186/1752-0509-2-109;
RA   Raman K., Yeturu K., Chandra N.;
RT   "targetTB: a target identification pipeline for Mycobacterium tuberculosis
RT   through an interactome, reactome and genome-scale structural analysis.";
RL   BMC Syst. Biol. 2:109-109(2008).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.81 ANGSTROMS) IN COMPLEX WITH FAD, MASS
RP   SPECTROMETRY, FUNCTION, SUBUNIT, SUBSTRATE SPECIFICITY, REACTION MECHANISM,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15456792; DOI=10.1074/jbc.m410704200;
RA   Argyrou A., Vetting M.W., Blanchard J.S.;
RT   "Characterization of a new member of the flavoprotein disulfide reductase
RT   family of enzymes from Mycobacterium tuberculosis.";
RL   J. Biol. Chem. 279:52694-52702(2004).
CC   -!- FUNCTION: May contribute to virulence by increasing resistance to
CC       reactive oxygen intermediates. It can reduce 2,6-dimethyl-1,4-
CC       benzoquinone (DMBQ), 5-hydroxy-1,4-naphthaquinone (5-HNQ) and
CC       menadione. NADPH is the physiological reductant rather than NADH.
CC       {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADH = a quinol + NAD(+);
CC         Xref=Rhea:RHEA:46160, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:132124; EC=1.6.5.2;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADPH = a quinol + NADP(+);
CC         Xref=Rhea:RHEA:46164, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:132124; EC=1.6.5.2;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.39 uM for 5-HNQ (with NADPH at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=0.44 uM for NADPH (with 5-HNQ at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=0.53 uM for NADPH (with DMBQ at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=1.6 uM for DMBQ (with NADPH at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=5.4 uM for oxidized thionicotinamide adenine dinucleotide
CC         (thio_NAD)(with NADH at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=5.5 uM for 5-HNQ (with NADH at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=11 uM for DMBQ (with NADH at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=18 uM for oxidized thionicotinamide adenine dinucleotide
CC         (thio_NAD)(with NADPH at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=28 uM for NADH (with 5-HNQ at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=35.7 uM for menadione (at pH 7.5) {ECO:0000269|PubMed:15456792,
CC         ECO:0000269|PubMed:17097323};
CC         KM=36 uM for NADH (with DMBQ at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         Vmax=20 umol/min/mg enzyme with menadione (at pH 7.5)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:15456792}.
CC   -!- MASS SPECTROMETRY: Mass=52543; Mass_error=3; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:15456792};
CC   -!- MISCELLANEOUS: Catalysis proceeds by a classical ping-pong bi-bi
CC       reaction mechanism.
CC   -!- MISCELLANEOUS: Was identified as a high-confidence drug target.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   -!- CAUTION: Despite significant sequence similarity to lipoamide
CC       dehydrogenases this protein cannot catalyze the reduction of lipoyl
CC       substrates. It lacks one of two cysteine residues involved in dithiol-
CC       disulfide interchange with lipoyl substrates and a His-Glu pair
CC       involved in general acid catalysis. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP46122.1; -; Genomic_DNA.
DR   PIR; F70841; F70841.
DR   RefSeq; NP_217820.1; NC_000962.3.
DR   RefSeq; WP_009936266.1; NZ_NVQJ01000003.1.
DR   PDB; 1XDI; X-ray; 2.81 A; A/B=1-493.
DR   PDBsum; 1XDI; -.
DR   SMR; P9WHH7; -.
DR   STRING; 83332.Rv3303c; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   PaxDb; P9WHH7; -.
DR   DNASU; 887659; -.
DR   GeneID; 887659; -.
DR   KEGG; mtu:Rv3303c; -.
DR   TubercuList; Rv3303c; -.
DR   eggNOG; COG1249; Bacteria.
DR   OMA; SHCLMAV; -.
DR   PhylomeDB; P9WHH7; -.
DR   SABIO-RK; P9WHH7; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:MTBBASE.
DR   GO; GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; IDA:MTBBASE.
DR   GO; GO:0050136; F:NADH dehydrogenase (quinone) activity; IEA:RHEA.
DR   GO; GO:0070401; F:NADP+ binding; IDA:MTBBASE.
DR   GO; GO:0008753; F:NADPH dehydrogenase (quinone) activity; IEA:RHEA.
DR   GO; GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; IDA:MTBBASE.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:0009405; P:pathogenesis; IMP:MTBBASE.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR001100; Pyr_nuc-diS_OxRdtase.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   PIRSF; PIRSF000350; Mercury_reductase_MerA; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; NAD; Oxidoreductase; Reference proteome.
FT   CHAIN           1..493
FT                   /note="NAD(P)H dehydrogenase (quinone)"
FT                   /id="PRO_0000391461"
FT   NP_BIND         12..13
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   NP_BIND         35..37
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   NP_BIND         42..43
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   NP_BIND         324..325
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   BINDING         52
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   BINDING         117
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   BINDING         317
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   BINDING         450
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   STRAND          3..8
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           12..24
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   TURN            26..28
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          29..37
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           41..45
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           48..64
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   TURN            65..71
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           83..107
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          111..119
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          122..124
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          127..134
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          140..150
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          154..156
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           160..162
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          166..171
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           172..177
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          183..189
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           192..203
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          208..211
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          213..218
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           223..235
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          239..241
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          246..251
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          253..260
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          265..273
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          277..279
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          282..284
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   TURN            286..290
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   TURN            295..297
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          303..306
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          312..314
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           317..319
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           325..339
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           349..351
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          353..356
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          358..367
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           369..373
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          379..386
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           390..394
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          401..407
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   TURN            408..410
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          412..420
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           423..436
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           440..444
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   STRAND          450..452
FT                   /evidence="ECO:0007829|PDB:1XDI"
FT   HELIX           454..464
FT                   /evidence="ECO:0007829|PDB:1XDI"
SQ   SEQUENCE   493 AA;  51489 MW;  71C3F1483665278C CRC64;
     MVTRIVILGG GPAGYEAALV AATSHPETTQ VTVIDCDGIG GAAVLDDCVP SKTFIASTGL
     RTELRRAPHL GFHIDFDDAK ISLPQIHARV KTLAAAQSAD ITAQLLSMGV QVIAGRGELI
     DSTPGLARHR IKATAADGST SEHEADVVLV ATGASPRILP SAQPDGERIL TWRQLYDLDA
     LPDHLIVVGS GVTGAEFVDA YTELGVPVTV VASQDHVLPY EDADAALVLE ESFAERGVRL
     FKNARAASVT RTGAGVLVTM TDGRTVEGSH ALMTIGSVPN TSGLGLERVG IQLGRGNYLT
     VDRVSRTLAT GIYAAGDCTG LLPLASVAAM QGRIAMYHAL GEGVSPIRLR TVAATVFTRP
     EIAAVGVPQS VIDAGSVAAR TIMLPLRTNA RAKMSEMRHG FVKIFCRRST GVVIGGVVVA
     PIASELILPI AVAVQNRITV NELAQTLAVY PSLSGSITEA ARRLMAHDDL DCTAAQDAAE
     QLALVPHHLP TSN
//
ID   GASHR_MARGR             Reviewed;         463 AA.
AC   D0VWY5;
DT   16-MAY-2012, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2009, sequence version 1.
DT   02-JUN-2021, entry version 53.
DE   RecName: Full=Glutathione amide reductase {ECO:0000303|PubMed:11399772};
DE            Short=GAR {ECO:0000303|PubMed:11399772};
DE            EC=1.8.1.16 {ECO:0000303|PubMed:11399772};
GN   Name=garB {ECO:0000303|PubMed:11399772};
OS   Marichromatium gracile (Chromatium gracile).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Chromatiales; Chromatiaceae;
OC   Marichromatium.
OX   NCBI_TaxID=1048;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-52, CLEAVAGE OF
RP   INITIATOR METHIONINE, FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND MASS SPECTROMETRY.
RC   STRAIN=DSM 1712 / HOL-1 {ECO:0000269|PubMed:11399772};
RX   PubMed=11399772; DOI=10.1074/jbc.m102026200;
RA   Vergauwen B., Pauwels F., Jacquemotte F., Meyer T.E., Cusanovich M.A.,
RA   Bartsch R.G., Van Beeumen J.J.;
RT   "Characterization of glutathione amide reductase from Chromatium gracile.
RT   Identification of a novel thiol peroxidase (Prx/Grx) fueled by glutathione
RT   amide redox cycling.";
RL   J. Biol. Chem. 276:20890-20897(2001).
RN   [2] {ECO:0000305}
RP   CRYSTALLIZATION, AND PRELIMINARY X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS).
RX   PubMed=11807270; DOI=10.1107/s0907444901020303;
RA   Vergauwen B., Van Petegem F., Remaut H., Pauwels F., Van Beeumen J.J.;
RT   "Crystallization and preliminary X-ray crystallographic analysis of
RT   glutathione amide reductase from Chromatium gracile.";
RL   Acta Crystallogr. D 58:339-340(2002).
RN   [3] {ECO:0000305, ECO:0000312|PDB:2RAB}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH FAD; NAD AND NICKEL,
RP   AND SUBUNIT.
RX   PubMed=17977556; DOI=10.1016/j.jmb.2007.09.072;
RA   Van Petegem F., De Vos D., Savvides S., Vergauwen B., Van Beeumen J.;
RT   "Understanding nicotinamide dinucleotide cofactor and substrate specificity
RT   in class I flavoprotein disulfide oxidoreductases: crystallographic
RT   analysis of a glutathione amide reductase.";
RL   J. Mol. Biol. 374:883-889(2007).
CC   -!- FUNCTION: Catalyzes the reduction of glutathione amide disulfide
CC       (GASSAG) to restore glutathione amide (GASH) in the presence of NADH.
CC       May play a role in GASH metabolism under anaerobic conditions as a
CC       sulfide carrier necessary for cytoplasmic sulfide oxidation.
CC       {ECO:0000269|PubMed:11399772}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 glutathione amide + NAD(+) = glutathione amide disulfide +
CC         H(+) + NADH; Xref=Rhea:RHEA:27433, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:59895,
CC         ChEBI:CHEBI:59896; EC=1.8.1.16;
CC         Evidence={ECO:0000269|PubMed:11399772};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:11399772, ECO:0000269|PubMed:17977556};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:11399772,
CC       ECO:0000269|PubMed:17977556};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=97 uM for glutathione amide disulfide (GASSAG) for the reverse
CC         reaction (in the presence of 100 uM NADH)
CC         {ECO:0000269|PubMed:11399772};
CC         KM=6.9 mM for glutathione disulfide (GSH) for the reverse reaction
CC         {ECO:0000269|PubMed:11399772};
CC         KM=13.2 uM for NADH for the reverse reaction (in the presence of 500
CC         uM GASSAG) {ECO:0000269|PubMed:11399772};
CC         KM=1.98 mM for NADPH for the reverse reaction
CC         {ECO:0000269|PubMed:11399772};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11399772,
CC       ECO:0000269|PubMed:17977556}.
CC   -!- MASS SPECTROMETRY: Mass=49030; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:11399772};
CC   -!- MISCELLANEOUS: The active site is a redox-active disulfide bond.
CC       {ECO:0000269|PubMed:17977556}.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   PDB; 2R9Z; X-ray; 2.10 A; A/B=1-463.
DR   PDB; 2RAB; X-ray; 2.50 A; A/B=1-463.
DR   PDBsum; 2R9Z; -.
DR   PDBsum; 2RAB; -.
DR   SMR; D0VWY5; -.
DR   EvolutionaryTrace; D0VWY5; -.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0004362; F:glutathione-disulfide reductase activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050661; F:NADP binding; IEA:InterPro.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:0006749; P:glutathione metabolic process; IEA:InterPro.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR006322; Glutathione_Rdtase_euk/bac.
DR   InterPro; IPR001100; Pyr_nuc-diS_OxRdtase.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   InterPro; IPR012999; Pyr_OxRdtase_I_AS.
DR   PANTHER; PTHR42737; PTHR42737; 1.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   PIRSF; PIRSF000350; Mercury_reductase_MerA; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
DR   TIGRFAMs; TIGR01421; gluta_reduc_1; 1.
DR   PROSITE; PS00076; PYRIDINE_REDOX_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Disulfide bond; FAD; Flavoprotein;
KW   Metal-binding; NAD; Nickel; Nucleotide-binding; Oxidoreductase;
KW   Redox-active center.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:11399772"
FT   CHAIN           2..463
FT                   /note="Glutathione amide reductase"
FT                   /evidence="ECO:0000269|PubMed:11399772"
FT                   /id="PRO_0000417371"
FT   NP_BIND         14..15
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   NP_BIND         113..114
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   NP_BIND         174..180
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   NP_BIND         197..198
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   NP_BIND         308..310
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   ACT_SITE        437
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   METAL           2
FT                   /note="Nickel"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   METAL           3
FT                   /note="Nickel"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   METAL           4
FT                   /note="Nickel; via pros nitrogen"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   BINDING         34
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   BINDING         41
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   BINDING         50
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   BINDING         50
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   BINDING         230
FT                   /note="NAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   BINDING         261
FT                   /note="NAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   BINDING         302
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   BINDING         308
FT                   /note="NAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   BINDING         341
FT                   /note="NAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   BINDING         437
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   DISULFID        42..47
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:17977556"
FT   STRAND          5..10
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           14..25
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          30..36
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           40..45
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           47..65
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           66..69
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           80..104
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          108..112
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          114..118
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          121..124
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          127..136
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          140..142
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           150..152
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           156..161
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          167..172
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           176..187
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          191..195
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          197..202
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           207..219
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          223..227
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          230..236
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          239..244
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          249..258
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          262..265
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           271..274
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          297..299
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           301..304
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           310..325
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          340..342
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          348..352
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           355..362
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          366..373
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           376..378
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          381..383
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          387..394
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   TURN            395..398
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          399..407
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           410..412
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           415..422
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           427..431
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   STRAND          437..440
FT                   /evidence="ECO:0007829|PDB:2R9Z"
FT   HELIX           441..445
FT                   /evidence="ECO:0007829|PDB:2R9Z"
SQ   SEQUENCE   463 AA;  49159 MW;  95EC9202CAD02846 CRC64;
     MTQHFDLIAI GGGSGGLAVA EKAAAFGKRV ALIESKALGG TCVNVGCVPK KVMWYASHLA
     EAVRDAPGFG VQASGGTLDW PRLVAGRDRY IGAINSFWDG YVERLGITRV DGHARFVDAH
     TIEVEGQRLS ADHIVIATGG RPIVPRLPGA ELGITSDGFF ALQQQPKRVA IIGAGYIGIE
     LAGLLRSFGS EVTVVALEDR LLFQFDPLLS ATLAENMHAQ GIETHLEFAV AALERDAQGT
     TLVAQDGTRL EGFDSVIWAV GRAPNTRDLG LEAAGIEVQS NGMVPTDAYQ NTNVPGVYAL
     GDITGRDQLT PVAIAAGRRL AERLFDGQSE RKLDYDNIPT VVFAHPPLSK VGLSEPEARE
     RLGDVLTVYE TSFTPMRYAL NEHGPKTAMK LVCAGPEQRV VGVHVIGDGA DEMLQGFAVA
     VKMGATKADF DNTVAIHPGS AEELVTLKEP VRRPGDPLPE GAA
//
ID   KDM1A_HUMAN             Reviewed;         852 AA.
AC   O60341; A8MWP9; Q5TH94; Q5TH95; Q86VT7; Q8IXK4; Q8NDP6; Q8TAZ3; Q96AW4;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 2.
DT   02-JUN-2021, entry version 213.
DE   RecName: Full=Lysine-specific histone demethylase 1A;
DE            EC=1.14.99.66 {ECO:0000269|PubMed:15620353, ECO:0000269|PubMed:15811342};
DE   AltName: Full=BRAF35-HDAC complex protein BHC110;
DE   AltName: Full=Flavin-containing amine oxidase domain-containing protein 2;
DE   AltName: Full=[histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A;
GN   Name=KDM1A; Synonyms=AOF2, KDM1, KIAA0601, LSD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 245-852 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   PARTIAL PROTEIN SEQUENCE, INTERACTION WITH A HISTONE DEACETYLASE-CONTAINING
RP   COMPLEX, AND FUNCTION.
RX   PubMed=12032298; DOI=10.1073/pnas.112008599;
RA   Hakimi M.-A., Bochar D.A., Chenoweth J., Lane W.S., Mandel G.,
RA   Shiekhattar R.;
RT   "A core-BRAF35 complex containing histone deacetylase mediates repression
RT   of neuronal-specific genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7420-7425(2002).
RN   [6]
RP   INTERACTION WITH THE HDAC1 COMPLEX, IDENTIFICATION BY MASS SPECTROMETRY,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=11102443; DOI=10.1074/jbc.m007372200;
RA   Humphrey G.W., Wang Y., Russanova V.R., Hirai T., Qin J., Nakatani Y.,
RA   Howard B.H.;
RT   "Stable histone deacetylase complexes distinguished by the presence of SANT
RT   domain proteins CoREST/kiaa0071 and Mta-L1.";
RL   J. Biol. Chem. 276:6817-6824(2001).
RN   [7]
RP   INTERACTION WITH A HISTONE DEACETYLASE-CONTAINING COMPLEX, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12493763; DOI=10.1074/jbc.m208992200;
RA   Hakimi M.-A., Dong Y., Lane W.S., Speicher D.W., Shiekhattar R.;
RT   "A candidate X-linked mental retardation gene is a component of a new
RT   family of histone deacetylase-containing complexes.";
RL   J. Biol. Chem. 278:7234-7239(2003).
RN   [8]
RP   CATALYTIC ACTIVITY, FUNCTION, AND COFACTOR.
RX   PubMed=15620353; DOI=10.1016/j.cell.2004.12.012;
RA   Shi Y.-J., Lan F., Matson C., Mulligan P., Whetstine J.R., Cole P.A.,
RA   Casero R.A., Shi Y.;
RT   "Histone demethylation mediated by the nuclear amine oxidase homolog
RT   LSD1.";
RL   Cell 119:941-953(2004).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, AND COFACTOR.
RX   PubMed=15811342; DOI=10.1016/j.febslet.2005.03.015;
RA   Forneris F., Binda C., Vanoni M.A., Mattevi A., Battaglioli E.;
RT   "Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative
RT   process.";
RL   FEBS Lett. 579:2203-2207(2005).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH RCOR1 AND PHF21A.
RX   PubMed=16140033; DOI=10.1016/j.molcel.2005.08.027;
RA   Shi Y.-J., Matson C., Lan F., Iwase S., Baba T., Shi Y.;
RT   "Regulation of LSD1 histone demethylase activity by its associated
RT   factors.";
RL   Mol. Cell 19:857-864(2005).
RN   [11]
RP   FUNCTION, INTERACTION WITH RCOR1, AND MUTAGENESIS OF LYS-661.
RX   PubMed=16079794; DOI=10.1038/nature04021;
RA   Lee M.G., Wynder C., Cooch N., Shiekhattar R.;
RT   "An essential role for CoREST in nucleosomal histone 3 lysine 4
RT   demethylation.";
RL   Nature 437:432-435(2005).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INTERACTION WITH
RP   AR.
RX   PubMed=16079795; DOI=10.1038/nature04020;
RA   Metzger E., Wissmann M., Yin N., Mueller J.M., Schneider R.,
RA   Peters A.H.F.M., Guenther T., Buettner R., Schuele R.;
RT   "LSD1 demethylates repressive histone marks to promote androgen-receptor-
RT   dependent transcription.";
RL   Nature 437:436-439(2005).
RN   [13]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16223729; DOI=10.1074/jbc.m509549200;
RA   Forneris F., Binda C., Vanoni M.A., Battaglioli E., Mattevi A.;
RT   "Human histone demethylase LSD1 reads the histone code.";
RL   J. Biol. Chem. 280:41360-41365(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   FUNCTION.
RX   PubMed=17805299; DOI=10.1038/nature06092;
RA   Huang J., Sengupta R., Espejo A.B., Lee M.G., Dorsey J.A., Richter M.,
RA   Opravil S., Shiekhattar R., Bedford M.T., Jenuwein T., Berger S.L.;
RT   "p53 is regulated by the lysine demethylase LSD1.";
RL   Nature 449:105-108(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-59; THR-104; SER-126;
RP   SER-131; SER-166 AND SER-849, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-104; SER-131 AND SER-137, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   FUNCTION, INTERACTION WITH SNAI1 AND RCOR1, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=20389281; DOI=10.1038/emboj.2010.63;
RA   Lin Y., Wu Y., Li J., Dong C., Ye X., Chi Y.I., Evers B.M., Zhou B.P.;
RT   "The SNAG domain of Snail1 functions as a molecular hook for recruiting
RT   lysine-specific demethylase 1.";
RL   EMBO J. 29:1803-1816(2010).
RN   [23]
RP   RETRACTED PAPER.
RX   PubMed=19880879; DOI=10.1074/jbc.m109.065862;
RA   Lee S.W., Cho Y.S., Na J.M., Park U.H., Kang M., Kim E.J., Um S.J.;
RT   "ASXL1 represses retinoic acid receptor-mediated transcription through
RT   associating with HP1 and LSD1.";
RL   J. Biol. Chem. 285:18-29(2010).
RN   [24]
RP   RETRACTION NOTICE OF PUBMED:19880879 NOTICE FOR PUBMED:19880879.
RX   PubMed=25750265; DOI=10.1074/jbc.a109.065862;
RA   Lee S.W., Cho Y.S., Na J.M., Park U.H., Kang M., Kim E.J., Um S.J.;
RT   "Retraction: 'ASXL1 represses retinoic acid receptor-mediated transcription
RT   through associating with HP1 and LSD1'.";
RL   J. Biol. Chem. 290:6008-6008(2015).
RN   [25]
RP   FUNCTION.
RX   PubMed=20228790; DOI=10.1038/nature08839;
RA   Metzger E., Imhof A., Patel D., Kahl P., Hoffmeyer K., Friedrichs N.,
RA   Muller J.M., Greschik H., Kirfel J., Ji S., Kunowska N.,
RA   Beisenherz-Huss C., Gunther T., Buettner R., Schule R.;
RT   "Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at
RT   histone H3K4.";
RL   Nature 464:792-796(2010).
RN   [26]
RP   FUNCTION, AND INTERACTION WITH SNAI.
RX   PubMed=20562920; DOI=10.1038/onc.2010.234;
RA   Lin T., Ponn A., Hu X., Law B.K., Lu J.;
RT   "Requirement of the histone demethylase LSD1 in Snai1-mediated
RT   transcriptional repression during epithelial-mesenchymal transition.";
RL   Oncogene 29:4896-4904(2010).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-137; SER-166 AND
RP   SER-849, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-137 AND SER-166, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-137; SER-166 AND
RP   SER-611, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-126; SER-131; TYR-135 AND
RP   SER-137, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [32]
RP   INTERACTION WITH JADE2, INDUCTION, UBIQUITINATION, AND MUTAGENESIS OF
RP   LYS-503.
RX   PubMed=25018020; DOI=10.1016/j.molcel.2014.06.006;
RA   Han X., Gui B., Xiong C., Zhao L., Liang J., Sun L., Yang X., Yu W., Si W.,
RA   Yan R., Yi X., Zhang D., Li W., Li L., Yang J., Wang Y., Sun Y.E.,
RA   Zhang D., Meng A., Shang Y.;
RT   "Destabilizing LSD1 by Jade-2 promotes neurogenesis: an antibraking system
RT   in neural development.";
RL   Mol. Cell 55:482-494(2014).
RN   [33]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-442 AND LYS-469, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.57 ANGSTROMS) OF 171-836 IN COMPLEX WITH FAD AND
RP   RCOR1.
RX   PubMed=16885027; DOI=10.1016/j.molcel.2006.07.012;
RA   Yang M., Gocke C.B., Luo X., Borek D., Tomchick D.R., Machius M.,
RA   Otwinowski Z., Yu H.;
RT   "Structural basis for CoREST-dependent demethylation of nucleosomes by the
RT   human LSD1 histone demethylase.";
RL   Mol. Cell 23:377-387(2006).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 172-835 IN COMPLEX WITH FAD,
RP   FUNCTION, COFACTOR, AND MUTAGENESIS OF ASN-535; HIS-564 AND TYR-761.
RX   PubMed=16956976; DOI=10.1073/pnas.0606381103;
RA   Chen Y., Yang Y., Wang F., Wan K., Yamane K., Zhang Y., Lei M.;
RT   "Crystal structure of human histone lysine-specific demethylase 1 (LSD1).";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:13956-13961(2006).
RN   [36]
RP   STRUCTURE BY NMR OF 166-285, AND DOMAIN.
RX   PubMed=16531230; DOI=10.1016/j.str.2005.12.004;
RA   Tochio N., Umehara T., Koshiba S., Inoue M., Yabuki T., Aoki M., Seki E.,
RA   Watanabe S., Tomo Y., Hanada M., Ikari M., Sato M., Terada T., Nagase T.,
RA   Ohara O., Shirouzu M., Tanaka A., Kigawa T., Yokoyama S.;
RT   "Solution structure of the SWIRM domain of human histone demethylase
RT   LSD1.";
RL   Structure 14:457-468(2006).
RN   [37] {ECO:0007744|PDB:2Y48}
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 123-852 IN COMPLEX WITH FAD;
RP   SNAI1 PEPTIDE AND RCOR1, FUNCTION, ACTIVITY REGULATION, COFACTOR, AND
RP   SUBUNIT.
RX   PubMed=21300290; DOI=10.1016/j.str.2011.01.001;
RA   Baron R., Binda C., Tortorici M., McCammon J.A., Mattevi A.;
RT   "Molecular mimicry and ligand recognition in binding and catalysis by the
RT   histone demethylase LSD1-CoREST complex.";
RL   Structure 19:212-220(2011).
RN   [38] {ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT, ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV, ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0, ECO:0007744|PDB:3ZN1}
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) IN COMPLEXES WITH FAD; RCOR1; INSM1
RP   PEPTIDE AND SNAI1 PEPTIDE, FUNCTION, ACTIVITY REGULATION, COFACTOR, AND
RP   SUBUNIT.
RX   PubMed=23721412; DOI=10.1021/cb4001926;
RA   Tortorici M., Borrello M.T., Tardugno M., Chiarelli L.R., Pilotto S.,
RA   Ciossani G., Vellore N.A., Bailey S.G., Cowan J., O'Connell M., Crabb S.J.,
RA   Packham G., Mai A., Baron R., Ganesan A., Mattevi A.;
RT   "Protein recognition by short peptide reversible inhibitors of the
RT   chromatin-modifying LSD1/CoREST lysine demethylase.";
RL   ACS Chem. Biol. 8:1677-1682(2013).
RN   [39]
RP   VARIANT CPRF GLY-556.
RX   PubMed=23020937; DOI=10.1016/s0140-6736(12)61480-9;
RA   Rauch A., Wieczorek D., Graf E., Wieland T., Endele S., Schwarzmayr T.,
RA   Albrecht B., Bartholdi D., Beygo J., Di Donato N., Dufke A., Cremer K.,
RA   Hempel M., Horn D., Hoyer J., Joset P., Roepke A., Moog U., Riess A.,
RA   Thiel C.T., Tzschach A., Wiesener A., Wohlleber E., Zweier C., Ekici A.B.,
RA   Zink A.M., Rump A., Meisinger C., Grallert H., Sticht H., Schenck A.,
RA   Engels H., Rappold G., Schroeck E., Wieacker P., Riess O., Meitinger T.,
RA   Reis A., Strom T.M.;
RT   "Range of genetic mutations associated with severe non-syndromic sporadic
RT   intellectual disability: an exome sequencing study.";
RL   Lancet 380:1674-1682(2012).
RN   [40]
RP   VARIANT CPRF HIS-761.
RX   PubMed=24838796; DOI=10.1002/ajmg.a.36450;
RA   Tunovic S., Barkovich J., Sherr E.H., Slavotinek A.M.;
RT   "De novo ANKRD11 and KDM1A gene mutations in a male with features of KBG
RT   syndrome and Kabuki syndrome.";
RL   Am. J. Med. Genet. A 164A:1744-1749(2014).
RN   [41]
RP   VARIANTS CPRF LYS-379; GLY-556 AND HIS-761.
RX   PubMed=26656649; DOI=10.1038/gim.2015.161;
RA   Chong J.X., Yu J.H., Lorentzen P., Park K.M., Jamal S.M., Tabor H.K.,
RA   Rauch A., Saenz M.S., Boltshauser E., Patterson K.E., Nickerson D.A.,
RA   Bamshad M.J.;
RT   "Gene discovery for Mendelian conditions via social networking: de novo
RT   variants in KDM1A cause developmental delay and distinctive facial
RT   features.";
RL   Genet. Med. 18:788-795(2016).
CC   -!- FUNCTION: Histone demethylase that can demethylate both 'Lys-4'
CC       (H3K4me) and 'Lys-9' (H3K9me) of histone H3, thereby acting as a
CC       coactivator or a corepressor, depending on the context
CC       (PubMed:15620353, PubMed:15811342, PubMed:16140033, PubMed:16079794,
CC       PubMed:16079795, PubMed:16223729). Acts by oxidizing the substrate by
CC       FAD to generate the corresponding imine that is subsequently hydrolyzed
CC       (PubMed:15620353, PubMed:15811342, PubMed:16079794, PubMed:21300290).
CC       Acts as a corepressor by mediating demethylation of H3K4me, a specific
CC       tag for epigenetic transcriptional activation. Demethylates both
CC       mono- (H3K4me1) and di-methylated (H3K4me2) H3K4me (PubMed:15620353,
CC       PubMed:20389281, PubMed:21300290, PubMed:23721412). May play a role in
CC       the repression of neuronal genes. Alone, it is unable to demethylate
CC       H3K4me on nucleosomes and requires the presence of RCOR1/CoREST to
CC       achieve such activity (PubMed:16140033, PubMed:16079794,
CC       PubMed:16885027, PubMed:21300290, PubMed:23721412). Also acts as a
CC       coactivator of androgen receptor (AR)-dependent transcription, by being
CC       recruited to AR target genes and mediating demethylation of H3K9me, a
CC       specific tag for epigenetic transcriptional repression. The presence of
CC       PRKCB in AR-containing complexes, which mediates phosphorylation of
CC       'Thr-6' of histone H3 (H3T6ph), a specific tag that prevents
CC       demethylation H3K4me, prevents H3K4me demethylase activity of KDM1A
CC       (PubMed:16079795). Demethylates di-methylated 'Lys-370' of p53/TP53
CC       which prevents interaction of p53/TP53 with TP53BP1 and represses
CC       p53/TP53-mediated transcriptional activation. Demethylates and
CC       stabilizes the DNA methylase DNMT1. Required for gastrulation during
CC       embryogenesis. Component of a RCOR/GFI/KDM1A/HDAC complex that
CC       suppresses, via histone deacetylase (HDAC) recruitment, a number of
CC       genes implicated in multilineage blood cell development. Effector of
CC       SNAI1-mediated transcription repression of E-cadherin/CDH1, CDN7 and
CC       KRT8. Required for the maintenance of the silenced state of the SNAI1
CC       target genes E-cadherin/CDH1 and CDN7 (PubMed:20389281).
CC       {ECO:0000269|PubMed:12032298, ECO:0000269|PubMed:15620353,
CC       ECO:0000269|PubMed:15811342, ECO:0000269|PubMed:16079794,
CC       ECO:0000269|PubMed:16079795, ECO:0000269|PubMed:16140033,
CC       ECO:0000269|PubMed:16223729, ECO:0000269|PubMed:16885027,
CC       ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:17805299,
CC       ECO:0000269|PubMed:20228790, ECO:0000269|PubMed:20389281,
CC       ECO:0000269|PubMed:20562920, ECO:0000269|PubMed:21300290,
CC       ECO:0000269|PubMed:23721412}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 A + 2 H2O + N(6),N(6)-dimethyl-L-lysyl(4)-[histone H3] = 2
CC         AH2 + 2 formaldehyde + L-lysyl(4)-[histone H3]; Xref=Rhea:RHEA:60244,
CC         Rhea:RHEA-COMP:15540, Rhea:RHEA-COMP:15547, ChEBI:CHEBI:13193,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:16842, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:29969, ChEBI:CHEBI:61976; EC=1.14.99.66;
CC         Evidence={ECO:0000269|PubMed:15620353, ECO:0000269|PubMed:15811342};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:15620353, ECO:0000269|PubMed:15811342,
CC         ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
CC         ECO:0000269|PubMed:23721412};
CC   -!- ACTIVITY REGULATION: The N-terminal sequences of INSM1 and SNAI1
CC       compete with histone H3 for the same binding site and thereby inhibit
CC       histone demethylation (in vitro). {ECO:0000269|PubMed:21300290,
CC       ECO:0000269|PubMed:23721412}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.0 uM for H3 monomethyl-K4 {ECO:0000269|PubMed:16223729};
CC         KM=4.2 uM for H3 dimethyl-K4 {ECO:0000269|PubMed:16223729};
CC         KM=3.9 uM for H3 monomethyl-K4-monomethyl-K9
CC         {ECO:0000269|PubMed:16223729};
CC         KM=17.5 uM for monomethyl-K4-acetyl-K9 {ECO:0000269|PubMed:16223729};
CC   -!- SUBUNIT: Component of a histone demethylase complex with RCOR1
CC       (PubMed:20389281, PubMed:23721412, PubMed:16885027, PubMed:21300290).
CC       Component of a RCOR/GFI/KDM1A/HDAC complex (PubMed:12032298,
CC       PubMed:11102443). Interacts directly with GFI1 and GFI1B. Interacts
CC       with INSM1 (via N-terminus) (PubMed:23721412). Component of a BHC
CC       histone deacetylase complex that contains HDAC1, HDAC2, HMG20B, KDM1A,
CC       RCOR1 and PHF21A. The BHC complex may also contain ZMYM2, ZNF217,
CC       ZMYM3, GSE1 and GTF2I (PubMed:12493763, PubMed:16140033,
CC       PubMed:16885027). In the complex, RCOR1/CoREST strongly enhances the
CC       demethylase activity and protects it from the proteasome while
CC       PHF21A/BHC80 inhibits the demethylase activity (PubMed:16079794,
CC       PubMed:16956976). Interacts with the androgen receptor (AR)
CC       (PubMed:16079795). Interacts with SNAI1 (via SNAG domain)
CC       (PubMed:20389281, PubMed:20562920, PubMed:21300290, PubMed:23721412).
CC       Interacts (via AOD/Tower domain) with JADE2 (via C-terminus)
CC       (PubMed:25018020). Interacts with ESRRB; co-occupes the core set of
CC       ESRRB targets (By similarity). {ECO:0000250|UniProtKB:Q6ZQ88,
CC       ECO:0000269|PubMed:11102443, ECO:0000269|PubMed:12032298,
CC       ECO:0000269|PubMed:12493763, ECO:0000269|PubMed:16079794,
CC       ECO:0000269|PubMed:16079795, ECO:0000269|PubMed:16140033,
CC       ECO:0000269|PubMed:16885027, ECO:0000269|PubMed:16956976,
CC       ECO:0000269|PubMed:20389281, ECO:0000269|PubMed:20562920,
CC       ECO:0000269|PubMed:21300290, ECO:0000269|PubMed:23721412,
CC       ECO:0000269|PubMed:25018020}.
CC   -!- INTERACTION:
CC       O60341; Q99996: AKAP9; NbExp=2; IntAct=EBI-710124, EBI-1048311;
CC       O60341; Q86SG2: ANKRD23; NbExp=3; IntAct=EBI-710124, EBI-5661893;
CC       O60341; Q13490: BIRC2; NbExp=3; IntAct=EBI-710124, EBI-514538;
CC       O60341; Q6P047: C8orf74; NbExp=2; IntAct=EBI-710124, EBI-8466055;
CC       O60341; Q8TC20-4: CAGE1; NbExp=3; IntAct=EBI-710124, EBI-11522698;
CC       O60341; Q9BWT7: CARD10; NbExp=3; IntAct=EBI-710124, EBI-3866279;
CC       O60341; Q49A88-3: CCDC14; NbExp=3; IntAct=EBI-710124, EBI-12105646;
CC       O60341; Q99459: CDC5L; NbExp=3; IntAct=EBI-710124, EBI-374880;
CC       O60341; Q9BXL8: CDCA4; NbExp=2; IntAct=EBI-710124, EBI-1773949;
CC       O60341; Q86XR8-3: CEP57; NbExp=3; IntAct=EBI-710124, EBI-11752486;
CC       O60341; Q8NHQ1: CEP70; NbExp=2; IntAct=EBI-710124, EBI-739624;
CC       O60341; Q8TAP6: CEP76; NbExp=3; IntAct=EBI-710124, EBI-742887;
CC       O60341; Q12873: CHD3; NbExp=4; IntAct=EBI-710124, EBI-523590;
CC       O60341; P38432: COIL; NbExp=3; IntAct=EBI-710124, EBI-945751;
CC       O60341; Q96EY1: DNAJA3; NbExp=2; IntAct=EBI-710124, EBI-356767;
CC       O60341; P26378-2: ELAVL4; NbExp=3; IntAct=EBI-710124, EBI-21603100;
CC       O60341; Q9UPT5-1: EXOC7; NbExp=3; IntAct=EBI-710124, EBI-6251402;
CC       O60341; Q3B820: FAM161A; NbExp=3; IntAct=EBI-710124, EBI-719941;
CC       O60341; Q9H8W3: FAM204A; NbExp=3; IntAct=EBI-710124, EBI-8465160;
CC       O60341; Q8IZU1: FAM9A; NbExp=2; IntAct=EBI-710124, EBI-8468186;
CC       O60341; Q9BQS8: FYCO1; NbExp=2; IntAct=EBI-710124, EBI-2869338;
CC       O60341; O95995: GAS8; NbExp=3; IntAct=EBI-710124, EBI-1052570;
CC       O60341; Q96CN9: GCC1; NbExp=3; IntAct=EBI-710124, EBI-746252;
CC       O60341; Q08379: GOLGA2; NbExp=3; IntAct=EBI-710124, EBI-618309;
CC       O60341; Q9NYA3: GOLGA6A; NbExp=3; IntAct=EBI-710124, EBI-11163335;
CC       O60341; Q8NEC7: GSTCD; NbExp=2; IntAct=EBI-710124, EBI-8469616;
CC       O60341; Q9BX10: GTPBP2; NbExp=2; IntAct=EBI-710124, EBI-6115579;
CC       O60341; Q16695: H3-4; NbExp=2; IntAct=EBI-710124, EBI-358900;
CC       O60341; Q96CS2: HAUS1; NbExp=2; IntAct=EBI-710124, EBI-2514791;
CC       O60341; O15379: HDAC3; NbExp=4; IntAct=EBI-710124, EBI-607682;
CC       O60341; Q9UBX0: HESX1; NbExp=2; IntAct=EBI-710124, EBI-8470369;
CC       O60341; Q9NSC5: HOMER3; NbExp=3; IntAct=EBI-710124, EBI-748420;
CC       O60341; Q16891: IMMT; NbExp=2; IntAct=EBI-710124, EBI-473801;
CC       O60341; O75564-2: JRK; NbExp=3; IntAct=EBI-710124, EBI-17181882;
CC       O60341; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-710124, EBI-14069005;
CC       O60341; Q8TBB5: KLHDC4; NbExp=2; IntAct=EBI-710124, EBI-8472352;
CC       O60341; P19012: KRT15; NbExp=3; IntAct=EBI-710124, EBI-739566;
CC       O60341; Q15323: KRT31; NbExp=3; IntAct=EBI-710124, EBI-948001;
CC       O60341; Q14525: KRT33B; NbExp=4; IntAct=EBI-710124, EBI-1049638;
CC       O60341; Q92764: KRT35; NbExp=3; IntAct=EBI-710124, EBI-1058674;
CC       O60341; Q6A163: KRT39; NbExp=3; IntAct=EBI-710124, EBI-11958242;
CC       O60341; Q6A162: KRT40; NbExp=3; IntAct=EBI-710124, EBI-10171697;
CC       O60341; Q96JB6: LOXL4; NbExp=2; IntAct=EBI-710124, EBI-749562;
CC       O60341; Q9Y250: LZTS1; NbExp=3; IntAct=EBI-710124, EBI-1216080;
CC       O60341; O95983: MBD3; NbExp=4; IntAct=EBI-710124, EBI-1783068;
CC       O60341; P01106: MYC; NbExp=4; IntAct=EBI-710124, EBI-447544;
CC       O60341; Q3BBV0: NBPF1; NbExp=5; IntAct=EBI-710124, EBI-2804530;
CC       O60341; Q7Z6G3-2: NECAB2; NbExp=3; IntAct=EBI-710124, EBI-10172876;
CC       O60341; P35240: NF2; NbExp=4; IntAct=EBI-710124, EBI-1014472;
CC       O60341; Q16236: NFE2L2; NbExp=5; IntAct=EBI-710124, EBI-2007911;
CC       O60341; P46531: NOTCH1; NbExp=8; IntAct=EBI-710124, EBI-636374;
CC       O60341; Q13133: NR1H3; NbExp=2; IntAct=EBI-710124, EBI-781356;
CC       O60341; Q96F24: NRBF2; NbExp=3; IntAct=EBI-710124, EBI-2362014;
CC       O60341; A5D8V7: ODAD3; NbExp=2; IntAct=EBI-710124, EBI-8466445;
CC       O60341; Q8IZS5: OFCC1; NbExp=2; IntAct=EBI-710124, EBI-8477661;
CC       O60341; Q9BYU1: PBX4; NbExp=3; IntAct=EBI-710124, EBI-10302990;
CC       O60341; Q8IZL8: PELP1; NbExp=6; IntAct=EBI-710124, EBI-716449;
CC       O60341; Q99471: PFDN5; NbExp=3; IntAct=EBI-710124, EBI-357275;
CC       O60341; Q5T6S3: PHF19; NbExp=2; IntAct=EBI-710124, EBI-2339674;
CC       O60341; Q03181: PPARD; NbExp=2; IntAct=EBI-710124, EBI-6426768;
CC       O60341; P62191: PSMC1; NbExp=2; IntAct=EBI-710124, EBI-357598;
CC       O60341; Q9NS23: RASSF1; NbExp=2; IntAct=EBI-710124, EBI-367363;
CC       O60341; P50749: RASSF2; NbExp=2; IntAct=EBI-710124, EBI-960081;
CC       O60341; Q86WH2: RASSF3; NbExp=3; IntAct=EBI-710124, EBI-2845202;
CC       O60341; Q06330: RBPJ; NbExp=4; IntAct=EBI-710124, EBI-632552;
CC       O60341; Q9UKL0: RCOR1; NbExp=6; IntAct=EBI-710124, EBI-926563;
CC       O60341; Q8IZ40: RCOR2; NbExp=3; IntAct=EBI-710124, EBI-723853;
CC       O60341; Q9P2K3-2: RCOR3; NbExp=6; IntAct=EBI-710124, EBI-1504830;
CC       O60341; Q96P16-3: RPRD1A; NbExp=3; IntAct=EBI-710124, EBI-12840198;
CC       O60341; Q8N6K7: SAMD3; NbExp=2; IntAct=EBI-710124, EBI-748741;
CC       O60341; Q9UGK8: SERGEF; NbExp=2; IntAct=EBI-710124, EBI-465368;
CC       O60341; Q13435: SF3B2; NbExp=2; IntAct=EBI-710124, EBI-749111;
CC       O60341; O15198: SMAD9; NbExp=2; IntAct=EBI-710124, EBI-748763;
CC       O60341; O95863: SNAI1; NbExp=32; IntAct=EBI-710124, EBI-1045459;
CC       O60341; Q96H20: SNF8; NbExp=2; IntAct=EBI-710124, EBI-747719;
CC       O60341; Q8N0Z3: SPICE1; NbExp=4; IntAct=EBI-710124, EBI-2361917;
CC       O60341; Q96BD6: SPSB1; NbExp=2; IntAct=EBI-710124, EBI-2659201;
CC       O60341; Q8N4C7: STX19; NbExp=2; IntAct=EBI-710124, EBI-8484990;
CC       O60341; Q8N6V9: TEX9; NbExp=4; IntAct=EBI-710124, EBI-746341;
CC       O60341; Q9UBB9: TFIP11; NbExp=3; IntAct=EBI-710124, EBI-1105213;
CC       O60341; Q08117-2: TLE5; NbExp=3; IntAct=EBI-710124, EBI-11741437;
CC       O60341; Q2M3C6: TMEM266; NbExp=3; IntAct=EBI-710124, EBI-12163061;
CC       O60341; P45379-11: TNNT2; NbExp=3; IntAct=EBI-710124, EBI-17559309;
CC       O60341; Q05BL1: TP53BP2; NbExp=3; IntAct=EBI-710124, EBI-11952721;
CC       O60341; Q9BUZ4: TRAF4; NbExp=4; IntAct=EBI-710124, EBI-3650647;
CC       O60341; Q5W5X9-3: TTC23; NbExp=3; IntAct=EBI-710124, EBI-9090990;
CC       O60341; Q8TF42: UBASH3B; NbExp=3; IntAct=EBI-710124, EBI-1380492;
CC       O60341; Q9H9H4: VPS37B; NbExp=3; IntAct=EBI-710124, EBI-4400866;
CC       O60341; Q9Y3C0: WASHC3; NbExp=3; IntAct=EBI-710124, EBI-712969;
CC       O60341; O96006: ZBED1; NbExp=4; IntAct=EBI-710124, EBI-740037;
CC       O60341; O15060: ZBTB39; NbExp=3; IntAct=EBI-710124, EBI-9995672;
CC       O60341-1; O14646: CHD1; NbExp=8; IntAct=EBI-15599570, EBI-1560858;
CC       O60341-1; Q96KQ7: EHMT2; NbExp=2; IntAct=EBI-15599570, EBI-744366;
CC       O60341-1; Q96KQ7-1: EHMT2; NbExp=3; IntAct=EBI-15599570, EBI-15737402;
CC       O60341-1; P05771-1: PRKCB; NbExp=2; IntAct=EBI-15599570, EBI-5774492;
CC       O60341-1; Q9UKL0: RCOR1; NbExp=6; IntAct=EBI-15599570, EBI-926563;
CC       O60341-1; P17542: TAL1; NbExp=5; IntAct=EBI-15599570, EBI-1753878;
CC       O60341-1; P04637: TP53; NbExp=6; IntAct=EBI-15599570, EBI-366083;
CC       O60341-1; P22091: Tal1; Xeno; NbExp=2; IntAct=EBI-15599570, EBI-8006437;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11102443,
CC       ECO:0000269|PubMed:16079795, ECO:0000269|PubMed:20389281}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O60341-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60341-2; Sequence=VSP_011198, VSP_011199;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:16079795}.
CC   -!- INDUCTION: Down-regulated during neural differentiation in
CC       neuroblastoma cancer. {ECO:0000269|PubMed:25018020}.
CC   -!- DOMAIN: The SWIRM domain may act as an anchor site for a histone tail.
CC       {ECO:0000269|PubMed:16531230}.
CC   -!- PTM: Polyubiquitinated by JADE2; which leads to its proteasomal
CC       degradation. {ECO:0000269|PubMed:25018020}.
CC   -!- DISEASE: Cleft palate, psychomotor retardation, and distinctive facial
CC       features (CPRF) [MIM:616728]: A syndrome characterized by cleft palate,
CC       developmental delay, psychomotor retardation, and facial dysmorphic
CC       features including a prominent forehead, slightly arched eyebrows,
CC       elongated palpebral fissures, a wide nasal bridge, thin lips, and
CC       widely spaced teeth. Cleft palate is a congenital fissure of the soft
CC       and/or hard palate, due to faulty fusion. {ECO:0000269|PubMed:23020937,
CC       ECO:0000269|PubMed:24838796, ECO:0000269|PubMed:26656649}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the flavin monoamine oxidase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was previously reported to interact with ASXL1. However, this
CC       publication has been retracted. {ECO:0000305|PubMed:19880879,
CC       ECO:0000305|PubMed:25750265}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA25527.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB011173; BAA25527.1; ALT_INIT; mRNA.
DR   EMBL; AL031428; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC016639; AAH16639.1; -; mRNA.
DR   EMBL; BC025362; AAH25362.1; -; mRNA.
DR   EMBL; BC040194; AAH40194.3; -; mRNA.
DR   EMBL; BC048134; AAH48134.2; -; mRNA.
DR   EMBL; AL833812; CAD38675.2; -; mRNA.
DR   CCDS; CCDS30627.1; -. [O60341-1]
DR   CCDS; CCDS53278.1; -. [O60341-2]
DR   RefSeq; NP_001009999.1; NM_001009999.2. [O60341-2]
DR   RefSeq; NP_055828.2; NM_015013.3. [O60341-1]
DR   PDB; 2COM; NMR; -; A=169-279.
DR   PDB; 2DW4; X-ray; 2.30 A; A=172-831.
DR   PDB; 2EJR; X-ray; 2.70 A; A=172-833.
DR   PDB; 2H94; X-ray; 2.90 A; A=172-835.
DR   PDB; 2HKO; X-ray; 2.80 A; A=172-835.
DR   PDB; 2IW5; X-ray; 2.57 A; A=171-836.
DR   PDB; 2L3D; NMR; -; A=174-273.
DR   PDB; 2UXN; X-ray; 2.72 A; A=171-836.
DR   PDB; 2UXX; X-ray; 2.74 A; A=171-836.
DR   PDB; 2V1D; X-ray; 3.10 A; A=123-852.
DR   PDB; 2X0L; X-ray; 3.00 A; A=123-852.
DR   PDB; 2XAF; X-ray; 3.25 A; A=1-852.
DR   PDB; 2XAG; X-ray; 3.10 A; A=1-852.
DR   PDB; 2XAH; X-ray; 3.10 A; A=1-852.
DR   PDB; 2XAJ; X-ray; 3.30 A; A=1-852.
DR   PDB; 2XAQ; X-ray; 3.20 A; A=1-852.
DR   PDB; 2XAS; X-ray; 3.20 A; A=1-852.
DR   PDB; 2Y48; X-ray; 3.00 A; A=123-852.
DR   PDB; 2Z3Y; X-ray; 2.25 A; A=172-833.
DR   PDB; 2Z5U; X-ray; 2.25 A; A=172-833.
DR   PDB; 3ABT; X-ray; 3.20 A; A=172-833.
DR   PDB; 3ABU; X-ray; 3.10 A; A=172-833.
DR   PDB; 3ZMS; X-ray; 2.96 A; A=1-852.
DR   PDB; 3ZMT; X-ray; 3.10 A; A=1-852.
DR   PDB; 3ZMU; X-ray; 3.20 A; A=1-852.
DR   PDB; 3ZMV; X-ray; 3.00 A; A=1-852.
DR   PDB; 3ZMZ; X-ray; 3.00 A; A=1-852.
DR   PDB; 3ZN0; X-ray; 2.80 A; A=1-852.
DR   PDB; 3ZN1; X-ray; 3.10 A; A=1-852.
DR   PDB; 4BAY; X-ray; 3.10 A; A=172-852.
DR   PDB; 4CZZ; X-ray; 3.00 A; A=1-852.
DR   PDB; 4KUM; X-ray; 3.05 A; A=171-836.
DR   PDB; 4UV8; X-ray; 2.80 A; A=1-852.
DR   PDB; 4UV9; X-ray; 3.00 A; A=1-852.
DR   PDB; 4UVA; X-ray; 2.90 A; A=1-852.
DR   PDB; 4UVB; X-ray; 2.80 A; A=1-852.
DR   PDB; 4UVC; X-ray; 3.10 A; A=1-852.
DR   PDB; 4UXN; X-ray; 2.85 A; A=1-852.
DR   PDB; 4XBF; X-ray; 2.80 A; A=171-836.
DR   PDB; 5AFW; X-ray; 1.60 A; B=108-119.
DR   PDB; 5H6Q; X-ray; 2.53 A; A=172-833.
DR   PDB; 5H6R; X-ray; 2.60 A; A=172-833.
DR   PDB; 5IT3; X-ray; 1.40 A; A/B=183-267.
DR   PDB; 5L3B; X-ray; 3.30 A; A=1-852.
DR   PDB; 5L3C; X-ray; 3.31 A; A=1-852.
DR   PDB; 5L3D; X-ray; 2.60 A; A=1-852.
DR   PDB; 5L3E; X-ray; 2.80 A; A=123-852.
DR   PDB; 5L3F; X-ray; 3.50 A; A=123-852.
DR   PDB; 5L3G; X-ray; 3.10 A; A=123-852.
DR   PDB; 5LBQ; X-ray; 3.30 A; A=123-852.
DR   PDB; 5LGN; X-ray; 3.20 A; A=172-836.
DR   PDB; 5LGT; X-ray; 3.00 A; A=123-852.
DR   PDB; 5LGU; X-ray; 3.20 A; A=123-852.
DR   PDB; 5LHG; X-ray; 3.34 A; A=1-852.
DR   PDB; 5LHH; X-ray; 3.05 A; A=1-852.
DR   PDB; 5LHI; X-ray; 3.40 A; A=1-852.
DR   PDB; 5X60; X-ray; 2.69 A; A=172-833.
DR   PDB; 5YJB; X-ray; 2.96 A; A=172-833.
DR   PDB; 6E1F; X-ray; 1.16 A; A/B/C/D=183-267.
DR   PDB; 6K3E; X-ray; 2.87 A; A=172-833.
DR   PDB; 6KGK; X-ray; 2.70 A; A=172-833.
DR   PDB; 6KGL; X-ray; 2.70 A; A=172-833.
DR   PDB; 6KGM; X-ray; 2.62 A; A=172-833.
DR   PDB; 6KGN; X-ray; 2.62 A; A=172-833.
DR   PDB; 6KGO; X-ray; 2.25 A; A=172-833.
DR   PDB; 6KGP; X-ray; 2.25 A; A=172-833.
DR   PDB; 6KGQ; X-ray; 2.32 A; A=172-833.
DR   PDB; 6KGR; X-ray; 2.32 A; A=172-833.
DR   PDB; 6NQM; X-ray; 2.90 A; A=173-830.
DR   PDB; 6NQU; X-ray; 2.70 A; A=173-830.
DR   PDB; 6NR5; X-ray; 2.90 A; A=173-830.
DR   PDB; 6S35; X-ray; 3.10 A; A=172-833.
DR   PDB; 6TE1; X-ray; 3.11 A; A=1-852.
DR   PDB; 6VYP; X-ray; 4.99 A; K/M/k/m=171-852.
DR   PDB; 6W4K; X-ray; 2.93 A; A=174-832.
DR   PDB; 7JJL; X-ray; 2.60 A; B=104-129.
DR   PDB; 7JJM; X-ray; 2.06 A; A=104-129.
DR   PDB; 7JK7; X-ray; 1.96 A; A=104-129.
DR   PDBsum; 2COM; -.
DR   PDBsum; 2DW4; -.
DR   PDBsum; 2EJR; -.
DR   PDBsum; 2H94; -.
DR   PDBsum; 2HKO; -.
DR   PDBsum; 2IW5; -.
DR   PDBsum; 2L3D; -.
DR   PDBsum; 2UXN; -.
DR   PDBsum; 2UXX; -.
DR   PDBsum; 2V1D; -.
DR   PDBsum; 2X0L; -.
DR   PDBsum; 2XAF; -.
DR   PDBsum; 2XAG; -.
DR   PDBsum; 2XAH; -.
DR   PDBsum; 2XAJ; -.
DR   PDBsum; 2XAQ; -.
DR   PDBsum; 2XAS; -.
DR   PDBsum; 2Y48; -.
DR   PDBsum; 2Z3Y; -.
DR   PDBsum; 2Z5U; -.
DR   PDBsum; 3ABT; -.
DR   PDBsum; 3ABU; -.
DR   PDBsum; 3ZMS; -.
DR   PDBsum; 3ZMT; -.
DR   PDBsum; 3ZMU; -.
DR   PDBsum; 3ZMV; -.
DR   PDBsum; 3ZMZ; -.
DR   PDBsum; 3ZN0; -.
DR   PDBsum; 3ZN1; -.
DR   PDBsum; 4BAY; -.
DR   PDBsum; 4CZZ; -.
DR   PDBsum; 4KUM; -.
DR   PDBsum; 4UV8; -.
DR   PDBsum; 4UV9; -.
DR   PDBsum; 4UVA; -.
DR   PDBsum; 4UVB; -.
DR   PDBsum; 4UVC; -.
DR   PDBsum; 4UXN; -.
DR   PDBsum; 4XBF; -.
DR   PDBsum; 5AFW; -.
DR   PDBsum; 5H6Q; -.
DR   PDBsum; 5H6R; -.
DR   PDBsum; 5IT3; -.
DR   PDBsum; 5L3B; -.
DR   PDBsum; 5L3C; -.
DR   PDBsum; 5L3D; -.
DR   PDBsum; 5L3E; -.
DR   PDBsum; 5L3F; -.
DR   PDBsum; 5L3G; -.
DR   PDBsum; 5LBQ; -.
DR   PDBsum; 5LGN; -.
DR   PDBsum; 5LGT; -.
DR   PDBsum; 5LGU; -.
DR   PDBsum; 5LHG; -.
DR   PDBsum; 5LHH; -.
DR   PDBsum; 5LHI; -.
DR   PDBsum; 5X60; -.
DR   PDBsum; 5YJB; -.
DR   PDBsum; 6E1F; -.
DR   PDBsum; 6K3E; -.
DR   PDBsum; 6KGK; -.
DR   PDBsum; 6KGL; -.
DR   PDBsum; 6KGM; -.
DR   PDBsum; 6KGN; -.
DR   PDBsum; 6KGO; -.
DR   PDBsum; 6KGP; -.
DR   PDBsum; 6KGQ; -.
DR   PDBsum; 6KGR; -.
DR   PDBsum; 6NQM; -.
DR   PDBsum; 6NQU; -.
DR   PDBsum; 6NR5; -.
DR   PDBsum; 6S35; -.
DR   PDBsum; 6TE1; -.
DR   PDBsum; 6VYP; -.
DR   PDBsum; 6W4K; -.
DR   PDBsum; 7JJL; -.
DR   PDBsum; 7JJM; -.
DR   PDBsum; 7JK7; -.
DR   BMRB; O60341; -.
DR   SASBDB; O60341; -.
DR   SMR; O60341; -.
DR   BioGRID; 116667; 444.
DR   CORUM; O60341; -.
DR   DIP; DIP-34641N; -.
DR   IntAct; O60341; 311.
DR   MINT; O60341; -.
DR   STRING; 9606.ENSP00000383042; -.
DR   BindingDB; O60341; -.
DR   ChEMBL; CHEMBL6136; -.
DR   DrugCentral; O60341; -.
DR   GuidetoPHARMACOLOGY; 2669; -.
DR   MoonDB; O60341; Predicted.
DR   iPTMnet; O60341; -.
DR   MetOSite; O60341; -.
DR   PhosphoSitePlus; O60341; -.
DR   BioMuta; KDM1A; -.
DR   EPD; O60341; -.
DR   jPOST; O60341; -.
DR   MassIVE; O60341; -.
DR   MaxQB; O60341; -.
DR   PaxDb; O60341; -.
DR   PeptideAtlas; O60341; -.
DR   PRIDE; O60341; -.
DR   ProteomicsDB; 49364; -. [O60341-1]
DR   ProteomicsDB; 49365; -. [O60341-2]
DR   Antibodypedia; 3136; 688 antibodies.
DR   DNASU; 23028; -.
DR   Ensembl; ENST00000356634; ENSP00000349049; ENSG00000004487. [O60341-1]
DR   Ensembl; ENST00000400181; ENSP00000383042; ENSG00000004487. [O60341-2]
DR   GeneID; 23028; -.
DR   KEGG; hsa:23028; -.
DR   UCSC; uc001bgi.3; human. [O60341-1]
DR   CTD; 23028; -.
DR   DisGeNET; 23028; -.
DR   GeneCards; KDM1A; -.
DR   HGNC; HGNC:29079; KDM1A.
DR   HPA; ENSG00000004487; Low tissue specificity.
DR   MalaCards; KDM1A; -.
DR   MIM; 609132; gene.
DR   MIM; 616728; phenotype.
DR   neXtProt; NX_O60341; -.
DR   OpenTargets; ENSG00000004487; -.
DR   Orphanet; 477993; Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome.
DR   PharmGKB; PA165751392; -.
DR   VEuPathDB; HostDB:ENSG00000004487.15; -.
DR   eggNOG; KOG0029; Eukaryota.
DR   eggNOG; KOG0685; Eukaryota.
DR   GeneTree; ENSGT00940000157193; -.
DR   HOGENOM; CLU_004498_5_1_1; -.
DR   InParanoid; O60341; -.
DR   OMA; FNYAGNC; -.
DR   OrthoDB; 1034142at2759; -.
DR   PhylomeDB; O60341; -.
DR   TreeFam; TF312972; -.
DR   BioCyc; MetaCyc:ENSG00000004487-MONOMER; -.
DR   BRENDA; 1.14.11.65; 2681.
DR   BRENDA; 1.14.11.66; 2681.
DR   BRENDA; 1.14.11.67; 2681.
DR   BRENDA; 1.14.99.66; 2681.
DR   PathwayCommons; O60341; -.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214842; HDMs demethylate histones.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-8943724; Regulation of PTEN gene transcription.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-9029569; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux.
DR   Reactome; R-HSA-9679191; Potential therapeutics for SARS.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   SABIO-RK; O60341; -.
DR   SIGNOR; O60341; -.
DR   BioGRID-ORCS; 23028; 89 hits in 1018 CRISPR screens.
DR   ChiTaRS; KDM1A; human.
DR   EvolutionaryTrace; O60341; -.
DR   GenomeRNAi; 23028; -.
DR   Pharos; O60341; Tchem.
DR   PRO; PR:O60341; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O60341; protein.
DR   Bgee; ENSG00000004487; Expressed in subventricular zone (outer) (primate) and 244 other tissues.
DR   ExpressionAtlas; O60341; baseline and differential.
DR   Genevisible; O60341; HS.
DR   GO; GO:0000785; C:chromatin; IDA:BHF-UCL.
DR   GO; GO:0000781; C:chromosome, telomeric region; IDA:BHF-UCL.
DR   GO; GO:1990391; C:DNA repair complex; IDA:MGI.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0005667; C:transcription regulator complex; ISS:UniProtKB.
DR   GO; GO:0050681; F:androgen receptor binding; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0032451; F:demethylase activity; IMP:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0032452; F:histone demethylase activity; IDA:BHF-UCL.
DR   GO; GO:0034648; F:histone demethylase activity (H3-dimethyl-K4 specific); IDA:UniProtKB.
DR   GO; GO:0032453; F:histone demethylase activity (H3-K4 specific); IDA:UniProtKB.
DR   GO; GO:0032454; F:histone demethylase activity (H3-K9 specific); IDA:UniProtKB.
DR   GO; GO:0043426; F:MRF binding; IDA:BHF-UCL.
DR   GO; GO:0030374; F:nuclear receptor coactivator activity; IMP:UniProtKB.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:UniProtKB.
DR   GO; GO:0002039; F:p53 binding; IPI:BHF-UCL.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISS:BHF-UCL.
DR   GO; GO:0001085; F:RNA polymerase II transcription factor binding; ISS:ARUK-UCL.
DR   GO; GO:0061752; F:telomeric repeat-containing RNA binding; IDA:BHF-UCL.
DR   GO; GO:0008134; F:transcription factor binding; IDA:BHF-UCL.
DR   GO; GO:0000380; P:alternative mRNA splicing, via spliceosome; IEA:Ensembl.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0071320; P:cellular response to cAMP; IEA:Ensembl.
DR   GO; GO:0071480; P:cellular response to gamma radiation; IMP:MGI.
DR   GO; GO:0034644; P:cellular response to UV; IDA:MGI.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0046098; P:guanine metabolic process; IEA:Ensembl.
DR   GO; GO:0034720; P:histone H3-K4 demethylation; IDA:UniProtKB.
DR   GO; GO:0033169; P:histone H3-K9 demethylation; IDA:UniProtKB.
DR   GO; GO:0030522; P:intracellular receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0055001; P:muscle cell development; ISS:BHF-UCL.
DR   GO; GO:0043392; P:negative regulation of DNA binding; IC:BHF-UCL.
DR   GO; GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; IMP:BHF-UCL.
DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0051572; P:negative regulation of histone H3-K4 methylation; ISS:ARUK-UCL.
DR   GO; GO:0051573; P:negative regulation of histone H3-K9 methylation; ISS:ARUK-UCL.
DR   GO; GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:BHF-UCL.
DR   GO; GO:0032091; P:negative regulation of protein binding; IMP:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0042551; P:neuron maturation; IEA:Ensembl.
DR   GO; GO:0045793; P:positive regulation of cell size; IEA:Ensembl.
DR   GO; GO:0035563; P:positive regulation of chromatin binding; IEA:Ensembl.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0033184; P:positive regulation of histone ubiquitination; IMP:MGI.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; ISS:ARUK-UCL.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; IMP:BHF-UCL.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:2000648; P:positive regulation of stem cell proliferation; ISS:ARUK-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0006482; P:protein demethylation; IMP:BHF-UCL.
DR   GO; GO:0060765; P:regulation of androgen receptor signaling pathway; TAS:Reactome.
DR   GO; GO:1903827; P:regulation of cellular protein localization; IMP:MGI.
DR   GO; GO:0010569; P:regulation of double-strand break repair via homologous recombination; IMP:MGI.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0060992; P:response to fungicide; IEA:Ensembl.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   IDEAL; IID00009; -.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR017366; Hist_Lys-spec_deMease.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR007526; SWIRM.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   Pfam; PF04433; SWIRM; 1.
DR   PIRSF; PIRSF038051; Histone_Lys-demethylase; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   PROSITE; PS50934; SWIRM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromatin regulator; Coiled coil;
KW   Developmental protein; Direct protein sequencing; Disease variant; FAD;
KW   Flavoprotein; Isopeptide bond; Nucleus; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; Repressor; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..852
FT                   /note="Lysine-specific histone demethylase 1A"
FT                   /id="PRO_0000099881"
FT   DOMAIN          174..273
FT                   /note="SWIRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00247"
FT   NP_BIND         332..333
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16885027,
FT                   ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
FT                   ECO:0000269|PubMed:23721412, ECO:0007744|PDB:2DW4,
FT                   ECO:0007744|PDB:2H94, ECO:0007744|PDB:2HKO,
FT                   ECO:0007744|PDB:2IW5, ECO:0007744|PDB:2V1D,
FT                   ECO:0007744|PDB:2X0L, ECO:0007744|PDB:2XAF,
FT                   ECO:0007744|PDB:2XAG, ECO:0007744|PDB:2XAH,
FT                   ECO:0007744|PDB:2XAJ, ECO:0007744|PDB:2XAQ,
FT                   ECO:0007744|PDB:2XAS, ECO:0007744|PDB:2Y48,
FT                   ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT,
FT                   ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV,
FT                   ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0,
FT                   ECO:0007744|PDB:3ZN1"
FT   NP_BIND         810..811
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16885027,
FT                   ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
FT                   ECO:0000269|PubMed:23721412, ECO:0007744|PDB:2DW4,
FT                   ECO:0007744|PDB:2H94, ECO:0007744|PDB:2HKO,
FT                   ECO:0007744|PDB:2IW5, ECO:0007744|PDB:2V1D,
FT                   ECO:0007744|PDB:2X0L, ECO:0007744|PDB:2XAF,
FT                   ECO:0007744|PDB:2XAG, ECO:0007744|PDB:2XAH,
FT                   ECO:0007744|PDB:2XAJ, ECO:0007744|PDB:2XAQ,
FT                   ECO:0007744|PDB:2XAS, ECO:0007744|PDB:2Y48,
FT                   ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT,
FT                   ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV,
FT                   ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0,
FT                   ECO:0007744|PDB:3ZN1"
FT   REGION          1..176
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          300..852
FT                   /note="Demethylase activity"
FT   COILED          110..151
FT                   /evidence="ECO:0000255"
FT   COILED          428..514
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        105..151
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         289
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16885027,
FT                   ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
FT                   ECO:0000269|PubMed:23721412, ECO:0007744|PDB:2DW4,
FT                   ECO:0007744|PDB:2H94, ECO:0007744|PDB:2HKO,
FT                   ECO:0007744|PDB:2IW5, ECO:0007744|PDB:2V1D,
FT                   ECO:0007744|PDB:2X0L, ECO:0007744|PDB:2XAF,
FT                   ECO:0007744|PDB:2XAG, ECO:0007744|PDB:2XAH,
FT                   ECO:0007744|PDB:2XAJ, ECO:0007744|PDB:2XAQ,
FT                   ECO:0007744|PDB:2XAS, ECO:0007744|PDB:2Y48,
FT                   ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT,
FT                   ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV,
FT                   ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0,
FT                   ECO:0007744|PDB:3ZN1"
FT   BINDING         308
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16885027,
FT                   ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
FT                   ECO:0000269|PubMed:23721412, ECO:0007744|PDB:2DW4,
FT                   ECO:0007744|PDB:2H94, ECO:0007744|PDB:2HKO,
FT                   ECO:0007744|PDB:2IW5, ECO:0007744|PDB:2V1D,
FT                   ECO:0007744|PDB:2X0L, ECO:0007744|PDB:2XAF,
FT                   ECO:0007744|PDB:2XAG, ECO:0007744|PDB:2XAH,
FT                   ECO:0007744|PDB:2XAJ, ECO:0007744|PDB:2XAQ,
FT                   ECO:0007744|PDB:2XAS, ECO:0007744|PDB:2Y48,
FT                   ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT,
FT                   ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV,
FT                   ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0,
FT                   ECO:0007744|PDB:3ZN1"
FT   BINDING         310
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16885027,
FT                   ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
FT                   ECO:0000269|PubMed:23721412, ECO:0007744|PDB:2DW4,
FT                   ECO:0007744|PDB:2H94, ECO:0007744|PDB:2HKO,
FT                   ECO:0007744|PDB:2IW5, ECO:0007744|PDB:2V1D,
FT                   ECO:0007744|PDB:2X0L, ECO:0007744|PDB:2XAF,
FT                   ECO:0007744|PDB:2XAG, ECO:0007744|PDB:2XAH,
FT                   ECO:0007744|PDB:2XAJ, ECO:0007744|PDB:2XAQ,
FT                   ECO:0007744|PDB:2XAS, ECO:0007744|PDB:2Y48,
FT                   ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT,
FT                   ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV,
FT                   ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0,
FT                   ECO:0007744|PDB:3ZN1"
FT   BINDING         316
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16885027,
FT                   ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
FT                   ECO:0000269|PubMed:23721412, ECO:0007744|PDB:2DW4,
FT                   ECO:0007744|PDB:2H94, ECO:0007744|PDB:2HKO,
FT                   ECO:0007744|PDB:2IW5, ECO:0007744|PDB:2V1D,
FT                   ECO:0007744|PDB:2X0L, ECO:0007744|PDB:2XAF,
FT                   ECO:0007744|PDB:2XAG, ECO:0007744|PDB:2XAH,
FT                   ECO:0007744|PDB:2XAJ, ECO:0007744|PDB:2XAQ,
FT                   ECO:0007744|PDB:2XAS, ECO:0007744|PDB:2Y48,
FT                   ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT,
FT                   ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV,
FT                   ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0,
FT                   ECO:0007744|PDB:3ZN1"
FT   BINDING         801
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16885027,
FT                   ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
FT                   ECO:0000269|PubMed:23721412, ECO:0007744|PDB:2DW4,
FT                   ECO:0007744|PDB:2H94, ECO:0007744|PDB:2HKO,
FT                   ECO:0007744|PDB:2IW5, ECO:0007744|PDB:2V1D,
FT                   ECO:0007744|PDB:2X0L, ECO:0007744|PDB:2XAF,
FT                   ECO:0007744|PDB:2XAG, ECO:0007744|PDB:2XAH,
FT                   ECO:0007744|PDB:2XAJ, ECO:0007744|PDB:2XAQ,
FT                   ECO:0007744|PDB:2XAS, ECO:0007744|PDB:2Y48,
FT                   ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT,
FT                   ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV,
FT                   ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0,
FT                   ECO:0007744|PDB:3ZN1"
FT   MOD_RES         59
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         104
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         126
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         131
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         135
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         137
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         166
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18220336,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         611
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         849
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   CROSSLNK        442
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        469
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        503
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000305|PubMed:25018020"
FT   VAR_SEQ         173
FT                   /note="G -> GQAGGLQDDSSGGYGDGQASG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011198"
FT   VAR_SEQ         369
FT                   /note="A -> ADTVK (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011199"
FT   VARIANT         379
FT                   /note="E -> K (in CPRF; dbSNP:rs864309715)"
FT                   /evidence="ECO:0000269|PubMed:26656649"
FT                   /id="VAR_076366"
FT   VARIANT         556
FT                   /note="D -> G (in CPRF; dbSNP:rs864309716)"
FT                   /evidence="ECO:0000269|PubMed:23020937,
FT                   ECO:0000269|PubMed:26656649"
FT                   /id="VAR_076367"
FT   VARIANT         761
FT                   /note="Y -> H (in CPRF; dbSNP:rs864309714)"
FT                   /evidence="ECO:0000269|PubMed:24838796,
FT                   ECO:0000269|PubMed:26656649"
FT                   /id="VAR_076368"
FT   MUTAGEN         503
FT                   /note="K->R: Loss of polyubiquitination."
FT                   /evidence="ECO:0000269|PubMed:25018020"
FT   MUTAGEN         535
FT                   /note="N->A: Strongly reduces demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:16956976"
FT   MUTAGEN         564
FT                   /note="H->A: Strongly reduces demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:16956976"
FT   MUTAGEN         661
FT                   /note="K->A: Abolishes histone demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:16079794"
FT   MUTAGEN         761
FT                   /note="Y->A: Strongly reduces demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:16956976"
FT   CONFLICT        78
FT                   /note="P -> Q (in Ref. 3; AAH40194)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        405
FT                   /note="P -> H (in Ref. 3; AAH48134)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        669
FT                   /note="V -> A (in Ref. 4; CAD38675)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        814
FT                   /note="A -> V (in Ref. 3; AAH16639)"
FT                   /evidence="ECO:0000305"
FT   HELIX           173..180
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          181..183
FT                   /evidence="ECO:0007829|PDB:2COM"
FT   STRAND          185..187
FT                   /evidence="ECO:0007829|PDB:2HKO"
FT   HELIX           190..195
FT                   /evidence="ECO:0007829|PDB:6E1F"
FT   HELIX           197..200
FT                   /evidence="ECO:0007829|PDB:6E1F"
FT   HELIX           204..223
FT                   /evidence="ECO:0007829|PDB:6E1F"
FT   HELIX           231..236
FT                   /evidence="ECO:0007829|PDB:6E1F"
FT   HELIX           242..244
FT                   /evidence="ECO:0007829|PDB:6E1F"
FT   HELIX           246..258
FT                   /evidence="ECO:0007829|PDB:6E1F"
FT   STRAND          261..263
FT                   /evidence="ECO:0007829|PDB:5IT3"
FT   STRAND          265..267
FT                   /evidence="ECO:0007829|PDB:2COM"
FT   STRAND          280..284
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           288..299
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          303..307
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          309..314
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          319..322
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          325..330
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          333..335
FT                   /evidence="ECO:0007829|PDB:6NQU"
FT   HELIX           341..349
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          353..355
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          362..364
FT                   /evidence="ECO:0007829|PDB:6KGM"
FT   STRAND          367..369
FT                   /evidence="ECO:0007829|PDB:5LHH"
FT   HELIX           372..393
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            394..396
FT                   /evidence="ECO:0007829|PDB:2HKO"
FT   STRAND          400..405
FT                   /evidence="ECO:0007829|PDB:5H6Q"
FT   HELIX           408..456
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            457..461
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           476..487
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            488..490
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           491..497
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           499..511
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          518..521
FT                   /evidence="ECO:0007829|PDB:3ABU"
FT   HELIX           523..539
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           544..546
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            549..555
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           556..558
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          565..567
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           573..578
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            579..581
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          583..585
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          588..596
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          599..608
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          613..623
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           627..631
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          636..641
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           645..653
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          654..656
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          660..665
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          676..680
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          683..685
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            686..689
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          690..695
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          698..707
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           710..715
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           720..735
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           737..739
FT                   /evidence="ECO:0007829|PDB:6KGO"
FT   STRAND          744..748
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            751..753
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            755..757
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          758..760
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          765..767
FT                   /evidence="ECO:0007829|PDB:6NQM"
FT   HELIX           771..777
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          785..788
FT                   /evidence="ECO:0007829|PDB:6S35"
FT   STRAND          796..798
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           801..803
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          805..807
FT                   /evidence="ECO:0007829|PDB:5H6R"
FT   HELIX           811..829
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           833..835
FT                   /evidence="ECO:0007829|PDB:5L3D"
SQ   SEQUENCE   852 AA;  92903 MW;  A61CEDE51E4E0C1D CRC64;
     MLSGKKAAAA AAAAAAAATG TEAGPGTAGG SENGSEVAAQ PAGLSGPAEV GPGAVGERTP
     RKKEPPRASP PGGLAEPPGS AGPQAGPTVV PGSATPMETG IAETPEGRRT SRRKRAKVEY
     REMDESLANL SEDEYYSEEE RNAKAEKEKK LPPPPPQAPP EEENESEPEE PSGVEGAAFQ
     SRLPHDRMTS QEAACFPDII SGPQQTQKVF LFIRNRTLQL WLDNPKIQLT FEATLQQLEA
     PYNSDTVLVH RVHSYLERHG LINFGIYKRI KPLPTKKTGK VIIIGSGVSG LAAARQLQSF
     GMDVTLLEAR DRVGGRVATF RKGNYVADLG AMVVTGLGGN PMAVVSKQVN MELAKIKQKC
     PLYEANGQAV PKEKDEMVEQ EFNRLLEATS YLSHQLDFNV LNNKPVSLGQ ALEVVIQLQE
     KHVKDEQIEH WKKIVKTQEE LKELLNKMVN LKEKIKELHQ QYKEASEVKP PRDITAEFLV
     KSKHRDLTAL CKEYDELAET QGKLEEKLQE LEANPPSDVY LSSRDRQILD WHFANLEFAN
     ATPLSTLSLK HWDQDDDFEF TGSHLTVRNG YSCVPVALAE GLDIKLNTAV RQVRYTASGC
     EVIAVNTRST SQTFIYKCDA VLCTLPLGVL KQQPPAVQFV PPLPEWKTSA VQRMGFGNLN
     KVVLCFDRVF WDPSVNLFGH VGSTTASRGE LFLFWNLYKA PILLALVAGE AAGIMENISD
     DVIVGRCLAI LKGIFGSSAV PQPKETVVSR WRADPWARGS YSYVAAGSSG NDYDLMAQPI
     TPGPSIPGAP QPIPRLFFAG EHTIRNYPAT VHGALLSGLR EAGRIADQFL GAMYTLPRQA
     TPGVPAQQSP SM
//
ID   MOBA_COMTE              Reviewed;         639 AA.
AC   Q6SSJ6; Q05KQ5;
DT   01-OCT-2014, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   02-JUN-2021, entry version 66.
DE   RecName: Full=3-hydroxybenzoate 4-monooxygenase;
DE            EC=1.14.13.23;
DE   AltName: Full=3-hydroxybenzoate 4-hydroxylase;
DE   AltName: Full=M-hydroxybenzoate hydroxylase;
GN   Name=mobA;
OS   Comamonas testosteroni (Pseudomonas testosteroni).
OC   Bacteria; Proteobacteria; Betaproteobacteria; Burkholderiales;
OC   Comamonadaceae; Comamonas.
OX   NCBI_TaxID=285;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=KH122-3S;
RA   Chen R., Chaen H., Hosokawa K.;
RT   "Studies on m-hydroxybenzoate 4-hydroxylase I. Purification and
RT   properties.";
RL   Res. Commun. Biochem. Cell Mol. Biol. 1:304-322(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP   MUTAGENESIS OF ASN-227; VAL-257; GLN-292; ALA-400; ASP-416 AND LYS-429.
RC   STRAIN=GZ39;
RX   PubMed=18417078; DOI=10.1016/j.bbrc.2008.04.032;
RA   Chang H.K., Zylstra G.J.;
RT   "Examination and expansion of the substrate range of m-hydroxybenzoate
RT   hydroxylase.";
RL   Biochem. Biophys. Res. Commun. 371:149-153(2008).
RN   [3]
RP   CRYSTALLIZATION.
RC   STRAIN=KH122-3S;
RA   Chen R., Oki H., Scott R.P. Jr., Yamaguchi H., Kusunoki M., Matsuura Y.,
RA   Chaen H., Tsugita A., Hosokawa K.;
RT   "Crystallization and future characterization of meta-hydroxybenzoate 4-
RT   hydroxylase from Comamonas testosteroni.";
RL   Res. Commun. Biochem. Cell Mol. Biol. 2:253-274(1998).
RN   [4]
RP   IDENTIFICATION.
RX   PubMed=24826896; DOI=10.1371/journal.pone.0097250;
RA   Shearer A.G., Altman T., Rhee C.D.;
RT   "Finding sequences for over 270 orphan enzymes.";
RL   PLoS ONE 9:E97250-E97250(2014).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH FAD, COFACTOR, AND
RP   SUBUNIT.
RC   STRAIN=KH122-3S;
RX   PubMed=17045293; DOI=10.1016/j.jmb.2006.09.031;
RA   Hiromoto T., Fujiwara S., Hosokawa K., Yamaguchi H.;
RT   "Crystal structure of 3-hydroxybenzoate hydroxylase from Comamonas
RT   testosteroni has a large tunnel for substrate and oxygen access to the
RT   active site.";
RL   J. Mol. Biol. 364:878-896(2006).
CC   -!- FUNCTION: Converts 3-hydroxybenzoate (m-hydroxybenzoate), and to a
CC       lesser extent p-hydroxybenzoate, to 3,4-dihydroxybenzoate
CC       (protocatechuate). Also acts on a number of analogs of 3-
CC       hydroxybenzoate substituted in the 2, 4, 5 and 6 positions.
CC       {ECO:0000269|PubMed:18417078}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-hydroxybenzoate + H(+) + NADPH + O2 = 3,4-dihydroxybenzoate
CC         + H2O + NADP(+); Xref=Rhea:RHEA:11480, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16193,
CC         ChEBI:CHEBI:36241, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         EC=1.14.13.23; Evidence={ECO:0000269|PubMed:18417078};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:17045293};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:17045293}.
CC   -!- SIMILARITY: Belongs to the PheA/TfdB FAD monooxygenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY450844; AAR25885.1; -; Genomic_DNA.
DR   EMBL; EF394133; ABN58510.1; -; Genomic_DNA.
DR   EMBL; EF394138; ABN58515.1; -; Genomic_DNA.
DR   EMBL; AB119008; BAF34928.1; -; Genomic_DNA.
DR   RefSeq; WP_003074815.1; NZ_UFXL01000001.1.
DR   PDB; 2DKH; X-ray; 1.80 A; A=1-639.
DR   PDB; 2DKI; X-ray; 2.50 A; A=1-639.
DR   PDBsum; 2DKH; -.
DR   PDBsum; 2DKI; -.
DR   SMR; Q6SSJ6; -.
DR   GeneID; 60679299; -.
DR   BRENDA; 1.14.13.2; 1590.
DR   BRENDA; 1.14.13.23; 1590.
DR   GO; GO:0018668; F:3-hydroxybenzoate 4-monooxygenase activity; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   Gene3D; 3.40.30.20; -; 1.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR012941; Phe_hydrox_C_dim_dom.
DR   InterPro; IPR038220; PHOX_C_sf.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   Pfam; PF07976; Phe_hydrox_dim; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; NADP; Oxidoreductase.
FT   CHAIN           1..639
FT                   /note="3-hydroxybenzoate 4-monooxygenase"
FT                   /id="PRO_0000430458"
FT   NP_BIND         34..64
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17045293"
FT   NP_BIND         269..271
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17045293"
FT   BINDING         73
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17045293"
FT   BINDING         166
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:17045293"
FT   BINDING         212
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17045293"
FT   BINDING         317
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17045293"
FT   BINDING         349
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17045293"
FT   BINDING         365
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:17045293"
FT   MUTAGEN         227
FT                   /note="N->H: In MobA3-1; able to hydroxylate 3-aminophenol;
FT                   when associated with R-292 and A-416."
FT                   /evidence="ECO:0000269|PubMed:18417078"
FT   MUTAGEN         257
FT                   /note="V->A: Broadens the substrate range rendering it able
FT                   to transform phenol to catechol."
FT                   /evidence="ECO:0000269|PubMed:18417078"
FT   MUTAGEN         292
FT                   /note="Q->R: In MobA3-1; able to hydroxylate 3-aminophenol;
FT                   when associated with H-227 and A-416."
FT                   /evidence="ECO:0000269|PubMed:18417078"
FT   MUTAGEN         400
FT                   /note="A->G: In MobA14-1; able to hydroxylate 3-
FT                   aminophenol; when associated with R-429."
FT                   /evidence="ECO:0000269|PubMed:18417078"
FT   MUTAGEN         416
FT                   /note="D->A: In MobA3-1; able to hydroxylate 3-aminophenol;
FT                   when associated with H-227 and R-292."
FT                   /evidence="ECO:0000269|PubMed:18417078"
FT   MUTAGEN         429
FT                   /note="K->R: In MobA14-1; able to hydroxylate 3-
FT                   aminophenol; when associated with G-400."
FT                   /evidence="ECO:0000269|PubMed:18417078"
FT   CONFLICT        112
FT                   /note="A -> G (in Ref. 1; ABN58515/BAF34928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        171
FT                   /note="I -> V (in Ref. 1; ABN58515/BAF34928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        307
FT                   /note="D -> E (in Ref. 1; ABN58515/BAF34928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        331
FT                   /note="A -> V (in Ref. 1; ABN58515/BAF34928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        459
FT                   /note="S -> K (in Ref. 1; ABN58515/BAF34928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        482
FT                   /note="S -> C (in Ref. 1; ABN58515/BAF34928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        487
FT                   /note="L -> V (in Ref. 1; ABN58515/BAF34928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        506
FT                   /note="G -> A (in Ref. 1; ABN58515/BAF34928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        526
FT                   /note="S -> G (in Ref. 1; ABN58515/BAF34928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        538
FT                   /note="S -> A (in Ref. 1; ABN58515/BAF34928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        551
FT                   /note="I -> V (in Ref. 1; ABN58515/BAF34928)"
FT                   /evidence="ECO:0000305"
FT   STRAND          31..38
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           42..51
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          59..62
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          64..67
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           79..87
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           91..97
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          98..101
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          103..109
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:2DKI"
FT   STRAND          117..126
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          135..137
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           140..153
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          163..171
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          180..186
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           189..191
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          195..205
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           212..216
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          230..239
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   TURN            242..245
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          246..252
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          255..261
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          268..273
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           290..301
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          306..317
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          327..329
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          344..346
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           348..350
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           356..358
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           363..380
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           386..389
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           390..409
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           428..442
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          451..455
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           461..463
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          477..480
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   TURN            481..483
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          486..488
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           489..492
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          495..497
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          499..504
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   TURN            507..511
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           516..526
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           531..535
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          544..551
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           556..558
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           561..563
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           566..568
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   TURN            573..576
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          582..585
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           595..598
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   TURN            603..605
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          607..611
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   STRAND          615..621
FT                   /evidence="ECO:0007829|PDB:2DKH"
FT   HELIX           626..634
FT                   /evidence="ECO:0007829|PDB:2DKH"
SQ   SEQUENCE   639 AA;  70489 MW;  AB056E8831F14E58 CRC64;
     MQFHLNGFRP GNPLIAPASP LAPAHTEAVP SQVDVLIVGC GPAGLTLAAQ LAAFPDIRTC
     IVEQKEGPME LGQADGIACR TMEMFEAFEF ADSILKEACW INDVTFWKPD PAQPGRIARH
     GRVQDTEDGL SEFPHVILNQ ARVHDHYLER MRNSPSRLEP HYARRVLDVK IDHGAADYPV
     TVTLERCDAA HAGQIETVQA RYVVGCDGAR SNVRRAIGRQ LVGDSANQAW GVMDVLAVTD
     FPDVRYKVAI QSEQGNVLII PREGGHLVRF YVEMDKLDAD ERVASRNITV EQLIATAQRV
     LHPYKLDVKN VPWWSVYEIG QRICAKYDDV ADAVATPDSP LPRVFIAGDA CHTHSPKAGQ
     GMNFSMQDSF NLGWKLAAVL RKQCAPELLH TYSSERQVVA QQLIDFDREW AKMFSDPAKE
     GGQGGVDPKE FQKYFEQHGR FTAGVGTHYA PSLLTGQASH QALASGFTVG MRFHSAPVVR
     VSDAKPLQLG HCGKADGRWR LYAFAGQNDL AQPESGLLAL CRFLESDAAS PLRRFTPSGQ
     DIDSIFDLRA IFPQAYTEVA LETLPALLLP PKGQLGMIDY EKVFSPDLKN AGQDIFELRG
     IDRQQGALVV VRPDQYVAQV LPLGDHAALS AYFESFMRA
//
ID   THYX_MYCTU              Reviewed;         250 AA.
AC   P9WG57; L0TD90; O33296; P66930;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   02-JUN-2021, entry version 39.
DE   RecName: Full=Flavin-dependent thymidylate synthase {ECO:0000303|PubMed:16139296, ECO:0000303|PubMed:16730023};
DE            Short=FDTS {ECO:0000303|PubMed:21657202};
DE            EC=2.1.1.148 {ECO:0000269|PubMed:18493582};
DE   AltName: Full=FAD-dependent thymidylate synthase {ECO:0000303|PubMed:18192395};
DE   AltName: Full=Thymidylate synthase ThyX {ECO:0000303|PubMed:18493582};
DE            Short=TS {ECO:0000303|PubMed:18493582};
DE            Short=TSase {ECO:0000255|HAMAP-Rule:MF_01408};
GN   Name=thyX {ECO:0000303|PubMed:16139296}; OrderedLocusNames=Rv2754c;
GN   ORFNames=MTV002.19c;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=12657046; DOI=10.1046/j.1365-2958.2003.03425.x;
RA   Sassetti C.M., Boyd D.H., Rubin E.J.;
RT   "Genes required for mycobacterial growth defined by high density
RT   mutagenesis.";
RL   Mol. Microbiol. 48:77-84(2003).
RN   [3]
RP   IDENTIFICATION AS A DRUG TARGET [LARGE SCALE ANALYSIS].
RX   PubMed=19099550; DOI=10.1186/1752-0509-2-109;
RA   Raman K., Yeturu K., Chandra N.;
RT   "targetTB: a target identification pipeline for Mycobacterium tuberculosis
RT   through an interactome, reactome and genome-scale structural analysis.";
RL   BMC Syst. Biol. 2:109-109(2008).
RN   [4]
RP   MUTAGENESIS STUDY, AND SUBUNIT.
RC   STRAIN=H37Rv;
RX   PubMed=18192395; DOI=10.1128/jb.01094-07;
RA   Ulmer J.E., Boum Y., Thouvenel C.D., Myllykallio H., Sibley C.H.;
RT   "Functional analysis of the Mycobacterium tuberculosis FAD-dependent
RT   thymidylate synthase, ThyX, reveals new amino acid residues contributing to
RT   an extended ThyX motif.";
RL   J. Bacteriol. 190:2056-2064(2008).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY
RP   REGULATION, AND SUBUNIT.
RX   PubMed=18493582; DOI=10.1371/journal.pone.0002237;
RA   Hunter J.H., Gujjar R., Pang C.K., Rathod P.K.;
RT   "Kinetics and ligand-binding preferences of Mycobacterium tuberculosis
RT   thymidylate synthases, ThyA and ThyX.";
RL   PLoS ONE 3:E2237-E2237(2008).
RN   [6]
RP   ACTIVITY REGULATION.
RX   PubMed=21657202; DOI=10.1021/jm2004688;
RA   Koegler M., Vanderhoydonck B., De Jonghe S., Rozenski J., Van Belle K.,
RA   Herman J., Louat T., Parchina A., Sibley C., Lescrinier E., Herdewijn P.;
RT   "Synthesis and evaluation of 5-substituted 2'-deoxyuridine monophosphate
RT   analogues as inhibitors of flavin-dependent thymidylate synthase in
RT   Mycobacterium tuberculosis.";
RL   J. Med. Chem. 54:4847-4862(2011).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [8]
RP   INDUCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=H37Rv;
RX   PubMed=22034487; DOI=10.1099/mic.0.053983-0;
RA   Fivian-Hughes A.S., Houghton J., Davis E.O.;
RT   "Mycobacterium tuberculosis thymidylate synthase gene thyX is essential and
RT   potentially bifunctional, while thyA deletion confers resistance to p-
RT   aminosalicylic acid.";
RL   Microbiology 158:308-318(2012).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.01 ANGSTROMS) OF DOUBLE MUTANT MET-65/MET-175 IN
RP   COMPLEX WITH THE SUBSTRATE ANALOG 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE
RP   AND FAD, FUNCTION, COFACTOR, SUBUNIT, AND MUTAGENESIS OF ILE-65; HIS-69;
RP   ARG-95; SER-105; TYR-108; LYS-165; ARG-168 AND LEU-175.
RC   STRAIN=H37Rv;
RX   PubMed=16139296; DOI=10.1016/j.jmb.2005.07.071;
RA   Sampathkumar P., Turley S., Ulmer J.E., Rhie H.G., Sibley C.H., Hol W.G.;
RT   "Structure of the Mycobacterium tuberculosis flavin dependent thymidylate
RT   synthase (MtbThyX) at 2.0A resolution.";
RL   J. Mol. Biol. 352:1091-1104(2005).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF DOUBLE MUTANT MET-65/MET-175 IN
RP   COMPLEX WITH NADP.
RC   STRAIN=H37Rv;
RX   PubMed=16730023; DOI=10.1016/j.jmb.2006.04.061;
RA   Sampathkumar P., Turley S., Sibley C.H., Hol W.G.;
RT   "NADP+ expels both the co-factor and a substrate analog from the
RT   Mycobacterium tuberculosis ThyX active site: opportunities for anti-
RT   bacterial drug design.";
RL   J. Mol. Biol. 360:1-6(2006).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH FAD AND
RP   5-FLUORO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE.
RX   PubMed=25613812; DOI=10.1016/j.tube.2014.12.003;
RA   Baugh L., Phan I., Begley D.W., Clifton M.C., Armour B., Dranow D.M.,
RA   Taylor B.M., Muruthi M.M., Abendroth J., Fairman J.W., Fox D. III,
RA   Dieterich S.H., Staker B.L., Gardberg A.S., Choi R., Hewitt S.N.,
RA   Napuli A.J., Myers J., Barrett L.K., Zhang Y., Ferrell M., Mundt E.,
RA   Thompkins K., Tran N., Lyons-Abbott S., Abramov A., Sekar A.,
RA   Serbzhinskiy D., Lorimer D., Buchko G.W., Stacy R., Stewart L.J.,
RA   Edwards T.E., Van Voorhis W.C., Myler P.J.;
RT   "Increasing the structural coverage of tuberculosis drug targets.";
RL   Tuberculosis 95:142-148(2015).
CC   -!- FUNCTION: Catalyzes the reductive methylation of 2'-deoxyuridine-5'-
CC       monophosphate (dUMP) to 2'-deoxythymidine-5'-monophosphate (dTMP) while
CC       utilizing 5,10-methylenetetrahydrofolate (mTHF) as the methyl donor,
CC       and NADPH and FADH(2) as the reductant (PubMed:18493582). Is essential
CC       for growth of the pathogen on solid media in vitro; the essential
CC       function is something other than dTMP synthase (PubMed:12657046)
CC       (PubMed:22034487). {ECO:0000269|PubMed:12657046,
CC       ECO:0000269|PubMed:16139296, ECO:0000269|PubMed:18493582,
CC       ECO:0000269|PubMed:22034487}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6R)-5,10-methylene-5,6,7,8-tetrahydrofolate + dUMP + H(+) +
CC         NADPH = (6S)-5,6,7,8-tetrahydrofolate + dTMP + NADP(+);
CC         Xref=Rhea:RHEA:29043, ChEBI:CHEBI:15378, ChEBI:CHEBI:15636,
CC         ChEBI:CHEBI:57453, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:63528, ChEBI:CHEBI:246422; EC=2.1.1.148;
CC         Evidence={ECO:0000269|PubMed:18493582};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:16139296};
CC       Note=Binds 4 FAD per tetramer. Each FAD binding site is formed by three
CC       monomers. {ECO:0000269|PubMed:16139296};
CC   -!- ACTIVITY REGULATION: Is potently inhibited by 5-fluoro-2'-deoxyuridine
CC       5'-monophosphate (FdUMP), but in contrast to ThyA, is not inhibited by
CC       the folate-based 1843U89 (PubMed:18493582). A 5-alkynyl dUMP analog has
CC       been shown to highly inhibit ThyX (IC(50) value of 0.91 uM), while
CC       lacking activity against the classical mycobacterial thymidylate
CC       synthase ThyA, and therefore is a selective mycobacterial FDTS
CC       inhibitor (PubMed:21657202). {ECO:0000269|PubMed:18493582,
CC       ECO:0000269|PubMed:21657202}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3 uM for dUMP {ECO:0000269|PubMed:18493582};
CC         KM=4 uM for 5,10-methylenetetrahydrofolate
CC         {ECO:0000269|PubMed:18493582};
CC         KM=47 uM for NADPH {ECO:0000269|PubMed:18493582};
CC         Note=kcat is 0.4 min(-1). {ECO:0000269|PubMed:18493582};
CC   -!- PATHWAY: Pyrimidine metabolism; dTTP biosynthesis. {ECO:0000255|HAMAP-
CC       Rule:MF_01408}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:16139296,
CC       ECO:0000269|PubMed:18192395, ECO:0000269|PubMed:18493582}.
CC   -!- INDUCTION: Is expressed under the exponential phase of growth, and
CC       down-regulated upon starvation. Expression of thyX is significantly
CC       increased within murine macrophages or under acid stress. Is expressed
CC       at a lower level than thyA under all of the in vitro and in vivo growth
CC       conditions tested. {ECO:0000269|PubMed:22034487}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene display impaired growth
CC       (PubMed:12657046). Strains with a thyX deletion could not be obtained
CC       (PubMed:22034487). {ECO:0000269|PubMed:12657046,
CC       ECO:0000269|PubMed:22034487}.
CC   -!- MISCELLANEOUS: Was identified as a high-confidence drug target.
CC       {ECO:0000305|PubMed:19099550}.
CC   -!- MISCELLANEOUS: Crystallographic studies have shown that NADPH/NADP(+)
CC       binding expels both FAD and dUMP from the active site, by competing for
CC       the binding site (PubMed:16730023). However, the location of NADPH
CC       binding might not be biologically relevant (PubMed:18192395).
CC       {ECO:0000269|PubMed:16730023, ECO:0000305|PubMed:18192395}.
CC   -!- SIMILARITY: Belongs to the thymidylate synthase ThyX family.
CC       {ECO:0000255|HAMAP-Rule:MF_01408}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP45553.1; -; Genomic_DNA.
DR   PIR; A70880; A70880.
DR   RefSeq; NP_217270.1; NC_000962.3.
DR   RefSeq; WP_003899465.1; NZ_NVQJ01000020.1.
DR   PDB; 2AF6; X-ray; 2.01 A; A/B/C/D/E/F/G/H=1-250.
DR   PDB; 2GQ2; X-ray; 2.10 A; A/B/C/D=1-250.
DR   PDB; 3GWC; X-ray; 1.90 A; A/B/C/D/E/F/G/H=1-250.
DR   PDB; 3HZG; X-ray; 2.45 A; A/B/C/D=1-250.
DR   PDBsum; 2AF6; -.
DR   PDBsum; 2GQ2; -.
DR   PDBsum; 3GWC; -.
DR   PDBsum; 3HZG; -.
DR   SMR; P9WG57; -.
DR   STRING; 83332.Rv2754c; -.
DR   BindingDB; P9WG57; -.
DR   ChEMBL; CHEMBL1795161; -.
DR   PaxDb; P9WG57; -.
DR   DNASU; 887766; -.
DR   GeneID; 887766; -.
DR   KEGG; mtu:Rv2754c; -.
DR   TubercuList; Rv2754c; -.
DR   eggNOG; COG1351; Bacteria.
DR   OMA; WAKLGPR; -.
DR   PhylomeDB; P9WG57; -.
DR   BioCyc; MetaCyc:G185E-7003-MONOMER; -.
DR   BRENDA; 2.1.1.148; 3445.
DR   UniPathway; UPA00575; -.
DR   PRO; PR:P9WG57; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:MTBBASE.
DR   GO; GO:0070402; F:NADPH binding; IDA:MTBBASE.
DR   GO; GO:0050797; F:thymidylate synthase (FAD) activity; IDA:MTBBASE.
DR   GO; GO:0004799; F:thymidylate synthase activity; IDA:MTBBASE.
DR   GO; GO:0006231; P:dTMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006235; P:dTTP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.70.3180; -; 2.
DR   HAMAP; MF_01408; ThyX; 1.
DR   InterPro; IPR003669; Thymidylate_synthase_ThyX.
DR   InterPro; IPR036098; Thymidylate_synthase_ThyX_sf.
DR   PANTHER; PTHR34934; PTHR34934; 1.
DR   Pfam; PF02511; Thy1; 1.
DR   SUPFAM; SSF69796; SSF69796; 1.
DR   TIGRFAMs; TIGR02170; thyX; 1.
DR   PROSITE; PS51331; THYX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Methyltransferase; NADP;
KW   Nucleotide biosynthesis; Reference proteome; Transferase.
FT   CHAIN           1..250
FT                   /note="Flavin-dependent thymidylate synthase"
FT                   /id="PRO_0000175570"
FT   DOMAIN          7..233
FT                   /note="ThyX"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00661"
FT   NP_BIND         92..95
FT                   /note="dUMP; shared with dimeric partner"
FT                   /evidence="ECO:0000305|PubMed:16139296,
FT                   ECO:0007744|PDB:2AF6"
FT   NP_BIND         95..97
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16139296,
FT                   ECO:0007744|PDB:2AF6, ECO:0007744|PDB:3GWC,
FT                   ECO:0007744|PDB:3HZG"
FT   NP_BIND         103..107
FT                   /note="dUMP"
FT                   /evidence="ECO:0000305|PubMed:16139296,
FT                   ECO:0007744|PDB:2AF6"
FT   NP_BIND         188..190
FT                   /note="FAD; shared with neighboring subunits"
FT                   /evidence="ECO:0000269|PubMed:16139296,
FT                   ECO:0007744|PDB:2AF6, ECO:0007744|PDB:3GWC,
FT                   ECO:0007744|PDB:3HZG"
FT   MOTIF           95..105
FT                   /note="ThyX motif"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01408"
FT   ACT_SITE        199
FT                   /note="Involved in ionization of N3 of dUMP, leading to its
FT                   activation"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01408"
FT   BINDING         71
FT                   /note="FAD; shared with neighboring subunits"
FT                   /evidence="ECO:0000269|PubMed:16139296,
FT                   ECO:0007744|PDB:2AF6, ECO:0007744|PDB:3GWC,
FT                   ECO:0007744|PDB:3HZG"
FT   BINDING         87
FT                   /note="dUMP"
FT                   /evidence="ECO:0000305|PubMed:16139296,
FT                   ECO:0007744|PDB:2AF6"
FT   BINDING         103
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen; shared
FT                   with neighboring subunits"
FT                   /evidence="ECO:0000269|PubMed:16139296,
FT                   ECO:0007744|PDB:2AF6, ECO:0007744|PDB:3GWC,
FT                   ECO:0007744|PDB:3HZG"
FT   BINDING         172
FT                   /note="dUMP"
FT                   /evidence="ECO:0000305|PubMed:16139296,
FT                   ECO:0007744|PDB:2AF6"
FT   BINDING         194
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16139296,
FT                   ECO:0007744|PDB:2AF6, ECO:0007744|PDB:3GWC,
FT                   ECO:0007744|PDB:3HZG"
FT   BINDING         199
FT                   /note="dUMP; shared with dimeric partner"
FT                   /evidence="ECO:0000305|PubMed:16139296,
FT                   ECO:0007744|PDB:2AF6"
FT   MUTAGEN         65
FT                   /note="I->M: Still able to complement an E.coli thyA
FT                   deletion mutant."
FT                   /evidence="ECO:0000269|PubMed:16139296"
FT   MUTAGEN         69
FT                   /note="H->E: Loss of catalytic activity since it is not
FT                   able to complement an E.coli thyA deletion mutant."
FT                   /evidence="ECO:0000269|PubMed:16139296"
FT   MUTAGEN         95
FT                   /note="R->A,D: Loss of catalytic activity since it is not
FT                   able to complement an E.coli thyA deletion mutant."
FT                   /evidence="ECO:0000269|PubMed:16139296"
FT   MUTAGEN         95
FT                   /note="R->K: Still able to complement an E.coli thyA
FT                   deletion mutant."
FT                   /evidence="ECO:0000269|PubMed:16139296"
FT   MUTAGEN         105
FT                   /note="S->E: Loss of catalytic activity since it is not
FT                   able to complement an E.coli thyA deletion mutant."
FT                   /evidence="ECO:0000269|PubMed:16139296"
FT   MUTAGEN         108
FT                   /note="Y->F: Still able to complement an E.coli thyA
FT                   deletion mutant."
FT                   /evidence="ECO:0000269|PubMed:16139296"
FT   MUTAGEN         165
FT                   /note="K->A: Loss of catalytic activity since it is not
FT                   able to complement an E.coli thyA deletion mutant."
FT                   /evidence="ECO:0000269|PubMed:16139296"
FT   MUTAGEN         168
FT                   /note="R->A: Loss of catalytic activity since it is not
FT                   able to complement an E.coli thyA deletion mutant."
FT                   /evidence="ECO:0000269|PubMed:16139296"
FT   MUTAGEN         175
FT                   /note="L->M: Still able to complement an E.coli thyA
FT                   deletion mutant."
FT                   /evidence="ECO:0000269|PubMed:16139296"
FT   STRAND          8..17
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   HELIX           31..44
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   HELIX           52..54
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   HELIX           57..66
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   HELIX           70..75
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   STRAND          77..86
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   HELIX           87..93
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   STRAND          99..103
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   TURN            106..108
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:2GQ2"
FT   HELIX           120..122
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   HELIX           126..154
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   HELIX           160..171
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   HELIX           172..174
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   STRAND          179..188
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   HELIX           189..199
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   STRAND          200..204
FT                   /evidence="ECO:0007829|PDB:3HZG"
FT   HELIX           206..222
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   TURN            224..226
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   STRAND          231..234
FT                   /evidence="ECO:0007829|PDB:3GWC"
FT   STRAND          240..243
FT                   /evidence="ECO:0007829|PDB:3GWC"
SQ   SEQUENCE   250 AA;  27591 MW;  7BACFA59B5DA7294 CRC64;
     MAETAPLRVQ LIAKTDFLAP PDVPWTTDAD GGPALVEFAG RACYQSWSKP NPKTATNAGY
     LRHIIDVGHF SVLEHASVSF YITGISRSCT HELIRHRHFS YSQLSQRYVP EKDSRVVVPP
     GMEDDADLRH ILTEAADAAR ATYSELLAKL EAKFADQPNA ILRRKQARQA ARAVLPNATE
     TRIVVTGNYR AWRHFIAMRA SEHADVEIRR LAIECLRQLA AVAPAVFADF EVTTLADGTE
     VATSPLATEA
//
ID   TRXB_MYCTU              Reviewed;         335 AA.
AC   P9WHH1; L0TFM3; O53592; P52214;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   02-JUN-2021, entry version 44.
DE   RecName: Full=Thioredoxin reductase {ECO:0000303|Ref.1};
DE            Short=TR;
DE            Short=TRXR;
DE            EC=1.8.1.9 {ECO:0000269|PubMed:16301794};
GN   Name=trxB;
GN   Synonyms=trxB2 {ECO:0000303|PubMed:11567012, ECO:0000303|PubMed:9634230},
GN   trxR {ECO:0000303|PubMed:16301794}; OrderedLocusNames=Rv3913;
GN   ORFNames=MTV028.04;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Wieles B., Phillip W., Drijfhout J.W., Offringa R., Ottenhoff T.H.M.;
RT   "Sequence analysis and functional characterization of thioredoxin and
RT   thioredoxin reductase of Mycobacterium tuberculosis.";
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [3]
RP   INDUCTION BY SIGH.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=11567012; DOI=10.1128/jb.183.20.6119-6125.2001;
RA   Raman S., Song T., Puyang X., Bardarov S., Jacobs W.R. Jr., Husson R.N.;
RT   "The alternative sigma factor SigH regulates major components of oxidative
RT   and heat stress responses in Mycobacterium tuberculosis.";
RL   J. Bacteriol. 183:6119-6125(2001).
RN   [4]
RP   IDENTIFICATION AS A DRUG TARGET [LARGE SCALE ANALYSIS].
RX   PubMed=19099550; DOI=10.1186/1752-0509-2-109;
RA   Raman K., Yeturu K., Chandra N.;
RT   "targetTB: a target identification pipeline for Mycobacterium tuberculosis
RT   through an interactome, reactome and genome-scale structural analysis.";
RL   BMC Syst. Biol. 2:109-109(2008).
RN   [5]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=27249779; DOI=10.1371/journal.ppat.1005675;
RA   Lin K., O'Brien K.M., Trujillo C., Wang R., Wallach J.B., Schnappinger D.,
RA   Ehrt S.;
RT   "Mycobacterium tuberculosis thioredoxin reductase is essential for thiol
RT   redox homeostasis but plays a minor role in antioxidant defense.";
RL   PLoS Pathog. 12:e1005675-e1005675(2016).
RN   [7]
RP   PHOSPHORYLATION AT TYR-32, AND MUTAGENESIS OF TYR-32.
RX   PubMed=29317718; DOI=10.1038/s41598-017-18547-9;
RA   Wong D., Li W., Chao J.D., Zhou P., Narula G., Tsui C., Ko M., Xie J.,
RA   Martinez-Frailes C., Av-Gay Y.;
RT   "Protein tyrosine kinase, PtkA, is required for Mycobacterium tuberculosis
RT   growth in macrophages.";
RL   Sci. Rep. 8:155-155(2018).
RN   [8] {ECO:0007744|PDB:2A87}
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) IN COMPLEX WITH FAD AND NADP,
RP   CATALYTIC ACTIVITY, COFACTOR, SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=16301794; DOI=10.1107/s0907444905030519;
RA   Akif M., Suhre K., Verma C., Mande S.C.;
RT   "Conformational flexibility of Mycobacterium tuberculosis thioredoxin
RT   reductase: crystal structure and normal-mode analysis.";
RL   Acta Crystallogr. D 61:1603-1611(2005).
CC   -!- FUNCTION: Essential thiol-reducing enzyme that protects the cell from
CC       thiol-specific oxidizing stress. Plays a minor role in defense against
CC       oxidative and nitrosative stress. Is essential to establish and
CC       maintain infection in mice. {ECO:0000269|PubMed:27249779}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[thioredoxin]-dithiol + NADP(+) = [thioredoxin]-disulfide +
CC         H(+) + NADPH; Xref=Rhea:RHEA:20345, Rhea:RHEA-COMP:10698, Rhea:RHEA-
CC         COMP:10700, ChEBI:CHEBI:15378, ChEBI:CHEBI:29950, ChEBI:CHEBI:50058,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.8.1.9;
CC         Evidence={ECO:0000269|PubMed:16301794};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:16301794};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:16301794};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:16301794}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- INDUCTION: Expressed following oxidative stress under control of SigH.
CC       {ECO:0000269|PubMed:11567012}.
CC   -!- PTM: Phosphorylated on Tyr-32 by PtkA. {ECO:0000269|PubMed:29317718}.
CC   -!- DISRUPTION PHENOTYPE: Essential, a deletion mutant cannot be isolated.
CC       TrxB depletion inhibits mycobacterial growth and causes lytic death of
CC       the cells. Depletion affects growth-essential processes, including
CC       sulfur and DNA metabolism. Partially depleted cells are highly
CC       susceptible to thiol-specific oxidizing stress, but not to peroxide and
CC       reactive nitrogen species. Depleted cells are highly susceptible to the
CC       cell wall biosynthesis inhibitors vancomycin and moenomycin. In vivo,
CC       depletion of TrxB results in clearance of M.tuberculosis during both
CC       the acute and chronic phases of infection.
CC       {ECO:0000269|PubMed:27249779}.
CC   -!- MISCELLANEOUS: The active site is a redox-active disulfide bond.
CC       {ECO:0000269|PubMed:16301794}.
CC   -!- MISCELLANEOUS: Was identified as a high-confidence drug target.
CC       {ECO:0000269|PubMed:19099550}.
CC   -!- SIMILARITY: Belongs to the class-II pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X95798; CAA65070.1; -; Genomic_DNA.
DR   EMBL; AL123456; CCP46742.1; -; Genomic_DNA.
DR   PIR; A70851; A70851.
DR   RefSeq; NP_218430.1; NC_000962.3.
DR   RefSeq; WP_003900782.1; NZ_NVQJ01000005.1.
DR   PDB; 2A87; X-ray; 3.00 A; A/B=1-335.
DR   PDBsum; 2A87; -.
DR   SMR; P9WHH1; -.
DR   STRING; 83332.Rv3913; -.
DR   BindingDB; P9WHH1; -.
DR   ChEMBL; CHEMBL2390811; -.
DR   iPTMnet; P9WHH1; -.
DR   PaxDb; P9WHH1; -.
DR   DNASU; 886232; -.
DR   GeneID; 45427913; -.
DR   GeneID; 886232; -.
DR   KEGG; mtu:Rv3913; -.
DR   TubercuList; Rv3913; -.
DR   eggNOG; COG0492; Bacteria.
DR   OMA; VDNFPGY; -.
DR   PhylomeDB; P9WHH1; -.
DR   Reactome; R-HSA-1222541; Cell redox homeostasis.
DR   PRO; PR:P9WHH1; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:MTBBASE.
DR   GO; GO:0070402; F:NADPH binding; IDA:MTBBASE.
DR   GO; GO:0015035; F:protein disulfide oxidoreductase activity; IDA:MTBBASE.
DR   GO; GO:0004791; F:thioredoxin-disulfide reductase activity; IDA:MTBBASE.
DR   GO; GO:0045454; P:cell redox homeostasis; IDA:MTBBASE.
DR   GO; GO:0019430; P:removal of superoxide radicals; IEA:InterPro.
DR   GO; GO:0001666; P:response to hypoxia; IEP:MTBBASE.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR008255; Pyr_nucl-diS_OxRdtase_2_AS.
DR   InterPro; IPR005982; Thioredox_Rdtase.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR01292; TRX_reduct; 1.
DR   PROSITE; PS00573; PYRIDINE_REDOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Disulfide bond; FAD; Flavoprotein;
KW   NADP; Oxidoreductase; Phosphoprotein; Redox-active center;
KW   Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:21969609"
FT   CHAIN           2..335
FT                   /note="Thioredoxin reductase"
FT                   /id="PRO_0000166741"
FT   NP_BIND         22..25
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16301794,
FT                   ECO:0007744|PDB:2A87"
FT   NP_BIND         44..51
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16301794,
FT                   ECO:0007744|PDB:2A87"
FT   NP_BIND         295..298
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16301794,
FT                   ECO:0007744|PDB:2A87"
FT   BINDING         60
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16301794,
FT                   ECO:0007744|PDB:2A87"
FT   BINDING         93
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:16301794,
FT                   ECO:0007744|PDB:2A87"
FT   BINDING         166
FT                   /note="NADP; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:16301794,
FT                   ECO:0007744|PDB:2A87"
FT   BINDING         185
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:16301794,
FT                   ECO:0007744|PDB:2A87"
FT   BINDING         191
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:16301794,
FT                   ECO:0007744|PDB:2A87"
FT   BINDING         248
FT                   /note="NADP; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:16301794,
FT                   ECO:0007744|PDB:2A87"
FT   BINDING         268
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:16301794,
FT                   ECO:0007744|PDB:2A87"
FT   BINDING         288
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16301794,
FT                   ECO:0007744|PDB:2A87"
FT   BINDING         295
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:16301794,
FT                   ECO:0007744|PDB:2A87"
FT   MOD_RES         2
FT                   /note="N-acetylthreonine"
FT                   /evidence="ECO:0007744|PubMed:21969609"
FT   MOD_RES         32
FT                   /note="Phosphotyrosine; by PtkA"
FT                   /evidence="ECO:0000269|PubMed:29317718"
FT   DISULFID        145..148
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:16301794"
FT   MUTAGEN         32
FT                   /note="Y->A: Significantly reduces phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:29317718"
FT   CONFLICT        125
FT                   /note="A -> R (in Ref. 1; CAA65070)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        215
FT                   /note="V -> C (in Ref. 1; CAA65070)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        228
FT                   /note="V -> Y (in Ref. 1; CAA65070)"
FT                   /evidence="ECO:0000305"
FT   STRAND          15..20
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   HELIX           23..35
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          41..43
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   HELIX           51..53
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   HELIX           70..83
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          87..89
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          93..97
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          99..107
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          112..120
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          124..126
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   HELIX           133..136
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   TURN            139..141
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          142..144
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   HELIX           146..149
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   HELIX           150..153
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          157..161
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   HELIX           165..174
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   TURN            175..177
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          179..184
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          186..189
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   HELIX           196..202
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          206..209
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          211..218
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          220..222
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          225..231
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          237..239
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          244..246
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          250..252
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   TURN            255..257
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          275..277
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   STRAND          283..285
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   HELIX           287..289
FT                   /evidence="ECO:0007829|PDB:2A87"
FT   HELIX           297..320
FT                   /evidence="ECO:0007829|PDB:2A87"
SQ   SEQUENCE   335 AA;  35643 MW;  3D0DD581E6C187E2 CRC64;
     MTAPPVHDRA HHPVRDVIVI GSGPAGYTAA LYAARAQLAP LVFEGTSFGG ALMTTTDVEN
     YPGFRNGITG PELMDEMREQ ALRFGADLRM EDVESVSLHG PLKSVVTADG QTHRARAVIL
     AMGAAARYLQ VPGEQELLGR GVSSCATCDG FFFRDQDIAV IGGGDSAMEE ATFLTRFARS
     VTLVHRRDEF RASKIMLDRA RNNDKIRFLT NHTVVAVDGD TTVTGLRVRD TNTGAETTLP
     VTGVFVAIGH EPRSGLVREA IDVDPDGYVL VQGRTTSTSL PGVFAAGDLV DRTYRQAVTA
     AGSGCAAAID AERWLAEHAA TGEADSTDAL IGAQR
//
ID   KDM1B_HUMAN             Reviewed;         822 AA.
AC   Q8NB78; A2A2C5; A2A2C6; Q5TGV3; Q6AI15; Q6ZUU4; Q8N258; Q96EL7;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   02-JUN-2021, entry version 158.
DE   RecName: Full=Lysine-specific histone demethylase 1B;
DE            EC=1.14.99.66 {ECO:0000269|PubMed:23260659, ECO:0000269|PubMed:23357850};
DE   AltName: Full=Flavin-containing amine oxidase domain-containing protein 1;
DE   AltName: Full=Lysine-specific histone demethylase 2;
GN   Name=KDM1B; Synonyms=AOF1, C6orf193, LSD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 185-822 (ISOFORM 1).
RC   TISSUE=Brain, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 624-822 (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17 AND SER-247, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13; SER-17; SER-26 AND
RP   SER-247, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.13 ANGSTROMS) OF 30-822 IN COMPLEX WITH HISTONE H3
RP   ANALOG PEPTIDE; FAD AND ZINC, AND MUTAGENESIS OF 48-LYS-LYS-49;
RP   51-ARG-LYS-52; CYS-53; TRP-82; HIS-84; HIS-90; ARG-101; 114-LYS-LYS-115;
RP   TRP-139; TRP-150; ARG-151; CYS-185; 318-TRP-TYR-319; 340-LEU-VAL-341;
RP   361-LEU-ILE-362; 443-ILE-ASN-444; ASN-542; LEU-543; CYS-547; TRP-559 AND
RP   TYR-767.
RX   PubMed=23266887; DOI=10.1038/cr.2012.177;
RA   Zhang Q., Qi S., Xu M., Yu L., Tao Y., Deng Z., Wu W., Li J., Chen Z.,
RA   Wong J.;
RT   "Structure-function analysis reveals a novel mechanism for regulation of
RT   histone demethylase LSD2/AOF1/KDM1b.";
RL   Cell Res. 23:225-241(2013).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.99 ANGSTROMS) OF 51-822 IN COMPLEX WITH FAD AND
RP   ZINC, FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF 273-TYR--CYS-278;
RP   285-ARG--ASP-287; GLU-563 AND LYS-661.
RX   PubMed=23357850; DOI=10.1038/cr.2013.17;
RA   Chen F., Yang H., Dong Z., Fang J., Wang P., Zhu T., Gong W., Fang R.,
RA   Shi Y.G., Li Z., Xu Y.;
RT   "Structural insight into substrate recognition by histone demethylase
RT   LSD2/KDM1b.";
RL   Cell Res. 23:306-309(2013).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 51-822 IN COMPLEX WITH GLYR1;
RP   HISTONE H3 PEPTIDE; FAD; ZINC AND FAD ANALOG, FUNCTION, CATALYTIC ACTIVITY,
RP   INTERACTION WITH GLYR1, AND ACTIVITY REGULATION.
RX   PubMed=23260659; DOI=10.1016/j.molcel.2012.11.019;
RA   Fang R., Chen F., Dong Z., Hu D., Barbera A.J., Clark E.A., Fang J.,
RA   Yang Y., Mei P., Rutenberg M., Li Z., Zhang Y., Xu Y., Yang H., Wang P.,
RA   Simon M.D., Zhou Q., Li J., Marynick M.P., Li X., Lu H., Kaiser U.B.,
RA   Kingston R.E., Xu Y., Shi Y.G.;
RT   "LSD2/KDM1B and its cofactor NPAC/GLYR1 endow a structural and molecular
RT   model for regulation of H3K4 demethylation.";
RL   Mol. Cell 49:558-570(2013).
CC   -!- FUNCTION: Histone demethylase that demethylates 'Lys-4' of histone H3,
CC       a specific tag for epigenetic transcriptional activation, thereby
CC       acting as a corepressor. Required for de novo DNA methylation of a
CC       subset of imprinted genes during oogenesis. Acts by oxidizing the
CC       substrate by FAD to generate the corresponding imine that is
CC       subsequently hydrolyzed. Demethylates both mono- and di-methylated
CC       'Lys-4' of histone H3. Has no effect on tri-methylated 'Lys-4', mono-,
CC       di- or tri-methylated 'Lys-9', mono-, di- or tri-methylated 'Lys-27',
CC       mono-, di- or tri-methylated 'Lys-36' of histone H3, or on mono-,
CC       di- or tri-methylated 'Lys-20' of histone H4.
CC       {ECO:0000269|PubMed:23260659, ECO:0000269|PubMed:23357850}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 A + 2 H2O + N(6),N(6)-dimethyl-L-lysyl(4)-[histone H3] = 2
CC         AH2 + 2 formaldehyde + L-lysyl(4)-[histone H3]; Xref=Rhea:RHEA:60244,
CC         Rhea:RHEA-COMP:15540, Rhea:RHEA-COMP:15547, ChEBI:CHEBI:13193,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:16842, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:29969, ChEBI:CHEBI:61976; EC=1.14.99.66;
CC         Evidence={ECO:0000269|PubMed:23260659, ECO:0000269|PubMed:23357850};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:23260659, ECO:0000269|PubMed:23266887,
CC         ECO:0000269|PubMed:23357850};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:23260659, ECO:0000269|PubMed:23266887,
CC         ECO:0000269|PubMed:23357850};
CC       Note=Binds 3 Zn(2+) ions per subunit. {ECO:0000269|PubMed:23260659,
CC       ECO:0000269|PubMed:23266887, ECO:0000269|PubMed:23357850};
CC   -!- ACTIVITY REGULATION: Histone H3K4me1 and H3K4me2 demethylase activity
CC       is enhanced by GLYR1. {ECO:0000269|PubMed:23260659}.
CC   -!- SUBUNIT: Does not form a complex with RCOR1/CoREST (By similarity).
CC       Interacts with its cofactor GLYR1 at nucleosomes; this interaction
CC       stimulates H3K4me1 and H3K4me2 demethylation (PubMed:23260659).
CC       {ECO:0000250, ECO:0000269|PubMed:23260659}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8NB78-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NB78-2; Sequence=VSP_019964, VSP_019965;
CC       Name=4;
CC         IsoId=Q8NB78-4; Sequence=VSP_019963;
CC   -!- DOMAIN: The SWIRM domain may act as an anchor site for a histone tail.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the flavin monoamine oxidase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC03663.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK091217; BAC03612.1; -; mRNA.
DR   EMBL; AK091428; BAC03663.1; ALT_INIT; mRNA.
DR   EMBL; AK125318; BAC86124.1; -; mRNA.
DR   EMBL; AL031774; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL589723; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471087; EAW55401.1; -; Genomic_DNA.
DR   EMBL; CR627410; CAH10499.1; -; mRNA.
DR   CCDS; CCDS34343.1; -. [Q8NB78-2]
DR   RefSeq; NP_694587.3; NM_153042.3. [Q8NB78-2]
DR   RefSeq; XP_005248983.1; XM_005248926.1.
DR   PDB; 4FWE; X-ray; 2.13 A; A=30-822.
DR   PDB; 4FWF; X-ray; 2.70 A; A=30-822.
DR   PDB; 4FWJ; X-ray; 2.90 A; A/B=30-822.
DR   PDB; 4GU0; X-ray; 3.10 A; A/B/C/D=51-822.
DR   PDB; 4GU1; X-ray; 2.94 A; A/B=51-822.
DR   PDB; 4GUR; X-ray; 2.51 A; A=51-822.
DR   PDB; 4GUS; X-ray; 2.23 A; A=51-822.
DR   PDB; 4GUT; X-ray; 2.00 A; A=51-822.
DR   PDB; 4GUU; X-ray; 2.30 A; A=51-822.
DR   PDB; 4HSU; X-ray; 1.99 A; A=51-822.
DR   PDB; 6R1U; EM; 4.36 A; K=51-822.
DR   PDB; 6R25; EM; 4.61 A; K=51-822.
DR   PDBsum; 4FWE; -.
DR   PDBsum; 4FWF; -.
DR   PDBsum; 4FWJ; -.
DR   PDBsum; 4GU0; -.
DR   PDBsum; 4GU1; -.
DR   PDBsum; 4GUR; -.
DR   PDBsum; 4GUS; -.
DR   PDBsum; 4GUT; -.
DR   PDBsum; 4GUU; -.
DR   PDBsum; 4HSU; -.
DR   PDBsum; 6R1U; -.
DR   PDBsum; 6R25; -.
DR   SASBDB; Q8NB78; -.
DR   SMR; Q8NB78; -.
DR   BioGRID; 128743; 42.
DR   IntAct; Q8NB78; 23.
DR   STRING; 9606.ENSP00000297792; -.
DR   BindingDB; Q8NB78; -.
DR   ChEMBL; CHEMBL1938208; -.
DR   DrugCentral; Q8NB78; -.
DR   iPTMnet; Q8NB78; -.
DR   PhosphoSitePlus; Q8NB78; -.
DR   BioMuta; KDM1B; -.
DR   DMDM; 317373434; -.
DR   EPD; Q8NB78; -.
DR   jPOST; Q8NB78; -.
DR   MassIVE; Q8NB78; -.
DR   MaxQB; Q8NB78; -.
DR   PaxDb; Q8NB78; -.
DR   PeptideAtlas; Q8NB78; -.
DR   PRIDE; Q8NB78; -.
DR   ProteomicsDB; 72745; -. [Q8NB78-1]
DR   ProteomicsDB; 72746; -. [Q8NB78-2]
DR   ProteomicsDB; 72747; -. [Q8NB78-4]
DR   Antibodypedia; 25190; 150 antibodies.
DR   DNASU; 221656; -.
DR   Ensembl; ENST00000297792; ENSP00000297792; ENSG00000165097. [Q8NB78-2]
DR   Ensembl; ENST00000650836; ENSP00000499208; ENSG00000165097. [Q8NB78-1]
DR   GeneID; 221656; -.
DR   KEGG; hsa:221656; -.
DR   UCSC; uc003ncn.2; human. [Q8NB78-1]
DR   CTD; 221656; -.
DR   DisGeNET; 221656; -.
DR   GeneCards; KDM1B; -.
DR   HGNC; HGNC:21577; KDM1B.
DR   HPA; ENSG00000165097; Low tissue specificity.
DR   MIM; 613081; gene.
DR   neXtProt; NX_Q8NB78; -.
DR   OpenTargets; ENSG00000165097; -.
DR   PharmGKB; PA162379723; -.
DR   PharmGKB; PA165617946; -.
DR   VEuPathDB; HostDB:ENSG00000165097.13; -.
DR   eggNOG; KOG0029; Eukaryota.
DR   GeneTree; ENSGT00940000157751; -.
DR   InParanoid; Q8NB78; -.
DR   OrthoDB; 1034142at2759; -.
DR   PhylomeDB; Q8NB78; -.
DR   TreeFam; TF352593; -.
DR   BioCyc; MetaCyc:ENSG00000165097-MONOMER; -.
DR   PathwayCommons; Q8NB78; -.
DR   Reactome; R-HSA-3214842; HDMs demethylate histones.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-9029569; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux.
DR   BioGRID-ORCS; 221656; 14 hits in 999 CRISPR screens.
DR   ChiTaRS; KDM1B; human.
DR   GenomeRNAi; 221656; -.
DR   Pharos; Q8NB78; Tbio.
DR   PRO; PR:Q8NB78; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q8NB78; protein.
DR   Bgee; ENSG00000165097; Expressed in secondary oocyte and 205 other tissues.
DR   ExpressionAtlas; Q8NB78; baseline and differential.
DR   Genevisible; Q8NB78; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000786; C:nucleosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:0042393; F:histone binding; IDA:UniProtKB.
DR   GO; GO:0034648; F:histone demethylase activity (H3-dimethyl-K4 specific); IDA:UniProtKB.
DR   GO; GO:0034649; F:histone demethylase activity (H3-monomethyl-K4 specific); IDA:UniProtKB.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0008134; F:transcription factor binding; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0034720; P:histone H3-K4 demethylation; IDA:UniProtKB.
DR   GO; GO:0030522; P:intracellular receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0044030; P:regulation of DNA methylation; ISS:UniProtKB.
DR   GO; GO:0006349; P:regulation of gene expression by genetic imprinting; ISS:UniProtKB.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 3.50.50.60; -; 1.
DR   IDEAL; IID00487; -.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR007526; SWIRM.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR011124; Znf_CW.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   Pfam; PF04433; SWIRM; 1.
DR   Pfam; PF07496; zf-CW; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   PROSITE; PS50934; SWIRM; 1.
DR   PROSITE; PS51050; ZF_CW; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromatin regulator;
KW   Developmental protein; FAD; Flavoprotein; Metal-binding; Nucleus;
KW   Oxidoreductase; Phosphoprotein; Reference proteome; Repressor;
KW   Transcription; Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..822
FT                   /note="Lysine-specific histone demethylase 1B"
FT                   /id="PRO_0000247336"
FT   DOMAIN          275..373
FT                   /note="SWIRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00247"
FT   ZN_FING         133..193
FT                   /note="CW-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00454"
FT   NP_BIND         383..439
FT                   /note="FAD"
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:23260659,
FT                   ECO:0000269|PubMed:23266887, ECO:0000269|PubMed:23357850,
FT                   ECO:0007744|PDB:4FWE, ECO:0007744|PDB:4FWF,
FT                   ECO:0007744|PDB:4FWJ, ECO:0007744|PDB:4GU0,
FT                   ECO:0007744|PDB:4GU1, ECO:0007744|PDB:4GUR,
FT                   ECO:0007744|PDB:4GUS, ECO:0007744|PDB:4GUT,
FT                   ECO:0007744|PDB:4GUU, ECO:0007744|PDB:4HSU"
FT   NP_BIND         803..805
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0000269|PubMed:23266887, ECO:0000269|PubMed:23357850,
FT                   ECO:0007744|PDB:4FWE, ECO:0007744|PDB:4FWF,
FT                   ECO:0007744|PDB:4FWJ, ECO:0007744|PDB:4GU0,
FT                   ECO:0007744|PDB:4GU1, ECO:0007744|PDB:4GUR,
FT                   ECO:0007744|PDB:4GUS, ECO:0007744|PDB:4GUT,
FT                   ECO:0007744|PDB:4GUU, ECO:0007744|PDB:4HSU"
FT   REGION          1..47
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          273..292
FT                   /note="GLYR1-binding"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0007744|PDB:4GUR, ECO:0007744|PDB:4GUS,
FT                   ECO:0007744|PDB:4GUT, ECO:0007744|PDB:4GUU"
FT   REGION          438..467
FT                   /note="Histone H3-binding"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0000269|PubMed:23266887, ECO:0007744|PDB:4FWF,
FT                   ECO:0007744|PDB:4GUR, ECO:0007744|PDB:4GUS"
FT   REGION          487..498
FT                   /note="Histone H3-binding"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0000269|PubMed:23266887, ECO:0007744|PDB:4FWF,
FT                   ECO:0007744|PDB:4GUR, ECO:0007744|PDB:4GUS"
FT   REGION          538..572
FT                   /note="Histone H3-binding"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0000269|PubMed:23266887, ECO:0007744|PDB:4FWF,
FT                   ECO:0007744|PDB:4GUR, ECO:0007744|PDB:4GUS"
FT   REGION          564..566
FT                   /note="GLYR1-binding"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0007744|PDB:4GUR, ECO:0007744|PDB:4GUS,
FT                   ECO:0007744|PDB:4GUT, ECO:0007744|PDB:4GUU"
FT   REGION          798..814
FT                   /note="GLYR1-binding"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0007744|PDB:4GUR, ECO:0007744|PDB:4GUS,
FT                   ECO:0007744|PDB:4GUT, ECO:0007744|PDB:4GUU"
FT   COMPBIAS        29..47
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   METAL           53
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0000269|PubMed:23266887, ECO:0000269|PubMed:23357850,
FT                   ECO:0007744|PDB:4FWE, ECO:0007744|PDB:4FWF,
FT                   ECO:0007744|PDB:4FWJ, ECO:0007744|PDB:4GU0,
FT                   ECO:0007744|PDB:4GU1, ECO:0007744|PDB:4GUR,
FT                   ECO:0007744|PDB:4GUS, ECO:0007744|PDB:4GUT,
FT                   ECO:0007744|PDB:4GUU, ECO:0007744|PDB:4HSU"
FT   METAL           58
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0000269|PubMed:23266887, ECO:0000269|PubMed:23357850,
FT                   ECO:0007744|PDB:4FWE, ECO:0007744|PDB:4FWF,
FT                   ECO:0007744|PDB:4FWJ, ECO:0007744|PDB:4GU0,
FT                   ECO:0007744|PDB:4GU1, ECO:0007744|PDB:4GUR,
FT                   ECO:0007744|PDB:4GUS, ECO:0007744|PDB:4GUT,
FT                   ECO:0007744|PDB:4GUU, ECO:0007744|PDB:4HSU"
FT   METAL           65
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0000269|PubMed:23266887, ECO:0000269|PubMed:23357850,
FT                   ECO:0007744|PDB:4FWE, ECO:0007744|PDB:4FWF,
FT                   ECO:0007744|PDB:4FWJ, ECO:0007744|PDB:4GU0,
FT                   ECO:0007744|PDB:4GU1, ECO:0007744|PDB:4GUR,
FT                   ECO:0007744|PDB:4GUS, ECO:0007744|PDB:4GUT,
FT                   ECO:0007744|PDB:4GUU, ECO:0007744|PDB:4HSU"
FT   METAL           73
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0000269|PubMed:23266887, ECO:0000269|PubMed:23357850,
FT                   ECO:0007744|PDB:4FWE, ECO:0007744|PDB:4FWF,
FT                   ECO:0007744|PDB:4FWJ, ECO:0007744|PDB:4GU0,
FT                   ECO:0007744|PDB:4GU1, ECO:0007744|PDB:4GUR,
FT                   ECO:0007744|PDB:4GUS, ECO:0007744|PDB:4GUT,
FT                   ECO:0007744|PDB:4GUU, ECO:0007744|PDB:4HSU"
FT   METAL           84
FT                   /note="Zinc 1; via pros nitrogen"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0000269|PubMed:23266887, ECO:0000269|PubMed:23357850,
FT                   ECO:0007744|PDB:4FWE, ECO:0007744|PDB:4FWF,
FT                   ECO:0007744|PDB:4FWJ, ECO:0007744|PDB:4GU0,
FT                   ECO:0007744|PDB:4GU1, ECO:0007744|PDB:4GUR,
FT                   ECO:0007744|PDB:4GUS, ECO:0007744|PDB:4GUT,
FT                   ECO:0007744|PDB:4GUU, ECO:0007744|PDB:4HSU"
FT   METAL           90
FT                   /note="Zinc 1; via tele nitrogen"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0000269|PubMed:23266887, ECO:0000269|PubMed:23357850,
FT                   ECO:0007744|PDB:4FWE, ECO:0007744|PDB:4FWF,
FT                   ECO:0007744|PDB:4FWJ, ECO:0007744|PDB:4GU0,
FT                   ECO:0007744|PDB:4GU1, ECO:0007744|PDB:4GUR,
FT                   ECO:0007744|PDB:4GUS, ECO:0007744|PDB:4GUT,
FT                   ECO:0007744|PDB:4GUU, ECO:0007744|PDB:4HSU"
FT   METAL           92
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0000269|PubMed:23266887, ECO:0000269|PubMed:23357850,
FT                   ECO:0007744|PDB:4FWE, ECO:0007744|PDB:4FWF,
FT                   ECO:0007744|PDB:4FWJ, ECO:0007744|PDB:4GU0,
FT                   ECO:0007744|PDB:4GU1, ECO:0007744|PDB:4GUR,
FT                   ECO:0007744|PDB:4GUS, ECO:0007744|PDB:4GUT,
FT                   ECO:0007744|PDB:4GUU, ECO:0007744|PDB:4HSU"
FT   METAL           95
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0000269|PubMed:23266887, ECO:0000269|PubMed:23357850,
FT                   ECO:0007744|PDB:4FWE, ECO:0007744|PDB:4FWF,
FT                   ECO:0007744|PDB:4FWJ, ECO:0007744|PDB:4GU0,
FT                   ECO:0007744|PDB:4GU1, ECO:0007744|PDB:4GUR,
FT                   ECO:0007744|PDB:4GUS, ECO:0007744|PDB:4GUT,
FT                   ECO:0007744|PDB:4GUU, ECO:0007744|PDB:4HSU"
FT   METAL           142
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00454,
FT                   ECO:0000269|PubMed:23260659, ECO:0000269|PubMed:23266887,
FT                   ECO:0000269|PubMed:23357850, ECO:0007744|PDB:4FWE,
FT                   ECO:0007744|PDB:4FWF, ECO:0007744|PDB:4FWJ,
FT                   ECO:0007744|PDB:4GU0, ECO:0007744|PDB:4GU1,
FT                   ECO:0007744|PDB:4GUR, ECO:0007744|PDB:4GUS,
FT                   ECO:0007744|PDB:4GUT, ECO:0007744|PDB:4GUU,
FT                   ECO:0007744|PDB:4HSU"
FT   METAL           147
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00454,
FT                   ECO:0000269|PubMed:23260659, ECO:0000269|PubMed:23266887,
FT                   ECO:0000269|PubMed:23357850, ECO:0007744|PDB:4FWE,
FT                   ECO:0007744|PDB:4FWF, ECO:0007744|PDB:4FWJ,
FT                   ECO:0007744|PDB:4GU0, ECO:0007744|PDB:4GU1,
FT                   ECO:0007744|PDB:4GUR, ECO:0007744|PDB:4GUS,
FT                   ECO:0007744|PDB:4GUT, ECO:0007744|PDB:4GUU,
FT                   ECO:0007744|PDB:4HSU"
FT   METAL           169
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00454,
FT                   ECO:0000269|PubMed:23260659, ECO:0000269|PubMed:23266887,
FT                   ECO:0000269|PubMed:23357850, ECO:0007744|PDB:4FWE,
FT                   ECO:0007744|PDB:4FWF, ECO:0007744|PDB:4FWJ,
FT                   ECO:0007744|PDB:4GU0, ECO:0007744|PDB:4GU1,
FT                   ECO:0007744|PDB:4GUR, ECO:0007744|PDB:4GUS,
FT                   ECO:0007744|PDB:4GUT, ECO:0007744|PDB:4GUU,
FT                   ECO:0007744|PDB:4HSU"
FT   METAL           185
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00454,
FT                   ECO:0000269|PubMed:23260659, ECO:0000269|PubMed:23266887,
FT                   ECO:0000269|PubMed:23357850, ECO:0007744|PDB:4FWE,
FT                   ECO:0007744|PDB:4FWF, ECO:0007744|PDB:4FWJ,
FT                   ECO:0007744|PDB:4GU0, ECO:0007744|PDB:4GU1,
FT                   ECO:0007744|PDB:4GUR, ECO:0007744|PDB:4GUS,
FT                   ECO:0007744|PDB:4GUT, ECO:0007744|PDB:4GUU,
FT                   ECO:0007744|PDB:4HSU"
FT   BINDING         598
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0000269|PubMed:23266887, ECO:0000269|PubMed:23357850,
FT                   ECO:0007744|PDB:4FWE, ECO:0007744|PDB:4FWF,
FT                   ECO:0007744|PDB:4FWJ, ECO:0007744|PDB:4GU0,
FT                   ECO:0007744|PDB:4GU1, ECO:0007744|PDB:4GUR,
FT                   ECO:0007744|PDB:4GUS, ECO:0007744|PDB:4GUT,
FT                   ECO:0007744|PDB:4GUU, ECO:0007744|PDB:4HSU"
FT   BINDING         795
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:23260659,
FT                   ECO:0000269|PubMed:23266887, ECO:0007744|PDB:4FWE,
FT                   ECO:0007744|PDB:4FWF, ECO:0007744|PDB:4FWJ,
FT                   ECO:0007744|PDB:4GU1, ECO:0007744|PDB:4GUS,
FT                   ECO:0007744|PDB:4GUT, ECO:0007744|PDB:4GUU"
FT   MOD_RES         13
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         17
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18220336,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         26
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         247
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         1..647
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_019963"
FT   VAR_SEQ         192..323
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_019964"
FT   VAR_SEQ         453..552
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_019965"
FT   MUTAGEN         48..49
FT                   /note="KK->AA: Normal demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         51..52
FT                   /note="RK->AA: Reduced demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         53
FT                   /note="C->A: Loss of demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         82
FT                   /note="W->A: Loss of demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         84
FT                   /note="H->A: Loss of demethylase activity. Defective in the
FT                   binding of FAD."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         90
FT                   /note="H->A: Loss of demethylase activity. Defective in the
FT                   binding of FAD."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         101
FT                   /note="R->A: Reduced demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         114..115
FT                   /note="KK->AA: Reduced demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         139
FT                   /note="W->A: Loss of demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         150
FT                   /note="W->A: Loss of demethylase activity. Defective in the
FT                   binding of FAD."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         151
FT                   /note="R->A: Loss of demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         185
FT                   /note="C->A: Loss of demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         273..278
FT                   /note="YQPNEC->GSGSGS: Strongly reduced demethylase
FT                   activity. Loss of enzymatic activity; when associated with
FT                   285-A--A-287."
FT                   /evidence="ECO:0000269|PubMed:23357850"
FT   MUTAGEN         285..287
FT                   /note="RPD->APA: Strongly reduced demethylase activity.
FT                   Loss of enzymatic activity; when associated with 273-G--S-
FT                   278."
FT                   /evidence="ECO:0000269|PubMed:23357850"
FT   MUTAGEN         318..319
FT                   /note="WY->AA: Loss of demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         340..341
FT                   /note="LV->AA: Loss of demethylase activity. Defective in
FT                   the binding of FAD."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         361..362
FT                   /note="LI->AA: Loss of demethylase activity. Defective in
FT                   the binding of FAD."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         443..444
FT                   /note="IN->GG: Loss of demethylase activity. Defective in
FT                   the binding of FAD."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         542
FT                   /note="N->A: Loss of demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         543
FT                   /note="L->A: Reduced demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         547
FT                   /note="C->A: Reduced demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         559
FT                   /note="W->A: Loss of demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   MUTAGEN         563
FT                   /note="E->A: Loss of demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23357850"
FT   MUTAGEN         661
FT                   /note="K->A: Normal demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23357850"
FT   MUTAGEN         767
FT                   /note="Y->A: Loss of demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:23266887"
FT   CONFLICT        651
FT                   /note="I -> T (in Ref. 1; BAC86124)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        794..795
FT                   /note="Missing (in Ref. 4; CAH10499)"
FT                   /evidence="ECO:0000305"
FT   STRAND          51..55
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          70..72
FT                   /evidence="ECO:0007829|PDB:4FWF"
FT   STRAND          75..77
FT                   /evidence="ECO:0007829|PDB:4FWJ"
FT   STRAND          82..86
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          89..92
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           93..100
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           104..106
FT                   /evidence="ECO:0007829|PDB:4FWJ"
FT   HELIX           107..116
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   TURN            117..120
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           127..134
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          139..141
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   TURN            145..147
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          150..152
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           161..166
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          173..175
FT                   /evidence="ECO:0007829|PDB:4GU0"
FT   STRAND          180..182
FT                   /evidence="ECO:0007829|PDB:4FWE"
FT   HELIX           184..186
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           192..195
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           199..203
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          211..213
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           217..219
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           225..227
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           267..269
FT                   /evidence="ECO:0007829|PDB:4GU1"
FT   STRAND          286..288
FT                   /evidence="ECO:0007829|PDB:4GU1"
FT   HELIX           291..296
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           298..300
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           305..320
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           328..331
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           332..334
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           341..358
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          361..363
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           371..373
FT                   /evidence="ECO:0007829|PDB:4GUT"
FT   HELIX           378..380
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          384..388
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           392..404
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          407..411
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          413..417
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          427..430
FT                   /evidence="ECO:0007829|PDB:4FWF"
FT   STRAND          432..435
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          438..440
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           446..454
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          458..460
FT                   /evidence="ECO:0007829|PDB:4FWF"
FT   STRAND          467..469
FT                   /evidence="ECO:0007829|PDB:4FWF"
FT   HELIX           477..497
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           498..500
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           503..505
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           509..523
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           530..547
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   TURN            551..553
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   TURN            556..560
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           561..564
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          572..574
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           580..587
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          592..595
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          598..602
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          604..612
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          617..625
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           629..634
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          637..641
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           645..653
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          654..657
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          660..665
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           672..675
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          679..683
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          686..688
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   TURN            689..692
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          693..700
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          708..713
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           716..720
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   TURN            721..723
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           726..740
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   TURN            741..743
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          750..754
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           757..759
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   TURN            761..763
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          766..771
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           777..783
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   TURN            787..789
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          790..792
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           795..797
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   STRAND          799..801
FT                   /evidence="ECO:0007829|PDB:4HSU"
FT   HELIX           805..821
FT                   /evidence="ECO:0007829|PDB:4HSU"
SQ   SEQUENCE   822 AA;  92098 MW;  6C0A9BD6B2CEA2EA CRC64;
     MATPRGRTKK KASFDHSPDS LPLRSSGRQA KKKATETTDE DEDGGSEKKY RKCEKAGCTA
     TCPVCFASAS ERCAKNGYTS RWYHLSCGEH FCNECFDHYY RSHKDGYDKY TTWKKIWTSN
     GKTEPSPKAF MADQQLPYWV QCTKPECRKW RQLTKEIQLT PQIAKTYRCG MKPNTAIKPE
     TSDHCSLPED LRVLEVSNHW WYSMLILPPL LKDSVAAPLL SAYYPDCVGM SPSCTSTNRA
     AATGNASPGK LEHSKAALSV HVPGMNRYFQ PFYQPNECGK ALCVRPDVME LDELYEFPEY
     SRDPTMYLAL RNLILALWYT NCKEALTPQK CIPHIIVRGL VRIRCVQEVE RILYFMTRKG
     LINTGVLSVG ADQYLLPKDY HNKSVIIIGA GPAGLAAARQ LHNFGIKVTV LEAKDRIGGR
     VWDDKSFKGV TVGRGAQIVN GCINNPVALM CEQLGISMHK FGERCDLIQE GGRITDPTID
     KRMDFHFNAL LDVVSEWRKD KTQLQDVPLG EKIEEIYKAF IKESGIQFSE LEGQVLQFHL
     SNLEYACGSN LHQVSARSWD HNEFFAQFAG DHTLLTPGYS VIIEKLAEGL DIQLKSPVQC
     IDYSGDEVQV TTTDGTGYSA QKVLVTVPLA LLQKGAIQFN PPLSEKKMKA INSLGAGIIE
     KIALQFPYRF WDSKVQGADF FGHVPPSASK RGLFAVFYDM DPQKKHSVLM SVIAGEAVAS
     VRTLDDKQVL QQCMATLREL FKEQEVPDPT KYFVTRWSTD PWIQMAYSFV KTGGSGEAYD
     IIAEDIQGTV FFAGEATNRH FPQTVTGAYL SGVREASKIA AF
//
ID   TETX_BACT4              Reviewed;         388 AA.
AC   Q93L51;
DT   16-OCT-2019, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   02-JUN-2021, entry version 111.
DE   RecName: Full=Flavin-dependent monooxygenase {ECO:0000255|HAMAP-Rule:MF_00845, ECO:0000303|PubMed:15452119};
DE   AltName: Full=TetX monooxygenase {ECO:0000255|HAMAP-Rule:MF_00845, ECO:0000303|PubMed:16128584};
DE            Short=TetX {ECO:0000255|HAMAP-Rule:MF_00845};
DE            EC=1.14.13.231 {ECO:0000255|HAMAP-Rule:MF_00845, ECO:0000269|PubMed:15452119};
DE   AltName: Full=TetX2 {ECO:0000303|PubMed:21590745};
GN   Name=tetX2 {ECO:0000303|PubMed:11472924};
OS   Bacteroides thetaiotaomicron.
OC   Bacteria; Bacteroidetes; Bacteroidia; Bacteroidales; Bacteroidaceae;
OC   Bacteroides.
OX   NCBI_TaxID=818;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=BT5482A; TRANSPOSON=CTnDOT;
RX   PubMed=11472924; DOI=10.1128/aem.67.8.3488-3495.2001;
RA   Whittle G., Hund B.D., Shoemaker N.B., Salyers A.A.;
RT   "Characterization of the 13-kilobase ermF region of the Bacteroides
RT   conjugative transposon CTnDOT.";
RL   Appl. Environ. Microbiol. 67:3488-3495(2001).
RN   [2]
RP   FUNCTION IN INACTIVATING OXYTETRACYCLINE, CATALYTIC ACTIVITY, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND ANTIBIOTIC RESISTANCE.
RC   STRAIN=BT5482A; TRANSPOSON=CTnDOT;
RX   PubMed=15452119; DOI=10.1074/jbc.m409573200;
RA   Yang W., Moore I.F., Koteva K.P., Bareich D.C., Hughes D.W., Wright G.D.;
RT   "TetX is a flavin-dependent monooxygenase conferring resistance to
RT   tetracycline antibiotics.";
RL   J. Biol. Chem. 279:52346-52352(2004).
RN   [3]
RP   FUNCTION IN INACTIVATING TIGECYCLINE, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   ANTIBIOTIC RESISTANCE.
RC   STRAIN=BT5482A; TRANSPOSON=CTnDOT;
RX   PubMed=16128584; DOI=10.1021/bi0506066;
RA   Moore I.F., Hughes D.W., Wright G.D.;
RT   "Tigecycline is modified by the flavin-dependent monooxygenase TetX.";
RL   Biochemistry 44:11829-11835(2005).
RN   [4]
RP   FUNCTION IN INACTIVATING TETRACYCLINE AND ANALOGS, AND ANTIBIOTIC
RP   RESISTANCE.
RX   PubMed=26097034; DOI=10.1016/j.chembiol.2015.05.017;
RA   Forsberg K.J., Patel S., Wencewicz T.A., Dantas G.;
RT   "The Tetracycline Destructases: A Novel Family of Tetracycline-Inactivating
RT   Enzymes.";
RL   Chem. Biol. 22:888-897(2015).
RN   [5]
RP   FUNCTION IN INACTIVATING CHLORTETRACYCLINE, AND ACTIVITY REGULATION.
RX   PubMed=28481346; DOI=10.1038/nchembio.2376;
RA   Park J., Gasparrini A.J., Reck M.R., Symister C.T., Elliott J.L.,
RA   Vogel J.P., Wencewicz T.A., Dantas G., Tolia N.H.;
RT   "Plasticity, dynamics, and inhibition of emerging tetracycline resistance
RT   enzymes.";
RL   Nat. Chem. Biol. 13:730-736(2017).
RN   [6] {ECO:0007744|PDB:2XDO, ECO:0007744|PDB:2XYO, ECO:0007744|PDB:2Y6Q, ECO:0007744|PDB:2Y6R}
RP   X-RAY CRYSTALLOGRAPHY (2.09 ANGSTROMS) OF 11-388 IN COMPLEX WITH FAD WITH
RP   AND WITHOUT ANTIBIOTICS, COFACTOR, SUBUNIT, AND DOMAIN.
RC   STRAIN=BT5482A; TRANSPOSON=CTnDOT;
RX   PubMed=21402075; DOI=10.1016/j.febslet.2011.03.012;
RA   Volkers G., Palm G.J., Weiss M.S., Wright G.D., Hinrichs W.;
RT   "Structural basis for a new tetracycline resistance mechanism relying on
RT   the TetX monooxygenase.";
RL   FEBS Lett. 585:1061-1066(2011).
RN   [7] {ECO:0007744|PDB:3P9U}
RP   X-RAY CRYSTALLOGRAPHY (2.81 ANGSTROMS) OF 11-388 IN COMPLEX WITH FAD,
RP   COFACTOR, SUBUNIT, AND DOMAIN.
RX   PubMed=21590745; DOI=10.1002/prot.23052;
RA   Walkiewicz K., Davlieva M., Wu G., Shamoo Y.;
RT   "Crystal structure of Bacteroides thetaiotaomicron TetX2: a tetracycline
RT   degrading monooxygenase at 2.8 A resolution.";
RL   Proteins 79:2335-2340(2011).
RN   [8] {ECO:0007744|PDB:3V3N}
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 11-388 IN COMPLEX WITH FAD AND
RP   MINOCYCLINE, FUNCTION, REACTION MECHANISM, COFACTOR, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBUNIT, DOMAIN, MUTAGENESIS OF LYS-64; PHE-235; THR-280;
RP   SER-326 AND ASN-371, AND EXPRESSION IN E.COLI.
RX   PubMed=23236139; DOI=10.1073/pnas.1209335110;
RA   Walkiewicz K., Benitez Cardenas A.S., Sun C., Bacorn C., Saxer G.,
RA   Shamoo Y.;
RT   "Small changes in enzyme function can lead to surprisingly large fitness
RT   effects during adaptive evolution of antibiotic resistance.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:21408-21413(2012).
RN   [9] {ECO:0007744|PDB:3V3O}
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 11-388 IN COMPLEX WITH FAD AND
RP   TIGECYCLINE, AND COFACTOR.
RA   Walkiewicz K., Shamoo Y.;
RT   "Crystal structure of TetX2 T280A: an adaptive mutant in complex with
RT   tigecycline.";
RL   Submitted (DEC-2011) to the PDB data bank.
RN   [10] {ECO:0007744|PDB:4A6N, ECO:0007744|PDB:4A99, ECO:0007744|PDB:4GUV}
RP   X-RAY CRYSTALLOGRAPHY (2.18 ANGSTROMS) OF 11-388 IN COMPLEX WITH FAD AND
RP   WITH ANTIBIOTICS, COFACTOR, AND SUBUNIT.
RX   PubMed=23999299; DOI=10.1107/s0907444913013802;
RA   Volkers G., Damas J.M., Palm G.J., Panjikar S., Soares C.M., Hinrichs W.;
RT   "Putative dioxygen-binding sites and recognition of tigecycline and
RT   minocycline in the tetracycline-degrading monooxygenase TetX.";
RL   Acta Crystallogr. D 69:1758-1767(2013).
CC   -!- FUNCTION: An FAD-requiring monooxygenase active on tetracycline
CC       antibiotic derivatives, which leads to their inactivation
CC       (PubMed:15452119, PubMed:16128584). Hydroxylates carbon 11a of
CC       oxytetracycline and tigecycline (PubMed:15452119, PubMed:26097034).
CC       Acts on many tetracycline analogs (chlorotetracycline, demeclocycline,
CC       doxycycline, minocycline, oxytetracyclinee), probably by
CC       monooxygenization (PubMed:15452119, PubMed:16128584). Tigecycline, a
CC       new generation tetracycline antibiotic, is rendered less effective
CC       against E.coli by this monooxygenation, is much weaker at inhibiting
CC       translation in vitro and binds Mg(2+) considerably less well
CC       (PubMed:16128584, PubMed:26097034). Expression in E.coli BW25113
CC       reduces its growth rate about 5%. The reaction probably proceeds by FAD
CC       reduction by NADPH and, second, hydroxylation of antibiotic in a ping-
CC       pong mechanism (PubMed:23236139). Degrades chlortetracycline, probably
CC       by monooxygenation (PubMed:15452119, PubMed:28481346). Slowly oxidizes
CC       anhydrotetracycline, the final substrate in tetracycline biosynthesis
CC       (PubMed:26097034). {ECO:0000255|HAMAP-Rule:MF_00845,
CC       ECO:0000269|PubMed:15452119, ECO:0000269|PubMed:16128584,
CC       ECO:0000269|PubMed:23236139, ECO:0000269|PubMed:26097034,
CC       ECO:0000269|PubMed:28481346}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a tetracycline + H(+) + NADPH + O2 = an 11a-
CC         hydroxytetracycline + H2O + NADP(+); Xref=Rhea:RHEA:61444,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:144644,
CC         ChEBI:CHEBI:144645; Evidence={ECO:0000255|HAMAP-Rule:MF_00845,
CC         ECO:0000269|PubMed:15452119, ECO:0000269|PubMed:16128584,
CC         ECO:0000269|PubMed:23236139, ECO:0000269|PubMed:26097034,
CC         ECO:0000269|PubMed:28481346};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADPH + O2 + tetracycline = 11a-hydroxytetracycline +
CC         H2O + NADP(+); Xref=Rhea:RHEA:50004, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:77932, ChEBI:CHEBI:132727;
CC         EC=1.14.13.231; Evidence={ECO:0000305|PubMed:15452119,
CC         ECO:0000305|PubMed:26097034};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADPH + O2 + tigecycline = 11a-hydroxytigecycline + H2O
CC         + NADP(+); Xref=Rhea:RHEA:61448, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:142708, ChEBI:CHEBI:142709;
CC         Evidence={ECO:0000269|PubMed:16128584};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADPH + O2 + oxytetracycline = 11a-hydroxy-
CC         oxytetracycline + H2O + NADP(+); Xref=Rhea:RHEA:61452,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:133011,
CC         ChEBI:CHEBI:144646; Evidence={ECO:0000269|PubMed:15452119};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00845,
CC         ECO:0000269|PubMed:15452119, ECO:0000269|PubMed:21402075,
CC         ECO:0000269|PubMed:21590745, ECO:0000269|PubMed:23236139,
CC         ECO:0000269|PubMed:23999299, ECO:0000269|Ref.9};
CC       Note=Binds 1 FAD per subunit, which helps bind the antibiotic
CC       substrate. {ECO:0000269|PubMed:21402075, ECO:0000269|PubMed:21590745,
CC       ECO:0000269|PubMed:23236139, ECO:0000269|PubMed:23999299,
CC       ECO:0000269|Ref.9};
CC   -!- ACTIVITY REGULATION: Anhydrotetracycline, a poor substrate, prevents
CC       tetracycline degradation in vitro. {ECO:0000269|PubMed:28481346}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=19.9 uM for demeclocycline {ECO:0000269|PubMed:15452119};
CC         KM=28.4 uM for minocycline {ECO:0000269|PubMed:15452119};
CC         KM=35.0 uM for minocycline {ECO:0000269|PubMed:23236139};
CC         KM=44.0 uM for tigecycline {ECO:0000269|PubMed:16128584};
CC         KM=54.0 uM for tetracycline {ECO:0000269|PubMed:15452119};
CC         KM=76.3 uM for oxytetracycline {ECO:0000269|PubMed:15452119};
CC         KM=83.7 uM for doxycycline {ECO:0000269|PubMed:15452119};
CC         KM=110 uM for chlortetracycline {ECO:0000269|PubMed:15452119};
CC         KM=133 uM for NADPH {ECO:0000269|PubMed:15452119};
CC         KM=75.0 uM for NADPH {ECO:0000269|PubMed:23236139};
CC         Note=kcat varies from 1.3 s(-1) for oxytetracycline to 0.12 s(-1) for
CC         minocycline. {ECO:0000269|PubMed:15452119};
CC       pH dependence:
CC         Optimum pH is 8.5. {ECO:0000269|PubMed:15452119};
CC   -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_00845,
CC       ECO:0000269|PubMed:15452119, ECO:0000269|PubMed:21402075,
CC       ECO:0000269|PubMed:21590745, ECO:0000269|PubMed:23236139,
CC       ECO:0000269|PubMed:23999299}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00845}.
CC   -!- DOMAIN: Consists of an N-terminal FAD-binding domain with a Rossman
CC       fold and a C-terminal substrate-binding domain. {ECO:0000255|HAMAP-
CC       Rule:MF_00845, ECO:0000269|PubMed:21402075,
CC       ECO:0000269|PubMed:21590745, ECO:0000269|PubMed:23236139,
CC       ECO:0000269|PubMed:23999299}.
CC   -!- MISCELLANEOUS: Encoded in a conjugative transposon. Immediately
CC       upstream of this gene is an N-terminally truncated tetX1 gene that is
CC       inactive. {ECO:0000269|PubMed:11472924}.
CC   -!- MISCELLANEOUS: Tetracycline antibiotics bind to the ribosomal acceptor
CC       site (A-site), preventing binding of the aminoacyl-tRNA to the A-site.
CC       The hydrophilic side of tetracycline makes many hydrogen-bonding
CC       interactions with oxygen atoms of the ribosome's phosphate backbone.
CC       {ECO:0000305|PubMed:16128584}.
CC   -!- SIMILARITY: Belongs to the aromatic-ring hydroxylase family. TetX
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_00845}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ311171; CAC47932.1; -; Genomic_DNA.
DR   RefSeq; WP_008651082.1; NZ_RWHY01000040.1.
DR   PDB; 2XDO; X-ray; 2.09 A; A/B/C/D=11-388.
DR   PDB; 2XYO; X-ray; 3.00 A; A/B/C/D=11-388.
DR   PDB; 2Y6Q; X-ray; 2.37 A; A/B/C/D=11-388.
DR   PDB; 2Y6R; X-ray; 3.10 A; A/B/C/D=11-388.
DR   PDB; 3P9U; X-ray; 2.81 A; A/B/C/D=11-388.
DR   PDB; 3V3N; X-ray; 2.70 A; A/B/C/D=11-388.
DR   PDB; 3V3O; X-ray; 2.90 A; A/B/C/D=11-388.
DR   PDB; 4A6N; X-ray; 2.30 A; A/B/C/D=11-388.
DR   PDB; 4A99; X-ray; 2.18 A; A/B/C/D=11-388.
DR   PDB; 4GUV; X-ray; 2.73 A; A/B/C/D=11-388.
DR   PDBsum; 2XDO; -.
DR   PDBsum; 2XYO; -.
DR   PDBsum; 2Y6Q; -.
DR   PDBsum; 2Y6R; -.
DR   PDBsum; 3P9U; -.
DR   PDBsum; 3V3N; -.
DR   PDBsum; 3V3O; -.
DR   PDBsum; 4A6N; -.
DR   PDBsum; 4A99; -.
DR   PDBsum; 4GUV; -.
DR   SMR; Q93L51; -.
DR   DrugBank; DB13092; Meclocycline.
DR   BRENDA; 1.14.13.231; 709.
DR   EvolutionaryTrace; Q93L51; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 1.
DR   HAMAP; MF_00845; TetX_monooxygenase; 1.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR043683; TetX_monooxygenase.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic resistance; Cytoplasm; FAD; Flavoprotein;
KW   Monooxygenase; NADP; Nucleotide-binding; Oxidoreductase;
KW   Transposable element.
FT   CHAIN           1..388
FT                   /note="Flavin-dependent monooxygenase"
FT                   /id="PRO_0000448378"
FT   NP_BIND         26..27
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21402075,
FT                   ECO:0000269|PubMed:21590745, ECO:0007744|PDB:2XDO,
FT                   ECO:0007744|PDB:2XYO, ECO:0007744|PDB:2Y6Q,
FT                   ECO:0007744|PDB:2Y6R, ECO:0007744|PDB:3P9U,
FT                   ECO:0007744|PDB:3V3N, ECO:0007744|PDB:3V3O,
FT                   ECO:0007744|PDB:4A6N, ECO:0007744|PDB:4A99,
FT                   ECO:0007744|PDB:4GUV"
FT   NP_BIND         45..48
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21402075,
FT                   ECO:0000269|PubMed:21590745, ECO:0007744|PDB:2XDO,
FT                   ECO:0007744|PDB:2XYO, ECO:0007744|PDB:2Y6Q,
FT                   ECO:0007744|PDB:2Y6R, ECO:0007744|PDB:3P9U,
FT                   ECO:0007744|PDB:3V3N, ECO:0007744|PDB:3V3O,
FT                   ECO:0007744|PDB:4A6N, ECO:0007744|PDB:4A99,
FT                   ECO:0007744|PDB:4GUV"
FT   NP_BIND         321..324
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:21402075,
FT                   ECO:0000269|PubMed:21590745, ECO:0007744|PDB:2XDO,
FT                   ECO:0007744|PDB:2XYO, ECO:0007744|PDB:2Y6Q,
FT                   ECO:0007744|PDB:2Y6R, ECO:0007744|PDB:3P9U,
FT                   ECO:0007744|PDB:3V3N, ECO:0007744|PDB:3V3O,
FT                   ECO:0007744|PDB:4A6N, ECO:0007744|PDB:4A99,
FT                   ECO:0007744|PDB:4GUV"
FT   BINDING         54
FT                   /note="NADPH"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00845,
FT                   ECO:0000305|PubMed:21402075"
FT   BINDING         61
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00845,
FT                   ECO:0007744|PDB:3V3O"
FT   BINDING         117
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00845,
FT                   ECO:0000269|PubMed:21402075, ECO:0000269|PubMed:21590745,
FT                   ECO:0007744|PDB:2XDO, ECO:0007744|PDB:2XYO,
FT                   ECO:0007744|PDB:2Y6Q, ECO:0007744|PDB:2Y6R,
FT                   ECO:0007744|PDB:3P9U, ECO:0007744|PDB:3V3N,
FT                   ECO:0007744|PDB:3V3O, ECO:0007744|PDB:4A6N,
FT                   ECO:0007744|PDB:4A99, ECO:0007744|PDB:4GUV"
FT   BINDING         139
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:21402075,
FT                   ECO:0000269|PubMed:21590745, ECO:0007744|PDB:2XDO,
FT                   ECO:0007744|PDB:2XYO, ECO:0007744|PDB:2Y6Q,
FT                   ECO:0007744|PDB:2Y6R, ECO:0007744|PDB:3P9U,
FT                   ECO:0007744|PDB:3V3N, ECO:0007744|PDB:3V3O,
FT                   ECO:0007744|PDB:4A6N, ECO:0007744|PDB:4A99,
FT                   ECO:0007744|PDB:4GUV"
FT   BINDING         192
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:21402075,
FT                   ECO:0000269|PubMed:23999299, ECO:0007744|PDB:2Y6Q,
FT                   ECO:0007744|PDB:2Y6R, ECO:0007744|PDB:3V3N,
FT                   ECO:0007744|PDB:4A99"
FT   BINDING         213
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:21402075,
FT                   ECO:0000269|PubMed:23999299, ECO:0007744|PDB:2Y6Q,
FT                   ECO:0007744|PDB:2Y6R, ECO:0007744|PDB:3V3O,
FT                   ECO:0007744|PDB:4A6N, ECO:0007744|PDB:4A99"
FT   BINDING         311
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00845,
FT                   ECO:0000269|PubMed:21402075, ECO:0000269|PubMed:21590745,
FT                   ECO:0007744|PDB:2XDO, ECO:0007744|PDB:2XYO,
FT                   ECO:0007744|PDB:2Y6Q, ECO:0007744|PDB:2Y6R,
FT                   ECO:0007744|PDB:3P9U, ECO:0007744|PDB:3V3N,
FT                   ECO:0007744|PDB:3V3O, ECO:0007744|PDB:4A6N,
FT                   ECO:0007744|PDB:4A99, ECO:0007744|PDB:4GUV"
FT   MUTAGEN         64
FT                   /note="K->R: E.coli is more resistant to minocycline (MCN),
FT                   no change in affinity for MCN, decreased affinity for
FT                   NADPH, decreased growth rate in E.coli."
FT                   /evidence="ECO:0000269|PubMed:23236139"
FT   MUTAGEN         235
FT                   /note="F->Y: E.coli is more resistant to MCN, decreased
FT                   affinity for MCN, slightly decrased affinity for NADPH,
FT                   increased growth rate in E.coli."
FT                   /evidence="ECO:0000269|PubMed:23236139"
FT   MUTAGEN         280
FT                   /note="T->A: E.coli is more resistant to MCN, 2-fold
FT                   increased affinity for MCN, 4-fold increase for NADPH,
FT                   increased growth rate in E.coli."
FT                   /evidence="ECO:0000269|PubMed:23236139"
FT   MUTAGEN         280
FT                   /note="T->S: E.coli is more resistant to MCN, slightly
FT                   increased affinity for MCN, decreased affinity for NADPH,
FT                   decreased growth rate in E.coli."
FT                   /evidence="ECO:0000269|PubMed:23236139"
FT   MUTAGEN         326
FT                   /note="S->I: E.coli is more resistant to MCN, no change in
FT                   affinity for MCN or NADPH, increased growth rate in
FT                   E.coli."
FT                   /evidence="ECO:0000269|PubMed:23236139"
FT   MUTAGEN         371
FT                   /note="N->I: E.coli is more resistant to MCN, 2-fold
FT                   increased affinity for MCN, slightly increased affinity for
FT                   NADPH, increased growth rate in E.coli."
FT                   /evidence="ECO:0000269|PubMed:23236139"
FT   MUTAGEN         371
FT                   /note="N->T: E.coli is more resistant to MCN, increased
FT                   affinity for MCN, decreased affinity for NADPH, increased
FT                   growth rate in E.coli."
FT                   /evidence="ECO:0000269|PubMed:23236139"
FT   TURN            13..16
FT                   /evidence="ECO:0007829|PDB:4A99"
FT   STRAND          18..22
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   HELIX           26..36
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   TURN            37..39
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          41..46
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          48..50
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          59..61
FT                   /evidence="ECO:0007829|PDB:3V3N"
FT   TURN            64..66
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   HELIX           67..73
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   HELIX           77..83
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          89..92
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          94..101
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   HELIX           105..107
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   HELIX           108..110
FT                   /evidence="ECO:0007829|PDB:3V3N"
FT   STRAND          114..116
FT                   /evidence="ECO:0007829|PDB:3V3N"
FT   HELIX           117..126
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          132..136
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          139..144
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          146..153
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          159..166
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   TURN            176..178
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          184..197
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   HELIX           198..201
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   HELIX           203..209
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          212..218
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          221..229
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          232..240
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          253..255
FT                   /evidence="ECO:0007829|PDB:3P9U"
FT   HELIX           256..266
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   TURN            267..269
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   HELIX           272..280
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          285..291
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          306..308
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   HELIX           311..314
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          318..321
FT                   /evidence="ECO:0007829|PDB:4A99"
FT   HELIX           324..339
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          343..345
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   HELIX           346..376
FT                   /evidence="ECO:0007829|PDB:2XDO"
FT   STRAND          377..379
FT                   /evidence="ECO:0007829|PDB:4A99"
SQ   SEQUENCE   388 AA;  43708 MW;  C0F8976A7A82F394 CRC64;
     MTMRIDTDKQ MNLLSDKNVA IIGGGPVGLT MAKLLQQNGI DVSVYERDND REARIFGGTL
     DLHKGSGQEA MKKAGLLQTY YDLALPMGVN IADEKGNILS TKNVKPENRF DNPEINRNDL
     RAILLNSLEN DTVIWDRKLV MLEPGKKKWT LTFENKPSET ADLVILANGG MSKVRKFVTD
     TEVEETGTFN IQADIHQPEI NCPGFFQLCN GNRLMASHQG NLLFANPNNN GALHFGISFK
     TPDEWKNQTQ VDFQNRNSVV DFLLKEFSDW DERYKELIHT TLSFVGLATR IFPLEKPWKS
     KRPLPITMIG DAAHLMPPFA GQGVNSGLVD ALILSDNLAD GKFNSIEEAV KNYEQQMFIY
     GKEAQEESTQ NEIEMFKPDF TFQQLLNV
//
ID   TFTC_BURCE              Reviewed;         179 AA.
AC   O87008;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   02-JUN-2021, entry version 73.
DE   RecName: Full=NADH:FAD oxidoreductase;
DE            EC=1.5.1.37;
DE   AltName: Full=Chlorophenol-4-monooxygenase component 1;
DE   AltName: Full=Two component enzyme C;
GN   Name=tftC;
OS   Burkholderia cepacia (Pseudomonas cepacia).
OC   Bacteria; Proteobacteria; Betaproteobacteria; Burkholderiales;
OC   Burkholderiaceae; Burkholderia; Burkholderia cepacia complex.
OX   NCBI_TaxID=292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=AC1100;
RX   PubMed=9603818; DOI=10.1128/aem.64.6.2086-2093.1998;
RA   Hubner A., Danganan C.E., Xun L., Chakrabarty A.M., Hendrickson W.;
RT   "Genes for 2,4,5-trichlorophenoxyacetic acid metabolism in Burkholderia
RT   cepacia AC1100: characterization of the tftC and tftD genes and locations
RT   of the tft operons on multiple replicons.";
RL   Appl. Environ. Microbiol. 64:2086-2093(1998).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   STRAIN=AC1100;
RX   PubMed=12700257; DOI=10.1128/jb.185.9.2786-2792.2003;
RA   Gisi M.R., Xun L.;
RT   "Characterization of chlorophenol 4-monooxygenase (TftD) and NADH:flavin
RT   adenine dinucleotide oxidoreductase (TftC) of Burkholderia cepacia
RT   AC1100.";
RL   J. Bacteriol. 185:2786-2792(2003).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH FAD AND NAD,
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19915006; DOI=10.1074/jbc.m109.056135;
RA   Webb B.N., Ballinger J.W., Kim E., Belchik S.M., Lam K.S., Youn B.,
RA   Nissen M.S., Xun L., Kang C.;
RT   "Characterization of chlorophenol 4-monooxygenase (TftD) and NADH:FAD
RT   oxidoreductase (TftC) of Burkholderia cepacia AC1100.";
RL   J. Biol. Chem. 285:2014-2027(2010).
CC   -!- FUNCTION: Reductase component of a two-component system that degrades
CC       2,4,5-trichlorophenol. TftC provides the FADH(2) required by TftD. TftD
CC       oxidizes 2,4,5-trichlorophenol (2,4,5-TCP) to 2,5-dichloro-p-
CC       benzoquinone, which is chemically reduced to 2,5-dichloro-p-
CC       hydroquinone (2,5-DiCHQ). Then, TftD oxidizes the latter to 5-chloro-2-
CC       hydroxy-p-benzoquinone. {ECO:0000269|PubMed:12700257,
CC       ECO:0000269|PubMed:19915006}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=FADH2 + NAD(+) = FAD + 2 H(+) + NADH; Xref=Rhea:RHEA:30147,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57540, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:58307; EC=1.5.1.37;
CC         Evidence={ECO:0000269|PubMed:12700257, ECO:0000269|PubMed:19915006};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=10.3 uM for FMN (with fixed NADH concentration at 300 uM)
CC         {ECO:0000269|PubMed:12700257, ECO:0000269|PubMed:19915006};
CC         KM=2.0 uM for FAD {ECO:0000269|PubMed:12700257,
CC         ECO:0000269|PubMed:19915006};
CC         KM=4.8 uM for FAD (with fixed NADH concentration at 300 uM)
CC         {ECO:0000269|PubMed:12700257, ECO:0000269|PubMed:19915006};
CC         KM=45.3 uM for NADH {ECO:0000269|PubMed:12700257,
CC         ECO:0000269|PubMed:19915006};
CC         KM=40.1 uM for NADH (with fixed FAD concentration at 18 uM)
CC         {ECO:0000269|PubMed:12700257, ECO:0000269|PubMed:19915006};
CC         KM=164.0 uM for NADH (with fixed FMN concentration at 20 uM)
CC         {ECO:0000269|PubMed:12700257, ECO:0000269|PubMed:19915006};
CC         Vmax=120 umol/min/mg enzyme {ECO:0000269|PubMed:12700257,
CC         ECO:0000269|PubMed:19915006};
CC   -!- PATHWAY: Xenobiotic degradation.
CC   -!- SUBUNIT: Homodimer. The chlorophenol-4-monooxygenase is composed of an
CC       oxygenase component TftD and a reductase component TftC.
CC       {ECO:0000269|PubMed:19915006}.
CC   -!- SIMILARITY: Belongs to the non-flavoprotein flavin reductase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U83405; AAC23547.1; -; Genomic_DNA.
DR   PDB; 3K86; X-ray; 2.00 A; A/B=1-179.
DR   PDB; 3K87; X-ray; 2.00 A; A/B=1-179.
DR   PDB; 3K88; X-ray; 2.00 A; A/B=1-179.
DR   PDBsum; 3K86; -.
DR   PDBsum; 3K87; -.
DR   PDBsum; 3K88; -.
DR   SMR; O87008; -.
DR   PRIDE; O87008; -.
DR   KEGG; ag:AAC23547; -.
DR   BioCyc; MetaCyc:MONOMER-14673; -.
DR   BRENDA; 1.5.1.37; 1028.
DR   EvolutionaryTrace; O87008; -.
DR   GO; GO:0010181; F:FMN binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016646; F:oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-KW.
DR   Gene3D; 2.30.110.10; -; 1.
DR   InterPro; IPR002563; Flavin_Rdtase-like_dom.
DR   InterPro; IPR012349; Split_barrel_FMN-bd.
DR   Pfam; PF01613; Flavin_Reduct; 1.
DR   SMART; SM00903; Flavin_Reduct; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aromatic hydrocarbons catabolism; FAD; Flavoprotein;
KW   Monooxygenase; NAD; Nucleotide-binding; Oxidoreductase.
FT   CHAIN           1..179
FT                   /note="NADH:FAD oxidoreductase"
FT                   /id="PRO_0000418739"
FT   NP_BIND         48..51
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19915006"
FT   NP_BIND         54..57
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:19915006"
FT   NP_BIND         65..71
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19915006"
FT   NP_BIND         104..109
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19915006"
FT   NP_BIND         166..169
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:19915006"
FT   BINDING         99
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:19915006"
FT   BINDING         144
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19915006"
FT   BINDING         145
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:19915006"
FT   BINDING         166
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:19915006"
FT   HELIX           19..26
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   STRAND          29..32
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   STRAND          34..38
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   STRAND          45..49
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   STRAND          52..56
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   TURN            57..60
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   STRAND          61..67
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   HELIX           71..79
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   STRAND          81..86
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   HELIX           89..91
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   HELIX           92..98
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   HELIX           101..103
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   HELIX           106..108
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   STRAND          119..122
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   STRAND          128..142
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   STRAND          145..156
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   STRAND          165..167
FT                   /evidence="ECO:0007829|PDB:3K86"
FT   STRAND          170..175
FT                   /evidence="ECO:0007829|PDB:3K86"
SQ   SEQUENCE   179 AA;  19028 MW;  8944587144256B80 CRC64;
     MHAGEAVQQL KKAFETVASF DFRDALSKAS TPVTVVATNG PFGLAGLTCS AVCSVCDRPP
     TVLLCINRKS YAAGIIKSNG VLSVNWLAAG QAVISQTFAG VGSVPMEERF ADKGWQTIAT
     GAPYRMDAAV SFDCTIANIV DVGSHSVIFA EVVARNHAEE CTPLIYHRRQ YATTRSLAE
//
ID   TRXB1_YEAST             Reviewed;         319 AA.
AC   P29509; D6VSY3;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-JUN-2021, entry version 197.
DE   RecName: Full=Thioredoxin reductase 1;
DE            EC=1.8.1.9;
GN   Name=TRR1; OrderedLocusNames=YDR353W; ORFNames=D9476.5;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PARTIAL PROTEIN SEQUENCE OF 2-16; 90-97;
RP   126-137; 176-179; 233-238 AND 296-303, AND CLEAVAGE OF INITIATOR
RP   METHIONINE.
RC   STRAIN=ATCC 200358 / YNN 295;
RX   PubMed=7961686;
RA   Chae H.Z., Chung S.J., Rhee S.G.;
RT   "Thioredoxin-dependent peroxide reductase from yeast.";
RL   J. Biol. Chem. 269:27670-27678(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169867;
RA   Jacq C., Alt-Moerbe J., Andre B., Arnold W., Bahr A., Ballesta J.P.G.,
RA   Bargues M., Baron L., Becker A., Biteau N., Bloecker H., Blugeon C.,
RA   Boskovic J., Brandt P., Brueckner M., Buitrago M.J., Coster F.,
RA   Delaveau T., del Rey F., Dujon B., Eide L.G., Garcia-Cantalejo J.M.,
RA   Goffeau A., Gomez-Peris A., Granotier C., Hanemann V., Hankeln T.,
RA   Hoheisel J.D., Jaeger W., Jimenez A., Jonniaux J.-L., Kraemer C.,
RA   Kuester H., Laamanen P., Legros Y., Louis E.J., Moeller-Rieker S.,
RA   Monnet A., Moro M., Mueller-Auer S., Nussbaumer B., Paricio N., Paulin L.,
RA   Perea J., Perez-Alonso M., Perez-Ortin J.E., Pohl T.M., Prydz H.,
RA   Purnelle B., Rasmussen S.W., Remacha M.A., Revuelta J.L., Rieger M.,
RA   Salom D., Saluz H.P., Saiz J.E., Saren A.-M., Schaefer M., Scharfe M.,
RA   Schmidt E.R., Schneider C., Scholler P., Schwarz S., Soler-Mira A.,
RA   Urrestarazu L.A., Verhasselt P., Vissers S., Voet M., Volckaert G.,
RA   Wagner G., Wambutt R., Wedler E., Wedler H., Woelfl S., Harris D.E.,
RA   Bowman S., Brown D., Churcher C.M., Connor R., Dedman K., Gentles S.,
RA   Hamlin N., Hunt S., Jones L., McDonald S., Murphy L.D., Niblett D.,
RA   Odell C., Oliver K., Rajandream M.A., Richards C., Shore L., Walsh S.V.,
RA   Barrell B.G., Dietrich F.S., Mulligan J.T., Allen E., Araujo R., Aviles E.,
RA   Berno A., Carpenter J., Chen E., Cherry J.M., Chung E., Duncan M.,
RA   Hunicke-Smith S., Hyman R.W., Komp C., Lashkari D., Lew H., Lin D.,
RA   Mosedale D., Nakahara K., Namath A., Oefner P., Oh C., Petel F.X.,
RA   Roberts D., Schramm S., Schroeder M., Shogren T., Shroff N., Winant A.,
RA   Yelton M.A., Botstein D., Davis R.W., Johnston M., Andrews S., Brinkman R.,
RA   Cooper J., Ding H., Du Z., Favello A., Fulton L., Gattung S., Greco T.,
RA   Hallsworth K., Hawkins J., Hillier L.W., Jier M., Johnson D., Johnston L.,
RA   Kirsten J., Kucaba T., Langston Y., Latreille P., Le T., Mardis E.,
RA   Menezes S., Miller N., Nhan M., Pauley A., Peluso D., Rifkin L., Riles L.,
RA   Taich A., Trevaskis E., Vignati D., Wilcox L., Wohldman P., Vaudin M.,
RA   Wilson R., Waterston R., Albermann K., Hani J., Heumann K., Kleine K.,
RA   Mewes H.-W., Zollner A., Zaccaria P.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome IV.";
RL   Nature 387:75-78(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A., Raphael J.,
RA   Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F., Williamson J.,
RA   Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G., Kolodner R.D.,
RA   LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-encoding
RT   clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 261-319.
RX   PubMed=2428012; DOI=10.1093/nar/14.16.6357;
RA   Furter R., Paravicini G., Aebi M., Braus G., Prantl F., Niederberger P.,
RA   Huetter R.;
RT   "The TRP4 gene of Saccharomyces cerevisiae: isolation and structural
RT   analysis.";
RL   Nucleic Acids Res. 14:6357-6373(1986).
RN   [6]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-303, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth phosphoproteome
RT   analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22984289; DOI=10.1074/mcp.m112.021105;
RA   Voegtle F.N., Burkhart J.M., Rao S., Gerbeth C., Hinrichs J.,
RA   Martinou J.C., Chacinska A., Sickmann A., Zahedi R.P., Meisinger C.;
RT   "Intermembrane space proteome of yeast mitochondria.";
RL   Mol. Cell. Proteomics 11:1840-1852(2012).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 2-319 IN COMPLEX WITH FAD,
RP   COFACTOR, AND SUBUNIT.
RX   PubMed=18930846; DOI=10.1016/j.bbapap.2008.09.011;
RA   Zhang Z., Bao R., Zhang Y., Yu J., Zhou C.Z., Chen Y.;
RT   "Crystal structure of Saccharomyces cerevisiae cytoplasmic thioredoxin
RT   reductase Trr1 reveals the structural basis for species-specific
RT   recognition of thioredoxin.";
RL   Biochim. Biophys. Acta 1794:124-128(2009).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 2-319 IN COMPLEX WITH FAD,
RP   FUNCTION, COFACTOR, SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=20235561; DOI=10.1021/bi901962p;
RA   Oliveira M.A., Discola K.F., Alves S.V., Medrano F.J., Guimaraes B.G.,
RA   Netto L.E.;
RT   "Insights into the specificity of thioredoxin reductase-thioredoxin
RT   interactions. A structural and functional investigation of the yeast
RT   thioredoxin system.";
RL   Biochemistry 49:3317-3326(2010).
CC   -!- FUNCTION: Acts on thioredoxins 1 and 2. {ECO:0000269|PubMed:20235561}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[thioredoxin]-dithiol + NADP(+) = [thioredoxin]-disulfide +
CC         H(+) + NADPH; Xref=Rhea:RHEA:20345, Rhea:RHEA-COMP:10698, Rhea:RHEA-
CC         COMP:10700, ChEBI:CHEBI:15378, ChEBI:CHEBI:29950, ChEBI:CHEBI:50058,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.8.1.9;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:18930846, ECO:0000269|PubMed:20235561};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:18930846,
CC       ECO:0000269|PubMed:20235561};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:18930846,
CC       ECO:0000269|PubMed:20235561}.
CC   -!- INTERACTION:
CC       P29509; P53879: RHO5; NbExp=4; IntAct=EBI-19497, EBI-29054;
CC       P29509; P38816: TRR2; NbExp=4; IntAct=EBI-19497, EBI-19502;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Mitochondrion intermembrane space
CC       {ECO:0000269|PubMed:22984289}.
CC   -!- MISCELLANEOUS: The active site is a redox-active disulfide bond.
CC   -!- MISCELLANEOUS: Present with 292000 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the class-II pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U10274; AAA64747.1; -; Genomic_DNA.
DR   EMBL; U28372; AAB64789.1; -; Genomic_DNA.
DR   EMBL; X04273; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AY557749; AAS56075.1; -; Genomic_DNA.
DR   EMBL; BK006938; DAA12193.1; -; Genomic_DNA.
DR   PIR; S61150; S61150.
DR   RefSeq; NP_010640.1; NM_001180661.1.
DR   PDB; 3D8X; X-ray; 2.80 A; A/B=2-319.
DR   PDB; 3ITJ; X-ray; 2.40 A; A/B/C/D=2-319.
DR   PDBsum; 3D8X; -.
DR   PDBsum; 3ITJ; -.
DR   SMR; P29509; -.
DR   BioGRID; 32410; 56.
DR   DIP; DIP-4319N; -.
DR   IntAct; P29509; 10.
DR   MINT; P29509; -.
DR   STRING; 4932.YDR353W; -.
DR   iPTMnet; P29509; -.
DR   MaxQB; P29509; -.
DR   PaxDb; P29509; -.
DR   PRIDE; P29509; -.
DR   EnsemblFungi; YDR353W_mRNA; YDR353W; YDR353W.
DR   GeneID; 851955; -.
DR   KEGG; sce:YDR353W; -.
DR   SGD; S000002761; TRR1.
DR   VEuPathDB; FungiDB:YDR353W; -.
DR   eggNOG; KOG0404; Eukaryota.
DR   GeneTree; ENSGT00940000176591; -.
DR   HOGENOM; CLU_031864_5_1_1; -.
DR   InParanoid; P29509; -.
DR   OMA; VDNFPGY; -.
DR   BRENDA; 1.8.1.9; 984.
DR   EvolutionaryTrace; P29509; -.
DR   PRO; PR:P29509; -.
DR   Proteomes; UP000002311; Chromosome IV.
DR   RNAct; P29509; protein.
DR   GO; GO:0005829; C:cytosol; IDA:SGD.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IDA:SGD.
DR   GO; GO:0005739; C:mitochondrion; HDA:SGD.
DR   GO; GO:0008198; F:ferrous iron binding; IDA:SGD.
DR   GO; GO:0004791; F:thioredoxin-disulfide reductase activity; IDA:SGD.
DR   GO; GO:0045454; P:cell redox homeostasis; IDA:SGD.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IGI:SGD.
DR   GO; GO:0019430; P:removal of superoxide radicals; IEA:InterPro.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR008255; Pyr_nucl-diS_OxRdtase_2_AS.
DR   InterPro; IPR005982; Thioredox_Rdtase.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR01292; TRX_reduct; 1.
DR   PROSITE; PS00573; PYRIDINE_REDOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Direct protein sequencing; Disulfide bond; FAD;
KW   Flavoprotein; Mitochondrion; NADP; Oxidoreductase; Phosphoprotein;
KW   Redox-active center; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:7961686"
FT   CHAIN           2..319
FT                   /note="Thioredoxin reductase 1"
FT                   /id="PRO_0000166770"
FT   NP_BIND         11..14
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18930846,
FT                   ECO:0000269|PubMed:20235561"
FT   NP_BIND         40..41
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18930846,
FT                   ECO:0000269|PubMed:20235561"
FT   NP_BIND         295..297
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18930846,
FT                   ECO:0000269|PubMed:20235561"
FT   BINDING         45
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:18930846,
FT                   ECO:0000269|PubMed:20235561"
FT   BINDING         54
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18930846,
FT                   ECO:0000269|PubMed:20235561"
FT   BINDING         87
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:18930846,
FT                   ECO:0000269|PubMed:20235561"
FT   BINDING         145
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18930846,
FT                   ECO:0000269|PubMed:20235561"
FT   BINDING         288
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18930846,
FT                   ECO:0000269|PubMed:20235561"
FT   MOD_RES         303
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18407956"
FT   DISULFID        142..145
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:20235561"
FT   CONFLICT        18
FT                   /note="A -> V (in Ref. 1; AAA64747)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        101
FT                   /note="T -> A (in Ref. 1; AAA64747)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        111
FT                   /note="T -> A (in Ref. 1; AAA64747)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        180..196
FT                   /note="VFMLVRKDHLRASTIMQ -> CLCLSEKTICVLLPLCK (in Ref. 1;
FT                   AAA64747)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..9
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   HELIX           13..24
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          30..32
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          35..37
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   HELIX           45..48
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          49..52
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   HELIX           64..77
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          81..83
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          87..91
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          93..101
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          105..107
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          110..117
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          121..123
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   HELIX           131..134
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   TURN            136..138
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          139..141
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   HELIX           143..146
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   HELIX           150..152
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          155..160
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   HELIX           164..173
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   TURN            174..176
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          177..183
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          185..188
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   HELIX           193..201
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          205..208
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          210..230
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   TURN            231..234
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          235..240
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          242..246
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          250..252
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   HELIX           255..257
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   TURN            258..260
FT                   /evidence="ECO:0007829|PDB:3D8X"
FT   STRAND          275..277
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   STRAND          283..285
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   HELIX           287..290
FT                   /evidence="ECO:0007829|PDB:3ITJ"
FT   HELIX           297..315
FT                   /evidence="ECO:0007829|PDB:3ITJ"
SQ   SEQUENCE   319 AA;  34238 MW;  9F9E58A4BAD859E1 CRC64;
     MVHNKVTIIG SGPAAHTAAI YLARAEIKPI LYEGMMANGI AAGGQLTTTT EIENFPGFPD
     GLTGSELMDR MREQSTKFGT EIITETVSKV DLSSKPFKLW TEFNEDAEPV TTDAIILATG
     ASAKRMHLPG EETYWQKGIS ACAVCDGAVP IFRNKPLAVI GGGDSACEEA QFLTKYGSKV
     FMLVRKDHLR ASTIMQKRAE KNEKIEILYN TVALEAKGDG KLLNALRIKN TKKNEETDLP
     VSGLFYAIGH TPATKIVAGQ VDTDEAGYIK TVPGSSLTSV PGFFAAGDVQ DSKYRQAITS
     AGSGCMAALD AEKYLTSLE
//
ID   PAMO_THEFY              Reviewed;         542 AA.
AC   Q47PU3;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 1.
DT   02-JUN-2021, entry version 118.
DE   RecName: Full=Phenylacetone monooxygenase;
DE            Short=PAMO;
DE            EC=1.14.13.92;
DE   AltName: Full=Baeyer-Villiger monooxygenase;
DE            Short=BVMO;
GN   Name=pamO; OrderedLocusNames=Tfu_1490;
OS   Thermobifida fusca (strain YX).
OC   Bacteria; Actinobacteria; Streptosporangiales; Nocardiopsaceae;
OC   Thermobifida.
OX   NCBI_TaxID=269800;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=YX;
RX   PubMed=17209016; DOI=10.1128/jb.01899-06;
RA   Lykidis A., Mavromatis K., Ivanova N., Anderson I., Land M., DiBartolo G.,
RA   Martinez M., Lapidus A., Lucas S., Copeland A., Richardson P., Wilson D.B.,
RA   Kyrpides N.;
RT   "Genome sequence and analysis of the soil cellulolytic actinomycete
RT   Thermobifida fusca YX.";
RL   J. Bacteriol. 189:2477-2486(2007).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, COFACTOR, SUBUNIT, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15599520; DOI=10.1007/s00253-004-1749-5;
RA   Fraaije M.W., Wu J., Heuts D.P.H.M., van Hellemond E.W.,
RA   Lutje Spelberg J.H., Janssen D.B.;
RT   "Discovery of a thermostable Baeyer-Villiger monooxygenase by genome
RT   mining.";
RL   Appl. Microbiol. Biotechnol. 66:393-400(2005).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH FAD.
RX   PubMed=15328411; DOI=10.1073/pnas.0404538101;
RA   Malito E., Alfieri A., Fraaije M.W., Mattevi A.;
RT   "Crystal structure of a Baeyer-Villiger monooxygenase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:13157-13162(2004).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH FAD AND NADP.
RX   PubMed=21697090; DOI=10.1074/jbc.m111.255075;
RA   Orru R., Dudek H.M., Martinoli C., Torres Pazmino D.E., Royant A., Weik M.,
RA   Fraaije M.W., Mattevi A.;
RT   "Snapshots of enzymatic Baeyer-Villiger catalysis: oxygen activation and
RT   intermediate stabilization.";
RL   J. Biol. Chem. 286:29284-29291(2011).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.87 ANGSTROMS) IN COMPLEX WITH FAD.
RX   PubMed=24443704; DOI=10.1021/cs400837z;
RA   Martinoli C., Dudek H.M., Orru R., Edmondson D.E., Fraaije M.W.,
RA   Mattevi A.;
RT   "Beyond the protein matrix: Probing cofactor variants in a Baeyer-Villiger
RT   oxygenation reaction.";
RL   ACS Catal. 3:3058-3062(2013).
CC   -!- FUNCTION: Catalyzes a Baeyer-Villiger oxidation reaction, i.e. the
CC       insertion of an oxygen atom into a carbon-carbon bond adjacent to a
CC       carbonyl, which converts ketones to esters. Is most efficient with
CC       phenylacetone as substrate, leading to the formation of benzyl acetate.
CC       Can also oxidize other aromatic ketones (benzylacetone, alpha-
CC       methylphenylacetone and 4-hydroxyacetophenone), some aliphatic ketones
CC       (dodecan-2-one and bicyclohept-2-en-6-one) and sulfides (e.g. methyl 4-
CC       tolylsulfide). {ECO:0000269|PubMed:15599520}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADPH + O2 + phenylacetone = benzyl acetate + H2O +
CC         NADP(+); Xref=Rhea:RHEA:10124, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:52051, ChEBI:CHEBI:52052,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.14.13.92;
CC         Evidence={ECO:0000269|PubMed:15599520};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:15599520};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:15599520};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3 uM for NADPH {ECO:0000269|PubMed:15599520};
CC         KM=59 uM for phenylacetone {ECO:0000269|PubMed:15599520};
CC         KM=360 uM for benzylacetone {ECO:0000269|PubMed:15599520};
CC         KM=830 uM for alpha-methylphenylacetone
CC         {ECO:0000269|PubMed:15599520};
CC         KM=2.2 mM for 4-hydroxyacetophenone {ECO:0000269|PubMed:15599520};
CC         KM=260 uM for 2-dodecanone {ECO:0000269|PubMed:15599520};
CC         KM=15 mM for bicyclohept-2-en-6-one {ECO:0000269|PubMed:15599520};
CC         KM=860 uM for methyl 4-tolylsulfide {ECO:0000269|PubMed:15599520};
CC       pH dependence:
CC         Optimum pH is 8.0. {ECO:0000269|PubMed:15599520};
CC       Temperature dependence:
CC         Thermostable. Displays an activity half-life of 1 day at 52 degrees
CC         Celsius. {ECO:0000269|PubMed:15599520};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:15328411,
CC       ECO:0000269|PubMed:15599520}.
CC   -!- SIMILARITY: Belongs to the FAD-binding monooxygenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000088; AAZ55526.1; -; Genomic_DNA.
DR   RefSeq; WP_011291921.1; NC_007333.1.
DR   PDB; 1W4X; X-ray; 1.70 A; A=1-542.
DR   PDB; 2YLR; X-ray; 2.26 A; A=1-542.
DR   PDB; 2YLS; X-ray; 2.26 A; A=1-542.
DR   PDB; 2YLT; X-ray; 2.65 A; A=1-542.
DR   PDB; 2YLW; X-ray; 2.90 A; A=1-542.
DR   PDB; 2YLX; X-ray; 2.20 A; A=1-542.
DR   PDB; 2YLZ; X-ray; 2.00 A; A=1-542.
DR   PDB; 2YM1; X-ray; 2.28 A; A=1-542.
DR   PDB; 2YM2; X-ray; 2.70 A; A=1-542.
DR   PDB; 4C74; X-ray; 1.97 A; A=1-542.
DR   PDB; 4C77; X-ray; 2.70 A; A=1-542.
DR   PDB; 4D03; X-ray; 1.81 A; A=1-542.
DR   PDB; 4D04; X-ray; 1.75 A; A=1-542.
DR   PDB; 4OVI; X-ray; 1.87 A; A=1-542.
DR   PDBsum; 1W4X; -.
DR   PDBsum; 2YLR; -.
DR   PDBsum; 2YLS; -.
DR   PDBsum; 2YLT; -.
DR   PDBsum; 2YLW; -.
DR   PDBsum; 2YLX; -.
DR   PDBsum; 2YLZ; -.
DR   PDBsum; 2YM1; -.
DR   PDBsum; 2YM2; -.
DR   PDBsum; 4C74; -.
DR   PDBsum; 4C77; -.
DR   PDBsum; 4D03; -.
DR   PDBsum; 4D04; -.
DR   PDBsum; 4OVI; -.
DR   SMR; Q47PU3; -.
DR   STRING; 269800.Tfu_1490; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   EnsemblBacteria; AAZ55526; AAZ55526; Tfu_1490.
DR   KEGG; tfu:Tfu_1490; -.
DR   eggNOG; COG2072; Bacteria.
DR   HOGENOM; CLU_006937_8_1_11; -.
DR   OMA; YRYSWDL; -.
DR   OrthoDB; 630753at2; -.
DR   BioCyc; TFUS269800:G1G4Q-1502-MONOMER; -.
DR   BRENDA; 1.14.13.92; 6298.
DR   EvolutionaryTrace; Q47PU3; -.
DR   Proteomes; UP000000434; Chromosome.
DR   GO; GO:0033776; F:phenylacetone monooxygenase activity; IEA:UniProtKB-EC.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   SUPFAM; SSF51905; SSF51905; 2.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Monooxygenase; NADP; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN           1..542
FT                   /note="Phenylacetone monooxygenase"
FT                   /id="PRO_0000287885"
FT   NP_BIND         54..57
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15328411,
FT                   ECO:0000269|PubMed:21697090, ECO:0000269|PubMed:24443704"
FT   NP_BIND         64..66
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:21697090"
FT   NP_BIND         194..200
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:21697090"
FT   NP_BIND         217..218
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:21697090"
FT   NP_BIND         336..337
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:21697090"
FT   BINDING         27
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15328411,
FT                   ECO:0000269|PubMed:21697090, ECO:0000269|PubMed:24443704"
FT   BINDING         46
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15328411,
FT                   ECO:0000269|PubMed:21697090, ECO:0000269|PubMed:24443704"
FT   BINDING         66
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15328411,
FT                   ECO:0000269|PubMed:21697090, ECO:0000269|PubMed:24443704"
FT   BINDING         72
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15328411,
FT                   ECO:0000269|PubMed:21697090, ECO:0000269|PubMed:24443704"
FT   BINDING         119
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:15328411,
FT                   ECO:0000269|PubMed:21697090, ECO:0000269|PubMed:24443704"
FT   BINDING         152
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15328411,
FT                   ECO:0000269|PubMed:21697090, ECO:0000269|PubMed:24443704"
FT   BINDING         446
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:15328411,
FT                   ECO:0000269|PubMed:21697090, ECO:0000269|PubMed:24443704"
FT   BINDING         501
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:21697090"
FT   SITE            337
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000269|PubMed:15328411,
FT                   ECO:0000269|PubMed:21697090"
FT   STRAND          15..22
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           26..37
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          42..45
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          47..51
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           54..57
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   TURN            69..71
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           78..83
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          88..90
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           93..106
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           109..112
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          119..125
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   TURN            126..129
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          130..135
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          140..148
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           164..166
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          169..173
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           174..176
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          188..192
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           196..208
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          209..218
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          222..224
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           232..239
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           242..250
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          252..256
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   TURN            265..267
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           270..283
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           286..290
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   TURN            293..297
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           299..316
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          317..319
FT                   /evidence="ECO:0007829|PDB:2YLX"
FT   HELIX           320..326
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          333..336
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          339..343
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           344..347
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          353..357
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   TURN            358..360
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          363..366
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          368..375
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          377..379
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          381..385
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   TURN            391..393
FT                   /evidence="ECO:0007829|PDB:4D04"
FT   HELIX           394..397
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          399..402
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           404..406
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           409..412
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   TURN            413..415
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   TURN            421..423
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          431..435
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           441..443
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           446..466
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          471..474
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           476..490
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           495..497
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           499..501
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          502..504
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   HELIX           521..533
FT                   /evidence="ECO:0007829|PDB:1W4X"
FT   STRAND          539..542
FT                   /evidence="ECO:0007829|PDB:1W4X"
SQ   SEQUENCE   542 AA;  61124 MW;  B24DF347F3D23D02 CRC64;
     MAGQTTVDSR RQPPEEVDVL VVGAGFSGLY ALYRLRELGR SVHVIETAGD VGGVWYWNRY
     PGARCDIESI EYCYSFSEEV LQEWNWTERY ASQPEILRYI NFVADKFDLR SGITFHTTVT
     AAAFDEATNT WTVDTNHGDR IRARYLIMAS GQLSVPQLPN FPGLKDFAGN LYHTGNWPHE
     PVDFSGQRVG VIGTGSSGIQ VSPQIAKQAA ELFVFQRTPH FAVPARNAPL DPEFLADLKK
     RYAEFREESR NTPGGTHRYQ GPKSALEVSD EELVETLERY WQEGGPDILA AYRDILRDRD
     ANERVAEFIR NKIRNTVRDP EVAERLVPKG YPFGTKRLIL EIDYYEMFNR DNVHLVDTLS
     APIETITPRG VRTSEREYEL DSLVLATGFD ALTGALFKID IRGVGNVALK EKWAAGPRTY
     LGLSTAGFPN LFFIAGPGSP SALSNMLVSI EQHVEWVTDH IAYMFKNGLT RSEAVLEKED
     EWVEHVNEIA DETLYPMTAS WYTGANVPGK PRVFMLYVGG FHRYRQICDE VAAKGYEGFV
     LT
//
ID   ROX_NOCFA               Reviewed;         473 AA.
AC   Q5YTV5;
DT   13-FEB-2019, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   02-JUN-2021, entry version 100.
DE   RecName: Full=Rifampicin monooxygenase {ECO:0000303|PubMed:19942945};
DE            Short=RIFMO {ECO:0000303|PubMed:19942945};
DE            EC=1.14.13.- {ECO:0000303|PubMed:19942945};
GN   Name=rox; OrderedLocusNames=NFA_35380;
OS   Nocardia farcinica (strain IFM 10152).
OC   Bacteria; Actinobacteria; Corynebacteriales; Nocardiaceae; Nocardia.
OX   NCBI_TaxID=247156;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=IFM 10152;
RX   PubMed=15466710; DOI=10.1073/pnas.0406410101;
RA   Ishikawa J., Yamashita A., Mikami Y., Hoshino Y., Kurita H., Hotta K.,
RA   Shiba T., Hattori M.;
RT   "The complete genomic sequence of Nocardia farcinica IFM 10152.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:14925-14930(2004).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=19942945; DOI=10.1038/ja.2009.116;
RA   Hoshino Y., Fujii S., Shinonaga H., Arai K., Saito F., Fukai T., Satoh H.,
RA   Miyazaki Y., Ishikawa J.;
RT   "Monooxygenation of rifampicin catalyzed by the rox gene product of
RT   Nocardia farcinica: structure elucidation, gene identification and role in
RT   drug resistance.";
RL   J. Antibiot. 63:23-28(2010).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH FAD, SUBUNIT, AND
RP   COFACTOR.
RX   PubMed=27557658; DOI=10.1074/jbc.m116.745315;
RA   Liu L.K., Abdelwahab H., Martin Del Campo J.S., Mehra-Chaudhary R.,
RA   Sobrado P., Tanner J.J.;
RT   "The Structure of the Antibiotic Deactivating, N-hydroxylating Rifampicin
RT   Monooxygenase.";
RL   J. Biol. Chem. 291:21553-21562(2016).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS), AND COFACTOR.
RX   PubMed=29578336; DOI=10.1021/acs.biochem.8b00190;
RA   Liu L.K., Dai Y., Abdelwahab H., Sobrado P., Tanner J.J.;
RT   "Structural Evidence for Rifampicin Monooxygenase Inactivating Rifampicin
RT   by Cleaving Its Ansa-Bridge.";
RL   Biochemistry 57:2065-2068(2018).
CC   -!- FUNCTION: Monooxygenase that can modify rifampicin, thereby
CC       inactivating its antibiotic activity. It constitutes a secondary
CC       rifampicin resistance factor. {ECO:0000269|PubMed:19942945}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADPH + O2 + rifampicin = H(+) + H2O + NADP(+) + rifampicin
CC         para-naphthoquinone carboxamide; Xref=Rhea:RHEA:58696,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:71365,
CC         ChEBI:CHEBI:142731; Evidence={ECO:0000269|PubMed:19942945};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58697;
CC         Evidence={ECO:0000303|PubMed:15466710};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADH + O2 + rifampicin = H(+) + H2O + NAD(+) + rifampicin
CC         para-naphthoquinone carboxamide; Xref=Rhea:RHEA:58712,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:71365,
CC         ChEBI:CHEBI:142731; Evidence={ECO:0000269|PubMed:19942945};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58713;
CC         Evidence={ECO:0000303|PubMed:19942945};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:27557658, ECO:0000269|PubMed:29578336};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:27557658}.
CC   -!- DISRUPTION PHENOTYPE: No visible effect on rifampicin resistance.
CC       {ECO:0000269|PubMed:19942945}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AP006618; BAD58386.1; -; Genomic_DNA.
DR   RefSeq; WP_011210071.1; NG_052045.1.
DR   PDB; 5KOW; X-ray; 2.10 A; A=1-473.
DR   PDB; 5KOX; X-ray; 1.80 A; A=1-473.
DR   PDB; 6C7S; X-ray; 2.10 A; A=1-473.
DR   PDBsum; 5KOW; -.
DR   PDBsum; 5KOX; -.
DR   PDBsum; 6C7S; -.
DR   SMR; Q5YTV5; -.
DR   STRING; 247156.NFA_35380; -.
DR   EnsemblBacteria; BAD58386; BAD58386; NFA_35380.
DR   GeneID; 61134239; -.
DR   KEGG; nfa:NFA_35380; -.
DR   eggNOG; COG0654; Bacteria.
DR   HOGENOM; CLU_009665_20_1_11; -.
DR   OMA; KNFLMIG; -.
DR   BRENDA; 1.14.13.211; 10091.
DR   Proteomes; UP000006820; Chromosome.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Monooxygenase; Nucleotide-binding;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN           1..473
FT                   /note="Rifampicin monooxygenase"
FT                   /id="PRO_0000446368"
FT   NP_BIND         11..12
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27557658,
FT                   ECO:0000269|PubMed:29578336"
FT   NP_BIND         31..32
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27557658,
FT                   ECO:0000269|PubMed:29578336"
FT   NP_BIND         41..43
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27557658,
FT                   ECO:0000269|PubMed:29578336"
FT   NP_BIND         283..290
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27557658,
FT                   ECO:0000269|PubMed:29578336"
FT   BINDING         98
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27557658,
FT                   ECO:0000269|PubMed:29578336"
FT   BINDING         122
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:27557658,
FT                   ECO:0000269|PubMed:29578336"
FT   BINDING         156
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27557658,
FT                   ECO:0000269|PubMed:29578336"
FT   BINDING         276
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27557658,
FT                   ECO:0000269|PubMed:29578336"
FT   STRAND          2..7
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   HELIX           11..21
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   TURN            22..24
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          27..32
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   HELIX           47..55
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   HELIX           59..63
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          66..69
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   TURN            74..77
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          87..89
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          92..95
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   HELIX           98..111
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          115..118
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          122..127
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          132..136
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          141..149
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   HELIX           156..161
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          173..180
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   HELIX           185..195
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   TURN            196..198
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          203..206
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          208..210
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          212..217
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   HELIX           230..241
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          248..257
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          260..262
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          266..268
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          271..273
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   HELIX           275..277
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   TURN            283..285
FT                   /evidence="ECO:0007829|PDB:5KOW"
FT   HELIX           288..307
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   TURN            313..316
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   HELIX           317..340
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   HELIX           345..358
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   HELIX           361..371
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   TURN            372..375
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   TURN            385..388
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          397..400
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   HELIX           401..404
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          410..414
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   TURN            425..427
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          428..432
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          439..445
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   STRAND          449..454
FT                   /evidence="ECO:0007829|PDB:5KOX"
FT   HELIX           458..469
FT                   /evidence="ECO:0007829|PDB:5KOX"
SQ   SEQUENCE   473 AA;  51364 MW;  DBC19CD1A8AA2806 CRC64;
     MIDVIIAGGG PTGLMLAGEL RLHGVRTVVL EKEPTPNQHS RSRGLHARSI EVMDQRGLLE
     RFLAHGEQFR VGGFFAGLAA EWPADLDTAH SYVLAIPQVV TERLLTEHAT ELGAEIRRGC
     EVAGLDQDAD GVTAELADGT RLRARYLVGC DGGRSTVRRL LGVDFPGEPT RVETLLADVR
     IDVPVETLTA VVAEVRKTQL RFGAVPAGDG FFRLIVPAQG LSADRAAPTL DELKRCLHAT
     AGTDFGVHSP RWLSRFGDAT RLAERYRTGR VLLAGDAAHI HPPTGGQGLN LGIQDAFNLG
     WKLAAAIGGW APPDLLDSYH DERHPVAAEV LDNTRAQMTL LSLDPGPRAV RRLMAELVEF
     PDVNRHLIEK ITAIAVRYDL GDGHDLVGRR LRDIPLTEGR LYERMRGGRG LLLDRTGRLS
     VSGWSDRVDH LADPGAALDV PAALLRPDGH VAWVGEDQDD LLAHLPRWFG AAT
//
ID   M2GD_HUMAN              Reviewed;         866 AA.
AC   Q9UI17; B2RBN0; B4E1J9;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   02-JUN-2021, entry version 177.
DE   RecName: Full=Dimethylglycine dehydrogenase, mitochondrial;
DE            EC=1.5.8.4 {ECO:0000269|PubMed:27486859};
DE   AltName: Full=ME2GLYDH;
DE   Flags: Precursor;
GN   Name=DMGDH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT PRO-279.
RX   PubMed=10767172; DOI=10.1006/mgme.2000.2980;
RA   Binzak B.A., Vockley J.G., Jenkins R.B., Vockley J.;
RT   "Structure and analysis of the human dimethylglycine dehydrogenase gene.";
RL   Mol. Genet. Metab. 69:181-187(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS GLY-530 AND PRO-646, AND
RP   VARIANT DMGDHD ARG-109.
RX   PubMed=11231903; DOI=10.1086/319520;
RA   Binzak B.A., Wevers R.A., Moolenaar S.H., Lee Y.-M., Hwu W.-L.,
RA   Poggi-Bach J., Engelke U.F.H., Hoard H.M., Vockley J.G., Vockley J.;
RT   "Cloning of dimethylglycine dehydrogenase and a new human inborn error of
RT   metabolism, dimethylglycine dehydrogenase deficiency.";
RL   Am. J. Hum. Genet. 68:839-847(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   PRO-279.
RC   TISSUE=Synovial cell, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [5]
RP   DISEASE.
RX   PubMed=10102904;
RA   Moolenaar S.H., Poggi-Bach J., Engelke U.F.H., Corstiaensen J.M.B.,
RA   Heerschap A., de Jong J.G.N., Binzak B.A., Vockley J., Wevers R.A.;
RT   "Defect in dimethylglycine dehydrogenase, a new inborn error of metabolism:
RT   NMR spectroscopy study.";
RL   Clin. Chem. 45:459-464(1999).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (3.09 ANGSTROMS) OF 29-866 IN COMPLEX WITH FAD,
RP   CHARACTERIZATION OF VARIANT DMGDHD ARG-109, FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND ENZYME KINETICS.
RX   PubMed=27486859; DOI=10.1111/febs.13828;
RA   Augustin P., Hromic A., Pavkov-Keller T., Gruber K., Macheroux P.;
RT   "Structure and biochemical properties of recombinant human dimethylglycine
RT   dehydrogenase and comparison to the disease-related H109R variant.";
RL   FEBS J. 283:3587-3603(2016).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] PRO-646, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Catalyzes the demethylation of N,N-dimethylglycine to
CC       sarcosine. Also has activity with sarcosine in vitro.
CC       {ECO:0000269|PubMed:27486859}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6S)-5,6,7,8-tetrahydrofolyl-(gamma-L-Glu)n + H(+) + N,N-
CC         dimethylglycine + oxidized [electron-transfer flavoprotein] = (6R)-
CC         5,10-methylenetetrahydrofolyl-(gamma-L-Glu)(n) + reduced [electron-
CC         transfer flavoprotein] + sarcosine; Xref=Rhea:RHEA:52856, Rhea:RHEA-
CC         COMP:10685, Rhea:RHEA-COMP:10686, Rhea:RHEA-COMP:13257, Rhea:RHEA-
CC         COMP:14738, ChEBI:CHEBI:15378, ChEBI:CHEBI:57433, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58251, ChEBI:CHEBI:58307, ChEBI:CHEBI:136572,
CC         ChEBI:CHEBI:141005; EC=1.5.8.4;
CC         Evidence={ECO:0000269|PubMed:27486859};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:27486859};
CC       Note=Binds 1 FAD covalently per monomer. {ECO:0000269|PubMed:27486859};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.4 mM for N,N-dimethylglycine {ECO:0000269|PubMed:27486859};
CC         Vmax=22.1 umol/min/mg enzyme;
CC         Note=kcat is 213 min(-1) for N,N-dimethylglycine.
CC         {ECO:0000269|PubMed:27486859};
CC   -!- PATHWAY: Amine and polyamine degradation; betaine degradation;
CC       sarcosine from betaine: step 2/2.
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UI17-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UI17-2; Sequence=VSP_056959, VSP_056960, VSP_056961,
CC                                  VSP_056962;
CC   -!- DISEASE: DMGDH deficiency (DMGDHD) [MIM:605850]: Disorder characterized
CC       by fish odor, muscle fatigue with increased serum creatine kinase.
CC       Biochemically it is characterized by an increase of N,N-dimethylglycine
CC       (DMG) in serum and urine. {ECO:0000269|PubMed:11231903,
CC       ECO:0000269|PubMed:27486859}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the GcvT family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF111858; AAF21941.1; -; mRNA.
DR   EMBL; AK303873; BAG64811.1; -; mRNA.
DR   EMBL; AK314736; BAG37277.1; -; mRNA.
DR   EMBL; AC008502; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016559; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020937; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS4044.1; -. [Q9UI17-1]
DR   RefSeq; NP_037523.2; NM_013391.3. [Q9UI17-1]
DR   PDB; 5L46; X-ray; 3.09 A; A/B=29-866.
DR   PDBsum; 5L46; -.
DR   SMR; Q9UI17; -.
DR   BioGRID; 118994; 2.
DR   IntAct; Q9UI17; 2.
DR   STRING; 9606.ENSP00000255189; -.
DR   CarbonylDB; Q9UI17; -.
DR   iPTMnet; Q9UI17; -.
DR   PhosphoSitePlus; Q9UI17; -.
DR   BioMuta; DMGDH; -.
DR   DMDM; 296434575; -.
DR   MassIVE; Q9UI17; -.
DR   PaxDb; Q9UI17; -.
DR   PeptideAtlas; Q9UI17; -.
DR   PRIDE; Q9UI17; -.
DR   ProteomicsDB; 5764; -.
DR   ProteomicsDB; 84455; -. [Q9UI17-1]
DR   Antibodypedia; 48453; 185 antibodies.
DR   DNASU; 29958; -.
DR   Ensembl; ENST00000255189; ENSP00000255189; ENSG00000132837. [Q9UI17-1]
DR   GeneID; 29958; -.
DR   KEGG; hsa:29958; -.
DR   UCSC; uc003kfs.5; human. [Q9UI17-1]
DR   CTD; 29958; -.
DR   DisGeNET; 29958; -.
DR   GeneCards; DMGDH; -.
DR   HGNC; HGNC:24475; DMGDH.
DR   HPA; ENSG00000132837; Group enriched (kidney, liver).
DR   MalaCards; DMGDH; -.
DR   MIM; 605849; gene.
DR   MIM; 605850; phenotype.
DR   neXtProt; NX_Q9UI17; -.
DR   OpenTargets; ENSG00000132837; -.
DR   Orphanet; 243343; Dimethylglycine dehydrogenase deficiency.
DR   PharmGKB; PA134947212; -.
DR   VEuPathDB; HostDB:ENSG00000132837.14; -.
DR   eggNOG; KOG2844; Eukaryota.
DR   GeneTree; ENSGT00940000158176; -.
DR   HOGENOM; CLU_007884_11_1_1; -.
DR   InParanoid; Q9UI17; -.
DR   OMA; PAIPVEH; -.
DR   PhylomeDB; Q9UI17; -.
DR   TreeFam; TF314735; -.
DR   BioCyc; MetaCyc:HS05695-MONOMER; -.
DR   BRENDA; 1.5.8.4; 2681.
DR   PathwayCommons; Q9UI17; -.
DR   Reactome; R-HSA-6798163; Choline catabolism.
DR   UniPathway; UPA00291; UER00433.
DR   BioGRID-ORCS; 29958; 1 hit in 988 CRISPR screens.
DR   ChiTaRS; DMGDH; human.
DR   GenomeRNAi; 29958; -.
DR   Pharos; Q9UI17; Tbio.
DR   PRO; PR:Q9UI17; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q9UI17; protein.
DR   Bgee; ENSG00000132837; Expressed in adult mammalian kidney and 162 other tissues.
DR   ExpressionAtlas; Q9UI17; baseline and differential.
DR   Genevisible; Q9UI17; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005759; C:mitochondrial matrix; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0047865; F:dimethylglycine dehydrogenase activity; IMP:UniProtKB.
DR   GO; GO:0009055; F:electron transfer activity; NAS:UniProtKB.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0006579; P:amino-acid betaine catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0042426; P:choline catabolic process; IMP:UniProtKB.
DR   GO; GO:0019695; P:choline metabolic process; NAS:UniProtKB.
DR   Gene3D; 3.30.1360.120; -; 1.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR032503; FAO_M.
DR   InterPro; IPR013977; GCV_T_C.
DR   InterPro; IPR006222; GCV_T_N.
DR   InterPro; IPR029043; GcvT/YgfZ_C.
DR   InterPro; IPR027266; TrmE/GcvT_dom1.
DR   Pfam; PF01266; DAO; 1.
DR   Pfam; PF16350; FAO_M; 1.
DR   Pfam; PF01571; GCV_T; 1.
DR   Pfam; PF08669; GCV_T_C; 1.
DR   SUPFAM; SSF101790; SSF101790; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Disease variant; FAD;
KW   Flavoprotein; Mitochondrion; Oxidoreductase; Reference proteome;
KW   Transit peptide.
FT   TRANSIT         1..50
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           51..866
FT                   /note="Dimethylglycine dehydrogenase, mitochondrial"
FT                   /id="PRO_0000010767"
FT   NP_BIND         59..60
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27486859,
FT                   ECO:0007744|PDB:5L46"
FT   NP_BIND         80..81
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27486859,
FT                   ECO:0007744|PDB:5L46"
FT   NP_BIND         87..95
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27486859,
FT                   ECO:0007744|PDB:5L46"
FT   NP_BIND         397..402
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:27486859,
FT                   ECO:0007744|PDB:5L46"
FT   REGION          20..42
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          580..582
FT                   /note="Tetrahydrofolate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q63342"
FT   REGION          683..685
FT                   /note="Tetrahydrofolate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q63342"
FT   BINDING         219
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:27486859,
FT                   ECO:0007744|PDB:5L46"
FT   BINDING         251
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q63342"
FT   BINDING         676
FT                   /note="Tetrahydrofolate"
FT                   /evidence="ECO:0000250|UniProtKB:Q63342"
FT   BINDING         744
FT                   /note="Tetrahydrofolate"
FT                   /evidence="ECO:0000250|UniProtKB:Q63342"
FT   MOD_RES         91
FT                   /note="Tele-8alpha-FAD histidine"
FT                   /evidence="ECO:0000269|PubMed:27486859,
FT                   ECO:0007744|PDB:5L46"
FT   MOD_RES         114
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         148
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         148
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         168
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         223
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         317
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         319
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         335
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         360
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         434
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         434
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         523
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         523
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         655
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         655
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         764
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   MOD_RES         795
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBT9"
FT   VAR_SEQ         1..18
FT                   /note="MLRPGAQLLRGLLLRSCP -> MWSCWRNQSSRLDLPGTQ (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056959"
FT   VAR_SEQ         19..398
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056960"
FT   VAR_SEQ         751..774
FT                   /note="PADFIGKQALKQIKAKGLKRRLVC -> DQNSCFAHFKEENGWVSRWAIRPY
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056961"
FT   VAR_SEQ         775..866
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056962"
FT   VARIANT         109
FT                   /note="H -> R (in DMGDHD; shows 10 fold lower catalytic
FT                   efficiency due to lower cofactor saturation and reduced
FT                   thermal stability; dbSNP:rs121908331)"
FT                   /evidence="ECO:0000269|PubMed:11231903,
FT                   ECO:0000269|PubMed:27486859"
FT                   /id="VAR_011505"
FT   VARIANT         279
FT                   /note="S -> P (in dbSNP:rs532964)"
FT                   /evidence="ECO:0000269|PubMed:10767172,
FT                   ECO:0000269|PubMed:14702039"
FT                   /id="VAR_014950"
FT   VARIANT         530
FT                   /note="A -> G (in dbSNP:rs1805073)"
FT                   /evidence="ECO:0000269|PubMed:11231903"
FT                   /id="VAR_014951"
FT   VARIANT         646
FT                   /note="S -> P (in dbSNP:rs1805074)"
FT                   /evidence="ECO:0000269|PubMed:11231903,
FT                   ECO:0007744|PubMed:24275569"
FT                   /id="VAR_014952"
FT   CONFLICT        381
FT                   /note="M -> I (in Ref. 3; BAG37277)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        627
FT                   /note="L -> F (in Ref. 3; BAG37277)"
FT                   /evidence="ECO:0000305"
FT   STRAND          48..55
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           59..70
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          74..79
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          81..83
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   TURN            84..88
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           89..91
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          101..103
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           105..123
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          134..138
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           141..154
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          157..159
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          162..164
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           166..170
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          183..187
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           195..208
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          212..214
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          221..224
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          230..233
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          238..246
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           249..251
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           252..256
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           257..259
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          266..275
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           279..283
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          290..293
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   TURN            294..296
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          298..303
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          306..311
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   TURN            315..317
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           323..326
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           342..344
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           346..355
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           357..360
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          364..374
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          381..384
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          391..395
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           400..415
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   TURN            425..427
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           438..450
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           451..453
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           474..478
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           479..481
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          482..487
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          490..496
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           515..527
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          530..533
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          537..544
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           547..554
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          564..571
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          577..585
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          591..595
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           597..599
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           600..613
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          619..622
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   TURN            624..626
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          630..634
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           637..642
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   TURN            651..653
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          658..664
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          667..673
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          678..687
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           690..702
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   TURN            703..706
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           712..722
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   TURN            727..729
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   TURN            737..741
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           743..745
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          750..752
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           757..766
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          769..777
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          789..792
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          795..806
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   TURN            807..810
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          811..819
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   HELIX           820..822
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          828..833
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   STRAND          836..842
FT                   /evidence="ECO:0007829|PDB:5L46"
FT   TURN            851..853
FT                   /evidence="ECO:0007829|PDB:5L46"
SQ   SEQUENCE   866 AA;  96811 MW;  2EC1FA7DCB6C1F8C CRC64;
     MLRPGAQLLR GLLLRSCPLQ GSPGRPRSVC GREGEEKPPL SAETQWKDRA ETVIIGGGCV
     GVSLAYHLAK AGMKDVVLLE KSELTAGSTW HAAGLTTYFH PGINLKKIHY DSIKLYEKLE
     EETGQVVGFH QPGSIRLATT PVRVDEFKYQ MTRTGWHATE QYLIEPEKIQ EMFPLLNMNK
     VLAGLYNPGD GHIDPYSLTM ALAAGARKCG ALLKYPAPVT SLKARSDGTW DVETPQGSMR
     ANRIVNAAGF WAREVGKMIG LEHPLIPVQH QYVVTSTISE VKALKRELPV LRDLEGSYYL
     RQERDGLLFG PYESQEKMKV QDSWVTNGVP PGFGKELFES DLDRIMEHIK AAMEMVPVLK
     KADIINVVNG PITYSPDILP MVGPHQGVRN YWVAIGFGYG IIHAGGVGKY LSDWILHGEP
     PFDLIELDPN RYGKWTTTQY TEAKARESYG FNNIVGYPKE ERFAGRPTQR VSGLYQRLES
     KCSMGFHAGW EQPHWFYKPG QDTQYRPSFR RTNWFEPVGS EYKQVMQRVA VTDLSPFGKF
     NIKGQDSIRL LDHLFANVIP KVGFTNISHM LTPKGRVYAE LTVSHQSPGE FLLITGSGSE
     LHDLRWIEEE AVKGGYDVEI KNITDELGVL GVAGPQARKV LQKLTSEDLS DDVFKFLQTK
     SLKVSNIPVT AIRISYTGEL GWELYHRRED SVALYDAIMN AGQEEGIDNF GTYAMNALRL
     EKAFRAWGLE MNCDTNPLEA GLEYFVKLNK PADFIGKQAL KQIKAKGLKR RLVCLTLATD
     DVDPEGNESI WYNGKVVGNT TSGSYSYSIQ KSLAFAYVPV QLSEVGQQVE VELLGKNYPA
     VIIQEPLVLT EPTRNRLQKK GGKDKT
//
ID   NAO_FUSOX               Reviewed;         439 AA.
AC   Q8X1D8;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   02-JUN-2021, entry version 97.
DE   RecName: Full=Nitroalkane oxidase;
DE            Short=NAO;
DE            EC=1.7.3.1;
OS   Fusarium oxysporum (Fusarium vascular wilt).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;
OC   Hypocreomycetidae; Hypocreales; Nectriaceae; Fusarium;
OC   Fusarium oxysporum species complex.
OX   NCBI_TaxID=5507;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, CATALYTIC ACTIVITY,
RP   FUNCTION, MUTAGENESIS OF ASP-402, ACTIVE SITE, AND COFACTOR.
RC   STRAIN=ATCC 695;
RX   PubMed=11867731; DOI=10.1073/pnas.052527799;
RA   Daubner S.C., Gadda G., Valley M.P., Fitzpatrick P.F.;
RT   "Cloning of nitroalkane oxidase from Fusarium oxysporum identifies a new
RT   member of the acyl-CoA dehydrogenase superfamily.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:2702-2707(2002).
RN   [2]
RP   CATALYTIC ACTIVITY, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT,
RP   COFACTOR, ACTIVITY REGULATION, AND INDUCTION.
RC   STRAIN=ATCC 659 / NBRC 5942 / DR 1004;
RX   PubMed=22538; DOI=10.1128/jb.133.1.53-58.1978;
RA   Kido T., Hashizume K., Soda K.;
RT   "Purification and properties of nitroalkane oxidase from Fusarium
RT   oxysporum.";
RL   J. Bacteriol. 133:53-58(1978).
RN   [3]
RP   CATALYTIC ACTIVITY, ACTIVE SITE, AND MUTAGENESIS OF ASP-402.
RX   PubMed=12862464; DOI=10.1021/ja036045s;
RA   Valley M.P., Fitzpatrick P.F.;
RT   "Inactivation of nitroalkane oxidase upon mutation of the active site base
RT   and rescue with a deprotonated substrate.";
RL   J. Am. Chem. Soc. 125:8738-8739(2003).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) IN COMPLEX WITH THE SUBSTRATE
RP   NITROBUTANE AND FAD, FUNCTION, COFACTOR, ACTIVE SITE, AND SUBUNIT.
RX   PubMed=16430210; DOI=10.1021/bi051966w;
RA   Nagpal A., Valley M.P., Fitzpatrick P.F., Orville A.M.;
RT   "Crystal structures of nitroalkane oxidase: insights into the reaction
RT   mechanism from a covalent complex of the flavoenzyme trapped during
RT   turnover.";
RL   Biochemistry 45:1138-1150(2006).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF MUTANT LYS-409 IN COMPLEX WITH
RP   FAD, COFACTOR, CATALYTIC ACTIVITY, AND MUTAGENESIS OF ARG-409.
RX   PubMed=17994768; DOI=10.1021/bi701557k;
RA   Fitzpatrick P.F., Bozinovski D.M., Heroux A., Shaw P.G., Valley M.P.,
RA   Orville A.M.;
RT   "Mechanistic and structural analyses of the roles of Arg409 and Asp402 in
RT   the reaction of the flavoprotein nitroalkane oxidase.";
RL   Biochemistry 46:13800-13808(2007).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF MUTANTS ALA-276 AND ASN-402 IN
RP   COMPLEXES WITH THE SUBSTRATE 1-NITROHEXANE AND FAD, CATALYTIC ACTIVITY,
RP   COFACTOR, AND MUTAGENESIS OF SER-276 AND ASP-402.
RX   PubMed=19265437; DOI=10.1021/bi8023042;
RA   Heroux A., Bozinovski D.M., Valley M.P., Fitzpatrick P.F., Orville A.M.;
RT   "Crystal structures of intermediates in the nitroalkane oxidase reaction.";
RL   Biochemistry 48:3407-3416(2009).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF MUTANT ASN-402 IN COMPLEX WITH
RP   FAD AND THE SUBSTRATE NITROETHANE, AND COFACTOR.
RX   PubMed=19926855; DOI=10.1073/pnas.0911416106;
RA   Major D.T., Heroux A., Orville A.M., Valley M.P., Fitzpatrick P.F., Gao J.;
RT   "Differential quantum tunneling contributions in nitroalkane oxidase
RT   catalyzed and the uncatalyzed proton transfer reaction.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:20734-20739(2009).
CC   -!- FUNCTION: Catalyzes the oxidative denitrification of neutral
CC       nitroalkanes, including 3-nitro-2-pentanol, 1-nitropropane, 2-
CC       nitropropane, nitroethane and nitrocyclohexane, and may thereby protect
CC       the organism against toxic compounds. Has no detectable acyl-CoA
CC       dehydrogenase activity. {ECO:0000269|PubMed:11867731,
CC       ECO:0000269|PubMed:16430210, ECO:0000269|PubMed:22538}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a primary nitroalkane + H2O + O2 = an aldehyde + H(+) + H2O2 +
CC         nitrite; Xref=Rhea:RHEA:20976, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:16301,
CC         ChEBI:CHEBI:17478, ChEBI:CHEBI:133972; EC=1.7.3.1;
CC         Evidence={ECO:0000269|PubMed:11867731, ECO:0000269|PubMed:12862464,
CC         ECO:0000269|PubMed:17994768, ECO:0000269|PubMed:19265437,
CC         ECO:0000269|PubMed:22538};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a secondary nitroalkane + H2O + O2 = a ketone + H(+) + H2O2 +
CC         nitrite; Xref=Rhea:RHEA:26490, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:16301,
CC         ChEBI:CHEBI:17087, ChEBI:CHEBI:139218; EC=1.7.3.1;
CC         Evidence={ECO:0000269|PubMed:11867731, ECO:0000269|PubMed:12862464,
CC         ECO:0000269|PubMed:17994768, ECO:0000269|PubMed:19265437,
CC         ECO:0000269|PubMed:22538};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:11867731, ECO:0000269|PubMed:16430210,
CC         ECO:0000269|PubMed:17994768, ECO:0000269|PubMed:19265437,
CC         ECO:0000269|PubMed:19926855, ECO:0000269|PubMed:22538};
CC   -!- ACTIVITY REGULATION: Strongly inhibited by mercury chloride and KCN.
CC       {ECO:0000269|PubMed:22538}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.54 mM for 1-nitropropane {ECO:0000269|PubMed:22538};
CC         KM=7.4 mM for 2-nitropropane {ECO:0000269|PubMed:22538};
CC         KM=1.0 mM for nitroethane {ECO:0000269|PubMed:22538};
CC         KM=3.1 mM for 3-nitro-2-pentanol {ECO:0000269|PubMed:22538};
CC         KM=0.9 mM for nitrocyclohexane {ECO:0000269|PubMed:22538};
CC         KM=1.33 uM for FAD {ECO:0000269|PubMed:22538};
CC       pH dependence:
CC         Optimum pH is 8.0. {ECO:0000269|PubMed:22538};
CC       Temperature dependence:
CC         Optimum temperature is 40 degrees Celsius.
CC         {ECO:0000269|PubMed:22538};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:16430210,
CC       ECO:0000269|PubMed:17994768, ECO:0000269|PubMed:19926855,
CC       ECO:0000269|PubMed:22538}.
CC   -!- INDUCTION: Up-regulated by nitroethane. {ECO:0000269|PubMed:22538}.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF425595; AAL57485.1; -; mRNA.
DR   PDB; 2C0U; X-ray; 2.20 A; A/B/C/D=1-439.
DR   PDB; 2C12; X-ray; 2.07 A; A/B/C/D/E/F=1-439.
DR   PDB; 2REH; X-ray; 2.40 A; A/B/C/D=1-439.
DR   PDB; 2ZAF; X-ray; 2.50 A; A/B/C/D=1-439.
DR   PDB; 3D9D; X-ray; 2.10 A; A/B/C/D=2-439.
DR   PDB; 3D9E; X-ray; 2.20 A; A/B/C/D=2-439.
DR   PDB; 3D9F; X-ray; 2.20 A; A/B/C/D=2-439.
DR   PDB; 3D9G; X-ray; 2.15 A; A/B/C/D=2-439.
DR   PDB; 3FCJ; X-ray; 2.40 A; A/B/C/D=2-439.
DR   PDBsum; 2C0U; -.
DR   PDBsum; 2C12; -.
DR   PDBsum; 2REH; -.
DR   PDBsum; 2ZAF; -.
DR   PDBsum; 3D9D; -.
DR   PDBsum; 3D9E; -.
DR   PDBsum; 3D9F; -.
DR   PDBsum; 3D9G; -.
DR   PDBsum; 3FCJ; -.
DR   SMR; Q8X1D8; -.
DR   KEGG; ag:AAL57485; -.
DR   BioCyc; MetaCyc:MONOMER-12547; -.
DR   BRENDA; 1.7.3.1; 2351.
DR   SABIO-RK; Q8X1D8; -.
DR   EvolutionaryTrace; Q8X1D8; -.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0052664; F:nitroalkane oxidase activity; IDA:UniProtKB.
DR   GO; GO:0050141; F:nitroethane oxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016627; F:oxidoreductase activity, acting on the CH-CH group of donors; IEA:InterPro.
DR   GO; GO:0006807; P:nitrogen compound metabolic process; IDA:UniProtKB.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; FAD; Flavoprotein;
KW   Nucleotide-binding; Oxidoreductase.
FT   CHAIN           1..439
FT                   /note="Nitroalkane oxidase"
FT                   /id="PRO_0000418397"
FT   NP_BIND         131..134
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16430210,
FT                   ECO:0000269|PubMed:17994768, ECO:0000269|PubMed:19926855"
FT   NP_BIND         139..141
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16430210,
FT                   ECO:0000269|PubMed:17994768, ECO:0000269|PubMed:19926855"
FT   NP_BIND         169..171
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16430210,
FT                   ECO:0000269|PubMed:17994768, ECO:0000269|PubMed:19926855"
FT   NP_BIND         313..314
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16430210,
FT                   ECO:0000269|PubMed:17994768, ECO:0000269|PubMed:19926855"
FT   NP_BIND         375..379
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16430210,
FT                   ECO:0000269|PubMed:17994768, ECO:0000269|PubMed:19926855"
FT   NP_BIND         400..404
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16430210,
FT                   ECO:0000269|PubMed:17994768, ECO:0000269|PubMed:19926855"
FT   ACT_SITE        402
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:11867731,
FT                   ECO:0000305|PubMed:12862464, ECO:0000305|PubMed:16430210"
FT   BINDING         304
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:16430210,
FT                   ECO:0000269|PubMed:17994768, ECO:0000269|PubMed:19926855"
FT   MUTAGEN         276
FT                   /note="S->A: Decreases catalytic activity about tenfold."
FT                   /evidence="ECO:0000269|PubMed:19265437"
FT   MUTAGEN         402
FT                   /note="D->E: Decreases enzyme activity about twentyfold."
FT                   /evidence="ECO:0000269|PubMed:11867731,
FT                   ECO:0000269|PubMed:12862464, ECO:0000269|PubMed:19265437"
FT   MUTAGEN         402
FT                   /note="D->N: Almost abolishes enzyme activity towards
FT                   neutral nitroethane, but retains activity towards anionic
FT                   nitroethane."
FT                   /evidence="ECO:0000269|PubMed:11867731,
FT                   ECO:0000269|PubMed:12862464, ECO:0000269|PubMed:19265437"
FT   MUTAGEN         409
FT                   /note="R->K: Reduces catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:17994768"
FT   HELIX           8..23
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           25..27
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           28..32
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           38..43
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           46..54
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   TURN            55..58
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           59..61
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           64..66
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           73..84
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           91..106
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           110..116
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           118..121
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   STRAND          129..132
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   TURN            140..143
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   STRAND          153..157
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   STRAND          160..168
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   TURN            171..177
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   STRAND          182..190
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           204..207
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   STRAND          208..213
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           215..219
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           223..225
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   STRAND          226..230
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   STRAND          234..236
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   STRAND          244..253
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           254..256
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           263..301
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   STRAND          306..308
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           310..312
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           314..341
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   STRAND          344..346
FT                   /evidence="ECO:0007829|PDB:2ZAF"
FT   HELIX           348..377
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           379..382
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           388..395
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   TURN            396..400
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   STRAND          401..403
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   TURN            405..408
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           409..417
FT                   /evidence="ECO:0007829|PDB:2C12"
FT   HELIX           426..429
FT                   /evidence="ECO:0007829|PDB:2C12"
SQ   SEQUENCE   439 AA;  48162 MW;  9F156889F2A5901A CRC64;
     MVDFKLSPSQ LEARRHAQAF ANTVLTKASA EYSTQKDQLS RFQATRPFYR EAVRHGLIKA
     QVPIPLGGTM ESLVHESIIL EELFAVEPAT SITIVATALG LMPVILCDSP SLQEKFLKPF
     ISGEGEPLAS LMHSEPNGTA NWLQKGGPGL QTTARKVGNE WVISGEKLWP SNSGGWDYKG
     ADLACVVCRV SDDPSKPQDP NVDPATQIAV LLVTRETIAN NKKDAYQILG EPELAGHITT
     SGPHTRFTEF HVPHENLLCT PGLKAQGLVE TAFAMSAALV GAMAIGTARA AFEEALVFAK
     SDTRGGSKHI IEHQSVADKL IDCKIRLETS RLLVWKAVTT LEDEALEWKV KLEMAMQTKI
     YTTDVAVECV IDAMKAVGMK SYAKDMSFPR LLNEVMCYPL FDGGNIGLRR RQMQRVMALE
     DYEPWAATYG SSKVDKSRL
//
ID   NCPR_HUMAN              Reviewed;         677 AA.
AC   P16435; Q16455; Q197M5; Q8N181; Q9H3M8; Q9UDT3;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   02-JUN-2021, entry version 230.
DE   RecName: Full=NADPH--cytochrome P450 reductase {ECO:0000255|HAMAP-Rule:MF_03212};
DE            Short=CPR {ECO:0000255|HAMAP-Rule:MF_03212};
DE            Short=P450R {ECO:0000255|HAMAP-Rule:MF_03212};
DE            EC=1.6.2.4 {ECO:0000255|HAMAP-Rule:MF_03212};
GN   Name=POR {ECO:0000255|HAMAP-Rule:MF_03212}; Synonyms=CYPOR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-500.
RX   PubMed=1550342; DOI=10.1016/0003-9861(92)90152-m;
RA   Shephard E.A., Palmer C.N., Segall H.J., Phillips I.R.;
RT   "Quantification of cytochrome P450 reductase gene expression in human
RT   tissues.";
RL   Arch. Biochem. Biophys. 294:168-172(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RA   Czerwinski M., Sahni M., Madan A., Parkinson A.;
RT   "Polymorphism of human CYPOR: expression of new allele.";
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Murakami H.O., Ogawa H., Nisimoto Y.;
RT   "cDNA cloning and characterization of NADPH-cytochrome P-450 reductase in
RT   human HL-60 cell.";
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-225; ASN-252 AND
RP   VAL-500.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS LEU-225 AND VAL-500.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-677, CLEAVAGE OF INITIATOR METHIONINE, AND
RP   ACETYLATION AT GLY-2.
RC   TISSUE=Liver;
RX   PubMed=2513880; DOI=10.1021/bi00447a054;
RA   Haniu M., McManus M.E., Birkett D.J., Lee T.D., Shively J.E.;
RT   "Structural and functional analysis of NADPH-cytochrome P-450 reductase
RT   from human liver: complete sequence of human enzyme and NADPH-binding
RT   sites.";
RL   Biochemistry 28:8639-8645(1989).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.93 ANGSTROMS) OF 61-241 IN COMPLEX WITH FMN.
RX   PubMed=10048323; DOI=10.1110/ps.8.2.298;
RA   Zhao Q., Modi S., Smith G., Paine M., McDonagh P.D., Wolf C.R., Tew D.,
RA   Lian L.Y., Roberts G.C., Driessen H.P.;
RT   "Crystal structure of the FMN-binding domain of human cytochrome P450
RT   reductase at 1.93 A resolution.";
RL   Protein Sci. 8:298-306(1999).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 232-677 IN COMPLEX WITH FAD.
RX   PubMed=19483672; DOI=10.1038/embor.2009.82;
RA   Aigrain L., Pompon D., Morera S., Truan G.;
RT   "Structure of the open conformation of a functional chimeric NADPH
RT   cytochrome P450 reductase.";
RL   EMBO Rep. 10:742-747(2009).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) OF 241-677 IN COMPLEX WITH FAD; FMN
RP   AND NADP.
RX   PubMed=21808038; DOI=10.1073/pnas.1106632108;
RA   Xia C., Panda S.P., Marohnic C.C., Martasek P., Masters B.S., Kim J.J.;
RT   "Structural basis for human NADPH-cytochrome P450 oxidoreductase
RT   deficiency.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:13486-13491(2011).
RN   [15]
RP   VARIANT ABS1 HIS-454.
RX   PubMed=15264278; DOI=10.1002/ajmg.a.30169;
RA   Adachi M., Tachibana K., Asakura Y., Yamamoto T., Hanaki K., Oka A.;
RT   "Compound heterozygous mutations of cytochrome P450 oxidoreductase gene
RT   (POR) in two patients with Antley-Bixler syndrome.";
RL   Am. J. Med. Genet. A 128:333-339(2004).
RN   [16]
RP   VARIANTS ABS1 HIS-454; CYS-575 AND 608-LEU--TRP-617 DELINS ARG, AND VARIANT
RP   VAL-500.
RX   PubMed=15483095; DOI=10.1210/jc.2004-0810;
RA   Fukami M., Horikawa R., Nagai T., Tanaka T., Naiki Y., Sato N., Okuyama T.,
RA   Nakai H., Soneda S., Tachibana K., Matsuo N., Sato S., Homma K.,
RA   Nishimura G., Hasegawa T., Ogata T.;
RT   "Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome
RT   with abnormal genitalia and/or impaired steroidogenesis: molecular and
RT   clinical studies in 10 patients.";
RL   J. Clin. Endocrinol. Metab. 90:414-426(2005).
RN   [17]
RP   VARIANTS DISPORD ASP-178; PRO-284; HIS-454 AND TYR-566, AND
RP   CHARACTERIZATION OF VARIANTS DISPORD ASP-178; PRO-284; HIS-454 AND TYR-566.
RX   PubMed=15220035; DOI=10.1016/s0140-6736(04)16503-3;
RA   Arlt W., Walker E.A., Draper N., Ivison H.E., Ride J.P., Hammer F.,
RA   Chalder S.M., Borucka-Mankiewicz M., Hauffa B.P., Malunowicz E.M.,
RA   Stewart P.M., Shackleton C.H.L.;
RT   "Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and
RT   human androgen synthesis: analytical study.";
RL   Lancet 363:2128-2135(2004).
RN   [18]
RP   VARIANTS ABS1 PRO-284; HIS-454 AND GLU-489, VARIANTS DISPORD TYR-566 AND
RP   PHE-605, CHARACTERIZATION OF VARIANTS ABS1 PRO-284; HIS-454 AND GLU-489,
RP   AND CHARACTERIZATION OF VARIANTS DISPORD TYR-566 AND PHE-605.
RX   PubMed=14758361; DOI=10.1038/ng1300;
RA   Flueck C.E., Tajima T., Pandey A.V., Arlt W., Okuhara K., Verge C.F.,
RA   Jabs E.W., Mendonca B.B., Fujieda K., Miller W.L.;
RT   "Mutant P450 oxidoreductase causes disordered steroidogenesis with and
RT   without Antley-Bixler syndrome.";
RL   Nat. Genet. 36:228-230(2004).
RN   [19]
RP   VARIANT HIS-454.
RX   PubMed=27610946; DOI=10.1002/humu.23116;
RA   Igarashi M., Takasawa K., Hakoda A., Kanno J., Takada S., Miyado M.,
RA   Baba T., Morohashi K.I., Tajima T., Hata K., Nakabayashi K., Matsubara Y.,
RA   Sekido R., Ogata T., Kashimada K., Fukami M.;
RT   "Identical NR5A1 missense mutations in two unrelated 46,XX individuals with
RT   testicular tissues.";
RL   Hum. Mutat. 38:39-42(2017).
CC   -!- FUNCTION: This enzyme is required for electron transfer from NADP to
CC       cytochrome P450 in microsomes. It can also provide electron transfer to
CC       heme oxygenase and cytochrome B5. {ECO:0000255|HAMAP-Rule:MF_03212}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADPH + 2 oxidized [cytochrome P450] = H(+) + NADP(+) + 2
CC         reduced [cytochrome P450]; Xref=Rhea:RHEA:24040, Rhea:RHEA-
CC         COMP:14627, Rhea:RHEA-COMP:14628, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:55376, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:60344; EC=1.6.2.4; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_03212};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03212,
CC         ECO:0000269|PubMed:21808038};
CC       Note=Binds 1 FAD per monomer. {ECO:0000255|HAMAP-Rule:MF_03212,
CC       ECO:0000269|PubMed:21808038};
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03212,
CC         ECO:0000269|PubMed:21808038};
CC       Note=Binds 1 FMN per monomer. {ECO:0000255|HAMAP-Rule:MF_03212,
CC       ECO:0000269|PubMed:21808038};
CC   -!- INTERACTION:
CC       P16435; O00264: PGRMC1; NbExp=5; IntAct=EBI-726554, EBI-1045534;
CC       P16435; P00181: CYP2C2; Xeno; NbExp=4; IntAct=EBI-726554, EBI-4320576;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000255|HAMAP-Rule:MF_03212}; Single-pass membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_03212}; Cytoplasmic side {ECO:0000255|HAMAP-
CC       Rule:MF_03212}.
CC   -!- DISEASE: Antley-Bixler syndrome, with genital anomalies and disordered
CC       steroidogenesis (ABS1) [MIM:201750]: A disease characterized by the
CC       association of Antley-Bixler syndrome with steroidogenesis defects and
CC       abnormal genitalia. Antley-Bixler syndrome is characterized by
CC       craniosynostosis, radiohumeral synostosis present from the perinatal
CC       period, midface hypoplasia, choanal stenosis or atresia, femoral bowing
CC       and multiple joint contractures. {ECO:0000269|PubMed:14758361,
CC       ECO:0000269|PubMed:15264278, ECO:0000269|PubMed:15483095}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Disordered steroidogenesis due to cytochrome P450
CC       oxidoreductase deficiency (DISPORD) [MIM:613571]: A disorder resulting
CC       in a rare variant of congenital adrenal hyperplasia, with apparent
CC       combined P450C17 and P450C21 deficiency and accumulation of steroid
CC       metabolites. Affected girls are born with ambiguous genitalia, but
CC       their circulating androgens are low and virilization does not progress.
CC       Conversely, affected boys are sometimes born undermasculinized. Boys
CC       and girls can present with bone malformations, in some cases resembling
CC       the pattern seen in patients with Antley-Bixler syndrome.
CC       {ECO:0000269|PubMed:14758361, ECO:0000269|PubMed:15220035}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the NADPH--cytochrome P450 reductase family.
CC       {ECO:0000255|HAMAP-Rule:MF_03212}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the flavodoxin
CC       family. {ECO:0000255|HAMAP-Rule:MF_03212}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the flavoprotein
CC       pyridine nucleotide cytochrome reductase family. {ECO:0000255|HAMAP-
CC       Rule:MF_03212}.
CC   -!- CAUTION: An alternative upstream Met is found in primates and
CC       translation may initiate from the upstream Met which would give rise to
CC       a 680-residue protein. However, the upstream codon has a weak Kozak
CC       signal while the codon used for translation of the shorter 677-residue
CC       sequence has a strong Kozak signal and is widely conserved. In
CC       addition, protein sequencing indicates that this is the preferred start
CC       codon in vivo. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH34277.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/por/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S90469; AAB21814.1; -; mRNA.
DR   EMBL; AF258341; AAG09798.1; -; mRNA.
DR   EMBL; AB051763; BAB18572.1; -; mRNA.
DR   EMBL; DQ640499; ABF70199.1; -; Genomic_DNA.
DR   EMBL; AC005067; AAD45961.1; -; Genomic_DNA.
DR   EMBL; AC006330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC034277; AAH34277.1; ALT_INIT; mRNA.
DR   PIR; A33421; A60557.
DR   RefSeq; NP_000932.3; NM_000941.2.
DR   PDB; 1B1C; X-ray; 1.93 A; A=61-241.
DR   PDB; 3FJO; X-ray; 2.50 A; A=232-677.
DR   PDB; 3QE2; X-ray; 1.75 A; A/B=64-677.
DR   PDB; 3QFC; X-ray; 1.80 A; A/B=64-677.
DR   PDB; 3QFR; X-ray; 2.40 A; A/B=64-677.
DR   PDB; 3QFS; X-ray; 1.40 A; A=241-677.
DR   PDB; 3QFT; X-ray; 1.40 A; A=241-677.
DR   PDB; 5EMN; X-ray; 2.20 A; A/B=64-677.
DR   PDB; 5FA6; X-ray; 2.30 A; A/B=64-677.
DR   PDBsum; 1B1C; -.
DR   PDBsum; 3FJO; -.
DR   PDBsum; 3QE2; -.
DR   PDBsum; 3QFC; -.
DR   PDBsum; 3QFR; -.
DR   PDBsum; 3QFS; -.
DR   PDBsum; 3QFT; -.
DR   PDBsum; 5EMN; -.
DR   PDBsum; 5FA6; -.
DR   BMRB; P16435; -.
DR   SMR; P16435; -.
DR   BioGRID; 111443; 140.
DR   DIP; DIP-29682N; -.
DR   IntAct; P16435; 23.
DR   MINT; P16435; -.
DR   STRING; 9606.ENSP00000419970; -.
DR   BindingDB; P16435; -.
DR   ChEMBL; CHEMBL2169731; -.
DR   DrugBank; DB06263; Amrubicin.
DR   DrugBank; DB00865; Benzphetamine.
DR   DrugBank; DB00694; Daunorubicin.
DR   DrugBank; DB00997; Doxorubicin.
DR   DrugBank; DB01466; Ethylmorphine.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB03247; Flavin mononucleotide.
DR   DrugBank; DB09332; Kappadione.
DR   DrugBank; DB00166; Lipoic acid.
DR   DrugBank; DB00305; Mitomycin.
DR   DrugBank; DB03461; Nicotinamide adenine dinucleotide phosphate.
DR   DrugBank; DB00665; Nilutamide.
DR   DrugBank; DB00698; Nitrofurantoin.
DR   GlyConnect; 1535; 1 N-Linked glycan (1 site).
DR   GlyGen; P16435; 1 site.
DR   iPTMnet; P16435; -.
DR   PhosphoSitePlus; P16435; -.
DR   SwissPalm; P16435; -.
DR   BioMuta; POR; -.
DR   DMDM; 2851393; -.
DR   EPD; P16435; -.
DR   jPOST; P16435; -.
DR   MassIVE; P16435; -.
DR   MaxQB; P16435; -.
DR   PaxDb; P16435; -.
DR   PeptideAtlas; P16435; -.
DR   PRIDE; P16435; -.
DR   ProteomicsDB; 53360; -.
DR   Antibodypedia; 2433; 434 antibodies.
DR   DNASU; 5447; -.
DR   Ensembl; ENST00000394893; ENSP00000378355; ENSG00000127948.
DR   Ensembl; ENST00000412064; ENSP00000404731; ENSG00000127948.
DR   Ensembl; ENST00000412521; ENSP00000409238; ENSG00000127948.
DR   Ensembl; ENST00000414186; ENSP00000399327; ENSG00000127948.
DR   Ensembl; ENST00000418341; ENSP00000389719; ENSG00000127948.
DR   Ensembl; ENST00000432753; ENSP00000389409; ENSG00000127948.
DR   Ensembl; ENST00000439963; ENSP00000390540; ENSG00000127948.
DR   Ensembl; ENST00000449920; ENSP00000399556; ENSG00000127948.
DR   Ensembl; ENST00000453773; ENSP00000395813; ENSG00000127948.
DR   Ensembl; ENST00000454934; ENSP00000414263; ENSG00000127948.
DR   Ensembl; ENST00000461988; ENSP00000419970; ENSG00000127948.
DR   GeneID; 5447; -.
DR   KEGG; hsa:5447; -.
DR   UCSC; uc003udy.4; human.
DR   CTD; 5447; -.
DR   DisGeNET; 5447; -.
DR   GeneCards; POR; -.
DR   GeneReviews; POR; -.
DR   HGNC; HGNC:9208; POR.
DR   HPA; ENSG00000127948; Tissue enhanced (liver).
DR   MalaCards; POR; -.
DR   MIM; 124015; gene.
DR   MIM; 201750; phenotype.
DR   MIM; 613571; phenotype.
DR   neXtProt; NX_P16435; -.
DR   Orphanet; 95699; Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency.
DR   PharmGKB; PA33532; -.
DR   VEuPathDB; HostDB:ENSG00000127948.13; -.
DR   eggNOG; KOG1158; Eukaryota.
DR   HOGENOM; CLU_001570_17_3_1; -.
DR   InParanoid; P16435; -.
DR   OrthoDB; 318396at2759; -.
DR   PhylomeDB; P16435; -.
DR   TreeFam; TF105719; -.
DR   BRENDA; 1.6.2.4; 2681.
DR   PathwayCommons; P16435; -.
DR   Reactome; R-HSA-211897; Cytochrome P450 - arranged by substrate type.
DR   SABIO-RK; P16435; -.
DR   SIGNOR; P16435; -.
DR   BioGRID-ORCS; 5447; 12 hits in 997 CRISPR screens.
DR   ChiTaRS; POR; human.
DR   EvolutionaryTrace; P16435; -.
DR   GeneWiki; Cytochrome_P450_reductase; -.
DR   GenomeRNAi; 5447; -.
DR   Pharos; P16435; Tbio.
DR   PRO; PR:P16435; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; P16435; protein.
DR   Bgee; ENSG00000127948; Expressed in right adrenal gland and 220 other tissues.
DR   ExpressionAtlas; P16435; baseline and differential.
DR   Genevisible; P16435; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:0010181; F:FMN binding; IBA:GO_Central.
DR   GO; GO:0050661; F:NADP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003958; F:NADPH-hemoprotein reductase activity; IDA:UniProtKB.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; IBA:GO_Central.
DR   GO; GO:0090346; P:cellular organofluorine metabolic process; IDA:BHF-UCL.
DR   GO; GO:0022900; P:electron transport chain; IDA:UniProtKB.
DR   GO; GO:0032770; P:positive regulation of monooxygenase activity; IDA:BHF-UCL.
DR   GO; GO:0009725; P:response to hormone; IBA:GO_Central.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   Gene3D; 1.20.990.10; -; 2.
DR   Gene3D; 3.40.50.360; -; 1.
DR   Gene3D; 3.40.50.80; -; 1.
DR   HAMAP; MF_03212; NCPR; 1.
DR   InterPro; IPR003097; CysJ-like_FAD-binding.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001094; Flavdoxin-like.
DR   InterPro; IPR008254; Flavodoxin/NO_synth.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR023173; NADPH_Cyt_P450_Rdtase_alpha.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR023208; P450R.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF00667; FAD_binding_1; 1.
DR   Pfam; PF00258; Flavodoxin_1; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   PIRSF; PIRSF000208; P450R; 1.
DR   PRINTS; PR00369; FLAVODOXIN.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52218; SSF52218; 1.
DR   SUPFAM; SSF52343; SSF52343; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
DR   PROSITE; PS50902; FLAVODOXIN_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Congenital adrenal hyperplasia;
KW   Craniosynostosis; Direct protein sequencing; Disease variant;
KW   Endoplasmic reticulum; FAD; Flavoprotein; FMN; Membrane; NADP;
KW   Oxidoreductase; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:2513880"
FT   CHAIN           2..677
FT                   /note="NADPH--cytochrome P450 reductase"
FT                   /id="PRO_0000167596"
FT   TOPO_DOM        2..21
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212"
FT   TRANSMEM        22..42
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212"
FT   TOPO_DOM        43..677
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212"
FT   DOMAIN          80..224
FT                   /note="Flavodoxin-like"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212"
FT   DOMAIN          279..521
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212"
FT   NP_BIND         86..91
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:10048323, ECO:0000269|PubMed:21808038"
FT   NP_BIND         138..141
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:10048323, ECO:0000269|PubMed:21808038"
FT   NP_BIND         173..182
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:10048323, ECO:0000269|PubMed:21808038"
FT   NP_BIND         454..457
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:19483672, ECO:0000269|PubMed:21808038"
FT   NP_BIND         472..474
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:19483672, ECO:0000269|PubMed:21808038"
FT   NP_BIND         488..491
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:19483672, ECO:0000269|PubMed:21808038"
FT   NP_BIND         596..597
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:21808038"
FT   NP_BIND         602..606
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:21808038"
FT   BINDING         208
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:10048323, ECO:0000269|PubMed:21808038"
FT   BINDING         298
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:21808038"
FT   BINDING         424
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:19483672, ECO:0000269|PubMed:21808038"
FT   BINDING         478
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:19483672, ECO:0000269|PubMed:21808038"
FT   BINDING         535
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:21808038"
FT   BINDING         638
FT                   /note="NADP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:21808038"
FT   BINDING         676
FT                   /note="FAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03212,
FT                   ECO:0000269|PubMed:19483672, ECO:0000269|PubMed:21808038"
FT   MOD_RES         2
FT                   /note="N-acetylglycine"
FT                   /evidence="ECO:0000269|PubMed:2513880"
FT   MOD_RES         63
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VARIANT         178
FT                   /note="Y -> D (in DISPORD; complete loss of activity)"
FT                   /evidence="ECO:0000269|PubMed:15220035"
FT                   /id="VAR_021154"
FT   VARIANT         225
FT                   /note="P -> L (in dbSNP:rs782427303)"
FT                   /evidence="ECO:0000269|PubMed:15489334, ECO:0000269|Ref.4"
FT                   /id="VAR_047885"
FT   VARIANT         252
FT                   /note="D -> N"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_047886"
FT   VARIANT         284
FT                   /note="A -> P (in ABS1 and DISPORD; significant reduction
FT                   of activity)"
FT                   /evidence="ECO:0000269|PubMed:14758361,
FT                   ECO:0000269|PubMed:15220035"
FT                   /id="VAR_021155"
FT   VARIANT         454
FT                   /note="R -> H (in ABS1 and DISPORD; significant reduction
FT                   of activity)"
FT                   /evidence="ECO:0000269|PubMed:14758361,
FT                   ECO:0000269|PubMed:15220035, ECO:0000269|PubMed:15264278,
FT                   ECO:0000269|PubMed:15483095, ECO:0000269|PubMed:27610946"
FT                   /id="VAR_021156"
FT   VARIANT         489
FT                   /note="V -> E (in ABS1; significant reduction of activity)"
FT                   /evidence="ECO:0000269|PubMed:14758361"
FT                   /id="VAR_021157"
FT   VARIANT         500
FT                   /note="A -> V (in dbSNP:rs1057868)"
FT                   /evidence="ECO:0000269|PubMed:15483095,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:1550342,
FT                   ECO:0000269|Ref.4"
FT                   /id="VAR_004617"
FT   VARIANT         551
FT                   /note="R -> Q"
FT                   /id="VAR_004618"
FT   VARIANT         566
FT                   /note="C -> Y (in DISPORD; significant reduction of
FT                   activity; dbSNP:rs72552772)"
FT                   /evidence="ECO:0000269|PubMed:14758361,
FT                   ECO:0000269|PubMed:15220035"
FT                   /id="VAR_021158"
FT   VARIANT         575
FT                   /note="Y -> C (in ABS1)"
FT                   /evidence="ECO:0000269|PubMed:15483095"
FT                   /id="VAR_021159"
FT   VARIANT         605
FT                   /note="V -> F (in DISPORD; significant reduction of
FT                   activity)"
FT                   /evidence="ECO:0000269|PubMed:14758361"
FT                   /id="VAR_021160"
FT   VARIANT         609..617
FT                   /note="LKQDREHLW -> R (in ABS1)"
FT                   /id="VAR_021161"
FT   CONFLICT        405
FT                   /note="M -> L (in Ref. 3; BAB18572)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        518
FT                   /note="F -> L (in Ref. 1; AAB21814 and 3; BAB18572)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        537..538
FT                   /note="VA -> WH (in Ref. 1; AAB21814)"
FT                   /evidence="ECO:0000305"
FT   HELIX           69..76
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   STRAND          79..85
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   STRAND          87..89
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   HELIX           90..101
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   HELIX           102..105
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   STRAND          109..112
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   HELIX           114..116
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   HELIX           119..127
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   STRAND          132..138
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   HELIX           141..143
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   HELIX           147..149
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   HELIX           150..158
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   STRAND          167..174
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   STRAND          178..180
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   HELIX           183..194
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   STRAND          198..201
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   STRAND          204..207
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   TURN            208..210
FT                   /evidence="ECO:0007829|PDB:5EMN"
FT   HELIX           212..231
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   STRAND          245..249
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           255..257
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          259..261
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          263..265
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   TURN            266..270
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          278..280
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          282..291
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          294..298
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          300..306
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          319..322
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           328..338
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          345..352
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          360..366
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           367..373
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           383..389
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           390..392
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           396..406
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          407..409
FT                   /evidence="ECO:0007829|PDB:5FA6"
FT   HELIX           410..419
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   TURN            420..424
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           427..433
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           441..447
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          454..457
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   TURN            462..464
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          468..474
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          477..479
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          485..487
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           489..495
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   TURN            501..503
FT                   /evidence="ECO:0007829|PDB:3QE2"
FT   STRAND          508..514
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          528..531
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           534..537
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           538..553
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          560..567
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   TURN            569..571
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           576..584
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          587..595
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          598..601
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           605..611
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           613..621
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          625..631
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   TURN            632..634
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           635..650
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   HELIX           655..667
FT                   /evidence="ECO:0007829|PDB:3QFS"
FT   STRAND          670..676
FT                   /evidence="ECO:0007829|PDB:3QFS"
SQ   SEQUENCE   677 AA;  76690 MW;  2F7D4B9CDFDF5A74 CRC64;
     MGDSHVDTSS TVSEAVAEEV SLFSMTDMIL FSLIVGLLTY WFLFRKKKEE VPEFTKIQTL
     TSSVRESSFV EKMKKTGRNI IVFYGSQTGT AEEFANRLSK DAHRYGMRGM SADPEEYDLA
     DLSSLPEIDN ALVVFCMATY GEGDPTDNAQ DFYDWLQETD VDLSGVKFAV FGLGNKTYEH
     FNAMGKYVDK RLEQLGAQRI FELGLGDDDG NLEEDFITWR EQFWPAVCEH FGVEATGEES
     SIRQYELVVH TDIDAAKVYM GEMGRLKSYE NQKPPFDAKN PFLAAVTTNR KLNQGTERHL
     MHLELDISDS KIRYESGDHV AVYPANDSAL VNQLGKILGA DLDVVMSLNN LDEESNKKHP
     FPCPTSYRTA LTYYLDITNP PRTNVLYELA QYASEPSEQE LLRKMASSSG EGKELYLSWV
     VEARRHILAI LQDCPSLRPP IDHLCELLPR LQARYYSIAS SSKVHPNSVH ICAVVVEYET
     KAGRINKGVA TNWLRAKEPA GENGGRALVP MFVRKSQFRL PFKATTPVIM VGPGTGVAPF
     IGFIQERAWL RQQGKEVGET LLYYGCRRSD EDYLYREELA QFHRDGALTQ LNVAFSREQS
     HKVYVQHLLK QDREHLWKLI EGGAHIYVCG DARNMARDVQ NTFYDIVAEL GAMEHAQAVD
     YIKKLMTKGR YSLDVWS
//
ID   PHHY_PSEAE              Reviewed;         394 AA.
AC   P20586;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   02-JUN-2021, entry version 142.
DE   RecName: Full=p-hydroxybenzoate hydroxylase {ECO:0000303|PubMed:1910043};
DE            Short=PHBH {ECO:0000303|PubMed:1910043};
DE            EC=1.14.13.2 {ECO:0000269|PubMed:1910043};
DE   AltName: Full=4-hydroxybenzoate 3-monooxygenase {ECO:0000305};
GN   Name=pobA {ECO:0000303|PubMed:2465205}; OrderedLocusNames=PA0247;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2465205; DOI=10.1016/0378-1119(88)90044-3;
RA   Entsch B., Nan Y., Weaich K., Scott K.F.;
RT   "Sequence and organization of pobA, the gene coding for p-hydroxybenzoate
RT   hydroxylase, an inducible enzyme from Pseudomonas aeruginosa.";
RL   Gene 71:279-291(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF TYR-201 AND TYR-385, AND
RP   COFACTOR.
RX   PubMed=1910043;
RA   Entsch B., Palfey B.A., Ballou D.P., Massey V.;
RT   "Catalytic function of tyrosine residues in para-hydroxybenzoate
RT   hydroxylase as determined by the study of site-directed mutants.";
RL   J. Biol. Chem. 266:17341-17349(1991).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF MUTANTS PHE-201; ASP-300 AND
RP   PHE-385 IN COMPLEX WITH SUBSTRATE AND FAD, FUNCTION, MUTAGENESIS OF
RP   TYR-201; ASN-300 AND TYR-385, COFACTOR, AND SUBUNIT.
RX   PubMed=8312276; DOI=10.1021/bi00172a036;
RA   Lah M.S., Palfey B.A., Schreuder H.A., Ludwig M.L.;
RT   "Crystal structures of mutant Pseudomonas aeruginosa p-hydroxybenzoate
RT   hydroxylases: the Tyr201Phe, Tyr385Phe, and Asn300Asp variants.";
RL   Biochemistry 33:1555-1564(1994).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH SUBSTRATE AND FAD,
RP   FUNCTION, COFACTOR, AND SUBUNIT.
RX   PubMed=7939628; DOI=10.1126/science.7939628;
RA   Gatti D.L., Palfey B.A., Lah M.S., Entsch B., Massey V., Ballou D.P.,
RA   Ludwig M.L.;
RT   "The mobile flavin of 4-OH benzoate hydroxylase.";
RL   Science 266:110-114(1994).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH SUBSTRATE ANALOG AND
RP   FAD, FUNCTION, COFACTOR, SUBUNIT, AND REACTION MECHANISM.
RX   PubMed=8555229; DOI=10.1021/bi951344i;
RA   Gatti D.L., Entsch B., Ballou D.P., Ludwig M.L.;
RT   "pH-dependent structural changes in the active site of p-hydroxybenzoate
RT   hydroxylase point to the importance of proton and water movements during
RT   catalysis.";
RL   Biochemistry 35:567-578(1996).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) IN COMPLEX WITH SUBSTRATE AND FAD
RP   ANALOG, FUNCTION, AND SUBUNIT.
RX   PubMed=10600126; DOI=10.1021/bi991603u;
RA   Ortiz-Maldonado M., Gatti D., Ballou D.P., Massey V.;
RT   "Structure-function correlations of the reaction of reduced nicotinamide
RT   analogues with p-hydroxybenzoate hydroxylase substituted with a series of
RT   8-substituted flavins.";
RL   Biochemistry 38:16636-16647(1999).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF MUTANT GLN-220 IN COMPLEX WITH
RP   SUBSTRATE AND FAD, FUNCTION, MUTAGENESIS OF ARG-220, COFACTOR, AND SUBUNIT.
RX   PubMed=11805318; DOI=10.1073/pnas.022640199;
RA   Wang J., Ortiz-Maldonado M., Entsch B., Massey V., Ballou D., Gatti D.L.;
RT   "Protein and ligand dynamics in 4-hydroxybenzoate hydroxylase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:608-613(2002).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF WILD-TYPE AND MUTANT GLY-45 IN
RP   COMPLEX WITH SUBSTRATE AND FAD, MUTAGENESIS OF ALA-45, FUNCTION, COFACTOR,
RP   AND SUBUNIT.
RX   PubMed=15924424; DOI=10.1021/bi050108x;
RA   Cole L.J., Gatti D.L., Entsch B., Ballou D.P.;
RT   "Removal of a methyl group causes global changes in p-hydroxybenzoate
RT   hydroxylase.";
RL   Biochemistry 44:8047-8058(2005).
CC   -!- FUNCTION: Catalyzes the incorporation of an atom of dioxygen into p-
CC       hydroxybenzoate (p-OHB) to form 3,4-dihydroxybenzoate (3,4DOHB). The
CC       reaction occurs in two parts: reduction of the flavin adenine
CC       dinucleotide (FAD) in the enzyme by reduced nicotinamide adenine
CC       dinucleotide phosphate (NADPH) in response to binding p-hydroxybenzoate
CC       to the enzyme and oxidation of reduced FAD with oxygen to form a
CC       hydroperoxide, which then oxygenates p-hydroxybenzoate.
CC       {ECO:0000269|PubMed:10600126, ECO:0000269|PubMed:11805318,
CC       ECO:0000269|PubMed:15924424, ECO:0000269|PubMed:1910043,
CC       ECO:0000269|PubMed:7939628, ECO:0000269|PubMed:8312276,
CC       ECO:0000269|PubMed:8555229}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-hydroxybenzoate + H(+) + NADPH + O2 = 3,4-dihydroxybenzoate
CC         + H2O + NADP(+); Xref=Rhea:RHEA:19477, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:17879,
CC         ChEBI:CHEBI:36241, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         EC=1.14.13.2; Evidence={ECO:0000269|PubMed:1910043};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:11805318, ECO:0000269|PubMed:15924424,
CC         ECO:0000269|PubMed:1910043, ECO:0000269|PubMed:7939628,
CC         ECO:0000269|PubMed:8312276, ECO:0000269|PubMed:8555229};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:11805318,
CC       ECO:0000269|PubMed:15924424, ECO:0000269|PubMed:7939628,
CC       ECO:0000269|PubMed:8312276, ECO:0000269|PubMed:8555229};
CC   -!- PATHWAY: Aromatic compound metabolism; benzoate degradation via
CC       hydroxylation; 3,4-dihydroxybenzoate from benzoate: step 2/2.
CC       {ECO:0000305}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:10600126,
CC       ECO:0000269|PubMed:11805318, ECO:0000269|PubMed:15924424,
CC       ECO:0000269|PubMed:7939628, ECO:0000269|PubMed:8312276,
CC       ECO:0000269|PubMed:8555229}.
CC   -!- MISCELLANEOUS: Controlled catalysis is achieved by movement of the
CC       flavin and protein between three conformations: in, out and open. The
CC       open conformation is important for substrate binding and product
CC       release, the in conformation for reaction with oxygen and
CC       hydroxylation, and the out conformation for the reduction of FAD by
CC       NADPH. {ECO:0000269|PubMed:8555229}.
CC   -!- SIMILARITY: Belongs to the aromatic-ring hydroxylase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M23173; AAA88455.1; -; Genomic_DNA.
DR   EMBL; AE004091; AAG03636.1; -; Genomic_DNA.
DR   PIR; JT0384; WHPSBA.
DR   RefSeq; NP_248938.1; NC_002516.2.
DR   RefSeq; WP_003112685.1; NZ_QZGE01000024.1.
DR   PDB; 1D7L; X-ray; 2.20 A; A=1-394.
DR   PDB; 1DOB; X-ray; 2.00 A; A=1-394.
DR   PDB; 1DOC; X-ray; 2.00 A; A=1-394.
DR   PDB; 1DOD; X-ray; 2.10 A; A=1-394.
DR   PDB; 1DOE; X-ray; 2.30 A; A=1-394.
DR   PDB; 1IUS; X-ray; 2.20 A; A=1-394.
DR   PDB; 1IUT; X-ray; 2.00 A; A=1-394.
DR   PDB; 1IUU; X-ray; 2.00 A; A=1-394.
DR   PDB; 1IUV; X-ray; 2.50 A; A=1-394.
DR   PDB; 1IUW; X-ray; 2.00 A; A=1-394.
DR   PDB; 1IUX; X-ray; 2.00 A; A=1-394.
DR   PDB; 1K0I; X-ray; 1.80 A; A=1-394.
DR   PDB; 1K0J; X-ray; 2.20 A; A=1-394.
DR   PDB; 1K0L; X-ray; 2.00 A; A=1-394.
DR   PDB; 1PXA; X-ray; 2.30 A; A=1-394.
DR   PDB; 1PXB; X-ray; 2.30 A; A=1-394.
DR   PDB; 1PXC; X-ray; 2.10 A; A=1-394.
DR   PDB; 1YKJ; X-ray; 2.00 A; A/B=1-394.
DR   PDB; 6JU1; X-ray; 1.60 A; A=1-394.
DR   PDBsum; 1D7L; -.
DR   PDBsum; 1DOB; -.
DR   PDBsum; 1DOC; -.
DR   PDBsum; 1DOD; -.
DR   PDBsum; 1DOE; -.
DR   PDBsum; 1IUS; -.
DR   PDBsum; 1IUT; -.
DR   PDBsum; 1IUU; -.
DR   PDBsum; 1IUV; -.
DR   PDBsum; 1IUW; -.
DR   PDBsum; 1IUX; -.
DR   PDBsum; 1K0I; -.
DR   PDBsum; 1K0J; -.
DR   PDBsum; 1K0L; -.
DR   PDBsum; 1PXA; -.
DR   PDBsum; 1PXB; -.
DR   PDBsum; 1PXC; -.
DR   PDBsum; 1YKJ; -.
DR   PDBsum; 6JU1; -.
DR   SMR; P20586; -.
DR   DrugBank; DB02839; 2,4-Dihydroxybenzoic Acid.
DR   DrugBank; DB04242; 4-hydroxybenzoic acid.
DR   DrugBank; DB03482; 8-demethyl-8-dimethylamino-flavin-adenine-dinucleotide.
DR   DrugBank; DB02362; Aminobenzoic acid.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   PaxDb; P20586; -.
DR   EnsemblBacteria; AAG03636; AAG03636; PA0247.
DR   GeneID; 882128; -.
DR   KEGG; pae:PA0247; -.
DR   PATRIC; fig|208964.12.peg.257; -.
DR   PseudoCAP; PA0247; -.
DR   HOGENOM; CLU_057691_0_0_6; -.
DR   InParanoid; P20586; -.
DR   OMA; VEPMQYG; -.
DR   PhylomeDB; P20586; -.
DR   BioCyc; PAER208964:G1FZ6-249-MONOMER; -.
DR   BRENDA; 1.14.13.2; 5087.
DR   UniPathway; UPA00156; UER00257.
DR   EvolutionaryTrace; P20586; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0018659; F:4-hydroxybenzoate 3-monooxygenase activity; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0043640; P:benzoate catabolic process via hydroxylation; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR012733; HB_mOase.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR02360; pbenz_hydroxyl; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aromatic hydrocarbons catabolism; FAD; Flavoprotein;
KW   Monooxygenase; NADP; Oxidoreductase; Reference proteome.
FT   CHAIN           1..394
FT                   /note="p-hydroxybenzoate hydroxylase"
FT                   /id="PRO_0000058381"
FT   NP_BIND         42..47
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10600126,
FT                   ECO:0000269|PubMed:11805318, ECO:0000269|PubMed:15924424,
FT                   ECO:0000269|PubMed:7939628, ECO:0000269|PubMed:8312276,
FT                   ECO:0000269|PubMed:8555229"
FT   NP_BIND         299..300
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10600126,
FT                   ECO:0000269|PubMed:11805318, ECO:0000269|PubMed:15924424,
FT                   ECO:0000269|PubMed:7939628, ECO:0000269|PubMed:8312276,
FT                   ECO:0000269|PubMed:8555229"
FT   REGION          212..214
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000269|PubMed:10600126,
FT                   ECO:0000269|PubMed:11805318, ECO:0000269|PubMed:15924424,
FT                   ECO:0000269|PubMed:7939628, ECO:0000269|PubMed:8312276,
FT                   ECO:0000269|PubMed:8555229"
FT   BINDING         13
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10600126,
FT                   ECO:0000269|PubMed:11805318, ECO:0000269|PubMed:15924424,
FT                   ECO:0000269|PubMed:7939628, ECO:0000269|PubMed:8312276,
FT                   ECO:0000269|PubMed:8555229"
FT   BINDING         32
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10600126,
FT                   ECO:0000269|PubMed:11805318, ECO:0000269|PubMed:15924424,
FT                   ECO:0000269|PubMed:7939628, ECO:0000269|PubMed:8312276,
FT                   ECO:0000269|PubMed:8555229"
FT   BINDING         102
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10600126,
FT                   ECO:0000269|PubMed:11805318, ECO:0000269|PubMed:15924424,
FT                   ECO:0000269|PubMed:7939628, ECO:0000269|PubMed:8312276,
FT                   ECO:0000269|PubMed:8555229"
FT   BINDING         201
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:10600126,
FT                   ECO:0000269|PubMed:11805318, ECO:0000269|PubMed:15924424,
FT                   ECO:0000269|PubMed:7939628, ECO:0000269|PubMed:8312276,
FT                   ECO:0000269|PubMed:8555229"
FT   BINDING         222
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:10600126,
FT                   ECO:0000269|PubMed:11805318, ECO:0000269|PubMed:15924424,
FT                   ECO:0000269|PubMed:7939628, ECO:0000269|PubMed:8312276,
FT                   ECO:0000269|PubMed:8555229"
FT   BINDING         286
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:10600126,
FT                   ECO:0000269|PubMed:15924424, ECO:0000269|PubMed:7939628,
FT                   ECO:0000269|PubMed:8312276, ECO:0000269|PubMed:8555229"
FT   BINDING         293
FT                   /note="Substrate; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:10600126,
FT                   ECO:0000269|PubMed:11805318, ECO:0000269|PubMed:15924424,
FT                   ECO:0000269|PubMed:7939628, ECO:0000269|PubMed:8312276,
FT                   ECO:0000269|PubMed:8555229"
FT   SITE            201
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000269|PubMed:8312276"
FT   SITE            385
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000269|PubMed:8312276"
FT   MUTAGEN         45
FT                   /note="A->G: The positions of the substrate and the flavin
FT                   are not altered."
FT                   /evidence="ECO:0000269|PubMed:15924424"
FT   MUTAGEN         201
FT                   /note="Y->F: Reduction of hydroxylase activity."
FT                   /evidence="ECO:0000269|PubMed:1910043,
FT                   ECO:0000269|PubMed:8312276"
FT   MUTAGEN         220
FT                   /note="R->Q: Lower affinity for p-OHB than the wild-type."
FT                   /evidence="ECO:0000269|PubMed:11805318"
FT   MUTAGEN         300
FT                   /note="N->D: The side chain of Asp300 moves away from the
FT                   flavin, disrupting the interactions of the carboxamide
FT                   group with the flavin O(2) atom, and the alpha-helix H10
FT                   that begins at residue 297 is displaced, altering its
FT                   dipole interactions with the flavin ring."
FT                   /evidence="ECO:0000269|PubMed:8312276"
FT   MUTAGEN         385
FT                   /note="Y->F: The positions of the substrate and the flavin
FT                   are not altered."
FT                   /evidence="ECO:0000269|PubMed:1910043,
FT                   ECO:0000269|PubMed:8312276"
FT   STRAND          4..8
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           12..23
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          28..31
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           36..40
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          47..49
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           50..58
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           63..68
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          70..72
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          74..79
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          82..87
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           88..91
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          97..99
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           102..116
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          119..123
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          125..130
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          134..136
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          138..143
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          146..151
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          153..157
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           166..168
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           171..173
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          175..192
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          195..198
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          200..202
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          209..215
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          218..225
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           231..233
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           236..245
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           249..252
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          261..278
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   STRAND          281..283
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           285..287
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           293..295
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           298..319
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           322..327
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           328..350
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           358..373
FT                   /evidence="ECO:0007829|PDB:6JU1"
FT   HELIX           375..386
FT                   /evidence="ECO:0007829|PDB:6JU1"
SQ   SEQUENCE   394 AA;  44324 MW;  1E7232854D9EC792 CRC64;
     MKTQVAIIGA GPSGLLLGQL LHKAGIDNVI LERQTPDYVL GRIRAGVLEQ GMVDLLREAG
     VDRRMARDGL VHEGVEIAFA GQRRRIDLKR LSGGKTVTVY GQTEVTRDLM EAREACGATT
     VYQAAEVRLH DLQGERPYVT FERDGERLRL DCDYIAGCDG FHGISRQSIP AERLKVFERV
     YPFGWLGLLA DTPPVSHELI YANHPRGFAL CSQRSATRSR YYVQVPLSEK VEDWSDERFW
     TELKARLPSE VAEKLVTGPS LEKSIAPLRS FVVEPMQHGR LFLAGDAAHI VPPTGAKGLN
     LAASDVSTLY RLLLKAYREG RGELLERYSA ICLRRIWKAE RFSWWMTSVL HRFPDTDAFS
     QRIQQTELEY YLGSEAGLAT IAENYVGLPY EEIE
//
ID   PAO_PSESP               Reviewed;         714 AA.
AC   Q5W9R9; Q7M1A6;
DT   16-OCT-2013, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 1.
DT   02-JUN-2021, entry version 66.
DE   RecName: Full=Phenylalanine 2-monooxygenase precursor;
DE            Short=proPAO;
DE            EC=1.13.12.9;
DE   AltName: Full=L-phenylalanine oxidase (deaminating and decarboxylating);
DE            Short=PAO;
DE   Contains:
DE     RecName: Full=Phenylalanine 2-monooxygenase alpha subunit;
DE   Contains:
DE     RecName: Full=Phenylalanine 2-monooxygenase beta subunit;
DE   Flags: Precursor;
OS   Pseudomonas sp.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=306;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, COFACTOR, AND PROTEOLYTIC
RP   PROCESSING.
RC   STRAIN=P-501;
RX   PubMed=15632301; DOI=10.1093/jb/mvh169;
RA   Suzuki H., Higashi Y., Asano M., Suguro M., Kigawa M., Maeda M.,
RA   Katayama S., Mukouyama E.B., Uchiyama K.;
RT   "Sequencing and expression of the L-phenylalanine oxidase gene from
RT   Pseudomonas sp. P-501. Proteolytic activation of the proenzyme.";
RL   J. Biochem. 136:617-627(2004).
RN   [2]
RP   PROTEIN SEQUENCE OF 16-107, AND SUBUNIT.
RC   STRAIN=P-501;
RX   PubMed=8109968; DOI=10.1006/abbi.1994.1056;
RA   Mukouyama E.B., Suzuki H., Koyama H.;
RT   "New subunit in L-phenylalanine oxidase from Pseudomonas sp. P-501 and the
RT   primary structure.";
RL   Arch. Biochem. Biophys. 308:400-406(1994).
RN   [3]
RP   PROTEIN SEQUENCE OF 110-183.
RX   PubMed=9603998; DOI=10.1093/oxfordjournals.jbchem.a022048;
RA   Mukouyama E.B., Hirose T., Suzuki H.;
RT   "Chemical modification of L-phenylalanine oxidase from Pseudomonas sp. P-
RT   501 by phenylglyoxal. Identification of one essential arginyl residue.";
RL   J. Biochem. 123:1097-1103(1998).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBSTRATE SPECIFICITY.
RX   PubMed=7174643; DOI=10.1093/oxfordjournals.jbchem.a134041;
RA   Koyama H.;
RT   "Purification and characterization of a novel L-phenylalanine oxidase
RT   (deaminating and decarboxylating) from Pseudomonas sp. P-501.";
RL   J. Biochem. 92:1235-1240(1982).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=6885723; DOI=10.1093/oxfordjournals.jbchem.a134265;
RA   Koyama H.;
RT   "Further characterization of a novel L-phenylalanine oxidase (deaminating
RT   and decarboxylating) from Pseudomonas sp. P-501.";
RL   J. Biochem. 93:1313-1319(1983).
RN   [6]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=6501250; DOI=10.1093/oxfordjournals.jbchem.a134853;
RA   Koyama H.;
RT   "Oxidation and oxygenation of L-amino acids catalyzed by a L-phenylalanine
RT   oxidase (deaminating and decarboxylating) from Pseudomonas sp. P-501.";
RL   J. Biochem. 96:421-427(1984).
RN   [7]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=3818566; DOI=10.1093/oxfordjournals.jbchem.a121798;
RA   Koyama H., Suzuki H.;
RT   "Spectral and kinetic studies on Pseudomonas L-phenylalanine oxidase
RT   (deaminating and decarboxylating).";
RL   J. Biochem. 100:859-866(1986).
RN   [8]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=16567420; DOI=10.1093/jb/mvj049;
RA   Ohta Y., Mukouyama E.B., Suzuki H.;
RT   "Kinetic isotope effect of the L-phenylalanine oxidase from Pseudomonas sp.
RT   P-501.";
RL   J. Biochem. 139:551-555(2006).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS) OF 2-714 IN COMPLEX WITH FAD AND
RP   SUBSTRATE ANALOG, AND MUTAGENESIS OF MET-143 AND LYS-479.
RC   STRAIN=P-501;
RX   PubMed=18417467; DOI=10.1074/jbc.m800366200;
RA   Ida K., Kurabayashi M., Suguro M., Hiruma Y., Hikima T., Yamomoto M.,
RA   Suzuki H.;
RT   "Structural basis of proteolytic activation of L-phenylalanine oxidase from
RT   Pseudomonas sp. P-501.";
RL   J. Biol. Chem. 283:16584-16590(2008).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.10 ANGSTROMS) OF 2-714 IN COMPLEXES WITH
RP   L-PHENYLALANINE AND L-METHIONINE, AND MUTAGENESIS OF ARG-144 AND TYR-537.
RC   STRAIN=P-501;
RX   PubMed=21841183; DOI=10.1093/jb/mvr103;
RA   Ida K., Suguro M., Suzuki H.;
RT   "High resolution X-ray crystal structures of L-phenylalanine oxidase
RT   (deaminating and decarboxylating) from Pseudomonas sp. P-501. Structures of
RT   the enzyme-ligand complex and catalytic mechanism.";
RL   J. Biochem. 150:659-669(2011).
CC   -!- FUNCTION: Catalyzes both oxygenative decarboxylation and oxidative
CC       deamination, depending on the substrate used. Has high activity for L-
CC       Phe and L-Tyr, but relatively low activities for L-Met and L-Trp. L-Phe
CC       is mainly oxygenated and L-Met is mainly oxidized.
CC       {ECO:0000269|PubMed:15632301, ECO:0000269|PubMed:16567420,
CC       ECO:0000269|PubMed:3818566, ECO:0000269|PubMed:6501250,
CC       ECO:0000269|PubMed:6885723, ECO:0000269|PubMed:7174643}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-phenylalanine + O2 = 2-phenylacetamide + CO2 + H2O;
CC         Xref=Rhea:RHEA:10712, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:16562, ChEBI:CHEBI:58095;
CC         EC=1.13.12.9; Evidence={ECO:0000269|PubMed:16567420,
CC         ECO:0000269|PubMed:6885723, ECO:0000269|PubMed:7174643};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:15632301, ECO:0000269|PubMed:6885723};
CC       Note=Binds 2 FAD per tetramer. {ECO:0000269|PubMed:15632301,
CC       ECO:0000269|PubMed:6885723};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=11.1 uM for L-Phe (for the oxygenation reaction)
CC         {ECO:0000269|PubMed:3818566, ECO:0000269|PubMed:6501250,
CC         ECO:0000269|PubMed:6885723};
CC         KM=13.3 uM for L-Phe (for the oxidation reaction)
CC         {ECO:0000269|PubMed:3818566, ECO:0000269|PubMed:6501250,
CC         ECO:0000269|PubMed:6885723};
CC         KM=4 mM for L-Tyr {ECO:0000269|PubMed:3818566,
CC         ECO:0000269|PubMed:6501250, ECO:0000269|PubMed:6885723};
CC         KM=2.2 mM for L-Met {ECO:0000269|PubMed:3818566,
CC         ECO:0000269|PubMed:6501250, ECO:0000269|PubMed:6885723};
CC         KM=1.96 mM for O(2) (for the oxygenation reaction with L-Phe as
CC         cosubstrate) {ECO:0000269|PubMed:3818566, ECO:0000269|PubMed:6501250,
CC         ECO:0000269|PubMed:6885723};
CC         KM=2.04 mM for O(2) (for the oxidation reaction with L-Phe as
CC         cosubstrate) {ECO:0000269|PubMed:3818566, ECO:0000269|PubMed:6501250,
CC         ECO:0000269|PubMed:6885723};
CC         KM=3.145 mM for O(2) (with L-Tyr as cosubstrate)
CC         {ECO:0000269|PubMed:3818566, ECO:0000269|PubMed:6501250,
CC         ECO:0000269|PubMed:6885723};
CC         KM=1.258 mM for O(2) (with L-Met as cosubstrate)
CC         {ECO:0000269|PubMed:3818566, ECO:0000269|PubMed:6501250,
CC         ECO:0000269|PubMed:6885723};
CC       pH dependence:
CC         Optimum pH is 6-9 for the oxygenation reaction and 10.5 for the
CC         oxidation reaction. {ECO:0000269|PubMed:3818566,
CC         ECO:0000269|PubMed:6501250, ECO:0000269|PubMed:6885723};
CC       Temperature dependence:
CC         Optimum temperature is 45 degrees Celsius for the oxygenation
CC         reaction and 65 degrees Celsius for the oxygenation reaction. Stable
CC         up to 70 degrees Celsius. {ECO:0000269|PubMed:3818566,
CC         ECO:0000269|PubMed:6501250, ECO:0000269|PubMed:6885723};
CC   -!- SUBUNIT: Heterotetramer composed of 2 alpha and 2 beta subunits.
CC       {ECO:0000269|PubMed:18417467, ECO:0000269|PubMed:8109968}.
CC   -!- PTM: Proteolytically cleaved to yield the active enzyme. Cleavage of
CC       the linkage between the 2 subunits causes reshaping of the oxygen
CC       channel and the hydrophobic environment around the flavin ring. Removal
CC       of the prosequence causes opening of the amino acid channel.
CC       {ECO:0000269|PubMed:15632301}.
CC   -!- SIMILARITY: Belongs to the phenylalanine 2-monooxygenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB167410; BAD66877.1; -; Genomic_DNA.
DR   PIR; S41662; S41662.
DR   PDB; 2YR4; X-ray; 1.70 A; A/B=2-714.
DR   PDB; 2YR5; X-ray; 1.25 A; A/B=2-714.
DR   PDB; 2YR6; X-ray; 1.35 A; A/B=2-714.
DR   PDB; 3AYI; X-ray; 1.25 A; A/B=2-714.
DR   PDB; 3AYJ; X-ray; 1.10 A; A/B=2-714.
DR   PDB; 3AYL; X-ray; 1.25 A; A/B=2-714.
DR   PDBsum; 2YR4; -.
DR   PDBsum; 2YR5; -.
DR   PDBsum; 2YR6; -.
DR   PDBsum; 3AYI; -.
DR   PDBsum; 3AYJ; -.
DR   PDBsum; 3AYL; -.
DR   SMR; Q5W9R9; -.
DR   KEGG; ag:BAD66877; -.
DR   BRENDA; 1.13.12.9; 5085.
DR   EvolutionaryTrace; Q5W9R9; -.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0050172; F:phenylalanine 2-monooxygenase activity; IDA:UniProtKB.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; FAD; Flavoprotein; Monooxygenase;
KW   Nucleotide-binding; Oxidoreductase; Zymogen.
FT   PROPEP          1..15
FT                   /note="Removed in mature form; occupies the channel of the
FT                   substrate amino acid from the outside of the protein to the
FT                   interior flavin ring in the precursor"
FT                   /evidence="ECO:0000269|PubMed:8109968"
FT                   /id="PRO_0000424222"
FT   CHAIN           16..107
FT                   /note="Phenylalanine 2-monooxygenase alpha subunit"
FT                   /id="PRO_5000051132"
FT   PROPEP          108..109
FT                   /note="Linker peptide"
FT                   /evidence="ECO:0000269|PubMed:9603998"
FT                   /id="PRO_0000424223"
FT   CHAIN           110..714
FT                   /note="Phenylalanine 2-monooxygenase beta subunit"
FT                   /id="PRO_0000424224"
FT   NP_BIND         95..96
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18417467"
FT   NP_BIND         141..144
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18417467"
FT   NP_BIND         652..653
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18417467"
FT   NP_BIND         660..662
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18417467"
FT   BINDING         2
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:18417467"
FT   BINDING         68
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:18417467"
FT   BINDING         120
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:18417467"
FT   BINDING         144
FT                   /note="Substrate"
FT   BINDING         375
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:18417467"
FT   BINDING         537
FT                   /note="Substrate"
FT   BINDING         660
FT                   /note="Substrate; via carbonyl oxygen"
FT   MUTAGEN         143
FT                   /note="M->A: Reduces catalytic efficiency 10-fold."
FT                   /evidence="ECO:0000269|PubMed:18417467"
FT   MUTAGEN         144
FT                   /note="R->A: Abolishes catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:21841183"
FT   MUTAGEN         144
FT                   /note="R->K: Reduces catalytic activity 400-fold."
FT                   /evidence="ECO:0000269|PubMed:21841183"
FT   MUTAGEN         479
FT                   /note="K->A: Reduces catalytic efficiency 200-fold."
FT                   /evidence="ECO:0000269|PubMed:18417467"
FT   MUTAGEN         537
FT                   /note="Y->A: Abolishes catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:21841183"
FT   MUTAGEN         537
FT                   /note="Y->F: Reduces catalytic activity 17-fold."
FT                   /evidence="ECO:0000269|PubMed:21841183"
FT   CONFLICT        178
FT                   /note="E -> W (in Ref. 3; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   HELIX           22..28
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   TURN            29..31
FT                   /evidence="ECO:0007829|PDB:2YR5"
FT   HELIX           35..37
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           42..45
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          55..63
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           67..80
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          88..94
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           101..103
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          121..126
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           131..133
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          135..139
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           150..160
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          177..181
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          184..191
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           193..195
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          196..198
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           202..214
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          218..221
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           233..240
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           247..255
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           257..265
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           270..283
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           290..292
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           296..310
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          312..315
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           318..320
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           325..333
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   TURN            334..337
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          339..341
FT                   /evidence="ECO:0007829|PDB:2YR4"
FT   STRAND          343..346
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           348..361
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   TURN            362..364
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          365..371
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          373..380
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          382..385
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          388..394
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          399..409
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           413..420
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          421..423
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          428..434
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           436..438
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          443..449
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           459..470
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          477..485
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           486..490
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          504..507
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   TURN            508..511
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          512..518
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          529..539
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           541..547
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          552..561
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           565..574
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           591..597
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          605..608
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           609..611
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          615..619
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   TURN            623..625
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           626..634
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           635..640
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   TURN            642..644
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   STRAND          648..650
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           653..655
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           662..680
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   TURN            681..683
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           685..687
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   TURN            690..693
FT                   /evidence="ECO:0007829|PDB:3AYJ"
FT   HELIX           694..697
FT                   /evidence="ECO:0007829|PDB:3AYJ"
SQ   SEQUENCE   714 AA;  76883 MW;  2EBEA742F1D41189 CRC64;
     MGVTVIPRLL GLKDEKKIAT TVGEARLSGI NYRHPDSALV SYPVAAAAPL GRLPAGNYRI
     AIVGGGAGGI AALYELGRLA ATLPAGSGID VQIYEADPDS FLHDRPGIKA IKVRGLKAGR
     VSAALVHNGD PASGDTIYEV GAMRFPEIAG LTWHYASAAF GDAAPIKVFP NPGKVPTEFV
     FGNRVDRYVG SDPKDWEDPD SPTLKVLGVV AGGLVGNPQG ENVAMYPIAN VDPAKIAAIL
     NAATPPADAL ERIQTKYWPE FIAQYDGLTL GAAVREIVTV AFEKGTLPPV DGVLDVDESI
     SYYVELFGRF GFGTGGFKPL YNISLVEMMR LILWDYSNEY TLPVTENVEF IRNLFLKAQN
     VGAGKLVVQV RQERVANACH SGTASARAQL LSYDSHNAVH SEAYDFVILA VPHDQLTPIV
     SRSGFEHAAS QNLGDAGLGL ETHTYNQVYP PLLLSDSSPA ANARIVTAIG QLHMARSSKV
     FATVKTAALD QPWVPQWRGE PIKAVVSDSG LAASYVVPSP IVEDGQAPEY SSLLASYTWE
     DDSTRLRHDF GLYPQNPATE TGTADGMYRT MVNRAYRYVK YAGASNAQPW WFYQLLAEAR
     TADRFVFDWT TNKTAGGFKL DMTGDHHQSN LCFRYHTHAL AASLDNRFFI ASDSYSHLGG
     WLEGAFMSAL NAVAGLIVRA NRGDVSALST EARPLVIGLR PVVKVPAAEL ATSQ
//
ID   XDH_BOVIN               Reviewed;        1332 AA.
AC   P80457; Q95325;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   02-JUN-2021, entry version 172.
DE   RecName: Full=Xanthine dehydrogenase/oxidase;
DE   Includes:
DE     RecName: Full=Xanthine dehydrogenase;
DE              Short=XD;
DE              EC=1.17.1.4 {ECO:0000269|PubMed:11005854, ECO:0000269|PubMed:12421831, ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:4352904};
DE   Includes:
DE     RecName: Full=Xanthine oxidase;
DE              Short=XO;
DE              EC=1.17.3.2 {ECO:0000269|PubMed:11005854, ECO:0000269|PubMed:12421831, ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:4352904};
DE     AltName: Full=Xanthine oxidoreductase;
DE              Short=XOR;
GN   Name=XDH;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Mammary gland;
RX   PubMed=8708081; DOI=10.3168/jds.s0022-0302(96)76351-8;
RA   Berglund L., Rasmussen J.T., Andersen M.D., Rasmussen M.S., Petersen T.E.;
RT   "Purification of the bovine xanthine oxidoreductase from milk fat globule
RT   membranes and cloning of complementary deoxyribonucleic acid.";
RL   J. Dairy Sci. 79:198-204(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=9388547; DOI=10.1042/bst0250791;
RA   Terao M., Kurosaki M., Zanotta S., Garattini E.;
RT   "The xanthine oxidoreductase gene: structure and regulation.";
RL   Biochem. Soc. Trans. 25:791-796(1997).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-23; 186-205 AND 552-562.
RC   TISSUE=Milk;
RX   PubMed=7556219; DOI=10.1111/j.1432-1033.1995.646zz.x;
RA   Turner N.A., Doyle W.A., Ventom A.M., Bray R.C.;
RT   "Properties of rabbit liver aldehyde oxidase and the relationship of the
RT   enzyme to xanthine oxidase and dehydrogenase.";
RL   Eur. J. Biochem. 232:646-657(1995).
RN   [4]
RP   CATALYTIC ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   CONVERSION BY PARTIAL PROTEOLYSIS AND BY REDUCING AGENTS.
RX   PubMed=4352904; DOI=10.1042/bj1310191;
RA   Battelli M.G., Lorenzoni E., Stripe F.;
RT   "Milk xanthine oxidase type D (dehydrogenase) and type O (oxidase).
RT   Purification, interconversion and some properties.";
RL   Biochem. J. 131:191-198(1973).
RN   [5]
RP   ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF
RP   ARG-335; TRP-336 AND ARG-427.
RX   PubMed=12817083; DOI=10.1073/pnas.1431485100;
RA   Kuwabara Y., Nishino T., Okamoto K., Matsumura T., Eger B.T., Pai E.F.,
RA   Nishino T.;
RT   "Unique amino acids cluster for switching from the dehydrogenase to oxidase
RT   form of xanthine oxidoreductase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:8170-8175(2003).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEXES WITH FAD; IRON-SULFUR
RP   CENTERS; SALICYLATE, SUBUNIT, COFACTOR, CATALYTIC ACTIVITY, ACTIVITY
RP   REGULATION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11005854; DOI=10.1073/pnas.97.20.10723;
RA   Enroth C., Eger B.T., Okamoto K., Nishino T., Nishino T., Pai E.F.;
RT   "Crystal structures of bovine milk xanthine dehydrogenase and xanthine
RT   oxidase: structure-based mechanism of conversion.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:10723-10728(2000).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH FAD; MOLYBDOPTERIN;
RP   IRON-SULFUR CENTERS AND SYNTHETIC INHIBITOR TEI-6720, COFACTOR, CATALYTIC
RP   ACTIVITY, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=12421831; DOI=10.1074/jbc.m208307200;
RA   Okamoto K., Eger B.T., Nishino T., Kondo S., Pai E.F., Nishino T.;
RT   "An extremely potent inhibitor of xanthine oxidoreductase. Crystal
RT   structure of the enzyme-inhibitor complex and mechanism of inhibition.";
RL   J. Biol. Chem. 278:1848-1855(2003).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) IN COMPLEX WITH FAD; MOLYBDOPTERIN;
RP   IRON-SULFUR CENTERS AND INHIBITOR FYX-051, ACTIVE SITE, COFACTOR, CATALYTIC
RP   ACTIVITY, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=15148401; DOI=10.1073/pnas.0400973101;
RA   Okamoto K., Matsumoto K., Hille R., Eger B.T., Pai E.F., Nishino T.;
RT   "The crystal structure of xanthine oxidoreductase during catalysis:
RT   implications for reaction mechanism and enzyme inhibition.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:7931-7936(2004).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEXES WITH FAD; MOLYBDOPTERIN;
RP   IRON-SULFUR CENTERS; CALCIUM IONS; XANTHINE AND LUMAZINE, COFACTOR, AND
RP   SUBUNIT.
RX   PubMed=19109252; DOI=10.1074/jbc.m804517200;
RA   Pauff J.M., Cao H., Hille R.;
RT   "Substrate orientation and catalysis at the molybdenum site in xanthine
RT   oxidase: crystal structures in complex with xanthine and lumazine.";
RL   J. Biol. Chem. 284:8760-8767(2009).
CC   -!- FUNCTION: Key enzyme in purine degradation. Catalyzes the oxidation of
CC       hypoxanthine to xanthine. Catalyzes the oxidation of xanthine to uric
CC       acid. Contributes to the generation of reactive oxygen species.
CC       {ECO:0000250|UniProtKB:P22985}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NAD(+) + xanthine = H(+) + NADH + urate;
CC         Xref=Rhea:RHEA:16669, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17712, ChEBI:CHEBI:17775, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.17.1.4;
CC         Evidence={ECO:0000269|PubMed:11005854, ECO:0000269|PubMed:12421831,
CC         ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:4352904};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + hypoxanthine + NAD(+) = H(+) + NADH + xanthine;
CC         Xref=Rhea:RHEA:24670, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17368, ChEBI:CHEBI:17712, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.17.1.4;
CC         Evidence={ECO:0000269|PubMed:11005854, ECO:0000269|PubMed:12421831,
CC         ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:4352904};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O2 + xanthine = H2O2 + urate; Xref=Rhea:RHEA:21132,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:17712, ChEBI:CHEBI:17775; EC=1.17.3.2;
CC         Evidence={ECO:0000269|PubMed:11005854, ECO:0000269|PubMed:12421831,
CC         ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:4352904};
CC   -!- COFACTOR:
CC       Name=[2Fe-2S] cluster; Xref=ChEBI:CHEBI:49601;
CC         Evidence={ECO:0000269|PubMed:12421831, ECO:0000269|PubMed:15148401,
CC         ECO:0000269|PubMed:19109252};
CC       Note=Binds 2 [2Fe-2S] clusters. {ECO:0000269|PubMed:12421831,
CC       ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:19109252};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:12421831, ECO:0000269|PubMed:15148401,
CC         ECO:0000269|PubMed:19109252};
CC   -!- COFACTOR:
CC       Name=Mo-molybdopterin; Xref=ChEBI:CHEBI:71302;
CC         Evidence={ECO:0000269|PubMed:12421831, ECO:0000269|PubMed:15148401,
CC         ECO:0000269|PubMed:19109252};
CC       Note=Binds 1 Mo-molybdopterin (Mo-MPT) cofactor per subunit.
CC       {ECO:0000269|PubMed:12421831, ECO:0000269|PubMed:15148401,
CC       ECO:0000269|PubMed:19109252};
CC   -!- ACTIVITY REGULATION: Can be converted from the dehydrogenase form (D)
CC       to the oxidase form (O) irreversibly by proteolysis or reversibly
CC       through the oxidation of sulfhydryl groups.
CC       {ECO:0000269|PubMed:11005854, ECO:0000269|PubMed:12817083,
CC       ECO:0000269|PubMed:4352904}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=111 uM for molecular oxygen in dehydrogenase form
CC         {ECO:0000269|PubMed:12817083, ECO:0000269|PubMed:4352904};
CC         KM=37.7 uM for molecular oxygen in oxygenase form
CC         {ECO:0000269|PubMed:12817083, ECO:0000269|PubMed:4352904};
CC         KM=20.8 uM for NAD {ECO:0000269|PubMed:12817083,
CC         ECO:0000269|PubMed:4352904};
CC         KM=5 uM for xanthine {ECO:0000269|PubMed:12817083,
CC         ECO:0000269|PubMed:4352904};
CC   -!- SUBUNIT: Homodimer. Interacts with BTN1A1 (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Peroxisome. Secreted.
CC   -!- TISSUE SPECIFICITY: Detected in milk (at protein level).
CC       {ECO:0000269|PubMed:11005854, ECO:0000269|PubMed:12421831,
CC       ECO:0000269|PubMed:15148401}.
CC   -!- PTM: Subject to partial proteolysis; this alters the enzyme from the
CC       dehydrogenase form (D) to the oxidase form (O).
CC   -!- PTM: Contains sulfhydryl groups that are easily oxidized (in vitro);
CC       this alters the enzyme from the dehydrogenase form (D) to the oxidase
CC       form (O).
CC   -!- SIMILARITY: Belongs to the xanthine dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Worthington enzyme manual;
CC       URL="http://www.worthington-biochem.com/XO/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X83508; CAA58497.1; -; mRNA.
DR   EMBL; X98491; CAA67117.1; -; mRNA.
DR   PIR; S65135; S65135.
DR   RefSeq; NP_776397.1; NM_173972.2.
DR   PDB; 1FIQ; X-ray; 2.50 A; A=1-219, B=220-569, C=570-1332.
DR   PDB; 1FO4; X-ray; 2.10 A; A/B=1-1332.
DR   PDB; 1N5X; X-ray; 2.80 A; A/B=2-1332.
DR   PDB; 1V97; X-ray; 1.94 A; A/B=1-1332.
DR   PDB; 1VDV; X-ray; 1.98 A; A/B=1-1332.
DR   PDB; 3AM9; X-ray; 2.17 A; A/B=1-1332.
DR   PDB; 3AMZ; X-ray; 2.10 A; A/B=1-1332.
DR   PDB; 3AX7; X-ray; 2.34 A; A/B=1-1332.
DR   PDB; 3AX9; X-ray; 2.30 A; A/B=1-1332.
DR   PDB; 3B9J; X-ray; 2.30 A; A/I=1-219, B/J=220-569, C/K=570-1332.
DR   PDB; 3BDJ; X-ray; 2.00 A; A/B=1-1332.
DR   PDB; 3ETR; X-ray; 2.20 A; A/L=2-165, B/M=224-528, C/N=571-1325.
DR   PDB; 3EUB; X-ray; 2.60 A; 2/A/J/S=1-165, 3/B/K/T=224-528, 4/C/L/U=571-1332.
DR   PDB; 3NRZ; X-ray; 1.80 A; A/J=2-165, B/K=224-528, C/L=571-1326.
DR   PDB; 3NS1; X-ray; 2.60 A; A/J=2-165, B/K=224-528, C/L=571-1325.
DR   PDB; 3NVV; X-ray; 1.82 A; A/J=2-165, B/K=195-528, C/L=571-1325.
DR   PDB; 3NVW; X-ray; 1.60 A; A/J=2-165, B/K=195-528, C/L=571-1326.
DR   PDB; 3NVY; X-ray; 2.00 A; A/J=2-165, B/K=195-528, C/L=571-1326.
DR   PDB; 3NVZ; X-ray; 1.60 A; A/J=2-165, B/K=224-528, C/L=571-1325.
DR   PDB; 3SR6; X-ray; 2.10 A; A/J=2-165, B/K=224-528, C/L=571-1315.
DR   PDB; 3UNA; X-ray; 1.90 A; A/B=1-1332.
DR   PDB; 3UNC; X-ray; 1.65 A; A/B=1-1332.
DR   PDB; 3UNI; X-ray; 2.20 A; A/B=1-1332.
DR   PDBsum; 1FIQ; -.
DR   PDBsum; 1FO4; -.
DR   PDBsum; 1N5X; -.
DR   PDBsum; 1V97; -.
DR   PDBsum; 1VDV; -.
DR   PDBsum; 3AM9; -.
DR   PDBsum; 3AMZ; -.
DR   PDBsum; 3AX7; -.
DR   PDBsum; 3AX9; -.
DR   PDBsum; 3B9J; -.
DR   PDBsum; 3BDJ; -.
DR   PDBsum; 3ETR; -.
DR   PDBsum; 3EUB; -.
DR   PDBsum; 3NRZ; -.
DR   PDBsum; 3NS1; -.
DR   PDBsum; 3NVV; -.
DR   PDBsum; 3NVW; -.
DR   PDBsum; 3NVY; -.
DR   PDBsum; 3NVZ; -.
DR   PDBsum; 3SR6; -.
DR   PDBsum; 3UNA; -.
DR   PDBsum; 3UNC; -.
DR   PDBsum; 3UNI; -.
DR   SMR; P80457; -.
DR   IntAct; P80457; 1.
DR   STRING; 9913.ENSBTAP00000016620; -.
DR   BindingDB; P80457; -.
DR   ChEMBL; CHEMBL3649; -.
DR   DrugCentral; P80457; -.
DR   PaxDb; P80457; -.
DR   PeptideAtlas; P80457; -.
DR   PRIDE; P80457; -.
DR   GeneID; 280960; -.
DR   KEGG; bta:280960; -.
DR   CTD; 7498; -.
DR   eggNOG; KOG0430; Eukaryota.
DR   InParanoid; P80457; -.
DR   OrthoDB; 48717at2759; -.
DR   BRENDA; 1.17.1.4; 908.
DR   BRENDA; 1.17.3.2; 908.
DR   SABIO-RK; P80457; -.
DR   EvolutionaryTrace; P80457; -.
DR   PRO; PR:P80457; -.
DR   Proteomes; UP000009136; Unplaced.
DR   GO; GO:0005615; C:extracellular space; IDA:CAFA.
DR   GO; GO:0005777; C:peroxisome; IEA:UniProtKB-SubCell.
DR   GO; GO:0002197; C:xanthine dehydrogenase complex; IDA:CAFA.
DR   GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; IDA:CAFA.
DR   GO; GO:0009055; F:electron transfer activity; IEA:InterPro.
DR   GO; GO:0071949; F:FAD binding; IDA:CAFA.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; ISS:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0030151; F:molybdenum ion binding; IDA:CAFA.
DR   GO; GO:0043546; F:molybdopterin cofactor binding; IDA:CAFA.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:CAFA.
DR   GO; GO:0004854; F:xanthine dehydrogenase activity; ISS:UniProtKB.
DR   GO; GO:0004855; F:xanthine oxidase activity; ISS:UniProtKB.
DR   GO; GO:0009115; P:xanthine catabolic process; ISS:UniProtKB.
DR   DisProt; DP00450; -.
DR   InterPro; IPR002888; 2Fe-2S-bd.
DR   InterPro; IPR036884; 2Fe-2S-bd_dom_sf.
DR   InterPro; IPR036010; 2Fe-2S_ferredoxin-like_sf.
DR   InterPro; IPR001041; 2Fe-2S_ferredoxin-type.
DR   InterPro; IPR006058; 2Fe2S_fd_BS.
DR   InterPro; IPR000674; Ald_Oxase/Xan_DH_a/b.
DR   InterPro; IPR036856; Ald_Oxase/Xan_DH_a/b_sf.
DR   InterPro; IPR016208; Ald_Oxase/xanthine_DH.
DR   InterPro; IPR008274; AldOxase/xan_DH_Mopterin-bd.
DR   InterPro; IPR037165; AldOxase/xan_DH_Mopterin-bd_sf.
DR   InterPro; IPR005107; CO_DH_flav_C.
DR   InterPro; IPR036683; CO_DH_flav_C_dom_sf.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR002346; Mopterin_DH_FAD-bd.
DR   InterPro; IPR022407; OxRdtase_Mopterin_BS.
DR   InterPro; IPR014307; Xanthine_DH_ssu.
DR   Pfam; PF01315; Ald_Xan_dh_C; 1.
DR   Pfam; PF02738; Ald_Xan_dh_C2; 1.
DR   Pfam; PF03450; CO_deh_flav_C; 1.
DR   Pfam; PF00941; FAD_binding_5; 1.
DR   Pfam; PF00111; Fer2; 1.
DR   Pfam; PF01799; Fer2_2; 1.
DR   PIRSF; PIRSF000127; Xanthine_DH; 1.
DR   SMART; SM01008; Ald_Xan_dh_C; 1.
DR   SMART; SM01092; CO_deh_flav_C; 1.
DR   SUPFAM; SSF47741; SSF47741; 1.
DR   SUPFAM; SSF54292; SSF54292; 1.
DR   SUPFAM; SSF54665; SSF54665; 1.
DR   SUPFAM; SSF55447; SSF55447; 1.
DR   SUPFAM; SSF56003; SSF56003; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   TIGRFAMs; TIGR02963; xanthine_xdhA; 1.
DR   PROSITE; PS00197; 2FE2S_FER_1; 1.
DR   PROSITE; PS51085; 2FE2S_FER_2; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
DR   PROSITE; PS00559; MOLYBDOPTERIN_EUK; 1.
PE   1: Evidence at protein level;
KW   2Fe-2S; 3D-structure; Cytoplasm; Direct protein sequencing; Disulfide bond;
KW   FAD; Flavoprotein; Iron; Iron-sulfur; Metal-binding; Molybdenum; NAD;
KW   Oxidoreductase; Peroxisome; Reference proteome; Secreted.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:7556219"
FT   CHAIN           2..1332
FT                   /note="Xanthine dehydrogenase/oxidase"
FT                   /id="PRO_0000166082"
FT   DOMAIN          4..91
FT                   /note="2Fe-2S ferredoxin-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00465"
FT   DOMAIN          229..414
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   NP_BIND         257..264
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401"
FT   NP_BIND         347..351
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401"
FT   ACT_SITE        1261
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000269|PubMed:15148401"
FT   METAL           43
FT                   /note="Iron-sulfur 1"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:19109252"
FT   METAL           48
FT                   /note="Iron-sulfur 1"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:19109252"
FT   METAL           51
FT                   /note="Iron-sulfur 1"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:19109252"
FT   METAL           73
FT                   /note="Iron-sulfur 1"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:19109252"
FT   METAL           113
FT                   /note="Iron-sulfur 2"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:19109252"
FT   METAL           116
FT                   /note="Iron-sulfur 2"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:19109252"
FT   METAL           148
FT                   /note="Iron-sulfur 2"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:19109252"
FT   METAL           150
FT                   /note="Iron-sulfur 2"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:19109252"
FT   METAL           767
FT                   /note="Molybdenum"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:19109252"
FT   METAL           798
FT                   /note="Molybdenum; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:19109252"
FT   METAL           912
FT                   /note="Molybdenum; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:19109252"
FT   METAL           1079
FT                   /note="Molybdenum; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401, ECO:0000269|PubMed:19109252"
FT   BINDING         337
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401"
FT   BINDING         360
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401"
FT   BINDING         404
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401"
FT   BINDING         422
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:12421831,
FT                   ECO:0000269|PubMed:15148401"
FT   BINDING         802
FT                   /note="Substrate"
FT   BINDING         880
FT                   /note="Substrate"
FT   BINDING         914
FT                   /note="Substrate"
FT   BINDING         1010
FT                   /note="Substrate; via amide nitrogen"
FT   DISULFID        535..992
FT                   /note="In oxidase form"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         335
FT                   /note="R->A: Promotes conversion to the oxidase form that
FT                   utilizes molecular oxygen as electron acceptor. Interferes
FT                   with normal conversion to the dehydrogenase form by
FT                   reducing agents."
FT                   /evidence="ECO:0000269|PubMed:12817083"
FT   MUTAGEN         336
FT                   /note="W->A: Promotes conversion to the oxidase form that
FT                   utilizes molecular oxygen as electron acceptor. Interferes
FT                   with normal conversion to the dehydrogenase form by
FT                   reducing agents."
FT                   /evidence="ECO:0000269|PubMed:12817083"
FT   MUTAGEN         427
FT                   /note="R->Q: Promotes conversion to the oxidase form that
FT                   utilizes molecular oxygen as electron acceptor. Interferes
FT                   with normal conversion to the dehydrogenase form by
FT                   reducing agents."
FT                   /evidence="ECO:0000269|PubMed:12817083"
FT   CONFLICT        188
FT                   /note="T -> TQ (in Ref. 2; CAA67117)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        199
FT                   /note="E -> K (in Ref. 2; CAA67117)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        366
FT                   /note="M -> V (in Ref. 2; CAA67117)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        552
FT                   /note="D -> H (in Ref. 1; CAA58497)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        958
FT                   /note="R -> K (in Ref. 2; CAA67117)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        976
FT                   /note="Q -> E (in Ref. 2; CAA67117)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1039..1040
FT                   /note="GQ -> E (in Ref. 2; CAA67117)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1244
FT                   /note="L -> V (in Ref. 2; CAA67117)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1268
FT                   /note="A -> P (in Ref. 2; CAA67117)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1279..1281
FT                   /note="RAA -> ARG (in Ref. 2; CAA67117)"
FT                   /evidence="ECO:0000305"
FT   STRAND          6..10
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          13..17
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           26..32
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          44..48
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          52..59
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   TURN            60..63
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          64..71
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   TURN            72..74
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           77..79
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          84..86
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           88..90
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          94..96
FT                   /evidence="ECO:0007829|PDB:1V97"
FT   HELIX           100..107
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           117..130
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           136..140
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   TURN            142..145
FT                   /evidence="ECO:0007829|PDB:3NVZ"
FT   STRAND          149..151
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           154..161
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           198..200
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           206..208
FT                   /evidence="ECO:0007829|PDB:3UNC"
FT   HELIX           214..218
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           219..221
FT                   /evidence="ECO:0007829|PDB:1FO4"
FT   STRAND          227..230
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          235..238
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           242..251
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           264..270
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          276..280
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           285..287
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          290..292
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          294..300
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           305..318
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           321..323
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           325..334
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          336..338
FT                   /evidence="ECO:0007829|PDB:3EUB"
FT   HELIX           340..343
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           348..354
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           362..367
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          371..376
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          379..384
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           387..389
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          403..410
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          416..422
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          428..431
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          435..443
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          446..462
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           467..471
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   TURN            472..475
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          477..479
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           480..493
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           505..527
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   TURN            540..542
FT                   /evidence="ECO:0007829|PDB:3UNC"
FT   HELIX           543..546
FT                   /evidence="ECO:0007829|PDB:3UNC"
FT   STRAND          555..559
FT                   /evidence="ECO:0007829|PDB:3UNC"
FT   HELIX           582..586
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           593..595
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          603..609
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          611..621
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           625..627
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          631..635
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           637..639
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          644..647
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          652..655
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          658..660
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          666..674
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           675..683
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          686..691
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           698..703
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          707..717
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           719..725
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          727..736
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          748..753
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          760..764
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           769..780
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           784..786
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          787..791
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   TURN            798..801
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           806..819
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          823..826
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           829..835
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          842..850
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          856..866
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           874..883
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   TURN            884..888
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          892..901
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   TURN            912..915
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           916..934
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           938..945
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           964..974
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           977..990
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          992..1008
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           1012..1014
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          1016..1023
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          1029..1034
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          1038..1040
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           1042..1054
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           1058..1060
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          1061..1063
FT                   /evidence="ECO:0007829|PDB:3SR6"
FT   TURN            1068..1070
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   TURN            1079..1081
FT                   /evidence="ECO:0007829|PDB:3B9J"
FT   HELIX           1082..1107
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           1113..1122
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          1128..1134
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   TURN            1142..1145
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          1151..1165
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   TURN            1166..1168
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          1171..1181
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           1188..1207
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   TURN            1224..1226
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           1232..1234
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   STRAND          1237..1243
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           1253..1255
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           1264..1267
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           1268..1285
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           1302..1308
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   TURN            1312..1314
FT                   /evidence="ECO:0007829|PDB:3NVW"
FT   HELIX           1317..1319
FT                   /evidence="ECO:0007829|PDB:3NVW"
SQ   SEQUENCE   1332 AA;  146790 MW;  744BA523471948B7 CRC64;
     MTADELVFFV NGKKVVEKNA DPETTLLAYL RRKLGLRGTK LGCGEGGCGA CTVMLSKYDR
     LQDKIIHFSA NACLAPICTL HHVAVTTVEG IGSTKTRLHP VQERIAKSHG SQCGFCTPGI
     VMSMYTLLRN QPEPTVEEIE DAFQGNLCRC TGYRPILQGF RTFAKNGGCC GGNGNNPNCC
     MNQKKDHTVT LSPSLFNPEE FMPLDPTQEP IFPPELLRLK DVPPKQLRFE GERVTWIQAS
     TLKELLDLKA QHPEAKLVVG NTEIGIEMKF KNQLFPMIIC PAWIPELNAV EHGPEGISFG
     AACALSSVEK TLLEAVAKLP TQKTEVFRGV LEQLRWFAGK QVKSVASLGG NIITASPISD
     LNPVFMASGT KLTIVSRGTR RTVPMDHTFF PSYRKTLLGP EEILLSIEIP YSREDEFFSA
     FKQASRREDD IAKVTCGMRV LFQPGSMQVK ELALCYGGMA DRTISALKTT QKQLSKFWNE
     KLLQDVCAGL AEELSLSPDA PGGMIEFRRT LTLSFFFKFY LTVLKKLGKD SKDKCGKLDP
     TYTSATLLFQ KDPPANIQLF QEVPNGQSKE DTVGRPLPHL AAAMQASGEA VYCDDIPRYE
     NELFLRLVTS TRAHAKIKSI DVSEAQKVPG FVCFLSADDI PGSNETGLFN DETVFAKDTV
     TCVGHIIGAV VADTPEHAER AAHVVKVTYE DLPAIITIED AIKNNSFYGS ELKIEKGDLK
     KGFSEADNVV SGELYIGGQD HFYLETHCTI AIPKGEEGEM ELFVSTQNAM KTQSFVAKML
     GVPVNRILVR VKRMGGGFGG KETRSTLVSV AVALAAYKTG HPVRCMLDRN EDMLITGGRH
     PFLARYKVGF MKTGTIVALE VDHYSNAGNS RDLSHSIMER ALFHMDNCYK IPNIRGTGRL
     CKTNLSSNTA FRGFGGPQAL FIAENWMSEV AVTCGLPAEE VRWKNMYKEG DLTHFNQRLE
     GFSVPRCWDE CLKSSQYYAR KSEVDKFNKE NCWKKRGLCI IPTKFGISFT VPFLNQAGAL
     IHVYTDGSVL VSHGGTEMGQ GLHTKMVQVA SKALKIPISK IYISETSTNT VPNSSPTAAS
     VSTDIYGQAV YEACQTILKR LEPFKKKNPD GSWEDWVMAA YQDRVSLSTT GFYRTPNLGY
     SFETNSGNAF HYFTYGVACS EVEIDCLTGD HKNLRTDIVM DVGSSLNPAI DIGQVEGAFV
     QGLGLFTLEE LHYSPEGSLH TRGPSTYKIP AFGSIPTEFR VSLLRDCPNK KAIYASKAVG
     EPPLFLGASV FFAIKDAIRA ARAQHTNNNT KELFRLDSPA TPEKIRNACV DKFTTLCVTG
     APGNCKPWSL RV
//
ID   CRY1_ARATH              Reviewed;         681 AA.
AC   Q43125; Q43126; Q8L7Y1; Q9ASZ2; Q9M0S9; Q9ZPF0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   03-MAY-2011, sequence version 2.
DT   02-JUN-2021, entry version 185.
DE   RecName: Full=Cryptochrome-1 {ECO:0000303|PubMed:8953250};
DE            Short=AtCry {ECO:0000303|PubMed:22421133};
DE            Short=Atcry1 {ECO:0000303|PubMed:8953250};
DE   AltName: Full=Blue light photoreceptor {ECO:0000303|PubMed:7756321};
DE   AltName: Full=Protein BLUE LIGHT UNINHIBITED 1 {ECO:0000303|PubMed:12324610};
DE   AltName: Full=Protein ELONGATED HYPOCOTYL 4 {ECO:0000303|PubMed:8232555};
DE   AltName: Full=Protein OUT OF PHASE 2;
DE            Short=OOP2;
GN   Name=CRY1 {ECO:0000303|PubMed:8953250};
GN   Synonyms=BLU1 {ECO:0000303|PubMed:12324610},
GN   HY4 {ECO:0000303|PubMed:8232555};
GN   OrderedLocusNames=At4g08920 {ECO:0000312|Araport:AT4G08920};
GN   ORFNames=T3H13.14 {ECO:0000312|EMBL:AAD17364.1},
GN   T3H13.5 {ECO:0000312|EMBL:AAD17364.1};
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=8232555; DOI=10.1038/366162a0;
RA   Ahmad M., Cashmore A.R.;
RT   "HY4 gene of A. thaliana encodes a protein with characteristics of a blue-
RT   light photoreceptor.";
RL   Nature 366:162-166(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617198; DOI=10.1038/47134;
RA   Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G., Pohl T.,
RA   Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N., Harris B.,
RA   Ansorge W., Brandt P., Grivell L.A., Rieger M., Weichselgartner M.,
RA   de Simone V., Obermaier B., Mache R., Mueller M., Kreis M., Delseny M.,
RA   Puigdomenech P., Watson M., Schmidtheini T., Reichert B., Portetelle D.,
RA   Perez-Alonso M., Boutry M., Bancroft I., Vos P., Hoheisel J.,
RA   Zimmermann W., Wedler H., Ridley P., Langham S.-A., McCullagh B.,
RA   Bilham L., Robben J., van der Schueren J., Grymonprez B., Chuang Y.-J.,
RA   Vandenbussche F., Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R.,
RA   Defoor E., Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M.,
RA   Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W., Mooijman P.,
RA   Klein Lankhorst R., Rose M., Hauf J., Koetter P., Berneiser S., Hempel S.,
RA   Feldpausch M., Lamberth S., Van den Daele H., De Keyser A., Buysshaert C.,
RA   Gielen J., Villarroel R., De Clercq R., van Montagu M., Rogers J.,
RA   Cronin A., Quail M.A., Bray-Allen S., Clark L., Doggett J., Hall S.,
RA   Kay M., Lennard N., McLay K., Mayes R., Pettett A., Rajandream M.A.,
RA   Lyne M., Benes V., Rechmann S., Borkova D., Bloecker H., Scharfe M.,
RA   Grimm M., Loehnert T.-H., Dose S., de Haan M., Maarse A.C., Schaefer M.,
RA   Mueller-Auer S., Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D.,
RA   Herzl A., Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E.,
RA   Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R., Schnabl S.,
RA   Hiller R., Schmidt W., Lecharny A., Aubourg S., Chefdor F., Cooke R.,
RA   Berger C., Monfort A., Casacuberta E., Gibbons T., Weber N., Vandenbol M.,
RA   Bargues M., Terol J., Torres A., Perez-Perez A., Purnelle B., Bent E.,
RA   Johnson S., Tacon D., Jesse T., Heijnen L., Schwarz S., Scholler P.,
RA   Heber S., Francs P., Bielke C., Frishman D., Haase D., Lemcke K.,
RA   Mewes H.-W., Stocker S., Zaccaria P., Bevan M., Wilson R.K.,
RA   de la Bastide M., Habermann K., Parnell L., Dedhia N., Gnoj L., Schutz K.,
RA   Huang E., Spiegel L., Sekhon M., Murray J., Sheet P., Cordes M.,
RA   Abu-Threideh J., Stoneking T., Kalicki J., Graves T., Harmon G.,
RA   Edwards J., Latreille P., Courtney L., Cloud J., Abbott A., Scott K.,
RA   Johnson D., Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K.,
RA   Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W.,
RA   Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D., Du H.,
RA   Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C., Antonoiu B.,
RA   Zidanic M., Strong C., Sun H., Lamar B., Yordan C., Ma P., Zhong J.,
RA   Preston R., Vil D., Shekher M., Matero A., Shah R., Swaby I.K.,
RA   O'Shaughnessy A., Rodriguez M., Hoffman J., Till S., Granat S., Shohdy N.,
RA   Hasegawa A., Hameed A., Lodhi M., Johnson A., Chen E., Marra M.A.,
RA   Martienssen R., McCombie W.R.;
RT   "Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana.";
RL   Nature 402:769-777(1999).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J., Southwick A.M.,
RA   Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F., Karlin-Newmann G.,
RA   Liu S.X., Lam B., Sakano H., Wu T., Yu G., Miranda M., Quach H.L.,
RA   Tripp M., Chang C.H., Lee J.M., Toriumi M.J., Chan M.M., Tang C.C.,
RA   Onodera C.S., Deng J.M., Akiyama K., Ansari Y., Arakawa T., Banh J.,
RA   Banno F., Bowser L., Brooks S.Y., Carninci P., Chao Q., Choy N., Enju A.,
RA   Goldsmith A.D., Gurjal M., Hansen N.F., Hayashizaki Y., Johnson-Hopson C.,
RA   Hsuan V.W., Iida K., Karnes M., Khan S., Koesema E., Ishida J., Jiang P.X.,
RA   Jones T., Kawai J., Kamiya A., Meyers C., Nakajima M., Narusaka M.,
RA   Seki M., Sakurai T., Satou M., Tamse R., Vaysberg M., Wallender E.K.,
RA   Wong C., Yamamura Y., Yuan S., Shinozaki K., Davis R.W., Theologis A.,
RA   Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=12324610; DOI=10.2307/3869250;
RA   Liscum E., Hangarter R.P.;
RT   "Arabidopsis mutants lacking blue light-dependent inhibition of hypocotyl
RT   elongation.";
RL   Plant Cell 3:685-694(1991).
RN   [6]
RP   FUNCTION, AND COFACTOR.
RX   PubMed=7756321; DOI=10.1021/bi00020a037;
RA   Malhotra K., Kim S.-T., Batschauer A., Dawut L., Sancar A.;
RT   "Putative blue-light photoreceptors from Arabidopsis thaliana and Sinapis
RT   alba with a high degree of sequence homology to DNA photolyase contain the
RT   two photolyase cofactors but lack DNA repair activity.";
RL   Biochemistry 34:6892-6899(1995).
RN   [7]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF GLY-220; GLY-283;
RP   GLY-340; GLY-347; GLU-515; GLU-531; PRO-549; GLU-559; ARG-576; ARG-581 AND
RP   ARG-611.
RX   PubMed=8528277; DOI=10.1046/j.1365-313x.1995.08050653.x;
RA   Ahmad M., Lin C., Cashmore A.R.;
RT   "Mutations throughout an Arabidopsis blue-light photoreceptor impair blue-
RT   light-responsive anthocyanin accumulation and inhibition of hypocotyl
RT   elongation.";
RL   Plant J. 8:653-658(1995).
RN   [8]
RP   CHARACTERIZATION.
RX   PubMed=8953250; DOI=10.1046/j.1365-313x.1996.10050893.x;
RA   Lin C., Ahmad M., Cashmore A.R.;
RT   "Arabidopsis cryptochrome 1 is a soluble protein mediating blue light-
RT   dependent regulation of plant growth and development.";
RL   Plant J. 10:893-902(1996).
RN   [9]
RP   FUNCTION, AND MUTAGENESIS OF GLY-340.
RX   PubMed=9565033; DOI=10.1038/33701;
RA   Ahmad M., Jarillo J.A., Smirnova O., Cashmore A.R.;
RT   "Cryptochrome blue-light photoreceptors of Arabidopsis implicated in
RT   phototropism.";
RL   Nature 392:720-723(1998).
RN   [10]
RP   INTERACTION WITH PHYA, AND PHOSPHORYLATION.
RX   PubMed=9651577; DOI=10.1016/s1097-2765(00)80094-5;
RA   Ahmad M., Jarillo J.A., Smirnova O., Cashmore A.R.;
RT   "The CRY1 blue light photoreceptor of Arabidopsis interacts with
RT   phytochrome A in vitro.";
RL   Mol. Cell 1:939-948(1998).
RN   [11]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=cv. Landsberg erecta;
RX   PubMed=9733523; DOI=10.1104/pp.118.1.27;
RA   Neff M.M., Chory J.;
RT   "Genetic interactions between phytochrome A, phytochrome B, and
RT   cryptochrome 1 during Arabidopsis development.";
RL   Plant Physiol. 118:27-35(1998).
RN   [12]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=cv. Landsberg erecta;
RX   PubMed=9765547; DOI=10.1104/pp.118.2.609;
RA   Parks B.M., Cho M.H., Spalding E.P.;
RT   "Two genetically separable phases of growth inhibition induced by blue
RT   light in Arabidopsis seedlings.";
RL   Plant Physiol. 118:609-615(1998).
RN   [13]
RP   DOMAINS.
RX   PubMed=11114337; DOI=10.1016/s0092-8674(00)00184-7;
RA   Yang H.-Q., Wu Y.-J., Tang R.-H., Liu D., Liu Y., Cashmore A.R.;
RT   "The C termini of Arabidopsis cryptochromes mediate a constitutive light
RT   response.";
RL   Cell 103:815-827(2000).
RN   [14]
RP   INTERACTION WITH ADO1.
RX   PubMed=11260718; DOI=10.1038/35068589;
RA   Jarillo J.A., Capel J., Tang R.-H., Yang H.-Q., Alonso J.M., Ecker J.R.,
RA   Cashmore A.R.;
RT   "An Arabidopsis circadian clock component interacts with both CRY1 and
RT   phyB.";
RL   Nature 410:487-490(2001).
RN   [15]
RP   INTERACTION WITH COP1.
RX   PubMed=11509693; DOI=10.1126/science.1063630;
RA   Wang H., Ma L.-G., Li J.-M., Zhao H.-Y., Deng X.W.;
RT   "Direct interaction of Arabidopsis cryptochromes with COP1 in light control
RT   development.";
RL   Science 294:154-158(2001).
RN   [16]
RP   INTERACTION WITH COP1.
RX   PubMed=11752373; DOI=10.2307/3871520;
RA   Yang H.-Q., Tang R.-H., Cashmore A.R.;
RT   "The signaling mechanism of Arabidopsis CRY1 involves direct interaction
RT   with COP1.";
RL   Plant Cell 13:2573-2587(2001).
RN   [17]
RP   INDUCTION BY CIRCADIAN CLOCK AND LIGHT, AND TISSUE SPECIFICITY.
RX   PubMed=11743105; DOI=10.1104/pp.010467;
RA   Toth R., Kevei E., Hall A., Millar A.J., Nagy F., Kozma-Bognar L.;
RT   "Circadian clock-regulated expression of phytochrome and cryptochrome genes
RT   in Arabidopsis.";
RL   Plant Physiol. 127:1607-1616(2001).
RN   [18]
RP   PHOSPHORYLATION.
RX   PubMed=12846824; DOI=10.1046/j.1432-1033.2003.03691.x;
RA   Bouly J.-P., Giovani B., Djamei A., Mueller M., Zeugner A., Dudkin E.A.,
RA   Batschauer A., Ahmad M.;
RT   "Novel ATP-binding and autophosphorylation activity associated with
RT   Arabidopsis and human cryptochrome-1.";
RL   Eur. J. Biochem. 270:2921-2928(2003).
RN   [19]
RP   PHOSPHORYLATION.
RX   PubMed=14523249; DOI=10.1105/tpc013011;
RA   Shalitin D., Yu X., Maymon M., Mockler T., Lin C.;
RT   "Blue light-dependent in vivo and in vitro phosphorylation of Arabidopsis
RT   cryptochrome 1.";
RL   Plant Cell 15:2421-2429(2003).
RN   [20]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=12857830; DOI=10.1104/pp.102.018481;
RA   Whippo C.W., Hangarter R.P.;
RT   "Second positive phototropism results from coordinated co-action of the
RT   phototropins and cryptochromes.";
RL   Plant Physiol. 132:1499-1507(2003).
RN   [21]
RP   FUNCTION.
RX   PubMed=16093319; DOI=10.1073/pnas.0501011102;
RA   Mao J., Zhang Y.C., Sang Y., Li Q.H., Yang H.Q.;
RT   "A role for Arabidopsis cryptochromes and COP1 in the regulation of
RT   stomatal opening.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:12270-12275(2005).
RN   [22]
RP   ACTIVITY REGULATION.
RX   PubMed=15751956; DOI=10.1021/bi047545g;
RA   Partch C.L., Clarkson M.W., Ozgur S., Lee A.L., Sancar A.;
RT   "Role of structural plasticity in signal transduction by the cryptochrome
RT   blue-light photoreceptor.";
RL   Biochemistry 44:3795-3805(2005).
RN   [23]
RP   SUBUNIT, AND MUTAGENESIS OF SER-66; GLY-347 AND ALA-462.
RX   PubMed=15805487; DOI=10.1105/tpc.104.029645;
RA   Sang Y., Li Q.-H., Rubio V., Zhang Y.-C., Mao J., Deng X.-W., Yang H.-Q.;
RT   "N-terminal domain-mediated homodimerization is required for photoreceptor
RT   activity of Arabidopsis CRYPTOCHROME 1.";
RL   Plant Cell 17:1569-1584(2005).
RN   [24]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15610358; DOI=10.1111/j.1365-313x.2004.02281.x;
RA   Koroleva O.A., Tomlinson M.L., Leader D., Shaw P., Doonan J.H.;
RT   "High-throughput protein localization in Arabidopsis using Agrobacterium-
RT   mediated transient expression of GFP-ORF fusions.";
RL   Plant J. 41:162-174(2005).
RN   [25]
RP   AUTOPHOSPHORYLATION, COFACTOR, AND ATP-BINDING.
RX   PubMed=17073458; DOI=10.1021/bi061556n;
RA   Ozguer S., Sancar A.;
RT   "Analysis of autophosphorylating kinase activities of Arabidopsis and human
RT   cryptochromes.";
RL   Biochemistry 45:13369-13374(2006).
RN   [26]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16703358; DOI=10.1007/s00425-006-0280-6;
RA   Canamero R.C., Bakrim N., Bouly J.-P., Garay A., Dudkin E.E., Habricot Y.,
RA   Ahmad M.;
RT   "Cryptochrome photoreceptors cry1 and cry2 antagonistically regulate
RT   primary root elongation in Arabidopsis thaliana.";
RL   Planta 224:995-1003(2006).
RN   [27]
RP   FUNCTION IN PCD, AND DISRUPTION PHENOTYPE.
RX   PubMed=17075038; DOI=10.1073/pnas.0608139103;
RA   Danon A., Coll N.S., Apel K.;
RT   "Cryptochrome-1-dependent execution of programmed cell death induced by
RT   singlet oxygen in Arabidopsis thaliana.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17036-17041(2006).
RN   [28]
RP   MUTAGENESIS OF ASP-21; SER-286; GLY-340 AND GLU-623.
RC   STRAIN=cv. Columbia;
RX   PubMed=18065688; DOI=10.1105/tpc.107.054312;
RA   Ruckle M.E., DeMarco S.M., Larkin R.M.;
RT   "Plastid signals remodel light signaling networks and are essential for
RT   efficient chloroplast biogenesis in Arabidopsis.";
RL   Plant Cell 19:3944-3960(2007).
RN   [29]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18003924; DOI=10.1073/pnas.0705082104;
RA   Wu G., Spalding E.P.;
RT   "Separate functions for nuclear and cytoplasmic cryptochrome 1 during
RT   photomorphogenesis of Arabidopsis seedlings.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:18813-18818(2007).
RN   [30]
RP   FUNCTION.
RX   PubMed=18397371; DOI=10.1111/j.1365-313x.2008.03508.x;
RA   Hong S.H., Kim H.J., Ryu J.S., Choi H., Jeong S., Shin J., Choi G.,
RA   Nam H.G.;
RT   "CRY1 inhibits COP1-mediated degradation of BIT1, a MYB transcription
RT   factor, to activate blue light-dependent gene expression in Arabidopsis.";
RL   Plant J. 55:361-371(2008).
RN   [31]
RP   ATP BINDING.
RX   PubMed=19327354; DOI=10.1016/j.febslet.2009.03.040;
RA   Burney S., Hoang N., Caruso M., Dudkin E.A., Ahmad M., Bouly J.-P.;
RT   "Conformational change induced by ATP binding correlates with enhanced
RT   biological function of Arabidopsis cryptochrome.";
RL   FEBS Lett. 583:1427-1433(2009).
RN   [32]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=cv. Columbia;
RX   PubMed=19558423; DOI=10.1111/j.1469-8137.2009.02921.x;
RA   Millenaar F.F., van Zanten M., Cox M.C., Pierik R., Voesenek L.A.,
RA   Peeters A.J.;
RT   "Differential petiole growth in Arabidopsis thaliana: photocontrol and
RT   hormonal regulation.";
RL   New Phytol. 184:141-152(2009).
RN   [33]
RP   REVIEW ON CRYPTOCHROMES.
RX   PubMed=21841916; DOI=10.1199/tab.0135;
RA   Yu X., Liu H., Klejnot J., Lin C.;
RT   "The cryptochrome blue light receptors.";
RL   Arabidopsis Book 8:E0135-E0135(2010).
RN   [34]
RP   REVIEW ON PHOTORECEPTORS.
RX   PubMed=20705178; DOI=10.1016/s0070-2153(10)91002-8;
RA   Kami C., Lorrain S., Hornitschek P., Fankhauser C.;
RT   "Light-regulated plant growth and development.";
RL   Curr. Top. Dev. Biol. 91:29-66(2010).
RN   [35]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=20133010; DOI=10.1016/j.jplph.2009.12.003;
RA   Zeng J., Wang Q., Lin J., Deng K., Zhao X., Tang D., Liu X.;
RT   "Arabidopsis cryptochrome-1 restrains lateral roots growth by inhibiting
RT   auxin transport.";
RL   J. Plant Physiol. 167:670-673(2010).
RN   [36]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=cv. Columbia;
RX   PubMed=20053798; DOI=10.1093/mp/ssp107;
RA   Wu L., Yang H.-Q.;
RT   "CRYPTOCHROME 1 is implicated in promoting R protein-mediated plant
RT   resistance to Pseudomonas syringae in Arabidopsis.";
RL   Mol. Plant 3:539-548(2010).
RN   [37]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=cv. Landsberg erecta;
RX   PubMed=20668058; DOI=10.1104/pp.110.160820;
RA   Sellaro R., Crepy M., Trupkin S.A., Karayekov E., Buchovsky A.S., Rossi C.,
RA   Casal J.J.;
RT   "Cryptochrome as a sensor of the blue/green ratio of natural radiation in
RT   Arabidopsis.";
RL   Plant Physiol. 154:401-409(2010).
RN   [38]
RP   MUTAGENESIS OF LEU-407.
RC   STRAIN=cv. Columbia, and cv. Landsberg erecta;
RX   PubMed=20926618; DOI=10.1104/pp.110.160895;
RA   Exner V., Alexandre C., Rosenfeldt G., Alfarano P., Nater M., Caflisch A.,
RA   Gruissem W., Batschauer A., Hennig L.;
RT   "A gain-of-function mutation of Arabidopsis cryptochrome1 promotes
RT   flowering.";
RL   Plant Physiol. 154:1633-1645(2010).
RN   [39]
RP   FUNCTION, DISRUPTION PHENOTYPE, SUBCELLULAR LOCATION, AND INTERACTION WITH
RP   SPA1.
RC   STRAIN=cv. Columbia;
RX   PubMed=21511872; DOI=10.1101/gad.2025111;
RA   Lian H.-L., He S.-B., Zhang Y.-C., Zhu D.-M., Zhang J.-Y., Jia K.-P.,
RA   Sun S.-X., Li L., Yang H.-Q.;
RT   "Blue-light-dependent interaction of cryptochrome 1 with SPA1 defines a
RT   dynamic signaling mechanism.";
RL   Genes Dev. 25:1023-1028(2011).
RN   [40]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND INTERACTION WITH SPA1 AND SPA4.
RX   PubMed=21511871; DOI=10.1101/gad.2025011;
RA   Liu B., Zuo Z., Liu H., Liu X., Lin C.;
RT   "Arabidopsis cryptochrome 1 interacts with SPA1 to suppress COP1 activity
RT   in response to blue light.";
RL   Genes Dev. 25:1029-1034(2011).
RN   [41]
RP   FUNCTION.
RX   PubMed=21467031; DOI=10.1074/jbc.m111.228940;
RA   Mueller P., Ahmad M.;
RT   "Light-activated cryptochrome reacts with molecular oxygen to form a
RT   flavin-superoxide radical pair consistent with magnetoreception.";
RL   J. Biol. Chem. 286:21033-21040(2011).
RN   [42]
RP   FUNCTION, AND MUTAGENESIS OF TRP-324.
RX   PubMed=21875594; DOI=10.1016/j.jmb.2011.08.031;
RA   Kondoh M., Shiraishi C., Mueller P., Ahmad M., Hitomi K., Getzoff E.D.,
RA   Terazima M.;
RT   "Light-induced conformational changes in full-length Arabidopsis thaliana
RT   cryptochrome.";
RL   J. Mol. Biol. 413:128-137(2011).
RN   [43]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=21265897; DOI=10.1111/j.1365-313x.2010.04434.x;
RA   Foreman J., Johansson H., Hornitschek P., Josse E.-M., Fankhauser C.,
RA   Halliday K.J.;
RT   "Light receptor action is critical for maintaining plant biomass at warm
RT   ambient temperatures.";
RL   Plant J. 65:441-452(2011).
RN   [44]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=21457375; DOI=10.1111/j.1365-313x.2011.04598.x;
RA   Keller M.M., Jaillais Y., Pedmale U.V., Moreno J.E., Chory J.,
RA   Ballare C.L.;
RT   "Cryptochrome 1 and phytochrome B control shade-avoidance responses in
RT   Arabidopsis via partially independent hormonal cascades.";
RL   Plant J. 67:195-207(2011).
RN   [45]
RP   MUTAGENESIS OF ASP-396.
RX   PubMed=22890584; DOI=10.1002/anie.201203476;
RA   Burney S., Wenzel R., Kottke T., Roussel T., Hoang N., Bouly J.P.,
RA   Bittl R., Heberle J., Ahmad M.;
RT   "Single amino acid substitution reveals latent photolyase activity in
RT   Arabidopsis cry1.";
RL   Angew. Chem. Int. Ed. 51:9356-9360(2012).
RN   [46]
RP   INTERACTION WITH PHYB, AND MUTAGENESIS OF LEU-407.
RX   PubMed=22577138; DOI=10.1074/jbc.m112.360545;
RA   Hughes R.M., Vrana J.D., Song J., Tucker C.L.;
RT   "Light-dependent, dark-promoted interaction between Arabidopsis
RT   cryptochrome 1 and phytochrome B proteins.";
RL   J. Biol. Chem. 287:22165-22172(2012).
RN   [47]
RP   MUTAGENESIS OF GLY-380, AND SUBCELLULAR LOCATION.
RX   PubMed=21765176; DOI=10.1093/mp/ssr052;
RA   Gu N.-N., Zhang Y.-C., Yang H.-Q.;
RT   "Substitution of a conserved glycine in the PHR domain of Arabidopsis
RT   cryptochrome 1 confers a constitutive light response.";
RL   Mol. Plant 5:85-97(2012).
RN   [48]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=22786870; DOI=10.1105/tpc.112.100099;
RA   Shaikhali J., de Dios Barajas-Lopez J., Oetvoes K., Kremnev D.,
RA   Garcia A.S., Srivastava V., Wingsle G., Bako L., Strand A.;
RT   "The CRYPTOCHROME1-dependent response to excess light is mediated through
RT   the transcriptional activators ZINC FINGER PROTEIN EXPRESSED IN
RT   INFLORESCENCE MERISTEM LIKE1 and ZML2 in Arabidopsis.";
RL   Plant Cell 24:3009-3025(2012).
RN   [49]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=cv. Columbia, and cv. Landsberg erecta;
RX   PubMed=22855128; DOI=10.1007/s11103-012-9950-x;
RA   Fox A.R., Soto G.C., Jones A.M., Casal J.J., Muschietti J.P.,
RA   Mazzella M.A.;
RT   "cry1 and GPA1 signaling genetically interact in hook opening and
RT   anthocyanin synthesis in Arabidopsis.";
RL   Plant Mol. Biol. 80:315-324(2012).
RN   [50]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=cv. Columbia;
RX   PubMed=22147516; DOI=10.1104/pp.111.187237;
RA   Boccalandro H.E., Giordano C.V., Ploschuk E.L., Piccoli P.N., Bottini R.,
RA   Casal J.J.;
RT   "Phototropins but not cryptochromes mediate the blue light-specific
RT   promotion of stomatal conductance, while both enhance photosynthesis and
RT   transpiration under full sunlight.";
RL   Plant Physiol. 158:1475-1484(2012).
RN   [51]
RP   FUNCTION.
RX   PubMed=22421133; DOI=10.1073/pnas.1118959109;
RA   Maeda K., Robinson A.J., Henbest K.B., Hogben H.J., Biskup T., Ahmad M.,
RA   Schleicher E., Weber S., Timmel C.R., Hore P.J.;
RT   "Magnetically sensitive light-induced reactions in cryptochrome are
RT   consistent with its proposed role as a magnetoreceptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:4774-4779(2012).
RN   [52]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND INDUCTION BY TEMPERATURE.
RC   STRAIN=cv. Columbia;
RX   PubMed=23511208; DOI=10.1038/msb.2013.7;
RA   Gould P.D., Ugarte N., Domijan M., Costa M., Foreman J., Macgregor D.,
RA   Rose K., Griffiths J., Millar A.J., Finkenstaedt B., Penfield S.,
RA   Rand D.A., Halliday K.J., Hall A.J.W.;
RT   "Network balance via CRY signalling controls the Arabidopsis circadian
RT   clock over ambient temperatures.";
RL   Mol. Syst. Biol. 9:650-650(2013).
RN   [53]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=cv. Landsberg erecta;
RX   PubMed=22681544; DOI=10.1111/j.1365-3040.2012.02554.x;
RA   Nameth B., Dinka S.J., Chatfield S.P., Morris A., English J., Lewis D.,
RA   Oro R., Raizada M.N.;
RT   "The shoot regeneration capacity of excised Arabidopsis cotyledons is
RT   established during the initial hours after injury and is modulated by a
RT   complex genetic network of light signalling.";
RL   Plant Cell Environ. 36:68-86(2013).
RN   [54]
RP   FUNCTION.
RC   STRAIN=cv. Landsberg erecta;
RX   PubMed=23398192; DOI=10.1111/tpj.12144;
RA   Herbel V., Orth C., Wenzel R., Ahmad M., Bittl R., Batschauer A.;
RT   "Lifetimes of Arabidopsis cryptochrome signaling states in vivo.";
RL   Plant J. 74:583-592(2013).
RN   [55]
RP   FUNCTION.
RX   PubMed=25157750; DOI=10.1021/ja506084f;
RA   Cailliez F., Mueller P., Gallois M., de la Lande A.;
RT   "ATP binding and aspartate protonation enhance photoinduced electron
RT   transfer in plant cryptochrome.";
RL   J. Am. Chem. Soc. 136:12974-12986(2014).
RN   [56]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=cv. Columbia;
RX   PubMed=24126495; DOI=10.1093/mp/sst093;
RA   Jia K.-P., Luo Q., He S.-B., Lu X.-D., Yang H.-Q.;
RT   "Strigolactone-regulated hypocotyl elongation is dependent on cryptochrome
RT   and phytochrome signaling pathways in Arabidopsis.";
RL   Mol. Plant 7:528-540(2014).
RN   [57]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=26095447; DOI=10.1002/bem.21927;
RA   Xu C., Li Y., Yu Y., Zhang Y., Wei S.;
RT   "Suppression of Arabidopsis flowering by near-null magnetic field is
RT   affected by light.";
RL   Bioelectromagnetics 36:476-479(2015).
RN   [58]
RP   INTERACTION WITH TCP2.
RX   PubMed=26596765; DOI=10.1093/jxb/erv495;
RA   He Z., Zhao X., Kong F., Zuo Z., Liu X.;
RT   "TCP2 positively regulates HY5/HYH and photomorphogenesis in Arabidopsis.";
RL   J. Exp. Bot. 67:775-785(2015).
RN   [59]
RP   FUNCTION, DISRUPTION PHENOTYPE, MUTAGENESIS OF SER-66; GLY-220; GLY-283;
RP   GLY-337; GLY-340; GLY-347 AND ALA-462, AND DOMAINS.
RX   PubMed=25721730; DOI=10.1016/j.molp.2015.02.008;
RA   He S.B., Wang W.X., Zhang J.Y., Xu F., Lian H.L., Li L., Yang H.Q.;
RT   "The CNT1 domain of Arabidopsis CRY1 Alone is sufficient to mediate blue
RT   light inhibition of hypocotyl elongation.";
RL   Mol. Plant 8:822-825(2015).
RN   [60]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=cv. Wassilewskija;
RX   PubMed=25728686; DOI=10.1111/nph.13341;
RA   Consentino L., Lambert S., Martino C., Jourdan N., Bouchet P.-E.,
RA   Witczak J., Castello P., El-Esawi M., Corbineau F., d'Harlingue A.,
RA   Ahmad M.;
RT   "Blue-light dependent reactive oxygen species formation by Arabidopsis
RT   cryptochrome may define a novel evolutionarily conserved signaling
RT   mechanism.";
RL   New Phytol. 206:1450-1462(2015).
RN   [61]
RP   FUNCTION, AND MUTAGENESIS OF TRP-324 AND TRP-400.
RX   PubMed=26313597; DOI=10.1080/15592324.2015.1063758;
RA   El-Esawi M., Glascoe A., Engle D., Ritz T., Link J., Ahmad M.;
RT   "Cellular metabolites modulate in vivo signaling of Arabidopsis
RT   cryptochrome-1.";
RL   Plant Signal. Behav. 10:E1063758-E1063758(2015).
RN   [62]
RP   FUNCTION, INDUCTION BY LOW BLUE LIGHT, INTERACTION WITH PIF4 AND PIF5, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=26724867; DOI=10.1016/j.cell.2015.12.018;
RA   Pedmale U.V., Huang S.S., Zander M., Cole B.J., Hetzel J., Ljung K.,
RA   Reis P.A., Sridevi P., Nito K., Nery J.R., Ecker J.R., Chory J.;
RT   "Cryptochromes interact directly with PIFs to control plant growth in
RT   limiting blue light.";
RL   Cell 164:233-245(2016).
RN   [63]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 1-509 IN COMPLEX WITH ATP; FAD
RP   AND MAGNESIUM, DISULFIDE BONDS, AND BINDING SITES.
RX   PubMed=15299148; DOI=10.1073/pnas.0404851101;
RA   Brautigam C.A., Smith B.S., Ma Z., Palnitkar M., Tomchick D.R., Machius M.,
RA   Deisenhofer J.;
RT   "Structure of the photolyase-like domain of cryptochrome 1 from Arabidopsis
RT   thaliana.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12142-12147(2004).
CC   -!- FUNCTION: Photoreceptor that mediates primarily blue light inhibition
CC       of hypocotyl elongation and photoperiodic control of floral initiation,
CC       and regulates other light responses, including circadian rhythms,
CC       tropic growth, stomata opening, guard cell development, root
CC       development, bacterial and viral pathogen responses, abiotic stress
CC       responses, cell cycles, programmed cell death, apical dominance, fruit
CC       and ovule development, seed dormancy, and magnetoreception.
CC       Photoexcited cryptochromes interact with signaling partner proteins to
CC       alter gene expression at both transcriptional and post-translational
CC       levels and, consequently, regulate the corresponding metabolic and
CC       developmental programs (PubMed:21841916). Blue-light absorbing
CC       flavoprotein that activates reversible flavin photoreduction via an
CC       electron transport chain comprising a tryptophan triad (W-324, W-377
CC       and W-400), accompanied by a large conformational change upon
CC       photoexcitation, or via an alternative electron transport that involves
CC       small metabolites, including NADPH, NADH, and ATP. The half-life of the
CC       activated signaling state is about 5 minutes (PubMed:26313597,
CC       PubMed:25157750, PubMed:23398192, PubMed:21875594, PubMed:21467031).
CC       Also involved in the detection of blue/green ratio in light (shade
CC       under leaf canopies) and subsequent adaptations on plant growth and
CC       development (PubMed:20668058). In darkness, the dark reoxidation of
CC       flavin occurs and leads to inactivated state (PubMed:21467031,
CC       PubMed:23398192). Perceives low blue light (LBL) and responds by
CC       directly contacting two bHLH transcription factors, PIF4 and PIF5, at
CC       chromatin on E-box variant 5'-CA[CT]GTG-3' to promote their activity
CC       and stimulate specific gene expression to adapt global physiology (e.g.
CC       hypocotyl elongation and hyponastic growth in low blue light)
CC       (PubMed:26724867, PubMed:19558423). When activated by high-intensity
CC       blue light, catalyzes direct enzymatic conversion of molecular oxygen
CC       O(2) to reactive oxygen species (ROS) and hydrogen peroxide H(2)O(2) in
CC       vitro. ROS accumulation upon activation by blue light leads to cell
CC       death in protoplasts (PubMed:25728686). Seems essential for blue-light-
CC       triggered and singlet oxygen-mediated programmed cell death (PCD)
CC       (PubMed:17075038). Required for the induction of nuclear genes encoding
CC       photoprotective components by GATA24 and GATA28 in extreme light
CC       intensities that exceed the electron utilization capacity of the
CC       chloroplast (PubMed:22786870). Involved in shortening the circadian
CC       clock period, especially at 27 degrees Celsius, in blue light (BL) and
CC       required to maintain clock genes expression rhythm (PubMed:23511208).
CC       Mediates blue light-induced gene expression and hypocotyl elongation
CC       through the inhibition of COP1-mediated degradation of the
CC       transcription factors BIT1 and HY5 and via the activation of anion
CC       channels at the plasma membrane, probably via auxin signaling
CC       (PubMed:21511872, PubMed:21511871, PubMed:16093319, PubMed:18397371,
CC       PubMed:12324610, PubMed:8528277, PubMed:9765547, PubMed:25721730).
CC       Required for the hypocotyl hook formation in darkness
CC       (PubMed:22855128). Involved in blue light-dependent stomatal opening,
CC       CHS gene expression, transpiration, inhibition of stem growth and
CC       increase of root growth, probably by regulating abscisic acid (ABA)
CC       (PubMed:22147516, PubMed:16093319, PubMed:16703358, PubMed:7756321,
CC       PubMed:9565033). Prevents lateral roots growth by inhibiting auxin
CC       transport (PubMed:20133010). Necessary for shade avoidance syndrome
CC       (SAS), characterized by leaf hyponasty and reduced lamina/petiole
CC       ratio, when exposed to blue light attenuation (PubMed:21457375).
CC       Together with phototropins, involved in phototropism regulation by
CC       various blue light fluence; blue light attenuates phototropism in high
CC       fluence rates (100 umol.m-2.s-1) but enhances phototropism in low
CC       fluence rates (<1.0 umol.m-2.s-1) (PubMed:12857830). Required for
CC       blue/UV-A wavelengths-mediated inhibition of explants shoot
CC       regeneration in vitro (e.g. new shoot apical meristems regeneration
CC       from excised cotyledons) (PubMed:22681544). Modulates anthocyanin
CC       accumulation in a PHYA-dependent manner in far-red-light. Acts as a
CC       PHYA/PHYB-dependent modulator of chlorophyll accumulation in red light.
CC       Contributes to most blue light deetiolation responses (PubMed:9733523,
CC       PubMed:8528277). May act as a chemical magnetoreceptor, via
CC       magnetically sensitive kinetics and quantum yields of photo-induced
CC       flavin / tryptophan radical pairs (PubMed:22421133). The effect of
CC       near-null magnetic field on flowering is altered by changes of blue
CC       light cycle and intensity in a CRY1/CRY2-dependent manner
CC       (PubMed:26095447). Involved in the strigolactone signaling that
CC       regulates hypocotyl growth in response to blue light (PubMed:24126495).
CC       Modulates temperature-dependent growth and physiology maintenance,
CC       especially at warm ambient temperatures, via HFR1-dependent activity
CC       (PubMed:21265897). {ECO:0000269|PubMed:12324610,
CC       ECO:0000269|PubMed:12857830, ECO:0000269|PubMed:16093319,
CC       ECO:0000269|PubMed:16703358, ECO:0000269|PubMed:17075038,
CC       ECO:0000269|PubMed:18397371, ECO:0000269|PubMed:19558423,
CC       ECO:0000269|PubMed:20133010, ECO:0000269|PubMed:20668058,
CC       ECO:0000269|PubMed:21265897, ECO:0000269|PubMed:21457375,
CC       ECO:0000269|PubMed:21467031, ECO:0000269|PubMed:21511871,
CC       ECO:0000269|PubMed:21511872, ECO:0000269|PubMed:21875594,
CC       ECO:0000269|PubMed:22147516, ECO:0000269|PubMed:22421133,
CC       ECO:0000269|PubMed:22681544, ECO:0000269|PubMed:22786870,
CC       ECO:0000269|PubMed:22855128, ECO:0000269|PubMed:23398192,
CC       ECO:0000269|PubMed:23511208, ECO:0000269|PubMed:24126495,
CC       ECO:0000269|PubMed:25157750, ECO:0000269|PubMed:25721730,
CC       ECO:0000269|PubMed:25728686, ECO:0000269|PubMed:26095447,
CC       ECO:0000269|PubMed:26313597, ECO:0000269|PubMed:26724867,
CC       ECO:0000269|PubMed:7756321, ECO:0000269|PubMed:8528277,
CC       ECO:0000269|PubMed:9565033, ECO:0000269|PubMed:9733523,
CC       ECO:0000269|PubMed:9765547, ECO:0000303|PubMed:21841916}.
CC   -!- FUNCTION: Implicated in promoting R protein-mediated resistance to
CC       Pseudomonas syringae pv. tomato (Pst.) DC3000 under continuous light
CC       conditions. Promotes systemic acquired resistance (SAR) and PR gene
CC       expression triggered by P. syringae. {ECO:0000269|PubMed:20053798}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:17073458, ECO:0000269|PubMed:7756321};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:17073458,
CC       ECO:0000269|PubMed:7756321};
CC   -!- COFACTOR:
CC       Name=(6R)-5,10-methylene-5,6,7,8-tetrahydrofolate;
CC         Xref=ChEBI:CHEBI:15636; Evidence={ECO:0000269|PubMed:7756321};
CC       Note=Binds 1 5,10-methenyltetrahydrofolate (MTHF) per subunit.
CC       {ECO:0000269|PubMed:7756321};
CC   -!- ACTIVITY REGULATION: Light exposure induces a conformational change in
CC       the C-terminal domain CCT1 required for activity.
CC       {ECO:0000269|PubMed:15751956}.
CC   -!- SUBUNIT: Homodimer. Interacts with ADO1, COP1 and PHYA. Interacts
CC       specifically with the dark/far-red (Pr) state of PHYB, but not with the
CC       red light-activated (Pfr) (PubMed:22577138). Interacts with PIF4 and
CC       PIF5 in the nucleus in response to low blue light (LBL)
CC       (PubMed:26724867). Binds to SPA1 and SPA4 in response to blue light,
CC       this interaction prevents SPA1/COP1 complex formation and thus avoid
CC       COP1-dependent degradation of the transcription factor HY5 by the
CC       proteasome and promotes hypocotyl elongation (PubMed:21511872,
CC       PubMed:21511871). Interacts with TCP2 (PubMed:26596765). Binding to ATP
CC       mediates conformational changes which facilitate flavin binding
CC       (PubMed:19327354, PubMed:17073458). {ECO:0000269|PubMed:11260718,
CC       ECO:0000269|PubMed:11509693, ECO:0000269|PubMed:11752373,
CC       ECO:0000269|PubMed:15299148, ECO:0000269|PubMed:15805487,
CC       ECO:0000269|PubMed:17073458, ECO:0000269|PubMed:19327354,
CC       ECO:0000269|PubMed:21511871, ECO:0000269|PubMed:21511872,
CC       ECO:0000269|PubMed:22577138, ECO:0000269|PubMed:26596765,
CC       ECO:0000269|PubMed:26724867, ECO:0000269|PubMed:9651577}.
CC   -!- INTERACTION:
CC       Q43125; P43254: COP1; NbExp=4; IntAct=EBI-300703, EBI-301649;
CC       Q43125; Q43125: CRY1; NbExp=6; IntAct=EBI-300703, EBI-300703;
CC       Q43125; P06593: PHYA3; Xeno; NbExp=2; IntAct=EBI-300703, EBI-630413;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18003924}. Nucleus
CC       {ECO:0000269|PubMed:15610358, ECO:0000269|PubMed:18003924,
CC       ECO:0000269|PubMed:26724867}. Nucleus, PML body
CC       {ECO:0000269|PubMed:21511872, ECO:0000269|PubMed:21765176}. Note=The
CC       nuclear pool is involved in hypocotyl and petiole growth inhibition and
CC       anthocyanin production, while the cytoplasmic pool is involved in root
CC       growth and cotyledon expansion (PubMed:18003924). Present in nuclear
CC       bodies (NBs) (PubMed:21511872, PubMed:21765176).
CC       {ECO:0000269|PubMed:18003924, ECO:0000269|PubMed:21511872,
CC       ECO:0000269|PubMed:21765176}.
CC   -!- TISSUE SPECIFICITY: Widely expressed (PubMed:8953250). Expressed in the
CC       aerial tissues (e.g. cotyledons and leaf primordia), but not detected
CC       in the roots (PubMed:11743105). {ECO:0000269|PubMed:11743105,
CC       ECO:0000269|PubMed:8953250}.
CC   -!- INDUCTION: Expression levels display circadian oscillations under
CC       constant conditions, with a high amplitude and an early phase, with
CC       maximal expression around 4-6 hours of the light phase. Induced by
CC       light (PubMed:11743105). Transcripts levels oscillate weakly and
CC       proportionally to temperature, but protein levels are stable, with
CC       higher levels at low temperature (12 degrees Celsius)
CC       (PubMed:23511208). Accumulates in response to low blue light (LBL)
CC       (PubMed:26724867). {ECO:0000269|PubMed:11743105,
CC       ECO:0000269|PubMed:23511208, ECO:0000269|PubMed:26724867}.
CC   -!- DOMAIN: The N-terminal domain CNT1 (1-489) is sufficient for
CC       autophosphorylation and is required for dimerization. The C-terminal
CC       domain CCT1 (490-681) of the homodimer binds to COP1.
CC   -!- PTM: Autophosphorylated; in response to blue light and when in complex
CC       with FAD cofactor (PubMed:12846824, PubMed:14523249, PubMed:9651577,
CC       PubMed:17073458). Kinase activity is optimal in the presence of
CC       magnesium ions, about 30 percent of the optimal activity in the
CC       presence of manganese ions, but inactive with calcium ions
CC       (PubMed:17073458). Adopts an open conformation when phosphorylated upon
CC       photoexcitation and thus interacts with signaling partner proteins
CC       (PubMed:21841916). {ECO:0000269|PubMed:12846824,
CC       ECO:0000269|PubMed:14523249, ECO:0000269|PubMed:17073458,
CC       ECO:0000269|PubMed:9651577, ECO:0000303|PubMed:21841916}.
CC   -!- DISRUPTION PHENOTYPE: Prevents the shortening of period at 27 degrees
CC       Celsius, resulting in a long period phenotype. The double mutant cry1
CC       cry2 is impaired in blue light signaling, resulting in long-period,
CC       lower-amplitude oscillations at 12 and 17 degrees Celsius and
CC       completely abolishing rhythms at 27 degrees Celsius (PubMed:23511208).
CC       Plants show reduced root and hypocotyl elongation in an anion channels
CC       activation-dependent manner at the plasma membrane, as well a reduced
CC       anthocyanin accumulation in blue light (PubMed:8528277,
CC       PubMed:12324610, PubMed:16703358, PubMed:21511871, PubMed:21511872,
CC       PubMed:9765547). Impaired blue/UV-A wavelengths-mediated inhibition of
CC       shoot regeneration (PubMed:22681544). Impaired detection of blue/green
CC       ratio in light leading to abnormal inhibition of hypocotyl growth
CC       (PubMed:20668058). Reduced attenuating effect of high fluence rates of
CC       blue light. This phenotype is stronger in the cry1 cry2 double mutant.
CC       Slow rate of curvature at low fluence rates of blue light in cry1 cry2
CC       (PubMed:12857830). Lower anthocyanin accumulation in the phyB cry1
CC       double mutant exposed to far-red light. Reduced chlorophyll levels in
CC       the phyB cry1 double mutant exposed to red light. In blue light,
CC       impaired cotyledon unfolding and smaller cotyledons, longer hypocotyls
CC       and less chlorophyll (PubMed:9733523). Impaired accumulation of
CC       reactive oxygen species (ROS) in double mutant cry1 cry2 exposed to
CC       high-intensity blue light (PubMed:25728686). Altered blue-light-
CC       triggered and singlet oxygen-mediated programmed cell death (PCD)
CC       (PubMed:17075038). The double mutant cry1 cry2 exhibits a reduced
CC       impact of near-null magnetic field on flowering in lower blue light
CC       intensity and short days (PubMed:26095447). Reduced hyponastic growth
CC       (differential growth-driven upward leaf movement) in low blue light
CC       fluence (PubMed:19558423). The double mutant cry1 cry2 is hyposensitive
CC       to the strigolactone analog GR24 (PubMed:24126495). The mutant cry1
CC       exposed to a background of red light show severely impaired stomatal
CC       opening responses to blue light. The double mutant cry1 cry2 has
CC       reduced stomatal conductance, transpiration, and photosynthesis,
CC       particularly under the high irradiance of full sunlight at midday,
CC       associated with elevated abscisic acid levels (PubMed:22147516). The
CC       cry1 mutants grown in complete darkness have premature opening of the
CC       hypocotyl hook (PubMed:22855128). Reduced expression of nuclear genes
CC       encoding photoprotective components in response to extreme high light
CC       (PubMed:22786870). Reduced shade avoidance syndrome (SAS) when exposed
CC       to blue light attenuation (PubMed:21457375). Reduced growth at warm
CC       ambient temperatures (PubMed:21265897). Down-regulated local resistance
CC       and systemic acquired resistance (SAR) to Pseudomonas syringae pv.
CC       tomato (Pst.) DC3000 under continuous light conditions, leading to
CC       pathogen proliferation (PubMed:20053798). When grown in blue light,
CC       increased growth of lateral roots and reduced sensitivity to auxin
CC       (IAA) on this phenotype (PubMed:20133010).
CC       {ECO:0000269|PubMed:12324610, ECO:0000269|PubMed:12857830,
CC       ECO:0000269|PubMed:16703358, ECO:0000269|PubMed:17075038,
CC       ECO:0000269|PubMed:19558423, ECO:0000269|PubMed:20053798,
CC       ECO:0000269|PubMed:20133010, ECO:0000269|PubMed:20668058,
CC       ECO:0000269|PubMed:21265897, ECO:0000269|PubMed:21457375,
CC       ECO:0000269|PubMed:21511871, ECO:0000269|PubMed:21511872,
CC       ECO:0000269|PubMed:22147516, ECO:0000269|PubMed:22681544,
CC       ECO:0000269|PubMed:22786870, ECO:0000269|PubMed:22855128,
CC       ECO:0000269|PubMed:23511208, ECO:0000269|PubMed:24126495,
CC       ECO:0000269|PubMed:25728686, ECO:0000269|PubMed:26095447,
CC       ECO:0000269|PubMed:8528277, ECO:0000269|PubMed:9733523,
CC       ECO:0000269|PubMed:9765547}.
CC   -!- SIMILARITY: Belongs to the DNA photolyase class-1 family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to be a DNA photolyase.
CC       {ECO:0000305|PubMed:8232555}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB28725.2; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAD17364.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAB78016.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S66907; AAB28724.1; -; mRNA.
DR   EMBL; S66909; AAB28725.2; ALT_FRAME; mRNA.
DR   EMBL; AF128396; AAD17364.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL161513; CAB78016.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002687; AEE82696.1; -; Genomic_DNA.
DR   EMBL; AF361588; AAK32756.1; -; mRNA.
DR   EMBL; AY124863; AAM70572.1; -; mRNA.
DR   PIR; H85089; H85089.
DR   PIR; S39058; S39058.
DR   RefSeq; NP_567341.1; NM_116961.5.
DR   PDB; 1U3C; X-ray; 2.60 A; A=1-509.
DR   PDB; 1U3D; X-ray; 2.45 A; A=1-509.
DR   PDB; 6QTW; X-ray; 1.39 A; B=544-553.
DR   PDBsum; 1U3C; -.
DR   PDBsum; 1U3D; -.
DR   PDBsum; 6QTW; -.
DR   SMR; Q43125; -.
DR   BioGRID; 11769; 7.
DR   IntAct; Q43125; 3.
DR   MINT; Q43125; -.
DR   STRING; 3702.AT4G08920.1; -.
DR   iPTMnet; Q43125; -.
DR   PaxDb; Q43125; -.
DR   PRIDE; Q43125; -.
DR   ProteomicsDB; 224510; -.
DR   EnsemblPlants; AT4G08920.1; AT4G08920.1; AT4G08920.
DR   GeneID; 826470; -.
DR   Gramene; AT4G08920.1; AT4G08920.1; AT4G08920.
DR   KEGG; ath:AT4G08920; -.
DR   Araport; AT4G08920; -.
DR   TAIR; locus:2138728; AT4G08920.
DR   eggNOG; KOG0133; Eukaryota.
DR   HOGENOM; CLU_010348_5_0_1; -.
DR   InParanoid; Q43125; -.
DR   OMA; IHNRPRQ; -.
DR   OrthoDB; 378952at2759; -.
DR   EvolutionaryTrace; Q43125; -.
DR   PRO; PR:Q43125; -.
DR   Proteomes; UP000006548; Chromosome 4.
DR   ExpressionAtlas; Q43125; baseline and differential.
DR   Genevisible; Q43125; AT.
DR   GO; GO:0005737; C:cytoplasm; IDA:TAIR.
DR   GO; GO:0005829; C:cytosol; HDA:TAIR.
DR   GO; GO:0016604; C:nuclear body; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0009882; F:blue light photoreceptor activity; IDA:TAIR.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0016301; F:kinase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:TAIR.
DR   GO; GO:0046283; P:anthocyanin-containing compound metabolic process; IMP:UniProtKB.
DR   GO; GO:0060918; P:auxin transport; IMP:UniProtKB.
DR   GO; GO:0009785; P:blue light signaling pathway; TAS:TAIR.
DR   GO; GO:0010617; P:circadian regulation of calcium ion oscillation; IMP:TAIR.
DR   GO; GO:0032922; P:circadian regulation of gene expression; IBA:GO_Central.
DR   GO; GO:0007623; P:circadian rhythm; IEP:UniProtKB.
DR   GO; GO:0006952; P:defense response; IEA:UniProtKB-KW.
DR   GO; GO:0009583; P:detection of light stimulus; IMP:TAIR.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; IBA:GO_Central.
DR   GO; GO:0072387; P:flavin adenine dinucleotide metabolic process; IDA:UniProtKB.
DR   GO; GO:1901332; P:negative regulation of lateral root development; IMP:UniProtKB.
DR   GO; GO:0009640; P:photomorphogenesis; IMP:TAIR.
DR   GO; GO:0010117; P:photoprotection; IMP:UniProtKB.
DR   GO; GO:0009638; P:phototropism; IMP:UniProtKB.
DR   GO; GO:0099402; P:plant organ development; IMP:UniProtKB.
DR   GO; GO:1901529; P:positive regulation of anion channel activity; IMP:UniProtKB.
DR   GO; GO:1900426; P:positive regulation of defense response to bacterium; IMP:UniProtKB.
DR   GO; GO:1902448; P:positive regulation of shade avoidance; IMP:UniProtKB.
DR   GO; GO:1901672; P:positive regulation of systemic acquired resistance; IMP:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IMP:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:TAIR.
DR   GO; GO:0010310; P:regulation of hydrogen peroxide metabolic process; IDA:UniProtKB.
DR   GO; GO:1901371; P:regulation of leaf morphogenesis; IMP:UniProtKB.
DR   GO; GO:0010075; P:regulation of meristem growth; IGI:TAIR.
DR   GO; GO:2000377; P:regulation of reactive oxygen species metabolic process; IDA:UniProtKB.
DR   GO; GO:2000652; P:regulation of secondary cell wall biogenesis; IDA:TAIR.
DR   GO; GO:0051510; P:regulation of unidimensional cell growth; IMP:TAIR.
DR   GO; GO:0009646; P:response to absence of light; IMP:UniProtKB.
DR   GO; GO:0009637; P:response to blue light; IDA:UniProtKB.
DR   GO; GO:0010218; P:response to far red light; IMP:UniProtKB.
DR   GO; GO:0009644; P:response to high light intensity; IMP:UniProtKB.
DR   GO; GO:0009416; P:response to light stimulus; IDA:UniProtKB.
DR   GO; GO:0010244; P:response to low fluence blue light stimulus by blue low-fluence system; IMP:UniProtKB.
DR   GO; GO:0071000; P:response to magnetism; IDA:UniProtKB.
DR   GO; GO:0010114; P:response to red light; IMP:UniProtKB.
DR   GO; GO:1902347; P:response to strigolactone; IMP:UniProtKB.
DR   GO; GO:0009414; P:response to water deprivation; IGI:TAIR.
DR   GO; GO:0010343; P:singlet oxygen-mediated programmed cell death; IMP:TAIR.
DR   GO; GO:0010118; P:stomatal movement; IMP:UniProtKB.
DR   DisProt; DP00474; -.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR036134; Crypto/Photolyase_FAD-like_sf.
DR   InterPro; IPR036155; Crypto/Photolyase_N_sf.
DR   InterPro; IPR005101; Cryptochr/Photolyase_FAD-bd.
DR   InterPro; IPR002081; Cryptochrome/DNA_photolyase_1.
DR   InterPro; IPR020978; Cryptochrome_C.
DR   InterPro; IPR014134; Cryptochrome_pln.
DR   InterPro; IPR018394; DNA_photolyase_1_CS_C.
DR   InterPro; IPR006050; DNA_photolyase_N.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF12546; Cryptochrome_C; 1.
DR   Pfam; PF00875; DNA_photolyase; 1.
DR   Pfam; PF03441; FAD_binding_7; 1.
DR   PRINTS; PR00147; DNAPHOTLYASE.
DR   SUPFAM; SSF48173; SSF48173; 1.
DR   SUPFAM; SSF52425; SSF52425; 1.
DR   TIGRFAMs; TIGR02766; crypt_chrom_pln; 1.
DR   PROSITE; PS00394; DNA_PHOTOLYASES_1_1; 1.
DR   PROSITE; PS00691; DNA_PHOTOLYASES_1_2; 1.
DR   PROSITE; PS51645; PHR_CRY_ALPHA_BETA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; ATP-binding; Chromophore; Cytoplasm;
KW   Disulfide bond; FAD; Flavoprotein; Magnesium; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Photoreceptor protein;
KW   Plant defense; Receptor; Reference proteome; Sensory transduction.
FT   CHAIN           1..681
FT                   /note="Cryptochrome-1"
FT                   /id="PRO_0000085121"
FT   DOMAIN          12..141
FT                   /note="Photolyase/cryptochrome alpha/beta"
FT                   /evidence="ECO:0000255"
FT   NP_BIND         247..251
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15299148,
FT                   ECO:0007744|PDB:1U3C, ECO:0007744|PDB:1U3D"
FT   NP_BIND         359..360
FT                   /note="ATP"
FT                   /evidence="ECO:0000269|PubMed:15299148,
FT                   ECO:0007744|PDB:1U3D"
FT   NP_BIND         390..392
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15299148,
FT                   ECO:0007744|PDB:1U3C, ECO:0007744|PDB:1U3D"
FT   REGION          1..489
FT                   /note="CNT1, binds chromophores to sense blue light and
FT                   mediate CRY dimerization"
FT                   /evidence="ECO:0000303|PubMed:25721730"
FT   REGION          490..681
FT                   /note="CCT1/CCE1, mediates blue light signaling"
FT                   /evidence="ECO:0000269|PubMed:11114337,
FT                   ECO:0000303|PubMed:25721730"
FT   REGION          525..598
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          616..664
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        525..540
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        580..598
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        616..631
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        646..664
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   METAL           238
FT                   /note="Magnesium 1; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:15299148,
FT                   ECO:0007744|PDB:1U3C"
FT   METAL           241
FT                   /note="Magnesium 2; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:15299148,
FT                   ECO:0007744|PDB:1U3C"
FT   METAL           244
FT                   /note="Magnesium 2"
FT                   /evidence="ECO:0000269|PubMed:15299148,
FT                   ECO:0007744|PDB:1U3C, ECO:0007744|PDB:1U3D"
FT   METAL           246
FT                   /note="Magnesium 1"
FT                   /evidence="ECO:0000269|PubMed:15299148,
FT                   ECO:0007744|PDB:1U3C"
FT   METAL           246
FT                   /note="Magnesium 2"
FT                   /evidence="ECO:0000269|PubMed:15299148,
FT                   ECO:0007744|PDB:1U3C, ECO:0007744|PDB:1U3D"
FT   METAL           358
FT                   /note="Magnesium 1; via tele nitrogen"
FT                   /evidence="ECO:0000269|PubMed:15299148,
FT                   ECO:0007744|PDB:1U3C"
FT   BINDING         235
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15299148,
FT                   ECO:0007744|PDB:1U3C, ECO:0007744|PDB:1U3D"
FT   BINDING         239
FT                   /note="ATP"
FT                   /evidence="ECO:0000269|PubMed:15299148,
FT                   ECO:0007744|PDB:1U3D"
FT   BINDING         293
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:15299148,
FT                   ECO:0007744|PDB:1U3D"
FT   BINDING         359
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15299148,
FT                   ECO:0007744|PDB:1U3C, ECO:0007744|PDB:1U3D"
FT   BINDING         409
FT                   /note="ATP"
FT                   /evidence="ECO:0000269|PubMed:15299148,
FT                   ECO:0007744|PDB:1U3D"
FT   SITE            324
FT                   /note="Involved in electron transfer from the protein
FT                   surface to the FAD cofactor"
FT                   /evidence="ECO:0000269|PubMed:26313597,
FT                   ECO:0000303|PubMed:22421133"
FT   SITE            377
FT                   /note="Involved in electron transfer from the protein
FT                   surface to the FAD cofactor"
FT                   /evidence="ECO:0000303|PubMed:22421133"
FT   SITE            400
FT                   /note="Involved in electron transfer from the protein
FT                   surface to the FAD cofactor"
FT                   /evidence="ECO:0000269|PubMed:26313597,
FT                   ECO:0000303|PubMed:22421133"
FT   MOD_RES         616
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96524"
FT   MOD_RES         621
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96524"
FT   DISULFID        80..190
FT                   /evidence="ECO:0000269|PubMed:15299148,
FT                   ECO:0007744|PDB:1U3C, ECO:0007744|PDB:1U3D"
FT   MUTAGEN         21
FT                   /note="D->N: In cry1-401; genomes uncoupled mutant (gun)
FT                   with defects in plastid-to-nucleus signaling."
FT                   /evidence="ECO:0000269|PubMed:18065688"
FT   MUTAGEN         66
FT                   /note="S->N: Loss of dimerization and activity. Abnormal
FT                   hypocotyl elongation in blue light."
FT                   /evidence="ECO:0000269|PubMed:15805487,
FT                   ECO:0000269|PubMed:25721730"
FT   MUTAGEN         220
FT                   /note="G->D: In hy4-6; reduced anthocyanin accumulation and
FT                   abnormal hypocotyl elongation in blue light."
FT                   /evidence="ECO:0000269|PubMed:25721730,
FT                   ECO:0000269|PubMed:8528277"
FT   MUTAGEN         283
FT                   /note="G->E: In hy4-5; reduced anthocyanin accumulation and
FT                   abnormal hypocotyl elongation in blue light."
FT                   /evidence="ECO:0000269|PubMed:25721730,
FT                   ECO:0000269|PubMed:8528277"
FT   MUTAGEN         286
FT                   /note="S->N: In cry1-402; genomes uncoupled mutant (gun)
FT                   with defects in plastid-to-nucleus signaling."
FT                   /evidence="ECO:0000269|PubMed:18065688"
FT   MUTAGEN         324
FT                   /note="W->F: Impaired photoreduction in vitro, but not in
FT                   vivo or in whole cell extracts, due to an alternative
FT                   electron transport that involves small metabolites.
FT                   Abolished intra-protein electron transfer cascade and
FT                   impaired conformational change upon photoexcitation."
FT                   /evidence="ECO:0000269|PubMed:21875594,
FT                   ECO:0000269|PubMed:26313597"
FT   MUTAGEN         337
FT                   /note="G->D: Abnormal hypocotyl elongation in blue light."
FT                   /evidence="ECO:0000269|PubMed:25721730"
FT   MUTAGEN         340
FT                   /note="G->E: In cry1-404 and hy4-1; reduced anthocyanin
FT                   accumulation and abnormal hypocotyl elongation in blue
FT                   light. Loss of activity. Genomes uncoupled mutant (gun)
FT                   with defects in plastid-to-nucleus signaling."
FT                   /evidence="ECO:0000269|PubMed:18065688,
FT                   ECO:0000269|PubMed:25721730, ECO:0000269|PubMed:8528277,
FT                   ECO:0000269|PubMed:9565033"
FT   MUTAGEN         347
FT                   /note="G->E: In hy4-16; reduced anthocyanin accumulation
FT                   and abnormal hypocotyl elongation in blue light."
FT                   /evidence="ECO:0000269|PubMed:25721730,
FT                   ECO:0000269|PubMed:8528277"
FT   MUTAGEN         347
FT                   /note="G->R: In hy4-15; reduced anthocyanin accumulation
FT                   and abnormal hypocotyl elongation in blue light. Loss of
FT                   dimerization and activity."
FT                   /evidence="ECO:0000269|PubMed:15805487,
FT                   ECO:0000269|PubMed:25721730, ECO:0000269|PubMed:8528277"
FT   MUTAGEN         380
FT                   /note="G->R: Constitutive light response."
FT                   /evidence="ECO:0000269|PubMed:21765176"
FT   MUTAGEN         396
FT                   /note="D->N: Upon illumination, formation of the reduced
FT                   anionic flavin (RED) flavin, useful for DNA repair, rather
FT                   than the semi-reduced radical form (SR) flavin, which is
FT                   correlated with cryptochrome activity."
FT                   /evidence="ECO:0000269|PubMed:22890584"
FT   MUTAGEN         400
FT                   /note="W->F: Impaired photoreduction in vitro, but not in
FT                   vivo or whole cell extracts, due to an alternative electron
FT                   transport that involves small metabolites."
FT                   /evidence="ECO:0000269|PubMed:26313597"
FT   MUTAGEN         407
FT                   /note="L->F: Gain of function mutant. Hypersensitive toward
FT                   blue, red, and far-red light in hypocotyl growth
FT                   inhibition. Very early flowering in short-day conditions,
FT                   associated with enhanced expression of CO and FT. Impaired
FT                   interaction with PHYB."
FT                   /evidence="ECO:0000269|PubMed:20926618,
FT                   ECO:0000269|PubMed:22577138"
FT   MUTAGEN         462
FT                   /note="A->V: Loss of dimerization and activity. Abnormal
FT                   hypocotyl elongation in blue light."
FT                   /evidence="ECO:0000269|PubMed:15805487,
FT                   ECO:0000269|PubMed:25721730"
FT   MUTAGEN         515
FT                   /note="E->K: In hy4-19; reduced anthocyanin accumulation
FT                   and abnormal hypocotyl elongation in blue light."
FT                   /evidence="ECO:0000269|PubMed:8528277"
FT   MUTAGEN         531
FT                   /note="E->K: In hy4-20; reduced anthocyanin accumulation
FT                   and abnormal hypocotyl elongation in blue light."
FT                   /evidence="ECO:0000269|PubMed:8528277"
FT   MUTAGEN         549
FT                   /note="P->L: In hy4-9; reduced anthocyanin accumulation and
FT                   abnormal hypocotyl elongation in blue light."
FT                   /evidence="ECO:0000269|PubMed:8528277"
FT   MUTAGEN         559
FT                   /note="E->K: In hy4-22; reduced anthocyanin accumulation
FT                   and abnormal hypocotyl elongation in blue light."
FT                   /evidence="ECO:0000269|PubMed:8528277"
FT   MUTAGEN         576
FT                   /note="R->K: In hy4-10; reduced anthocyanin accumulation
FT                   and abnormal hypocotyl elongation in blue light."
FT                   /evidence="ECO:0000269|PubMed:8528277"
FT   MUTAGEN         581
FT                   /note="R->K: In hy4-23; reduced anthocyanin accumulation
FT                   and abnormal hypocotyl elongation in blue light."
FT                   /evidence="ECO:0000269|PubMed:8528277"
FT   MUTAGEN         611
FT                   /note="R->K: In hy4-24; reduced anthocyanin accumulation
FT                   and abnormal hypocotyl elongation in blue light."
FT                   /evidence="ECO:0000269|PubMed:8528277"
FT   MUTAGEN         623
FT                   /note="E->K: In cry1-403; genomes uncoupled mutant (gun)
FT                   with defects in plastid-to-nucleus signaling."
FT                   /evidence="ECO:0000269|PubMed:18065688"
FT   CONFLICT        40
FT                   /note="I -> N (in Ref. 4; AAK32756)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        654
FT                   /note="G -> R (in Ref. 1; AAB28724)"
FT                   /evidence="ECO:0000305"
FT   STRAND          14..20
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   STRAND          24..26
FT                   /evidence="ECO:0007829|PDB:1U3C"
FT   HELIX           28..36
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   STRAND          39..45
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           47..50
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           57..76
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   STRAND          81..85
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           89..100
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   STRAND          104..108
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           113..127
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   TURN            128..130
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   STRAND          132..136
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           144..146
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   STRAND          150..152
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           158..166
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           187..189
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           200..206
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           209..212
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           217..228
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           231..234
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   TURN            235..240
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   STRAND          242..244
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           251..255
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           261..278
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           281..305
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   TURN            308..312
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   TURN            318..321
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           328..336
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           342..354
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           359..371
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           377..387
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           393..404
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           419..426
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           431..436
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           438..440
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           445..448
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   TURN            451..453
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           456..462
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   TURN            467..469
FT                   /evidence="ECO:0007829|PDB:1U3D"
FT   HELIX           477..495
FT                   /evidence="ECO:0007829|PDB:1U3D"
SQ   SEQUENCE   681 AA;  76695 MW;  372A7E6DDC2AC076 CRC64;
     MSGSVSGCGS GGCSIVWFRR DLRVEDNPAL AAAVRAGPVI ALFVWAPEEE GHYHPGRVSR
     WWLKNSLAQL DSSLRSLGTC LITKRSTDSV ASLLDVVKST GASQIFFNHL YDPLSLVRDH
     RAKDVLTAQG IAVRSFNADL LYEPWEVTDE LGRPFSMFAA FWERCLSMPY DPESPLLPPK
     KIISGDVSKC VADPLVFEDD SEKGSNALLA RAWSPGWSNG DKALTTFING PLLEYSKNRR
     KADSATTSFL SPHLHFGEVS VRKVFHLVRI KQVAWANEGN EAGEESVNLF LKSIGLREYS
     RYISFNHPYS HERPLLGHLK FFPWAVDENY FKAWRQGRTG YPLVDAGMRE LWATGWLHDR
     IRVVVSSFFV KVLQLPWRWG MKYFWDTLLD ADLESDALGW QYITGTLPDS REFDRIDNPQ
     FEGYKFDPNG EYVRRWLPEL SRLPTDWIHH PWNAPESVLQ AAGIELGSNY PLPIVGLDEA
     KARLHEALSQ MWQLEAASRA AIENGSEEGL GDSAEVEEAP IEFPRDITME ETEPTRLNPN
     RRYEDQMVPS ITSSLIRPEE DEESSLNLRN SVGDSRAEVP RNMVNTNQAQ QRRAEPASNQ
     VTAMIPEFNI RIVAESTEDS TAESSSSGRR ERSGGIVPEW SPGYSEQFPS EENGIGGGST
     TSSYLQNHHE ILNWRRLSQT G
//
